PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brink-Jensen, K; Bak, S; Jorgensen, K; Ekstrom, CT				Brink-Jensen, Kasper; Bak, Soren; Jorgensen, Kirsten; Ekstrom, Claus Thorn			Integrative Analysis of Metabolomics and Transcriptomics Data: A Unified Model Framework to Identify Underlying System Pathways	PLOS ONE			English	Article							GENE-EXPRESSION; PARAFAC; SELECTION; NUMBER	The abundance of high-dimensional measurements in the form of gene expression and mass spectroscopy calls for models to elucidate the underlying biological system. For widely studied organisms like yeast, it is possible to incorporate prior knowledge from a variety of databases, an approach used in several recent studies. However if such information is not available for a particular organism these methods fall short. In this paper we propose a statistical method that is applicable to a dataset consisting of Liquid Chromatography-Mass Spectroscopy (LC-MS) and gene expression (DNA microarray) measurements from the same samples, to identify genes controlling the production of metabolites. Due to the high dimensionality of both LC-MS and DNA microarray data, dimension reduction and variable selection are key elements of the analysis. Our proposed approach starts by identifying the basis functions ("building blocks") that constitute the output from a mass spectrometry experiment. Subsequently, the weights of these basis functions are related to the observations from the corresponding gene expression data in order to identify which genes are associated with specific patterns seen in the metabolite data. The modeling framework is extremely flexible as well as computationally fast and can accommodate treatment effects and other variables related to the experimental design. We demonstrate that within the proposed framework, genes regulating the production of specific metabolites can be identified correctly unless the variation in the noise is more than twice that of the signal.	[Brink-Jensen, Kasper] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Bak, Soren; Jorgensen, Kirsten] Univ Copenhagen, Dept Plant Biol & Biotechnol, Copenhagen, Denmark; [Ekstrom, Claus Thorn] Univ Southern Denmark, Dept Biostat, Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark	Brink-Jensen, K (corresponding author), Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark.	kbrink@life.ku.dk	Bak, Soren/H-4404-2014; jørgensen, kirsten/H-4346-2014	Bak, Soren/0000-0003-4100-115X; jørgensen, kirsten/0000-0003-2855-7735; Ekstrom, Claus Thorn/0000-0003-1191-373X	University of Copenhagen	University of Copenhagen	Funding was provided by the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Andersen MD, 2000, J BIOL CHEM, V275, P1966, DOI 10.1074/jbc.275.3.1966; Antikainen J, 2011, PARALLEL DISTRIBUTED, V22, P1; Bondell HD, 2008, BIOMETRICS, V64, P115, DOI 10.1111/j.1541-0420.2007.00843.x; Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fagan A, 2007, PROTEOMICS, V7, P2162, DOI 10.1002/pmic.200600898; HARSHMAN RA, 1994, COMPUT STAT DATA AN, V18, P39, DOI 10.1016/0167-9473(94)90132-5; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Hoggard JC, 2007, ANAL CHEM, V79, P1611, DOI 10.1021/ac061710b; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li Z, 2004, J BIOL CHEM, V279, P27124, DOI 10.1074/jbc.M403494200; Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212; Sakurai T, 2013, PLANT CELL PHYSIOL, V54, pE5, DOI 10.1093/pcp/pcs184; Smilde A, 2004, MULTI WAY ANALYSIS W, V978; Smolka B, 2005, LECT NOTES COMPUT SC, V3656, P990, DOI 10.1007/11559573_120; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Su G, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S36; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Witting amd M, 2012, PLOS ONE; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0	23	11	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e72116	10.1371/journal.pone.0072116	http://dx.doi.org/10.1371/journal.pone.0072116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086255	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700003
J	Afeli, SAY; Malysz, J; Petkov, GV				Afeli, Serge A. Y.; Malysz, John; Petkov, Georgi V.			Molecular Expression and Pharmacological Evidence for a Functional Role of Kv7 Channel Subtypes in Guinea Pig Urinary Bladder Smooth Muscle	PLOS ONE			English	Article							POTASSIUM CHANNELS; K(V)7 CHANNELS; K+ CHANNEL; KCNQ; ACTIVATION; EXCITABILITY; RETIGABINE; CONTRACTILITY; TARGETS; CELLS	Voltage-gated Kv7 (KCNQ) channels are emerging as essential regulators of smooth muscle excitability and contractility. However, their physiological role in detrusor smooth muscle (DSM) remains to be elucidated. Here, we explored the molecular expression and function of Kv7 channel subtypes in guinea pig DSM by RT-PCR, qRT-PCR, immunohistochemistry, electrophysiology, and isometric tension recordings. In whole DSM tissue, mRNAs for all Kv7 channel subtypes were detected in a rank order: Kv7.1 similar to Kv7.2Kv7.3 similar to Kv7.5Kv7.4. In contrast, freshly-isolated DSM cells showed mRNA expression of: Kv7.1 similar to Kv7.2Kv7.5Kv7.3 similar to Kv7.4. Immunohistochemical confocal microscopy analyses of DSM, conducted by using co-labeling of Kv7 channel subtype-specific antibodies and alpha-smooth muscle actin, detected protein expression for all Kv7 channel subtypes, except for the Kv7.4, in DSM cells. L-364373 (R-L3), a Kv7.1 channel activator, and retigabine, a Kv7.2-7.5 channel activator, inhibited spontaneous phasic contractions and the 10-Hz electrical field stimulation (EFS)-induced contractions of DSM isolated strips. Linopiridine and XE991, two pan-Kv7 (effective at Kv7.1-Kv7.5 subtypes) channel inhibitors, had opposite effects increasing DSM spontaneous phasic and 10 Hz EFS-induced contractions. EFS-induced DSM contractions generated by a wide range of stimulation frequencies were decreased by L-364373 (10 mu M) or retigabine (10 mu M), and increased by XE991 (10 mu M). Retigabine (10 mu M) induced hyperpolarization and inhibited spontaneous action potentials in freshly-isolated DSM cells. In summary, Kv7 channel subtypes are expressed at mRNA and protein levels in guinea pig DSM cells. Their pharmacological modulation can control DSM contractility and excitability; therefore, Kv7 channel subtypes provide potential novel therapeutic targets for urinary bladder dysfunction.	[Afeli, Serge A. Y.; Malysz, John; Petkov, Georgi V.] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA	Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Petkov, GV (corresponding author), Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA.	petkov@cop.sc.edu			National Institutes of Health [DK084284]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health DK084284 to Georgi V. Petkov. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott G W, 2001, Mol Interv, V1, P95; Afeli SAY, 2012, AM J PHYSIOL-RENAL, V303, pF559, DOI 10.1152/ajprenal.00615.2011; Afeli SAY, 2012, AM J PHYSIOL-RENAL, V302, pF251, DOI 10.1152/ajprenal.00378.2011; Anderson UA, 2013, BRIT J PHARMACOL, V169, P1290, DOI 10.1111/bph.12210; Anderson UA, 2009, J UROLOGY, V182, P330, DOI 10.1016/j.juro.2009.02.108; Andersson KE, 2004, PHARMACOL REV, V56, P581, DOI 10.1124/pr.56.4.4; Argentieri TM, 2006, METHODS SELECTING CO; Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Brickel N, 2012, EPILEPSIA, V53, P606, DOI 10.1111/j.1528-1167.2012.03441.x; Brown BS, 2000, PROG BIOPHYS MOL BIO, V73, P135, DOI 10.1016/S0079-6107(00)00004-3; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Brueggemann LI, 2012, AM J PHYSIOL-LUNG C, V302, pL120, DOI 10.1152/ajplung.00194.2011; Brueggemann LI, 2011, MOL PHARMACOL, V79, P10, DOI 10.1124/mol.110.067496; Chadha PS, 2012, BRIT J PHARMACOL, V166, P1377, DOI 10.1111/j.1476-5381.2012.01863.x; Chen MY, 2009, J UROLOGY, V182, P374, DOI 10.1016/j.juro.2009.02.109; Davies AM, 2002, J UROLOGY, V167, P1881, DOI 10.1016/S0022-5347(05)65254-8; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hashitani H, 2003, BRIT J PHARMACOL, V140, P159, DOI 10.1038/sj.bjp.0705320; Heppner TJ, 2011, AM J PHYSIOL-REG I, V301, pR351, DOI 10.1152/ajpregu.00656.2010; Heppner TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC110; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Hristov KL, 2012, AM J PHYSIOL-CELL PH, V302, pC1599, DOI 10.1152/ajpcell.00447.2011; Hristov KL, 2012, AM J PHYSIOL-CELL PH, V302, pC360, DOI 10.1152/ajpcell.00303.2010; Ipavec V, 2011, PHARMACOL RES, V64, P397, DOI 10.1016/j.phrs.2011.06.016; Jepps TA, 2013, BRIT J PHARMACOL, V168, P19, DOI 10.1111/j.1476-5381.2012.02133.x; Jepps TA, 2011, CIRCULATION, V124, P602, DOI 10.1161/CIRCULATIONAHA.111.032136; Jepps TA, 2009, AM J PHYSIOL-GASTR L, V297, pG107, DOI 10.1152/ajpgi.00057.2009; Layne JJ, 2010, AM J PHYSIOL-REG I, V298, pR378, DOI 10.1152/ajpregu.00458.2009; Mackie AR, 2008, MOL PHARMACOL, V74, P1171, DOI 10.1124/mol.108.049825; Mani BK, 2013, J CARDIOVASC PHARM, V61, P51, DOI 10.1097/FJC.0b013e3182771708; Mani BK, 2011, BRIT J PHARMACOL, V164, P237, DOI 10.1111/j.1476-5381.2011.01273.x; McCallum LA, 2011, J CELL MOL MED, V15, P577, DOI 10.1111/j.1582-4934.2010.01021.x; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Navarro-Lopez J, 2009, J MOL NEUROSCI, V37, P263, DOI 10.1007/s12031-008-9130-2; Ng FL, 2011, BRIT J PHARMACOL, V162, P42, DOI 10.1111/j.1476-5381.2010.01027.x; Ohya S, 2002, AM J PHYSIOL-GASTR L, V282, pG277, DOI 10.1152/ajpgi.00200.2001; Ohya Susumu, 2000, Journal of Smooth Muscle Research, V36, P101, DOI 10.1540/jsmr.36.101; Orhan G, 2012, EXPERT OPIN PHARMACO, V13, P1807, DOI 10.1517/14656566.2012.706278; Parajuli SP, 2012, J PHARMACOL EXP THER, V340, P114, DOI 10.1124/jpet.111.186213; Petkov GV, 2012, NAT REV UROL, V9, P30, DOI 10.1038/nrurol.2011.194; Petkov GV, 2001, AM J PHYSIOL-REG I, V280, pR1427, DOI 10.1152/ajpregu.2001.280.5.R1427; Rode F, 2010, EUR J PHARMACOL, V638, P121, DOI 10.1016/j.ejphar.2010.03.050; Smith AC, 2013, AM J PHYSIOL-CELL PH, V304, pC467, DOI 10.1152/ajpcell.00169.2012; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Streng T, 2004, J UROLOGY, V172, P2054, DOI 10.1097/01.ju.0000138155.33749.f4; Sui G, 2009, CELL CALCIUM, V45, P456, DOI 10.1016/j.ceca.2009.03.001; Svalo J, 2013, EUR J PHARMACOL, V715, P312, DOI 10.1016/j.ejphar.2013.05.005; Svalo J, 2012, BASIC CLIN PHARMACOL, V110, P145, DOI 10.1111/j.1742-7843.2011.00765.x; Thorneloe KS, 2003, J PHYSIOL-LONDON, V549, P65, DOI 10.1113/jphysiol.2003.039859; Wickenden AD, 2001, BRIT J PHARMACOL, V132, P381, DOI 10.1038/sj.bjp.0703861; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Xin WK, 2012, AM J PHYSIOL-CELL PH, V302, pC1361, DOI 10.1152/ajpcell.00432.2011; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Yeung SYM, 2008, BRIT J PHARMACOL, V155, P62, DOI 10.1038/bjp.2008.231; Yeung SYM, 2007, BRIT J PHARMACOL, V151, P758, DOI 10.1038/sj.bjp.0707284; Yeung SYM, 2008, BIOCHEM BIOPH RES CO, V371, P741, DOI 10.1016/j.bbrc.2008.04.129; Yeung SYM, 2005, BRIT J PHARMACOL, V146, P585, DOI 10.1038/sj.bjp.0706342; Zhong XZ, 2010, J PHYSIOL-LONDON, V588, P3277, DOI 10.1113/jphysiol.2010.192823	60	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75875	10.1371/journal.pone.0075875	http://dx.doi.org/10.1371/journal.pone.0075875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073284	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000094
J	Chang, SLY; Chou, RH; Zeng, HJ; Lin, YH; Chiu, TY; Yang, DM; Hung, SC; Lai, CH; Hsieh, JT; Shyu, WC; Yu, YL				Chang, Sunny Li-Yun; Chou, Ruey-Hwang; Zeng, Hong-Jie; Lin, Yu-Hsuan; Chiu, Tai-Yu; Yang, De-Ming; Hung, Shih-Chieh; Lai, Chih-Ho; Hsieh, Jer-Tsong; Shyu, Woei-Cherng; Yu, Yung-Luen			Downregulation of DAB2IP Promotes Mesenchymal-To-Neuroepithelial Transition and Neuronal Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							PROTEIN HDAB2IP GENE; NEURITE OUTGROWTH; SIGNALING PATHWAY; MOUSE; METHYLATION; DISABLED-1; SCRAMBLER; REELIN; CANCER; BRAIN	The DOC-2/DAB2 interactive protein (DAB2IP) is a new member of the Ras GTPase-activating protein family. Recent studies have shown that, in addition to its tumor suppressive role in various tumors, DAB2IP also plays an important role in regulating neuronal migration and positioning during brain development. In this study, we determined the roles of DAB2IP in the neuronal differentiation of human mesenchymal stem cells (hMSCs). We found that lentiviral short hairpin RNA (shRNA)-mediated knockdown of DAB2IP promoted the mesenchymal-to-neuroepithelial stem cell transition (MtNeST) and neuronal differentiation, which were accompanied by a reduction of cell proliferation but not apoptosis or cellular senescence. This suggests that DAB2IP plays an important role in the neuronal induction of hMSCs. Moreover, our finding that reduction of glycogen synthase kinase 3 beta (GSK3 beta) activity upon LiCl pretreatment inhibited both the MtNeST and production of MAP2-positive cells upon DAB2IP knockdown suggests that this transition is most likely mediated by regulation of the GSK3 beta signaling pathway. Our study demonstrates that DAB2IP participates in the first step of neuron induction of hMSCs, which implies a potentially important role for DAB2IP in the MtNeST during neurogenesis.	[Chang, Sunny Li-Yun] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Sunny Li-Yun] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Chou, Ruey-Hwang; Zeng, Hong-Jie; Lin, Yu-Hsuan; Yu, Yung-Luen] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Ruey-Hwang; Zeng, Hong-Jie; Lin, Yu-Hsuan; Yu, Yung-Luen] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang; Yu, Yung-Luen] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chiu, Tai-Yu; Yang, De-Ming] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chiu, Tai-Yu; Yang, De-Ming] Natl Yang Ming Univ, Inst Biophoton, Sch Med Technol & Engn, Taipei 112, Taiwan; [Chiu, Tai-Yu; Yang, De-Ming] Natl Yang Ming Univ, Inst Biophoton, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Med Res & Educ Orthopaed & Traumatol, Stem Cell Lab, Taipei, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Pharmacol, Inst Clin Med, Taipei 112, Taiwan; [Lai, Chih-Ho] China Med Univ, Grad Inst Basic Med Sci, Sch Med, Dept Microbiol, Taichung, Taiwan; [Hsieh, Jer-Tsong] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Shyu, Woei-Cherng] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; University of Texas System; University of Texas Southwestern Medical Center Dallas; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Shyu, WC (corresponding author), China Med Univ, Grad Inst Immunol, Taichung, Taiwan.	shyu9423@gmail.com; ylyu@mail.cmu.edu.tw	Chou, Ruey-Hwang/K-8541-2013; Yang, De-Ming/AAW-9886-2020; Lai, Chih-Ho/M-2433-2013	Chou, Ruey-Hwang/0000-0002-2297-2180; Yang, De-Ming/0000-0002-6923-4855; Lai, Chih-Ho/0000-0001-9229-818X	National Science Council [NSC-98-2320-B-039-034-MY3, NSC99-2320-B-039-030-MY3, NSC99-2632-B-039-001-MY3, NSC101-2321-B-039-004, NSC101-2311-B-039-001]; National Health Research Institutes [NHRI-EX102-10245BI]; China Medical University [CMU 98-N1-32, CMU100-N2-09]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); China Medical University(China Medical University)	This work were supported by the National Science Council (NSC-98-2320-B-039-034-MY3, NSC99-2320-B-039-030-MY3, NSC99-2632-B-039-001-MY3, NSC101-2321-B-039-004, and NSC101-2311-B-039-001), National Health Research Institutes (NHRI-EX102-10245BI), and China Medical University (CMU 98-N1-32, and CMU100-N2-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang SLY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054485; Chen H, 2002, GENOMICS, V79, P573, DOI 10.1006/geno.2002.6739; Chen YH, 2011, J BIOL CHEM, V286, P10671, DOI 10.1074/jbc.M110.199612; Chu MS, 2006, CELL SIGNAL, V18, P519, DOI 10.1016/j.cellsig.2005.05.018; Dote H, 2004, CLIN CANCER RES, V10, P2082, DOI 10.1158/1078-0432.CCR-03-0236; Gao ZH, 2013, CELL MOL LIFE SCI, V70, P2319, DOI 10.1007/s00018-012-1171-6; Guicciardi ME, 2003, J CLIN INVEST, V111, P1813, DOI 10.1172/JCI200318911; Homayouni R, 2003, MOL BRAIN RES, V115, P121, DOI 10.1016/S0169-328X(03)00176-1; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Huang CH, 2007, CELL SIGNAL, V19, P1339, DOI 10.1016/j.cellsig.2007.01.019; Hung SC, 2002, STEM CELLS, V20, P522, DOI 10.1634/stemcells.20-6-522; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kanehira M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032185; Kitada M, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/873706; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Lee GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046592; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Noel A, 2011, J NEUROSCI RES, V89, P755, DOI 10.1002/jnr.22587; Qiao SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053635; Rice DS, 1998, DEVELOPMENT, V125, P3719; Santiago JA, 2009, TISSUE ENG PT A, V15, P3911, DOI 10.1089/ten.tea.2008.0603; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Smits M, 2012, CLIN CANCER RES, V18, P4048, DOI 10.1158/1078-0432.CCR-12-0399; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; Wei CW, 2009, ACTA PHARMACOL SIN, V30, P1297, DOI 10.1038/aps.2009.124; Woodgett J R, 2001, Sci STKE, V2001, pre12, DOI 10.1126/stke.2001.100.re12; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yano M, 2005, INT J CANCER, V113, P59, DOI 10.1002/ijc.20531; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061362; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Yu YL, 2010, INT J ONCOL, V36, P365, DOI 10.3892/ijo_00000508; Zhang XJ, 2012, J GASTROEN HEPATOL, V27, P1117, DOI 10.1111/j.1440-1746.2011.07049.x	45	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75884	10.1371/journal.pone.0075884	http://dx.doi.org/10.1371/journal.pone.0075884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073285	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000095
J	Fritz, KS; Green, MF; Petersen, DR; Hirschey, MD				Fritz, Kristofer S.; Green, Michelle F.; Petersen, Dennis R.; Hirschey, Matthew D.			Ethanol Metabolism Modifies Hepatic Protein Acylation in Mice	PLOS ONE			English	Article							FATTY-ACID OXIDATION; LYSINE PROPIONYLATION; SIRT3; ACETALDEHYDE; ACETYLATION; ADDUCTS; ENZYMES; LIVER	Mitochondrial protein acetylation increases in response to chronic ethanol ingestion in mice, and is thought to reduce mitochondrial function and contribute to the pathogenesis of alcoholic liver disease. The mitochondrial deacetylase SIRT3 regulates the acetylation status of several mitochondrial proteins, including those involved in ethanol metabolism. The newly discovered desuccinylase activity of the mitochondrial sirtuin SIRT5 suggests that protein succinylation could be an important post-translational modification regulating mitochondrial metabolism. To assess the possible role of protein succinylation in ethanol metabolism, we surveyed hepatic sub-cellular protein fractions from mice fed a control or ethanol-supplemented diet for succinyl-lysine, as well as acetyl-, propionyl-, and butyryl-lysine post-translational modifications. We found mitochondrial protein propionylation increases, similar to mitochondrial protein acetylation. In contrast, mitochondrial protein succinylation is reduced. These mitochondrial protein modifications appear to be primarily driven by ethanol metabolism, and not by changes in mitochondrial sirtuin levels. Similar trends in acyl modifications were observed in the nucleus. However, comparatively fewer acyl modifications were observed in the cytoplasmic or the microsomal compartments, and were generally unchanged by ethanol metabolism. Using a mass spectrometry proteomics approach, we identified several candidate acetylated, propionylated, and succinylated proteins, which were enriched using antibodies against each modification. Additionally, we identified several acetyl and propionyl lysine residues on the same sites for a number of proteins and supports the idea of the overlapping nature of lysine-specific acylation. Thus, we show that novel post-translational modifications are present in hepatic mitochondrial, nuclear, cytoplasmic, and microsomal compartments and ethanol ingestion, and its associated metabolism, induce specific changes in these acyl modifications. These data suggest that protein acylation, beyond protein acetylation, contributes to the overall metabolic regulatory network and could play an important role in the pathogenesis of alcoholic liver disease.	[Fritz, Kristofer S.; Petersen, Dennis R.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Green, Michelle F.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; Duke University; Duke University	Fritz, KS (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	kristofer.fritz@ucdenver.edu; matthew.hirschey@duke.edu		Fritz, Kristofer/0000-0002-1499-6174; Hirschey, Matthew/0000-0003-4541-5376; Green, Michelle/0000-0002-6055-4342	National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse [R37AA09300, R01DK074487, 1R01AA022146-01]; American Heart Association [12SDG8840004, 12IRG9010008]; NATIONAL CANCER INSTITUTE [T32CA059365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493, R01DK074487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009300, R01AA022146] Funding Source: NIH RePORTER	National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Studies were supported by the National Institutes of Health/National Institutes of Alcoholism and Alcohol Abuse grants R37AA09300 (DRP), R01DK074487 (DRP), 1R01AA022146-01 (KSF & MDH), and by the American Heart Association grants 12SDG8840004 (MDH) and 12IRG9010008 (MDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birt JEEC, 1998, CHEM RES TOXICOL, V11, P136, DOI 10.1021/tx970169z; Bootorabi Fatemeh, 2008, BMC Biochemistry, V9, P32, DOI 10.1186/1471-2091-9-32; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DU J, 2011, SCI IN PRESS; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fritz KS, 2011, CHEM RES TOXICOL, V24, P651, DOI 10.1021/tx100355a; FRITZ KS, 2012, J PROTEOME RES, P39000; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2011, CELL METAB, V14, P718, DOI 10.1016/j.cmet.2011.10.006; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V373, P246, DOI 10.1016/j.bbrc.2008.06.006; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; NIEMELA O, 1991, J CLIN INVEST, V87, P1367, DOI 10.1172/JCI115141; Picklo MJ, 2008, BIOCHEM BIOPH RES CO, V376, P615, DOI 10.1016/j.bbrc.2008.09.039; Roede JR, 2008, FREE RADICAL BIO MED, V45, P1551, DOI 10.1016/j.freeradbiomed.2008.08.032; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Scott I, 2012, BIOCHEM J, V443, P655, DOI 10.1042/BJ20120118; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Tuma DJ, 1996, HEPATOLOGY, V23, P872, DOI 10.1002/hep.510230431; VEECH RL, 1972, BIOCHEM J, V127, P387, DOI 10.1042/bj1270387; Verdin E, 2004, METHOD ENZYMOL, V377, P180; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; XIE Z, 2012, MOL CELLULA IN PRESS; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yu HS, 2010, CHEM-BIOL INTERACT, V188, P367, DOI 10.1016/j.cbi.2010.08.005; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	33	38	38	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75868	10.1371/journal.pone.0075868	http://dx.doi.org/10.1371/journal.pone.0075868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073283	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000093
J	Schwarz, J; Bringmann, H				Schwarz, Juliane; Bringmann, Henrik			Reduced Sleep-Like Quiescence in Both Hyperactive and Hypoactive Mutants of the Galphaq Gene egl-30 during lethargus in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; NERVOUS-SYSTEM; SIGNALING NETWORK; RIC-8 SYNEMBRYN; PROTEIN; G(Q)ALPHA; MUTATIONS; ADAPTATION; SEROTONIN; DOMAIN	Sleep-like states are characterized by massively reduced behavioral activity. Little is known about genetic control of sleep-like behavior. It is also not clear how general activity levels during wake-like behavior influence activity levels during sleep-like behavior. Mutations that increase wake-like activity are generally believed to also increase activity during sleep-like behavior and mutations that decrease wake-like activity are believed to have decreased activity during sleep-like behavior. We studied sleep-like behavior during lethargus in larvae of Caenorhabditis elegans. We looked through a small set of known mutants with altered activity levels. As expected, mutants with increased activity levels typically showed less sleep-like behavior. Among these hyperactive mutants was a gain-of-function mutant of the conserved heterotrimeric G protein subunit Galphaq gene egl-30. We found, however, that an unusual semidominant hypoactive mutant of egl-30 also had reduced sleep-like behavior. While movement was severely reduced and impaired in the semidominant egl-30 mutant, sleep-like behavior was severely reduced: the semidominant egl-30 mutant lacked prolonged periods of complete immobility, reduced spontaneous neural activity less, and reduced responsiveness to stimulation less. egl-30 is a well-known regulator of behavior. Our results suggest that egl-30 controls not only general activity levels, but also differences between wake-like and sleep-like behavior.	[Schwarz, Juliane; Bringmann, Henrik] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Bringmann, H (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	Henrik.Bringmann@mpibpc.mpg.de			Max Planck Society; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; AVERY L, 1993, GENETICS, V133, P897; Avery Leon, 1993, Genetics, V134, P455; Barger AJ, 1998, J NEUROSCI, V18, P2871; BRENNER S, 1974, GENETICS, V77, P71; Bringmann H, 2011, J NEUROSCI METH, V201, P78, DOI 10.1016/j.jneumeth.2011.07.013; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CHALFIE M, 1985, J NEUROSCI, V5, P956; Coulon P, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00132; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; FIRE A, 1989, EMBO J, V8, P3419, DOI 10.1002/j.1460-2075.1989.tb08506.x; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Iwanir S, 2012, SLEEP; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Jose AM, 2007, GENETICS, V175, P93, DOI 10.1534/genetics.106.065516; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; MADURO M, 1995, GENETICS, V141, P977; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054; Moorman C, 2002, GENETICS, V161, P133; PARK EC, 1986, GENETICS, V113, P821; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Robatzek M, 2000, GENETICS, V156, P1069; Rogulja D, 2012, SCIENCE, V335, P1617, DOI 10.1126/science.1212476; Schade MA, 2005, GENETICS, V169, P631, DOI 10.1534/genetics.104.032334; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schafer WR, 1996, GENETICS, V143, P1219; Schwarz Juliane, 2012, Worm, V1, P12, DOI 10.4161/worm.19499; Schwarz J, 2011, CURR BIOL, V21, pR983, DOI 10.1016/j.cub.2011.10.046; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Singh K, 2013, SLEEP, V36, P307, DOI 10.5665/sleep.2436; Singh K, 2011, CURR BIOL, V21, P825, DOI 10.1016/j.cub.2011.04.010; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; TABUSE Y, 1989, SCIENCE, V243, P1713, DOI 10.1126/science.2538925; TRENT C, 1983, GENETICS, V104, P619; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Zhan XJ, 1999, J NEUROPHYSIOL, V81, P2360, DOI 10.1152/jn.1999.81.5.2360	56	17	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75853	10.1371/journal.pone.0075853	http://dx.doi.org/10.1371/journal.pone.0075853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073282	gold, Green Submitted, Green Published			2022-12-27	WOS:000324768000092
J	Shen, M; Zhang, YQ; Saba, N; Austin, CP; Wiestner, A; Auld, DS				Shen, Min; Zhang, Yaqin; Saba, Nakhle; Austin, Christopher P.; Wiestner, Adrian; Auld, Douglas S.			Identification of Therapeutic Candidates for Chronic Lymphocytic Leukemia from a Library of Approved Drugs	PLOS ONE			English	Article							BIOLOGICAL-ACTIVITIES; UNTREATED PATIENTS; INITIAL THERAPY; FLUDARABINE; CYCLOPHOSPHAMIDE; DISEASE; PREGABALIN; RITUXIMAB; AGENT; PHASE	Chronic lymphocytic leukemia (CLL) is an adult lymphoid malignancy with a variable clinical course. There is considerable interest in the identification of new treatments, as most current approaches are not curative. While most patients respond to initial chemotherapy, relapsed disease is often resistant to the drugs commonly used in CLL and patients are left with limited therapeutic options. In this study, we used a luminescent cell viability assay based on ATP levels to find compounds that were potent and efficacious in killing CLL cells. We employed an in-house process of quantitative high throughput screening (qHTS) to assess 8 concentrations of each member of a 2,816 compound library (including FDA-approved drugs and those known to be bio-active from commercial suppliers). Using qHTS we generated potency values on each compound in lymphocytes donated from each of six individuals with CLL and five unaffected individuals. We found 102 compounds efficacious against cells from all six individuals with CLL ("consensus" drugs) with five of these showing low or no activity on lymphocytes from a majority of normal donors, suggesting some degree of specificity for the leukemic cells. To our knowledge, this is the first study to screen a drug library against primary CLL cells to identify candidate agents for anti-cancer therapy. The results presented here offer possibilities for the development of novel drug candidates for therapeutic uses to treat CLL and other diseases.	[Shen, Min; Zhang, Yaqin; Austin, Christopher P.; Auld, Douglas S.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Saba, Nakhle; Wiestner, Adrian] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Shen, M (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA.	shenmin@mail.nih.gov; douglas.auld@novartis.com			Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ARCHIMBAUD E, 1989, CANCER CHEMOTH PHARM, V25, P223, DOI 10.1007/BF00689589; Blommel ML, 2007, AM J HEALTH-SYST PH, V64, P1475, DOI 10.2146/ajhp060371; Bosch F, 2008, CLIN CANCER RES, V14, P155, DOI 10.1158/1078-0432.CCR-07-1371; Byrd JC, 2003, BLOOD, V101, P6, DOI 10.1182/blood-2002-04-1258; Canel C, 2000, PHYTOCHEMISTRY, V54, P115, DOI 10.1016/S0031-9422(00)00094-7; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; DENNYBROWN D, 1951, NEW ENGL J MED, V245, P917, DOI 10.1056/NEJM195112132452401; Derissen EJB, 2013, ONCOLOGIST, V18, P619, DOI 10.1634/theoncologist.2012-0465; Dutcher JP, 1997, LEUKEMIA RES, V21, P375, DOI 10.1016/S0145-2126(96)00108-7; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Gandin V, 1981, BIOCHEM PHARMACOL, V41, P94; GREVER MR, 1988, NOUV REV FR HEMATOL, V30, P457; Gribben JG, 2011, J CLIN ONCOL, V29, P544, DOI 10.1200/JCO.2010.32.3865; Hallek M, 2010, LANCET, V376, P1164, DOI 10.1016/S0140-6736(10)61381-5; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Issa JPJ, 2005, NAT REV DRUG DISCOV, V4, P275, DOI 10.1038/nrd1698; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jacobson J M, 2000, Expert Opin Pharmacother, V1, P849, DOI 10.1517/14656566.1.4.849; JOHNSON IS, 1963, CANCER RES, V23, P1390; Kean WF, 1997, BRIT J RHEUMATOL, V36, P560; Keating MJ, 2002, BLOOD, V99, P3554, DOI 10.1182/blood.V99.10.3554; KEATING MJ, 1989, BLOOD, V74, P19; KENNEDY BJ, 1995, MED PEDIATR ONCOL, V24, P327, DOI 10.1002/mpo.2950240511; KENNEDY BJ, 1968, CANCER RES, V28, P91; Lacro RV, 2007, AM HEART J, V154, P624, DOI 10.1016/j.ahj.2007.06.024; Malik A, 2012, CLIN LYMPHOMA MYELOM, V13, P292; Mazerski J, 1998, ACTA BIOCHIM POL, V45, P1; Mease PJ, 2008, J RHEUMATOL, V35, P502; Muckter H, 1997, HUM EXP TOXICOL, V16, P460, DOI 10.1177/096032719701600807; Rai KR, 2000, NEW ENGL J MED, V343, P1750, DOI 10.1056/NEJM200012143432402; Rao R, 2011, BLOOD, V118, P929; Rassenti LZ, 2008, BLOOD, V112, P1923, DOI 10.1182/blood-2007-05-092882; Saba N, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.865.865; Sellner L, 2012, CURR HEMATOL MALIG R, V7, P3, DOI 10.1007/s11899-011-0110-1; Simon TM, 1985, CANCER RES, V45, P32; Spaeth M, 2008, NAT CLIN PRACT RHEUM, V4, P514, DOI 10.1038/ncprheum0906; Takimoto CH., 2008, CANC MANAGEMENT MULT, V11; Tam CS, 2008, BLOOD, V112, P975, DOI 10.1182/blood-2008-02-140582; Tam CS, 2010, NAT REV CLIN ONCOL, V7, P521, DOI 10.1038/nrclinonc.2010.101; Tournilhac O, 2004, BLOOD, V103, P363, DOI 10.1182/blood-2003-05-1449; Vilensky JA, 2003, ANN EMERG MED, V41, P378, DOI 10.1067/mem.2003.72; Von Hoff D D, 1976, Ann Intern Med, V85, P237; Wierda WG, 2007, BLOOD, V109, P4679, DOI 10.1182/blood-2005-12-051458; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Xu H, 2009, CURR MED CHEM, V16, P327, DOI 10.2174/092986709787002682; You YJ, 2005, CURR PHARM DESIGN, V11, P1695, DOI 10.2174/1381612053764724	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75252	10.1371/journal.pone.0075252	http://dx.doi.org/10.1371/journal.pone.0075252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073257	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000066
J	Yuan, ML; Tong, ZH; Jin, XG; Zhang, JC; Wang, XJ; Ma, WL; Yin, W; Zhou, Q; Ye, H; Shi, HZ				Yuan, Ming-Li; Tong, Zhao-Hui; Jin, Xiao-Guang; Zhang, Jian-Chu; Wang, Xiao-Juan; Ma, Wan-Li; Yin, Wen; Zhou, Qiong; Ye, Hong; Shi, Huan-Zhong			Regulation of CD4(+) T Cells by Pleural Mesothelial Cells via Adhesion Molecule-Dependent Mechanisms in Tuberculous Pleurisy	PLOS ONE			English	Article							ICAM-1; RECRUITMENT; IMMUNITY	Background: Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) have been demonstrated to be expressed on pleural mesothelial cells (PMCs), and to mediate leukocyte adhesion and migration; however, little is known about whether adhesion molecule-dependent mechanisms are involved in the regulation of CD4(+) T cells by PMCs in tuberculous pleural effusion (TPE). Methods: Expressions of ICAM-1 and VCAM-1 on PMCs, as well as expressions of CD11a and CD29, the counter-receptors for ICAM-1 and VCAM-1, respectively, expressed on CD4(+) T cells in TPE were determined using flow cytometry. The immune regulations on adhesion, proliferation, activation, selective expansion of CD4(+) helper T cell subgroups exerted by PMCs via adhesion molecule-dependent mechanisms were explored. Results: Percentages of ICAM-1-positive and VCAM-1-positive PMCs in TPE were increased compared with PMC line. Interferon-gamma enhanced fluorescence intensity of ICAM-1, while IL-4 promoted VCAM-1 expression on PMCs. Percentages of CD11a(high)CD4(+) and CD29(high)CD4(+) T cells in TPE significantly increased as compared with peripheral blood. Prestimulation of PMCs with anti-ICAM-1 or -VCAM-1 mAb significantly inhibited adhesion, activation, as well as effector regulatory T cell expansion induced by PMCs. Conclusions: Our current data showed that adhesion molecule pathways on PMCs regulated adhesion and activation of CD4(+) T cells, and selectively promoted the expansion of effector regulatory T cells.	[Yuan, Ming-Li; Tong, Zhao-Hui; Jin, Xiao-Guang; Wang, Xiao-Juan; Yin, Wen; Shi, Huan-Zhong] Capital Med Univ, Beijing Chaoyang Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Yuan, Ming-Li; Zhang, Jian-Chu; Ma, Wan-Li; Yin, Wen; Zhou, Qiong; Shi, Huan-Zhong] Huazhong Univ Sci & Technol, Dept Resp & Crit Care Med, Tongji Med Coll, Union Hosp, Wuhan 430074, Peoples R China; [Ye, Hong] Huazhong Univ Sci & Technol, Dept Pathophysiol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Tong, Zhao-Hui; Shi, Huan-Zhong] Beijing Inst Resp Dis, Med Res Ctr, Beijing, Peoples R China	Capital Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Shi, HZ (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China.	shihuanzhong@sina.com			National Natural Science Foundation of China [81270149, 81272591]; National Science Fund for Distinguished Young Scholars of China [30925032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported in part by grants from National Natural Science Foundation of China (No. 81270149 and No. 81272591); in part by a grant from National Science Fund for Distinguished Young Scholars of China (No. 30925032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PF, 1989, J IMMUNOL, V142, P1114; Choe N, 1999, AM J PHYSIOL-LUNG C, V277, pL292, DOI 10.1152/ajplung.1999.277.2.L292; Feng CG, 2000, J IMMUNOL, V164, P4853, DOI 10.4049/jimmunol.164.9.4853; Gaglia JL, 2000, J IMMUNOL, V165, P6091, DOI 10.4049/jimmunol.165.11.6091; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Jantz MA, 2008, RESPIRATION, V75, P121, DOI 10.1159/000113629; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Leitner J, 2010, IMMUNOL LETT, V128, P89, DOI 10.1016/j.imlet.2009.11.009; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; Miyara M, 2011, IMMUNOL CELL BIOL, V89, P346, DOI 10.1038/icb.2010.137; Mutti L., 1993, Pathologica (Genoa), V85, P725; Nasreen N, 1999, J INFECT DIS, V180, P1616, DOI 10.1086/315057; National Technical Steering Group of the Epidemiological Sampling Survey for Tuberculosis, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P665; OKUMURA M, 1993, EUR J IMMUNOL, V23, P1057, DOI 10.1002/eji.1830230512; Parameswaran N, 2005, J IMMUNOL, V175, P2201, DOI 10.4049/jimmunol.175.4.2201; Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3; Salomon B, 1998, J IMMUNOL, V161, P5138; Schierlohl P, 2009, EUR J IMMUNOL, V39, P2450, DOI 10.1002/eji.200939515; Smits HH, 2002, J IMMUNOL, V168, P1710, DOI 10.4049/jimmunol.168.4.1710; Taflin C, 2011, P NATL ACAD SCI USA, V108, P2891, DOI 10.1073/pnas.1011811108; Takamoto M, 1998, IMMUNOLOGY, V95, P419, DOI 10.1046/j.1365-2567.1998.00616.x; VANDERMEEREN A, 1993, AM J RESP CELL MOL, V8, P214, DOI 10.1165/ajrcmb/8.2.214; Verma NK, 2012, J BIOL CHEM, V287, P27204, DOI 10.1074/jbc.M112.376616; Wang TT, 2011, TUBERCULOSIS, V91, P231, DOI 10.1016/j.tube.2011.02.002; Windish HP, 2009, J LEUKOCYTE BIOL, V86, P713, DOI 10.1189/jlb.1208740; Wu C, 2010, RESPIROLOGY, V15, P522, DOI 10.1111/j.1440-1843.2010.01719.x; Ye ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031710; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74624	10.1371/journal.pone.0074624	http://dx.doi.org/10.1371/journal.pone.0074624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069325	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300037
J	Hu, J; Hopping, KA; Bump, JK; Kang, SC; Klein, JA				Hu, Jia; Hopping, Kelly A.; Bump, Joseph K.; Kang, Sichang; Klein, Julia A.			Climate Change and Water Use Partitioning by Different Plant Functional Groups in a Grassland on the Tibetan Plateau	PLOS ONE			English	Article							ARCTIC TUNDRA; SOIL-MOISTURE; CO2 FLUX; HIGH-ELEVATION; LONG-TERM; KOBRESIA-PYGMAEA; STABLE-ISOTOPES; FIELD RESPONSES; CARBON STORAGE; WINTER SNOW	Tibetan Plateau (TP) is predicted to experience increases in air temperature, increases in snowfall, and decreases in monsoon rains; however, there is currently a paucity of data that examine the ecological responses to such climate changes. In this study, we examined the effects of increased air temperature and snowfall on: 1) water use partitioning by different plant functional groups, and 2) ecosystem CO2 fluxes throughout the growing season. At the individual plant scale, we used stable hydrogen isotopes (delta D) to partition water use between shallow-and deep-rooted species. Prior to the arrival of summer precipitation (typically mid-July), snowmelt was the main water source in the soils. During this time, shallow and deep-rooted species partitioned water use by accessing water from shallow and deep soils, respectively. However, once the monsoon rains arrived, all plants used rainwater from the upper soils as the main water source. Snow addition did not result in increased snowmelt use throughout the growing season; instead, snowmelt water was pushed down into deeper soils when the rains arrived. At the larger plot scale, CO2 flux measurements demonstrated that rain was the main driver for net ecosystem productivity (NEP). NEP rates were low during June and July and reached a maximum during the monsoon season in August. Warming decreased NEP through a reduction in gross primary productivity (GPP), and snow additions did not mitigate the negative effects of warming by increasing NEP or GPP. Both the isotope and CO2 flux results suggest that rain drives productivity in the Nam Tso region on the TP. This also suggests that the effects of warming-induced drought on the TP may not be mitigated by increased snowfall. Further decreases in summer monsoon rains may affect ecosystem productivity, with large implications for livestock-based livelihoods.	[Hu, Jia] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Hopping, Kelly A.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Bump, Joseph K.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Kang, Sichang] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing, Peoples R China; [Klein, Julia A.] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA	Montana State University System; Montana State University Bozeman; Colorado State University; Michigan Technological University; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Colorado State University	Hu, J (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	jia.hu02@montana.edu	Kang, Shichang/I-6830-2018	Kang, Shichang/0000-0003-2115-9005; Hopping, Kelly/0000-0002-0557-0526; Hu, Jia/0000-0001-6858-6659	National Science Foundation [SBE-0624315]; National Center for Atmospheric Research Advanced Studies Post-Doctoral Fellowship; National Science Foundation East Asia and Pacific Summer Institute Fellowship; Office Of The Director [1443108] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Center for Atmospheric Research Advanced Studies Post-Doctoral Fellowship; National Science Foundation East Asia and Pacific Summer Institute Fellowship; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was funded by the following grant agencies: National Science Foundation SBE-0624315, National Center for Atmospheric Research Advanced Studies Post-Doctoral Fellowship, and an National Science Foundation East Asia and Pacific Summer Institute Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Baumann F, 2009, GLOBAL CHANGE BIOL, V15, P3001, DOI 10.1111/j.1365-2486.2009.01953.x; Berdanier AB, 2011, ECOSYSTEMS, V14, P963, DOI 10.1007/s10021-011-9459-1; BILLINGS WD, 1959, ECOLOGY, V40, P388, DOI 10.2307/1929755; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Chu D, 2007, ARCT ANTARCT ALP RES, V39, P635, DOI 10.1657/1523-0430(07-501)[CHU]2.0.CO;2; CINCOTTA RP, 1991, ARCTIC ALPINE RES, V23, P149, DOI 10.2307/1551379; DANSGAARD W, 1964, TELLUS, V16, P436; Ehleringer J. R., 1989, Plant physiological ecology: field methods and instrumentation., P281; EHLERINGER JR, 1991, OECOLOGIA, V88, P430, DOI 10.1007/BF00317589; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; EVANS RD, 1994, OECOLOGIA, V99, P233, DOI 10.1007/BF00627735; Feng L, 2011, ADV ATMOS SCI, V28, P464, DOI 10.1007/s00376-010-0016-1; Flanagan LB, 2002, GLOBAL CHANGE BIOL, V8, P599, DOI 10.1046/j.1365-2486.2002.00491.x; Gao XJ, 2012, CLIM RES, V52, P213, DOI 10.3354/cr01084; GAT JR, 1994, GEOPHYS RES LETT, V21, P557, DOI 10.1029/94GL00069; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Gebauer RLE, 2000, ECOLOGY, V81, P1415, DOI 10.1890/0012-9658(2000)081[1415:WANUPF]2.0.CO;2; Golluscio RA, 1998, OECOLOGIA, V115, P17, DOI 10.1007/s004420050486; Grogan P, 2000, OECOLOGIA, V125, P512, DOI 10.1007/s004420000490; Grogan P, 2003, ECOLOGY, V84, P202, DOI 10.1890/0012-9658(2003)084[0202:COANCI]2.0.CO;2; HARTE J, 1995, ECOL APPL, V5, P132, DOI 10.2307/1942058; Henry GHR, 1997, GLOB CHANGE BIOL, V3, P1, DOI 10.1111/j.1365-2486.1997.gcb132.x; Hobbie SE, 1998, ECOLOGY, V79, P1526; Hollister RD, 2005, GLOBAL CHANGE BIOL, V11, P525, DOI 10.1111/j.1365-2486.2005.00926.x; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Kang S. C, 2011, MODERN ENV PROCESSES; Keller F, 2003, ARCT ANTARCT ALP RES, V35, P361, DOI 10.1657/1523-0430(2003)035[0361:TROPIA]2.0.CO;2; Klein JA, 2007, ECOL APPL, V17, P541, DOI 10.1890/05-0685; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Lafleur PM, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001983; Li GP, 2001, ADV ATMOS SCI, V18, P1207; Li Na, 2011, Soil Biology & Biochemistry, V43, P942, DOI 10.1016/j.soilbio.2011.01.009; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Loik ME, 1997, ENVIRON EXP BOT, V37, P115, DOI 10.1016/S0098-8472(96)01043-X; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Miehe G, 2008, AMBIO, V37, P272, DOI 10.1579/0044-7447(2008)37[272:SADOTK]2.0.CO;2; Miller DJ, 2005, TIBETAN STEPPE GRASS, P305; Miller DJ., 1998, RANGELANDS, V20, P24; Monson RK, 2006, INTEGR COMP BIOL, V46, P35, DOI 10.1093/icb/icj006; Monson RK, 2002, GLOBAL CHANGE BIOL, V8, P459, DOI 10.1046/j.1365-2486.2002.00480.x; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Oberbauer SF, 2007, ECOL MONOGR, V77, P221, DOI 10.1890/06-0649; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Schwinning S, 2002, OECOLOGIA, V130, P345, DOI 10.1007/s00442-001-0817-0; Street LE, 2007, J ECOL, V95, P139, DOI 10.1111/j.1365-2745.2006.01187.x; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Su Z, 2011, HYDROL EARTH SYST SC, V15, P2303, DOI 10.5194/hess-15-2303-2011; Suyker AE, 2001, GLOBAL CHANGE BIOL, V7, P279, DOI 10.1046/j.1365-2486.2001.00407.x; Thompson LG, 2000, SCIENCE, V289, P1916, DOI 10.1126/science.289.5486.1916; WALKER DA, 1993, BIOSCIENCE, V43, P287, DOI 10.2307/1312061; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Wang GX, 2011, CLIMATIC CHANGE, V106, P463, DOI 10.1007/s10584-010-9952-0; Weintraub MN, 2005, BIOSCIENCE, V55, P408, DOI 10.1641/0006-3568(2005)055[0408:NCATSO]2.0.CO;2; Welker JM, 1999, ARCT ANTARCT ALP RES, V31, P272, DOI 10.2307/1552257; Welker JM, 2000, CLIMATIC CHANGE, V44, P139, DOI 10.1023/A:1005555012742; Welker JM, 2004, ARCT ANTARCT ALP RES, V36, P11, DOI 10.1657/1523-0430(2004)036[0011:AGCEAN]2.0.CO;2; Welker JM, 2004, GLOBAL CHANGE BIOL, V10, P1981, DOI 10.1111/j.1365-2486.2004.00857.x; Weltzin JF, 1997, OECOLOGIA, V112, P156, DOI 10.1007/s004420050295; WILLIAMS MW, 1995, BIOGEOCHEMISTRY, V28, P1, DOI 10.1007/BF02178059; Wipf S, 2010, POLAR RES-SWEDEN, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x; Wu TW, 2003, J CLIMATE, V16, P2038, DOI [10.1175/1520-0442(2003)016<2038:TRBTTW>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;2038:TRBTTW&gt;2.0.CO;2]; Xu YW, 2011, CHINESE SCI BULL, V56, P1511, DOI 10.1007/s11434-011-4467-2; Xu ZX, 2008, HYDROL PROCESS, V22, P3056, DOI 10.1002/hyp.6892; Yang Y, 2012, ACTA OECOL, V39, P109, DOI 10.1016/j.actao.2012.01.012; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; You QL, 2010, GLOBAL PLANET CHANGE, V72, P11, DOI 10.1016/j.gloplacha.2010.04.003; Yu WS, 2008, ATMOS RES, V87, P158, DOI 10.1016/j.atmosres.2007.08.004; Zhang B, 2011, J HYDROL, V405, P161, DOI 10.1016/j.jhydrol.2011.05.018; Zhang YQ, 1996, ARCTIC ALPINE RES, V28, P203, DOI 10.2307/1551761	72	27	29	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75503	10.1371/journal.pone.0075503	http://dx.doi.org/10.1371/journal.pone.0075503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069425	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300086
J	Azmat, SK; Shaikh, BT; Hameed, W; Mustafa, G; Hussain, W; Asghar, J; Ishaque, M; Ahmed, A; Bilgrami, M				Azmat, Syed Khurram; Shaikh, Babar Tasneem; Hameed, Waqas; Mustafa, Ghulam; Hussain, Wajahat; Asghar, Jamshaid; Ishaque, Muhammad; Ahmed, Aftab; Bilgrami, Mohsina			Impact of Social Franchising on Contraceptive Use When Complemented by Vouchers: A Quasi-Experimental Study in Rural Pakistan	PLOS ONE			English	Article							PRIVATE-SECTOR; HEALTH; SERVICES; NEED	Background: Pakistan has had a low contraceptive prevalence rate for the last two decades; with preference for natural birth spacing methods and condoms. Family planning services offered by the public sector have never fulfilled the demand for contraception, particularly in rural areas. In the private sector, cost is a major constraint. In 2008, Marie Stopes Society - a local NGO started a social franchise programme along with a free voucher scheme to promote uptake of IUCDs amongst the poor. This paper evaluates the effectiveness of this approach, which is designed to increase modern long term contraceptive awareness and use in rural areas of Pakistan. Methodology: We used a quasi-experimental study design with controls, selecting one intervention district and one control district from the Sindh and Punjab provinces. In each district, we chose a total of four service providers. A baseline survey was carried out among 4,992 married women of reproductive age (MWRA) in February 2009. Eighteen months after the start of intervention, an independent endline survey was conducted among 4,003 women. We used multilevel logistic regression for analysis using Stata 11. Results: Social franchising used alongside free vouchers for long term contraceptive choices significantly increased the awareness of modern contraception. Awareness increased by 5% in the intervention district. Similarly, the ever use of modern contraceptive increased by 28.5%, and the overall contraceptive prevalence rate increased by 19.6%. A significant change (11.1%) was recorded in the uptake of IUCDs, which were being promoted with vouchers. Conclusion: Family planning franchise model promotes awareness and uptake of contraceptives. Moreover, supplemented with vouchers, it may enhance the use of IUCDs, which have a significant cost attached. Our research also supports a multi-pronged approach-generating demand through counselling, overcoming financial constraints by offering vouchers, training, accreditation and branding of the service providers, and ensuring uninterrupted contraceptive supplies.	[Azmat, Syed Khurram; Shaikh, Babar Tasneem; Hameed, Waqas; Mustafa, Ghulam; Hussain, Wajahat; Asghar, Jamshaid; Ishaque, Muhammad; Ahmed, Aftab; Bilgrami, Mohsina] Marie Stopes Soc, Karachi, Pakistan		Shaikh, BT (corresponding author), Marie Stopes Soc, Karachi, Pakistan.	shaikh.babar@gmail.com	Shaikh, Babar Tasneem/J-4900-2017; Azmat, Syed Khurram/C-7244-2019	Shaikh, Babar Tasneem/0000-0002-2056-4132; Azmat, Syed Khurram/0000-0003-0158-8734	Marie Stopes International	Marie Stopes International	Marie Stopes International provided the necessary funding for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Azmat SK, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-8; Bank World, 1993, WORLD DEV REP 1993; Basinga P, 2011, B WORLD HEALTH ORGAN, V89, P698, DOI 10.2471/BLT.11.089912; Beyeler N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060669; Chandani T, 2006, PRIVATE PROVIDER NET; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Eldridge C, 2009, HEALTH POLICY PLANN, V24, P160, DOI 10.1093/heapol/czp002; Frost N, 2006, SOCIAL FRANCHISING S; Gold RB, 2010, GUTTMACHER POLICY RE, V13; Government of Pakistan, 2011, PAK SURV LIV STAND M; Hafeez A, 2011, J PAK MED ASSOC, V61, P210; Hardee K., 2008, POPULATION ACTION IN, P1; Khan A, 2012, POLICY BRIEFS SERIES, V1; Koehlmoos TP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007136.pub2; Kumaranayake I, 2000, HEALTH POLICY PLANN, V15, P357, DOI 10.1093/heapol/15.4.357; Lassner K J, 1995, Bull Pan Am Health Organ, V29, P206; Marek T., 2005, TRENDS OPPORTUNITIES; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; Montagu D, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-5; National Institute of Population Studies (NIPS) [Pakistan] and Macro International Inc, 2008, PAK DEM HLTH SURV 20; O'Connell K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028364; Prata N, 2005, B WORLD HEALTH ORGAN, V83, P274; Preker AS, 2000, B WORLD HEALTH ORGAN, V78, P779; Qureshi AM, 2010, BMC INT HEALTH HUM R, V10, P25, DOI [10.1186/1472-698X-10-25, DOI 10.1186/1472-698X-10-25]; Shah NM, 2011, HEALTH POLICY PLANN, V26, pi63, DOI 10.1093/heapol/czr027; Shaikh BT, 2010, OPEN ACCESS J CONTR, V1, P113, DOI 10.2147/OAJC.S13715; Shaikh BT., 2008, WORLD HLTH POPUL, V10, P44; Smith E, 2001, WORKING PRIVATE SECT; Stephenson R, 2004, HEALTH SERV RES, V39, P2053, DOI 10.1111/j.1475-6773.2004.00332.x; Swan M, 1997, PRIVATE PRACTITIONER; Winfrey W, 2000, POLICY PROJECT WORKI, V6; World Health Organization, 2007, PUBL POL FRANCH REPR; World Health Organization, 2000, WORLD HLTH REP 2000	34	37	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74260	10.1371/journal.pone.0074260	http://dx.doi.org/10.1371/journal.pone.0074260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069287	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100094
J	Encinas, P; Garcia-Valtanen, P; Chinchilla, B; Gomez-Casado, E; Estepa, A; Coll, J				Encinas, Paloma; Garcia-Valtanen, Pablo; Chinchilla, Blanca; Gomez-Casado, Eduardo; Estepa, Amparo; Coll, Julio			Identification of Multipath Genes Differentially Expressed in Pathway-Targeted Microarrays in Zebrafish Infected and Surviving Spring Viremia Carp Virus (SVCV) Suggest Preventive Drug Candidates	PLOS ONE			English	Article							NF-KAPPA-B; HEMATOPOIETIC NECROSIS VIRUS; HOST SHUTOFF PROTEIN; TROUT ONCORHYNCHUS-MYKISS; PARALICHTHYS-OLIVACEUS; JAPANESE FLOUNDER; RAINBOW-TROUT; HIRAME RHABDOVIRUS; DNA VACCINATION; DANIO-RERIO	Spring viremia carp virus (SVCV) is a rhabdovirus seasonally affecting warm-water cyprinid fish farming causing high impacts in worldwide economy. Because of the lack of effective preventive treatments, the identification of multipath genes involved in SVCV infection might be an alternative to explore the possibilities of using drugs for seasonal prevention of this fish disease. Because the zebrafish (Danio rerio) is a cyprinid susceptible to SVCV and their genetics and genome sequence are well advanced, it has been chosen as a model for SVCV infections. We have used newly designed pathway-targeted microarrays 3-4-fold enriched for immune/infection functional-relevant probes by using zebrafish orthologous to human genes from selected pathways of the Kyoto Encyclopedia of Genes and Genomes (KEGG). The comparative analysis of differential expression of genes through 20 pathways in 2-day exposed or 30-day survivors of SVCV infection allowed the identification of 16 multipath genes common to more than 6 pathways. In addition, receptors (Toll-like, B-cell, T-cell, RIG1-like) as well as viral RNA infection pathways were identified as the most important human-like pathways targeted by SVCV infection. Furthermore, by using bioinformatic tools to compare the promoter sequences corresponding to up and downregulated multipath gene groups, we identified putative common transcription factors which might be controlling such responses in a coordinated manner. Possible drug candidates to be tested in fish, can be identified now through search of data bases among those associated with the human orthologous to the zebrafish multipath genes. With the use of pathway-targeted microarrays, we identified some of the most important genes and transcription factors which might be implicated in viral shutoff and/or host survival responses after SVCV infection. These results could contribute to develop novel drug-based prevention methods and consolidate the zebrafish/SVCV as a model for vertebrate viral diseases.	[Encinas, Paloma; Chinchilla, Blanca; Gomez-Casado, Eduardo; Coll, Julio] INIA, Dept Biotechnol, Madrid, Spain; [Garcia-Valtanen, Pablo; Estepa, Amparo] Univ Miguel Hernandez, Dept Biochem, Elche UMH, Alicante, Spain	Universidad Miguel Hernandez de Elche	Coll, J (corresponding author), INIA, Dept Biotechnol, Madrid, Spain.	juliocoll@inia.es	Valtanen, Pablo Garcia/U-2921-2018; Coll, julio/M-6071-2019; Rodriguez, Blanca Chinchilla/AAA-3695-2021; Gomez-Casado, Eduardo/G-5502-2010; Coll, Julio M/G-4533-2010	Valtanen, Pablo Garcia/0000-0003-4382-6446; Coll, julio/0000-0001-8496-3493; Rodriguez, Blanca Chinchilla/0000-0002-0679-9023; Gomez-Casado, Eduardo/0000-0001-6904-1300; Coll, Julio M/0000-0001-8496-3493	CICYT of the Ministerio de Economia y Competitividad of Spain [AGL2011-28921-CO3, CSD2007-00002]	CICYT of the Ministerio de Economia y Competitividad of Spain	BC is a research fellow FPI of the Ministry of Innovation and Economy (MINECO) of Spain. This work was supported by CICYT project AGL2011-28921-CO3 and CSD2007-00002 of the Ministerio de Economia y Competitividad of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta F, 2006, FISH SHELLFISH IMMUN, V21, P272, DOI 10.1016/j.fsi.2005.12.006; Aggad D, 2010, J IMMUNOL, V185, P6774, DOI 10.4049/jimmunol.1000549; Ahne W, 2002, DIS AQUAT ORGAN, V52, P261, DOI 10.3354/dao052261; Aoki T, 1999, MAR BIOTECHNOL, V1, P477, DOI 10.1007/PL00011804; Ballesteros NA, 2012, FISH SHELLFISH IMMUN, V33, P174, DOI 10.1016/j.fsi.2012.03.016; Bovo G, 2005, VET RES COMMUN, V29, P123, DOI 10.1007/s11259-005-0014-4; Byon JY, 2006, VACCINE, V24, P921, DOI 10.1016/j.vaccine.2005.08.087; Byon JY, 2005, FISH SHELLFISH IMMUN, V18, P135, DOI 10.1016/j.fsi.2004.06.008; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cotter CR, 2011, J VIROL, V85, P12662, DOI 10.1128/JVI.05557-11; de las Heras AI, 2010, FISH SHELLFISH IMMUN, V28, P562, DOI 10.1016/j.fsi.2009.12.006; Desforges M, 2001, VIRUS RES, V76, P87, DOI 10.1016/S0168-1702(01)00251-9; Diaz-Rosales P, 2012, MAR BIOTECHNOL, V14, P515, DOI 10.1007/s10126-012-9465-0; Doukas T, 2011, J VIROL, V85, P10101, DOI 10.1128/JVI.00575-11; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Encinas P, 2012, USE MICROARRAY TECHN, P251; Encinas P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-518; Falco A, 2012, DEV COMP IMMUNOL, V37, P127, DOI 10.1016/j.dci.2011.10.005; Filjan N, 1971, Vet Arhiv, V41, P125; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gillette MA, 2013, NAT METHODS, V10, P28, DOI 10.1038/nmeth.2309; Goetz FW, 2008, FISH FISH, V9, P378, DOI 10.1111/j.1467-2979.2008.00301.x; Gomez-Casado E, 2011, VACCINE, V29, P2657, DOI 10.1016/j.vaccine.2011.01.097; Hoffmann B, 2002, VIRUS RES, V84, P89, DOI 10.1016/S0168-1702(01)00441-5; Horst D, 2012, J VIROL, V86, P9175, DOI 10.1128/JVI.00309-12; Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042; Korom M, 2008, J VIROL, V82, P3642, DOI 10.1128/JVI.02409-07; Kurath G, 2008, REV SCI TECH OIE, V27, P175, DOI 10.20506/rst.27.1.1793; Kurobe T, 2005, DEV COMP IMMUNOL, V29, P515, DOI 10.1016/j.dci.2004.10.005; LaPatra SE, 2000, BLOOD CELL MOL DIS, V26, P445, DOI 10.1006/bcmd.2000.0320; Lopez-Munoz A, 2011, MOL IMMUNOL, V48, P1073, DOI 10.1016/j.molimm.2011.01.015; Lopez-Munoz A, 2010, DEV COMP IMMUNOL, V34, P546, DOI 10.1016/j.dci.2009.12.015; Lopez-Munoz A, 2009, J IMMUNOL, V182, P3440, DOI 10.4049/jimmunol.0802528; Ludwig M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001269; MacKenzie S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-141; Nair S, 2008, BRIT J CANCER, V99, P2070, DOI 10.1038/sj.bjc.6604703; Nam BH, 2000, DEV COMP IMMUNOL, V24, P13, DOI 10.1016/S0145-305X(99)00058-0; Novoa B, 2006, VACCINE, V24, P5806, DOI 10.1016/j.vaccine.2006.05.015; Padhi A, 2012, VET MICROBIOL, V156, P54, DOI 10.1016/j.vetmic.2011.10.005; Page HG, 2010, J VIROL, V84, P6886, DOI 10.1128/JVI.00166-10; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Phelan PE, 2005, J VIROL, V79, P1842, DOI 10.1128/JVI.79.3.1842-1852.2005; Picotti P, 2013, NAT METHODS, V10, P24, DOI 10.1038/nmeth.2291; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Purcell MK, 2012, VIRUSES-BASEL, V4, P140, DOI 10.3390/v4010140; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sanders GE, 2003, COMPARATIVE MED, V53, P514; Secombes C, 2008, FISH SHELLFISH IMMUN, V25, P409, DOI 10.1016/j.fsi.2008.05.001; Sepulcre MP, 2007, MOL IMMUNOL, V44, P3751, DOI 10.1016/j.molimm.2007.03.021; Sepulcre MP, 2010, DEV COMP IMMUNOL, V34, P603, DOI 10.1016/j.dci.2010.01.010; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Smith SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033174; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; Tafalla C, 2007, FISH SHELLFISH IMMUN, V23, P210, DOI 10.1016/j.fsi.2006.10.009; Tafalla C, 2005, DEV COMP IMMUNOL, V29, P615, DOI 10.1016/j.dci.2004.12.001; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; von Schalburg KR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-126; Wang WL, 2011, FISH SHELLFISH IMMUN, V31, P10, DOI 10.1016/j.fsi.2011.01.015; Yao XD, 2011, J GEN VIROL, V92, P1981, DOI 10.1099/vir.0.030296-0; Yasuike M, 2007, FISH SHELLFISH IMMUN, V23, P531, DOI 10.1016/j.fsi.2006.12.006	60	38	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73553	10.1371/journal.pone.0073553	http://dx.doi.org/10.1371/journal.pone.0073553			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069208	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100050
J	Nakamura, K; White, AJ; Parnell, SM; Lane, PJ; Jenkinson, EJ; Jenkinson, WE; Anderson, G				Nakamura, Kyoko; White, Andrea J.; Parnell, Sonia M.; Lane, Peter J.; Jenkinson, Eric J.; Jenkinson, William E.; Anderson, Graham			Differential Requirement for CCR4 in the Maintenance but Not Establishment of the Invariant V gamma 5(+) Dendritic Epidermal T-Cell Pool	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITORS; BETA-CHEMOKINE; THYMOCYTES; THYMUS; MIGRATION; MEDULLA; CD4(+); SKIN; LOCALIZATION; TRAFFICKING	Thymocytes expressing the invariant V gamma 5 gamma delta T-cell receptor represent progenitors of dendritic epidermal T-cells (DETC) that play an important immune surveillance role in the skin. In contrast to the bulk of alpha beta T-cell development, V gamma 5(+) DETC progenitor development occurs exclusively in fetal thymus. Whilst alpha beta T-cell development is known to require chemokine receptor mediated migration through distinct thymus regions, culminating in medullary entry and thymic egress, the importance and control of intrathymic migration for DETC progenitors is unclear. We recently revealed a link between V gamma 5(+) DETC progenitor development and medullary thymic epithelial cells expressing Aire, a known regulator of thymic chemokine expression, demonstrating that normal V gamma 5(+) DETC progenitor development requires regulated intramedullary positioning. Here we investigate the role of chemokines and their receptors during intrathymic V gamma 5(+) DETC progenitor development and establishment of the DETC pool in the skin. We report that thymic medullary accumulation of V gamma 5(+) DETC progenitors is a G-protein coupled receptor dependent process. However, this process occurs independently of Aire's influences on intrathymic chemokines, and in the absence of CCR4 and CCR7 expression by DETC progenitors. In contrast, analysis of epidermal gamma delta T-cells at neonatal and adult stages in CCR4(-/-) mice reveals that reduced numbers of DETC in adult epidermis are not a consequence of diminished intrathymic embryonic development, nor deficiencies in initial epidermal seeding in the neonate. Collectively, our data reveal differences in the chemokine receptor requirements for intrathymic migration of alpha beta and invariant gamma delta T-cells, and highlight a differential role for CCR4 in the maintenance, but not initial seeding, of DETC in the epidermis.	[Nakamura, Kyoko; White, Andrea J.; Parnell, Sonia M.; Lane, Peter J.; Jenkinson, Eric J.; Jenkinson, William E.; Anderson, Graham] Univ Birmingham, Ctr Immune Regulat, Med Res Council, Birmingham, W Midlands, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Birmingham	Anderson, G (corresponding author), Univ Birmingham, Ctr Immune Regulat, Med Res Council, Birmingham, W Midlands, England.	g.anderson@bham.ac.uk	Nakamura, Kyoko/B-4184-2013	anderson, graham/0000-0002-2917-4085; Jenkinson, William/0000-0003-3422-8372	MRC; MRC [G1001055, G0401620, G1000213] Funding Source: UKRI; Medical Research Council [G1000213, G0401620, G1001055] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by an MRC Programme Grant (GA, PL, EJ) and an MRC New Investigator Award (WEJ) (WWW.MRC.AC.UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alferink J, 2003, J EXP MED, V197, P585, DOI 10.1084/jem.20021859; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Benz C, 2004, EUR J IMMUNOL, V34, P3652, DOI 10.1002/eji.200425248; BLUESTONE JA, 1987, NATURE, V326, P82, DOI 10.1038/326082a0; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; Campbell JJ, 1999, J IMMUNOL, V163, P2353; Chantry D, 1999, BLOOD, V94, P1890; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; FARR A, 1991, J HISTOCHEM CYTOCHEM, V39, P645, DOI 10.1177/39.5.2016514; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hu SM, 2013, J IMMUNOL, V190, P3267, DOI 10.4049/jimmunol.1202261; Jenkinson W, 2008, J VIS EXP; Jiang XD, 2010, P NATL ACAD SCI USA, V107, P7443, DOI 10.1073/pnas.0912943107; Jin Y, 2010, J IMMUNOL, V185, P5723, DOI 10.4049/jimmunol.1001612; Krueger A, 2010, BLOOD, V115, P1906, DOI 10.1182/blood-2009-07-235721; Laan M, 2009, J IMMUNOL, V183, P7682, DOI 10.4049/jimmunol.0804133; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Lieberam I, 1999, EUR J IMMUNOL, V29, P2684, DOI 10.1002/(SICI)1521-4141(199909)29:09<2684::AID-IMMU2684>3.3.CO;2-P; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Lkhagvasuren E, 2013, J IMMUNOL, V190, P5110, DOI 10.4049/jimmunol.1203203; MacLeod AS, 2011, CELL MOL LIFE SCI, V68, P2399, DOI 10.1007/s00018-011-0702-x; Misslitz A, 2004, J EXP MED, V200, P481, DOI 10.1084/jem.20040383; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Nitta T, 2009, P NATL ACAD SCI USA, V106, P17129, DOI 10.1073/pnas.0906956106; Pahuja A, 2006, SCAND J IMMUNOL, V64, P361, DOI 10.1111/j.1365-3083.2006.01787.x; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; Plotkin J, 2003, J IMMUNOL, V171, P4521, DOI 10.4049/jimmunol.171.9.4521; Proietto AI, 2008, IMMUNOL CELL BIOL, V86, P700, DOI 10.1038/icb.2008.63; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Roberts NA, 2012, IMMUNITY, V36, P427, DOI 10.1016/j.immuni.2012.01.016; Suzuki G, 1999, J IMMUNOL, V162, P5981; Tanabe S, 1997, J IMMUNOL, V159, P5671; Taniguchi RT, 2012, P NATL ACAD SCI USA, V109, P7847, DOI 10.1073/pnas.1120607109; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Ueno T, 2002, IMMUNITY, V16, P205, DOI 10.1016/S1074-7613(02)00267-4; VANVLIET E, 1984, EUR J IMMUNOL, V14, P524, DOI 10.1002/eji.1830140608; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	41	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74019	10.1371/journal.pone.0074019	http://dx.doi.org/10.1371/journal.pone.0074019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069263	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100082
J	Surya, W; Li, Y; Millet, O; Diercks, T; Torres, J				Surya, Wahyu; Li, Yan; Millet, Oscar; Diercks, Tammo; Torres, Jaume			Transmembrane and Juxtamembrane Structure of alpha L Integrin in Bicelles	PLOS ONE			English	Article							TORSION ANGLE DYNAMICS; CYTOPLASMIC DOMAINS; BINDING PROTEIN; SIGNAL-TRANSDUCTION; NMR SYSTEM; ALPHA(IIB)BETA(3); ASSOCIATION; ACTIVATION; SUBUNIT; CRYSTALLOGRAPHY	The accepted model for the interaction of alpha and beta integrins in the transmembrane (TM) domain is based on the pair alpha IIb beta 3. This involves the so-called outer and inner membrane association clasps (OMC and IMC, respectively). In the alpha chain, the OMC involves a GxxxG-like motif, whereas in the IMC a conserved juxtamembrane GFFKR motif experiences a backbone reversal that partially fills the void generated by TM separation towards the cytoplasmic half. However, the GFFKR motif of several alpha integrin cytoplasmic tails in non-bicelle environments has been shown to adopt an alpha-helical structure that is not membrane-embedded and which was shown to bind a variety of cytoplasmic proteins. Thus it is not known if a membrane-embedded backbone reversal is a conserved structural feature in alpha integrins. We have studied the system alpha L beta 2 because of its importance in leukocytes, where integrin deactivation is particularly important. Herein we show that the backbone reversal feature is not only present in alpha IIb but also in alpha L-TM when reconstituted in bicelles. Additionally, titration with beta 2 TM showed eight residues clustering along one side of alpha L-TM, forming a plausible interacting face with beta 2. The latter orientation is consistent with a previously predicted reported polar interaction between alpha L Ser-1071 and beta 2 Thr-686.	[Surya, Wahyu; Li, Yan; Torres, Jaume] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Millet, Oscar; Diercks, Tammo] CIC BioGUNE, Struct Biol Unit, Derio Vizcaya, Spain	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; CIC bioGUNE	Torres, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	jtorres@ntu.edu.sg	Millet, Oscar/F-9696-2011; Torres, Jaume/A-2179-2011; Torres, Jaume/AAJ-4510-2020; Diercks, Tammo/G-1167-2011; Diercks, Tammo/AAT-3731-2021; Li, Yan/G-4642-2013	Millet, Oscar/0000-0001-8748-4105; Torres, Jaume/0000-0002-1282-9727; Diercks, Tammo/0000-0002-5200-0905; Diercks, Tammo/0000-0002-5200-0905; Li, Yan/0000-0003-1963-839X; Surya, Wahyu/0000-0001-9240-371X	National Research Foundation of Singapore [NRF-CRP4-2008-02]	National Research Foundation of Singapore(National Research Foundation, Singapore)	This work has been funded by the National Research Foundation of Singapore (www.nrf.gov.sg) grant NRF-CRP4-2008-02 (J.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Armulik A, 1999, J BIOL CHEM, V274, P37030, DOI 10.1074/jbc.274.52.37030; Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chng CP, 2011, PROTEINS, V79, P2203, DOI 10.1002/prot.23044; Chua GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055184; Chua GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041924; Chua GL, 2011, J BIOL CHEM, V286, P43842, DOI 10.1074/jbc.M111.280164; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Gottschalk KE, 2002, PROTEIN SCI, V11, P1800, DOI 10.1110/ps.4120102; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Hantgan RR, 1999, BIOCHEMISTRY-US, V38, P14461, DOI 10.1021/bi9907680; Hemler M, 1999, EXTRACELLULAR MATRIX; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lai CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062954; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Lu CF, 1997, J IMMUNOL, V159, P268; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Nevo J, 2010, ONCOGENE, V29, P6452, DOI 10.1038/onc.2010.376; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suk JE, 2012, J AM CHEM SOC, V134, P9030, DOI 10.1021/ja304247f; Travis MA, 2003, TRENDS PHARMACOL SCI, V24, P192, DOI 10.1016/S0165-6147(03)00069-5; Tsuboi S, 2002, J BIOL CHEM, V277, P1919, DOI 10.1074/jbc.M110643200; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vararattanavech A, 2010, J MOL BIOL, V398, P569, DOI 10.1016/j.jmb.2010.03.027; Vararattanavech A, 2009, J BIOL CHEM, V284, P3239, DOI 10.1074/jbc.M802782200; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vold RR, 1997, J BIOMOL NMR, V9, P329, DOI 10.1023/A:1018643312309; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154; Zhu J, 2009, MOL CELL, V34, P234, DOI 10.1016/j.molcel.2009.02.022	56	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74281	10.1371/journal.pone.0074281	http://dx.doi.org/10.1371/journal.pone.0074281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069290	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100096
J	Suzuki, A; Mimaki, S; Yamane, Y; Kawase, A; Matsushima, K; Suzuki, M; Goto, K; Sugano, S; Esumi, H; Suzuki, Y; Tsuchihara, K				Suzuki, Ayako; Mimaki, Sachiyo; Yamane, Yuki; Kawase, Akikazu; Matsushima, Koutatsu; Suzuki, Makito; Goto, Koichi; Sugano, Sumio; Esumi, Hiroyasu; Suzuki, Yutaka; Tsuchihara, Katsuya			Identification and Characterization of Cancer Mutations in Japanese Lung Adenocarcinoma without Sequencing of Normal Tissue Counterparts	PLOS ONE			English	Article							SOMATIC MUTATIONS; TENASCIN-W; PLASMA PROTEIN-A2; BREAST-CANCER; GROWTH; DOMAINS; P-REX1; PREGNANCY; FRAMEWORK; CAPTURE	We analyzed whole-exome sequencing data from 97 Japanese lung adenocarcinoma patients and identified several putative cancer-related genes and pathways. Particularly, we observed that cancer-related mutation patterns were significantly different between different ethnic groups. As previously reported, mutations in the EGFR gene were characteristic to Japanese, while those in the KRAS gene were more frequent in Caucasians. Furthermore, during the course of this analysis, we found that cancer-specific somatic mutations can be detected without sequencing normal tissue counterparts. 64% of the germline variants could be excluded using a total of 217 external Japanese exome datasets. We also show that a similar approach may be used for other three ethnic groups, although the discriminative power depends on the ethnic group. We demonstrate that the ATM gene and the PAPPA2 gene could be identified as cancer prognosis related genes. By bypassing the sequencing of normal tissue counterparts, this approach provides a useful means of not only reducing the time and cost of sequencing but also analyzing archive samples, for which normal tissue counterparts are not available.	[Suzuki, Ayako; Sugano, Sumio; Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan; [Mimaki, Sachiyo; Matsushima, Koutatsu; Suzuki, Makito; Esumi, Hiroyasu; Tsuchihara, Katsuya] Natl Canc Ctr Hosp East, Div Translat Res, Res Ctr Innovat Oncol, Chiba, Japan; [Yamane, Yuki; Kawase, Akikazu; Goto, Koichi] Natl Canc Ctr Hosp East, Thorac Oncol Div, Chiba, Japan	University of Tokyo; National Cancer Center - Japan; National Cancer Center - Japan	Suzuki, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan.	ysuzuki@hgc.jp	Kawase, Akikazu/AAX-5820-2021	Kawase, Akikazu/0000-0002-1736-3874	JSPS KAKENHI [24300345]; MEXT KAKENHI [221S0002]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant number 24300345. This work was also supported by MEXT KAKENHI Grant Number 221S0002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Biesecker LG, 2010, NAT GENET, V42, P13, DOI 10.1038/ng0110-13; BOS JL, 1989, CANCER RES, V49, P4682; Brellier F, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-14; Cancer Genome Atlas Research Network, 2012, NATURE; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Degen M, 2008, INT J CANCER, V122, P2454, DOI 10.1002/ijc.23417; Degen M, 2007, CANCER RES, V67, P9169, DOI 10.1158/0008-5472.CAN-07-0666; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Huang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043441; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Li CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028204; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Louis-Dit-Picard H, 2012, NAT GENET; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; SHIMASAKI S, 1991, J BIOL CHEM, V266, P10646; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yan XL, 2010, J CLIN ENDOCR METAB, V95, P1412, DOI 10.1210/jc.2009-2277	51	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73484	10.1371/journal.pone.0073484	http://dx.doi.org/10.1371/journal.pone.0073484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069199	Green Submitted, gold, Green Published			2022-12-27	WOS:000326240100045
J	Nakano, S; Ikebe, E; Tsukamoto, Y; Wang, Y; Matsumoto, T; Mitsui, T; Yahiro, T; Inoue, K; Kawazato, H; Yasuda, A; Ito, K; Yokoyama, S; Takahashi, N; Hori, M; Shimada, T; Moriyama, M; Kubota, T; Ono, K; Fujibuchi, W; Jeang, KT; Iha, H; Nishizono, A				Nakano, Satoko; Ikebe, Emi; Tsukamoto, Yoshiyuki; Wang, Yan; Matsumoto, Takashi; Mitsui, Takahiro; Yahiro, Takaaki; Inoue, Kunimitsu; Kawazato, Hiroaki; Yasuda, Aiko; Ito, Kanako; Yokoyama, Shigeo; Takahashi, Naohiko; Hori, Mitsuo; Shimada, Tatsuo; Moriyama, Masatsugu; Kubota, Toshiaki; Ono, Katsushige; Fujibuchi, Wataru; Jeang, Kuan-Teh; Iha, Hidekatsu; Nishizono, Akira			Commensal Microbiota Contributes to Chronic Endocarditis in TAX1BP1 Deficient Mice	PLOS ONE			English	Article							NF-KAPPA-B; VIRUS TYPE-I; TAX PROTEIN; HTLV-1 TAX; TNF-ALPHA; INFECTION; INFLAMMATION; CELLS; OSTEOPONTIN; ASSOCIATION	Tax1-binding protein 1 (Tax1bp1) negatively regulates NF-kappa B by editing the ubiquitylation of target molecules by its catalytic partner A20. Genetically engineered TAX1BP1-deficient (KO) mice develop age-dependent inflammatory constitutions in multiple organs manifested as valvulitis or dermatitis and succumb to premature death. Laser capture dissection and gene expression microarray analysis on the mitral valves of TAX1BP1-KO mice (8 and 16 week old) revealed 588 gene transcription alterations from the wild type. SAA3 (serum amyloid A3), CHI3L1, HP, IL1B and SPP1/OPN were induced 1,180-, 361-, 187-, 122- and 101-fold respectively. WIF1 (Wnt inhibitory factor 1) exhibited 11-fold reduction. Intense Saa3 staining and significant I-kappa B alpha reduction were reconfirmed and massive infiltration of inflammatory lymphocytes and edema formation were seen in the area. Antibiotics-induced 'germ free' status or the additional MyD88 deficiency significantly ameliorated TAX1BP1-KO mice's inflammatory lesions. These pathological conditions, as we named 'pseudo-infective endocarditis' were boosted by the commensal microbiota who are usually harmless by their nature. This experimental outcome raises a novel mechanistic linkage between endothelial inflammation caused by the ubiquitin remodeling immune regulators and fatal cardiac dysfunction.	[Nakano, Satoko; Ikebe, Emi; Matsumoto, Takashi; Mitsui, Takahiro; Yahiro, Takaaki; Inoue, Kunimitsu; Iha, Hidekatsu; Nishizono, Akira] Oita Univ, Fac Med, Dept Microbiol, Oita 87011, Japan; [Nakano, Satoko; Kubota, Toshiaki] Oita Univ, Fac Med, Dept Ophthalmol, Oita 87011, Japan; [Tsukamoto, Yoshiyuki; Moriyama, Masatsugu] Oita Univ, Fac Med, Dept Mol Pathol, Oita 87011, Japan; [Wang, Yan; Ono, Katsushige] Oita Univ, Fac Med, Dept Pathophysiol, Oita 87011, Japan; [Kawazato, Hiroaki; Yasuda, Aiko] Oita Univ, Fac Med, Res Promot Inst, Oita 87011, Japan; [Ito, Kanako] Oita Univ, Fac Med, Dept Internal Med 2, Oita 87011, Japan; [Yokoyama, Shigeo] Oita Univ, Fac Med, Dept Diagnost Pathol, Oita 87011, Japan; [Takahashi, Naohiko] Oita Univ, Fac Med, Dept Lab Examinat & Diagnost, Oita 87011, Japan; [Hori, Mitsuo] Ibaragi Prefectural Cent Hosp, Div Hematol, Kasama, Ibaraki, Japan; [Shimada, Tatsuo] Oita Univ, Sch Nursing, Dept Hlth Sci, Oita 87011, Japan; [Fujibuchi, Wataru] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Jeang, Kuan-Teh] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	Oita University; Oita University; Oita University; Oita University; Oita University; Oita University; Oita University; Oita University; Oita University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Iha, H (corresponding author), Oita Univ, Fac Med, Dept Microbiol, Oita 87011, Japan.	hiha@oita-u.ac.jp	Kubota, Toshiaki/AAN-4334-2021; Inoue, Kunimitsu/ABA-5951-2020	Iha, Hidekatsu/0000-0002-0999-5636; Nakano, Satoko/0000-0003-4016-7676; Ono, Katsushige/0000-0001-7949-1823; Yahiro, Takaaki/0000-0003-1094-4497; yong mei, chi bian/0000-0003-0285-0466	Ministry of Education, Culture, Sports, Science, and Technology; Okinawa Science and Technology Promotion Center (OSTPC); Miyazaki Prefectural Industrial Support Foundation; Hita Tenryosui Co. Ltd.; Grants-in-Aid for Scientific Research [24591952] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Okinawa Science and Technology Promotion Center (OSTPC); Miyazaki Prefectural Industrial Support Foundation; Hita Tenryosui Co. Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology; Okinawa Science and Technology Promotion Center (OSTPC); Miyazaki Prefectural Industrial Support Foundation. E. I. is a research fellow of the OSTPC and was a recipient of the Hita Tenryosui Research Scholarship from Hita Tenryosui Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Chervonsky AV, 2010, NAT IMMUNOL, V11, P28, DOI 10.1038/ni.1801; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; Dewan MZ, 2003, J VIROL, V77, P5286, DOI 10.1128/JVI.77.9.5286-5294.2003; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Giam CZ, 2007, FRONT BIOSCI, V12, P1496, DOI 10.2741/2163; Goldszmid RS, 2012, NAT IMMUNOL, V13, P932, DOI 10.1038/ni.2422; Gould FK, 2012, J ANTIMICROB CHEMOTH, V67, P269, DOI 10.1093/jac/dkr450; GREEN JE, 1989, NATURE, V341, P72, DOI 10.1038/341072a0; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1849, DOI 10.1038/jid.2010.67; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Hayashi Jun, 2008, Fukuoka Acta Medica, V99, P67; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Hida A, 2010, ANN RHEUM DIS, V69, P2056, DOI 10.1136/ard.2010.128736; Iha H, 2003, ONCOGENE, V22, P8912, DOI 10.1038/sj.onc.1207058; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; ISHIGURO N, 1992, J EXP MED, V176, P981, DOI 10.1084/jem.176.4.981; IWAKURA Y, 1991, SCIENCE, V253, P1026, DOI 10.1126/science.1887217; Jang SY, 2012, GLIA, V60, P1619, DOI 10.1002/glia.22382; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kira J, 1997, ACTA NEUROL SCAND, V96, P305, DOI 10.1111/j.1600-0404.1997.tb00288.x; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Ling L, 2000, P NATL ACAD SCI USA, V97, P9567, DOI 10.1073/pnas.170279097; Martin F, 2011, AIDS REV, V13, P161; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Newton K., 2012, COLD SPRING HARB PER; Obici L, 2012, AUTOIMMUN REV, V12, P14, DOI 10.1016/j.autrev.2012.07.016; Ohsugi T, 2007, NAT MED, V13, P527, DOI 10.1038/nm0507-527; Oliere S, 2011, CYTOKINE GROWTH F R, V22, P197, DOI 10.1016/j.cytogfr.2011.08.002; Peloponese JM, 2006, IMMUNOL RES, V34, P1, DOI 10.1385/IR:34:1:1; Poynter ME, 2012, PULM PHARMACOL THER, V25, P438, DOI 10.1016/j.pupt.2012.04.005; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Roufosse FE, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-37; Ruiz MT, 2010, BRAZ J OTORHINOLAR, V76, P193, DOI 10.1590/S1808-86942010000200008; Sadanaga A, 2007, ARTHRITIS RHEUM-US, V56, P1618, DOI 10.1002/art.22571; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Sartelet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002581; Seckeler Michael D, 2011, Clin Epidemiol, V3, P67, DOI 10.2147/CLEP.S12977; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Surmann-Schmitt C, 2008, J BIOL CHEM, V283, P7082, DOI 10.1074/jbc.M702792200; Tattermusch S, 2012, TRENDS MICROBIOL, V20, P494, DOI 10.1016/j.tim.2012.07.004; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Verstrepen L, 2011, TRENDS BIOCHEM SCI, V36, P347, DOI 10.1016/j.tibs.2011.03.004; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Wilson W, 2008, J AM DENT ASSOC, V139, p3S, DOI 10.14219/jada.archive.2008.0346; Yagi H, 2003, J DERMATOL, V30, P641, DOI 10.1111/j.1346-8138.2003.tb00451.x; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	64	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73205	10.1371/journal.pone.0073205	http://dx.doi.org/10.1371/journal.pone.0073205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086273	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900012
J	Coletta, A; Castelli, S; Chillemi, G; Sanna, N; Cushman, M; Pommier, Y; Desideri, A				Coletta, Andrea; Castelli, Silvia; Chillemi, Giovanni; Sanna, Nico; Cushman, Mark; Pommier, Yves; Desideri, Alessandro			Solvent Dependency of the UV-Vis Spectrum of Indenoisoquinolines: Role of Keto-Oxygens as Polarity Interaction Probes	PLOS ONE			English	Article							TOPOISOMERASE-I INHIBITORS; TOPOTECAN ANTICANCER DRUG; DNA COVALENT COMPLEX; CLEAVAGE COMPLEX; AQUEOUS-SOLUTION; NORINDENOISOQUINOLINE; RESISTANCE; MECHANISM; DENSITY; BINDING	Indenoisoquinolines are the most promising non-campthotecins topoisomerase IB inhibitors. We present an integrated experimental/computational investigation of the UV-Vis spectra of the IQNs parental compound (NSC314622) and two of its derivatives (NSC724998 and NSC725776) currently undergoing Phase I clinical trials. In all the three compounds a similar dependence of the relative absorption intensities at 270 nm and 290 nm on solvent polarity is found. The keto-oxygens in positions 5 and 11 of the molecular scaffold of the molecule are the principal chromophores involved in this dependence. Protic interactions on these sites are also found to give rise to absorptions at wavelength <250 nm observed in water solution, due to the stabilization of highly polarized tautomers of the molecule. These results suggest that the keto-oxygens are important polarizable groups that can act as useful interactors with the molecular receptor, providing at the same time an useful fingerprint for the monitoring of the drug binding to topoisomerase IB.	[Coletta, Andrea; Castelli, Silvia; Desideri, Alessandro] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Chillemi, Giovanni; Sanna, Nico] Consorzio Interuniv Applicaz Supercalcolo Univ &, Rome, Italy; [Cushman, Mark] Purdue Univ, Sch Pharm & Pharmaceut Sci, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Cushman, Mark] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	University of Rome Tor Vergata; CINECA, Italy; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Desideri, A (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy.	desideri@uniroma2.it	Sanna, Nico/AAB-7170-2020; Chillemi, Giovanni/O-2825-2019; Coletta, Andrea/H-9856-2012; Coletta, Andrea/GXF-2972-2022; SANNA, Nico/R-8799-2016; Chillemi, Giovanni/E-5201-2010	Sanna, Nico/0000-0002-1947-7939; Chillemi, Giovanni/0000-0003-3901-6926; Coletta, Andrea/0000-0003-4032-394X; SANNA, Nico/0000-0002-1947-7939; Chillemi, Giovanni/0000-0003-3901-6926; desideri, alessandro/0000-0003-1541-4217	Associazione Italiana per la Ricerca sul Cancro Research Project [IG-10121]; National Institutes of Health Research Grant [UO1 CA89566]; CASPUR/CINECA [std11-434]; National Cancer Institute Intramural Program, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC006161, U01CA089566] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro Research Project(Fondazione AIRC per la ricerca sul cancro); National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CASPUR/CINECA(CINECA, Italy); National Cancer Institute Intramural Program, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding from Associazione Italiana per la Ricerca sul Cancro Research Project IG-10121; National Institutes of Health Research Grant UO1 CA89566; CASPUR/CINECA std11-434, "Characterization of anticancer drug selectively targeting human topoisomerase IB by ab-initio calculations"; and National Cancer Institute Intramural Program, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony S, 2007, CANCER RES, V67, P10397, DOI 10.1158/0008-5472.CAN-07-0938; Aschi M, 2001, CHEM PHYS LETT, V344, P374, DOI 10.1016/S0009-2614(01)00638-8; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chillemi G, 2008, NUCLEIC ACIDS RES, V36, P5645, DOI 10.1093/nar/gkn558; Chillemi G, 2010, THEOR CHEM ACC, V127, P293, DOI 10.1007/s00214-009-0715-9; Chillemi Giovanni, 2007, Ital J Biochem, V56, P110; Coletta A, 2010, J PHYS CHEM A, V114, P7121, DOI 10.1021/jp101494d; Craig IM, 2009, CHEM PHYS LETT, V477, P319, DOI 10.1016/j.cplett.2009.07.041; CUSHMAN M, 1978, J ORG CHEM, V43, P3781, DOI 10.1021/jo00413a036; Cushman M, 2000, J MED CHEM, V43, P3688, DOI 10.1021/jm000029d; Fiorani P, 2009, NUCLEIC ACIDS RES, V37, P6849, DOI 10.1093/nar/gkp669; Frisch M.J., 2016, GAUSSIAN16 REV B01; Ioanoviciu A, 2005, J MED CHEM, V48, P4803, DOI 10.1021/jm050076b; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Losasso C, 2008, NUCLEIC ACIDS RES, V36, P5635, DOI 10.1093/nar/gkn557; Malcioglu OB, 2011, J AM CHEM SOC, V133, P15425, DOI 10.1021/ja201733v; Mancini G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010934; Marchand C, 2006, MOL CANCER THER, V5, P287, DOI 10.1158/1535-7163.MCT-05-0456; Nagarajan M, 2006, J MED CHEM, V49, P6283, DOI 10.1021/jm060564z; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Pommier Y, 2009, MOL CANCER THER, V8, P1008, DOI 10.1158/1535-7163.MCT-08-0706; Sanna N, 2005, J AM CHEM SOC, V127, P15429, DOI 10.1021/ja052637u; Sanna N, 2009, J PHYS CHEM B, V113, P5369, DOI 10.1021/jp809801y; Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436; Song Y, 2010, J MED CHEM; Song YL, 2008, J PHYS CHEM B, V112, P9484, DOI 10.1021/jp8005603; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stratmann RE, 1998, J CHEM PHYS, V109, P8218, DOI 10.1063/1.477483; Strumberg D, 1999, J MED CHEM, V42, P446, DOI 10.1021/jm9803323; Teicher BA, 2008, BIOCHEM PHARMACOL, V75, P1262, DOI 10.1016/j.bcp.2007.10.016; Tonzani S, 2008, J AM CHEM SOC, V130, P7607, DOI 10.1021/ja7103894; Xiao XS, 2005, J MED CHEM, V48, P3231, DOI 10.1021/jm050017y; Zazza C, 2010, J PHYS CHEM B, V114, P6770, DOI 10.1021/jp1015824	38	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e73881	10.1371/journal.pone.0073881	http://dx.doi.org/10.1371/journal.pone.0073881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086299	Green Submitted, Green Published, gold			2022-12-27	WOS:000325220000004
J	Gobbetti, T; Le Faouder, P; Bertrand, J; Dubourdeau, M; Barocelli, E; Cenac, N; Vergnolle, N				Gobbetti, Thomas; Le Faouder, Pauline; Bertrand, Justine; Dubourdeau, Marc; Barocelli, Elisabetta; Cenac, Nicolas; Vergnolle, Nathalie			Polyunsaturated Fatty Acid Metabolism Signature in Ischemia Differs from Reperfusion in Mouse Intestine	PLOS ONE			English	Article							PPAR-GAMMA; EPOXYEICOSATRIENOIC ACIDS; COX-2 EXPRESSION; LIPOXIN A(4); LUNG INJURY; INFLAMMATION; PHOSPHOLIPASE-A2; ACTIVATION; RESOLUTION; INHIBITION	Polyunsaturated fatty acid (PUFA) metabolites are bioactive autoacoids that play an important role in the pathogenesis of a vast number of pathologies, including gut diseases. The induction and the resolution of inflammation depend on PUFA metabolic pathways that are favored. Therefore, understanding the profile of n-6 (eicosanoids)/n-3 (docosanoids) PUFA-derived metabolites appear to be as important as gene or protein array approaches, to uncover the molecules potentially implicated in inflammatory diseases. Using high sensitivity liquid chromatography tandem mass spectrometry, we characterized the tissue profile of PUFA metabolites in an experimental model of murine intestinal ischemia reperfusion. We identified temporal and quantitative differences in PUFA metabolite production, which correlated with inflammatory damage. Analysis revealed that early ischemia induces both pro-inflammatory and anti-inflammatory eicosanoid production. Primarily, LOX-(5/15/12/8-HETE, LTB4, LxA(4)) and CYP-(5, 6-EET) metabolites were produced upon ischemia, but also PGE(3), and PDx. This suggests that different lipids simultaneously play a role in the induction and counterbalance of ischemic inflammatory response from its onset. COX-derived metabolites were more present from 2 to 5 hours after reperfusion, fitting with the concomitant inflammatory peaks. All metabolites were decreased 48 hours post-reperfusion except for to the pro-resolving RvE precursor 18-HEPE and the PPAR-gamma alpha mu mu alpha agonist, 15d-PGJ(2). Data obtained through the pharmacological blockade of transient receptor potential vanilloid-4, which can be activated by 5, 6-EET, revealed that the endogenous activation of this receptor modulates post-ischemic intestinal inflammation. Altogether, these results demonstrate that different lipid pathways are involved in intestinal ischemia-reperfusion processes. Some metabolites, which expression is severely changed upon intestinal ischemia-reperfusion could provide novel targets and may facilitate the development of new pharmacological treatments.	[Gobbetti, Thomas; Le Faouder, Pauline; Cenac, Nicolas; Vergnolle, Nathalie] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Gobbetti, Thomas; Le Faouder, Pauline; Cenac, Nicolas; Vergnolle, Nathalie] CNRS, U5282, Toulouse, France; [Gobbetti, Thomas; Le Faouder, Pauline; Cenac, Nicolas; Vergnolle, Nathalie] Univ Toulouse, UPS, CPTP, Toulouse, France; [Gobbetti, Thomas] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Le Faouder, Pauline; Bertrand, Justine] Univ Toulouse 3, Lipid Core Facil, F-31062 Toulouse, France; [Dubourdeau, Marc] Ambiotis SAS, Canal Biotech 2, Toulouse, France; [Barocelli, Elisabetta] Univ Parma, Dept Pharm, I-43100 Parma, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; Queen Mary University London; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Parma	Vergnolle, N (corresponding author), Fac Med Toulouse, INSERM, U1043, U317, F-31073 Toulouse, France.	nathalie.vergnolle@inserm.fr	Cenac, Nicolas/P-4557-2017; Vergnolle, Nathalie/C-7677-2018	Cenac, Nicolas/0000-0002-1552-7812; Vergnolle, Nathalie/0000-0003-1825-6015	Agence Nationale de la Recherche; region Midi-Pyrenees; 10th World Congress of Inflammation	Agence Nationale de la Recherche(French National Research Agency (ANR)); region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); 10th World Congress of Inflammation	This research was supported by the Agence Nationale de la Recherche (to NV and to NC) and by the region Midi-Pyrenees (to NV). TG was the recipient of an award from the 10th World Congress of Inflammation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahman M, 2005, CARDIOVASC RES, V65, P772, DOI 10.1016/j.cardiores.2004.12.008; Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Arumugam TV, 2003, BRIT J PHARMACOL, V140, P71, DOI 10.1038/sj.bjp.0705402; Batchu SN, 2012, J MOL CELL CARDIOL, V53, P43, DOI 10.1016/j.yjmcc.2012.04.008; BOROS M, 1991, EUR SURG RES, V23, P141, DOI 10.1159/000129146; Brancaleone V, 2013, BLOOD, V122, P608, DOI 10.1182/blood-2013-04-496661; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Camacho M, 2011, J LIPID RES, V52, P720, DOI 10.1194/jlr.M011007; Cattaruzza F, 2006, AM J PATHOL, V169, P177, DOI 10.2353/ajpath.2006.051098; Cenac N, 2008, GASTROENTEROLOGY, V134, pA559; Cenac N, 2010, GUT, V59, P481, DOI 10.1136/gut.2009.192567; Chatter R, 2012, NEUROGASTROENT MOTIL, V24, pe336, DOI 10.1111/j.1365-2982.2012.01940.x; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Denadai-Souza A, 2012, ARTHRITIS RHEUM-US, V64, P1848, DOI 10.1002/art.34345; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Domoki F, 1999, AM J PHYSIOL-HEART C, V277, pH1207, DOI 10.1152/ajpheart.1999.277.3.H1207; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Dupouy VM, 2006, J APPL PHYSIOL, V100, P233, DOI 10.1152/japplphysiol.00673.2004; Fabre JE, 2002, J CLIN INVEST, V109, P1373, DOI 10.1172/JCI200214869; Fiorucci S, 2002, GASTROENTEROLOGY, V123, P1598, DOI 10.1053/gast.2002.36558; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gobbetti T, 2012, AM J PATHOL, V180, P141, DOI 10.1016/j.ajpath.2011.09.031; Gobbetti T, 2011, INFLAMM RES, V60, P295; Jin G, 2008, STROKE, V39, P2538, DOI 10.1161/STROKEAHA.108.514927; Kawata K, 2003, HEPATO-GASTROENTEROL, V50, P1970; Keyes KT, 2010, AM J PHYSIOL-HEART C, V299, pH153, DOI 10.1152/ajpheart.01057.2009; Koike K, 2000, ANN SURG, V232, P90, DOI 10.1097/00000658-200007000-00013; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Moore EE, 2010, AM J SURG, V200, P681, DOI 10.1016/j.amjsurg.2010.05.010; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Nakajima A, 2001, GASTROENTEROLOGY, V120, P460, DOI 10.1053/gast.2001.21191; NAKAMURA H, 1991, J CLIN INVEST, V87, P1810, DOI 10.1172/JCI115202; OTAMIRI T, 1988, GUT, V29, P489, DOI 10.1136/gut.29.4.489; OTAMIRI T, 1987, GUT, V28, P1445, DOI 10.1136/gut.28.11.1445; Rossi A, 2007, THESCIENTIFICWORLDJO, V7, P56, DOI 10.1100/tsw.2007.34; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Sapirstein A, 2000, NEUROCHEM RES, V25, P745, DOI 10.1023/A:1007583708713; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; TURNAGE RH, 1995, J SURG RES, V58, P558, DOI 10.1006/jsre.1995.1088; Vergnolle N, 2010, BRIT J PHARMACOL, V159, P1161, DOI 10.1111/j.1476-5381.2009.00590.x; Visioli F, 1998, BIOCHEM BIOPH RES CO, V245, P487, DOI 10.1006/bbrc.1998.8463; Vollmar B, 2011, LANGENBECK ARCH SURG, V396, P13, DOI 10.1007/s00423-010-0727-x; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Zeiger SLH, 2009, FREE RADICAL BIO MED, V47, P1422, DOI 10.1016/j.freeradbiomed.2009.08.011; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402	53	14	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75581	10.1371/journal.pone.0075581	http://dx.doi.org/10.1371/journal.pone.0075581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073272	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000082
J	Nativel, B; Marimoutou, M; Thon-Hon, VG; Gunasekaran, MK; Andries, J; Stanislas, G; Planesse, C; Da Silva, CR; Cesari, M; Iwema, T; Gasque, P; Viranaicken, W				Nativel, Brice; Marimoutou, Mery; Thon-Hon, Vincent G.; Gunasekaran, Manoj Kumar; Andries, Jessica; Stanislas, Giovedie; Planesse, Cynthia; Da Silva, Christine Robert; Cesari, Maya; Iwema, Thomas; Gasque, Philippe; Viranaicken, Wildriss			Soluble HMGB1 Is a Novel Adipokine Stimulating IL-6 Secretion through RAGE Receptor in SW872 Preadipocyte Cell Line: Contribution to Chronic Inflammation in Fat Tissue	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GLYCATION END-PRODUCTS; SUBCUTANEOUS ADIPOSE-TISSUE; DNA-BINDING PROTEINS; INSULIN-RESISTANCE; HUMAN ADIPOCYTES; FACTOR-ALPHA; THERAPEUTIC TARGET; 3T3-L1 ADIPOCYTES; SIGNALING PATHWAY	Low-grade inflammation (LGI) is a central phenomenon in the genesis of obesity and insulin-resistance characterized by IL-6 in human serum. Whereas this LGI was initially thought to be mainly attributed to macrophage activation, it is now known that pre-adipocytes and adipocytes secrete several adipokines including IL-6 and participate to LGI and associated pathologies. In macrophages, HMGB1 is a nuclear yet secreted protein and acts as a cytokine to drive the production of inflammatory molecules through RAGE and TLR2/4. In this paper we tested the secretion of HMGB1 and the auto-and paracrine contribution to fat inflammation using the human preadipocyte cell line SW872 as a model. We showed that 1) human SW872 secreted actively HMGB1, 2) IL-6 production was positively linked to high levels of secreted HMGB1, 3) recombinant HMGB1 boosted IL-6 expression and this effect was mediated by the receptor RAGE and did not involve TLR2 or TLR4. These results suggest that HMGB1 is a major adipokine contributing to LGI implementation and maintenance, and can be considered as a target to develop news therapeutics in LGI associated pathologies such as obesity and type II diabetes.				wildriss.viranaicken@univ-reunion.fr		CESARI, Maya/0000-0002-2795-6059; NATIVEL, Brice/0000-0003-3719-7903	CPER-FEDER GRII, University of La Reunion; "Structure Federative Environnement, Biodiversite, Sante'' University of La La Reunion; Biodiversite, Sante'' Environnement, Biodiversite, Sante" University of La Reunion; Regional Council of La Reunion; French Ministry	CPER-FEDER GRII, University of La Reunion; "Structure Federative Environnement, Biodiversite, Sante'' University of La La Reunion; Biodiversite, Sante'' Environnement, Biodiversite, Sante" University of La Reunion; Regional Council of La Reunion; French Ministry	This work was supported by grants from CPER-FEDER GRII, University of La Reunion and the the "Structure Federative Environnement, Biodiversite, Sante ''University of La La Reunion. BN holds a fellowship from the Biodiversite, Sante'' Environnement, Biodiversite, Sante" University of La Reunion. MM and MKG hold fellowships from Regional Council of La Reunion. VGTH is a fellow from the French Ministry (contrat doctoral). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084; Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1; Borcherding DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025537; Borde C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016145; Brull F, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.036343; Carmel JF, 2009, J CELL BIOCHEM, V106, P608, DOI 10.1002/jcb.22037; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Considine RV, 1996, AM J PHYSIOL-ENDOC M, V270, pE895, DOI 10.1152/ajpendo.1996.270.5.E895; Cousin B, 1999, FASEB J, V13, P305, DOI 10.1096/fasebj.13.2.305; Dave SH, 2009, J LEUKOCYTE BIOL, V86, P633, DOI 10.1189/jlb.1008662; Fasshauer M, 2003, HORM METAB RES, V35, P147, DOI 10.1055/s-2003-39075; Feng DR, 2011, DIABETES, V60, P2134, DOI 10.2337/db10-1411; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Flyvbjerg A, 2004, DIABETES, V53, P166, DOI 10.2337/diabetes.53.1.166; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Han YS, 2005, J PHARMACOL EXP THER, V312, P1097, DOI 10.1124/jpet.104.079707; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Hoareau L, 2006, CYTOKINE, V34, P291, DOI 10.1016/j.cyto.2006.06.005; Hoch M, 2008, CYTOKINE, V41, P29, DOI 10.1016/j.cyto.2007.10.008; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Huth C, 2006, DIABETES, V55, P2915, DOI 10.2337/db06-0600; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Izem L, 2007, J BIOL CHEM, V282, P21856, DOI 10.1074/jbc.M701075200; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Lehrke M, 2008, CRIT CARE, V12, DOI 10.1186/cc7152; Leuner B, 2012, Z GERONTOL GERIATR, V45, P102, DOI 10.1007/s00391-011-0279-x; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Mantell LL, 2006, SHOCK, V25, P4, DOI 10.1097/01.shk.0000188710.04777.9e; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Nair S, 2005, DIABETOLOGIA, V48, P1784, DOI 10.1007/s00125-005-1868-2; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Ogawa W, 2008, SCIENCE, V322, P1483, DOI 10.1126/science.1167571; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Rodino-Janeiro BK, 2011, EUR J ENDOCRINOL, V164, P529, DOI 10.1530/EJE-10-0904; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Samuvel DJ, 2010, J BIOL CHEM, V285, P3916, DOI 10.1074/jbc.M109.033951; Sitia G, 2007, J LEUKOCYTE BIOL, V81, P100, DOI 10.1189/jlb.0306173; Tarnus E, 2009, FEBS LETT, V583, P2042, DOI 10.1016/j.febslet.2009.05.016; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Unoki H, 2008, CURR PHARM DESIGN, V14, P987, DOI 10.2174/138161208784139747; Unoki H, 2007, DIABETES RES CLIN PR, V76, P236, DOI 10.1016/j.diabres.2006.09.016; Viranaicken W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022296; Wahamaa H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3450; Wassef H, 2004, J NUTR, V134, P2935, DOI 10.1093/jn/134.11.2935; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wendt T, 2006, ATHEROSCLEROSIS, V185, P70, DOI 10.1016/j.atherosclerosis.2005.06.013; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648	57	71	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76039	10.1371/journal.pone.0076039	http://dx.doi.org/10.1371/journal.pone.0076039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073286	Green Published, gold			2022-12-27	WOS:000324768000096
J	Pan, H; Wu, NP; Ding, H; Ding, Q; Dai, JC; Ling, LJ; Chen, L; Zha, XM; Liu, XA; Zhou, WB; Wang, S				Pan, Hong; Wu, Naping; Ding, Hao; Ding, Qiang; Dai, Juncheng; Ling, Lijun; Chen, Lin; Zha, Xiaoming; Liu, Xiaoan; Zhou, Wenbin; Wang, Shui			Intraoperative Ultrasound Guidance Is Associated with Clear Lumpectomy Margins for Breast Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							LESION LOCALIZATION ROLL; 20-YEAR FOLLOW-UP; CONSERVING SURGERY; GUIDED LUMPECTOMY; NEEDLE LOCALIZATION; RE-EXCISION; THERAPY; MASTECTOMY; RESECTION; TUMOR	Purpose: Margin status is one of the most important predictors of local recurrence after breast conserving surgery (BCS). Intraoperative ultrasound guidance (IOUS) has the potential to improve surgical accuracy for breast cancer. The purpose of the present meta-analysis was to determine the efficacy of IOUS in breast cancer surgery and to compare the margin status to that of the more traditional Guide wire localization (GWL) or palpation-guidance. Methods: We searched the database of PubMed for prospective and retrospective studies about the impact of IOUS on margin status of breast cancer, and a meta-analysis was conducted. Results: Of the 13 studies included, 8 were eligible for the impact of IOUS on margin status of non-palpable breast cancers, 4 were eligible for palpable breast cancers, and 1 was for both non-palpable and palpable breast cancers. The rate of negative margins of breast cancers in IOUS group was significantly higher than that in control group without IOUS (risk ratio (RR) = 1.37, 95% confidence interval (CI) = 1.18-1.59 from 7 prospective studies, odds ratio (OR) = 2.75, 95% CI = 1.66-4.55 from 4 retrospective studies). For non-palpable breast cancers, IOUS-guidance enabled a significantly higher rate of negative margins than that of GWL-guidance (RR = 1.26, 95% CI = 1.09-1.46 from 6 prospective studies; OR = 1.45, 95% CI = 0.86-2.43 from 2 retrospective studies). For palpable breast cancers, relative to control group without IOUS, the RR for IOUS associated negative margins was 2.36 (95% CI = 1.26-4.43) from 2 prospective studies, the OR was 2.71 (95% CI = 1.25-5.87) from 2 retrospective studies. Conclusion: This study strongly suggests that IOUS is an accurate method for localization of non-palpable and palpable breast cancers. It is an efficient method of obtaining high proportion of negative margins and optimum resection volumes in patients undergoing BCS.	[Pan, Hong; Wu, Naping; Ding, Qiang; Ling, Lijun; Chen, Lin; Zha, Xiaoming; Liu, Xiaoan; Zhou, Wenbin; Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China; [Ding, Hao] Baoying Cty Hosp, Dept Surg, Yangzhou, Jiangsu, Peoples R China; [Dai, Juncheng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Liu, XA (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	liuxiaoan@126.com; zhouwenbin_1984@foxmail.com			National Natural Science Foundation of China [81071753, 81172505, 81202077, 81272916]; Natural Science Foundation of Jiangsu Province [BK201058, BK2011853, BK2011855]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008]; Priority Academic Program Development of Jiangsu higher Education Institutions [PAPD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu higher Education Institutions [PAPD]	This work was supported in part by the National Natural Science Foundation of China [81071753, 81172505, 81202077 and 81272916], the Natural Science Foundation of Jiangsu Province [BK201058, BK2011853 and BK2011855], the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU [IRT-008] and a project Funded by the Priority Academic Program Development of Jiangsu higher Education Institutions [PAPD]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barentsz MW, 2012, BREAST CANCER RES TR, V135, P209, DOI 10.1007/s10549-012-2165-7; Bennett IC, 2005, WORLD J SURG, V29, P369, DOI 10.1007/s00268-004-7554-6; Bouton ME, 2011, AM SURGEON, V77, P640; Cochrane RA, 2003, BRIT J SURG, V90, P1505, DOI 10.1002/bjs.4344; Davis KM, 2011, AM SURGEON, V77, P720; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eichler C, 2012, ANTICANCER RES, V32, P1051; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Fisher CS, 2011, ANN SURG ONCOL, V18, P3198, DOI 10.1245/s10434-011-1958-y; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Haid A, 2007, ANN SURG ONCOL, V14, P3090, DOI 10.1245/s10434-007-9490-9; Henry-Tillman R, 2001, SEMIN SURG ONCOL, V20, P206, DOI 10.1002/ssu.1035; HOMER MJ, 1992, RADIOL CLIN N AM, V30, P139; James TA, 2009, ANN SURG ONCOL, V16, P1164, DOI 10.1245/s10434-009-0388-6; Krekel NMA, 2011, EJSO-EUR J SURG ONC, V37, P109, DOI 10.1016/j.ejso.2010.12.006; Krekel N, 2011, BREAST J, V17, P602, DOI 10.1111/j.1524-4741.2011.01198.x; Krekel NMA, 2013, LANCET ONCOL, V14, P48, DOI 10.1016/S1470-2045(12)70527-2; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moore MM, 2001, ANN SURG, V233, P761, DOI 10.1097/00000658-200106000-00005; Nadeem R, 2005, BREAST, V14, P283, DOI 10.1016/j.breast.2005.04.002; Park CC, 2000, J CLIN ONCOL, V18, P1668, DOI 10.1200/JCO.2000.18.8.1668; Pleijhuis RG, 2009, ANN SURG ONCOL, V16, P2717, DOI 10.1245/s10434-009-0609-z; Postma EL, 2011, EXPERT REV ANTICANC, V11, P1295, DOI [10.1586/ERA.11.116, 10.1586/era.11.116]; Rahusen FD, 2002, ANN SURG ONCOL, V9, P994, DOI 10.1245/ASO.2002.04.009; Rahusen FD, 1999, J SURG ONCOL, V72, P72, DOI 10.1002/(SICI)1096-9098(199910)72:2<72::AID-JSO6>3.0.CO;2-M; SCHWARTZ GF, 1988, SURGERY, V104, P870; Snider HC, 1999, ANN SURG ONCOL, V6, P308, DOI 10.1007/s10434-999-0308-9; Taghian A, 2005, ANN SURG, V241, P629, DOI 10.1097/01.sla.0000157272.04803.1b; van der Ploeg IMC, 2008, EJSO-EUR J SURG ONC, V34, P1, DOI 10.1016/j.ejso.2007.03.002; van Rijk MC, 2007, ANN SURG ONCOL, V14, P627, DOI 10.1245/s10434-006-9070-4; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Vrieling C, 2000, RADIOTHER ONCOL, V55, P219, DOI 10.1016/S0167-8140(00)00210-3; Waljee JF, 2008, ANN SURG ONCOL, V15, P1297, DOI 10.1245/s10434-007-9777-x; WILD JJ, 1951, LANCET, V260, P655; Zhou WB, 2011, BREAST CANCER RES TR, V128, P625, DOI 10.1007/s10549-011-1556-5; Zhou WB, 2011, J CANCER RES CLIN, V137, P1053, DOI 10.1007/s00432-011-0979-z	39	43	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74028	10.1371/journal.pone.0074028	http://dx.doi.org/10.1371/journal.pone.0074028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073200	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000009
J	Slezak-Prochazka, I; Kluiver, J; de Jong, D; Kortman, G; Halsema, N; Poppema, S; Kroesen, BJ; van den Berg, A				Slezak-Prochazka, Izabella; Kluiver, Joost; de Jong, Debora; Kortman, Gertrud; Halsema, Nancy; Poppema, Sibrand; Kroesen, Bart-Jan; van den Berg, Anke			Cellular Localization and Processing of Primary Transcripts of Exonic MicroRNAs	PLOS ONE			English	Article							MICROPROCESSOR COMPLEX; LYMPHOMA; HODGKIN; EXPRESSION; GENE; MIR-155; SITES; RNA; BIOGENESIS; CELLS	Processing of miRNAs occurs simultaneous with the transcription and splicing of their primary transcripts. For the small subset of exonic miRNAs it is unclear if the unspliced and/or spliced transcripts are used for miRNA biogenesis. We assessed endogenous levels and cellular location of primary transcripts of three exonic miRNAs. The ratio between unspliced and spliced transcripts varied markedly, i.e. >1 for BIC, <1 for pri-miR-146a and variable for pri-miR-22. Endogenous unspliced transcripts were located almost exclusively in the nucleus and thus available for miRNA processing for all three miRNAs. Endogenous spliced pri-miRNA transcripts were present both in the nucleus and in the cytoplasm and thus only partly available for miRNA processing. Overexpression of constructs containing the 5' upstream exonic or intronic sequence flanking pre-miR-155 resulted in strongly enhanced miR-155 levels, indicating that the flanking sequence does not affect processing efficiency. Exogenously overexpressed full-length spliced BIC transcripts were present both in the nucleus and in the cytoplasm, were bound by the Microprocessor complex and resulted in enhanced miR-155 levels. We conclude that both unspliced and spliced transcripts of exonic miRNAs can be used for pre-miRNA cleavage. Splicing and cytoplasmic transport of spliced transcripts may present a mechanism to regulate levels of exonic microRNAs.	[Slezak-Prochazka, Izabella; Kluiver, Joost; de Jong, Debora; Kortman, Gertrud; Halsema, Nancy; Poppema, Sibrand; Kroesen, Bart-Jan; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen	van den Berg, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.van.den.berg01@umcg.nl	van den Berg, Anke/H-1718-2011; Slezak-Prochazka, Izabella/F-7674-2019; Kluiver, Joost/G-6406-2014; Poppema, Sibrand/D-1204-2012	van den Berg, Anke/0000-0002-8894-2638; Slezak-Prochazka, Izabella/0000-0002-0707-2213; Kluiver, Joost/0000-0001-7650-2937; 	Dutch Cancer Society [RUG 2009-4279]; Ubbo Emmius Foundation	Dutch Cancer Society(KWF Kankerbestrijding); Ubbo Emmius Foundation	This study was supported by a grant from the Dutch Cancer Society (RUG 2009-4279) to B.J.K. and A.v.d.B and by a grant from the Ubbo Emmius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Atayar C, 2005, AM J PATHOL, V166, P127, DOI 10.1016/S0002-9440(10)62238-9; Atayar C, 2006, HUM PATHOL, V37, P675, DOI 10.1016/j.humpath.2006.01.018; Ballarino M, 2009, MOL CELL BIOL, V29, P5632, DOI 10.1128/MCB.00664-09; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Copie-Bergman C, 2003, BLOOD, V101, P2756, DOI 10.1182/blood-2002-07-2215; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; DIEHL V, 1985, CANCER SURV, V4, P399; DIEHL V, 1982, CANCER TREAT REP, V66, P615; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Gherzi R, 2010, WIRES RNA, V1, P230, DOI 10.1002/wrna.2; Gibcus JH, 2009, NEOPLASIA, V11, P167, DOI 10.1593/neo.08980; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Janas MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002330; Kanzler H, 1996, BLOOD, V87, P3429, DOI 10.1182/blood.V87.8.3429.bloodjournal8783429; Kataoka N, 2009, MOL CELL BIOL, V29, P3243, DOI 10.1128/MCB.00360-09; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; Mader A, 2007, CYTOGENET GENOME RES, V119, P204, DOI 10.1159/000112062; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Pawlicki JM, 2008, J CELL BIOL, V182, P61, DOI 10.1083/jcb.200803111; Pawlicki JM, 2009, CELL CYCLE, V8, P345, DOI 10.4161/cc.8.3.7494; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Saini HK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-564; SCHAADT M, 1980, INT J CANCER, V26, P723, DOI 10.1002/ijc.2910260605; Shapiro JS, 2012, RNA, V18, P1338, DOI 10.1261/rna.032268.112; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Taft RJ, 2010, NAT STRUCT MOL BIOL, V17, P1030, DOI 10.1038/nsmb.1841; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; TWEEDDALE ME, 1987, BLOOD, V69, P1307; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Zhang T, 2008, LEUKEMIA, V22, P1795, DOI 10.1038/leu.2008.62	60	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76647	10.1371/journal.pone.0076647	http://dx.doi.org/10.1371/journal.pone.0076647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073292	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000102
J	Wysocka-Kapcinska, M; Torocsik, B; Turiak, L; Tsaprailis, G; David, CL; Hunt, AM; Vekey, K; Adam-Vizi, V; Kucharczyk, R; Chinopoulos, C				Wysocka-Kapcinska, Monika; Torocsik, Beata; Turiak, Lilla; Tsaprailis, George; David, Cynthia L.; Hunt, Andrea M.; Vekey, Karoly; Adam-Vizi, Vera; Kucharczyk, Roza; Chinopoulos, Christos			The Suppressor of AAC2 Lethality SAL1 Modulates Sensitivity of Heterologously Expressed Artemia ADP/ATP Carrier to Bongkrekate in Yeast	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; ADENINE-NUCLEOTIDE TRANSLOCASE; TANDEM MASS-SPECTROMETRY; BEEF-HEART MITOCHONDRIA; SACCHAROMYCES-CEREVISIAE; ATP SYNTHASE; FRANCISCANA EMBRYOS; CALCIUM UNIPORTER; OXIDATIVE STRESS; PROTEIN	The ADP/ATP carrier protein (AAC) expressed in Artemia franciscana is refractory to bongkrekate. We generated two strains of Saccharomyces cerevisiae where AAC1 and AAC3 were inactivated and the AAC2 isoform was replaced with Artemia AAC containing a hemagglutinin tag (ArAAC-HA). In one of the strains the suppressor of Delta AAC2 lethality, SAL1, was also inactivated but a plasmid coding for yeast AAC2 was included, because the ArAAC Delta sal1 Delta strain was lethal. In both strains ArAAC-HA was expressed and correctly localized to the mitochondria. Peptide sequencing of ArAAC expressed in Artemia and that expressed in the modified yeasts revealed identical amino acid sequences. The isolated mitochondria from both modified strains developed 85% of the membrane potential attained by mitochondria of control strains, and addition of ADP yielded bongkrekate-sensitive depolarizations implying acquired sensitivity of ArAAC-mediated adenine nucleotide exchange to this poison, independent from SAL1. However, growth of ArAAC-expressing yeasts in glycerol-containing media was arrested by bongkrekate only in the presence of SAL1. We conclude that the mitochondrial environment of yeasts relying on respiratory growth conferred sensitivity of ArAAC to bongkrekate in a SAL1-dependent manner.	[Wysocka-Kapcinska, Monika; Kucharczyk, Roza] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Torocsik, Beata; Adam-Vizi, Vera; Chinopoulos, Christos] Semmelweis Univ, Dept Med Biochem, H-1085 Budapest, Hungary; [Turiak, Lilla; Vekey, Karoly] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Organ Chem, Budapest, Hungary; [Tsaprailis, George; David, Cynthia L.; Hunt, Andrea M.] Univ Arizona, Coll Pharm, Ctr Toxicol, Tucson, AZ 85721 USA	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Arizona	Kucharczyk, R (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	roza@ibb.waw.pl; chinopoulos.christos@eok.sote.hu	Kucharczyk, Roza/H-8154-2012	Chinopoulos, Christos/0000-0003-0183-4149; Kucharczyk, Roza/0000-0002-8712-7535; Tsaprailis, George/0000-0003-1239-2358; Adam-Vizi, Vera/0000-0002-8350-8701; Torocsik, Beata/0000-0002-9838-3710	National Science Centre of Poland [1932/B/P01/2010/39]; Magyar Tudomanyos Akademia (MTA-SE) Lendulet Neurobiochemistry Research Division [95003]; Orszagos Tudomanyos Kutatasi Alapprogram [NNF 78905, NNF2 85658, K 100918]; European Community grant ASSEMBLE [227799]; OTKA [81983, 83857]; MTA grants; NIEHS [ES06694]; NIH/NCI [CA023074]; BIO5 Institute of the University of Arizona; NIH/NCRR [1S10 RR028868-01]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Science Centre of Poland(National Science Centre, Poland); Magyar Tudomanyos Akademia (MTA-SE) Lendulet Neurobiochemistry Research Division; Orszagos Tudomanyos Kutatasi Alapprogram; European Community grant ASSEMBLE; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MTA grants; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Science Centre of Poland nr 1932/B/P01/2010/39 to R.K., Magyar Tudomanyos Akademia (MTA-SE) Lendulet Neurobiochemistry Research Division grant 95003 and the Orszagos Tudomanyos Kutatasi Alapprogram grants NNF 78905, NNF2 85658, and K 100918 and the European Community grant ASSEMBLE (project agreement no. 227799, BKA binding on ANT) to C.C, OTKA 81983 and MTA grants to V.A.-V., and OTKA grant 83857 to K.V. Mass spectrometry and proteomics data were acquired by the Arizona Proteomics Consortium supported by NIEHS grant ES06694 to the SWEHSC, NIH/NCI grant CA023074 to the AZCC and by the BIO5 Institute of the University of Arizona. The Thermo Fisher LTQ Orbitrap Velos mass spectrometer was provided by grant 1S10 RR028868-01 from NIH/NCRR to G.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amigo I, 2013, J BIOL CHEM, V288, P7791, DOI 10.1074/jbc.M112.409144; Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; AQUILA H, 1978, EUR J BIOCHEM, V85, P549, DOI 10.1111/j.1432-1033.1978.tb12270.x; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; BRANDOLIN G, 1980, BIOCHIM BIOPHYS ACTA, V592, P592, DOI 10.1016/0005-2728(80)90103-6; Cavero S, 2005, BIOCHEM J, V392, P537, DOI 10.1042/BJ20050806; Chen XJ, 2004, GENETICS, V167, P607, DOI 10.1534/genetics.103.023655; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Clegg JS, 1997, J EXP BIOL, V200, P467; Cooper B, 2003, J AM SOC MASS SPECTR, V14, P736, DOI 10.1016/S1044-0305(03)00125-9; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Csaba K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039839; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fiore C, 1998, BIOCHIMIE, V80, P137, DOI 10.1016/S0300-9084(98)80020-5; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guerin B, 1979, Methods Enzymol, V55, P149; Hamazaki T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019250; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Haworth RA, 2000, J BIOENERG BIOMEMBR, V32, P91, DOI 10.1023/A:1005568630151; HENDERSON PJ, 1970, BIOCHEMISTRY-US, V9, P3453, DOI 10.1021/bi00819a026; HOFFMANN B, 1994, J BIOL CHEM, V269, P1940; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KEMP A JR, 1970, Biochimica et Biophysica Acta, V223, P460, DOI 10.1016/0005-2728(70)90210-0; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Konrad C, 2011, FEBS J, V278, P822, DOI 10.1111/j.1742-4658.2010.08001.x; KRAMER R, 1977, BIOCHEMISTRY-US, V16, P4954; Kucejova B, 2008, MOL GENET GENOMICS, V280, P25, DOI 10.1007/s00438-008-0342-5; KWAST KE, 1993, AM J PHYSIOL, V265, pR1238, DOI 10.1152/ajpregu.1993.265.6.R1238; Laco J, 2010, FEMS YEAST RES, V10, P290, DOI 10.1111/j.1567-1364.2010.00606.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUQUIN G, 1973, FEBS LETT, V35, P198, DOI 10.1016/0014-5793(73)80283-2; LAUQUIN GJM, 1976, BIOCHEMISTRY-US, V15, P2323, DOI 10.1021/bi00656a012; Lemasters JJ, 1997, MOL CELL BIOCHEM, V174, P159, DOI 10.1023/A:1006827601337; Manon S, 1998, J BIOENERG BIOMEMBR, V30, P419, DOI 10.1023/A:1020533928491; Menze MA, 2005, AM J PHYSIOL-REG I, V289, pR68, DOI 10.1152/ajpregu.00844.2004; Ozohanics O, 2012, J CHROMATOGR A, V1259, P200, DOI 10.1016/j.chroma.2012.05.031; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Parvin R, 1969, METHODS ENZYMOL, P16; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Rey M, 2010, J BIOL CHEM, V285, P34981, DOI 10.1074/jbc.M110.146209; Reynolds JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P366, DOI 10.1086/420950; RICKEY TM, 1986, MOL CELL BIOL, V6, P488, DOI 10.1128/MCB.6.2.488; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith CP, 2008, GENETICS, V179, P1285, DOI 10.1534/genetics.108.087700; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Szabadkai G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00140; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Traba J, 2008, MOL MICROBIOL, V69, P570, DOI 10.1111/j.1365-2958.2008.06300.x; URIBE S, 1992, CELL CALCIUM, V13, P211, DOI 10.1016/0143-4160(92)90009-H; WOLDEGIORGIS G, 1985, J BIOL CHEM, V260, P7585; Zheleznova NN, 2012, PHYSIOL GENOMICS, V44, P829, DOI 10.1152/physiolgenomics.00060.2012	63	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74187	10.1371/journal.pone.0074187	http://dx.doi.org/10.1371/journal.pone.0074187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073201	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000324768000010
J	Lam, MHY; Emili, A				Lam, Mandy H. Y.; Emili, Andrew			Ubp2 Regulates Rsp5 Ubiquitination Activity In Vivo and In Vitro	PLOS ONE			English	Article							RNA-POLYMERASE-II; YEAST SACCHAROMYCES-CEREVISIAE; DEUBIQUITINATING ENZYME UBP2; MULTIVESICULAR BODY PATHWAY; AMINO-ACID PERMEASE; PROTEIN LIGASE; MEMBRANE-PROTEINS; ENDOCYTOSIS; FAMILY; ITCH	The yeast HECT-family E3 ubiquitin ligase Rsp5 has been implicated in diverse cell functions. Previously, we and others [1,2] reported the physical and functional interaction of Rsp5 with the deubiquitinating enzyme Ubp2, and the ubiquitin associated (UBA) domain-containing cofactor Rup1. To investigate the mechanism and significance of the Rsp5-Rup1-Ubp2 complex, we examined Rsp5 ubiquitination status in the presence or absence of these cofactors. We found that, similar to its mammalian homologues, Rsp5 is auto-ubiquitinated in vivo. Association with a substrate or Rup1 increased Rsp5 self-ubiquitination, whereas Ubp2 efficiently deubiquitinates Rsp5 in vivo and in vitro. The data reported here imply an auto-modulatory mechanism of Rsp5 regulation common to other E3 ligases.	[Lam, Mandy H. Y.; Emili, Andrew] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada	University of Toronto	Emili, A (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON, Canada.	andrew.emili@utoronto.ca			Protein Engineering Network Centre of Excellence of Canada (PENCE); Ontario Graduate Scholarships; University of Toronto Open Fellowships	Protein Engineering Network Centre of Excellence of Canada (PENCE); Ontario Graduate Scholarships(Ontario Graduate Scholarship); University of Toronto Open Fellowships	This work was supported by funds from the Protein Engineering Network Centre of Excellence of Canada (PENCE) to A. E., and Ontario Graduate Scholarships and University of Toronto Open Fellowships to M.H.Y.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER RT, 1992, J BIOL CHEM, V267, P23364; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hitchcock AL, 2003, P NATL ACAD SCI USA, V100, P12735, DOI 10.1073/pnas.2135500100; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jarmoszewicz K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039582; Kaminska J, 2002, MOL CELL BIOL, V22, P6946, DOI 10.1128/MCB.22.20.6946-6958.2002; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kus B, 2005, J BIOL CHEM, V280, P29470, DOI 10.1074/jbc.M502197200; Lam MHY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004259; Lee JRE, 2009, J BIOL CHEM, V284, P32126, DOI 10.1074/jbc.M109.048629; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Macdonald C, 2011, TRAFFIC; MacDonald C, 2012, TRAFFIC, V13, P586, DOI 10.1111/j.1600-0854.2011.01326.x; Marchenko ND, 2009, CELL DEATH DIFFER; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Morvan J, 2004, TRAFFIC, V5, P383, DOI 10.1111/j.1398-9219.2004.00183.x; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Novoselova TV, 2012, EUKARYOT CELL, V11, P463, DOI 10.1128/EC.00009-12; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Starita LM, 2012, PROTEOMICS, V12, P236, DOI 10.1002/pmic.201100166; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	55	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75372	10.1371/journal.pone.0075372	http://dx.doi.org/10.1371/journal.pone.0075372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069405	gold, Green Submitted, Green Published			2022-12-27	WOS:000324777300074
J	Szenczi, P; Banszegi, O; Groo, Z; Altbacker, V				Peter Szenczi; Oxana Banszegi; Zita Groo; Vilmos Altbaecker			Anogenital Distance and Condition as Predictors of Litter Sex Ratio in Two Mouse Species: A Study of the House Mouse (Mus musculus) and Mound-Building Mouse (Mus spicilegus)	PLOS ONE			English	Article							INTRAUTERINE POSITION AFFECTS; FEMALE RATS; MESOCRICETUS-AURATUS; GENITAL MORPHOLOGY; MONGOLIAN GERBILS; SOCIAL STRESS; WILD BOAR; MICE; BEHAVIOR; TESTOSTERONE	The Trivers - Willard hypothesis (1973) suggests that the maternal condition may affect the female's litter size and sex ratio. Since then other factors had been found. Previous findings revealed in the case of some mammalian species, that females with larger anogenital distance have smaller litters, while the sex ratio is male-biased. That has only been demonstrated in laboratory animals, while the genetic diversity of a wild population could mask the phenomenon seen in laboratory colonies. We examined the connection between morphological traits (weight and anogenital distance) and the reproductive capacity of two wild mice species, the house mouse and the mound-building mice. We showed in both species that anogenital distance and body weight correlated positively in pre-pubertal females, but not in adults. Neither the house mouse nor the mound-building mouse mothers' weight had effect on their litter's size and sex ratio. Otherwise connection was found between the mothers' anogenital distance and their litters' sex ratio in both species. The results revealed that females with larger anogenital distance delivered male biased litter in both species. The bias occurred as while the number of female pups remained the same; mothers with large anogenital distance delivered more male pups compared to the mothers with small anogenital distance. We concluded that a female's prenatal life affects her reproductive success more than previously anticipated.	[Peter Szenczi; Zita Groo; Vilmos Altbaecker] Eotvos Lorand Univ, Dept Ethol, God, Hungary; [Oxana Banszegi] Hungarian Acad Sci, Agr Res Ctr, Inst Soil Sci & Agr Chem, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Szenczi, P (corresponding author), Eotvos Lorand Univ, Dept Ethol, God, Hungary.	peter.szenczi@gmail.com	Szenczi, Péter/C-7233-2015; Bánszegi, Oxána/ABF-7208-2020	Szenczi, Péter/0000-0002-8495-1633; Bánszegi, Oxána/0000-0002-1704-3539	GEBACO EU FP6 grant [28696]	GEBACO EU FP6 grant	This work was supported by the GEBACO EU FP6 grant no. 28696 to Vilmos Altbacker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaine D, 2000, BEHAV ECOL, V11, P507, DOI 10.1093/beheco/11.5.507; Banszegi O, 2012, PHYSIOL BEHAV, V105, P1226, DOI 10.1016/j.physbeh.2012.01.002; Banszegi O, 2009, PHYSIOL BEHAV, V98, P258, DOI 10.1016/j.physbeh.2009.05.016; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Clark MM, 1998, DEV NEUROPSYCHOL, V14, P197, DOI 10.1080/87565649809540709; CLARK MM, 1991, PHYSIOL BEHAV, V49, P239, DOI 10.1016/0031-9384(91)90038-P; CLARK MM, 1995, PHYSIOL BEHAV, V57, P297, DOI 10.1016/0031-9384(94)00239-2; CLARK MM, 1993, NATURE, V364, P712, DOI 10.1038/364712a0; CLEMENS LG, 1978, HORM BEHAV, V10, P40, DOI 10.1016/0018-506X(78)90023-5; Csatadi K., 2007, THESIS EOTVOS LORAND; Dama MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016296; Drickamer LC, 2001, ETHOLOGY, V107, P509, DOI 10.1046/j.1439-0310.2001.00677.x; Drickamer LC, 1996, ANIM BEHAV, V51, P925, DOI 10.1006/anbe.1996.0096; Dusek A, 2011, BEHAV ECOL SOCIOBIOL, V65, P2209, DOI 10.1007/s00265-011-1229-8; Fernandez-Llario P, 1999, ANIM BEHAV, V58, P1079, DOI 10.1006/anbe.1999.1234; Feron C, 2003, PHYSIOL BEHAV, V78, P717, DOI 10.1016/S0031-9384(03)00044-1; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; GANDELMAN R, 1977, NATURE, V266, P722, DOI 10.1038/266722a0; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goerlich VC, 2009, GEN COMP ENDOCR, V163, P184, DOI 10.1016/j.ygcen.2009.01.004; Gouat P, 2003, REPROD FERT DEVELOP, V15, P187, DOI 10.1071/RD02105; Grant VJ, 2007, J THEOR BIOL, V246, P708, DOI 10.1016/j.jtbi.2007.02.005; Grant VJ, 2011, ANIM BEHAV, V82, P893, DOI 10.1016/j.anbehav.2011.07.029; Grant VJ, 2005, J EXP ZOOL PART A, V303A, P1120, DOI 10.1002/jez.a.233; Hardy I.C.W, 2002, SEX RATIOS CONCEPTS; Helle S, 2008, ANIM BEHAV, V75, P1031, DOI 10.1016/j.anbehav.2007.08.015; Helle S, 2013, BEHAV ECOL, V24, P205, DOI 10.1093/beheco/ars155; HIRLEMANN S, 1990, B ZOOL, V57, P67, DOI 10.1080/11250009009355676; HOWARD ALMA, 1955, JOUR GENETICS, V53, P200, DOI 10.1007/BF02981523; Krackow S, 1997, BEHAV ECOL SOCIOBIOL, V41, P435, DOI 10.1007/s002650050404; LABOV JB, 1986, BEHAV ECOL SOCIOBIOL, V18, P241, DOI 10.1007/BF00300000; Manning JT, 2002, J THEOR BIOL, V217, P93, DOI 10.1006/jtbi.2002.3014; MCCLURE PA, 1981, SCIENCE, V211, P1058, DOI 10.1126/science.211.4486.1058; MCDERMOTT NJ, 1978, PHYSIOL BEHAV, V20, P661, DOI 10.1016/0031-9384(78)90261-5; MEIKLE DB, 1986, J REPROD FERTIL, V78, P587, DOI 10.1530/jrf.0.0780587; MEISEL RL, 1981, SCIENCE, V213, P239, DOI 10.1126/science.7244634; MENDL M, 1995, ANIM BEHAV, V50, P1361, DOI 10.1016/0003-3472(95)80051-4; Owusu BA, 2010, ANIM REPROD SCI, V118, P366, DOI 10.1016/j.anireprosci.2009.08.013; PALANZA P, 1995, PHYSIOL BEHAV, V58, P827, DOI 10.1016/0031-9384(95)00107-T; Peaker M, 1996, J REPROD FERTIL, V108, P63, DOI 10.1530/jrf.0.1080063; PRATT NC, 1989, J REPROD FERTIL, V87, P763, DOI 10.1530/jrf.0.0870763; QUADAGNO DM, 1987, PHYSIOL BEHAV, V41, P639, DOI 10.1016/0031-9384(87)90323-4; Rosenfeld CS, 2004, BIOL REPROD, V71, P1063, DOI 10.1095/biolreprod.104.030890; Rutkowska J, 2006, ANIM BEHAV, V71, P1283, DOI 10.1016/j.anbehav.2005.07.025; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; Ryan CP, 2012, BEHAV ECOL, V23, P160, DOI 10.1093/beheco/arr169; SAAL FSV, 1980, SCIENCE, V208, P597, DOI 10.1126/science.7367881; SAAL FSV, 1985, BIOL REPROD, V32, P1116, DOI 10.1095/biolreprod32.5.1116; SAAL FSV, 1989, J ANIM SCI, V67, P1824; SAAL FSV, 1991, PHYSIOL BEHAV, V49, P1073, DOI 10.1016/0031-9384(91)90333-J; Servanty S, 2007, BEHAV ECOL, V18, P427, DOI 10.1093/beheco/arl099; StatSoft I., 2007, STATISTICA DAT AN SO; TOBET SA, 1982, HORM BEHAV, V16, P251, DOI 10.1016/0018-506X(82)90025-3; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; VANDENBERGH JG, 1995, LAB ANIM SCI, V45, P567; VANDENBERGH JG, 1994, P NATL ACAD SCI USA, V91, P11055, DOI 10.1073/pnas.91.23.11055; VOMSAAL FS, 1978, BIOL REPROD, V19, P842, DOI 10.1095/biolreprod19.4.842; vomSaal FS, 1999, ENCY REPROD, V2, P893; WEIR JA, 1960, GENETICS, V45, P1539; WILLIAMS GC, 1979, PROC R SOC SER B-BIO, V205, P567, DOI 10.1098/rspb.1979.0085; ZIELINSKI WJ, 1991, PHYSIOL BEHAV, V49, P117, DOI 10.1016/0031-9384(91)90241-F; ZIELINSKI WJ, 1992, BEHAV ECOL SOCIOBIOL, V30, P185, DOI 10.1007/BF00166702	62	10	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74066	10.1371/journal.pone.0074066	http://dx.doi.org/10.1371/journal.pone.0074066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069268	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300027
J	Jackson, A; Kloverpris, HN; Boffito, M; Handley, A; Atkins, M; Hayes, P; Gilmour, J; Riddel, L; Chen, F; Bailey-Tippets, M; Walker, B; Ackland, J; Sullivan, M; Goulder, P				Jackson, Akil; Kloverpris, Henrik N.; Boffito, Marta; Handley, Amanda; Atkins, Mark; Hayes, Peter; Gilmour, Jill; Riddel, Lynn; Chen, Fabian; Bailey-Tippets, Melanie; Walker, Bruce; Ackland, Jim; Sullivan, Mark; Goulder, Philip			A Randomised, Placebo-Controlled, First-In-Human Study of a Novel Clade C Therapeutic Peptide Vaccine Administered Ex Vivo to Autologous White Blood Cells in HIV Infected Individuals	PLOS ONE			English	Article							VIRAL LOAD; IMMUNOTHERAPY; MACAQUES; RESPONSES; GAG	Background: Preclinical studies of overlapping 15mer peptides, spanning SIV, SHIV or HIV, pulsed on autologous PBMC ex vivo have demonstrated high level, virus-specific T cell responses and viral suppression in non-human primates (NHP). Opal-HIV-Gag(c) consists of 120 synthetic 15mer peptides spanning Clade C, consensus Gag, manufactured to current good manufacturing practice; having been evaluated in a good laboratory practice toxicology study in Macaca mulatta. We evaluated the safety and preliminary immunogenicity of such peptides administered intravenously after short-duration ex vivo incubation, to HIV-positive adults on suppressive antiretroviral therapy. Methods and Findings: A first-in-human, placebo-controlled, double-blind, dose escalation study was conducted. Twenty-three patients with virus suppressed by antiretroviral therapy were enrolled in four groups 12 mg (n = 6), 24 mg (n = 6), 48 mg (n = 2) or matching placebo (n = 8). Treatment was administered intravenously after bedside enrichment of 120 mL whole blood for white cells using a closed system (Sepax S-100 device), with ex vivo peptide admixture (or diluent alone) and 37 degrees C incubation for one hour prior to reinfusion. Patients received 4 administrations at monthly intervals followed by a 12-week observation post-treatment. Opal-HIV-Gag(c) was reasonably tolerated at doses of 12 and 24 mg. There was an increased incidence of temporally associated pyrexia, chills, and transient/self-limiting lymphopenia in Opal-HIV-Gag(c) recipients compared to placebo. The study was terminated early, after two patients were recruited to the 48 mg cohort; a serious adverse event of hypotension, tachycardia secondary to diarrhoea occurred following a single product administration. An infectious cause for the event could not be identified, leaving the possibility of immunologically mediated product reaction. Conclusions: A serious, potentially life-threatening event of hypotension led to early, precautionary termination of the study. In the absence of a clearly defined mechanism or ability to predict such occurrence, further development of Opal-HIV-Gag(c) will not be undertaken in the current form. Registration: ClinicalTrials.gov NCT01123915; EudraCT: 2008-005142-23	[Jackson, Akil; Boffito, Marta] St Stephens AIDS Trust, Chelsea & Westminster Hosp, London, England; [Kloverpris, Henrik N.; Goulder, Philip] Univ Oxford, Dept Paediat, Oxford, England; [Handley, Amanda; Sullivan, Mark] Med Dev, Melbourne, Vic, Australia; [Atkins, Mark; Hayes, Peter; Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, London, England; [Riddel, Lynn] Northampton Gen Hosp, Dept Genitourinary Med, Northampton, England; [Chen, Fabian] Royal Berkshire Hosp, Dept Sexual Hlth, Reading RG1 5AN, Berks, England; [Bailey-Tippets, Melanie] INC, Oakleigh, Vic, Australia; [Walker, Bruce; Goulder, Philip] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA; [Ackland, Jim] Global Biosolut, Craigieburn, Vic, Australia; [Kloverpris, Henrik N.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Kloverpris, Henrik N.] Univ Kwazulu Natal, K RITH, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa	Imperial College London; University of Oxford; Imperial College London; Royal Berkshire Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Copenhagen; University of Kwazulu Natal	Jackson, A (corresponding author), St Stephens AIDS Trust, Chelsea & Westminster Hosp, London, England.	akil.jackson@chelwest.nhs.uk		Kloverpris, Henrik/0000-0002-2165-3313; Jackson, Akil/0000-0002-4574-544X	Phillip T; Susan M Ragon Foundation	Phillip T; Susan M Ragon Foundation	The funding for this project was provided by the Phillip T and Susan M Ragon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Chea S, 2005, J VIROL, V79, P3748, DOI 10.1128/JVI.79.6.3748-3757.2005; Chow SC, 2005, DESIGN ANAL CLIN TRI, V2nd; De Rose R, 2008, VIROLOGY, V378, P201, DOI 10.1016/j.virol.2008.06.006; De Rose R, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000055; De Rose R, 2008, J MED PRIMATOL, V37, P69, DOI 10.1111/j.1600-0684.2008.00329.x; F CDER, 1997, GUID IND GEN CONS CL; Ferrucci PF, 2000, BONE MARROW TRANSPL, V25, P173, DOI 10.1038/sj.bmt.1702120; Food and Drug Administration (FDA), 2005, GUID IND EST MAX SAF; Geels MJ, 2005, J VIROL, V79, P11247, DOI 10.1128/JVI.79.17.11247-11258.2005; Girard MP, 2012, CURR OPIN HIV AIDS, V7, P4, DOI 10.1097/COH.0b013e32834ddc96; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Haining WN, 2008, CLIN CANCER RES, V14, P5626, DOI 10.1158/1078-0432.CCR-08-0526; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; McKim AS, 2008, DIMETHYL SULFOXIDE U; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Rowley SD, 1999, CYTOTHERAPY, V1, P439, DOI 10.1080/0032472031000141303; Staprans Silvija I, 2004, Expert Rev Vaccines, V3, pS5, DOI 10.1586/14760584.3.4.S5; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; UNAIDS JUNPOHA, 2012, GLOB REP UNAIDS REP; Windrum P, 2005, BONE MARROW TRANSPL, V36, P601, DOI 10.1038/sj.bmt.1705100	22	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73765	10.1371/journal.pone.0073765	http://dx.doi.org/10.1371/journal.pone.0073765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069230	gold, Green Published			2022-12-27	WOS:000324547300022
J	Fang, YJ; Wu, XJ; Zhao, Q; Li, LR; Lu, ZH; Ding, PR; Zhang, RX; Kong, LH; Wang, FL; Lin, JZ; Chen, G; Pan, ZZ; Wan, DS				Fang, Yu-Jing; Wu, Xiao-Jun; Zhao, Qian; Li, Li-Ren; Lu, Zhen-Hai; Ding, Pei-Rong; Zhang, Rong-Xin; Kong, Ling-Heng; Wang, Fu-Long; Lin, Jun-Zhong; Chen, Gong; Pan, Zhi-Zhong; Wan, De-Sen			Hospital-Based Colorectal Cancer Survival Trend of Different Tumor Locations from 1960s to 2000s	PLOS ONE			English	Article							OCCULT BLOOD-TEST; PLUS IRINOTECAN; SUBSITE; CHINESE; COLON; FLUOROURACIL; LEUCOVORIN; MORTALITY; CETUXIMAB; RESECTION	Background: Our aim is to explore the trend of association between the survival rates of colorectal cancer (CRC) and the different clinical characteristics in patients registered from 1960s to 2000s. We hypothesized that the survival rate of CRC increases over time and varies according to anatomic subsites. Methods: Information from a total of 4558 stage T(1-4)N(1-2)M0 CRC patients registered from 1960s to 2008 were analyzed. The association of CRC overall survival with age, gender, tumor locations, time, histopathology types, pathology grades, no. of examined lymph nodes, the T stage, and the N stage was analyzed. The assessment of the influence of prognostic factors on patient survival was performed using Cox's proportional hazard regression models. Results: From 1960 to 2008, the studied CRC patients included 2625 (57.6%) and 1933 (42.4%) males and females, respectively. These included 1896 (41.6%) colon cancers, and 2662 (58.4%) rectum cancers. The 5-year survival rate was 49%, 58%, 58%, 70%, and 77% for the time duration of 1960s, 1970s, 1980s, 1990s and 2000s, respectively. An increased 5-year survival rate was observed in the colon cancer and rectum cancer patients. Patients older than 60 years of age were more likely to develop colonic cancer (sigmoid) than rectum cancer (49.2% vs. 39.9%). The Cox regression model showed that only rectum cancer survival was related to time duration. Conclusion: The overall survival and 5-year survival rates showed an increase from the 1960s to 2000s. There is a trend of rightward shift of tumor location in CRC patients.	[Fang, Yu-Jing; Wu, Xiao-Jun; Li, Li-Ren; Lu, Zhen-Hai; Ding, Pei-Rong; Zhang, Rong-Xin; Kong, Ling-Heng; Wang, Fu-Long; Lin, Jun-Zhong; Chen, Gong; Pan, Zhi-Zhong; Wan, De-Sen] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Yu-Jing] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Fang, Yu-Jing; Wu, Xiao-Jun; Li, Li-Ren; Lu, Zhen-Hai; Ding, Pei-Rong; Zhang, Rong-Xin; Kong, Ling-Heng; Wang, Fu-Long; Lin, Jun-Zhong; Chen, Gong; Pan, Zhi-Zhong; Wan, De-Sen] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Qian] Guangzhou Med Univ, Sch Publ Hlth, Dept Stat, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University	Pan, ZZ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China.	panzhzh@sysucc.org.cn; wds@medmail.com.cn			National Natural Science Foundation of the Republic of China [81101861]	National Natural Science Foundation of the Republic of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of the Republic of China (grant No. 81101861) to Dr. YJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Breivik J, 1997, INT J CANCER, V74, P664, DOI 10.1002/(SICI)1097-0215(19971219)74:6<664::AID-IJC18>3.0.CO;2-5; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Distler P, 1997, DIGEST DIS, V15, P302, DOI 10.1159/000171605; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GOLAN T, 2013, CANCER IN PRESS; GREENE FL, 2002, UNKNOWN AJCC CANC ST; Huang J, 1999, CANCER, V85, P2519, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2519::AID-CNCR5>3.0.CO;2-6; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji BT, 1998, CANCER EPIDEM BIOMAR, V7, P661; Kim DH, 2000, J KOREAN MED SCI, V15, P675, DOI 10.3346/jkms.2000.15.6.675; Larsson SC, 2006, EUR J CANCER, V42, P2590, DOI 10.1016/j.ejca.2006.04.015; Lee KJ, 2007, CANCER DETECT PREV, V31, P3, DOI 10.1016/j.cdp.2006.11.002; LI M, 2004, CHIN J GASTROINTEST, V7, P214; Lu JB, 2003, WORLD J GASTROENTERO, V9, P2400; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; McMichael A J, 1985, Natl Cancer Inst Monogr, V69, P223; Moore Malcolm A, 2005, Asian Pac J Cancer Prev, V6, P412; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Oort FA, 2010, ALIMENT PHARM THER, V31, P432, DOI 10.1111/j.1365-2036.2009.04184.x; Petrelli NJ, 2005, J CLIN ONCOL, V23, P4475, DOI 10.1200/JCO.2005.05.025; Pfannschmidt J, 2007, ANN THORAC SURG, V84, P324, DOI 10.1016/j.athoracsur.2007.02.093; Qing SH, 2003, WORLD J GASTROENTERO, V9, P721, DOI 10.3748/wjg.v9.i4.721; *SOC AC, 2007, GLOB CANC FACTS FIG; Stewart BW, 2003, WORLD CANC REPORT, P198; Sung JJY, 2003, GASTROENTEROLOGY, V124, P608, DOI 10.1053/gast.2003.50090; Takada H, 2002, DIS COLON RECTUM, V45, P1249, DOI 10.1007/s10350-004-6400-0; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Toyoda Y, 2009, JPN J CLIN ONCOL, V39, P189, DOI 10.1093/jjco/hyn144; van Rossum LGM, 2009, NETH J MED, V67, P182; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Wu XC, 2004, CANCER EPIDEM BIOMAR, V13, P1215; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813; Zheng S, 2003, CHINESE GERMAN J CLI, V2, P72, DOI DOI 10.1007/BF02855647; ZHENG S, 2006, COLORECTAL TUMOR BAS	39	21	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73528	10.1371/journal.pone.0073528	http://dx.doi.org/10.1371/journal.pone.0073528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069202	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100048
J	Ho, CH; Yu, HJ; Wang, CY; Jaw, FS; Hsieh, JT; Liao, WC; Pu, YS; Liu, SP				Ho, Chen-Hsun; Yu, Hong-Jeng; Wang, Chih-Yuan; Jaw, Fu-Shan; Hsieh, Ju-Ton; Liao, Wan-Chung; Pu, Yeong-Shiau; Liu, Shih-Ping			Prediabetes Is Associated with an Increased Risk of Testosterone Deficiency, Independent of Obesity and Metabolic Syndrome	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; IMPAIRED FASTING GLUCOSE; POSTPRANDIAL BLOOD-GLUCOSE; TYPE-2 DIABETES-MELLITUS; ALL-CAUSE MORTALITY; INSULIN-RESISTANCE; OLDER MEN; ANDROGEN DEFICIENCY; CARDIOVASCULAR EVENTS; SERUM TESTOSTERONE	Objective: The association between type 2 diabetes and low testosterone has been well recognized. However, testosterone levels in men with prediabetes have been rarely reported. We aimed to investigate whether prediabetes was associated with an increased risk of testosterone deficiency. Methods: This study included 1,306 men whose sex hormones was measured during a medical examination. Serum total testosterone and sex hormone-binding globulin were measured; free and bioavailable testosterone concentrations were calculated by Vermeulen's formula. Prediabetes was defined by impaired fasting glucose (IFG), impaired postprandial glucose (IPG), or glycated hemoglobin (HbA1c) 5.7%-6.4%. Logistic regression was performed to obtain the odds ratios (OR) for subnormal total testosterone (<300 ng/dL) or free testosterone (<6 ng/dL) in prediabetic and diabetic men compared with normoglycemic individuals, while adjusting for age, BMI, waist circumference, and metabolic syndrome (MetS). Results: Normoglycemia, prediabetes, and diabetes were diagnosed in 577 (44.2%), 543 (41.6%), and 186 (14.2%) men, respectively. Prediabetes was associated with an increased risk of subnormal total testosterone compared to normoglycemic individuals (age-adjusted OR=1.87; 95%CI=1.38-2.54). The risk remained significant in all multivariate analyses. After adjusting for MetS, the OR in prediabetic men equals that of diabetic patients (1.49 versus 1.50). IFG, IPG, and HbA1c 5.7%-6.4% were all associated with an increased risk of testosterone deficiency, with different levels of significance in multivariate analyses. However, neither prediabetes nor diabetes was associated with subnormal free testosterone in multivariate analyses. Conclusions: Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and MetS. After adjusting for MetS, the risk equals that of diabetes. Our data suggest that testosterone should be measured routinely in men with prediabetes.	[Ho, Chen-Hsun] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Ho, Chen-Hsun; Yu, Hong-Jeng; Hsieh, Ju-Ton; Pu, Yeong-Shiau; Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Ho, Chen-Hsun; Yu, Hong-Jeng; Wang, Chih-Yuan; Hsieh, Ju-Ton; Pu, Yeong-Shiau; Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Wang, Chih-Yuan] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Jaw, Fu-Shan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Liao, Wan-Chung] Natl Taiwan Univ Hosp, Hlth Management Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Liu, SP (corresponding author), Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan.	spliu@ntuh.gov.tw		WANG, CHIH-YUAN/0000-0002-6742-3935; YU, HONG-JENG/0000-0003-3287-5736; Ho, Chen-Hsun/0000-0002-8706-7464; HSIEH, JU-TON/0000-0001-7545-8487; PU, YEONG-SHIAU/0000-0002-2859-3966; LIU, SHIH-PING/0000-0002-8015-0695				Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Avogaro A, 2011, DIABETES CARE, V34, P2333, DOI 10.2337/dc11-1442; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Barr RG, 2002, ANN INTERN MED, V137, P263, DOI 10.7326/0003-4819-137-4-200208200-00011; Basu R, 2013, J CLIN ENDOCR METAB, V98, pE409, DOI 10.1210/jc.2012-3056; Bergman M, 2013, ENDOCRINE, V43, P504, DOI 10.1007/s12020-012-9830-9; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Cavalot F, 2011, DIABETES CARE, V34, P2237, DOI 10.2337/dc10-2414; Cichosz SL, 2013, DIABETES TECHNOL THE, V15, P78, DOI 10.1089/dia.2012.0199; Corona G, 2012, J SEX MED, V9, P1669, DOI 10.1111/j.1743-6109.2012.02717.x; Dhindsa S, 2004, J CLIN ENDOCR METAB, V89, P5462, DOI 10.1210/jc.2004-0804; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Goodman-Gruen D, 2000, DIABETES CARE, V23, P912, DOI 10.2337/diacare.23.7.912; Grossmann M, 2008, J CLIN ENDOCR METAB, V93, P1834, DOI 10.1210/jc.2007-2177; Grossmann M, 2011, J CLIN ENDOCR METAB, V96, P2341, DOI 10.1210/jc.2011-0118; Haffner SM, 1996, AM J EPIDEMIOL, V143, P889; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Heufelder AE, 2009, J ANDROL, V30, P726, DOI 10.2164/jandrol.108.007005; Jones TH, 2011, DIABETES CARE, V34, P828, DOI 10.2337/dc10-1233; Kalinchenko SY, 2010, CLIN ENDOCRINOL, V73, P602, DOI 10.1111/j.1365-2265.2010.03845.x; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Kapoor D, 2007, DIABETES CARE, V30, P911, DOI 10.2337/dc06-1426; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Lakshman KM, 2010, J GERONTOL A-BIOL, V65, P503, DOI 10.1093/gerona/glq002; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; Meyer C, 2006, DIABETES CARE, V29, P1909, DOI 10.2337/dc06-0438; Mulligan T, 2006, INT J CLIN PRACT, V60, P762, DOI 10.1111/j.1742-1241.2006.00992.x; Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55; ONAT A, 2011, ACTA DIABETOL, DOI DOI 10.1007/S00592-011-0313-X.PUBMED:21769500; Rosenstock J, 2010, DIABETES CARE, V33, P1173, DOI 10.2337/dc09-1203; Saukkonen T, 2011, DIABETES CARE, V34, P2314, DOI 10.2337/dc11-0183; SIMON D, 1992, DIABETOLOGIA, V35, P173, DOI 10.1007/BF00402551; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tsai EC, 2004, DIABETES CARE, V27, P861, DOI 10.2337/diacare.27.4.861; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wang C, 2011, DIABETES CARE, V34, P1669, DOI 10.2337/dc10-2339; Yeap BB, 2009, EUR J ENDOCRINOL, V161, P591, DOI 10.1530/EJE-09-0348	43	33	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74173	10.1371/journal.pone.0074173	http://dx.doi.org/10.1371/journal.pone.0074173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069277	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100088
J	Sasaki, T; Hwang, H; Nguyen, C; Kloner, RA; Kahn, M				Sasaki, Tomoyo; Hwang, Hyosook; Cu Nguyen; Kloner, Robert A.; Kahn, Michael			The Small Molecule Wnt Signaling Modulator ICG-001 Improves Contractile Function in Chronically Infarcted Rat Myocardium	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; CARDIAC PROGENITOR CELLS; EPICARDIUM-DERIVED CELLS; EMBRYONIC STEM-CELLS; BINDING-PROTEIN; MOUSE EPICARDIUM; CATENIN PATHWAY; SELF-RENEWAL; HEART; FIBROSIS	The adult mammalian heart has limited capability for self-repair after myocardial infarction. Therefore, therapeutic strategies that improve post-infarct cardiac function are critically needed. The small molecule ICG-001 modulates Wnt signaling and increased the expression of genes beneficial for cardiac regeneration in epicardial cells. Lineage tracing experiments, demonstrated the importance of beta-catenin/p300 mediated transcription for epicardial progenitor contribution to the myocardium. Female rats given ICG-001 for 10 days post-occlusion significantly improved ejection fraction by 8.4%, compared to controls (P<0.05). Taken together, Wnt modulation via beta-catenin/CBP inhibition offers a promising therapeutic strategy towards restoration of myocardial tissues and an enhancement of cardiac functions following infarction.	[Sasaki, Tomoyo; Cu Nguyen; Kahn, Michael] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Hwang, Hyosook; Kloner, Robert A.] Good Samaritan Hosp, Inst Heart, Los Angeles, CA USA; [Kloner, Robert A.] Univ So Calif, Keck Sch Med, Div Cardiovasc Med, Los Angeles, CA 90033 USA; [Kahn, Michael] Univ So Calif, Norris Comprehens Canc Res Ctr, Los Angeles, CA USA; [Hwang, Hyosook] Chonbuk Natl Univ, Med Sch & Hosp, Dept Nucl Med, Jeonju, Jeonbuk, South Korea	University of Southern California; University of Southern California; University of Southern California; Jeonbuk National University	Kahn, M (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	kahnm@usc.edu			University of Southern California; Heart Institute of Good Samaritan Hospital	University of Southern California; Heart Institute of Good Samaritan Hospital	This study was supported by funding from the University of Southern California and the Heart Institute of Good Samaritan Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Bollini S, 2011, J MOL CELL CARDIOL, V50, P296, DOI 10.1016/j.yjmcc.2010.07.006; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Dai WD, 2010, METHODS MOL BIOL, V660, P99, DOI 10.1007/978-1-60761-705-1_7; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; Daskalopoulos EP, 2012, TRENDS CARDIOVASC ME; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; EID H, 1992, CIRC RES, V71, P40, DOI 10.1161/01.RES.71.1.40; el-Khoueiry A., 2013, J CLIN ONC ABSTR, V31, P2501, DOI DOI 10.1200/jco.2013.31.15_suppl.2501; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Gravning J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052120; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Horb ME, 1999, DEVELOPMENT, V126, P1739; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Kanashiro-Takeuchi RM, 2011, J MOL CELL CARDIOL, V51, P619, DOI 10.1016/j.yjmcc.2011.05.015; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kempf T, 2011, NAT MED; Khan SQ, 2009, EUR HEART J, V30, P1057, DOI 10.1093/eurheartj/ehn600; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Laeremans H, 2011, CIRCULATION, V124, P1626, DOI 10.1161/CIRCULATIONAHA.110.976969; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Lim MJ, 2013, PROG CARDIOVASC DIS, V55, P504, DOI 10.1016/j.pcad.2013.01.003; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Limana F, 2011, PHARMACOL THERAPEUT, V129, P82, DOI 10.1016/j.pharmthera.2010.09.002; Lukaszewicz AI, 2010, J MED CHEM, V53, P3439, DOI 10.1021/jm901361d; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92; Perez-Pomares JM, 2002, DEV BIOL, V247, P307, DOI 10.1006/dbio.2002.0706; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Schenke-Layland K, 2011, BIOMATERIALS, V32, P2748, DOI 10.1016/j.biomaterials.2010.12.046; Schnabel K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018503; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Singh AM, 2007, CIRCULATION, V115, P617, DOI 10.1161/CIRCULATIONAHA.106.642298; Singla DK, 2010, J CARDIOVASC TRANSL, V3, P73, DOI 10.1007/s12265-009-9151-4; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Takeshita K, 2004, AM J PATHOL, V164, P449, DOI 10.1016/S0002-9440(10)63135-5; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; Vieira JM, 2011, HEART, V97, P15, DOI 10.1136/hrt.2010.193292; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Yao M, 2003, J MOL CELL CARDIOL, V35, P661, DOI 10.1016/S0022-2828(03)00098-1; Zamora M, 2007, P NATL ACAD SCI USA, V104, P18109, DOI 10.1073/pnas.0702415104; Zelarayan LC, 2008, P NATL ACAD SCI USA, V105, P19762, DOI 10.1073/pnas.0808393105; Zhou B, 2008, REGEN MED, V3, P633, DOI 10.2217/17460751.3.5.633; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	63	41	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75010	10.1371/journal.pone.0075010	http://dx.doi.org/10.1371/journal.pone.0075010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069374	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100118
J	Tan, MHE; Zhou, XE; Soon, FF; Li, XD; Li, J; Yong, EL; Melcher, K; Xu, HE				Tan, M. H. Eileen; Zhou, X. Edward; Soon, Fen-Fen; Li, Xiaodan; Li, Jun; Yong, Eu-Leong; Melcher, Karsten; Xu, H. Eric			The Crystal Structure of the Orphan Nuclear Receptor NR2E3/PNR Ligand Binding Domain Reveals a Dimeric Auto-Repressed Conformation	PLOS ONE			English	Article							S-CONE-SYNDROME; PHOTORECEPTOR DEVELOPMENT; TRANSCRIPTIONAL REGULATION; MOLECULAR RECOGNITION; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; PROTEIN; ROD; MUTATIONS; HORMONE	Photoreceptor-specific nuclear receptor (PNR, NR2E3) is a key transcriptional regulator of human photoreceptor differentiation and maintenance. Mutations in the NR2E3-encoding gene cause various retinal degenerations, including Enhanced S-cone syndrome, retinitis pigmentosa, and Goldman-Favre disease. Although physiological ligands have not been identified, it is believed that binding of small molecule agonists, receptor desumoylation, and receptor heterodimerization may switch NR2E3 from a transcriptional repressor to an activator. While these features make NR2E3 a potential therapeutic target for the treatment of retinal diseases, there has been a clear lack of structural information for the receptor. Here, we report the crystal structure of the apo NR2E3 ligand binding domain (LBD) at 2.8 angstrom resolution. Apo NR2E3 functions as transcriptional repressor in cells and the structure of its LBD is in a dimeric auto-repressed conformation. In this conformation, the putative ligand binding pocket is filled with bulky hydrophobic residues and the activation-function-2 (AF2) helix occupies the canonical cofactor binding site. Mutations designed to disrupt either the AF2/cofactor-binding site interface or the dimer interface compromised the transcriptional repressor activity of this receptor. Together, these results reveal several conserved structural features shared by related orphan nuclear receptors, suggest that most disease-causing mutations affect the receptor's structural integrity, and allowed us to model a putative active conformation that can accommodate small ligands in its pocket.	[Tan, M. H. Eileen; Zhou, X. Edward; Soon, Fen-Fen; Li, Xiaodan; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI USA; [Tan, M. H. Eileen; Soon, Fen-Fen; Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Natl Univ Hosp, Singapore 117595, Singapore; [Li, Xiaodan] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Van Andel Res Inst,Shanghai Inst Mat Med Ctr, Shanghai 200031, Peoples R China	Van Andel Institute; National University of Singapore; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Melcher, K (corresponding author), Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI USA.	Karsten.Melcher@vai.org; Eric.Xu@vai.org	Melcher, Karsten/AAZ-3861-2020; Tan, Min/GQQ-2702-2022; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Yong, Eu-Leong/0000-0001-6511-770X	Jay and Betty Van Andel Foundation; Amway (China) Limited; National Institutes of Health [5R01DK071662-08]; National Research Foundation Singapore [NMRC/CSA/026/2011]; NUS Graduate School for Integrative Sciences Engineering; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER	Jay and Betty Van Andel Foundation; Amway (China) Limited; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation Singapore(National Research Foundation, Singapore); NUS Graduate School for Integrative Sciences Engineering; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Jay and Betty Van Andel Foundation (HEX and KM - vai.org), Amway (China) Limited (HEX), National Institutes of Health 5R01DK071662-08 (HEX - http://projectreporter.nih.gov/project_info_description.cfm?icde=0&aid=8326720), and by the National Research Foundation Singapore under its Clinician Scientist Award (NMRC/CSA/026/2011) and administered by Singapore Ministry of Health's National Medical Research Council (E-LY). MHET is supported by a PhD scholarship from the NUS Graduate School for Integrative Sciences & Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; [Anonymous], PYMOL MOL GRAPH SYST; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernal S, 2008, CLIN GENET, V73, P360, DOI 10.1111/j.1399-0004.2008.00963.x; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chavala SH, 2005, BRIT J OPHTHALMOL, V89, P1065, DOI 10.1136/bjo.2005.068130; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Cheng H, 2011, HUM MOL GENET, V20, P4102, DOI 10.1093/hmg/ddr334; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Dale GE, 2003, J STRUCT BIOL, V142, P88, DOI 10.1016/S1047-8477(03)00041-8; Egea PF, 2000, EMBO J, V19, P2592, DOI 10.1093/emboj/19.11.2592; Fradot M, 2007, MOL VIS, V13, P594; Gerber S, 2000, HUM GENET, V107, P276, DOI 10.1007/s004390000350; Gire AI, 2007, MOL VIS, V13, P1970; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X; Haider NB, 2009, EXP EYE RES, V89, P365, DOI 10.1016/j.exer.2009.04.006; Hayashi T, 2005, OPHTHALMOLOGY, V112, P2115, DOI 10.1016/j.ophtha.2005.07.002; Jacobson SG, 2004, HUM MOL GENET, V13, P1893, DOI 10.1093/hmg/ddh198; Kanda A, 2009, MOL VIS, V15, P2174; Kannabiran C, 2012, MOL VIS, V18, P1165; Kapitskaya M, 2006, ASSAY DRUG DEV TECHN, V4, P253, DOI 10.1089/adt.2006.4.253; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; Lam BL, 2007, AM J OPHTHALMOL, V144, P157, DOI 10.1016/j.ajo.2007.03.012; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; O'Brien KMB, 2004, INVEST OPHTH VIS SCI, V45, P2807, DOI 10.1167/iovs.03-1317; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pachydaki SI, 2009, ARCH OPHTHALMOL-CHIC, V127, P71, DOI 10.1001/archophthalmol.2008.534; Pal K, 2010, J BIOL CHEM, V285, P40351, DOI 10.1074/jbc.M110.186072; Park YY, 2012, EMBO MOL MED, V4, P52, DOI 10.1002/emmm.201100187; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Qin Q, 2013, J OCUL PHARMACOL TH, V29, P298, DOI 10.1089/jop.2012.0135; Roduit R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007379; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Ruggiero A, 2012, PROTEIN PEPTIDE LETT, V19, P732, DOI 10.2174/092986612800793172; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; Schorderet DF, 2009, HUM MUTAT, V30, P1475, DOI 10.1002/humu.21096; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Wang Q, 2001, Ophthalmic Genet, V22, P133, DOI 10.1076/opge.22.3.133.2224; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Webber AL, 2008, EXP EYE RES, V87, P35, DOI 10.1016/j.exer.2008.04.006; Wen Z, 2012, MOL CELL BIOL, V32, P26, DOI 10.1128/MCB.05513-11; Wolkenberg SE, 2006, BIOORG MED CHEM LETT, V16, P5001, DOI 10.1016/j.bmcl.2006.07.056; Woo EJ, 2007, J MOL BIOL, V373, P735, DOI 10.1016/j.jmb.2007.08.037; Wright Alan F, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9285; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3489; Yang YP, 2010, INVEST OPHTH VIS SCI, V51, P2229, DOI 10.1167/iovs.09-4299; Zhou XE, 2011, J BIOL CHEM, V286, P2877, DOI 10.1074/jbc.M110.168740; Zou YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046039	70	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74359	10.1371/journal.pone.0074359	http://dx.doi.org/10.1371/journal.pone.0074359			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069298	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100102
J	Villarreal, MF; Cerquetti, D; Caruso, S; Aranguren, VSL; Gerschcovich, ER; Frega, AL; Leiguarda, RC				Villarreal, Mirta F.; Cerquetti, Daniel; Caruso, Silvina; Lopez Aranguren, Violeta Schwarcz; Roldan Gerschcovich, Eliana; Lucia Frega, Ana; Leiguarda, Ramon C.			Neural Correlates of Musical Creativity: Differences between High and Low Creative Subjects	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN; PERFORMANCE; GENERATION; NETWORKS; FMRI	Previous studies of musical creativity suggest that this process involves multi-regional intra and interhemispheric interactions, particularly in the prefrontal cortex. However, the activity of the prefrontal cortex and that of the parieto-temporal regions, seems to depend on the domains of creativity that are evaluated and the task that is performed. In the field of music, only few studies have investigated the brain process of a creative task and none of them have investigated the effect of the level of creativity on the recruit networks. In this work we used magnetic resonance imaging to explore these issues by comparing the brain activities of subjects with higher creative abilities to those with lesser abilities, while the subjects improvised on different rhythmic fragments. We evaluated the products the subjects created during the fMRI scan using two musical parameters: fluidity and flexibility, and classified the subjects according to their punctuation. We examined the relation between brain activity and creativity level. Subjects with higher abilities generated their own creations based on modifications of the original rhythm with little adhesion to it. They showed activation in prefrontal regions of both hemispheres and the right insula. Subjects with lower abilities made only partial changes to the original musical patterns. In these subjects, activation was only observed in left unimodal areas. We demonstrated that the activations of prefrontal and paralimbic areas, such as the insula, are related to creativity level, which is related to a widespread integration of networks that are mainly associated with cognitive, motivational and emotional processes.	[Cerquetti, Daniel; Roldan Gerschcovich, Eliana; Leiguarda, Ramon C.] FLENI, Dept Neurol Cognit, Buenos Aires, DF, Argentina; [Villarreal, Mirta F.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Villarreal, Mirta F.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina; [Lopez Aranguren, Violeta Schwarcz] Univ Salvador, Fac Med, Buenos Aires, DF, Argentina; [Caruso, Silvina] Univ CAECE, Dept Humanidades & Ciencias Sociales, Buenos Aires, DF, Argentina; [Lucia Frega, Ana; Leiguarda, Ramon C.] Natl Acad Educ, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Villarreal, MF (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	mvillarreal@fleni.org.ar			Fundacion contra la Lucha de las Enfermedades Neurologicas de la Infancia, Buenos Aires, Argentina	Fundacion contra la Lucha de las Enfermedades Neurologicas de la Infancia, Buenos Aires, Argentina	This work was supported by the Fundacion contra la Lucha de las Enfermedades Neurologicas de la Infancia, Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Bengtsson SL, 2006, NEUROIMAGE, V30, P272, DOI 10.1016/j.neuroimage.2005.09.019; Berkowitz AL, 2010, NEUROIMAGE, V49, P712, DOI 10.1016/j.neuroimage.2009.08.042; Carlsson I, 2000, NEUROPSYCHOLOGIA, V38, P873, DOI 10.1016/S0028-3932(99)00128-1; CARLSSON I, 1990, SCAND J PSYCHOL, V31, P241, DOI 10.1111/j.1467-9450.1990.tb00836.x; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; D'Esposito M, 1998, NEUROIMAGE, V8, P274, DOI 10.1006/nimg.1998.0364; Di Pietro M, 2004, NEUROPSYCHOLOGIA, V42, P868, DOI 10.1016/j.neuropsychologia.2003.12.004; DYKES M, 1976, BRIT J PSYCHIAT, V128, P50, DOI 10.1192/bjp.128.1.50; Flaherty AW, 2005, J COMP NEUROL, V493, P147, DOI 10.1002/cne.20768; FORD DY, 1992, J CREATIVE BEHAV, V26, P186, DOI 10.1002/j.2162-6057.1992.tb01175.x; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Geiser E, 2009, CORTEX, V45, P93, DOI 10.1016/j.cortex.2007.09.010; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; GUILFORD JP, 1967, P NATL ACAD SCI USA, V58, P1812, DOI 10.1073/pnas.58.4.1812; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; Hoppe K. D., 1990, CREATIVITY RES J, V3, P150, DOI DOI 10.1080/10400419009534348; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Jung-Beeman M, 2004, PLOS BIOL, V2, P500, DOI 10.1371/journal.pbio.0020097; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Kowatari Y, 2009, HUM BRAIN MAPP, V30, P1678, DOI 10.1002/hbm.20633; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Pressing J., 1988, GENERATIVE PROCESSES, P129, DOI DOI 10.1093/ACPROF:OSO/9780198508465.003.0007; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Runco MA, 2004, ANNU REV PSYCHOL, V55, P657, DOI 10.1146/annurev.psych.55.090902.141502; Simons JS, 2008, J COGNITIVE NEUROSCI, V20, P447, DOI 10.1162/jocn.2008.20036; Takeuchi H, 2010, NEUROIMAGE, V51, P11, DOI 10.1016/j.neuroimage.2010.02.035; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Thaut MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002312; TREFFINGER DJ, 1986, GIFTED CHILD QUART, V30, P15, DOI 10.1177/001698628603000103; Wager TD, 2004, AFFECT CONTROL FUNCT; Wendelken C, 2008, J COGNITIVE NEUROSCI, V20, P682, DOI 10.1162/jocn.2008.20055; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; YOUNG JG, 1985, J CREATIVE BEHAV, V19, P77, DOI 10.1002/j.2162-6057.1985.tb00640.x; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	43	23	24	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75427	10.1371/journal.pone.0075427	http://dx.doi.org/10.1371/journal.pone.0075427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069414	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100124
J	Cong, HL; Ning, D; Tian, HC; Yang, Y; Zhang, W; Zhang, H; Zhang, WL; Song, L; Tien, P				Cong Haolong; Ning Du; Tian Hongchao; Yang Yang; Zhang Wei; Zhang Hua; Zhang Wenliang; Song Lei; Tien Po			Enterovirus 71 VP1 Activates Calmodulin-Dependent Protein Kinase II and Results in the Rearrangement of Vimentin in Human Astrocyte Cells	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; VIRAL INTERACTIONS; CLINICAL-FEATURES; VIRUS-INFECTION; PHOSPHORYLATION; CYTOSKELETON; AGGRESOMES; SITES; AUTOPHOSPHORYLATION; MICROTUBULES	Enterovirus 71 (EV71) is one of the main causative agents of foot, hand and mouth disease. Its infection usually causes severe central nervous system diseases and complications in infected infants and young children. In the present study, we demonstrated that EV71 infection caused the rearrangement of vimentin in human astrocytoma cells. The rearranged vimentin, together with various EV71 components, formed aggresomes-like structures in the perinuclear region. Electron microscopy and viral RNA labeling indicated that the aggresomes were virus replication sites since most of the EV71 particles and the newly synthesized viral RNA were concentrated here. Further analysis revealed that the vimentin in the virus factories was serine-82 phosphorylated. More importantly, EV71 VP1 protein is responsible for the activation of calmodulin-dependent protein kinase II (CaMK-II) which phosphorylated the N-terminal domain of vimentin on serine 82. Phosphorylation of vimentin and the formation of aggresomes were required for the replication of EV71 since the latter was decreased markedly after phosphorylation was blocked by KN93, a CaMK-II inhibitor. Thus, as one of the consequences of CaMK-II activation, vimentin phosphorylation and rearrangement may support virus replication by playing a structural role for the formation of the replication factories. Collectively, this study identified the replication centers of EV71 in human astrocyte cells. This may help us understand the replication mechanism and pathogenesis of EV71 in human.	[Cong Haolong; Ning Du; Tian Hongchao; Yang Yang; Zhang Wei; Zhang Hua; Zhang Wenliang; Song Lei; Tien Po] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China; [Ning Du; Yang Yang; Zhang Wei; Zhang Hua; Zhang Wenliang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tien, P (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Ctr Mol Virol, Beijing, Peoples R China.	tienpo@sun.im.ac.cn			National Basic Research Program of China (973 Program) [2011CB504703, 2010CB530102]; National Natural Science Foundation of China (NSFC) [81021003, 31270211]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by the grants from the National Basic Research Program of China (973 Program, Nos. 2011CB504703 and 2010CB530102) and the National Natural Science Foundation of China (NSFC, Grant Nos. 81021003 and 31270211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; AZUMI N, 1987, AM J CLIN PATHOL, V88, P286, DOI 10.1093/ajcp/88.3.286; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; CHOU YH, 1989, P NATL ACAD SCI USA, V86, P1885, DOI 10.1073/pnas.86.6.1885; Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11; Dohner K, 2005, CURR TOP MICROBIOL, V285, P67; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; FERREIRA LRL, 1994, ARCH VIROL, V138, P273; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Hanson LK, 2009, J VIROL, V83, P7449, DOI 10.1128/JVI.00325-09; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; HOOGHEPETERS EL, 1979, J VIROL, V29, P666, DOI 10.1128/JVI.29.2.666-676.1979; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang SC, 2009, J MED VIROL, V81, P1241, DOI 10.1002/jmv.21502; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; Irvine EE, 2006, TRENDS NEUROSCI, V29, P459, DOI 10.1016/j.tins.2006.06.009; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Lin YW, 2009, J VIROL, V83, P6477, DOI 10.1128/JVI.00434-09; Lu J, 2012, J VIROL, V86, P3767, DOI 10.1128/JVI.06687-11; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; MURTI KG, 1983, J CELL BIOL, V96, P1248, DOI 10.1083/jcb.96.5.1248; Netherton C, 2007, ADV VIRUS RES, V70, P101, DOI 10.1016/S0065-3527(07)70004-0; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; OKERBLOM C, 1983, J VIROL, V46, P964, DOI 10.1128/JVI.46.3.964-973.1983; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Piet R, 2004, P NATL ACAD SCI USA, V101, P2151, DOI 10.1073/pnas.0308408100; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Santello M, 2009, NEUROSCIENCE, V158, P253, DOI 10.1016/j.neuroscience.2008.03.039; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Stefanovic S, 2005, J VIROL, V79, P11766, DOI 10.1128/JVI.79.18.11766-11775.2005; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Vyboh K, 2012, JOVE-J VIS EXP, DOI 10.3791/4002; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407	48	19	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73900	10.1371/journal.pone.0073900	http://dx.doi.org/10.1371/journal.pone.0073900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073199	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000008
J	Murray, SE				Murray, Susan E.			Cell-Intrinsic Role for NF-kappa B-Inducing Kinase in Peripheral Maintenance but Not Thymic Development of Foxp3(+) Regulatory T Cells in Mice	PLOS ONE			English	Article							C-REL; RECEPTOR; DIFFERENTIATION; ACTIVATION; EXPRESSION; EFFECTOR; ALYMPHOPLASIA; AUTOIMMUNITY; NF-KAPPA-B2; INDUCTION	NF-kappa B inducing kinase (NIK, MAP3K14) is a key signaling molecule in non-canonical NF-kappa B activation, and NIK deficient mice have been instrumental in deciphering the immunologic role of this pathway. Global ablation of NIK prevents lymph node development, impairs thymic stromal development, and drastically reduces B cells. Despite altered thymic selection, T cell numbers are near normal in NIK deficient mice. The exception is CD4(+) regulatory T cells (Tregs), which are reduced in the thymus and periphery. Defects in thymic stroma are known to contribute to impaired Treg generation, but whether NIK also plays a cell intrinsic role in Tregs is unknown. Here, we compared intact mice with single and mixed BM chimeric mice to assess the intrinsic role of NIK in Treg generation and maintenance. We found that while NIK expression in stromal cells suffices for normal thymic Treg development, NIK is required cell-intrinsically to maintain peripheral Tregs. In addition, we unexpectedly discovered a cell-intrinsic role for NIK in memory phenotype conventional T cells that is masked in intact mice, but revealed in BM chimeras. These results demonstrate a novel role for NIK in peripheral regulatory and memory phenotype T cell homeostasis.	Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Oregon Health & Science University	Murray, SE (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	murrays@ohsu.edu		Murray, Susan/0000-0002-6470-3827	National Institutes of Health [AI077032]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077032, R01AI092080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (http://www.nih.gov/) grant number AI077032 to David C. Parker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Andreakos E, 2006, P NATL ACAD SCI USA, V103, P14459, DOI 10.1073/pnas.0603493103; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Griseri T, 2010, J EXP MED, V207, P699, DOI 10.1084/jem.20091618; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jin W, 2009, BLOOD, V113, P6603, DOI 10.1182/blood-2008-12-192914; Kajiura F, 2004, J IMMUNOL, V172, P2067, DOI 10.4049/jimmunol.172.4.2067; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Lu LF, 2005, J IMMUNOL, V175, P1651, DOI 10.4049/jimmunol.175.3.1651; MacDonald KPA, 2007, BLOOD, V109, P5049, DOI 10.1182/blood-2007-01-067249; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Murray SE, 2011, J CLIN INVEST, V121, P4775, DOI 10.1172/JCI44943; Rowe AM, 2013, J IMMUNOL IN PRESS; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sanchez-Valdepenas C, 2006, J IMMUNOL, V176, P4666, DOI 10.4049/jimmunol.176.8.4666; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Stephens GL, 2004, J IMMUNOL, V173, P5008, DOI 10.4049/jimmunol.173.8.5008; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Takeda I, 2004, J IMMUNOL, V172, P3580, DOI 10.4049/jimmunol.172.6.3580; Tamura C, 2006, AUTOIMMUNITY, V39, P445, DOI 10.1080/08916930600833390; van der Vliet HJJ, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/89017; van Olffen RW, 2009, J IMMUNOL, V182, P7490, DOI 10.4049/jimmunol.0802751; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	34	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76216	10.1371/journal.pone.0076216	http://dx.doi.org/10.1371/journal.pone.0076216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073289	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000099
J	Nakano, M; Nishihara, M; Yoshioka, H; Takahashi, H; Sawasaki, T; Ohnishi, K; Hikichi, Y; Kiba, A				Nakano, Masahito; Nishihara, Masahiro; Yoshioka, Hirofumi; Takahashi, Hirotaka; Sawasaki, Tatsuya; Ohnishi, Kouhei; Hikichi, Yasufumi; Kiba, Akinori			Suppression of DS1 Phosphatidic Acid Phosphatase Confirms Resistance to Ralstonia solanacearum in Nicotiana benthamiana	PLOS ONE			English	Article							PHOSPHOLIPASE-D ACTIVITY; POWDERY MILDEW; DIACYLGLYCEROL PYROPHOSPHATE; DISEASE RESISTANCE; DEFENSE RESPONSES; SACCHAROMYCES-CEREVISIAE; PENETRATION RESISTANCE; SIGNAL-TRANSDUCTION; MOLECULAR-PATTERNS; LIPID-METABOLISM	Nicotiana benthamiana is susceptible to Ralstonia solanacearum. To analyze molecular mechanisms for disease susceptibility, we screened a gene-silenced plant showing resistance to R. solanacearum, designated as DS1 (Disease suppression 1). The deduced amino acid sequence of DS1 cDNA encoded a phosphatidic acid phosphatase (PAP) 2. DS1 expression was induced by infection with a virulent strain of R. solanacearum in an hrp-gene-dependent manner. DS1 rescued growth defects of the temperature-sensitive Delta lpp1 Delta dpp1 Delta pah1 mutant yeast. Recombinant DS1 protein showed Mg2+-independent PAP activity. DS1 plants showed reduced PAP activity and increased phosphatidic acid (PA) content. After inoculation with R. solanacearum, DS1 plants showed accelerated cell death, over-accumulation of reactive oxygen species (ROS), and hyper-induction of PR-4 expression. In contrast, DS1-overexpressing tobacco plants showed reduced PA content, greater susceptibility to R. solanacearum, and reduced ROS production and PR-4 expression. The DS1 phenotype was partially compromised in the plants in which both DS1 and NbCoi1 or DS1 and NbrbohB were silenced. These results show that DS1 PAP may affect plant immune responses related to ROS and JA cascades via regulation of PA levels. Suppression of DS1 function or DS1 expression could rapidly activate plant defenses to achieve effective resistance against Ralstonia solanacearum.	[Nakano, Masahito; Hikichi, Yasufumi; Kiba, Akinori] Kochi Univ, Fac Agr, Lab Plant Pathol & Biotechnol, Nankoku, Kochi 783, Japan; [Nishihara, Masahiro] Iwate Biotechnol Res Ctr, Kitakami, Iwate, Japan; [Yoshioka, Hirofumi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Def Plant Pathogen Interact, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Takahashi, Hirotaka; Sawasaki, Tatsuya] Ehime Univ, Cell Free Sci & Technol Res Ctr, Div Proteomed Sci, Matsuyama, Ehime, Japan; [Ohnishi, Kouhei] Kochi Univ, Res Inst Mol Genet, Nankoku, Kochi, Japan	Kochi University; Iwate Biotechnology Research Center; Nagoya University; Ehime University; Kochi University	Kiba, A (corresponding author), Kochi Univ, Fac Agr, Lab Plant Pathol & Biotechnol, Nankoku, Kochi 783, Japan.	akiba@kochi-u.ac.jp	Nakano, Masahito/AAA-8370-2020; Ohnishi, Kouhei/AAN-9527-2020	Nakano, Masahito/0000-0002-2842-0977; Sawasaki, Tatsuya/0000-0002-7952-0556; Nishihara, Masahiro/0000-0002-1454-8785	Ministry of Education, Culture, Sports, Science and Technology, Japan [16780031, 18780029, 15028214, 16380037]; Asahi Glass Foundation;  [25-7248]; Grants-in-Aid for Scientific Research [25117719] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants in Aid for Scientific Research to AK (16780031 and 18780029) and YH (15028214 and 16380037) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. AK is also grateful for financial support from the Asahi Glass Foundation. Grant-in-Aid for Japan Society for the Promotion of Science Fellows M. Nakano (25-7248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai S, 2011, J GEN PLANT PATHOL, V77, P152, DOI 10.1007/s10327-011-0304-3; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Chern M, 2005, PLANT J, V43, P623, DOI 10.1111/j.1365-313X.2005.02485.x; Farmer PK, 1999, BBA-PROTEIN STRUCT M, V1434, P6, DOI 10.1016/S0167-4838(99)00166-1; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; GOMEZMUNOZ A, 1992, FEBS LETT, V301, P103, DOI 10.1016/0014-5793(92)80219-7; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hardham AR, 2007, CURR OPIN PLANT BIOL, V10, P342, DOI 10.1016/j.pbi.2007.05.001; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Humphry M, 2006, MOL PLANT PATHOL, V7, P605, DOI 10.1111/j.1364-3703.2006.00362.X; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Jiang CJ, 2009, MOL PLANT MICROBE IN, V22, P820, DOI 10.1094/MPMI-22-7-0820; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanda A, 2003, MOL PLANT MICROBE IN, V16, P447, DOI 10.1094/MPMI.2003.16.5.447; Kanda Ayami, 2003, Journal of General Plant Pathology, V69, P250, DOI 10.1007/s10327-003-0041-3; Katagiri T, 2005, PLANT J, V43, P107, DOI 10.1111/j.1365-313X.2005.02431.x; Kiba A, 2006, MOL PLANT MICROBE IN, V19, P112, DOI 10.1094/MPMI-19-0112; Kiba A, 2003, PLANT CELL PHYSIOL, V44, P287, DOI 10.1093/pcp/pcg037; Kiba A, 2007, PLANT BIOTECHNOL-NAR, V24, P409, DOI 10.5511/plantbiotechnology.24.409; Kiba A, 2012, J PLANT PHYSIOL, V169, P1017, DOI 10.1016/j.jplph.2012.04.002; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Koo SC, 2009, MOL CELLS, V27, P563, DOI 10.1007/s10059-009-0081-4; Lee S, 2001, PLANT J, V26, P479, DOI 10.1046/j.1365-313x.2001.01037.x; Liu YL, 2004, PLANT J, V38, P800, DOI 10.1111/j.1365-313X.2004.02085.x; Maimbo M, 2007, PLANT PHYSIOL, V145, P1588, DOI 10.1104/pp.107.105353; Maimbo M, 2010, PLANT PHYSIOL, V152, P2023, DOI 10.1104/pp.109.148189; Munnik T, 2000, PLANT J, V22, P147, DOI 10.1046/j.1365-313x.2000.00725.x; Munnik T, 1998, PLANTA, V207, P133, DOI 10.1007/s004250050465; MUNNIK T, 1994, PLANTA, V193, P89, DOI 10.1007/BF00191611; Munnik T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; Pierrugues O, 2001, J BIOL CHEM, V276, P20300, DOI 10.1074/jbc.M009726200; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Rathjen JP, 2003, CURR OPIN PLANT BIOL, V6, P300, DOI 10.1016/S1369-5266(03)00057-8; Ryu SB, 1996, BBA-LIPID LIPID MET, V1303, P243, DOI 10.1016/0005-2760(96)00096-3; RYU SB, 1995, PLANT PHYSIOL, V108, P713, DOI 10.1104/pp.108.2.713; Sang YM, 2001, PLANT PHYSIOL, V126, P1449, DOI 10.1104/pp.126.4.1449; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Shinohara R, 2005, APPL ENVIRON MICROB, V71, P417, DOI 10.1128/AEM.71.1.417-422.2005; Testerink C, 2008, PLANT SIGNAL BEHAV, V3, P681, DOI 10.4161/psb.3.9.5814; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Van Damme M, 2005, MOL PLANT MICROBE IN, V18, P583, DOI 10.1094/MPMI-18-0583; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Vogel JP, 2002, PLANT CELL, V14, P2095, DOI 10.1105/tpc.003509; Wang CX, 2000, PLANT CELL, V12, P2237, DOI 10.1105/tpc.12.11.2237; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Young SA, 1996, PLANT CELL, V8, P1079, DOI 10.1105/tpc.8.6.1079; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992	62	36	37	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75124	10.1371/journal.pone.0075124	http://dx.doi.org/10.1371/journal.pone.0075124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073238	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000047
J	Bello, JP; Modrono, C; Marcano, F; Gonzalez-Mora, JL				Plata Bello, Julio; Modrono, Cristian; Marcano, Francisco; Luis Gonzalez-Mora, Jose			Observation of Simple Intransitive Actions: The Effect of Familiarity	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; THUMB OPPOSITION TASK; FUNCTIONAL-ANATOMY; CORTICAL ACTIVITY; MOTOR; MOVEMENTS; FMRI; EXECUTION; RECOGNITION; MODULATION	Introduction: Humans are more familiar with index - thumb than with any other finger to thumb grasping. The effect of familiarity has been previously tested with complex, specialized and/or transitive movements, but not with simple intransitive ones. The aim of this study is to evaluate brain activity patterns during the observation of simple and intransitive finger movements with differing degrees of familiarity. Methodology: A functional Magnetic Resonance Imaging (fMRI) study was performed using a paradigm consisting of the observation of 4 videos showing a finger opposition task between the thumb and the other fingers (index, middle, ring and little) in a repetitive manner with a fixed frequency (1 Hz). This movement is considered as the pantomime of a precision grasping action. Results: Significant activity was identified in the bilateral Inferior Parietal Lobule and premotor regions with the selected level of significance (FDR [False Discovery Rate] = 0.01). The extent of the activation in both regions tended to decrease when the finger that performed the action was further from the thumb. More specifically, this effect showed a linear trend (index>middle>ring>little) in the right parietal and premotor regions. Conclusions: The observation of less familiar simple intransitive movements produces less activation of parietal and premotor areas than familiar ones. The most important implication of this study is the identification of differences in brain activity during the observation of simple intransitive movements with different degrees of familiarity.	[Plata Bello, Julio; Modrono, Cristian; Marcano, Francisco; Luis Gonzalez-Mora, Jose] Univ La Laguna, Fac Med, Dept Physiol, San Cristobal La Laguna, Spain; [Plata Bello, Julio] Hosp Univ Canarias, Dept Neurosurg, Santa Cruz de Tenerife, Spain; [Modrono, Cristian; Marcano, Francisco; Luis Gonzalez-Mora, Jose] Univ La Laguna, SRMIB, San Cristobal La Laguna, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna	Bello, JP (corresponding author), Univ La Laguna, Fac Med, Dept Physiol, San Cristobal La Laguna, Spain.	jplata5@hotmail.com	Modroño, Cristián/M-1985-2014; González-Mora, José Luis/L-6100-2014; Marcano, Francisco J/I-1723-2015; Modrono, Cristian/N-6378-2019	Modroño, Cristián/0000-0001-5623-8681; González-Mora, José Luis/0000-0001-8920-1375; Marcano, Francisco J/0000-0003-3310-4722; 	Ministerio de Ciencia e Innovacion [PTA2011-4995-I, TIN2008-06867-C02-01/TIN, TIN2011-28146]; Ministerio de Industria, Turismo y Comercio [TSI-020100-2010-346]; Gobierno de Canarias [SolSubC200801000142]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Industria, Turismo y Comercio(Spanish Government); Gobierno de Canarias	Financial support was provided by the following national public projects: Ministerio de Ciencia e Innovacion [PTA2011-4995-I, TIN2008-06867-C02-01/TIN, TIN2011-28146]; Ministerio de Industria, Turismo y Comercio [TSI-020100-2010-346]; and Gobierno de Canarias [SolSubC200801000142]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Calautti C, 2001, STROKE, V32, P139, DOI 10.1161/01.STR.32.1.139; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Chen X K, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1877; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Faillenot I, 1991, CEREB CORTEX, V7, P77; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gemignani A, 2004, ARCH ITAL BIOL, V142, P1; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hetu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024728; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Iacoboni M, 2007, ANN NEUROL, V62, P213, DOI 10.1002/ana.21198; Jonas M, 2007, NEUROIMAGE, V36, pT44, DOI 10.1016/j.neuroimage.2007.03.028; Kollias SS, 2001, BRAIN RES REV, V36, P185, DOI 10.1016/S0165-0173(01)00094-7; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Lui F, 2008, SOC NEUROSCI-UK, V3, P261, DOI 10.1080/17470910701458551; Matsumura M, 1996, NEUROREPORT, V7, P749, DOI 10.1097/00001756-199602290-00017; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; Naccarato M, 2006, NEUROIMAGE, V32, P1250, DOI 10.1016/j.neuroimage.2006.05.003; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Shimada S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008034; Van Vaerenbergh J, 2001, J REHABIL MED, V33, P256; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844	33	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74485	10.1371/journal.pone.0074485	http://dx.doi.org/10.1371/journal.pone.0074485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073213	gold, Green Published, Green Submitted			2022-12-27	WOS:000324768000022
J	Prochnow, H; Gollan, R; Rohne, P; Hassemer, M; Koch-Brandt, C; Baiersdorfer, M				Prochnow, Hans; Gollan, Rene; Rohne, Philipp; Hassemer, Matthias; Koch-Brandt, Claudia; Baiersdoerfer, Markus			Non-Secreted Clusterin Isoforms Are Translated in Rare Amounts from Distinct Human mRNA Variants and Do Not Affect Bax-Mediated Apoptosis or the NF-kappa B Signaling Pathway	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; BREAST-CANCER CELLS; NUCLEAR CLUSTERIN; CLUSTERIN/APOLIPOPROTEIN-J; APOLIPOPROTEIN-J; GENE-EXPRESSION; CYTOPROTECTIVE CHAPERONE; OXIDATIVE STRESS; EPITHELIAL-CELLS; GROWTH-FACTOR	Clusterin, also known as apolipoprotein J, is expressed from a variety of tissues and implicated in pathological disorders such as neurodegenerative diseases, ischemia and cancer. In contrast to secretory clusterin (sCLU), which acts as an extracellular chaperone, the synthesis, subcellular localization and function(s) of intracellular CLU isoforms is currently a matter of intense discussion. By investigating human CLU mRNAs we here unravel mechanisms leading to the synthesis of distinct CLU protein isoforms and analyze their subcellular localization and their impact on apoptosis and on NF-kappa B-activity. Quantitative PCR-analyses revealed the expression of four different stress-inducible CLU mRNA variants in non-cancer and cancer cell lines. In all cell lines variant 1 represents the most abundant mRNA, whereas all other variants collectively account for no more than 0.34% of total CLU mRNA, even under stressed conditions. Overexpression of CLU cDNAs combined with in vitro mutagenesis revealed distinct translational start sites including a so far uncharacterized non-canonical CUG start codon. We show that all exon 2-containing mRNAs encode sCLU and at least three non-glycosylated intracellular isoforms, CLU1-449, CLU21-449 and CLU34-449, which all reside in the cytosol of unstressed and stressed HEK-293 cells. The latter is the only form expressed from an alternatively spliced mRNA variant lacking exon 2. Functional analysis revealed that none of these cytosolic CLU forms modulate caspase-mediated intrinsic apoptosis or significantly affects TNF-alpha-induced NF-kappa B-activity. Therefore our data challenge some of the current ideas regarding the physiological functions of CLU isoforms in pathologies.	[Prochnow, Hans; Rohne, Philipp; Hassemer, Matthias; Koch-Brandt, Claudia; Baiersdoerfer, Markus] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany; [Gollan, Rene] Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Dept Neurol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Baiersdorfer, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany.	mbaiersdoerfer@gmx.de						Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200; Baiersdorfer M, 2010, EXP CELL RES, V316, P3489, DOI 10.1016/j.yexcr.2010.07.022; Balantinou E, 2009, FREE RADICAL BIO MED, V46, P1267, DOI 10.1016/j.freeradbiomed.2009.01.025; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bettuzzi S, 2002, ONCOGENE, V21, P4328, DOI 10.1038/sj.onc.1205594; Bettuzzi S, 2009, ONCOGENE, V28, P4344, DOI 10.1038/onc.2009.286; Bettuzzi S, 2009, ADV CANCER RES, V104, P59, DOI 10.1016/S0065-230X(09)04005-6; Bhutia SK, 2012, J CELL PHYSIOL, V227, P1805, DOI 10.1002/jcp.22904; Biamonti G, 2009, TRENDS BIOCHEM SCI, V34, P146, DOI 10.1016/j.tibs.2008.11.004; Caccamo AE, 2006, J CELL PHYSIOL, V207, P208, DOI 10.1002/jcp.20561; Calero M, 2005, SUB CELL BIOCHEM, V38, P273; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; CHOI I, 2013, EXP CELL RES; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dumont P, 2002, CELL STRESS CHAPERON, V7, P23, DOI 10.1379/1466-1268(2002)007<0023:OOAJIH>2.0.CO;2; Essabbani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054920; Gutacker C, 1999, BIOCHEM J, V339, P759, DOI 10.1042/0264-6021:3390759; Hamada N, 2011, J ATHEROSCLER THROMB, V18, P209, DOI 10.5551/jat.5819; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; Holtzman DM, 2001, NAT MED, V7, P977, DOI 10.1038/nm0901-977; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Imhof A, 2006, NEUROBIOL DIS, V22, P274, DOI 10.1016/j.nbd.2005.11.009; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Kempster S, 2004, NEUROREPORT, V15, P1735, DOI 10.1097/01.wnr.0000134990.97051.22; Kim HJ, 2009, ARTERIOSCL THROM VAS, V29, P1558, DOI 10.1161/ATVBAHA.109.190058; Kim N, 2012, J CELL PHYSIOL, V227, P1157, DOI 10.1002/jcp.22836; Laskin JJ, 2012, J THORAC ONCOL, V7, P579, DOI 10.1097/JTO.0b013e31823f459c; Leskov KS, 2011, J BIOL CHEM, V286, P40083, DOI 10.1074/jbc.M111.252957; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Li N, 2013, ONCOGENE, V32, P1933, DOI 10.1038/onc.2012.212; Ling IF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033923; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; Mclaughlin L, 2000, J CLIN INVEST, V106, P1105, DOI 10.1172/JCI9037; Michel D, 1997, BIOCHEM J, V328, P45, DOI 10.1042/bj3280045; Miyake H, 2004, PROSTATE, V61, P318, DOI 10.1002/pros.20087; Moretti RM, 2007, CANCER RES, V67, P10325, DOI 10.1158/0008-5472.CAN-07-0516; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Orsi A, 2006, J BIOL CHEM, V281, P30431, DOI 10.1074/jbc.M605320200; Reddy KB, 1996, BIOCHEMISTRY-US, V35, P6157, DOI 10.1021/bi952981b; Redondo M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1835; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Rizzi F, 2009, ADV CANCER RES, V104, P9, DOI 10.1016/S0065-230X(09)04002-0; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Ruegsegger U, 2001, CELL, V107, P103, DOI 10.1016/S0092-8674(01)00505-0; Sala A, 2009, ADV CANCER RES, V105, P115, DOI 10.1016/S0065-230X(09)05007-6; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Scaltriti M, 2004, CANCER RES, V64, P6174, DOI 10.1158/0008-5472.CAN-04-0920; Schepeler Troels, 2007, J Mol Signal, V2, P6, DOI 10.1186/1750-2187-2-6; Schwarz M, 2008, THROMB HAEMOSTASIS, V100, P110, DOI 10.1160/TH07-12-0737; So A, 2005, MOL CANCER THER, V4, P1837, DOI 10.1158/1535-7163.MCT-05-0178; Thomas-Tikhonenko A, 2004, CANCER RES, V64, P3126, DOI 10.1158/0008-5472.CAN-03-1953; Trougakos IP, 2009, ADV CANCER RES, V104, P171, DOI 10.1016/S0065-230X(09)04009-3; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Trougakos IP, 2005, FREE RADICAL BIO MED, V38, P436, DOI 10.1016/j.freeradbiomed.2004.10.038; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; van Dijk A, 2010, EUR J CLIN INVEST, V40, P893, DOI 10.1111/j.1365-2362.2010.02345.x; Viard I, 1999, J INVEST DERMATOL, V112, P290, DOI 10.1046/j.1523-1747.1999.00531.x; Wei L, 2009, INT J CANCER, V125, P791, DOI 10.1002/ijc.24316; WONG P, 1994, EUR J BIOCHEM, V221, P917, DOI 10.1111/j.1432-1033.1994.tb18807.x; Xue J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035848; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010; Zoubeidi A, 2010, CLIN CANCER RES, V16, P1088, DOI 10.1158/1078-0432.CCR-09-2917; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	70	40	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75303	10.1371/journal.pone.0075303	http://dx.doi.org/10.1371/journal.pone.0075303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073260	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000069
J	Rodriguez-Hernandez, I; Garcia, JL; Santos-Briz, A; Hernandez-Lain, A; Gonzalez-Valero, JM; Gomez-Moreta, JA; Toldos-Gonzalez, O; Cruz, JJ; Martin-Vallejo, J; Gonzalez-Sarmiento, R				Rodriguez-Hernandez, Irene; Luis Garcia, Juan; Santos-Briz, Angel; Hernandez-Lain, Aurelio; Maria Gonzalez-Valero, Jose; Antonio Gomez-Moreta, Juan; Toldos-Gonzalez, Oscar; Jesus Cruz, Juan; Martin-Vallejo, Javier; Gonzalez-Sarmiento, Rogelio			Integrated Analysis of Mismatch Repair System in Malignant Astrocytomas	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; HMSH2 PROTEIN EXPRESSION; MICROSATELLITE INSTABILITY; LYNCH-SYNDROME; PROMOTER METHYLATION; GLIOBLASTOMA-MULTIFORME; ADJUVANT TEMOZOLOMIDE; BRAIN-TUMORS; GLIOMAS; MLH1	Malignant astrocytomas are the most aggressive primary brain tumors with a poor prognosis despite optimal treatment. Dysfunction of mismatch repair (MMR) system accelerates the accumulation of mutations throughout the genome causing uncontrolled cell growth. The aim of this study was to characterize the MMR system defects that could be involved in malignant astrocytoma pathogenesis. We analyzed protein expression and promoter methylation of MLH1, MSH2 and MSH6 as well as microsatellite instability (MSI) and MMR gene mutations in a set of 96 low-and high-grade astrocytomas. Forty-one astrocytomas failed to express at least one MMR protein. Loss of MSH2 expression was more frequent in low-grade astrocytomas. Loss of MLH1 expression was associated with MLH1 promoter hypermethylation and MLH1 -93G>A promoter polymorphism. However, MSI was not related with MMR protein expression and only 5% of tumors were MSI-High. Furthermore, the incidence of tumors carrying germline mutations in MMR genes was low and only one glioblastoma was associated with Lynch syndrome. Interestingly, survival analysis identified that tumors lacking MSH6 expression presented longer overall survival in high-grade astrocytoma patients treated only with radiotherapy while MSH6 expression did not modify the prognosis of those patients treated with both radiotherapy and chemotherapy. Our findings suggest that MMR system alterations are a frequent event in malignant astrocytomas and might help to define a subgroup of patients with different outcome.	[Rodriguez-Hernandez, Irene; Gonzalez-Sarmiento, Rogelio] Univ Salamanca, Dept Med, Mol Med Unit, E-37008 Salamanca, Spain; [Rodriguez-Hernandez, Irene; Luis Garcia, Juan; Santos-Briz, Angel; Maria Gonzalez-Valero, Jose; Jesus Cruz, Juan; Gonzalez-Sarmiento, Rogelio] USAL CSIC Univ Hosp, IBMCC, Salamanca, Spain; [Rodriguez-Hernandez, Irene; Luis Garcia, Juan; Santos-Briz, Angel; Maria Gonzalez-Valero, Jose; Jesus Cruz, Juan; Gonzalez-Sarmiento, Rogelio] USAL CSIC Univ Hosp, IBSAL, Salamanca, Spain; [Luis Garcia, Juan; Maria Gonzalez-Valero, Jose] Inst Hlth Sci Studies Castilla & Leon, Salamanca, Spain; [Santos-Briz, Angel] Univ Hosp Salamanca, Dept Pathol, Salamanca, Spain; [Hernandez-Lain, Aurelio; Toldos-Gonzalez, Oscar] Univ Hosp 12 Octubre, Dept Pathol, Madrid, Spain; [Antonio Gomez-Moreta, Juan] Univ Hosp Salamanca, Dept Neurosurg, Salamanca, Spain; [Jesus Cruz, Juan] Univ Hosp Salamanca, Dept Oncol, Salamanca, Spain; [Martin-Vallejo, Javier] Univ Salamanca, Dept Stat, E-37008 Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Consejo Superior de Investigaciones Cientificas (CSIC); University of Salamanca; Hospital Universitario 12 de Octubre; University of Salamanca; University of Salamanca	Gonzalez-Sarmiento, R (corresponding author), Univ Salamanca, Dept Med, Mol Med Unit, E-37008 Salamanca, Spain.	gonzalez@usal.es	Vallejo, Francisco Javier F J Martin/B-4029-2012; Santos-Briz, Ángel/AAS-4156-2021; Lain, Aurelio Hernandez/S-6172-2018; Gonzalez-Sarmiento, Rogelio/V-5526-2019; Santos-Briz, Ángel/AFR-7833-2022; garcia, Juan/B-4617-2017	Vallejo, Francisco Javier F J Martin/0000-0003-3962-7356; Lain, Aurelio Hernandez/0000-0003-1642-4505; Gonzalez-Sarmiento, Rogelio/0000-0002-2726-6795; garcia, Juan/0000-0002-2146-5726; Cruz Hernandez, Juan Jesus/0000-0003-1980-2751; Rodriguez-Hernandez, Irene/0000-0002-6487-452X	Fondo de Investigacion Sanitaria [FIS PI 10/00219]; Instituto de Estudios de Ciencias de la Salud de Castilla y Leon IECSCYL; Junta de Castilla y Leon y Fondo Social Europeo [Orden EDU/330/2008]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Estudios de Ciencias de la Salud de Castilla y Leon IECSCYL; Junta de Castilla y Leon y Fondo Social Europeo	This work was supported by Fondo de Investigacion Sanitaria (FIS PI 10/00219), Instituto de Estudios de Ciencias de la Salud de Castilla y Leon IECSCYL and Junta de Castilla y Leon y Fondo Social Europeo (Orden EDU/330/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JM, 2008, INT J CANCER, V123, P2456, DOI 10.1002/ijc.23770; Alldinger I, 2007, J CANCER RES CLIN, V133, P749, DOI 10.1007/s00432-007-0220-2; Arita M, 2003, GENE, V306, P57, DOI 10.1016/S0378-1119(03)00385-8; Barnetson RA, 2008, HUM MUTAT, V29, P367, DOI 10.1002/humu.20635; Belvederesi L, 2006, EUR J HUM GENET, V14, P853, DOI 10.1038/sj.ejhg.5201628; Boland CR, 1998, CANCER RES, V58, P5248; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Caldes T, 2002, INT J CANCER, V98, P774, DOI 10.1002/ijc.10240; Capel E, 2007, ONCOGENE, V26, P7596, DOI 10.1038/sj.onc.1210581; Castrilli G, 2002, J ORAL PATHOL MED, V31, P234, DOI 10.1034/j.1600-0714.2002.310407.x; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DeAngelis LM, 2009, J CLIN ONCOL, V27, P5861, DOI 10.1200/JCO.2009.24.5985; Eckert A, 2007, BRAIN PATHOL, V17, P146, DOI 10.1111/j.1750-3639.2007.00049.x; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Felsberg J, 2011, INT J CANCER, V129, P659, DOI 10.1002/ijc.26083; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Hussein MR, 2006, INT J EXP PATHOL, V87, P297, DOI 10.1111/j.1365-2613.2006.00482.x; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Kastrinos F, 2012, J CLIN ONCOL, V30, P1024, DOI 10.1200/JCO.2011.40.7171; Koornstra JJ, 2009, LANCET ONCOL, V10, P400, DOI 10.1016/S1470-2045(09)70041-5; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Martinez R, 2005, J CANCER RES CLIN, V131, P87, DOI 10.1007/s00432-004-0592-5; Maxwell JA, 2008, CLIN CANCER RES, V14, P4859, DOI 10.1158/1078-0432.CCR-07-4807; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mrkonjic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013314; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Park SH, 2004, INT J CANCER, V112, P678, DOI 10.1002/ijc.20359; Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0; Rass K, 2001, HISTOCHEM J, V33, P459, DOI 10.1023/A:1014472314354; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Schleinitz D, 2011, METHODS MOL BIOL, V700, P77, DOI 10.1007/978-1-61737-954-3_6; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shahi A, 2011, NUCLEIC ACIDS RES, V39, P2130, DOI 10.1093/nar/gkq1095; Srivastava T, 2004, J NEURO-ONCOL, V66, P51, DOI 10.1023/B:NEON.0000013482.99032.b0; Stark AM, 2010, NEUROL RES, V32, P816, DOI 10.1179/016164110X12645013515052; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Viana-Pereira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020588; Viana-Pereira M, 2009, NEURO-ONCOLOGY, V11, P458, DOI 10.1215/15228517-2008-115; Watson P, 2008, INT J CANCER, V123, P444, DOI 10.1002/ijc.23508; Wehming FM, 2012, CLIN NEUROL NEUROSUR, V114, P617, DOI 10.1016/j.clineuro.2011.12.024; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012	52	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76401	10.1371/journal.pone.0076401	http://dx.doi.org/10.1371/journal.pone.0076401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073290	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000100
J	Schijf, MA; Kerperien, J; Bastiaans, J; Szklany, K; Meerding, J; Hofman, G; Boon, L; van Wijk, F; Garssen, J; van't Land, B				Schijf, Marcel A.; Kerperien, Joann; Bastiaans, Jacqueline; Szklany, Kirsten; Meerding, Jenny; Hofman, Gerard; Boon, Louis; van Wijk, Femke; Garssen, Johan; van't Land, Belinda			Alterations in Regulatory T Cells Induced by Specific Oligosaccharides Improve Vaccine Responsiveness in Mice	PLOS ONE			English	Article							VIRUS-INFECTION; RESPONSES; HOMEOSTASIS; REG; BET	Prophylactic vaccinations are generally performed to protect nave individuals with or without suppressed immune responsiveness. In a mouse model for Influenza vaccinations the specific alterations of CD4(+)CD25(+)Foxp3(+) regulatory T-cells (Tregs) in the immune modulation induced by orally supplied oligosaccharides containing scGOS/lcFOS/pAOS was assessed. This dietary intervention increased vaccine specific DTH responses. In addition, a significant increased percentage of T-bet(+) (Th1) activated CD69(+)CD4(+) T cells (p<0.001) and reduced percentage of Gata-3(+) (Th2) activated CD69(+)CD4(+) T cells (p<0.001) was detected in the mesenteric lymph nodes (MLN) of mice receiving scGOS/lcFOS/pAOS compared to control mice. Although no difference in the number or percentage of Tregs (CD4(+)Foxp3(+)) could be determined after scGOS/lcFOS/pAOS intervention, the percentage of CXCR3(+)/T-bet(+) (Th1-Tregs) was significantly reduced (p<0.05) in mice receiving scGOS/lcFOS/pAOS as compared to mice receiving placebo diets. Moreover, although no absolute difference in suppressive capacity could be detected, an alteration in cytokine profile suggests a regulatory T cell shift towards a reducing Th1 suppression profile, supporting an improved vaccination response. In conclusion: These data are indicative for improved vaccine responsiveness due to reduced Th1 suppressive capacity in the Treg population of mice fed the oligosaccharide specific diet, showing compartmentalization within the Treg population. The modulation of Tregs to control immune responses provides an additional arm of intervention using alternative strategies possibly leading to the development of improved vaccines.	[Schijf, Marcel A.; Meerding, Jenny; van Wijk, Femke; van't Land, Belinda] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol, Utrecht, Netherlands; [Schijf, Marcel A.; Bastiaans, Jacqueline; Szklany, Kirsten; Garssen, Johan; van't Land, Belinda] Nutricia Res, Dept Immunol, Utrecht, Netherlands; [Kerperien, Joann; Bastiaans, Jacqueline; Hofman, Gerard; Garssen, Johan] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Boon, Louis] Bioceros, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Danone Nutricia; Utrecht University	van't Land, B (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol, Utrecht, Netherlands.	b.vantland@umcutrecht.nl	Boon, Laurence/HCI-3629-2022; Land, Belinda van't/K-2986-2012; garssen, johan/I-7159-2016	Land, Belinda van't/0000-0001-8601-5032; Boon, Louis/0000-0002-0937-9171	TIpharma	TIpharma	The work is funded by TIpharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes I, 2010, J VIROL, V84, P12564, DOI 10.1128/JVI.01559-10; Arslanoglu S, 2008, J NUTR, V138, P1091, DOI 10.1093/jn/138.6.1091; Barnes MJ, 2009, NAT IMMUNOL, V10, P563, DOI 10.1038/ni0609-563; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Brandenburg AH, 2000, J MED VIROL, V62, P267, DOI 10.1002/1096-9071(200010)62:2&lt;267::AID-JMV20&gt;3.0.CO;2-8; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Fulton RB, 2010, J IMMUNOL, V185, P2382, DOI 10.4049/jimmunol.1000423; Gori A, 2011, MUCOSAL IMMUNOL, V4, P554, DOI 10.1038/mi.2011.15; Ishikawa H, 2008, CLIN EXP IMMUNOL, V153, P127, DOI 10.1111/j.1365-2249.2008.03668.x; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Schijf MA, 2012, J VIROL, V86, P11472, DOI 10.1128/JVI.06708-11; Schonland SO, 2003, BLOOD, V102, P1428, DOI 10.1182/blood-2002-11-3591; Schouten B., 2011, BR J NUTR, P1; Suchard MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011762; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737; Van't Land B, 2011, DIETARY COMPONENTS I; van't Land B, 2011, EUR J PHARMACOL, V668, pS101, DOI 10.1016/j.ejphar.2011.05.082; van't Land B, 2010, VACCINE, V28, P5711, DOI 10.1016/j.vaccine.2010.06.046; Vos AP, 2007, CRIT REV IMMUNOL, V27, P97, DOI 10.1615/CritRevImmunol.v27.i2.10; Vos AP, 2007, PEDIAT ALLERG IMM-UK, V18, P304, DOI 10.1111/j.1399-3038.2007.00515.x; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	28	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75148	10.1371/journal.pone.0075148	http://dx.doi.org/10.1371/journal.pone.0075148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073243	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000052
J	Wang, Y; Wang, J; Pan, WH; Zhou, Y; Xiao, YT; Zhou, KJ; Wen, J; Yu, TX; Cai, W				Wang, Yang; Wang, Jun; Pan, Weihua; Zhou, Ying; Xiao, Yongtao; Zhou, Kejun; Wen, Jie; Yu, Tingxi; Cai, Wei			Common Genetic Variations in Patched1 (PTCH1) Gene and Risk of Hirschsprung Disease in the Han Chinese Population	PLOS ONE			English	Article							NEURAL CREST; LINKAGE DISEQUILIBRIUM; ASSOCIATION; RET; BASAL; MICE	Hirschsprung disease (HSCR) is the most frequent genetic cause of congenital intestinal obstruction with an incidence of 1: 5000 live births. In a pathway-based epistasis analysis of data generated by genome-wide association study on HSCR, specific genotype of Patched 1 (PTCH1) has been linked to an increased risk for HSCR. The aim of the present study is to examine the contribution of genetic variants in PTCH1 to the susceptibility to HSCR in Han Chinese. Accordingly, we assessed 8 single nucleotide polymorphisms (SNPs) within PTCH1 gene in 104 subjects with sporadic HSCR and 151 normal controls of Han Chinese origin by the Sequenom MassArray technology (iPLEX GOLD). Two of the eight genetic markers were found to be significantly associated with Hirschsprung disease (rs357565, allele P = 0.005; rs2236405, allele P = 0.002, genotype P = 0.003). Both the C allele of rs357565 and the A allele of rs2236405 served as risk factors for HSCR. During haplotype analysis, one seven-SNP-based haplotype was the most significant, giving a global P = 0.0036. Our results firstly suggest common variations of PTCH1 may be involved in the altered risk for HSCR in the Han Chinese population, providing potential molecular markers for early diagnosis of Hirschsprung disease.	[Wang, Yang; Wang, Jun; Pan, Weihua; Zhou, Ying; Xiao, Yongtao; Zhou, Kejun; Wen, Jie; Yu, Tingxi; Cai, Wei] Shanghai Jiao Tong Univ, Dept Pediat Surg, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Wang, Yang; Wang, Jun; Pan, Weihua; Zhou, Ying; Xiao, Yongtao; Zhou, Kejun; Wen, Jie; Yu, Tingxi; Cai, Wei] Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai, Peoples R China; [Wang, Yang; Wang, Jun; Pan, Weihua; Zhou, Ying; Xiao, Yongtao; Zhou, Kejun; Wen, Jie; Yu, Tingxi; Cai, Wei] Shanghai Inst Pediat Res, Shanghai, Peoples R China	Shanghai Jiao Tong University	Cai, W (corresponding author), Shanghai Jiao Tong Univ, Dept Pediat Surg, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China.	caiw1978@163.com	Wang, Yang/HCG-9543-2022		National Nature Science Foundation of China [81200259]; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [11DZ2260500]; "Medicine and Engineering" Interdisciplinary Research Foundation of Shanghai Jiao Tong University [YG2012MS04]; Shanghai Education Commission Foundation for Excellent Young Teachers [ZZjdyx12094]; Science and Technology Program of Shanghai Jiao Tong University School of Medicine [12XJ10067]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition; "Medicine and Engineering" Interdisciplinary Research Foundation of Shanghai Jiao Tong University; Shanghai Education Commission Foundation for Excellent Young Teachers; Science and Technology Program of Shanghai Jiao Tong University School of Medicine	This work was supported by the National Nature Science Foundation of China (81200259), the Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition (11DZ2260500), "Medicine and Engineering" Interdisciplinary Research Foundation of Shanghai Jiao Tong University (YG2012MS04), the Shanghai Education Commission Foundation for Excellent Young Teachers (ZZjdyx12094) and the Science and Technology Program of Shanghai Jiao Tong University School of Medicine (12XJ10067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Anderson RB, 2006, ADV EXP MED BIOL, V589, P181; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barlow AJ, 2012, HUM MOL GENET, V21, P1782, DOI 10.1093/hmg/ddr611; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Danaee H, 2006, J INVEST DERMATOL, V126, P1152, DOI 10.1038/sj.jid.5700209; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kogerman P, 2002, ONCOGENE, V21, P6007, DOI 10.1038/sj.onc.1205865; Kosaki R, 2012, AM J MED GENET A, V158A, P1724, DOI 10.1002/ajmg.a.35412; Laranjeira C, 2009, AUTON NEUROSCI-BASIC, V151, P61, DOI 10.1016/j.autneu.2009.09.001; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Miao XP, 2007, GUT, V56, P736, DOI 10.1136/gut.2006.116145; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Ngan ESW, 2011, J CLIN INVEST, V121, P3467, DOI 10.1172/JCI43737; Orr N, 2008, ADV GENET, V62, P1, DOI 10.1016/S0065-2660(08)00601-9; Peng L, 2013, INT J CANCER, V132, pE18, DOI 10.1002/ijc.27812; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Tam PKH, 2009, PEDIATR SURG INT, V25, P543, DOI 10.1007/s00383-009-2402-2; Tang ChengCai, 2012, Journal of Resources and Ecology, V3, P8; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Yang J, 2013, MOL NEUROBIOL, V47, P957, DOI 10.1007/s12035-012-8392-4; Zhang DC, 2010, DEV BIOL, V339, P280, DOI 10.1016/j.ydbio.2009.12.014	30	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75407	10.1371/journal.pone.0075407	http://dx.doi.org/10.1371/journal.pone.0075407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073265	gold, Green Submitted, Green Published			2022-12-27	WOS:000324768000074
J	Areeshi, MY; Haque, S; Panda, AK; Mandal, RK				Areeshi, Mohammed Y.; Haque, Shafiul; Panda, Aditya K.; Mandal, Raju K.			A Serotonin Transporter Gene (SLC6A4) Polymorphism Is Associated with Reduced Risk of Irritable Bowel Syndrome in American and Asian Population: A Meta-Analysis	PLOS ONE			English	Article							FUNCTIONAL POLYMORPHISM; METABOLISM; DISORDERS; PROTEIN	Aim: Association studies of serotonin transporter gene SLC6A4 I/S polymorphism and irritable bowel syndrome (IBS) have shown inconsistent and contradictory results among different populations. In the present study, meta-analysis was performed to evaluate the association between SLC6A4 I/S polymorphism and IBS susceptibility. Methodology: Systemic assessment was performed for the published studies based on the association of SLC6A4 I/S polymorphism and IBS risk from PubMed (Medline), EMBASE search. A meta-analysis was done to appraise the said association. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for allele contrast, homozygous, heterozygous, dominant and recessive genetic model. Results: A total of twelve studies comprising 2068 IBS cases and 2076 controls were included in this meta-analysis. Overall, no significant results were obtained for S allele carrier (S vs. I: p=0.488; OR=1.073, 95% CI=0.879 to 1.311) Co-dominant (SS vs. II; p=0.587; OR=1.112, 95% CI=0.758 to 1.631), (IS vs. II; p=0.361; OR=0.878, 95% CI=0.665 to 1.160). Similarly, dominant (SS+IS vs. II: p=0.853; OR=0.974, 95% CI=0.736 to 1.288) and recessive (SS vs. II+IS: p=0.267; OR=1.172, 95% CI=0.886 to 1.522) genetic models did not demonstrate risk. In the subgroup population based analysis, reduced risks were found in American (IS vs. II: p=0.009; OR=0.685, 95% CI=0.516 to 0.908) and Asian (SS+IS vs. II; p=0.001; OR=0.116, 95% CI=0.068 to 0.197) population. However, no risk was observed in European population. Conclusions: This investigation clearly demonstrates that SLC6A4 (Ins/Del) polymorphism is associated with reduced risk of IBS in American and Asian population. However, future well-designed studies with stratified case control and biological characterization will be needed to validate this finding.	[Areeshi, Mohammed Y.] Jazan Univ, Coll Nursing & Allied Hlth Sci, Dept Med Microbiol, Jazan, Saudi Arabia; [Haque, Shafiul] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India; [Panda, Aditya K.] Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Odisha, India; [Mandal, Raju K.] Sanjay Gandhi Post Grad Inst Med Sci, Dept Urol, Lucknow, Uttar Pradesh, India	College Nursing & Allied Health Science Saudi Arabia; Jazan University; Jamia Millia Islamia; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Sanjay Gandhi Postgraduate Institute of Medical Sciences	Mandal, RK (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Urol, Lucknow, Uttar Pradesh, India.	rkmandal@live.com	HAQUE, SHAFIUL/AAN-2946-2020; Panda, Aditya K/E-1267-2012	HAQUE, SHAFIUL/0000-0002-2989-121X; Panda, Aditya K/0000-0002-1192-1978; Mandal, Raju/0000-0001-6206-1413				Barbara G, 2004, ALIMENT PHARM THER, V20, P1, DOI 10.1111/j.1365-2036.2004.02036.x; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Cremonini F, 2005, GASTROENTEROL CLIN N, V34, P189, DOI 10.1016/j.gtc.2005.02.008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunlop SP, 2005, CLIN GASTROENTEROL H, V3, P349, DOI 10.1016/S1542-3565(04)00726-8; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gershon MD, 2005, J CLIN GASTROENTEROL, V39, pS184, DOI 10.1097/01.mcg.0000156403.37240.30; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.3.CO;2-S; Hansen MB, 2003, PHYSIOL RES, V52, P1; Heils A, 1996, J NEUROCHEM, V66, P2621; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Kim HJ, 2004, GUT, V53, P829, DOI 10.1136/gut.2003.030882; Kohen R, 2009, DIGEST DIS SCI, V54, P2663, DOI 10.1007/s10620-008-0666-3; Kumar S, 2012, J GASTROINTEST LIVER, V21, P31; Lembo A, 2007, ALIMENT PHARM THER, V25, P1343, DOI 10.1111/j.1365-2036.2007.03326.x; Li YY, 2007, DIGEST DIS SCI, V52, P2942, DOI 10.1007/s10620-006-9679-y; MANTEL N, 1959, J NATL CANCER I, V22, P719; Markoutsaki T, 2011, DIGEST DIS SCI, V56, P3276, DOI 10.1007/s10620-011-1726-7; Mawe GM, 2006, ALIMENT PHARM THER, V23, P1067, DOI 10.1111/j.1365-2036.2006.02858.x; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Niesler B, 2010, EUR J GASTROEN HEPAT, V22, P856, DOI 10.1097/MEG.0b013e32832e9d6b; Park JM, 2006, NEUROGASTROENT MOTIL, V18, P995, DOI 10.1111/j.1365-2982.2006.00829.x; Pata C, 2002, AM J GASTROENTEROL, V97, P1780; Saito YA, 2007, NEUROGASTROENT MOTIL, V19, P465, DOI 10.1111/j.1365-2982.2007.00905.x; Sikander A, 2009, J CLIN GASTROENTEROL, V43, P957, DOI 10.1097/MCG.0b013e3181b37e8c; Spiller R, 2007, NEUROGASTROENT MOTIL, V19, P25, DOI 10.1111/j.1365-2982.2007.00965.x; Stoltenberg SF, 2002, AM J MED GENET, V114, P230, DOI 10.1002/ajmg.10187; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thompson WG, 1999, GUT, V45, P43; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Van Kerkhoven LAS, 2007, ALIMENT PHARM THER, V26, P979, DOI 10.1111/j.1365-2036.2007.03453.x; Wang YM, 2012, NEUROGASTROENT MOTIL, V24, P560, DOI 10.1111/j.1365-2982.2012.01902.x; Wu RL, 1999, BIOMETRICS, V55, P355; Yeo A, 2004, GUT, V53, P1452, DOI 10.1136/gut.2003.035451	37	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75567	10.1371/journal.pone.0075567	http://dx.doi.org/10.1371/journal.pone.0075567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069428	Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300084
J	He, JQ; Lang, GJ; Ding, SP; Li, LJ				He, Jianqin; Lang, Guanjing; Ding, Shiping; Li, Lanjuan			Pathological Role of Interleukin-17 in Poly I:C-Induced Hepatitis	PLOS ONE			English	Article							B-VIRUS INFECTION; DELTA-T-CELLS; LISTERIA-MONOCYTOGENES INFECTION; NATURAL-KILLER-CELLS; INDUCED LIVER-INJURY; DOUBLE-STRANDED-RNA; NK CELLS; TH17 CELLS; IL-17 PRODUCTION; INNATE IMMUNITY	Immune-mediated responses were the main causes of liver damage during viral hepatitis, and recently viral RNA mimetic Poly I: C was used to induce a NK cell-dominated acute hepatitis. Interleukin-17A (IL-17A), the cytokine tightly associated with various autoimmune diseases, was known to play protective or pathological roles in LPS and ConA-induced hepatitis. However, its role in NK cell-mediated acute hepatitis remains unknown. Here we demonstrated that Poly I:C treatment triggered IL-17A production from hepatic gamma delta T cells. Neutralizing IL-17A by monoclonal antibodies reduced Poly I:C-induced intrahepatic inflammatory responses and the liver injury through decreased accumulation, activation and cytolytic activity of NK cells in the liver. Furthermore, Poly I:C didn't trigger IL-17A secretion from cdT cells directly, and Kuppfer cells were demonstrated to be the accessory cell that can secrete IL-23. Finally, our findings demonstrated a pathological role of IL-17A and cdT cells in Poly I:C-induced acute hepatitis, which provides novel insights into viral infection-induced hepatitis and may serve as potential target in clinic immunotherapy against these disease.	[He, Jianqin; Lang, Guanjing; Ding, Shiping; Li, Lanjuan] Zhejiang Univ, Dept Infect Dis, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Coll Me, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Dept Infect Dis, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Coll Me, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn			12th Five-Year Significant New Drugs Creation Plan of the Ministry of Science and Technology of China [2011ZX09302-003-03]; Medical Scientific Research Foundation of Zhejiang Province [Y2100347]; Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases [2010KF12]; "11th Five-Year'' Major Science and Technology Projects of Infectious Disease about AIDS and Viral Hepatitis [2008ZX10003011]; National Natural Science Foundation of China [81072339]	12th Five-Year Significant New Drugs Creation Plan of the Ministry of Science and Technology of China; Medical Scientific Research Foundation of Zhejiang Province; Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases; "11th Five-Year'' Major Science and Technology Projects of Infectious Disease about AIDS and Viral Hepatitis; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 12th Five-Year Significant New Drugs Creation Plan of the Ministry of Science and Technology of China (No. 2011ZX09302-003-03), Medical Scientific Research Foundation of Zhejiang Province (Y2100347), the Opening Foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (2010KF12), "11th Five-Year'' Major Science and Technology Projects of Infectious Disease about AIDS and Viral Hepatitis (2008ZX10003011), and the National Natural Science Foundation of China (81072339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Chen Y, 2005, J VIRAL HEPATITIS, V12, P38, DOI 10.1111/j.1365-2893.2005.00543.x; Chen YY, 2007, J HEPATOL, V47, P183, DOI 10.1016/j.jhep.2007.02.020; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Dong ZJ, 2004, J HEPATOL, V41, P966, DOI 10.1016/j.jhep.2004.08.021; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Graeber KE, 2012, INFLAMM RES, V61, P87, DOI 10.1007/s00011-011-0419-1; Haak S, 2009, IMMUNOTHERAPY-UK, V1, P199, DOI 10.2217/1750743X.1.2.199; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Hanafiah KM, 2012, HEPATOLOGY; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kawakami Y, 2009, J EXP MED, V206, P1219, DOI 10.1084/jem.20082835; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kobayashi E, 2009, TOXICOL SCI, V111, P302, DOI 10.1093/toxsci/kfp165; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Lafdil F, 2009, GASTROENTEROLOGY, V137, P2125, DOI 10.1053/j.gastro.2009.08.004; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Liu ZX, 2000, J IMMUNOL, V164, P6480, DOI 10.4049/jimmunol.164.12.6480; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Nagata T, 2008, J IMMUNOL, V181, P7473, DOI 10.4049/jimmunol.181.11.7473; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Oyoshi MK, 2009, P NATL ACAD SCI USA, V106, P14954, DOI 10.1073/pnas.0904021106; Passos ST, 2010, J IMMUNOL, V184, P1776, DOI 10.4049/jimmunol.0901843; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Schmidt KN, 2004, J IMMUNOL, V172, P138, DOI 10.4049/jimmunol.172.1.138; Shimizu Y, 2012, WORLD J GASTROENTERO, V18, P2443, DOI 10.3748/wjg.v18.i20.2443; Sivori S, 2004, P NATL ACAD SCI USA, V101, P10116, DOI 10.1073/pnas.0403744101; Stout-Delgado HW, 2009, CELL HOST MICROBE, V6, P446, DOI 10.1016/j.chom.2009.09.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tu Z, 2008, J EXP MED, V205, P233, DOI 10.1084/jem.20072195; von Vietinghoff S, 2009, J IMMUNOL, V183, P865, DOI 10.4049/jimmunol.0804080; Wang XF, 2013, HEPATOLOGY, V57, P373, DOI 10.1002/hep.25982; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763; Yasumi Y, 2007, HEPATOL RES, V37, P248, DOI 10.1111/j.1872-034X.2007.00040.x; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977; Zhao N, 2011, J IMMUNOL, V187, P5007, DOI 10.4049/jimmunol.1101315; Zou Y, 2010, J IMMUNOL, V184, P466, DOI 10.4049/jimmunol.0900687	52	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73909	10.1371/journal.pone.0073909	http://dx.doi.org/10.1371/journal.pone.0073909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069246	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300023
J	Le Coz, C; Joublin, A; Pasquali, JL; Korganow, AS; Dumortier, H; Monneaux, F				Le Coz, Carole; Joublin, Aurelie; Pasquali, Jean-Louis; Korganow, Anne-Sophie; Dumortier, Helene; Monneaux, Fanny			Circulating T-FH Subset Distribution Is Strongly Affected in Lupus Patients with an Active Disease	PLOS ONE			English	Article							INCREASED FREQUENCY; CELLS EXPRESS; BLOOD; IL-21; ERYTHEMATOSUS; CD27; POPULATION; PHENOTYPE; IGD	Follicular helper T cells (T-FH) represent a distinct subset of CD4(+) T cells specialized in providing help to B lymphocytes, which may play a central role in autoimmune diseases having a major B cell component such as systemic lupus erythematosus. Recently, T-FH subsets that share common phenotypic and functional characteristics with T-FH cells from germinal centers, have been described in the peripheral blood from healthy individuals. The aim of this study was to analyze the distribution of such populations in lupus patients. Circulating T-FH cell subsets were defined by multicolor flow cytometry as T(FH)17 (CXCR3(-)CCR6(+)), T(FH)1 (CXCR3(+) CCR6(-)) or T(FH)2 (CXCR3(-)CCR6(-)) cells among CXCR5(+) CD45RA(-)CD4(+) T cells in the peripheral blood of 23 SLE patients and 23 sex and age-matched healthy controls. IL-21 receptor expression by B cells was analyzed by flow cytometry and the serum levels of IL-21 and Igs were determined by ELISA tests. We found that the T(FH)2 cell subset frequency is strongly and significantly increased in lupus patients with an active disease (SLEDAI score>8), while the T(FH)1 cell subset percentage is greatly decreased. The T(FH)2 and T(FH)1 cell subset frequency alteration is associated with the presence of high Ig levels and autoantibodies in patient's sera. Moreover, the T(FH)2 cell subset enhancement correlates with an increased frequency of double negative memory B cells (CD27(-)IgD(-)CD19(+) cells) expressing the IL-21R. Finally, we found that IgE levels in lupus patients' sera correlate with disease activity and seem to be associated with high T(FH)2 cell subset frequency. In conclusion, our study describes for the first time the distribution of circulating T-FH cell subsets in lupus patients. Interestingly, we found an increased frequency of T(FH)2 cells, which correlates with disease activity. Our results suggest that this subset might play a key role in lupus pathogenesis.	[Le Coz, Carole; Joublin, Aurelie; Pasquali, Jean-Louis; Korganow, Anne-Sophie; Dumortier, Helene; Monneaux, Fanny] CNRS, Inst Biol Mol & Cellulaire, Lab Excellence MEDALIS, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Monneaux, F (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Lab Excellence MEDALIS, F-67084 Strasbourg, France.	f.monneaux@ibmc-cnrs.unistra.fr		Korganow, Anne-Sophie/0000-0002-1664-6311; Le Coz, Carole/0000-0002-9228-5896	French Centre National de la Recherche Scientifique (CNRS); Fondation Athritis-Courtin; Hopitaux Universitaires de Strasbourg (PHRC)	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation Athritis-Courtin; Hopitaux Universitaires de Strasbourg (PHRC)	This study was supported by the French Centre National de la Recherche Scientifique (CNRS), by grants from the Fondation Athritis-Courtin and from the Hopitaux Universitaires de Strasbourg (PHRC). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Atta AM, 2010, INT ARCH ALLERGY IMM, V152, P401, DOI 10.1159/000288293; Bossaller L, 2006, J IMMUNOL, V177, P4927, DOI 10.4049/jimmunol.177.7.4927; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Crispin JC, 2010, CURR OPIN RHEUMATOL, V22, P499, DOI 10.1097/BOR.0b013e32833c62b0; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Davidson A, 2010, NAT REV RHEUMATOL, V6, P13, DOI 10.1038/nrrheum.2009.240; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Ettinger R, 2008, IMMUNOL REV, V223, P60, DOI 10.1111/j.1600-065X.2008.00631.x; Ettinger R, 2007, J IMMUNOL, V178, P2872, DOI 10.4049/jimmunol.178.5.2872; FENG W, 2012, PLOS ONE, V7, P51982, DOI DOI 10.1371/J0URNAL.P0NE.0051982.PUBMED:23284839; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hu YL, 2009, J IMMUNOL, V182, P1421, DOI 10.4049/jimmunol.182.3.1421; Iwai H, 2003, J IMMUNOL, V171, P2848, DOI 10.4049/jimmunol.171.6.2848; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Korganow AS, 2010, J AUTOIMMUN, V34, P426, DOI 10.1016/j.jaut.2009.11.002; Lacotte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058140; Lacotte S, 2010, J IMMUNOL, V184, P3937, DOI 10.4049/jimmunol.0902595; Li XY, 2012, BIOCHEM BIOPH RES CO, V422, P238, DOI 10.1016/j.bbrc.2012.04.133; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Mazerolles F, 2013, J ALLERGY CLIN IMMUN, V131, P1146, DOI 10.1016/j.jaci.2012.12.1519; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Rodriguez-Bayona B, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3042; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Steinmetz OM, 2009, J IMMUNOL, V183, P4693, DOI 10.4049/jimmunol.0802626; Stemmer C, 1997, J MOL BIOL, V273, P52, DOI 10.1006/jmbi.1997.1270; Terrier B, 2012, J RHEUMATOL, V39, P1819, DOI 10.3899/jrheum.120468; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang Xiao-Fei, 2007, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V23, P1041; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Zhu CL, 2012, J CLIN ENDOCR METAB, V97, P943, DOI 10.1210/jc.2011-2003	40	132	133	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75319	10.1371/journal.pone.0075319	http://dx.doi.org/10.1371/journal.pone.0075319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069401	gold, Green Published			2022-12-27	WOS:000324777300072
J	Xu, Z; Li, S; Li, J; Li, Y; Feng, XH; Wang, RX; Xu, H; Zhou, JH				Xu, Zheng; Li, Sha; Li, Jie; Li, Yan; Feng, Xiaohai; Wang, Renxiao; Xu, Hong; Zhou, Jiahai			The Structural Basis of Erwinia rhapontici Isomaltulose Synthase	PLOS ONE			English	Article							SUCROSE ISOMERASE; SYNTHESIZING ENZYME; PRODUCT SPECIFICITY; MECHANISM; CONVERSION; SITE; VALIDATION; PREVENTION; ALGORITHM; RESIDUES	Sucrose isomerase NX-5 from Erwinia rhapontici efficiently catalyzes the isomerization of sucrose to isomaltulose (main product) and trehalulose (by-product). To investigate the molecular mechanism controlling sucrose isomer formation, we determined the crystal structures of native NX-5 and its mutant complexes E295Q/sucrose and D241A/glucose at 1.70 angstrom, 1.70 angstrom and 2.00 angstrom, respectively. The overall structure and active site architecture of NX-5 resemble those of other reported sucrose isomerases. Strikingly, the substrate binding mode of NX-5 is also similar to that of trehalulose synthase from Pseudomonas mesoacidophila MX-45 (MutB). Detailed structural analysis revealed the catalytic RXDRX motif and the adjacent 10-residue loop of NX-5 and isomaltulose synthase PalI from Klebsiella sp. LX3 adopt a distinct orientation from those of trehalulose synthases. Mutations of the loop region of NX-5 resulted in significant changes of the product ratio between isomaltulose and trehalulose. The molecular dynamics simulation data supported the product specificity of NX-5 towards isomaltulose and the role of the loop330-339 in NX-5 catalysis. This work should prove useful for the engineering of sucrose isomerase for industrial carbohydrate biotransformations.	[Xu, Zheng; Li, Sha; Feng, Xiaohai; Xu, Hong] Nanjing Univ Technol, Coll Food Sci & Light Ind, State Key Lab Mat Oriented Chem Engn, Nanjing 210009, Jiangsu, Peoples R China; [Xu, Zheng; Li, Jie; Li, Yan; Wang, Renxiao; Zhou, Jiahai] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Nanjing Tech University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Xu, H (corresponding author), Nanjing Univ Technol, Coll Food Sci & Light Ind, State Key Lab Mat Oriented Chem Engn, Nanjing 210009, Jiangsu, Peoples R China.	xuh@njut.edu.cn; jiahai@mail.sioc.ac.cn	Li, Yan/AAB-8280-2021		National Basic Research Program of China [2009CB724700, 2013CB733600, 2009CB918600, 2011CB710800]; National High Technology Research and Development Program of China [2012AA021503]; Specialized Research Fund for the Doctoral Program of Higher Education [20103221110006]; Program for Changjiang Scholars and Innovative Research Team in University; National Nature Science Foundation of China [21176123, 21276082]; State Key Laboratory of Material-Oriented Chemical Engineering	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Material-Oriented Chemical Engineering	This work was supported by the National Basic Research Program of China (2009CB724700 and 2013CB733600 to H. X.; 2009CB918600 and 2011CB710800 to J.Z.), the National High Technology Research and Development Program of China (2012AA021503 to H. X.), the Specialized Research Fund for the Doctoral Program of Higher Education (20103221110006 to H. X.), the Program for Changjiang Scholars and Innovative Research Team in University (to H. X.), and the National Nature Science Foundation of China (21176123 to H. X.; 21276082 to J.Z.). This work is also funded by the open grant from the State Key Laboratory of Material-Oriented Chemical Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aroonnual A, 2007, ENZYME MICROB TECH, V40, P1221, DOI 10.1016/j.enzmictec.2006.09.011; BAER A, 1989, LEBENSM WISS TECHNOL, V22, P46; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case D, 2006, AMBER 9; CHEETHAM PSJ, 1982, NATURE, V299, P628, DOI 10.1038/299628a0; CHEETHAM PSJ, 1984, BIOCHEM J, V220, P213, DOI 10.1042/bj2200213; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho MH, 2007, BIOTECHNOL LETT, V29, P453, DOI 10.1007/s10529-006-9257-6; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRISCH M, 1990, CHEM PHYS, V141, P189, DOI 10.1016/0301-0104(90)87055-G; Gorl J, 2012, CHEMBIOCHEM, V13, P149, DOI 10.1002/cbic.201100576; Goulter KC, 2012, ENZYME MICROB TECH, V50, P57, DOI 10.1016/j.enzmictec.2011.09.011; Hamada S, 2002, PURE APPL CHEM, V74, P1293, DOI 10.1351/pac200274071293; Huang JH, 1998, J IND MICROBIOL BIOT, V21, P22, DOI 10.1038/sj.jim.2900552; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KAWAI K, 1985, ENDOCRINOL JAPON, V32, P933; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HC, 2008, APPL ENVIRON MICROB, V74, P5183, DOI 10.1128/AEM.00181-08; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Li S, 2011, APPL BIOCHEM BIOTECH, V163, P52, DOI 10.1007/s12010-010-9015-z; Lichtenthaler FW, 2004, CR CHIM, V7, P65, DOI 10.1016/j.crci.2004.02.002; Lina BAR, 2002, FOOD CHEM TOXICOL, V40, P1375, DOI 10.1016/S0278-6915(02)00105-9; Lipski A, 2013, ACTA CRYSTALLOGR D, V69, P298, DOI 10.1107/S0907444912045532; Matsukubo T, 2006, INT DENT J, V56, P119; MCALLISTER M, 1990, BIOTECHNOL LETT, V12, P667, DOI 10.1007/BF01088191; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MIYATA Y, 1992, BIOSCI BIOTECH BIOCH, V56, P1680, DOI 10.1271/bbb.56.1680; NAGAI Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1789, DOI 10.1271/bbb.58.1789; NAGAIMIYATA Y, 1993, BIOSCI BIOTECH BIOCH, V57, P2049, DOI 10.1271/bbb.57.2049; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ravaud S, 2007, J BIOL CHEM, V282, P28126, DOI 10.1074/jbc.M704515200; Ravaud S, 2009, FEBS LETT, V583, P1964, DOI 10.1016/j.febslet.2009.05.002; Ren B, 2011, BIOPROC BIOSYST ENG, V34, P629, DOI 10.1007/s00449-010-0512-9; Takazoe I., 1989, PROGR SWEETENERS, P143; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Veronese T, 1998, FEBS LETT, V441, P348, DOI 10.1016/S0014-5793(98)01582-8; Veronese T, 1999, ENZYME MICROB TECH, V24, P263, DOI 10.1016/S0141-0229(98)00115-X; Wu L, 2004, J APPL MICROBIOL, V97, P93, DOI 10.1111/j.1365-2672.2004.02274.x; Zhang DH, 2003, J BIOL CHEM, V278, P35428, DOI 10.1074/jbc.M302616200; Zhang DH, 2003, FEBS LETT, V534, P151, DOI 10.1016/S0014-5793(02)03835-8; Zhang DH, 2002, APPL ENVIRON MICROB, V68, P2676, DOI 10.1128/AEM.68.6.2676-2682.2002; Zhou X, 2011, PROTEIN PEPTIDE LETT, V18, P1028, DOI 10.2174/092986611796378774	48	12	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74788	10.1371/journal.pone.0074788	http://dx.doi.org/10.1371/journal.pone.0074788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069347	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300045
J	Olmedo, SB; De Vincentiis, S; De Martino, E; Bedecarras, P; Blanco, AM; Freire, A; Buffone, MG; Rey, RA				Brugo Olmedo, Santiago; De Vincentiis, Sabrina; De Martino, Evelyn; Bedecarras, Patricia; Maria Blanco, Ana; Freire, Analia; Buffone, Mariano G.; Rey, Rodolfo A.			Prediction of Reproductive Outcomes According to Different Serum Anti-Mullerian Hormone Levels in Females Undergoing Intracystoplasmic Sperm Injection	PLOS ONE			English	Article							ANTRAL FOLLICLE COUNT; INHIBITING SUBSTANCE LEVELS; POLYCYSTIC-OVARY-SYNDROME; ANTIMULLERIAN-HORMONE; STIMULATED CYCLES; TECHNOLOGY CYCLES; MENSTRUAL-CYCLE; EMBRYO QUALITY; OOCYTE QUALITY; MARKER	Background and aim of the study: Serum anti-Mullerian hormone (AMH) is a reliable marker of ovarian reserve, and it has been shown to be correlated with reproductive outcomes in grouped analyses. However, practical data is scarce for the physician and the patients to predict these outcomes in an individual couple according to serum AMH measured prior to assisted reproduction technology (ART) procedures. Study Design: To address this question, we performed an analytic observational study including 145 females undergoing intracytoplasmic sperm injection (ICSI) in a single center. Results were analyzed according to serum AMH; subgroup analyses were performed by grouping patients according to patient's age and FSH levels. Results: The risk of cycle cancelation decreased from 64% in patients with serum AMH <= 3 pmol/L (0.42 ng/mL) to 21% with AMH >= 15 pmol/L (2.10 ng/mL). Cycle cancelation occurred in approximately two-thirds of the patients with AMH <= 3 pmol/L irrespective of the FSH level. However, with higher AMH values the risk of cycle cancelation decreased more significantly in patients with normal FSH. The rate of good response increased from almost null in patients with AMH <= 3 pmol/L to 61% in those with AMH >= 15 pmol/L. The positive correlation between good response and AMH was also significant, but with lower absolute rates, when patients were grouped according to their age or FSH levels. Pregnancy rate increased moderately, but significantly, from 31% with AMH <= 3 pmol/L to 35% with AMH >= 15 pmol/L. Conclusions: We provide estimates of reproductive outcomes according to individualized values of serum AMH, in general and in subgroups according to patient's age or serum FSH, which are helpful for the clinician and the couple in their decision making about starting an assisted reproductive treatment.	[Brugo Olmedo, Santiago; De Vincentiis, Sabrina; De Martino, Evelyn; Buffone, Mariano G.] Seremas, Ctr Med, Buenos Aires, DF, Argentina; [Bedecarras, Patricia; Freire, Analia; Rey, Rodolfo A.] Hosp Ninos Dr Ricardo Gutierrez, Ctr Invest Endocrinol Dr Cesar Bergada CEDIE, CONICET, FEI,Div Endocrinol, Buenos Aires, DF, Argentina; [Maria Blanco, Ana] Ctr Estudios Bioquim Androl & Ginecol, Buenos Aires, DF, Argentina; [Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn, IBYME, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine	Rey, RA (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Ctr Invest Endocrinol Dr Cesar Bergada CEDIE, CONICET, FEI,Div Endocrinol, Buenos Aires, DF, Argentina.	rodolforey@cedie.org.ar	Rey, Rodolfo/E-5552-2012	Rey, Rodolfo/0000-0002-1100-3843	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina)	CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was partially funded by CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina) to cover the cost of AMH assay reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson RA, 2012, MATURITAS, V71, P28, DOI 10.1016/j.maturitas.2011.11.008; BAKER ML, 1990, J CLIN ENDOCR METAB, V70, P11, DOI 10.1210/jcem-70-1-11; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Broer SL, 2011, HUM REPROD UPDATE, V17, P46, DOI 10.1093/humupd/dmq034; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Cook CL, 2002, FERTIL STERIL, V77, P141, DOI 10.1016/S0015-0282(01)02944-2; Cook CL, 2000, FERTIL STERIL, V73, P859, DOI 10.1016/S0015-0282(99)00639-1; Ebner T, 2006, HUM REPROD, V21, P2022, DOI 10.1093/humrep/del127; Fallat ME, 1997, FERTIL STERIL, V67, P962, DOI 10.1016/S0015-0282(97)81417-3; Fanchin R, 2003, HUM REPROD, V18, P328, DOI 10.1093/humrep/deg043; Feyereisen E, 2006, REPROD BIOMED ONLINE, V12, P695, DOI 10.1016/S1472-6483(10)61081-4; Fong SL, 2008, REPROD BIOMED ONLINE, V16, P664, DOI 10.1016/S1472-6483(10)60480-4; Freour T, 2007, CLIN CHIM ACTA, V375, P162, DOI 10.1016/j.cca.2006.06.013; Friden B, 2011, AUST NZ J OBSTET GYN, V51, P411, DOI 10.1111/j.1479-828X.2011.01374.x; Grinspon RP, 2012, CLIN ENDOCRINOL, V76, P698, DOI 10.1111/j.1365-2265.2011.04297.x; Hagen CP, 2010, J CLIN ENDOCR METAB, V95, P5003, DOI 10.1210/jc.2010-0930; Hazout A, 2004, FERTIL STERIL, V82, P1323, DOI 10.1016/j.fertnstert.2004.03.061; Hehenkamp WJK, 2006, J CLIN ENDOCR METAB, V91, P4057, DOI 10.1210/jc.2006-0331; Hendriks DJ, 2007, FERTIL STERIL, V87, P764, DOI 10.1016/j.fertnstert.2006.11.006; HUDSON PL, 1990, J CLIN ENDOCR METAB, V70, P16, DOI 10.1210/jcem-70-1-16; Jayaprakasan K, 2010, FERTIL STERIL, V93, P855, DOI 10.1016/j.fertnstert.2008.10.042; JOSSO N, 1990, J CLIN ENDOCR METAB, V70, P23, DOI 10.1210/jcem-70-1-23; Josso Nathalie, 2006, Pediatr Endocrinol Rev, V3, P347; La Marca A, 2006, HUM REPROD, V21, P3103, DOI 10.1093/humrep/del291; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Lekamge DN, 2007, REPROD BIOMED ONLINE, V14, P602, DOI 10.1016/S1472-6483(10)61053-X; Long WQ, 2000, J CLIN ENDOCR METAB, V85, P540, DOI 10.1210/jc.85.2.540; McIlveen M, 2007, HUM REPROD, V22, P778, DOI 10.1093/humrep/del435; Muttukrishna S, 2005, BJOG-INT J OBSTET GY, V112, P1384, DOI 10.1111/j.1471-0528.2005.00670.x; Muttukrishna S, 2004, BJOG-INT J OBSTET GY, V111, P1248, DOI 10.1111/j.1471-0528.2004.00452.x; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nelson SM, 2011, REPROD BIOMED ONLINE, V23, P204, DOI 10.1016/j.rbmo.2011.05.006; Olmedo SB, 2000, ASIAN J ANDROL, V2, P125; Penarrubia J, 2005, HUM REPROD, V20, P915, DOI 10.1093/humrep/deh718; Pigny P, 2006, J CLIN ENDOCR METAB, V91, P941, DOI 10.1210/jc.2005-2076; Rey R, 2000, HUM PATHOL, V31, P1202, DOI 10.1053/hupa.2000.18498; Rey RA, 1996, AM J OBSTET GYNECOL, V174, P958, DOI 10.1016/S0002-9378(96)70333-2; Rey RA, 1999, J CLIN ENDOCR METAB, V84, P627, DOI 10.1210/jc.84.2.627; Seifer DB, 2002, FERTIL STERIL, V77, P468, DOI 10.1016/S0015-0282(01)03201-0; Silberstein T, 2006, HUM REPROD, V21, P159, DOI 10.1093/humrep/dei270; Smeenk JMJ, 2007, FERTIL STERIL, V87, P223, DOI 10.1016/j.fertnstert.2006.06.019; Velde ERT, 2002, HUM REPROD UPDATE, V8, P141, DOI 10.1093/humupd/8.2.141; VIGIER B, 1984, ENDOCRINOLOGY, V114, P1315, DOI 10.1210/endo-114-4-1315	44	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75685	10.1371/journal.pone.0075685	http://dx.doi.org/10.1371/journal.pone.0075685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069435	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300091
J	Park, J; Munagala, I; Xu, H; Blankenship, D; Maffucci, P; Chaussabel, D; Banchereau, J; Pascual, V; Cunningham-Rundles, C				Park, Joon; Munagala, Indira; Xu, Hui; Blankenship, Derek; Maffucci, Patrick; Chaussabel, Damien; Banchereau, Jacques; Pascual, Virginia; Cunningham-Rundles, Charlotte			Interferon Signature in the Blood in Inflammatory Common Variable Immune Deficiency	PLOS ONE			English	Article							MEMORY B-CELLS; ANTIBODY-DEFICIENCY; IMMUNODEFICIENCY DISORDERS; TRANSCRIPTIONAL SIGNATURE; PERIPHERAL-BLOOD; EXPRESSION; MUTATIONS; PATTERNS; PATIENT; ALPHA	About half of all subjects with common variable immune deficiency (CVID) are afflicted with inflammatory complications including hematologic autoimmunity, granulomatous infiltrations, interstitial lung disease, lymphoid hyperplasia and/or gastrointestinal inflammatory disease. The pathogenesis of these conditions is poorly understood but singly and in aggregate, these lead to significantly increased (11 fold) morbidity and mortality, not experienced by CVID subjects without these complications. To explore the dysregulated networks in these subjects, we applied whole blood transcriptional profiling to 91 CVID subjects, 47 with inflammatory conditions and 44 without, in comparison to subjects with XLA and healthy controls. As compared to other CVID subjects, males with XLA or healthy controls, the signature of CVID subjects with inflammatory complications was distinguished by a marked up-regulation of IFN responsive genes. Chronic up-regulation of IFN pathways is known to occur in autoimmune disease due to activation of TLRs and other still unclarified cytoplasmic sensors. As subjects with inflammatory complications were also more likely to be lymphopenic, have reduced B cell numbers, and a greater reduction of B, T and plasma cell networks, we suggest that more impaired adaptive immunity in these subjects may lead to chronic activation of innate IFN pathways in response to environmental antigens. The unbiased use of whole blood transcriptome analysis may provides a tool for distinguishing CVID subjects who are at risk for increased morbidity and earlier mortality. As more effective therapeutic options are developed, whole blood transcriptome analyses could also provide an efficient means of monitoring the effects of treatment of the inflammatory phenotype.	[Park, Joon; Maffucci, Patrick; Cunningham-Rundles, Charlotte] Mt Sinai, Icahn Sch Med, Dept Med, New York, NY 10029 USA; [Park, Joon; Maffucci, Patrick; Cunningham-Rundles, Charlotte] Mt Sinai, Icahn Sch Med, Inst Immunol, New York, NY USA; [Munagala, Indira; Banchereau, Jacques; Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX USA; [Chaussabel, Damien] Benaroya Res Inst, Seattle, WA USA; [Xu, Hui; Blankenship, Derek] Baylor HealthCare Syst, Inst Hlth Care Res & Improvement, Dept Quantitat Sci, Dallas, TX USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Baylor Scott & White Health; Benaroya Research Institute; Baylor Health Care System	Cunningham-Rundles, C (corresponding author), Mt Sinai, Icahn Sch Med, Dept Med, New York, NY 10029 USA.	Charlotte.Cunningham-Rundles@mssm.edu	Pascual, Virginia/ABD-3099-2020; Chaussabel, Damien/AAX-1909-2020	Chaussabel, Damien/0000-0002-6131-7242	National Institutes of Health [AI-101093, AI-086037, AI-48693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101093, U24AI086037, R18AI048693, P01AI061093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health AI-101093, AI-086037, AI-48693. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2009, J ALLERGY CLIN IMMUN, V124, P658, DOI 10.1016/j.jaci.2009.06.018; Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Alachkar H, 2006, CLIN IMMUNOL, V120, P310, DOI 10.1016/j.clim.2006.05.003; Allantaz F, 2007, CURR OPIN IMMUNOL, V19, P623, DOI 10.1016/j.coi.2007.10.003; Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Ardeniz O, 2009, CLIN IMMUNOL, V133, P198, DOI 10.1016/j.clim.2009.05.001; Baldovino S, 2013, AUTOIMMUN REV, V12, P796, DOI 10.1016/j.autrev.2012.11.003; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Banchereau R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034390; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernink J, 2013, IMMUNOL REV, V252, P133, DOI 10.1111/imr.12034; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Bolen CR, 2013, J INTERF CYTOK RES, V33, P15, DOI 10.1089/jir.2012.0037; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chapel H, 2009, BRIT J HAEMATOL, V145, P709, DOI 10.1111/j.1365-2141.2009.07669.x; Chaussabel D, 2005, ANN NY ACAD SCI, V1062, P146, DOI 10.1196/annals.1358.017; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705; Crow YJ, 2011, ANN NY ACAD SCI, V1238, P91, DOI 10.1111/j.1749-6632.2011.06220.x; Cunningham-Rundles C, 2001, Curr Allergy Asthma Rep, V1, P421, DOI 10.1007/s11882-001-0027-1; Cunningham-Rundles C, 2002, BLOOD REV, V16, P61, DOI 10.1054/blre.2001.0185; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Fevang B, 2007, CLIN EXP IMMUNOL, V147, P521, DOI 10.1111/j.1365-2249.2006.03314.x; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Genre J, 2009, CLIN IMMUNOL, V132, P215, DOI 10.1016/j.clim.2009.03.519; Greenfest-Allen E, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-38; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hardy GA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056527, DOI 10.1371/J0URNAL.P0NE.0056527.PUBMED:23437155]; Hinze CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3061; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Kanegane H, 2007, GENES IMMUN, V8, P663, DOI 10.1038/sj.gene.6364431; Kuijpers TW, 2010, J CLIN INVEST, V120, P214, DOI 10.1172/JCI40231; Kwok SK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2382; Lubbers J, 2013, ANN RHEUM DIS, V72, P776, DOI 10.1136/annrheumdis-2012-202753; Marashi SM, 2012, J ALLERGY CLIN IMMUN, V129, P1349, DOI 10.1016/j.jaci.2012.02.011; Morimoto Y, 2005, CURR ALLERGY ASTHM R, V5, P370, DOI 10.1007/s11882-005-0008-x; Park JH, 2011, ANN NY ACAD SCI, V1246, P41, DOI 10.1111/j.1749-6632.2011.06338.x; Pascual V, 2008, IMMUNOL REV, V223, P39, DOI 10.1111/j.1600-065X.2008.00643.x; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Resnick ES, 2012, BLOOD, V119, P1650, DOI 10.1182/blood-2011-09-377945; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Ronnblom L, 2013, CURR OPIN RHEUMATOL, V25, P248, DOI 10.1097/BOR.0b013e32835c7e32; Sanchez-Ramon S, 2008, CLIN IMMUNOL, V128, P314, DOI 10.1016/j.clim.2008.02.013; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Serana F, 2011, J CLIN IMMUNOL, V31, P540, DOI 10.1007/s10875-011-9526-6; Shi MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041292; Tattermusch S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002480; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Wehr C, 2004, CLIN IMMUNOL, V113, P161, DOI 10.1016/j.clim.2004.05.010; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744; Wheat WH, 2005, J EXP MED, V202, P479, DOI 10.1084/jem.20050381; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad; Yu JE, 2012, J CLIN IMMUNOL, V32, P50, DOI 10.1007/s10875-011-9602-y; Yu JE, 2009, J ALLERGY CLIN IMMUN, V124, P349, DOI 10.1016/j.jaci.2009.05.019	62	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74893	10.1371/journal.pone.0074893	http://dx.doi.org/10.1371/journal.pone.0074893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069364	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300065
J	Van den Broeck, A; Vankelecom, H; Van Delm, W; Gremeaux, L; Wouters, J; Allemeersch, J; Govaere, O; Roskams, T; Topal, B				Van den Broeck, Anke; Vankelecom, Hugo; Van Delm, Wouter; Gremeaux, Lies; Wouters, Jasper; Allemeersch, Joke; Govaere, Olivier; Roskams, Tania; Topal, Baki			Human Pancreatic Cancer Contains a Side Population Expressing Cancer Stem Cell-Associated and Prognostic Genes	PLOS ONE			English	Article							DRUG EFFLUX CAPACITY; MULTIDRUG-RESISTANCE; ADENOCARCINOMA; TARGET; MDR1	In many types of cancers, a side population (SP) has been identified based on high efflux capacity, thereby enriching for chemoresistant cells as well as for candidate cancer stem cells (CSC). Here, we explored whether human pancreatic ductal adenocarcinoma (PDAC) contains a SP, and whether its gene expression profile is associated with chemoresistance, CSC and prognosis. After dispersion into single cells and incubation with Hoechst dye, we analyzed human PDAC resections specimens using flow cytometry (FACS). We identified a SP and main population (MP) in all human PDAC resection specimens (n = 52) analyzed, but detected immune (CD45(+)) and endothelial (CD31(+)) cells in this fraction together with tumor cells. The SP and MP cells, or more purified fractions depleted from CD31(+)/CD45(+) cells (pSP and pMP), were sorted by FACS and subjected to whole-genome expression analysis. This revealed upregulation of genes associated with therapy resistance and of markers identified before in putative pancreatic CSC. pSP gene signatures of 32 or 10 up-or downregulated genes were developed and tested for discriminatory competence between pSP and pMP in different sets of PDAC samples. The prognostic value of the pSP genes was validated in a large independent series of PDAC patients (n = 78) using nCounter analysis of expression (in tumor versus surrounding pancreatic tissue) and Cox regression for disease-free and overall survival. Of these genes, expression levels of ABCB1 and CXCR4 were correlated with worse patient survival. Thus, our study for the first time demonstrates that human PDAC contains a SP. This tumor subpopulation may represent a valuable therapeutic target given its chemoresistance-and CSC-associated gene expression characteristics with potential prognostic value.	[Van den Broeck, Anke; Topal, Baki] Univ Hosp Leuven, Dept Abdominal Surg, Louvain, Belgium; [Van den Broeck, Anke; Vankelecom, Hugo; Gremeaux, Lies; Wouters, Jasper] Univ Leuven KU Leuven, Dept Dev & Regenerat, Res Unit Embryo & Stem Cells, Lab Tissue Plast, Louvain, Belgium; [Van Delm, Wouter; Allemeersch, Joke] Univ Leuven KU Leuven, VIB Nucle Core, Louvain, Belgium; [Govaere, Olivier; Roskams, Tania] Univ Hosp Leuven, Dept Pathol, Louvain, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven	Topal, B (corresponding author), Univ Hosp Leuven, Dept Abdominal Surg, Louvain, Belgium.	baki.topal@med.kuleuven.be	Wouters, Jasper/AAK-8597-2020; Govaere, Olivier/R-9372-2019; Topal, Baki/AAH-9019-2021	Wouters, Jasper/0000-0002-7129-2990; Govaere, Olivier/0000-0002-4426-6930; Topal, Baki/0000-0002-2687-7535; Roskams, Tania/0000-0002-2816-1530; Vankelecom, Hugo/0000-0002-2251-7284	Fund for Scientific Research Flanders [FWO ASP-08-00379, 3M080177]	Fund for Scientific Research Flanders(FWO)	The study is supported by the Fund for Scientific Research Flanders (FWO ASP-08-00379; 3M080177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; Duxbury MS, 2004, ONCOGENE, V23, P1448, DOI 10.1038/sj.onc.1207247; Friess H, 1995, CLIN CANCER RES, V1, P1413; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Iiizumi M, 2006, CANCER SCI, V97, P1211, DOI 10.1111/j.1349-7006.2006.00313.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Khanna A, 2011, CELL MOL BIOL LETT, V16, P101, DOI 10.2478/s11658-010-0043-z; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Liles JS, 2011, BRIT J CANCER, V105, P523, DOI 10.1038/bjc.2011.263; Lu Z, 2000, PANCREAS, V21, P240, DOI 10.1097/00006676-200010000-00004; Marechal R, 2009, BRIT J CANCER, V100, P1444, DOI 10.1038/sj.bjc.6605020; Mohelnikova-Duchonova B, 2013, PANCREAS, V42, P707, DOI 10.1097/MPA.0b013e318279b861; Nitsch D, 2011, NUCLEIC ACIDS RES, V39, pW334, DOI 10.1093/nar/gkr289; Ohta T, 2004, ONCOL REP, V12, P749; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Sergeant G, 2009, NAT REV CLIN ONCOL, V6, P580, DOI 10.1038/nrclinonc.2009.127; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tong XZ, 2012, BIOCHEM PHARMACOL, V83, P586, DOI 10.1016/j.bcp.2011.12.007; Van den Broeck A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-354; Wang YH, 2009, NEOPLASMA, V56, P371, DOI 10.4149/neo_2009_05_371; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yao J, 2010, ONCOL REP, V23, P1375, DOI 10.3892/or_00000774; Zhang HY, 2012, J CANCER RES THER, V8, P226, DOI 10.4103/0973-1482.98975; Zhang SN, 2010, TUMORI J, V96, P985, DOI 10.1177/548.6520; Zhou J, 2008, WORLD J GASTROENTERO, V14, P925, DOI 10.3748/wjg.14.925	38	52	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73968	10.1371/journal.pone.0073968	http://dx.doi.org/10.1371/journal.pone.0073968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069258	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300026
J	Bemis, DK; Pylkkanen, L				Bemis, Douglas K.; Pylkkaenen, Liina			Flexible Composition: MEG Evidence for the Deployment of Basic Combinatorial Linguistic Mechanisms in Response to Task Demands	PLOS ONE			English	Article							GOOD-ENOUGH REPRESENTATIONS; ANTERIOR TEMPORAL CORTEX; LANGUAGE COMPREHENSION; ELECTROPHYSIOLOGICAL EVIDENCE; CORTICAL REPRESENTATION; SELECTIVE ATTENTION; SYNTACTIC STRUCTURE; SEMANTIC MEMORY; BRAIN; AUTOMATICITY	The present study investigates whether a minimal manipulation in task demands can induce core linguistic combinatorial mechanisms to extend beyond the bounds of normal grammatical phrases. Using magnetoencephalography, we measured neural activity evoked by the processing of adjective-noun phrases in canonical (red cup) and reversed order (cup red). During a task not requiring composition (verification against a color blob and shape outline), we observed significant combinatorial activity during canonical phrases only - as indexed by minimum norm source activity localized to the left anterior temporal lobe at 200-250 ms(cf. [1], [2]). When combinatorial task demands were introduced (by simply combining the blob and outline into a single colored shape) we observed significant combinatorial activity during reversed sequences as well. These results demonstrate the first direct evidence that basic linguistic combinatorial mechanisms can be deployed outside of normal grammatical expressions in response to task demands, independent of changes in lexical or attentional factors.	[Bemis, Douglas K.; Pylkkaenen, Liina] NYU, Dept Psychol, New York, NY 10003 USA; [Pylkkaenen, Liina] NYU, Dept Linguist, New York, NY USA; [Pylkkaenen, Liina] New York Univ Abu Dhabi, NYU Abu Dhabi Inst, Abu Dhabi, U Arab Emirates	New York University; New York University	Pylkkanen, L (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	liina.pylkkanen@nyu.edu			National Science Foundation [BCS-0545186, BCS-1221723]; NYUAD Institute, New York University Abu Dhabi [G1001]; Whitehead Fellowship for Junior Faculty Biomedical and Biological Sciences	National Science Foundation(National Science Foundation (NSF)); NYUAD Institute, New York University Abu Dhabi; Whitehead Fellowship for Junior Faculty Biomedical and Biological Sciences	This research was supported by the National Science Foundation Grants BCS-0545186 and BCS-1221723 (to LP), grant G1001 from the NYUAD Institute, New York University Abu Dhabi (to LP), and the Whitehead Fellowship for Junior Faculty Biomedical and Biological Sciences (to LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2001, IEEE T APPL SUPERCON, V11, P669, DOI 10.1109/77.919433; Amato MS, 2010, COGNITION, V116, P143, DOI 10.1016/j.cognition.2010.04.001; Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bahlmann J, 2009, BRAIN RES, V1298, P161, DOI 10.1016/j.brainres.2009.08.017; Bemis DK, 2013, CEREB CORTEX, V23, P1859, DOI 10.1093/cercor/bhs170; Bemis DK, 2011, J NEUROSCI, V31, P2801, DOI 10.1523/JNEUROSCI.5003-10.2011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brennan J, 2008, BRAIN LANG, V106, P132, DOI 10.1016/j.bandl.2008.04.003; Brennan J, 2012, BRAIN LANG, V120, P163, DOI 10.1016/j.bandl.2010.04.002; Caplan D, 2008, CORTEX, V44, P257, DOI 10.1016/j.cortex.2006.06.005; Caplan D, 2010, LANG COGNITIVE PROC, V25, P866, DOI 10.1080/01690961003672447; Carruthers P, 2002, BEHAV BRAIN SCI, V25, P657, DOI 10.1017/S0140525X02000122; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; de Vries MH, 2008, COGNITION, V107, P763, DOI 10.1016/j.cognition.2007.09.002; de Vries MH, 2011, BIOLINGUISTICS, V5, P10; Deacon D, 2000, FRONT BIOSCI, V5, pE82, DOI 10.2741/deacon; Fedor A, 2012, J EXP PSYCHOL LEARN; Ferreira F, 2003, COGNITIVE PSYCHOL, V47, P164, DOI 10.1016/S0010-0285(03)00005-7; Ferreira F, 2002, CURR DIR PSYCHOL SCI, V11, P11, DOI 10.1111/1467-8721.00158; Fodor J. A, 1983, MODULARITY MIND; FRAZIER L, 1989, Language and Cognitive Processes, V4, P93, DOI 10.1080/01690968908406359; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2002, P NATL ACAD SCI USA, V99, P529, DOI 10.1073/pnas.012611199; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; Graves WW, 2010, NEUROIMAGE, V53, P638, DOI 10.1016/j.neuroimage.2010.06.055; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Gunter TC, 1999, PSYCHOPHYSIOLOGY, V36, P126, DOI 10.1017/S004857729997155X; Gunter TC, 2000, J COGNITIVE NEUROSCI, V12, P556, DOI 10.1162/089892900562336; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Hasting AS, 2008, J COGNITIVE NEUROSCI, V20, P1207, DOI 10.1162/jocn.2008.20083; Hasting AS, 2008, SYNTAX BLINK EARLY A; Heim Irene, 1998, SEMANTICS GENERATIVE; Hinojosa JA, 2004, BRAIN LANG, V88, P39, DOI 10.1016/S0093-934X(03)00158-5; HOLCOMB PJ, 1988, BRAIN LANG, V35, P66, DOI 10.1016/0093-934X(88)90101-0; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Jobard G, 2007, NEUROIMAGE, V34, P784, DOI 10.1016/j.neuroimage.2006.06.067; Kotz SA, 2009, BRAIN LANG, V109, P68, DOI 10.1016/j.bandl.2008.06.002; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; Maidhof C, 2011, J COGNITIVE NEUROSCI, V23, P2252, DOI 10.1162/jocn.2010.21542; Marcus GF, 2003, NAT NEUROSCI, V6, P651, DOI 10.1038/nn0703-651; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; MCCARTHY G, 1993, ELECTROEN CLIN NEURO, V88, P210, DOI 10.1016/0168-5597(93)90005-A; Misyak JB, 2010, TOP COGN SCI, V2, P138, DOI 10.1111/j.1756-8765.2009.01072.x; Mosher JC, 1998, IEEE T BIO-MED ENG, V45, P1342, DOI 10.1109/10.725331; Murphy G. L., 2002, BIG BOOK CONCEPTS; MURPHY GL, 1988, COGNITIVE SCI, V12, P529, DOI 10.1207/s15516709cog1204_2; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Noppeney U, 2004, J COGNITIVE NEUROSCI, V16, P702, DOI 10.1162/089892904323057399; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Perruchet P, 2005, PSYCHON B REV, V12, P307, DOI 10.3758/BF03196377; Petersson KM, 2012, BRAIN LANG, V120, P83, DOI 10.1016/j.bandl.2010.08.003; Petersson KM, 2004, COGNITIVE SCI, V28, P383, DOI 10.1016/j.cogsci.2003.12.003; Petersson KM, 2010, BRAIN LANG, DOI [10.1016/j.bandl.2010.1008.1003, DOI 10.1016/J.BANDL.2010.1008.1003]; Phillips C, 2011, EXPT INTERFACES SYNT; Pothos EM, 2007, PSYCHOL BULL, V133, P227, DOI 10.1037/0033-2909.133.2.227; Pulvermuler F, 2008, BRAIN LANG, V104, P244, DOI 10.1016/j.bandl.2007.05.002; Pylkkanen L, 2007, J COGNITIVE NEUROSCI, V19, P1905, DOI 10.1162/jocn.2007.19.11.1905; Pylkkanen L, 2003, TRENDS COGN SCI, V7, P187, DOI 10.1016/S1364-6613(03)00092-5; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Rogers TT, 2006, COGN AFFECT BEHAV NE, V6, P201, DOI 10.3758/CABN.6.3.201; Rossi S, 2006, J COGNITIVE NEUROSCI, V18, P2030, DOI 10.1162/jocn.2006.18.12.2030; SADLER L, 1994, J LINGUIST, V30, P187, DOI 10.1017/S0022226700016224; Sanford AJ, 2002, TRENDS COGN SCI, V6, P382, DOI 10.1016/S1364-6613(02)01958-7; Shtyrov Y, 2003, J COGNITIVE NEUROSCI, V15, P1195, DOI 10.1162/089892903322598148; Spelke ES, 2003, BRADFORD BOOKS, P277; Sturt P, 2004, PSYCHON B REV, V11, P882, DOI 10.3758/BF03196716; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Tettamanti M, 2009, CORTEX, V45, P825, DOI 10.1016/j.cortex.2008.11.014; Vandenberghe R, 2002, J COGNITIVE NEUROSCI, V14, P550, DOI 10.1162/08989290260045800; Willems RM, 2009, TRENDS COGN SCI, V13, P101, DOI 10.1016/j.tics.2008.12.001	79	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73949	10.1371/journal.pone.0073949	http://dx.doi.org/10.1371/journal.pone.0073949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069253	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100076
J	Jarvandi, S; Davidson, NO; Schootman, M				Jarvandi, Soghra; Davidson, Nicholas O.; Schootman, Mario			Increased Risk of Colorectal Cancer in Type 2 Diabetes Is Independent of Diet Quality	PLOS ONE			English	Article							HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; BODY-MASS INDEX; COLON-CANCER; NATIONAL-INSTITUTES; POOLED ANALYSIS; WOMENS HEALTH; MELLITUS; COHORT; METAANALYSIS	Background: Poor diet increases the risk of both colorectal cancer and type 2 diabetes. We investigated the role of diet in the association between diabetes and colorectal cancer. Methods: We analyzed data from 484,020 individuals, aged 50-71 years who participated in the prospective National Institutes of Health-AARP Diet and Health Study and were cancer free at baseline (1995-1996). History of diabetes was self-reported. Diet quality was measured with the Healthy Eating Index-2005 (HEI-2005), using a self-administered food-frequency questionnaire. Cox regression models were constructed to estimate the hazard ratios (HR) and 95% confidence intervals (CI) of first primary incident colorectal cancer, overall and by anatomical location. Results: During an average follow-up of 9.2 years, we identified 7,598 new cases of colorectal cancer. After controlling for non-dietary confounders, diabetes was associated with increased risk of colorectal cancer (HR 1.27, 95% CI: 1.18, 1.36). Further adjustment for diet quality did not attenuate this association. Diabetes was associated with a HR of 1.23 (95% CI: 1.07, 1.40) in individuals with good diet (quartile 4 of HEI-2005) and 1.58 (95% CI: 1.34, 1.86) in those with poor diet (quartile 1 of HEI-2005), compared to those with no diabetes and good diet. Moreover, diabetes was associated with a stronger risk of proximal than distal colon cancer (HR: 1.33 vs. HR: 1.20), while poor diet was associated with a weaker risk of proximal colon cancer (HR: 1.18 vs. HR: 1.46). Conclusion: Diabetes and poor diet, independently and additively are associated with the increased risk of colorectal cancer.	[Jarvandi, Soghra; Schootman, Mario] Washington Univ, Sch Med, Dept Med, Div Hlth Behav Res, St Louis, MO 63110 USA; [Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Davidson, Nicholas O.; Schootman, Mario] Barnes Jewish Hosp, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA; [Davidson, Nicholas O.; Schootman, Mario] Washington Univ, Sch Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Barnes-Jewish Hospital; Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Jarvandi, S (corresponding author), Washington Univ, Sch Med, Dept Med, Div Hlth Behav Res, St Louis, MO 63110 USA.	sjarvand@dom.wustl.edu	Schootman, Mario/AAF-3941-2019	Schootman, Mario/0000-0003-1162-8824	Washington University School of Medicine; National Cancer Institute at the National Institutes of Health [CA112159]; DDRCC [P30 DK-52574]; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA112159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574] Funding Source: NIH RePORTER	Washington University School of Medicine; National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DDRCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the Washington University School of Medicine and a grant from the National Cancer Institute at the National Institutes of Health (grant number CA112159). NOD was supported in part by DDRCC grant P30 DK-52574. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN E, 1988, EUR J CLIN INVEST, V18, P166, DOI 10.1111/j.1365-2362.1988.tb02408.x; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Campbell PT, 2010, GASTROENTEROLOGY, V139, P1138, DOI 10.1053/j.gastro.2010.06.072; Chang CK, 2003, DIABETOLOGIA, V46, P595, DOI 10.1007/s00125-003-1109-5; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Deng LY, 2012, DIGEST DIS SCI, V57, P1576, DOI 10.1007/s10620-012-2055-1; Fung T, 2003, ARCH INTERN MED, V163, P309, DOI 10.1001/archinte.163.3.309; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; HELZLSOUER KJ, 1994, CANCER RES, V54, pS2044; Hu FB, 1999, JNCI-J NATL CANCER I, V91, P542, DOI 10.1093/jnci/91.6.542; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; IBER FL, 1993, DIGEST DIS SCI, V38, P45, DOI 10.1007/BF01296772; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; Koushik A, 2007, JNCI-J NATL CANCER I, V99, P1471, DOI 10.1093/jnci/djm155; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Larsson SC, 2005, DIABETES CARE, V28, P1805, DOI 10.2337/diacare.28.7.1805; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; LeMarchand L, 1997, CANCER RES, V57, P4787; Li CY, 2011, DIABETES CARE, V34, P1365, DOI 10.2337/dc11-0020; Limburg PJ, 2006, AM J GASTROENTEROL, V101, P1872, DOI 10.1111/j.1572-0241.2006.00725.x; Limburg PJ, 2005, CANCER EPIDEM BIOMAR, V14, P133; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Murphy TK, 2000, AM J EPIDEMIOL, V152, P847, DOI 10.1093/aje/152.9.847; Reedy J, 2008, AM J EPIDEMIOL, V168, P38, DOI 10.1093/aje/kwn097; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Shin A, 2006, INT J CANCER, V119, P2938, DOI 10.1002/ijc.22196; Slattery ML, 2003, CANCER CAUSE CONTROL, V14, P75, DOI 10.1023/A:1022545017867; Strickler H D, 2001, Diabetes Technol Ther, V3, P263, DOI 10.1089/152091501300209633; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; Terry PD, 2002, GUT, V51, P191, DOI 10.1136/gut.51.2.191; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; US Department of Health and Human Services and USDA, 2005, DIET GUID AM 2005; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Wei XC, 2012, CELL HOST MICROBE, V11, P140, DOI 10.1016/j.chom.2011.12.006; WEST DW, 1989, AM J EPIDEMIOL, V130, P883, DOI 10.1093/oxfordjournals.aje.a115421; Will JC, 1998, AM J EPIDEMIOL, V147, P816, DOI 10.1093/oxfordjournals.aje.a009534; Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; YOUNG TB, 1988, INT J CANCER, V42, P167, DOI 10.1002/ijc.2910420205; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301	43	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74616	10.1371/journal.pone.0074616	http://dx.doi.org/10.1371/journal.pone.0074616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069323	gold, Green Published			2022-12-27	WOS:000326240100113
J	Marzoli, D; Moretto, F; Monti, A; Tocci, O; Roberts, SC; Tommasi, L				Marzoli, Daniele; Moretto, Francesco; Monti, Aura; Tocci, Ornella; Roberts, S. Craig; Tommasi, Luca			Environmental Influences on Mate Preferences as Assessed by a Scenario Manipulation Experiment	PLOS ONE			English	Article							GAP-PREDICTS-DEGREE; LIFE-HISTORY THEORY; WOMENS PREFERENCES; BENEVOLENT SEXISM; FACIAL ATTRACTIVENESS; PATHOGEN PREVALENCE; INTERVIEWER GENDER; VISUAL CUES; TRADE-OFFS; MALE FACES	Many evolutionary psychology studies have addressed the topic of mate preferences, focusing particularly on gender and cultural differences. However, the extent to which situational and environmental variables might affect mate preferences has been comparatively neglected. We tested 288 participants in order to investigate the perceived relative importance of six traits of an ideal partner (wealth, dominance, intelligence, height, kindness, attractiveness) under four different hypothetical scenarios (status quo/nowadays, violence/post-nuclear, poverty/resource exhaustion, prosperity/global wellbeing). An equal number of participants (36 women, 36 men) was allotted to each scenario; each was asked to allocate 120 points across the six traits according to their perceived value. Overall, intelligence was the trait to which participants assigned most importance, followed by kindness and attractiveness, and then by wealth, dominance and height. Men appraised attractiveness as more valuable than women. Scenario strongly influenced the relative importance attributed to traits, the main finding being that wealth and dominance were more valued in the poverty and post-nuclear scenarios, respectively, compared to the other scenarios. Scenario manipulation generally had similar effects in both sexes, but women appeared particularly prone to trade off other traits for dominance in the violence scenario, and men particularly prone to trade off other traits for wealth in the poverty scenario. Our results are in line with other correlational studies of situational variables and mate preferences, and represent strong evidence of a causal relationship of environmental factors on specific mate preferences, corroborating the notion of an evolved plasticity to current ecological conditions. A control experiment seems to suggest that our scenarios can be considered as realistic descriptions of the intended ecological conditions.	[Marzoli, Daniele; Moretto, Francesco; Monti, Aura; Tocci, Ornella; Tommasi, Luca] Univ G dAnnunzio, Dipartimento Sci Psicol Umanist & Terr, Chieti, Italy; [Roberts, S. Craig] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland	G d'Annunzio University of Chieti-Pescara; University of Stirling	Marzoli, D (corresponding author), Univ G dAnnunzio, Dipartimento Sci Psicol Umanist & Terr, Chieti, Italy.	d.marzoli@unich.it	Roberts, Craig/E-6919-2011	Roberts, Craig/0000-0002-9641-6101; Tommasi, Luca/0000-0003-0664-714X				BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Burriss RP, 2011, PERS INDIV DIFFER, V50, P542, DOI 10.1016/j.paid.2010.11.022; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; BUSS DM, 1990, J CROSS CULT PSYCHOL, V21, P5, DOI 10.1177/0022022190211001; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Buss DM., 2003, EVOLUTION DESIRE; Campos LD, 2002, EVOL HUM BEHAV, V23, P395; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Cohen DanielleL., 2008, J EVOLUTIONARY PSYCH, V6, P25, DOI [DOI 10.1556/JEP.2008.1001, 10.1556/jep.2008.1001]; DeBruine LM, 2011, P ROY SOC B-BIOL SCI, V278, P813, DOI 10.1098/rspb.2010.2200; DeBruine LM, 2010, P ROY SOC B-BIOL SCI, V277, P2405, DOI 10.1098/rspb.2009.2184; Del Giudice M, 2009, BEHAV BRAIN SCI, V32, P1, DOI 10.1017/S0140525X09000016; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Edlund JE, 2010, PERS INDIV DIFFER, V49, P835, DOI 10.1016/j.paid.2010.07.004; EGOLF DB, 1991, SEX ROLES, V24, P365, DOI 10.1007/BF00288309; Figueredo AJ, 2010, LIFE HIST STRATEGY C; Figueredo AJ, 2006, DEV REV, V26, P243, DOI 10.1016/j.dr.2006.02.002; Fisher TD, 2007, ARCH SEX BEHAV, V36, P89, DOI 10.1007/s10508-006-9094-7; Fraley RC, 2002, PERS SOC PSYCHOL REV, V6, P123, DOI 10.1207/S15327957PSPR0602_03; GALLA JP, 1981, PSYCHOL REP, V49, P935, DOI 10.2466/pr0.1981.49.3.935; GANGESTAD SW, 1993, ETHOL SOCIOBIOL, V14, P89, DOI 10.1016/0162-3095(93)90009-7; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Gawley T, 2009, SEX ROLES, V60, P208, DOI 10.1007/s11199-008-9520-5; Geary DC, 2004, J SEX RES, V41, P27, DOI 10.1080/00224490409552211; Glick P, 2001, AM PSYCHOL, V56, P109, DOI 10.1037//0003-066X.56.2.109; Gowaty, 1997, FEMINISM EVOLUTIONAR, P505, DOI DOI 10.1007/978-1-4615-5985-6_21; HOLM S, 1979, SCAND J STAT, V6, P65; Huddy L, 1997, POLIT BEHAV, V19, P197, DOI 10.1023/A:1024882714254; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones BC, 2011, BIOL PSYCHOL, V87, P453, DOI 10.1016/j.biopsycho.2011.04.004; Jost JT, 2005, J PERS SOC PSYCHOL, V88, P498, DOI 10.1037/0022-3514.88.3.498; KANE EW, 1993, PUBLIC OPIN QUART, V57, P1, DOI 10.1086/269352; Kang MJ, 2011, J NEUROSCI, V31, P461, DOI 10.1523/JNEUROSCI.1583-10.2011; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lee AJ, 2011, BIOL LETTERS, V7, P892, DOI 10.1098/rsbl.2011.0454; LEVIN IP, 1983, ORGAN BEHAV HUM PERF, V31, P173, DOI 10.1016/0030-5073(83)90119-8; Li NP, 2006, J PERS SOC PSYCHOL, V90, P468, DOI 10.1037/0022-3514.90.3.468; Li NP, 2002, J PERS SOC PSYCHOL, V82, P947, DOI 10.1037//0022-3514.82.6.947; Lippa RA, 2007, ARCH SEX BEHAV, V36, P209, DOI 10.1007/s10508-006-9146-z; Little AC, 2001, P ROY SOC B-BIOL SCI, V268, P39, DOI 10.1098/rspb.2000.1327; Little AC, 2007, BEHAV ECOL SOCIOBIOL, V61, P967, DOI 10.1007/s00265-006-0325-7; Little AC, 2013, PSYCHONEUROENDOCRINO, V38, P1777, DOI 10.1016/j.psyneuen.2013.02.014; Little AC, 2013, EVOL HUM BEHAV, V34, P193, DOI 10.1016/j.evolhumbehav.2012.11.008; Little AC, 2011, P ROY SOC B-BIOL SCI, V278, P2032, DOI 10.1098/rspb.2010.1925; Little AC, 2010, PSYCHONEUROENDOCRINO, V35, P912, DOI 10.1016/j.psyneuen.2009.12.006; Lorber MF, 2004, J FAM VIOLENCE, V19, P329, DOI 10.1007/s10896-004-0678-5; McGraw KJ, 2002, ETHOLOGY, V108, P303, DOI 10.1046/j.1439-0310.2002.00757.x; MELAMED T, 1992, PERS INDIV DIFFER, V13, P1349, DOI 10.1016/0191-8869(92)90179-S; Mesnick S.L., 1997, FEMINISM EVOLUTIONAR; Montoya R. M., 2005, SEXUALITIES EVOLUTIO, V7, P115, DOI DOI 10.1080/14616660500173339; NORRIS AE, 1992, PERS SOC PSYCHOL B, V18, P118, DOI 10.1177/0146167292182002; Oda R, 2001, HUM NATURE-INT BIOS, V12, P191, DOI 10.1007/s12110-001-1006-x; OLEARY KD, 1994, J CONSULT CLIN PSYCH, V62, P594, DOI 10.1037/0022-006X.62.3.594; Pawlowski B, 1999, P ROY SOC B-BIOL SCI, V266, P281, DOI 10.1098/rspb.1999.0634; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P355, DOI 10.1016/j.evolhumbehav.2004.06.002; Penton-Voak IS, 2000, EVOL HUM BEHAV, V21, P39, DOI 10.1016/S1090-5138(99)00033-1; Phelan JE, 2010, SEX ROLES, V62, P35, DOI 10.1007/s11199-009-9711-8; Puts DA, 2013, HORM BEHAV, V63, P13, DOI 10.1016/j.yhbeh.2012.11.007; Regan PC, 1998, PERS SOC PSYCHOL B, V24, P1294, DOI 10.1177/01461672982412004; Roberts SC, 2008, P ROY SOC B-BIOL SCI, V275, P2715, DOI 10.1098/rspb.2008.0825; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Rozin P., 2015, EVOLUTIONARY PSYCHOL; Schmitt DP, 2012, EVOL PSYCHOL-US, V10, P720, DOI 10.1177/147470491201000406; Scott I, 2008, EVOL HUM BEHAV, V29, P289, DOI 10.1016/j.evolhumbehav.2008.02.004; Snyder JK, 2011, EVOL HUM BEHAV, V32, P127, DOI 10.1016/j.evolhumbehav.2010.08.007; SPECTOR PE, 1976, PERS SOC PSYCHOL B, V2, P290, DOI 10.1177/014616727600200318; Stone EA, 2008, EVOL PSYCHOL-US, V6, P447; Waynforth D, 2001, HUM NATURE-INT BIOS, V12, P207, DOI 10.1007/s12110-001-1007-9; WAYNFORTH D, 1995, BEHAVIOUR, V132, P755, DOI 10.1163/156853995X00135; Wiseman DB, 1996, ORGAN BEHAV HUM DEC, V66, P241, DOI 10.1006/obhd.1996.0053; Zentner M, 2012, PSYCHOL SCI, V23, P1176, DOI 10.1177/0956797612441004	72	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74282	10.1371/journal.pone.0074282	http://dx.doi.org/10.1371/journal.pone.0074282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069291	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100097
J	Rey, M; Hess, P; Clozel, M; Delahaye, S; Gatfield, J; Nayler, O; Steiner, B				Rey, Markus; Hess, Patrick; Clozel, Martine; Delahaye, Stephane; Gatfield, John; Nayler, Oliver; Steiner, Beat			Desensitization by Progressive Up-Titration Prevents First-Dose Effects on the Heart: Guinea Pig Study with Ponesimod, a Selective S1P(1) Receptor Modulator	PLOS ONE			English	Article							G-PROTEIN; ATRIAL MYOCYTES; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; ELECTROCARDIOGRAM; SUBTYPES; AGONISTS; FTY720	Ponesimod, a selective S1P(1) receptor modulator, reduces the blood lymphocyte count in all tested species by preventing egress of T and B cells from thymus and peripheral lymphoid organs. In addition, ponesimod transiently affects heart rate and atrioventricular (AV) conduction in humans, effects not observed in mice, rats, and dogs with selective S1P(1) receptor modulators, suggesting that the regulation of heart rate and rhythm is species dependent. In the present study, we used conscious guinea pigs implanted with a telemetry device to investigate the effects of single and multiple oral doses of ponesimod on ECG variables, heart rate, and blood pressure. Oral administration of ponesimod did not affect the sinus rate (P rate) but dose-dependently induced AV block type I to III. A single oral dose of 0.1 mg/kg had no effect on ECG variables, while a dose of 3 mg/kg induced AV block type III in all treated guinea pigs. Repeated oral dosing of 1 or 3 mg/kg ponesimod resulted in rapid desensitization, so that the second dose had no or a clearly reduced effect on ECG variables as compared with the first dose. Resensitization of the S1P(1) receptor in the heart was concentration dependent. After desensitization had been induced by the first dose of ponesimod, the cardiac system remained desensitized as long as the plasma concentration was >= 75 ng/ml. By using a progressive up-titration regimen, the first-dose effect of ponesimod on heart rate and AV conduction was significantly reduced due to desensitization of the S1P(1) receptor. In summary, conscious guinea pigs implanted with a telemetry device represent a useful model to study first-dose effects of S1P(1) receptor modulators on heart rate and rhythm. This knowledge was translated to a dosing regimen of ponesimod to be tested in humans to avoid or significantly reduce the first-dose effects.	[Rey, Markus; Hess, Patrick; Clozel, Martine; Delahaye, Stephane; Gatfield, John; Nayler, Oliver; Steiner, Beat] Actel Pharmaceut Ltd, Allschwil, Switzerland	Actelion Pharmaceuticals Ltd	Gatfield, J (corresponding author), Actel Pharmaceut Ltd, Allschwil, Switzerland.	markus.rey@actelion.com						BELARDINELLI L, 1980, CIRC RES, V47, P684, DOI 10.1161/01.RES.47.5.684; Berg KA, 2001, J PHARMACOL EXP THER, V299, P593; Bolli MH, 2011, CURR TOP MED CHEM, V11, P726; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; Brossard P, 2013, BR J CLIN PHARM, DOI 10.1111/bcp.12129; Budde K, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341073; Bunemann M, 1995, J PHYSIOL-LONDON, V489, P701; Drici MD, 2000, BRIT J PHARMACOL, V131, P569, DOI 10.1038/sj.bjp.0703611; Farraj AK, 2011, TOXICOL SCI, V121, P11, DOI 10.1093/toxsci/kfr021; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Fryer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052985; Fu Y, 2007, AM J PHYSIOL-HEART C, V292, pH2532, DOI 10.1152/ajpheart.01391.2006; Gatfield J, 2012, ECTRIMS 2012 28 C EU, P926; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Goetzl EJ, 2004, J CLIN INVEST, V114, P1531, DOI 10.1172/JCI200423704; Hess P, 2007, LAB ANIM-UK, V41, P470, DOI 10.1258/002367707782314337; Himmel HM, 2000, MOL PHARMACOL, V58, P449, DOI 10.1124/mol.58.2.449; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Ochi R, 2006, CARDIOVASC RES, V70, P88, DOI 10.1016/j.cardiores.2006.01.010; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Rivera R, 2008, REV PHYSIOL BIOCH P, V160, P25, DOI 10.1007/112_0507; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shiotani Motohiro, 2005, Journal of Toxicological Sciences, V30, P239, DOI 10.2131/jts.30.239; Zu Heringdorf D. M., 2013, HDB EXP PHARM, V215, P239, DOI [10.1007/978-3-7091-1368-4_13, DOI 10.1007/978-3-7091-1368-4_13]	29	14	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74285	10.1371/journal.pone.0074285	http://dx.doi.org/10.1371/journal.pone.0074285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069292	Green Submitted, gold, Green Published			2022-12-27	WOS:000326240100098
J	Shin, IJ; Shon, SM; Schellingerhout, D; Park, JY; Kim, JY; Lee, SK; Lee, DK; Lee, HW; Ahn, BC; Kim, K; Kwon, IC; Kim, DE				Shin, Ik Jae; Shon, Soo-Min; Schellingerhout, Dawid; Park, Jin-Yong; Kim, Jeong-Yeon; Lee, Su Kyoung; Lee, Dong Kun; Lee, Ho Won; Ahn, Byeong-Cheol; Kim, Kwangmeyung; Kwon, Ick Chan; Kim, Dong-Eog			Characterization of Partial Ligation-Induced Carotid Atherosclerosis Model Using Dual-Modality Molecular Imaging in ApoE Knock-out Mice	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; INCREASED EXPRESSION; HEME OXYGENASE-1; IN-VIVO; MOUSE; FLOW; ARTERY; ATHEROGENESIS; INFLAMMATION; TARGET	Background: Recently, partial ligation of the common carotid artery (CCA) was reported to induce carotid atheromata rapidly in apolipoprotein-E knockout (ApoE(-/-)) mice. We investigated this new atherosclerosis model by using combined matrix-metalloproteinase (MMP) near-infrared fluorescent (NIRF) imaging and macrophage-tracking luciferase imaging. Methodology and Principal Findings: Partial ligation of the left CCA was performed in 10-week-old ApoE(-/-) mice on a high fat diet (n=33); the internal and external carotid arteries and occipital artery were ligated, while the superior thyroid artery was left intact. Two thirds of the animals were treated with either LiCl or atorvastatin. At 1-week, Raw264.7 macrophages modified to express the enhanced firefly-luciferase reporter gene (10(7) Raw-luc cells) were injected intravenously. At 2-week, NIRF molecular imaging visualized strong MMP-2/9 activity in the ligated area of the left CCA as well as in the aortic arch. Left-to-right ratios of the NIRF signal intensities in the CCA had a decreasing gradient from the highest value in the upper-most ligated area to the lowest value in the lower-most region adjacent to the aortic arch. Luciferase imaging showed that most Raw-luc macrophages were recruited to the ligated area of the CCA rather than to the aortic arch, despite similarly strong MMP-2/9-related NIRF signal intensities in both areas. In addition, LiCl or atorvastatin could reduce MMP-2/9 activity in the aortic arch but not in the ligated area of the CCA. Conclusions/Significance: This is the first molecular imaging study to characterize the partial ligation-induced carotid atherosclerosis model. Molecularly divergent types of atherosclerosis were identified: conventional lipogenic atherosclerosis in the aorta vs. flow-related mechanical atherosclerosis in the partially ligated left system.	[Shin, Ik Jae; Shon, Soo-Min; Park, Jin-Yong; Kim, Jeong-Yeon; Lee, Su Kyoung; Kim, Dong-Eog] Dongguk Univ, Coll Med, Mol Imaging & Neurovasc Res MINER Lab, Goyang, South Korea; [Schellingerhout, Dawid] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA; [Schellingerhout, Dawid] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Lee, Ho Won; Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Daegu, South Korea; [Kim, Kwangmeyung; Kwon, Ick Chan] Korea Inst Sci & Technol, Biomed Res Ctr, Seoul, South Korea	Dongguk University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Kyungpook National University; Korea Institute of Science & Technology (KIST)	Kim, DE (corresponding author), Dongguk Univ, Coll Med, Mol Imaging & Neurovasc Res MINER Lab, Goyang, South Korea.	kdongeog@duih.org	Kim, Kwangmeyung/ABB-2882-2021; KWON, ICK CHAN/AAS-4776-2020	KWON, ICK CHAN/0000-0003-1272-7074; Kim, Jeong Yeon/0000-0002-5449-9519; Shin, Ikjae/0000-0001-6582-8827	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A120099]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	The present study was supported by a grant (A120099) of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts-Grill N, 2012, ARTERIOSCL THROM VAS, V32, P623, DOI 10.1161/ATVBAHA.111.242180; Ali F, 2009, J BIOL CHEM, V284, P18882, DOI 10.1074/jbc.M109.009886; Chang K, 2010, ARTERIOSCL THROM VAS, V30, P1933, DOI 10.1161/ATVBAHA.110.206342; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Choi ET, 2005, ARTERIOSCL THROM VAS, V25, P1020, DOI 10.1161/01.ATV.0000161275.82687.f6; Choi SE, 2010, VASC PHARMACOL, V53, P264, DOI 10.1016/j.vph.2010.09.004; Conway RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050349; Deguchi J, 2006, CIRCULATION, V114, P55, DOI 10.1161/CIRCULATIONAHA.106.619056; Eschert H, 2009, ATHEROSCLEROSIS, V204, P96, DOI 10.1016/j.atherosclerosis.2008.08.025; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Godin D, 2000, CIRCULATION, V102, P2861; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; Kim DE, 2011, STROKE, V42, P3566, DOI 10.1161/STROKEAHA.111.629428; Kim DE, 2010, ARTERIOSCL THROM VAS, V30, P449, DOI 10.1161/ATVBAHA.109.194613; Kim DE, 2009, MOL IMAGING, V8, P291, DOI 10.2310/7290.2009.00027; Kirkby NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016906; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Muratoglu SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028846; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; New SEP, 2011, CIRC J, V75, P1305, DOI 10.1253/circj.CJ-11-0395; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Shon SM, 2011, ATHEROSCLEROSIS, V216, P67, DOI 10.1016/j.atherosclerosis.2011.01.036; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698	28	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73451	10.1371/journal.pone.0073451	http://dx.doi.org/10.1371/journal.pone.0073451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069197	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100044
J	Verma, ML; Naebe, M; Barrow, CJ; Puri, M				Verma, Madan L.; Naebe, Minoo; Barrow, Colin J.; Puri, Munish			Enzyme Immobilisation on Amino-Functionalised Multi-Walled Carbon Nanotubes: Structural and Biocatalytic Characterisation	PLOS ONE			English	Article							THERMOMYCES-LANUGINOSUS LIPASE; POTENTIAL APPLICATIONS; CANDIDA-ANTARCTICA; BETA-GLUCOSIDASE; STABILIZATION; STABILITY; CHITOSAN	Background: The aim of this work is to investigate the structure and function of enzymes immobilised on nanomaterials. This work will allow better understanding of enzyme-nanomaterial interactions, as well as designing functional protein-nanomaterial conjugates. Methodology/Principal Findings: Multiwalled carbon nanotubes (MWNTs) were functionalised with amino groups to improve solubility and biocompatibility. The pristine and functionalised forms of MWNTs were characterised with Fourier-transform infrared spectroscopy. Thermogravimetric analysis was done to examine the degree of the functionalisation process. An immobilised biocatalyst was prepared on functionalised nanomaterial by covalent binding. Thermomyces lanuginosus lipase was used as a model enzyme. The structural change of the immobilised and free lipases were characterised with transmission electron Microscopy, X-ray photoelectron spectroscopy, Fourier-transform infrared spectroscopy and Circular dichroism spectroscopy. Biochemical characterisation of immobilised enzyme showed broader pH and thermal optima compared to soluble form. Reusability of the immobilised enzyme for hydrolysis of long chain esters was demonstrated up to ten cycles. Conclusion/Significance: Lipase immobilised on MWNTs has exhibited significantly improved thermal stability. The exploration of advanced nanomaterial for enzyme immobilisation support using sophisticated techniques makes nanobiocatalyst of potential interest for biosensor applications.	[Verma, Madan L.; Barrow, Colin J.; Puri, Munish] Deakin Univ, Ctr Chem & Biotechnol, Geelong Technol Precinct, Geelong, Vic 3217, Australia; [Naebe, Minoo] Deakin Univ, Inst Frontier Mat, Geelong Technol Precinct, Geelong, Vic 3217, Australia	Deakin University; Deakin University	Puri, M (corresponding author), Deakin Univ, Ctr Chem & Biotechnol, Geelong Technol Precinct, Geelong, Vic 3217, Australia.	munish.puri@deakin.edu.au	Verma, Madan L/AFV-9575-2022; Puri, Munish/M-5577-2019; Puri, Munish/C-2398-2013; Verma, Madan/H-1365-2011	Puri, Munish/0000-0003-2469-3326; Barrow, Colin/0000-0002-2153-7267; Naebe, Minoo/0000-0002-0607-6327; Verma, Madan/0000-0002-8145-6549	ITRI think tank initiative [C0021.31.01]; Deakin University [RM 25148]	ITRI think tank initiative; Deakin University	The research was supported under the "ITRI think tank initiative (C0021.31.01)'' and "Central Research Grant Scheme,'' Deakin University (Project RM 25148). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanbi TO, 2012, CATAL SCI TECHNOL, V2, P1839, DOI 10.1039/c2cy20392h; Ansari SA, 2012, BIOTECHNOL ADV, V30, P512, DOI 10.1016/j.biotechadv.2011.09.005; Asuri P, 2007, LANGMUIR, V23, P12318, DOI 10.1021/la702091c; Boncel S, 2013, ENZYME MICROB TECH, V53, P263, DOI 10.1016/j.enzmictec.2013.05.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chronopoulou L, 2011, SOFT MATTER, V7, P2653, DOI 10.1039/c0sm00712a; Cruz JC, 2010, COLLOID SURFACE B, V79, P97, DOI 10.1016/j.colsurfb.2010.03.036; Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83; Fernandez-Lafuente R, 2010, J MOL CATAL B-ENZYM, V62, P197, DOI 10.1016/j.molcatb.2009.11.010; Ganesan A, 2009, CHEMPHYSCHEM, V10, P1492, DOI 10.1002/cphc.200800759; Ji PJ, 2010, AICHE J, V56, P3005, DOI 10.1002/aic.12180; Johnson PA, 2011, METHODS MOL BIOL, V679, P183, DOI 10.1007/978-1-60761-895-9_15; Kim JB, 2008, TRENDS BIOTECHNOL, V26, P639, DOI 10.1016/j.tibtech.2008.07.009; Lee SH, 2010, J MOL CATAL B-ENZYM, V62, P169, DOI 10.1016/j.molcatb.2009.10.004; Liu Y, 2008, J AM CHEM SOC, V130, P10431, DOI 10.1021/ja802465g; Ondul E, 2012, COLLOID SURFACE B, V95, P109, DOI 10.1016/j.colsurfb.2012.02.020; Pavlidis IV, 2010, ADV ENG MATER, V12, pB179, DOI 10.1002/adem.200980021; Pavlidis IV, 2012, BIORESOURCE TECHNOL, V115, P164, DOI 10.1016/j.biortech.2011.11.007; Puri M, 2005, J CHEM TECHNOL BIOT, V80, P1160, DOI 10.1002/jctb.1303; Puri M, 2013, TRENDS BIOTECHNOL, V31, P215, DOI 10.1016/j.tibtech.2013.01.002; Puri M, 2010, APPL BIOCHEM BIOTECH, V160, P98, DOI 10.1007/s12010-009-8542-y; Raghavendra T, 2013, BIORESOURCE TECHNOL, V140, P103, DOI 10.1016/j.biortech.2013.04.071; Ramanathan T, 2005, CHEM MATER, V17, P1290, DOI 10.1021/cm048357f; Rodrigues RC, 2009, PROCESS BIOCHEM, V44, P963, DOI 10.1016/j.procbio.2009.04.015; Shah S, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-30; Shi Q, 2007, J NANOPART RES, V9, P1205, DOI 10.1007/s11051-006-9200-8; Shim M, 2002, NANO LETT, V2, P285, DOI 10.1021/nl015692j; Sorensen MH, 2010, J COLLOID INTERF SCI, V343, P359, DOI 10.1016/j.jcis.2009.11.014; Talbert JN, 2013, PROCESS BIOCHEM, V48, P656, DOI 10.1016/j.procbio.2013.03.001; Tan HS, 2012, BIORESOURCE TECHNOL, V115, P172, DOI 10.1016/j.biortech.2011.10.066; Taqieddin E, 2004, BIOMATERIALS, V25, P1937, DOI 10.1016/j.biomaterials.2003.08.034; Tu MB, 2006, BIOTECHNOL LETT, V28, P151, DOI 10.1007/s10529-005-5328-3; Verma ML, 2013, BIORESOURCE TECHNOL, V145, P302, DOI 10.1016/j.biortech.2013.01.065; Verma ML, 2013, BIORESOURCE TECHNOL, V135, P2, DOI 10.1016/j.biortech.2013.01.047; Verma ML, 2008, J APPL POLYM SCI, V110, P837, DOI 10.1002/app.28539; Verma ML, 2013, APPL MICROBIOL BIOT, V97, P23, DOI 10.1007/s00253-012-4535-9; Verma ML, 2012, INT J BIOL MACROMOL, V50, P432, DOI 10.1016/j.ijbiomac.2011.12.029; Wang SR, 2006, NANOTECHNOLOGY, V17, P1551, DOI 10.1088/0957-4484/17/6/003; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979	39	118	119	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73642	10.1371/journal.pone.0073642	http://dx.doi.org/10.1371/journal.pone.0073642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069216	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100052
J	Wu, WJ; Zhang, SW; Li, X; Xue, M; Cao, SC; Chen, W				Wu, Wenjing; Zhang, Shuwan; Li, Xu; Xue, Mei; Cao, Sancheng; Chen, Wei			Ets-2 Regulates Cell Apoptosis via the Akt Pathway, through the Regulation of Urothelial Cancer Associated 1, a Long Non-Coding RNA, in Bladder Cancer Cells	PLOS ONE			English	Article							MEG3 GENE-EXPRESSION; PROMOTER REGION; CARCINOMA; GROWTH; UCA1; METASTASIS; SURVIVAL; SEQUENCE; MARKER; HULC	The majority of the human genome is transcribed and generates non-coding RNAs (ncRNAs) that fail to encode protein information. Long non-coding RNAs (lncRNAs) are emerging as a novel class of ncRNAs, but our knowledge about these ncRNAs is limited. Previously, our laboratory has identified that a lncRNA, Urothelial cancer associated 1 (UCA1), played an important role in bladder cancer. Despite the recent interest in UCA1 as a diagnostic marker for bladder cancer, little is known about its transcriptional regulation. To elucidate the regulation of UCA1 gene expression, we have characterized the human UCA1 gene promoter. A 2.0-kb fragment of its 59 flanking region was cloned into a luciferase reporter vector. Deletion and mutation analysis suggested that an Ets-2 binding site was critical for UCA1 gene promoter activity. Further analysis of this site by gel shifting, chromatin immune precipitation (ChIP), and co-transfection experiments showed that transcription factor Ets-2 directly bound to the UCA1 promoter region and stimulated UCA1 promoter activity in bladder cancer cells. Taking into account the anti-apoptosis function of Ets-2, our data suggested that Ets-2 regulates apoptosis process by regulating the expression of UCA1, moreover UCA1 may be involved in the activation of Akt signaling pathway by Ets-2 in bladder cancer cells.	[Wu, Wenjing; Zhang, Shuwan; Chen, Wei] Xi An Jiao Tong Univ, Clin Lab, Affiliated Hosp 1, Sch Med, Xian 710049, Peoples R China; [Li, Xu; Xue, Mei] Xi An Jiao Tong Univ, Translat Med Ctr, Affiliated Hosp 1, Sch Med, Xian 710049, Peoples R China; [Zhang, Shuwan; Cao, Sancheng] Xian Childrens Hosp, Clin Lab, Xian, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Chen, W (corresponding author), Xi An Jiao Tong Univ, Clin Lab, Affiliated Hosp 1, Sch Med, Xian 710049, Peoples R China.	chenwei808@mail.xjtu.edu.cn			Natural Science Foundation of China [81072104]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the Natural Science Foundation of China (Grant No. 81072104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Arun G, 2012, MOL CELL BIOL, V32, P3140, DOI 10.1128/MCB.00006-12; Braconi C, 2011, ONCOGENE; Cao XB, 2009, AM J PATHOL, V175, P2207, DOI 10.2353/ajpath.2009.090070; Carbone GM, 2004, NUCLEIC ACIDS RES, V32, P4358, DOI 10.1093/nar/gkh744; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen W, 2004, J XIAN JIAOTONG U ME, V5, P96; [陈葳 Chen Wei], 2004, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University.Medical Sciences], V25, P89; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hanke M, 2007, CLIN CHEM, V53, P2070, DOI 10.1373/clinchem.2007.091363; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Lin R, 2000, J XIAN MED U, V21, P39; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rorive S, 2009, EJC SUPPL, V7, P28, DOI 10.1016/S1359-6349(09)72204-9; Rotblat B, 2011, MED HYPOTHESES, V77, P962, DOI 10.1016/j.mehy.2011.08.020; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; SETH A, 1990, ONCOGENE, V5, P1761; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang XS, 2006, CLIN CANCER RES, V12, P4851, DOI 10.1158/1078-0432.CCR-06-0134; Wang Y, 2012, INT J ONCOL, V41, P276, DOI 10.3892/ijo.2012.1443; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wu SC, 2010, CELL RES, V20, P1109, DOI 10.1038/cr.2010.114; Yang C, 2012, GENE, V496, P8, DOI 10.1016/j.gene.2012.01.012; Yang YC, 2006, J SO MED U, V26, P170; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Zhao J, 2006, INT J BIOCHEM CELL B, V38, P1808, DOI 10.1016/j.biocel.2006.05.004; 陈葳, 1999, [西安医科大学学报, Journal of Xi'an Medical University], V20, P37	41	27	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73920	10.1371/journal.pone.0073920	http://dx.doi.org/10.1371/journal.pone.0073920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069250	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100073
J	Gu, CM; Lu, JC; Cui, TP; Lu, C; Shi, H; Xu, WM; Yuan, XL; Yang, XB; Huang, YX; Lu, MX				Gu, Changmei; Lu, Jiachun; Cui, Tianpen; Lu, Cheng; Shi, Hao; Xu, Wenmao; Yuan, Xueli; Yang, Xiaobo; Huang, Yangxin; Lu, Meixia			Association between MGMT Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							DNA METHYLATION; O6-METHYLGUANINE-DNA METHYLTRANSFERASE; MULTIPLE GENES; CPG ISLANDS; HYPERMETHYLATION; TUMOR; EXPRESSION; BRAIN; BIAS	Background: O-6-methylguanine-DNA methyltransferase (MGMT) is one of most important DNA repair enzyme against common carcinogens such as alkylate and tobacco. Aberrant promoter methylation of the gene is frequently observed in non-small cell lung cancer (NSCLC). However, the importance of epigenetic inactivation of the gene in NSCLC published in the literature showed inconsistence. We quantified the association between MGMT promoter methylation and NSCLC using a meta-analysis method. Methods: We systematically reviewed studies of MGMT promoter methylation and NSCLC in PubMed, EMBASE, Ovid, ISI Web of Science, Elsevier and CNKI databases and quantified the association between MGMT promoter methylation and NSCLC using meta-analysis method. Odds ratio (OR) and corresponding 95% confidence interval (CI) were calculated to evaluate the strength of association. Potential sources of heterogeneity were assessed by subgroup analysis and meta-regression. Results: A total of 18 studies from 2001 to 2011, with 1, 160 tumor tissues and 970 controls, were involved in the meta-analysis. The frequencies of MGMT promote methylation ranged from 1.5% to 70.0% (median, 26.1%) in NSCLC tissue and 0.0% to 55.0% (median, 2.4%) in non-cancerous control, respectively. The summary of OR was 4.43 (95% CI: 2.85, 6.89) in the random-effects model. With stratification by potential source of heterogeneity, the OR was 20.45 (95% CI: 5.83, 71.73) in heterogeneous control subgroup, while it was 4.16 (95% CI: 3.02, 5.72) in the autologous control subgroup. The OR was 5.31 (95% CI: 3.00, 9.41) in MSP subgroup and 3.06 (95% CI: 1.75, 5.33) in Q-MSP subgroup. Conclusion: This meta-analysis identified a strong association between methylation of MGMT gene and NSCLC. Prospective studies should be required to confirm the results in the future.	[Gu, Changmei; Shi, Hao; Yuan, Xueli; Lu, Meixia] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat, Sch Publ Hlth, Wuhan 430074, Hubei, Peoples R China; [Gu, Changmei; Shi, Hao; Yuan, Xueli; Lu, Meixia] Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ, Key Lab Environm & Hlth,Sch Publ Hlth, Wuhan 430074, Hubei, Peoples R China; [Lu, Jiachun] Guangzhou Med Univ, Sch Publ Hlth, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China; [Cui, Tianpen; Xu, Wenmao] Wuhan First Hosp, Dept Clin Lab, Wuhan, Hubei, Peoples R China; [Lu, Cheng] Nanchang Univ, Dept Anat, Coll Med, Nanchang, Jiangxi, Peoples R China; [Yang, Xiaobo] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China; [Huang, Yangxin] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Nanchang University; Guangxi Medical University; State University System of Florida; University of South Florida	Lu, MX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat, Sch Publ Hlth, Wuhan 430074, Hubei, Peoples R China.	mlu@hust.edu.cn	Yang, Xiaobo/G-3854-2016					Ali AHK, 2011, MOL CARCINOGEN, V50, P89, DOI 10.1002/mc.20697; Belinsky SA, 2007, BRIT J CANCER, V96, P1278, DOI 10.1038/sj.bjc.6603721; Belinsky SA, 2004, CARCINOGENESIS, V25, P1063, DOI 10.1093/carcin/bgh096; Brabender J, 2003, CLIN CANCER RES, V9, P223; CITRON M, 1991, CANCER RES, V51, P4131; CITRON M, 1993, CANCER INVEST, V11, P258, DOI 10.3109/07357909309024850; De Jong WK, 2009, ANTICANCER RES, V29, P363; Ekim M, 2010, CLIN GENET, V78, P65; Esteller M, 1999, CANCER RES, V59, P67; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feng QH, 2008, CANCER EPIDEM BIOMAR, V17, P645, DOI 10.1158/1055-9965.EPI-07-2518; Fujii M, 2012, CANCER SCI, V103, P510, DOI 10.1111/j.1349-7006.2011.02180.x; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Hang C, 2011, CHIN J LAB DIAGN, V15, P81; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; [金永堂 Jin Yongtang], 2010, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V37, P1109; Kim DS, 2007, LUNG CANCER, V58, P1, DOI 10.1016/j.lungcan.2007.04.008; Kim YT, 2005, ANN THORAC SURG, V79, P1180, DOI 10.1016/j.athoracsur.2004.09.060; Lin Q, 2009, J CANCER RES CLIN, V135, P1675, DOI 10.1007/s00432-009-0614-4; Liu Y, 2010, J MED FORUM, V31, P1; Lv Jinfang, 2003, Zhongguo Fei Ai Za Zhi, V6, P63, DOI 10.3779/j.issn.1009-3419.2003.01.16; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rucker G, 2008, STAT MED, V27, P746, DOI 10.1002/sim.2971; Russo AL, 2005, CLIN CANCER RES, V11, P2466, DOI 10.1158/1078-0432.CCR-04-1962; Safar AM, 2005, CLIN CANCER RES, V11, P4400, DOI 10.1158/1078-0432.CCR-04-2378; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Topaloglu O, 2004, CLIN CANCER RES, V10, P2284, DOI 10.1158/1078-0432.CCR-1111-3; Vallbohmer D, 2006, CLIN LUNG CANCER, V8, P39, DOI 10.3816/CLC.2006.n.031; Wu PF, 2010, LUNG CANCER, V68, P484, DOI 10.1016/j.lungcan.2009.08.010; Yanagawa N, 2007, LUNG CANCER, V58, P131, DOI 10.1016/j.lungcan.2007.05.011; Zhang YW, 2011, CANCER LETT, V303, P21, DOI 10.1016/j.canlet.2010.12.011; Zochbauer-Muller S, 2001, CANCER RES, V61, P249; Zou XP, 2009, HUM PATHOL, V40, P1534, DOI 10.1016/j.humpath.2009.01.029	36	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e72633	10.1371/journal.pone.0072633	http://dx.doi.org/10.1371/journal.pone.0072633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086261	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000001
J	Garcia-Martin, E; Agundez, JAG; Maestro, ML; Suarez, A; Vidaurreta, M; Martinez, C; Fernandez-Perez, C; Ortega, L; Ladero, JM				Garcia-Martin, Elena; Agundez, Jose A. G.; Maestro, Maria L.; Suarez, Avelina; Vidaurreta, Marta; Martinez, Carmen; Fernandez-Perez, Cristina; Ortega, Luis; Ladero, Jose M.			Influence of Vitamin D-Related Gene Polymorphisms (CYP27B and VDR) on the Response to Interferon/Ribavirin Therapy in Chronic Hepatitis C	PLOS ONE			English	Article							PLUS RIBAVIRIN; D DEFICIENCY; FIBROSIS	Background and Aims: Vitamin D exerts immunomodulatory effects on the host response against infection with hepatitis C virus (HCV). This study was performed to assess the putative influence of polymorphisms in vitamin D-related genes on the response to antiviral therapy in patients with chronic hepatitis C (CHC). Methods: Single nucleotide polymorphisms (SNPs) in CYP27B-1260 gene promoter (rs10877012AC) and in vitamin D receptor (VDR) gene rs2228570TC, rs1544410CT, rs7975232AC and rs731236AT were analyzed in a cohort of 238 Caucasian CHC patients treated with pegylated interferon (Peg-IFN) plus ribavirin (RBV). Multivariate analyses were performed to exclude confounding effects of well-known baseline predictors of response to therapy (HCV genotype and load, IL28B genotype, age, and GGT and serum cholesterol). Results: Three SNPs at the VDR gene (rs1544410, rs7975232 and rs731236) were in strong linkage disequilibrium, with the CCA haplotype predicting therapeutic failure [Odds ratio 2.743; (95% C. I. 1.313-5.731), p = 0.007]. The carrier state of the VDR rs2228570 T allele was inversely related to the probability of therapeutic failure [Odds ratio 0.438; 95 C. I. (0.204-0.882), p = 0.021]. No relation existed between CYP27B-1260 rs10877012 polymorphism and response to therapy. The area under the operating curve (AUROC) based on the model including all variables significantly related to the response to therapy was 0.846 (95% confidence interval = 0.793-0.899). Conclusion: VDR gene polymorphisms are independently related to the response to Peg-IFN+RBV therapy in chronic hepatitis C and could be used as complementary biomarkers of response when included in a prediction algorithm in association with demographic, virologic, biochemical and genetic traits.	[Garcia-Martin, Elena] Univ Extremadura, Dept Biochem & Mol Biol, Caceres, Spain; [Agundez, Jose A. G.; Martinez, Carmen] Univ Extremadura, Dept Pharmacol, Caceres, Spain; [Maestro, Maria L.; Vidaurreta, Marta] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Hosp Clin San Carlos, Genom Unit,Clin Lab Dept, Madrid, Spain; [Suarez, Avelina] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Hosp Clin San Carlos, Serv Clin Microbiol, Madrid, Spain; [Fernandez-Perez, Cristina] Univ Complutense, Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Clin Res & Methodol Unit,Hosp Clin San Carlos,Med, E-28040 Madrid, Spain; [Ortega, Luis] Hosp Clin San Carlos IdISSC, Hosp Clin San Carlos, Inst Invest Sanitaria, Serv Pathol, Madrid, Spain; [Ladero, Jose M.] Univ Complutense, Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria,Med Sch, Serv Gastroenterol,Hosp Clin San Carlos,Dept Med, E-28040 Madrid, Spain	Universidad de Extremadura; Universidad de Extremadura; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid; Hospital Clinico San Carlos	Ladero, JM (corresponding author), Univ Complutense, Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria,Med Sch, Serv Gastroenterol,Hosp Clin San Carlos,Dept Med, E-28040 Madrid, Spain.	jladero.hcsc@salud.madrid.org	Pérez, Cristina Fernández/K-8078-2019; Agúndez, José A. G./A-5503-2008; Pérez, Cristina Fernández/I-2220-2015; García-Martin, Elena/H-9828-2016	Pérez, Cristina Fernández/0000-0001-9853-6257; Agúndez, José A. G./0000-0001-6895-9160; Pérez, Cristina Fernández/0000-0001-9853-6257; García-Martin, Elena/0000-0002-8094-046X; Vidaurreta, Marta/0000-0002-7790-6252; Ortega, Luis/0000-0002-7987-8531	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [PS09/00943, PS09/00469, PI12/00241, PI12/00324, RETICS RIRAAF RD12/0013/0002]; Junta de Extremadura, Spain [GR10068]; European Union	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Junta de Extremadura, Spain; European Union(European Commission)	This work was supported by PS09/00943, PS09/00469, PI12/00241, PI12/00324, RETICS RIRAAF RD12/0013/0002 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain, and GR10068 from Junta de Extremadura, Spain. Financed in part with FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2008, CLIN CHEM, V54, P1390, DOI 10.1373/clinchem.2008.105569; Arteh J, 2010, DIGEST DIS SCI, V55, P513; Baur K, 2012, ANTIVIR THER, V17, P541, DOI 10.3851/IMP2018; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Bitetto D, 2013, HEPATOLOGY, V57, P925, DOI 10.1002/hep.26186; Bitetto D, 2011, HEPATOLOGY, V53, P1118, DOI 10.1002/hep.24201; Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Cuenca F, 2010, REV ESP ENFERM DIG, V102, P234, DOI 10.4321/s1130-01082010000400003; Fisher L, 2007, CLIN GASTROENTEROL H, V5, P513, DOI 10.1016/j.cgh.2006.10.015; Gonzalez-Molero I, 2011, EUR J CLIN NUTR, V65, P321, DOI 10.1038/ejcn.2010.265; Gutierrez JA, 2011, SEMIN LIVER DIS, V31, P387, DOI 10.1055/s-0031-1297927; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kitanaka S, 2012, ENDOCR J, V59, P1007, DOI 10.1507/endocrj.EJ12-0143; Kitson MT, 2013, J HEPATOL, V58, P467, DOI 10.1016/j.jhep.2012.11.017; Ladero JM, 2013, ANN HEPATOL, V12, P199, DOI 10.1016/S1665-2681(19)31357-2; Ladero JM, 2012, J GASTROEN HEPATOL, V27, P279, DOI 10.1111/j.1440-1746.2011.06834.x; Lange CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040159; Lange CM, 2011, J HEPATOL, V54, P887, DOI 10.1016/j.jhep.2010.08.036; Maekawa S, 2012, HEPATOLOGY, V56, P1611, DOI 10.1002/hep.25826; Miroliaee A, 2010, HEPATOL INT, V4, P634, DOI 10.1007/s12072-010-9194-2; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Witthoft T, 2007, J VIRAL HEPATITIS, V14, P788, DOI 10.1111/j.1365-2893.2007.00871.x	27	32	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74764	10.1371/journal.pone.0074764	http://dx.doi.org/10.1371/journal.pone.0074764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073221	gold, Green Published, Green Submitted			2022-12-27	WOS:000324768000030
J	Strain, EMA; Johnson, CR; Thomson, RJ				Strain, Elisabeth M. A.; Johnson, Craig R.; Thomson, Russell J.			Effects of a Range-Expanding Sea Urchin on Behaviour of Commercially Fished Abalone	PLOS ONE			English	Article							COMPETITION; COMMUNITY; HALIOTIS; HABITAT; EXPANSION; RESPONSES; IMPACTS; ECOLOGY	Background: Global climate change has resulted in a southerly range expansion of the habitat modifying sea urchin Centrostephanus rodgersii to the east coast of Tasmania, Australia. Various studies have suggested that this urchin outcompetes black-lipped abalone (Haliotis rubra) for resources, but experiments elucidating the mechanisms are lacking. Methodology/Principal Findings: We outline a new framework involving experimental manipulations and Markov chain and Pareto modelling to examine the effects of interspecific competition between urchins and abalone and the effect of intraspecific competition in abalone, assessed as effects on behaviour. Manipulations of abalone densities had no detectable effect on urchin behavioural transitions, movement patterns or resightability through time. In contrast, additions of urchins resulted in abalone shifting microhabitats from exposed to sheltered positions, an increase in the proportion of mobile abalone, and declines in abalone resightability through time relative to controls without the urchins. Our results support the hypothesis of asymmetrical competitive interactions between urchins and abalone. Conclusions/Significance: The introduction of urchins to intact algal beds causes abalone to flee and seek shelter in cryptic microhabitat which will negatively impact both their accessibility to such microhabitats, and productivity of the abalone fishery, and will potentially affect their growth and survival, while the presence of the abalone has no detectable effect on the urchin. Our approach involving field-based experiments and modelling could be used to test the effects of other invasive species on native species behaviour.	[Strain, Elisabeth M. A.] Univ Bologna, Ravenna, Italy; [Strain, Elisabeth M. A.; Johnson, Craig R.; Thomson, Russell J.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of Bologna; University of Tasmania	Strain, EMA (corresponding author), Univ Bologna, Ravenna, Italy.	strain.beth@gmail.com	Johnson, Craig R/E-1788-2013; Thomson, Russell J/H-5653-2012; Strain, Elisabeth/U-3520-2017	Johnson, Craig R/0000-0002-9511-905X; Thomson, Russell J/0000-0003-4949-4120; Strain, Elisabeth/0000-0003-2165-9544	Australian Postgraduate Award; Commonwealth Scientific and Industrial Research Organisation; University of Tasmania Quantitative Marine Science Program; Tasmanian Aquaculture and Fisheries Institute; Tasmanian Abalone Council	Australian Postgraduate Award(Australian Government); Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Tasmania Quantitative Marine Science Program; Tasmanian Aquaculture and Fisheries Institute; Tasmanian Abalone Council	This study was part of a PhD supported by an Australian Postgraduate Award and the Commonwealth Scientific and Industrial Research Organisation and University of Tasmania Quantitative Marine Science Program. The research was supported by Tasmanian Aquaculture and Fisheries Institute and Tasmanian Abalone Council grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NL, 1992, MAR FRESHWATER RES, V43, P547; Byers JE, 2000, ECOLOGY, V81, P1225, DOI 10.2307/177203; Carlton JT, 1993, BIO CON, V78, P97; CHAPMAN MG, 1986, J EXP MAR BIOL ECOL, V103, P181, DOI 10.1016/0022-0981(86)90140-1; CREESE RG, 1982, OECOLOGIA, V53, P337, DOI 10.1007/BF00389010; Edgar G.J., 1997, REED BOOKS; Edgar GJ, 1999, J EXP MAR BIOL ECOL, V242, P107, DOI 10.1016/S0022-0981(99)00098-2; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Firth LB, 2009, GLOBAL CHANGE BIOL, V15, P1413, DOI 10.1111/j.1365-2486.2009.01863.x; Firth LB, 2010, OECOLOGIA, V162, P163, DOI 10.1007/s00442-009-1441-7; Flukes EB, 2012, MAR ECOL PROG SER, V464, P179, DOI 10.3354/meps09881; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Huchette SMH, 2003, AQUACULT INT, V11, P411, DOI 10.1023/B:AQUI.0000004194.85299.38; Johnson C., 2005, ESTABLISHMENT LONG S; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; KALBFLEISCH JD, 1985, J AM STAT ASSOC, V80, P863, DOI 10.2307/2288545; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; Mieszkowska N, 2006, HYDROBIOLOGIA, V555, P241, DOI 10.1007/s10750-005-1120-6; Moore P, 2007, MAR ECOL PROG SER, V334, P11, DOI 10.3354/meps334011; Naylor R, 2001, WATER ATMOS, V9, P16; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; SHEPHERD SA, 1973, AUST J MAR FRESH RES, V24, P217, DOI 10.1071/MF9730217; Shepherd SA, 1973, AUST FISH, V4, P4; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Strain EMA, 2013, BIOL INVASIONS, V15, P1391, DOI 10.1007/s10530-012-0378-7; Strain EMA, 2009, MAR ECOL PROG SER, V377, P169, DOI 10.3354/meps07816; Stuart-Smith RD, 2010, GLOBAL CHANGE BIOL, V16, P122, DOI 10.1111/j.1365-2486.2009.01955.x; TODD CD, 1994, J EXP MAR BIOL ECOL, V181, P159, DOI 10.1016/0022-0981(94)90126-0; TUTSCHULTE TC, 1988, MAR ECOL PROG SER, V49, P57, DOI 10.3354/meps049057; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021	37	6	6	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73477	10.1371/journal.pone.0073477	http://dx.doi.org/10.1371/journal.pone.0073477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073195	Green Published, gold			2022-12-27	WOS:000324768000004
J	Chidlow, G; Wood, JPM; Sharma, S; Dimasi, DP; Burdon, KP; Casson, RJ; Craig, JE				Chidlow, Glyn; Wood, John P. M.; Sharma, Shiwani; Dimasi, David P.; Burdon, Kathryn P.; Casson, Robert J.; Craig, Jamie E.			Ocular Expression and Distribution of Products of the POAG-Associated Chromosome 9p21 Gene Region	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GENOME-WIDE ASSOCIATION; TUMOR-SUPPRESSOR GENE; SQUAMOUS-CELL CARCINOMA; TO-DISC RATIO; METHYLTHIOADENOSINE PHOSPHORYLASE; SUSCEPTIBILITY LOCI; P15(INK4B) PROTEIN; COMMON VARIANTS; DOWN-REGULATION	It has recently been shown that there are highly significant associations for common single nucleotide polymorphisms (SNPs) near the CDKN2B-AS1 gene region at the 9p21 locus with primary open angle glaucoma (POAG), a leading cause of irreversible blindness. This gene region houses the CDKN2B/p15(INK4B), CDKN2A/p16(INK4A) and p14ARF (rat equivalent, p19(ARF)) tumour suppressor genes and is adjacent to the S-methyl-59-thioadenosine phosphorylase (MTAP) gene. In order to understand the ocular function of these genes and, therefore, how they may be involved in the pathogenesis of POAG, we studied the distribution patterns of each of their products within human and rat ocular tissues. MTAP mRNA was detected in the rat retina and optic nerve and its protein product was localised to the corneal epithelium, trabecular meshwork and retinal glial cells in both human and rat eyes. There was a very low level of p16(INK4A) mRNA present within the rat retina and slightly more in the optic nerve, although no protein product could be detected in either rat or human eyes with any of the antibodies tested. P19(ARF) mRNA was likewise only present at very low levels in rat retina and slightly higher levels in the optic nerve. However, no unambiguous evidence was found to indicate expression of specific P19(ARF)/p14(ARF) proteins in either rat or human eyes, respectively. In contrast, p15(INK4B) mRNA was detected in much higher amounts in both retina and optic nerve compared with the other genes under analysis. Moreover, p15(INK4B) protein was clearly localised to the retinal inner nuclear and ganglion cell layers and the corneal epithelium and trabecular meshwork in rat and human eyes. The presented data provide the basis for future studies that can explore the roles that these gene products may play in the pathogenesis of glaucoma and other models of optic nerve damage.	[Chidlow, Glyn; Wood, John P. M.; Casson, Robert J.] Hanson Inst Ctr Neurol Dis, South Australian Inst Ophthalmol, Ophthalm Res Labs, Adelaide, SA, Australia; [Chidlow, Glyn; Wood, John P. M.; Casson, Robert J.] Univ Adelaide, Dept Ophthalmol & Visual Sci, Adelaide, SA, Australia; [Sharma, Shiwani; Dimasi, David P.; Burdon, Kathryn P.; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA 5042, Australia	Hanson Institute; University of Adelaide; Flinders University South Australia	Wood, JPM (corresponding author), Hanson Inst Ctr Neurol Dis, South Australian Inst Ophthalmol, Ophthalm Res Labs, Adelaide, SA, Australia.	john.wood@health.sa.gov.au	Burdon, Kathryn/A-5026-2009; Burdon, Kathryn/AAD-2334-2022	Burdon, Kathryn/0000-0001-8217-1249; Burdon, Kathryn/0000-0001-8217-1249; Craig, Jamie/0000-0001-9955-9696; Sharma, Shiwani/0000-0002-0828-025X	National Health and Medical Research Council [APP1031347]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Support from the National Health and Medical Research Council (http://www.nhmrc.gov.au/) in terms of a project grant (number APP1031347) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad MM, 2000, FEBS LETT, V483, P160, DOI 10.1016/S0014-5793(00)02108-6; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Bulten J, 2006, GYNECOL ONCOL, V101, P487, DOI 10.1016/j.ygyno.2005.11.036; Burdon KP, 2012, OPHTHALMOLOGY, V119, P1539, DOI 10.1016/j.ophtha.2012.02.004; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Burry RW, 2011, J HISTOCHEM CYTOCHEM, V59, P6, DOI 10.1369/jhc.2010.956920; Cao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039278; Chidlow G, 2007, DRUGS, V67, P725, DOI 10.2165/00003495-200767050-00006; Chidlow G, 2011, J HISTOCHEM CYTOCHEM, V59, P884, DOI 10.1369/0022155411418115; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Christopher SA, 2002, CANCER RES, V62, P6639; Cunnington MS, 2011, CURR ATHEROSCLER REP, V13, P193, DOI 10.1007/s11883-011-0178-z; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Feng W, 2007, MODERN PATHOL, V20, P961, DOI 10.1038/modpathol.3800927; Fritschy JM, 2008, EUR J NEUROSCI, V28, P2365, DOI 10.1111/j.1460-9568.2008.06552.x; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; GARBERS DL, 1978, BIOCHIM BIOPHYS ACTA, V523, P82, DOI 10.1016/0005-2744(78)90011-6; Gibson J, 2012, MOL VIS, V18, P1083; HALL M, 1995, ONCOGENE, V11, P1581; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Huang HY, 2009, CLIN CANCER RES, V15, P6963, DOI 10.1158/1078-0432.CCR-09-1511; Indovina P, 2010, J CELL PHYSIOL, V223, P143, DOI 10.1002/jcp.22019; Kim J, 2011, GENE CHROMOSOME CANC, V50, P421, DOI 10.1002/gcc.20867; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Legrier ME, 2001, NEUROREPORT, V12, P3127, DOI 10.1097/00001756-200110080-00029; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Mabuchi F, 2012, OPHTHALMOLOGY, V119, P1819, DOI 10.1016/j.ophtha.2012.02.044; MAO L, 1995, CANCER RES, V55, P2995; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Moad AI, 2009, J CUTAN PATHOL, V36, P183, DOI 10.1111/j.1600-0560.2008.00989.x; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Mulvany NJ, 2008, PATHOLOGY, V40, P335, DOI 10.1080/00313020802035907; Nakano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033389; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; QUELLE DE, 1995, CELL, V83, P993; QUELLE DE, 1995, ONCOGENE, V11, P635; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Robertson KD, 1999, ONCOGENE, V18, P3810, DOI 10.1038/sj.onc.1202737; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Sandhu C, 1997, MOL CELL BIOL, V17, P2458, DOI 10.1128/MCB.17.5.2458; Sano T, 2002, PATHOL INT, V52, P375, DOI 10.1046/j.1440-1827.2002.01359.x; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Sato K, 2010, ONCOL REP, V24, P701, DOI 10.3892/or_00000910; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sharma S, 2012, INVEST OPHTH VIS SCI, V53, P4917, DOI 10.1167/iovs.11-9047; Sommer J, 2010, J PATHOL, V220, P608, DOI 10.1002/path.2679; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Takamoto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040107; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Watanabe G, 1998, DEV BRAIN RES, V108, P77, DOI 10.1016/S0165-3806(98)00032-7; Wiggs JL, 2012, PLOS GENET, V8, P413, DOI 10.1371/journal.pgen.1002654; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; Wood JPM, 2010, INVEST OPHTH VIS SCI, V51, P3774, DOI 10.1167/iovs.09-4305; Wood JPM, 2005, J NEUROCHEM, V93, P686, DOI 10.1111/j.1471-4159.2005.03059.x; Zimling ZG, 2012, HISTOPATHOLOGY, V60, pE96, DOI 10.1111/j.1365-2559.2012.04196.x; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	71	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75067	10.1371/journal.pone.0075067	http://dx.doi.org/10.1371/journal.pone.0075067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069379	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300063
J	Merelli, I; Lio, P; Milanesi, L				Merelli, Ivan; Lio, Pietro; Milanesi, Luciano			NuChart: An R Package to Study Gene Spatial Neighbourhoods with Multi-Omics Annotations	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; GENOME ORGANIZATION; CHROMATIN; CTCF; EPIGENETICS; PRINCIPLES; PREDICTION; FACTORIES; DATABASE; DOMAINS	Long-range chromosomal associations between genomic regions, and their repositioning in the 3D space of the nucleus, are now considered to be key contributors to the regulation of gene expression and important links have been highlighted with other genomic features involved in DNA rearrangements. Recent Chromosome Conformation Capture (3C) measurements performed with high throughput sequencing (Hi-C) and molecular dynamics studies show that there is a large correlation between colocalization and coregulation of genes, but these important researches are hampered by the lack of biologists-friendly analysis and visualisation software. Here, we describe NuChart, an R package that allows the user to annotate and statistically analyse a list of input genes with information relying on Hi-C data, integrating knowledge about genomic features that are involved in the chromosome spatial organization. NuChart works directly with sequenced reads to identify the related Hi-C fragments, with the aim of creating gene-centric neighbourhood graphs on which multi-omics features can be mapped. Predictions about CTCF binding sites, isochores and cryptic Recombination Signal Sequences are provided directly with the package for mapping, although other annotation data in bed format can be used (such as methylation profiles and histone patterns). Gene expression data can be automatically retrieved and processed from the Gene Expression Omnibus and ArrayExpress repositories to highlight the expression profile of genes in the identified neighbourhood. Moreover, statistical inferences about the graph structure and correlations between its topology and multi-omics features can be performed using Exponential-family Random Graph Models. The Hi-C fragment visualisation provided by NuChart allows the comparisons of cells in different conditions, thus providing the possibility of novel biomarkers identification. NuChart is compliant with the Bioconductor standard and it is freely available at ftp://fileserver.itb.cnr.it/nuchart.	[Merelli, Ivan; Milanesi, Luciano] CNR, Inst Biomed Technol, Milan, Italy; [Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Cambridge	Merelli, I (corresponding author), CNR, Inst Biomed Technol, Milan, Italy.	ivan.merelli@itb.cnr.it	Merelli, Ivan/O-2543-2015; Merelli, Ivan/AAX-6171-2020; Milanesi, Luciano/AAE-7230-2019; P. Lió, Pietro Lio/AAV-3358-2021	Merelli, Ivan/0000-0003-3587-3680; Merelli, Ivan/0000-0003-3587-3680; Milanesi, Luciano/0000-0002-1201-3939; P. Lió, Pietro Lio/0000-0002-0540-5053	Italian Ministry of Education and Research (MIUR) through the Flagship InterOmics [PB05]; HIRMA [RBAP11YS7K]; European MIMOMICS projects	Italian Ministry of Education and Research (MIUR) through the Flagship InterOmics(Ministry of Education, Universities and Research (MIUR)); HIRMA; European MIMOMICS projects	This work has been supported by the Italian Ministry of Education and Research (MIUR) through the Flagship (PB05) InterOmics, HIRMA (RBAP11YS7K) and the European MIMOMICS projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal R, 2007, J STAT SOFTW, V24; Botta M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.79; Chepelev I, 2012, CELL RES, V22, P490, DOI 10.1038/cr.2012.15; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deng BW, 2013, SEMIN CANCER BIOL, V23, P65, DOI 10.1016/j.semcancer.2012.01.003; Di Stefano M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003019; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan ZJ, 2012, METHODS, V58, P277, DOI 10.1016/j.ymeth.2012.06.018; Fraser J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r37; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Harmston N, 2013, NUCLEIC ACIDS RES, V41, P7185, DOI 10.1093/nar/gkt499; Hu M, 2012, BIOINFORMATICS, V28, P3131, DOI 10.1093/bioinformatics/bts570; Kruse K, 2013, NUCLEIC ACIDS RES, V41, P701, DOI 10.1093/nar/gks1096; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Ling JQ, 2007, PEDIATR RES, V61, p11R, DOI 10.1203/pdr.0b013e31804575db; Marculescu R, 2006, DNA REPAIR, V5, P1246, DOI 10.1016/j.dnarep.2006.05.015; Merelli I, 2010, NUCLEIC ACIDS RES, V38, pW262, DOI 10.1093/nar/gkq391; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Oliver JL, 2004, NUCLEIC ACIDS RES, V32, pW287, DOI 10.1093/nar/gkh399; Papantonis A, 2012, EMBO J, V31, P4404, DOI 10.1038/emboj.2012.288; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018; Ross-Innes CS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-593; Sandhu KS, 2012, CELL REP, V2, P1207, DOI 10.1016/j.celrep.2012.09.022; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Selga E, 2008, BIOCHEM PHARMACOL, V75, P414, DOI 10.1016/j.bcp.2007.08.034; Servant N, 2012, BIOINFORMATICS, V28, P2843, DOI 10.1093/bioinformatics/bts521; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Varriale A, 2010, GENOMICS, V95, P25, DOI 10.1016/j.ygeno.2009.09.006; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	39	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75146	10.1371/journal.pone.0075146	http://dx.doi.org/10.1371/journal.pone.0075146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069388	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300068
J	Rosenfeld, CS; Johnson, SA; Ellersieck, MR; Roberts, RM				Rosenfeld, Cheryl S.; Johnson, Sarah A.; Ellersieck, Mark R.; Roberts, R. Michael			Interactions between Parents and Parents and Pups in the Monogamous California Mouse (Peromyscus californicus)	PLOS ONE			English	Article							VOLE MICROTUS-PENNSYLVANICUS; MALE MONGOLIAN GERBILS; MATERNAL-CARE; PATERNAL BEHAVIOR; REPRODUCTIVE SUCCESS; STRESS RESPONSES; SEXUAL-BEHAVIOR; BIPARENTAL CARE; TESTOSTERONE; EXPRESSION	The California mouse (Peromyscus californicus) may be a valuable animal model to study parenting as it is one of the few monogamous and biparental rodent species. By using automated infra-red imaging and video documentation of established pairs spanning two days prior to birth of the litter until d 5 of post natal development (PND), it was possible to follow interactions between parents and between parents and pups. The paired males were attentive to their partners in the form of grooming and sniffing throughout the time period studied. Both these and other activities of the partners, such as eating and drinking, peaked during late light/mid-dark period. Beginning the day before birth, and most significantly on PND 0, the female made aggressive attempts to exclude the male from nest-attending, acts that were not reciprocated by the male, although he made repeated attempts to mate his partner during that period. By PND 1, males were permitted to return to the nest, where they initiated grooming, licking, and huddling over the litter, although time spent by the male on parental care was still less than that of the female. Male and female pups were of similar size and grew at the same rate. Pups, which are believed to be exothermic for at least the first two weeks post-natally, maintained a body temperature higher than that of their parents until PND 16. Data are consistent with the inference that the male California mouse parent is important in helping retain pup body heat and permit dams increased time to procure food to accommodate her increased energy needs for lactation. These assessments provide indices that may be used to assess the effects of extrinsic factors, such as endocrine disrupting chemicals, on biparental behaviors and offspring development.	[Rosenfeld, Cheryl S.; Johnson, Sarah A.; Roberts, R. Michael] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Rosenfeld, Cheryl S.; Johnson, Sarah A.] Univ Missouri, Dept Biomed Sci, Columbia, MO USA; [Ellersieck, Mark R.] Univ Missouri, Agr Expt Stn Stat, Columbia, MO USA; [Roberts, R. Michael] Univ Missouri, Dept Anim Sci, Columbia, MO USA; [Roberts, R. Michael] Univ Missouri, Dept Biochem, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Rosenfeld, CS (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.	rosenfeldc@missouri.edu			University of Missouri College of Veterinary Medicine	University of Missouri College of Veterinary Medicine	The project was funded by a grant from the University of Missouri College of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern TH, 2011, DEV PSYCHOBIOL, V53, P118, DOI 10.1002/dev.20498; Alberts JR, 2007, DEV PSYCHOBIOL, V49, P22, DOI 10.1002/dev.20190; ALEXANDER G, 1964, SCIENCE, V146, P665, DOI 10.1126/science.146.3644.665; Bagot RC, 2012, BIOL PSYCHIAT, V72, P491, DOI 10.1016/j.biopsych.2012.03.016; Becker EA, 2010, HORM BEHAV, V58, P385, DOI 10.1016/j.yhbeh.2010.03.019; Bredy TW, 2007, EUR J NEUROSCI, V25, P567, DOI 10.1111/j.1460-9568.2006.05266.x; Bredy TW, 2004, HORM BEHAV, V46, P30, DOI 10.1016/j.yhbeh.2003.09.017; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Cameron NM, 2011, J NEUROENDOCRINOL, V23, P393, DOI 10.1111/j.1365-2826.2011.02124.x; Cameron NM, 2008, HORM BEHAV, V54, P178, DOI 10.1016/j.yhbeh.2008.02.013; Cantoni D, 1997, ANIM BEHAV, V54, P377, DOI 10.1006/anbe.1996.0583; CAPEK K, 1956, Physiol Bohemoslov, V5, P91; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; CHANDLER T, 1979, POPULATION BIOL COAS; Clark MM, 2001, DEV PSYCHOBIOL, V39, P179, DOI 10.1002/dev.1043; Clark MM, 1999, J COMP PSYCHOL, V113, P388, DOI 10.1037/0735-7036.113.4.388; Clark MM, 2000, ANIM BEHAV, V59, P801, DOI 10.1006/anbe.1999.1365; Clark MM, 2000, DEV PSYCHOBIOL, V36, P177, DOI 10.1002/(SICI)1098-2302(200004)36:3<177::AID-DEV1>3.0.CO;2-W; Clark MM, 1998, DEV PSYCHOBIOL, V32, P177, DOI 10.1002/(SICI)1098-2302(199804)32:3<177::AID-DEV2>3.0.CO;2-L; Clark MM, 1997, ANIM BEHAV, V54, P635, DOI 10.1006/anbe.1997.0468; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; DEWSBURY DA, 1985, AM ZOOL, V25, P841; DRICKAMER LC, 1973, J MAMMAL, V54, P523, DOI 10.2307/1379147; DUDLEY D, 1974, BEHAV BIOL, V11, P155, DOI 10.1016/S0091-6773(74)90305-8; DUDLEY D, 1974, BEHAV BIOL, V11, P247, DOI 10.1016/S0091-6773(74)90433-7; EISENBERG JOHN F., 1963, AMER MIDLAND NAT, V69, P240, DOI 10.2307/2422858; EISENBERG JOHN F., 1962, BEHAVIOUR, V19, P177, DOI 10.1163/156853962X00014; ELWOOD RW, 1975, ANIM BEHAV, V23, P766, DOI 10.1016/0003-3472(75)90104-9; ELWOOD RW, 1983, PARENTAL BEHAVIOUR R, P235; Ewer, 1968, ETHOLOGY MAMMALS; Farrell WJ, 2007, BEHAV NEUROSCI, V121, P1333, DOI 10.1037/0735-7044.121.6.1333; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; GAULIN SJC, 1990, J COMP PSYCHOL, V104, P88, DOI 10.1037/0735-7036.104.1.88; Gerrish CJ, 1996, DEV PSYCHOBIOL, V29, P483, DOI 10.1002/(SICI)1098-2302(199609)29:6<483::AID-DEV1>3.0.CO;2-I; Gerrish CJ, 1998, PHYSIOL BEHAV, V64, P463, DOI 10.1016/S0031-9384(98)00077-8; Gilbert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033553; Gleason ED, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0824; Gleason ED, 2010, HORM BEHAV, V57, P147, DOI 10.1016/j.yhbeh.2009.10.006; GUBERNICK DJ, 1987, J COMP PSYCHOL, V101, P169, DOI 10.1037/0735-7036.101.2.169; Gubernick DJ, 2000, P ROY SOC B-BIOL SCI, V267, P147, DOI 10.1098/rspb.2000.0979; HAMMEL HT, 1955, AM J PHYSIOL, V182, P369, DOI 10.1152/ajplegacy.1955.182.2.369; Harshaw C, 2012, PHYSIOL BEHAV, V106, P670, DOI 10.1016/j.physbeh.2012.05.002; HARTUNG TG, 1979, BEHAV NEURAL BIOL, V26, P466, DOI 10.1016/S0163-1047(79)91500-0; HATFIELD DM, 1935, J MAMMAL, V116, P261; Hellstrom IC, 2012, PHILOS T R SOC B, V367, P2495, DOI 10.1098/rstb.2012.0223; Jasarevic E, 2013, J COMP PSYCHOL, V127, P91, DOI 10.1037/a0027936; Jasarevic E, 2012, ANIM BEHAV, V84, P1141, DOI 10.1016/j.anbehav.2012.08.015; Kleiman D.G., 1981, P347; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Layne JN, 1968, BIOL PEROMYSCUS RODE; Lent PC, 1974, BEHAV UNGULATES ITS; Littell RC, 1998, J ANIM SCI, V76, P1216; Liu HX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2336; LOPEZ G, 2013, J NONDESTR EVAL; Luis J, 2009, REV BIOL TROP, V57, P433; Marler CA, 2008, NEUROBIOLOGY OF THE PARENTAL BRAIN, P435, DOI 10.1016/B978-012374285-8.00028-7; MARTEN GG, 1973, J MAMMAL, V54, P169, DOI 10.2307/1378878; MCCARTY R, 1977, ANIM BEHAV, V25, P945, DOI 10.1016/0003-3472(77)90044-6; McGowan PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014739; MCGUIRE B, 1984, ANIM BEHAV, V32, P1132, DOI 10.1016/S0003-3472(84)80229-8; MCGUIRE B, 1992, BIOL REPROD, V47, P37, DOI 10.1095/biolreprod47.1.37; McInroy JKE, 2000, HORM BEHAV, V37, P399, DOI 10.1006/hbeh.2000.1591; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MOORE CL, 1984, DEV PSYCHOBIOL, V17, P347, DOI 10.1002/dev.420170403; O'Connell LA, 2012, HORM BEHAV, V61, P725, DOI 10.1016/j.yhbeh.2012.03.009; OLIVERAS D, 1986, ANIM BEHAV, V34, P519, DOI 10.1016/S0003-3472(86)80120-8; Parent CI, 2008, DEV PSYCHOBIOL, V50, P767, DOI 10.1002/dev.20342; PARENT CI, 2012, DEV PSYCHOBIOL, P86820; Reyes-Meza V, 2011, PHYSIOL BEHAV, V104, P778, DOI 10.1016/j.physbeh.2011.07.019; RIBBLE DO, 1990, BEHAV ECOL SOCIOBIOL, V26, P9; ROOD JP, 1966, AM MIDL NAT, V76, P496, DOI 10.2307/2423101; Suderman M, 2012, P NATL ACAD SCI USA, V109, P17266, DOI 10.1073/pnas.1121260109; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Trainor BC, 2001, HORM BEHAV, V40, P32, DOI 10.1006/hbeh.2001.1652; Vieira ML, 2003, DEV PSYCHOBIOL, V42, P246, DOI 10.1002/dev.10097; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weaver ICG, 2002, J NEUROCHEM, V82, P998, DOI 10.1046/j.1471-4159.2002.01054.x; Wright SL, 2002, BEHAV PROCESS, V60, P41, DOI 10.1016/S0376-6357(02)00101-8; WYNNEEDWARDS KE, 1989, PHYSIOL BEHAV, V45, P465, DOI 10.1016/0031-9384(89)90059-0; Zhang Y, 2013, NEUROPSYCHOPHARMACOL, V38, P111, DOI 10.1038/npp.2012.149	86	29	29	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75725	10.1371/journal.pone.0075725	http://dx.doi.org/10.1371/journal.pone.0075725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069441	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300092
J	Sobral, M; Guitian, J; Guitian, P; Larrinaga, AR				Sobral, Mar; Guitian, Jose; Guitian, Pablo; Larrinaga, Asier R.			Selective Pressure along a Latitudinal Gradient Affects Subindividual Variation in Plants	PLOS ONE			English	Article							HAWTHORN CRATAEGUS-MONOGYNA; SEED SIZE; FRUIT-SIZE; PHENOTYPIC PLASTICITY; BIRDS; ESTABLISHMENT; CONSEQUENCES; PREFERENCES; VARIABILITY; GERMINATION	Individual plants produce repeated structures such as leaves, flowers or fruits, which, although belonging to the same genotype, are not phenotypically identical. Such subindividual variation reflects the potential of individual genotypes to vary with micro-environmental conditions. Furthermore, variation in organ traits imposes costs to foraging animals such as time, energy and increased predation risk. Therefore, animals that interact with plants may respond to this variation and affect plant fitness. Thus, phenotypic variation within an individual plant could be, in part, an adaptive trait. Here we investigated this idea and we found that subindividual variation of fruit size of Crataegus monogyna, in different populations throughout the latitudinal gradient in Europe, was explained at some extent by the selective pressures exerted by seed-dispersing birds. These findings support the hypothesis that within-individual variation in plants is an adaptive trait selected by interacting animals which may have important implications for plant evolution.	[Sobral, Mar] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Guitian, Jose] Univ Santiago de Compostela, Dept Cellular Biol & Ecol, Santiago De Compostela, Spain; [Guitian, Pablo] Univ Santiago de Compostela, Dept Bot, Santiago De Compostela, Spain; [Larrinaga, Asier R.] Mediterranean Inst Adv Studies, Esporles, Spain	Stanford University; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA)	Sobral, M (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	sobral@stanford.edu	Sobral, Mar/Q-9812-2017; Larrinaga, Asier/B-3826-2013	Sobral, Mar/0000-0001-6995-0491; Larrinaga, Asier/0000-0001-6813-8784	Spanish Ministry of Science and Education [CGL2005-03826]; European Commission; Maria Barbeito fellowship (Galicia regional government, Spain); Fundacion Pedro Barrie de la Maza grant; Spanish Research Council	Spanish Ministry of Science and Education(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Maria Barbeito fellowship (Galicia regional government, Spain); Fundacion Pedro Barrie de la Maza grant; Spanish Research Council	This work was supported by the Spanish Ministry of Science and Education (project CGL2005-03826) and the European Commission (FEDER program). M.S. was the recipient of a Maria Barbeito fellowship (Galicia regional government, Spain) and a Fundacion Pedro Barrie de la Maza grant. A.R.L. received financial support from the Spanish Research Council (JAEDoc program, partially funded by the European Social Fund) during the preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COMPLETE BOOK BRIT B; Banuelos MJ, 2003, EVOL ECOL, V17, P19, DOI 10.1023/A:1022430302689; Bertin N, 1998, J HORTIC SCI BIOTECH, V73, P541, DOI 10.1080/14620316.1998.11511012; BIERE A, 1991, J EVOLUTION BIOL, V4, P447, DOI 10.1046/j.1420-9101.1991.4030447.x; CARACO T, 1980, ANIM BEHAV, V28, P820, DOI 10.1016/S0003-3472(80)80142-4; Conner J. K., 2004, PRIMER ECOLOGICAL GE; DIGGLE PK, 1995, ANNU REV ECOL SYST, V26, P531, DOI 10.1146/annurev.es.26.110195.002531; GUITIAN J., 2000, ZORZALES ESPINOS SER; Herrera C.M., 2009, MULTIPLICITY UNITY P; Herrera CM, 2013, BOT J LINN SOC, V171, P441, DOI 10.1111/boj.12007; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Martinez I, 2007, EVOL ECOL, V21, P517, DOI 10.1007/s10682-006-9132-x; Moegenburg SM, 1996, OECOLOGIA, V106, P539, DOI 10.1007/BF00329713; MOSSOP R, 1994, FUNCT ECOL, V8, P410, DOI 10.2307/2389835; Murray BR, 2004, J BIOGEOGR, V31, P379, DOI 10.1046/j.0305-0270.2003.00993.x; PAXMAN G. J., 1956, Annals of Botany, V20, P331; Pearson K, 1901, PHILOS T R SOC LOND, V197, P285, DOI 10.1098/rsta.1901.0020; PETERS RH, 1988, OECOLOGIA, V74, P612, DOI 10.1007/BF00380061; PRIMACK RB, 1987, ANNU REV ECOL SYST, V18, P409, DOI 10.1146/annurev.ecolsys.18.1.409; Quinn GP, 2003, EXPT DESIGN DATA ANA; SALLABANKS R, 1992, OECOLOGIA, V91, P296, DOI 10.1007/BF00317800; SEBURN CNL, 1990, J EVOLUTION BIOL, V3, P103, DOI 10.1046/j.1420-9101.1990.3010103.x; SEYFFERT W, 1983, THEOR APPL GENET, V64, P205, DOI 10.1007/BF00303765; Sobral M, 2010, SELECCION EJERCIDA M; Sobral M, 2010, EVOL ECOL, V24, P1277, DOI 10.1007/s10682-010-9380-7; Sobral M, 2010, AUK, V127, P532, DOI 10.1525/auk.2010.09079; Thompson JD., 1994, COEVOLUTIONARY PROCE; Traveset A, 2008, ECOLOGY, V89, P95, DOI 10.1890/07-0094.1; WHEELWRIGHT NT, 1993, VEGETATIO, V108, P163; WHEELWRIGHT NT, 1985, ECOLOGY, V66, P808, DOI 10.2307/1940542; Winn AA, 1996, J EVOLUTION BIOL, V9, P737, DOI 10.1046/j.1420-9101.1996.9060737.x; WOOD DM, 1990, AM J BOT, V77, P1411, DOI 10.2307/2444751; Zar JH., 2010, BIOSTAT ANAL, V5th	36	25	25	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74356	10.1371/journal.pone.0074356	http://dx.doi.org/10.1371/journal.pone.0074356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069297	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300031
J	Tang, Z; Araysi, LM; Fathallah-Shaykh, HM				Tang, Zhuo; Araysi, Lita M.; Fathallah-Shaykh, Hassan M.			c-Src and Neural Wiskott-Aldrich Syndrome Protein (NWASP) Promote Low Oxygen-Induced Accelerated Brain Invasion by Gliomas	PLOS ONE			English	Article							RECURRENT MALIGNANT GLIOMAS; INDUCIBLE FACTOR-I; ARP2/3 COMPLEX; N-WASP; CELL-MIGRATION; ORGANOTYPIC CULTURES; TUMOR PROGRESSION; NERVOUS-TISSUE; HYPOXIA; GLIOBLASTOMA	Malignant gliomas remain associated with poor prognosis and high morbidity because of their ability to invade the brain; furthermore, human gliomas exhibit a phenotype of accelerated brain invasion in response to anti-angiogenic drugs. Here, we study 8 human glioblastoma cell lines; U251, U87, D54 and LN229 show accelerated motility in low ambient oxygen. Src inhibition by Dasatinib abrogates this phenotype. Molecular discovery and validation studies evaluate 46 molecules related to motility or the src pathway in U251 cells. Demanding that the molecular changes induced by low ambient oxygen are reversed by Dasatinib in U251 cells, identifies neural Wiskott-Aldrich syndrome protein (NWASP), Focal adhesion Kinase (FAK), beta-Catenin, and Cofilin. However, only Src-mediated NWASP phosphorylation distinguishes the four cell lines that exhibit enhanced motility in low ambient oxygen. Downregulating c-Src or NWASP by RNA interference abrogates the low-oxygen-induced enhancement in motility by in vitro assays and in organotypic brain slice cultures. The findings support the idea that c-Src and NWASP play key roles in mediating the molecular pathogenesis of low oxygen-induced accelerated brain invasion by gliomas.	[Tang, Zhuo; Araysi, Lita M.; Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Math, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Mech Engn, Birmingham, AL USA; [Fathallah-Shaykh, Hassan M.] UAB Comprehens Neurosci Ctr, Birmingham, AL USA; [Fathallah-Shaykh, Hassan M.] UAB Comprehens Canc Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fathallah-Shaykh, HM (corresponding author), Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	hfathall@uab.edu		Fathallah-Shaykh, Hassan/0000-0002-2690-7685	Gaining Life Initiative Foundation	Gaining Life Initiative Foundation	The research is funded in part by the Gaining Life Initiative Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Agha CA, 2010, ANTICANCER RES, V30, P609; BIGNER DD, 1977, J NEUROPATH EXP NEUR, V36, P593, DOI 10.1097/00005072-197705000-00027; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Fathallah-Shaykh HM, 2005, BIOCHEM BIOPH RES CO, V336, P1278, DOI 10.1016/j.bbrc.2005.08.254; Fathallah-Shaykh HM, 2000, GENE THER, V7, P2094, DOI 10.1038/sj.gt.3301346; Fujiwara S, 2007, INT J ONCOL, V30, P793; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Gerlee P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002556; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hatzikirou H, 2012, MATH MED BIOL, V29, P49, DOI 10.1093/imammb/dqq011; Hatzikirou H, 2010, MATH MED BIOL; Hockel M, 1999, CANCER RES, V59, P4525; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ji HT, 2011, J NEURO-ONCOL, V103, P445, DOI 10.1007/s11060-010-0413-4; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Lagas JS, 2009, CLIN CANCER RES, V15, P2344, DOI 10.1158/1078-0432.CCR-08-2253; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Levin VA, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-5; Lu KV, 2009, CANCER RES, V69, P6889, DOI 10.1158/0008-5472.CAN-09-0347; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; MILLER LDP, 1993, SYNAPSE, V13, P195, DOI 10.1002/syn.890130302; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Palazon A, 2012, CLIN CANCER RES, V18, P1207, DOI 10.1158/1078-0432.CCR-11-1591; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Pham K, 2012, J BIOL DYNAM, V6, P54, DOI 10.1080/17513758.2011.590610; Pichot CS, 2010, CANCER RES, V70, P8347, DOI 10.1158/0008-5472.CAN-09-4149; PIGUET V, 1985, SPRINGER SEMIN IMMUN, V8, P111, DOI 10.1007/BF00197250; Plasswilm L, 2000, PATHOBIOLOGY, V68, P99, DOI 10.1159/000055909; Ponten J, 1975, HUMAN TUMOR CELLS IN, P175, DOI [10.1007/9781-47571647-4_7, DOI 10.1007/9781-47571647-4_7]; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; SCHNEGG JF, 1981, CANCER RES, V41, P1209; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 1998, J LAB CLIN MED, V131, P207, DOI 10.1016/S0022-2143(98)90091-9; Stein AM, 2007, BIOPHYS J, V92, P356, DOI 10.1529/biophysj.106.093468; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SUZUKI K, 1995, J BIOL CHEM, V270, P19551, DOI 10.1074/jbc.270.33.19551; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takahashi K, 2011, J CELL BIOCHEM, V112, P3421, DOI 10.1002/jcb.23276; Tektonidis M, 2011, J THEOR BIOL, V287, P131, DOI 10.1016/j.jtbi.2011.07.012; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Thompson EM, 2011, J NEURO-ONCOL, V103, P353, DOI 10.1007/s11060-010-0397-0; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WELCH WC, 1995, IN VITRO CELL DEV-AN, V31, P610; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Zhu SK, 2011, MOL CARCINOGEN, V50, P770, DOI 10.1002/mc.20678	61	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75436	10.1371/journal.pone.0075436	http://dx.doi.org/10.1371/journal.pone.0075436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069415	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300079
J	Han, XJ; Sun, LF; Nishiyama, Y; Feng, B; Michiue, H; Seno, M; Matsui, H; Tomizawa, K				Han, Xiao-Jian; Sun, Ling-Fei; Nishiyama, Yuki; Feng, Bin; Michiue, Hiroyuki; Seno, Masaharu; Matsui, Hideki; Tomizawa, Kazuhito			Theranostic Protein Targeting ErbB2 for Bioluminescence Imaging and Therapy for Cancer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; IN-VIVO; GAUSSIA LUCIFERASE; BREAST-CANCER; TRANSDUCTION THERAPY; SIGNALING NETWORK; BLADDER-CANCER; OVARIAN-CANCER; MUTANT P53; CELLS	A combination of molecular-targeted cancer imaging and therapy is an emerging strategy to improve cancer diagnosis and minimize the side effects of conventional treatments. Here, we generated a recombinant protein, EC1-GLuc-p53C, by fusing EC1 peptide, an artificial ligand of ErbB2, with Gaussia luciferase (GLuc) and a p53-activating peptide, p53C. EC1-GLuc-p53C was expressed and purified from E. coli BL21. In vitro experiments showed that EC1-GLuc-p53c was stable in luminescent activity and selectively targeted ErbB2-overexpressing BT474 cells for bioluminescence imaging. Moreover, the internalized EC1-GLuc-p53C in BT474 cells exerted its function to reactivate p53 and significantly inhibited cellular proliferation. In tumor-bearing mice, the ErbB2-targeted bioluminescence imaging and therapeutic effect of EC1-GLuc-p53C were also observed specifically in BT474 tumors but not in MCF7 tumors, which does not overexpress ErbB2. Thus, the present study demonstrates EC1-GLuc-p53C to be an effective theranostic reagent targeting ErbB2 for bioluminescence imaging and cancer therapy.	[Han, Xiao-Jian; Sun, Ling-Fei; Nishiyama, Yuki; Feng, Bin; Michiue, Hiroyuki; Matsui, Hideki] Okayama Univ, Dept Physiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Tomizawa, Kazuhito] Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Kumamoto, Japan; [Han, Xiao-Jian] Japan Soc Promot Sci, Tokyo, Japan; [Seno, Masaharu] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med & Bioengn Sci, Okayama 7008530, Japan; [Han, Xiao-Jian] Nanchang Univ, Inst Translat Med, Nanchang, Peoples R China; [Feng, Bin] Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China	Okayama University; Kumamoto University; Japan Society for the Promotion of Science; Okayama University; Nanchang University; Dalian Medical University	Tomizawa, K (corresponding author), Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Kumamoto, Japan.	tomikt@kumamoto-u.ac.jp	Tomizawa, Kazuhito/F-2405-2015; MICHIUE, Hiroyuki/B-2320-2011	Tomizawa, Kazuhito/0000-0002-5663-2627; 	Ministry of Education, Science, Sports and Culture of Japan [21790202]; Japan Society for the Promotion of Science [22.00119]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grant-in-aid for Young Scientists (B) from the Ministry of Education, Science, Sports and Culture of Japan (No: 21790202, http://www.waseda.jp/rps/en/manual/kakenhi_honbun.html) and by Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (No: 22.00119, http://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki D, 2010, UROLOGY, V75, P813, DOI 10.1016/j.urology.2009.10.002; BERCHUCK A, 1990, CANCER RES, V50, P4087; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Del Vecchio S, 2007, Q J NUCL MED MOL IM, V51, P152; Ding H, 2012, THERANOSTICS, V2, P1040, DOI 10.7150/thno.4652; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Feng B, 2010, BIOMATERIALS, V31, P4139, DOI 10.1016/j.biomaterials.2010.01.086; Feng B, 2009, BIOMATERIALS, V30, P1746, DOI 10.1016/j.biomaterials.2008.12.010; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Funkhouser J., 2002, CURR DRUG DISCOV, V2, P17; Govindarajan S, 2012, BIOMATERIALS, V33, P2570, DOI 10.1016/j.biomaterials.2011.12.003; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Haberkorn U, 2011, Q J NUCL MED MOL IM, V55, P655; Hashizume T, 2008, CELL BIOL INT, V32, P814, DOI 10.1016/j.cellbi.2008.03.012; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Inoue M, 2006, EUR UROL, V49, P161, DOI 10.1016/j.eururo.2005.08.019; Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D; Kim AL, 1999, J BIOL CHEM, V274, P34924, DOI 10.1074/jbc.274.49.34924; Kim R, 2002, ONCOL REP, V9, P3; LEMBERT N, 1995, BIOCHEM J, V305, P929, DOI 10.1042/bj3050929; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P5217, DOI 10.1021/bi00643a009; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Pero SC, 2004, INT J CANCER, V111, P951, DOI 10.1002/ijc.20306; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Takayama K, 2009, J CONTROL RELEASE, V138, P128, DOI 10.1016/j.jconrel.2009.05.019; Takenobu T, 2002, MOL CANCER THER, V1, P1043; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Vaidyanath A, 2011, J CELL MOL MED, V15, P2525, DOI 10.1111/j.1582-4934.2011.01277.x; Venisnik KM, 2007, MOL IMAGING BIOL, V9, P267, DOI 10.1007/s11307-007-0101-8; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SC, 2001, SEMIN ONCOL, V28, P115, DOI 10.1016/S0093-7754(01)90289-1; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Yu MK, 2012, THERANOSTICS, V2, P3, DOI 10.7150/thno.3463	43	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75288	10.1371/journal.pone.0075288	http://dx.doi.org/10.1371/journal.pone.0075288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069396	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300075
J	Wen, J; Xiong, ZQ; Nie, ZL; Mao, LK; Zhu, YB; Kan, XZ; Ickert-Bond, SM; Gerrath, J; Zimmer, EA; Fang, XD				Wen, Jun; Xiong, Zhiqiang; Nie, Ze-Long; Mao, Likai; Zhu, Yabing; Kan, Xian-Zhao; Ickert-Bond, Stefanie M.; Gerrath, Jean; Zimmer, Elizabeth A.; Fang, Xiao-Dong			Transcriptome Sequences Resolve Deep Relationships of the Grape Family	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; NUCLEAR GENE DATA; RNA-SEQ DATA; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; ANGIOSPERM DIVERSIFICATION; PARTHENOCISSUS VITACEAE; SEED MORPHOLOGY; EVOLUTION	Previous phylogenetic studies of the grape family (Vitaceae) yielded poorly resolved deep relationships, thus impeding our understanding of the evolution of the family. Next-generation sequencing now offers access to protein coding sequences very easily, quickly and cost-effectively. To improve upon earlier work, we extracted 417 orthologous single-copy nuclear genes from the transcriptomes of 15 species of the Vitaceae, covering its phylogenetic diversity. The resulting transcriptome phylogeny provides robust support for the deep relationships, showing the phylogenetic utility of transcriptome data for plants over a time scale at least since the mid-Cretaceous. The pros and cons of transcriptome data for phylogenetic inference in plants are also evaluated.	[Wen, Jun; Zimmer, Elizabeth A.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC166, Washington, DC 20560 USA; [Xiong, Zhiqiang; Mao, Likai; Zhu, Yabing; Fang, Xiao-Dong] BGI Shenzhen, Shenzhen, Peoples R China; [Nie, Ze-Long] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Kan, Xian-Zhao] Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China; [Ickert-Bond, Stefanie M.] Univ Alaska Fairbanks, UA Museum North Herbarium, Fairbanks, AK USA; [Ickert-Bond, Stefanie M.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA; [Gerrath, Jean] Univ No Iowa, Dept Biol, Cedar Falls, IA 50614 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Anhui Normal University; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Northern Iowa	Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC166, Washington, DC 20560 USA.	wenj@si.edu; fangxd@genomics.org.cn	Kan, Xianzhao/AAA-5050-2021; Hou, Chen/L-2249-2015; Fang, Xiaodong/K-6743-2018; Nie, Ze-Long/N-8471-2015; Ickert-Bond, Stefanie M./B-3216-2012	Kan, Xianzhao/0000-0002-9225-407X; Fang, Xiaodong/0000-0001-7061-3337; Nie, Ze-Long/0000-0001-8065-3981; Ickert-Bond, Stefanie M./0000-0001-8198-8898	Office of the Smithsonian Undersecretary of Science; US National Science Foundation [DEB 0743474, DEB 0743499]; National Museum of Natural History of the Smithsonian Institution; trust funds	Office of the Smithsonian Undersecretary of Science; US National Science Foundation(National Science Foundation (NSF)); National Museum of Natural History of the Smithsonian Institution(Smithsonian InstitutionSmithsonian National Museum of Natural History); trust funds	This study was funded by grants from the Office of the Smithsonian Undersecretary of Science, the US National Science Foundation (grant DEB 0743474 to S. R. Manchester and J. Wen, and grant DEB 0743499 to J. Gerrath), the Small Grants Program of the National Museum of Natural History of the Smithsonian Institution to JW, and trust funds generated by EAZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Bell CD, 2012, MOL PHYLOGENET EVOL, V63, P724, DOI 10.1016/j.ympev.2012.02.015; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Chen I, 2007, AM J BOT, V94, P1534, DOI 10.3732/ajb.94.9.1534; Chen I, 2011, INT J PLANT SCI, V172, P1, DOI 10.1086/657283; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Cronn R, 2012, AM J BOT, V99, P291, DOI 10.3732/ajb.1100356; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Franzke A, 2009, TAXON, V58, P425, DOI 10.1002/tax.582009; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grover CE, 2012, AM J BOT, V99, P312, DOI 10.3732/ajb.1100323; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Lartillot NS, 2012, PHYLOBAYES P 3 3 BAY; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Liu XQ, 2013, MOL PHYLOGENET EVOL, V66, P43, DOI 10.1016/j.ympev.2012.09.003; Lu LM, 2013, MOL PHYLOGENET EVOL, V68, P502, DOI 10.1016/j.ympev.2013.04.023; Lu LM, 2012, BOT J LINN SOC, V168, P43, DOI 10.1111/j.1095-8339.2011.01186.x; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; McKain MR, 2012, AM J BOT, V99, P397, DOI 10.3732/ajb.1100537; Nie ZL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-17; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Olmstead RG, 2009, AM J BOT, V96, P1731, DOI 10.3732/ajb.0900004; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Plunkett GM, 2004, PLANT SYST EVOL, V245, P1, DOI 10.1007/s00606-003-0101-3; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ren H, 2011, TAXON, V60, P629, DOI 10.1002/tax.603001; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Soejima A, 2006, AM J BOT, V93, P278, DOI 10.3732/ajb.93.2.278; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wen J, 2001, SYST BOT, V26, P144; Wen J, 2007, VITACEAE K KUBITZKI, V9, P466; Wen J, 2007, CAN J BOT, V85, P731, DOI 10.1139/B07-071; Whittall JB, 2006, MOL PHYLOGENET EVOL, V39, P124, DOI 10.1016/j.ympev.2005.10.010; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Zecca G, 2012, MOL PHYLOGENET EVOL, V62, P736, DOI 10.1016/j.ympev.2011.11.015; Zimmer EA, 2012, MOL PHYLOGENET EVOL, V65, P774, DOI 10.1016/j.ympev.2012.07.015	59	76	79	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74394	10.1371/journal.pone.0074394	http://dx.doi.org/10.1371/journal.pone.0074394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069307	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300039
J	Egge, E; Bittner, L; Andersen, T; Audic, S; de Vargas, C; Edvardsen, B				Egge, Elianne; Bittner, Lucie; Andersen, Tom; Audic, Stephane; de Vargas, Colomban; Edvardsen, Bente			454 Pyrosequencing to Describe Microbial Eukaryotic Community Composition, Diversity and Relative Abundance: A Test for Marine Haptophytes	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; CHRYSOCHROMULINA-POLYLEPIS; BLOOM DYNAMICS; RARE BIOSPHERE; GENOME SIZE; GROWTH-RATE; COMPLEXITY; SEQUENCES; ACCURACY; WRINKLES	Next generation sequencing of ribosomal DNA is increasingly used to assess the diversity and structure of microbial communities. Here we test the ability of 454 pyrosequencing to detect the number of species present, and assess the relative abundance in terms of cell numbers and biomass of protists in the phylum Haptophyta. We used a mock community consisting of equal number of cells of 11 haptophyte species and compared targeting DNA and RNA/cDNA, and two different V4 SSU rDNA haptophyte-biased primer pairs. Further, we tested four different bioinformatic filtering methods to reduce errors in the resulting sequence dataset. With sequencing depth of 11000-20000 reads and targeting cDNA with Haptophyta specific primers Hap454 we detected all 11 species. A rarefaction analysis of expected number of species recovered as a function of sampling depth suggested that minimum 1400 reads were required here to recover all species in the mock community. Relative read abundance did not correlate to relative cell numbers. Although the species represented with the largest biomass was also proportionally most abundant among the reads, there was generally a weak correlation between proportional read abundance and proportional biomass of the different species, both with DNA and cDNA as template. The 454 sequencing generated considerable spurious diversity, and more with cDNA than DNA as template. With initial filtering based only on match with barcode and primer we observed 100-fold more operational taxonomic units (OTUs) at 99% similarity than the number of species present in the mock community. Filtering based on quality scores, or denoising with PyroNoise resulted in ten times more OTU99% than the number of species. Denoising with AmpliconNoise reduced the number of OTU99% to match the number of species present in the mock community. Based on our analyses, we propose a strategy to more accurately depict haptophyte diversity using 454 pyrosequencing.	[Egge, Elianne; Andersen, Tom; Edvardsen, Bente] Univ Oslo, Dept Biosci, Oslo, Norway; [Bittner, Lucie; Audic, Stephane; de Vargas, Colomban] CNRS, UMR7144, Roscoff, France; [Bittner, Lucie; Audic, Stephane; de Vargas, Colomban] UPMC, Stn Biol Roscoff, Roscoff, France; [Bittner, Lucie] Univ Kaiserslautern, Dept Ecol, D-67663 Kaiserslautern, Germany	University of Oslo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Kaiserslautern	Egge, E (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	e.s.egge@ibv.uio.no; bente.edvardsen@ibv.uio.no	Bittner, Lucie/ABF-4617-2020; Bittner, Lucie/AAD-8921-2019	Bittner, Lucie/0000-0001-8291-7063; de Vargas, Colomban/0000-0002-6476-6019; Edvardsen, Bente/0000-0002-6806-4807; Audic, Stephane/0000-0001-6193-4374	Norwegian Research Council [190307 HAPTODIV]; ASSEMBLE [227799]; EU	Norwegian Research Council(Research Council of NorwayEuropean Commission); ASSEMBLE; EU(European Commission)	Financial support was given by the Norwegian Research Council (www.forskningsradet.no), through grant 190307 HAPTODIV to ESE and BE, by ASSEMBLE (www.assemblemarine.org) FP7 grant agreement no 227799 (research stay for ESE at the SBR), and through the EU project BioMarKs (www.biomarks.eu) to LB, CdV and BE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bachy C, 2013, ISME J, V7, P244, DOI 10.1038/ismej.2012.106; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Binder BJ, 1998, APPL ENVIRON MICROB, V64, P3346; Bittner L, 2013, MOL ECOL, V22, P87, DOI 10.1111/mec.12108; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Dittami SM, 2012, J PHYCOL, V48, P1050, DOI 10.1111/j.1529-8817.2012.01183.x; DORTCH Q, 1983, MAR ECOL PROG SER, V13, P61, DOI 10.3354/meps013061; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edvardsen B, 2000, PHYCOLOGIA, V39, P19, DOI 10.2216/i0031-8884-39-1-19.1; Edvardsen B., 1998, NATO ASI Series Series G Ecological Sciences, V41, P193; Edvardsen B, 1998, PHYCOLOGIA, V37, P275, DOI 10.2216/i0031-8884-37-4-275.1; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; Eller G, 2007, J PLANKTON RES, V29, P629, DOI 10.1093/plankt/fbm045; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Eppley RW, 1967, J EXP MAR BIOL ECOL, V1, P208; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Graneli E, 2012, HARMFUL ALGAE, V14, P260, DOI 10.1016/j.hal.2011.10.024; Green JC, 1994, HAPTOPHYTE ALGAE; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Heywood JL, 2011, ISME J, V5, P674, DOI 10.1038/ismej.2010.155; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jacobs J, 2009, R FUNCTION RAREFACTI; John U, 2010, EUR J PHYCOL, V45, P215, DOI 10.1080/09670261003746193; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kauserud H, 2012, MYCORRHIZA, V22, P309, DOI 10.1007/s00572-011-0403-1; KJELDGAARD NO, 1963, J MOL BIOL, V6, P341, DOI 10.1016/S0022-2836(63)80093-5; Koid A, 2012, APPL ENVIRON MICROB, V78, P3958, DOI 10.1128/AEM.06941-11; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lange M, 1996, J PHYCOL, V32, P858, DOI 10.1111/j.0022-3646.1996.00858.x; Lekve K, 2006, P ROY SOC B-BIOL SCI, V273, P3047, DOI 10.1098/rspb.2006.3656; Lepere C, 2011, FEMS MICROBIOL ECOL, V76, P513, DOI 10.1111/j.1574-6941.2011.01072.x; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; Malin G, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P127; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; McDonald SM, 2007, AQUAT MICROB ECOL, V50, P75, DOI 10.3354/ame01148; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Medlin Linda K., 2010, Diversity, V2, P973, DOI 10.3390/d2070973; Nosenko T, 2007, J PHYCOL, V43, P763, DOI 10.1111/j.1529-8817.2007.00365.x; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pedros-Alio C, 2007, SCIENCE, V315, P192, DOI 10.1126/science.1135933; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R Development Core Team, 2012, R LANG ENV STAT COMP; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; TANG EPY, 1995, J PLANKTON RES, V17, P1325, DOI 10.1093/plankt/17.6.1325; Thomsen Helge A., 1994, Systematics Association Special Volume Series, V51, P187; Throndsen J., 1978, PHYTOPLANKTON MANUAL, P218; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; von Dassow P, 2008, J PHYCOL, V44, P335, DOI 10.1111/j.1529-8817.2008.00476.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wintzingerode F., 1997, MICROBIOLOGY REV, V21, P213, DOI DOI 10.1111/J.1574-6976.1997.TB00351.X.PUBMED:9451814	67	93	97	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74371	10.1371/journal.pone.0074371	http://dx.doi.org/10.1371/journal.pone.0074371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069303	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100103
J	de la Camara, CMF; Salom, D; Sequedo, MD; Hervas, D; Marin-Lambies, C; Aller, E; Jaijo, T; Diaz-LLopis, M; Millan, JM; Rodrigo, R				Martinez-Fernandez de la Camara, Cristina; Salom, David; Dolores Sequedo, Ma; Hervas, David; Marin-Lambies, Cristina; Aller, Elena; Jaijo, Teresa; Diaz-LLopis, Manuel; Maria Millan, Jose; Rodrigo, Regina			Altered Antioxidant-Oxidant Status in the Aqueous Humor and Peripheral Blood of Patients with Retinitis Pigmentosa	PLOS ONE			English	Article							CONE CELL-DEATH; EXTRACELLULAR-SUPEROXIDE DISMUTASE; CHRONIC INFLAMMATORY REACTION; OXIDATIVE STRESS; NITRIC-OXIDE; GLUTATHIONE-PEROXIDASE; RETINAL DEGENERATION; PHOTORECEPTOR CELLS; PLASMA-LEVELS; FLOW	Retinitis Pigmentosa is a common form of hereditary retinal degeneration constituting the largest Mendelian genetic cause of blindness in the developed world. It has been widely suggested that oxidative stress possibly contributes to its pathogenesis. We measured the levels of total antioxidant capacity, free nitrotyrosine, thiobarbituric acid reactive substances (TBARS) formation, extracellular superoxide dismutase (SOD3) activity, protein, metabolites of the nitric oxide/cyclic GMP pathway, heme oxygenase-I and inducible nitric oxide synthase expression in aqueous humor or/and peripheral blood from fifty-six patients with retinitis pigmentosa and sixty subjects without systemic or ocular oxidative stress-related disease. Multivariate analysis of covariance revealed that retinitis pigmentosa alters ocular antioxidant defence machinery and the redox status in blood. Patients with retinitis pigmentosa present low total antioxidant capacity including reduced SOD3 activity and protein concentration in aqueous humor. Patients also show reduced SOD3 activity, increased TBARS formation and upregulation of the nitric oxide/cyclic GMP pathway in peripheral blood. Together these findings confirmed the hypothesis that patients with retinitis pigmentosa present reduced ocular antioxidant status. Moreover, these patients show changes in some oxidative-nitrosative markers in the peripheral blood. Further studies are needed to clarify the relationship between these peripheral markers and retinitis pigmentosa.	[Martinez-Fernandez de la Camara, Cristina; Dolores Sequedo, Ma; Aller, Elena; Jaijo, Teresa; Maria Millan, Jose; Rodrigo, Regina] Hlth Res Inst La Fe, Valencia, Spain; [Salom, David; Marin-Lambies, Cristina; Diaz-LLopis, Manuel] La Fe Univ Hosp, Dept Ophthalmol, Valencia, Spain; [Hervas, David] Hlth Res Inst La Fe, Biostat Unit, Valencia, Spain; [Aller, Elena; Jaijo, Teresa; Maria Millan, Jose] Ctr Biomed Network Res Rare Dis CIBERER, Valencia, Spain; [Maria Millan, Jose] La Fe Univ Hosp, Genet Unit, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe); Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Rodrigo, R (corresponding author), Hlth Res Inst La Fe, Valencia, Spain.	regina.rodrigo@yahoo.es	Rodrigo, Regina/I-1868-2015; Salom, David/ABH-6567-2020; Hervas, David/L-1322-2016; Jaijo, Teresa/A-4801-2010; Martinez, Cristina/ABH-7295-2020; Aller, Elena/A-4803-2010	Rodrigo, Regina/0000-0001-5875-986X; Hervas, David/0000-0003-0635-4961; Martinez, Cristina/0000-0002-6612-6162; Aller, Elena/0000-0001-7973-5250; Jaijo, Teresa/0000-0003-0973-9146; Marin-Lambies, Cristina/0000-0002-2334-1313; Salom, David/0000-0002-6341-2905	European Regional Development Fund, Institute of Health Carlos III; Spanish Ministry of Science and Innovation (MICINN) [PI10/01825]; Institute of Health Carlos III [CP09/118]	European Regional Development Fund, Institute of Health Carlos III; Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institute of Health Carlos III(Instituto de Salud Carlos III)	This work was supported by the European Regional Development Fund, Institute of Health Carlos III and PI10/01825 from the Spanish Ministry of Science and Innovation (MICINN). CIBERER is an initiative of the Institute of Health Carlos III from the MICINN. Regina Rodrigo has a researcher-contract SNS Miguel Servet (CP09/118) from Institute of Health Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja-Jensen P, 2007, NEUROREPORT, V18, P797, DOI 10.1097/WNR.0b013e3280c1e344; Akeo K, 1999, PIGM CELL RES, V12, P107, DOI 10.1111/j.1600-0749.1999.tb00750.x; Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Ayuso C, 2010, GENOME MED, V2, DOI 10.1186/gm155; Bagnis A, 2012, EXP EYE RES, V103, P55, DOI 10.1016/j.exer.2012.07.011; BAZAN NG, 1994, J OCUL PHARMACOL, V10, P591, DOI 10.1089/jop.1994.10.591; Behndig A, 1998, INVEST OPHTH VIS SCI, V39, P471; Berson EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1306, DOI 10.1001/archopht.122.9.1306; Berson EL, 2012, ARCH OPHTHALMOL-CHIC, V130, P707, DOI 10.1001/archophthalmol.2011.2580; Beutelspacher SC, 2011, GRAEF ARCH CLIN EXP, V249, P1855, DOI 10.1007/s00417-011-1757-y; Break TJ, 2012, J IMMUNOL, V188, P3342, DOI 10.4049/jimmunol.1102341; Catala Angel, 2011, Front Biosci (Schol Ed), V3, P52, DOI 10.2741/s131; Romero CC, 2012, REV ESP SALUD PUBLIC, V86, P177; Cellini M, 2002, OPHTHALMOLOGICA, V216, P265, DOI 10.1159/000063841; Cellini M, 2010, CAN J PHYSIOL PHARM, V88, P630, DOI 10.1139/Y10-036; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dong A, 2006, J CELL PHYSIOL, V208, P516, DOI 10.1002/jcp.20683; Falsini B, 2011, INVEST OPHTH VIS SCI, V52, P1064, DOI 10.1167/iovs.10-5964; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; FLANAGAN JG, 1993, GRAEF ARCH CLIN EXP, V231, P465, DOI 10.1007/BF02044233; Frank RN, 1999, AM J OPHTHALMOL, V127, P694, DOI 10.1016/S0002-9394(99)00032-X; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Grunwald JE, 1996, AM J OPHTHALMOL, V122, P502, DOI 10.1016/S0002-9394(14)72109-9; Guo L, 1994, Yan Ke Xue Bao, V10, P224; HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Huberty C., 2006, APPL MANOVA DISCRIMI; Jung O, 2003, CIRC RES, V93, P622, DOI 10.1161/01.RES.0000092140.81594.A8; Kalloniatis Michael, 2004, Clin Exp Optom, V87, P65; Kassoff A, 1999, CONTROL CLIN TRIALS, V20, P573; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; KIMURA S, 1987, J IMMUNOL, V138, P4387; Komeima K, 2008, FREE RADICAL BIO MED, V45, P905, DOI 10.1016/j.freeradbiomed.2008.06.020; Komeima K, 2007, J CELL PHYSIOL, V213, P809, DOI 10.1002/jcp.21152; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; LANGHAM ME, 1990, EYE, V4, P374, DOI 10.1038/eye.1990.50; Lau LI, 2010, INVEST OPHTH VIS SCI, V51, P5486, DOI 10.1167/iovs.10-5663; Lee SY, 2011, J CELL PHYSIOL, V226, P1843, DOI 10.1002/jcp.22508; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; Mamo LB, 2004, AM J RESP CRIT CARE, V170, P313, DOI 10.1164/rccm.200309-1282OC; Mancino R, 2011, MOL VIS, V17, P1298; Massof RW, 2010, ARCH OPHTHALMOL-CHIC, V128, P493, DOI 10.1001/archophthalmol.2010.46; Minagawa I, 2012, BIOCHEM J, V441, P265, DOI 10.1042/BJ20111107; Ohguro H, 2010, CLIN OPHTHALMOL, V4, P569; PETERS RM, 1995, AM J CARDIOL, V76, P648, DOI 10.1016/S0002-9149(99)80190-8; Punzo C, 2012, J BIOL CHEM, V287, P1642, DOI 10.1074/jbc.R111.304428; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P5360, DOI 10.1167/iovs.07-0254; Rapp LM, 2000, INVEST OPHTH VIS SCI, V41, P1200; Rivera JC, 2011, NEONATOLOGY, V100, P343, DOI 10.1159/000330174; Rosenbaum PR, 2005, SENSITIVITY ANAL OBS; Salom D, 2008, INVEST OPHTH VIS SCI, V49, P3499, DOI 10.1167/iovs.07-1168; Sanz MM, 2007, NEUROSCIENCE, V145, P1120, DOI 10.1016/j.neuroscience.2006.12.034; SCHAUMBERGER M, 1995, INVEST OPHTH VIS SCI, V36, P1390; Schmidt KG, 2001, BRIT J OPHTHALMOL, V85, P678, DOI 10.1136/bjo.85.6.678; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; STANZIAL AM, 1991, J ENDOCRINOL INVEST, V14, P367, DOI 10.1007/BF03349085; Sun MH, 2007, INVEST OPHTH VIS SCI, V48, P5699, DOI 10.1167/iovs.07-0340; Usui S, 2011, FREE RADICAL BIO MED, V51, P1347, DOI 10.1016/j.freeradbiomed.2011.06.010; Usui S, 2009, MOL THER, V17, P778, DOI 10.1038/mt.2009.47; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; Vingolo EM, 2010, REGUL PEPTIDES, V160, P64, DOI 10.1016/j.regpep.2009.12.006; Wittes J, 2011, ARCH OPHTHALMOL-CHIC, V129, P675, DOI 10.1001/archophthalmol.2011.76; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Yoshida N, 2013, OPHTHALMOLOGY, V120, P100, DOI 10.1016/j.ophtha.2012.07.006; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018; Yu DY, 2004, INVEST OPHTH VIS SCI, V45, P2013, DOI 10.1167/iovs.03-0845	69	60	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74223	10.1371/journal.pone.0074223	http://dx.doi.org/10.1371/journal.pone.0074223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069283	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100091
J	Shen, J; Kassir, MA; Wu, JL; Zhang, Q; Zhou, SY; Xuan, SY; Li, QH; Ye, YQ; Hu, JN				Shen, Jing; Kassir, Mohammad A.; Wu, Jianlin; Zhang, Qing; Zhou, Shiyu; Xuan, Stephanie Y.; Li, Qinghang; Ye, Yongquan; Hu, Jiani			MR Volumetric Study of Piriform-Cortical Amygdala and Orbitofrontal Cortices: The Aging Effect	PLOS ONE			English	Article							OLFACTORY-BULB VOLUME; ODOR IDENTIFICATION; PARKINSONS-DISEASE; IN-VIVO; CORTEX; DISCRIMINATION; SCHIZOPHRENIA; DYSFUNCTION; DEMENTIA; SUGGEST	Introduction: The piriform cortex and cortical amygdala (PCA) and the orbitofrontal cortex (OFC) are considered olfactory-related brain regions. This study aims to elucidate the normal volumes of PCA and OFC of each age groups (20.0-70.0 year old), and whether the volumes of PCA and OFC decline with increasing age and diminishing olfactory function. Methods: One hundred and eleven healthy right-handed participants (54 males, 57 females), age 20.0 to 70.0 years were recruited to join this study after excluding all the major causes of olfactory dysfunction. Volumetric measurements of PCA and OFC were performed using consecutive 1-mm thick coronal slices of high-resolution 3-D MRIs. A validated olfactory function test (Sniffin' Sticks) assessed olfactory function, which measured odor threshold (THD), odor discrimination (DIS), and odor identification (ID) as well as their sum score (TDI). Results: The volume of OFC decreased with age and significantly correlated with age-related declines in olfactory function. The volume of OFC showed significant age-group differences, particularly after 40 years old (p < 0.001), while olfactory function decreased significantly after 60 years old (p < 0.001). Similar age-related volumetric changes were not found for PCA (p = 0.772). Additionally, there was significant correlation between OFC and DIS on the Right Side (p = 0.028) and between OFC and TDI on both sides (p < 0.05). There was no similar correlation for PCA. Conclusions: Aging can have a great impact on the volume of OFC and olfactory function while it has much smaller effect on the volume of PCA. The result could be useful to establish normal volumes of PCA and OFC of each age group to assess neurological disorders that affect olfactory function.	[Shen, Jing; Wu, Jianlin; Zhang, Qing] Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian 116012, Peoples R China; [Kassir, Mohammad A.; Ye, Yongquan; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Zhou, Shiyu] Dalian Med Univ, Dept Mental Hlth, Dalian, Peoples R China; [Xuan, Stephanie Y.] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada; [Li, Qinghang] Wayne State Univ, Dept Neurol Surg, Detroit, MI USA	Dalian University; Wayne State University; Dalian Medical University; University of Toronto; Wayne State University	Wu, JL (corresponding author), Dalian Univ, Affiliated Zhongshan Hosp, Dept Radiol, Dalian 116012, Peoples R China.	cjr.wujianlin@vip.163.com			National Natural Science Foundation of China [30470515, 30770768]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30470515 and No. 30770768). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolmaali ND, 2002, AM J NEURORADIOL, V23, P157; Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; CAIN WS, 1989, ANN NY ACAD SCI, V561, P29; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; Chase HW, 2008, NEUROPSYCHOLOGIA, V46, P1326, DOI 10.1016/j.neuropsychologia.2007.12.011; Crespo-Facorro B, 1999, NEUROIMAGE, V10, P500, DOI 10.1006/nimg.1999.0489; CURCIO CA, 1985, J COMP NEUROL, V235, P519, DOI 10.1002/cne.902350409; Delon-Martin C, 2013, NEUROIMAGE, V68, P55, DOI 10.1016/j.neuroimage.2012.11.044; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; DOTY RL, 1989, ANN NY ACAD SCI, V561, P76, DOI 10.1111/j.1749-6632.1989.tb20971.x; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Frasnelli J, 2010, EXP BRAIN RES, V201, P1, DOI 10.1007/s00221-009-1999-7; Gloor P., 1997, TEMPORAL LOBE LIMBIC; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Illig KR, 2005, J COMP NEUROL, V488, P224, DOI 10.1002/cne.20595; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Kareken DA, 2004, NEUROIMAGE, V22, P456, DOI 10.1016/j.neuroimage.2004.01.008; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kolb B, 1996, FUNDAMENTALS HUMAN N; Koritnik B, 2009, PULM PHARMACOL THER, V22, P97, DOI 10.1016/j.pupt.2008.10.009; Moscovich M, 2012, J NEUROL NEUROSUR PS, V83, P970, DOI 10.1136/jnnp-2012-302770; Mueller A, 2005, J NEURAL TRANSM, V112, P1363, DOI 10.1007/s00702-005-0280-x; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Negoias S, 2010, NEUROSCIENCE, V169, P415, DOI 10.1016/j.neuroscience.2010.05.012; Pardini M, 2009, ARCH NEUROL-CHICAGO, V66, P92, DOI 10.1001/archneurol.2008.521; Pereira PMG, 2005, AM J NEURORADIOL, V26, P319; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Seubert J, 2012, CEREB CORTEX; Shen J, 2012, MR VOLUMETRIC ANAL P; Shu CH, 2008, EUR ARCH OTO-RHINO-L, V265, P787, DOI 10.1007/s00405-007-0551-2; TANABE T, 1975, J NEUROPHYSIOL, V38, P1269, DOI 10.1152/jn.1975.38.5.1269; TANABE T, 1975, J NEUROPHYSIOL, V38, P1284, DOI 10.1152/jn.1975.38.5.1284; TUKEY JW, 1977, SCIENCE, V198, P679, DOI 10.1126/science.333584; Turetsky BI, 2000, AM J PSYCHIAT, V157, P828, DOI 10.1176/appi.ajp.157.5.828; Turkheimer F, 2000, NEUROIMAGE, V12, P219, DOI 10.1006/nimg.2000.0608; Wilson DA, 2010, NEUROBIOLOGY OLFACTI, P14; ZATORRE RJ, 1991, BRAIN, V114, P71; Zhou SY, 2007, SCHIZOPHR RES, V89, P35, DOI 10.1016/j.schres.2006.08.032; Zhou SY, 2005, PSYCHIAT RES-NEUROIM, V139, P127, DOI 10.1016/j.pscychresns.2005.05.005; Zhou SY, 2003, BIOL PSYCHIAT, V54, P427, DOI 10.1016/S0006-3223(03)00007-6	48	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74526	10.1371/journal.pone.0074526	http://dx.doi.org/10.1371/journal.pone.0074526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069317	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100109
J	Tsa, CH; Muo, CH; Tzeng, HE; Tang, CH; Hsu, HC; Sung, FC				Tsa, Chun-Hao; Muo, Chih-Hsin; Tzeng, Huey-En; Tang, Chih-Hsin; Hsu, Horng-Chang; Sung, Fung-Chang			Fracture in Asian Women with Breast Cancer Occurs at Younger Age	PLOS ONE			English	Article							BONE-MINERAL DENSITY; GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; ZOLEDRONIC ACID; OSTEOPOROTIC FRACTURES; ADJUVANT CHEMOTHERAPY; INTERGROUP EXEMESTANE; EARLY MENOPAUSE; OLDER WOMEN	Background: Western breast cancer survivors have an increased risk of osteoporosis and bone fracture. Breast cancer occurs 10 to 20 years earlier in Asian women than in Western women. We investigated if younger Asian women with breast cancer also have increased risk of fracture. Methods: We used the universal insurance claims data from 2000 to 2003 to identify 22,076 patients with breast cancer and 88,304 women without cancer, frequency matched with age and index date (the date for a health care visit). The incidence of fracture in both cohorts and the hazard ratios (HRs) of fracture in the cancer cohort were estimated by the end of 2009. Results: The incidence of all types of fracture was higher in the breast cancer cohort than in the comparison cohort (46.72 vs. 42.52 per 10,000 person-years), with adjusted HRs (aHRs) of 1.18 (95% confidence intervals [CI], 1.03-1.35) for hip fractures, 1.12 (95% CI, 0.98-1.28) for forearm fractures and 1.24 (95% CI, 1.04-1.48) for vertebral fractures. The aHRs were significant in both non-traumatic fractures (1.29; 95% CI, 1.11-1.51) and traumatic fractures (1.12; 95% CI, 1.01-1.23). The age-specific aHR was higher for younger breast cancer patients, and was significant for,50 years old patients in both traumatic (aHR 1.35; 95% CI 1.08-1.68) and non-traumatic (aHR, 1.72; 95% CI, 1.21-2.44) fractures. Conclusion: This study suggests that Asian women with breast cancer might have an increased risk of fracture.	[Tsa, Chun-Hao; Tzeng, Huey-En; Hsu, Horng-Chang] China Med Univ, Grad Inst Med, Taichung, Taiwan; [Tsa, Chun-Hao; Tang, Chih-Hsin; Hsu, Horng-Chang] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan; [Muo, Chih-Hsin; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Muo, Chih-Hsin; Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Tzeng, Huey-En] Taichung Vet Gen Hosp, Div Hematol Oncol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; China Medical University Taiwan	Sung, FC (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.	ritsai8615@gmail.com	Tang, Chih Hsin/O-5212-2015; Tsai, Chun-Hao/H-3140-2013	Tang, Chih Hsin/0000-0002-7113-8352; Tsai, Chun-Hao/0000-0002-4428-3132	Executive Yuan National Science Council [NSC 100-2621-M-039-001]; Department of Health [DOH100-TD-B-111-004, DOH100-TD-C-111-005]; China Medical University Hospital [1MS1]	Executive Yuan National Science Council; Department of Health; China Medical University Hospital	This study was supported in part by Executive Yuan National Science Council (Grant No. NSC 100-2621-M-039-001), the Department of Health (Grant Nos. DOH100-TD-B-111-004 and DOH100-TD-C-111-005), and the China Medical University Hospital (Grant No. 1MS1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami S, 2010, BONE, V46, P244, DOI 10.1016/j.bone.2009.10.011; Anderson BO, 2008, WORLD J SURG, V32, P2578, DOI 10.1007/s00268-007-9454-z; [Anonymous], 1997, OSTEOPOROS INT S3, V7, P1; Brufsky A, 2006, SEMIN ONCOL, V33, pS13, DOI 10.1053/j.seminoncol.2006.03.022; Cauley JA, 1996, JAMA-J AM MED ASSOC, V276, P1404, DOI 10.1001/jama.276.17.1404; Cauley JA, 2011, CLIN ORTHOP RELAT R, V469, P1891, DOI 10.1007/s11999-011-1863-5; Chen Z, 2005, ARCH INTERN MED, V165, P552, DOI 10.1001/archinte.165.5.552; Coleman RE, 2007, LANCET ONCOL, V8, P119, DOI 10.1016/S1470-2045(07)70003-7; Coleman RE, 2010, BREAST CANCER RES TR, V124, P153, DOI 10.1007/s10549-010-1121-7; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Fogelman I, 2003, OSTEOPOROSIS INT, V14, P1001, DOI 10.1007/s00198-003-1508-y; Gallagher JC, 2007, MENOPAUSE, V14, P567, DOI 10.1097/gme.0b013e31804c793d; Ganry O, 2001, BREAST, V10, P313, DOI 10.1054/brst.2000.0247; Gnant MFX, 2007, J CLIN ONCOL, V25, P820, DOI 10.1200/JCO.2005.02.7102; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; Gunter MJ, 2009, JNCI-J NATL CANCER I, V101, P48, DOI 10.1093/jnci/djn415; Hadji P, 2012, CANCER TREAT REV, V38, P798, DOI 10.1016/j.ctrv.2012.02.008; Hershman DL, 2010, J CLIN ENDOCR METAB, V95, P559, DOI 10.1210/jc.2009-1366; Honkanen K, 1999, AM J EPIDEMIOL, V150, P511; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Ismail AA, 2000, OSTEOPOROSIS INT, V11, P248, DOI 10.1007/s001980050288; Jacoby VL, 2011, ARCH INTERN MED, V171, P760, DOI 10.1001/archinternmed.2011.121; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kerlikowske K, 2005, J NATL CANCER I, V97, P368, DOI 10.1093/jnci/dji056; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Khan MN, 2008, CURR ONCOL, V15, pS30; Kim JE, 2011, BREAST CANCER RES TR, V125, P99, DOI 10.1007/s10549-010-1201-8; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Malpe R, 1997, J BONE MINER RES, V12, P423, DOI 10.1359/jbmr.1997.12.3.423; Neuner JM, 2011, OSTEOPOROSIS INT, V22, P2847, DOI 10.1007/s00198-010-1493-x; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; Newcomb PA, 2001, AM J EPIDEMIOL, V153, P1071, DOI 10.1093/aje/153.11.1071; Qiu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036497; Qu X, 2013, BREAST CANC RES TREA; Rabaglio M, 2009, ANN ONCOL, V20, P1489, DOI 10.1093/annonc/mdp033; Ramaswamy B, 2003, SEMIN ONCOL, V30, P763, DOI 10.1053/j.seminoncol.2003.08.028; Shuster LT, 2010, MATURITAS, V65, P161, DOI 10.1016/j.maturitas.2009.08.003; STEINBERG KK, 1991, JAMA-J AM MED ASSOC, V265, P1985, DOI 10.1001/jama.265.15.1985; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; van der Klift M, 2003, BONE, V32, P211, DOI 10.1016/S8756-3282(02)00972-9; Wen CP, 2005, TOB CONTROL, V14, pI51, DOI 10.1136/tc.2004.008011; Zhang YQ, 1997, NEW ENGL J MED, V336, P611, DOI 10.1056/NEJM199702273360903	42	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75109	10.1371/journal.pone.0075109	http://dx.doi.org/10.1371/journal.pone.0075109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069386	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100121
J	Toledano, N; Gur-Wahnon, D; Ben-Yehuda, A; Rachmilewitz, J				Toledano, Natan; Gur-Wahnon, Devorah; Ben-Yehuda, Adi; Rachmilewitz, Jacob			Novel CD47: SIRP alpha Dependent Mechanism for the Activation of STAT3 in Antigen-Presenting Cell	PLOS ONE			English	Article							SIGNAL-REGULATORY-PROTEIN; MESENCHYMAL STEM-CELLS; DENDRITIC CELLS; APOPTOTIC CELLS; T-CELL; NEGATIVE REGULATION; TUMOR-CELLS; TOLERANCE; INFLAMMATION; MATURATION	Cell surface CD47 interacts with its receptor, signal-regulatory-protein alpha (SIRP alpha) that is expressed predominantly on macrophages, to inhibit phagocytosis of normal, healthy cells. This "don't eat me" signal is mediated through tyrosine phosphorylation of SIRP alpha at the cytoplasmic ITIM motifs and the recruitment of the phosphatase, SHP-1. We previously revealed a novel mechanism for the activation of the STAT3 pathway and the regulation of human APC maturation and function that is based on cell: cell interaction. In this study, we present evidence supporting the notion that CD47: SIRP alpha serves as a cell surface receptor: ligand pair involved in this contact-dependent STAT3 activation and regulation of APC maturation. We show that upon co-culturing APC with various primary and tumor cell lines STAT3 phosphorylation and IL-10 expression are induced, and such regulation could be suppressed by specific CD47 siRNAs and shRNAs. Significantly, >50% reduction in CD47 expression abolished the contact-dependent inhibition of T cell activation. Furthermore, co-immunoprecipitation experiments revealed a physical association between SIRP alpha and STAT3. Thus, we suggest that in addition to signaling through the ITIM-SHP-1 complex that transmit an anti-phagocytotic, CD47: SIRP alpha also triggers STAT3 signaling that is linked to an immature APC phenotype and peripheral tolerance under steady state and pathological conditions.	[Toledano, Natan; Gur-Wahnon, Devorah; Ben-Yehuda, Adi; Rachmilewitz, Jacob] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Rachmilewitz, J (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	rjacob@cc.huji.ac.il			Israel Science Foundation (ISF) [337/08]	Israel Science Foundation (ISF)(Israel Science Foundation)	This research was supported by the Israel Science Foundation (ISF; grant No. 337/08). (www.isf.org.il). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 1998, J IMMUNOL, V161, P1853; Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Braun D, 2006, J IMMUNOL, V177, P8550, DOI 10.4049/jimmunol.177.12.8550; Cappellesso-Fleury S, J CLIN IMMUNOL, V30, P607; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gur-Wahnon D, 2007, EXP HEMATOL, V35, P426, DOI 10.1016/j.exphem.2006.11.001; Gur-Wahnon D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006846; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Lee WY, 2007, J IMMUNOL, V179, P7741, DOI 10.4049/jimmunol.179.11.7741; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; Nilsson A, 2009, BIOCHEM BIOPH RES CO, V387, P58, DOI 10.1016/j.bbrc.2009.06.121; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Roos A, 2004, EUR J IMMUNOL, V34, P921, DOI 10.1002/eji.200424904; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; Shortman K, 2001, NAT IMMUNOL, V2, P988, DOI 10.1038/ni1101-988; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Singh NJ, 2006, NAT CLIN PRACT RHEUM, V2, P44, DOI 10.1038/ncprheum0049; Stofega MR, 2000, J BIOL CHEM, V275, P28222; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Wang H, 2007, P NATL ACAD SCI USA, V104, P13744, DOI 10.1073/pnas.0702881104; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976	43	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75595	10.1371/journal.pone.0075595	http://dx.doi.org/10.1371/journal.pone.0075595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073274	gold, Green Published, Green Submitted			2022-12-27	WOS:000324768000084
J	Chai, W; Lian, ZJ; Chen, C; Liu, JY; Shi, LL; Wang, Y				Chai, Wei; Lian, Zijian; Chen, Chao; Liu, Jingyi; Shi, Lewis L.; Wang, Yan			JARID1A, JMY, and PTGER4 Polymorphisms Are Related to Ankylosing Spondylitis in Chinese Han Patients: A Case-Control Study	PLOS ONE			English	Article							PROGRESSION; COFACTOR	Susceptibility to ankylosing spondylitis (AS) is largely genetically determined. JARID1A, JMY and PTGER4 have recently been found to be associated with AS in patients of western European descent. We aim to examine the influence of JARID1A, JMY, and PTGER4 polymorphisms on the susceptibility to and the severity of ankylosing spondylitis in Chinese ethnic majority Han population. This work can lead the clinical doctors to intervene earlier. Blood samples were drawn from 396 AS patients and 404 unrelated healthy controls. Both the AS patients and the controls are Han Chinese. The AS patients are classified based on the severity of the disease. Thirteen tag single nucleotide polymorphisms (tagSNPs) in JARID1A, JMY and PTGER4 are selected and genotyped. Frequencies of different genotypes and alleles are analyzed among the different severity AS patients and the controls. The rs2284336 SNP in JARID1A, the rs16876619 and rs16876657 SNPs in JMY are associated with susceptibility of AS. The rs11062357 SNP in JARID1A, the rs2607142 SNP in JMY and rs10440635 in PTGER4 are related to severity of AS. Haplotype analyses indicate PTGER4 is related to susceptibility to AS; JARID1A and JMY are related to severity of AS.	[Chai, Wei; Wang, Yan] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing, Peoples R China; [Lian, Zijian; Chen, Chao] Tianjin Hosp, Dept Orthopaed, Tianjin, Peoples R China; [Liu, Jingyi; Wang, Yan] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Shi, Lewis L.] Univ Chicago Hosp, Dept Orthopaed, Chicago, IL 60637 USA	Chinese People's Liberation Army General Hospital; Nankai University; University of Chicago; University of Illinois System	Wang, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing, Peoples R China.	wangyaneasy@163.com		Chen, Chao/0000-0002-8397-4294	Natural Science Foundation of Beijing [7102146]	Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by the Natural Science Foundation of Beijing (7102146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOR B, 1994, J RHEUMATOL, V21, P1883; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Brown MA, 2002, CLIN EXP RHEUMATOL, V20, pS43; CALIN A, 1994, J RHEUMATOL, V21, P2281; CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186, DOI 10.1002/art.1780260210; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; Coutts AS, 2007, EMBO REP, V8, P84, DOI 10.1038/sj.embor.7400855; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gran JT, 1997, BRIT J RHEUMATOL, V36, P766; Hamersma J, 2001, ARTHRITIS RHEUM, V44, P1396, DOI 10.1002/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A; Kiaer T, 2010, EUR SPINE J, V19, P57, DOI 10.1007/s00586-009-1104-8; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pointon JJ, 2011, GENES IMMUN, V12, P395, DOI 10.1038/gene.2011.23; Prijatelj M, 2011, PROSTAG OTH LIPID M, V95, P19, DOI 10.1016/j.prostaglandins.2011.04.001; Robertson FM, 2010, CANCER-AM CANCER SOC, V116, P2806, DOI 10.1002/cncr.25167; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Soontrapa K, 2011, P NATL ACAD SCI USA, V108, P6668, DOI 10.1073/pnas.1018625108; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; *TASC, 2011, NATURE GENETICS; Tost J, 2005, CLIN BIOCHEM, V38, P335, DOI 10.1016/j.clinbiochem.2004.12.005; Van der Heijde DMFM, 2004, ANN RHEUM DIS, V63, P98; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74794	10.1371/journal.pone.0074794	http://dx.doi.org/10.1371/journal.pone.0074794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069348	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300046
J	Gaudart, J; Cloutman-Green, E; Guillas, S; D'Arcy, N; Hartley, JC; Gant, V; Klein, N				Gaudart, Jean; Cloutman-Green, Elaine; Guillas, Serge; D'Arcy, Nikki; Hartley, John C.; Gant, Vanya; Klein, Nigel			Healthcare Environments and Spatial Variability of Healthcare Associated Infection Risk: Cross-Sectional Surveys	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; STAPHYLOCOCCUS-AUREUS; SURFACES; HOSPITALS; STANDARDS; DESIGN; UNIT	Prevalence of healthcare associated infections remains high in patients in intensive care units (ICU), estimated at 23.4% in 2011. It is important to reduce the overall risk while minimizing the cost and disruption to service provision by targeted infection control interventions. The aim of this study was to develop a monitoring tool to analyze the spatial variability of bacteriological contamination within the healthcare environment to assist in the planning of interventions. Within three cross-sectional surveys, in two ICU wards, air and surface samples from different heights and locations were analyzed. Surface sampling was carried out with tryptic Soy Agar contact plates and Total Viable Counts (TVC) were calculated at 48hrs (incubation at 37 C). TVCs were analyzed using Poisson Generalized Additive Mixed Model for surface type analysis, and for spatial analysis. Through three cross-sectional survey, 370 samples were collected. Contamination varied from place-to-place, height-to-height, and by surface type. Hard-to-reach surfaces, such as bed wheels and floor area under beds, were generally more contaminated, but the height level at which maximal TVCs were found changed between cross-sectional surveys. Bedside locations and bed occupation were risk factors for contamination. Air sampling identified clusters of contamination around the nursing station and surface sampling identified contamination clusters at numerous bed locations. By investigating dynamic hospital wards, the methodology employed in this study will be useful to monitor contamination variability within the healthcare environment and should help to assist in the planning of interventions.	[Gaudart, Jean] Aix Marseille Univ, INSERM, IRD, SESSTIM UMR912, Marseille, France; [Gaudart, Jean; Guillas, Serge] UCL, Dept Stat Sci, London, England; [Cloutman-Green, Elaine; D'Arcy, Nikki; Hartley, John C.] Great Ormond St Hosp NHS Trust, Camelia Botnar Labs, Dept Microbiol, London, England; [Gant, Vanya] Univ Coll London Hosp, Dept Microbiol, London, England; [Klein, Nigel] UCL, Inst Child Hlth, Infect Dis & Microbiol Unit, London, England	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Gaudart, J (corresponding author), Aix Marseille Univ, INSERM, IRD, SESSTIM UMR912, Marseille, France.	jean.gaudart@univ-amu.fr	gaudart, jean/D-9071-2013; Guillas, Serge/A-2700-2012	gaudart, jean/0000-0001-9006-5729; Klein, Nigel/0000-0003-3925-9258; Cloutman-Green, Elaine/0000-0001-7534-3196; Guillas, Serge/0000-0002-3910-3408	Health and Care Infrastructure Research Centre; Engineering and Physical Sciences Research Council; National Institute of Health Research; National Institute for Health Research Biomedical Research Centre Funding Scheme at Great Ormond Street Hospital; Institute of Child Health; Association for the development of research in biology and medicine at the Department of Statistical Science University College London; EPSRC [EP/I029788/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I029788/1] Funding Source: researchfish; National Institute for Health Research [HCS/D10/010] Funding Source: researchfish	Health and Care Infrastructure Research Centre; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research Biomedical Research Centre Funding Scheme at Great Ormond Street Hospital; Institute of Child Health; Association for the development of research in biology and medicine at the Department of Statistical Science University College London; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was undertaken with funding provided by the Health and Care Infrastructure Research Centre supported by the Engineering and Physical Sciences Research Council. ECG received salary funding from the National Institute of Health Research during the course of this research. NK was supported in part by the National Institute for Health Research Biomedical Research Centre Funding Scheme at Great Ormond Street Hospital and the Institute of Child Health. JG received a research fellowship from the Association for the development of research in biology and medicine during his 2012 stay at the Department of Statistical Science University College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agvald-Ohman C, 2006, SCAND J INFECT DIS, V38, P441, DOI 10.1080/00365540600561751; Allegranzi B, 2011, REPORT BURDEN ENDEMI; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Augustin NH, 2012, COMPUT STAT DATA AN, V56, P2404, DOI 10.1016/j.csda.2012.01.026; Bartley J, 2010, CRIT CARE MED, V38, pS388, DOI 10.1097/CCM.0b013e3181e6d0c1; Bartley JM, 2010, AM J INFECT CONTROL, V38, pS1, DOI 10.1016/j.ajic.2010.04.195; Beggs CB, 2008, AM J INFECT CONTROL, V36, P250, DOI 10.1016/j.ajic.2007.07.012; Bogusz A., 2013, Healthcare Infection, V18, P3, DOI 10.1071/HI12063; Campos GB, 2012, NEW MICROBIOL, V35, P183; D'Arcy N, 2012, AEROBIOLOGIA, V28, P1, DOI [10.1007/s10453-011-9206-2, DOI 10.1007/S10453-011-9206-2]; Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030; Department of Health, 2006, HLTH ACT 2006 COD PR; Department of Health, 2007, SAV LIV RED INF DEL; Dettenkofer M, 2011, J HOSP INFECT, V77, P7, DOI 10.1016/j.jhin.2010.07.025; Frabetti A, 2009, AM J INFECT CONTROL, V37, P658, DOI 10.1016/j.ajic.2009.03.011; Griffith CJ, 2007, J HOSP INFECT, V66, P352, DOI 10.1016/j.jhin.2007.05.016; Griffith CJ, 2000, J HOSP INFECT, V45, P19, DOI 10.1053/jhin.1999.0717; Hathway EA, 2011, INDOOR BUILT ENVIRON, V22, P410; Health Protection Agency, 2012, ENGL NAT POINT PREV; HOLAH JT, 1988, J APPL BACTERIOL, V65, P215, DOI 10.1111/j.1365-2672.1988.tb01888.x; King MF, 2013, BUILD ENVIRON, V59, P436, DOI 10.1016/j.buildenv.2012.09.011; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lewis T, 2008, J HOSP INFECT, V69, P156, DOI 10.1016/j.jhin.2008.03.013; Marra AR, 2011, J CLIN MICROBIOL, V49, P1866, DOI 10.1128/JCM.00376-11; Mitt P, 2009, J HOSP INFECT, V71, P365, DOI 10.1016/j.jhin.2009.01.008; Moore G, 2013, INFECT CONT HOSP EP, V34, P500, DOI 10.1086/670219; Mulvey D, 2011, J HOSP INFECT, V77, P25, DOI 10.1016/j.jhin.2010.08.006; National Audit Office, 2009, RED HEALTHC ASS INF; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; White LF, 2008, AM J INFECT CONTROL, V36, P381, DOI 10.1016/j.ajic.2007.10.015; Wilson APR, 2011, CRIT CARE MED, V39, P651, DOI 10.1097/CCM.0b013e318206bc66; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374	35	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76249	10.1371/journal.pone.0076249	http://dx.doi.org/10.1371/journal.pone.0076249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069459	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300105
J	Jones, JO; Chin, SF; Wong-Taylor, LA; Leaford, D; Ponder, BAJ; Caldas, C; Maia, AT				Jones, James Owain; Chin, Suet-Feung; Wong-Taylor, Li-An; Leaford, Donna; Ponder, Bruce A. J.; Caldas, Carlos; Maia, Ana-Teresa			TOX3 Mutations in Breast Cancer	PLOS ONE			English	Article							EXPRESSION; SUSCEPTIBILITY; TRANSCRIPTION; SURVIVAL	TOX3 maps to 16q12, a region commonly lost in breast cancers and recently implicated in the risk of developing breast cancer. However, not much is known of the role of TOX3 itself in breast cancer biology. This is the first study to determine the importance of TOX3 mutations in breast cancers. We screened TOX3 for mutations in 133 breast tumours and identified four mutations (three missense, one in-frame deletion of 30 base pairs) in six primary tumours, corresponding to an overall mutation frequency of 4.5%. One potentially deleterious missense mutation in exon 3 (Leu129Phe) was identified in one tumour (genomic DNA and cDNA). Whilst copy number changes of 16q12 are common in breast cancer, our data show that mutations of TOX3 are present at low frequency in tumours. Our results support that TOX3 should be further investigated to elucidate its role in breast cancer biology.	[Jones, James Owain; Chin, Suet-Feung; Wong-Taylor, Li-An; Leaford, Donna; Ponder, Bruce A. J.; Caldas, Carlos; Maia, Ana-Teresa] Canc Res UK, Cambridge Res Inst, Cambridge, England; [Chin, Suet-Feung; Ponder, Bruce A. J.; Caldas, Carlos; Maia, Ana-Teresa] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England; [Caldas, Carlos] Li Ka Shing Ctr, Cambridge Expt Canc Med Ctr, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CRUK Cambridge Institute	Maia, AT (corresponding author), Univ Algarve, Dept Biomed Sci & Med, Regenerat Med Programme, Faro, Portugal.	atmaia@ualg.pt	Maia, Ana-Teresa/F-4404-2012; Caldas, Carlos/U-7250-2019	Maia, Ana-Teresa/0000-0002-0454-9207; Caldas, Carlos/0000-0003-3547-1489; Brown, Li-An/0000-0002-8261-0288; chin, suet-feung/0000-0001-5697-1082	Breast Cancer Research Foundation grant; University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre; Marie Curie Career Integration Grant; Cancer Research UK [16942] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	Breast Cancer Research Foundation grant; University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Marie Curie Career Integration Grant; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Breast Cancer Research Foundation grant to ATM and BAJP; the University of Cambridge, Cancer Research UK, Hutchison Whampoa Limited and NIHR Cambridge Biomedical Research Centre. ATM is supported by a Marie Curie Career Integration Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyault S, 2012, BREAST CANCER RES TR, V132, P29, DOI 10.1007/s10549-011-1518-y; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dittmer S, 2011, J CELL SCI, V124, P252, DOI 10.1242/jcs.068759; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gudmundsdottir ET, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-621; Maia AT, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2458; Naderi A, 2007, ONCOGENE, V26, P1507, DOI 10.1038/sj.onc.1209920; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Shan JX, 2013, CANCER RES, V73, P2840, DOI 10.1158/0008-5472.CAN-12-4313; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Udler MS, 2010, HUM MOL GENET; Yuan SH, 2009, P NATL ACAD SCI USA, V106, P2909, DOI 10.1073/pnas.0805555106	20	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74102	10.1371/journal.pone.0074102	http://dx.doi.org/10.1371/journal.pone.0074102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069272	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300028
J	Vrzal, R; Frauenstein, K; Proksch, P; Abel, J; Dvorak, Z; Haarmann-Stemmann, T				Vrzal, Radim; Frauenstein, Katrin; Proksch, Peter; Abel, Josef; Dvorak, Zdenek; Haarmann-Stemmann, Thomas			Khellin and Visnagin Differentially Modulate AHR Signaling and Downstream CYP1A Activity in Human Liver Cells	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; ARYLHYDROCARBON RECEPTOR; TRANSCRIPTIONAL REGULATION; CYTOCHROME-P450 1A1; MICE LACKING; SRC KINASE; REPRESSOR; DIOXIN; PHARMACOKINETICS; ACTIVATION	Khellin and visnagin are two furanochromones that can be frequently found in ethnomedical formulations in Asia and the Middle East. Both compounds possess anti-inflammatory and analgesic properties, therefore modern medicine uses these compounds or structurally related derivatives for treatment of vitiligo, bronchial asthma and renal colics. Despite their frequent usage, the potential toxic properties of visnagin and khellin are not well characterized up-to-now. Many natural compounds modulate the expression and activity of cytochrome P450 1A1 (CYP1A1), which is well-known to bioactivate pro-carcinogens. The expression of this enzyme is controlled by the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor and regulator of drug metabolism. Here, we investigated the influence of both furanochromones on AHR signaling in human HepG2 hepatocarcinoma cells and primary human hepatocytes. Both compounds transactivated xenobiotic response element (XRE)-driven reporter gene activity in a dose-dependent manner and induced CYP1A1 transcription in HepG2 cells and primary hepatocytes. The latter was abolished in presence of a specific AHR antagonist. CYP1A enzyme activity assays done in HepG2 cells and primary hepatocytes revealed an inhibition of enzyme activity by both furanochromones, which may become relevant regarding the metabolism of xenobiotics and co-administered therapeutic drugs. The observed induction of several other members of the AHR gene battery, whose gene products are involved in regulation of cell growth, differentiation and migration, indicates that a further toxicological characterization of visnagin and khelllin is urgently required in order to minimize potential drug-drug interactions and other toxic side-effects that may occur during therapeutic usage of these furanochromones.	[Vrzal, Radim; Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic; [Frauenstein, Katrin; Abel, Josef; Haarmann-Stemmann, Thomas] IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Proksch, Peter] Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, D-40225 Dusseldorf, Germany	Palacky University Olomouc; Leibniz Institut fur Umweltmedizinische Forschung (IUF); Heinrich Heine University Dusseldorf	Vrzal, R (corresponding author), Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic.	radim.vrzal@email.cz	Proksch, Peter/AAR-4593-2020	Dvorak, Zdenek/0000-0002-3938-3585	Grant Agency of Czech Republic [GACR 303/12/0472, GACR 303/12/G163]; Palacky University [PRF-2013-002]; Graduate School 1427 of the Deutsche Forschungsgemeinschaft (DFG)	Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Palacky University; Graduate School 1427 of the Deutsche Forschungsgemeinschaft (DFG)	This research was supported by the Grant Agency of Czech Republic GACR 303/12/0472 (RV) and GACR 303/12/G163 (ZD, RV), Student grant from Palacky University PRF-2013-002 (ZD, RV) and the Graduate School 1427 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel J, 2010, BIOL CHEM, V391, P1235, DOI 10.1515/BC.2010.128; Abu-Hashem AA, 2011, MOLECULES, V16, P1956, DOI 10.3390/molecules16031956; Aitchison KJ, 2000, J PSYCHOPHARMACOL, V14, P353, DOI 10.1177/026988110001400403; Atta SMS, 2010, EUR J MED CHEM, V45, P4920, DOI 10.1016/j.ejmech.2010.07.065; Baba T, 2001, J BIOL CHEM, V276, P33101, DOI 10.1074/jbc.M011497200; Baumgart A, 2005, BIOCHEM PHARMACOL, V69, P657, DOI 10.1016/j.bcp.2004.11.017; Chao HR, 2007, J HAZARD MATER, V149, P234, DOI 10.1016/j.jhazmat.2007.07.022; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; de Leeuw J, 2011, J EUR ACAD DERMATOL, V25, P74, DOI 10.1111/j.1468-3083.2010.03701.x; Dong B, 2008, MOL PHARMACOL, V74, P255, DOI 10.1124/mol.107.044669; DUARTE J, 1995, EUR J PHARMACOL, V286, P115, DOI 10.1016/0014-2999(95)00418-K; DUSCHET P, 1989, J AM ACAD DERMATOL, V21, P592, DOI 10.1016/S0190-9622(89)80248-8; Dvorak Z, 2008, BIOCHEM PHARMACOL, V75, P580, DOI 10.1016/j.bcp.2007.09.013; EDENHARDER R, 1995, MUTAT RES-GENET TOX, V345, P57, DOI 10.1016/0165-1218(95)90070-5; Fabricant DS, 2001, ENVIRON HEALTH PERSP, V109, P69, DOI 10.2307/3434847; Fernandez-Soria V, 2006, INT J ONCOL, V28, P143; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fritsche E, 2005, ENVIRON HEALTH PERSP, V113, P871, DOI 10.1289/ehp.7793; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; FUHR U, 1992, EUR J CLIN PHARMACOL, V42, P463; GROSSMAN SJ, 1993, DRUG METAB DISPOS, V21, P1029; Haarmann-Stemmann T, 2007, DRUG METAB DISPOS, V35, P2262, DOI 10.1124/dmd.107.016253; Haarmann-Stemmann T, 2006, BIOL CHEM, V387, P1195, DOI 10.1515/BC.2006.147; Haarmann-Stemmann T, 2010, ARCH TOXICOL, V84, P619, DOI 10.1007/s00204-010-0548-2; Haarmann-Stemmann T, 2009, BIOCHEM PHARMACOL, V77, P508, DOI 10.1016/j.bcp.2008.09.013; Hasa D, 2013, EUR J PHARM BIOPHARM, V84, P138, DOI 10.1016/j.ejpb.2012.11.025; Hasebe Y, 2003, BIOL PHARM BULL, V26, P1379, DOI 10.1248/bpb.26.1379; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; Ide F, 2004, CANCER LETT, V214, P35, DOI 10.1016/j.canlet.2004.04.014; Jux B, 2011, J INVEST DERMATOL, V131, P203, DOI 10.1038/jid.2010.269; Lee JK, 2010, ARCH PHARM RES, V33, P1843, DOI 10.1007/s12272-010-1117-1; Lee SK, 2007, ARCH PHARM RES, V30, P1629, DOI 10.1007/BF02977334; LU YF, 1995, ARCH BIOCHEM BIOPHYS, V316, P470, DOI 10.1006/abbi.1995.1062; Luecke S, 2010, PIGM CELL MELANOMA R, V23, P828, DOI 10.1111/j.1755-148X.2010.00762.x; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Modi BG, 2012, SCIENCE, V335, P104, DOI 10.1126/science.1211600; MORLIERE P, 1988, J INVEST DERMATOL, V90, P720, DOI 10.1111/1523-1747.ep13083852; Novotna A, 2011, ENVIRON SCI TECHNOL, V45, P10133, DOI 10.1021/es2029334; ORTEL B, 1988, J AM ACAD DERMATOL, V18, P693, DOI 10.1016/S0190-9622(88)70092-4; OSHER HL, 1951, NEW ENGL J MED, V244, P315, DOI 10.1056/NEJM195103012440901; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Park S, 2007, BIOCHEMISTRY-US, V46, P899, DOI 10.1021/bi061925f; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Ragab FAF, 2010, CHEM PHARM BULL, V58, P1148, DOI 10.1248/cpb.58.1148; Rapisarda A, 2012, ADV CANCER RES, V114, P237, DOI 10.1016/B978-0-12-386503-8.00006-5; RAUWALD HW, 1994, PLANTA MED, V60, P101, DOI 10.1055/s-2006-959426; Schimmer O, 1998, MUTAGENESIS, V13, P385, DOI 10.1093/mutage/13.4.385; SCOTT RC, 1951, CIRCULATION, V3, P80, DOI 10.1161/01.CIR.3.1.80; Seidel SD, 2000, TOXICOL SCI, V55, P107, DOI 10.1093/toxsci/55.1.107; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; Stejskalova L, 2011, CURR DRUG METAB, V12, P198, DOI 10.2174/138920011795016818; SUTTER TR, 1991, SCIENCE, V254, P415, DOI 10.1126/science.1925598; Ueng YF, 2005, J PHARM PHARMACOL, V57, P227, DOI 10.1211/0022357055489; Vanachayangkul P, 2011, UROL RES, V39, P189, DOI 10.1007/s00240-010-0333-y; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	57	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74917	10.1371/journal.pone.0074917	http://dx.doi.org/10.1371/journal.pone.0074917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069365	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300054
J	Kim, HJ; Son, ED; Jung, JY; Choi, H; Lee, TR; Shin, DW				Kim, Hyoung-June; Son, Eui Dong; Jung, Ji-Yong; Choi, Hyun; Lee, Tae Ryong; Shin, Dong Wook			Violet Light Down-Regulates the Expression of Specific Differentiation Markers through Rhodopsin in Normal Human Epidermal Keratinocytes	PLOS ONE			English	Article							BLUE-LIGHT; PROTEIN; PROLIFERATION; RADIATION; RPE65; ACTIVATION; MOLECULE; RECEPTOR; GROWTH; CELLS	Several recent reports have demonstrated that photoreceptors are expressed in human skin. The rod and cone photoreceptor-like proteins are expressed in human skin and rhodopsin, long wavelength-opsin, and short wavelength-opsin are also present in cultured murine melanocytes. Furthermore, the photopigment rhodopsin is expressed in human melanocytes and is involved in ultraviolet A phototransduction which induces early melanin synthesis. In this study, we investigated whether rhodopsin is expressed and plays any physiological roles in the normal human epidermal keratinocytes (NHEKs). We found that rhodopsin was expressed and localized on the plasma membrane in NHEKs, and only violet light among several wavelengths within the visible range significantly increased the expression of rhodopsin mRNA. We further found that rhodopsin over-expression decreased the mRNA expression levels of keratinocyte differentiation markers, such as keratin-1 and keratin-10, and violet light also decreased the mRNA expression levels of keratinocyte differentiation markers and these decreased expression levels were recovered by a rhodopsin-directed siRNA. Moreover, we further demonstrated that violet light significantly decreased the phosphorylation levels of cAMP responsive element-binding protein (CREB) and that it more effectively decreased the phosphorylation of CREB when rhodopsin was over-expressed. In addition, we observed that pertussis toxin, a G alpha(i) protein inhibitor, restored the rhodopsin-induced decrease in the differentiation markers in NHEKs. Taken together, these results suggest that rhodopsin down-regulates the expression levels of specific keratinocyte differentiation markers via the G alpha(i) signaling pathway in NHEKs.	[Kim, Hyoung-June; Son, Eui Dong; Jung, Ji-Yong; Choi, Hyun; Lee, Tae Ryong; Shin, Dong Wook] Amorepacific Corp R&D Ctr, Biosci Res Inst, Yongin, Gyeonggi Do, South Korea; [Kim, Hyoung-June] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea	Sungkyunkwan University (SKKU)	Lee, TR (corresponding author), Amorepacific Corp R&D Ctr, Biosci Res Inst, Yongin, Gyeonggi Do, South Korea.	TRLee@amorepacific.com; biopang@amorepacific.com						Albert PR, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-21; Albert PR, 2002, CELL SIGNAL, V14, P407, DOI 10.1016/S0898-6568(01)00259-5; Bikle DD, 2010, J BONE MINER METAB, V28, P117, DOI 10.1007/s00774-009-0153-8; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Denda M, 2008, J INVEST DERMATOL, V128, P1335, DOI 10.1038/sj.jid.5701168; El-Abaseri TB, 2006, CARCINOGENESIS, V27, P225, DOI 10.1093/carcin/bgi220; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Hinterhuber G, 2004, J INVEST DERMATOL, V122, P406, DOI 10.1046/j.0022-202X.2004.22216.x; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Horner TJ, 2005, J BIOL CHEM, V280, P28241, DOI 10.1074/jbc.M505117200; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; LAVKER RM, 1995, J AM ACAD DERMATOL, V32, P53, DOI 10.1016/0190-9622(95)90184-1; Lee JH, 2002, PHOTODERMATOL PHOTO, V18, P253, DOI 10.1034/j.1600-0781.2002.02755.x; Lewis JB, 2005, J BIOMED MATER RES B, V72B, P223, DOI 10.1002/jbm.b.30126; Liebmann J, 2010, J INVEST DERMATOL, V130, P259, DOI 10.1038/jid.2009.194; Mangmool S, 2011, TOXINS, V3, P884, DOI 10.3390/toxins3070884; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Miyashita Y, 2001, J INVEST DERM SYMP P, V6, P54, DOI 10.1046/j.0022-202x.2001.00018.x; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; Moore P, 2005, LASER SURG MED, V36, P8, DOI 10.1002/lsm.20117; Ohara M, 2003, INT J ONCOL, V22, P1291; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; SLOMINSKI A, 1993, J THEOR BIOL, V164, P103, DOI 10.1006/jtbi.1993.1142; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 1998, CLIN DERMATOL, V16, P503, DOI 10.1016/S0738-081X(98)00023-6; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; STRYER L, 1988, COLD SPRING HARB SYM, V53, P283, DOI 10.1101/SQB.1988.053.01.035; Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291; Tsutsumi M, 2009, EXP DERMATOL, V18, P567, DOI 10.1111/j.1600-0625.2009.00851.x; Wicks NL, 2011, CURR BIOL, V21, P1906, DOI 10.1016/j.cub.2011.09.047; Young AR, 1997, PHYS MED BIOL, V42, P789, DOI 10.1088/0031-9155/42/5/004	39	17	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73678	10.1371/journal.pone.0073678	http://dx.doi.org/10.1371/journal.pone.0073678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069221	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300020
J	Wang, H; Zheng, HH; Cao, JY; Zhou, WT; Yi, Y; Jia, ZY; Bi, SL				Wang, Hao; Zheng, Huihui; Cao, Jingyuan; Zhou, Wenting; Yi, Yao; Jia, Zhiyuan; Bi, Shengli			Genetic Diversity of Hepatitis A Virus in China: VP3-VP1-2A Genes and Evidence of Quasispecies Distribution in the Isolates	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; UNITED-STATES; CODON USAGE; OUTBREAK; VARIABILITY; CIRCULATION; MULTISTATE; INFECTION; EVOLUTIONARY; CONFIRMATION	Hepatitis A virus (HAV) is the most common cause of infectious hepatitis throughout the world, spread largely by the fecal-oral route. To characterize the genetic diversity of the virus circulating in China where HAV in endemic, we selected the outbreak cases with identical sequences in VP1-2A junction region and compiled a panel of 42 isolates. The VP3-VP1-2A regions of the HAV capsid-coding genes were further sequenced and analyzed. The quasispecies distribution was evaluated by cloning the VP3 and VP1-2A genes in three clinical samples. Phylogenetic analysis demonstrated that the same genotyping results could be obtained whether using the complete VP3, VP1, or partial VP1-2A genes for analysis in this study, although some differences did exist. Most isolates clustered in sub-genotype IA, and fewer in sub-genotype IB. No amino acid mutations were found at the published neutralizing epitope sites, however, several unique amino acid substitutions in the VP3 or VP1 region were identified, with two amino acid variants closely located to the immunodominant site. Quasispecies analysis showed the mutation frequencies were in the range of 7.22x10(-4)-2.33x10(-3) substitutions per nucleotide for VP3, VP1, or VP1-2A. When compared with the consensus sequences, mutated nucleotide sites represented the minority of all the analyzed sequences sites. HAV replicated as a complex distribution of closely genetically related variants referred to as quasispecies, and were under negative selection. The results indicate that diverse HAV strains and quasispecies inside the viral populations are presented in China, with unique amino acid substitutions detected close to the immunodominant site, and that the possibility of antigenic escaping mutants cannot be ruled out and needs to be further analyzed.	[Wang, Hao; Zheng, Huihui; Cao, Jingyuan; Zhou, Wenting; Yi, Yao; Jia, Zhiyuan; Bi, Shengli] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Cao, JY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	caojy@126.com; shengli_bi@163.com		Wang, Hao/0000-0001-9425-4666; Wang, Hao/0000-0001-7988-6120; Bi, Shengli/0000-0002-0380-5790	863 Hi-Tech Research and Development program of China [2011AA02A114]	863 Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China)	This study was supported by grant from the 863 Hi-Tech Research and Development program of China (2011AA02A114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LA, 2011, J MED VIROL, V83, P768, DOI 10.1002/jmv.22045; Amon JJ, 2005, J INFECT DIS, V192, P1323, DOI 10.1086/462425; Aragones L, 2008, J VIROL, V82, P1688, DOI 10.1128/JVI.01842-07; Belalov IS, 2011, J GEN VIROL, V92, P860, DOI 10.1099/vir.0.024786-0; Bialek SR, 2007, CLIN INFECT DIS, V44, P838, DOI 10.1086/511874; Cao JY, 2011, J MED VIROL, V83, P1134, DOI 10.1002/jmv.22086; Chudy M, 1999, J MED VIROL, V57, P91, DOI 10.1002/(SICI)1096-9071(199902)57:2&lt;91::AID-JMV1&gt;3.0.CO;2-L; Costa-Mattioli M, 2006, J GEN VIROL, V87, P115, DOI 10.1099/vir.0.81286-0; Costa-Mattioli M, 2003, J GEN VIROL, V84, P3191, DOI 10.1099/vir.0.19532-0; Costa-Mattioli M, 2002, J VIROL, V76, P9516, DOI 10.1128/JVI.76.18.9516-9525.2002; Costa-Mattioli M, 2001, J GEN VIROL, V82, P2647, DOI 10.1099/0022-1317-82-11-2647; Cristina J, 2007, VIRUS RES, V127, P151, DOI 10.1016/j.virusres.2007.01.005; Cui FQ, 2009, J EPIDEMIOL, V19, P189, DOI 10.2188/jea.JE20080087; De Serres G, 1999, J INFECT DIS, V179, P37, DOI 10.1086/314565; Desbois D, 2010, J CLIN MICROBIOL, V48, P3306, DOI 10.1128/JCM.00667-10; Hollinger FB., 2001, FIELDS VIROLOGY, P799; Hutin YJF, 1999, NEW ENGL J MED, V340, P595, DOI 10.1056/NEJM199902253400802; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Joshi MS, 2010, J MED VIROL, V82, P913, DOI 10.1002/jmv.21757; Klevens RM, 2010, ARCH INTERN MED, V170, P1811, DOI 10.1001/archinternmed.2010.401; Kulkarni MA, 2009, INFECT GENET EVOL, V9, P1287, DOI 10.1016/j.meegid.2009.08.009; Lam TTY, 2010, CRIT REV CL LAB SCI, V47, P5, DOI 10.3109/10408361003633318; Martin A, 2006, HEPATOLOGY, V43, pS164, DOI 10.1002/hep.21052; Moratorio G, 2007, J GEN VIROL, V88, P3039, DOI 10.1099/vir.0.83038-0; Nainan OV, 2006, CLIN MICROBIOL REV, V19, P63, DOI 10.1128/CMR.19.1.63-79.2006; Nainan OV, 2005, J INFECT DIS, V191, P957, DOI 10.1086/427992; NAINAN OV, 1992, VIROLOGY, V191, P984, DOI 10.1016/0042-6822(92)90277-V; NEI M, 1986, MOL BIOL EVOL, V3, P418; O'Donovan D, 2001, EPIDEMIOL INFECT, V127, P469, DOI 10.1017/S0950268801006185; Perez-Sautu U, 2011, J CLIN VIROL, V52, P98, DOI 10.1016/j.jcv.2011.06.011; Perez-Sautu U, 2011, EMERG INFECT DIS, V17, P734, DOI 10.3201/eid1704.101169; PING LH, 1992, J VIROL, V66, P2208, DOI 10.1128/JVI.66.4.2208-2216.1992; Pinto RM, 2007, VIRUS RES, V127, P158, DOI 10.1016/j.virusres.2007.04.010; ROBERTSON BH, 1992, J GEN VIROL, V73, P1365, DOI 10.1099/0022-1317-73-6-1365; Sanchez G, 2003, VIROLOGY, V315, P34, DOI 10.1016/S0042-6822(03)00483-5; Sanchez G, 2003, J VIROL, V77, P452, DOI 10.1128/JVI.77.1.452-459.2003; Sanchez G, 2002, J CLIN MICROBIOL, V40, P4148, DOI 10.1128/JCM.40.11.4148-4155.2002; Shieh YC, 2007, J FOOD PROTECT, V70, P145, DOI 10.4315/0362-028X-70.1.145; Sulbaran Y, 2010, J MED VIROL, V82, P1829, DOI 10.1002/jmv.21856; Tallon LA, 2008, APPL ENVIRON MICROB, V74, P6158, DOI 10.1128/AEM.02872-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wasley A, 2005, JAMA-J AM MED ASSOC, V294, P194, DOI 10.1001/jama.294.2.194; Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855; Zhu Y, 2012, EPIDEMIOL INFECT, V1, P1	44	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74752	10.1371/journal.pone.0074752	http://dx.doi.org/10.1371/journal.pone.0074752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069343	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300056
J	Zhao, N; Wang, XL; Zhang, Y; Gu, QH; Huang, F; Zheng, W; Li, ZW				Zhao, Ning; Wang, Xuelian; Zhang, Ying; Gu, Qiuhong; Huang, Fen; Zheng, Wei; Li, Zhiwei			Gestational Zinc Deficiency Impairs Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Offspring Mice	PLOS ONE			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; ORAL CHOLERA VACCINE; SERUM THYMIC-FACTOR; SUBUNIT-WHOLE-CELL; NUTRITIONAL-STATUS; ANTIBODY-RESPONSE; T-CELLS; SUPPLEMENTATION; CHILDREN; DEPRIVATION	Background: Gestational zinc deficiency has been confirmed to impair the infant immune function. However, knowledge about effects of maternal mild zinc deficiency during pregnancy on hepatitis B vaccine responsiveness in offspring is limited. In this report, we aimed to examine how maternal zinc deficiency during pregnancy influences humoral and cellular immune responses to hepatitis B vaccination in offspring of BALB/c mice. Methodology/Principal Findings: From day 1 of pregnancy upon delivery, maternal mice were given a standard diet (30 mg/kg/day zinc), zinc deficient diet (8 mg/kg/day zinc), or combination of zinc deficient diet (8 mg/kg/day zinc in the first 2 weeks of gestation) and zinc supplement diet (150 mg/kg/day zinc for the last week of pregnancy), respectively. Newborn pups of these maternal mice were immunized with hepatitis B vaccine at postnatal weeks 0, 2 and 4. Then, splenocytes and blood samples from the offspring mice were harvested for detection of serum zinc concentrations, humoral and cell-mediated immune responses, expression of cytokines using ELISA, CCK-8 and flow cytometric analysis. Results from the present study demonstrated that gestational zinc deficiency inhibited antibody responses, and decreased the proliferative capacity of T cells in offsprings immunized with hepatitis B vaccine. Additionally, HBsAg-specific cytokines analysis revealed that gestational zinc deficiency could inhibit secretion of IFN-gamma from splenocytes, and decrease IFN-gamma expression of CD4(+) and CD8(+) T cells. Conclusions/Significance: Gestational zinc deficiency can weaken the humoral and cell-mediated immune responses to hepatitis B vaccine via decreasing B cell counts and hepatitis B virus-specific immunoglobulin G production, as well as reducing T cell proliferation, CD4(+)/CD8(+) T cell ratio, and Th1-type immune responses.	[Zhao, Ning; Wang, Xuelian; Gu, Qiuhong; Huang, Fen; Li, Zhiwei] China Med Univ, Affiliated Hosp, Shengjing Hosp, Dept Infect Dis, Shenyang, Peoples R China; [Zhang, Ying] China Med Univ, Med Lab Technol Ctr, Div 3, Shenyang, Peoples R China; [Zheng, Wei] China Med Univ, Dept Pathophysiol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Li, ZW (corresponding author), China Med Univ, Affiliated Hosp, Shengjing Hosp, Dept Infect Dis, Shenyang, Peoples R China.	lizw@sj-hospital.org			Natural Science Foundation of China [81000468]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the Natural Science Foundation of China (No.81000468) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2009, VACCINE, V28, P422, DOI 10.1016/j.vaccine.2009.10.032; Albert MJ, 2003, J INFECT DIS, V187, P909, DOI 10.1086/368132; Armstrong Kia E, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P179, DOI 10.1177/1545109710368721; BEACH RS, 1983, AM J CLIN NUTR, V38, P579, DOI 10.1093/ajcn/38.4.579; BEACH RS, 1982, J NUTR, V112, P1169, DOI 10.1093/jn/112.6.1169; BEACH RS, 1982, SCIENCE, V218, P469, DOI 10.1126/science.7123244; BONOMINI M, 1993, NEPHROL DIAL TRANSPL, V8, P1166; Briefel RR, 2000, J NUTR, V130, p1367S, DOI 10.1093/jn/130.5.1367S; Campo CA, 2001, BIOL TRACE ELEM RES, V79, P15, DOI 10.1385/BTER:79:1:15; Caulfield LE, 1998, AM J CLIN NUTR, V68, p499S, DOI 10.1093/ajcn/68.2.499S; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Chen DS, 2009, J HEPATOL, V50, P805, DOI 10.1016/j.jhep.2009.01.002; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; Chou HY, 2010, J IMMUNOL, V185, P5468, DOI 10.4049/jimmunol.1001875; Cui FQ, 2010, VACCINE, V28, P5973, DOI 10.1016/j.vaccine.2010.06.111; DARDENNE M, 1982, P NATL ACAD SCI-BIOL, V79, P5370, DOI 10.1073/pnas.79.17.5370; DescampsLatscha B, 1996, SEMIN NEPHROL, V16, P183; DIENSTAG JL, 1984, ANN INTERN MED, V101, P34, DOI 10.7326/0003-4819-101-1-34; DUCHATEAU J, 1981, AM J MED, V70, P1001, DOI 10.1016/0002-9343(81)90849-4; Faber C, 2004, BONE MARROW TRANSPL, V33, P1241, DOI 10.1038/sj.bmt.1704509; FAVIER AE, 1992, BIOL TRACE ELEM RES, V32, P363, DOI 10.1007/BF02784623; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; FRAKER PJ, 1987, ARCH DERMATOL, V123, P1699, DOI 10.1001/archderm.123.12.1699; Guilbert J J, 2003, Educ Health (Abingdon), V16, P230; Guo CH, 2011, CLIN BIOCHEM, V44, P275, DOI 10.1016/j.clinbiochem.2010.12.017; Hodkinson CF, 2007, J GERONTOL A-BIOL, V62, P598, DOI 10.1093/gerona/62.6.598; Karlsen TH, 2003, INFECT IMMUN, V71, P3909, DOI 10.1128/IAI.71.7.3909-3913.2003; Kreft B, 2000, BIOGERONTOLOGY, V1, P61, DOI 10.1023/A:1010077622172; Lai CL, 2008, NEW ENGL J MED, V359, P2488, DOI 10.1056/NEJMe0808185; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Litjens NHR, 2008, J AM SOC NEPHROL, V19, P1483, DOI 10.1681/ASN.2007090971; Moore SE, 2003, ACTA PAEDIATR, V92, P170, DOI 10.1111/j.1651-2227.2003.tb00522.x; Ozgenc F, 2006, HEPATOL RES, V35, P26, DOI 10.1016/j.hepres.2006.01.012; PLEAU JM, 1980, P NATL ACAD SCI-BIOL, V77, P2861, DOI 10.1073/pnas.77.5.2861; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Qadri F, 2004, VACCINE, V22, P416, DOI 10.1016/j.vaccine.2003.07.005; Rahman F, 2000, HEPATOLOGY, V31, P521, DOI 10.1002/hep.510310237; Sari F, 2012, INT UROL NEPHROL, V44, P1501, DOI 10.1007/s11255-011-0043-6; Strand TA, 2003, INFECT IMMUN, V71, P2009, DOI 10.1128/IAI.71.4.2009-2013.2003; Turk S, 1998, INT J ARTIF ORGANS, V21, P274; Viviani S, 1999, VACCINE, V17, P2946, DOI 10.1016/S0264-410X(99)00178-4; Wellinghausen N, 2001, BRIT J NUTR, V85, pS81, DOI 10.1079/BJN2000298; Willis MS, 2005, AM J CLIN PATHOL, V123, P125, DOI 10.1309/V6GVYW2QTYD5C5PJ; Wuehler SE, 2005, PUBLIC HEALTH NUTR, V8, P812, DOI 10.1079/PHN2005724; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	46	17	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73461	10.1371/journal.pone.0073461	http://dx.doi.org/10.1371/journal.pone.0073461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069198	gold, Green Submitted, Green Published			2022-12-27	WOS:000324547300012
J	Fischer, HF; Binting, S; Bockelbrink, A; Heusser, P; Hueck, C; Keil, T; Roll, S; Witt, C				Fischer, H. Felix; Binting, Sylvia; Bockelbrink, Angelina; Heusser, Peter; Hueck, Christoph; Keil, Thomas; Roll, Stephanie; Witt, Claudia			The Effect of Attending Steiner Schools during Childhood on Health in Adulthood: A Multicentre Cross-Sectional Study	PLOS ONE			English	Article							ATOPIC SENSITIZATION; ALLERGIC DISEASE; LIFE-STYLE; CHILDREN; WHEEZE; ECZEMA	Background: It is speculated that attending Steiner schools, whose pedagogical principles include an account for healthy psycho-physical development, may have long-term beneficial health effects. We examined whether the current health status differed between former attendees of German Steiner schools and adults from the general population. Furthermore, we examined factors that might explain those differences. Methods: We included former Steiner school attendees from 4 schools in Berlin, Hanover, Nuremberg and Stuttgart and randomly selected population controls. Using a self-report questionnaire we assessed sociodemographics, current and childhood lifestyle and health status. Outcomes were self-reports on 16 diseases: atopic dermatitis, allergic rhinitis, bronchial asthma, chronic obstructive pulmonary disease (COPD), cardiac arrhythmia, cardiac insufficiency, angina pectoris, arteriosclerosis, hypertension, hypercholesterolemia, osteoarthritis, rheumatism, cancer, diabetes, depression and multiple sclerosis. Furthermore, participants rated the symptom burden resulting from back pain, cold symptoms, headache, insomnia, joint pain, gastrointestinal symptoms and imbalance. Unadjusted and adjusted odds ratios were calculated for each outcome. Results: 1136 Steiner school attendees and 1746 controls were eligible for analysis. Both groups were comparable regarding sex, age and region, but differed in nationality and educational status. After adjusting for possible confounders, we found statistically significant effects of Steiner school attendance for osteoarthritis (OR 0.69 [0.49-0.97]) and allergic rhinitis (OR 0.77, [0.59-1.00]) as well as for symptom burden from back pain (OR 0.80, [0.64-1.00]), insomnia (OR 0.65, [0.50-0.84]), joint pain (OR 0.62, [0.48-0.82]), gastrointestinal symptoms (OR 0.76, [0.58-1.00]) and imbalance (OR 0.60, [0.38-0.93]). Conclusions: The risk of most examined diseases did not differ between former Steiner school attendees and the general population after adjustment for sociodemographics, current and childhood lifestyle features, but symptom burden from some current health complaints was reported less by former Steiner school attendees. Results must be interpreted with caution since the analysis was exploratory.	[Fischer, H. Felix; Binting, Sylvia; Bockelbrink, Angelina; Keil, Thomas; Roll, Stephanie; Witt, Claudia] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Heusser, Peter] Univ Witten Herdecke, Fac Hlth, Chair Theory Med Integrat & Anthroposoph Med, Witten, Germany; [Hueck, Christoph] Freie Hsch Stuttgart, Seminar Waldorfpadag, Stuttgart, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Witten Herdecke University	Fischer, HF (corresponding author), Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.	felix.fischer@charite.de	Binting, Sylvia/AAU-8682-2021; fischer, felix/AAW-6634-2021; Witt, Claudia M./AAX-2370-2021; Fischer, Felix/AAF-2612-2020	Binting, Sylvia/0000-0003-4241-0924; fischer, felix/0000-0002-9693-6676; Witt, Claudia M./0000-0002-5440-7805; Roll, Stephanie/0000-0003-1191-3289	Verein zur Forderung der Freien Hochschule Stuttgart e.V. [1605 FPG]	Verein zur Forderung der Freien Hochschule Stuttgart e.V.	The study was founded by "Verein zur Forderung der Freien Hochschule Stuttgart e.V.", file: 1605 FPG (http://www.freie-hochschule-stuttgart.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x; Alm JS, 1999, LANCET, V353, P1485, DOI 10.1016/S0140-6736(98)09344-1; Bund der Freien Waldorfschulen, 2011, BUND FREIEN WALD JAH; Bussing A, 2007, ABSOLVENTEN WALDORFS; Ellert U, 2006, TELEFONISCHER GESUND; Floistrup H, 2006, J ALLERGY CLIN IMMUN, V117, P59, DOI 10.1016/j.jaci.2005.09.039; Heusser P, 2002, GESUNDHEITSFORDERUNG, V6, P101; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Kummeling I, 2007, PEDIATRICS, V119, pE367, DOI 10.1542/peds.2006-1479; Kummeling I, 2007, PEDIATRICS, V119, pE225, DOI 10.1542/peds.2006-0896; Kurth BM, 2012, BUNDESGESUNDHEITSBLA, V55, P980, DOI 10.1007/s00103-012-1504-5; Kurth BM, 2009, BUNDESGESUNDHEITSBLA, V52, P557, DOI 10.1007/s00103-009-0843-3; Loebell P, 2007, ABSOLVENTEN WALDORFS, P323; Marti T, 2009, GESUNDHEIT VIER BIS; Nielsen Thomas., 2004, R STEINERS PEDAGOGY R STEINERS PEDAGOGY; R Core Team, 2018, R LANG ENV STAT COMP; Robert-Koch-Institute, 2009, DEGS STUD GES ERW DE; Rosenlund H, 2009, PEDIATRICS, V123, P771, DOI 10.1542/peds.2008-0013; Sekretariat der Standigen Konferenz der Kultusminister der Lander in der Bundesrepublik Deutschland, 2011, SCHUL KLASS LEHR ABS; Steiner R, 2006, UNTERRICHT ERZIEHUNG; Stenius F, 2011, ALLERGY, V66, P1330, DOI 10.1111/j.1398-9995.2011.02662.x; Stenius F, 2010, PSYCHONEUROENDOCRINO, V35, P1431, DOI 10.1016/j.psyneuen.2010.05.010; van Buuren S, 2011, J STAT SOFTW, V45, P1; Zdrazil T, 2000, THESIS	24	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73135	10.1371/journal.pone.0073135	http://dx.doi.org/10.1371/journal.pone.0073135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069175	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100031
J	Lachance, C; Wojewodka, G; Skinner, TAA; Guilbault, C; De Sanctis, JB; Radzioch, D				Lachance, Claude; Wojewodka, Gabriella; Skinner, Tom A. A.; Guilbault, Claudine; De Sanctis, Juan B.; Radzioch, Danuta			Fenretinide Corrects the Imbalance between Omega-6 to Omega-3 Polyunsaturated Fatty Acids and Inhibits Macrophage Inflammatory Mediators via the ERK Pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ALPHA-MESSENGER-RNA; 3'-UNTRANSLATED REGION; CERAMIDE DEFICIENCY; MURINE MACROPHAGES; NECROSIS; TRISTETRAPROLIN; EXPRESSION; STABILITY; BINDING	We previously identified Fragile X-related protein 1 (FXR1) as an RNA-binding protein involved in the post-transcriptional control of TNF and other cytokines in macrophages. Macrophages derived from FXR1-KO mice overexpress several inflammatory cytokines including TNF. Recently, we showed that fenretinide (4HPR) is able to inhibit several inflammatory cytokines in the lungs of cystic fibrosis mice, which also have abnormal immune responses. Therefore, we hypothesized that 4HPR might also be able to downregulate excessive inflammation even in macrophages with ablated FXR1. Indeed, our results demonstrate that 4HPR inhibited the excessive production of inflammatory mediators, including TNF, IL-6, CCL2 and CCL-5 in LPS-stimulated FXR1-KO macrophages, by selectively inhibiting phosphorylation of ERK1/2, which is naturally more phosphorylated in FXR1-KO cells. We also found that LPS stimulation of FXR1-KO macrophages led to significantly higher ratio of arachidonic acid/docosahexaenoic acid than observed in FXR1-WT macrophages. Interestingly, treatment with 4HPR was associated with the normalization of arachidonic acid/docosahexaenoic acid ratio in macrophages, which we found to impact phosphorylation of ERK1/2. Overall, this study shows for the first time that 4HPR modulates inflammatory cytokine expression in macrophages by correcting a phospholipid-bound fatty acid imbalance that impacts the phosphorylation of ERK1/2.	[Lachance, Claude; Wojewodka, Gabriella; Skinner, Tom A. A.; Guilbault, Claudine; Radzioch, Danuta] McGill Univ, Dept Med, Montreal, PQ, Canada; [Lachance, Claude; Wojewodka, Gabriella; Skinner, Tom A. A.; Guilbault, Claudine; Radzioch, Danuta] McGill Univ, Ctr Hlth, Res Inst, Dept Human Genet, Montreal, PQ, Canada; [De Sanctis, Juan B.] Cent Univ Venezuela, Inst Immunol, Caracas, Venezuela	McGill University; McGill University; University of Central Venezuela	Radzioch, D (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	danuta.radzioch@mcgill.ca		Radzioch, Danuta/0000-0002-1601-2757; De Sanctis, Juan/0000-0002-5480-4608	Canadian Cystic Fibrosis Foundation [216714(DR)]; Natural Sciences and Engineering Research Council of Canada [201406]; Canadian Institute of Health Research; Universidad Central de Venezuela/CDCH grant [ICC09-0219-2008]; FRSQ; CIHR	Canadian Cystic Fibrosis Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Universidad Central de Venezuela/CDCH grant; FRSQ(Fonds de la Recherche en Sante du Quebec); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Cystic Fibrosis Foundation grant (216714(DR)), Natural Sciences and Engineering Research Council of Canada grant (NSERC (201406)), Canadian Institute of Health Research grant (CIHR- Proof of Principle 1), and Universidad Central de Venezuela/CDCH grant (ICC09-0219-2008). C. L. was a recipient of a Doctoral Scholarship from FRSQ. G. W. was a recipient of a Doctoral Scholarship from CIHR. T. A. S. was a recipient of a Master Scholarship from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carter AB, 1999, AM J RESP CELL MOL, V20, P751, DOI 10.1165/ajrcmb.20.4.3420; de Oca MM, 2008, CHEST, V133, P13, DOI 10.1378/chest.07-1592; Dean JLE, 2002, BIOCHEM J, V366, P709, DOI 10.1042/BJ20020402; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Di Marco S, 2001, NUCLEIC ACIDS RES, V29, P863, DOI 10.1093/nar/29.4.863; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garnon J, 2005, J BIOL CHEM, V280, P5750, DOI 10.1074/jbc.M401988200; GEPPERT TD, 1994, MOL MED, V1, P93; Guilbault C, 2008, AM J RESP CELL MOL, V38, P47, DOI 10.1165/rcmb.2007-0036OC; Guilbault C, 2009, AM J RESP CELL MOL, V41, P100, DOI 10.1165/rcmb.2008-0279OC; HAMBLETON J, 1995, J EXP MED, V182, P147, DOI 10.1084/jem.182.1.147; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Jang BC, 2000, J BIOL CHEM, V275, P39507, DOI 10.1074/jbc.M003224200; Katsanou V, 2007, ERNST SCHERING FOUND, V4, P37, DOI 10.1007/2789_2007_038; Kim JY, 2005, IMMUNOGENETICS, V57, P297, DOI 10.1007/s00251-005-0800-8; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lachance C, 2007, FEMS IMMUNOL MED MIC, V51, P422, DOI 10.1111/j.1574-695X.2007.00317.x; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo CJ, 2000, JPEN-PARENTER ENTER, V24, P159, DOI 10.1177/0148607100024003159; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Lykkesfeldt J, 2007, CLIN CHIM ACTA, V380, P50, DOI 10.1016/j.cca.2007.01.028; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Maurer BJ, 1999, JNCI-J NATL CANCER I, V91, P1138, DOI 10.1093/jnci/91.13.1138; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Osone S, 2004, INT J CANCER, V112, P219, DOI 10.1002/ijc.20412; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Saeed Z, 2008, J CYST FIBROS, V7, P222, DOI 10.1016/j.jcf.2007.09.001; SCHLENK H, 1960, ANAL CHEM, V32, P1412, DOI 10.1021/ac60167a011; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Sun HG, 2011, CARCINOGENESIS, V32, P1518, DOI 10.1093/carcin/bgr132; TAYLOR GA, 1995, J BIOL CHEM, V270, P13341, DOI 10.1074/jbc.270.22.13341; Vilela RM, 2006, INT IMMUNOPHARMACOL, V6, P1651, DOI 10.1016/j.intimp.2006.06.012; Weldon SM, 2007, J NUTR BIOCHEM, V18, P250, DOI 10.1016/j.jnutbio.2006.04.003; Ye YZ, 1996, METHOD ENZYMOL, V269, P201	52	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74875	10.1371/journal.pone.0074875	http://dx.doi.org/10.1371/journal.pone.0074875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069363	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100117
J	Zhang, GB; Liu, G; Zhang, Y; Ma, J; Xu, H; Yagi, K				Zhang, Guangbin; Liu, Gang; Zhang, Yi; Ma, Jing; Xu, Hua; Yagi, Kazuyuki			Methanogenic Pathway and Fraction of CH4 Oxidized in Paddy Fields: Seasonal Variation and Effect of Water Management in Winter Fallow Season	PLOS ONE			English	Article							CARBON-ISOTOPE FRACTIONATION; 16S RIBOSOMAL-RNA; RICE FIELD; METHANE OXIDATION; STABLE-ISOTOPE; SOIL MICROCOSMS; FERRIC IRON; EMISSION; ROOTS; HYDROGEN	A 2-year field and incubation experiment was conducted to investigate delta C-13 during the processes of CH4 emission from the fields subjected to two water managements (flooding and drainage) in the winter fallow season, and further to estimate relative contribution of acetate to total methanogenesis (F-ac) and fraction of CH4 oxidized (F-ox) based on the isotopic data. Compared with flooding, drainage generally caused CH4, either anaerobically or aerobically produced, depleted in C-13. There was no obvious difference between the two in transport fractionation F(ac)tor (epsilon(transport)) and delta C-13-value of emitted CH4. CH4 emission was negatively related to its delta C-13-value in seasonal variation (P<0.01). Acetate-dependent methanogenesis in soil was dominant (60-70%) in the late season, while drainage decreased F-ac-value by 5-10%. On roots however, CH4 was mostly produced through H-2/CO2 reduction (60-100%) over the season. CH4 oxidation mainly occurred in the first half of the season and roughly 10-90% of the CH4 was oxidized in the rhizosphere. Drainage increased F-ox-value by 5-15%, which is possibly attributed to a significant decrease in production while no simultaneous decrease in oxidation. Around 30-70% of the CH4 was oxidized at the soil-water interface when CH4 in pore water was released into floodwater, although the amount of CH4 oxidized therein might be negligible relative to that in the rhizosphere. CH4 oxidation was also more important in the first half of the season in lab conditions and about 5-50% of the CH4 was oxidized in soil while almost 100% on roots. Drainage decreased F-ox-value on roots by 15% as their CH4 oxidation potential was highly reduced. The findings suggest that water management in the winter fallow season substantially affects F-ac in the soil and F-ox in the rhizosphere and roots rather than F-ac on roots and F-ox at the soil-water interface.	[Zhang, Guangbin; Liu, Gang; Zhang, Yi; Ma, Jing; Xu, Hua] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Liu, Gang; Zhang, Yi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yagi, Kazuyuki] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Institute for Agro-Environmental Sciences (NIAES) Japan	Xu, H (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	hxu@issas.ac.cn	zhang, guangbin/M-1698-2015	zhang, guangbin/0000-0002-9651-6110	Chinese Academy of Sciences [XDA05020200]; National Natural Sciences Foundation of China [41071169]; Ministry of Science and Technology of China [S2012GR0080]; Special Fund for Agro-scientific Research in the Public Interest [201103039]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Special Fund for Agro-scientific Research in the Public Interest	This research work was financially supported by the "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences (XDA05020200), the National Natural Sciences Foundation of China (41071169), the Ministry of Science and Technology of China (S2012GR0080), and the Special Fund for Agro-scientific Research in the Public Interest (201103039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto M., 2000, CHEMOSPHERE GLOBAL C, V2, P57, DOI DOI 10.1016/S1465-9972(99)00044-6; Bender M, 1995, SOIL BIOL BIOCHEM, V27, P1517, DOI 10.1016/0038-0717(95)00104-M; Bergamaschi P, 1997, J GEOPHYS RES-ATMOS, V102, P25383, DOI 10.1029/97JD01664; Bilek RS, 1999, GLOBAL BIOGEOCHEM CY, V13, P1029, DOI 10.1029/1999GB900040; Blair NE, 1993, CARBON ISOTOPE BIOGE, V1, P574; Bosse U, 1997, APPL ENVIRON MICROB, V63, P1199, DOI 10.1128/AEM.63.4.1199-1207.1997; Botz R, 1996, ORG GEOCHEM, V25, P255, DOI 10.1016/S0146-6380(96)00129-5; Cai ZC, 1999, SOIL BIOL BIOCHEM, V31, P715, DOI 10.1016/S0038-0717(98)00170-9; Cai ZC, 2000, J GEOPHYS RES-ATMOS, V105, P17231, DOI 10.1029/2000JD900014; Cao YaCheng, 2008, Acta Pedologica Sinica, V45, P249; Chanton J, 2000, GLOBAL BIOGEOCHEM CY, V14, P51, DOI 10.1029/1999GB900087; Chanton JP, 2008, ENVIRON SCI TECHNOL, V42, P7818, DOI 10.1021/es801221y; Chanton JP, 2005, ORG GEOCHEM, V36, P753, DOI 10.1016/j.orggeochem.2004.10.007; Chen HuiZhe, 2007, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V15, P34; Chidthaisong A, 2000, FEMS MICROBIOL ECOL, V31, P73, DOI 10.1111/j.1574-6941.2000.tb00673.x; COLEMAN DD, 1981, GEOCHIM COSMOCHIM AC, V45, P1033, DOI 10.1016/0016-7037(81)90129-0; Conrad R, 1999, FEMS MICROBIOL ECOL, V28, P193, DOI 10.1016/S0168-6496(98)00086-5; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 2005, SOIL BIOL BIOCHEM, V37, P2099, DOI 10.1016/j.soilbio.2005.03.012; Conrad R, 2005, BIOGEOCHEMISTRY, V73, P381, DOI 10.1007/s10533-004-0366-9; Conrad R, 2002, CHEMOSPHERE, V47, P797, DOI 10.1016/S0045-6535(02)00120-0; CONRAD R, 1991, BIOL FERT SOILS, V12, P28, DOI 10.1007/BF00369384; Conrad R, 2012, SOIL BIOL BIOCHEM, V49, P193, DOI 10.1016/j.soilbio.2012.02.030; Dan JG, 2001, AGR ECOSYST ENVIRON, V83, P191, DOI 10.1016/S0167-8809(00)00265-6; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Fey A, 2004, GEOCHIM COSMOCHIM AC, V68, P293, DOI 10.1016/S0016-7037(03)00426-5; Frenzel P, 1999, SOIL BIOL BIOCHEM, V31, P421, DOI 10.1016/S0038-0717(98)00144-8; GILBERT B, 1995, BIOL FERT SOILS, V20, P93, DOI 10.1007/BF00336586; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P960; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P4983; HAYES JM, 1993, MAR GEOL, V113, P111, DOI 10.1016/0025-3227(93)90153-M; [何春林 He Chunlin], 2003, [农业现代化研究, Research of Agricultural Modernization], V24, P452; HOLZAPFELPSCHORN A, 1986, PLANT SOIL, V92, P223, DOI 10.1007/BF02372636; Horz HP, 2001, APPL ENVIRON MICROB, V67, P4177, DOI 10.1128/AEM.67.9.4177-4185.2001; Kimura M, 2004, SOIL BIOL BIOCHEM, V36, P1399, DOI 10.1016/j.soilbio.2004.03.006; Kruger M, 2003, GLOBAL CHANGE BIOL, V9, P773, DOI 10.1046/j.1365-2486.2003.00576.x; Kruger M, 2002, GLOBAL CHANGE BIOL, V8, P265, DOI 10.1046/j.1365-2486.2002.00476.x; Kruger M, 2001, GLOBAL CHANGE BIOL, V7, P49, DOI 10.1046/j.1365-2486.2001.00395.x; Kumaraswamy S, 1997, PLANT SOIL, V191, P241, DOI 10.1023/A:1004274302326; Lassey KR, 2000, GLOBAL BIOGEOCHEM CY, V14, P41, DOI 10.1029/1999GB900094; Lehmann-Richter S, 1999, ENVIRON MICROBIOL, V1, P159; Liptay K, 1998, J GEOPHYS RES-ATMOS, V103, P8243, DOI 10.1029/97JD02630; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Lu YH, 2005, ENVIRON MICROBIOL, V7, P326, DOI 10.1111/j.1462-2920.2005.00697.x; Ma J, 2009, SOIL BIOL BIOCHEM, V41, P1022, DOI 10.1016/j.soilbio.2009.01.024; Ma K, 2012, APPL ENVIRON MICROB, V78, P445, DOI 10.1128/AEM.06934-11; Ma K, 2011, FEMS MICROBIOL ECOL, V75, P446, DOI 10.1111/j.1574-6941.2010.01018.x; Marik T, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001428; Nakagawa F, 2002, BIOGEOCHEMISTRY, V61, P1, DOI 10.1023/A:1020270032512; PAVLOSTATHIS SG, 1991, WATER SCI TECHNOL, V24, P35, DOI 10.2166/wst.1991.0217; Sass RL, 1992, GLOBAL BIOGEOCHEM CY, V6, P249, DOI 10.1029/92GB01674; SCHUTZ H, 1989, BIOGEOCHEMISTRY, V7, P33, DOI 10.1007/BF00000896; Sigren LK, 1997, GLOBAL BIOGEOCHEM CY, V11, P151, DOI 10.1029/97GB00627; STEVENS CM, 1988, J GEOPHYS RES-ATMOS, V93, P725, DOI 10.1029/JD093iD01p00725; SUGIMOTO A, 1993, GEOCHIM COSMOCHIM AC, V57, P4015, DOI 10.1016/0016-7037(93)90350-6; Towprayoon S, 2005, CHEMOSPHERE, V59, P1547, DOI 10.1016/j.chemosphere.2005.02.009; Tyler SC, 1997, GLOBAL BIOGEOCHEM CY, V11, P323, DOI 10.1029/97GB01624; Ueki A, 1997, WATER SCI TECHNOL, V36, P517, DOI 10.1016/S0273-1223(97)00563-5; Watanabe A, 1999, J GEOPHYS RES-ATMOS, V104, P23623, DOI 10.1029/1999JD900467; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; WINFREY MR, 1983, APPL ENVIRON MICROB, V45, P193, DOI 10.1128/AEM.45.1.193-199.1983; Wu LQ, 2009, SYST APPL MICROBIOL, V32, P421, DOI 10.1016/j.syapm.2009.05.001; Yagi K, 1996, GLOBAL BIOGEOCHEM CY, V10, P255, DOI 10.1029/96GB00517; Yan XY, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003299; Yan XY, 2005, GLOBAL CHANGE BIOL, V11, P1131, DOI 10.1111/j.1365-2486.2005.00976.x; Zhang GB, 2013, BIOGEOSCIENCES, V10, P3375, DOI 10.5194/bg-10-3375-2013; Zhang GB, 2011, SOIL RES, V49, P238, DOI 10.1071/SR10117; Zhang GB, 2012, SOIL BIOL BIOCHEM, V52, P108, DOI 10.1016/j.soilbio.2012.04.017; Zhang GB, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2011JG001696; Zhang GB, 2011, NUTR CYCL AGROECOSYS, V89, P81, DOI 10.1007/s10705-010-9378-0	71	14	16	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73982	10.1371/journal.pone.0073982	http://dx.doi.org/10.1371/journal.pone.0073982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069259	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100079
J	Yamashita, F; Sasa, Y; Yoshida, S; Hisaka, A; Asai, Y; Kitano, H; Hashida, M; Suzuki, H				Yamashita, Fumiyoshi; Sasa, Yukako; Yoshida, Shuya; Hisaka, Akihiro; Asai, Yoshiyuki; Kitano, Hiroaki; Hashida, Mitsuru; Suzuki, Hiroshi			Modeling of Rifampicin-Induced CYP3A4 Activation Dynamics for the Prediction of Clinical Drug-Drug Interactions from In Vitro Data	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; REDUCES PLASMA-CONCENTRATIONS; PRIMARY HUMAN HEPATOCYTES; CYTOCHROME-P450 INDUCTION; QUANTITATIVE PREDICTION; HEALTHY-VOLUNTEERS; GENERAL FRAMEWORK; SYSTEMS BIOLOGY; PHARMACOKINETICS; VIVO	Induction of cytochrome P450 3A4 (CYP3A4) expression is often implicated in clinically relevant drug-drug interactions (DDI), as metabolism catalyzed by this enzyme is the dominant route of elimination for many drugs. Although several DDI models have been proposed, none have comprehensively considered the effects of enzyme transcription/translation dynamics on induction-based DDI. Rifampicin is a well-known CYP3A4 inducer, and is commonly used as a positive control for evaluating the CYP3A4 induction potential of test compounds. Herein, we report the compilation of in vitro induction data for CYP3A4 by rifampicin in human hepatocytes, and the transcription/translation model developed for this enzyme using an extended least squares method that can account for inherent inter-individual variability. We also developed physiologically based pharmacokinetic (PBPK) models for the CYP3A4 inducer and CYP3A4 substrates. Finally, we demonstrated that rifampicin-induced DDI can be predicted with reasonable accuracy, and that a static model can be used to simulate DDI once the blood concentration of the inducer reaches a steady state following repeated dosing. This dynamic PBPK-based DDI model was implemented on a new multi-hierarchical physiology simulation platform named PhysioDesigner.	[Yamashita, Fumiyoshi; Sasa, Yukako; Yoshida, Shuya; Hashida, Mitsuru] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Kyoto, Japan; [Hisaka, Akihiro] Univ Tokyo, Fac Med, Tokyo Univ Hosp, Dept Pharmacol & Pharmacokinet, Tokyo 113, Japan; [Asai, Yoshiyuki; Kitano, Hiroaki] Grad Univ, Okinawa Inst Sci & Technol, Open Biol Unit, Okinawa, Japan; [Kitano, Hiroaki] Sony Comp Sci Labs Inc, Tokyo, Japan; [Hashida, Mitsuru] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto, Japan; [Suzuki, Hiroshi] Univ Tokyo, Fac Med, Tokyo Univ Hosp, Dept Pharm, Tokyo 113, Japan	Kyoto University; University of Tokyo; Okinawa Institute of Science & Technology Graduate University; Sony Corporation; Kyoto University; University of Tokyo	Yamashita, F (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Kyoto, Japan.	yama@pharm.kyoto-u.ac.jp		hashida, mitsuru/0000-0001-7383-8080; , Akihiro/0000-0003-4863-9308	Ministry of Education, Culture, Sports, Science and Technology, Japan [23136102]; Grants-in-Aid for Scientific Research [25730180, 23136102, 22136002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grant-in-Aid for Scientific Research on Innovative Areas (23136102) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOCELLA G, 1978, CLIN PHARMACOKINET, V3, P108, DOI 10.2165/00003088-197803020-00002; ACOCELLA G, 1971, CHEMOTHERAPY, V16, P356, DOI 10.1159/000220750; Almond LM, 2009, CURR DRUG METAB, V10, P420, DOI 10.2174/138920009788498978; Asai Y, 2008, J PHYSIOL SCI, V58, P447, DOI 10.2170/physiolsci.RP013308; Backman JT, 2005, CLIN PHARMACOL THER, V78, P154, DOI 10.1016/j.clpt.2005.04.007; Backman JT, 1996, CLIN PHARMACOL THER, V59, P7, DOI 10.1016/S0009-9236(96)90018-1; Bolton AE, 2004, CANCER CHEMOTH PHARM, V53, P102, DOI 10.1007/s00280-003-0722-9; Capone D, 1996, INT J CLIN PHARM RES, V16, P73; Chen Jiezhong, 2006, Ann Clin Microbiol Antimicrob, V5, P3, DOI 10.1186/1476-0711-5-3; Chen YP, 2004, J PHARMACOL EXP THER, V308, P495, DOI 10.1124/jpet.103.058818; Chung E, 2006, CLIN PHARMACOL THER, V79, P350, DOI 10.1016/j.clpt.2005.11.016; Chung JY, 2011, DRUG METAB DISPOS, V39, P92, DOI 10.1124/dmd.110.035246; Fahmi OA, 2009, DRUG METAB DISPOS, V37, P1658, DOI 10.1124/dmd.108.026252; Friedman EJ, 2011, J CLIN PHARMACOL, V51, P1561, DOI 10.1177/0091270010387141; FURESZ S, 1967, ARZNEI-FORSCHUNG, V17, P534; Galetin A, 2006, DRUG METAB DISPOS, V34, P166, DOI 10.1124/dmd.105.006874; Garcia M, 2003, IN VITRO CELL DEV-AN, V39, P283; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Grime K, 2010, CURR DRUG METAB, V11, P870, DOI 10.2174/138920010794479637; Grub S, 2001, EUR J CLIN PHARMACOL, V57, P115, DOI 10.1007/s002280100277; Hariparsad N, 2004, J CLIN PHARMACOL, V44, P1273, DOI 10.1177/0091270004269142; Hariparsad N, 2008, DRUG METAB DISPOS, V36, P1046, DOI 10.1124/dmd.108.020677; HEBERT MF, 1992, CLIN PHARMACOL THER, V52, P453, DOI 10.1038/clpt.1992.171; HEIMARK LD, 1987, CLIN PHARMACOL THER, V42, P388, DOI 10.1038/clpt.1987.168; Holtbecker N, 1996, DRUG METAB DISPOS, V24, P1121; HONIG PK, 1993, JAMA-J AM MED ASSOC, V269, P1513, DOI 10.1001/jama.269.12.1513; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ito K, 2004, BRIT J CLIN PHARMACO, V57, P473, DOI 10.1111/j.1365-2125.2003.02041.x; Josephson F, 2010, J INTERN MED, V268, P530, DOI 10.1111/j.1365-2796.2010.02301.x; Kanamitsu S, 2000, PHARMACEUT RES, V17, P336, DOI 10.1023/A:1007509324428; Kato M, 2008, PHARM RES-DORDR, V25, P1891, DOI 10.1007/s11095-008-9607-2; Kato Motohiro, 2005, Drug Metab Pharmacokinet, V20, P236, DOI 10.2133/dmpk.20.236; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kivisto KT, 1999, PHARMACOL TOXICOL, V84, P94, DOI 10.1111/j.1600-0773.1999.tb00880.x; Kyrklund C, 2000, CLIN PHARMACOL THER, V68, P592, DOI 10.1067/mcp.2000.111414; Lattes R, 1999, Transpl Infect Dis, V1, P98, DOI 10.1034/j.1399-3062.1999.010203.x; LeCluyse E, 2000, J BIOCHEM MOL TOXIC, V14, P177, DOI 10.1002/(SICI)1099-0461(2000)14:4<177::AID-JBT1>3.0.CO;2-4; Li AP, 1997, CELL BIOL TOXICOL, V13, P365, DOI 10.1023/A:1007451911843; Li J, 2007, CLIN CANCER RES, V13, P3731, DOI 10.1158/1078-0432.CCR-07-0088; Li TG, 2006, DRUG METAB DISPOS, V34, P756, DOI 10.1124/dmd.105.007575; MCALLISTER WAC, 1983, BRIT MED J, V286, P923, DOI 10.1136/bmj.286.6369.923; MODRY DL, 1985, TRANSPLANTATION, V39, P313; Nakajima A, 2011, BIOCHEM PHARMACOL, V82, P1747, DOI 10.1016/j.bcp.2011.08.003; Nebot N, 2010, BRIT J PHARMACOL, V161, P1059, DOI 10.1111/j.1476-5381.2010.00946.x; Niemi M, 2000, CLIN PHARMACOL THER, V68, P495, DOI 10.1067/mcp.2000.111183; Ohno Y, 2008, CLIN PHARMACOKINET, V47, P669, DOI 10.2165/00003088-200847100-00004; Ohno Y, 2007, CLIN PHARMACOKINET, V46, P681, DOI 10.2165/00003088-200746080-00005; OREILLY RA, 1974, ANN INTERN MED, V81, P337, DOI 10.7326/0003-4819-81-3-337; Ourlin JC, 2003, MOL ENDOCRINOL, V17, P1693, DOI 10.1210/me.2002-0383; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867; Poulin P, 2002, J PHARM SCI-US, V91, P129, DOI 10.1002/jps.10005; Prueksaritanont T, 2005, PHARM RES-DORDR, V22, P71, DOI 10.1007/s11095-004-9011-5; Ridtitid W, 2000, J PHARM PHARMACOL, V52, P1265, DOI 10.1211/0022357001777243; Schmider J, 1999, PHARMACOGENETICS, V9, P725, DOI 10.1097/01213011-199912000-00007; SHEINER LB, 1985, J PHARMACOKINET BIOP, V13, P185, DOI 10.1007/BF01059398; SHEINER LB, 1984, DRUG METAB REV, V15, P293, DOI 10.3109/03602538409015067; Shi J, 2005, CLIN PHARMACOKINET, V44, P915, DOI 10.2165/00003088-200544090-00003; Shou MG, 2008, DRUG METAB DISPOS, V36, P2355, DOI 10.1124/dmd.108.020602; Swaisland HC, 2005, CLIN PHARMACOKINET, V44, P1067, DOI 10.2165/00003088-200544100-00005; Villikka K, 1997, CLIN PHARMACOL THER, V62, P629, DOI 10.1016/S0009-9236(97)90082-5; Villikka K, 1997, CLIN PHARMACOL THER, V61, P8, DOI 10.1016/S0009-9236(97)90176-4; Villikka K, 1997, BRIT J CLIN PHARMACO, V43, P471, DOI 10.1046/j.1365-2125.1997.00579.x; Wang YH, 2010, DRUG METAB DISPOS, V38, P1094, DOI 10.1124/dmd.110.032177; Xie W, 2003, P NATL ACAD SCI USA, V100, P4150, DOI 10.1073/pnas.0438010100; Yang J, 2007, TOXICOL SCI, V95, P13, DOI 10.1093/toxsci/kfl120; Yang JS, 2008, CURR DRUG METAB, V9, P384, DOI 10.2174/138920008784746382; Zhang J G, 2010, Drug Metab Lett, V4, P185; Zhang ZY, 2009, J PHARMACEUT BIOMED, V50, P200, DOI 10.1016/j.jpba.2009.04.013	69	63	74	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e70330	10.1371/journal.pone.0070330	http://dx.doi.org/10.1371/journal.pone.0070330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086247	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200003
J	Aravinthan, A; Pietrosi, G; Hoare, M; Jupp, J; Marshall, A; Verrill, C; Davies, S; Bateman, A; Sheron, N; Allison, M; Alexander, GJM				Aravinthan, Aloysious; Pietrosi, Giada; Hoare, Matthew; Jupp, James; Marshall, Aileen; Verrill, Clare; Davies, Susan; Bateman, Adrian; Sheron, Nick; Allison, Michael; Alexander, Graeme J. M.			Hepatocyte Expression of the Senescence Marker p21 Is Linked to Fibrosis and an Adverse Liver-Related Outcome in Alcohol-Related Liver Disease	PLOS ONE			English	Article							CELLULAR SENESCENCE; DNA-DAMAGE; CELLS; PROGRESSION	Background and Aim: Alcohol-related liver disease (ALD) remains a leading cause of liver-related morbidity and mortality. Age, fibrosis stage, MELD score and continued alcohol consumption predict outcome in everyday clinical practice. In previous studies increased hepatocyte nuclear area and hepatocyte expression of p21, both markers of senescence, were associated with increased fibrosis stage and a poor outcome in non-alcohol-related fatty liver disease, while increased hepatocyte nuclear area was related to liver dysfunction in ALD cirrhosis. This study, therefore, investigated the pattern of hepatocyte cell cycle phase distribution and hepatocyte p21 expression in relation to outcome in ALD. Methods: Liver sections from two cohorts were studied. The first comprised 42 patients across the full spectrum of ALD. The second cohort comprised 77 patients with ALD cirrhosis. Immunohistochemistry assessed hepatocyte expression of cell cycle phase markers and p21. Regenerating liver (n=12) and "normal" liver sections (n=5) served as positive and negative controls, respectively. Results: In the first cohort there was little cell cycle progression beyond G1/S phase and increased hepatocyte p21 expression (p<0.0001), which correlated independently with fibrosis stage (p=0.005) and an adverse liver-related outcome (p=0.03). In the second cohort, both hepatocyte p21 expression (p<0.001) and MELD score (p=0.006) were associated independently with an adverse liver-related outcome; this association was stronger with hepatocyte p21 expression (AUROC 0.74; p=0.0002) than with MELD score (AUROC 0.59; p=0.13). Further, hepatocyte p21 expression co-localised with increased hepatic stellate cell activation. Conclusions: The findings are consistent with impaired cell cycle progression beyond the G1/S phase in ALD. The striking independent associations between increased hepatocyte p21 expression and both fibrosis stage and an adverse liver-related outcome in both cohorts suggests hepatocyte senescence plays an important role in ALD. Measuring hepatocyte p21 expression is simple and cheap and in this series was a useful measure of long-term prognosis in ALD.	[Aravinthan, Aloysious; Pietrosi, Giada; Hoare, Matthew; Marshall, Aileen; Allison, Michael; Alexander, Graeme J. M.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Hoare, Matthew] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Jupp, James; Verrill, Clare; Sheron, Nick] Southampton Univ Hosp, Dept Hepatol, Southampton, Hants, England; [Davies, Susan] Cambridge Univ Hosp, Dept Histopathol, Cambridge, England; [Bateman, Adrian] Southampton Univ Hosp, Dept Histopathol, Southampton, Hants, England	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Southampton; University of Cambridge; University of Southampton	Alexander, GJM (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	gja1000@doctors.org.uk	Aravinthan, Aloysious D/I-2557-2019; Pietrosi, Giada/R-5493-2016	Aravinthan, Aloysious D/0000-0003-0527-5137; Sheron, Nick/0000-0002-6156-8367; Pietrosi, Giada/0000-0002-2299-7118; Sheron, Nick/0000-0001-5232-8292; Hoare, Matthew/0000-0001-5990-9604; Allison, Michael/0000-0003-3677-3294; Bateman, Adrian/0000-0003-2222-4104; Verrill, Clare/0000-0002-4905-8233	Hepatology Endowment Fund; Addenbrooke's Charitable Fund	Hepatology Endowment Fund; Addenbrooke's Charitable Fund	This work received support from the Hepatology Endowment Fund and Addenbrooke's Charitable Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031; Bell H, 2004, SCAND J GASTROENTERO, V39, P858, DOI 10.1080/00365520410006350; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Borel F, 2002, J CELL SCI, V115, P2829; Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GONZALEZREIMERS E, 1988, DRUG ALCOHOL DEPEN, V22, P195, DOI 10.1016/0376-8716(88)90018-X; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; Michalopoulos George K, 2012, Hepatology, V55, P2024, DOI 10.1002/hep.25703; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Ozen A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0357-y; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013	18	59	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e72904	10.1371/journal.pone.0072904	http://dx.doi.org/10.1371/journal.pone.0072904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086266	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000326520200004
J	Mialet, B; Majdi, N; Tackx, M; Azemar, F; Buffan-Dubau, E				Mialet, Benoit; Majdi, Nabil; Tackx, Micky; Azemar, Frederic; Buffan-Dubau, Evelyne			Selective Feeding of Bdelloid Rotifers in River Biofilms	PLOS ONE			English	Article							CYANOBACTERIAL BIOFILMS; MICROCYSTIS-AERUGINOSA; MEIOFAUNA; CAROTENOIDS; CARBON; COMMUNITY; CHLOROPHYLLS; ZOOPLANKTON; TOLERANCE; PREDATION	In situ pigment contents of biofilm-dwelling bdelloid rotifers of the Garonne River (France) were measured by high performance liquid chromatography (HPLC) and compared with pigment composition of surrounding biofilm microphytobenthic communities. Among pigments that were detected in rotifers, the presence of carotenoids fucoxanthin and myxoxanthophyll showed that the rotifers fed on diatoms and cyanobacteria. Unexpectedly, while diatoms strongly dominated microphytobenthic communities in terms of biomass, HPLC results hinted that rotifers selectively ingested benthic filamentous cyanobacteria. In doing so, rotifers could daily remove a substantial fraction (up to 28%) of this cyanobacterial biomass. The possibility that the rotifers hosted symbiotic myxoxanthophyll-containing cyanobacteria was examined by localisation of chlorophyll fluorescence within rotifers using confocal laser scanning microscopy (CLSM). CLSM results showed an even distribution of quasi-circular fluorescent objects (FO) throughout rotifer bodies, whereas myxoxanthophyll is a biomarker pigment of filamentous cyanobacteria, so the hypothesis was rejected. Our results also suggest that rotifers converted beta-carotene (provided by ingested algae) into echinenone, a photoprotective pigment. This study, which is the first one to detail in situ pigment contents of rotifers, clearly shows that the role of cyanobacteria as a food source for meiobenthic invertebrates has been underestimated so far, and deserves urgent consideration.	[Mialet, Benoit; Majdi, Nabil; Tackx, Micky; Azemar, Frederic; Buffan-Dubau, Evelyne] Univ Toulouse, UPS, INP, Ecolab,Lab Ecol Fonct & Environm, Toulouse, France; [Mialet, Benoit; Majdi, Nabil; Tackx, Micky; Azemar, Frederic; Buffan-Dubau, Evelyne] Ctr Natl Rech Sci, Ecolab, Toulouse, France; [Mialet, Benoit] Univ Rochelle, CNRS, UMR LIENSs Littoral Environm & Soc 7266, La Rochelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Mialet, B (corresponding author), Univ Toulouse, UPS, INP, Ecolab,Lab Ecol Fonct & Environm, Toulouse, France.	benoit.mialet@hotmail.fr	Azémar, Frédéric/A-9041-2010; Majdi, Nabil/J-8578-2016	Azémar, Frédéric/0000-0002-3098-8676; Majdi, Nabil/0000-0001-7052-4297	national CNRS EC2CO-CYTRIX program	national CNRS EC2CO-CYTRIX program	This study was funded by a national CNRS EC2CO-CYTRIX program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Azim M. E., 2005, Periphyton: ecology, exploitation and management, P15, DOI 10.1079/9780851990965.0015; Baker JR, 1988, ADV PARASIT, P263; Barlow RG, 1997, MAR ECOL PROG SER, V161, P303, DOI 10.3354/meps161303; Battaglia B, 1997, ANTARCTIC COMMUNITIE; BORCHARDT MA, 1995, J N AM BENTHOL SOC, V14, P278, DOI 10.2307/1467780; Boschetti C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003035; Bouletreau S, 2006, FRESHWATER BIOL, V51, P901, DOI 10.1111/j.1365-2427.2006.01541.x; Brotas V, 2003, ACTA OECOL, V24, pS109, DOI 10.1016/S1146-609X(03)00013-4; Buffan-Dubau E, 2000, LIMNOL OCEANOGR, V45, P381, DOI 10.4319/lo.2000.45.2.0381; BuffanDubau E, 1996, MAR ECOL PROG SER, V137, P71, DOI 10.3354/meps137071; Caramujo MJ, 2012, MAR DRUGS, V10, P998, DOI 10.3390/md10050998; CLEMENT P, 1983, HYDROBIOLOGIA, V104, P89, DOI 10.1007/BF00045957; de Quiros ARB, 2001, EUR FOOD RES TECHNOL, V212, P687, DOI 10.1007/s002170100316; Eulin A, 1998, ARCH HYDROBIOL, V143, P79; Evrard V, 2010, MAR ECOL PROG SER, V416, P1, DOI 10.3354/meps08770; Gaudes A, 2006, NEMATOLOGY, V8, P909, DOI 10.1163/156854106779799169; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; GILCHRIST BM, 1962, NATURE, V195, P905, DOI 10.1038/195905a0; Goldfinch AC, 2000, ESTUARIES, V23, P536, DOI 10.2307/1353144; Gulati RD, 1997, FRESHWATER BIOL, V38, P753, DOI 10.1046/j.1365-2427.1997.00275.x; Gullberg KR, 1997, LIMNOL OCEANOGR, V42, P452, DOI 10.4319/lo.1997.42.3.0452; Guo NC, 2006, ENVIRON POLLUT, V143, P513, DOI 10.1016/j.envpol.2005.11.044; Hall RI, 1999, LIMNOL OCEANOGR, V44, P739, DOI 10.4319/lo.1999.44.3_part_2.0739; Hildrew A.G., 1992, P309; Hockelmann C, 2004, LIMNOL OCEANOGR, V49, P1809, DOI 10.4319/lo.2004.49.5.1809; Irigoien X, 2000, FEEDING SELECTIVITY; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; Kathol M, 2011, FRESHWATER BIOL, V56, P1160, DOI 10.1111/j.1365-2427.2010.02561.x; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keesing JK, 2012, MAR FRESHWATER RES, V63, P403, DOI 10.1071/MF11216; LAMBERTI GA, 1983, ECOLOGY, V64, P1124, DOI 10.2307/1937823; Lauritano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047262; Leflaive J, 2008, FUND APPL LIMNOL, V173, P121, DOI 10.1127/1863-9135/2008/0173-0121; LOCK MA, 1984, OIKOS, V42, P10, DOI 10.2307/3544604; Lurling M, 2003, HYDROBIOLOGIA, V491, P145, DOI 10.1023/A:1024436508387; Lyautey E, 2005, MICROB ECOL, V50, P589, DOI 10.1007/s00248-005-5032-9; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Majdi N, 2012, FRESHWATER BIOL, V57, P1180, DOI 10.1111/j.1365-2427.2012.02784.x; Majdi N, 2012, FRESHW SCI, V31, P38, DOI 10.1899/11-073.1; Majdi N, 2012, HYDROBIOLOGIA, V680, P219, DOI 10.1007/s10750-011-0920-0; Majdi N, 2011, HYDROBIOLOGIA, V673, P229, DOI 10.1007/s10750-011-0781-6; Maoka T, 2005, J AGR FOOD CHEM, V53, P8357, DOI 10.1021/jf058088t; Marotta R, 2012, J MORPHOL, V273, P1, DOI 10.1002/jmor.11000; Matsuno T, 2001, FISHERIES SCI, V67, P771, DOI 10.1046/j.1444-2906.2001.00323.x; Melone G, 1998, CAN J ZOOL, V76, P1755, DOI 10.1139/cjz-76-9-1755; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Moens T, 1999, MAR BIOL, V133, P69, DOI 10.1007/s002270050444; Moens T, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P105, DOI 10.1079/9780851990095.0105; Novakova E, 2012, MOL BIOL EVOL, V29, P313, DOI 10.1093/molbev/msr206; Paerl HW, 2004, ENVIRON SCI TECHNOL, V38, P3068, DOI 10.1021/es0352350; Pinckney JL, 2003, AQUAT MICROB ECOL, V31, P99, DOI 10.3354/ame031099; Reiss J, 2010, ECOLOGY, V91, P497, DOI 10.1890/08-1248.1; Ricci C, 2000, FRESHWATER BIOL, V44, P15, DOI 10.1046/j.1365-2427.2000.00584.x; Romani A. M., 2010, BIOFOULING, P137; Rowell K, 2003, FRESHWATER BIOL, V48, P247, DOI 10.1046/j.1365-2427.2003.00999.x; Sabater S, 2003, AQUAT MICROB ECOL, V32, P175, DOI 10.3354/ame032175; Schmid PE, 2002, FRESHWATER MEIOFAUNA: BIOLOGY AND ECOLOGY, P295; Schmid PE, 1997, FRESHWATER BIOL, V38, P67, DOI 10.1046/j.1365-2427.1997.00197.x; Schmid-Araya JM, 2002, ECOLOGY, V83, P1271, DOI 10.2307/3071942; Soares MCS, 2010, J PLANKTON RES, V32, P999, DOI 10.1093/plankt/fbq042; Spieth HR, 2011, J FISH BIOL, V78, P138, DOI 10.1111/j.1095-8649.2010.02850.x; Tekwani N, 2013, AQUAT MICROB ECOL, V69, P47, DOI 10.3354/ame01616; Teneva I, 2005, TOXICON, V45, P711, DOI 10.1016/j.toxicon.2005.01.018; Traunspurger W, 1997, OECOLOGIA, V112, P118, DOI 10.1007/s004420050291; UHLIG G, 1973, HELGOLAND WISS MEER, V25, P173, DOI 10.1007/BF01609968; Vega IA, 2006, BIOCELL, V30, P367; WALLACE RL, 1983, HYDROBIOLOGIA, V104, P379, DOI 10.1007/BF00045995; Ward JV, 1998, FRESHWATER BIOL, V40, P531, DOI 10.1046/j.1365-2427.1998.00368.x; WEBSTER KE, 1978, LIMNOL OCEANOGR, V23, P1238, DOI 10.4319/lo.1978.23.6.1238; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183	71	18	20	5	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75352	10.1371/journal.pone.0075352	http://dx.doi.org/10.1371/journal.pone.0075352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073263	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000072
J	Wu, JH; Shen, SD; Yang, JL; Xia, ZW; Zhong, XP				Wu, Jinhong; Shen, Shudan; Yang, Jialong; Xia, Zhenwei; Zhong, Xiao-Ping			Diacylglycerol Kinase Zeta Positively Controls the Development of iNKT-17 Cells	PLOS ONE			English	Article							INVARIANT NKT CELLS; SCLEROSIS COMPLEX 1; KILLER T-CELLS; ROR-GAMMA-T; CYTOKINE PRODUCTION; ACTIVATION; RECEPTOR; PATHWAY; IDENTIFICATION; EXPRESSION	Invariant natural killer T (iNKT) cells play important roles in bridging innate and adaptive immunity via rapidly producing a variety of cytokines. A small subset of iNKT cells produces IL-17 and is generated in the thymus during iNKT-cell ontogeny. The mechanisms that control the development of these IL-17-producing iNKT-17 cells (iNKT-17) are still not well defined. Diacylglycerol kinase zeta (DGK zeta) belongs to a family of enzymes that catalyze the phosphorylation and conversion of diacylglycerol to phosphatidic acid, two important second messengers involved in signaling from numerous receptors. We report here that DGK zeta plays an important role in iNKT-17 development. A deficiency of DGK zeta in mice causes a significant reduction of iNKT-17 cells, which is correlated with decreased ROR gamma t and IL-23 receptor expression. Interestingly, iNKT-17 defects caused by DGK zeta deficiency can be corrected in chimeric mice reconstituted with mixed wild-type and DGK zeta deficient bone marrow cells. Taken together, our data identify DGK zeta as an important regulator of iNKT-17 development through iNKT-cell extrinsic mechanisms.	[Wu, Jinhong; Shen, Shudan; Yang, Jialong; Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA; [Wu, Jinhong; Xia, Zhenwei] Shanghai Jiao Tong Univ, Sch Med, Dept Pediat, Shanghai 200030, Peoples R China; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Duke University; Shanghai Jiao Tong University; Duke University	Zhong, XP (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA.	zhong001@mc.duke.edu			National Institutes of Health [AI076357, AI079088, AI101206]; American Cancer Society [RSG-08-186-01-LIB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076357, R01AI101206, R01AI079088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study is supported by the National Institutes of Health (AI076357, AI079088, and AI101206) and the American Cancer Society (RSG-08-186-01-LIB) to X-PZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brutkiewicz RR, 2002, CRIT REV ONCOL HEMAT, V41, P287, DOI 10.1016/S1040-8428(01)00198-6; Cerundolo V, 2010, SEMIN IMMUNOL, V22, P59, DOI 10.1016/j.smim.2010.01.002; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Das R, 2010, IMMUNOL REV, V238, P195, DOI 10.1111/j.1600-065X.2010.00962.x; Doisne JM, 2009, J IMMUNOL, V183, P2142, DOI 10.4049/jimmunol.0901059; Enders A, 2012, J IMMUNOL, V189, P5240, DOI 10.4049/jimmunol.1201486; Engel I, 2012, BLOOD, V120, P4524, DOI 10.1182/blood-2012-01-406280; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gorentla BK, 2011, BLOOD, V117, P4022, DOI 10.1182/blood-2010-08-300731; Guo R, 2008, P NATL ACAD SCI USA, V105, P11909, DOI 10.1073/pnas.0711856105; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Krishna S, 2013, CRIT REV IMMUNOL, V33, P97, DOI 10.1615/CritRevImmunol.2013006696; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Liu CH, 2007, J EXP MED, V204, P781, DOI 10.1084/jem.20061856; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Milpied P, 2011, BLOOD, V118, P2993, DOI 10.1182/blood-2011-01-329268; Monteiro M, 2013, J IMMUNOL, V190, P805, DOI 10.4049/jimmunol.1201010; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Olenchock BA, 2006, J EXP MED, V203, P1471, DOI 10.1084/jem.20052424; Pan HJ, 2013, J IMMUNOL, V191, P699, DOI 10.4049/jimmunol.1201443; Pan HJ, 2012, J IMMUNOL, V188, P3658, DOI 10.4049/jimmunol.1102187; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Seino K, 2005, J EXP MED, V202, P1623, DOI 10.1084/jem.20051600; Shen SD, 2011, J IMMUNOL, V187, P4467, DOI 10.4049/jimmunol.1003798; Shen SD, 2011, J IMMUNOL, V187, P2122, DOI 10.4049/jimmunol.1100495; Shin J, 2012, J IMMUNOL, V188, P2111, DOI 10.4049/jimmunol.1102265; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wondimu Z, 2010, AM J PATHOL, V177, P2334, DOI 10.2353/ajpath.2010.100028; Yang CS, 2006, CELL MICROBIOL, V8, P1158, DOI 10.1111/j.1462-5822.2006.00699.x; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x; Zhong XP, 2011, IMMUNOL RES, V49, P109, DOI 10.1007/s12026-010-8175-9; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75202	10.1371/journal.pone.0075202	http://dx.doi.org/10.1371/journal.pone.0075202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073253	gold, Green Submitted, Green Published			2022-12-27	WOS:000324768000062
J	Holmoy, T; Loken-Amsrud, KI; Bakke, SJ; Beiske, AG; Bjerve, KS; Hovdal, H; Lilleas, F; Midgard, R; Pedersen, T; Benth, JS; Torkildsen, O; Wergeland, S; Myhr, KM; Michelsen, AE; Aukrust, P; Ueland, T				Holmoy, Trygve; Loken-Amsrud, Kristin Ingeleiv; Bakke, Soren Jacob; Beiske, Antonie G.; Bjerve, Kristian S.; Hovdal, Harald; Lilleas, Finn; Midgard, Rune; Pedersen, Tom; Benth, Jutrate Saltyte; Torkildsen, Oivind; Wergeland, Stig; Myhr, Kjell-Morten; Michelsen, Annika E.; Aukrust, Pal; Ueland, Thor			Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CIRCULATING ADHESION MOLECULES; POLYUNSATURATED FATTY-ACIDS; NECROSIS-FACTOR RECEPTOR; CEREBROSPINAL-FLUID; TGF-BETA; PROTECT NEURONS; UP-REGULATION; SERUM-LEVELS; T-CELLS	Background: Serum markers of inflammation are candidate biomarkers in multiple sclerosis (MS). omega-3 fatty acids are suggested to have anti-inflammatory properties that might be beneficial in MS. We aimed to explore the relationship between serum levels of inflammation markers and MRI activity in patients with relapsing remitting MS, as well as the effect of omega-3 fatty acids on these markers. Methods: We performed a prospective cohort study in 85 relapsing remitting MS patients who participated in a randomized clinical trial of omega-3 fatty acids versus placebo (the OFAMS study). During a period of 24 months 12 repeated magnetic resonance imaging (MRI) scans and nine serum samples were obtained. We measured 10 inflammation markers, including general down-stream markers of inflammation, specific markers of up-stream inflammatory pathways, endothelial action, and matrix regulation. Results: After Bonferroni correction, increasing serum levels of CXCL16 and osteoprotegerin were associated with low odds ratio for simultaneous MRI activity, whereas a positive association was observed for matrix metalloproteinase (MMP) 9. CXCL16 were also associated with low MRI activity the next month, but this was not significant after Bonferroni correction. In agreement with previously reported MRI and clinical results, omega-3 fatty acid treatment did not induce any change in the inflammation markers. Conclusions: Serum levels of CXCL16, MMP-9, and osteoprotegerin reflect disease activity in MS, but are not affected by omega-3 fatty acid treatment. CXCL16 could be a novel biomarker and potential predictor of disease activity in MS.	[Holmoy, Trygve] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway; [Holmoy, Trygve; Loken-Amsrud, Kristin Ingeleiv; Benth, Jutrate Saltyte; Aukrust, Pal; Ueland, Thor] Univ Oslo, Inst Clin Med, Oslo, Norway; [Loken-Amsrud, Kristin Ingeleiv] Innlandet Hosp Trust, Dept Neurol, Lillehammer, Norway; [Bakke, Soren Jacob] Oslo Univ Hosp, Dept Neuroradiol, Oslo, Norway; [Beiske, Antonie G.] Multiple Sclerosis Ctr Hakadal, Hakadal, Norway; [Bjerve, Kristian S.] Univ Trondheim Hosp, St Olavs Hosp, Dept Med Biochem, Trondheim, Norway; [Hovdal, Harald] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurol, Trondheim, Norway; [Lilleas, Finn] Curato Oslo, Oslo, Norway; [Midgard, Rune] Molde Hosp, Dept Neurol, Molde, Norway; [Midgard, Rune] Norwegian Univ Sci & Technol, Unit Appl Clin Res, N-7034 Trondheim, Norway; [Pedersen, Tom] Unilabs Drammen, Drammen, Norway; [Benth, Jutrate Saltyte] Akershus Univ Hosp, Helse Sor Ost Hlth Serv Res Ctr, Lorenskog, Norway; [Torkildsen, Oivind; Wergeland, Stig; Myhr, Kjell-Morten] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway; [Torkildsen, Oivind; Wergeland, Stig; Myhr, Kjell-Morten] Univ Bergen, Dept Clin Med, KG KG Jebsen MS Res Ctr, Bergen, Norway; [Michelsen, Annika E.; Aukrust, Pal; Ueland, Thor] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway	University of Oslo; University of Oslo; Innlandet Hospital Trust; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; National Hospital Norway	Holmoy, T (corresponding author), Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway.	trygve.holmoy@medisin.uio.no	Torkildsen, Øivind/A-1606-2008; Myhr, Kjell-Morten/H-1528-2018	Torkildsen, Øivind/0000-0001-5294-2866; Myhr, Kjell-Morten/0000-0002-0980-510X	Merck-Serono; Pronova Biocare; Bayer Schering; Innlandet Hospital Trust; Western Norway Regional Health Authority; Odd Fellow Research Foundation for multiple sclerosis; Kare Waerner's Legacy; Norwegian MS Society	Merck-Serono(Merck & Company); Pronova Biocare; Bayer Schering(Bayer AG); Innlandet Hospital Trust; Western Norway Regional Health Authority; Odd Fellow Research Foundation for multiple sclerosis; Kare Waerner's Legacy; Norwegian MS Society	The study was partly supported by Merck-Serono, Pronova Biocare, Bayer Schering, Innlandet Hospital Trust, The Western Norway Regional Health Authority, Odd Fellow Research Foundation for multiple sclerosis, Kare Waerner's Legacy and The Norwegian MS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; [Anonymous], J NEUROL SCI, V305, P1, DOI [10.1016/j.jns.2011.03.026, DOI 10.1016/J.JNS.2011.03.026.PUBMED:21463872]; Bilinska M, 2002, MED SCI MONITOR, V8; Calder PC, 2013, BRIT J CLIN PHARMACO, V75, P645, DOI 10.1111/j.1365-2125.2012.04374.x; Fainardi E, 2006, MULT SCLER J, V12, P294, DOI 10.1191/135248506ms1274oa; Franciotta D, 2001, J NEUROIMMUNOL, V115, P192, DOI 10.1016/S0165-5728(01)00261-2; Fukumoto N, 2004, J IMMUNOL, V173, P1620, DOI 10.4049/jimmunol.173.3.1620; GALLAI V, 1995, J NEUROIMMUNOL, V56, P143, DOI 10.1016/0165-5728(94)00140-J; HARTUNG HP, 1995, ANN NEUROL, V38, P186, DOI 10.1002/ana.410380210; Hendrickx DAE, 2013, J NEUROPATH EXP NEUR, V72, P106, DOI 10.1097/NEN.0b013e31827fd9e8; Hofbauer LC, 2004, ACTA NEUROPATHOL, V107, P575, DOI 10.1007/s00401-004-0854-y; Huss DJ, 2011, EUR J IMMUNOL, V41, P2987, DOI 10.1002/eji.201141666; Johnson GH, 2012, J ACAD NUTR DIET, V112, P1029, DOI 10.1016/j.jand.2012.03.029; Krumbholz M, 2007, J NEUROIMMUNOL, V190, P72, DOI 10.1016/j.jneuroim.2007.07.024; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Kurban S, 2008, MULT SCLER, V14, P431, DOI 10.1177/1352458507084028; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; le Blanc LMP, 2006, NEUROSCI LETT, V397, P145, DOI 10.1016/j.neulet.2005.12.029; Luo J, 2007, J CLIN INVEST, V117, P3306, DOI 10.1172/JCI31763; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mehta LR, 2009, NAT CLIN PRACT NEURO, V5, P82, DOI 10.1038/ncpneuro1009; Mirshafiey A, 2009, NEUROPHARMACOLOGY, V56, P929, DOI 10.1016/j.neuropharm.2009.02.007; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; O'Connor RA, 2012, J IMMUNOL, V188, P2093, DOI 10.4049/jimmunol.1101118; RIECKMANN P, 1994, NEUROLOGY, V44, P2367, DOI 10.1212/WNL.44.12.2367; Romi F, 2012, EUR NEUROL, V67, P121, DOI 10.1159/000334862; Rosito M, 2012, J NEUROSCI, V32, P3154, DOI 10.1523/JNEUROSCI.4046-11.2012; Schwarz S, 2008, MULT SCLER J, V14, P1113, DOI 10.1177/1352458508092808; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; SELMAJ K, 1995, J NEUROIMMUNOL, V56, P135, DOI 10.1016/0165-5728(94)00139-F; Shinto L, 2009, PROSTAG LEUKOTR ESS, V80, P131, DOI 10.1016/j.plefa.2008.12.001; Torkildsen O, 2012, ARCH NEUROL-CHICAGO, V69, P1044, DOI 10.1001/archneurol.2012.283; Voltz R, 1997, J NEUROL NEUROSUR PS, V62, P200, DOI 10.1136/jnnp.62.2.200-b; Wang HH, 2013, MULT SCLER J, V19, P926, DOI 10.1177/1352458512457845; Waubant E, 1999, NEUROLOGY, V53, P1397, DOI 10.1212/WNL.53.7.1397; Waubant E, 2006, DIS MARKERS, V22, P235, DOI 10.1155/2006/709869; Weinstock-Guttman B, 2005, PROSTAG LEUKOTR ESS, V73, P397, DOI 10.1016/j.plefa.2005.05.024; Zhang WT, 2011, FRONT BIOSCI-LANDMRK, V16, P2653, DOI 10.2741/3878	38	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75021	10.1371/journal.pone.0075021	http://dx.doi.org/10.1371/journal.pone.0075021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069377	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300061
J	Ottis, P; Topic, B; Loos, M; Li, KW; de Souza, A; Schulz, D; Smit, AB; Huston, JP; Korth, C				Ottis, Philipp; Topic, Bianca; Loos, Maarten; Li, Ka Wan; de Souza, Angelica; Schulz, Daniela; Smit, August B.; Huston, Joseph P.; Korth, Carsten			Aging-Induced Proteostatic Changes in the Rat Hippocampus Identify ARP3, NEB2 and BRAG2 as a Molecular Circuitry for Cognitive Impairment	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GENE-EXPRESSION ATLAS; ARP2/3 COMPLEX; DENDRITIC SPINES; WATER MAZE; AGED RATS; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; SPATIAL INFORMATION; PROTEOMIC ANALYSIS	Disturbed proteostasis as a particular phenotype of the aging organism has been advanced in C. elegans experiments and is also conceived to underlie neurodegenerative diseases in humans. Here, we investigated whether particular changes in non-disease related proteostasis can be identified in the aged mammalian brain, and whether a particular signature of aberrant proteostasis is related to behavioral performance of learning and memory. Young (adult, n = 30) and aged (2 years, n = 50) Wistar rats were tested in the Morris Water Maze (MWM) to distinguish superior and inferior performers. For both young and old rats, the best and worst performers in the MWM were selected and the insoluble proteome, termed aggregome, was purified from the hippocampus as evidence for aberrant proteostasis. Quantitative proteomics (iTRAQ) was performed. The aged inferior performers were considered as a model for spontaneous, age-associated cognitive impairment. Whereas variability of the insoluble proteome increased with age, absolute changes in the levels of insoluble proteins were small compared to the findings in the whole C. elegans insoluble proteome. However, we identified proteins with aberrant proteostasis in aging. For the cognitively impaired rats, we identified a changed molecular circuitry of proteins selectively involved in F-actin remodeling, synapse building and long-term depression: actin related protein 3 (ARP3), neurabin II (NEB2) and IQ motif and SEC7 domain-containing protein 1 (BRAG2). We demonstrate that aberrant proteostasis is a specific phenotype of brain aging in mammals. We identify a distinct molecular circuitry where changes in proteostasis are characteristic for poor learning and memory performance in the wild type, aged rat. Our findings 1. establish the search for aberrant proteostasis as a successful strategy to identify neuronal dysfunction in deficient cognitive behavior, 2. reveal a previously unknown functional network of proteins (ARP3, NEB2, BRAG2) involved in age-associated cognitive dysfunction.	[Ottis, Philipp; Korth, Carsten] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Topic, Bianca; de Souza, Angelica; Schulz, Daniela; Huston, Joseph P.] Univ Dusseldorf, Dept Expt Psychol, Ctr Behav Neurosci, D-40225 Dusseldorf, Germany; [Loos, Maarten; Li, Ka Wan; Smit, August B.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, Amsterdam, Netherlands; [Loos, Maarten] Synaptologics BV, Amsterdam, Netherlands	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Vrije Universiteit Amsterdam	Korth, C (corresponding author), Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany.	ckorth@uni-duesseldorf.de	Loos, Maarten/A-2768-2012	Loos, Maarten/0000-0003-1629-2928; li, ka wan/0000-0001-6983-5055	KNDD BMBF [01ED1201B]; EU-FP7-PRIORITY; DFG [Hu 306/27-2]; EU-FP7 project 'SynSys' [242167];  [DFG-GRK1033]	KNDD BMBF(Federal Ministry of Education & Research (BMBF)); EU-FP7-PRIORITY; DFG(German Research Foundation (DFG)); EU-FP7 project 'SynSys'; 	Funding for this project was provided by DFG-GRK1033, KNDD BMBF 01ED1201B), EU-FP7-PRIORITY to CK, and DFG Hu 306/27-2 to JPH. ABS and KWL received funding from the EU-FP7 project 'SynSys' (grant # 242167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Barnes AP, 2004, MOL BRAIN RES, V124, P105, DOI 10.1016/j.molbrainres.2003.12.020; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Calhoun ME, 2008, NEUROBIOL AGING, V29, P1256, DOI 10.1016/j.neurobiolaging.2007.02.013; Carrette O, 2006, PROTEOMICS, V6, P4940, DOI 10.1002/pmic.200600084; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Chen WQ, 2007, ELECTROPHORESIS, V28, P4392, DOI 10.1002/elps.200700336; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fitzjohn SM, 2010, NEURON, V66, P627, DOI 10.1016/j.neuron.2010.05.027; Focking M, 2006, PROTEOMICS, V6, P4914, DOI 10.1002/pmic.200600269; Freeman WM, 2009, NEUROSCIENCE, V159, P183, DOI 10.1016/j.neuroscience.2008.12.004; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; GALLAGHER M, 1989, NEUROBIOL AGING, V10, P691, DOI 10.1016/0197-4580(89)90006-7; GALLAGHER M, 1993, BEHAV BRAIN RES, V57, P155, DOI 10.1016/0166-4328(93)90131-9; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Geslani DM, 2005, DEMENT GERIATR COGN, V19, P383, DOI 10.1159/000084709; Grossman SD, 2004, J NEUROCHEM, V90, P317, DOI 10.1111/j.1471-4159.2004.02491.x; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Guo J, 2011, J PROTEOMICS, V74, P2370, DOI 10.1016/j.jprot.2011.07.009; Hasenohrl RU, 1997, EXP BRAIN RES, V114, P205, DOI 10.1007/PL00005629; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Henninger N, 2007, GENES BRAIN BEHAV, V6, P128, DOI 10.1111/j.1601-183X.2006.00239.x; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; Hsieh-Wilson LC, 2003, J BIOL CHEM, V278, P1186, DOI 10.1074/jbc.M205754200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kosik KS, 2012, J GERONTOL A-BIOL, V67, P741, DOI 10.1093/gerona/gls110; KRAUTH J, 1980, J NEUROSCI METH, V2, P239, DOI 10.1016/0165-0270(80)90013-8; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Leuba G, 2008, J ALZHEIMERS DIS, V15, P139; Li KW, 2007, J PROTEOME RES, V6, P3127, DOI 10.1021/pr070086w; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lupien SJ, 2004, PHILOS T R SOC B, V359, P1413, DOI 10.1098/rstb.2004.1516; Machesky LM, 1997, BIOCHEM J, V328, P105; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; McNair K, 2007, NEUROSCIENCE, V145, P413, DOI 10.1016/j.neuroscience.2006.12.033; McNair K, 2006, EUR J NEUROSCI, V23, P575, DOI 10.1111/j.1460-9568.2005.04542.x; Meijer OC, 2005, ENDOCRINOLOGY, V146, P1372, DOI 10.1210/en.2004-0416; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Nelson TJ, 2004, HIPPOCAMPUS, V14, P46, DOI 10.1002/hipo.10152; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; ONEILL C, 2010, BIOCHEM SOC T, V40, P721; Ottis P, 2012, PROTEOMICS, V12, P2445, DOI 10.1002/pmic.201100668; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Poon HF, 2006, NEUROBIOL AGING, V27, P1020, DOI 10.1016/j.neurobiolaging.2005.05.014; Racz B, 2008, J NEUROSCI, V28, P5654, DOI 10.1523/JNEUROSCI.0756-08.2008; Ramachandran B, 2009, J NEUROSCI, V29, P12167, DOI 10.1523/JNEUROSCI.2045-09.2009; RAPP PR, 1987, BEHAV NEUROSCI, V101, P3, DOI 10.1037/0735-7044.101.1.3; RAPP PR, 1992, TRENDS NEUROSCI, V15, P340, DOI 10.1016/0166-2236(92)90051-9; Reis-Rodrigues P, 2012, AGING CELL, V11, P120, DOI 10.1111/j.1474-9726.2011.00765.x; REISBERG B, 1988, DRUG DEVELOP RES, V15, P101, DOI 10.1002/ddr.430150203; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; SAITO S, 1994, J BIOL CHEM, V269, P29710; Sato Y, 2005, NEUROSCI LETT, V382, P22, DOI 10.1016/j.neulet.2005.02.053; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Schulz D, 2004, EUR J NEUROSCI, V19, P1373, DOI 10.1111/j.1460-9568.2004.03234.x; Schulz D, 2002, EUR J NEUROSCI, V16, P2175, DOI 10.1046/j.1460-9568.2002.02282.x; Schulz D, 2007, NEUROBIOL LEARN MEM, V87, P309, DOI 10.1016/j.nlm.2006.09.006; Schutt F, 2002, FEBS LETT, V528, P217, DOI 10.1016/S0014-5793(02)03312-4; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Topic B, 2007, HIPPOCAMPUS, V17, P68, DOI 10.1002/hipo.20246; Topic B, 2005, BEHAV NEUROSCI, V119, P127, DOI 10.1037/0735-7044.119.1.127; Uematsu K, 2005, J NEUROCHEM, V95, P1642, DOI 10.1111/j.1471-4159.2005.03491.x; VanGuilder HD, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00008; VanGuilder HD, 2010, J NEUROCHEM, V113, P1577, DOI 10.1111/j.1471-4159.2010.06719.x; Vauti F, 2007, FEBS LETT, V581, P5691, DOI 10.1016/j.febslet.2007.11.031; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Weinreb O, 2007, ANTIOXID REDOX SIGN, V9, P169, DOI 10.1089/ars.2007.9.169; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yang S, 2008, NEUROSCIENCE, V154, P1107, DOI 10.1016/j.neuroscience.2008.04.012; Zheng JF, 2009, J PROTEOME RES, V8, P4479, DOI 10.1021/pr9002596	100	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75112	10.1371/journal.pone.0075112	http://dx.doi.org/10.1371/journal.pone.0075112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069387	Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300067
J	Nigro, D; Gu, YQ; Huo, NX; Marcotuli, I; Blanco, A; Gadaleta, A; Anderson, OD				Nigro, Domenica; Gu, Yong Q.; Huo, Naxin; Marcotuli, Ilaria; Blanco, Antonio; Gadaleta, Agata; Anderson, Olin D.			Structural Analysis of the Wheat Genes Encoding NADH-Dependent Glutamine-2-oxoglutarate Amidotransferases and Correlation with Grain Protein Content	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; GLUTAMATE-SYNTHASE; RICE; SYNTHETASE; REMOBILIZATION; NORMALIZATION; LOCATION; ENZYMES; PLANTS	Background: Nitrogen uptake and the efficient absorption and metabolism of nitrogen are essential elements in attempts to breed improved cereal cultivars for grain or silage production. One of the enzymes related to nitrogen metabolism is glutamine-2-oxoglutarate amidotransferase (GOGAT). Together with glutamine synthetase (GS), GOGAT maintains the flow of nitrogen from NH4+ into glutamine and glutamate, which are then used for several aminotransferase reactions during amino acid synthesis. Results: The aim of the present work was to identify and analyse the structure of wheat NADH-GOGAT genomic sequences, and study the expression in two durum wheat cultivars characterized by low and high kernel protein content. The genomic sequences of the three homoeologous A, B and D NADH-GOGAT genes were obtained for hexaploid Triticum aestivum and the tetraploid A and B genes of Triticum turgidum ssp. durum. Analysis of the gene sequences indicates that all wheat NADH-GOGAT genes are composed of 22 exons and 21 introns. The three hexaploid wheat homoeologous genes have high conservation of sequence except intron 13 which shows differences in both length and sequence. A comparative analysis of sequences among di- and mono-cotyledonous plants shows both regions of high conservation and of divergence. qRT-PCR performed with the two durum wheat cvs Svevo and Ciccio (characterized by high and low protein content, respectively) indicates different expression levels of the two NADH-GOGAT-3A and NADH-GOGAT-3B genes. Conclusion: The three hexaploid wheat homoeologous NADH-GOGAT gene sequences are highly conserved - consistent with the key metabolic role of this gene. However, the dicot and monocot amino acid sequences show distinctive patterns, particularly in the transit peptide, the exon 16-17 junction, and the C-terminus. The lack of conservation in the transit peptide may indicate subcellular differences between the two plant divisions - while the sequence conservation within enzyme functional domains remains high. Higher expression levels of NADH-GOGAT are associated with higher grain protein content in two durum wheats.	[Nigro, Domenica; Marcotuli, Ilaria; Blanco, Antonio; Gadaleta, Agata] Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Bari, Italy; [Gu, Yong Q.; Huo, Naxin; Anderson, Olin D.] ARS, Genom & Gene Discovery Res Unit, Western Reg Res Ctr, USDA, Albany, CA USA	Universita degli Studi di Bari Aldo Moro; United States Department of Agriculture (USDA)	Gadaleta, A (corresponding author), Univ Bari Aldo Moro, Sect Genet & Plant Breeding, Dept Soil Plant & Food Sci, Bari, Italy.	agata.gadaleta@agr.uniba.it; olin.anderson@ars.usda.gov	Gadaleta, Agata/H-2627-2012	Gadaleta, Agata/0000-0002-6312-249X; BLANCO, ANTONIO/0000-0002-2222-1133; Marcotuli, Ilaria/0000-0002-0146-5286	Ministero dell'Istruzione, dell'Universita e della Ricerca; USDA Agricultural Research Service [5325-21000-015]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The research project was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, projects 'PON-ISCOCEM' and 'PRIN-2010-11'; and USDA Agricultural Research Service project 5325-21000-015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anderson OD, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-113; BARON A, 1994, PLANT PHYSIOL BIOCH, V32, P555; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; CHEN FL, 1989, PLANTA, V179, P441, DOI 10.1007/BF00397583; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Cren M, 1999, PLANT CELL PHYSIOL, V40, P1187, DOI 10.1093/oxfordjournals.pcp.a029506; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; Finnemann J, 2000, PLANT J, V24, P171, DOI 10.1046/j.1365-313x.2000.00863.x; Gadaleta A, 2008, MOL BREEDING, V22, P267, DOI 10.1007/s11032-008-9172-8; Gadaleta A, 2009, THEOR APPL GENET, V118, P1015, DOI 10.1007/s00122-008-0958-1; Gimenez MJ, 2011, PLANTA, V233, P163, DOI 10.1007/s00425-010-1290-y; Goto S, 1998, BBA-PROTEIN STRUCT M, V1387, P298, DOI 10.1016/S0167-4838(98)00142-3; HAYAKAWA T, 1994, PLANTA, V193, P455, DOI 10.1007/BF00201826; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Ireland RJ, 1999, BOOK SOIL P, P49; KAMACHI K, 1991, PLANT PHYSIOL, V96, P411, DOI 10.1104/pp.96.2.411; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; Krapp A, 2005, PHOTOSYNTH RES, V83, P251, DOI 10.1007/s11120-004-3196-7; Lancien M, 2002, PLANT J, V29, P347, DOI 10.1046/j.1365-313X.2002.01218.x; Laperche A, 2006, THEOR APPL GENET, V112, P797, DOI 10.1007/s00122-005-0176-z; Lu YE, 2011, SCI CHINA LIFE SCI, V54, P651, DOI 10.1007/s11427-011-4191-9; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Qi LiLi, 2003, Functional & Integrative Genomics, V3, P39; Quraishi UM, 2011, PLANT J, V65, P745, DOI 10.1111/j.1365-313X.2010.04461.x; Sears E. R., 1978, Proceedings of the fifth international wheat genetics symposium. Volume 1. Session IV. Cytogenetics., P389; Sears E. R., 1966, Chromosome manipulations and plant genetics., P29; Sears E.R., 1954, MISSOURI AGR EXPT ST, V572, P1; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Tobin AK, 2001, J EXP BOT, V52, P591, DOI 10.1093/jexbot/52.356.591; van den Heuvel RHH, 2002, J BIOL CHEM, V277, P24579, DOI 10.1074/jbc.M202541200; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Yamaya T, 2002, J EXP BOT, V53, P917, DOI 10.1093/jexbot/53.370.917	33	21	22	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73751	10.1371/journal.pone.0073751	http://dx.doi.org/10.1371/journal.pone.0073751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069228	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300021
J	Rawizza, HE; Chaplin, B; Meloni, ST; Darin, KM; Olaitan, O; Scarsi, KK; Onwuamah, CK; Audu, RA; Chebu, PR; Imade, GE; Okonkwo, P; Kanki, PJ				Rawizza, Holly E.; Chaplin, Beth; Meloni, Seema T.; Darin, Kristin M.; Olaitan, Oluremi; Scarsi, Kimberly K.; Onwuamah, Chika K.; Audu, Rosemary A.; Chebu, Philippe R.; Imade, Godwin E.; Okonkwo, Prosper; Kanki, Phyllis J.			Accumulation of Protease Mutations among Patients Failing Second-Line Antiretroviral Therapy and Response to Salvage Therapy in Nigeria	PLOS ONE			English	Article							LOPINAVIR-RITONAVIR MONOTHERAPY; DRUG-RESISTANCE MUTATIONS; 1-INFECTED PATIENTS; PLUS ZIDOVUDINE; OUTCOMES; LAMIVUDINE; INHIBITORS; SELECTION; FAILURE; PROGRAM	Background: To date, antiretroviral therapy (ART) guidelines and programs in resource-limited settings (RLS) have focused on 1st- and 2nd-line (2 L) therapy. As programs approach a decade of implementation, policy regarding access to 3rd-line (3 L) ART is needed. We aimed to examine the impact of maintaining patients on failing 2 L ART on the accumulation of protease (PR) mutations. Methods and Findings: From 2004-2011, the Harvard/APIN PEPFAR Program provided ART to >100,000 people in Nigeria. Genotypic resistance testing was performed on a subset of patients experiencing 2 L failure, defined as 2 consecutive viral loads (VL)>1000 copies/mL after >= 6 months on 2 L. Of 6714 patients who received protease inhibitor (PI)-based ART, 673 (10.0%) met virologic failure criteria. Genotypes were performed on 61 samples. Patients on non-suppressive 2 L therapy for <12 months prior to genotyping had a median of 2 (IQR: 0-5) International AIDS Society (IAS) PR mutations compared with 5 (IQR: 0-6) among patients failing for >24 months. Patients developed a median of 0.6 (IQR: 0-1.4) IAS PR mutations per 6 months on failing 2 L therapy. In 38% of failing patients no PR mutations were present. For patients failing >24 months, high-or intermediate-level resistance to lopinavir and atazanavir was present in 63%, with 5% to darunavir. Conclusions: This is the first report assessing the impact of duration of non-suppressive 2 L therapy on the accumulation of PR resistance in a RLS. This information provides insight into the resistance cost of failing to switch non-suppressive 2 L regimens and highlights the issue of 3 L access.	[Rawizza, Holly E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Rawizza, Holly E.; Chaplin, Beth; Meloni, Seema T.; Kanki, Phyllis J.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Darin, Kristin M.; Scarsi, Kimberly K.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Olaitan, Oluremi; Okonkwo, Prosper] AIDS Prevent Initiat Nigeria, Abuja, Nigeria; [Onwuamah, Chika K.; Audu, Rosemary A.] Nigerian Inst Med Res, Lagos, Nigeria; [Chebu, Philippe R.; Imade, Godwin E.] Jos Univ Teaching Hosp, Jos, Nigeria	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Northwestern University; Feinberg School of Medicine	Rawizza, HE (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	hrawizza@hsph.harvard.edu	Audu, Rosemary A/G-1726-2017; Onwuamah, Chika Kingsley/ABB-9926-2020	Audu, Rosemary A/0000-0002-0330-5219; Onwuamah, Chika Kingsley/0000-0002-5111-1822; Scarsi, Kimberly/0000-0001-9406-693X	US Department of Health and Human Services, Health Resources and Services Administration [U51HA02522]; Centers for Disease Control and Prevention (CDC) [PS 001058]; Harvard School of Public Health	US Department of Health and Human Services, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Harvard School of Public Health	This work was funded in part by the US Department of Health and Human Services, Health Resources and Services Administration (U51HA02522) and the Centers for Disease Control and Prevention (CDC) through a cooperative agreement with APIN (PS 001058). The authors would also like to acknowledge the Harvard School of Public Health for the provision of funds for a portion of the third-line antiretrovirals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HIV SEQ AL; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Chaplin B, 2011, AIDS RES HUM RETROV, V27, P71, DOI 10.1089/aid.2010.0050; Condra JH, 1998, HAEMOPHILIA, V4, P610, DOI 10.1046/j.1365-2516.1998.440610.x; Delaugerre C, 2009, ANTIMICROB AGENTS CH, V53, P2934, DOI 10.1128/AAC.01643-08; Delfraissy JFO, 2008, AIDS, V22, P385, DOI 10.1097/QAD.0b013e3282f3f16d; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; Federal Ministry of Health Nigeria, 2010, NAT GUID HIV AIDS TR; Ferradini L, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-14; FOX M, 2009, J ACQ IMMUN DEF SYND, V53, P500; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Johnston V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036997; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, UNAIDSJC2296E; Koenig SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001095; Kuritzkes DR, 2004, AIDS, V18, pS45, DOI 10.1097/00002030-200406003-00009; Levison JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032144; Levison JH, 2011, ANTIVIR THER, V16, P853, DOI 10.3851/IMP1819; Loemba H, 2002, ANTIMICROB AGENTS CH, V46, P2087, DOI 10.1128/AAC.46.7.2087-2094.2002; Maguire M, 2002, ANTIMICROB AGENTS CH, V46, P731, DOI 10.1128/AAC.46.3.731-738.2002; Maiga AI, 2012, J ANTIMICROB CHEMOTH, V67, P2943, DOI [10.1093/jac/dks310, 10.1093]; Mo HM, 2005, J VIROL, V79, P3329, DOI 10.1128/JVI.79.6.3329-3338.2005; Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760; Murphy RA, 2012, JAIDS-J ACQ IMM DEF, V61, P158, DOI 10.1097/QAI.0b013e3182615ad1; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Pulido F, 2008, AIDS, V22, pF1, DOI 10.1097/QAD.0b013e3282f4243b; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Saravanan S, 2012, CLIN INFECT DIS, V54, P995, DOI 10.1093/cid/cir967; Steegen Kim, 2009, AIDS Res Ther, V6, P12, DOI 10.1186/1742-6405-6-12; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Supply Chain Management System (SCMS), PEPFAR IMPL PARTN EC; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Wallis CL, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/769627; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2006, ANT THER HIV INF AD; Zazzi M, 2009, J ANTIMICROB CHEMOTH, V64, P616, DOI 10.1093/jac/dkp252	38	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73582	10.1371/journal.pone.0073582	http://dx.doi.org/10.1371/journal.pone.0073582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069209	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300015
J	Ren, ZG; Chen, XH; Cui, GY; Yin, SY; Chen, LY; Jiang, JW; Hu, ZH; Xie, HY; Zheng, SS; Zhou, L				Ren, Zhigang; Chen, Xinhua; Cui, Guangying; Yin, Shengyong; Chen, Luyan; Jiang, Jianwen; Hu, Zhenhua; Xie, Haiyang; Zheng, Shusen; Zhou, Lin			Nanosecond Pulsed Electric Field Inhibits Cancer Growth Followed by Alteration in Expressions of NF-kappa B and Wnt/beta-Catenin Signaling Molecules	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; GENE-EXPRESSION; APOPTOSIS; WNT; MELANOMAS; SURVIVAL; PROTEIN; NOTCH; PROLIFERATION	Cancer remains a leading cause of death worldwide and total number of cases globally is increasing. Novel treatment strategies are therefore desperately required for radical treatment of cancers and long survival of patients. A new technology using high pulsed electric field has emerged from military application into biology and medicine by applying nsPEF as a means to inhibit cancer. However, molecular mechanisms of nsPEF on tumors or cancers are still unclear. In this paper, we found that nsPEF had extensive biological effects in cancers, and clarified its possible molecular mechanisms in vitro and in vivo. It could not only induce cell apoptosis via dependent-mitochondria intrinsic apoptosis pathway that was triggered by imbalance of anti-or pro-apoptosis Bcl-2 family proteins, but also inhibit cell proliferation through repressing NF-kappa B signaling pathway to reduce expressions of cyclin proteins. Moreover, nsPEF could also inactivate metastasis and invasion in cancer cells by suppressing Wnt/beta-Catenin signaling pathway to down-regulating expressions of VEGF and MMPs family proteins. More importantly, nsPEF could function safely and effectively as an anti-cancer therapy through inducing tumor cell apoptosis, destroying tumor microenvironment, and depressing angiogenesis in tumor tissue in vivo. These findings may provide a creative and effective therapeutic strategy for cancers.	[Ren, Zhigang; Chen, Xinhua; Yin, Shengyong; Chen, Luyan; Jiang, Jianwen; Hu, Zhenhua; Xie, Haiyang; Zheng, Shusen; Zhou, Lin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China; [Ren, Zhigang; Chen, Xinhua; Yin, Shengyong; Chen, Luyan; Jiang, Jianwen; Hu, Zhenhua; Xie, Haiyang; Zheng, Shusen; Zhou, Lin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Cui, Guangying] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhou, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat,Minist P, Hangzhou 310003, Zhejiang, Peoples R China.	zhoulin99@zju.edu.cn	Ren, Zhigang/AAO-8576-2020		National S&T Major Project of China [2012ZX10002-017, 2012ZX10002-004]; NSFC for Innovative Research Group of China [81121002]; Zhejiang Medical Research Funding [2008B079, LY13H180003]; SRF for ROCS, SEM [J20120279]; Xinjiang Science and Technology Bureau Project [2013911131]	National S&T Major Project of China; NSFC for Innovative Research Group of China; Zhejiang Medical Research Funding; SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Xinjiang Science and Technology Bureau Project	This work was supported by the National S&T Major Project of China (2012ZX10002-017, 2012ZX10002-004), NSFC for Innovative Research Group of China (81121002), Zhejiang Medical Research Funding (2008B079, LY13H180003), SRF for ROCS, SEM (J20120279), and Xinjiang Science and Technology Bureau Project (2013911131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcellos-De-Souza P, 2012, BBA-MOL CELL RES, V1823, P1990, DOI 10.1016/j.bbamcr.2012.07.012; Beebe SJ, 2004, PHYSIOL MEAS, V25, P1077, DOI 10.1088/0967-3334/25/4/023; Chen X, 2012, TECHNOL CANCER RES T, V11, P83, DOI 10.7785/tcrt.2012.500237; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Chen XH, 2009, MELANOMA RES, V19, P361, DOI 10.1097/CMR.0b013e32832f1558; Cheng J, 2010, PROTEOMICS, V10, P1557, DOI 10.1002/pmic.200900646; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Czymek R, 2012, SURG ONCOL, V21, P79, DOI 10.1016/j.suronc.2010.10.007; Davis JL, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-129; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Ford WE, 2010, ARCH BIOCHEM BIOPHYS, V497, P82, DOI 10.1016/j.abb.2010.03.008; Fukuyama R, 2007, MOL CARCINOGEN, V46, P402, DOI 10.1002/mc.20288; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang JW, 2011, HEPATOB PANCREAT DIS, V10, P380, DOI 10.1016/S1499-3872(11)60064-7; Jiang W, 2012, WORLD J SURG; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kolb JF, 2006, BIOELECTROMAGNETICS, V27, P172, DOI 10.1002/bem.20185; Lee JH, 2011, P NATL ACAD SCI USA, V108, P12036, DOI 10.1073/pnas.1108125108; Meulenbeld HJ, 2013, BJU INT, V111, P44, DOI 10.1111/j.1464-410X.2012.11404.x; Meyer C, 2011, ORAL ONCOL, V47, P818, DOI 10.1016/j.oraloncology.2011.06.010; Mulier S, 2005, ANN SURG, V242, P158, DOI 10.1097/01.sla.0000171032.99149.fe; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2013, INT J CANCER, V132, P1933, DOI 10.1002/ijc.27860; Nuccitelli R, 2010, INT J CANCER, V127, P1727, DOI 10.1002/ijc.25364; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schoenbach KH, 2004, P ANN INT IEEE EMBS, V26, P5447; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043213; Wu LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014460; Xing CY, 2013, MOL CANCER THER, V12, P94, DOI 10.1158/1535-7163.MCT-12-0672; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Zhang F, 2008, ANN SURG ONCOL, V15, P3494, DOI 10.1245/s10434-008-0146-1; Zhu HP, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-1; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	49	27	31	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74322	10.1371/journal.pone.0074322	http://dx.doi.org/10.1371/journal.pone.0074322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069295	gold, Green Submitted, Green Published			2022-12-27	WOS:000324547300034
J	Vargas-Alarcon, G; Posadas-Romero, C; Villarreal-Molina, T; Alvarez-Leon, E; Angeles, J; Vallejo, M; Posadas-Sanchez, R; Cardoso, G; Medina-Urrutia, A; Kimura-Hayama, E				Vargas-Alarcon, Gilberto; Posadas-Romero, Carlos; Villarreal-Molina, Teresa; Alvarez-Leon, Edith; Angeles, Javier; Vallejo, Maite; Posadas-Sanchez, Rosalinda; Cardoso, Guillermo; Medina-Urrutia, Aida; Kimura-Hayama, Eric			Single Nucleotide Polymorphisms within LIPA (Lysosomal Acid Lipase A) Gene Are Associated with Susceptibility to Premature Coronary Artery Disease. A Replication in the Genetic of Atherosclerotic Disease (GEA) Mexican Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHOLESTEROL; LOCI	Aim: The rs1412444 and rs2246833 polymorphisms within the LIPA gene were recently found to be significantly associated with coronary artery disease (CAD) in genome-wide association studies in Caucasian and Asian populations. The aim of the present study was to replicate this association in an independent population with a different genetic background. Methods: The rs1412444 and rs2246833 polymorphisms of the LIPA gene were genotyped by 5' exonuclease TaqMan genotyping assays in a sample of 899 Mexican patients with premature CAD, 270 individuals with subclinical atherosclerosis, and 677 healthy unrelated controls. Haplotypes were constructed after linkage disequilibrium analysis. Results: Under recessive and additive models, the rs1412444 T and rs2246833 T alleles were associated with an increased risk of premature CAD when compared to controls adjusting for age, gender, BMI, and total cholesterol (OR = 1.53, P-Rec = 0.0013 and OR = 1.34, P-Add = 5 x 10(-4) for rs1412444 and OR = 1.45, P-Rec = 0.0039 and OR = 1.28, P-Add = 0.0023 for rs2246833). The effect of the two polymorphisms on various metabolic cardiovascular risk factors was analyzed in premature CAD and controls (CAC score = 0). The T alleles in both polymorphisms after adjusting for age, gender, BMI, and medication were associated with hypo-a-lipoproteinemia, hypercholesterolemia, hypertriglyceridemia, metabolic syndrome, and type 2 diabetes mellitus using recessive and additive models. The polymorphisms were in strong linkage disequilibrium and, based on SNP functional prediction software, only the rs1412444 polymorphism seemed to be functional. Conclusions: These results indicate that the rs1412444 and rs2246833 of the LIPA gene are shared susceptibility polymorphisms for CAD among different ethnicities.	[Vargas-Alarcon, Gilberto; Alvarez-Leon, Edith; Angeles, Javier] Inst Nacl Cardiol Ignacio, Dept Mol Biol, Mexico City, DF, Mexico; [Posadas-Romero, Carlos; Posadas-Sanchez, Rosalinda; Cardoso, Guillermo; Medina-Urrutia, Aida] Inst Nacl Cardiol Ignacio, Dept Endocrinol, Mexico City, DF, Mexico; [Villarreal-Molina, Teresa] Inst Nacl Med Genom INMEGEN, Cardiovasc Genom Lab, Mexico City, DF, Mexico; [Vallejo, Maite] Inst Nacl Cardiol Ignacio, Sociomed Dept, Mexico City, DF, Mexico; [Kimura-Hayama, Eric] Inst Nacl Cardiol Ignacio, Dept Tomog, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica	Vargas-Alarcon, G (corresponding author), Inst Nacl Cardiol Ignacio, Dept Mol Biol, Mexico City, DF, Mexico.	gvargas63@yahoo.com		Vargas-Alarcon, Gilberto/0000-0001-7916-5163; Cardoso, Guillermo/0000-0001-9525-1731; Angeles Martinez, Javier/0000-0001-5405-0482; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690	Consejo Nacional de Ciencia y Tecnologia [156911, 112547]; Fundacion Gonzalo Rio Arronte, Mexico City, Mexico	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Gonzalo Rio Arronte, Mexico City, Mexico	This work was supported in part by grants from the Consejo Nacional de Ciencia y Tecnologia (projects 156911 and 112547) and Fundacion Gonzalo Rio Arronte, Mexico City, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS GENET, V7; Bernstein DL, 2013, J HEPATOL, V58, P1230, DOI 10.1016/j.jhep.2013.02.014; Bhakdi S, 2004, THROMB HAEMOSTASIS, V91, P639, DOI 10.1160/TH-03-12-d733; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Garcia-Moll X, 2005, REV ESP CARDIOL, V58, P615, DOI 10.1157/13076412; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Lee JY, 2013, J HUM GENET, V58, P120, DOI 10.1038/jhg.2012.124; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Muntoni S, 2013, NUTR METAB CARDIOVAS, V23, P732, DOI 10.1016/j.numecd.2012.05.009; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; O'Donnell CJ, 2011, CIRCULATION, V124, P2855, DOI 10.1161/CIRCULATIONAHA.110.974899; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Villarreal-Molina T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049285; Wild PS, 2011, CIRC-CARDIOVASC GENE, V4, P403, DOI 10.1161/CIRCGENETICS.110.958728; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zschenker O, 2006, J BIOCHEM, V140, P23, DOI 10.1093/jb/mvj137	20	18	19	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74703	10.1371/journal.pone.0074703	http://dx.doi.org/10.1371/journal.pone.0074703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069331	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300050
J	Camara-Clayette, V; Koscielny, S; Roux, S; Lamy, T; Bosq, J; Bernard, M; Fest, T; Lazar, V; Lenoir, G; Ribrag, V				Camara-Clayette, Valerie; Koscielny, Serge; Roux, Sebastien; Lamy, Thierry; Bosq, Jacques; Bernard, Marc; Fest, Thierry; Lazar, Vladimir; Lenoir, Gilbert; Ribrag, Vincent			BMP7 Expression Correlates with Secondary Drug Resistance in Mantle Cell Lymphoma	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; GASTRIC-CANCER; GENES; INVASION	Purpose: We designed a gene profiling experiment to identify genes involved in secondary drug resistance in mantle cell lymphomas (MCL). Experimental Design: We obtained paired tissue samples collected from the same patients before treatment and after relapse or progression. Variations in gene expression between the 2 samples were estimated for 5 patients. For each gene, the mean variation was estimated for patients with a refractory primary tumor and for responders who developed secondary drug resistance. Nine genes of interest were selected on the basis of the magnitude and statistical significance of the variation of expression in responders and non-responders. Results: BMP7 was the only one with significantly increased expression at relapse in patients who developed secondary resistance. Validation of BMP7 as a key gene involved in secondary resistance was performed using cultures of cell line. Incubation of BMP7 with MCL cell lines increased their resistance to bortezomib and cytarabine, while inhibition of BMP7 expression by siRNA correlated with increased cell death linked to drug application. Conclusion: Variations in gene expression after treatment point out BMP7 as a key gene involved in secondary resistance in mantle cell lymphoma.	[Camara-Clayette, Valerie; Roux, Sebastien; Lazar, Vladimir; Lenoir, Gilbert] Inst Cancerol Gustave Roussy, IRCIV, Villejuif, France; [Camara-Clayette, Valerie; Roux, Sebastien; Ribrag, Vincent] Univ Paris 11, INSERM, U1009, Inst Cancerol Gustave Roussy, Villejuif, France; [Koscielny, Serge] Inst Cancerol Gustave Roussy, Dept Translat Res, Biostat & Epidemiol Serv, Villejuif, France; [Lamy, Thierry; Bernard, Marc; Fest, Thierry] Ctr Hosp Univ Rennes, Serv Hematol, F-35033 Rennes, France; [Lamy, Thierry; Fest, Thierry] Univ Rennes 1, INSERM, UMR U917, Rennes, France; [Bosq, Jacques] Inst Cancerol Gustave Roussy, Dept Biopathol, Villejuif, France; [Ribrag, Vincent] Inst Cancerol Gustave Roussy, Dept Med, Villejuif, France	UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Ribrag, V (corresponding author), Univ Paris 11, INSERM, U1009, Inst Cancerol Gustave Roussy, Villejuif, France.	ribrag@igr.fr	Lazar, Vladimir/AAV-2087-2020; Lazar, Vladimir/AAQ-2086-2020	fest, thierry/0000-0002-6437-4189				Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028; Aoki M, 2011, BRIT J CANCER, V104, P714, DOI 10.1038/sj.bjc.6606075; Beck SE, 2007, CANCER BIOL THER, V6, P1313; Ghielmini M, 2009, BLOOD, V114, P1469, DOI 10.1182/blood-2009-02-179739; Gomez-Roca CA, 2012, ANN ONCOL, V23, P1301, DOI 10.1093/annonc/mdr383; Goy A, 2011, CRIT REV ONCOL HEMAT, V80, P69, DOI 10.1016/j.critrevonc.2010.09.003; Grcevic D, 2010, LEUKEMIA RES, V34, P742, DOI 10.1016/j.leukres.2009.10.016; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Hu MC, 2004, J BIOL CHEM, V279, P12051, DOI 10.1074/jbc.M310526200; Huse K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046117; Huse K, 2011, EUR J IMMUNOL, V41, P3135, DOI 10.1002/eji.201141558; Kazuo M, 2008, ANN SURG ONCOL, V15, P1530, DOI 10.1245/s10434-007-9746-4; Kron K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004830; Leonard JP, 2009, CLIN LYMPHOMA MYELOM, V9, P267, DOI 10.3816/CLM.2009.n.055; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Rothhammer T, 2005, CANCER RES, V65, P448; Rothhammer Tania, 2007, Cancer Biomarkers, V3, P111; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Tamaki K, 1998, J CELL PHYSIOL, V177, P355, DOI 10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Yang S, 2008, CANCER RES, V68, P198, DOI 10.1158/0008-5472.CAN-07-5074; Yang SX, 2006, CANCER RES, V66, P4285, DOI 10.1158/0008-5472.CAN-05-4456; Zwijsen A, 2003, FEBS LETT, V546, P133, DOI 10.1016/S0014-5793(03)00566-0	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73993	10.1371/journal.pone.0073993	http://dx.doi.org/10.1371/journal.pone.0073993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069261	Green Published, gold			2022-12-27	WOS:000326240100080
J	Ferrari, J; Knoflach, M; Seyfang, L; Lang, W				Ferrari, Julia; Knoflach, Michael; Seyfang, Leonhard; Lang, Wilfried		Austrian Stroke Unit Registry	Differences in Process Management and In-Hospital Delays in Treatment with iv Thrombolysis	PLOS ONE			English	Article							STROKE UNIT REGISTRY; ACUTE ISCHEMIC-STROKE; ALTEPLASE; INTERVENTION; THERAPY; SCALE; TIME	Objectives: Rapid initiation of intravenous thrombolysis improves patient's outcome in acute stroke. We analyzed intercenter variability and factors that influence the door-to-needle time with a special focus on process measurements in all Austrian stroke units. Methods: Case level data of patients receiving intravenous thrombolysis in the Austrian Stroke Unit Registry were enriched with information of a structured questionnaire on center specific process measures of all Austrian stroke units. Influence of case and center specific variables was determined by LASSO procedure. Results: Center specific median door-to-needle time ranged between 30 and 78 minutes. Between April 2004 and November 2012, 6246 of 57991 patients treated in Austrian stroke units with acute ischemic stroke received intravenous thrombolysis. An onset-to-door time >120 minutes, patients with total anterior circulation stroke, recent year of admission, patient transportation with ambulance crew and emergency physician, the use of point of care tests reduced the door-to-needle time, whereas onset-to-door <= 60 minutes, unknown onset-to-door, patients with an NIHSS <= 4 or posterior circulation stroke, initial admission to a general emergency department, a distant radiology department, primary imaging modality other than plain CT and waiting for the lab results were associated with an increase in door-to-needle time. Case level and center specific factors could explain the inter center variability of door-to-needle times in 31 of 34 stroke units in Austria. Conclusions: In light of our results it seems crucial that every single stroke center documents and critically reviews possibilities of optimizing practice strategies in acute stroke care.	[Ferrari, Julia; Lang, Wilfried] Hosp Barmherzige Brueder, Dept Neurol, Vienna, Austria; [Knoflach, Michael] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Seyfang, Leonhard] Danube Univ, Dept Clin Neurosci & Prevent Med, Krems, Austria; Gesundheit Osterreich GmbH BIQG, Vienna, Austria	Konventhospital Der Barmherzigen Bruder; Medical University of Innsbruck; Danube University Krems	Knoflach, M (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria.	michael.knoflach@i-med.ac.at		Trinka, Eugen/0000-0002-5950-2692; Knoflach, Michael/0000-0001-5576-6562				Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Ferrari J, 2010, NEUROLOGY, V74, P136, DOI 10.1212/WNL.0b013e3181c9188b; Ferrari J, 2010, STROKE, V41, P2001, DOI 10.1161/STROKEAHA.110.590372; Fonarow GC, 2011, STROKE, V42, P2983, DOI 10.1161/STROKEAHA.111.621342; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Ford AL, 2012, STROKE, V43, P3395, DOI 10.1161/STROKEAHA.112.670687; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hastie T., 2011, LARS LEAST ANGLE REG; Knoflach M, 2012, NEUROLOGY, V78, P279, DOI 10.1212/WNL.0b013e31824367ab; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Linfante I, 2001, ARCH NEUROL-CHICAGO, V58, P621, DOI 10.1001/archneur.58.4.621; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Mikulik R, 2012, STROKE, V43, P1578, DOI 10.1161/STROKEAHA.111.644120; R Development Core Team, 2010, R LANG ENV STAT COMP; Rizos T, 2009, STROKE, V40, P3547, DOI 10.1161/STROKEAHA.109.562769; Rost NS, 2009, NEUROLOGY, V73, P1957, DOI 10.1212/WNL.0b013e3181c5b46d; Sato S, 2008, NEUROLOGY, V70, P2371, DOI 10.1212/01.wnl.0000304346.14354.0b; Scott PA, 2013, LANCET NEUROL, V12, P139, DOI 10.1016/S1474-4422(12)70311-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Topakian R, 2011, EUR J NEUROL, V18, P306, DOI 10.1111/j.1468-1331.2010.03141.x; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2	22	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75378	10.1371/journal.pone.0075378	http://dx.doi.org/10.1371/journal.pone.0075378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069406	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100123
J	Saisho, Y; Hirose, H; Roberts, R; Abe, T; Kawabe, H; Itoh, H				Saisho, Yoshifumi; Hirose, Hiroshi; Roberts, Rachel; Abe, Takayuki; Kawabe, Hiroshi; Itoh, Hiroshi			C-Reactive Protein, High-Molecular-Weight Adiponectin and Development of Metabolic Syndrome in the Japanese General Population: A Longitudinal Cohort Study	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; INSULIN-RESISTANCE; CIRCULATING ADIPONECTIN; MAJOR DETERMINANT; RISK; DISEASE; PLASMA; HEALTH; FORM; INFLAMMATION	Aims: To clarify predictive values of C-reactive protein (CRP) and high-molecular-weight (HMW) adiponectin for development of metabolic syndrome. Research Design and Methods: We conducted a prospective cohort study of Japanese workers who had participated in an annual health checkup in 2007 and 2011. A total of 750 subjects (558 men and 192 women, age 46 +/- 8 years) who had not met the criteria of metabolic syndrome and whose CRP and HMW-adiponectin levels had been measured in 2007 were enrolled in this study. Associations between CRP, HMW-adiponectin and development of metabolic syndrome after 4 years were assessed by logistic regression analysis and their predictive values were compared by receiver operating characteristic analysis. Results: Among 750 subjects, 61 (8.1%) developed metabolic syndrome defined by modified National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria and 53 (7.1%) developed metabolic syndrome defined by Japan Society for the Study of Obesity (JASSO) in 2011. Although CRP and HMW-adiponectin were both significantly correlated with development of metabolic syndrome, multivariate logistic regression analysis revealed that HMW-adiponectin but not CRP was associated with metabolic syndrome independently of BMI or waist circumference. Adding these biomarkers to BMI or waist circumference did not improve the predictive value for metabolic syndrome. Conclusion: Our findings indicate that the traditional markers of adiposity such as BMI or waist circumference remain superior markers for predicting metabolic syndrome compared to CRP, HMW-adiponectin, or the combination of both among the Japanese population.	[Saisho, Yoshifumi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Hirose, Hiroshi; Kawabe, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo, Japan; [Roberts, Rachel; Abe, Takayuki] Keio Univ, Sch Med, Clin Res Ctr, Tokyo, Japan	Keio University; Keio University; Keio University	Saisho, Y (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan.	ysaisho@z5.keio.jp	Hirose, Hiroshi/F-8556-2014; Saisho, Yoshifumi/H-2925-2019	Saisho, Yoshifumi/0000-0002-6071-4393	Ministry of Education, Culture, Sports, Science and Technology, Japan; Keio University, Tokyo	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio University, Tokyo	This study was supported in part by a Grant-in Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to H. H.), and by research grants from Keio University, Tokyo (to H. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Aronson D, 2004, INT J OBESITY, V28, P674, DOI 10.1038/sj.ijo.0802609; Aso Y, 2006, DIABETES, V55, P1954, DOI 10.2337/db05-1525; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Chao C, 2010, ARCH INTERN MED, V170, P1557, DOI 10.1001/archinternmed.2010.312; Corrado E, 2010, J ATHEROSCLER THROMB, V17, P1, DOI 10.5551/jat.2600; Daimon M, 2003, DIABETES CARE, V26, P2015, DOI 10.2337/diacare.26.7.2015; Dallmeier D, 2012, J AM HEART ASSOC, V1, DOI DOI 10.1161/JAHA.112.000869; Devaraj S, 2008, AM J CLIN PATHOL, V129, P815, DOI 10.1309/RN84K51B2JJY1Y0B; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Ford ES, 2003, ATHEROSCLEROSIS, V168, P351, DOI 10.1016/S0021-9150(03)00134-5; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Hirose H, 2010, J ATHEROSCLER THROMB, V17, P1201, DOI 10.5551/jat.6106; Inoue T, 2007, AM J CARDIOL, V100, P569, DOI 10.1016/j.amjcard.2007.03.062; Kahn SE, 2006, DIABETES, V55, P2357, DOI 10.2337/db06-0116; Kizer JR, 2013, J CLIN ENDOCR METAB, V98, P255, DOI 10.1210/jc.2012-2103; Kizer JR, 2012, CIRCULATION, V126, P2951, DOI 10.1161/CIRCULATIONAHA.112.135202; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Matsushita K, 2006, ARTERIOSCL THROM VAS, V26, P871, DOI 10.1161/01.ATV.0000208363.85388.8f; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ministry of Health Labour and Welfare, 2007, NAT HLTH NUTR SURV; Nakano Y, 2006, J LIPID RES, V47, P1572, DOI 10.1194/jlr.D600010-JLR200; Ong KL, 2011, DIABETOLOGIA, V54, P2552, DOI 10.1007/s00125-011-2227-0; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Saisho Y, 2010, J ATHEROSCLER THROMB, V17, P944, DOI 10.5551/jat.4234; Saito I, 2013, ATHEROSCLEROSIS; Seino Y, 2007, METABOLISM, V56, P1493, DOI 10.1016/j.metabol.2007.06.015; Seino Y, 2009, METABOLISM, V58, P355, DOI 10.1016/j.metabol.2008.10.008; Tabara Y, 2008, J CLIN ENDOCR METAB, V93, P715, DOI 10.1210/jc.2007-0397; The Examination Committee of Criteria for Metabolic Syndrome, 2005, J JPN SOC INT MED, V94, P794; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wannamethee SG, 2007, ARCH INTERN MED, V167, P1510, DOI 10.1001/archinte.167.14.1510; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yatagai T, 2003, METABOLISM, V52, P1274, DOI 10.1016/S0026-0495(03)00195-1	36	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73430	10.1371/journal.pone.0073430	http://dx.doi.org/10.1371/journal.pone.0073430			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069195	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100043
J	Mao, YH; Li, Q; Zhang, YW; Zhang, JJ; Wei, GH; Tao, SH				Mao, Yuanhui; Li, Qian; Zhang, Yinwen; Zhang, Junjie; Wei, Gehong; Tao, Shiheng			Genome-Wide Analysis of Selective Constraints on High Stability Regions of mRNA Reveals Multiple Compensatory Mutations in Escherichia coli	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; SECONDARY STRUCTURE; NONCODING RNA; CODON USAGE; TRANSLATIONAL EFFICIENCY; EVOLUTION; BIAS; DETERMINANTS; ARCHITECTURE; PRESSURES	Message RNA (mRNA) carries a large number of local secondary structures, with structural stability to participate in the regulations of gene expression. A worthy question is how the local structural stability is maintained under the constraint that multiple selective pressures are imposed on mRNA local regions. Here, we performed the first genome-wide study of natural selection operating on high structural stability regions (HSRs) of mRNAs in Escherichia coli. We found that HSR tends to adjust the folded conformation to reduce the harm of mutations, showing a high level of mutational robustness. Moreover, guanine preference in HSR was observed, supporting the hypothesis that the selective constraint for high structural stability may partly account for the high percentage of G content in Escherichia coli genome. Notably, we found a substantially reduced synonymous substitution rate in HSRs compared with that in their adjacent regions. Surprisingly and interestingly, the non-key sites in HSRs, which have slight effect on structural stability, have synonymous substitution rate equivalent to background regions. To explain this result, we identified compensatory mutations in HSRs based on structural stability, and found that a considerable number of synonymous mutations occur to restore the structural stability decreased heavily by the mutations on key sites. Overall, these results suggest a significant role of local structural stability as a selective force operating on mRNA, which furthers our understanding of the constraints imposed on protein-coding RNAs.	[Mao, Yuanhui; Li, Qian; Zhang, Yinwen; Zhang, Junjie; Wei, Gehong; Tao, Shiheng] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Mao, Yuanhui; Li, Qian; Zhang, Yinwen; Zhang, Junjie; Wei, Gehong; Tao, Shiheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Mao, Yuanhui; Li, Qian; Zhang, Yinwen; Zhang, Junjie; Tao, Shiheng] Northwest A&F Univ, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Tao, SH (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	weigehong@nwsuaf.edu.cn; shihengt@nwsuaf.edu.cn	zhang, yinwen/HHZ-1518-2022	zhang, yinwen/0000-0001-8776-6823	PhD Programs Foundation of the Ministry of Education of China [20100204110026]; National Science Foundation of China [31125007]	PhD Programs Foundation of the Ministry of Education of China(Ministry of Education, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the PhD Programs Foundation of the Ministry of Education of China (20100204110026) and project from National Science Foundation of China (31125007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchette Mathieu, 2008, V422, P171, DOI 10.1007/978-1-59745-581-7_11; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Caetano-Anolles G, 2002, J MOL EVOL, V54, P333, DOI 10.1007/s00239-001-0048-3; Carmel I, 2012, RNA, V18, P1947, DOI 10.1261/rna.032185.111; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cheng N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044376; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Dutheil JY, 2010, MOL BIOL EVOL, V27, P1868, DOI 10.1093/molbev/msq069; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garcia-Vallve S, 2000, GENOME RES, V10, P1719, DOI 10.1101/gr.130000; Gingold H, 2012, NUCLEIC ACIDS RES, V40, P10053, DOI 10.1093/nar/gks772; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gu WJ, 2012, MOL BIOL EVOL, V29, P3037, DOI 10.1093/molbev/mss109; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katz L, 2003, GENOME RES, V13, P2042, DOI 10.1101/gr.1257503; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Knies JL, 2008, MOL BIOL EVOL, V25, P1778, DOI 10.1093/molbev/msn130; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lee MT, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000150; Levin BR, 2000, GENETICS, V154, P985; Li F, 2012, CELL REP, V1, P69, DOI 10.1016/j.celrep.2011.10.002; Lind PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063373; Mao YH, 2013, GENOME BIOL EVOL, V5, P484, DOI 10.1093/gbe/evt020; Mao YH, 2013, GENE, V517, P230, DOI 10.1016/j.gene.2012.12.062; Mimouni NK, 2009, MOL BIOL EVOL, V26, P209, DOI 10.1093/molbev/msn240; Moss WN, 2011, RNA, V17, P991, DOI 10.1261/rna.2619511; Novikova IV, 2012, NUCLEIC ACIDS RES, V40, P5034, DOI 10.1093/nar/gks071; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Park C, 2013, P NATL ACAD SCI USA, V110, pE678, DOI 10.1073/pnas.1218066110; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pereira F, 2008, MOL BIOL EVOL, V25, P2759, DOI 10.1093/molbev/msn225; Piskol R, 2011, MOL BIOL EVOL, V28, P1519, DOI 10.1093/molbev/msq343; Price N, 2011, MOL BIOL EVOL, V28, P2115, DOI 10.1093/molbev/msr029; Proctor JR, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt174; Rocha EPC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001104; Schroeder R, 2004, NAT REV MOL CELL BIO, V5, P908, DOI 10.1038/nrm1497; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Stoletzki N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-224; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tuller T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r110; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu CH, 2011, NUCLEIC ACIDS RES, V39, P8952, DOI 10.1093/nar/gkr579; Zur H, 2012, EMBO REP, V13, P272, DOI 10.1038/embor.2011.262	57	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73299	10.1371/journal.pone.0073299	http://dx.doi.org/10.1371/journal.pone.0073299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086278	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900013
J	Endlein, T; Barnes, WJP; Samuel, DS; Crawford, NA; Biaw, AB; Grafe, U				Endlein, Thomas; Barnes, W. Jon P.; Samuel, Diana S.; Crawford, Niall A.; Biaw, Ang Bee; Grafe, Ulmar			Sticking under Wet Conditions: The Remarkable Attachment Abilities of the Torrent Frog, Staurois guttatus	PLOS ONE			English	Article							TOE-PADS; TREE FROG; ADHESIVE SURFACE; MECHANISMS; DETACHMENT; MORPHOLOGY	Tree frogs climb smooth surfaces utilising capillary forces arising from an air-fluid interface around their toe pads, whereas torrent frogs are able to climb in wet environments near waterfalls where the integrity of the meniscus is at risk. This study compares the adhesive capabilities of a torrent frog to a tree frog, investigating possible adaptations for adhesion under wet conditions. We challenged both frog species to cling to a platform which could be tilted from the horizontal to an upside-down orientation, testing the frogs on different levels of roughness and water flow. On dry, smooth surfaces, both frog species stayed attached to overhanging slopes equally well. In contrast, under both low and high flow rate conditions, the torrent frogs performed significantly better, even adhering under conditions where their toe pads were submerged in water, abolishing the meniscus that underlies capillarity. Using a transparent platform where areas of contact are illuminated, we measured the contact area of frogs during platform rotation under dry conditions. Both frog species not only used the contact area of their pads to adhere, but also large parts of their belly and thigh skin. In the tree frogs, the belly and thighs often detached on steeper slopes, whereas the torrent frogs increased the use of these areas as the slope angle increased. Probing small areas of the different skin parts with a force transducer revealed that forces declined significantly in wet conditions, with only minor differences between the frog species. The superior abilities of the torrent frogs were thus due to the large contact area they used on steep, overhanging surfaces. SEM images revealed slightly elongated cells in the periphery of the toe pads in the torrent frogs, with straightened channels in between them which could facilitate drainage of excess fluid underneath the pad.	[Endlein, Thomas; Barnes, W. Jon P.; Samuel, Diana S.; Crawford, Niall A.] Univ Glasgow, Ctr Cell Engn, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Biaw, Ang Bee; Grafe, Ulmar] Univ Brunei Darussalam, Belalong Field Studies Ctr, Fac Sci Biol, Gadong, Brunei	University of Glasgow; University Brunei Darussalam	Endlein, T (corresponding author), Univ Glasgow, Ctr Cell Engn, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	thomas.endlein@glasgow.ac.uk			Deutsche Forschungsgemeinschaft [SPP1420]; Company of Biologists; Carnegie Trust for the Universities of Scotland	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Company of Biologists; Carnegie Trust for the Universities of Scotland	This study was supported by grants from the Deutsche Forschungsgemeinschaft (program SPP1420, http://spp1420.mpikg.mpg.de/) awarded to Dr Jon Barnes, a travel grant from The Company of Biologists (http://workshops.biologists.com/grant_information.html) awarded to Dr Thomas Endlein and a grant from the Carnegie Trust for the Universities of Scotland (http://www.carnegie-trust.org/) awarded to Dr Jon Barnes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autumn K, 2002, INTEGR COMP BIOL, V42, P1081, DOI 10.1093/icb/42.6.1081; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Barnes J, 2006, COMP BIOCHEM PHYS A, V143, pS94; Barnes J, 2002, TIRE TECHNOL INT, P56; Barnes WJP, 2006, J COMP PHYSIOL A, V192, P1179, DOI 10.1007/s00359-006-0146-1; BETTS RP, 1980, J MED ENG TECHNOL, V4, P136, DOI 10.3109/03091908009161107; Crawford N, 2012, J EXP BIOL, V215, P3965, DOI 10.1242/jeb.073809; Drotlef D.-M., 2012, ADV FUNCTIONAL MAT, V9, P1094; Duellman W.E., 1985, BIOL AMPHIBIANS; EMERSON SB, 1980, BIOL J LINN SOC, V13, P199, DOI 10.1111/j.1095-8312.1980.tb00082.x; Endlein T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0838; ERNST VV, 1973, TISSUE CELL, V5, P97, DOI 10.1016/S0040-8166(73)80008-4; Federle W, 2004, ARTHROPOD STRUCT DEV, V33, P67, DOI 10.1016/j.asd.2003.11.001; Federle W, 2006, J R SOC INTERFACE, V3, P689, DOI 10.1098/rsif.2006.0135; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866; Grafe TU, 2007, ETHOLOGY, V113, P772, DOI 10.1111/j.1439-0310.2007.01378.x; Grafe T. Ulmar, 2009, Salamandra, V45, P25; GREEN DM, 1979, CAN J ZOOL, V57, P2033, DOI 10.1139/z79-268; GREEN DM, 1981, COPEIA, P790, DOI 10.2307/1444179; Gupta R, 2012, LANGMUIR, V28, P14703, DOI 10.1021/la303508x; HANNA G, 1991, J EXP BIOL, V155, P103; Matz D, 2008, COMP BIOCHEM PHYS A, V150, pS90, DOI 10.1016/j.cbpa.2008.04.169; Ohler Annemarie, 1995, Asiatic Herpetological Research, V6, P85; Scholz I, 2009, J EXP BIOL, V212, P155, DOI 10.1242/jeb.019232; Smith JM, 2006, J ZOOL, V270, P372, DOI 10.1111/j.1469-7998.2006.00145.x; Smith JM, 2006, J COMP PHYSIOL A, V192, P1193, DOI 10.1007/s00359-006-0151-4	26	52	52	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73810	10.1371/journal.pone.0073810	http://dx.doi.org/10.1371/journal.pone.0073810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086297	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000325218700013
J	Readman, GD; Owen, SF; Murrell, JC; Knowles, TG				Readman, Gareth D.; Owen, Stewart F.; Murrell, Joanna C.; Knowles, Toby G.			Do Fish Perceive Anaesthetics as Aversive?	PLOS ONE			English	Article							TRICAINE METHANESULFONATE; COMPARATIVE EFFICACY; AVOIDANCE-BEHAVIOR; CARBON-DIOXIDE; CLOVE OIL; STRESS; 2-PHENOXYETHANOL; EUTHANASIA; WELFARE; MS-222	This study addresses a fundamental question in fish welfare: are the anaesthetics used for fish aversive? Despite years of routine general use of many agents, within both scientific research and aquaculture, there is a paucity of information regarding their tolerance and associated behavioural responses by fish. This study examined nine of the most commonly used fish anaesthetic agents, and performed preference tests using adult mixed sex zebrafish (Danio rerio), the most commonly held laboratory fish. Video tracking software quantified swimming behaviour related to aversion for each anaesthetic at 50% of its standard recommended dose compared with clean water in a flow-through chemotaxic choice chamber. Results suggest that several commonly used anaesthetics were aversive, including two of the most commonly recommended and used: MS222 (ethyl 3-aminobenzoate methanesulphate) and benzocaine. For ethical best practice, it is recommended that compounds that are aversive, even at low concentration, should no longer be used routinely for anaesthesia or indeed the first step of humane euthanasia of adult zebrafish. Two agents were found not to induce aversive behavioural responses: etomidate and 2,2,2 tribromoethanol. For the millions of adult zebrafish used in laboratories and breeding worldwide, etomidate appears best suited for future routine humane use.	[Readman, Gareth D.; Owen, Stewart F.] AstraZeneca, Brixham Environm Lab, Brixham, Devon, England; [Readman, Gareth D.; Murrell, Joanna C.; Knowles, Toby G.] Univ Bristol, Sch Vet Sci, Langford, North Somerset, England	AstraZeneca; University of Bristol	Readman, GD (corresponding author), AstraZeneca, Brixham Environm Lab, Brixham, Devon, England.	gareth.readman@astrazeneca.com	Owen, Stewart/ABF-1216-2021; Knowles, Toby G/A-2026-2008	Knowles, Toby G/0000-0002-3845-0942; Readman, Gareth/0000-0003-3736-8186; Owen, Stewart/0000-0003-1398-7142	AstraZeneca under the Saftey Health and Environment research programme	AstraZeneca under the Saftey Health and Environment research programme	This work was funded by AstraZeneca under the Saftey Health and Environment research programme. AstraZeneca does not have any products, patents, or products under development that are marketed as fish-specific anaesthetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PA, 2007, ANAESTHETICS 2007 07; AMEND DF, 1982, T AM FISH SOC, V111, P337, DOI 10.1577/1548-8659(1982)111&lt;337:E&gt;2.0.CO;2; Carter KM, 2011, REV FISH BIOL FISHER, V21, P51, DOI 10.1007/s11160-010-9188-0; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; Colwill RM, 2011, BEHAV PROCESS, V86, P222, DOI 10.1016/j.beproc.2010.12.003; Delicio Helton Carlos, 2006, Journal of Experimental Animal Science, V43, P141, DOI 10.1016/j.jeas.2006.01.001; Gressler LT, 2012, J FISH BIOL, V81, P1436, DOI 10.1111/j.1095-8649.2012.03409.x; Gressler LT, 2012, AQUAC RES, P1, DOI [10.1111/are.12043, DOI 10.1111/ARE.12043)]; HIDAKA H, 1989, ENVIRON POLLUT, V56, P299, DOI 10.1016/0269-7491(89)90075-4; HOUSTON AH, 1973, J FISH RES BOARD CAN, V30, P1705, DOI 10.1139/f73-270; Ilkiw JE, 1999, CLIN TECH SMALL AN P, V14, P27, DOI 10.1016/S1096-2867(99)80024-3; JOSA A, 1992, VET REC, V131, P468, DOI 10.1136/vr.131.20.468; Kazun K., 2012, Archives of Polish Fisheries, V20, P173; Kristiansen TS, 2004, AQUACULTURE, V230, P137, DOI 10.1016/S0044-8486(03)00436-8; Kucuk S, 2010, AFR J BIOTECHNOL, V9, P755; Leach MC, 2004, ANIM WELFARE, V13, pS77; Leach MC, 2002, COMPARATIVE MED, V52, P249; Lewbart G, 1998, SELF ASSESSMENT COLO; LIMSUWAN C, 1983, CAN J FISH AQUAT SCI, V40, P2105, DOI 10.1139/f83-244; Maximino C, 2010, BEHAV BRAIN RES, V210, P1, DOI 10.1016/j.bbr.2010.01.031; MCFARLAND WN, 1969, FED PROC, V28, P1535; MCNICOL RE, 1991, ENVIRON TOXICOL CHEM, V10, P225, DOI 10.1002/etc.5620100211; Munday PL, 1997, J FISH BIOL, V51, P931, DOI 10.1006/jfbi.1997.0498; Niel L, 2006, APPL ANIM BEHAV SCI, V100, P295, DOI 10.1016/j.applanim.2005.12.001; Pelkowski SD, 2011, BEHAV BRAIN RES, V223, P135, DOI 10.1016/j.bbr.2011.04.033; PLUMB JA, 1983, PROG FISH CULT, V45, P30, DOI 10.1577/1548-8659(1983)45[30:EAOTSO]2.0.CO;2; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; RAJ ABM, 1995, ANIM WELFARE, V4, P273; Rasbash J, 2009, MLWIN VERSION 21; Reed B, 2011, GUIDANCE ON THE HOUS; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Rinkwitz S, 2011, PROG NEUROBIOL, V93, P231, DOI 10.1016/j.pneurobio.2010.11.003; Roberts R, 1997, HANDBOOK OF TROUT AN, P152; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P69; Sladky KK, 2001, AM J VET RES, V62, P337, DOI 10.2460/ajvr.2001.62.337; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Statistics of Scientific Procedures on Living Animals, 2011, STAT SCI PROC LIV AN; Stockman J, 2013, VET ANAESTH ANALG, V40, P35, DOI 10.1111/j.1467-2995.2012.00739.x; Strieck F, 1924, J COMP PHYSIOL A, V2, P122, DOI [10.1007/BF00339042, DOI 10.1007/BF00339042]; Thienpoint D., 1965, International Zoo Yearbook, V5, P202, DOI 10.1111/j.1748-1090.1965.tb01646.x; Toth LA, 2006, REPORT OF THE ACLAM; Velisek J, 2007, VET MED-CZECH, V52, P103, DOI 10.17221/2011-VETMED; Weber E. Scott III, 2011, Veterinary Clinics of North America Exotic Animal Practice, V14, P21, DOI 10.1016/j.cvex.2010.09.002; WEDEMEYER G, 1970, J FISH RES BOARD CAN, V27, P909, DOI 10.1139/f70-097; Weyl O., 1996, Aquaculture Research, V27, P757, DOI 10.1111/j.1365-2109.1996.tb01234.x; Williams TD, 2009, LAB ANIM-UK, V43, P107, DOI 10.1258/la.2007.007023; Winter Matthew J., 2008, Journal of Pharmacological and Toxicological Methods, V57, P176, DOI 10.1016/j.vascn.2008.01.004; Woody CA, 2002, J FISH BIOL, V60, P340, DOI [10.1006/jfbi.2001.1842, 10.1111/j.1095-8649.2002.tb00284.x]; Zahl IH, 2012, FISH PHYSIOL BIOCHEM, V38, P201, DOI 10.1007/s10695-011-9565-1; Zahl IH, 2010, FISH PHYSIOL BIOCHEM, V36, P719, DOI 10.1007/s10695-009-9346-2	52	105	108	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73773	10.1371/journal.pone.0073773	http://dx.doi.org/10.1371/journal.pone.0073773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086294	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200014
J	Hwang, CC; Umeki, S; Kubo, M; Hayashi, T; Shimoda, H; Mochizuki, M; Maeda, K; Baba, K; Hiraoka, H; Coffey, M; Okuda, M; Mizuno, T				Hwang, Chung Chew; Umeki, Saori; Kubo, Masahito; Hayashi, Toshiharu; Shimoda, Hiroshi; Mochizuki, Masami; Maeda, Ken; Baba, Kenji; Hiraoka, Hiroko; Coffey, Matt; Okuda, Masaru; Mizuno, Takuya			Oncolytic Reovirus in Canine Mast Cell Tumor	PLOS ONE			English	Article							TYROSINE KINASE; MUTATIONS; INFECTION; APOPTOSIS; THERAPY; ANTIBODIES; RELEASE; PATHWAY; VIRUS; LINES	The usage of reovirus has reached phase II and III clinical trials in human cancers. However, this is the first study to report the oncolytic effects of reovirus in veterinary oncology, focusing on canine mast cell tumor (MCT), the most common cutaneous tumor in dogs. As human and canine cancers share many similarities, we hypothesized that the oncolytic effects of reovirus can be exploited in canine cancers. The objective of this study was to determine the oncolytic effects of reovirus in canine MCT in vitro, in vivo and ex vivo. We demonstrated that MCT cell lines were highly susceptible to reovirus as indicated by marked cell death, high production of progeny virus and virus replication. Reovirus induced apoptosis in the canine MCT cell lines with no correlation to their Ras activation status. In vivo studies were conducted using unilateral and bilateral subcutaneous MCT xenograft models with a single intratumoral reovirus treatment and apparent reduction of tumor mass was exhibited. Furthermore, cell death was induced by reovirus in primary canine MCT samples in vitro. However, canine and murine bone marrow-derived mast cells (BMCMC) were also susceptible to reovirus. The combination of these results supports the potential value of reovirus as a therapy in canine MCT but warrants further investigation on the determinants of reovirus susceptibility.	[Hwang, Chung Chew; Umeki, Saori; Okuda, Masaru; Mizuno, Takuya] Yamaguchi Univ, United Grad Sch Vet Sci, Lab Vet Internal Med, Yamaguchi, Japan; [Kubo, Masahito; Hayashi, Toshiharu] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pathol, Yamaguchi, Japan; [Shimoda, Hiroshi; Maeda, Ken] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Microbiol, Yamaguchi, Japan; [Mochizuki, Masami] Kagoshima Univ, Joint Fac Vet Med, Kagoshima 890, Japan; [Baba, Kenji; Hiraoka, Hiroko] Yamaguchi Univ, Anim Med Ctr, Yamaguchi, Japan; [Coffey, Matt] Oncolyt Biotech Inc, Calgary, AB, Canada; [Okuda, Masaru; Mizuno, Takuya] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Internal Med, Yamaguchi, Japan; [Okuda, Masaru; Mizuno, Takuya] Yamaguchi Univ, United Grad Sch Vet Sci, Biomed Sci Ctr Translat Res, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University; Yamaguchi University; Kagoshima University; Yamaguchi University; Oncolytics Biotech; Yamaguchi University; Yamaguchi University	Mizuno, T (corresponding author), Yamaguchi Univ, United Grad Sch Vet Sci, Lab Vet Internal Med, Yamaguchi, Japan.	mizutaku@yamaguchi-u.ac.jp		Mizuno, Takuya/0000-0002-9580-7557; Okuda, Masaru/0000-0003-4690-8244	Grants-in-Aid for Scientific Research [24580460, 25850208] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adair RA, 2013, INT J CANCER, V132, P2327, DOI 10.1002/ijc.27918; Alain T, 2002, BLOOD, V100, P4146, DOI 10.1182/blood-2002-02-0503; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Butler M., 2013, SMALL ANIMAL CLIN ON, P68; Chappell JD, 1997, J VIROL, V71, P1834, DOI 10.1128/JVI.71.3.1834-1841.1997; Cho IR, 2010, INT J ONCOL, V36, P1023, DOI 10.3892/ijo_00000583; Clarke P, 2004, J VIROL, V78, P13132, DOI 10.1128/JVI.78.23.13132-13138.2004; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Connolly JL, 2000, J VIROL, V74, P2981, DOI 10.1128/JVI.74.7.2981-2989.2000; Decaro N, 2005, VET MICROBIOL, V109, P19, DOI 10.1016/j.vetmic.2005.05.014; DUNCAN MR, 1978, J VIROL, V28, P444, DOI 10.1128/JVI.28.2.444-449.1978; Errington F, 2008, GENE THER, V15, P1257, DOI 10.1038/gt.2008.58; Errington F, 2008, J IMMUNOL, V180, P6018, DOI 10.4049/jimmunol.180.9.6018; Escobar HM, 2004, ANTICANCER RES, V24, P3027; FUKUMI H, 1969, JPN J MED SCI BIOL, V22, P13, DOI 10.7883/yoken1952.22.13; Gordon IK, 2010, ILAR J, V51, P214, DOI 10.1093/ilar.51.3.214; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Ilett EJ, 2011, CLIN CANCER RES, V17, P2767, DOI 10.1158/1078-0432.CCR-10-3266; Ishiguro T, 2001, J VET MED SCI, V63, P1031, DOI 10.1292/jvms.63.1031; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalesnikoff J, 2011, METHODS MOL BIOL, V677, P207, DOI 10.1007/978-1-60761-869-0_15; Kawarai S, 2010, J VET MED SCI, V72, P131, DOI 10.1292/jvms.09-0281; Kim M, 2010, ONCOGENE, V29, P3990, DOI 10.1038/onc.2010.137; Lin TY, 2006, VET IMMUNOL IMMUNOP, V113, P37, DOI 10.1016/j.vetimm.2006.03.024; Loken SD, 2004, CANCER BIOL THER, V3, P734, DOI 10.4161/cbt.3.8.963; Lolkema MP, 2011, CLIN CANCER RES, V17, P581, DOI 10.1158/1078-0432.CCR-10-2159; London CA, 2013, WITHROW MACEWENS SMA, P335; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Meerani S, 2010, EUROPEAN J SCI RES, V40, P156; Metcalfe Dean D, 2005, Trans Am Clin Climatol Assoc, V116, P185; MURAKAMI T, 1975, NATL I ANIM HEALTH Q, V15, P8; Norman KL, 2004, P NATL ACAD SCI USA, V101, P11099, DOI 10.1073/pnas.0404310101; Ohmori K, 2008, VET IMMUNOL IMMUNOP, V126, P43, DOI 10.1016/j.vetimm.2008.06.014; Pan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054006; Patil SS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-3; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Reed LJ, 1938, AM J HYG, V27, P493, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A118408; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Sei S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-47; SELB B, 1994, J VIROL METHODS, V47, P15, DOI 10.1016/0166-0934(94)90062-0; Strong JE, 1996, J VIROL, V70, P612, DOI 10.1128/JVI.70.1.612-616.1996; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Takahashi T, 2001, INT ARCH ALLERGY IMM, V125, P228, DOI 10.1159/000053820; Takeuchi Y, 2012, J VET PHARMACOL THER, V35, P97, DOI 10.1111/j.1365-2885.2011.01296.x; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Thirukkumaran CM, 2010, CANCER RES, V70, P2435, DOI 10.1158/0008-5472.CAN-09-2408; Thirukkumaran CM, 2003, BLOOD, V102, P377, DOI 10.1182/blood-2002-08-2508; Twigger K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-368; Umeki S, 2011, VET IMMUNOL IMMUNOP, V142, P119, DOI 10.1016/j.vetimm.2011.04.009; van Houdt WJ, 2008, CANCER GENE THER, V15, P284, DOI 10.1038/cgt.2008.2; Watzinger F, 2001, MOL CARCINOGEN, V30, P190, DOI 10.1002/mc.1027	51	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73555	10.1371/journal.pone.0073555	http://dx.doi.org/10.1371/journal.pone.0073555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073198	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000007
J	Zou, T; Yang, Y; Xia, F; Huang, AF; Gao, XM; Fang, DY; Xiong, SD; Zhang, JP				Zou, Ting; Yang, Yi; Xia, Fei; Huang, Anfei; Gao, Xiaoming; Fang, Deyu; Xiong, Sidong; Zhang, Jinping			Resveratrol Inhibits CD4(+) T Cell Activation by Enhancing the Expression and Activity of Sirt1	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; FRENCH PARADOX; MICE; MECHANISMS; PROTECTS; WINE; P53; DEACETYLATION; ACETYLATION; EXPLANATION	Resveratrol, a natural polyphenol compound, has broad effects on critical events, including inflammation, oxidation, cancer and aging. However, the function and molecular mechanisms of resveratrol on T cell activation are controversial. In the present study, we found that resveratrol significantly inhibits the activation and cytokine production of T cells in vitro and in vivo. Sirt1 expression was up-regulated in resveratrol-treated T cells. Once Sirt1 was down-regulated in the T cells, the resveratrol-induced inhibition of T cell activation noticeably diminished. The acetylation of c-Jun decreased and its translocation was impeded in the resveratrol-treated T cells. The incidence and severity of collagen-induced arthritis in the resveratrol-treated mice were considerably reduced.	[Zou, Ting; Yang, Yi; Xia, Fei; Huang, Anfei; Gao, Xiaoming; Xiong, Sidong; Zhang, Jinping] Soochow Univ, Inst Biol, Suzhou, Jiangsu, Peoples R China; [Zou, Ting; Yang, Yi; Xia, Fei; Huang, Anfei; Gao, Xiaoming; Xiong, Sidong; Zhang, Jinping] Soochow Univ, Inst Med Sci, Suzhou, Jiangsu, Peoples R China; [Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Soochow University - China; Soochow University - China; Northwestern University; Feinberg School of Medicine	Xiong, SD (corresponding author), Soochow Univ, Inst Biol, Suzhou, Jiangsu, Peoples R China.	sdxiong@suda.edu.cn; j_pzhang@suda.edu.cn	Fang, Deyu/I-7245-2013; zhang, jin/GXV-9154-2022	Fang, Deyu/0000-0002-4211-2751; 	Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1075]; Jiangsu Key Laboratory of Infection and Immunity; Institutes of Biology and Medical Sciences of Soochow University; Soochow University [Q413401810, Q313406711]; National Natural Science Foundation of China [31270939, 31200660]; Natural Science Foundation of Jiangsu Province [BK2012617]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056] Funding Source: NIH RePORTER	Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Jiangsu Key Laboratory of Infection and Immunity; Institutes of Biology and Medical Sciences of Soochow University; Soochow University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from the Priority Academic Development Program of Jiangsu Higher Education Institutions (PAPD), Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, IRT1075), Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University, and intramural research funding to Jinping Zhang (Q413401810, Q313406711) from Soochow University, National Natural Science Foundation of China to Jinping Zhang (number 31270939) and Fei Xia (number 31200660) and Natural Science Foundation of Jiangsu Province to Jinping Zhang (BK2012617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Choi JM, 2012, MOL CELLS, V33, P217, DOI 10.1007/s10059-012-2297-y; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Gao BX, 2012, P NATL ACAD SCI USA, V109, P899, DOI 10.1073/pnas.1118462109; Gao XH, 2001, BIOCHEM PHARMACOL, V62, P1299, DOI 10.1016/S0006-2952(01)00775-4; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeong MH, 2012, INT IMMUNOPHARMACOL, V14, P328, DOI 10.1016/j.intimp.2012.07.018; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kopp P, 1998, EUR J ENDOCRINOL, V138, P619, DOI 10.1530/eje.0.1380619; Kwon HS, 2012, J IMMUNOL, V188, P2712, DOI 10.4049/jimmunol.1100903; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Li L, 2012, CANCER CELL, V21, P266, DOI 10.1016/j.ccr.2011.12.020; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Ramadori G, 2011, CELL METAB, V14, P301, DOI 10.1016/j.cmet.2011.06.014; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; SIEMANN EH, 1992, AM J ENOL VITICULT, V43, P49; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Tennen RI, 2012, CELL, V148, P387, DOI 10.1016/j.cell.2012.01.032; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Williams Richard O., 2007, V136, P191; Wu SL, 2006, TRANSPL P, V38, P3052, DOI 10.1016/j.transproceed.2006.08.150; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang Y, 2008, INT IMMUNOPHARMACOL, V8, P542, DOI 10.1016/j.intimp.2007.12.006; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902	43	63	66	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75139	10.1371/journal.pone.0075139	http://dx.doi.org/10.1371/journal.pone.0075139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073240	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000049
J	delBarco-Trillo, J; Tourmente, M; Roldan, ERS				delBarco-Trillo, Javier; Tourmente, Maximiliano; Roldan, Eduardo R. S.			Metabolic Rate Limits the Effect of Sperm Competition on Mammalian Spermatogenesis	PLOS ONE			English	Article							CYCLE LENGTH; TESTIS SIZE; EVOLUTION	Sperm competition leads to increased sperm production in many taxa. This response may result from increases in testes size, changes in testicular architecture or changes in the kinetics of spermatogenesis, but the impact of each one of these processes on sperm production has not been studied in an integrated manner. Furthermore, such response may be limited in species with low mass-specific metabolic rate (MSMR), i.e., large-bodied species, because they cannot process energy and resources efficiently enough both at the organismic and cellular levels. Here we compare 99 mammalian species and show that higher levels of sperm competition correlated with a) higher proportions of seminiferous tubules, b) shorter seminiferous epithelium cycle lengths (SECL) which reduce the time required to produce sperm, and c) higher efficiencies of Sertoli cells (involved in sperm maturation). These responses to sperm competition, in turn, result in higher daily sperm production, more sperm stored in the epididymides, and more sperm in the ejaculate. However, the two processes that require processing resources at faster rates (SECL and efficiency of Sertoli cells) only respond to sperm competition in species with high MSMR. Thus, increases in sperm production with intense sperm competition occur via a complex network of mechanisms, but some are constrained by MSMR.	[delBarco-Trillo, Javier; Tourmente, Maximiliano; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	delBarco-Trillo, J (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	delbarcotrillo@gmail.com	Roldan, Eduardo R.S./M-7947-2014; delBarco-Trillo, Javier/F-6728-2010; Tourmente, Maximiliano/I-2852-2019	Roldan, Eduardo R.S./0000-0002-7545-4248; delBarco-Trillo, Javier/0000-0002-9948-6674; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Economy and Competitiveness [CGL-2011-26341, CGL2012-37423]; Ramon y Cajal fellowship from Spanish Ministry of Economy and Competitiveness [RYC-2011-07943]; "Juan de la Cierva" fellowship from Spanish Ministry of Economy and Competitiveness [JCI-2011-10381]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Ramon y Cajal fellowship from Spanish Ministry of Economy and Competitiveness; "Juan de la Cierva" fellowship from Spanish Ministry of Economy and Competitiveness	This work was supported by the Spanish Ministry of Economy and Competitiveness (grants CGL-2011-26341 to ERSR and CGL2012-37423 to JdT). JdT was supported by a Ramon y Cajal fellowship (RYC-2011-07943) whereas MT was supported by a "Juan de la Cierva" fellowship (JCI-2011-10381), both from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1998, SPERM COMPETITION SE; DelBarco-Trillo J, 2011, J EVOLUTION BIOL, V24, P1706, DOI 10.1111/j.1420-9101.2011.02293.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fujii-Hanamoto H, 2011, AM J PRIMATOL, V73, P570, DOI 10.1002/ajp.20930; Gomendio M, 2011, P ROY SOC B-BIOL SCI, V278, P3135, DOI 10.1098/rspb.2011.0275; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Kerr JB, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P827; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; Lupold S, 2011, REPRODUCTION, V141, P595, DOI 10.1530/REP-10-0501; Lupold S, 2009, EVOLUTION, V63, P391, DOI 10.1111/j.1558-5646.2008.00571.x; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; Nakai M, 2004, TISSUE CELL, V36, P439, DOI 10.1016/j.tice.2004.08.003; Parapanov R, 2008, REPROD FERT DEVELOP, V20, P431, DOI 10.1071/RD07207; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Peirce EJ, 2001, REPRODUCTION, V121, P239, DOI 10.1530/rep.0.1210239; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramm SA, 2010, BIOL LETTERS, V6, P219, DOI 10.1098/rsbl.2009.0635; ROOSENRUNGE EC, 1962, BIOL REV, V37, P343, DOI 10.1111/j.1469-185X.1962.tb01616.x; Rowe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015720; RUSSELL LD, 1984, J REPROD FERTIL, V70, P635, DOI 10.1530/jrf.0.0700635; Schultz AH, 1938, ANAT REC, V72, P387, DOI 10.1002/ar.1090720310; Segatelli TM, 2004, J ANDROL, V25, P872; Setchell BP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P771; Simmons L. W., 2001, MG BEH ECOL; Stockley P, 1997, AM NAT, V149, P933, DOI 10.1086/286031; Tourmente M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021244; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12	30	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76510	10.1371/journal.pone.0076510	http://dx.doi.org/10.1371/journal.pone.0076510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069461	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300107
J	Gerlach, JQ; Kruger, A; Gallogly, S; Hanley, SA; Hogan, MC; Ward, CJ; Joshi, L; Griffin, MD				Gerlach, Jared Q.; Krueger, Anja; Gallogly, Susan; Hanley, Shirley A.; Hogan, Marie C.; Ward, Christopher J.; Joshi, Lokesh; Griffin, Matthew D.			Surface Glycosylation Profiles of Urine Extracellular Vesicles	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CHRONIC KIDNEY-DISEASE; LECTIN MICROARRAY; RENAL BIOPSY; EXOSOMES; GLYCAN; BIOMARKERS; PROTEOMICS; STRATEGY; PROTEIN	Urinary extracellular vesicles (uEVs) are released by cells throughout the nephron and contain biomolecules from their cells of origin. Although uEV-associated proteins and RNA have been studied in detail, little information exists regarding uEV glycosylation characteristics. Surface glycosylation profiling by flow cytometry and lectin microarray was applied to uEVs enriched from urine of healthy adults by ultracentrifugation and centrifugal filtration. The carbohydrate specificity of lectin microarray profiles was confirmed by competitive sugar inhibition and carbohydrate-specific enzyme hydrolysis. Glycosylation profiles of uEVs and purified Tamm Horsfall protein were compared. In both flow cytometry and lectin microarray assays, uEVs demonstrated surface binding, at low to moderate intensities, of a broad range of lectins whether prepared by ultracentrifugation or centrifugal filtration. In general, ultracentrifugation-prepared uEVs demonstrated higher lectin binding intensities than centrifugal filtration-prepared uEVs consistent with lesser amounts of co-purified non-vesicular proteins. The surface glycosylation profiles of uEVs showed little inter-individual variation and were distinct from those of Tamm Horsfall protein, which bound a limited number of lectins. In a pilot study, lectin microarray was used to compare uEVs from individuals with autosomal dominant polycystic kidney disease to those of age-matched controls. The lectin microarray profiles of polycystic kidney disease and healthy uEVs showed differences in binding intensity of 6/43 lectins. Our results reveal a complex surface glycosylation profile of uEVs that is accessible to lectin-based analysis following multiple uEV enrichment techniques, is distinct from co-purified Tamm Horsfall protein and may demonstrate disease-specific modifications.	[Gerlach, Jared Q.; Krueger, Anja; Gallogly, Susan; Hanley, Shirley A.; Griffin, Matthew D.] Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Regenerat Med Inst REMEDI, Galway, Ireland; [Gerlach, Jared Q.; Krueger, Anja; Joshi, Lokesh] Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Glycosci Grp, Galway, Ireland; [Hogan, Marie C.; Ward, Christopher J.] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Mayo Clinic	Griffin, MD (corresponding author), Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Regenerat Med Inst REMEDI, Galway, Ireland.	matthew.griffin@nuigalway.ie	Griffin, Matthew/A-1688-2009; Gerlach, Jared Q/K-2698-2013	Griffin, Matthew/0000-0002-8701-8056; Gerlach, Jared Q/0000-0001-7343-7201; Joshi, Lokesh/0000-0002-3612-0747; Krueger, Anja/0000-0003-0227-8674	Health Research Board of Ireland [HRA_HSR/2010/63]; Science Foundation Ireland [SFI 09/SRC/B1794]; SFI Alimentary Glycoscience Research Cluster grant [08/SRC/B1393]; SFI Stokes Professor for Glycosciences grant [07/SK/B1250]; Higher Education Authority of Ireland; European Regional Development Fund; National Institutes of Health NIDDK ARRA Challenge grant [5RC1DK086161-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086161] Funding Source: NIH RePORTER	Health Research Board of Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); SFI Alimentary Glycoscience Research Cluster grant(Science Foundation Ireland); SFI Stokes Professor for Glycosciences grant(Science Foundation Ireland); Higher Education Authority of Ireland; European Regional Development Fund(European Commission); National Institutes of Health NIDDK ARRA Challenge grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Health Research Board of Ireland (www.hrb.ie/) under grant HRA_HSR/2010/63 (JQG, AK, MG, LJ), by Science Foundation Ireland (www.sfi.ie/) under grant SFI 09/SRC/B1794 (MG), SFI Alimentary Glycoscience Research Cluster grant 08/SRC/B1393, SFI Stokes Professor for Glycosciences grant 07/SK/B1250 (LJ), the Higher Education Authority of Ireland (www.hea.ie/) (SAH), by the European Regional Development Fund (http://europa.eu/) and by National Institutes of Health NIDDK (http://www2.niddk.nih.gov/) ARRA Challenge grant 5RC1DK086161-02 (MCH, CJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Adam J, 2012, AM J KIDNEY DIS, V59, P117, DOI 10.1053/j.ajkd.2011.08.014; Afshin S., 2012, ENDOPLASMIC RETICULU, P23; Batista BS, 2011, J PROTEOME RES, V10, P4624, DOI 10.1021/pr200434y; Chen P, 2008, J CANCER RES CLIN, V134, P851, DOI 10.1007/s00432-008-0357-7; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cunard R, 2011, AM J PHYSIOL-RENAL, V300, pF1054, DOI 10.1152/ajprenal.00021.2011; Cybulsky AV, 2010, KIDNEY INT, V77, P187, DOI 10.1038/ki.2009.389; Dickhout JG, 2009, ANTIOXID REDOX SIGN, V11, P2341, DOI [10.1089/ars.2009.2705, 10.1089/ARS.2009.2705]; Ebe Y, 2006, J BIOCHEM, V139, P323, DOI 10.1093/jb/mvj070; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fernandez-Llama P, 2010, KIDNEY INT, V77, P736, DOI 10.1038/ki.2009.550; Gerlach JQ, 2012, MOL BIOSYST, V8, P1472, DOI 10.1039/c2mb05455h; Gerlach JQ, 2010, BIOCHEM SOC T, V38, P1333, DOI 10.1042/BST0381333; Gomes MM, 2010, BIOCHEMISTRY-US, V49, P5671, DOI 10.1021/bi9019498; Gonzales P, 2008, NEPHROL DIAL TRANSPL, V23, P1799, DOI 10.1093/ndt/gfn058; Gonzales PA, 2010, METHODS MOL BIOL, V641, P89, DOI 10.1007/978-1-60761-711-2_6; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Grabska Teresa, 1996, Archivum Immunologiae et Therapiae Experimentalis, V44, P241; Hashii N, 2009, IMMUNOLOGY, V126, P336, DOI 10.1111/j.1365-2567.2008.02898.x; Hirabayashi J, 2008, J BIOCHEM, V144, P139, DOI 10.1093/jb/mvn043; Hogan MC, 2009, J AM SOC NEPHROL, V20, P278, DOI 10.1681/ASN.2008060564; Hoorn EJ, 2005, NEPHROLOGY, V10, P283, DOI 10.1111/j.1440-1797.2005.00387.x; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Joseph AJ, 2010, NEPHROLOGY, V15, P544, DOI 10.1111/j.1440-1797.2010.01293.x; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Kilcoyne M, 2012, ANAL CHEM, V84, P3330, DOI 10.1021/ac203404n; Kojima K, 2011, KIDNEY INT, V79, P311, DOI 10.1038/ki.2010.403; Krishnamoorthy L, 2009, NAT CHEM BIOL, V5, P244, DOI 10.1038/nchembio.151; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Mathias Rommel A., 2009, V528, P227, DOI 10.1007/978-1-60327-310-7_16; Matsumura K, 2009, ANAL BIOCHEM, V386, P217, DOI 10.1016/j.ab.2008.11.044; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; O'Riordan E, 2007, ACTA PHYSIOL HUNG, V94, P133, DOI 10.1556/APhysiol.94.2007.1-2.12; Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pisitkun T, 2006, MOL CELL PROTEOMICS, V5, P1760, DOI 10.1074/mcp.R600004-MCP200; Raj DAA, 2012, KIDNEY INT, V81, P1263, DOI 10.1038/ki.2012.25; Robinson LN, 2012, ELECTROPHORESIS, V33, P797, DOI 10.1002/elps.201100231; Rood IM, 2010, KIDNEY INT, V78, P810, DOI 10.1038/ki.2010.262; Rosenfeld R, 2007, J BIOCHEM BIOPH METH, V70, P415, DOI 10.1016/j.jbbm.2006.09.008; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Stanley P, 2009, ESSENTIALS GLYCOBIOL; Staubach S, 2012, J PROTEOME RES, V11, P906, DOI 10.1021/pr200711w; Stratta P, 2007, EUR J CLIN INVEST, V37, P954, DOI 10.1111/j.1365-2362.2007.01885.x; TAMM I, 1952, J EXP MED, V95, P71, DOI 10.1084/jem.95.1.71; Tanaka M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/470803; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; Thery C., 2006, CURR PROTOC CELL BIO, V30; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; Whittier WL, 2004, J AM SOC NEPHROL, V15, P142, DOI 10.1097/01.ASN.0000102472.37947.14; Wu TH, 2008, TRANSPL IMMUNOL, V18, P237, DOI 10.1016/j.trim.2007.07.001; Yang L, 2012, PHARM RES-DORDR, V29, P2578, DOI 10.1007/s11095-012-0788-3; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273; Zhou H, 2008, KIDNEY INT, V74, P613, DOI 10.1038/ki.2008.206	61	77	78	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74801	10.1371/journal.pone.0074801	http://dx.doi.org/10.1371/journal.pone.0074801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069349	Green Published, gold			2022-12-27	WOS:000324777300047
J	Hofmann, JC; Tegha-Dunghu, J; Drager, S; Will, CL; Luhrmann, R; Gruss, OJ				Hofmann, Jennifer C.; Tegha-Dunghu, Justus; Draeger, Stefanie; Will, Cindy L.; Luehrmann, Reinhard; Gruss, Oliver J.			The Prp19 Complex Directly Functions in Mitotic Spindle Assembly	PLOS ONE			English	Article							MECHANISMS; MICROTUBULES; COMPONENTS; SEPARATION; PROTEINS; GENOME; RAN	The conserved Prp19 (pre-RNA processing 19) complex is required for pre-mRNA splicing in eukaryotic nuclei. Recent RNAi screens indicated that knockdown of Prp19 complex subunits strongly delays cell proliferation. Here we show that knockdown of the smallest subunit, BCAS2/Spf27, destabilizes the entire complex and leads to specific mitotic defects in human cells. These could result from splicing failures in interphase or reflect a direct function of the complex in open mitosis. Using Xenopus extracts, in which cell cycle progression and spindle formation can be reconstituted in vitro, we tested Prp19 complex functions during a complete cell cycle and directly in open mitosis. Strikingly, immunodepletion of the complex either before or after interphase significantly reduces the number of intact spindles, and increases the percentage of spindles with lower microtubule density and impaired metaphase alignment of chromosomes. Our data identify the Prp19 complex as the first spliceosome subcomplex that directly contributes to mitosis in vertebrates independently of its function in interphase.	[Hofmann, Jennifer C.; Tegha-Dunghu, Justus; Draeger, Stefanie; Gruss, Oliver J.] DKFZ ZMBH Alliance, Zentrum Mol Biol Univ Heidelberg ZMBH, Heidelberg, Germany; [Will, Cindy L.; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Gruss, OJ (corresponding author), DKFZ ZMBH Alliance, Zentrum Mol Biol Univ Heidelberg ZMBH, Heidelberg, Germany.	o.gruss@zmbh.uni-heidelberg.de			DKFZ-ZMBH Alliance; DFG Normalverfahren [1737/4]; DGF [SFB 860]	DKFZ-ZMBH Alliance; DFG Normalverfahren(German Research Foundation (DFG)); DGF(German Research Foundation (DFG))	The project was supported by the DKFZ-ZMBH Alliance and DFG Normalverfahren 1737/4 to OG, and a grant from the DGF SFB 860 to RL (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Cassimeris Lynne, 2003, Current Issues in Molecular Biology, V5, P99; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0; Gatlin JC, 2010, SEMIN CELL DEV BIOL, V21, P248, DOI 10.1016/j.semcdb.2010.01.015; Goodman B, 2010, J BIOL CHEM, V285, P35238, DOI 10.1074/jbc.M110.140749; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hofmann JC, 2010, NUCLEUS-PHILA, V1, P447, DOI 10.4161/nucl.1.6.13328; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Rino J, 2009, TRENDS CELL BIOL, V19, P375, DOI 10.1016/j.tcb.2009.05.004; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; TOVEY ER, 1987, J BIOCHEM BIOPH METH, V14, P1, DOI 10.1016/0165-022X(87)90002-9; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669	33	31	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74851	10.1371/journal.pone.0074851	http://dx.doi.org/10.1371/journal.pone.0074851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069358	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300052
J	Iacovakis, C; Mamuris, Z; Moutou, KA; Touloudi, A; Hammer, AS; Valiakos, G; Giannoulis, T; Stamatis, C; Spyrou, V; Athanasiou, LV; Kantere, M; Asferg, T; Giannakopoulos, A; Salomonsen, CM; Bogdanos, D; Birtsas, P; Petrovska, L; Hannant, D; Billinis, C				Iacovakis, Christos; Mamuris, Zissis; Moutou, Katerina A.; Touloudi, Antonia; Hammer, Anne Sofie; Valiakos, George; Giannoulis, Themis; Stamatis, Costas; Spyrou, Vassiliki; Athanasiou, Labrini V.; Kantere, Maria; Asferg, Tommy; Giannakopoulos, Alexios; Salomonsen, Charlotte M.; Bogdanos, Dimitrios; Birtsas, Periklis; Petrovska, Liljana; Hannant, Duncan; Billinis, Charalambos			Polarisation of Major Histocompatibility Complex II Host Genotype with Pathogenesis of European Brown Hare Syndrome Virus	PLOS ONE			English	Article							RABBIT HEMORRHAGIC-DISEASE; PARASITE RESISTANCE; MITOCHONDRIAL-DNA; LEPUS-EUROPAEUS; EVOLUTIONARY GENETICS; MHC POLYMORPHISM; ASSOCIATION; SUSCEPTIBILITY; SELECTION; GENES	A study was conducted in order to determine the occurrence of European Brown Hare Syndrome virus (EBHSV) in Denmark and possible relation between disease pathogenesis and Major Histocompatibility Complex (MHC) host genotype. Liver samples were examined from 170 brown hares (hunted, found sick or dead), collected between 2004 and 2009. Macroscopical and histopathological findings consistent with EBHS were detected in 24 (14.1%) hares; 35 (20.6%) had liver lesions not typical of the syndrome, 50 (29.4%) had lesions in other tissues and 61 (35.9%) had no lesions. Sixty five (38.2%) of 170 samples were found to be EBHSV-positive (RT-PCR, VP60 gene). In order to investigate associations between viral pathogenesis and host genotype, variation within the exon 2 DQA gene of MHC was assessed. DQA exon 2 analysis revealed the occurrence of seven different alleles in Denmark. Consistent with other populations examined so far in Europe, observed heterozygosity of DQA (H-o = 0.1180) was lower than expected (H-e = 0.5835). The overall variation for both nucleotide and amino acid differences (2.9% and 14.9%, respectively) were lower in Denmark than those assessed in other European countries (8.3% and 16.9%, respectively). Within the peptide binding region codons the number of nonsynonymous substitutions (dN) was much higher than synonymous substitutions (dS), which would be expected for MHC alleles under balancing selection. Allele frequencies did not significantly differ between EBHSV-positive and -negative hares. However, allele Leeu-DQA*30 was detected in significantly higher (P = 0.000006) frequency among the positive hares found dead with severe histopathological lesions than among those found sick or apparently healthy. In contrast, the latter group was characterized by a higher frequency of the allele Leeu-DQA*14 as well as the proportion of heterozygous individuals (P = 0.000006 and P = 0.027). These data reveal a polarisation between EBHSV pathogenesis and MHC class II genotype within the European brown hare in Denmark.	[Iacovakis, Christos; Touloudi, Antonia; Valiakos, George; Athanasiou, Labrini V.; Kantere, Maria; Giannakopoulos, Alexios; Billinis, Charalambos] Univ Thessaly, Fac Vet Med, Kardhitsa, Greece; [Iacovakis, Christos; Touloudi, Antonia; Valiakos, George; Athanasiou, Labrini V.; Billinis, Charalambos] Inst Res & Technol Thessaly, Larisa, Greece; [Mamuris, Zissis; Moutou, Katerina A.; Giannoulis, Themis; Stamatis, Costas] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece; [Hammer, Anne Sofie] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Spyrou, Vassiliki] Technol Educ Inst Larissa, Dept Anim Prod, Larisa, Greece; [Asferg, Tommy] Aarhus Univ, Inst Biosci, Aarhus, Denmark; [Salomonsen, Charlotte M.] Tech Univ Denmark, Natl Vet Inst, Sect Anim & Wildlife Dis, Aarhus, Denmark; [Bogdanos, Dimitrios] Univ Thessaly, Dept Med, Larisa, Greece; [Bogdanos, Dimitrios] Kings Coll London, Inst Liver Studies, London, England; [Birtsas, Periklis] Technol Educ Inst Larissa, Dept Forestry & Nat Environm Adm, Kardhitsa, Greece; [Petrovska, Liljana] Vet Labs Agcy, Dept Bacteriol, Weybridge, Surrey, England; [Hannant, Duncan] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England	University of Thessaly; University of Thessaly; University of Copenhagen; Aarhus University; Technical University of Denmark; University of Thessaly; University of London; King's College London; Veterinary Laboratories Agency; University of Nottingham	Billinis, C (corresponding author), Univ Thessaly, Fac Vet Med, Kardhitsa, Greece.	billinis@vet.uth.gr	Athanasiou, Labrini V/AAI-2744-2020; Hannant, Duncan/G-4185-2011; Giannoulis, Themistoklis/AAM-5042-2021; Petrovska, Liljana/D-7319-2011; Bogdanos, Dimitrios/AAF-8620-2020; ATHANASIOU, LABRINI/H-7463-2019; Valiakos, George/C-5328-2011; Kantere, Maria/ABC-6726-2021; Mamuris, Zissis/AAN-2576-2021	Athanasiou, Labrini V/0000-0001-8723-2629; Hannant, Duncan/0000-0003-0792-7418; Bogdanos, Dimitrios/0000-0002-9697-7902; Valiakos, George/0000-0002-3869-5026; Kantere, Maria/0000-0002-5383-5031; MOUTOU, KATERINA/0000-0002-6429-3776; Giannoulis, Themistoklis/0000-0002-1842-5432	European Union [222633]	European Union(European Commission)	The research leading to these results received partial funding from the European Union Seventh Framework Programme (2007-2013) under grant agreement no. 222633 (WildTech) (http://www.wildtechproject.com/wildtech/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acevedo-Whitehouse K, 2006, TRENDS ECOL EVOL, V21, P433, DOI 10.1016/j.tree.2006.05.010; Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Alves PC, 2008, MOL PHYLOGENET EVOL, V46, P1191, DOI 10.1016/j.ympev.2007.11.010; Alves PC, 2008, PHILOS T R SOC B, V363, P2831, DOI 10.1098/rstb.2008.0053; Alves PC, 2003, MOL PHYLOGENET EVOL, V27, P70, DOI 10.1016/S1055-7903(02)00417-7; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Arkush KD, 2002, CAN J FISH AQUAT SCI, V59, P966, DOI 10.1139/F02-066; Bascunana CR, 1997, J CLIN MICROBIOL, V35, P2492; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Billinis C, 2005, J WILDLIFE DIS, V41, P783, DOI 10.7589/0090-3558-41.4.783; Billinis C., 2005, Wildlife Biology in Practice, V1, P118; Bondinas GP, 2007, IMMUNOGENETICS, V59, P539, DOI 10.1007/s00251-007-0224-8; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Bowen L, 2006, MOL ECOL, V15, P529, DOI 10.1111/j.1365-294X.2005.02612.x; Boytim ML, 1998, J IMMUNOL, V160, P2215; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; Bronson PG, 2010, HUM MOL GENET, V19, P2331, DOI 10.1093/hmg/ddq101; Capucci L, 1991, Rev Sci Tech, V10, P347; Carrington M, 1999, HUM MOL GENET, V8, P1939, DOI 10.1093/hmg/8.10.1939; Chapman JA., 1990, RABBITS HARES PIKAS; CHASEY D, 1990, VET REC, V126, P623; CHASEY D, 1992, ARCH VIROL, V124, P363, DOI 10.1007/BF01309816; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Deter J, 2008, INFECT GENET EVOL, V8, P450, DOI 10.1016/j.meegid.2007.07.003; Ditchkoff SS, 2005, WILDLIFE SOC B, V33, P1164, DOI 10.2193/0091-7648(2005)33[1164:FTFCOW]2.0.CO;2; Drews B, 2011, VET MICROBIOL, V154, P37, DOI 10.1016/j.vetmic.2011.06.021; Eisenlohr LC, 2013, MOL IMMUNOL, V55, P169, DOI 10.1016/j.molimm.2012.10.020; ESKENS U, 1989, DEUT TIERARZTL WOCH, V96, P464; Fain MA, 2001, TISSUE ANTIGENS, V57, P332, DOI 10.1034/j.1399-0039.2001.057004332.x; de Mera IGF, 2008, DEV COMP IMMUNOL, V32, P85, DOI 10.1016/j.dci.2007.05.001; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; Frolich K, 1996, J WILDLIFE DIS, V32, P280; Frolich K, 2001, J WILDLIFE DIS, V37, P803, DOI 10.7589/0090-3558-37.4.803; FRYLESTAM B, 1980, HOLARCTIC ECOL, V3, P74; Garrigan D, 2003, EVOLUTION, V57, P1707; Gavier-Widen D., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P453; GAVIERWIDEN D, 1993, J WILDLIFE DIS, V29, P15, DOI 10.7589/0090-3558-29.1.15; Grimholt U, 2003, IMMUNOGENETICS, V55, P210, DOI 10.1007/s00251-003-0567-8; Harf R, 2005, MOL ECOL, V14, P85, DOI 10.1111/j.1365-294X.2004.02402.x; Hasegawa A, 1985, Nucleic Acids Symp Ser, P269; Hedrick P.W., 2000, EVOL GENET, P204; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hedrick PW, 2001, MOL ECOL, V10, P1399, DOI 10.1046/j.1365-294X.2001.01289.x; HENRIKSEN P, 1989, VET REC, V125, P486, DOI 10.1136/vr.125.19.486; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Hohler T, 1997, J HEPATOL, V27, P259, DOI 10.1016/S0168-8278(97)80169-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AM, 2010, TISSUE ANTIGENS, V75, P684, DOI 10.1111/j.1399-0039.2010.01440.x; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Ilmonen P, 2007, GENETICS, V176, P2501, DOI 10.1534/genetics.107.074815; It V, 2010, TISSUE ANTIGENS, V76, P67, DOI 10.1111/j.1399-0039.2010.01463.x; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kasapidis P, 2005, MOL PHYLOGENET EVOL, V34, P55, DOI 10.1016/j.ympev.2004.09.007; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; Koutsogiannouli EA, 2009, MOL ECOL, V18, P4631, DOI 10.1111/j.1365-294X.2009.04394.x; Koutsogiannouli EA, 2012, MAMM BIOL, V77, P428, DOI 10.1016/j.mambio.2012.01.005; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Larruskain A, 2010, IMMUNOGENETICS, V62, P75, DOI 10.1007/s00251-009-0419-2; LeGall G, 1996, J GEN VIROL, V77, P1693, DOI 10.1099/0022-1317-77-8-1693; Lenghaus Cor, 2001, P280, DOI 10.1002/9780470344880.ch16; Marcato P.S., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P371; Martin MP, 1999, METH MOLEC MED, V17, P205, DOI 10.1385/0-89603-369-4:205; McClelland EE, 2003, INFECT IMMUN, V71, P4815, DOI 10.1128/IAI.71.8.4815-4817.2003; Melo-Ferreira J, 2007, MOL ECOL, V16, P605, DOI 10.1111/j.1365-294X.2006.03166.x; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Morisse J.-P., 1991, Revue Scientifique et Technique Office International des Epizooties, V10, P269; NAUWYNCK H, 1993, J WILDLIFE DIS, V29, P203, DOI 10.7589/0090-3558-29.2.203; Nowotny N, 1997, ARCH VIROL, V142, P657, DOI 10.1007/s007050050109; Ohlinger V F, 1991, Rev Sci Tech, V10, P311; Okerman L, 1989, BELGIE VLAAMS DIERGE, V59, P44; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rakus KL, 2009, FISH SHELLFISH IMMUN, V26, P737, DOI 10.1016/j.fsi.2009.03.001; SALMELA P, 1993, ACTA VET SCAND, V34, P215; Schad J, 2005, EVOLUTION, V59, P439, DOI 10.1111/j.0014-3820.2005.tb01002.x; Schmidt Niels M., 2004, BMC Ecology, V4, P15, DOI 10.1186/1472-6785-4-15; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; Sert H, 2005, MAMM BIOL, V70, P171, DOI 10.1016/j.mambio.2004.10.003; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Slamecka Jaroslav, 1997, Acta Scientarium Naturalium Academiae Scientarum Bohemicae Brno, V31, P1; Smith S, 2011, IMMUNOGENETICS, V63, P743, DOI 10.1007/s00251-011-0539-3; Smith S, 2010, MOL ECOL, V19, P4131, DOI 10.1111/j.1365-294X.2010.04765.x; SOSTARIC B, 1991, Veterinarski Arhiv, V61, P133; Stamatis A, 2007, BIOINORG CHEM APPL, V2007, DOI 10.1155/2007/23286; Stamatis C, 2009, J BIOGEOGR, V36, P515, DOI 10.1111/j.1365-2699.2008.02013.x; Stamatis C, 2008, GENE, V410, P154, DOI 10.1016/j.gene.2007.12.010; STEINECK T, 1993, TIERARZTL UMSCHAU, V48, P225; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAKAHATA N, 1990, GENETICS, V124, P967; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thulin CG, 1997, MOL ECOL, V6, P463, DOI 10.1046/j.1365-294X.1997.t01-1-00199.x; Thursz MR, 1997, J VIRAL HEPATITIS, V4, P215, DOI 10.1046/j.1365-2893.1997.00052.x; THURSZ MR, 1995, NAT MED, V1, P374, DOI 10.1038/nm0495-374; Tobias JA, 2008, SCIENCE, V319, DOI 10.1126/science.1150568; Wedekind C, 2005, GENETICS, V170, P1427, DOI 10.1534/genetics.105.040683; WIRBLICH C, 1994, J VIROL, V68, P5164, DOI 10.1128/JVI.68.8.5164-5173.1994; Wu P, 2004, SCIENCE, V305, P1465, DOI 10.1126/science.1098109; Zachos FE, 2010, J ZOOL, V282, P47, DOI 10.1111/j.1469-7998.2010.00710.x; Zhang Chenhong, 2006, Journal of Bioinformatics and Computational Biology, V4, P959, DOI 10.1142/S0219720006002314; Zhang YN, 2006, IMMUNOL RES, V35, P151, DOI 10.1385/IR:35:1:151	108	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74360	10.1371/journal.pone.0074360	http://dx.doi.org/10.1371/journal.pone.0074360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069299	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300032
J	la Cour, JM; Schindler, AJ; Berchtold, MW; Schekman, R				la Cour, Jonas M.; Schindler, Adam J.; Berchtold, Martin W.; Schekman, Randy			ALG-2 Attenuates COPII Budding In Vitro and Stabilizes the Sec23/Sec31A Complex	PLOS ONE			English	Article							RETICULUM EXIT SITES; COATED VESICLE FORMATION; LINKED PROTEIN ALG-2; STRUCTURAL BASIS; CALCIUM-BINDING; ER; SEC31A; CARGO; RECONSTITUTION; LOCALIZATION	Coated vesicles mediate the traffic of secretory and membrane cargo proteins from the endoplasmic reticulum (ER) to the Golgi apparatus. The coat protein complex (COPII) involved in vesicle budding is constituted by a GTPase, Sar1, the inner coat components of Sec23/Sec24 and the components of the outer coat Sec13/Sec31A. The Ca2+-binding protein ALG-2 was recently identified as a Sec31A binding partner and a possible link to Ca2+ regulation of COPII vesicle budding. Here we show that ALG-2/Ca2+ is capable of attenuating vesicle budding in vitro through interaction with an ALG-2 binding domain in the proline rich region of Sec31A. Binding of ALG-2 to Sec31A and inhibition of COPII vesicle budding is furthermore dependent on an intact Ca2+-binding site at EF-hand 1 of ALG-2. ALG-2 increased recruitment of COPII proteins Sec23/24 and Sec13/31A to artificial liposomes and was capable of mediating binding of Sec13/31A to Sec23. These results introduce a regulatory role for ALG-2/Ca2+ in COPII tethering and vesicle budding.	[la Cour, Jonas M.; Berchtold, Martin W.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Schindler, Adam J.] Duke Univ, Dept Biol, Durham, NC USA; [Schekman, Randy] Univ Calif Berkeley, Dept Cellular Biochem, Berkeley, CA 94720 USA	University of Copenhagen; Duke University; University of California System; University of California Berkeley	la Cour, JM (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	jonaslacour@gmail.com	Berchtold, Martin/L-1695-2014; la Cour, Jonas/M-5088-2016	Berchtold, Martin/0000-0001-8995-9047; Schindler, Adam/0000-0001-5408-9141; Schekman, Randy/0000-0001-8615-6409; la Cour, Jonas/0000-0002-1588-0608	Danish Cancer Society; Danish Research Council (FNU); Lundbeck Foundation; Hansen Foundation; Danielsens Foundation; Fraenkel Foundation; Willumsen Foundation; Weddel-Weddelsborg Foundation	Danish Cancer Society(Danish Cancer Society); Danish Research Council (FNU)(Danish Natural Science Research CouncilDet Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Hansen Foundation; Danielsens Foundation; Fraenkel Foundation; Willumsen Foundation; Weddel-Weddelsborg Foundation	This work was supported by a grant from The Danish Cancer Society to JMC and grants by the Danish Research Council (FNU), Lundbeck, Hansen, Danielsens, Fraenkel, Willumsen and Weddel-Weddelsborg Foundations to MWB. RS is a Senior Fellow of the Miller Institute, UC Berkeley and an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Hoj BR, 2009, BIOCHEM BIOPH RES CO, V378, P145, DOI 10.1016/j.bbrc.2008.11.021; Jang IK, 2002, MOL CELL BIOL, V22, P4094, DOI 10.1128/MCB.22.12.4094-4100.2002; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2008, MOL ONCOL, V1, P431, DOI 10.1016/j.molonc.2007.08.002; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Matsuoka K, 2000, METHODS, V20, P417, DOI 10.1006/meth.2000.0955; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Paddock BE, 2011, J NEUROSCI, V31, P2248, DOI 10.1523/JNEUROSCI.3153-09.2011; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Subramanian L, 2004, BIOCHEMISTRY-US, V43, P11175, DOI 10.1021/bi048848d; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Tarabykina S, 2004, FRONT BIOSCI-LANDMRK, V9, P1817, DOI 10.2741/1358; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; Venditti R, 2012, SCIENCE, V337, P1668, DOI 10.1126/science.1224947; Vito P, 1996, SCIENCE, V271, P521, DOI 10.1126/science.271.5248.521; VOLPI M, 1988, J CELL BIOL, V107, P2533, DOI 10.1083/jcb.107.6.2533; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yoshibori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040765	39	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75309	10.1371/journal.pone.0075309	http://dx.doi.org/10.1371/journal.pone.0075309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069399	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300071
J	Park, IW; Ndjomou, J; Wen, YH; Liu, ZQ; Ridgway, ND; Kao, CC; He, JJ				Park, In-Woo; Ndjomou, Jean; Wen, Yahong; Liu, Ziqing; Ridgway, Neale D.; Kao, C. Cheng; He, Johnny J.			Inhibition of HCV Replication by Oxysterol-Binding Protein-Related Protein 4 (ORP4) through Interaction with HCV NS5B and Alteration of Lipid Droplet Formation	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; NONVESICULAR STEROL TRANSPORT; DEPENDENT RNA-POLYMERASE; 3' NONTRANSLATED REGION; CORE PROTEIN; NONSTRUCTURAL PROTEINS; ENDOPLASMIC-RETICULUM; UNTRANSLATED REGION; GENOME REPLICATION; VIRAL REPLICATION	Hepatitis C virus (HCV) RNA replication involves complex interactions among the 3'x RNA element within the HCV 3' untranslated region, viral and host proteins. However, many of the host proteins remain unknown. In this study, we devised an RNA affinity chromatography /2D/MASS proteomics strategy and identified nine putative 3' X-associated host proteins; among them is oxysterol-binding protein-related protein 4 (ORP4), a cytoplasmic receptor for oxysterols. We determined the relationship between ORP4 expression and HCV replication. A very low level of constitutive ORP4 expression was detected in hepatocytes. Ectopically expressed ORP4 was detected in the endoplasmic reticulum and inhibited luciferase reporter gene expression in HCV subgenomic replicon cells and HCV core expression in JFH-1-infected cells. Expression of ORP4S, an ORP4 variant that lacked the N-terminal pleckstrin-homology domain but contained the C-terminal oxysterol-binding domain also inhibited HCV replication, pointing to an important role of the oxysterol-binding domain in ORP4-mediated inhibition of HCV replication. ORP4 was found to associate with HCV NS5B and its expression led to inhibition of the NS5B activity. ORP4 expression had little effect on intracellular lipid synthesis and secretion, but it induced lipid droplet formation in the context of HCV replication. Taken together, these results demonstrate that ORP4 is a negative regulator of HCV replication, likely via interaction with HCV NS5B in the replication complex and regulation of intracellular lipid homeostasis. This work supports the important role of lipids and their metabolism in HCV replication and pathogenesis.	[Park, In-Woo; Ndjomou, Jean; Liu, Ziqing; He, Johnny J.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Park, In-Woo; He, Johnny J.] Indiana Univ Sch Med, Ctr AIDS Res, Indianapolis, IN 46202 USA; [Park, In-Woo; He, Johnny J.] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX USA; [Wen, Yahong; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN USA; [Ridgway, Neale D.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Health Science Center; Indiana University System; Indiana University Bloomington; Dalhousie University	He, JJ (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	johnny.he@unthsc.edu		Ridgway, Neale/0000-0002-0441-6228				Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; BOYER JC, 1994, VIROLOGY, V198, P415, DOI 10.1006/viro.1994.1053; Chen YJ, 2010, J BIOL CHEM, V285, P28183, DOI 10.1074/jbc.M110.118323; Clouston AD, 2002, BEST PRACT RES CL GA, V16, P767, DOI 10.1053/bega.2002.0329; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; El-Hage N, 2003, J GEN VIROL, V84, P2761, DOI 10.1099/vir.0.19305-0; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Friebe P, 2002, J VIROL, V76, P5326, DOI 10.1128/JVI.76.11.5326-5338.2002; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gontarek RR, 1999, NUCLEIC ACIDS RES, V27, P1457, DOI 10.1093/nar/27.6.1457; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; GUINEA R, 1990, EMBO J, V9, P2011, DOI 10.1002/j.1460-2075.1990.tb08329.x; Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005; Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Huang Y, 2006, HEPATOLOGY, V43, P81, DOI 10.1002/hep.21011; Hugle T, 2001, VIROLOGY, V284, P70, DOI 10.1006/viro.2001.0873; Ito T, 1997, J VIROL, V71, P8698, DOI 10.1128/JVI.71.11.8698-8706.1997; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kim JH, 2003, MOL CELL BIOL, V23, P708, DOI 10.1128/MCB.23.2.708-720.2003; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lagace TA, 1997, BIOCHEM J, V326, P205, DOI 10.1042/bj3260205; Laitinen S, 2002, J LIPID RES, V43, P245; Lee EG, 2000, J VIROL, V74, P9167, DOI 10.1128/JVI.74.19.9167-9174.2000; Lehto M, 2003, BBA-MOL CELL BIOL L, V1631, P1, DOI 10.1016/S1388-1981(02)00364-5; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Lohmann V, 1997, J VIROL, V71, P8416, DOI 10.1128/JVI.71.11.8416-8428.1997; Mamiya N, 1999, J BIOL CHEM, V274, P15751, DOI 10.1074/jbc.274.22.15751; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; Miyanari Y, 2003, J BIOL CHEM, V278, P50301, DOI 10.1074/jbc.M305684200; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Ogawa K, 2009, P JPN ACAD B-PHYS, V85, P217, DOI 10.2183/pjab.85.217; Olkkonen VM, 2004, CURR OPIN LIPIDOL, V15, P321, DOI 10.1097/00041433-200406000-00013; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Parrish NM, 1999, J ANTIMICROB CHEMOTH, V43, P219, DOI 10.1093/jac/43.2.219; Petrik J, 1999, J GEN VIROL, V80, P3109, DOI 10.1099/0022-1317-80-12-3109; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Quadri R, 2001, ANTIVIR RES, V52, P161, DOI 10.1016/S0166-3542(01)00181-4; Ranjith-Kumar CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022575; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Sagan SM, 2006, BIOCHEM CELL BIOL, V84, P67, DOI 10.1139/O05-149; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Spangberg K, 1999, J HUMAN VIROL, V2, P296; Spangberg K, 2001, J GEN VIROL, V82, P113, DOI 10.1099/0022-1317-82-1-113; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Tang HL, 2009, CLIN SCI, V117, P49, DOI 10.1042/CS20080631; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tsuchihara K, 1997, J VIROL, V71, P6720, DOI 10.1128/JVI.71.9.6720-6726.1997; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Wood J, 2001, J VIROL, V75, P1348, DOI 10.1128/JVI.75.3.1348-1358.2001; Wyles JP, 2007, EXP CELL RES, V313, P1426, DOI 10.1016/j.yexcr.2007.01.018; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052; Xu YQ, 2001, J BIOL CHEM, V276, P18407, DOI 10.1074/jbc.M101204200; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Yanagi M, 1999, P NATL ACAD SCI USA, V96, P2291, DOI 10.1073/pnas.96.5.2291; Yang HY, 2006, TRENDS CELL BIOL, V16, P427, DOI 10.1016/j.tcb.2006.07.002; Yang W, 2008, HEPATOLOGY, V48, P1396, DOI 10.1002/hep.22508; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Yi MK, 2003, J VIROL, V77, P3557, DOI 10.1128/JVI.77.6.3557-3568.2003	89	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75648	10.1371/journal.pone.0075648	http://dx.doi.org/10.1371/journal.pone.0075648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069433	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300089
J	Roales, J; Duran, J; Bechtold, HA; Groffman, PM; Rosi-Marshall, EJ				Roales, Javier; Duran, Jorge; Bechtold, Heather A.; Groffman, Peter M.; Rosi-Marshall, Emma J.			High Resolution Measurement of Light in Terrestrial Ecosystems Using Photodegrading Dyes	PLOS ONE			English	Article							PHOTON FLUX-DENSITY; PLANT LITTER DECOMPOSITION; RHODAMINE-WT; RAIN-FOREST; UNDERSTORY; TEMPERATE; REGIMES; GAPS	Incoming solar radiation is the main determinant of terrestrial ecosystem processes, such as primary production, litter decomposition, or soil mineralization rates. Light in terrestrial ecosystems is spatially and temporally heterogeneous due to the interaction among sunlight angle, cloud cover and tree-canopy structure. To integrate this variability and to know light distribution over time and space, a high number of measurements are needed, but tools to do this are usually expensive and limited. An easy-to-use and inexpensive method that can be used to measure light over time and space is needed. We used two photodegrading fluorescent organic dyes, rhodamine WT (RWT) and fluorescein, for the quantification of light. We measured dye photodegradation as the decrease in fluorescence across an irradiance gradient from full sunlight to deep shade. Then, we correlated it to accumulated light measured with PAR quantum sensors and obtained a model for this behavior. Rhodamine WT and fluorescein photodegradation followed an exponential decay curve with respect to accumulated light. Rhodamine WT degraded slower than fluorescein and remained unaltered after exposure to temperature changes. Under controlled conditions, fluorescence of both dyes decreased when temperatures increased, but returned to its initial values after cooling to the pre-heating temperature, indicating no degradation. RWT and fluorescein can be used to measure light under a varying range of light conditions in terrestrial ecosystems. This method is particularly useful to integrate solar radiation over time and to measure light simultaneously at different locations, and might be a better alternative to the expensive and time consuming traditional light measurement methods. The accuracy, low price and ease of this method make it a powerful tool for intensive sampling of large areas and for developing high resolution maps of light in an ecosystem.	[Roales, Javier] Univ Pablo de Olavide, Dept Sistemas Fis Quim & Nat, Seville, Spain; [Roales, Javier; Duran, Jorge; Bechtold, Heather A.; Groffman, Peter M.; Rosi-Marshall, Emma J.] Cary Inst Ecosyst Studies, Millbrook, NY USA	Universidad Pablo de Olavide; Cary Institute of Ecosystem Studies	Roales, J (corresponding author), Univ Pablo de Olavide, Dept Sistemas Fis Quim & Nat, Seville, Spain.	javier.roales@gmail.com	Duran, Jorge/AFN-5619-2022; Rosi-Marshall, Emma J/F-1777-2011; Roales, Javier/D-4399-2013	Duran, Jorge/0000-0002-7375-5290; Rosi-Marshall, Emma J/0000-0002-3476-6368; Roales, Javier/0000-0003-2110-5023; Groffman, Peter/0000-0001-8371-6255	US National Science Foundation [DEB 0423259]; Hubbard Brook Experimental Forest; Fulbright fellowship of the Spanish Ministry of Education	US National Science Foundation(National Science Foundation (NSF)); Hubbard Brook Experimental Forest; Fulbright fellowship of the Spanish Ministry of Education	This research was supported by US National Science Foundation Grant DEB 0423259 (Hubbard Brook Long Term Ecological Research), and conducted at the Hubbard Brook Experimental Forest, which is operated by the Northeastern Research Station, USDA Forest Service, Newtown Square, PA. J. Duran was supported by a Fulbright fellowship of the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MC, 1970, AGR METEOROL, V7, P19, DOI 10.1016/0002-1571(70)90003-8; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Austin AT, 2010, P NATL ACAD SCI USA, V107, P4618, DOI 10.1073/pnas.0909396107; BALDOCCHI D, 1994, EXPLOITATION ENV HET, P21; Bechtold HA, 2012, FRESHW SCI, V31, P1070, DOI 10.1899/12-003.1; Brackmann U, 1997, LAMBDACHROME LASER G; Brandt LA, 2010, ECOSYSTEMS, V13, P765, DOI 10.1007/s10021-010-9353-2; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; CANHAM CD, 1988, ECOLOGY, V69, P1634, DOI 10.2307/1941664; FRIEND DT, 1961, ECOLOGY, V42, P577, DOI 10.2307/1932246; Gendron F, 1998, AGR FOREST METEOROL, V92, P55, DOI 10.1016/S0168-1923(98)00082-3; Gendron F, 2001, AGR FOREST METEOROL, V106, P23, DOI 10.1016/S0168-1923(00)00174-X; Givnish T.J., 1988, FUNCTIONAL PLANT BIO, V15, P63; KUBIN RF, 1982, J LUMIN, V27, P455, DOI 10.1016/0022-2313(82)90045-X; KURACHI N, 1994, JARQ-JPN AGR RES Q, V28, P62; Lee DW, 1996, ECOLOGY, V77, P568, DOI 10.2307/2265631; Lieffers VJ, 1999, CAN J FOREST RES, V29, P796, DOI 10.1139/cjfr-29-6-796; Machado JL, 1999, CAN J FOREST RES, V29, P1438, DOI 10.1139/cjfr-29-9-1438; Marquis D, 1962, CHEM LIGHT METER FOR; Mines CH, 2009, HYDROL EARTH SYST SC, V13, P2169, DOI 10.5194/hess-13-2169-2009; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Reche I, 2000, ECOSYSTEMS, V3, P419, DOI 10.1007/s100210000038; Replogle A, 1976, J HYDRAULICS DIVISIO, V5, P1; Schmitz OJ, 2006, ECOSYSTEMS, V9, P659, DOI 10.1007/s10021-006-0006-4; SMART PL, 1977, WATER RESOUR RES, V13, P15, DOI 10.1029/WR013i001p00015; Smith SA, 2002, WATER SA, V28, P403; Stracke F, 1999, J PHOTOCH PHOTOBIO A, V126, P51, DOI 10.1016/S1010-6030(99)00123-9; SUIJLEN JM, 1994, LIMNOL OCEANOGR, V39, P1411, DOI 10.4319/lo.1994.39.6.1411; SULLIVAN TJ, 1983, ENVIRON SCI TECHNOL, V17, P127, DOI 10.1021/es00108a014; Taggart MJ, 2011, GEODERMA, V163, P238, DOI 10.1016/j.geoderma.2011.04.020; TAI DY, 1988, CHEMOSPHERE, V17, P559, DOI 10.1016/0045-6535(88)90031-8; TURNBULL MH, 1993, AGR FOREST METEOROL, V64, P111, DOI 10.1016/0168-1923(93)90096-Z; Upstill-Goddard RC, 2001, LIMNOL OCEANOGR, V46, P927, DOI 10.4319/lo.2001.46.4.0927; Warren DR, 2013, AQUAT SCI, V75, P547, DOI 10.1007/s00027-013-0299-2; Wilhelm P, 2007, J PHOTOCH PHOTOBIO A, V185, P19, DOI 10.1016/j.jphotochem.2006.05.003; Wilson JF, 1986, FLUOROMETRIC PROCEDU, P34	37	3	3	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75715	10.1371/journal.pone.0075715	http://dx.doi.org/10.1371/journal.pone.0075715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069440	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300092
J	Tadros, M; Williams, V; Coleman, BL; McGeer, AJ; Haider, S; Lee, C; Iacovides, H; Rubinstein, E; John, M; Johnston, L; McNeil, S; Katz, K; Laffin, N; Suh, KN; Powis, J; Smith, S; Taylor, G; Watt, C; Simor, AE				Tadros, Manal; Williams, Victoria; Coleman, Brenda L.; McGeer, Allison J.; Haider, Shariq; Lee, Christine; Iacovides, Harris; Rubinstein, Ethan; John, Michael; Johnston, Lynn; McNeil, Shelly; Katz, Kevin; Laffin, Nancy; Suh, Kathryn N.; Powis, Jeff; Smith, Stephanie; Taylor, Geoff; Watt, Christine; Simor, Andrew E.			Epidemiology and Outcome of Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus (MRSA) in Canadian Hospitals	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; COMMUNITY-ACQUIRED PNEUMONIA; NECROTIZING PNEUMONIA; NOSOCOMIAL PNEUMONIA; CLINICAL-OUTCOMES; INFLUENZA SEASON; INFECTIONS; SURVEILLANCE; VANCOMYCIN; STRAINS	Background: MRSA remains a leading cause of hospital-acquired (HAP) and healthcare-associated pneumonia (HCAP). We describe the epidemiology and outcome of MRSA pneumonia in Canadian hospitals, and identify factors contributing to mortality. Methods: Prospective surveillance for MRSA pneumonia in adults was done for one year (2011) in 11 Canadian hospitals. Standard criteria for MRSA HAP, HCAP, ventilator-associated pneumonia (VAP), and community-acquired pneumonia (CAP) were used to identify cases. MRSA isolates underwent antimicrobial susceptibility testing, and were characterized by pulsed-field gel electrophoresis (PFGE) and Panton-Valentine leukocidin (PVL) gene detection. The primary outcome was all-cause mortality at 30 days. A multivariable analysis was done to examine the association between various host and microbial factors and mortality. Results: A total of 161 patients with MRSA pneumonia were identified: 90 (56%) with HAP, 26 (16%) HCAP, and 45 (28%) CAP; 23 (14%) patients had VAP. The mean (+/- SD) incidence of MRSA HAP was 0.32 (+/- 0.26) per 10,000 patient-days, and of MRSA VAP was 0.30 (+/- 0.5) per 1,000 ventilator-days. The 30-day all-cause mortality was 28.0%. In multivariable analysis, variables associated with mortality were the presence of multiorgan failure (OR 8.1; 95% CI 2.5-26.0), and infection with an isolate with reduced susceptibility to vancomycin (OR 2.5, 95% CI 1.0-6.3). Conclusions: MRSA pneumonia is associated with significant mortality. Severity of disease at presentation, and infection caused by an isolate with elevated MIC to vancomcyin are associated with increased mortality. Additional studies are required to better understand the impact of host and microbial variables on outcome.	[Tadros, Manal; Coleman, Brenda L.; McGeer, Allison J.; Powis, Jeff; Simor, Andrew E.] Univ Toronto, Toronto, ON, Canada; [Williams, Victoria; Watt, Christine; Simor, Andrew E.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Coleman, Brenda L.; McGeer, Allison J.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Haider, Shariq] Hamilton Hlth Sci Ctr, Hamilton, ON, Canada; [Lee, Christine] St Josephs Hlth Care, Hamilton, ON, Canada; [Iacovides, Harris; Rubinstein, Ethan] Hlth Sci Ctr, Winnipeg, MB, Canada; [John, Michael] London Hlth Sci Ctr, London, ON, Canada; [Johnston, Lynn; McNeil, Shelly] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Katz, Kevin] North York Gen Hosp, Toronto, ON, Canada; [Laffin, Nancy; Suh, Kathryn N.] Ottawa Hosp, Ottawa, ON, Canada; [Powis, Jeff] Toronto East Gen Hosp, Toronto, ON, Canada; [Smith, Stephanie; Taylor, Geoff] Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; McMaster University; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Toronto East General Hospital; University of Alberta	Simor, AE (corresponding author), Univ Toronto, Toronto, ON, Canada.	andrew.simor@sunnybrook.ca	Tadros, Manal/W-8169-2019; Tadros, Manal/AAF-2646-2020; McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014	Tadros, Manal/0000-0002-5546-0261; McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137; Coleman, Brenda L./0000-0002-7144-4827; McNeil, Shelly/0000-0001-5444-4166; Powis, Jeff/0000-0003-2053-6083; Iacovides, Harris/0000-0002-9244-1019	Pfizer Canada, Inc.	Pfizer Canada, Inc.	This work was supported by an investigator-initiated grant from Pfizer Canada, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bouza E, 2012, J HOSP INFECT, V80, P150, DOI 10.1016/j.jhin.2011.11.013; Choi EY, 2011, INTENS CARE MED, V37, P639, DOI 10.1007/s00134-011-2130-7; Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT SUS S; DeRyke CA, 2005, CHEST, V128, P1414, DOI 10.1378/chest.128.3.1414; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; Hague NZ, 2010, CHEST, V138, P1356, DOI 10.1378/chest.09-2453; Haque NZ, 2012, J CLIN MICROBIOL, V50, P1640, DOI 10.1128/JCM.06701-11; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jeffres MN, 2006, CHEST, V130, P947, DOI 10.1378/chest.130.4.947; Johnson AP, 2012, J ANTIMICROB CHEMOTH, V67, P802, DOI 10.1093/jac/dkr561; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Kallen AJ, 2009, ANN EMERG MED, V53, P358, DOI 10.1016/j.annemergmed.2008.04.027; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Lobo LJ, 2010, CHEST, V138, P130, DOI 10.1378/chest.09-1562; Louie L, 2002, J CLIN MICROBIOL, V40, P2786, DOI 10.1128/JCM.40.8.2786-2790.2002; Mendes RE, 2012, J CLIN MICROBIOL, V50, P3694, DOI 10.1128/JCM.02024-12; Moalla M, 2008, INFECT CONT HOSP EP, V29, P454, DOI 10.1086/533547; Moran GJ, 2012, CLIN INFECT DIS, V54, P1126, DOI 10.1093/cid/cis022; Peyrani P, 2011, CLIN INFECT DIS, V53, P766, DOI 10.1093/cid/cir541; Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Sharma-Kuinkel BK, 2012, J CLIN MICROBIOL, V50, P848, DOI 10.1128/JCM.06219-11; Shorr AF, 2006, CRIT CARE, V10, DOI 10.1186/cc4934; Shorr AF, 2010, J CLIN MICROBIOL, V48, P3258, DOI 10.1128/JCM.02529-09; Simor AE, 2010, INFECT CONT HOSP EP, V31, P348, DOI 10.1086/651313; Tsai YF, 2012, CURR OPIN PULM MED, V18, P246, DOI 10.1097/MCP.0b013e3283521022; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vardakas KZ, 2009, EUR RESPIR J, V34, P1148, DOI 10.1183/09031936.00041009; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895	39	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75171	10.1371/journal.pone.0075171	http://dx.doi.org/10.1371/journal.pone.0075171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069391	Green Submitted, gold, Green Published			2022-12-27	WOS:000324547300071
J	Ali, HI; Jarrar, AH; El Sadig, M; Yeatts, KB				Ali, Habiba I.; Jarrar, Amjad H.; El Sadig, Mohamed; Yeatts, Karin B.			Diet and Carbohydrate Food Knowledge of Multi-Ethnic Women: A Comparative Analysis of Pregnant Women with and without Gestational Diabetes Mellitus	PLOS ONE			English	Article							GLYCEMIC-INDEX DIET; NUTRITION TRANSITION; GLUCOSE-INTOLERANCE; WEIGHT; RISK; RECOMMENDATIONS; COMPLICATIONS; QUESTIONNAIRE; RESTRICTION; ASSOCIATION	Background: Diet therapy is the cornerstone for the management of gestational diabetes mellitus (GDM). Carbohydrate is the primary nutrient affecting postprandial blood glucose levels. Hence, knowledge of food containing carbohydrates can assist women with GDM optimize glycemic control. Despite that, there is a paucity of research on carbohydrate-related knowledge of women with GDM. The United Arab Emirates (UAE) has one of the highest prevalence of diabetes (19.2%) in the world. This study compared diet and knowledge of carbohydrate-containing foods among pregnant women with and without GDM in the UAE. Methods: The sample consisted of multi-ethnic women with GDM (n = 94) and a control group of healthy pregnant women (n = 90) attending prenatal clinics in three hospitals in Al Ain, UAE. Data were collected using a questionnaire and a 24-hour recall. Knowledge of food sources of carbohydrate, dietary patterns, and nutrient intakes of the two groups were compared. Results: There were no significant differences in the mean knowledge score of food sources of carbohydrate between women with GDM and that of pregnant women without GDM. Similarly, there were no significant differences in energy and nutrient intakes between the two groups with the exception of percent energy from protein. Women with GDM reported significantly lower intake of fruits and fruit juices (P = 0.012) and higher consumption of milk and yogurt (P = 0.004) compared to that of women without GDM. Twenty-two percent of women with GDM indicated they never visited a dietitian for counseling while 65% reported they visited a dietitian only once or twice during the pregnancy. Predictors of carbohydrate knowledge score were perceived knowledge of diet and GDM and parity among women with GDM and parity and educational level among those without GDM. Conclusion: The results of the study highlight the urgent need to provide nutrition education for women with GDM in the UAE.	[Ali, Habiba I.; Jarrar, Amjad H.] United Arab Emirates Univ, Coll Food & Agr, Dept Nutr & Hlth, Al Ain, U Arab Emirates; [El Sadig, Mohamed] United Arab Emirates Univ, Dept Community Med, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Yeatts, Karin B.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	United Arab Emirates University; United Arab Emirates University; University of North Carolina; University of North Carolina Chapel Hill	Ali, HI (corresponding author), United Arab Emirates Univ, Coll Food & Agr, Dept Nutr & Hlth, Al Ain, U Arab Emirates.	habAli@uaeu.ac.ae	Elsadig, Mohamed/AAX-7935-2020; Ali, Habiba/ABE-7828-2020	Elsadig, Mohamed/0000-0001-5795-8189; Ali, Habiba/0000-0003-2685-1244; Jarrar, Amjad/0000-0001-7185-6330				Agarwal MM, 2005, DIABETIC MED, V22, P1731, DOI 10.1111/j.1464-5491.2005.01706.x; Agarwal MM, 2000, DIABETIC MED, V17, P720, DOI 10.1046/j.1464-5491.2000.00371.x; Agarwal MM, 2010, DIABETES CARE, V33, P2018, DOI 10.2337/dc10-0572; Al-Maskari F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052857; Ali HI, 2013, NUTR RES, V33, P447, DOI 10.1016/j.nutres.2013.03.008; Ali HI, 2008, INT J DIABETES METAB, V16, P23; Alwan N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003395.pub2; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; American Dietetic Association, 2001, MED NUTR THER EV BAS; Artal R, 2007, APPL PHYSIOL NUTR ME, V32, P596, DOI 10.1139/H07-024; Asemi Z, 2013, NUTRITION, V29, P619, DOI 10.1016/j.nut.2012.11.020; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Bo S, 2004, J ENDOCRINOL INVEST, V27, P629, DOI 10.1007/BF03347494; Bonomo M, 2005, DIABETIC MED, V22, P1536, DOI 10.1111/j.1464-5491.2005.01690.x; Carolan M, 2010, MIDWIFERY, V26, P579, DOI 10.1016/j.midw.2009.01.006; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-18; Esha Research, 2006, FOOD PROC GEN SQL DA; Franz MJ, 2008, J AM DIET ASSOC, V108, pS52, DOI 10.1016/j.jada.2008.01.021; George GC, 2005, J AM DIET ASSOC, V105, P899, DOI 10.1016/j.jada.2005.03.028; Grant SM, 2011, DIABETES RES CLIN PR, V91, P15, DOI 10.1016/j.diabres.2010.09.002; Gunderson EP, 1997, DIABETES CARE, V20, P221, DOI 10.2337/diacare.20.2.221; Han S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009275.pub2; Hanna FWF, 2002, DIABETIC MED, V19, P351, DOI 10.1046/j.1464-5491.2002.00684.x; Hollander MH, 2007, OBSTET GYNECOL SURV, V62, P125, DOI 10.1097/01.ogx.0000253303.92229.59; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Jovanovic L, 2004, DRUGS, V64, P1401, DOI 10.2165/00003495-200464130-00002; Keshavarz M, 2005, DIABETES RES CLIN PR, V69, P279, DOI 10.1016/j.diabres.2005.01.011; Kjos SL, 1999, NEW ENGL J MED, V341, P1749, DOI 10.1056/NEJM199912023412307; Louie JCY, 2013, CURR DIABETES REP, V13, P6, DOI 10.1007/s11892-012-0332-1; Louie JCY, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/282464; Major CA, 1998, OBSTET GYNECOL, V91, P600, DOI 10.1016/S0029-7844(98)00003-9; Metzger BE, 1998, DIABETES CARE, V21, pB161; Millen AE, 2006, AM J EPIDEMIOL, V163, P279, DOI 10.1093/aje/kwj031; Moses RG, 2006, AM J CLIN NUTR, V84, P807, DOI 10.1093/ajcn/84.4.807; Moses RG, 2009, DIABETES CARE, V32, P996, DOI 10.2337/dc09-0007; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; Ng SW, 2011, OBES REV, V12, P1, DOI 10.1111/j.1467-789X.2010.00750.x; Nuss H, 2007, J AM DIET ASSOC, V107, P1801, DOI 10.1016/j.jada.2007.07.010; Pace R, 2008, ETHNIC DIS, V18, P6; Reader D, 2006, J AM DIET ASSOC, V106, P1426, DOI 10.1016/j.jada.2006.06.009; Reader DM, 2007, DIABETES CARE, V30, pS188, DOI 10.2337/dc07-s214; Reedy J, 2008, J AM DIET ASSOC, V108, P522, DOI 10.1016/j.jada.2007.12.014; Retnakaran R, 2010, J CLIN ENDOCR METAB, V95, P670, DOI 10.1210/jc.2009-1990; SNYDER J, 1994, AM J CLIN NUTR, V59, P1409, DOI 10.1093/ajcn/59.6.1409; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Sunsaneevithayakul Prasert, 2006, Journal of the Medical Association of Thailand, V89, P8; Svare JA, 2001, ACTA OBSTET GYN SCAN, V80, P899; Thomas B, 2006, NUTRITION, V22, P230, DOI 10.1016/j.nut.2005.07.017; Tieu J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007222.pub2; Walker JD, 2008, DIABETIC MED, V25, P1025, DOI 10.1111/j.1464-5491.2008.02532.x; Wheeler MLDA, 2008, J AM DIET ASS, V108; Zaghloul S, 2013, PUBLIC HEALTH NUTR, V16, P596, DOI 10.1017/S1368980012003941	55	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73486	10.1371/journal.pone.0073486	http://dx.doi.org/10.1371/journal.pone.0073486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069200	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100046
J	Dogan, T; Karacali, B				Dogan, Tunca; Karacali, Bilge			Automatic Identification of Highly Conserved Family Regions and Relationships in Genome Wide Datasets Including Remote Protein Sequences	PLOS ONE			English	Article							DOMAIN; ALGORITHM; DATABASE; IMPLEMENTATION; CDD	Identifying shared sequence segments along amino acid sequences generally requires a collection of closely related proteins, most often curated manually from the sequence datasets to suit the purpose at hand. Currently developed statistical methods are strained, however, when the collection contains remote sequences with poor alignment to the rest, or sequences containing multiple domains. In this paper, we propose a completely unsupervised and automated method to identify the shared sequence segments observed in a diverse collection of protein sequences including those present in a smaller fraction of the sequences in the collection, using a combination of sequence alignment, residue conservation scoring and graph-theoretical approaches. Since shared sequence fragments often imply conserved functional or structural attributes, the method produces a table of associations between the sequences and the identified conserved regions that can reveal previously unknown protein families as well as new members to existing ones. We evaluated the biological relevance of the method by clustering the proteins in gold standard datasets and assessing the clustering performance in comparison with previous methods from the literature. We have then applied the proposed method to a genome wide dataset of 17793 human proteins and generated a global association map to each of the 4753 identified conserved regions. Investigations on the major conserved regions revealed that they corresponded strongly to annotated structural domains. This suggests that the method can be useful in predicting novel domains on protein sequences.	[Dogan, Tunca] Izmir Inst Technol, Biotechnol & Bioengn Grad Program, Izmir, Turkey; [Dogan, Tunca] Dokuz Eylul Univ, Inst Hlth Sci, Izmir, Turkey; [Karacali, Bilge] Izmir Inst Technol, Elect & Elect Engn Dept, Izmir, Turkey	Izmir Institute of Technology; Dokuz Eylul University; Izmir Institute of Technology	Dogan, T (corresponding author), Izmir Inst Technol, Biotechnol & Bioengn Grad Program, Izmir, Turkey.	tuncadogan@gmail.com	Dogan, Tunca/B-5274-2017; KARAÇALI, Bilge/A-1347-2018	Dogan, Tunca/0000-0002-1298-9763; KARAÇALI, Bilge/0000-0002-7765-6329				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Apeltsin L, 2011, BIOINFORMATICS, V27, P326, DOI 10.1093/bioinformatics/btq655; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballard DH, 1982, COMPUTER VISION; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boyle R, 1988, COMPUTER VISION 1 CO; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Camacho C, 2008, BLAST COMMAND LINE A; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fariselli P, 2007, LECT NOTES COMPUT SC, V4414, P292; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Joseph JM, 2009, BIOINFORMATICS, V25, pI45, DOI 10.1093/bioinformatics/btp207; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Mohseni-Zadeh S, 2004, COMPUT BIOL CHEM, V28, P211, DOI 10.1016/j.compbiolchem.2004.03.002; Nepusz T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-120; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75458	10.1371/journal.pone.0075458	http://dx.doi.org/10.1371/journal.pone.0075458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069417	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100126
J	Fuller, C; Robotham, J; Savage, J; Hopkins, S; Deeny, SR; Stone, S; Cookson, B				Fuller, Christopher; Robotham, Julie; Savage, Joanne; Hopkins, Susan; Deeny, Sarah R.; Stone, Sheldon; Cookson, Barry			The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012	PLOS ONE			English	Article							INFECTION; COMMUNITY; HOSPITALS	Introduction: The English Department of Health introduced universal MRSA screening of admissions to English hospitals in 2010. It commissioned a national audit to review implementation, impact on patient management, admission prevalence and extra yield of MRSA identified compared to "high-risk" specialty or "checklist-activated" screening (CLAS) of patients with MRSA risk factors. Methods: National audit May 2011. Questionnaires to infection control teams in all English NHS acute trusts, requesting number patients admitted and screened, new or previously known MRSA; MRSA point prevalence; screening and isolation policies; individual risk factors and patient management for all new MRSA patients and random sample of negatives. Results: 144/167 (86.2%) trusts responded. Individual patient data for 760 new MRSA patients and 951 negatives. 61% of emergency admissions (median 67.3%), 81% (median 59.4%) electives and 47% (median 41.4%) day-cases were screened. MRSA admission prevalence: 1% (median 0.9%) emergencies, 0.6% (median 0.4%) electives, 0.4% (median 0%) day-cases. Approximately 50% all MRSA identified was new. Inpatient MRSA point prevalence: 3.3% (median 2.9%). 104 (77%) trusts pre-emptively isolated patients with previous MRSA, 63 (35%) pre-emptively isolated admissions to "high-risk" specialties; 7 (5%) used PCR routinely. Mean time to MRSA positive result: 2.87 days (+/- 1.33); 37% (219/596) newly identified MRSA patients discharged before result available; 55% remainder (205/376) isolated post-result. In an average trust, CLAS would reduce screening by 50%, identifying 81% of all MRSA. "High risk" specialty screening would reduce screening by 89%, identifying 9% of MRSA. Conclusions: Implementation of universal screening was poor. Admission prevalence (new cases) was low. CLAS reduced screening effort for minor decreases in identification, but implementation may prove difficult. Cost effectiveness of this and other policies, awaits evaluation by transmission dynamic economic modelling, using data from this audit. Until then trusts should seek to improve implementation of current policy and use of isolation facilities.	[Fuller, Christopher; Savage, Joanne; Stone, Sheldon; Cookson, Barry] UCL, London, England; [Robotham, Julie; Hopkins, Susan; Deeny, Sarah R.] Publ Hlth England, London, England; [Hopkins, Susan; Stone, Sheldon] Royal Free Hosp, London NW3 2QG, England; [Cookson, Barry] Hlth Protect Agcy, London, England	University of London; University College London; Public Health England; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Health Protection Agency	Fuller, C (corresponding author), UCL, London, England.	christopher.fuller@ucl.ac.uk		Robotham, Julie/0000-0003-2515-4084; Deeny, Sarah/0000-0001-5994-1583; Hopkins, Susan/0000-0001-5179-5702	Department of Health	Department of Health	This study was funded by the Department of Health. The funders had no role in data collection, analysis, decision ot publish or preparation of this manuscript. Representatives of the Department were members of the study steering group. The views of the authors are not necessarily those of the Department of Health.	[Anonymous], 2011, NHS SCOTL MRSA SCREE, V1; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; Cooper B S, 2003, Health Technol Assess, V7, P1; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Creamer E, 2010, INFECT CONT HOSP EP, V31, P374, DOI 10.1086/651093; Department of Health, 2008, IMP ASS SCREEN EL PA; Department of Health, 2006, COD PRACT PREV CONTR; Department of Health, 2010, OP FRAM 2011 12 NHS; Department of Health, 2005, SAV LIV DEL PROGR RE; Fuller C, 2012, NOW PREVALENCE AUDIT, P150; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Hardy K, 2010, CLIN MICROBIOL INFEC, V16, P333, DOI 10.1111/j.1469-0691.2009.02899.x; Health Protection Agency, 2012, Q EP COMM MAND MRSA; Health Scotland Protection, 2011, NHS SCOTL MRSA SCREE, V2; Health Scotland Protection, 2011, NAT SERV SCOTL FIN R, V3; Health Scotland Protection, 2011, NAT SERV SCOTL FIN R, V4; HPA, 2004, CDR WKLY, V14; Hubben G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014783; Jeyaratnam D, 2008, BMJ-BRIT MED J, V336, P927, DOI 10.1136/bmj.39525.579063.BE; Kessel AS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1601; Kjonegaard R, 2013, AM J INFECT CONTROL, V41, P45, DOI 10.1016/j.ajic.2012.01.038; Lee BY, 2009, INFECT CONT HOSP EP, V30, P1158, DOI 10.1086/648087; Leonhardt KK, 2011, INFECT CONT HOSP EP, V32, P797, DOI 10.1086/660875; Murthy A, 2010, CLIN MICROBIOL INFEC, V16, P1747, DOI 10.1111/j.1469-0691.2010.03220.x; National Audit Office, 2009, COMPTR AUD GEN HC 56; NPSA, 2004, READ STEAD GO FULL G; Public accounts Committee, 2009, 52 SESS 2008 9; Rao GG, 2007, J HOSP INFECT, V66, P15, DOI 10.1016/j.jhin.2007.01.013; Ritchie K, 2007, HLTH TECHNOL ASSESS; Robotham JV, 2011, PRIP08070410026 DH; Smith A, 2011, HLTH PROTECTION SCOT; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74219	10.1371/journal.pone.0074219	http://dx.doi.org/10.1371/journal.pone.0074219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069282	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100090
J	Kennedy, KM; Scarbrough, PM; Ribeiro, A; Richardson, R; Yuan, H; Sonveaux, P; Landon, CD; Chi, JT; Pizzo, S; Schroeder, T; Dewhirst, MW				Kennedy, Kelly M.; Scarbrough, Peter M.; Ribeiro, Anthony; Richardson, Rachel; Yuan, Hong; Sonveaux, Pierre; Landon, Chelsea D.; Chi, Jen-Tsan; Pizzo, Salvatore; Schroeder, Thies; Dewhirst, Mark W.			Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer	PLOS ONE			English	Article							GLUCOSE DEPRIVATION; OXIDATIVE STRESS; TRANSPORTER MCT4; TUMOR-CELLS; EXPRESSION; HYPOXIA; METASTASES; CARCINOMA; SURVIVAL; TISSUE	Lactate accumulation in tumors has been associated with metastases and poor overall survival in cancer patients. Lactate promotes angiogenesis and metastasis, providing rationale for understanding how it is processed by cells. The concentration of lactate in tumors is a balance between the amount produced, amount carried away by vasculature and if/how it is catabolized by aerobic tumor or stromal cells. We examined lactate metabolism in human normal and breast tumor cell lines and rat breast cancer: 1. at relevant concentrations, 2. under aerobic vs. hypoxic conditions, 3. under conditions of normo vs. hypoglucosis. We also compared the avidity of tumors for lactate vs. glucose and identified key lactate catabolites to reveal how breast cancer cells process it. Lactate was non-toxic at clinically relevant concentrations. It was taken up and catabolized to alanine and glutamate by all cell lines. Kinetic uptake rates of lactate in vivo surpassed that of glucose in R3230Ac mammary carcinomas. The uptake appeared specific to aerobic tumor regions, consistent with the proposed "metabolic symbiont'' model; here lactate produced by hypoxic cells is used by aerobic cells. We investigated whether treatment with alpha-cyano-4-hydroxycinnamate (CHC), a MCT1 inhibitor, would kill cells in the presence of high lactate. Both 0.1 mM and 5 mM CHC prevented lactate uptake in R3230Ac cells at lactate concentrations at <= 20 mM but not at 40 mM. 0.1 mM CHC was well-tolerated by R3230Ac and MCF7 cells, but 5 mM CHC killed both cell lines +/- lactate, indicating off-target effects. This study showed that breast cancer cells tolerate and use lactate at clinically relevant concentrations in vitro (+/- glucose) and in vivo. We provided additional support for the metabolic symbiont model and discovered that breast cells prevailingly take up and catabolize lactate, providing rationale for future studies on manipulation of lactate catabolism pathways for therapy.	[Kennedy, Kelly M.; Landon, Chelsea D.; Pizzo, Salvatore; Dewhirst, Mark W.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Richardson, Rachel; Schroeder, Thies; Dewhirst, Mark W.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA; [Scarbrough, Peter M.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [Ribeiro, Anthony] Duke Univ, Duke Univ Shared Resources NMR Facil, Durham, NC USA; [Chi, Jen-Tsan] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC USA; [Chi, Jen-Tsan] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC USA; [Yuan, Hong] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Sonveaux, Pierre] UCL, IREC, Brussels, Belgium	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Universite Catholique Louvain	Dewhirst, MW (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	mark.dewhirst@duke.edu	Chi, Jen-Tsan/AAI-4125-2020; Dewhirst, Mark/Q-1302-2019; Schroeder, Thies/G-5244-2014	Chi, Jen-Tsan/0000-0003-3433-903X; Dewhirst, Mark/0000-0003-3459-6546; Sonveaux, Pierre/0000-0001-6484-8834; Yuan, Hong/0000-0002-0535-3214	NIH-NCI [CA40355]; BCRP [BC083154]; ERC [243188]; NATIONAL CANCER INSTITUTE [R01CA040355, T32CA078586, R01CA125618] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BCRP; ERC(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded through the following grants: NIH-NCI CA40355 (covering the majority of the work, P. I. Mark Dewhirst), BCRP BC083154 (Postdoctoral grant, US Department of Defense, supporting Kelly Kennedy), ERC Starting Grant 243188 TUMETABO (Pierre Sonveaux). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Asada K, 2003, ONCOLOGY-BASEL, V64, P380, DOI 10.1159/000070297; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; Blackburn RV, 1999, FREE RADICAL BIO MED, V26, P419, DOI 10.1016/S0891-5849(98)00217-2; Boidot R, CANC RES, V72, P939; Bonen A, 2000, AM J PHYSIOL-ENDOC M, V278, pE1067, DOI 10.1152/ajpendo.2000.278.6.E1067; Bonuccelli G, 2010, CELL CYCLE, V9, P1960, DOI 10.4161/cc.9.10.11601; Bouzier AK, 1998, DEV NEUROSCI-BASEL, V20, P331, DOI 10.1159/000017328; Bouzier-Sore AK, 2001, J NEUROSCI RES, V65, P543, DOI 10.1002/jnr.1184; Brizel DM, 1996, CANCER RES, V56, P941; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Chen JLY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000293; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Dhup S, CURR PHARM DES, V18, P1319; Diers AR, BIOCH J, V444, P561; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Duh S-H, 2005, LAB REFERENCE RANGE; Fang J, 2006, MOL PHARMACOL, V70, P2108, DOI 10.1124/mol.106.026245; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; FELIG P, 1970, SCIENCE, V167, P1003, DOI 10.1126/science.167.3920.1003; Filyak O. S., 2005, Ukrainskii Biokhimicheskii Zhurnal, V77, P136; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GENTON B, 1990, INTENS CARE MED, V16, P196, DOI 10.1007/BF01724802; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Halestrap AP, 2008, ELETTERS J CLIN INVE; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herrero P, 2007, J NUCL MED, V48, P2046, DOI 10.2967/jnumed.107.044503; HILF R, 1986, CANCER RES, V46, P211; Hui L, 2006, ONCOGENE, V25, P7305, DOI 10.1038/sj.onc.1209735; Hussien R, PHYSL GENOMICS, V43, P255; Ibrahim E, 2009, MED ONCOL, V26, P372, DOI 10.1007/s12032-008-9131-6; Katayose D, 1995, CLIN CANCER RES, V1, P889; Kellen JA, 1996, IN VIVO, V10, P511; Kennedy KM, 2010, FUTURE ONCOL, V6, P127, DOI [10.2217/fon.09.145, 10.2217/FON.09.145]; Kim HS, 2012, BJU INT, V110, P1062, DOI 10.1111/j.1464-410X.2012.10971.x; Komarova EA, 1997, CANCER RES, V57, P5217; Kumar A, 2013, ANTI-CANCER DRUG, V24, P158, DOI 10.1097/CAD.0b013e3283586743; Kumar V, 2014, ROBBINS COTRAN PATHO; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Manning JE, 2000, SHOCK, V13, P152, DOI 10.1097/00024382-200013020-00010; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68; MUELLERKLIESER W, 1993, HISTOCHEM J, V25, P407, DOI 10.1007/BF00157805; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oshida M, 1998, CANCER, V82, P2227, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W; Pavlides S, AGING ALBANY NY, V2, P185; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Peltz C, 2005, ADV EXP MED BIOL, V566, P343; Pinheiro C, 2008, INT J GYNECOL PATHOL, V27, P568, DOI 10.1097/PGP.0b013e31817b5b40; Pinheiro C, 2008, VIRCHOWS ARCH, V452, P139, DOI 10.1007/s00428-007-0558-5; Pinheiro C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/427694; Pinheiro C, 2010, HISTOPATHOLOGY, V56, P860, DOI 10.1111/j.1365-2559.2010.03560.x; Porporato PE, FRONT PHARM, V2, P49; Rasschaert J, 2001, INT J MOL MED, V8, P63; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Richardson RA, 2003, ADV EXP MED BIOL, V510, P375; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; SAUER LA, 1994, METABOLISM, V43, P1488, DOI 10.1016/0026-0495(94)90006-X; SAUER LA, 1986, CANCER RES, V46, P689; Schroeder T, 2005, CANCER RES, V65, P5163, DOI 10.1158/0008-5472.CAN-04-3900; SCHWICKERT G, 1995, CANCER RES, V55, P4757; Schwickert G, 1996, EXPERIENTIA, V52, P460, DOI 10.1007/BF01919316; Simons AL, 2009, J CANCER RES THER, V5, P2, DOI 10.4103/0973-1482.55133; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Walenta S, 2003, J CANCER RES CLIN, V129, P321, DOI 10.1007/s00432-003-0450-x; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; Walenta S, 2000, CANCER RES, V60, P916; Walenta S, 2001, INT J RADIAT ONCOL, V51, P840, DOI 10.1016/S0360-3016(01)01700-X; Walenta S, 1997, AM J PATHOL, V150, P409; Warburg O.H., 1930, METABOLISM TUMOURS I; Warburg OH, 1926, AOEBER STOFFWECHSEL; Yaligar J, 2012, NMR BIOMED, V25, P113, DOI 10.1002/nbm.1723; Yokota H, 2007, J MAGN RESON IMAGING, V25, P992, DOI 10.1002/jmri.20902; ZIELKE HR, 1980, J CELL PHYSIOL, V104, P433, DOI 10.1002/jcp.1041040316	88	121	123	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75154	10.1371/journal.pone.0075154	http://dx.doi.org/10.1371/journal.pone.0075154			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069390	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100122
J	Anel, JA; Allen, DR; Saenz, G; Gimeno, L; de la Torre, L				Anel, Juan A.; Allen, Douglas R.; Saenz, Guadalupe; Gimeno, Luis; de la Torre, Laura			Equivalent Latitude Computation Using Regions of Interest (ROI)	PLOS ONE			English	Article							REANALYSIS; TRANSPORT	This paper introduces a novel algorithm to compute equivalent latitude by applying regions of interest (ROI). The technique is illustrated using code written in Interactive Data Language (IDL). The ROI method is compared with the "piecewise-constant'' method, the approach commonly used in atmospheric sciences, using global fields of atmospheric potential vorticity. The ROI method is considerably more accurate and computationally faster than the piecewise-constant method, and it also works well with irregular grids. Both the ROI and piecewise-constant IDL codes for equivalent latitude are included as a useful reference for the research community.	[Anel, Juan A.; Saenz, Guadalupe] Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England; [Anel, Juan A.; Gimeno, Luis; de la Torre, Laura] Univ Vigo, EPhysLab, Fac Ciencias, Orense, Spain; [Allen, Douglas R.] Naval Res Lab, Washington, DC USA; [Saenz, Guadalupe] Univ Extremadura, Fac Ciencias, Dept Fis, E-06071 Badajoz, Spain	University of Oxford; Universidade de Vigo; United States Department of Defense; United States Navy; Naval Research Laboratory; Universidad de Extremadura	Anel, JA (corresponding author), Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England.	juan.anel@smithschool.ox.ac.uk	de la Torre, Laura/Y-3723-2019; , Juan Antonio Añel Cabanelas/N-1866-2019; Allen, Douglas Ray/GWZ-8901-2022; GIMENO, LUIS/B-8137-2008	de la Torre, Laura/0000-0001-5305-6946; , Juan Antonio Añel Cabanelas/0000-0003-2448-4647; Allen, Douglas/0000-0003-2747-9712; GIMENO, LUIS/0000-0002-0778-3605	TRODIM project [CGL2007-65891-C05-01]; ExCirEs project [CGL2011-24826]; Spanish Ministry of Science and Innovation; Spanish Ministry of Economy and Competitiveness; Xunta de Galicia under "Programa de Consolidacion e Estruturacion de Unidades de Investigacion (Grupos de Referencia Competitiva)"; European Regional Development Fund; University of Oxford; Engineering and Physical Sciences Research Council of the United Kingdom; United States Office of Naval Research	TRODIM project; ExCirEs project; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Xunta de Galicia under "Programa de Consolidacion e Estruturacion de Unidades de Investigacion (Grupos de Referencia Competitiva)"; European Regional Development Fund(European Commission); University of Oxford; Engineering and Physical Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); United States Office of Naval Research(Office of Naval Research)	This work was partially supported by the TRODIM (CGL2007-65891-C05-01) and ExCirEs projects (CGL2011-24826) funded by the Spanish Ministry of Science and Innovation, Spanish Ministry of Economy and Competitiveness and by the Xunta de Galicia under "Programa de Consolidacion e Estruturacion de Unidades de Investigacion (Grupos de Referencia Competitiva)'' funded by European Regional Development Fund. JAA research is partially supported by the University of Oxford and the Engineering and Physical Sciences Research Council of the United Kingdom. Work at the Naval Research Lab is sponsored by the United States Office of Naval Research. Part of the simulations performed were carried out in the Centro de Supercomputacion de Galicia through a "Reto Computacional 2009'' project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DR, 2003, J ATMOS SCI, V60, P287, DOI 10.1175/1520-0469(2003)060<0287:TELADT>2.0.CO;2; Anel JA, PLOS ONE UNPUB; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; Bowman K.P., 2006, INTRO PROGRAMMING ID; BUTCHART N, 1986, J ATMOS SCI, V43, P1319, DOI 10.1175/1520-0469(1986)043<1319:TAOTSP>2.0.CO;2; Garcia RR, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007485; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; LARY DJ, 1995, Q J ROY METEOR SOC, V121, P187; McIntyre M. E., 2003, ENCY ATMOS SCI, V2, P685; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Schoeberl MR, 2003, ENCY ATMOSPHERIC SCI, V3, P1321; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176	14	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e72970	10.1371/journal.pone.0072970	http://dx.doi.org/10.1371/journal.pone.0072970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086267	Green Submitted, Green Published, gold			2022-12-27	WOS:000325218700006
J	Esmaeili, A; Pourbabaee, AA; Alikhani, HA; Shabani, F; Esmaeili, E				Esmaeili, Atefeh; Pourbabaee, Ahmad Ali; Alikhani, Hossein Ali; Shabani, Farzin; Esmaeili, Ensieh			Biodegradation of Low-Density Polyethylene (LDPE) by Mixed Culture of Lysinibacillus xylanilyticus and Aspergillus niger in Soil	PLOS ONE			English	Article							DISPOSABLE POLYETHYLENE; DEGRADATION; FILMS	In this study, two strains of Aspergillus sp. and Lysinibacillus sp. with remarkable abilities to degrade low-density polyethylene (LDPE) were isolated from landfill soils in Tehran using enrichment culture and screening procedures. The biodegradation process was performed for 126 days in soil using UV- and non-UV-irradiated pure LDPE films without pro-oxidant additives in the presence and absence of mixed cultures of selected microorganisms. The process was monitored by measuring the microbial population, the biomass carbon, pH and respiration in the soil, and the mechanical properties of the films. The carbon dioxide measurements in the soil showed that the biodegradation in the un-inoculated treatments were slow and were about 7.6% and 8.6% of the mineralisation measured for the non-UV-irradiated and UV-irradiated LDPE, respectively, after 126 days. In contrast, in the presence of the selected microorganisms, biodegradation was much more efficient and the percentages of biodegradation were 29.5% and 15.8% for the UV-irradiated and non-UV-irradiated films, respectively. The percentage decrease in the carbonyl index was higher for the UV-irradiated LDPE when the biodegradation was performed in soil inoculated with the selected microorganisms. The percentage elongation of the films decreased during the biodegradation process. The Fourier transform infra-red (FT-IR), x-ray diffraction (XRD) and scanning electron microscopy (SEM) were used to determine structural, morphological and surface changes on polyethylene. These analyses showed that the selected microorganisms could modify and colonise both types of polyethylene. This study also confirmed the ability of these isolates to utilise virgin polyethylene without pro-oxidant additives and oxidation pretreatment, as the carbon source.	[Esmaeili, Atefeh; Pourbabaee, Ahmad Ali; Alikhani, Hossein Ali] Univ Tehran, Univ Coll Agr & Nat Resources, Fac Agr Engn & Technol, Dept Soil Sci, Karaj, Iran; [Shabani, Farzin] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Esmaeili, Ensieh] Dept Environm, Tehran, Iran	University of Tehran; University of New England	Esmaeili, A (corresponding author), Univ Tehran, Univ Coll Agr & Nat Resources, Fac Agr Engn & Technol, Dept Soil Sci, Karaj, Iran.	aesmaeili@ut.ac.ir	Alikhani, Hossein Ali/Y-8783-2018; Pourbabaee, Ahmad/ABD-9376-2021; shabani, Farzin/P-1033-2019	Alikhani, Hossein Ali/0000-0002-8740-6059; shabani, Farzin/0000-0002-5100-8921; pourbabaei, Ahmad Ali/0000-0002-5273-2161				Abd El-Rehim HA, 2004, J PHOTOCH PHOTOBIO A, V163, P547, DOI 10.1016/j.jphotochem.2004.02.003; Abrusci C, 2011, INT BIODETER BIODEGR, V65, P451, DOI 10.1016/j.ibiod.2010.10.012; ALBERTSSON AC, 1980, EUR POLYM J, V16, P623, DOI 10.1016/0014-3057(80)90100-7; ALBERTSSON AC, 1987, POLYM DEGRAD STABIL, V18, P73, DOI 10.1016/0141-3910(87)90084-X; ALBERTSSON AC, 1978, J APPL POLYM SCI, V22, P3419, DOI 10.1002/app.1978.070221207; American Society for Testing and Materials (ASTM), 2003, D5988 ASTM; [Anonymous], 1999, D1293 ASTM; [Anonymous], 2003, ISO17556; [Anonymous], 2003, D882 ASTM; Chiellini E, 2003, POLYM DEGRAD STABIL, V81, P341, DOI 10.1016/S0141-3910(03)00105-8; Claus D., 1986, BERGEYS MANUAL SYSTE, P1105, DOI DOI 10.1016/0922-338X(92)90270-5; CORNELL JH, 1984, J APPL POLYM SCI, V29, P2581, DOI 10.1002/app.1984.070290814; Corti A, 2010, POLYM DEGRAD STABIL, V95, P1106, DOI 10.1016/j.polymdegradstab.2010.02.018; El-Shafei HA, 1998, POLYM DEGRAD STABIL, V62, P361, DOI 10.1016/S0141-3910(98)00019-6; Fontanella S, 2010, POLYM DEGRAD STABIL, V95, P1011, DOI 10.1016/j.polymdegradstab.2010.03.009; Gilan I, 2004, APPL MICROBIOL BIOT, V65, P97, DOI 10.1007/s00253-004-1584-8; Hadad D, 2005, J APPL MICROBIOL, V98, P1093, DOI 10.1111/j.1365-2672.2005.02553.x; Jakubowicz I, 2006, POLYM DEGRAD STABIL, V91, P1556, DOI 10.1016/j.polymdegradstab.2005.09.018; Jakubowicz I, 2011, POLYM DEGRAD STABIL, V96, P919, DOI 10.1016/j.polymdegradstab.2011.01.031; Jenkinson DS, 2004, SOIL BIOL BIOCHEM, V36, P5, DOI 10.1016/j.soilbio.2003.10.002; Lau AK, 2009, J ENVIRON MANAGE, V90, P668, DOI 10.1016/j.jenvman.2008.03.001; LEE BT, 1991, APPL ENVIRON MICROB, V57, P678, DOI 10.1128/AEM.57.3.678-685.1991; Manzur A, 2004, J APPL POLYM SCI, V92, P265, DOI 10.1002/app.13644; Nowak B., 2011, INT BIODETER BIODEGR, V42, P1; Ojeda TFM, 2009, POLYM DEGRAD STABIL, V94, P965, DOI 10.1016/j.polymdegradstab.2009.03.011; Orhan Y, 2000, INT BIODETER BIODEGR, V45, P49, DOI 10.1016/S0964-8305(00)00048-2; Page AL, 2008, METHODS SOIL ANAL 2, P139; Roy PK, 2008, POLYM DEGRAD STABIL, V93, P1917, DOI 10.1016/j.polymdegradstab.2008.07.016; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Siotto M, 2012, J ENVIRON MANAGE, V93, P31, DOI 10.1016/j.jenvman.2011.08.018; Sivan A, 2006, APPL MICROBIOL BIOT, V72, P346, DOI 10.1007/s00253-005-0259-4; Sudhakar M, 2008, INT BIODETER BIODEGR, V61, P203, DOI 10.1016/j.ibiod.2007.07.011; Volke-Sepulveda T, 2002, J APPL POLYM SCI, V83, P305, DOI 10.1002/app.2245; Watanabe T., 2002, PICTORIAL ATLAS SOIL, V2nd; WEILAND M, 1995, POLYM DEGRAD STABIL, V48, P275, DOI 10.1016/0141-3910(95)00040-S; YABANNAVAR AV, 1994, APPL ENVIRON MICROB, V60, P3608, DOI 10.1128/AEM.60.10.3608-3614.1994; Zahra S, 2010, WASTE MANAGE, V30, P396, DOI 10.1016/j.wasman.2009.09.027	37	143	161	14	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e71720	10.1371/journal.pone.0071720	http://dx.doi.org/10.1371/journal.pone.0071720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086254	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200002
J	Noreen, S; Ahmed, B; Hayat, T				Noreen, Saima; Ahmed, Bashir; Hayat, Tasawar			Mixed Convection Flow of Nanofluid in Presence of an Inclined Magnetic Field	PLOS ONE			English	Article							PERISTALTIC FLOW; ASYMMETRIC CHANNEL; FLUID; SLIP; TRANSPORT	This research is concerned with the mixed convection peristaltic flow of nanofluid in an inclined asymmetric channel. The fluid is conducting in the presence of inclined magnetic field. The governing equations are modelled. Mathematical formulation is completed through long wavelength and low Reynolds number approach. Numerical solution to the nonlinear analysis is made by shooting technique. Attention is mainly focused to the effects of Brownian motion and thermophoretic diffusion of nanoparticle. Results for velocity, temperature, concentration, pumping and trapping are obtained and analyzed in detail.	[Noreen, Saima] Comsats Inst Informat Technol, Dept Math, Islamabad, Pakistan; [Ahmed, Bashir; Hayat, Tasawar] King Abdulaziz Univ, Fac Sci, Dept Math, Jeddah, Saudi Arabia; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan	COMSATS University Islamabad (CUI); King Abdulaziz University; Quaid I Azam University	Noreen, S (corresponding author), Comsats Inst Informat Technol, Dept Math, Islamabad, Pakistan.	laurel_lichen@yahoo.com	Hayat, Tasawar/Y-2524-2019; Hayat, Tasawar/E-9449-2015; Hayat, Tasawar/A-3853-2013; Ahmad, Bashir/B-1977-2012	Ahmad, Bashir/0000-0001-5350-2977	King Abdulaziz University (KAU) [10-130/1433 HiCi]; KAU; project for academic research at KAU	King Abdulaziz University (KAU); KAU; project for academic research at KAU	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University (KAU), under grant no. 10-130/1433 HiCi. The authors, therefore, acknowledge technical and financial support of KAU. The support is in the form of a project for academic research at KAU. This is to certify that this work is not funded through any external source/research organization including industry, etc. External funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmaboud Y, 2011, APPL MATH MODEL, V35, P2695, DOI 10.1016/j.apm.2010.11.031; Akbar NS, 2012, MECCANICA, V47, P1283, DOI 10.1007/s11012-011-9512-3; Akbar NS, 2012, INT J HEAT MASS TRAN, V55, P1855, DOI 10.1016/j.ijheatmasstransfer.2011.11.038; Choi S.U.S., 1995, P 1995 ASME INT MECH, P99; Das K, 2012, IRAN J MATH SCI INFO, V7, P35, DOI 10.7508/ijmsi.2012.02.004; Hayat T, 2012, APPL MATH MECH-ENGL, V33, P1035, DOI 10.1007/s10483-012-1603-6; Hayat T, 2011, COMMUN NONLINEAR SCI, V16, P1363, DOI 10.1016/j.cnsns.2010.06.034; Kothandapani M, 2008, INT J NONLIN MECH, V43, P915, DOI 10.1016/j.ijnonlinmec.2008.06.009; Latham T., 1966, THESIS MIT PRESS CAM; Mekheimer KS, 2008, PHYSICA A, V387, P2403, DOI 10.1016/j.physa.2007.12.017; Mekheimer KS, 1998, INT J THEOR PHYS, V37, P2895, DOI 10.1023/A:1026657629065; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Noreen S, 2013, INDIAN J PHYS, V87, P889, DOI 10.1007/s12648-013-0316-2; SHAPIRO AH, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; Srinivas S, 2011, COMMUN NONLINEAR SCI, V16, P1845, DOI 10.1016/j.cnsns.2010.08.004; Tripathi D, 2010, APPL MATH COMPUT, V215, P3645, DOI 10.1016/j.amc.2009.11.002; Tripathi D, 2011, ACTA ASTRONAUT, V69, P30, DOI 10.1016/j.actaastro.2010.12.010; Vries K de, 1990, AM J OBSTET GYNECOL, V162, P679	18	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73248	10.1371/journal.pone.0073248	http://dx.doi.org/10.1371/journal.pone.0073248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086276	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200009
J	Hu, JY; Luo, ZJ; Zhao, XQ; Chen, Q; Chen, ZY; Qin, H; Qin, YF; Liang, XH; Suo, YJ				Hu, Jieyu; Luo, Zuojie; Zhao, Xiaoqin; Chen, Qiang; Chen, Zhaoyan; Qin, Hua; Qin, Yingfen; Liang, Xinghuan; Suo, Yingjun			Changes in the Calcium-Parathyroid Hormone-Vitamin D Axis and Prognosis for Critically Ill Patients: A Prospective Observational Study	PLOS ONE			English	Article							D DEFICIENCY; INCREASED MORTALITY; HYPOVITAMINOSIS-D; CATHELICIDIN; HYPOCALCEMIA; PREVALENCE; SEVERITY; RECEPTOR; OUTCOMES; OLD	Objective: Vitamin D deficiency is prevalent in critically ill patients and may contribute to suboptimal clinical outcomes, but little is known about alterations of the calcium-parathyroid hormone (PTH)-vitamin D axis and prognosis in these individuals. Methods: A prospective observational study was conducted on 216 patients admitted to a university-affiliated, tertiary-care medical intensive care unit(MICU) between June 2011 and December 2012. Serum levels of 25-hydroxyvitamin D, ionised calcium and intact PTH were determined within 24 h of MICU admission. The primary end point was all-cause hospital mortality within 90-days of admission. Results: 95 patients (44%) showed 25-hydroxyvitamin D deficiency. Patients deficient in vitamin D showed significantly higher Acute Physiology and Chronic Health Evaluation II (APACHE II) score, rate of positive blood culture, incidence of multiple organ dysfunction syndrome, and 90-day mortality rate than did patients with vitamin D insufficiency or sufficiency (P<0.05), as well as lower levels of serum IgG. 25-Hydroxyvitamin D deficiency was identified as an independent risk factor for mortality (OR = 3.018, 95%CI 1.329-6.854, P = 0.008). Hypovitaminosis D in PTH-responders was associated with higher mortality than was the same condition in non-responders (P<0.05). Conclusions: These results suggest that vitamin D deficiency is prevalent among MICU patients, suggesting a significant derangement of the calcium-PTH-vitamin D axis in critically ill patients. Vitamin D deficiency is an independent risk factor for 90-day mortality, and hypovitaminosis D in PTH-responders is associated with higher mortality than is the same condition in non-responders.	[Hu, Jieyu; Zhao, Xiaoqin; Chen, Qiang; Chen, Zhaoyan; Qin, Hua] Guangxi Med Univ, Affiliated Hosp 1, Intens Care Unit, Nanning, Peoples R China; [Luo, Zuojie; Qin, Yingfen; Liang, Xinghuan; Suo, Yingjun] Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University	Luo, ZJ (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanning, Peoples R China.	1144532347@qq.com						Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Arnson Y, 2012, QJM-INT J MED, V105, P633, DOI 10.1093/qjmed/hcs014; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Baeke F, 2010, PEDIATR NEPHROL, V25, P1597, DOI 10.1007/s00467-010-1452-y; Bjelakovic G, 2011, COCHRANE DATABASE SY, V7; Bjorkman MP, 2008, EUR J ENDOCRINOL, V158, P749, DOI 10.1530/EJE-07-0849; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; Carlstedt F, 1997, EUR J CLIN INVEST, V27, P977, DOI 10.1046/j.1365-2362.1997.2310778.x; Chen JS, 2008, CLIN ENDOCRINOL, V68, P290, DOI 10.1111/j.1365-2265.2007.03040.x; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Fisher A, 2010, BONE, V47, P400, DOI 10.1016/j.bone.2010.04.610; Flynn L, 2011, AM J SURG, V203, P379; Hastbacka J, 2003, ACTA ANAESTH SCAND, V47, P1264, DOI 10.1046/j.1399-6576.2003.00236.x; Heaney RP, 2003, J AM COLL NUTR, V22, P142, DOI 10.1080/07315724.2003.10719287; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Higgins DM, 2012, JPEN-PARENTER ENTER, V36, P713, DOI 10.1177/0148607112444449; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3215, DOI 10.1210/jc.2004-2364; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Horl Walter H, 2004, Nephrol Dial Transplant, V19 Suppl 5, pV2, DOI 10.1093/ndt/gfh1049; Krishnan A, 2010, CRIT CARE, V14, DOI 10.1186/cc9341; Lee P, 2009, INTENS CARE MED, V35, P2028, DOI 10.1007/s00134-009-1642-x; Lee P, 2009, NEW ENGL J MED, V360, P1912, DOI 10.1056/NEJMc0809996; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Matthews LR, 2012, AM J SURG, V204, P37, DOI 10.1016/j.amjsurg.2011.07.021; Nair P, 2013, INTENS CARE MED, V39, P267, DOI 10.1007/s00134-012-2713-y; Pincikova T, 2011, EUR J CLIN NUTR, V65, P102, DOI 10.1038/ejcn.2010.194; Rostand SG, 1999, KIDNEY INT, V56, P383, DOI 10.1046/j.1523-1755.1999.00575.x; Sambrook PN, 2004, J CLIN ENDOCR METAB, V89, P5477, DOI 10.1210/jc.2004-0307; Selvaraj P, 2011, VITAM HORM, V86, P307, DOI 10.1016/B978-0-12-386960-9.00013-7; Venkatram S, 2011, CRIT CARE, V15, DOI 10.1186/cc10585; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Zivin JR, 2001, AM J KIDNEY DIS, V37, P689, DOI 10.1016/S0272-6386(01)80116-5	35	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75441	10.1371/journal.pone.0075441	http://dx.doi.org/10.1371/journal.pone.0075441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073266	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000076
J	Kishimoto-Yamada, K; Kamiya, K; Meleng, P; Diway, B; Kaliang, H; Chong, L; Itioka, T; Sakai, S; Ito, M				Kishimoto-Yamada, Keiko; Kamiya, Koichi; Meleng, Paulus; Diway, Bibian; Kaliang, Het; Chong, Lucy; Itioka, Takao; Sakai, Shoko; Ito, Motomi			Wide Host Ranges of Herbivorous Beetles? Insights from DNA Bar Coding	PLOS ONE			English	Article							DIPTEROCARP FOREST; TROPICAL FORESTS; INSECT HERBIVORES; PINUS-PUMILA; SPECIFICITY; COLEOPTERA; PATTERNS; TREES; SPECIALIZATION; IDENTIFICATION	There are very few studies that have investigated host-specificity among tropical herbivorous insects. Indeed, most of the trophic interactions of herbivorous insects in Southeast Asian tropical rainforests remain unknown, and whether polyphagous feeding is common in the herbivores of this ecosystem has not been determined. The present study employed DNA bar coding to reveal the trophic associations of adult leaf-chewing chrysomelid beetles in a Bornean rainforest. Plant material ingested by the adults was retrieved from the bodies of the insects, and a portion of the chloroplast rbcL sequence was then amplified from this material. The plants were identified at the family level using an existing reference database of chloroplast DNA. Our DNA-based diet analysis of eleven chrysomelid species successfully identified their host plant families and indicated that five beetle species fed on more than two families within the angiosperms, and four species fed on several families of gymnosperms and/or ferns together with multiple angiosperm families. These findings suggest that generalist chrysomelid beetles associated with ecologically and taxonomically distant plants constitute a part of the plant-insect network of the Bornean rainforest.	[Kishimoto-Yamada, Keiko; Ito, Motomi] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Kamiya, Koichi] Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; [Meleng, Paulus] Sarawak Forest Dept, Res Dev & Innovat Div, Kuching, Sarawak, Malaysia; [Diway, Bibian; Kaliang, Het; Chong, Lucy] Sarawak Forestry Corp, Appl Forest Sci & Ind Dev, Kuching, Sarawak, Malaysia; [Itioka, Takao] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan; [Sakai, Shoko] Res Inst Humanity & Nat, Kyoto, Japan	University of Tokyo; Ehime University; Jabatan Hutan Sarawak; Kyoto University; Research Institute for Humanity & Nature (RIHN)	Kishimoto-Yamada, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.	kky_kei@yahoo.co.jp	Sakai, Shoko/AFN-1913-2022	Sakai, Shoko/0000-0002-4267-8405; Kamiya, Koichi/0000-0003-3614-9029	Ministry of Education, Culture, Sports, Science and Technology-Japan [FY2012-2016];  [23-6333]; Grants-in-Aid for Scientific Research [21255004] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the National BioResource Project (FY2012-2016) from the Ministry of Education, Culture, Sports, Science and Technology-Japan, and a Grant-in-Aid for Japan Society for the Promotion of Science Fellows (23-6333 to KKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDE TM, 1993, ECOLOGY, V74, P455, DOI 10.2307/1939307; APPANAH S, 1993, J BIOSCIENCES, V18, P457, DOI 10.1007/BF02703079; ASHTON PS, 1988, ANNU REV ECOL SYST, V19, P347, DOI 10.1146/annurev.es.19.110188.002023; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; BASSET Y, 1992, BIOL J LINN SOC, V47, P115, DOI 10.1111/j.1095-8312.1992.tb00659.x; Basset Y, 1996, BIOL J LINN SOC, V59, P201, DOI 10.1111/j.1095-8312.1996.tb01461.x; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Chai PKP, 1984, SOME ORNAMENTAL ROAD; Charles E, 2005, J TROP ECOL, V21, P329, DOI 10.1017/S0266467405002300; Cognato AI, 2006, J ECON ENTOMOL, V99, P1037, DOI 10.1603/0022-0493-99.4.1037; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Coode MJE, 1996, CHECKLIST FLOWERING; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Ichie T, 2004, J TROP ECOL, V20, P697, DOI 10.1017/S0266467404001713; JOLIVET P, 1995, HOST PLANTS CHRYSOME; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; KATO M, 1995, RES POPUL ECOL, V37, P59, DOI 10.1007/BF02515762; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kishimoto-Yamada K, 2009, B ENTOMOL RES, V99, P217, DOI 10.1017/S000748530800624X; Kishimoto-Yamada K, 2008, BIOTROPICA, V40, P600, DOI 10.1111/j.1744-7429.2008.00410.x; Kishimoto-Yamada K, 2010, INSECT CONSERV DIVER, V3, P266, DOI 10.1111/j.1752-4598.2010.00099.x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kubisz D, 2012, CENT EUR J BIOL, V7, P69, DOI 10.2478/s11535-011-0099-4; Kumagai T, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007307; Lee H. S., 2002, The 52-Hectare Forest Research Plot at Lambir Hills, Sarawak, Malaysia: tree distribution maps, diameter tables and species documentation; Leigh EG, 2004, BIOTROPICA, V36, P447, DOI 10.1111/j.1744-7429.2004.tb00342.x; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Mawdsley N. A., 1997, P104; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; Nagamasu H, 1997, GEN FLOWERING TROPIC, P20; Nakagawa M, 2000, J TROP ECOL, V16, P355, DOI 10.1017/S0266467400001450; Navarro SP, 2010, ECOL ENTOMOL, V35, P18, DOI 10.1111/j.1365-2311.2009.01145.x; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2002, J ANIM ECOL, V71, P400, DOI 10.1046/j.1365-2656.2002.00608.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2003, ARTHROPODS OF TROPICAL FORESTS, P40; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Novotny V, 2012, AM NAT, V179, P351, DOI 10.1086/664082; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Odegaard F, 2000, J BIOGEOGR, V27, P283, DOI 10.1046/j.1365-2699.2000.00404.x; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Piggott A. G., 1988, FERNS MALAYSIA COLOU; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rodriguez-Castaneda G, 2010, ECOL LETT, V13, P1348, DOI 10.1111/j.1461-0248.2010.01525.x; Sakai S, 2002, BIOL J LINN SOC, V75, P233, DOI 10.1111/j.1095-8312.2002.tb01424.x; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; Sakai S, 2006, AM J BOT, V93, P1134, DOI 10.3732/ajb.93.8.1134; Staudacher K, 2011, SOIL BIOL BIOCHEM, V43, P346, DOI 10.1016/j.soilbio.2010.10.022; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wardhaugh CW, 2012, J ANIM ECOL, V81, P1086, DOI 10.1111/j.1365-2656.2012.01988.x; Watano Y, 1995, J PLANT RES, V108, P493, DOI 10.1007/BF02344239; Watano Y, 2004, AM J BOT, V91, P65, DOI 10.3732/ajb.91.1.65; Webb CO, 2006, ECOLOGY, V87, pS123, DOI 10.1890/0012-9658(2006)87[123:PSMSSA]2.0.CO;2; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Webber BL, 2006, AUST SYST BOT, V19, P541, DOI 10.1071/SB06001; Weiblen GD, 2006, ECOLOGY, V87, pS62, DOI 10.1890/0012-9658(2006)87[62:PDOHUI]2.0.CO;2; Whitmore T.C., 1984, TROPICAL RAM FORESTS; Yumoto T, 2005, ECOL STU AN, V174, P13	70	22	26	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74426	10.1371/journal.pone.0074426	http://dx.doi.org/10.1371/journal.pone.0074426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073210	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000019
J	Lin, YC; Chen, BM; Lu, WC; Su, CI; Prijovich, ZM; Chung, WC; Wu, PY; Chen, KC; Lee, IC; Juan, TY; Roffler, SR				Lin, Yi-Chieh; Chen, Bing-Mae; Lu, Wei-Cheng; Su, Chien-I; Prijovich, Zeljko M.; Chung, Wen-Chuan; Wu, Pei-Yu; Chen, Kai-Chuan; Lee, I-Chiao; Juan, Ting-Yi; Roffler, Steve R.			The B7-1 Cytoplasmic Tail Enhances Intracellular Transport and Mammalian Cell Surface Display of Chimeric Proteins in the Absence of a Linear ER Export Motif	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; ENDOPLASMIC-RETICULUM LOCALIZATION; COPII-DEPENDENT EXPORT; POTASSIUM CHANNEL; MEMBRANE-PROTEINS; TRANSMEMBRANE PROTEINS; BETA-GLUCURONIDASE; COUPLED RECEPTORS; VESICLE FORMATION; SELECTIVE EXPORT	Membrane-tethered proteins (mammalian surface display) are increasingly being used for novel therapeutic and biotechnology applications. Maximizing surface expression of chimeric proteins on mammalian cells is important for these applications. We show that the cytoplasmic domain from the B7-1 antigen, a commonly used element for mammalian surface display, can enhance the intracellular transport and surface display of chimeric proteins in a Sar1 and Rab1 dependent fashion. However, mutational, alanine scanning and deletion analysis demonstrate the absence of linear ER export motifs in the B7 cytoplasmic domain. Rather, efficient intracellular transport correlated with the presence of predicted secondary structure in the cytoplasmic tail. Examination of the cytoplasmic domains of 984 human and 782 mouse type I transmembrane proteins revealed that many previously identified ER export motifs are rarely found in the cytoplasmic tail of type I transmembrane proteins. Our results suggest that efficient intracellular transport of B7 chimeric proteins is associated with the structure rather than to the presence of a linear ER export motif in the cytoplasmic tail, and indicate that short (less than similar to 10-20 amino acids) and unstructured cytoplasmic tails should be avoided to express high levels of chimeric proteins on mammalian cells.	[Lin, Yi-Chieh; Chen, Bing-Mae; Lu, Wei-Cheng; Su, Chien-I; Prijovich, Zeljko M.; Chung, Wen-Chuan; Wu, Pei-Yu; Chen, Kai-Chuan; Lee, I-Chiao; Juan, Ting-Yi; Roffler, Steve R.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan	Roffler, SR (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	sroff@ibms.sinica.edu.tw	LU, Wei-Cheng/O-5577-2017; Roffler, Steve R/N-7791-2018	Roffler, Steve R/0000-0003-2543-7295	National Science Council, Taiwan [NSC-99-2320-B001-011-MY3, NSC-102-2320-B001-013-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grants to SRR from the National Science Council, Taiwan (NSC-99-2320-B001-011-MY3 and NSC-102-2320-B001-013-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; ARGOS P, 1990, J MOL BIOL, V211, P943, DOI 10.1016/0022-2836(90)90085-Z; Askanas V, 2009, BRAIN PATHOL, V19, P493, DOI 10.1111/j.1750-3639.2009.00290.x; Auer S, 2010, NAT METHODS, V7, P229, DOI [10.1038/NMETH.1425, 10.1038/nmeth.1425]; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bowers PM, 2011, P NATL ACAD SCI USA, V108, P20455, DOI 10.1073/pnas.1114010108; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Castro-Fernandez C, 2005, ENDOCR REV, V26, P479, DOI 10.1210/er.2004-0010; Chen KC, 2007, CANCER GENE THER, V14, P187, DOI 10.1038/sj.cgt.7700999; Chen KC, 2013, MOL PHARMACEUT, V10, P1773, DOI 10.1021/mp300581u; Chen KC, 2008, CHEM BIOL, V15, P1277, DOI 10.1016/j.chembiol.2008.10.008; Cheng TL, 2008, MED RES REV, V28, P885, DOI 10.1002/med.20127; Chiaw PK, 2009, CHEM BIOL, V16, P520, DOI 10.1016/j.chembiol.2009.04.005; Chou WC, 1999, BIOTECHNOL BIOENG, V65, P160, DOI 10.1002/(SICI)1097-0290(19991020)65:2<160::AID-BIT5>3.0.CO;2-U; Chuang KH, 2010, MOL CANCER THER, V9, P1903, DOI 10.1158/1535-7163.MCT-09-0899; Chuang KH, 2010, J NUCL MED, V51, P933, DOI 10.2967/jnumed.109.071977; Crambert G, 2004, J BIOL CHEM, V279, P30888, DOI 10.1074/jbc.M313494200; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Doty RT, 1996, J IMMUNOL, V157, P3270; Doty RT, 1998, J IMMUNOL, V161, P2700; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; Dyczynska E, 2008, INT J CANCER, V122, P2634, DOI 10.1002/ijc.23405; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hanton SL, 2005, PLANT CELL, V17, P3081, DOI 10.1105/tpc.105.034900; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Huang PT, 2011, CANCER GENE THER, V18, P381, DOI 10.1038/cgt.2011.3; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KANG HS, 1991, J BIOL CHEM, V266, P5643; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; KORNFELD R, 1976, ANNU REV BIOCHEM, V45, P217, DOI 10.1146/annurev.bi.45.070176.001245; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; Liao KW, 2003, CANCER GENE THER, V10, P779, DOI 10.1038/sj.cgt.7700637; Liao KW, 2001, BIOTECHNOL BIOENG, V73, P313, DOI 10.1002/bit.1064; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2005, MOL BIOL CELL, V16, P3719, DOI 10.1091/mbc.E05-03-0262; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Monne M, 1998, J MOL BIOL, V284, P1177, DOI 10.1006/jmbi.1998.2218; MORINAGA T, 1983, P NATL ACAD SCI-BIOL, V80, P4604, DOI 10.1073/pnas.80.15.4604; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nufer O, 2002, J CELL SCI, V115, P619; Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Pan WY, 2012, MOL THER, V20, P927, DOI 10.1038/mt.2012.10; Paulhe F, 2004, J BIOL CHEM, V279, P55545, DOI 10.1074/jbc.M407813200; Pollastri G, 2002, PROTEINS, V47, P228, DOI 10.1002/prot.10082; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Sharkey LM, 2009, J NEUROSCI, V29, P2733, DOI 10.1523/JNEUROSCI.6026-08.2009; Shieh SJ, 2009, J IMMUNOL, V183, P2277, DOI 10.4049/jimmunol.0900679; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Su YC, 2010, BIOCONJUGATE CHEM, V21, P1264, DOI 10.1021/bc100067t; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Volna P, 2007, NUCLEIC ACIDS RES, V35, P2748, DOI 10.1093/nar/gkm182; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742; Wang BZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013972; Wang TT, 2012, AM J PHYSIOL-CELL PH, V303, pC963, DOI 10.1152/ajpcell.00217.2012; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wolkowicz R, 2005, J BIOL CHEM, V280, P15195, DOI 10.1074/jbc.M500254200; Xia X, 2002, MOL BIOL EVOL, V19, P58, DOI 10.1093/oxfordjournals.molbev.a003982; Ye ZM, 2002, NAT MED, V8, P343, DOI 10.1038/nm0402-343; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zhou C, 2010, MABS-AUSTIN, V2, P508, DOI 10.4161/mabs.2.5.12970; Zuzarte M, 2007, TRAFFIC, V8, P1093, DOI 10.1111/j.1600-0854.2007.00593.x	101	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75084	10.1371/journal.pone.0075084	http://dx.doi.org/10.1371/journal.pone.0075084			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073236	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000045
J	Sha, W; Martins, AM; Laubenbacher, R; Mendes, P; Shulaev, V				Sha, Wei; Martins, Ana M.; Laubenbacher, Reinhard; Mendes, Pedro; Shulaev, Vladimir			The Genome-Wide Early Temporal Response of Saccharomyces cerevisiae to Oxidative Stress Induced by Cumene Hydroperoxide	PLOS ONE			English	Article							OXYGEN-FREE-RADICALS; GENE-EXPRESSION; MITOCHONDRIAL-FUNCTION; ALCOHOL-DEHYDROGENASE; ERYTHROASCORBIC ACID; YEAST; CELLS; YAP1; SENSITIVITY; PROTEASOME	Oxidative stress is a well-known biological process that occurs in all respiring cells and is involved in pathophysiological processes such as aging and apoptosis. Oxidative stress agents include peroxides such as hydrogen peroxide, cumene hydroperoxide, and linoleic acid hydroperoxide, the thiol oxidant diamide, and menadione, a generator of superoxide, amongst others. The present study analyzed the early temporal genome-wide transcriptional response of Saccharomyces cerevisiae to oxidative stress induced by the aromatic peroxide cumene hydroperoxide. The accurate dataset obtained, supported by the use of temporal controls, biological replicates and well controlled growth conditions, provided a detailed picture of the early dynamics of the process. We identified a set of genes previously not implicated in the oxidative stress response, including several transcriptional regulators showing a fast transient response, suggesting a coordinated process in the transcriptional reprogramming. We discuss the role of the glutathione, thioredoxin and reactive oxygen species-removing systems, the proteasome and the pentose phosphate pathway. A data-driven clustering of the expression patterns identified one specific cluster that mostly consisted of genes known to be regulated by the Yap1p and Skn7p transcription factors, emphasizing their mediator role in the transcriptional response to oxidants. Comparison of our results with data reported for hydrogen peroxide identified 664 genes that specifically respond to cumene hydroperoxide, suggesting distinct transcriptional responses to these two peroxides. Genes up-regulated only by cumene hydroperoxide are mainly related to the cell membrane and cell wall, and proteolysis process, while those down-regulated only by this aromatic peroxide are involved in mitochondrial function.	[Sha, Wei; Martins, Ana M.; Laubenbacher, Reinhard; Mendes, Pedro; Shulaev, Vladimir] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Sha, Wei] Univ North Carolina Charlotte, Bioinformat Res Div, Kannapolis, NC USA; [Martins, Ana M.] Univ Sharjah, Dept Appl Biol, Sharjah, U Arab Emirates; [Laubenbacher, Reinhard] Univ Connecticut, Ctr Hlth, Ctr Quantitat Med, Farmington, CT USA; [Mendes, Pedro] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England; [Mendes, Pedro] Univ Manchester, Manchester Ctr Integrat Syst Biol, Manchester, Lancs, England; [Shulaev, Vladimir] Univ N Texas, Dept Biol Sci, Coll Arts & Sci, Denton, TX 76203 USA	Virginia Polytechnic Institute & State University; University of North Carolina; University of North Carolina Charlotte; University of Sharjah; University of Connecticut; University of Manchester; University of Manchester; University of North Texas System; University of North Texas Denton	Martins, AM (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	amtbs.martins@gmail.com	Martons, Ana Margarida/AAP-4337-2021; Martins, Samir/P-6251-2014	Martons, Ana Margarida/0000-0003-4822-3249; Martins, Samir/0000-0003-1702-8504; Mendes, Pedro/0000-0001-6507-9168	National Institute for General Medical Sciences [GM068947]; Virginia Bioinformatics Institute; Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BPD/8033/2002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068947, R01GM080219] Funding Source: NIH RePORTER	National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Virginia Bioinformatics Institute; Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant (GM068947) to RL from the National Institute for General Medical Sciences (http://www.nigms.nih.gov), supplemented with funds from the Virginia Bioinformatics Institute (www.vbi.vt.edu), and a fellowship to AMM from the Portuguese Fundacao para a Ciencia e Tecnologia (SFRH/BPD/8033/2002)(www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic N, 2004, FREE RADICAL BIO MED, V37, P23, DOI 10.1016/j.freeradbiomed.2004.04.014; Amako K, 2006, BIOSCI BIOTECH BIOCH, V70, P3004, DOI 10.1271/bbb.60399; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azevedo D, 2003, FREE RADICAL BIO MED, V35, P889, DOI 10.1016/S0891-5849(03)00434-9; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROWN JL, 1994, EMBO J, V13, P5186, DOI 10.1002/j.1460-2075.1994.tb06849.x; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; CHENG L, 1994, MOL GEN GENET, V243, P358, DOI 10.1007/BF00301072; Cohen BA, 2002, MOL BIOL CELL, V13, P1608, DOI 10.1091/mbc.01-10-0472; Cyrne L, 2003, FREE RADICAL BIO MED, V34, P385, DOI 10.1016/S0891-5849(02)01300-X; Davermann D, 2002, FREE RADICAL BIO MED, V33, P1209, DOI 10.1016/S0891-5849(02)00984-X; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Delneri D, 1999, YEAST, V15, P1681, DOI 10.1002/(SICI)1097-0061(199911)15:15<1681::AID-YEA486>3.0.CO;2-A; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dreher D, 1996, EUR J CANCER, V32A, P30, DOI 10.1016/0959-8049(95)00531-5; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evans MV, 1998, J BACTERIOL, V180, P483, DOI 10.1128/JB.180.3.483-490.1998; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; HAMMEL KE, 1986, P NATL ACAD SCI USA, V83, P3708, DOI 10.1073/pnas.83.11.3708; Hancock RD, 2000, FEMS MICROBIOL LETT, V186, P245, DOI 10.1016/S0378-1097(00)00155-5; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, pW213, DOI 10.1093/nar/gkh402; Higgins VJ, 2002, YEAST, V19, P203, DOI 10.1002/yea.811; Hochstrasser M, 1999, PHILOS T ROY SOC B, V354, P1513, DOI 10.1098/rstb.1999.0495; Horan S, 2006, YEAST, V23, P519, DOI 10.1002/yea.1372; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Kosikova B, 1996, FOLIA MICROBIOL, V41, P430, DOI 10.1007/BF02815694; Krems B, 1996, CURR GENET, V29, P327, DOI 10.1007/s002940050053; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Kuge S, 2001, MOL CELL BIOL, V21, P6139, DOI 10.1128/MCB.21.18.6139-6150.2001; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Larroy C, 2002, BIOCHEM J, V361, P163, DOI 10.1042/0264-6021:3610163; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li S, 2002, MOL BIOL CELL, V13, P412, DOI 10.1091/mbc.01-09-0434; Lucau-Danila A, 2005, MOL CELL BIOL, V25, P1860, DOI 10.1128/MCB.25.5.1860-1868.2005; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Martins AM, 2004, CURR GENOMICS, V5, P649, DOI 10.2174/1389202043348643; Martins AM, 2007, YEAST, V24, P181, DOI 10.1002/yea.1442; MARX JL, 1987, SCIENCE, V235, P529, DOI 10.1126/science.3810154; Minard KL, 2001, FREE RADICAL BIO MED, V31, P832, DOI 10.1016/S0891-5849(01)00666-9; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nevitt T, 2004, YEAST, V21, P1365, DOI 10.1002/yea.1188; NICK JA, 1986, PLANT SCI, V46, P181, DOI 10.1016/0168-9452(86)90190-1; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Rodrigues-Pousada CA, 2004, FEBS LETT, V567, P80, DOI 10.1016/j.febslet.2004.03.119; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shringarpure R, 2000, CELL MOL LIFE SCI, V57, P1802, DOI 10.1007/PL00000660; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; STEPHEN DWS, 1995, MOL MICROBIOL, V16, P415, DOI 10.1111/j.1365-2958.1995.tb02407.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; Toledano MB, 2003, OXIDATIVE STRESS RES; Tsuzi D, 2004, FEBS LETT, V565, P148, DOI 10.1016/j.febslet.2004.03.091; VROEGOP SM, 1995, FREE RADICAL BIO MED, V18, P141, DOI 10.1016/0891-5849(94)00107-U; Winzeler EA, 1999, PARASITOLOGY, V118, pS73, DOI 10.1017/S0031182099004047; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	79	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74939	10.1371/journal.pone.0074939	http://dx.doi.org/10.1371/journal.pone.0074939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073228	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000037
J	Finkelstein, EA; Allaire, BT; Globe, D; Dixon, JB				Finkelstein, Eric A.; Allaire, Benjamin T.; Globe, Denise; Dixon, John B.			The Business Case for Bariatric Surgery Revisited: A Non-Randomized Case-Control Study	PLOS ONE			English	Article							INDUCED WEIGHT-LOSS; OBESE-PATIENTS; IMPACT; COSTS; MANAGEMENT	Background and Aim: Prior studies reporting that bariatric surgery (including laparoscopic adjustable gastric band (LAGB) and [laparoscopic Roux-en-Y] Gastric Bypass (LRYGB)) is cost-saving relied on a comparison sample of those with a morbid obesity (MO) diagnosis code, a high cost group who may not be reflective of those who opt for the procedures. We re-estimate net costs and time to breakeven using an alternative sample that does not rely on this code. Materials and Methods: Non-randomized case-control study using medical claims data from a commercial database in the USA. LAGB and LRYGB claimants were propensity score matched to two control samples: one restricted to those with a MO diagnosis code and one without this restriction. Results: When using the MO sample, costs for LAGB and LRYGB are recovered in 1.5 (Confidence Interval [CI]: 1.45 to 1.55) and 2.25 years (CI: 2.07 to 2.43), and 5 year savings are $78,980 (CI: 62,320 to 100,550) for LAGB and $61,420 (CI: 44,710 to 82,870) for LRYGB. Without the MO requirement, time to breakeven for LAGB increases to 5.25 (CI: 4.25 to 10+) years with a 5 year net cost of $690 (CI: 6,800 to 8.400). For LRYGB, time to breakeven exceeds 10 years and 5 year net costs are $18,940 (CI: 10,390 to 26,740). Conclusions: The net costs and time to breakeven resulting from bariatric surgery are likely less favorable than has been reported in prior studies, and especially for LRYGB, with a time to breakeven of more than twice the 5.25 year estimate for LAGB.	[Finkelstein, Eric A.] Duke NUS Grad Med Sch, Singapore, Singapore; [Finkelstein, Eric A.] Duke Univ, Global Hlth Inst, Durham, NC USA; [Allaire, Benjamin T.] RTI Int, Durham, NC USA; [Globe, Denise] Allergan Pharmaceut Inc, Global Hlth Outcomes Strategy & Res, Irvine, CA USA; [Dixon, John B.] Monash Univ, Dept Gen Practice, Sch Primary Hlth Care, Melbourne, Vic 3004, Australia; [Dixon, John B.] Baker IDI Heart & Diabet Inst, Vasc & Hypertens Unit, Human Neurotransmitters Lab, Melbourne, Vic, Australia	National University of Singapore; Duke University; Research Triangle Institute; AbbVie; Allergan; Monash University; Baker Heart and Diabetes Institute	Finkelstein, EA (corresponding author), Duke NUS Grad Med Sch, Singapore, Singapore.	eric.finkelstein@duke-nus.edu.sg	Dixon, John B/A-5318-2011	Dixon, John B/0000-0001-5391-4082; Allaire, Benjamin/0000-0002-7033-2129	Allergan Inc.	Allergan Inc.(AbbVieAllergan)	Funding for this study was provided by Allergan Inc., the employer of Denise Globe. John B. Dixon is a consultant for Allergan Inc. and Eric A. Finkelstein and Ben T. Allaire have consulted for Allergan Inc. in the past. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Centers for Disease Control and Prevention, 2012, OB OV HLTH CONS; Cremieux PY, 2008, AM J MANAG CARE, V14, P589; Cunneen SA, 2008, SURG OBES RELAT DIS, V4, pS47, DOI 10.1016/j.soard.2008.04.007; Dixon JB, 2012, OBES REV, V13, P57, DOI 10.1111/j.1467-789X.2011.00928.x; Finkelstein EA, 2011, J OCCUP ENVIRON MED, V53, P1025, DOI 10.1097/JOM.0b013e318229aae4; Finkelstein EA, 2011, SURG OBES RELAT DIS, V7, P295, DOI 10.1016/j.soard.2010.10.011; Finkelstein EA, 2010, J OCCUP ENVIRON MED, V52, P971, DOI 10.1097/JOM.0b013e3181f274d2; Keating CL, 2009, DIABETES CARE, V32, P580, DOI 10.2337/dc08-1748; Keating CL, 2009, DIABETES CARE, V32, P567, DOI 10.2337/dc08-1749; Maciejewski ML, 2010, MED CARE, V48, P989, DOI 10.1097/MLR.0b013e3181ef9cf7; Reuters Thomson(Healthcare) Inc, 2003, MARKETSCAN DAT; Sampalis JS, 2004, OBES SURG, V14, P939, DOI 10.1381/0960892041719662; StataCorp, 2009, STAT STAT SOFTW REL	14	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75498	10.1371/journal.pone.0075498	http://dx.doi.org/10.1371/journal.pone.0075498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069423	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300083
J	Klop, B; van de Geijn, GJM; Bovenberg, SA; van der Meulen, N; Elte, JWF; Birnie, E; Njo, TL; Janssen, HW; van Miltenburg, A; Jukema, JW; Cabezas, MC				Klop, Boudewijn; van de Geijn, Gert-Jan M.; Bovenberg, Sarah A.; van der Meulen, Noelle; Elte, Jan Willem F.; Birnie, Erwin; Njo, Tjin L.; Janssen, Hans W.; van Miltenburg, Addy; Jukema, J. Wouter; Cabezas, Manuel Castro			Erythrocyte-Bound Apolipoprotein B in Relation to Atherosclerosis, Serum Lipids and ABO Blood Group	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK-FACTOR; CHOLESTEROL; LIPOPROTEINS; ASSOCIATION; PLASMA; CELLS	Introduction: Erythrocytes carry apolipoprotein B on their membrane, but the determining factors of erythrocyte-bound apolipoprotein B (ery-apoB) are unknown. We aimed to explore the determinants of ery-apoB to gain more insight into potential mechanisms. Methods: Subjects with and without CVD were included (N=398). Ery-apoB was measured on fresh whole blood samples using flow cytometry. Subjects with ery-apoB levels <= 0.20 a.u. were considered deficient. Carotid intima media thickness (CIMT) was determined as a measure of (subclinical) atherosclerosis. Results: Mean ery-apoB value was 23.2% lower in subjects with increased CIMT (0.80 +/- 0.09 mm, N = 140) compared to subjects with a normal CIMT (0.57 +/- 0.08 mm, N = 258) (P = 0.007, adjusted P<0.001). CIMT and ery-apoB were inversely correlated (Spearman's n =0.116, P=0.021). A total of 55 subjects (13.6%) were considered ery-apoB deficient, which was associated with a medical history of CVD (OR: 1.86, 95% CI 1.04-3.33; adjusted OR: 1.55; 95% CI 0.85-2.82). Discontinuation of statins in 54 subjects did not influence ery-apoB values despite a 58.4% increase in serum apolipoprotein B. Subjects with blood group O had significantly higher ery-apoB values (1.56 +/- 0.94 a.u.) when compared to subjects with blood group A (0.89 +/- 1.15 a.u), blood group B (0.73 +/- 0.1.12 a.u.) or blood group AB (0.69 +/- 0.69 a.u.) (P-ANOVA = 0.002). Conclusion: Absence or very low values of ery-apoB are associated with clinical and subclinical atherosclerosis. While serum apolipoprotein B is not associated with ery-apoB, the ABO blood group seems to be a significant determinant.	[Klop, Boudewijn; Bovenberg, Sarah A.; van der Meulen, Noelle; Elte, Jan Willem F.; Cabezas, Manuel Castro] St Franciscus Gasthuis, Dept Internal Med, Rotterdam, Netherlands; [Klop, Boudewijn; Bovenberg, Sarah A.; van der Meulen, Noelle; Elte, Jan Willem F.; Cabezas, Manuel Castro] St Franciscus Gasthuis, Diabet & Vasc Ctr, Rotterdam, Netherlands; [van de Geijn, Gert-Jan M.; Njo, Tjin L.; Janssen, Hans W.] St Franciscus Gasthuis, Dept Clin Chem, Rotterdam, Netherlands; [Birnie, Erwin] St Franciscus Gasthuis, Dept Stat & Educ, Rotterdam, Netherlands; [van Miltenburg, Addy] St Franciscus Gasthuis, Dept Cardiol, Rotterdam, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands	Franciscus Gasthuis; Franciscus Gasthuis; Franciscus Gasthuis; Franciscus Gasthuis; Franciscus Gasthuis; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Cabezas, MC (corresponding author), St Franciscus Gasthuis, Dept Internal Med, Rotterdam, Netherlands.	m.castrocabezas@sfg.nl	Jukema, J. Wouter/ABD-6503-2021	Jukema, J. Wouter/0000-0002-3246-8359				Alipour A, 2008, ARTERIOSCL THROM VAS, V28, P792, DOI 10.1161/ATVBAHA.107.159749; Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366; Bovenberg SA, 2010, ATHEROSCLEROSIS SUPP, V11, P25, DOI 10.1016/j.atherosclerosissup.2010.04.003; Bovenberg SA, 2011, EUR J CLIN INVEST; Carpeggiani C, 2010, ATHEROSCLEROSIS, V211, P461, DOI 10.1016/j.atherosclerosis.2010.03.012; GARRISON RJ, 1976, ATHEROSCLEROSIS, V25, P311, DOI 10.1016/0021-9150(76)90036-8; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P267, DOI 10.1002/gepi.1370040405; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; He MA, 2012, ARTERIOSCL THROM VAS, V32, P2314, DOI 10.1161/ATVBAHA.112.248757; Hinderling PH, 1997, PHARMACOL REV, V49, P279; HUI DY, 1981, BIOCHIM BIOPHYS ACTA, V664, P513, DOI 10.1016/0005-2760(81)90129-6; HUI DY, 1979, BIOCHIM BIOPHYS ACTA, V550, P407, DOI 10.1016/0005-2736(79)90145-7; Hung KT, 2012, ARTERIOSCL THROM VAS, V32, P1460, DOI 10.1161/ATVBAHA.112.248971; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; LANGMAN MJS, 1969, LANCET, V2, P607; Mora S, 2008, CIRCULATION, V118; OLIVER MF, 1969, LANCET, V2, P605; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarnak MJ, 2002, J AM COLL CARDIOL, V40, P27, DOI 10.1016/S0735-1097(02)01938-1; SASAK WV, 1991, BIOCHEM J, V274, P159, DOI 10.1042/bj2740159; van Oostrom AJHHM, 2004, DRUGS, V64, P19, DOI 10.2165/00003495-200464002-00004; Verseyden C, 2004, J CLIN ENDOCR METAB, V89, P5021, DOI 10.1210/jc.2003-032171; WONG FL, 1992, GENET EPIDEMIOL, V9, P405; Zhang HR, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/641917	24	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75573	10.1371/journal.pone.0075573	http://dx.doi.org/10.1371/journal.pone.0075573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069429	Green Published, gold			2022-12-27	WOS:000324777300085
J	Zhang, XM; Shao, B; Wu, YL; Qi, O				Zhang, Xiaomeng; Shao, Bin; Wu, Yangle; Qi, Ouyang			A Reverse Engineering Approach to Optimize Experiments for the Construction of Biological Regulatory Networks	PLOS ONE			English	Article							GENE NETWORKS; INFERENCE; DREAM	One of the major objectives in systems biology is to understand the relation between the topological structures and the dynamics of biological regulatory networks. In this context, various mathematical tools have been developed to deduct structures of regulatory networks from microarray expression data. In general, from a single data set, one cannot deduct the whole network structure; additional expression data are usually needed. Thus how to design a microarray expression experiment in order to get the most information is a practical problem in systems biology. Here we propose three methods, namely, maximum distance method, trajectory entropy method, and sampling method, to derive the optimal initial conditions for experiments. The performance of these methods is tested and evaluated in three well-known regulatory networks (budding yeast cell cycle, fission yeast cell cycle, and E. coli. SOS network). Based on the evaluation, we propose an efficient strategy for the design of microarray expression experiments.	[Zhang, Xiaomeng; Shao, Bin; Wu, Yangle; Qi, Ouyang] Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing 100871, Peoples R China; [Zhang, Xiaomeng; Shao, Bin; Wu, Yangle; Qi, Ouyang] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Zhang, Xiaomeng; Shao, Bin; Wu, Yangle; Qi, Ouyang] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Qi, O (corresponding author), Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing 100871, Peoples R China.	qi@pku.edu.cn	Zhang, Xiaoming/L-2904-2013; SHAO, BIN/ABE-4975-2021	SHAO, BIN/0000-0001-8697-2174	Natural Science Foundation of China [11074009, 10721463]; Minister of Science and Technology of China [2009CB918500]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Minister of Science and Technology of China	Natural Science Foundation of China (11074009, 10721463), Minister of Science and Technology of China(2009CB918500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; de la Fuente A, 2006, IEE P SYST BIOL, V153, P257, DOI 10.1049/ip-syb:20050061; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Marbach D, 2009, ANN NY ACAD SCI, V1158, P234, DOI 10.1111/j.1749-6632.2008.03944.x; Prill RJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002212; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Stolovitzky G, 2007, ANN NY ACAD SCI, V1115, P1, DOI 10.1196/annals.1407.021; Wang GY, 2010, P NATL ACAD SCI USA, V107, P10478, DOI 10.1073/pnas.0914180107; Wu YL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000442	17	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75931	10.1371/journal.pone.0075931	http://dx.doi.org/10.1371/journal.pone.0075931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069453	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300100
J	Maynard, BF; Bass, C; Katanski, C; Thakur, K; Manoogian, B; Leander, M; Nichols, R				Maynard, Benjamin F.; Bass, Chloe; Katanski, Chris; Thakur, Kiran; Manoogian, Beth; Leander, Megan; Nichols, Ruthann			Structure-Activity Relationships of FMRF-NH2 Peptides Demonstrate A Role for the Conserved C Terminus and Unique N-Terminal Extension in Modulating Cardiac Contractility	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; CRYSTAL-STRUCTURE; PROTEIN; NEUROPEPTIDE; IDENTIFICATION; BINDING; RECEPTORS; ACCURACY; MODELS	FMRF-NH2 peptides which contain a conserved, identical C-terminal tetrapeptide but unique N terminus modulate cardiac contractility; yet, little is known about the mechanisms involved in signaling. Here, the structure-activity relationships (SARs) of the Drosophila melanogaster FMRF-NH2 peptides, PDNFMRF-NH2, SDNFMRF-NH2, DPKQDFMRF-NH2, SPKQDFMRF-NH2, and TPAEDFMRF-NH2, which bind FMRFa-R, were investigated. The hypothesis tested was the C-terminal tetrapeptide FMRF-NH2, particularly F1, makes extensive, strong ligand-receptor contacts, yet the unique N terminus influences docking and activity. To test this hypothesis, docking, binding, and bioactivity of the C-terminal tetrapeptide and analogs, and the FMRF-NH2 peptides were compared. Results for FMRF-NH2 and analogs were consistent with the hypothesis; F1 made extensive, strong ligand-receptor contacts with FMRFa-R; Y -> F (YMRF-NH2) retained binding, yet A -> F (AMRF-NH2) did not. These findings reflected amino acid physicochemical properties; the bulky, aromatic residues F and Y formed strong pi-stacking and hydrophobic contacts to anchor the ligand, interactions which could not be maintained in diversity or number by the small, aliphatic A. The FMRF-NH2 peptides modulated heart rate in larva, pupa, and adult distinctly, representative of the contact sites influenced by their unique N-terminal structures. Based on physicochemical properties, the peptides each docked to FMRFa-R with one best pose, except FMRF-NH2 which docked with two equally favorable poses, consistent with the N terminus influencing docking to define specific ligand-receptor contacts. Furthermore, SDNAMRF-NH2 was designed and, despite lacking the aromatic properties of one F, it binds FMRFa-R and demonstrated a unique SAR, consistent with the N terminus influencing docking and conferring binding and activity; thus, supporting our hypothesis.	[Maynard, Benjamin F.; Bass, Chloe; Katanski, Chris; Thakur, Kiran; Manoogian, Beth; Leander, Megan; Nichols, Ruthann] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Maynard, Benjamin F.; Katanski, Chris; Leander, Megan; Nichols, Ruthann] Univ Michigan, Dept Chem, Undergrad Biochem Honors Res Program, Ann Arbor, MI 48109 USA; [Bass, Chloe; Nichols, Ruthann] Univ Michigan, Dept Chem, Undergrad Chem Honors Res Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nichols, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	nicholsr@umich.edu			NIH [R21HL093627]; University of Michigan Medical Innovation Center; University of Michigan Cardiovascular Center Innovative Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093627] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Medical Innovation Center; University of Michigan Cardiovascular Center Innovative Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a NIH grant R21HL093627, Concept to Commercialization Funding from the University of Michigan Medical Innovation Center, and a University of Michigan Cardiovascular Center Innovative Grant to Ruthann Nichols. Chloe Bass received the Seyhan N. Ege-WISE Award to support her research to support his research in the Nichols' lab, and Ben Maynard received an Albert Euclid Hinsdale Award to support his research in the Nichols' lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bass C, 2013, PEPTIDES IN PRESS; Bortolato Andrea, 2013, Methods Mol Biol, V924, P339, DOI 10.1007/978-1-62703-017-5_13; Cazzamali G, 2002, P NATL ACAD SCI USA, V99, P12073, DOI 10.1073/pnas.192442799; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Claeys I, 2005, VITAM HORM, V73, P217, DOI 10.1016/S0083-6729(05)73007-7; Clark J, 2008, PEPTIDES, V29, P1140, DOI 10.1016/j.peptides.2008.02.013; Congreve M, 2011, J MED CHEM, V54, P4283, DOI 10.1021/jm200371q; Dunn TW, 2005, PEPTIDES, V26, P269, DOI 10.1016/j.peptides.2004.09.010; Duttlinger A, 2002, PEPTIDES, V23, P1953, DOI 10.1016/S0196-9781(02)00179-1; Foucaud M, 2008, REGUL PEPTIDES, V145, P17, DOI 10.1016/j.regpep.2007.09.024; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Hewes RS, 1998, J NEUROSCI, V18, P7138; Jeffery G.A., 1997, INTRO HYDROGEN BONDI; Klose MK, 2010, J NEUROSCI, V30, P14724, DOI 10.1523/JNEUROSCI.3612-10.2010; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Levit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027990; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; McCormick J, 1999, CELL TISSUE RES, V297, P197, DOI 10.1007/s004410051347; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; NAMBU JR, 1988, NEURON, V1, P55, DOI 10.1016/0896-6273(88)90209-7; NICHOLS R, 1988, J BIOL CHEM, V263, P12167; NICHOLS R, 1992, J MOL NEUROSCI, V3, P213, DOI 10.1007/BF03380141; Nichols R, 1999, J NEUROGENET, V13, P89, DOI 10.3109/01677069909083468; Nichols R, 2009, FRONT BIOSCI-LANDMRK, V14, P4035, DOI 10.2741/3510; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SCHNEIDER LE, 1988, P NATL ACAD SCI USA, V85, P1993, DOI 10.1073/pnas.85.6.1993; Staljanssens D, 2011, PEPTIDES, V32, P607, DOI 10.1016/j.peptides.2010.11.025; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Upadhyaya J, 2010, BIOCHEM BIOPH RES CO, V398, P331, DOI 10.1016/j.bbrc.2010.06.097; WHITE K, 1986, J COMP NEUROL, V247, P430, DOI 10.1002/cne.902470403; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Zhang J, 2010, BIOINFORMATICS, V26, P3004, DOI 10.1093/bioinformatics/btq563	40	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75502	10.1371/journal.pone.0075502	http://dx.doi.org/10.1371/journal.pone.0075502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069424	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300085
J	Sancisi, V; Gandolfi, G; Ragazzi, M; Nicoli, D; Tamagnini, I; Piana, S; Ciarrocchi, A				Sancisi, Valentina; Gandolfi, Greta; Ragazzi, Moira; Nicoli, Davide; Tamagnini, Ione; Piana, Simonetta; Ciarrocchi, Alessia			Cadherin 6 Is a New RUNX2 Target in TGF-beta Signalling Pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CARCINOMA CELL-LINE; GENE-EXPRESSION; EMT; ACTIVATION; INHIBITOR	Modifications in adhesion molecules profile may change the way tumor cells interact with the surrounding microenvironment. The Cadherin family is a large group of transmembrane proteins that dictate the specificity of the cellular interactions. The Cadherin switch that takes place during epithelial-mesenchymal transition (EMT) contributes to loosening the rigid organization of epithelial tissues and to enhancing motility and invasiveness of tumor cells. Recently, we found Cadherin-6 (CDH6, also known as K-CAD) highly expressed in thyroid tumor cells that display mesenchymal features and aggressive phenotype, following the overexpression of the transcriptional regulator Id1. In this work, we explored the possibility that CDH6 is part of the EMT program in thyroid tumors. We demonstrate that CDH6 is a new transforming growth factor-beta (TGF-beta) target and that its expression is modulated similarly to other EMT mesenchymal markers, both in vitro and in thyroid tumor patients. We show for the first time that CDH6 is expressed in human thyroid carcinomas and that its expression is enhanced at the invasive front of the tumor. Finally, we show that CDH6 is under the control of the transcription factor RUNX2, which we previously described as a crucial mediator of the Id1 pro-invasive function in thyroid tumor cells. Overall, these observations provide novel information on the mechanism of the EMT program in tumor progression and indicate CDH6 as a potential regulator of invasiveness in thyroid tumors.	[Sancisi, Valentina; Gandolfi, Greta; Nicoli, Davide; Ciarrocchi, Alessia] Azienda Osped Arcispedale S Maria Nuova IRCCS, Dept Oncol & Adv Technol, Mol Biol Lab, Reggio Emilia, Italy; [Ragazzi, Moira; Tamagnini, Ione; Piana, Simonetta] Azienda Osped Arcispedale S Maria Nuova IRCCS, Dept Oncol & Adv Technol, Pathol Unit, Reggio Emilia, Italy	IRCCS Arcispedale S. Maria Nuova; IRCCS Arcispedale S. Maria Nuova	Ciarrocchi, A (corresponding author), Azienda Osped Arcispedale S Maria Nuova IRCCS, Dept Oncol & Adv Technol, Mol Biol Lab, Reggio Emilia, Italy.	Alessia.Ciarrocchi@asmn.re.it	Ragazzi, Moira/J-5737-2018; PIANA, SIMONETTA/AAC-9158-2019; Sancisi, Valentina/H-6701-2018; Ciarrocchi, Alessia/AAA-1130-2019	Ragazzi, Moira/0000-0002-8761-9265; PIANA, SIMONETTA/0000-0003-4875-6977; Sancisi, Valentina/0000-0003-4357-1228; Ciarrocchi, Alessia/0000-0002-5541-2075; Gandolfi, Greta/0000-0001-7498-424X	Italian Association for Cancer Research (AIRC) [MFAG: 10745]; Guido Berlucchi Foundation	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Guido Berlucchi Foundation	This work was supported by grants from the Italian Association for Cancer Research (AIRC, MFAG: 10745)(http://www.airc.it/) and the Guido Berlucchi Foundation (http://www.fondazioneberlucchi.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastid J, 2012, CANCER METAST REV, V31, P277, DOI 10.1007/s10555-011-9344-6; Call G, 2012, ENDOCRINOLOGY, V153, P522, DOI 10.1210/en.2011-1572; Cheung PY, 2011, J CELL BIOCHEM, V112, P157, DOI 10.1002/jcb.22911; Chimge NO, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3073; Cho EA, 1998, DEVELOPMENT, V125, P803; Ciarrocchi A, 2011, EUR J CANCER, V47, P934, DOI 10.1016/j.ejca.2010.11.009; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Endo T, 2008, J CLIN ENDOCR METAB, V93, P2409, DOI 10.1210/jc.2007-2805; ESTOUR B, 1989, VIRCHOWS ARCH B, V57, P167, DOI 10.1007/BF02899078; FABIEN N, 1994, CANCER, V73, P2206, DOI 10.1002/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Inoue T, 1997, DEV BIOL, V183, P183, DOI 10.1006/dbio.1996.8501; Inoue YU, 2008, MOL CELL NEUROSCI, V39, P95, DOI 10.1016/j.mcn.2008.05.020; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Jia LW, 2011, MOL BIOL CELL, V22, P2031, DOI 10.1091/mbc.E11-01-0038; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Mah SP, 2000, DEV BIOL, V223, P38, DOI 10.1006/dbio.2000.9738; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Nagaharu K, 2011, AM J PATHOL, V178, P754, DOI 10.1016/j.ajpath.2010.10.015; Niu DF, 2012, LAB INVEST, V92, P1181, DOI 10.1038/labinvest.2012.84; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Paul R, 1997, CANCER RES, V57, P2741; Paul R, 2004, J UROLOGY, V171, P97, DOI 10.1097/01.ju.0000101512.47242.79; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Puxeddu E, 2005, ENDOCR-RELAT CANCER, V12, P319, DOI 10.1677/erc.1.00947; Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248; Saiselet Manuel, 2012, Front Endocrinol (Lausanne), V3, P133, DOI 10.3389/fendo.2012.00133; Sancisi V, 2012, J CLIN ENDOCR METAB, V97, pE2006, DOI 10.1210/jc.2012-1903; Shimazui T, 1998, CLIN CANCER RES, V4, P2419; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; TANAKA J, 1987, VIROLOGY, V161, P62, DOI 10.1016/0042-6822(87)90171-1; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	42	49	52	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75489	10.1371/journal.pone.0075489	http://dx.doi.org/10.1371/journal.pone.0075489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069422	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100127
J	Pan, LR; Patterson, JC				Pan, Lurong; Patterson, James C.			Molecular Dynamics Study of Zn(A beta) and Zn(A beta)(2)	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; ZINC-BINDING SITE; ALZHEIMER A-BETA; INDUCED AGGREGATION; 1ST-ROW ELEMENTS; METAL-BINDING; BASIS-SET; IN-VITRO; DISEASE; A-BETA-40	The aggregation of A beta-peptide (A beta) is widely considered to be the critical step in the pathology of Alzheimer's disease. Small, soluble A beta oligomers have been shown to be more neurotoxic than large, insoluble aggregates and fibrils. Recent studies suggest that biometal ions, including Zn(II), may play an important role in the aggregation process. Experimentally determining the details of the binding process is complicated by the kinetic lability of zinc. To study the dynamic nature of the zinc-bound A beta complexes and the potential mechanisms by which Zn(II) affects A beta oligomerization we have performed atomistic molecular dynamics (MD) simulations of Zn(A beta) and Zn(A beta)(2). The models were based on NMR data and predicted coordination environments from previous density functional theory calculations. When modeled as 4-coordinate covalently bound Zn(A beta)(n) complexes (where n = 1 or 2), zinc imposes conformational changes in the surrounding A beta residues. Moreover, zinc reduces the helix content and increases the random coil content of the full peptide. Although zinc binds at the N-terminus of A beta, beta-sheet formation is observed exclusively at the C-terminus in the Zn(A beta) and most of the Zn(A beta)(2) complexes. Furthermore, initial binding to zinc promotes the formation of intra-chain salt-bridges, while subsequent dissociation promotes the formation of inter-chain salt-bridges. These results suggest that Zn-binding to A beta accelerates the aggregation of A beta by unfolding the helical structure in A beta peptide and stabilizing the formation of vital salt-bridges within and between A beta peptides.	[Pan, Lurong; Patterson, James C.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Patterson, JC (corresponding author), Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA.	pattersj@uab.edu		Pan, Lurong/0000-0001-9321-8348	Department of Chemistry, University of Alabama at Birmingham	Department of Chemistry, University of Alabama at Birmingham	The work was supported by Department of Chemistry, University of Alabama at Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2009, ALZHEIMERS DEMENT, V5, P3; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Beauchemin D, 1998, ANAL CHEM, V70, P1026, DOI 10.1021/ac970783f; Becke AD, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768530; Becker JS, 2005, ANAL CHEM, V77, P3208, DOI 10.1021/ac040184q; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Curtain CC, 2001, J BIOL CHEM, V276, P20466, DOI 10.1074/jbc.M100175200; Danielsson J, 2007, FEBS J, V274, P46, DOI 10.1111/j.1742-4658.2006.05563.x; Deeth RJ, 2008, INORG CHEM, V47, P7377, DOI 10.1021/ic800628j; Dong JJ, 2006, J AM CHEM SOC, V128, P3540, DOI 10.1021/ja055973j; Esler WP, 1996, J NEUROCHEM, V66, P723; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Frisch G. W., 2013, GAUSSIAN 09; Gaggelli E, 2008, J PHYS CHEM B, V112, P100, DOI 10.1021/jp075168m; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kozin SA, 2001, BIOCHEM BIOPH RES CO, V285, P959, DOI 10.1006/bbrc.2001.5284; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Liu ST, 1999, BIOCHEMISTRY-US, V38, P9373, DOI 10.1021/bi990205o; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MacKerell AD, 2001, COMPUTATIONAL BIOCHEMISTRY AND BIOPHYSICS, P7; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mekmouche Y, 2005, CHEMBIOCHEM, V6, P1663, DOI 10.1002/cbic.200500057; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Parkin G, 2004, CHEM REV, V104, P699, DOI 10.1021/cr0206263; PARR RG, 1979, P NATL ACAD SCI USA, V76, P2522, DOI 10.1073/pnas.76.6.2522; PETERSSON GA, 1988, J CHEM PHYS, V89, P2193, DOI 10.1063/1.460448; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rajendran R, 2009, BIOCHEM BIOPH RES CO, V382, P91, DOI 10.1016/j.bbrc.2009.02.136; Roychaudhuri R, 2013, J MOL BIOL, V425, P292, DOI 10.1016/j.jmb.2012.11.006; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Shewmaker F, 2011, J BIOL CHEM, V286, P16533, DOI 10.1074/jbc.R111.227108; Shin BK, 2008, BIOCHEMISTRY-US, V47, P9117, DOI 10.1021/bi801014x; Sousa SF, 2009, DALTON T, P7946, DOI 10.1039/b904404c; Stellato F, 2006, EUR BIOPHYS J BIOPHY, V35, P340, DOI 10.1007/s00249-005-0041-7; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Talmard C, 2007, CHEMBIOCHEM, V8, P163, DOI 10.1002/cbic.200600319; Talmard C, 2009, J BIOL INORG CHEM, V14, P449, DOI 10.1007/s00775-008-0461-9; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Yang DS, 2000, EUR J BIOCHEM, V267, P6692, DOI 10.1046/j.1432-1327.2000.01767.x; Zirah S, 2006, J BIOL CHEM, V281, P2151, DOI 10.1074/jbc.M504454200	56	39	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e70681	10.1371/journal.pone.0070681	http://dx.doi.org/10.1371/journal.pone.0070681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086248	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900003
J	Larusso, ND; Ruttenberg, BE; Singh, A				Larusso, Nicholas D.; Ruttenberg, Brian E.; Singh, Ambuj			A Latent Parameter Node-Centric Model for Spatial Networks	PLOS ONE			English	Article							MODULARITY	Spatial networks, in which nodes and edges are embedded in space, play a vital role in the study of complex systems. For example, many social networks attach geo-location information to each user, allowing the study of not only topological interactions between users, but spatial interactions as well. The defining property of spatial networks is that edge distances are associated with a cost, which may subtly influence the topology of the network. However, the cost function over distance is rarely known, thus developing a model of connections in spatial networks is a difficult task. In this paper, we introduce a novel model for capturing the interaction between spatial effects and network structure. Our approach represents a unique combination of ideas from latent variable statistical models and spatial network modeling. In contrast to previous work, we view the ability to form long/short-distance connections to be dependent on the individual nodes involved. For example, a node's specific surroundings (e.g. network structure and node density) may make it more likely to form a long distance link than other nodes with the same degree. To capture this information, we attach a latent variable to each node which represents a node's spatial reach. These variables are inferred from the network structure using a Markov Chain Monte Carlo algorithm. We experimentally evaluate our proposed model on 4 different types of real-world spatial networks (e.g. transportation, biological, infrastructure, and social). We apply our model to the task of link prediction and achieve up to a 35% improvement over previous approaches in terms of the area under the ROC curve. Additionally, we show that our model is particularly helpful for predicting links between nodes with low degrees. In these cases, we see much larger improvements over previous models.	[Larusso, Nicholas D.; Ruttenberg, Brian E.; Singh, Ambuj] Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Larusso, ND (corresponding author), Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA.	nlarusso@cs.ucsb.edu			U.S. National Science Foundation [IIS-0808772]; Army Research Laboratory [W911NF-09-2-0053]	U.S. National Science Foundation(National Science Foundation (NSF)); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL))	This research was sponsored in part by the U.S. National Science Foundation under grant IIS-0808772 and by the Army Research Laboratory under cooperative agreement W911NF-09-2-0053 (NS-CTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi EM, 2008, J MACH LEARN RES, V9, P1981; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2012, NATURE, V489, P507, DOI 10.1038/nature11486; Barnett L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056115; Barrat A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/05/P05003; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Barthelemy M, 2003, EUROPHYS LETT, V63, P915, DOI 10.1209/epl/i2003-00600-6; Boguna Marian, 2010, Nat Commun, V1, P62, DOI 10.1038/ncomms1063; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Bonahon F., 2009, LOW DIMENSIONAL GEOM, V49; Bullock S, 2010, COMPLEXITY, V16, P20, DOI 10.1002/cplx.20338; Cerina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037507; Daraganova G, 2011, SOCIAL NETWORKS; Daraganova G, 2012, SOC NETWORKS, V34, P6, DOI 10.1016/j.socnet.2010.12.001; Diggle P., 2003, STAT ANAL SPATIAL PO; ERDOS P, 1960, B INT STATIST INST, V38, P343; Estevez PA, 2009, IEEE T NEURAL NETWOR, V20, P189, DOI 10.1109/TNN.2008.2005601; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Ferretti L, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016103; Fortuna MA, 2006, P ROY SOC B-BIOL SCI, V273, P1429, DOI 10.1098/rspb.2005.3448; Gastner MT, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016117; Goldenberg A, 2010, FOUND TRENDS MACH LE, V2, P129, DOI 10.1561/2200000005; Guimera R, 2004, EUR PHYS J B, V38, P381, DOI 10.1140/epjb/e2004-00131-0; Handcock MS, 2007, J ROY STAT SOC A STA, V170, P301, DOI 10.1111/j.1467-985X.2007.00471.x; Hayashi Y., 2006, IPSJ DIGITAL COURIER, V2, P155; Hoff P, 2007, NEURAL INFORM PROCES; Hoff PD, 2005, J AM STAT ASSOC, V100, P286, DOI 10.1198/016214504000001015; Hoff PD, 2002, J AM STAT ASSOC, V97, P1090, DOI 10.1198/016214502388618906; Hoff PD, 2009, COMPUT MQTH ORGAN TH, V15, P261, DOI 10.1007/s10588-008-9040-4; Kaiser M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036103; Kaiser M, 2004, NEUROCOMPUTING, V58, P297, DOI 10.1016/j.neucom.2004.01.059; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Kosmidis K, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/48005; Krioukov D, 2012, B AM PHYS SOC, V57; Krioukov D, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.035101; Krivitsky PN, 2009, SOC NETWORKS, V31, P204, DOI 10.1016/j.socnet.2009.04.001; Lennartsson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042679; Metcalf S, 2005, SPATIAL DYNAMICS SOC; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nowicki K, 2001, J AM STAT ASSOC, V96, P1077, DOI 10.1198/016214501753208735; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Penrose M., 2003, RANDOM GEOMETRIC GRA; Riddle D, 1997, C ELEGANS, V33; Sarkar Purnamrita, 2010, INT C LEARN THEOR CO, P295; Serrano MA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.078701; Snijders TAB., 2002, J SOCIAL STRUCTURE, V3(2), P1, DOI DOI 10.1016/j.socnet.2006.08.001; Turgut D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015551; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Voges N, 2007, NEUROCOMPUTING, V70, P1833, DOI 10.1016/j.neucom.2006.10.126; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WAXMAN BM, 1988, IEEE J SEL AREA COMM, V6, P1617, DOI 10.1109/49.12889; White DR, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016119; WILSON AG, 1967, TRANSPORT RES, V1, P253, DOI 10.1016/0041-1647(67)90035-4; Wong LH, 2006, PHYSICA A, V360, P99, DOI 10.1016/j.physa.2005.04.029; Xulvi-Brunet R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026118; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399	63	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e71293	10.1371/journal.pone.0071293	http://dx.doi.org/10.1371/journal.pone.0071293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086251	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200001
J	Parey, K; Demmer, U; Warkentin, E; Wynen, A; Ermler, U; Dahl, C				Parey, Kristian; Demmer, Ulrike; Warkentin, Eberhard; Wynen, Astrid; Ermler, Ulrich; Dahl, Christiane			Structural, Biochemical and Genetic Characterization of Dissimilatory ATP Sulfurylase from Allochromatium vinosum	PLOS ONE			English	Article							ADENOSINE-TRIPHOSPHATE SULFURYLASE; GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; PENICILLIUM-CHRYSOGENUM; SULFATE ASSIMILATION; SACCHAROMYCES-CEREVISIAE; CHROMATIUM-VINOSUM; RIFTIA-PACHYPTILA; AQUIFEX-AEOLICUS; MUTAGENESIS	ATP sulfurylase (ATPS) catalyzes a key reaction in the global sulfur cycle by reversibly converting inorganic sulfate (SO42-) with ATP to adenosine 5'-phosphosulfate (APS) and pyrophosphate (PPi). In this work we report on the sat encoded dissimilatory ATP sulfurylase from the sulfur-oxidizing purple sulfur bacterium Allochromatium vinosum. In this organism, the sat gene is located in one operon and co-transcribed with the aprMBA genes for membrane-bound APS reductase. Like APS reductase, Sat is dispensible for growth on reduced sulfur compounds due to the presence of an alternate, so far unidentified sulfite-oxidizing pathway in A. vinosum. Sulfate assimilation also proceeds independently of Sat by a separate pathway involving a cysDN-encoded assimilatory ATP sulfurylase. We produced the purple bacterial sat-encoded ATP sulfurylase as a recombinant protein in E. coli, determined crucial kinetic parameters and obtained a crystal structure in an open state with a ligand-free active site. By comparison with several known structures of the ATPS-APS complex in the closed state a scenario about substrate-induced conformational changes was worked out. Despite different kinetic properties ATPS involved in sulfur-oxidizing and sulfate-reducing processes are not distinguishable on a structural level presumably due to the interference between functional and evolutionary processes.	[Parey, Kristian; Demmer, Ulrike; Warkentin, Eberhard; Ermler, Ulrich] Max Planck Inst Biophys, Frankfurt, Germany; [Parey, Kristian] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Wynen, Astrid; Dahl, Christiane] Univ Bonn, Inst Mikrobiol & Biotechnol, Bonn, Germany	Max Planck Society; University of Regensburg; University of Bonn	Wynen, A (corresponding author), Univ Bonn, Inst Mikrobiol & Biotechnol, Bonn, Germany.	ulrich.ermler@mpibp-frankfurt.mpg.de	Dahl, Christiane/H-4786-2019	Dahl, Christiane/0000-0001-8288-7546; Parey, Kristian/0000-0002-4842-6479	Max-Planck Society; Deutsche Forschungsgemeinschaft	Max-Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max-Planck Society and the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beynon JD, 2001, BIOCHEMISTRY-US, V40, P14509, DOI 10.1021/bi015643l; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DAHL C, 1994, METHOD ENZYMOL, V243, P400; Dahl C, 1996, MICROBIOL-SGM, V142, P3363, DOI 10.1099/13500872-142-12-3363; Deyrup AT, 1999, J BIOL CHEM, V274, P28929, DOI 10.1074/jbc.274.41.28929; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; FOSTER BA, 1994, J BIOL CHEM, V269, P19777; Friedrich CG, 1998, ADV MICROB PHYSIOL, V39, P235; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Fritz G, 2005, J MOL MICROB BIOTECH, V10, P223, DOI 10.1159/000091567; Gavel OY, 1998, BIOCHEMISTRY-US, V37, P16225, DOI 10.1021/bi9816709; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gregersen LH, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00116; Hanna E, 2002, ARCH BIOCHEM BIOPHYS, V406, P275, DOI 10.1016/S0003-9861(02)00428-9; HANSEN TA, 1994, ANTON LEEUW INT J G, V66, P165, DOI 10.1007/BF00871638; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; Hipp WM, 1997, MICROBIOL-UK, V143, P2891, DOI 10.1099/00221287-143-9-2891; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karamohamed S, 1999, PROTEIN EXPRES PURIF, V15, P381, DOI 10.1006/prep.1999.1032; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; LEYH TS, 1988, J BIOL CHEM, V263, P2409; LI H, 1995, J BIOL CHEM, V270, P29453, DOI 10.1074/jbc.270.49.29453; Logan HM, 1996, J BIOL CHEM, V271, P12227, DOI 10.1074/jbc.271.21.12227; MacRae IJ, 2001, BIOCHEMISTRY-US, V40, P6795, DOI 10.1021/bi010367w; Meyer B, 2007, MICROBIOL-SGM, V153, P3478, DOI 10.1099/mic.0.2007/008250-0; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neumann S, 2000, MOL BIOL REP, V27, P27, DOI 10.1023/A:1007058421714; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; PATTARAGULWANIT K, 1995, ARCH MICROBIOL, V164, P217, DOI 10.1007/BF02529974; Pires RH, 2003, BBA-BIOENERGETICS, V1605, P67, DOI 10.1016/S0005-2728(03)00065-3; Postgate JR, 1984, SULPHATE REDUCING BA, V2nd; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Ramos AR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00137; RENOSTO F, 1991, ARCH BIOCHEM BIOPHYS, V290, P66, DOI 10.1016/0003-9861(91)90592-7; Rodriguez J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00112; Sanchez O, 2001, ARCH MICROBIOL, V176, P301, DOI 10.1007/s002030100327; Schwenn Jens D., 1997, P39; SEGEL IH, 1987, METHOD ENZYMOL, V143, P334; SEUBERT PA, 1985, ARCH BIOCHEM BIOPHYS, V240, P509, DOI 10.1016/0003-9861(85)90057-8; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Taguchi Y, 2004, BIOCHEMISTRY-US, V43, P4111, DOI 10.1021/bi036052t; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ullrich TC, 2001, J MOL BIOL, V313, P1117, DOI 10.1006/jmbi.2001.5098; Ullrich TC, 2001, EMBO J, V20, P316, DOI 10.1093/emboj/20.3.316; Venkatachalam KV, 1999, J BIOL CHEM, V274, P2601, DOI 10.1074/jbc.274.5.2601; Weissgerber T, 2011, STAND GENOMIC SCI, V5, P311, DOI 10.4056/sigs.2335270; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035	51	27	28	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74707	10.1371/journal.pone.0074707	http://dx.doi.org/10.1371/journal.pone.0074707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073218	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000027
J	Chen, XR; Yang, ZG; Lu, YF; Xu, QN; Wang, Q; Chen, L				Chen, Xiaorong; Yang, Zongguo; Lu, Yunfei; Xu, Qingnian; Wang, Qiang; Chen, Liang			Clinical Features and Factors Associated with Outcomes of Patients Infected with a Novel Influenza A (H7N9) Virus: A Preliminary Study	PLOS ONE			English	Article							AVIAN INFLUENZA; T-CELLS; CD45; H1N1; GENE; MEDICINE; H5N1	Objective: The present study aimed to analyze clinical features and factors associated with treatment outcomes of H7N9 influenza A virus infection. Methods: The clinical progress in 18 H7N9-infected patients was monitored and recorded. The clinical features of H7N9 infection were noted and factors associated with treatment outcomes were analyzed by univariate analyses. Results: The average ages of patients in recovered and critical conditions were 67.0 +/- 10.83 years and 72.75 +/- 12.0 years, respectively. Renal insufficiency developed more frequently in critically ill patients (P = 0.023). The duration of traditional Chinese medicine (TCM) therapy was longer in recovered patients than in critically ill patients (P = 0.01). Laboratory tests showed that levels of C-reactive protein, serum creatinine, and myoglobin were significantly higher in critically ill patients than in recovered patients (P = 0.011, 0.04, and 0.016, respectively). Meanwhile, levels of all T cell subsets examined including total CD3(+), CD4(+), CD8(+), and CD45(+) T cells were lower in critically ill patients than in recovered patients (P = 0.033, 0.059, 0.015, and 0.039, respectively). Logistic regression analysis demonstrated that C-reactive protein level, myoglobin level and TCM therapy duration were likely associated with treatment outcomes of H7N9 infection (P = 0.032, 0.041 and 0.017, respectively). Conclusion: Elderly people may have increased risk for H7N9 virus infection. T cell-mediated responses play an important role in defense against the H7N9 virus. C-reactive protein level, myoglobin level and TCM duration may be associated with treatment outcomes of H7N9 infection.	[Chen, Xiaorong; Yang, Zongguo; Lu, Yunfei; Xu, Qingnian; Wang, Qiang] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Tradit Chinese Med, Shanghai 200433, Peoples R China; [Chen, Xiaorong; Yang, Zongguo; Lu, Yunfei; Xu, Qingnian] State Adm Tradit Chinese Med, Key Lab Infect Dis, Clin Base, Shanghai, Peoples R China; [Chen, Liang] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Hepatitis, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Chen, XR (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Tradit Chinese Med, Shanghai 200433, Peoples R China.	xiaorong3chen@163.com	Yang, Zongguo/AAY-4190-2021; Lu, Yunfei/GQZ-6526-2022	Yang, Zongguo/0000-0002-6623-4841; 	National Science and Technology Major Projects of the Twelfth Five-year Plan [2012ZX10004301004]; Shanghai Traditional Chinese Medicine Development of the Three-year Action Plan (ZYSNXD-GW-JDJS)	National Science and Technology Major Projects of the Twelfth Five-year Plan; Shanghai Traditional Chinese Medicine Development of the Three-year Action Plan (ZYSNXD-GW-JDJS)	This work was supported mainly by the National Science and Technology Major Projects of the Twelfth Five-year Plan (2012ZX10004301004) and the Shanghai Traditional Chinese Medicine Development of the Three-year Action Plan (ZYSNXD-GW-JDJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Brincks EL, 2008, J IMMUNOL, V181, P4918, DOI 10.4049/jimmunol.181.7.4918; Brown DM, 2004, SEMIN IMMUNOL, V16, P171, DOI 10.1016/j.smim.2004.02.004; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Capua I, 2004, AVIAN PATHOL, V33, P393, DOI 10.1080/03079450410001724085; Carter MJ, 2007, J MED MICROBIOL, V56, P875, DOI 10.1099/jmm.0.47124-0; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Guleria R, 2009, INDIAN J MICROBIOL, V49, P315, DOI 10.1007/s12088-009-0056-3; Han K, 2011, CLIN INFECT DIS, V53, P326, DOI 10.1093/cid/cir398; Haran John P, 2012, J Emerg Trauma Shock, V5, P149, DOI 10.4103/0974-2700.96484; He Zhihui, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P655, DOI 10.3969/j.issn.1672-7347.2010.07.003; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Kung C, 2000, NAT MED, V6, P343; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu JP, 2004, J ALTERN COMPLEM MED, V10, P1041, DOI 10.1089/acm.2004.10.1041; Lu CJ, 2010, CHIN J INTEGR MED, V16, P493, DOI 10.1007/s11655-010-0563-4; National Health and Family Planning Commission of the People's Republic of China, 2013, DIAGN TREATM PROGR H; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2222; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2151; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Reemers SSN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031953; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; Swayne DE, 2000, VACCINE, V18, P1088, DOI 10.1016/S0264-410X(99)00369-2; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; The World Health Organization Influenza at human-animal interface, CUM NUMB CONF HUM CA; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Xinhua News, XINHUA NEWS; Zimmerman O, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-288	31	22	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73362	10.1371/journal.pone.0073362	http://dx.doi.org/10.1371/journal.pone.0073362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069191	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300009
J	Larsen, T; Ventura, M; Andersen, N; O'Brien, DM; Piatkowski, U; McCarthy, MD				Larsen, Thomas; Ventura, Marc; Andersen, Nils; O'Brien, Diane M.; Piatkowski, Uwe; McCarthy, Matthew D.			Tracing Carbon Sources through Aquatic and Terrestrial Food Webs Using Amino Acid Stable Isotope Fingerprinting	PLOS ONE			English	Article							RATIO MASS-SPECTROMETRY; ORGANIC-MATTER; PROTEIN-SYNTHESIS; FRACTIONATION; NITROGEN; PHYTOPLANKTON; BIOSYNTHESIS; ZOOPLANKTON; ENANTIOMERS; ABSORPTION	Tracing the origin of nutrients is a fundamental goal of food web research but methodological issues associated with current research techniques such as using stable isotope ratios of bulk tissue can lead to confounding results. We investigated whether naturally occurring delta C-13 patterns among amino acids (delta C-13(AA)) could distinguish between multiple aquatic and terrestrial primary production sources. We found that delta C-13(AA) patterns in contrast to bulk delta C-13 values distinguished between carbon derived from algae, seagrass, terrestrial plants, bacteria and fungi. Furthermore, we showed for two aquatic producers that their delta C-13(AA) patterns were largely unaffected by different environmental conditions despite substantial shifts in bulk delta C-13 values. The potential of assessing the major carbon sources at the base of the food web was demonstrated for freshwater, pelagic, and estuarine consumers; consumer delta C-13 patterns of essential amino acids largely matched those of the dominant primary producers in each system. Since amino acids make up about half of organismal carbon, source diagnostic isotope fingerprints can be used as a new complementary approach to overcome some of the limitations of variable source bulk isotope values commonly encountered in estuarine areas and other complex environments with mixed aquatic and terrestrial inputs.	[Larsen, Thomas; Andersen, Nils] Univ Kiel, Leibniz Lab Radiometr Dating & Stable Isotope Res, Kiel, Germany; [Larsen, Thomas; Ventura, Marc] Spanish Res Council CEAB CSIC, Ctr Adv Studies Blanes, Biogeodynam & Biodivers Grp, Blanes, Catalonia, Spain; [Ventura, Marc] Univ Barcelona, Inst Recerca Aigua, Barcelona, Catalonia, Spain; [O'Brien, Diane M.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [O'Brien, Diane M.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA; [Piatkowski, Uwe] Helmholtz Zentrum Ozeanforsch Kiel, GEOMAR, Kiel, Germany; [McCarthy, Matthew D.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA	University of Kiel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of California System; University of California Santa Cruz	Larsen, T (corresponding author), Univ Kiel, Leibniz Lab Radiometr Dating & Stable Isotope Res, Kiel, Germany.	natursyn@gmail.com	O'Brien, Diane/B-2919-2010; Piatkowski, Uwe/G-4161-2011; Ventura, Marc/A-5660-2008; Larsen, Thomas/D-3105-2012	O'Brien, Diane/0000-0001-5807-9661; Piatkowski, Uwe/0000-0003-1558-5817; Ventura, Marc/0000-0003-1401-414X; Larsen, Thomas/0000-0002-0311-9707	DFG [EXC 80/1, CP0937]; Carlsbergfondet [2007_01_0301]; Juan de la Cierva [JCI-2009-049330]; Spanish Government [CGL2010-14841, 427/2011]	DFG(German Research Foundation (DFG)); Carlsbergfondet(Carlsberg Foundation); Juan de la Cierva(Instituto de Salud Carlos III); Spanish Government(Spanish GovernmentEuropean Commission)	The study was funded by the DFG-supported Cluster of Excellence "The Future Ocean" (EXC 80/1, CP0937) and Carlsbergfondet (2007_01_0301). TL was supported by Juan de la Cierva (JCI-2009-049330) and MV by the Spanish Government projects Fundalzoo (CGL2010-14841) and Invasivefish (427/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini S, 1998, PHYTOCHEMISTRY, V48, P611, DOI 10.1016/S0031-9422(97)01118-7; Amelung W, 2001, SOIL BIOL BIOCHEM, V33, P553, DOI 10.1016/S0038-0717(00)00195-4; BINDER H J, 1970, Biochimica et Biophysica Acta, V219, P503, DOI 10.1016/0005-2736(70)90233-6; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bouillon S, 2008, J SEA RES, V59, P44, DOI 10.1016/j.seares.2007.05.001; BROWN MR, 1991, J EXP MAR BIOL ECOL, V145, P79, DOI 10.1016/0022-0981(91)90007-J; Buchanan BB, 2000, BIOCH MOL BIOL PLANT, Vxxxix; Chikaraishi Y, 2003, PHYTOCHEMISTRY, V63, P361, DOI 10.1016/S0031-9422(02)00749-5; Choy CA, 2009, P NATL ACAD SCI USA, V106, P13865, DOI 10.1073/pnas.0900711106; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; Corr LT, 2007, ANAL CHEM, V79, P9082, DOI 10.1021/ac071223b; De Troch M, 2012, MAR ECOL PROG SER, V465, P53, DOI 10.3354/meps09920; DEGENS ET, 1968, DEEP-SEA RES, V15, P1, DOI 10.1016/0011-7471(68)90024-7; DENNISON WC, 1982, OECOLOGIA, V55, P137, DOI 10.1007/BF00384478; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Falkowski PG, 1980, PRIMARY PRODUCTIVITY, Vix; Fernandes R, 2012, FRUHE MONUMENTALITAT, V2; FOGEL ML, 1992, MAR ECOL PROG SER, V82, P291, DOI 10.3354/meps082291; Foley MM, 2010, MAR ECOL PROG SER, V409, P41, DOI 10.3354/meps08600; Ford D, 2003, HISTOCHEM CELL BIOL, V119, P37, DOI 10.1007/s0418-002-0479-y; Francis TB, 2011, ECOL LETT, V14, P364, DOI 10.1111/j.1461-0248.2011.01597.x; Goericke G, 1994, STABLE ISOTOPES ECOL, P187; HAYES JM, 1993, MAR GEOL, V113, P111, DOI 10.1016/0025-3227(93)90153-M; Hayes JM, 2001, REV MINERAL GEOCHEM, V43, P225, DOI 10.2138/gsrmg.43.1.225; He HB, 2011, J SOIL SEDIMENT, V11, P731, DOI 10.1007/s11368-011-0360-5; Hedges JI, 2001, NATURE, V409, P801, DOI 10.1038/35057247; Jones WB, 2003, MAR ECOL PROG SER, V255, P15, DOI 10.3354/meps255015; Kaiser K, 2008, LIMNOL OCEANOGR, V53, P99, DOI 10.4319/lo.2008.53.1.0099; Keil RG, 2001, LIMNOL OCEANOGR, V46, P14, DOI 10.4319/lo.2001.46.1.0014; Larsen T, 2012, RAPID COMMUN MASS SP, V26, P1541, DOI 10.1002/rcm.6259; Larsen T, 2011, SOIL BIOL BIOCHEM, V43, P749, DOI 10.1016/j.soilbio.2010.12.008; Larsen T, 2009, ECOLOGY, V90, P3526, DOI 10.1890/08-1695.1; Macko S.A., 1984, ORG GEOCHEM, V6, P787, DOI DOI 10.1016/0146-6380(84)90100-1; Mateus H, 1976, BOT MAR, P155; McCarthy MD, 2004, MAR CHEM, V92, P123, DOI 10.1016/j.marchem.2004.06.021; McMahon KW, 2010, J ANIM ECOL, V79, P1132, DOI 10.1111/j.1365-2656.2010.01722.x; Miller RJ, 2012, MAR BIOL, V159, P1391, DOI 10.1007/s00227-012-1929-2; Newsome SD, 2011, FUNCT ECOL, V25, P1051, DOI 10.1111/j.1365-2435.2011.01866.x; O'Brien DM, 2002, P NATL ACAD SCI USA, V99, P4413, DOI 10.1073/pnas.072346699; Popp BN, 1998, GEOCHIM COSMOCHIM AC, V62, P69, DOI 10.1016/S0016-7037(97)00333-5; R Development Core Team, 2012, R LANG ENV STAT COMP; Rautio M, 2007, ECOGRAPHY, V30, P77, DOI 10.1111/j.2006.0906-7590.04462.x; Scott JH, 2006, ASTROBIOLOGY, V6, P867, DOI 10.1089/ast.2006.6.867; SILFER JA, 1991, ANAL CHEM, V63, P370, DOI 10.1021/ac00004a014; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Ugawa S, 2001, AM J PHYSIOL-GASTR L, V281, pG365, DOI 10.1152/ajpgi.2001.281.2.G365; Venables WN, 2002, MODERN APPL STAT S, Vxi; Zhou YP, 2010, PHYTOCHEMISTRY, V71, P388, DOI 10.1016/j.phytochem.2009.11.009; ZIMMERMAN RC, 1995, PLANT PHYSIOL, V108, P1665, DOI 10.1104/pp.108.4.1665	49	160	160	12	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73441	10.1371/journal.pone.0073441	http://dx.doi.org/10.1371/journal.pone.0073441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069196	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300011
J	Hirao, K; Kobayashi, R				Hirao, Kazuki; Kobayashi, Ryuji			Health-Related Quality of Life and Sense of Coherence among the Unemployed with Autotelic, Average, and Non-Autotelic Personalities: A Cross-Sectional Survey in Hiroshima, Japan	PLOS ONE			English	Article							FLOW; EXPERIENCE; SCALE	Background: Unemployment is known to have a negative effect on the quality of life (QOL) of individuals. However, the influence of an autotelic personality on QOL and SOC of unemployed individuals remains unclear. Our study compared health-related quality of life (HRQOL) and sense of coherence (SOC) among 3 groups: (i) an autotelic personality group (AP), which tends to "go with the flow,'' (ii) an average group (AV), and (iii) a non-autotelic personality group (NAP). Methods: In October 2010, we conducted a cross-sectional survey among 140 job trainees not receiving unemployment benefits in Hiroshima, Japan. We collected 134 completed questionnaires. Autotelic personality was investigated using the Flow Experience Checklist, health-related quality of life was assessed using the Short Form (SF-8) Health Survey, and SOC was measured using the University of Tokyo Health Sociology version of the SOC3 scale (SOC3-UTHS). Results: The average age of participants was 36.14+/-11.54 year. Participants were classified into 3 groups based on daily activity values: 4+ for AP (n = 22), 1-3 for AV (n = 82), and 0 for NAP (n = 30). Significant differences were observed in mental component summary (MCS) score and SOC3-UTHS total scores in the ranking order of AP (highest), AV, and NAP. Conclusion: Our findings indicate a need to develop programs for facilitating AP among unemployed people to enhance mental QOL and SOC.	[Hirao, Kazuki; Kobayashi, Ryuji] Kibi Int Univ, Dept Occupat Therapy, Sch Hlth Sci & Social Welf, Okayama, Japan		Hirao, K (corresponding author), Kibi Int Univ, Dept Occupat Therapy, Sch Hlth Sci & Social Welf, Okayama, Japan.	hirao-k@kiui.ac.jp		Kobayashi, Ryuji/0000-0001-9485-2877; Hirao, Kazuki/0000-0002-2467-7564				Antonovsky A., 1987, UNRAVELING MYSTERY H; Antonovsky A., 1979, HLTH STRESS COPING N; Artazcoz L, 2004, AM J PUBLIC HEALTH, V94, P82, DOI 10.2105/AJPH.94.1.82; Asakawa K., 2004, J HAPPINESS STUD, V5, P123, DOI [10.1023/b:johs.0000035915.97836.89, DOI 10.1023/B:JOHS.0000035915.97836.89, 10.1023/B:JOHS.0000035915.97836.89]; Asakawa K, 2010, J HAPPINESS STUD, V11, P205, DOI 10.1007/s10902-008-9132-3; Csikszentmihalyi M., 1993, TALENTED TEENAGERS R; Csikszentmihalyi M., 1975, BOREDOM ANXIETY; Eriksson M, 2006, J EPIDEMIOL COMMUN H, V60, P376, DOI 10.1136/jech.2005.041616; Fukuhara S., 2004, MANUAL SF 8 JAPANESE; Fullagar CJ, 2009, J OCCUP ORGAN PSYCH, V82, P595, DOI 10.1348/096317908X357903; Hirao K., 2011, JAPANESE J OCCUPATIO, V59, P13; Hirao K, 2011, MED BIOL, V155, P713; Hirao K, 2012, NURS HEALTH SCI, V14, P52, DOI 10.1111/j.1442-2018.2011.00663.x; Ishimura I, 2006, J HEALTH PSYCHOL, V13, P23; ISHIMURA I, 2008, THESIS U TSUKUBA; Ishimura I, 2009, JPN PSYCHOL RES, V51, P47, DOI 10.1111/j.1468-5884.2009.00387.x; Lutz Jonathan, 2009, Glob Health Promot, V16, P63, DOI 10.1177/1757975909339774; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Murphy GC, 1999, J OCCUP ORGAN PSYCH, V72, P83, DOI 10.1348/096317999166518; Nakamura J., 2005, HDB POSITIVE PSYCHOL; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Togari T, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.056697; Volanen SM, 2006, SCAND J PUBLIC HEALT, V34, P515, DOI 10.1080/14034940600585812	23	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73915	10.1371/journal.pone.0073915	http://dx.doi.org/10.1371/journal.pone.0073915			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069249	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100072
J	Kashyap, RS; Nayak, AR; Gaherwar, HM; Bhullar, SS; Husain, AA; Shekhawat, SD; Jain, RK; Gaikwad, SS; Satav, AR; Purohit, HJ; Taori, GM; Daginawala, HF				Kashyap, Rajpal S.; Nayak, Amit R.; Gaherwar, Hari M.; Bhullar, Shraddha S.; Husain, Aliabbas A.; Shekhawat, Seema D.; Jain, Ruchika K.; Gaikwad, Sonali S.; Satav, Ashish R.; Purohit, Hemant J.; Taori, Girdhar M.; Daginawala, Hatim F.			Laboratory Investigations on the Diagnosis of Tuberculosis in the Malnourished Tribal Population of Melghat, India	PLOS ONE			English	Article							ANTIGEN-85 COMPLEX; MYCOBACTERIUM-TUBERCULOSIS; INDIRECT ELISA; SUPPLEMENTATION; MALNUTRITION; MENINGITIS; RESPONSES; BLOOD; BCG	Background: Malnutrition is a major risk factor for the development of tuberculosis (TB). In India, Melghat is among the tribal regions which consist of highest number of malnutrition cases. Because of the paucity of TB data from these malnourished areas there is an urgent need for the development and evaluation of improved TB diagnostic tests. In the present study, three in house developed diagnostic tests namely TB-Ag(antigen) ELISA, Adenosine deaminase (ADA) estimation and IS6110 polymerase chain reaction (PCR) assay were investigated for the detection of Mycobacterium tuberculosis (M. tb.) infection. Methods: For investigation, blood samples were collected from 128 study subjects from six villages of Melghat tribal area and evaluated using three in house developed assays, namely TB-Ag ELISA, ADA estimation and IS6110 PCR. Results: The TB-Ag ELISA method yielded 83% sensitivity and 94% specificity. The ADA and PCR assay gave a sensitivity of 61% and 49% and specificity of 62% and 98% respectively. A considerable good agreement of 82.81% (k=0.472) between TB-Ag ELISA and PCR was observed. The overall sensitivity of TB-Ag ELISA was significantly higher (p<0.05) than the ADA and PCR while PCR yielded highest specificity among all the three evaluated tests. Conclusions: We concluded that the routine use of TB-Ag ELISA can be useful for screening of suspected TB patients in the malnourished population where sophisticated laboratory set up is difficult.	[Kashyap, Rajpal S.; Nayak, Amit R.; Gaherwar, Hari M.; Bhullar, Shraddha S.; Husain, Aliabbas A.; Shekhawat, Seema D.; Jain, Ruchika K.; Gaikwad, Sonali S.; Taori, Girdhar M.; Daginawala, Hatim F.] Cent India Inst Med Sci, Biochem Res Lab, Nagpur, Maharashtra, India; [Purohit, Hemant J.] CO Mahatma Gandhi Tribal Hosp, Meditat AIDS Hlth Addict & Nutr MAHAN Trust, Amaravati, Maharashtra, India; [Satav, Ashish R.] Natl Environm Engn Res Inst, Environm Genom Unit, Nagpur 440020, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Environmental Engineering Research Institute (NEERI)	Kashyap, RS (corresponding author), Cent India Inst Med Sci, Biochem Res Lab, Nagpur, Maharashtra, India.	raj_ciims@rediffmail.com	Kashyap, Rajpal/AAP-8461-2020		Central India Institute of Medical Sciences, Nagpur	Central India Institute of Medical Sciences, Nagpur	This work was supported by Central India Institute of Medical Sciences, Nagpur. The funders had also supported in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1995, J ISLAMIC ACAD SCI, V8, P155; Ahmed N, 1998, J CLIN MICROBIOL, V36, P3094, DOI 10.1128/JCM.36.10.3094-3095.1998; Baldwin S. L., 1999, Tubercle and Lung Disease, V79, P251, DOI 10.1054/tuld.1998.0196; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Condos R, 1996, LANCET, V347, P1082, DOI 10.1016/S0140-6736(96)90281-0; da Silva EB, 2011, VET J, V187, P276, DOI 10.1016/j.tvjl.2009.11.017; Deshpande PS, 2007, FLUIDS BARRIERS CNS, V4, DOI 10.1186/1743-8454-4-10; GiustiG HV, 1974, METHODS ENZYMATIC AN, P1092, DOI DOI 10.1016/B978-0-12-091302-2.50108-0; Gupta KB, 2009, LUNG INDIA, V26, P9, DOI 10.4103/0970-2113.45198; Kashyap RS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-74; Kashyap RS, 2010, BIOMARK INSIGHTS, V5, P87; Kashyap RS, 2005, CLIN DIAGN LAB IMMUN, V12, P752, DOI 10.1128/CDLI.12.6.752-758.2005; Kashyap RS, 2006, CEREBROSPINAL FLUID, V3, P1, DOI 10.1186/1743-8454-3-5; Kumar G, 2010, ARCH IMMUNOL THER EX, V58, P57, DOI 10.1007/s00005-009-0055-4; Launois P, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/640309; Macallan DC, 1999, DIAGN MICR INFEC DIS, V34, P153, DOI 10.1016/S0732-8893(99)00007-3; Meena LS, 2002, J CLIN LAB ANAL, V16, P151, DOI 10.1002/jcla.10031; Nagdev KJ, 2010, INT J TUBERC LUNG D, V14, P1032; Nagdev KJ, 2010, MED SCI MONITOR, V16, pCR289; Schmidt CW, 2008, ENVIRON HEALTH PERSP, V116, pA478, DOI 10.1289/ehp.116-a478; Singh R, 2008, STUD TRIBES TRIBALS, V6, P35; Tanghe A, 2001, INFECT IMMUN, V69, P5403, DOI 10.1128/IAI.69.9.5403-5411.2001; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; Wallis RS, 1998, J INFECT DIS, V178, P1115, DOI 10.1086/515701; Webb AL, 2007, NUTR REV, V65, P181, DOI 10.1111/j.1753-4887.2007.tb00298.x; Wu XQ, 2010, CLIN CHIM ACTA, V411, P1520, DOI 10.1016/j.cca.2010.06.014	26	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74652	10.1371/journal.pone.0074652	http://dx.doi.org/10.1371/journal.pone.0074652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069327	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100114
J	Schmidt, AH; Solloch, UV; Pingel, J; Sauter, J; Bohme, I; Cereb, N; Dubicka, K; Schumacher, S; Wachowiak, J; Ehninger, G				Schmidt, Alexander H.; Solloch, Ute V.; Pingel, Julia; Sauter, Juergen; Boehme, Irina; Cereb, Nezih; Dubicka, Kinga; Schumacher, Stephan; Wachowiak, Jacek; Ehninger, Gerhard			Regional HLA Differences in Poland and Their Effect on Stem Cell Donor Registry Planning	PLOS ONE			English	Article							BONE-MARROW DONORS; HAPLOTYPE FREQUENCIES; POLISH POPULATION; RECRUITMENT; GERMANY; ANTIGEN; ALLELE	Regional HLA frequency differences are of potential relevance for the optimization of stem cell donor recruitment. We analyzed a very large sample (n = 123,749) of registered Polish stem cell donors. Donor figures by 1-digit postal code regions ranged from n = 5,243 (region 9) to n = 19,661 (region 8). Simulations based on region-specific haplotype frequencies showed that donor recruitment in regions 0, 2, 3 and 4 (mainly located in the south-eastern part of Poland) resulted in an above-average increase of matching probabilities for Polish patients. Regions 1, 7, 8, 9 (mainly located in the northern part of Poland) showed an opposite behavior. However, HLA frequency differences between regions were generally small. A strong indication for regionally focused donor recruitment efforts can, therefore, not be derived from our analyses. Results of haplotype frequency estimations showed sample size effects even for sizes between n approximate to 5,000 and n approximate to 20,000. This observation deserves further attention as most published haplotype frequency estimations are based on much smaller samples.	[Schmidt, Alexander H.; Solloch, Ute V.; Pingel, Julia; Sauter, Juergen; Schumacher, Stephan] DKMS German Bone Marrow Donor Ctr, Tubingen, Germany; [Schmidt, Alexander H.; Boehme, Irina] DKMS Life Sci Lab, Dresden, Germany; [Cereb, Nezih] Histogenetics, Ossining, NY USA; [Dubicka, Kinga; Schumacher, Stephan] DKMS Polska, Warsaw, Poland; [Wachowiak, Jacek] Univ Med Sci, Dept Pediat Hematol & Oncol, Poznan, Poland; [Wachowiak, Jacek] Univ Med Sci, Poznan, Poland; [Ehninger, Gerhard] Univ Hosp Carl Gustav Carus, Dresden, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Schmidt, AH (corresponding author), DKMS German Bone Marrow Donor Ctr, Tubingen, Germany.	schmidt@dkms.de		Wachowiak, Jacek/0000-0002-4680-603X				Buhler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041400; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Eberhard H.-P., 2010, SCHATZUNG HOCHAUFGEL; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Hollenbach JA, 2013, INT J IMMUNOGENET, V40, P46, DOI 10.1111/iji.12026; Johansen KA, 2008, TRANSFUSION MED, V18, P250, DOI 10.1111/j.1365-3148.2008.00865.x; Laver JH, 2001, BIOL BLOOD MARROW TR, V7, P45, DOI 10.1053/bbmt.2001.v7.pm11215698; Marroni F, 2004, TISSUE ANTIGENS, V64, P478, DOI 10.1111/j.1399-0039.2004.00292.x; Nowak J, 2008, TISSUE ANTIGENS, V71, P193, DOI 10.1111/j.1399-0039.2007.00991.x; Pingel J, 2013, HUM IMMUNOL, V74, P330, DOI 10.1016/j.humimm.2012.10.029; Rendine S, 1998, TISSUE ANTIGENS, V52, P135, DOI 10.1111/j.1399-0039.1998.tb02277.x; Schmidt AH, 2008, BONE MARROW TRANSPL, V41, P605, DOI 10.1038/sj.bmt.1705950; Schmidt AH, 2007, BONE MARROW TRANSPL, V40, P823, DOI 10.1038/sj.bmt.1705832; Schmidt AH, 2010, TISSUE ANTIGENS, V76, P362, DOI 10.1111/j.1399-0039.2010.01520.x; Schmidt AH, 2009, BONE MARROW TRANSPL, V44, P405, DOI 10.1038/bmt.2009.55; Schmidt AH, 2011, HUM IMMUNOL, V72, P558, DOI 10.1016/j.humimm.2011.03.010; Schmidt AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020268; Schmidt AH, 2009, HUM IMMUNOL, V70, P895, DOI 10.1016/j.humimm.2009.08.006	20	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73835	10.1371/journal.pone.0073835	http://dx.doi.org/10.1371/journal.pone.0073835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069237	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100063
J	Noval, MG; Gallo, M; Perrone, S; Salvay, AG; Chemes, LB; de Prat-Gay, G				Noval, Maria G.; Gallo, Mariana; Perrone, Sebastian; Salvay, Andres G.; Chemes, Lucia B.; de Prat-Gay, Gonzalo			Conformational Dissection of a Viral Intrinsically Disordered Domain Involved in Cellular Transformation	PLOS ONE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; HUMAN PAPILLOMAVIRUS-E7 PROTEIN; POLYPROLINE-II; IONIZABLE GROUPS; STRUCTURAL BASIS; MOLECULAR-BASIS; E7 ONCOPROTEIN; ADENOVIRUS E1A; PK VALUES; RECOGNITION	Intrinsic disorder is abundant in viral genomes and provides conformational plasticity to its protein products. In order to gain insight into its structure-function relationships, we carried out a comprehensive analysis of structural propensities within the intrinsically disordered N-terminal domain from the human papillomavirus type-16 E7 oncoprotein (E7N). Two E7N segments located within the conserved CR1 and CR2 regions present transient alpha-helix structure. The helix in the CR1 region spans residues L8 to L13 and overlaps with the E2F mimic linear motif. The second helix, located within the highly acidic CR2 region, presents a pH-dependent structural transition. At neutral pH the helix spans residues P17 to N29, which include the retinoblastoma tumor suppressor LxCxE binding motif (residues 21-29), while the acidic CKII-PEST region spanning residues E33 to I38 populates polyproline type II (PII) structure. At pH 5.0, the CR2 helix propagates up to residue I38 at the expense of loss of PII due to charge neutralization of acidic residues. Using truncated forms of HPV-16 E7, we confirmed that pH-induced changes in alpha-helix content are governed by the intrinsically disordered E7N domain. Interestingly, while at both pH the region encompassing the LxCxE motif adopts alpha-helical structure, the isolated 21-29 fragment including this stretch is unable to populate an alpha-helix even at high TFE concentrations. Thus, the E7N domain can populate dynamic but discrete structural ensembles by sampling alpha-helix-coil-PII-beta-sheet structures. This high plasticity may modulate the exposure of linear binding motifs responsible for its multi-target binding properties, leading to interference with key cell signaling pathways and eventually to cellular transformation by the virus.	[Noval, Maria G.; Perrone, Sebastian; Chemes, Lucia B.; de Prat-Gay, Gonzalo] Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina; [Noval, Maria G.; Gallo, Mariana; Perrone, Sebastian; Chemes, Lucia B.; de Prat-Gay, Gonzalo] Consejo Nacl Invest Cient & Tecn, IIBBA, RA-1033 Buenos Aires, DF, Argentina; [Gallo, Mariana] Fdn Inst Leloir, NMR Lab, Buenos Aires, DF, Argentina; [Salvay, Andres G.] Univ Nacl La Plata, Inst Phys Liquids & Biol Syst, La Plata, Buenos Aires, Argentina; [Salvay, Andres G.] Univ Nacl Quilmes, Dept Sci & Technol, Bernal, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; National University of La Plata	de Prat-Gay, G (corresponding author), Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina.	gpg@leloir.org.ar	Noval, Maria Gabriela/GLV-0239-2022; Perrone, Sebastian/Z-4825-2019; Salvay, Andrés Gerardo/AAC-8505-2021	Prat Gay, Gonzalo/0000-0001-5748-6863; Salvay, Andres/0000-0003-4020-1336; Chemes, Lucia Beatriz/0000-0003-0192-9906; Gallo, Mariana/0000-0002-0022-4499	Instituto Nacional del Cancer-Ministerio de Salud-Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Instituto Nacional del Cancer-Ministerio de Salud-Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Instituto Nacional del Cancer-Ministerio de Salud-Argentina (Basic Research Grant 2012-2014) (http://www.msal.gov.ar/inc/). MGN holds a graduate fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). MG, AGS, LBC and GPG are career researchers from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LG, 2006, BIOCHEMISTRY-US, V45, P657, DOI 10.1021/bi0522549; Alonso LG, 2004, BIOCHEMISTRY-US, V43, P3310, DOI 10.1021/bi036037o; Alonso LG, 2002, BIOCHEMISTRY-US, V41, P10510, DOI 10.1021/bi025579n; BARBOSA MS, 1989, J VIROL, V63, P1404, DOI 10.1128/JVI.63.3.1404-1407.1989; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Chemes LB, 2012, WILEY SER PROTEIN P, P313; Chemes LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047661; Chemes LB, 2012, J MOL BIOL, V422, P336, DOI 10.1016/j.jmb.2012.05.036; Chemes Lucia B, 2012, Methods Mol Biol, V895, P387, DOI 10.1007/978-1-61779-927-3_22; Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Chen K, 2004, P NATL ACAD SCI USA, V101, P15352, DOI 10.1073/pnas.0406657101; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dick FA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-26; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; DYSON N, 1992, J VIROL, V66, P6893, DOI 10.1128/JVI.66.12.6893-6902.1992; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Fassolari M, 2013, J BIOL CHEM, V288, P13110, DOI 10.1074/jbc.M112.444554; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; Garcia-Alai MM, 2006, STRUCTURE, V14, P309, DOI 10.1016/j.str.2005.11.012; Howley Peter M., 1996, P947; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Kashtanov Stepan, 2012, Methods Mol Biol, V895, P139, DOI 10.1007/978-1-61779-927-3_11; Kim HY, 2001, EMBO J, V20, P295, DOI 10.1093/emboj/20.1.295; Kim MK, 1999, PROTEIN SCI, V8, P1492, DOI 10.1110/ps.8.7.1492; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lam SL, 2003, BIOPOLYMERS, V69, P270, DOI 10.1002/bip.10354; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Ma K, 1999, J AM CHEM SOC, V121, P8698, DOI 10.1021/ja990864o; Makowska J, 2007, BIOPHYS J, V92, P2904, DOI 10.1529/biophysj.106.097550; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; MERRILL MR, 1993, J MAGN RESON SER A, V103, P223, DOI 10.1006/jmra.1993.1157; Meszaros B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046829; Mikhonin AV, 2005, J AM CHEM SOC, V127, P7712, DOI 10.1021/ja044636s; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; MUNGER K, 1993, BIOCHIM BIOPHYS ACTA, V1155, P111, DOI 10.1016/0304-419X(93)90025-8; NICOLAUJUNIOR N, 2013, J MOL MODEL IN PRESS; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Salvay Andres G, 2012, Methods Mol Biol, V896, P91, DOI 10.1007/978-1-4614-3704-8_6; Schmidt JM, 2011, PROTEINS, V79, P428, DOI 10.1002/prot.22893; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Shi ZS, 2002, P NATL ACAD SCI USA, V99, P9190, DOI 10.1073/pnas.112193999; Shi ZS, 2002, ADV PROTEIN CHEM, V62, P163; Singh M, 2005, J BIOL CHEM, V280, P37868, DOI 10.1074/jbc.M504877200; Smal C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036457; Smal C, 2009, BIOCHEMISTRY-US, V48, P11939, DOI 10.1021/bi901415k; Stubenrauch F, 1999, SEMIN CANCER BIOL, V9, P379, DOI 10.1006/scbi.1999.0141; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388; Uversky VN, 2012, WILEY SER PROTEIN P, pIX; Uversky VN, 2011, BBA-PROTEINS PROTEOM, V1814, P693, DOI 10.1016/j.bbapap.2011.03.010; Uversky VN, 1999, BIOCHEMISTRY-US, V38, P15009, DOI 10.1021/bi990752+; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; UVERSKY VN, 2012, BIOCHIM BIOPHYS ACTA, V1834, P932; Uversky VN, 2012, METHODS MOL BIOL, V1; VUISTER GW, 1993, J BIOMOL NMR, V3, P67; WHISHART DS, 1994, NUCL MAGNETIC RESONA, V293, P363; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	78	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e72760	10.1371/journal.pone.0072760	http://dx.doi.org/10.1371/journal.pone.0072760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086265	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900009
J	Fassett, JT; Xu, X; Kwak, D; Wang, H; Liu, XY; Hu, XL; Bache, RJ; Chen, YJ				Fassett, John T.; Xu, Xin; Kwak, Dongmin; Wang, Huan; Liu, Xiaoyu; Hu, Xinli; Bache, Robert J.; Chen, Yingjie			Microtubule Actin Cross-Linking Factor 1 Regulates Cardiomyocyte Microtubule Distribution and Adaptation to Hemodynamic Overload	PLOS ONE			English	Article							KINASE-C-ALPHA; CONTRACTILE DYSFUNCTION; CYTOSKELETAL ROLE; PROTEINS; DYNAMICS; MICE; LOCALIZATION; MIGRATION; PLAKIN; ADULT	Aberrant cardiomyocyte microtubule growth is a feature of pressure overload induced cardiac hypertrophy believed to contribute to left ventricular (LV) dysfunction. Microtubule Actin Cross-linking Factor 1 (MACF1/Acf7) is a 600 kd spectraplakin that stabilizes and guides microtubule growth along actin filaments. MACF1 is expressed in the heart, but its impact on cardiac microtubules, and how this influences cardiac structure, function, and adaptation to hemodynamic overload is unknown. Here we used inducible cardiac-specific MACF1 knockout mice (MACF1 KO) to determine the impact of MACF1 on cardiac microtubules and adaptation to pressure overload (transverse aortic constriction (TAC). In adult mouse hearts, MACF1 expression was low under basal conditions, but increased significantly in response to TAC. While MACF1 KO had no observable effect on heart size or function under basal conditions, MACF1 KO exacerbated TAC induced LV hypertrophy, LV dilation and contractile dysfunction. Interestingly, subcellular fractionation of ventricular lysates revealed that MACF1 KO altered microtubule distribution in response to TAC, so that more tubulin was associated with the cell membrane fraction. Moreover, TAC induced microtubule redistribution into this cell membrane fraction in both WT and MACF1 KO mice correlated strikingly with the level of contractile dysfunction (r(2) = 0.786, p < .001). MACF1 disruption also resulted in reduction of membrane caveolin 3 levels, and increased levels of membrane PKC alpha and beta 1 integrin after TAC, suggesting MACF1 function is important for spatial regulation of several physiologically relevant signaling proteins during hypertrophy. Together, these data identify for the first time, a role for MACF1 in cardiomyocyte microtubule distribution and in adaptation to hemodynamic overload.	[Chen, Yingjie] Univ Minnesota, Sch Med, Div Cardiovasc, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Chen, YJ (corresponding author), Univ Minnesota, Sch Med, Div Cardiovasc, Minneapolis, MN 55455 USA.	chenx106@umn.edu	Chen, Yingjie/AAX-5295-2020; Bache, Robert/AAW-7602-2021	Chen, Yingjie/0000-0002-4059-7847; 	United States Public Health Service from the National Institutes of Health [R21HL098669, R21HL098719, R21HL102597, RO1HL105406, HL021872]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021872, R01HL105406, R21HL102597, R21HL098719, R21HL098669] Funding Source: NIH RePORTER	United States Public Health Service from the National Institutes of Health; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by United States Public Health Service Grants R21HL098669, R21HL098719, R21HL102597, RO1HL105406, and HL021872 from the National Institutes of Health. JF is recipient of a Scientist Development Award from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2012, J NEUROSCI, V32, P9143, DOI 10.1523/JNEUROSCI.0416-12.2012; Battistella-Patterson AS, 2000, ACTA PHYSIOL SCAND, V170, P87, DOI 10.1046/j.1365-201x.2000.00755.x; Chen YJ, 2012, HYPERTENSION, V59, P1170, DOI 10.1161/HYPERTENSIONAHA.111.186072; Dykes AC, 2003, AM J PHYSIOL-CELL PH, V285, pC76, DOI 10.1152/ajpcell.00515.2002; Fassett JT, 2013, AM J PHYSIOL-HEART C, V304, pH749, DOI 10.1152/ajpheart.00935.2011; Fassett JT, 2009, AM J PHYSIOL-HEART C, V297, pH523, DOI 10.1152/ajpheart.00462.2009; Goryunov D, 2010, MOL CELL NEUROSCI, V44, P1, DOI 10.1016/j.mcn.2010.01.010; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Iribe G, 2009, CIRC RES, V104, P787, DOI 10.1161/CIRCRESAHA.108.193334; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Lin CM, 2005, J CELL SCI, V118, P3727, DOI 10.1242/jcs.02510; Liu QH, 2009, CIRC RES, V105, P194, DOI 10.1161/CIRCRESAHA.109.195313; Melnikov S, 2009, CELL SIGNAL, V21, P1607, DOI 10.1016/j.cellsig.2009.06.007; Nakamura Y, 2004, CARDIOVASC RES, V64, P322, DOI 10.1016/j.cardiores.2004.07.013; Perhonen M, 1998, J MOL CELL CARDIOL, V30, P1713, DOI 10.1006/jmcc.1998.0734; Prevostel C, 2000, J CELL SCI, V113, P2575; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Tagawa H, 1998, CIRC RES, V82, P751, DOI 10.1161/01.RES.82.7.751; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; TSUTSUI H, 1994, CIRCULATION, V90, P533, DOI 10.1161/01.CIR.90.1.533; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038	32	40	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e73887	10.1371/journal.pone.0073887	http://dx.doi.org/10.1371/journal.pone.0073887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086300	Green Published, Green Submitted, gold			2022-12-27	WOS:000325220000005
J	Gonzalez-Porter, GP; Maldonado, JE; Flores-Villela, O; Vogt, RC; Janke, A; Fleischer, RC; Hailer, F				Gonzalez-Porter, Gracia P.; Maldonado, Jesus E.; Flores-Villela, Oscar; Vogt, Richard C.; Janke, Axel; Fleischer, Robert C.; Hailer, Frank			Cryptic Population Structuring and the Role of the Isthmus of Tehuantepec as a Gene Flow Barrier in the Critically Endangered Central American River Turtle	PLOS ONE			English	Article							COMPUTER-PROGRAM; EVOLUTIONARY PROCESSES; CONSERVATION GENETICS; F-STATISTICS; NUCLEAR; MITOCHONDRIAL; DIVERSIFICATION; PHYLOGEOGRAPHY; BOTTLENECK; DIVERSITY	The critically endangered Central American River Turtle (Dermatemys mawii) is the only remaining member of the Dermatemydidae family, yet little is known about its population structuring. In a previous study of mitochondrial (mt) DNA in the species, three main lineages were described. One lineage (Central) was dominant across most of the range, while two other lineages were restricted to Papaloapan (PAP; isolated by the Isthmus of Tehuantepec and the Sierra de Santa Marta) or the south-eastern part of the range (1D). Here we provide data from seven polymorphic microsatellite loci and the R35 intron to re-evaluate these findings using DNA from the nuclear genome. Based on a slightly expanded data set of a total of 253 samples from the same localities, we find that mtDNA and nuclear DNA markers yield a highly congruent picture of the evolutionary history and population structuring of D. mawii. While resolution provided by the R35 intron (sequenced for a subset of the samples) was very limited, the microsatellite data revealed pronounced population structuring. Within the Grijalva-Usumacinta drainage basin, however, many populations separated by more than 300 kilometers showed signals of high gene flow. Across the entire range, neither mitochondrial nor nuclear DNA show a significant isolation-by-distance pattern, but both genomes highlight that the D. mawii population in the Papaloapan basin is genetically distinctive. Further, both marker systems detect unique genomic signals in four individuals with mtDNA clade 1D sampled on the southeast edge of the Grijalva-Usumacinta basin. These individuals may represent a separate cryptic taxon that is likely impacted by recent admixture.	[Gonzalez-Porter, Gracia P.; Maldonado, Jesus E.; Fleischer, Robert C.; Hailer, Frank] Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Washington, DC 20008 USA; [Gonzalez-Porter, Gracia P.; Flores-Villela, Oscar] Univ Nacl Autonoma Mexico, Museo Zool, Fac Ciencias, Mexico City 04510, DF, Mexico; [Maldonado, Jesus E.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20560 USA; [Vogt, Richard C.] Coordinacao Biodiversidade, Inst Nacl Pesquisas Amazonia, Manaus, Amazonas, Brazil; [Janke, Axel] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Biologicum, D-60054 Frankfurt, Germany; [Janke, Axel; Hailer, Frank] Biodivers & Climate Res Ctr, Frankfurt, Germany; [Janke, Axel; Hailer, Frank] Senckenberg Gesell Nat Forsch, Frankfurt, Germany	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Universidad Nacional Autonoma de Mexico; Smithsonian Institution; Smithsonian National Museum of Natural History; Institute Nacional de Pesquisas da Amazonia; Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN)	Gonzalez-Porter, GP (corresponding author), Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Natl Zool Pk, Washington, DC 20008 USA.	graciasyed@gmail.com; frashai@gmx.net	Hailer, Frank/C-9114-2012; Hailer, Frank/Y-3595-2019; Maldonado, Jesus/AIE-8664-2022	Hailer, Frank/0000-0002-2340-1726; Hailer, Frank/0000-0002-2340-1726; Maldonado, Jesus/0000-0002-4282-1072; Flores-Villela, Oscar/0000-0002-2849-6912	Consejo Nacional de Ciencia y Tecnologia fellowship [210994]; Turtle Conservation Fund; Conservation International grants; Philadelphia Zoo Conservation Program; Philadelphia Zoo Docent council; Smithsonian Restricted Endowment funds; EA Schreiber; Seabird Research, Inc; "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts	Consejo Nacional de Ciencia y Tecnologia fellowship; Turtle Conservation Fund; Conservation International grants; Philadelphia Zoo Conservation Program; Philadelphia Zoo Docent council; Smithsonian Restricted Endowment funds; EA Schreiber; Seabird Research, Inc; "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts	Funding was provided by Consejo Nacional de Ciencia y Tecnologia fellowship No. 210994; the Turtle Conservation Fund grants in 2004, 2006 and 2009; Conservation International grants in 2007 and 2009; the Philadelphia Zoo Conservation Program Financial Support for 2005, 2006, 2007, 2008; and an award from the Philadelphia Zoo Docent council in 2007. FH received support from the Smithsonian Restricted Endowment funds, EA Schreiber, Seabird Research, Inc, and "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlichokonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Ichthyologists and Herpetologists, 2013, GUID US LIV AMPH REP; Andree K, 2010, MOL ECOL RESOUR, V10, P1098, DOI 10.1111/j.1755-0998.2010.02898.x; Athie LM, 1987, CALIDAD CANTIDAD AGU; Barber BR, 2010, P ROY SOC B-BIOL SCI, V277, P2675, DOI 10.1098/rspb.2010.0343; BELKHIR K, 2000, GENETIX 4 02 LOGICIE; Beu AG, 2001, J PALEONTOL, V75, P706, DOI 10.1017/S0022336000039743; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Campbell Jonathan A., 1989, AMPHIBIANS REPTILES; Castellanos-Cabrera J, 2007, BUENAVISTA NUEVO SAN; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CONABIO-DGVS-CONANP, 2006, ESTR NAC CONS MAN SO; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; Cornuet JM, 1999, GENETICS, V153, P1989; Cornuet JM, 1996, GENETICS, V144, P2001; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Croizat L, 1976, B ACAD CIENCIAS FISI; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DUELLMAN WILLIAM E., 1960, UNIV KANSAS PUBL MUS NAT HIST, V13, P19; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Echelle AA, 2010, CONSERV GENET, V11, P1375, DOI 10.1007/s10592-009-9966-1; Elson C. M., 2005, ANCIENT MESOAM, V16, P195; Emery K., 2001, CRAFTING BONE SKELET, V937, P73; Emery KF, 2005, ANIMALES RITUALES AC; ERVYNCK A., 2004, BEHAV BONES ZOOARCHA; Escalona T, 2009, CONSERV GENET, V10, P1683, DOI 10.1007/s10592-008-9746-3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fujita MK, 2004, MOL PHYLOGENET EVOL, V31, P1031, DOI 10.1016/j.ympev.2003.09.016; Gonzalez-Porter GP, 2011, CONSERV GENET, V12, P1229, DOI 10.1007/s10592-011-0225-x; Guevara-Chumacero LM, 2010, J MAMMAL, V91, P220, DOI 10.1644/08-MAMM-A-212R3.1; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hauswaldt JS, 2005, MOL ECOL, V14, P723, DOI 10.1111/j.1365-294X.2005.02451.x; Helander B, 2007, J ORNITHOL, V148, P435, DOI 10.1007/s10336-007-0156-y; Hobbs RJ, 1998, CONSERV BIOL, V12, P271, DOI 10.1046/j.1523-1739.1998.96233.x; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Huidobro L, 2006, J BIOGEOGR, V33, P731, DOI 10.1111/j.1365-2699.2005.01400.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; LAMB T, 1994, SYST BIOL, V43, P543, DOI 10.2307/2413551; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Maldonado JE, 2001, MOL ECOL, V10, P127, DOI 10.1046/j.1365-294X.2001.01178.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Moritz C, 1999, HEREDITAS, V130, P217, DOI 10.1111/j.1601-5223.1999.00217.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Mulcahy DG, 2006, J BIOGEOGR, V33, P1889, DOI 10.1111/j.1365-2699.2006.01546.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols RA, 2004, MOL ECOL, V13, P775, DOI 10.1111/j.1365-294X.2004.02112.x; Paquette SR, 2007, CONSERV GENET, V8, P797, DOI 10.1007/s10592-006-9227-5; Pearse DE, 2006, MOL ECOL, V15, P985, DOI 10.1111/j.1365-294X.2006.02869.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Polisar John, 1994, Herpetological Review, V25, P47; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rico Y, 2008, CONSERV GENET, V9, P1467, DOI 10.1007/s10592-007-9480-2; Robertson JM, 2009, J HERED, V100, P715, DOI 10.1093/jhered/esp041; Rousset F, 1997, GENETICS, V145, P1219; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schwartz TS, 2005, CONSERV GENET, V6, P917, DOI 10.1007/s10592-005-9078-5; Schwartz TS, 2003, MOL ECOL NOTES, V3, P283, DOI 10.1046/j.1471-8286.2003.00428.x; SEMARNAT, 2000, LEY GEN VID SILV; Soustelle J, 2003, OLMECAS; Sullivan J, 1997, SYST BIOL, V46, P426, DOI 10.2307/2413690; TEMPLETON AR, 1992, GENETICS, V132, P619; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Velo-Anton G, 2008, CONSERV GENET, V9, P1263, DOI 10.1007/s10592-007-9457-1; Vogt RC, 2006, IUCN 2012 IUCN RED L; Vogt RC., 1997, HIST NATURAL TUXTLAS; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Zarza E, 2008, MOL ECOL, V17, P3259, DOI 10.1111/j.1365-294X.2008.03826.x	77	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e71668	10.1371/journal.pone.0071668	http://dx.doi.org/10.1371/journal.pone.0071668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086253	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325218700002
J	Botchkina, GI; Zuniga, ES; Rowehl, RH; Park, R; Bhalla, R; Bialkowska, AB; Johnson, F; Golub, LM; Zhang, Y; Ojima, I; Shroyer, KR				Botchkina, Galina I.; Zuniga, Edison S.; Rowehl, Rebecca H.; Park, Rosa; Bhalla, Rahuldev; Bialkowska, Agnieszka B.; Johnson, Francis; Golub, Lorne M.; Zhang, Yu; Ojima, Iwao; Shroyer, Kenneth R.			Prostate Cancer Stem Cell-Targeted Efficacy of a New-Generation Taxoid, SBT-1214 and Novel Polyenolic Zinc-Binding Curcuminoid, CMC2.24	PLOS ONE			English	Article							Y-CHROMOSOME; INITIATING CELLS; GENE-EXPRESSION; SIDE POPULATION; TUMOR-GROWTH; RESISTANCE; IDENTIFICATION; MARKERS; NESTIN; CD44	Background: Prostate cancer is the second leading cause of cancer death among men. Multiple evidence suggests that a population of tumor-initiating, or cancer stem cells (CSCs) is responsible for cancer development and exceptional drug resistance, representing a highly important therapeutic target. The present study evaluated CSC-specific alterations induced by new-generation taxoid SBT-1214 and a novel polyenolic zinc-binding curcuminoid, CMC2.24, in prostate CSCs. Principal Findings: The CD133(high)/CD44(high) phenotype was isolated from spontaneously immortalized patient-derived PPT2 cells and highly metastatic PC3MM2 cells. Weekly treatment of the NOD/SCID mice bearing PPT2- and PC3MM3-induced tumors with the SBT-1214 led to dramatic suppression of tumor growth. Four of six PPT2 and 3 of 6 PC3MM2 tumors have shown the absence of viable cells in residual tumors. In vitro, SBT-1214 (100nM-1 mu M; for 72 hr) induced about 60% cell death in CD133h(igh)/CD44(+/high) cells cultured on collagen I in stem cell medium (in contrast, the same doses of paclitaxel increased proliferation of these cells). The cytotoxic effects were increased when SBT-1214 was combined with the CMC2.24. A stem cell-specific PCR array assay revealed that this drug combination mediated massive inhibition of multiple constitutively up-regulated stem cell-related genes, including key pluripotency transcription factors. Importantly, this drug combination induced expression of p21 and p53, which were absent in CD133(high)/CD44(high) cells. Viable cells that survived this treatment regimen were no longer able to induce secondary spheroids, exhibited significant morphological abnormalities and died in 2-5 days. Conclusions: We report here that the SBT-1214 alone, or in combination with CMC2.24, possesses significant activity against prostate CD133(high)/CD44(+/high) tumor-initiating cells. This drug combination efficiently inhibits expression of the majority of stem cell-related genes and pluripotency transcription factors. In addition, it induces a previously absent expression of p21 and p53 ("gene wake-up"), which can potentially reverse drug resistance by increasing sensitivity to anti-cancer drugs.	[Botchkina, Galina I.; Rowehl, Rebecca H.; Shroyer, Kenneth R.] SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA; [Botchkina, Galina I.; Zuniga, Edison S.; Ojima, Iwao] SUNY Stony Brook, Inst Chem Biol & Drug Dev, Stony Brook, NY 11794 USA; [Zuniga, Edison S.; Johnson, Francis; Zhang, Yu; Ojima, Iwao] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Park, Rosa; Bhalla, Rahuldev] SUNY Stony Brook, Med Ctr, Dept Urol, Stony Brook, NY 11794 USA; [Bialkowska, Agnieszka B.] SUNY Stony Brook, Dept Med, Med Ctr, Stony Brook, NY 11794 USA; [Johnson, Francis] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Johnson, Francis] SUNY Stony Brook, Chem Master Int Inc, Stony Brook, NY 11794 USA; [Golub, Lorne M.] SUNY Stony Brook, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Botchkina, GI (corresponding author), SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA.	gbotchkina@stonybrookmedicine.edu		Ojima, Iwao/0000-0002-3628-1161	NIH [R21 CA150085]; NYSTAR [1072170]; Stony Brook University Institute of Chemical Biology & Drug Discovery (ICBDD); Stony Brook University Cancer Center, NY; ChemMaster International, NY; SBU VP for Research; NATIONAL CANCER INSTITUTE [R21CA150085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTAR; Stony Brook University Institute of Chemical Biology & Drug Discovery (ICBDD); Stony Brook University Cancer Center, NY; ChemMaster International, NY; SBU VP for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH R21 CA150085, NYSTAR grant 1072170, and in part, by the Stony Brook University Institute of Chemical Biology & Drug Discovery (ICB & DD); Stony Brook University Cancer Center, NY; ChemMaster International, NY and SBU VP for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa S, 2001, EUR UROL, V39, P138, DOI 10.1159/000052428; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Alam TN, 2004, J HISTOCHEM CYTOCHEM, V52, P1083, DOI 10.1369/jhc.4a6256.2004; Attard G, 2009, PROSTATE, V69, P1507, DOI 10.1002/pros.20997; Bae KM, 2011, AM J CANCER RES, V1, P71; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; BARETTON GB, 1994, CANCER RES, V54, P4472; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Botchkina GI, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-192; BOTCHKINA GI, 2011, CANC STEM CELLS THEO, P135; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Cheng L, 2000, CLIN CANCER RES, V6, P1896; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dirks PB, 2006, NATURE, V444, P687, DOI 10.1038/444687a; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Fong D, 2010, CANCER LETT, V293, P65, DOI 10.1016/j.canlet.2009.12.018; Fusi A, 2011, J INVEST DERMATOL, V131, P487, DOI 10.1038/jid.2010.285; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034219; Hall CL, 2010, CANCER RES, V70, P9916, DOI 10.1158/0008-5472.CAN-10-0440; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirata T, 1998, CANCER RES, V58, P1108; Hour TC, 2002, PROSTATE, V51, P211, DOI 10.1002/pros.10089; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Kelly K, 2008, CELL RES, V18, P528, DOI 10.1038/cr.2008.50; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kleeberger W, 2007, CANCER RES, V67, P9199, DOI 10.1158/0008-5472.CAN-07-0806; KOIVISTO P, 1995, AM J PATHOL, V147, P1608; Kuznetsova L, 2006, BIOORG MED CHEM LETT, V16, P974, DOI 10.1016/j.bmcl.2005.10.089; Luo Jian-Hua, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006057; Marin-Aguilera M, 2012, MOL CANCER THER, V11, P329, DOI 10.1158/1535-7163.MCT-11-0289; Matsuda Y, 2011, CANCER BIOL THER, V11, P512, DOI 10.4161/cbt.11.5.14673; Matsushima H, 1998, HUM PATHOL, V29, P778, DOI 10.1016/S0046-8177(98)90445-2; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2010, HISTOL HISTOPATHOL, V25, P1057, DOI 10.14670/HH-25.1057; Mimeault M, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-31; Miyoshi Y, 2000, PROSTATE, V43, P225, DOI 10.1002/(SICI)1097-0045(20000515)43:3<225::AID-PROS9>3.0.CO;2-7; Nautiyal J, 2012, AM J PHYSIOL-GASTR L, V302, pG655, DOI 10.1152/ajpgi.00323.2011; Nielander I, 2008, HAEMATOLOGICA, V93, P949, DOI 10.3324/haematol.12656; Oliai BR, 2002, AM J SURG PATHOL, V26, P1151, DOI 10.1097/00000478-200209000-00005; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Peehl DM, 2005, ENDOCR-RELAT CANCER, V12, P19, DOI 10.1677/erc.1.00795; Peehl DM, 2004, J CELL BIOCHEM, V91, P185, DOI 10.1002/jcb.10691; Perinchery G, 2000, J UROLOGY, V163, P1339, DOI 10.1016/S0022-5347(05)67774-9; Piantino CB, 2009, INT BRAZ J UROL, V35, P354, DOI 10.1590/S1677-55382009000300012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rowehl Rebecca A., 2008, Cancer Genomics & Proteomics, V5, P301; Shah RB, 2002, AM J SURG PATHOL, V26, P1161, DOI 10.1097/00000478-200209000-00006; Shankar S, 2007, INT J ONCOL, V30, P905; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Singh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040021; Su CC, 2006, ANTICANCER RES, V26, P4379; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; TORTORETO M, 2009, P NATL ACAD SCI USA, V106; Uzgare AR, 2004, J CELL BIOCHEM, V91, P196, DOI 10.1002/jcb.10764; van Brussel JR, 2003, ONKOLOGIE, V26, P175, DOI 10.1159/000071510; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Vijayakumar S, 2005, GENE CHROMOSOME CANC, V44, P365, DOI 10.1002/gcc.20250; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zhang WH, 2011, CANCER-AM CANCER SOC, V117, P4092, DOI 10.1002/cncr.26021; Zhang Y, 2012, CURR MED CHEM, V19, P4348, DOI 10.2174/092986712802884295; Zhao Y, 2008, CELL BIOCHEM FUNCT, V26, P571, DOI 10.1002/cbf.1478; Zivi A, 2010, CLIN GENITOURIN CANC, V8, P17, DOI 10.3816/CGC.2010.n.003	71	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e69884	10.1371/journal.pone.0069884	http://dx.doi.org/10.1371/journal.pone.0069884			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086245	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200002
J	Martin-Vazquez, G; Makarova, J; Makarov, VA; Herreras, O				Martin-Vazquez, Gonzalo; Makarova, Julia; Makarov, Valeri A.; Herreras, Oscar			Determining the True Polarity and Amplitude of Synaptic Currents Underlying Gamma Oscillations of Local Field Potentials	PLOS ONE			English	Article							SOURCE DENSITY ANALYSIS; CA1 PYRAMIDAL CELLS; INDEPENDENT COMPONENT; RAT HIPPOCAMPUS; DENDRITIC MORPHOLOGY; OLFACTORY-BULB; COHERENCE; NEURONS; SPIKES; THETA	Fluctuations in successive waves of oscillatory local field potentials (LFPs) reflect the ongoing processing of neuron populations. However, their amplitude, polarity and synaptic origin are uncertain due to the blending of electric fields produced by multiple converging inputs, and the lack of a baseline in standard AC-coupled recordings. Consequently, the estimation of underlying currents by laminar analysis yields spurious sequences of inward and outward currents. We devised a combined analytical/experimental approach that is suitable to study laminated structures. The approach was essayed on an experimental oscillatory LFP as the Schaffer-CA1 gamma input in anesthetized rats, and it was verified by parallel processing of model LFPs obtained through a realistic CA1 aggregate of compartmental units. This approach requires laminar LFP recordings and the isolation of the oscillatory input from other converging pathways, which was achieved through an independent component analysis. It also allows the spatial and temporal components of pathway-specific LFPs to be separated. While reconstructed Schaffer-specific LFPs still show spurious inward/outward current sequences, these were clearly stratified into distinct subcellular domains. These spatial bands guided the localized delivery of neurotransmitter blockers in experiments. As expected, only Glutamate but not GABA blockers abolished Schaffer LFPs when applied to the active but not passive subcellular domains of pyramidal cells. The known chemical nature of the oscillatory LFP allowed an empirical offset of the temporal component of Schaffer LFPs, such that following reconstruction they yield only sinks or sources at the appropriate sites. In terms of number and polarity, some waves increased and others decreased proportional to the concomitant inputs in native multisynaptic LFPs. Interestingly, the processing also retrieved the initiation time for each wave, which can be used to discriminate afferent from postsynaptic cells in standard spike-phase correlations. The applicability of this approach to other pathways and structures is discussed.	[Martin-Vazquez, Gonzalo; Makarova, Julia; Herreras, Oscar] CSIC, Inst Cajal, Dept Syst Neurosci, Madrid, Spain; [Makarov, Valeri A.] Univ Complutense Madrid, Fac Math, Dept Appl Math, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Complutense University of Madrid	Herreras, O (corresponding author), CSIC, Inst Cajal, Dept Syst Neurosci, Madrid, Spain.	herreras@cajal.csic.es	Makarova, Julia/K-5912-2014; Makarov, Valeri A/L-5031-2014; Makarov, Valeri/AAF-4790-2019; Makarova, Julia/AAI-1213-2019; herreras, oscar/D-5256-2016; Herreras, Oscar/O-1711-2019	Makarova, Julia/0000-0001-9307-6167; Makarov, Valeri A/0000-0001-8789-7532; Makarov, Valeri/0000-0001-8789-7532; Makarova, Julia/0000-0001-9307-6167; herreras, oscar/0000-0002-8210-3710; Herreras, Oscar/0000-0002-8210-3710; Martin-Vazquez, Gonzalo/0000-0001-7761-3962	Spanish Ministry of Science and Innovation [BFU2010-19192/BFI, FIS2010-20054]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the grants BFU2010-19192/BFI and FIS2010-20054 from the former Spanish Ministry of Science and Innovation; http://www.idi.mineco.gob.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; BENITO N, 2013, CEREB CORTEX, DOI DOI 10.1093/CERC0R/BHT022.PUBMED:23395845; BOSS BD, 1987, BRAIN RES, V406, P280, DOI 10.1016/0006-8993(87)90793-1; Bower JM, 1998, BOOK GENESIS EXPLORI; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRANKACK J, 1993, BRAIN RES, V615, P310, DOI 10.1016/0006-8993(93)90043-M; BRESSLER SL, 1987, BRAIN RES, V409, P285, DOI 10.1016/0006-8993(87)90713-X; Bullock TH, 2003, NEUROSCIENCE, V121, P233, DOI 10.1016/S0306-4522(03)00208-2; BULLOCK TH, 1990, NEUROSCIENCE, V38, P609, DOI 10.1016/0306-4522(90)90055-9; BUZSAKI G, 1986, BRAIN RES, V365, P125, DOI 10.1016/0006-8993(86)90729-8; Canals S, 2005, J NEUROPHYSIOL, V93, P909, DOI 10.1152/jn.00686.2004; Castro-Alamancos MA, 2000, J NEUROSCI, V20, P9195; Chen AY, 2006, LECT NOTES COMPUT SC, V3889, P24; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; Elul R., 1972, INT REV NEUROBIOL, V15, P228; Fernandez-Ruiz A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00071; Fernandez-Ruiz A, 2012, J NEUROSCI, V32, P5165, DOI 10.1523/JNEUROSCI.4499-11.2012; FERNANDEZRUIZ A, 2013, J NEUROSCI IN PRESS; FERNANDEZRUIZ A, 2013, J COMPUT NEUROSCI, V5, P7, DOI DOI 10.3389/FNC0M.2013.00005; Florian G, 1998, ELECTROEN CLIN NEURO, V106, P87, DOI 10.1016/S0013-4694(97)00105-3; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; GLOOR P, 1985, J CLIN NEUROPHYSIOL, V2, P327, DOI 10.1097/00004691-198510000-00002; Golarai G, 1996, J NEUROPHYSIOL, V75, P329, DOI 10.1152/jn.1996.75.1.329; HERRERAS O, 1990, J NEUROPHYSIOL, V64, P1429, DOI 10.1152/jn.1990.64.5.1429; HERRERAS O, 1988, BRAIN RES, V461, P290, DOI 10.1016/0006-8993(88)90259-4; Ibarz JM, 2006, EUR J NEUROSCI, V23, P1219, DOI 10.1111/j.1460-9568.2006.04615.x; KETCHUM KL, 1993, J NEUROSCI, V13, P3980; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Korovaichuk A, 2010, J NEUROPHYSIOL, V104, P484, DOI 10.1152/jn.00297.2010; Leski S, 2010, J COMPUT NEUROSCI, V29, P459, DOI 10.1007/s10827-009-0203-1; Lopez-Aguado L, 2002, J NEUROPHYSIOL, V88, P2809, DOI 10.1152/jn.00183.2002; Lopez-Aguado L, 2001, NEUROSCIENCE, V108, P249, DOI 10.1016/S0306-4522(01)00417-1; LORENTE de NO R, 1947, Stud Rockefeller Inst Med Res Repr, V132, P384; Makarov VA, 2010, J COMPUT NEUROSCI, V29, P445, DOI 10.1007/s10827-009-0206-y; Makarova J, 2007, BIOPHYS J, V92, P4216, DOI 10.1529/biophysj.106.090332; Makarova J, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00077; Makarova J, 2010, J NEUROPHYSIOL, V103, P2446, DOI 10.1152/jn.01045.2009; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; MITZDORF U, 1977, J NEUROPHYSIOL, V40, P1227, DOI 10.1152/jn.1977.40.6.1227; Neville KR, 2003, J NEUROPHYSIOL, V90, P3921, DOI 10.1152/jn.00475.2003; Niedermeyer E, 1996, CLIN ELECTROENCEPHAL, V27, P121, DOI 10.1177/155005949602700305; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Pavlov Alexey, 2007, Natural Computing, V6, P269, DOI 10.1007/s11047-006-9014-8; Pavlov AN, 2006, BRIEF BIOINFORM, V7, P375, DOI 10.1093/bib/bbl041; Plonsey R., 1969, BIOELECTRIC PHENOMEN; RAPPELSBERGER P, 1981, PFLUG ARCH EUR J PHY, V389, P159, DOI 10.1007/BF00582108; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; RODRIGUEZ R, 1989, J NEUROPHYSIOL, V61, P702, DOI 10.1152/jn.1989.61.4.702; Scheffer-Teixeira R, 2012, CEREB CORTEX, V22, P2404, DOI 10.1093/cercor/bhr319; Steriade M, 1996, P NATL ACAD SCI USA, V93, P2533, DOI 10.1073/pnas.93.6.2533; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; Varona P, 2000, J NEUROPHYSIOL, V83, P2192, DOI 10.1152/jn.2000.83.4.2192; Woodbury JW., 1960, MEDICAL PHYSL BIOPHY, P83; Wu K, 1998, HIPPOCAMPUS, V8, P217, DOI 10.1002/(SICI)1098-1063(1998)8:3<217::AID-HIPO5>3.3.CO;2-Y; YLINEN A, 1995, J NEUROSCI, V15, P30	61	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75499	10.1371/journal.pone.0075499	http://dx.doi.org/10.1371/journal.pone.0075499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073269	Green Submitted, gold, Green Published			2022-12-27	WOS:000324768000079
J	Golet, WJ; Galuardi, B; Cooper, AB; Lutcavage, ME				Golet, Walter J.; Galuardi, Benjamin; Cooper, Andrew B.; Lutcavage, Molly E.			Changes in the Distribution of Atlantic Bluefin Tuna (Thunnus thynnus) in the Gulf of Maine 1979-2005	PLOS ONE			English	Article							LONG-TERM FLUCTUATIONS; POPULATION-STRUCTURE; FISH; TEMPERATURE; VARIABILITY; MOVEMENTS; MIGRATION; DYNAMICS; DECLINE; COMPLEX	The Gulf of Maine, NW Atlantic Ocean, is a productive, seasonal foraging ground for Atlantic bluefin tuna (Thunnus thynnus), but commercial landings of adult size classes were up to 40% below the allocated total allowable catch between 2004 to 2008 for the rod and reel, harpoon, and purse seine categories in the Gulf of Maine. Reduction in Atlantic bluefin tuna catches in the Gulf of Maine could represent a decline in spawning stock biomass, but given wide-ranging, complex migration patterns, and high energetic requirements, an alternative hypothesis is that their dispersal patterns shifted to regions with higher prey abundance or profitability, reducing availability to U. S. fishing fleets. This study fit generalized linear models to Atlantic bluefin tuna landings data collected from fishermen's logbooks (1979-2005) as well as the distances between bluefin tuna schools and Atlantic herring (Clupea harengus), a primary prey species, to test alternative hypotheses for observed shifts in Atlantic bluefin tuna availability in the Gulf of Maine. For the bluefin model, landings varied by day of year, latitude and longitude. The effect of latitude differed by day of year and the effect of longitude differed by year. The distances between Atlantic bluefin tuna schools and Atlantic herring schools were significantly smaller (p<0.05) than would be expected from a randomly distributed population. A time series of average bluefin tuna school positions was positively correlated with the average number of herring captured per tow on Georges Bank in spring and autumn surveys respectively (p<0.01, r(2)=0.24, p<0.01, r(2)=0.42). Fishermen's logbooks contributed novel spatial and temporal information towards testing these hypotheses for the bluefin tuna fishery.	[Golet, Walter J.] Univ Maine, Sch Marine Sci, Orono, ME USA; [Golet, Walter J.] Gulf Maine Res Inst, Portland, ME USA; [Galuardi, Benjamin; Lutcavage, Molly E.] UMass Amherst & Marine Fisheries Inst, Large Pelag Res Ctr, Gloucester, MA USA; [Cooper, Andrew B.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada	University of Maine System; University of Maine Orono; Gulf of Maine Research Institute; Simon Fraser University	Golet, WJ (corresponding author), Univ Maine, Sch Marine Sci, Orono, ME USA.	walter.golet@maine.edu			NOAA [NA04NMF4550391]; Division Of Ocean Sciences [1041731] Funding Source: National Science Foundation	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by NOAA grant #NA04NMF4550391 to Molly Lutcavage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ICCAT COL VOL SCI PA, V67, P505; Anthony VC, 1980, P V REUN CONS INT EX, V177, P72; Arni Magnusson, 2011, GMT INTERFACE GMT MA, P1; Atlantic Bluefin Tuna Status Review Team, 2011, STAT REV REP ATL BLU, P22; Bigelow H. B., 1954, Fishery Bulletin United States, V53, P1; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Brown CA, 2009, ICCAT COL VOL SCI PA, V64, P454; Brown CA, 2007, ICCAT COL VOL SCI PA, V60, P1087; Butler CM, 2009, FISH B, V108, P56; Butler M, 1971, BIOL INVESTIGATION A, p[1970, 1]; Butler M.J.A., 1977, ICCAT COL VOL SCI PA, V6, P318; Caddy JF, 1975, 1395 J FISHRESBOARD; CAREY FG, 1971, AM ZOOL, V11, P137; CAREY FG, 1966, P NATL ACAD SCI USA, V56, P1464, DOI 10.1073/pnas.56.5.1464; CAREY FG, 1973, COMP BIOCHEM PHYSIOL, V44, P375, DOI 10.1016/0300-9629(73)90490-8; CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P205, DOI 10.1016/0010-406X(69)91336-X; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; Chase BC, 2002, FISH B-NOAA, V100, P168; Crane J., 1936, ZOOLOGICA, V212, P207; Deng R, 2005, CAN J FISH AQUAT SCI, V62, P611, DOI 10.1139/F04-219; Drinkwater KF, 2002, AM FISH S S, V32, P113; Estrada JA, 2005, MAR BIOL, V147, P37, DOI 10.1007/s00227-004-1541-1; Fromentin JM, 2009, FISH FISH, V10, P197, DOI 10.1111/j.1467-2979.2008.00311.x; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Fromentin JM, 2001, FISH RES, V53, P133, DOI 10.1016/S0165-7836(00)00299-X; Fromentin JM, 2001, ICCAT COL VOL SCI, V50, P1780; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Gartside DF, 1999, FISH RES, V63, P405; Golet WJ, 2007, FISH B-NOAA, V105, P390; Greene CH, 2007, SCIENCE, V315, P1084, DOI 10.1126/science.1136495; Gutenkunst R, 2007, J THEOR BIOL, V245, P243, DOI 10.1016/j.jtbi.2006.10.014; Hamre J, 1968, CONSEIL PERMANENT IN, V38, P1; HILBORN R, 1992; Humston R, 2000, FISH OCEANOGR, V9, P136, DOI 10.1046/j.1365-2419.2000.00132.x; Hurley PCF, 1983, P INT WORKSH AG DET; Kane J, 2011, ICES J MAR SCI, V68, P1833, DOI 10.1093/icesjms/fsr122; Logan JM, 2011, MAR BIOL, V158, P73, DOI 10.1007/s00227-010-1543-0; LUTCAVAGE M, 1995, FISH B-NOAA, V93, P495; Lutcavage M., 1997, INT COMM CONSERV ATL, V47, P332; Lutcavage ME, 2000, MAR BIOL, V137, P347, DOI 10.1007/s002270000302; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; Maguire J, 2012, 2012002 FISH OC CAN; Marsac Francis, 1999, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V49, P346; Mather FJ, 1995, NMFSSEFSC370 NAT OC; McAllister Murdoch K., 2008, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V62, P1298; Melvin GD, 2007, ICES J MAR SCI, V64, P69, DOI 10.1093/icesjms/fsl018; Mesnil B, 2009, AQUAT LIVING RESOUR, V22, P207, DOI 10.1051/alr/2009003; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Mountain DG, 2010, MAR ECOL PROG SER, V398, P81, DOI 10.3354/meps08323; Neilson J.D., 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V60, P976; Nottestad L, 1999, CAN J FISH AQUAT SCI, V56, P26, DOI 10.1139/cjfas-56-S1-26; Nottestad L, 2009, COL ICCAT VOL SCI PA, V63, P231; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Overholtz WJ, 2002, FISH B-NOAA, V100, P593; Pershing AJ, 2005, ICES J MAR SCI, V62, P1511, DOI 10.1016/j.icesjms.2005.04.025; Pershing AJ, 2006, EOS T AM GEOPHYS UNI, V87; Polacheck T., 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V48, P61; Porch CE, 2006, FISH B-NOAA, V104, P89; Quin JT, 1999, QUANTITATIVE FISH DY; R Development Core Team, 2011, R LANG ENV STAT COMP; Ravier C, 2004, FISH OCEANOGR, V13, P145, DOI 10.1111/j.1365-2419.2004.00284.x; Ravier C, 2001, ICES J MAR SCI, V58, P1299, DOI 10.1006/jmsc.2001.1119; Rivas LR, 1955, P GULF CAR FISH I 7, V7, P133; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Royer F, 2004, MAR ECOL PROG SER, V269, P249, DOI 10.3354/meps269249; Schick RS, 2009, FISH OCEANOGR, V18, P77, DOI 10.1111/j.1365-2419.2008.00499.x; Schick RS, 2004, FISH OCEANOGR, V13, P225, DOI 10.1111/j.1365-2419.2004.00290.x; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; Takeuchi Y, 2009, ICCAT VOL SCI PAP, V63, P186; Tiews K., 1978, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V172, P301; van Putten IE, 2012, FISH FISH, V13, P216, DOI 10.1111/j.1467-2979.2011.00430.x; Venables WN., 2002, MODERN APPL STAT S 4; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Worm B, 2011, P NATL ACAD SCI USA, V108, P11942, DOI 10.1073/pnas.1102353108	75	20	20	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75480	10.1371/journal.pone.0075480	http://dx.doi.org/10.1371/journal.pone.0075480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069420	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300081
J	Hafid, SRA; Chakravarthi, S; Nesaretnam, K; Radhakrishnan, AK				Hafid, Sitti Rahma Abdul; Chakravarthi, Srikumar; Nesaretnam, Kalanithi; Radhakrishnan, Ammu Kutty			Tocotrienol-Adjuvanted Dendritic Cells Inhibit Tumor Growth and Metastasis: A Murine Model of Breast Cancer	PLOS ONE			English	Article							TOCOPHERYL SUCCINATE; EXPRESSION; VACCINES; RECEPTOR	Tocotrienol-rich fraction (TRF) from palm oil is reported to possess anti-cancer and immune-enhancing effects. In this study, TRF supplementation was used as an adjuvant to enhance the anti-cancer effects of dendritic cells (DC)-based cancer vaccine in a syngeneic mouse model of breast cancer. Female BALB/c mice were inoculated with 4T1 cells in mammary pad to induce tumor. When the tumor was palpable, the mice in the experimental groups were injected subcutaneously with DC-pulsed with tumor lysate (TL) from 4T1 cells (DC+TL) once a week for three weeks and fed daily with 1 mg TRF or vehicle. Control mice received unpulsed DC and were fed with vehicle. The combined therapy of using DC+TL injections and TRF supplementation (DC+TL+TRF) inhibited (p<0.05) tumor growth and metastasis. Splenocytes from the DC+TL+TRF group cultured with mitomycin-C (MMC)-treated 4T1 cells produced higher (p<0.05) levels of IFN-gamma and IL-12. The cytotoxic T-lymphocyte (CTL) assay also showed enhanced tumorspecific killing (p<0.05) by CD8(+) T-lymphocytes isolated from mice in the DC+TL+TRF group. This study shows that TRF has the potential to be used as an adjuvant to enhance effectiveness of DC-based vaccines.	[Hafid, Sitti Rahma Abdul; Chakravarthi, Srikumar; Radhakrishnan, Ammu Kutty] Int Med Univ, Div Pathol, Fac Med & Hlth, Kuala Lumpur 57000, Malaysia; [Hafid, Sitti Rahma Abdul; Nesaretnam, Kalanithi] Malaysian Palm Oil Board, Nutr Unit, Bandar Baru Bangi, Selangor, Malaysia	International Medical University Malaysia; Malaysian Palm Oil Board	Radhakrishnan, AK (corresponding author), Int Med Univ, Div Pathol, Fac Med & Hlth, Kuala Lumpur 57000, Malaysia.	ammu_radhakrishnan@imu.edu.my	Chakravarthi, Srikumar/AHB-7872-2022; Hafid, Sitti Rahma Abd/AAC-5198-2021; Radhakrishnan, Ammu Kutty/F-2877-2015	Chakravarthi, Srikumar/0000-0002-9888-3301; Radhakrishnan, Ammu Kutty/0000-0003-2638-907X; Abd Hafid, Sitti Rahma/0000-0002-1131-4617	International Medical University (IMU); Malaysian Palm Oil Board (MPOB)	International Medical University (IMU); Malaysian Palm Oil Board (MPOB)	This study was supported by a research grant from the International Medical University (IMU) and the Malaysian Palm Oil Board (MPOB). This work is part of the work that the first author did for her PhD, which is supported by the MPOB and IMU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brossart P, 1997, BLOOD, V90, P1594, DOI 10.1182/blood.V90.4.1594.1594_1594_1599; Choo YM, 2005, LIPIDS, V40, P429, DOI 10.1007/s11745-006-1400-6; Choo ZW, 2010, ONCOL LETT, V1, P215, DOI 10.3892/ol_00000039; Das S, 2008, AM J PHYSIOL-HEART C, V294, pH970, DOI 10.1152/ajpheart.01200.2007; Gatza E, 2002, J IMMUNOL, V169, P5227, DOI 10.4049/jimmunol.169.9.5227; Hafid SRA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-5; Herr W, 2000, BLOOD, V96, P1857, DOI 10.1182/blood.V96.5.1857.h8001857_1857_1864; Ingrid ED, 2005, J IMMUNOL, V174, P7506; Mihret Adane, 2011, BMC Res Notes, V4, P247, DOI 10.1186/1756-0500-4-247; Nagaraj S, 2004, INDIAN J MED RES, V119, P133; Nesaretnam K, 2004, LIPIDS, V39, P459, DOI 10.1007/s11745-004-1251-1; Nesaretnam K, 1998, LIPIDS, V33, P461, DOI 10.1007/s11745-998-0229-3; NESARETNAM K, 1995, LIPIDS, V30, P1139, DOI 10.1007/BF02536615; Nesaretnam K, 2000, PALM OILS DEV, V32; Porgador A, 1996, J IMMUNOL, V156, P2918; Puddu P, 1997, J IMMUNOL, V159, P3490; Radhakrishnan AK, 2012, BIORESEARCH OPEN ACC, V1, P239, DOI 10.1089/biores.2012.0229; Ramanathapuram LV, 2005, NUTR CANCER, V53, P177, DOI 10.1207/s15327914nc5302_7; Ramanathapuram LV, 2004, CANCER IMMUNOL IMMUN, V53, P580, DOI 10.1007/s00262-004-0499-7; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sato M, 2003, INT IMMUNOL, V15, P837, DOI 10.1093/intimm/dxg081; Schuler G, 1997, J EXP MED, V186, P1183, DOI 10.1084/jem.186.8.1183; Selvaduray KR, 2010, J INTERF CYTOK RES, V30, P909, DOI 10.1089/jir.2010.0021; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P2268, DOI 10.1073/pnas.96.5.2268; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; Steinman RM, 2001, INT J CANCER, V94, P459, DOI 10.1002/ijc.1503; Steinmann RM, 1999, ANNU REV IMMUNOL, V9, P271; Suzana M., 2005, EUR J SCI RES, V7, P41; Takahashi K, 2004, BIOCHEM PHARMACOL, V67, P315, DOI 10.1016/j.bcp.2003.07.015; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Weng-Yew W, 2009, NUTR CANCER, V61, P367, DOI 10.1080/01635580802582736; Wu RS, 2001, CANCER IMMUNOL IMMUN, V50, P229, DOI 10.1007/s002620100197; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200	35	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74753	10.1371/journal.pone.0074753	http://dx.doi.org/10.1371/journal.pone.0074753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069344	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300043
J	Pereira, HABD; Leite, AD; Charone, S; Lobo, JGVM; Cestari, TM; Peres-Buzalaf, C; Buzalaf, MAR				Barbosa da Silva Pereira, Heloisa Aparecida; Leite, Aline de Lima; Charone, Senda; Vaz Madureira Lobo, Janete Gualiume; Cestari, Tania Mary; Peres-Buzalaf, Camila; Rabelo Buzalaf, Marilia Afonso			Proteomic Analysis of Liver in Rats Chronically Exposed to Fluoride	PLOS ONE			English	Article							INDUCED APOPTOSIS; SODIUM-FLUORIDE; PROTEINS; STRESS; TRANSLATION; PEROXISOMES; PHOSPHATASE; INHIBITION; METABOLISM; ACTIVATION	Fluoride (F) is a potent anti-cariogenic element, but when ingestion is excessive, systemic toxicity may be observed. This can occur as acute or chronic responses, depending on both the amount of F and the time of exposure. The present study identified the profile of protein expression possibly associated with F-induced chronic hepatotoxicity. Weanling male Wistar rats (three-weeks old) were divided into three groups and treated with drinking water containing 0, 5 or 50 mg/L F for 60 days (n=6/group). At this time point, serum and livers were collected for F analysis, which was done using the ion-sensitive electrode, after hexamethyldisiloxane-facilitated diffusion. Livers were also submitted to histological and proteomic analyses (2D-PAGE followed by LC-MS/MS). Western blotting was done for confirmation of the proteomic data A dose-response was observed in serum F levels. In the livers, F levels were significantly increased in the 50 mg/L F group compared to groups treated with 0 and 5 mg/L F. Liver morphometric analysis did not reveal alterations in the cellular structures and lipid droplets were present in all groups. Proteomic quantitative intensity analysis detected 33, 44, and 29 spots differentially expressed in the comparisons between control vs. 5 mg/L F, control vs. 50 mg/L F, and 5 mg/L vs. 50 mg/L F, respectively. From these, 92 proteins were successfully identified. In addition, 18, 1, and 5 protein spots were shown to be exclusive in control, 5, and 50 mg/L F, respectively. Most of proteins were related to metabolic process and pronounced alterations were seen for the high-F level group. In F-treated rats, changes in the apolipoprotein E (ApoE) and GRP-78 expression may account for the F-induced toxicity in the liver. This can contribute to understanding the molecular mechanisms underlying hepatoxicity induced by F, by indicating key-proteins that should be better addressed in future studies.	[Barbosa da Silva Pereira, Heloisa Aparecida; Leite, Aline de Lima; Charone, Senda; Vaz Madureira Lobo, Janete Gualiume; Cestari, Tania Mary; Peres-Buzalaf, Camila; Rabelo Buzalaf, Marilia Afonso] Univ Sao Paulo, Dept Biol Sci, Bauru Dent Sch, Sao Paulo, Brazil	Universidade de Sao Paulo	Buzalaf, MAR (corresponding author), Univ Sao Paulo, Dept Biol Sci, Bauru Dent Sch, Sao Paulo, Brazil.	mbuzalaf@fob.usp.br	Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Heloisa Aparecida Barbosa da Silva, Pereira/M-1766-2013; Charone, Senda SC/D-1218-2017; Peres-Buzalaf, Camila/C-5109-2012; Charone, Senda/J-8393-2013; Cestari, Tania Mary/E-7060-2012; Leite, Aline/J-9748-2012; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021	Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Heloisa Aparecida Barbosa da Silva, Pereira/0000-0002-1839-2546; Charone, Senda/0000-0002-9713-8676; Cestari, Tania Mary/0000-0003-1287-5974; Leite, Aline/0000-0002-2112-1309; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951	Sao Paulo State Support Foundation (FAPESP) [2008/07263-9, 2009/06892-5]	Sao Paulo State Support Foundation (FAPESP)	This work was supported by Sao Paulo State Support Foundation (FAPESP) (grants 2008/07263-9 and 2009/06892-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; BAYKOV AA, 1992, ARCH BIOCHEM BIOPHYS, V294, P238, DOI 10.1016/0003-9861(92)90163-Q; BEKTAS M, 1994, FEBS LETT, V356, P89, DOI 10.1016/0014-5793(94)01239-3; Bonomini F, 2010, EXP GERONTOL, V45, P149, DOI 10.1016/j.exger.2009.11.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chattopadhyay A, 2011, ARCH TOXICOL, V85, P327, DOI 10.1007/s00204-010-0588-7; Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952; Cheng TJ, 1998, J CELL BIOCHEM, V69, P221, DOI 10.1002/(SICI)1097-4644(19980501)69:2<221::AID-JCB12>3.0.CO;2-H; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; Dabrowska E, 2006, Adv Med Sci, V51 Suppl 1, P91; DUNIPACE AJ, 1995, J DENT RES, V74, P358, DOI 10.1177/00220345950740011201; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Gangwani L, 1998, J CELL BIOL, V143, P1471, DOI 10.1083/jcb.143.6.1471; Ge YM, 2011, ARCH TOXICOL, V85, P27, DOI 10.1007/s00204-010-0537-5; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Ikemoto M, 2001, CLIN CHEM, V47, P946; JANCKILA AJ, 1992, LEUKEMIA, V6, P199; Jo H, 2013, HEPATOLOGY; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Keller ET, 2004, BIOCHEM PHARMACOL, V68, P1049, DOI 10.1016/j.bcp.2004.04.024; Kobayashi CAN, 2009, CHEM-BIOL INTERACT, V180, P305, DOI 10.1016/j.cbi.2009.03.009; Kubota K, 2005, J BIOL CHEM, V280, P23194, DOI 10.1074/jbc.M503288200; Lee JH, 2008, TOXICOLOGY, V243, P340, DOI 10.1016/j.tox.2007.10.026; McDonagh MS, 2000, BRIT MED J, V321, P855, DOI 10.1136/bmj.321.7265.855; Moura LP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-2; MULLENIX PJ, 1995, NEUROTOXICOL TERATOL, V17, P169, DOI 10.1016/0892-0362(94)00070-T; Nelson DLC, 2002, LEHNINGER PRINCIPLES, P975; Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001; Pinkse MWH, 1999, BIOCHEMISTRY-US, V38, P9926, DOI 10.1021/bi990446w; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Refsnes M, 2003, HUM EXP TOXICOL, V22, P111, DOI 10.1191/0960327103ht322oa; Refsnes M, 2001, TOXICOLOGY, V167, P145, DOI 10.1016/S0300-483X(01)00448-6; Rison Stuart C. G., 2000, Functional and Integrative Genomics, V1, P56; Shanthakumari D, 2004, TOXICOLOGY, V204, P219, DOI 10.1016/j.tox.2004.06.058; Strunecka A, 2007, CURR SIGNAL TRANSD T, V2, P190, DOI 10.2174/157436207781745300; TAVES DR, 1968, TALANTA, V15, P969, DOI 10.1016/0039-9140(68)80097-9; Thomas AB, 1996, J CLIN ENDOCR METAB, V81, P2570, DOI 10.1210/jc.81.7.2570; Thongboonkerd V, 2004, CONTRIB NEPHROL, V141, P11; Tucci S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045429; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang HQ, 2009, FEBS LETT, V583, P1511, DOI 10.1016/j.febslet.2009.04.009; Wang Y, 2005, PROTEOMICS, V5, P4496, DOI 10.1002/pmic.200401317; Warburg O, 1941, BIOCH Z, V37; Whitford GM, 1996, MONOGR ORAL SCI, V16, P1; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Wong MCM, 2011, J DENT RES, V90, P573, DOI 10.1177/0022034510393346; WOODEN SK, 1991, MOL CELL BIOL, V11, P5612, DOI 10.1128/MCB.11.11.5612; Xu H, 2005, TOXICOL LETT, V160, P69, DOI 10.1016/j.toxlet.2005.06.009; Xu H, 2008, BIOL TRACE ELEM RES, V123, P91, DOI 10.1007/s12011-007-8086-3; Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709; Zhan XA, 2006, J TRACE ELEM MED BIO, V20, P83, DOI 10.1016/j.jtemb.2005.11.003	55	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75343	10.1371/journal.pone.0075343	http://dx.doi.org/10.1371/journal.pone.0075343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069403	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300080
J	Chabbi-Achengli, Y; Launay, JM; Maroteaux, L; de Vernejoul, MC; Collet, C				Chabbi-Achengli, Yasmine; Launay, Jean-Marie; Maroteaux, Luc; de Vernejoul, Marie Christine; Collet, Corinne			Serotonin 2B Receptor (5-HT2B R) Signals through Prostacyclin and PPAR-beta/delta in Osteoblasts	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; DEFICIENT MICE; BONE MASS; ACTIVATION; EXPRESSION; DIFFERENTIATION; QUANTIFICATION; RECRUITMENT; INVOLVEMENT; SURVIVAL	Osteoporosis is due to an imbalance between decreased bone formation by osteoblasts and increased resorption by osteoclasts. Deciphering factors controlling bone formation is therefore of utmost importance for the understanding and the treatment of osteoporosis. Our previous in vivo results showed that bone formation is reduced in the absence of the serotonin receptor 5-HT2B, causing impaired osteoblast proliferation, recruitment, and matrix mineralization. In this study, we investigated the signaling pathways responsible for the osteoblast defect in 5-HT2BR-/- mice. Notably, we investigated the phospholipase A2 pathway and synthesis of eicosanoids in 5-HT2BR-/- compared to wild type (WT) osteoblasts. Compared to control osteoblasts, the lack of 5-HT2B receptors was only associated with a 10-fold over-production of prostacyclin (PGI(2)). Also, a specific prostacyclin synthase inhibitor (U51605) rescued totally osteoblast aggregation and matrix mineralization in the 5-HT2BR-/- osteoblasts without having any effect on WT osteoblasts. Prostacyclin is the endogenous ligand of the nuclear peroxisome proliferator activated receptor beta/delta (PPAR-beta/delta), and its inhibition in 5-HT2BR-/- cells rescued totally the alkaline phosphatase and osteopontin mRNA levels, cell-cell adhesion, and matrix mineralization. We conclude that the absence of 5-HT2B receptors leads to the overproduction of prostacyclin, inducing reduced osteoblast differentiation due to PPAR-beta/delta -dependent target regulation and defective cell-cell adhesion and matrix mineralization. This study thus reveals a previously unrecognized cell autonomous osteoblast defect in the absence of 5-HT2BR and highlights a new pathway linking 5-HT2B receptors and nuclear PPAR-beta/delta via prostacyclin.	[Chabbi-Achengli, Yasmine; de Vernejoul, Marie Christine; Collet, Corinne] Hop Lariboisiere, INSERM, UMR606, F-75475 Paris, France; [Chabbi-Achengli, Yasmine; de Vernejoul, Marie Christine] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Launay, Jean-Marie; Collet, Corinne] Hop Lariboisiere, Serv Biochim, F-75475 Paris, France; [Launay, Jean-Marie] Hop Lariboisiere, INSERM, U942, F-75475 Paris, France; [Maroteaux, Luc] Inst Fer Moulin, INSERM, UMR S839, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Collet, C (corresponding author), Hop Lariboisiere, INSERM, UMR606, F-75475 Paris, France.	corinne.collet@lrb.aphp.fr	Maroteaux, Luc/H-4585-2019	Maroteaux, Luc/0000-0002-9499-8603; collet, corinne/0000-0001-6990-863X	Ministere Superieur de l'Enseignement et de la Recherche; ECTS SERVIER grant; Fondation Pour La Recherche Medicale Subventions; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie; Fondation de France; Fondation pour la Recherche Medicale; European Union (DEVANX)	Ministere Superieur de l'Enseignement et de la Recherche; ECTS SERVIER grant; Fondation Pour La Recherche Medicale Subventions; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie; Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union (DEVANX)	YCA was the recipient of a fellowship from the Ministere Superieur de l'Enseignement et de la Recherche. CC was supported by an ECTS SERVIER 2012 grant. MCdV was supported by the Fondation Pour La Recherche Medicale Subventions. LM was supported by funds from the Centre National de la Recherche Scientifique, the Institut National de la Sante et de la Recherche Medicale, the Universite Pierre et Marie Curie, and by grants from the Fondation de France, the Fondation pour la Recherche Medicale, and the European Union (DEVANX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault P, 2011, P NATL ACAD SCI USA, V108, P13141, DOI 10.1073/pnas.1103964108; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Bley KR, 2006, BRIT J PHARMACOL, V147, P335, DOI 10.1038/sj.bjp.0706554; Bliziotes MM, 2001, BONE, V29, P477, DOI 10.1016/S8756-3282(01)00593-2; Cao H, 2008, ANAL BIOCHEM, V372, P41, DOI 10.1016/j.ab.2007.08.041; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Collet C, 2008, FASEB J, V22, P418, DOI 10.1096/fj.07-9209com; DANIEL VC, 1994, J CHROMATOGR B, V653, P117, DOI 10.1016/0378-4347(93)E0432-P; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Hertz R, 1996, EUR J BIOCHEM, V235, P242, DOI 10.1111/j.1432-1033.1996.00242.x; Jackson SM, 2000, FEBS LETT, V471, P119, DOI 10.1016/S0014-5793(00)01372-7; Jaffre F, 2004, CIRCULATION, V110, P969, DOI 10.1161/01.CIR.0000139856.20505.57; Launay JM, 2012, BLOOD, V119, P1772, DOI 10.1182/blood-2011-06-358374; Launay JM, 2002, NAT MED, V8, P1129, DOI 10.1038/nm764; Launay JM, 1996, J BIOL CHEM, V271, P3141, DOI 10.1074/jbc.271.6.3141; Launay JM, 2005, 5 HYDROXYTRYPTAMINE; Lecka-Czernik Beata, 2010, Curr Osteoporos Rep, V8, P84, DOI 10.1007/s11914-010-0016-1; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Locker M, 2006, CELL SIGNAL, V18, P628, DOI 10.1016/j.cellsig.2005.06.006; Manivet P, 2000, J BIOL CHEM, V275, P9324, DOI 10.1074/jbc.275.13.9324; Maurin AC, 2005, CALCIFIED TISSUE INT, V76, P385, DOI 10.1007/s00223-004-0108-y; Merciris D, 2007, AM J PATHOL, V170, P1676, DOI 10.2353/ajpath.2007.061069; Muller R, 2008, PPAR RES, V2008, DOI 10.1155/2008/614852; Nakalekha C, 2010, J ENDOCRINOL, V204, P125, DOI 10.1677/JOE-09-0376; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Nebigil CG, 2003, FASEB J, V17, P1373, DOI 10.1096/fj.02-1122fje; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P2591, DOI 10.1073/pnas.050282397; Nebigil CG, 2001, CIRCULATION, V103, P2973, DOI 10.1161/01.CIR.103.24.2973; Piqueras L, 2009, J LEUKOCYTE BIOL, V86, P115, DOI [10.1189/jlb.0508284, 10.1189/JLB.0508284]; ROBIN JC, 1982, RES COMMUN CHEM PATH, V35, P43; Rosenblum WD, 2010, CARDIOL REV, V18, P58, DOI 10.1097/CRD.0b013e3181cd2c9e; Scholtysek C, 2013, NAT MED, V19, P608, DOI 10.1038/nm.3146; Tuncbilek G, 2008, J CRANIOFAC SURG, V19, P1472, DOI 10.1097/SCS.0b013e318188a31b; Wainscott DB, 1996, J PHARMACOL EXP THER, V276, P720; Westbroek I, 2001, J BIOL CHEM, V276, P28961, DOI 10.1074/jbc.M101824200; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zou MH, 2011, AM J PATHOL, V179, P2835, DOI 10.1016/j.ajpath.2011.08.041	40	11	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75783	10.1371/journal.pone.0075783	http://dx.doi.org/10.1371/journal.pone.0075783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069449	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300095
J	Chen, JJ; Patel, A; Sodani, K; Xiao, ZJ; Tiwari, AK; Zhang, DM; Li, YJ; Yang, DH; Ye, WC; Chen, SD; Chen, ZS				Chen, Jun-Jiang; Patel, Atish; Sodani, Kamlesh; Xiao, Zhi-Jie; Tiwari, Amit K.; Zhang, Dong-Mei; Li, Ying-Jie; Yang, Dong-Hua; Ye, Wen-Cai; Chen, Si-Dong; Chen, Zhe-Sheng			BBA, a Synthetic Derivative of 23-hydroxybutulinic Acid, Reverses Multidrug Resistance by Inhibiting the Efflux Activity of MRP7 (ABCC10)	PLOS ONE			English	Article							CASSETTE DRUG TRANSPORTERS; CHINENSIS BUNGE REGEL; CELL LUNG-CANCER; 23-HYDROXYBETULINIC ACID; IN-VIVO; PROTEIN-7 ABCC10; CHEMOTHERAPY; EXPRESSION; ABCB1; VITRO	Natural products are frequently used for adjuvant chemotherapy in cancer treatment. 23-O-(1,4'-bipiperidine-1-carbonyl) betulinic acid (BBA) is a synthetic derivative of 23-hydroxybutulinic acid (23-HBA), which is a natural pentacyclic triterpene and the major active constituent of the root of Pulsatilla chinensis. We previously reported that BBA could reverse P-glycoprotein (P-gp/ABCB1)-mediated multidrug resistance (MDR). In the present study, we investigated whether BBA has the potential to reverse multidrug resistance protein 7 (MRP7/ABCC10)-mediated MDR. We found that BBA concentration-dependently enhanced the sensitivity of MRP7-transfected HEK293 cells to paclitaxel, docetaxel and vinblastine. Accumulation and efflux experiments demonstrated that BBA increased the intracellular accumulation of [H-3]-paclitaxel by inhibiting the efflux of [H-3]-paclitaxel from HEK293/MRP7 cells. In addition, immunoblotting and immunofluorescence analyses indicated no significant alteration of MRP7 protein expression and localization in plasma membranes after treatment with BBA. These results demonstrate that BBA reverses MRP7-mediated MDR through blocking the drug efflux function of MRP7 without affecting the intracellular ATP levels. Our findings suggest that BBA has the potential to be used in combination with conventional chemotherapeutic agents to augment the response to chemotherapy.	[Chen, Jun-Jiang; Chen, Si-Dong] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Chen, Jun-Jiang; Patel, Atish; Sodani, Kamlesh; Xiao, Zhi-Jie; Tiwari, Amit K.; Chen, Zhe-Sheng] St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY USA; [Zhang, Dong-Mei; Li, Ying-Jie; Ye, Wen-Cai] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Yang, Dong-Hua] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Guangdong Pharmaceutical University; Saint John's University; Jinan University; Fox Chase Cancer Center	Chen, SD (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China.	sdchen2@126.com; chenz@stjohns.edu	; Patel, Atish/J-4699-2014	Sodani, Kamlesh/0000-0003-4488-2984; Chen, Zhe-Sheng/0000-0002-8289-097X; Tiwari, Amit/0000-0002-0275-0724; TIWARI, AMIT K./0000-0002-7427-7155; Patel, Atish/0000-0002-5549-9166	National Institutes of Health [1R15CA143701]; Science and Technology Bureau of Guangzhou City [2011J5200017]; NATIONAL CANCER INSTITUTE [R15CA143701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science and Technology Bureau of Guangzhou City; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health (No. 1R15CA143701 to Z. S. C.) and Science and Technology Bureau of Guangzhou City (No. 2011J5200017 to S. D. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2001, JPN J CANCER RES, V92, P886, DOI 10.1111/j.1349-7006.2001.tb01177.x; Batrakova EV, 2001, BRIT J CANCER, V85, P1987, DOI 10.1054/bjoc.2001.2165; Bessho Y, 2009, ONCOL REP, V21, P263, DOI 10.3892/or_00000217; Borel F, 2012, HEPATOLOGY, V55, P821, DOI 10.1002/hep.24682; Chen JJ, 2012, CANCER SCI, V103, P1531, DOI 10.1111/j.1349-7006.2012.02328.x; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Chen ZS, 2003, MOL PHARMACOL, V63, P351, DOI 10.1124/mol.63.2.351; Cheng L, 2008, RAPID COMMUN MASS SP, V22, P3783, DOI 10.1002/rcm.3801; Coley HM, 2010, METHODS MOL BIOL, V596, P341, DOI 10.1007/978-1-60761-416-6_15; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Ding PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019329; Floridi A, 1998, BIOCHEM PHARMACOL, V56, P841, DOI 10.1016/S0006-2952(98)00054-9; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Hopper E, 2001, CANCER LETT, V162, P181, DOI 10.1016/S0304-3835(00)00646-7; Hopper-Borge E, 2004, CANCER RES, V64, P4927, DOI 10.1158/0008-5472.CAN-03-3111; Hopper-Borge E, 2009, CANCER RES, V69, P178, DOI 10.1158/0008-5472.CAN-08-1420; Hopper-Borge EA, 2011, CANCER RES, V71, P3649, DOI 10.1158/0008-5472.CAN-10-3623; Kruh GD, 2007, PFLUG ARCH EUR J PHY, V453, P675, DOI 10.1007/s00424-006-0114-1; Kuang YH, 2010, BIOCHEM PHARMACOL, V79, P154, DOI 10.1016/j.bcp.2009.08.021; Lan P, 2011, EUR J MED CHEM, V46, P2490, DOI 10.1016/j.ejmech.2011.03.038; Lee CH, 2010, METHODS MOL BIOL, V596, P325, DOI 10.1007/978-1-60761-416-6_14; Naramoto H, 2007, INT J ONCOL, V30, P393; Oguri T, 2008, MOL CANCER THER, V7, P1150, DOI 10.1158/1535-7163.MCT-07-2088; Pushpakom SP, 2011, J INFECT DIS, V204, P145, DOI 10.1093/infdis/jir215; Qi FH, 2010, BIOSCI TRENDS, V4, P297; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schmidt C, 2008, J NATL CANCER I, V100, P1428, DOI 10.1093/jnci/djn375; Shi Z, 2006, CANCER BIOL THER, V5, P39, DOI 10.4161/cbt.5.1.2236; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, BIOCHEM PHARMACOL, V77, P781, DOI 10.1016/j.bcp.2008.11.007; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Shukla S, 2008, EXPERT OPIN DRUG MET, V4, P205, DOI 10.1517/17425255.4.2.205; Sissung TM, 2010, MOL BIOTECHNOL, V44, P152, DOI 10.1007/s12033-009-9220-6; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Takayanagi Shin-Ichiro, 2004, J Exp Ther Oncol, V4, P239; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Yang M, 2005, RAPID COMMUN MASS SP, V19, P1619, DOI 10.1002/rcm.1961; Zhang DM, 2012, MOL PHARMACEUT, V9, P3147, DOI 10.1021/mp300249s; Zheng YT, 2010, J ETHNOPHARMACOL, V128, P615, DOI 10.1016/j.jep.2010.02.004; Zhou Y, 2009, BIOCHEM PHARMACOL, V77, P993, DOI 10.1016/j.bcp.2008.12.005; Zhou YF, 2012, CANCER RES, V72, P304, DOI 10.1158/0008-5472.CAN-11-1674	48	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74573	10.1371/journal.pone.0074573	http://dx.doi.org/10.1371/journal.pone.0074573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069321	gold, Green Submitted, Green Published			2022-12-27	WOS:000324547300045
J	Kahraman, A; Herzog, F; Leitner, A; Rosenberger, G; Aebersold, R; Malmstrom, L				Kahraman, Abdullah; Herzog, Franz; Leitner, Alexander; Rosenberger, George; Aebersold, Ruedi; Malmstroem, Lars			Cross-Link Guided Molecular Modeling with ROSETTA	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; MASS-SPECTROMETRY; BINDING POCKETS; PHOSPHATASE 2A; 26S PROTEASOME; PEPTIDES; IDENTIFICATION; PREDICTION; CHAPERONIN; DISTANCES	Chemical cross-links identified by mass spectrometry generate distance restraints that reveal low-resolution structural information on proteins and protein complexes. The technology to reliably generate such data has become mature and robust enough to shift the focus to the question of how these distance restraints can be best integrated into molecular modeling calculations. Here, we introduce three workflows for incorporating distance restraints generated by chemical cross-linking and mass spectrometry into ROSETTA protocols for comparative and de novo modeling and protein-protein docking. We demonstrate that the cross-link validation and visualization software Xwalk facilitates successful cross-link data integration. Besides the protocols we introduce XLdb, a database of chemical cross-links from 14 different publications with 506 intra-protein and 62 inter-protein cross-links, where each cross-link can be mapped on an experimental structure from the Protein Data Bank. Finally, we demonstrate on a protein-protein docking reference data set the impact of virtual cross-links on protein docking calculations and show that an inter-protein cross-link can reduce on average the RMSD of a docking prediction by 5.0 angstrom. The methods and results presented here provide guidelines for the effective integration of chemical cross-link data in molecular modeling calculations and should advance the structural analysis of particularly large and transient protein complexes via hybrid structural biology methods.	[Kahraman, Abdullah; Leitner, Alexander; Rosenberger, George; Aebersold, Ruedi; Malmstroem, Lars] ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland; [Herzog, Franz] Univ Munich, Gene Ctr, Munich, Germany; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; University of Zurich	Malmstrom, L (corresponding author), ETH, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland.	lars@imsb.biol.ethz.ch	Leitner, Alexander/U-1601-2019; Malmström, Lars/R-4991-2019; Herzog, Franz/G-4832-2012; Rosenberger, George/C-1412-2017; Rosenberger, George/S-7458-2019	Leitner, Alexander/0000-0003-4126-0725; Malmström, Lars/0000-0001-9885-9312; Herzog, Franz/0000-0001-8270-1449; Rosenberger, George/0000-0002-1655-6789; Kahraman, Abdullah/0000-0003-3523-4467	ETH Zurich; Commission of the European Communities through the PROSPETS consortium (EU FP7) [201648, 233226]; SystemsX.ch - The Swiss Initiative for Systems Biology	ETH Zurich(ETH Zurich); Commission of the European Communities through the PROSPETS consortium (EU FP7); SystemsX.ch - The Swiss Initiative for Systems Biology	This project was funded in part by ETH Zurich, the Commission of the European Communities through the PROSPETS consortium (EU FP7 projects 201648, 233226) and by SystemsX.ch - The Swiss Initiative for Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER EN, 1991, INT J BIOL MACROMOL, V13, P122, DOI 10.1016/0141-8130(91)90036-T; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blattner C, 2011, GENE DEV, V25, P2093, DOI 10.1101/gad.17363311; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Edwards A, 2009, ANNU REV BIOCHEM, V78, P541, DOI 10.1146/annurev.biochem.78.070907.103305; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hubbard S. J., 1993, NACCESS; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Kahraman A, 2011, BIOINFORMATICS, V27, P2163, DOI 10.1093/bioinformatics/btr348; Kahraman A, 2010, PROTEINS, V78, P1120, DOI 10.1002/prot.22633; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Luo J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.008318; Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544; Mayne SLN, 2011, BRIEF BIOINFORM, V12, P660, DOI 10.1093/bib/bbq087; Mosca R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000490; Paramelle D, 2013, PROTEOMICS, V13, P438, DOI 10.1002/pmic.201200305; Potluri S, 2004, Pac Symp Biocomput, P447; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; R Core Team, 2021, R LANGUAGE ENV STAT; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Shih ESC, 2012, PROTEINS, V80, P194, DOI 10.1002/prot.23179; Soding J, 2005, NUCL ACIDS RES; Trnka MJ, 2010, MOL CELL PROTEOMICS, V9, P2306, DOI 10.1074/mcp.M110.003764; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zelter A, 2010, J PROTEOME RES, V9, P3583, DOI 10.1021/pr1001115; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zheng CX, 2013, J PROTEOME RES, V12, P1989, DOI 10.1021/pr301162j	43	112	114	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73411	10.1371/journal.pone.0073411	http://dx.doi.org/10.1371/journal.pone.0073411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069194	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300010
J	Kozak, I; Sasik, R; Freeman, WR; Sprague, LJ; Gomez, ML; Cheng, LY; El-Emam, S; Mojana, F; Bartsch, DU; Bosten, J; Ayyagari, R; Hardiman, G				Kozak, Igor; Sasik, Roman; Freeman, William R.; Sprague, L. James; Gomez, Maria Laura; Cheng, Lingyun; El-Emam, Sharif; Mojana, Francesca; Bartsch, Dirk-Uwe; Bosten, Jenny; Ayyagari, Radha; Hardiman, Gary			A Degenerative Retinal Process in HIV-Associated Non-Infectious Retinopathy	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR OUTER SEGMENTS; OBJECTIVE ANALYSIS; POSITIVE PATIENTS; UNITED-STATES; MOUSE MODEL; HAART ERA; DYSTROPHY; CALCIUM	HIV retinopathy is the most common non-infectious complication in the eyes of HIV-positive individuals. Oncotic lesions in the retinal nerve fiber layer, referred to as cotton wool spots (CWS), and intraretinal (IR) hemorrhages are frequently observed but are not unique to this pathology. HIV-positive patients have impaired color vision and contrast sensitivity, which worsens with age. Evidence of inner-retinal lesions and damage have been documented ophthalmoscopically, however their long term structural effect has not been investigated. It has been hypothesized that they may be partially responsible for loss of visual function and visual field. In this study we utilized clinical data, retinal imaging and transcriptomics approaches to comprehensively interrogate non-infectious HIV retinopathy. The methods employed encompassed clinical examinations, fundus photography, indirect ophthalmoscopy, Farmsworth-Munsell 100 hue discrimination testing and Illumina BeadChip analyses. Here we show that changes in the outer retina, specifically in the retinal pigment epithelium (RPE) and photoreceptor outer segments (POS) contribute to vision changes in non-infectious HIV retinopathy. We find that in HIV-positive retinae there is an induction of rhodopsin and other transcripts (including PDE6A, PDE6B, PDE6G, CNGA1, CNGB1, CRX, NRL) involved in visual transduction, as well as structural components of the rod photoreceptors (ABCA4 and ROM1). This is consistent with an increased rate of renewal of rod outer segments induced via increased phagocytosis by HIV-infected RPE previously reported in culture. Cone-specific transcripts (OPN1SW, OPN1LW, PDE6C, PDE6H and GRK7) are uniformly downregulated in HIV positive retina, likely due to a partial loss of cone photoreceptors. Active cotton wool spots and intraretinal hemorrhages (IRH) may not affect photoreceptors directly and the interaction of photoreceptors with the aging RPE may be the key to the progressive vision changes in HIV-positive patients.	[Kozak, Igor; Freeman, William R.; Gomez, Maria Laura; Cheng, Lingyun; El-Emam, Sharif; Mojana, Francesca; Bartsch, Dirk-Uwe; Ayyagari, Radha] Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Ctr, Jacobs Retina Ctr, La Jolla, CA 92093 USA; [Sasik, Roman; Hardiman, Gary] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Sasik, Roman; Sprague, L. James; Hardiman, Gary] Univ Calif San Diego, Sch Med, BIOGEM, La Jolla, CA 92093 USA; [Bosten, Jenny] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Hardiman, Gary] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Hardiman, Gary] San Diego State Univ, Biomed Informat Res Ctr, San Diego, CA 92182 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University	Freeman, WR (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Shiley Eye Ctr, Jacobs Retina Ctr, La Jolla, CA 92093 USA.	wrfreeman@ucsd.edu; gthardiman@ucsd.edu	Kozak, Igor/AAC-4645-2019; Bosten, Jenny/AAB-1559-2019; Emam, Sharif El/AAA-6627-2020; Bosten, Jenny M/N-6211-2015	Bosten, Jenny/0000-0001-8944-0990; Emam, Sharif El/0000-0001-6357-0471; Bosten, Jenny M/0000-0001-8944-0990; Hardiman, Gary/0000-0003-4558-0400	National Eye Institute (NEI) National Institutes of Health (NIH)-NEI [EY16323]; NIH [EY07366, DK063491, CA023100, DK080506]; Research to Prevent Blindness, New York City, New York; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007366, P30EY022589, R01EY016323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R24DK080506] Funding Source: NIH RePORTER	National Eye Institute (NEI) National Institutes of Health (NIH)-NEI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, New York City, New York; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Eye Institute (NEI) National Institutes of Health (NIH)-NEI grant EY16323 (DUB), NIH grant #EY07366 (WRF), Research to Prevent Blindness, New York City, New York (WRF is the recipient of an RPB Physician Scientist award and an unrestricted grant to University of California San Diego (UCSD)), and unrestricted grants to the UCSD Jacobs Retina Center. GH gratefully acknowledge support from NIH grants DK063491, CA023100 and DK080506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman TS, 2009, INVEST OPHTH VIS SCI, V50, P5944, DOI 10.1167/iovs.09-3982; Baker ME, 2009, ENVIRON HEALTH PERSP, V117, P223, DOI 10.1289/ehp.11627; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booij Judith C, 2010, PLoS One, V5, pe9341, DOI 10.1371/journal.pone.0009341; Bugrim A, 2004, DRUG DISCOV TODAY, V9, P127, DOI 10.1016/S1359-6446(03)02971-4; Campsmith ML, 2010, JAIDS-J ACQ IMM DEF, V53, P619, DOI 10.1097/QAI.0b013e3181bf1c45; Canki M, 2000, AIDS RES HUM RETROV, V16, P453, DOI 10.1089/088922200309115; Chang B, 2008, HUM MOL GENET, V17, P3929, DOI 10.1093/hmg/ddn295; Chavali VRM, 2011, HUM MOL GENET, V20, P2000, DOI 10.1093/hmg/ddr080; DERETIC D, 1994, J BIOL CHEM, V269, P16853; Eichhoff G, 2008, EUR J NUCL MED MOL I, V35, pS99, DOI 10.1007/s00259-007-0709-6; EISENFELD AJ, 1984, J COMP NEUROL, V223, P22, DOI 10.1002/cne.902230103; Esumi N, 2009, HUM MOL GENET, V18, P128, DOI 10.1093/hmg/ddn323; Falkenstein IA, 2008, AM J OPHTHALMOL, V146, P579, DOI 10.1016/j.ajo.2007.12.021; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Fliesler SJ, 2010, ADV EXP MED BIOL, V664, P481, DOI 10.1007/978-1-4419-1399-9_55; FREEMAN WR, 1984, AM J OPHTHALMOL, V97, P133, DOI 10.1016/S0002-9394(14)76082-9; Fulton AB, 1999, INVEST OPHTH VIS SCI, V40, P1878; Goldbaum Michael H, 2008, Trans Am Ophthalmol Soc, V106, P196; Goldberg DE, 2005, RETINA-J RET VIT DIS, V25, P633, DOI 10.1097/00006982-200507000-00015; Gomez ML, 2009, OPHTHALMOLOGY, V116, P2407, DOI 10.1016/j.ophtha.2009.05.012; Hering L, 2012, MOL BIOL EVOL, V29, P3451, DOI 10.1093/molbev/mss148; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Kozak I, 2005, AM J OPHTHALMOL, V139, P295, DOI 10.1016/j.ajo.2004.09.039; Kozak I, 2010, RETINA, V30, P910; Kozak Igor, 2007, Trans Am Ophthalmol Soc, V105, P111; Kozak I, 2007, OPHTHALMOLOGY, V114, P537, DOI 10.1016/j.ophtha.2006.06.054; Krizaj D, 2012, ADV EXP MED BIOL, V740, P873, DOI 10.1007/978-94-007-2888-2_39; Lansky A, 2010, JAIDS-J ACQ IMM DEF, V55, pS64, DOI 10.1097/QAI.0b013e3181fbbe15; Mayer KH, 2010, CLIN INFECT DIS, V50, pS67, DOI 10.1086/651475; MCLEOD D, 1981, J ROY SOC MED, V74, P682, DOI 10.1177/014107688107400912; Meila M, 2003, LECT NOTES ARTIF INT, V2777, P173, DOI 10.1007/978-3-540-45167-9_14; Moschos MM, 2007, OCUL IMMUNOL INFLAMM, V15, P319, DOI 10.1080/09273940701375154; NEWMAN NM, 1987, BRIT J OPHTHALMOL, V71, P21, DOI 10.1136/bjo.71.1.21; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Roy SS, 2008, METHODS, V46, P213, DOI 10.1016/j.ymeth.2008.09.024; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Shah KH, 2006, AM J OPHTHALMOL, V142, P284, DOI 10.1016/j.ajo.2006.03.046; Strettoi E, 2002, J NEUROSCI, V22, P5492; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson DA, 2002, AM J HUM GENET, V70, P224, DOI 10.1086/338455; Toescu EC, 2007, AGING CELL, V6, P267, DOI 10.1111/j.1474-9726.2007.00296.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VillegasPerez MP, 1996, NEUROREPORT, V7, P1995, DOI 10.1097/00001756-199608120-00028; Vogt SD, 2011, EXP EYE RES, V93, P413, DOI 10.1016/j.exer.2011.06.002; Werner JS, 2011, EYE, V25, P279, DOI 10.1038/eye.2010.218; Zhang L, 2011, EYE, V25, P519, DOI 10.1038/eye.2011.7	48	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74712	10.1371/journal.pone.0074712	http://dx.doi.org/10.1371/journal.pone.0074712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069333	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000324547300051
J	Theobaldo, MC; Llimona, F; Petroni, RC; Rios, ECS; Velasco, IT; Soriano, FG				Theobaldo, Mariana Cardillo; Llimona, Flavia; Petroni, Ricardo Costa; Rios, Ester Correia Sarmento; Velasco, Irineu Tadeu; Soriano, Francisco Garcia			Hypertonic Saline Solution Drives Neutrophil from Bystander Organ to Infectious Site in Polymicrobial Sepsis: A Cecal Ligation and Puncture Model	PLOS ONE			English	Article							SEVERE HEMORRHAGIC-SHOCK; SEPTIC SHOCK; RESUSCITATION; MORTALITY; EPIDEMIOLOGY; PATHOGENESIS; PERITONITIS; RECRUITMENT; STRATEGIES; CLEARANCE	The effects of hypertonic saline solution (HSS) have been shown in several animal models of ischemia and shock. Literature has shown potential benefits of HSS modulating inflammatory response after sepsis in an animal model. We studied the HSS effects in sepsis through cecal ligation and puncture (CLP) in Balb-C mice. Groups studied: 1-CLP without treatment (CLP-C); 2-CLP treated with normal saline solution NaCl 0.9% - 34 ml/Kg (CLP-S); 3-CLP treated with HSS NaCl 7.5% - 4 ml/Kg (CLPH); and 4-group (Basal) without no CLP or treatment. Volume infusion was always applied 30 min after CLP. Lung and peritoneal lavage were harvested after 6h and 24h of CLP to analyze cytokines amount, oxide nitric, lipid peroxidation and neutrophil infiltration. Neutrophil infiltration, ICAM-1, CXCR-2, and CXCL-1 in lung were reduced by HSS (CLP-H) compared to CLP-C or CLP-S. Neutrophil in peritoneal lavage was increased in 24h with HSS (CLP-H) compared to CLP and CLP-S. Peritoneal CXCR-2 was increased in CLP-C and CLP-S but presented a lower increase with HSS (CLP-H) after 6 hours. GRK-2 presented difference among the groups at 24 h, showing a profile similar to neutrophil infiltration. Pro-inflammatory cytokines (TNF-alpha and IL-6) were reduced by HSS treatment; CLP-S increased TNF-alpha IL-10 was increased in lung tissue by the HSS treatment. The oxidative stress (TBARS and nitric oxide biochemistry markers) was reduced with HSS. Animal survival was 33.3% in CLP-C group, 46.6% in CLP-S group and 60% in the CLP-H group after the sixth day. The HSS protects the animal against sepsis. Our results suggest that the volume replacement modulate pro and anti-inflammatory mediators of an inflammatory response, but HSS presented a more effective and potent effect.	[Theobaldo, Mariana Cardillo; Llimona, Flavia; Petroni, Ricardo Costa; Rios, Ester Correia Sarmento; Velasco, Irineu Tadeu; Soriano, Francisco Garcia] Univ Sao Paulo, Fac Med, Emergency Med Div, Sao Paulo, Brazil	Universidade de Sao Paulo	Soriano, FG (corresponding author), Univ Sao Paulo, Fac Med, Emergency Med Div, Sao Paulo, Brazil.	gsoriano@usp.br	Petroni, Ricardo/K-5144-2013; Soriano, Francisco/C-3382-2012	Soriano, Francisco/0000-0003-4898-0135	FAPESP [2009/15530-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP grant 2009/15530-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 1999, INTENS CARE MED, V25, P556, DOI 10.1007/s001340050903; ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z; Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; da Silva FP, 2009, FRONT BIOSCI-LANDMRK, V14, P4464, DOI 10.2741/3542; Dal-Pizzol F, 2006, AM J RESP CRIT CARE, V173, P84, DOI 10.1164/rccm.200507-1118OC; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Frazier WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050071; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; GLAUSER MP, 1994, CLIN INFECT DIS, V18, pS205, DOI 10.1093/clinids/18.Supplement_2.S205; HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869; HOLZHEIMER RG, 1991, INFECTION, V19, P447, DOI 10.1007/BF01726463; Leendertse M, 2009, INFECT IMMUN, V77, P485, DOI 10.1128/IAI.00863-08; Majcherczyk PA, 1999, J BIOL CHEM, V274, P12537, DOI 10.1074/jbc.274.18.12537; Malbrain MLNG, 2005, CURR OPIN CRIT CARE, V11, P156, DOI 10.1097/01.ccx.0000155355.86241.1b; Melo ES, 2010, MOL IMMUNOL, V47, P2587, DOI 10.1016/j.molimm.2010.06.011; MercerJones MA, 1997, SHOCK, V8, P193, DOI 10.1097/00024382-199709000-00007; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Nduka OO, 2009, CRIT CARE CLIN, V25, P677, DOI 10.1016/j.ccc.2009.08.002; Noppens RR, 2012, CRIT CARE MED, V40, P2149, DOI 10.1097/CCM.0b013e31824e6750; Oliveira RP, 2002, CRIT CARE, V6, P418, DOI 10.1186/cc1541; Conde KAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064790; Petroni RC, 2012, SHOCK, V37, P524, DOI 10.1097/SHK.0b013e31824c7665; Remick DG, 1998, CRIT CARE MED, V26, P895, DOI 10.1097/00003246-199805000-00025; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rios ECS, 2011, CLINICS, V66, P469, DOI 10.1590/S1807-59322011000300019; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; SILVA MRF, 1987, AM J PHYSIOL, V253, pH751, DOI 10.1152/ajpheart.1987.253.4.H751; Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008; Soriano FG, 2001, CRIT CARE MED, V29, P703, DOI 10.1097/00003246-200104000-00001; Soriano FG, 2011, SHOCK, V35, P560, DOI 10.1097/SHK.0b013e31820fe5d5; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; van Haren FMP, 2012, SHOCK, V37, P268, DOI 10.1097/SHK.0b013e31823f152f; VELASCO IT, 1989, CRIT CARE MED, V17, P261, DOI 10.1097/00003246-198903000-00012; VELASCO IT, 1980, AM J PHYSIOL, V239, pH664, DOI 10.1152/ajpheart.1980.239.5.H664; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; ZAPATASIRVENT RL, 1995, BURNS, V21, P185, DOI 10.1016/0305-4179(95)80006-A	43	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74369	10.1371/journal.pone.0074369	http://dx.doi.org/10.1371/journal.pone.0074369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069301	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300037
J	Bennett, M; Walters, K; Drennan, V; Buszewicz, M				Bennett, Madeleine; Walters, Kate; Drennan, Vari; Buszewicz, Marta			Structured Pro-Active Care for Chronic Depression by Practice Nurses in Primary Care: A Qualitative Evaluation	PLOS ONE			English	Article							COLLABORATIVE CARE; PATIENTS PERCEPTIONS; MANAGEMENT; DISORDERS; IMPACT	Purpose: This qualitative study explored the impact and appropriateness of structured pro-active care reviews by practice nurses for patients with chronic or recurrent depression and dysthymia within the ProCEED trial. ProCEED (Pro-active Care and its Evaluation for Enduring Depression) was a United Kingdom wide randomised controlled trial, comparing usual general practitioner care with structured 'pro-active care' which involved 3 monthly review appointments with practice nurses over 2 years for patients with chronic or recurrent depression. Method: In-depth interviews were completed with 41 participants: 26 patients receiving pro-active care and 15 practice nurses providing this care. Interview transcripts were analysed thematically using a 'framework' approach. Results: Patients perceived the practice nurses to be appropriate professionals to engage with regarding their depression and most nurses felt confident in a case management role. The development of a therapeutic alliance between the patient and nurse was central to this model and, where it appeared lacking, dissatisfaction was felt by both patients and nurses with a likely negative impact on outcomes. Patient and nurse factors impacting on the therapeutic alliance were identified and nurse typologies explored. Discussion: Pro-active care reviews utilising practice nurses as case managers were found acceptable by the majority of patients and practice nurses and may be a suitable way to provide care for patients with long-term depression in primary care. Motivated and interested practice nurses could be an appropriate and valuable resource for this patient group. This has implications for resource decisions by clinicians and commissioners within primary care.	[Bennett, Madeleine; Walters, Kate; Buszewicz, Marta] UCL, Royal Free Hosp, Res Dept Primary Care & Populat Hlth, London, England; [Drennan, Vari] St Georges Univ London, Fac Hlth & Social Care Sci, London, England; [Drennan, Vari] Univ Kingston, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; St Georges University London; Kingston University	Bennett, M (corresponding author), UCL, Royal Free Hosp, Res Dept Primary Care & Populat Hlth, London, England.	m.hutson@ucl.ac.uk	Drennan, Vari M/K-8811-2017	Drennan, Vari M/0000-0002-8915-5185; Walters, Kate/0000-0003-2173-2430	Big Lottery [RG/1/010166750]; National Institute of Health Research; MRC [G106/1053, MC_U122788474] Funding Source: UKRI; Medical Research Council [G106/1053, MC_U122788474] Funding Source: researchfish	Big Lottery; National Institute of Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The main trial was funded by the Big Lottery - grant code RG/1/010166750 and conducted in collaboration with the voluntary organisation Mind. M. Bennett was an Academic Clinical Fellow funded by National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst J, 1997, BMJ-BRIT MED J, V315, P1143; Bodenheimer T, 2005, BRIT MED J, V330, P612, DOI 10.1136/bmj.330.7492.612; Bogner HR, 2008, ANN FAM MED, V363, P2611; Buszewicz M, 2011, PROCEED REPORT STUDY; Buszewicz M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-61; Creswell John W, 2012, QUALITATIVE INQUIRY; Ekers D, 2013, J AFFECT DISORDERS, V149, P14, DOI 10.1016/j.jad.2013.02.032; Ekers David, 2008, Ment Health Fam Med, V5, P111; Gask L, 2003, BRIT J GEN PRACT, V53, P278; Gensichen J, 2011, PATIENT EDUC COUNS, DOI [10.1016/j.pec2011, DOI 10.1016/J.PEC2011]; Gensichen J, 2009, ANN FAM MED, V7, P513, DOI 10.1370/afm.1037; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gilbody S, 2006, BRIT J PSYCHIAT, V189, P297, DOI 10.1192/bjp.bp.105.016006; Haddad M, 2007, INT J NURS STUD, V44, P447, DOI 10.1016/j.ijnurstu.2006.07.005; Jacob V, 2012, AM J PREV MED, V42, P539, DOI 10.1016/j.amepre.2012.01.011; Jansink R, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-41; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katon W, 2012, AM J PREV MED, V42, P550, DOI 10.1016/j.amepre.2012.01.017; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; KERR M, 1995, BRIT J GEN PRACT, V45, P89; KUPFER DJ, 1991, J CLIN PSYCHIAT, V52, P28; Laurant M, 2005, COCHRANE DB SYST REV, V2; Lin EHB, 1998, ARCH FAM MED, V7, P443, DOI 10.1001/archfami.7.5.443; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; May T., 1997, SOCIAL RES ISSUES ME; Morgan MAJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002171; National Institute for Clinical Excellence, 2009, DEPR MAN DEPR PRIM S; O'Donnell CA, 2010, BMC NURS, V9, DOI 10.1186/1472-6955-9-2; PICCINELLI M, 1994, BRIT J PSYCHIAT, V164, P297, DOI 10.1192/bjp.164.3.297; Pollock K, 2002, BRIT MED J, V325, P687, DOI 10.1136/bmj.325.7366.687; Richards DA, 2006, GEN HOSP PSYCHIAT, V28, P296, DOI 10.1016/j.genhosppsych.2006.03.005; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; ROGERS A, 2001, J MENTAL HLTH, V10, P317, DOI DOI 10.1080/09638230020023840; Simpson Angela, 2008, Ment Health Fam Med, V5, P95; Thota AB, 2012, AM J PREV MED, V42, P525, DOI 10.1016/j.amepre.2012.01.019; Vuorilehto MS, 2009, PSYCHOL MED, V39, P1697, DOI 10.1017/S0033291709005182	37	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75810	10.1371/journal.pone.0075810	http://dx.doi.org/10.1371/journal.pone.0075810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069451	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000326240100129
J	Weibel, R; Reiss, D; Karchewski, L; Gardon, O; Matifas, A; Filliol, D; Becker, JAJ; Wood, JN; Kieffer, BL; Gaveriaux-Ruff, C				Weibel, Raphael; Reiss, David; Karchewski, Laurie; Gardon, Olivier; Matifas, Audrey; Filliol, Dominique; Becker, Jerome A. J.; Wood, John N.; Kieffer, Brigitte L.; Gaveriaux-Ruff, Claire			Mu Opioid Receptors on Primary Afferent Nav1.8 Neurons Contribute to Opiate-Induced Analgesia: Insight from Conditional Knockout Mice	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; MESSENGER-RNA EXPRESSION; SPINAL-CORD; SENSORY NEURONS; RELATIVE CONTRIBUTION; NEUROPATHIC PAIN; RAT MODEL; MORPHINE; DELTA; GENE	Opiates are powerful drugs to treat severe pain, and act via mu opioid receptors distributed throughout the nervous system. Their clinical use is hampered by centrally-mediated adverse effects, including nausea or respiratory depression. Here we used a genetic approach to investigate the potential of peripheral mu opioid receptors as targets for pain treatment. We generated conditional knockout (cKO) mice in which mu opioid receptors are deleted specifically in primary afferent Nav1.8-positive neurons. Mutant animals were compared to controls for acute nociception, inflammatory pain, opiate-induced analgesia and constipation. There was a 76% decrease of mu receptor-positive neurons and a 60% reduction of mu-receptor mRNA in dorsal root ganglia of cKO mice. Mutant mice showed normal responses to heat, mechanical, visceral and chemical stimuli, as well as unchanged morphine antinociception and tolerance to antinociception in models of acute pain. Inflammatory pain developed similarly in cKO and controls mice after Complete Freund's Adjuvant. In the inflammation model, however, opiate-induced (morphine, fentanyl and loperamide) analgesia was reduced in mutant mice as compared to controls, and abolished at low doses. Morphine-induced constipation remained intact in cKO mice. We therefore genetically demonstrate for the first time that mu opioid receptors partly mediate opiate analgesia at the level of Nav1.8-positive sensory neurons. In our study, this mechanism operates under conditions of inflammatory pain, but not nociception. Previous pharmacology suggests that peripheral opiates may be clinically useful, and our data further demonstrate that Nav1.8 neuron-associated mu opioid receptors are feasible targets to alleviate some forms of persistent pain.	[Weibel, Raphael; Reiss, David; Karchewski, Laurie; Gardon, Olivier; Matifas, Audrey; Filliol, Dominique; Becker, Jerome A. J.; Kieffer, Brigitte L.; Gaveriaux-Ruff, Claire] UdS Univ Strasbourg, IGBMC, Translat Med & Neurogenet Programme, INSERM,U964,CNRS,UMR7104, Illkirch Graffenstaden, France; [Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London, England; [Gaveriaux-Ruff, Claire] UdS Univ Strasbourg, ESBS, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; University College London	Gaveriaux-Ruff, C (corresponding author), UdS Univ Strasbourg, IGBMC, Translat Med & Neurogenet Programme, INSERM,U964,CNRS,UMR7104, Illkirch Graffenstaden, France.	gaveriau@igbmc.fr	GAVERIAUX-RUFF, Claire/A-9671-2017; Becker, Jerome/I-7879-2016	GAVERIAUX-RUFF, Claire/0000-0002-3523-8102; Becker, Jerome/0000-0002-0039-0067	Universite de Strasbourg (UdS); CNRS; INSERM; ANR LYMPHOPIOID (CG-R); National Institute of Health, USA [NIAAA 016658, NIDA 005010, NIDA 016768]; European Union [GENADDICT/FP6 005166]; Wellcome Trust; MRC; BBSRC; Universite de Strasbourg (CG-R); NATIONAL INSTITUTE ON DRUG ABUSE [P50DA005010] Funding Source: NIH RePORTER; Medical Research Council [G0901905] Funding Source: researchfish; Wellcome Trust [101054/Z/13/Z] Funding Source: researchfish; MRC [G0901905] Funding Source: UKRI	Universite de Strasbourg (UdS); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR LYMPHOPIOID (CG-R)(French National Research Agency (ANR)); National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Universite de Strasbourg (CG-R); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by: Universite de Strasbourg (UdS, CG-R), CNRS, INSERM, ANR LYMPHOPIOID (CG-R), the National Institute of Health, USA (NIAAA 016658, BLK; NIDA 005010, BLK; NIDA 016768, BLK and RM), and the European Union (GENADDICT/FP6 005166, BLK RM); the Wellcome Trust, MRC and BBSRC (JNW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2002, BRAIN RES, V930, P150, DOI 10.1016/S0006-8993(02)02242-4; Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Al-Hasani R, 2011, ANESTHESIOLOGY, V115, P1363, DOI 10.1097/ALN.0b013e318238bba6; Baamonde A, 2005, N-S ARCH PHARMACOL, V372, P213, DOI 10.1007/s00210-005-0013-6; Ballet S, 2003, NEUROPEPTIDES, V37, P211, DOI 10.1016/S0143-4179(03)00045-3; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; BESSE D, 1992, BRAIN RES, V578, P115, DOI 10.1016/0006-8993(92)90237-4; Boue J, 2012, PAIN, V153, P485, DOI 10.1016/j.pain.2011.11.013; Cabanero D, 2009, PAIN, V141, P88, DOI 10.1016/j.pain.2008.10.011; Calza L, 2000, EXP NEUROL, V164, P333, DOI 10.1006/exnr.2000.7442; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chattopadhyay M, 2008, J NEUROSCI, V28, P6652, DOI 10.1523/JNEUROSCI.5530-07.2008; Chen SR, 2006, J NEUROPHYSIOL, V95, P3086, DOI 10.1152/jn.01343.2005; Contet C, 2006, NEUROPSYCHOPHARMACOL, V31, P1733, DOI 10.1038/sj.npp.1300934; Dehaven-Hudkins DL, 1999, J PHARMACOL EXP THER, V289, P494; Dominguez JE, 2013, CURR OPIN ANESTHESIO, V26, P288, DOI 10.1097/ACO.0b013e328360b086; Endres-Becker J, 2007, MOL PHARMACOL, V71, P12, DOI 10.1124/mol.106.026740; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Gautron L, 2011, J COMP NEUROL, V519, P3085, DOI 10.1002/cne.22667; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; Gaveriaux-Ruff C, 2011, PAIN, V152, P1238, DOI 10.1016/j.pain.2010.12.031; GAVERIAUXRUFF C, 2013, CURR PHARM DESIGN, P48470; Gonzalez-Rodriguez S, 2010, CELL MOL NEUROBIOL, V30, P113, DOI 10.1007/s10571-009-9436-9; GUSTAFSSON LL, 1985, ANESTHESIOLOGY, V63, P483, DOI 10.1097/00000542-198511000-00003; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Joseph EK, 2010, NEUROSCIENCE, V171, P344, DOI 10.1016/j.neuroscience.2010.08.035; Khalefa BI, 2012, EUR J PAIN, V16, P690, DOI 10.1002/j.1532-2149.2011.00070.x; Kreek MJ, 2012, J CLIN INVEST, V122, P3387, DOI 10.1172/JCI60390; Labuz D, 2007, BRAIN RES, V1160, P30, DOI 10.1016/j.brainres.2007.05.049; Labuz D, 2009, J CLIN INVEST, V119, P278, DOI [10.1172/JCI36246, 10.1172/JCI36246C1]; LAMOTTE C, 1976, BRAIN RES, V112, P407, DOI 10.1016/0006-8993(76)90296-1; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Lewanowitsch T, 2006, LIFE SCI, V78, P682, DOI 10.1016/j.lfs.2005.05.062; Luger NM, 2002, PAIN, V99, P397, DOI 10.1016/S0304-3959(02)00102-1; Lutz PE, 2013, CURR OPIN NEUROBIOL, V23, P473, DOI 10.1016/j.conb.2013.02.005; Lynch JL, 2008, BRAIN RES, V1191, P180, DOI 10.1016/j.brainres.2007.11.034; Mansikka H, 2004, ANESTHESIOLOGY, V100, P912, DOI 10.1097/00000542-200404000-00022; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Minami K, 2009, J PHARMACOL SCI, V111, P60, DOI 10.1254/jphs.09139FP; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Negus SS, 2006, J PHARMACOL EXP THER, V319, P507, DOI 10.1124/jpet.106.106377; Nozaki C, 2011, NAT NEUROSCI, V14, P1017, DOI 10.1038/nn.2844; Obara I, 2009, PAIN, V141, P283, DOI 10.1016/j.pain.2008.12.006; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Pol O, 2006, NEUROPHARMACOLOGY, V50, P123, DOI 10.1016/j.neuropharm.2005.11.002; Pradhan AAA, 2010, J NEUROSCI, V30, P16459, DOI 10.1523/JNEUROSCI.3748-10.2010; Pradhan AAA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005425; Puehler W, 2004, NEUROSCIENCE, V129, P473, DOI 10.1016/j.neuroscience.2004.06.086; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Raouf R, 2010, J CLIN INVEST, V120, P3745, DOI 10.1172/JCI43158; Ringkamp M, 2012, EUR J PAIN, V16, P621, DOI 10.1002/j.1532-2149.2012.00110.x; Roy S, 1998, MOL BRAIN RES, V56, P281, DOI 10.1016/S0169-328X(98)00051-5; Sasaki A, 2008, NEUROREPORT, V19, P975, DOI 10.1097/WNR.0b013e328302f123; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Schramm CL, 2010, PAIN, V151, P763, DOI 10.1016/j.pain.2010.09.009; Schug SA, 2006, CNS DRUGS, V20, P917, DOI 10.2165/00023210-200620110-00005; Shaqura MA, 2004, J PHARMACOL EXP THER, V308, P712, DOI 10.1124/jpet.103.057257; Shinoda K, 2007, NEUROSCI LETT, V411, P143, DOI 10.1016/j.neulet.2006.10.027; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Stein C, 2011, PHARMACOL REV, V63, P860, DOI 10.1124/pr.110.003145; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Thibault K, 2008, EUR J PHARMACOL, V600, P71, DOI 10.1016/j.ejphar.2008.10.004; Vetter I, 2012, EMBO J, V31, P3795, DOI 10.1038/emboj.2012.207; Wang H, 2001, J COMP NEUROL, V429, P590, DOI 10.1002/1096-9861(20010122)429:4<590::AID-CNE6>3.0.CO;2-V; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Zhang GH, 2008, ANESTHESIOLOGY, V108, P305, DOI 10.1097/01.anes.0000299836.61785.79; Zhang Z, 2010, J NEUROSCI, V30, P4735, DOI 10.1523/JNEUROSCI.5968-09.2010; Zollner C, 2008, J CLIN INVEST, V118, P1065, DOI 10.1172/JCI25911	72	78	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74706	10.1371/journal.pone.0074706	http://dx.doi.org/10.1371/journal.pone.0074706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069332	Green Published, gold			2022-12-27	WOS:000326240100116
J	Xu, YX; Ma, AN; Liu, L				Xu, Yu-Xin; Ma, Anna; Liu, Li			Transforming Growth Factor beta Signaling Upregulates the Expression of Human GDP-Fucose Transporter by Activating Transcription Factor Sp1	PLOS ONE			English	Article							NUCLEOTIDE-SUGAR TRANSPORTERS; RNA-POLYMERASE-II; BINDING-PROTEIN; TGF-BETA; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; MESSENGER-RNA; GLYCOSYLATION; INITIATOR; PROMOTER	GDP-fucose transporter plays a crucial role in fucosylation of glycoproteins by providing activated fucose donor, GDPfucose, for fucosyltransferases in the lumen of the Golgi apparatus. Fucose-containing glycans are involved in many biological processes, which are essential for growth and development. Mutations in the GDP-fucose transporter gene cause leukocyte adhesion deficiency syndrome II, a disease characterized by slow growth, mental retardation and immunodeficiency. However, no information is available regarding its transcriptional regulation. Here, by using human cells, we show that TGF-beta 1 specifically induces the GDP-fucose transporter expression, but not other transporters tested such as CMP-sialic acid transporter, suggesting a diversity of regulatory pathways for the expression of these transporters. The regulatory elements that are responsive to the TGF-beta 1 stimulation are present in the region between bp -330 and -268 in the GDP-fucose transporter promoter. We found that this region contains two identical octamer GC-rich motifs (GGGGCGTG) that were demonstrated to be essential for the transporter expression. We also show that the transcription factor Sp1 specifically binds to the GC-rich motifs in vitro and Sp1 coupled with phospho-Smad2 is associated with the promoter region covering the Sp1-beta inding motifs in vivo using chromatin immunoprecipitation (ChIP) assays. In addition, we further confirmed that Sp1 is essential for the GDP-fucose transporter expression stimulated by TGF-beta 1 using a luciferase reporter system. These results highlight the role of TGF-beta signaling in regulation of the GDP-fucose transporter expression via activating Sp1. This is the first transcriptional study for any nucleotide sugar transporters that have been identified so far. Notably, TGF-beta 1 receptor itself is known to be modified by fucosylation. Given the essential role of GDP-fucose transporter in fucosylation, the finding that TGF-beta 1 stimulates the expression of this transporter, suggests a possible intracellular link between the function of nucleotide sugar transporter and the TGF-beta signaling pathway.	[Xu, Yu-Xin; Ma, Anna; Liu, Li] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA; [Xu, Yu-Xin] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Xu, Yu-Xin] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Liu, L (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02215 USA.	liul@bu.edu		Xu, Yu-Xin/0000-0002-0200-4633	NIH [GM30365]; American Heart Association SDG [11SDG7670007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association SDG(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research work was financially supported by NIH Grant R01 (GM30365) to Carlos B. Hirschberg and by American Heart Association SDG (11SDG7670007) to Yu-Xin Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Caffaro CE, 2007, J BIOL CHEM, V282, P27970, DOI 10.1074/jbc.M704485200; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; CARCAMO J, 1991, P NATL ACAD SCI USA, V88, P8052, DOI 10.1073/pnas.88.18.8052; Deshane J, 2010, J BIOL CHEM, V285, P16476, DOI 10.1074/jbc.M109.058586; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Handford M, 2006, BRAZ J MED BIOL RES, V39, P1149, DOI 10.1590/S0100-879X2006000900002; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Hirschberg CB, 2001, J CLIN INVEST, V108, P3; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; KAUFMANN J, 1994, GENE DEV, V8, P821, DOI 10.1101/gad.8.7.821; Kaufmann J, 1998, MOL CELL BIOL, V18, P233, DOI 10.1128/MCB.18.1.233; Kumamoto K, 2001, CANCER RES, V61, P4620; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lauc G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001256; Lin HL, 2011, AM J PHYSIOL-RENAL, V300, pF1017, DOI 10.1152/ajprenal.00426.2010; Liu L, 2013, J BIOL CHEM; Liu L, 2013, GLYCOCONJUGATE J, V30, P5, DOI 10.1007/s10719-012-9375-4; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Luhn K, 2001, NAT GENET, V28, P69, DOI 10.1038/ng0501-69; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MARTINEZ E, 1994, EMBO J, V13, P3115, DOI 10.1002/j.1460-2075.1994.tb06610.x; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; Nishimura M, 2009, DRUG METAB PHARMACOK, V24, P91, DOI 10.2133/dmpk.24.91; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; PURNELL BA, 1993, MOL CELL BIOL, V13, P2593, DOI 10.1128/MCB.13.4.2593; Ranganathan P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-98; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Schachter H, 2005, P NATL ACAD SCI USA, V102, P15721, DOI 10.1073/pnas.0507659102; Smale ST, 1997, BBA-GENE STRUCT EXPR, V1351, P73, DOI 10.1016/S0167-4781(96)00206-0; Taylor IW, 2008, CELL, V133, DOI 10.1016/j.cell.2008.04.007; Thanabalasingham G, 2013, DIABETES, V62, P1329, DOI 10.2337/db12-0880; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Weis L, 1997, MOL CELL BIOL, V17, P2973, DOI 10.1128/MCB.17.6.2973; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Xu YX, 2007, MOL CELL, V26, P287, DOI 10.1016/j.molcel.2007.03.020; Xu YX, 2010, J BIOL CHEM, V285, P24600, DOI 10.1074/jbc.M110.134544; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503	49	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74424	10.1371/journal.pone.0074424	http://dx.doi.org/10.1371/journal.pone.0074424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069312	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100106
J	Yang, WH; Zhang, Z; Zhang, ZM; Chen, H; Liu, J; Ali, M; Liu, F; Li, L				Yang, Weihong; Zhang, Zhen; Zhang, Zhongming; Chen, Hong; Liu, Jin; Ali, Muhammad; Liu, Fan; Li, Lin			Population Structure of Manganese-Oxidizing Bacteria in Stratified Soils and Properties of Manganese Oxide Aggregates under Manganese-Complex Medium Enrichment	PLOS ONE			English	Article							MULTICOPPER OXIDASE; COMMUNITY STRUCTURE; OXIDATION; GENE; IDENTIFICATION; STRATEGIES; SPORES; MNXG	Manganese-oxidizing bacteria in the aquatic environment have been comprehensively investigated. However, little information is available about the distribution and biogeochemical significance of these bacteria in terrestrial soil environments. In this study, stratified soils were initially examined to investigate the community structure and diversity of manganese-oxidizing bacteria. Total 344 culturable bacterial isolates from all substrata exhibited Mn(II)-oxidizing activities at the range of 1 mu M to 240 mM of the equivalent MnO2. The high Mn(II)-oxidizing isolates (. 50 mM MnO2) were identified as the species of phyla Actinobacteria, Firmicutes and Proteobacteria. Seven novel Mn(II)-oxidizing bacterial genera (species), namely, Escherichia, Agromyces, Cellulomonas, Cupriavidus, Microbacterium, Ralstonia, and Variovorax, were revealed via comparative phylogenetic analysis. Moreover, an increase in the diversity of soil bacterial community was observed after the combined enrichment of Mn(II) and carbon-rich complex. The phylogenetic classification of the enriched bacteria represented by predominant denaturing gradient gel electrophoresis bands, was apparently similar to culturable Mn(II)oxidizing bacteria. The experiments were further undertaken to investigate the properties of the Mn oxide aggregates formed by the bacterial isolates with high Mn(II)-oxidizing activity. Results showed that these bacteria were closely encrusted with their Mn oxides and formed regular microspherical aggregates under prolonged Mn(II) and carbon-rich medium enrichment for three weeks. The biotic oxidation of Mn(II) to Mn(III/IV) by these isolates was confirmed by kinetic examinations. X-ray diffraction assays showed the characteristic peaks of several Mn oxides and rhodochrosite from these aggregates. Leucoberbelin blue tests also verified the Mn(II)-oxidizing activity of these aggregates. These results demonstrated that Mn oxides were formed at certain amounts under the enrichment conditions, along with the formation of rhodochrosite in such aggregates. Therefore, this study provides insights into the structure and diversity of soil-borne bacterial communities in Mn(II)-oxidizing habitats and supports the contribution of soil-borne Mn(II)-oxidizing bacteria to Mn oxide mineralization in soils.	[Yang, Weihong; Zhang, Zhen; Zhang, Zhongming; Chen, Hong; Liu, Jin; Ali, Muhammad; Li, Lin] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Zhang, Zhen; Liu, Fan] Huazhong Agr Univ, Minist Agr, Key Lab Subtrop Agr Resource & Environm, Wuhan, Peoples R China; [Ali, Muhammad] CIIT Ctr Hlth Res, Biotechnol Program, Dept Environm Sci, Abbottabad, Pakistan	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; COMSATS University Islamabad (CUI)	Li, L (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	lilin@mail.hzau.edu.cn	Ali, Muhammad/G-6286-2013; Liu, fan/B-2289-2012; Yang, Wei/GWV-4107-2022; Yang, Wei/HIA-0360-2022	Ali, Muhammad/0000-0001-8056-9245; Li, Lin/0000-0002-9241-6614	National Natural Science Foundation Council of China [40830527]; National Natural Science 573 Foundation of China [31270158, 31070111]; Fundamental Research Funds for the Central Universities [2012MBDX011]	National Natural Science Foundation Council of China(National Natural Science Foundation of China (NSFC)); National Natural Science 573 Foundation of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was approved and supported by the National Natural Science Foundation Council of China (grant number 40830527). This study was also supported by the National Natural Science 573 Foundation of China (grant numbers 31270158 and 31070111) and was partially supported by the Fundamental Research Funds for the Central Universities (program number 2012MBDX011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 1999, METHODS SOIL AGR CHE; Benner SG, 1999, ENVIRON SCI TECHNOL, V33, P2793, DOI 10.1021/es981040u; Brouwers GJ, 1999, APPL ENVIRON MICROB, V65, P1762; Caspi R, 1998, APPL ENVIRON MICROB, V64, P3549; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Corstjens PLAM, 1997, GEOMICROBIOL J, V14, P91, DOI 10.1080/01490459709378037; Das AP, 2011, BIORESOURCE TECHNOL, V102, P7381, DOI 10.1016/j.biortech.2011.05.018; Dick GJ, 2008, APPL ENVIRON MICROB, V74, P2646, DOI 10.1128/AEM.01656-07; Dick GJ, 2006, APPL ENVIRON MICROB, V72, P3184, DOI 10.1128/AEM.72.5.3184-3190.2006; Ercolini D, 2004, J MICROBIOL METH, V56, P297, DOI 10.1016/j.mimet.2003.11.006; Francis CA, 2002, ARCH MICROBIOL, V178, P450, DOI 10.1007/s00203-002-0472-9; Francis CA, 2001, APPL ENVIRON MICROB, V67, P4024, DOI 10.1128/AEM.67.9.4024-4029.2001; Germida JJ, 2007, SOIL SAMPLING METHOD; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; He JZ, 2008, GEOMICROBIOL J, V25, P14, DOI 10.1080/01490450701829014; Jambor JL, 2005, CAN MINERAL, V43, P2117, DOI 10.2113/gscanmin.43.6.2117; Kay JT, 2001, ENVIRON SCI TECHNOL, V35, P4719, DOI 10.1021/es010514d; Kim HS, 2003, J AM CHEM SOC, V125, P14284, DOI 10.1021/ja0375784; KRUMBEIN WE, 1973, HELGOLAND WISS MEER, V25, P347, DOI 10.1007/BF01611203; Lee JH, 2011, ENVIRON MICROBIOL, V13, P3275, DOI 10.1111/j.1462-2920.2011.02587.x; Mayhew LE, 2008, APPL ENVIRON MICROB, V74, P7265, DOI 10.1128/AEM.00540-08; Michalak I, 2011, MICROCHIM ACTA, V172, P65, DOI 10.1007/s00604-010-0468-0; Morgan JJ, 2005, GEOCHIM COSMOCHIM AC, V69, P35, DOI 10.1016/j.gca.2004.06.013; Muckian L, 2007, CHEMOSPHERE, V68, P1535, DOI 10.1016/j.chemosphere.2007.03.029; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Northup DE, 2003, ENVIRON MICROBIOL, V5, P1071, DOI 10.1046/j.1462-2920.2003.00500.x; Ren HT, 2013, J HAZARD MATER, V254, P89, DOI 10.1016/j.jhazmat.2013.03.022; Sambrook J., 2001, MOL CLONING; Smit E, 1997, FEMS MICROBIOL ECOL, V23, P249, DOI 10.1111/j.1574-6941.1997.tb00407.x; Stein LY, 2001, ENVIRON MICROBIOL, V3, P10, DOI 10.1046/j.1462-2920.2001.00154.x; SULLIVAN LA, 1993, AUST J SOIL RES, V31, P227, DOI 10.1071/SR9930227; Tan WF, 2006, PEDOSPHERE, V16, P72, DOI 10.1016/S1002-0160(06)60028-3; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOKASHIKI Y, 1986, SOIL SCI SOC AM J, V50, P1079, DOI 10.2136/sssaj1986.03615995005000040049x; VANWAASBERGEN LG, 1993, J BACTERIOL, V175, P7594, DOI 10.1128/JB.175.23.7594-7603.1993; vanWaasbergen LG, 1996, J BACTERIOL, V178, P3517, DOI 10.1128/JB.178.12.3517-3530.1996; Wang XH, 2009, MICRON, V40, P350, DOI 10.1016/j.micron.2008.10.005; Zhang LM, 2008, SOIL BIOL BIOCHEM, V40, P1364, DOI 10.1016/j.soilbio.2007.01.004; [周静晓 Zhou Jingxiao], 2010, [微生物学通报, Microbiology], V37, P573	42	16	20	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73778	10.1371/journal.pone.0073778	http://dx.doi.org/10.1371/journal.pone.0073778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069232	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100060
J	Bastir, M; Martinez, DG; Recheis, W; Barash, A; Coquerelle, M; Rios, L; Pena-Melian, A; Rio, FG; O'Higgins, P				Bastir, Markus; Garcia Martinez, Daniel; Recheis, Wolfgang; Barash, Alon; Coquerelle, Michael; Rios, Luis; Pena-Melian, Angel; Garcia Rio, Francisco; O'Higgins, Paul			Differential Growth and Development of the Upper and Lower Human Thorax	PLOS ONE			English	Article							RIB CAGE; PRETERM INFANTS; VENTILATION; GEOMETRY; CHEST; CHILDREN; ONTOGENY; GENDER; CO2	The difficulties in quantifying the 3D form and spatial relationships of the skeletal components of the ribcage present a barrier to studies of the growth of the thoracic skeleton. Thus, most studies to date have relied on traditional measurements such as distances and indices from single or few ribs. It is currently known that adult-like thoracic shape is achieved early, by the end of the second postnatal year, with the circular cross-section of the newborn thorax transforming into the ovoid shape of adults; and that the ribs become inclined such that their anterior borders come to lie inferior to their posterior. Here we present a study that revisits growth changes using geometric morphometrics applied to extensive landmark data taken from the ribcage. We digitized 402 (semi) landmarks on 3D reconstructions to assess growth changes in 27 computed tomography-scanned modern humans representing newborns to adults of both sexes. Our analyses show a curved ontogenetic trajectory, resulting from different ontogenetic growth allometries of upper and lower thoracic units. Adult thoracic morphology is achieved later than predicted, by diverse modifications in different anatomical regions during different ontogenetic stages. Besides a marked increase in antero-posterior dimensions, there is an increase in medio-lateral dimensions of the upper thorax, relative to the lower thorax. This transforms the pyramidal infant thorax into the barrel-shaped one of adults. Rib descent is produced by complex changes in 3D curvature. Developmental differences between upper and lower thoracic regions relate to differential timings and rates of maturation of the respiratory and digestive systems, the spine and the locomotor system. Our findings are relevant to understanding how changes in the relative rates of growth of these systems and structures impacted on the development and evolution of modern human body shape.	[Bastir, Markus; Garcia Martinez, Daniel; Coquerelle, Michael] Museo Nacl Ciencias Nat CSIC, Paleoanthropol Grp, Madrid, Spain; [Garcia Martinez, Daniel; Rios, Luis] Univ Autonoma Madrid, Fac Ciencias, E-28049 Madrid, Spain; [Recheis, Wolfgang] Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria; [Barash, Alon] Galilee Bar Ilan Univ, Fac Med, Safed, Israel; [Barash, Alon] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Rios, Luis] Fdn Aranzadi, San Sebastian, Spain; [Pena-Melian, Angel] Univ Complutense Madrid, Dept Anat & Embriol, Madrid, Spain; [Garcia Rio, Francisco] Hosp Univ La Paz, Biomed Res Inst IdiPAZ, Madrid, Spain; [O'Higgins, Paul] Univ York, HYMS, York YO10 5DD, N Yorkshire, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Autonomous University of Madrid; Medical University of Innsbruck; Tel Aviv University; Sackler Faculty of Medicine; Complutense University of Madrid; Hospital Universitario La Paz; University of York - UK	Bastir, M (corresponding author), Museo Nacl Ciencias Nat CSIC, Paleoanthropol Grp, Madrid, Spain.	mbastir@mncn.csic.es	Garcia-Rio, Francisco/AAC-9981-2020; Rios, Luis/G-3533-2015; Bastir, Markus/G-8987-2013	Rios, Luis/0000-0002-6720-2534; GARCIA-MARTINEZ, DANIEL/0000-0001-7518-3866; Barash, Alon/0000-0001-9682-6875; Bastir, Markus/0000-0002-3141-3401; Coquerelle, Michael/0000-0001-5183-3297; O'Higgins, Paul/0000-0002-9797-0809; Garcia-Rio, Francisco/0000-0002-7227-2238	(Spanish Ministry for Economy and Competition) Fyssen-foundation [CGL2012-37279]	(Spanish Ministry for Economy and Competition) Fyssen-foundation	CGL2012-37279 (Spanish Ministry for Economy and Competition) Fyssen-foundation (http://www.fondationfyssen.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aiello L, 1990, INTRO HUMAN EVOLUTIO; Aiello LC, 1997, BRAZ J GENET, V20, P141, DOI 10.1590/S0100-84551997000100023; Bastir M, 2004, J HUM EVOL, V47, P359, DOI 10.1016/j.jhevol.2004.08.009; BASTIR M, 2012, PESHE 2012 21 22 09; Bastir M, 2008, ANAT REC, V291, P130, DOI 10.1002/ar.20636; Bastir M, 2007, P ROY SOC B-BIOL SCI, V274, P1125, DOI 10.1098/rspb.2006.0448; Bastir M, 2006, J ANAT, V209, P637, DOI 10.1111/j.1469-7580.2006.00644.x; Bastir M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1593; Bastir M, 2009, EVOL BIOL, V36, P57, DOI 10.1007/s11692-008-9037-4; Bastir M, 2008, J ANTHROPOL SCI, V86, P37; BAUME RM, 1983, AM J ORTHOD DENTOFAC, V83, P477, DOI 10.1016/S0002-9416(83)90246-4; Bellemare F, 2006, RESP PHYSIOL NEUROBI, V150, P233, DOI 10.1016/j.resp.2005.04.002; Berry M., 1995, GRAYS ANATOMY; Cobb SN, 2004, J EXP ZOOL PART B, V302B, P302, DOI 10.1002/jez.b.21005; De Troyer A, 2005, PHYSIOL REV, V85, P717, DOI 10.1152/physrev.00007.2004; Dworzak J, 2010, INT J COMPUT ASS RAD, V5, P111, DOI 10.1007/s11548-009-0390-2; Ferretti GR, 2001, EUR RESPIR J, V18, P381, DOI 10.1183/09031936.01.00217701; GARCIAMARTINEZ D, 2013, BILBAO IN PRESS; GARCIAMARTINEZ D, 2012, WHOLE ITS PARTS 3D G; Gayzik FS, 2008, J BIOMECH, V41, P1545, DOI 10.1016/j.jbiomech.2008.02.006; GEA J, 2007, ACTA BRONCONEUM, V44, P263; Glass RBJ, 2002, RADIOGRAPHICS, V22, P87, DOI 10.1148/radiographics.22.1.g02ja1287; Goldfield EC, 1999, ECOL PSYCHOL, V11, P209, DOI 10.1207/s15326969eco1103_2; Gomez-Olivencia A, 2009, J HUM EVOL, V57, P75, DOI 10.1016/j.jhevol.2009.02.009; Goodyear MDE, 2007, BRIT MED J, V335, P624, DOI 10.1136/bmj.39339.610000.BE; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; Gunz P, 2009, J HUM EVOL, V57, P48, DOI 10.1016/j.jhevol.2009.04.004; HIBBERT M, 1995, PEDIATR PULM, V19, P129, DOI 10.1002/ppul.1950190208; Jellema Lyman M., 1993, P294; JORDANOGLOU J, 1969, THORAX, V24, P407, DOI 10.1136/thx.24.4.407; Kagaya M, 2008, PRIMATES, V49, P89, DOI 10.1007/s10329-007-0064-z; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; KLINGENBERG CP, 2013, SYST BIOL; LoMauro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035965; MANN RW, 1993, J FORENSIC SCI, V38, P151; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Mohr M, 2007, J BIOMECH, V40, P1310, DOI 10.1016/j.jbiomech.2006.05.017; MORIETTE G, 1985, RESP PHYSIOL, V62, P387, DOI 10.1016/0034-5687(85)90093-3; Nysom K, 1997, EUR RESPIR J, V10, P1591, DOI 10.1183/09031936.97.10071591; O'Higgins P, 2000, J ANAT, V197, P103, DOI 10.1046/j.1469-7580.2000.19710103.x; O'Higgins P., 2006, INT C SER, V1296, P55, DOI DOI 10.1016/J.ICS.2006.03.036; O'Higgins P, 2011, J ANAT, V218, P3, DOI 10.1111/j.1469-7580.2010.01301.x; OPENSHAW P, 1984, THORAX, V39, P624, DOI 10.1136/thx.39.8.624; Pham TMT, 2011, EUR RESPIR J, V37, P919, DOI 10.1183/09031936.00034310; Ravenel JG, 2003, RADIOL CLIN N AM, V41, P475, DOI 10.1016/S0033-8389(03)00032-0; REDDING GJ, 2012, PEDIAT PULMONOL; REIS FJC, 1994, BIOL NEONATE, V65, P69; Rios L, 2009, AM J PHYS ANTHROPOL, V140, P265, DOI 10.1002/ajpa.21065; Romei M, 2010, RESP PHYSIOL NEUROBI, V172, P184, DOI 10.1016/j.resp.2010.05.018; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; Sokal RR, 1998, BIOMETRY; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; THURLBECK WM, 1982, THORAX, V37, P564, DOI 10.1136/thx.37.8.564; Tsai A, 2012, J BIOMECH, V45, P1861, DOI 10.1016/j.jbiomech.2012.05.049; Wagner H, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-13; Ward J., 2005, SURGERY, V23, P419, DOI DOI 10.1383/surg.2005.23.11.419; WARD ME, 1992, J APPL PHYSIOL, V72, P1338, DOI 10.1152/jappl.1992.72.4.1338; Weitz CA, 2004, ANN HUM BIOL, V31, P292, DOI 10.1080/0301446042000196316; WILSON TA, 1987, J APPL PHYSIOL, V62, P1872, DOI 10.1152/jappl.1987.62.5.1872; Yoganandan N, 1998, J BIOMECH ENG-T ASME, V120, P100, DOI 10.1115/1.2834288; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	64	59	59	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75128	10.1371/journal.pone.0075128	http://dx.doi.org/10.1371/journal.pone.0075128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073239	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000048
J	Lorite, GS; Janissen, R; Clerici, JH; Rodrigues, CM; Tomaz, JP; Mizaikoff, B; Kranz, C; de Souza, AA; Cotta, MA				Lorite, Gabriela S.; Janissen, Richard; Clerici, Joao H.; Rodrigues, Carolina M.; Tomaz, Juarez P.; Mizaikoff, Boris; Kranz, Christine; de Souza, Alessandra A.; Cotta, Monica A.			Surface Physicochemical Properties at the Micro and Nano Length Scales: Role on Bacterial Adhesion and Xylella fastidiosa Biofilm Development	PLOS ONE			English	Article							PROBE FORCE MICROSCOPY; EXTRACELLULAR POLYMERIC SUBSTANCES; ESCHERICHIA-COLI; AXENIC CULTURE; DLVO THEORY; PLANT; EXPRESSION; VIRULENCE; TRANSMISSION; ATTACHMENT	The phytopathogen Xylella fastidiosa grows as a biofilm causing vascular occlusion and consequently nutrient and water stress in different plant hosts by adhesion on xylem vessel surfaces composed of cellulose, hemicellulose, pectin and proteins. Understanding the factors which influence bacterial adhesion and biofilm development is a key issue in identifying mechanisms for preventing biofilm formation in infected plants. In this study, we show that X. fastidiosa biofilm development and architecture correlate well with physicochemical surface properties after interaction with the culture medium. Different biotic and abiotic substrates such as silicon (Si) and derivatized cellulose films were studied. Both biofilms and substrates were characterized at the micro-and nanoscale, which corresponds to the actual bacterial cell and membrane/protein length scales, respectively. Our experimental results clearly indicate that the presence of surfaces with different chemical composition affect X. fastidiosa behavior from the point of view of gene expression and adhesion functionality. Bacterial adhesion is facilitated on more hydrophilic surfaces with higher surface potentials; XadA1 adhesin reveals different strengths of interaction on these surfaces. Nonetheless, despite different architectural biofilm geometries and rates of development, the colonization process occurs on all investigated surfaces. Our results univocally support the hypothesis that different adhesion mechanisms are active along the biofilm life cycle representing an adaptation mechanism for variations on the specific xylem vessel composition, which the bacterium encounters within the infected plant.	[Lorite, Gabriela S.; Janissen, Richard; Clerici, Joao H.; Cotta, Monica A.] Univ Estadual Campinas, Dept Fis Aplicada, Inst Fis Gleb Wataghin, Sao Paulo, Brazil; [Rodrigues, Carolina M.; Tomaz, Juarez P.; de Souza, Alessandra A.] Inst Agron Campinas, Ctr APTA Citros Sylvio Moreira, Sao Paulo, Brazil; [Mizaikoff, Boris; Kranz, Christine] Univ Ulm, Inst Analyt & Bioanalyt Chem, D-89069 Ulm, Germany	Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC); Ulm University	Cotta, MA (corresponding author), Univ Estadual Campinas, Dept Fis Aplicada, Inst Fis Gleb Wataghin, Sao Paulo, Brazil.	monica@ifi.unicamp.br	de Souza, Alessandra Alves/GLR-7357-2022; Mizaikoff, Boris/G-9959-2013; De Souza, Alessandra/C-3458-2012; Janissen, Richard/V-4973-2019; Kranz, Christine/F-3838-2014; Cotta, Monica A/H-3505-2012; Lorite, Gabriela S/M-9095-2016; Tomaz, Juarez/AAA-5067-2022	de Souza, Alessandra Alves/0000-0003-4589-8355; Mizaikoff, Boris/0000-0002-5583-7962; Janissen, Richard/0000-0003-0901-3433; Kranz, Christine/0000-0002-6001-0580; Cotta, Monica A/0000-0002-2779-5179; Lorite, Gabriela S/0000-0002-6530-5281; 	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/51748-7, 2009/53021-0, 2006/06397-6]; DAAD (Deutscher Akademischer Austauschdienst); DFG (Deutsche Forschungsgemeinschaft); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); DAAD (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD)); DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was financially supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, through grant #2010/51748-7 and fellowships #2009/53021-0, 2006/06397-6), DAAD (Deutscher Akademischer Austauschdienst), DFG (Deutsche Forschungsgemeinschaft), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albenne C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00111; Albenne C, 2009, MOL PLANT, V2, P977, DOI 10.1093/mp/ssp059; Asally M, 2012, P NATL ACAD SCI USA, V109, P18891, DOI 10.1073/pnas.1212429109; Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4; Bakker DP, 2003, COLLOID SURFACE B, V32, P179, DOI 10.1016/S0927-7765(03)00159-0; Beaussart A, 2012, ACS NANO, V6, P10950, DOI 10.1021/nn304505s; Caserta R, 2010, APPL ENVIRON MICROB, V76, P4250, DOI 10.1128/AEM.02114-09; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Chatterjee S, 2008, P NATL ACAD SCI USA, V105, P2670, DOI 10.1073/pnas.0712236105; Cobine PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054936; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; de Lima JEO, 1998, PLANT DIS, V82, P94, DOI 10.1094/PDIS.1998.82.1.94; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Dorobantu LS, 2009, LANGMUIR, V25, P6968, DOI 10.1021/la9001237; ELIMELECH M, 1994, DESALINATION, V95, P269, DOI 10.1016/0011-9164(94)00064-6; Enevoldsen GH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236104; Feil H, 2007, PHYTOPATHOLOGY, V97, P318, DOI 10.1094/PHYTO-97-3-0318; Gubner R, 2000, BIOFOULING, V15, P25, DOI 10.1080/08927010009386295; Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6; Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k; Hogg R, 1966, FARADAY SOC, V66, P1638; Hubbe MA, 2006, BIORESOURCES, V1, P116; Hunt SM, 2004, APPL ENVIRON MICROB, V70, P7418, DOI 10.1128/AEM.70.12.7418-7425.2004; Ishii M, 2004, APPL PHYS LETT, V85, P1610, DOI 10.1063/1.1787162; Jacobs HO, 1998, J APPL PHYS, V84, P1168, DOI 10.1063/1.368181; Jamet E, 2008, PROTEOMICS, V8, P893, DOI 10.1002/pmic.200700938; Jin HJ, 2012, SOFT MATTER, V8, P2194, DOI 10.1039/c1sm06518a; Killiny N, 2010, APPL ENVIRON MICROB, V76, P6134, DOI 10.1128/AEM.01036-10; Killiny N, 2009, P NATL ACAD SCI USA, V106, P22416, DOI 10.1073/pnas.0908562106; Killiny N, 2009, APPL ENVIRON MICROB, V75, P521, DOI 10.1128/AEM.01921-08; Lichter JA, 2008, BIOMACROMOLECULES, V9, P1571, DOI 10.1021/bm701430y; Liu DL, 2010, J ADHES SCI TECHNOL, V24, P2383, DOI 10.1163/016942410X508280; Liu DL, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2763981; Lorite GS, 2013, COLLOID SURFACE B, V102, P519, DOI 10.1016/j.colsurfb.2012.08.027; Lorite GS, 2011, J COLLOID INTERF SCI, V359, P289, DOI 10.1016/j.jcis.2011.03.066; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Melitz W, 2011, SURF SCI REP, V66, P1, DOI 10.1016/j.surfrep.2010.10.001; Meng YZ, 2005, J BACTERIOL, V187, P5560, DOI 10.1128/JB.187.16.5560-5567.2005; Moller J, 2012, NANO LETT, V12, P2901, DOI 10.1021/nl3004896; Moreau ALD, 2009, J APPL PHYS, V106, DOI 10.1063/1.3173172; Muranaka LS, 2012, J BACTERIOL, V194, P4561, DOI 10.1128/JB.00436-12; Narvaez AC, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/46/465705; Newman KL, 2004, P NATL ACAD SCI USA, V101, P1737, DOI 10.1073/pnas.0308399100; Oh YJ, 2009, ULTRAMICROSCOPY, V109, P874, DOI 10.1016/j.ultramic.2009.03.042; Osiro D, 2004, FEMS MICROBIOL LETT, V236, P313, DOI [10.1111/j.1574-6968.2004.tb09663.x, 10.1016/j.femsle.2004.06.003]; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Rizzello L, 2011, ACS NANO, V5, P1865, DOI 10.1021/nn102692m; Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o; Robledo M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-125; Saha N, 2013, BIOMACROMOLECULES, V14, P520, DOI 10.1021/bm301774a; Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219; Sheng XX, 2008, J COLLOID INTERF SCI, V321, P256, DOI 10.1016/j.jcis.2008.02.038; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Shusterman S, 2007, NANO LETT, V7, P2089, DOI 10.1021/nl071031w; Teixeira P, 1999, J ADHES SCI TECHNOL, V13, P1287, DOI 10.1163/156856199X00190; WEAVER JMR, 1991, J VAC SCI TECHNOL B, V9, P1559, DOI 10.1116/1.585423; Wulff NA, 2006, CURR MICROBIOL, V53, P198, DOI 10.1007/s00284-005-0475-2	58	35	35	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75247	10.1371/journal.pone.0075247	http://dx.doi.org/10.1371/journal.pone.0075247			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073256	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000065
J	Chaillou, S; Lucquin, I; Najjari, A; Zagorec, M; Champomier-Verges, MC				Chaillou, Stephane; Lucquin, Isabelle; Najjari, Afef; Zagorec, Monique; Champomier-Verges, Marie-Christine			Population Genetics of Lactobacillus sakei Reveals Three Lineages with Distinct Evolutionary Histories	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; CURVATUS ABO-ELNAGA; EMENDED DESCRIPTIONS; SEQUENCE; MEAT; DIVERSITY; IDENTIFICATION; INFERENCE; SUBPOPULATIONS; SOFTWARE	Lactobacillus sakei plays a major role in meat fermentation and in the preservation of fresh meat. The large diversity of L. sakei strains represents a valuable and exploitable asset in the development of a variety of industrial applications; however, an efficient method to identify and classify these strains has yet to be developed. In this study, we used multilocus sequence typing (MLST) to analyze the polymorphism and allelic distribution of eight loci within an L. sakei population of 232 strains collected worldwide. Within this population, we identified 116 unique sequence types with an average pairwise nucleotide diversity per site (pi) of 0.13%. Results from STRUCTURE, goeBURST, and CLONALFRAME software analyses demonstrated that the L. sakei population analyzed here is derived from three ancestral lineages, each of which shows evidence of a unique evolutionary history influenced by independent selection scenarios. However, the signature of selective events in the contemporary population of isolates was somewhat masked by the pervasive phenomenon of homologous recombination. Our results demonstrate that lineage 1 is a completely panmictic subpopulation in which alleles have been continually redistributed through the process of intra-lineage recombination. In contrast, lineage 2 was characterized by a high degree of clonality. Lineage 3, the earliest-diverging branch in the genealogy, showed evidence of both clonality and recombination. These evolutionary histories strongly indicate that the three lineages may correspond to distinct ecotypes, likely linked or specialized to different environmental reservoirs. The MLST scheme developed in this study represents an easy and straightforward tool that can be used to further analyze the population dynamics of L. sakei strains in food products.	[Chaillou, Stephane; Lucquin, Isabelle; Zagorec, Monique; Champomier-Verges, Marie-Christine] INRA, Micalis UMR1319, Jouy En Josas, France; [Chaillou, Stephane; Lucquin, Isabelle; Zagorec, Monique; Champomier-Verges, Marie-Christine] AgroParisTech, Micalis UMR1319, Jouy En Josas, France; [Najjari, Afef] Fac Sci Tunis, Lab Microbiol & Biomol Act, Tunis 1060, Tunisia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST)	Chaillou, S (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	stephane.chaillou@jouy.inra.fr	Chaillou, Stephane/C-5755-2016	Chaillou, Stephane/0000-0003-2229-0697; Zagorec, Monique/0000-0001-6439-983X	Agro Biotech Accelerateur	Agro Biotech Accelerateur	Agro Biotech Accelerateur has provided partial financial support to this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Berthier F, 1999, INT J SYST BACTERIOL, V49, P997, DOI 10.1099/00207713-49-3-997; Bilhere E, 2009, APPL ENVIRON MICROB, V75, P1291, DOI 10.1128/AEM.02563-08; Bredholt S, 2001, INT J FOOD MICROBIOL, V66, P191, DOI 10.1016/S0168-1605(00)00519-5; Bridier J, 2010, APPL ENVIRON MICROB, V76, P7754, DOI 10.1128/AEM.01544-10; Cai H, 2007, MICROBIOL-SGM, V153, P2655, DOI 10.1099/mic.0.2007/006452-0; Chaillou S, 2005, NAT BIOTECHNOL, V23, P1527, DOI 10.1038/nbt1160; Chaillou S, 2009, APPL ENVIRON MICROB, V75, P970, DOI 10.1128/AEM.01721-08; CHAMPOMIER MC, 1987, ANN INST PASTEUR MIC, V138, P751, DOI 10.1016/0769-2609(87)90153-0; Champomier-Verges MC, 2002, RES MICROBIOL, V153, P115, DOI 10.1016/S0923-2508(01)01296-7; Chiaramonte F, 2009, APPL ENVIRON MICROB, V75, P4498, DOI 10.1128/AEM.02868-08; Dal Bello F, 2003, MICROB ECOL, V45, P455, DOI 10.1007/s00248-003-2001-z; de las Rivas B, 2006, MICROBIOL-SGM, V152, P85, DOI 10.1099/mic.0.28482-0; Delorme C, 2010, APPL ENVIRON MICROB, V76, P451, DOI 10.1128/AEM.01018-09; Diancourt L, 2007, APPL ENVIRON MICROB, V73, P6601, DOI 10.1128/AEM.01095-07; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Falush D, 2003, GENETICS, V164, P1567; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAMMES WP, 1990, FEMS MICROBIOL LETT, V87, P165, DOI 10.1016/0378-1097(90)90704-T; Hammes WP, 1998, MEAT SCI, V49, pS125, DOI 10.1016/S0309-1740(98)00079-5; HUGAS M, 1993, INT J FOOD MICROBIOL, V18, P107, DOI 10.1016/0168-1605(93)90215-3; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Joffraud JJ, 2006, INT J FOOD MICROBIOL, V112, P51, DOI 10.1016/j.ijfoodmicro.2006.05.014; Jones RJ, 2009, FOOD MICROBIOL, V26, P876, DOI 10.1016/j.fm.2009.06.003; Klein G, 1996, INT J SYST BACTERIOL, V46, P367, DOI 10.1099/00207713-46-2-367; Labadie J, 1999, MEAT SCI, V52, P299, DOI 10.1016/S0309-1740(99)00006-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lucquin I, 2012, FOOD MICROBIOL, V29, P187, DOI 10.1016/j.fm.2011.08.001; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McLeod A, 2008, SYST APPL MICROBIOL, V31, P393, DOI 10.1016/j.syapm.2008.06.002; MORISHITA Y, 1986, INT J FOOD MICROBIOL, V3, P19, DOI 10.1016/0168-1605(86)90037-1; Najjari A, 2008, INT J FOOD MICROBIOL, V121, P342, DOI 10.1016/j.ijfoodmicro.2007.11.045; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Passerini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015306; Picozzi C, 2010, MICROBIOL-SGM, V156, P2035, DOI 10.1099/mic.0.037341-0; Pritchard JK, 2000, GENETICS, V155, P945; Raftis EJ, 2011, APPL ENVIRON MICROB, V77, P954, DOI 10.1128/AEM.01687-10; SAMELIS J, 1994, INT J FOOD MICROBIOL, V23, P179, DOI 10.1016/0168-1605(94)90051-5; Scheirlinck I, 2008, APPL ENVIRON MICROB, V74, P2414, DOI 10.1128/AEM.02771-07; SCHILLINGER U, 1989, APPL ENVIRON MICROB, V55, P1901, DOI 10.1128/AEM.55.8.1901-1906.1989; SHAW BG, 1984, J APPL BACTERIOL, V56, P25, DOI 10.1111/j.1365-2672.1984.tb04693.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanigawa K, 2011, MICROBIOL-SGM, V157, P727, DOI 10.1099/mic.0.043240-0; Tohno M, 2012, ANIM SCI J, V83, P318, DOI 10.1111/j.1740-0929.2011.00955.x; Torriani S, 1996, INT J SYST BACTERIOL, V46, P1158, DOI 10.1099/00207713-46-4-1158; Vermeiren L, 2004, INT J FOOD MICROBIOL, V96, P149, DOI 10.1016/j.ijfoodmicro.2004.03.016; VOGEL RF, 1991, FEMS MICROBIOL LETT, V84, P183, DOI 10.1016/0378-1097(91)90125-T; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; WATTERSON GA, 1978, GENETICS, V88, P405	54	47	47	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73253	10.1371/journal.pone.0073253	http://dx.doi.org/10.1371/journal.pone.0073253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069179	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300009
J	Wang, JY; Zhang, JX; Zhang, XL; Zhou, H				Wang, Jingyu; Zhang, Jinxiu; Zhang, Xiaoli; Zhou, Hao			A Protein-Based Hydrogel for In Vitro Expansion of Mesenchymal Stem Cells	PLOS ONE			English	Article							DESIGN; SCAFFOLDS	Hydrogels are widely used as scaffolds in tissue engineering because they can provide excellent environments for bioactive components including growth factors and cells. We reported in this study on a physical hydrogel formed by a specific protein-peptide interaction, which could be used for the three dimensional (3D) cell culture of murine mesenchymal stem cells (mMSC). The mMSC kept dividing during the 7-day culture period and the metabolic-active cell number at day 7 was 359% more than that at day 1. This kind of physical hydrogel could be converted to a homogeneous solution by firstly adding an equal volume of culture medium and then pipeting for several times. Therefore, mMSC post culture could be easily separated from cell-gel constructs. We believed that the protein-based hydrogel system in this study could be developed into a promising scaffold for in vitro expansion of stem cells and cell therapy. This work would be in the general interests of researchers in the fields of biomaterials and supramolecular chemistry.	[Wang, Jingyu; Zhang, Xiaoli; Zhou, Hao] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Wang, Jingyu; Zhang, Xiaoli; Zhou, Hao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Zhang, Jinxiu] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China	Nankai University; Nankai University; Hebei Normal University	Zhou, H (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	haozhou@nankai.edu.cn	Zhou, Hao/G-9693-2019	Zhou, Hao/0000-0001-6813-648X	Fundamental Research Funds for the Central Universities [65011621]; National Natural Science Foundation of China [31100527]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the Fundamental Research Funds for the Central Universities (65011621) and National Natural Science Foundation of China (31100527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]; Charati MB, 2009, SOFT MATTER, V5, P3412, DOI 10.1039/b910980c; Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250; Ehrick JD, 2009, MACROMOL BIOSCI, V9, P864, DOI 10.1002/mabi.200800337; Ehrick JD, 2005, NAT MATER, V4, P298, DOI 10.1038/nmat1352; Esser-Kahn AP, 2008, ANGEW CHEM INT EDIT, V47, P3751, DOI 10.1002/anie.200705564; Esser-Kahn AP, 2010, J AM CHEM SOC, V132, P13264, DOI 10.1021/ja103038p; Esser-Kahn AP, 2008, J AM CHEM SOC, V130, P15820, DOI 10.1021/ja807095r; Fischer SE, 2007, BIOMATERIALS, V28, P3325, DOI 10.1016/j.biomaterials.2007.03.026; Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106; Grove TZ, 2010, J AM CHEM SOC, V132, P14024, DOI 10.1021/ja106619w; Grzanka A, 2012, POL J PATHOL, V63, P101; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Ito F, 2010, BIOMATERIALS, V31, P58, DOI 10.1016/j.biomaterials.2009.09.026; Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284; Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333; Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p; Mosiewicz KA, 2010, J AM CHEM SOC, V132, P5972, DOI 10.1021/ja9098164; Mulyasasmita W, 2011, BIOMACROMOLECULES, V12, P3406, DOI 10.1021/bm200959e; Murphy WL, 2007, ANGEW CHEM INT EDIT, V46, P3066, DOI 10.1002/anie.200604808; Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057; Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389; Santos E, 2012, TRENDS BIOTECHNOL, V30, P331, DOI 10.1016/j.tibtech.2012.03.005; Sui ZJ, 2008, ADV FUNCT MATER, V18, P1824, DOI 10.1002/adfm.200701288; Sui ZJ, 2007, ADV MATER, V19, P3377, DOI 10.1002/adma.200700092; Tang Y, 2001, ANGEW CHEM INT EDIT, V40, P1494, DOI 10.1002/1521-3773(20010417)40:8<1494::AID-ANIE1494>3.0.CO;2-X; Topp S, 2006, J AM CHEM SOC, V128, P13994, DOI 10.1021/ja064546i; Wang HM, 2013, CHEM SOC REV, V42, P891, DOI 10.1039/c2cs35358j; Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358; Yan XJ, 2009, J MOL BIOL, V392, P967, DOI 10.1016/j.jmb.2009.07.060; Yuan WW, 2008, J AM CHEM SOC, V130, P15760, DOI 10.1021/ja805634x; Zhang XL, 2012, ANGEW CHEM INT EDIT, V51, P4388, DOI 10.1002/anie.201108612; Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010	33	12	12	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75727	10.1371/journal.pone.0075727	http://dx.doi.org/10.1371/journal.pone.0075727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069442	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300093
J	Yan, B; Li, H; Yang, XP; Shao, JF; Jang, M; Guan, DG; Zou, SG; Van Waes, C; Chen, Z; Zhan, M				Yan, Bin; Li, Huai; Yang, Xinping; Shao, Jiaofang; Jang, Minyoung; Guan, Daogang; Zou, Sige; Van Waes, Carter; Chen, Zhong; Zhan, Ming			Unraveling Regulatory Programs for NF-kappaB, p53 and MicroRNAs in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH-FACTOR; CONSTITUTIVE ACTIVATION; TRANSCRIPTION FACTORS; MALIGNANT PHENOTYPE; SIGNAL PATHWAYS; BINDING-SITES; CANCER; IDENTIFICATION; METASTASIS	In head and neck squamous cell carcinoma (HNSCC), mutations of p53 usually coexist with aberrant activation of NF-kappaB (NF-kappa B), other transcription factors and microRNAs, which promote tumor pathogenesis. However, how these factors and microRNAs interact to globally modulate gene expression and mediate oncogenesis is not fully understood. We devised a novel bioinformatics method to uncover interactive relationships between transcription factors or microRNAs and genes. This approach is based on matrix decomposition modeling under the joint constraints of sparseness and regulator-target connectivity, and able to integrate gene expression profiling and binding data of regulators. We employed this method to infer the gene regulatory networks in HNSCC. We found that the majority of the predicted p53 targets overlapped with those for NF-kappa B, suggesting that the two transcription factors exert a concerted modulation on regulatory programs in tumor cells. We further investigated the interrelationships of p53 and NF-kappa B with five additional transcription factors, AP1, CEBPB, EGR1, SP1 and STAT3, and microRNAs mir21 and mir34ac. The resulting gene networks indicate that interactions among NF-kappa B, p53, and the two miRNAs likely regulate progression of HNSCC. We experimentally validated our findings by determining expression of the predicted NF-kappa B and p53 target genes by siRNA knock down, and by examining p53 binding activity on promoters of predicted target genes in the tumor cell lines. Our results elucidating the cross-regulations among NF-kappa B, p53, and microRNAs provide insights into the complex regulatory mechanisms underlying HNSCC, and shows an efficient approach to inferring gene regulatory programs in biological complex systems.	[Yan, Bin; Shao, Jiaofang; Guan, Daogang] Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China; [Li, Huai; Zou, Sige] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Yang, Xinping; Jang, Minyoung; Van Waes, Carter; Chen, Zhong] NIDCD, Head & Neck Surg Branch, NIH, Bethesda, MD USA; [Jang, Minyoung] NIH, Clin Res Training Program, Bethesda, MD 20892 USA; [Jang, Minyoung] Pfizer, Bethesda, MD USA; [Zhan, Ming] Weill Cornell Med Coll, Methodist Hosp, Res Inst, Houston, TX USA	Hong Kong Baptist University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; Pfizer; Pfizer; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Yan, B (corresponding author), Hong Kong Baptist Univ, Dept Biol, Kowloon, Hong Kong, Peoples R China.	bin1999@hkbu.edu.hk; chenz@nidcd.nih.gov; mzhan@tmhs.org		Guan, Daogang/0000-0003-1414-0189; /0000-0002-2168-3379; Guan, Daogang/0000-0002-3289-1448	National Institute on Aging, National Institutes of Health (NIH); Grant of Science Faculty of Hong Kong Baptist University [3840062, FRG2/12-13/066]; Intramural Research Programs of National Institute on Deafness and Communication Disorders, NIH [ZIA-DC-000074]; NIH; Pfizer; NATIONAL INSTITUTE ON AGING [ZIAAG000365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000073, ZIADC000074] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grant of Science Faculty of Hong Kong Baptist University; Intramural Research Programs of National Institute on Deafness and Communication Disorders, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Authors would like thank funding supports from: National Institute on Aging, National Institutes of Health (NIH) to MZ BY HL SZ; Grant of Science Faculty of Hong Kong Baptist University [3840062] and [FRG2/12-13/066] to BY; Intramural Research Programs of National Institute on Deafness and Communication Disorders, NIH [ZIA-DC-000074] to ZC CVW XY; Clinical Research Training Program by NIH and Pfizer to MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bavendiek U, 2002, J BIOL CHEM, V277, P25032, DOI 10.1074/jbc.M204003200; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Catron KM, 1998, CELL GROWTH DIFFER, V9, P949; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r4; Chen Z, 2008, BIOMARK MED, V2, P409, DOI 10.2217/17520363.2.4.409; Chen ZG, 2007, CURR CANCER DRUG TAR, V7, P613, DOI 10.2174/156800907782418301; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Dell'Orso S, 2011, OMICS, V15, P305, DOI 10.1089/omi.2010.0084; Dong G, 2001, CANCER RES, V61, P5911; Dueck D, 2005, BIOINFORMATICS, V21, pI144, DOI 10.1093/bioinformatics/bti1041; Duffey DC, 1999, CANCER RES, V59, P3468; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freund A, 2004, ONCOGENE, V23, P6105, DOI 10.1038/sj.onc.1207815; Friedman J, 2007, CLIN CANCER RES, V13, P6568, DOI 10.1158/1078-0432.CCR-07-1591; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Geeven G, 2012, BIOINFORMATICS, V28, P214, DOI 10.1093/bioinformatics/btr641; Georgiev P, 2006, SPARSE COMPONENT ANA; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HERMEKING H, 2009, CELL DEATH DIFFER; Hong SH, 2000, FASEB J, V14, P1499, DOI 10.1096/fj.99-0802com; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Ikeda A, 2000, BIOCHEM BIOPH RES CO, V272, P375, DOI 10.1006/bbrc.2000.2786; Karin M, 2006, MOL CARCINOGEN, V45, P355, DOI 10.1002/mc.20217; Lee TL, 2008, INT J CANCER, V122, P1987, DOI 10.1002/ijc.23324; Lee TL, 2007, CLIN CANCER RES, V13, P5680, DOI 10.1158/1078-0432.CCR-07-0670; Li H, 2007, BIOINFORMATICS, V23, P473, DOI 10.1093/bioinformatics/btl640; LI X, 1992, NUCLEIC ACIDS RES, V20, P4765, DOI 10.1093/nar/20.18.4765; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Lu H, 2011, CANCER RES, V71, P6867, DOI 10.1158/0008-5472.CAN-11-2460; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Noda C, 2011, J BIOL CHEM, V286, P42524, DOI 10.1074/jbc.M111.271734; Nohata N, 2013, AURIS NASUS LARYNX, V40, P143, DOI 10.1016/j.anl.2012.07.001; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Pensa S, 2009, J MAMMARY GLAND BIOL, V14, P121, DOI 10.1007/s10911-009-9124-x; Pournara I, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/172840; Rasmussen MK, 2008, INFLAMM RES, V57, P329, DOI 10.1007/s00011-007-7220-1; Schneider G, 2011, BBA-REV CANCER, V1815, P90, DOI 10.1016/j.bbcan.2010.10.003; Shin JA, 2012, HEAD NECK; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Takahra T, 2004, INT J BIOCHEM CELL B, V36, P353, DOI 10.1016/S1357-2725(03)00260-7; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tang BH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00875; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Wang TH, 2002, BBA-GENE STRUCT EXPR, V1575, P108, DOI 10.1016/S0167-4781(02)00235-X; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Worden B, 2005, CANCER RES, V65, P7071, DOI 10.1158/0008-5472.CAN-04-0989; Wu J, 2010, J CELL BIOCHEM, V109, P702, DOI 10.1002/jcb.22449; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yamazaki H, 2012, EXP THER MED, V3, P793, DOI 10.3892/etm.2012.497; Yan B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r53; Yan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r78; Yang S, 2012, ONCOGENE; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	69	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73656	10.1371/journal.pone.0073656	http://dx.doi.org/10.1371/journal.pone.0073656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069219	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300017
J	Zhu, B; Xu, T; Yuan, JL; Guo, XD; Liu, DJ				Zhu, Bing; Xu, Teng; Yuan, Jianlong; Guo, Xudong; Liu, Dongjun			Transcriptome Sequencing Reveals Differences between Primary and Secondary Hair Follicle-derived Dermal Papilla Cells of the Cashmere Goat (Capra hircus)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OSTEOPONTIN INDUCES ANGIOGENESIS; NITRIC-OXIDE SYNTHASE; EXTRACELLULAR-MATRIX; TUMOR ANGIOGENESIS; TGF-BETA; IN-VIVO; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; REGULATES ANGIOGENESIS	The dermal papilla is thought to establish the character and control the size of hair follicles. Inner Mongolia Cashmere goats (Capra hircus) have a double coat comprising the primary and secondary hair follicles, which have dramatically different sizes and textures. The Cashmere goat is rapidly becoming a potent model for hair follicle morphogenesis research. In this study, we established two dermal papilla cell lines during the anagen phase of the hair growth cycle from the primary and secondary hair follicles and clarified the similarities and differences in their morphology and growth characteristics. High-throughput transcriptome sequencing was used to identify gene expression differences between the two dermal papilla cell lines. Many of the differentially expressed genes are involved in vascularization, ECM-receptor interaction and Wnt/beta-catenin/Lef1 signaling pathways, which intimately associated with hair follicle morphogenesis. These findings provide valuable information for research on postnatal morphogenesis of hair follicles.	[Zhu, Bing; Xu, Teng; Yuan, Jianlong; Guo, Xudong; Liu, Dongjun] Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Peoples R China	Inner Mongolia University	Guo, XD (corresponding author), Inner Mongolia Univ, Minist Educ, Key Lab Mammalian Reprod Biol & Biotechnol, Hohhot, Peoples R China.	xudguo@yahoo.com; nmliudongjun@sina.com		Zhu, Bing/0000-0002-5224-0829; Xu, Teng/0000-0001-6859-4202	Program of National Natural Science Foundation of China [31160228]; National High Technology Research and Development Program of China (863 Program) [2013AA102506]; National Genetically Modified Organisms Breeding Major Projects [2011ZX08008-002]	Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Genetically Modified Organisms Breeding Major Projects	The Program of National Natural Science Foundation of China (Grant No. 31160228); The National High Technology Research and Development Program of China (863 Program)(Grant No. 2013AA102506); The National Genetically Modified Organisms Breeding Major Projects (Grant No. 2011ZX08008-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs G, 2001, CANCER RES, V61, P3561; Adluri RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034790; AHARINEJAD S, 1995, BONE, V16, P315, DOI 10.1016/8756-3282(94)00044-1; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Arthur HM, 2000, DEV BIOL, V217, P42, DOI 10.1006/dbio.1999.9534; Azar WJ, 2011, ENDOCRINOLOGY, V152, P3332, DOI 10.1210/en.2011-1121; BARRIE R, 1993, J SURG RES, V55, P446, DOI 10.1006/jsre.1993.1167; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bodo E, 2007, FASEB J, V21, P3346, DOI 10.1096/fj.07-8628com; Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Campbell NE, 2010, J ONCOL, V2010, DOI 10.1155/2010/586905; Cao RH, 2002, FASEB J, V16, P1575, DOI 10.1096/fj.02-0319com; Clapp C, 2006, TRENDS ENDOCRIN MET, V17, P1, DOI 10.1016/j.tem.2005.11.009; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Dube A, 2001, CIRC RES, V88, P237; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Elliott K, 1999, J INVEST DERMATOL, V113, P873, DOI 10.1046/j.1523-1747.1999.00797.x; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Florio T, 2003, ENDOCRINOLOGY, V144, P1574, DOI 10.1210/en.2002-220949; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Fukushima T, 2007, ANTICANCER RES, V27, P3685; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Han DD, 2011, BIOCHEM BIOPH RES CO, V415, P608, DOI 10.1016/j.bbrc.2011.10.118; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hashimoto Y, 2011, J UROLOGY, V185, pE512, DOI 10.1016/j.juro.2011.02.966; HORNE KA, 1986, J EMBRYOL EXP MORPH, V97, P111; Hu HJ, 2005, BIOCHEM BIOPH RES CO, V329, P661, DOI 10.1016/j.bbrc.2005.01.158; Huang XL, 2006, BLOOD, V107, P3153, DOI 10.1182/blood-2005-08-3206; Hubmacher D, 2013, CURR OPIN RHEUMATOL, V25, P65, DOI 10.1097/BOR.0b013e32835b137b; Hunt DPJ, 2008, STEM CELLS, V26, P163, DOI 10.1634/stemcells.2007-0281; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IBRAHEEM M, 1994, J ANAT, V185, P135; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ivanciu L, 2007, ARTERIOSCL THROM VAS, V27, P310, DOI 10.1161/01.ATV.0000254147.89321.cf; JAHODA CAB, 1991, J CELL SCI, V99, P627; JAHODA CAB, 1992, DEVELOPMENT, V115, P1103; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Jones Peter Lloyd, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P137; Jubb AM, 2006, J CLIN ONCOL, V24, P217, DOI 10.1200/JCO.2005.01.5388; Kampmann A, 2009, MOL CELL BIOCHEM, V322, P15, DOI 10.1007/s11010-008-9935-x; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Khew-Goodall Y, 2012, EMBO J, V31, P786, DOI 10.1038/emboj.2011.504; Kim JH, 2011, BLOOD, V118, P2622, DOI 10.1182/blood-2010-08-299784; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kollmar O, 2010, INT J CANCER, V126, P1302, DOI 10.1002/ijc.24956; Kozlowska U, 1998, ARCH DERMATOL RES, V290, P661, DOI 10.1007/s004030050370; Kwack MH, 2013, EXP DERMATOL, V22, P229, DOI 10.1111/exd.12101; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lachgar S, 1996, J INVEST DERMATOL, V106, P17, DOI 10.1111/1523-1747.ep12326964; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leali D, 2012, ARTERIOSCL THROM VAS, V32, P696, DOI 10.1161/ATVBAHA.111.243998; LeBaron MJ, 2007, ENDOCRINOLOGY, V148, P989, DOI 10.1210/en.2006-1219; Lee MS, 2006, J IMMUNOL, V177, P5585, DOI 10.4049/jimmunol.177.8.5585; Lee P, 2002, P NATL ACAD SCI USA, V99, P10470, DOI 10.1073/pnas.162366299; Ling MT, 2005, CARCINOGENESIS, V26, P1668, DOI 10.1093/carcin/bgi128; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; Lucerna M, 2006, CANCER RES, V66, P6708, DOI 10.1158/0008-5472.CAN-05-2732; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Maeda T, 2006, ONCOGENE, V25, P1408, DOI 10.1038/sj.onc.1209168; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; MCDONALD BJ, 1987, AUST J AGR RES, V38, P597, DOI 10.1071/AR9870597; McNulty JC, 2005, J MOL BIOL, V346, P1059, DOI 10.1016/j.jmb.2004.12.030; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645; Muley A, 2010, AM J PATHOL, V176, P1505, DOI 10.2353/ajpath.2010.090465; Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518; Muller-Rover S, 1998, MOL BASIS EPITHELIAL, P283; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nakayama K, 2002, CANCER LETT, V176, P215, DOI 10.1016/S0304-3835(01)00762-5; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; NICOSIA RF, 1993, J CELL PHYSIOL, V154, P654, DOI 10.1002/jcp.1041540325; NIXON AJ, 1991, J ZOOL, V224, P589, DOI 10.1111/j.1469-7998.1991.tb03787.x; OBrien T, 1996, CANCER RES, V56, P2515; Oh H, 2002, P NATL ACAD SCI USA, V99, P383, DOI 10.1073/pnas.012074399; Oro AE, 1998, CELL, V95, P575, DOI 10.1016/S0092-8674(00)81624-4; Osada A, 2007, TISSUE ENG, V13, P975, DOI 10.1089/ten.2006.0304; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Park JA, 2008, GLIA, V56, P247, DOI 10.1002/glia.20600; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Pennisi D, 2000, NAT GENET, V24, P434, DOI 10.1038/74301; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perez-Pinera P, 2007, CELL CYCLE, V6, P2877, DOI 10.4161/cc.6.23.5090; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platten M, 2001, MICROSC RES TECHNIQ, V52, P401, DOI 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C; Puxeddu I, 2009, ALLERGY, V64, P368, DOI 10.1111/j.1398-9995.2008.01822.x; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Ribatti D, 2003, HISTOPATHOLOGY, V42, P246, DOI 10.1046/j.1365-2559.2003.01581.x; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Rutberg SE, 2006, J INVEST DERMATOL, V126, P2583, DOI 10.1038/sj.jid.5700454; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sadanandam A, 2010, MICROVASC RES, V79, P1, DOI 10.1016/j.mvr.2009.10.005; Scapini P, 2004, J IMMUNOL, V172, P5034, DOI 10.4049/jimmunol.172.8.5034; Seabrook TJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-95; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; Shimizu H, 2004, J INVEST DERMATOL, V122, P239, DOI 10.1046/j.0022-202X.2004.22224.x; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Siriwardena BSMS, 2006, BRIT J CANCER, V95, P1396, DOI 10.1038/sj.bjc.6603431; Souttou B, 2001, J CELL PHYSIOL, V187, P59, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1051>3.0.CO;2-F; Stiles JD, 1997, J NEUROPATH EXP NEUR, V56, P435, DOI 10.1097/00005072-199704000-00012; Takahashi F, 2002, INT J CANCER, V98, P707, DOI 10.1002/ijc.10261; Tamaki K, 2009, CANCER SCI, V100, P88, DOI 10.1111/j.1349-7006.2008.01015.x; TETI A, 1992, J AM SOC NEPHROL, V2, pS83; Tokes AM, 1999, PATHOL RES PRACT, V195, P821; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uyttendaele H, 2000, MICROVASC RES, V60, P91, DOI 10.1006/mvre.2000.2254; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; VOLPERT OV, 1995, BIOCHEM BIOPH RES CO, V217, P326, DOI 10.1006/bbrc.1995.2780; WESSELLS NK, 1965, DEV BIOL, V12, P419, DOI 10.1016/0012-1606(65)90007-2; Widelitz RB, 2004, J INVEST DERMATOL, V123, pVIII, DOI 10.1111/j.0022-202X.2004.23239.x; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Xu T, 2013, GENE, V520, P30, DOI 10.1016/j.gene.2013.01.068; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Zhang L, 2011, MED ONCOL, V28, P907, DOI 10.1007/s12032-010-9537-9; Zheng K, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-31	139	46	52	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76282.	10.1371/journal.pone.0076282	http://dx.doi.org/10.1371/journal.pone.0076282			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069460	Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300106
J	Shahid, MA; Markham, PF; Markham, JF; Marenda, MS; Noormohammadi, AH				Shahid, Muhammad A.; Markham, Philip F.; Markham, John F.; Marenda, Marc S.; Noormohammadi, Amir H.			Mutations in GTP Binding Protein Obg of Mycoplasma synoviae Vaccine Strain MS-H: Implications in Temperature-Sensitivity Phenotype	PLOS ONE			English	Article							50S RIBOSOMAL-SUBUNIT; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SWISS-MODEL; QUALITY; GTPASES; ENVIRONMENT; STABILITY; SERVER; SPORULATION	Mycoplasma synoviae strain MS-H, developed by chemical mutagenesis of the Australian field strain 86079/7NS, is a live temperature-sensitive (ts(+)) vaccine used for control of M. synoviae infection in poultry worldwide. Genetic basis of temperature sensitivity and attenuation of MS-H has not been revealed thus far. Comparison of the complete genome sequence of MS-H, its parent strain 86079/7NS and two non-temperature sensitive (ts(-)) reisolates of MS-H revealed a mutation in a highly conserved domain of GTP binding protein Obg of MS-H, with reversion in ts(-) MS-H reisolates. Nucleotide change from G to A at position 369 of the obg gene resulted in an alteration of glycine to arginine at position 123 in Obg fold. Further analysis of the complete obg gene sequence in several MS-H reisolates revealed that a Gly123Arg substitution was associated with alteration in temperature sensitivity phenotype of MS-H. A second mutation, C to T at position 629, in obg gene was found in some of the MS-H reisolates and appeared to suppress the effects of the Gly123Arg substitution. In silico analysis of point mutations revealed that Gly123Arg has highly destabilizing effect on the MS-H Obg structure that can potentially abolish its biological functions in vivo especially at non-permissive temperature. Findings of this study implicate Obg alteration (Gly123Arg) as one of the possible causes of MS-H attenuation/temperature sensitivity and warrant further investigations into exploring the role of Obg-like proteins, an evolutionarily conserved protein from human to bacteria, in the biology of mycoplasmas.	[Shahid, Muhammad A.; Marenda, Marc S.; Noormohammadi, Amir H.] Univ Melbourne, Fac Vet Sci, Werribee, Vic, Australia; [Markham, Philip F.] Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia; [Markham, John F.] Univ Melbourne, Sch Engn, Dept Elect & Elect Engn, Natl ICT Australia NICTA Victoria Res Lab, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; NICTA; University of Melbourne	Shahid, MA (corresponding author), Univ Melbourne, Fac Vet Sci, Werribee, Vic, Australia.	m.shahid@student.unimelb.edu.au	Shahid, Muhammad Akbar/M-7608-2019	Shahid, Muhammad Akbar/0000-0003-2554-5990; NOORMOHAMMADI, AMIR/0000-0003-3459-2692; Markham, John/0000-0002-5738-3861; MARENDA, MARC/0000-0001-6778-1110	University of Melbourne; Higher Education Commission of Pakistan; National ICT Australia (NICTA); Australian Government's Backing Australia's Ability initiative; Australian Research Council	University of Melbourne(University of Melbourne); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); National ICT Australia (NICTA); Australian Government's Backing Australia's Ability initiative(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council(Australian Research Council)	Financial support to conduct this study was provided jointly by the University of Melbourne and the Higher Education Commission of Pakistan. The senior author was supported by the Higher Education Commission of Pakistan. JFM is supported by National ICT Australia (NICTA). NICTA is funded by the Australian Government's Backing Australia's Ability initiative in part through the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Buglino J, 2002, STRUCTURE, V10, P1581, DOI 10.1016/S0969-2126(02)00882-1; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Cruz-Vera LR, 2000, J BACTERIOL, V182, P1523, DOI 10.1128/JB.182.6.1523-1528.2000; Czyz A, 2005, ACTA BIOCHIM POL, V52, P35; Datta K, 2004, MOL MICROBIOL, V54, P1379, DOI 10.1111/j.1365-2958.2004.04354.x; Drummond AJ, 2011, GENEIOUS V5 5 6; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Elsholz AKW, 2010, EMBO J, V29, P3621, DOI 10.1038/emboj.2010.228; Foti JJ, 2007, MOL MICROBIOL, V65, P569, DOI 10.1111/j.1365-2958.2007.05811.x; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; JACKWOOD MW, 1985, AVIAN DIS, V29, P1130, DOI 10.2307/1590467; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Kobayashi G, 2001, MOL MICROBIOL, V41, P1037, DOI 10.1046/j.1365-2958.2001.02574.x; KOK J, 1994, J BACTERIOL, V176, P7155, DOI 10.1128/JB.176.23.7155-7160.1994; Kukimoto-Niino M, 2004, J MOL BIOL, V337, P761, DOI 10.1016/j.jmb.2004.01.047; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lin B, 2004, J BACTERIOL, V186, P481, DOI 10.1128/JB.186.2.481-489.2004; Markham JF, 1998, AVIAN DIS, V42, P682, DOI 10.2307/1592703; Mohri Y, 2003, J BACTERIOL, V185, P1726, DOI 10.1128/JB.185.5.1726-1729.2003; Morrow CJ, 1998, AVIAN DIS, V42, P667, DOI 10.2307/1592700; Nakayashiki T, 1998, J BACTERIOL, V180, P2931, DOI 10.1128/JB.180.11.2931-2935.1998; Noormohammadi AH, 2000, MOL MICROBIOL, V35, P911, DOI 10.1046/j.1365-2958.2000.01766.x; Rokop ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006774; Sato A, 2005, GENES CELLS, V10, P393, DOI 10.1111/j.1365-2443.2005.00851.x; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scott JM, 2000, J BACTERIOL, V182, P2771, DOI 10.1128/JB.182.10.2771-2777.2000; Scott JM, 1999, J BACTERIOL, V181, P4653, DOI 10.1128/JB.181.15.4653-4660.1999; Shahid MA, 2013, AVIAN PATHOL, V42, P185, DOI 10.1080/03079457.2013.779363; Shil PK, 2011, MICROBIOL-SGM, V157, P1740, DOI 10.1099/mic.0.046789-0; Sikora AE, 2006, J BACTERIOL, V188, P1205, DOI 10.1128/JB.188.3.1205-1210.2006; Takeshi H, 2009, COMP IMMUNOL MICROB, V32, P395; Tan J, 2002, J BACTERIOL, V184, P2692, DOI 10.1128/JB.184.10.2692-2698.2002; Topham CM, 1997, PROTEIN ENG, V10, P7, DOI 10.1093/protein/10.1.7; TRACH K, 1989, J BACTERIOL, V171, P1362, DOI 10.1128/jb.171.3.1362-1371.1989; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; VIDWANS SJ, 1995, J BACTERIOL, V177, P3308, DOI 10.1128/jb.177.11.3308-3311.1995; Worth C.L., 2007, P MOL INT BRING CHEM, P11; Worth Catherine L, 2007, J Bioinform Comput Biol, V5, P1297, DOI 10.1142/S0219720007003120; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004; Yousin S, 2005, MUTAT RES, V573, P41; Zhongying C, 2008, VIROLOGY, V380, P354; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	54	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73954	10.1371/journal.pone.0073954	http://dx.doi.org/10.1371/journal.pone.0073954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069254	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300024
J	Valero, N; Mosquera, J; Anez, G; Levy, A; Marcucci, R; de Mon, MA				Valero, Nereida; Mosquera, Jesus; Anez, German; Levy, Alegria; Marcucci, Rafael; Alvarez de Mon, Melchor			Differential Oxidative Stress Induced by Dengue Virus in Monocytes from Human Neonates, Adult and Elderly Individuals	PLOS ONE			English	Article							NITRIC-OXIDE; MEMBRANE-FLUIDITY; NEWBORN BABIES; CORD BLOOD; IN-VITRO; INFECTION; RECEPTOR; LEUKOCYTES; AGE; MITOCHONDRIA	Changes in immune response during lifespan of man are well known. These changes involve decreased neonatal and elderly immune response. In addition, it has been shown a relationship between immune and oxidative mechanisms, suggesting that altered immune response could be associated to altered oxidative response. Increased expression of nitric oxide (NO) has been documented in dengue and in monocyte cultures infected with different types of dengue virus. However, there is no information about the age-dependent NO oxidative response in humans infected by dengue virus. In this study, monocyte cultures from neonatal, elderly and adult individuals (n = 10 each group) were infected with different dengue virus types (DENV-1 to 4) and oxidative/antioxidative responses and apoptosis were measured at days 1 and 3 of culture. Increased production of NO, lipid peroxidation and enzymatic and nonenzymatic anti-oxidative responses in dengue infected monocyte cultures were observed. However, neonatal and elderly monocytes had lower values of studied parameters when compared to those in adult-derived cultures. Apoptosis was present in infected monocytes with higher values at day 3 of culture. This reduced oxidant/antioxidant response of neonatal and elderly monocytes could be relevant in the pathogenesis of dengue disease.	[Valero, Nereida; Mosquera, Jesus; Anez, German] Univ Zulia, Fac Med, Inst Invest Clin Dr Americo Negrette, Maracaibo 4011, Venezuela; [Levy, Alegria; Marcucci, Rafael] Univ Zulia, Fac Med, Escuela Bioanal, Catedra Embriol, Maracaibo 4011, Venezuela; [Alvarez de Mon, Melchor] Alcala Univ, Univ Hosp Principe de Asturias, Dept Immune Syst Dis & Oncol, Madrid, Spain	Prince of Asturias University Hospital; Universidad de Alcala	Mosquera, J (corresponding author), Univ Zulia, Fac Med, Inst Invest Clin Dr Americo Negrette, Maracaibo 4011, Venezuela.	mosquera99ve@yahool.com	Añez, Germán/H-4912-2019	Añez, Germán/0000-0001-5361-3001	Fondo de Investigacion de la Seguridad Social (Spain); Consejeria de Educacion; Comunidad de Madrid; MITIC-CM [S-2010/BMD-2502]; Instituto de Salud Carlos III; MEC [PIO51871]; CONDES [CC-0393-12]	Fondo de Investigacion de la Seguridad Social (Spain); Consejeria de Educacion; Comunidad de Madrid(Comunidad de Madrid); MITIC-CM; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MEC(European Commission); CONDES	This work was supported by grants from Fondo de Investigacion de la Seguridad Social (Spain), Consejeria de Educacion, Comunidad de Madrid, MITIC-CM (S-2010/BMD-2502), Instituto de Salud Carlos III, MEC (PIO51871, CIBERehd) and CONDES CC-0393-12 (Maracaibo, Venezuela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKARID K, 1995, J VIROL, V69, P7001, DOI 10.1128/JVI.69.11.7001-7005.1995; Anez G., 2007, Dengue Bulletin, V31, P118; BENZI G, 1995, FREE RADICAL BIO MED, V19, P77, DOI 10.1016/0891-5849(94)00244-E; BERGOLD GH, 1968, J GEN VIROL, V2, P273, DOI 10.1099/0022-1317-2-2-273; BI ZB, 1995, J VIROL, V69, P2208, DOI 10.1128/JVI.69.4.2208-2213.1995; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Chan KS, 2009, J MICROBIOL IMMUNOL, V42, P471; Chen TH, 2011, VIROLOGY, V410, P410, DOI 10.1016/j.virol.2010.12.013; Courageot MP, 2003, ADV VIRUS RES, V60, P157, DOI 10.1016/S0065-3527(03)60005-9; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; Fiebeler A, 2005, HEART FAIL REV, V10, P47, DOI 10.1007/s10741-005-2348-y; Gille C, 2009, CYTOM PART B-CLIN CY, V76B, P271, DOI 10.1002/cyto.b.20474; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; HALSTEAD SB, 1977, J EXP MED, V146, P218, DOI 10.1084/jem.146.1.218; Khare Meenakshi, 1997, Indian Journal of Experimental Biology, V35, P855; Kobayashi Y, 2010, J LEUKOCYTE BIOL, V88, P1157, DOI 10.1189/jlb.0310149; Lee CC, 2013, AM J EMERG MED, V31, P783, DOI 10.1016/j.ajem.2013.01.011; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levy A, 2010, T ROY SOC TROP MED H, V104, P16, DOI 10.1016/j.trstmh.2009.06.013; Marianneau Philippe, 1998, Acta Cientifica Venezolana, V49, P13; Martino D, 2012, PEDIAT ALLERG IMM-UK, V23, P567, DOI 10.1111/j.1399-3038.2012.01287.x; MO JQ, 1995, MECH AGEING DEV, V81, P73, DOI 10.1016/0047-6374(95)01586-O; Mosquera JA, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-26; Noble JM, 1999, J GERONTOL A-BIOL, V54, pM601, DOI 10.1093/gerona/54.12.M601; Peoples JD, 2009, AM J PERINAT, V26, P647, DOI 10.1055/s-0029-1220788; PILLAY V, 1994, PFLUG ARCH EUR J PHY, V428, P197, DOI 10.1007/BF00724497; PILLAY V, 1993, PFLUG ARCH EUR J PHY, V424, P549, DOI 10.1007/BF00374921; RICH EA, 1993, GERONTOLOGY, V39, P93; Rojas EM, 2007, REV MED CHILE, V135, P743; Saraymen R, 2003, YONSEI MED J, V44, P9, DOI 10.3349/ymj.2003.44.1.9; Seet RCS, 2009, FREE RADICAL BIO MED, V47, P375, DOI 10.1016/j.freeradbiomed.2009.04.035; Soundravally R, 2008, PLATELETS, V19, P447, DOI 10.1080/09537100802155284; SPEER CP, 1985, INFECT IMMUN, V50, P919, DOI 10.1128/IAI.50.3.919-921.1985; Takuma K, 2013, CURR PROTEIN PEPT SC, V14, P43, DOI 10.2174/1389203711314010007; Tsuda K, 2010, INT HEART J, V51, P121, DOI 10.1536/ihj.51.121; Valero N, 2002, AM J TROP MED HYG, V66, P762, DOI 10.4269/ajtmh.2002.66.762; van Duin D, 2007, J AM GERIATR SOC, V55, P1438, DOI 10.1111/j.1532-5415.2007.01300.x; Ventura E, 2009, FREE RADICAL BIO MED, V46, P737, DOI 10.1016/j.freeradbiomed.2008.11.002; Walk J, 2012, CLIN EXP IMMUNOL, V169, P164, DOI 10.1111/j.1365-2249.2012.04599.x; Wick G, 1989, Curr Probl Dermatol, V18, P120	42	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73221	10.1371/journal.pone.0073221	http://dx.doi.org/10.1371/journal.pone.0073221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069178	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300007
J	Brownlow, ML; Benner, L; D'Agostino, D; Gordon, MN; Morgan, D				Brownlow, Milene L.; Benner, Leif; D'Agostino, Dominic; Gordon, Marcia N.; Morgan, Dave			Ketogenic Diet Improves Motor Performance but Not Cognition in Two Mouse Models of Alzheimer's Pathology	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; ENERGY-METABOLISM; BRAIN METABOLISM; MEMORY DEFICITS; DISEASE; DECLINE; KETONES; PROTEIN	Dietary manipulations are increasingly viewed as possible approaches to treating neurodegenerative diseases. Previous studies suggest that Alzheimer's disease (AD) patients present an energy imbalance with brain hypometabolism and mitochondrial deficits. Ketogenic diets (KDs), widely investigated in the treatment and prevention of seizures, have been suggested to bypass metabolic deficits present in AD brain by providing ketone bodies as an alternative fuel to neurons. We investigated the effects of a ketogenic diet in two transgenic mouse lines. Five months old APP/PS1 (a model of amyloid deposition) and Tg4510 (a model of tau deposition) mice were offered either a ketogenic or a control (NIH-31) diet for 3 months. Body weight and food intake were monitored throughout the experiment, and blood was collected at 4 weeks and 4 months for ketone and glucose assessments. Both lines of transgenic mice weighed less than nontransgenic mice, yet, surprisingly, had elevated food intake. The ketogenic diet did not affect these differences in body weight or food consumption. Behavioral testing during the last two weeks of treatment found that mice offered KD performed significantly better on the rotarod compared to mice on the control diet independent of genotype. In the open field test, both transgenic mouse lines presented increased locomotor activity compared to nontransgenic, age-matched controls, and this effect was not influenced by KD. The radial arm water maze identified learning deficits in both transgenic lines with no significant differences between diets. Tissue measures of amyloid, tau, astroglial and microglial markers in transgenic lines showed no differences between animals fed the control or the ketogenic diet. These data suggest that ketogenic diets may play an important role in enhancing motor performance in mice, but have minimal impact on the phenotype of murine models of amyloid or tau deposition.	[Brownlow, Milene L.; D'Agostino, Dominic; Gordon, Marcia N.; Morgan, Dave] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Brownlow, Milene L.; Benner, Leif; Gordon, Marcia N.; Morgan, Dave] USF Hlth Byrd Alzheimers Inst, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Morgan, D (corresponding author), Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	scientist.dave@gmail.com	D'Agostino, Dominic/GPJ-9744-2022; Brownlow, Milene/ABC-1063-2020; Morgan, David G/J-5989-2012	Brownlow, Milene/0000-0002-5804-6445	 [IIRG-10-174448]		This research was supported by: IIRG-10-174448. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; ANISMAN H, 1975, PSYCHOL REV, V82, P359; BECKETT TL, 2013, BRAIN RES; Blass JP, 2001, J NEUROSCI RES, V66, P851, DOI 10.1002/jnr.10087; Blass JP, 2000, ANN NY ACAD SCI, V903, P204, DOI 10.1111/j.1749-6632.2000.tb06370.x; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Bough K, 2008, EPILEPSIA, V49, P91, DOI 10.1111/j.1528-1167.2008.01846.x; Bough KJ, 2007, EPILEPSIA, V48, P43, DOI 10.1111/j.1528-1167.2007.00915.x; Caraballo Roberto H, 2012, Handb Clin Neurol, V108, P783, DOI 10.1016/B978-0-444-52899-5.00027-7; Costantini LC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S16; Dickey C, 2009, AM J PATHOL, V174, P228, DOI 10.2353/ajpath.2009.080764; Diehl J, 2004, NEUROBIOL AGING, V25, P1051, DOI 10.1016/j.neurobiolaging.2003.10.007; Diehl-Schmid J, 2007, NEUROBIOL AGING, V28, P42, DOI 10.1016/j.neurobiolaging.2005.11.002; FOSTER NL, 1983, NEUROLOGY, V33, P961, DOI 10.1212/WNL.33.8.961; Freeman JM, 2007, PEDIATRICS, V119, P535, DOI 10.1542/peds.2006-2447; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; HAMMAMI MM, 1997, ANN SAUDI MED, V17, P264; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; KASHIWAYA Y, 2012, NEUROBIOL AGING; Kim Do Y, 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0035476.PUBMED:22567104; Knight EM, 2012, NEUROBIOL AGING, V33, P187, DOI 10.1016/j.neurobiolaging.2010.02.003; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; LaManna JC, 2009, ADV EXP MED BIOL, V645, P301, DOI 10.1007/978-0-387-85998-9_45; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Liu YMC, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01830.x; Mohamed HE, 2010, J CLIN NEUROSCI, V17, P899, DOI 10.1016/j.jocn.2009.11.005; Morgan D, 2008, BEHAV NEUROSCI, V122, P730, DOI 10.1037/0735-7044.122.3.730; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; NASH KR, 2013, NEUROBIOL AGING; Noh HS, 2003, EPILEPSY RES, V53, P119, DOI 10.1016/S0920-1211(02)00262-0; Paoli A, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-34; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Srivastava S, 2012, FASEB J, V26, P2351, DOI 10.1096/fj.11-200410; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; Wang PN, 2004, J NEUROL, V251, P314, DOI 10.1007/s00415-004-0316-4; Westman Eric C, 2003, Curr Atheroscler Rep, V5, P476, DOI 10.1007/s11883-003-0038-6; Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; Yao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021788; Yao J, 2010, BBA-GEN SUBJECTS, V1800, P1121, DOI 10.1016/j.bbagen.2010.06.002; YEH YY, 1976, J NUTR, V106, P58, DOI 10.1093/jn/106.1.58; Zhao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049191; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29	49	88	93	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75713	10.1371/journal.pone.0075713	http://dx.doi.org/10.1371/journal.pone.0075713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069439	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100128
J	Opmeer, EM; Kortekaas, R; van Tol, MJ; van der Wee, NJA; Woudstra, S; van Buchem, MA; Penninx, BW; Veltman, DJ; Aleman, A				Opmeer, Esther M.; Kortekaas, Rudie; van Tol, Marie-Jose; van der Wee, Nic J. A.; Woudstra, Saskia; van Buchem, Mark A.; Penninx, Brenda W.; Veltman, Dick J.; Aleman, Andre			Influence of COMT val158met Genotype on the Depressed Brain during Emotional Processing and Working Memory	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; DOPAMINE REGULATING GENES; VAL(158)MET GENOTYPE; PSYCHOMETRIC PROPERTIES; PREFRONTAL DYSFUNCTION; MAJOR DEPRESSION; AVERSIVE STIMULI; LONDON TASK; DISORDER; AMYGDALA	Major depressive disorder (MDD) has been associated with abnormal prefrontal-limbic interactions and altered catecholaminergic neurotransmission. The val158met polymorphism on the catechol-O-methyltransferase (COMT) gene has been shown to influence prefrontal cortex (PFC) activation during both emotional processing and working memory (WM). Although COMT-genotype is not directly associated with MDD, it may affect MDD pathology by altering PFC activation, an endophenotype associated with both COMT and MDD. 125 participants, including healthy controls (HC, n=28) and MDD patients were genotyped for the COMT val158met polymorphism and underwent functional magnetic resonance imaging (fMRI-neuroimaging) during emotion processing (viewing of emotional facial expressions) and a WM task (visuospatial planning). Within HC, we observed a positive correlation between the number of met-alleles and right inferior frontal gyrus activation during emotional processing, whereas within patients the number of met-alleles was not correlated with PFC activation. During WM a negative correlation between the number of met-alleles and middle frontal gyrus activation was present in the total sample. In addition, during emotional processing there was an effect of genotype in a cluster including the amygdala and hippocampus. These results demonstrate that COMT genotype is associated with relevant endophenotypes for MDD. In addition, presence of MDD only interacts with genotype during emotional processing and not working memory.	[Opmeer, Esther M.; Kortekaas, Rudie; van Tol, Marie-Jose; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands; [van der Wee, Nic J. A.; Woudstra, Saskia; Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [van der Wee, Nic J. A.; Woudstra, Saskia; van Buchem, Mark A.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Woudstra, Saskia; Penninx, Brenda W.; Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Woudstra, Saskia] Vrije Univ Amsterdam, Med Ctr, Dept Med Genom, Amsterdam, Netherlands; [Woudstra, Saskia; Penninx, Brenda W.; Veltman, Dick J.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Woudstra, Saskia; van Buchem, Mark A.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Aleman, Andre] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands	University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen	Opmeer, EM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands.	e.m.opmeer@umcg.nl	Penninx, Brenda WJH/S-7627-2017; van Buchem, Mark/AAC-9843-2022; van Tol, 5/O-3108-2013	Penninx, Brenda WJH/0000-0001-7779-9672; van Buchem, Mark/0000-0003-1881-1998; 	Netherlands Organization for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Centre; GGZ inGeest; Arkin; Leiden University Medical Centre; GGZ Rivierduinen; University Medical Centre Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute)	Netherlands Organization for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Centre; GGZ inGeest; Arkin; Leiden University Medical Centre; GGZ Rivierduinen; University Medical Centre Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute)	The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Centre, GGZ inGeest, Arkin, Leiden University Medical Centre, GGZ Rivierduinen, University Medical Centre Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos Institute). The genotyping of the samples was provided through the Genetic Association Information Network (GAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026; [Anonymous], MATL 7 1; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Bertolino A, 2008, BIOL PSYCHIAT, V64, P226, DOI 10.1016/j.biopsych.2008.02.001; Bertolino A, 2006, PSYCHIAT RES-NEUROIM, V147, P221, DOI 10.1016/j.pscychresns.2006.04.001; Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Bistricky SL, 2011, PSYCHOL BULL, V137, P998, DOI 10.1037/a0025348; Brett M, 2002, NEUROIMAGE, V16; Cannon TD, 2006, ANNU REV CLIN PSYCHO, V2, P267, DOI 10.1146/annurev.clinpsy.2.022305.095232; Castaneda AE, 2008, J AFFECT DISORDERS, V110, P36, DOI 10.1016/j.jad.2007.12.239; de Frias CM, 2010, J COGNITIVE NEUROSCI, V22, P1614, DOI 10.1162/jocn.2009.21318; Demenescu L.R., 2011, PSYCHOL MED, P1; Di Giorgio A, 2011, PSYCHOL MED, V41, P1721, DOI 10.1017/S0033291710002278; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Domschke K, 2008, PSYCHIAT RES-NEUROIM, V163, P13, DOI 10.1016/j.pscychresns.2007.04.016; Domschke K, 2012, NEUROIMAGE, V60, P2222, DOI 10.1016/j.neuroimage.2012.02.039; Drabant EM, 2006, ARCH GEN PSYCHIAT, V63, P1396, DOI 10.1001/archpsyc.63.12.1396; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Elliott R, 1997, PSYCHOL MED, V27, P931, DOI 10.1017/S0033291797005187; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P490, DOI 10.1002/hbm.20414; Goethals I, 2005, PSYCHIAT RES-NEUROIM, V139, P31, DOI 10.1016/j.pscychresns.2004.09.007; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Jiang H, 1998, NEUROREPORT, V9, P2861, DOI 10.1097/00001756-199808240-00033; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kempton MJ, 2009, INT J NEUROPSYCHOPH, V12, P371, DOI 10.1017/S1461145708009395; Krach S, 2010, NEUROIMAGE, V53, P978, DOI 10.1016/j.neuroimage.2009.12.090; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lelli-Chiesa G, 2011, PSYCHOL MED, V41, P779, DOI 10.1017/S0033291710001431; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; Lonsdorf TB, 2011, BIOL PSYCHOL, V87, P106, DOI 10.1016/j.biopsycho.2011.02.014; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Lundqvist D., 1998, KAROLINSKA DIRECTED; Matsumoto M, 2003, NEUROSCIENCE, V116, P127, DOI 10.1016/S0306-4522(02)00556-0; Matsuo K, 2007, MOL PSYCHIATR, V12, P158, DOI 10.1038/sj.mp.4001894; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Paykel Eugene S, 2008, Dialogues Clin Neurosci, V10, P279; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Porter RJ, 2003, BRIT J PSYCHIAT, V182, P214, DOI 10.1192/bjp.182.3.214; Purcell R, 1997, PSYCHOL MED, V27, P1277, DOI 10.1017/S0033291797005448; Radley JJ, 2011, J NEUROSCI, V31, P9683, DOI 10.1523/JNEUROSCI.6040-10.2011; Rasch B, 2010, NEUROIMAGE, V52, P1712, DOI 10.1016/j.neuroimage.2010.05.054; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005; Snyder H.R., 2012, PSYCHOL B; Stein DJ, 2006, CNS SPECTRUMS, V11, P745, DOI 10.1017/S1092852900014863; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Swart M, 2011, NEUROIMAGE, V55, P338, DOI 10.1016/j.neuroimage.2010.12.017; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; van den Heuvel OA, 2003, NEUROIMAGE, V18, P367, DOI 10.1016/S1053-8119(02)00010-1; van der Meer L, 2011, NEUROIMAGE, V56, P2364, DOI 10.1016/j.neuroimage.2011.03.053; van Tol MJ, 2011, ACTA PSYCHIAT SCAND, V124, P273, DOI 10.1111/j.1600-0447.2011.01702.x; van Tol MJ, 2012, BIOL PSYCHIAT, V71, P593, DOI 10.1016/j.biopsych.2011.11.016; van Wingen GA, 2011, PSYCHOL MED, V41, P1397, DOI 10.1017/S0033291710002084; Wagner G, 2006, BIOL PSYCHIAT, V59, P958, DOI 10.1016/j.biopsych.2005.10.025; Welsh MC, 1999, BRAIN COGNITION, V41, P231, DOI 10.1006/brcg.1999.1123; Williams LM, 2010, NEUROIMAGE, V53, P918, DOI 10.1016/j.neuroimage.2010.01.084	66	31	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73290	10.1371/journal.pone.0073290	http://dx.doi.org/10.1371/journal.pone.0073290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069183	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100036
J	Potapova, IA; Cohen, IS; Doronin, SV				Potapova, Irina A.; Cohen, Ira S.; Doronin, Sergey V.			Caspases and p38 MAPK Regulate Endothelial Cell Adhesiveness for Mesenchymal Stem Cells	PLOS ONE			English	Article							OXIDIZED PHOSPHOLIPIDS; BONE-MARROW; APOPTOTIC CELLS; IN-VIVO; ADHESION; ACTIVATION; ADHERENCE; CXCR4	Mesenchymal stem cells natively circulating or delivered into the blood stream home to sites of injury. The mechanism of mesenchymal stem cell homing to sites of injury is poorly understood. We have shown that the development of apoptosis in endothelial cells stimulates endothelial cell adhesiveness for mesenchymal stem cells. Adhesion of mesenchymal stem cells to apoptotic endothelial cells depends on the activation of endothelial caspases and p38 MAPK. Activation of p38 MAPK in endothelial cells has a primary effect while the activation of caspases potentiates the mesenchymal stem cell adhesion. Overall, our study of the mesenchymal stem cell interaction with endothelial cells indicates that mesenchymal stem cells recognize and specifically adhere to distressed/apoptotic endothelial cells.	[Potapova, Irina A.; Cohen, Ira S.; Doronin, Sergey V.] SUNY Stony Brook, Dept Physiol & Biophys, Inst Mol Cardiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Doronin, SV (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Inst Mol Cardiol, Stony Brook, NY 11794 USA.	sergey.doronin@stonybrook.edu			National Institutes of Health [HL094410, GMR0188180]; New York State Stem Cell Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Stem Cell Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from National Institutes of Health grants HL094410, GMR0188180 and an institutional grant from New York State Stem Cell Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; BEVILACQUA MP, 1985, J CLIN INVEST, V76, P2003, DOI 10.1172/JCI112200; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Ciuculescu F, 2011, CYTOTHERAPY; GAMBLE JR, 1985, P NATL ACAD SCI USA, V82, P8667, DOI 10.1073/pnas.82.24.8667; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Huber J, 2002, ARTERIOSCL THROM VAS, V22, P101, DOI 10.1161/hq0102.101525; Huber J, 2006, J LIPID RES, V47, P1054, DOI 10.1194/jlr.M500555-JLR200; Jiang WH, 2006, PFLUG ARCH EUR J PHY, V453, P43, DOI 10.1007/s00424-006-0117-y; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; LEFKOWITH JB, 1992, J IMMUNOL, V149, P1729; Pohlman TH, 2000, J SURG RES, V89, P85, DOI 10.1006/jsre.1999.5801; Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200; Potapova IA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt35; Potapova IA, 2009, J CELL PHYSIOL, V219, P23, DOI 10.1002/jcp.21645; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005; Wang Y, 2006, HEART, V92, P768, DOI 10.1136/hrt.2005.069799; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	21	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73929	10.1371/journal.pone.0073929	http://dx.doi.org/10.1371/journal.pone.0073929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069252	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100075
J	Yin, SY; Xue, J; Sun, HD; Wen, B; Wang, QH; Perkins, G; Zhao, HWW; Ellisman, MH; Hsiao, YH; Yin, L; Xie, YY; Hou, GX; Zi, J; Lin, L; Haddad, GG; Zhou, D; Liu, SQ				Yin, Songyue; Xue, Jin; Sun, Haidan; Wen, Bo; Wang, Quanhui; Perkins, Guy; Zhao, Huiwen W.; Ellisman, Mark H.; Hsiao, Yu-hsin; Yin, Liang; Xie, Yingying; Hou, Guixue; Zi, Jin; Lin, Liang; Haddad, Gabriel G.; Zhou, Dan; Liu, Siqi			Quantitative Evaluation of the Mitochondrial Proteomes of Drosophila melanogaster Adapted to Extreme Oxygen Conditions	PLOS ONE			English	Article							EXPERIMENTAL SELECTION; ELECTRON-TRANSPORT; MESSENGER-RNA; CELL-DEATH; HYPOXIA; METABOLISM; EXPRESSION; ADAPTATION; RESPIRATION; SURVIVAL	Mitochondria are the primary organelles that consume oxygen and provide energy for cellular activities. To investigate the mitochondrial mechanisms underlying adaptation to extreme oxygen conditions, we generated Drosophila strains that could survive in low-or high-oxygen environments (LOF or HOF, respectively), examined their mitochondria at the ultrastructural level via transmission electron microscopy, studied the activity of their respiratory chain complexes, and quantitatively analyzed the protein abundance responses of the mitochondrial proteomes using Isobaric tag for relative and absolute quantitation (iTRAQ). A total of 718 proteins were identified with high confidence, and 55 and 75 mitochondrial proteins displayed significant differences in abundance in LOF and HOF, respectively, compared with the control flies. Importantly, these differentially expressed mitochondrial proteins are primarily involved in respiration, calcium regulation, the oxidative response, and mitochondrial protein translation. A correlation analysis of the changes in the levels of the mRNAs corresponding to differentially regulated mitochondrial proteins revealed two sets of proteins with different modes of regulation (transcriptional vs. post-transcriptional) in both LOF and HOF. We believe that these findings will not only enhance our understanding of the mechanisms underlying adaptation to extreme oxygen conditions in Drosophila but also provide a clue in studying human disease induced by altered oxygen tension in tissues and cells.	[Yin, Songyue; Sun, Haidan; Wang, Quanhui; Yin, Liang; Xie, Yingying; Hou, Guixue; Liu, Siqi] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Yin, Songyue; Liu, Siqi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xue, Jin; Zhao, Huiwen W.; Hsiao, Yu-hsin; Haddad, Gabriel G.; Zhou, Dan] Univ Calif San Diego, Dept Pediat, Div Resp Med, San Diego, CA 92103 USA; [Wen, Bo; Wang, Quanhui; Hou, Guixue; Zi, Jin; Lin, Liang; Liu, Siqi] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China; [Perkins, Guy; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92103 USA; [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California San Diego; Beijing Genomics Institute (BGI); University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Zhou, D (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, San Diego, CA 92103 USA.	d2zhou@ucsd.edu; siqiliu@genomics.cn	Zhou, Dan/T-7203-2017; Wen, Bo/I-1259-2019; Zi, Jin/AAH-8620-2020	Wen, Bo/0000-0003-2261-3150; Zhou, Dan/0000-0001-6401-9040; Perkins, Guy/0000-0002-1834-6646	973 program [2010CB912703]; National Natural Science Foundation of China [91131009]; American Heart Association [0835188N]; National Institutes of Health [5P41RR004050, P41GM103412-24, 5P01-HD-032573]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412] Funding Source: NIH RePORTER	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by an 973 program (http://www.973.gov.cn/AreaAppl.aspx) 2010CB912703 to Siqi Liu, National Natural Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) 91131009 to Siqi Liu, American Heart Association (http://www.heart.org/HEARTORG/) award (0835188N) to DZ, National Institutes of Health (http://www.nih.gov/) awards 5P41RR004050 and P41GM103412-24 to MHE, 5P01-HD-032573 to GGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2005, PROTEOMICS, V5, P2297, DOI 10.1002/pmic.200401231; Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Ali SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036801; Alonso J, 2005, J PROTEOME RES, V4, P1636, DOI 10.1021/pr050130c; Alves RMP, 2013, J BIOCHEM, V153, P209, DOI 10.1093/jb/mvs142; BHIMJI S, 1986, ACTA ANAT, V127, P205; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; Burkhart JM, 2011, PROTEOMICS, V11, P1125, DOI 10.1002/pmic.201000711; Casado-Vela J, 2010, PROTEOMICS, V10, P343, DOI 10.1002/pmic.200900509; Choe LH, 2005, ELECTROPHORESIS, V26, P2437, DOI 10.1002/elps.200410336; Claessens M, 2007, PROTEOM CLIN APPL, V1, P1306, DOI 10.1002/prca.200700049; Cooper GM, 2000, CELL MOL APPROACH; Feala JD, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-91; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Foss EJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001144; FREEMAN BA, 1981, J BIOL CHEM, V256, P986; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hardt M, 2005, ANAL CHEM, V77, P4947, DOI 10.1021/ac050161r; Heather LC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0268-2; Johnson DT, 2009, AM J PHYSIOL-ENDOC M, V296, pE422, DOI 10.1152/ajpendo.90352.2008; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim H, 2011, MOL CELL, V44, P532, DOI 10.1016/j.molcel.2011.08.045; KIMURA RE, 1983, J APPL PHYSIOL, V55, P1501, DOI 10.1152/jappl.1983.55.5.1501; Krieg RC, 2004, PROTEOMICS, V4, P2789, DOI 10.1002/pmic.200300796; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Lau E, 2011, MOL BIOSYST, V7, P1399, DOI 10.1039/c1mb05010a; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Li J, 2004, FREE RADICAL BIO MED, V36, P1460, DOI 10.1016/j.freeradbiomed.2004.03.005; Malka Florence, 2007, V372, P3, DOI 10.1007/978-1-59745-365-3_1; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; NEELY JR, 1981, AM J PATHOL, V102, P282; Nie L, 2007, CRIT REV BIOTECHNOL, V27, P63, DOI 10.1080/07388550701334212; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; PELOSI G, 1968, LAB INVEST, V18, P86; Perkins G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045344; Sacktor B., 1970, Adv. Insect Physiol., V7, P267, DOI 10.1016/S0065-2806(08)60243-X; SANDERS SP, 1993, J CLIN INVEST, V91, P46, DOI 10.1172/JCI116198; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Sims D, 2006, NUCLEIC ACIDS RES, V34, pD479, DOI 10.1093/nar/gkj038; Snyder CM, 2009, ANTIOXID REDOX SIGN, V11, P2673, DOI [10.1089/ars.2009.2730, 10.1089/ARS.2009.2730]; STRICKLAND EH, 1962, J APPL PHYS, V17, P535; Su LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054237; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Walker DW, 2004, P NATL ACAD SCI USA, V101, P10290, DOI 10.1073/pnas.0403767101; Yuan JF, 2012, TOXICOL SCI, V126, P149, DOI 10.1093/toxsci/kfr332; Zhang SY, 2013, J PROTEOME RES, V12, P2022, DOI 10.1021/pr301153z; Zhang XC, 2003, AM J RESP CELL MOL, V28, P305, DOI 10.1165/rcmb.2002-0156OC; Zhao HWW, 2012, ANTIOXID REDOX SIGN, V16, P1071, DOI 10.1089/ars.2011.4504; Zhao HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011701; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	60	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74011	10.1371/journal.pone.0074011	http://dx.doi.org/10.1371/journal.pone.0074011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069262	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100081
J	Dasenbrook, EC; Lu, L; Donnola, S; Weaver, DE; Gulani, V; Jakob, PM; Konstan, MW; Flask, CA				Dasenbrook, Elliott C.; Lu, Lan; Donnola, Shannon; Weaver, David E.; Gulani, Vikas; Jakob, Peter M.; Konstan, Michael W.; Flask, Chris A.			Normalized T1 Magnetic Resonance Imaging for Assessment of Regional Lung Function in Adult Cystic Fibrosis Patients - A Cross-Sectional Study	PLOS ONE			English	Article							INFANTS; DISEASE; VENTILATION; GUIDELINES; INFECTION; DIAGNOSIS; CHILDREN	Background: Cystic fibrosis (CF) patients would benefit from a safe and effective tool to detect early-stage, regional lung disease to allow for early intervention. Magnetic Resonance Imaging (MRI) is a safe, non-invasive procedure capable of providing quantitative assessments of disease without ionizing radiation. We developed a rapid normalized T1 MRI technique to detect regional lung disease in early-stage CF patients. Materials and Methods: Conventional multislice, pulmonary T1 relaxation time maps were obtained for 10 adult CF patients with normal spirometry and 5 healthy non-CF control subjects using a rapid Look-Locker MRI acquisition (5 seconds/imaging slice). Each lung absolute T1 map was separated into six regions of interest (ROI) by manually selecting upper, central, and lower lung regions in the left and right lungs. In order to reduce the effects of subject-to-subject variation, normalized T1 maps were calculated by dividing each pixel in the absolute T1 maps by the mean T1 time in the central lung region. The primary outcome was the differences in mean normalized T1 values in the upper lung regions between CF patients with normal spirometry and healthy volunteers. Results: Normalized T1 (nT1) maps showed visibly reduced subject-to-subject variation in comparison to conventional absolute T1 maps for healthy volunteers. An ROI analysis showed that the variation in the nT1 values in all regions was <= 2% of the mean. The primary outcome, the mean (SD) of the normalized T1 values in the upper right lung regions, was significantly lower in the CF subjects [.914 (.037)] compared to the upper right lung regions of the healthy subjects [.983 (.003)] [difference of .069 (95% confidence interval .032-.105); p=.001). Similar results were seen in the upper left lung region. Conclusion: Rapid normalized T1 MRI relaxometry obtained in 5 seconds/imaging slice may be used to detect regional early-stage lung disease in CF patients.	[Dasenbrook, Elliott C.; Weaver, David E.; Konstan, Michael W.; Flask, Chris A.] Case Western Reserve Univ, Sch Med, Dept Pediat, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.; Lu, Lan; Donnola, Shannon; Weaver, David E.; Gulani, Vikas; Konstan, Michael W.; Flask, Chris A.] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.] Case Western Reserve Univ, Dept Med, Sch Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Lu, Lan; Donnola, Shannon; Gulani, Vikas; Flask, Chris A.] Case Western Reserve Univ, Dept Radiol, Sch Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Flask, Chris A.] Case Western Reserve Univ, Dept Biomed Engn, Sch Med, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Jakob, Peter M.] Univ Wurzburg, Dept Phys, D-97070 Wurzburg, Germany	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University of Wurzburg	Dasenbrook, EC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.	ecd28@case.edu		Konstan, Michael/0000-0002-0557-7277; Dasenbrook, Elliott/0000-0001-9811-8004; Flask, Chris/0000-0002-1066-333X	National Institutes of Health (NIH) [P30-DK027651, CTSA-UL1TR000439]; Cystic Fibrosis Foundation [DASENB10A0, KONSTA03Y2]; Seimens Medical System; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Seimens Medical System; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health (NIH) grants P30-DK027651 and CTSA-UL1TR000439, the Cystic Fibrosis Foundation (DASENB10A0 and KONSTA03Y2), and Seimens Medical System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Bannier E, 2010, RADIOLOGY, V255, P225, DOI 10.1148/radiol.09090039; Cystic Fibrosis Foundation, 2012, CYST FIBR FDN PAT RE; Dasenbrook EC, 2012, JAMA-J AM MED ASSOC, V307, P2316, DOI 10.1001/jama.2012.5853; Dasenbrook EC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d726; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Edelman RR, 1996, NAT MED, V2, P1236, DOI 10.1038/nm1196-1236; Eichinger M, 2010, J MAGN RESON IMAGING, V32, P1370, DOI 10.1002/jmri.22374; Fain S, 2010, J MAGN RESON IMAGING, V32, P1398, DOI 10.1002/jmri.22375; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hoo AF, 2012, THORAX, V67, P874, DOI 10.1136/thoraxjnl-2012-201747; Hopkins SR, 2007, J APPL PHYSIOL, V102, P1244, DOI 10.1152/japplphysiol.00738.2006; Jakob PM, 2001, J MAGN RESON IMAGING, V14, P795, DOI 10.1002/jmri.10024; Kirby M, 2011, ACAD RADIOL, V18, P1006, DOI 10.1016/j.acra.2011.03.005; Koscik RE, 2000, PEDIATR PULM, V29, P457, DOI 10.1002/(SICI)1099-0496(200006)29:6<457::AID-PPUL8>3.3.CO;2-0; Linnane BM, 2008, AM J RESP CRIT CARE, V178, P1238, DOI 10.1164/rccm.200804-551OC; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Schraml C, 2012, MAGN RESON MATER PHY, V25, P155, DOI 10.1007/s10334-011-0271-x; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; Tiddens HAWM, 2010, PEDIATR PULM, V45, P107, DOI 10.1002/ppul.21154; Wainwright CE, 2011, JAMA-J AM MED ASSOC, V306, P163, DOI 10.1001/jama.2011.954	24	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73286	10.1371/journal.pone.0073286	http://dx.doi.org/10.1371/journal.pone.0073286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086277	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700007
J	Wynns, AA; Jensen, AB; Eilenberg, J				Wynns, Anja A.; Jensen, Annette B.; Eilenberg, Jorgen			Ascosphaera callicarpa, a New Species of Bee-Loving Fungus, with a Key to the Genus for Europe	PLOS ONE			English	Article							ALFALFA LEAFCUTTING BEE; AGGREGATA SKOU; APIS; MEGACHILIDAE; HYMENOPTERA; LARVAE	We studied the bee specialist fungus Ascosphaera in wild solitary bees to investigate the diversity of the genus in nature and the ecology of these fungi with their bee hosts. A new morphologically distinctive species was discovered which also has a unique nrITS sequence. This new species, here named Ascosphaera callicarpa, is common on the larval feces of the solitary bee Chelostoma florisomne which nests in the Phragmites reeds of thatched roofs in Europe. Because collections of Ascosphaera from wild bees are scarce and because little is known about the ecology and distribution of the majority of the species in the genus, a key to the species thus far reported for Europe is included.	[Wynns, Anja A.; Jensen, Annette B.; Eilenberg, Jorgen] Univ Copenhagen, Ctr Social Evolut, Dept Plant & Environm Sci, Frederiksberg, Denmark	University of Copenhagen	Wynns, AA (corresponding author), Univ Copenhagen, Ctr Social Evolut, Dept Plant & Environm Sci, Frederiksberg, Denmark.	aaw@life.ku.dk	Eilenberg, Jorgen/F-7444-2014; Jensen, Annette B/G-7558-2014; Jensen, Annette Bruun/AAH-1732-2021	Eilenberg, Jorgen/0000-0002-9273-5252; Jensen, Annette B/0000-0002-2044-2274; Jensen, Annette Bruun/0000-0002-2044-2274; Amtoft Wynns, Anja/0000-0002-6013-9456	University of Copenhagen; Danish National Research Foundation	University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the University of Copenhagen and the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 1998, AUST SYST BOT, V11, P53, DOI 10.1071/SB96026; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Aronstein KA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-391; BAKER GM, 1968, MYCOLOGIA, V60, P189, DOI 10.2307/3757322; BERBEE ML, 1992, MOL BIOL EVOL, V9, P278; BISSETT J, 1988, CAN J BOT, V66, P2541, DOI [10.1139/b88-346, 10.1139/b88-057]; Claussen P., 1921, Arbeiten aus der Biologischen Reichsanstalt fuer Land- u Forstwirtschaft Berlin, V10, P467; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geiser DM, 2006, MYCOLOGIA, V98, P1053, DOI 10.3852/mycologia.98.6.1053; GILLIAM M, 1994, J INVERTEBR PATHOL, V63, P307, DOI 10.1006/jipa.1994.1057; GILLIAM M, 1993, J INVERTEBR PATHOL, V61, P111, DOI 10.1006/jipa.1993.1021; GOERZEN DW, 1990, CAN ENTOMOL, V122, P1269, DOI 10.4039/Ent1221269-11; GOERZEN DW, 1992, CAN ENTOMOL, V124, P557, DOI 10.4039/Ent124557-3; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HERMOSO-DE-MENDOZA M, 1989, J APICULT RES, V28, P61; HITCHCOCK JD, 1972, MYCOLOGIA, V64, P1193, DOI 10.2307/3758091; HOLM S N, 1972, Entomologica Scandinavica, V3, P169; James Rosalind R., 2008, P124; James RR, 2005, J INVERTEBR PATHOL, V90, P98, DOI 10.1016/j.jip.2005.08.004; James RR, 2005, APIDOLOGIE, V36, P15, DOI 10.1051/apido:2004065; Maasen A, 1916, MITT KAISERL BIOL AN, V16, P51; Maurizio A, 1935, BER SCHWEIZ BOT GES, V44, P676; Melville R, 1944, NATURE, V153, P112, DOI 10.1038/153112a0; PROKSCHL H, 1953, ARCH MIKROBIOL, V18, P198; Sedivy C, 2011, FUNCT ECOL, V25, P718, DOI 10.1111/j.1365-2435.2010.01828.x; SKOU J P, 1972, Friesia, V10, P1; SKOU JP, 1989, MYCOTAXON, V35, P211; Skou JP., 1986, APIMONDIA, V30, P260; Skou JP, 1979, VET MICROBIOL, V149, P200; SPILTOIR CF, 1955, MYCOLOGIA, V47, P238, DOI 10.2307/3755414; SPILTOIR CF, 1955, AM J BOT, V42, P501, DOI 10.2307/2438686; Stephen WP, 1969, BIOL EXTERNAL MORPHO; Stephen WP, 1981, OREGON STATE U AGR E; Thiers B., 2008, INDEX HERBARIORUM GL; Westrich P, 1989, WILDBIENEN BADEN WUR; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Wynns A, 2012, THESIS U COPENHAGEN; Wynns AA, 2012, MYCOLOGIA, V104, P108, DOI 10.3852/10-047; YOUSSEF NN, 1984, J INVERTEBR PATHOL, V43, P11, DOI 10.1016/0022-2011(84)90059-4	40	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73419	10.1371/journal.pone.0073419	http://dx.doi.org/10.1371/journal.pone.0073419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086280	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700008
J	Edwards, CTT; Rasmussen, GSA; Riordan, P; Courchamp, F; Macdonald, DW				Edwards, Charles T. T.; Rasmussen, Gregory S. A.; Riordan, Philip; Courchamp, Franck; Macdonald, David W.			Non-Adaptive Phenotypic Evolution of the Endangered Carnivore Lycaon pictus	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; INBREEDING DEPRESSION; DEVELOPMENTAL STABILITY; CONTEMPORARY EVOLUTION; HABITAT DISTURBANCE; GENETIC DIVERSITY; CONSERVATION; EXTINCTION; FITNESS; STRESS	Decline in wild populations as a result of anthropogenic impact is widely considered to have evolutionary consequences for the species concerned. Here we examine changes in developmental stability in the painted hunting dog (Lycaon pictus), which once occupied most of sub-Saharan Africa but has undergone a dramatic population decline in the last century. Fluctuating asymmetry (FA) was used as an indicator of developmental stability and measured in museum skull specimens spanning a hundred year period. A comparison with the more ubiquitous black-backed jackal (Canis mesomelas) revealed FA in L. pictus to be high. Furthermore, the data indicate a temporal increase in FA over time in L. pictus, corresponding to the period of its population decline. The high rate of change is compatible with genetic drift although environmental factors are also likely to be important. Lowering developmental stability over time may have direct fitness consequences and as such represents an unacknowledged threat to future resilience of the population.	[Edwards, Charles T. T.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Rasmussen, Gregory S. A.; Riordan, Philip; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England; [Rasmussen, Gregory S. A.] Nat Hist Museum, Painted Dog Res Project, Bulawayo, Zimbabwe; [Courchamp, Franck] Univ Paris Sud, UMR CNRS 8079, Orsay, France	Imperial College London; University of Oxford; UDICE-French Research Universities; Universite Paris Saclay	Edwards, CTT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England.	charles.edwards@niwa.co.nz	Courchamp, Franck/ABE-7204-2020; Riordan, Philip/AAY-6420-2020	Courchamp, Franck/0000-0001-7605-4548; Riordan, Philip/0000-0001-6285-8596	Painted Dog Conservation, Ganda lodge, Hwange National Park, Dete, Zimbabwe; Peoples' Trust for Endangered Species	Painted Dog Conservation, Ganda lodge, Hwange National Park, Dete, Zimbabwe; Peoples' Trust for Endangered Species	This work was made possible through financial support of Painted Dog Conservation, Ganda lodge, Hwange National Park, P.O. Box 72, Dete, Zimbabwe. DWM is grateful for a grant from the Peoples' Trust for Endangered Species. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alados CL, 1995, CAN J ZOOL, V73, P1967, DOI 10.1139/z95-231; Ansell W. F. H., 1978, MAMMALS ZAMBIA; Bechshoft TO, 2008, ANN ZOOL FENN, V45, P32, DOI 10.5735/086.045.0103; Benitez HA, 2011, INT J MORPHOL, V29, P1459, DOI 10.4067/S0717-95022011000400066; BRADSHAW AD, 1989, BIOL J LINN SOC, V37, P137, DOI 10.1111/j.1095-8312.1989.tb02099.x; CARO TM, 1994, SCIENCE, V263, P485, DOI 10.1126/science.8290956; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Carter AJR, 2011, EVOLUTION, V65, P3558, DOI 10.1111/j.1558-5646.2011.01393.x; CHILDES SL, 1988, BIOL CONSERV, V44, P301, DOI 10.1016/0006-3207(88)90022-5; CLARKE GM, 1995, CONSERV BIOL, V9, P18, DOI 10.1046/j.1523-1739.1995.09010018.x; Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Dongen SV, 2006, J EVOLUTION BIOL, V19, P1727, DOI 10.1111/j.1420-9101.2006.01175.x; Dworkin I, 2005, VARIATION CENTRAL CO; Eldridge MDB, 1999, CONSERV BIOL, V13, P531, DOI 10.1046/j.1523-1739.1999.98115.x; Fanshawe JH, 1997, AFRICAN WILD DOG STA; Faraway J., 2004, LINEAR MODELS R; Faraway JJ., 2005, EXTENDING LINEAR MOD; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; FRANKEL OH, 1974, GENETICS, V78, P53; Frankel OH, 1981, CONSERVATION EVOLUTI; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Fredrickson RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2365, DOI 10.1098/rspb.2007.0785; Fuller Rebecca C., 2003, P157; FULLER TK, 1992, WILDLIFE 2001 : POPULATIONS, P1125; GINGERICH PD, 1993, AM J SCI, V293A, P453, DOI 10.2475/ajs.293.A.453; Girman DJ, 2001, MOL ECOL, V10, P1703, DOI 10.1046/j.0962-1083.2001.01302.x; GIRMAN DJ, 1993, J HERED, V84, P450, DOI 10.1093/oxfordjournals.jhered.a111371; Girman DJ, 1997, AFRICAN WILD DOG STA; Gomendio M, 2000, P ROY SOC B-BIOL SCI, V267, P875, DOI 10.1098/rspb.2000.1084; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gomulkiewicz R, 2010, EVOL APPL, V3, P97, DOI 10.1111/j.1752-4571.2009.00117.x; Grether GF, 2005, AM NAT, V166, pE115, DOI 10.1086/432023; HALDANE JBS, 1949, EVOLUTION, V3, P51, DOI 10.2307/2405451; HARTT L, 1995, EVOL ECOL, V9, P1, DOI 10.1007/BF01237691; Helle S, 2011, ECOL INDIC, V11, P861, DOI 10.1016/j.ecolind.2010.11.004; Hendrickx F, 2003, J EVOLUTION BIOL, V16, P1270, DOI 10.1046/j.1420-9101.2003.00633.x; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LANDE R, 1995, CONSERV BIOL, V9, P782, DOI 10.1046/j.1523-1739.1995.09040782.x; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; Lens L, 2000, ECOL LETT, V3, P516, DOI 10.1046/j.1461-0248.2000.00181.x; Lens L, 1999, P ROY SOC B-BIOL SCI, V266, P1241, DOI 10.1098/rspb.1999.0769; Lens L, 1999, P ROY SOC B-BIOL SCI, V266, P1055, DOI 10.1098/rspb.1999.0743; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lerner IM, 1954, GENETIC HOMEOSTASIS; Leung B, 1997, OIKOS, V78, P397, DOI 10.2307/3546309; Leung B, 2000, AM NAT, V155, P101, DOI 10.1086/303298; Lovatt FM, 2011, BIOL J LINN SOC, V102, P798, DOI 10.1111/j.1095-8312.2011.01600.x; Loveridge A. J., 2004, CANIDS FOXES WOLVES; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Lynch M, 1995, EVOLUTION, V49, P1067, DOI [10.1111/j.1558-5646.1995.tb04434.x, 10.2307/2410432]; LYNCH M, 1996, CONSERVATION GENETIC; Marsden CD, 2012, MOL ECOL, V21, P1379, DOI 10.1111/j.1365-294X.2012.05477.x; Marsden CD, 2009, J HERED, V100, pS54, DOI 10.1093/jhered/esp031; Masona T, 1987, COLONIAL GAME POLICY; MILLS LS, 1994, AM NAT, V144, P412, DOI 10.1086/285684; Morris MR, 2012, FUNCT ECOL, V26, P723, DOI 10.1111/j.1365-2435.2012.01983.x; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; Palmer A. R., 2003, DEV INSTABILITY DI C; Palmer A. Richard, 1992, Acta Zoologica Fennica, V191, P57; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Palumbi Stephen R., 2001, EVOLUTION EXPLOSION; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Pringle J., 1982, CONSERVATIONISTS KIL; Reed DH, 2003, CONSERV GENET, V4, P405, DOI 10.1023/A:1024081416729; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Roldan ERS, 1998, P ROY SOC B-BIOL SCI, V265, P243, DOI 10.1098/rspb.1998.0288; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SCHARLOO W, 1991, ANNU REV ECOL SYST, V22, P65, DOI 10.1146/annurev.es.22.110191.000433; Sokal R. R., 2012, BIOMETRY; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Spinage C., 1991, 3 BOTSW SOC; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Talloen W, 2010, BIOL J LINN SOC, V100, P103, DOI 10.1111/j.1095-8312.2010.01422.x; Vangestel C, 2011, ECOL INDIC, V11, P389, DOI 10.1016/j.ecolind.2010.06.009; VANVALEN L, 1962, EVOLUTION, V16, P125; Velickovic M, 2007, BELG J ZOOL, V137, P147; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Vollestad LA, 1999, HEREDITY, V83, P206, DOI 10.1046/j.1365-2540.1999.00555.x; VRIJENHOEK RC, 1994, EXS, V68, P37; Waddington C., 1957, STRATEGY GENES; WAYNE RK, 1986, EVOLUTION, V40, P78, DOI 10.1111/j.1558-5646.1986.tb05719.x; White TA, 2008, J EVOLUTION BIOL, V21, P636, DOI 10.1111/j.1420-9101.2007.01481.x; Woodroffe R., 2012, IUCN 2013 IUCN RED L; WOODROFFE R, 2004, CANIDS FOXES WOLVES; Woodroffe Rosie, 1997, P58; Wright S., 1977, EVOLUTION GENETICS P, V3	91	5	5	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73856	10.1371/journal.pone.0073856	http://dx.doi.org/10.1371/journal.pone.0073856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086298	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200015
J	Sanders, R; Mason, DJ; Foy, CA; Huggett, JF				Sanders, Rebecca; Mason, Deborah J.; Foy, Carole A.; Huggett, Jim F.			Evaluation of Digital PCR for Absolute RNA Quantification	PLOS ONE			English	Article							REAL-TIME PCR; GUIDELINES MINIMUM INFORMATION; VIRUS REVERSE-TRANSCRIPTASE; POLYMERASE-CHAIN-REACTION; COPY NUMBER VARIATION; QUANTITATIVE RT-PCR; DETECTION LIMITS; DNA; APPLICABILITY; PUBLICATION	Gene expression measurements detailing mRNA quantities are widely employed in molecular biology and are increasingly important in diagnostic fields. Reverse transcription (RT), necessary for generating complementary DNA, can be both inefficient and imprecise, but remains a quintessential RNA analysis tool using qPCR. This study developed a Transcriptomic Calibration Material and assessed the RT reaction using digital (d) PCR for RNA measurement. While many studies characterise dPCR capabilities for DNA quantification, less work has been performed investigating similar parameters using RT-dPCR for RNA analysis. RT-dPCR measurement using three, one-step RT-qPCR kits was evaluated using single and multiplex formats when measuring endogenous and synthetic RNAs. The best performing kit was compared to UV quantification and sensitivity and technical reproducibility investigated. Our results demonstrate assay and kit dependent RT-dPCR measurements differed significantly compared to UV quantification. Different values were reported by different kits for each target, despite evaluation of identical samples using the same instrument. RT-dPCR did not display the strong inter-assay agreement previously described when analysing DNA. This study demonstrates that, as with DNA measurement, RT-dPCR is capable of accurate quantification of low copy RNA targets, but the results are both kit and target dependent supporting the need for calibration controls.	[Sanders, Rebecca; Foy, Carole A.; Huggett, Jim F.] LGC, Teddington, Middx, England; [Sanders, Rebecca; Mason, Deborah J.] Cardiff Sch BioSci, Cardiff, S Glam, Wales	Cardiff University	Sanders, R (corresponding author), LGC, Teddington, Middx, England.	rebecca.sanders@lgcgroup.com	Mason, Deborah J/F-8265-2010; Huggett, Jim/N-9316-2013	Mason, Deborah J/0000-0003-4926-3365; Huggett, Jim/0000-0002-0945-1911	UK National Measurement System	UK National Measurement System	The work described in this manuscript was funded by the UK National Measurement System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BarraganGonzalez E, 1997, CLIN CHIM ACTA, V260, P73, DOI 10.1016/S0009-8981(96)06509-6; Bhat S, 2010, ANAL CHEM, V82, P7185, DOI 10.1021/ac100845m; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; Blotta Ida, 2005, Ann Ist Super Sanita, V41, P119; Burns MJ, 2010, EUR FOOD RES TECHNOL, V231, P353, DOI 10.1007/s00217-010-1277-8; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Chandler DP, 1998, APPL ENVIRON MICROB, V64, P669; CHUMAKOV KM, 1994, PCR METH APPL, V4, P62; Curry J, 2002, BIOTECHNIQUES, V32, P768, DOI 10.2144/02324st02; De Paula SO, 2004, J CLIN VIROL, V30, P297, DOI 10.1016/j.jcv.2003.11.004; Devonshire AS, 2013, METHODS, V59, P89, DOI 10.1016/j.ymeth.2012.07.021; Devonshire AS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-118; Dhanasekaran S, 2010, J IMMUNOL METHODS, V354, P34, DOI 10.1016/j.jim.2010.01.004; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Fan HC, 2007, ANAL CHEM, V79, P7576, DOI 10.1021/ac0709394; Gerard GF, 1997, MOL BIOTECHNOL, V8, P61, DOI 10.1007/BF02762340; Haque KA, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-20; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Levesque-Sergerie JP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-93; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Perez-Novo CA, 2005, BIOTECHNIQUES, V39, P52; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Quinn T, 2005, PHILOS T ROY SOC A, V363, P2307, DOI 10.1098/rsta.2005.1642; Sanders R, 2011, ANAL CHEM; SELLNER LN, 1992, NUCLEIC ACIDS RES, V20, P1487, DOI 10.1093/nar/20.7.1487; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; Suslov O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni176; Valasek MA, 2005, ADV PHYSIOL EDUC, V29, P151, DOI 10.1152/advan.00019.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wacker Michael J, 2005, J Biomol Tech, V16, P266; Whale AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058177; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; White RA, 2012, J VIROL METHODS, V179, P45, DOI 10.1016/j.jviromet.2011.09.017; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	113	120	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75296	10.1371/journal.pone.0075296	http://dx.doi.org/10.1371/journal.pone.0075296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073259	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000324768000068
J	Wang, SL; Chi, CY; Kuo, PH; Tsai, HP; Wang, SM; Liu, CC; Su, IJ; Wang, JR				Wang, Shan-Li; Chi, Chia-Yu; Kuo, Pin-Hwa; Tsai, Huey-Pin; Wang, Shih-Min; Liu, Ching-Chuan; Su, Ih-Jen; Wang, Jen-Ren			High-Incidence of Human Adenoviral Co-Infections in Taiwan	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; COMPUTATIONAL ANALYSIS; GENOME TYPE; SPECIES-C; IDENTIFICATION; CHILDREN; EPIDEMIOLOGY; TYPE-3; SEROTYPES; SPECIMENS	Background: Respiratory infections caused by adenovirus (HAdV) are common year round. Recently, a significant increase of adenoviral infections was observed in Taiwan. Objective: To understand the prevalence and molecular epidemiology of respiratory adenovirus circulating in Taiwan for the past decade. Study Design: One hundred and twenty-six human adenoviruses, isolated between 2002 to 2011, were characterized via DNA sequencing of the hexon and fiber genes. The nucleotide sequences were then compared by phylogenetic analysis. Results: HAdV-B3 accounted for 64.3% (81/126) and peaked almost every year, whereas the sequences of hexon and fiber genes of HAdV-B3 were highly conserved in different years. A high incidence of co-infection of adenoviruses was observed (19.0%, 24/126); HAdV-B3 co-infected with HAdV-C2 was the most common combination (58.3%, 14/24). An additional interesting finding of repeated infection was noted in 10 children, all of whom showed first infection with adenovirus species HAdV-C, followed by species HAdV-B or HAdV-E. Conclusions: HAdV-B3 was the predominant type of respiratory adenovirus circulating in Taiwan over the past ten years. This merits further attention for vaccine development. Furthermore, the observed high-incidence of adenoviral co-infections along with repeated infections found in our study provides important epidemiological insights into adenovirus infections.	[Wang, Shan-Li; Chi, Chia-Yu; Su, Ih-Jen; Wang, Jen-Ren] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Kuo, Pin-Hwa; Tsai, Huey-Pin; Wang, Jen-Ren] Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70428, Taiwan; [Wang, Shih-Min] Natl Cheng Kung Univ Hosp, Dept Emergency Med, Tainan 70428, Taiwan; [Wang, Jen-Ren] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Wang, Shih-Min; Liu, Ching-Chuan; Wang, Jen-Ren] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Liu, Ching-Chuan] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 70101, Taiwan; [Wang, Shih-Min] Natl Cheng Kung Univ, Coll Med, Dept Emergency Med, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Wang, JR (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan.	jrwang@mail.ncku.edu.tw	Wang, Jen-Ren/F-5254-2011; Su, Ih-Jen/B-2655-2010; Chi, Chia-Yu/E-3828-2010	Wang, Jen-Ren/0000-0002-4127-4046	National Health Research Institutes, Taiwan; Department of Health, Centers for Disease Control, Taiwan	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Department of Health, Centers for Disease Control, Taiwan	This study was supported by National Health Research Institutes, Taiwan and by Department of Health, Centers for Disease Control, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Jamil J, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-46; Alharbi S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-55; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; Biere B, 2010, J CLIN VIROL, V47, P366, DOI 10.1016/j.jcv.2010.01.005; Blasiole DA, 2004, J CLIN MICROBIOL, V42, P1686, DOI 10.1128/JCM.42.4.1686-1693.2004; Chang SY, 2008, J MED VIROL, V80, P102, DOI 10.1002/jmv.21045; Chen HL, 2004, J TROP PEDIATRICS, V50, P279, DOI 10.1093/tropej/50.5.279; Dehghan S, 2013, VIROLOGY, V443, P197, DOI 10.1016/j.virol.2013.05.014; Echavarria M, 2006, J CLIN MICROBIOL, V44, P625, DOI 10.1128/JCM.44.2.625-627.2006; Fujimoto T, 2012, JPN J INFECT DIS, V65, P260, DOI 10.7883/yoken.65.260; Gu L, 2012, J CLIN VIROL, V54, P295, DOI 10.1016/j.jcv.2012.04.018; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; JOHANSSON ME, 1980, J CLIN MICROBIOL, V12, P95, DOI 10.1128/JCM.12.1.95-100.1980; JULKUNEN I, 1986, J CLIN MICROBIOL, V24, P112, DOI 10.1128/JCM.24.1.112-115.1986; Kajon AE, 2010, J INFECT DIS, V202, P93, DOI 10.1086/653083; Kajon Adriana E, 2007, Methods Mol Med, V131, P335; Kalu SU, 2010, PEDIATR INFECT DIS J, V29, P746, DOI 10.1097/INF.0b013e3181d743c8; Kim YJ, 2003, J CLIN MICROBIOL, V41, P4594, DOI 10.1128/JCM.41.10.4594-4599.2003; Lee JA, 2005, J CLIN MICROBIOL, V43, P5509, DOI 10.1128/JCM.43.11.5509-5514.2005; Lee J, 2010, J MED VIROL, V82, P624, DOI 10.1002/jmv.21701; Ludwig SL, 1998, J INFECT DIS, V178, P1776, DOI 10.1086/314498; Madisch I, 2005, J VIROL, V79, P15265, DOI 10.1128/JVI.79.24.15265-15276.2005; Mandelboim M, 2011, J CLIN MICROBIOL, V49, P597, DOI 10.1128/JCM.00979-10; McCarthy T, 2009, J CLIN VIROL, V46, P80, DOI 10.1016/j.jcv.2009.06.008; Metzgar D, 2005, J CLIN MICROBIOL, V43, P5743, DOI 10.1128/JCM.43.11.5743-5752.2005; Mizuta K, 2009, VIRUS RES, V140, P32, DOI 10.1016/j.virusres.2008.10.014; Qurei L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042732; Selvaraju SB, 2011, J CLIN VIROL, V51, P126, DOI 10.1016/j.jcv.2011.02.014; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; Vora GJ, 2006, EMERG INFECT DIS, V12, P921, DOI 10.3201/eid1206.050245; WADELL G, 1980, INFECT IMMUN, V27, P292, DOI 10.1128/IAI.27.2.292-296.1980; Walsh MP, 2011, J CLIN MICROBIOL, V49, P3482, DOI 10.1128/JCM.00156-11; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Zou LR, 2012, APMIS, V120, P683, DOI 10.1111/j.1600-0463.2012.02890.x	34	7	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75208	10.1371/journal.pone.0075208	http://dx.doi.org/10.1371/journal.pone.0075208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073254	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000063
J	Casiraghi, F; Lertwattanarak, R; Luzi, L; Chavez, AO; Davalli, AM; Naegelin, T; Comuzzie, AG; Frost, P; Musi, N; Folli, F				Casiraghi, Francesca; Lertwattanarak, Raweewan; Luzi, Livio; Chavez, Alberto O.; Davalli, Alberto M.; Naegelin, Terry; Comuzzie, Anthony G.; Frost, Patricia; Musi, Nicolas; Folli, Franco			Energy Expenditure Evaluation in Humans and Non-Human Primates by SenseWear Armband. Validation of Energy Expenditure Evaluation by SenseWear Armband by Direct Comparison with Indirect Calorimetry	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MULTISENSOR ARMBAND; ACTIVITY MONITORS; DETERMINANTS; ACCURACY; VALIDITY; DEVICE; COST	Introduction: The purpose of this study was to compare and validate the use of SenseWear Armband (SWA) placed on the arm (SWA ARM) and on the back (SWA BACK) in healthy humans during resting and a cycle-ergometer exercise and to evaluate the SWA to estimate Resting Energy Expenditure (REE) and Total Energy Expenditure (TEE) in healthy baboons. Methods: We studied 26 (15F/11M) human subjects wearing SWA in two different anatomical sites (arm and back) during resting and a cycle-ergometer test and directly compared these results with indirect calorimetry evaluation (IC), performed at the same time. We then inserted the SWA in a metabolic jacket for baboons and evaluated the TEE and REE in free living condition for 6 days in 21 (8F/13M) non-human primates. Results: In humans we found a good correlation between SWA place on the ARM and on the BACK with IC during the resting experiment (1.1 +/- 0.3 SWAs, 1 +/- 0.2 IC kcal/min) and a slight underestimation in the SWAs data compared with IC during the cycle-ergometer exercise (5 +/- 1.9 SWA ARM, 4.5 +/- 1.5 SWA BACK and 5.4 +/- 2.1 IC kcal/min). In the non- human primate (baboons) experiment SWA estimated a TEE of 0.54 +/- 0.009 kcal/min during free living and a REE of 0.82 +/- 0.06 kcal/min. Conclusion: SWA, an extremely simple and inexpensive apparatus, provides quite accurate measurements of energy expenditure in humans and in baboons. Energy expenditure data obtained with SWA are highly correlated with the data obtained with "gold standard'', IC, in humans.	[Casiraghi, Francesca; Lertwattanarak, Raweewan; Chavez, Alberto O.; Musi, Nicolas; Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Diabet, San Antonio, TX 78229 USA; [Casiraghi, Francesca; Luzi, Livio] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Casiraghi, Francesca; Luzi, Livio] IRCCS Policlin San Donato Hosp, Metab Res Ctr, Milan, Italy; [Lertwattanarak, Raweewan; Musi, Nicolas] Texas Diabet Inst, San Antonio, TX USA; [Davalli, Alberto M.] Univ Milan, Osped San Raffaele, Dept Internal Med, I-20127 Milan, Italy; [Naegelin, Terry; Comuzzie, Anthony G.; Frost, Patricia] Southwest Natl Primate Res Ctr, San Antonio, TX USA; [Comuzzie, Anthony G.; Folli, Franco] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Milan; IRCCS Policlinico San Donato; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Texas Biomedical Research Institute; Texas Biomedical Research Institute	Folli, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Diabet, San Antonio, TX 78229 USA.	folli@uthscsa.edu	Casiraghi, Francesca/GLS-0884-2022; Luzi, Livio LL/M-2696-2016; folli, franco/J-2795-2018	Luzi, Livio LL/0000-0003-3183-0552; folli, franco/0000-0001-9824-5222	National Institutes of Health (NIH) [RO1 0801148]; Borsa di Studio di Perfezionamento all'Estero; University of Milan; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Borsa di Studio di Perfezionamento all'Estero; University of Milan; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by National Institutes of Health (NIH) grant RO1 0801148, and by Borsa di Studio di Perfezionamento all'Estero by University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson D, 2007, MED SCI SPORT EXER, V39, P2076, DOI 10.1249/mss.0b013e31814fb439; Berntsen S, 2010, BRIT J SPORT MED, V44, P657, DOI 10.1136/bjsm.2008.048868; Bertoli S, 2008, CLIN NUTR, V27, P307, DOI 10.1016/j.clnu.2007.11.005; Brazeau AS, 2011, INT J SPORTS MED, V32, P761, DOI 10.1055/s-0031-1279768; Calabro MA, 2009, MED SCI SPORT EXER, V41, P1714, DOI 10.1249/MSS.0b013e3181a071cf; Cereda E, 2007, JPEN-PARENTER ENTER, V31, P502, DOI 10.1177/0148607107031006502; Cereda E, 2010, NUTRITION, V26, P240, DOI 10.1016/j.nut.2009.06.003; Chaput JP, 2011, J OBES, V2011, DOI 10.1155/2011/360257; Chavez AO, 2008, DIABETES, V57, P899, DOI 10.2337/db07-0790; Chavez AO, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-22; COELHO AM, 1990, LAB ANIM SCI, V40, P388; Comuzzie AG, 2003, OBES RES, V11, P75, DOI 10.1038/oby.2003.12; Dorwny CA, 2008, MED SCI SPORT EXER, V40, P699, DOI 10.1249/MSS.0b013e318161ea8f; Drenowatz C, 2011, EUR J APPL PHYSIOL, V111, P883, DOI 10.1007/s00421-010-1695-0; Dwyer TJ, 2009, RESP MED, V103, P1511, DOI 10.1016/j.rmed.2009.04.013; Fruin ML, 2004, MED SCI SPORT EXER, V36, P1063, DOI 10.1249/01.MSS.0000128144.91337.38; Guardado-Mendoza R, 2012, INT J OBES LOND; Guardado-Mendoza R, 2009, P NATL ACAD SCI USA, V106, P13992, DOI 10.1073/pnas.0906471106; Heiermann S, 2011, GERONTOLOGY, V57, P473, DOI 10.1159/000322109; Hill K, 2010, THORAX, V65, P486, DOI 10.1136/thx.2009.128702; Jakicic JM, 2004, MED SCI SPORT EXER, V36, P897, DOI 10.1249/01.MSS.0000126805.32659.43; Johannsen DL, 2010, MED SCI SPORT EXER, V42, P2134, DOI 10.1249/MSS.0b013e3181e0b3ff; Josbeno DA, 2011, OBES SURG, V21, P1243, DOI 10.1007/s11695-010-0327-4; Kamath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027617; King GA, 2004, MED SCI SPORT EXER, V36, P1244, DOI 10.1249/01.MSS.0000132379.09364.F8; Koehler K, 2011, MED SCI SPORT EXER, V43, P1328, DOI 10.1249/MSS.0b013e31820750f5; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Leenders NYJM, 2001, MED SCI SPORT EXER, V33, P1233; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; Mafra D, 2009, J RENAL NUTR, V19, P16, DOI 10.1053/j.jrn.2008.10.012; Malavolti M, 2007, NUTR METAB CARDIOVAS, V17, P338, DOI 10.1016/j.numecd.2005.12.009; Mignault D, 2005, DIABETES CARE, V28, P225, DOI 10.2337/diacare.28.1.225-a; Montoye HJ, 2000, MED SCI SPORT EXER, V32, pS439, DOI 10.1097/00005768-200009001-00001; Papazoglou D, 2006, OBESITY, V14, P2217, DOI 10.1038/oby.2006.260; Quinn AR, 2012, J ENDOCRINOL, V214, P289, DOI 10.1530/JOE-12-0070; Rosetta L, 2011, AM J PHYS ANTHROPOL, V144, P661, DOI 10.1002/ajpa.21475; Soric M, 2012, EUR J APPL PHYSIOL, V112, P1183, DOI 10.1007/s00421-011-2045-6; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Van Remoortel H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-84; Welk GJ, 2007, OBESITY, V15, P918, DOI 10.1038/oby.2007.624; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2	41	40	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73651	10.1371/journal.pone.0073651	http://dx.doi.org/10.1371/journal.pone.0073651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069218	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300016
J	Zhou, X; Luo, YC; Ji, WJ; Zhang, L; Dong, Y; Ge, L; Lu, RY; Sun, HY; Guo, ZZ; Yang, GH; Jiang, TM; Li, YM				Zhou, Xin; Luo, Yue-Chen; Ji, Wen-Jie; Zhang, Li; Dong, Yan; Ge, Lan; Lu, Rui-Yi; Sun, Hai-Ying; Guo, Zao-Zeng; Yang, Guo-Hong; Jiang, Tie-Min; Li, Yu-Ming			Modulation of Mononuclear Phagocyte Inflammatory Response by Liposome-Encapsulated Voltage Gated Sodium Channel Inhibitor Ameliorates Myocardial Ischemia/Reperfusion Injury in Rats	PLOS ONE			English	Article							MEDIATED DEPLETION; REPERFUSION INJURY; GENE-EXPRESSION; MACROPHAGES; PHENYTOIN; MONOCYTES; ATHEROSCLEROSIS; INFARCTION; CELLS; REPAIR	Background: Emerging evidence shows that anti-inflammatory strategies targeting inflammatory monocyte subset could reduce excessive inflammation and improve cardiovascular outcomes. Functional expression of voltage-gated sodium channels (VGSCs) have been demonstrated in monocytes and macrophages. We hypothesized that mononuclear phagocyte VGSCs are a target for monocyte/macrophage phenotypic switch, and liposome mediated inhibition of mononuclear phagocyte VGSC may attenuate myocardial ischemia/reperfusion (I/R) injury and improve post-infarction left ventricular remodeling. Methodology/Principal Findings: Thin film dispersion method was used to prepare phenytoin (PHT, a non-selective VGSC inhibitor) entrapped liposomes. Pharmacokinetic study revealed that the distribution and elimination half-life of PHT entrapped liposomes were shorter than those of free PHT, indicating a rapid uptake by mononuclear phagocytes after intravenous injection. In rat peritoneal macrophages, several VGSC a subunits (NaV1.1, NaV1.3, NaV1.4, NaV1.5, NaV1.6, NaV1.7, NaVX, Scn1b, Scn3b and Scn4b) and beta subunits were expressed at mRNA level, and PHT could suppress lipopolysaccharide induced M1 polarization (decreased TNF-alpha and CCL5 expression) and facilitate interleukin-4 induced M2 polarization (increased Arg1 and TGF-beta 1 expression). In vivo study using rat model of myocardial I/R injury, demonstrated that PHT entrapped liposome could partially suppress I/R injury induced CD43+ inflammatory monocyte expansion, along with decreased infarct size and left ventricular fibrosis. Transthoracic echocardiography and invasive hemodynamic analysis revealed that PHT entrapped liposome treatment could attenuate left ventricular structural and functional remodeling, as shown by increased ejection fraction, reduced end-systolic and end-diastolic volume, as well as an amelioration of left ventricular systolic (+dP/dt(max)) and diastolic (-dP/dt(min)) functions. Conclusions/Significance: Our work for the first time demonstrates the therapeutic potential of VGSC antagonism via liposome mediated monocyte/macrophage targeting in acute phase after myocardial I/R injury. These results suggest that VGSCs in mononuclear phagocyte system might be a novel target for immunomodulation and treatment of myocardial I/R injury.	[Zhou, Xin; Luo, Yue-Chen; Dong, Yan; Ge, Lan; Lu, Rui-Yi; Sun, Hai-Ying; Guo, Zao-Zeng; Yang, Guo-Hong; Jiang, Tie-Min; Li, Yu-Ming] Logist Univ Chinese Peoples Armed Police Forces, Inst Cardiovasc Dis, Pingjin Hosp, Tianjin, Peoples R China; [Zhou, Xin; Luo, Yue-Chen; Dong, Yan; Ge, Lan; Lu, Rui-Yi; Sun, Hai-Ying; Guo, Zao-Zeng; Yang, Guo-Hong; Jiang, Tie-Min; Li, Yu-Ming] Logist Univ Chinese Peoples Armed Police Forces, Ctr Heart, Pingjin Hosp, Tianjin, Peoples R China; [Zhou, Xin; Luo, Yue-Chen; Ji, Wen-Jie; Ge, Lan; Lu, Rui-Yi; Sun, Hai-Ying; Guo, Zao-Zeng; Yang, Guo-Hong; Jiang, Tie-Min; Li, Yu-Ming] Tianjin Key Lab Cardiovasc Remodeling & Target Or, Tianjin, Peoples R China; [Zhang, Li] Logist Univ Chinese Peoples Armed Police Forces, Dept Pharmacognosy & Pharmaceut, Tianjin, Peoples R China		Li, YM (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Inst Cardiovasc Dis, Pingjin Hosp, Tianjin, Peoples R China.	cardiolab@gmail.com	JI, WENJIE/H-1274-2015; Zhou, Xin/AAH-7351-2019	Zhou, Xin/0000-0003-1395-7103	National Natural Science Foundation of China [81070121, 81102088, 81170238]; Tianjin Municipal Science and Technology Committee [09ZCZDSF04200, 11JCYBJC12000, 12JCYBJC16600]; Tianjin Public Health Bureau [2010KZ122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Committee; Tianjin Public Health Bureau	Funding provided by National Natural Science Foundation of China (81070121, 81102088 and 81170238), Tianjin Municipal Science and Technology Committee (09ZCZDSF04200, 11JCYBJC12000 and 12JCYBJC16600) and Tianjin Public Health Bureau (2010KZ122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan FL, 2002, J CONTROL RELEASE, V79, P29, DOI 10.1016/S0168-3659(01)00549-1; AHUJA V, 1995, CELL IMMUNOL, V163, P59, DOI 10.1006/cimm.1995.1099; Andrikopoulos P, 2011, J BIOL CHEM, V286, P16846, DOI 10.1074/jbc.M110.187559; Anstead GM, 1996, ANN PHARMACOTHER, V30, P768, DOI 10.1177/106002809603000712; Baruch A, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0327-7; BUITING AMJ, 1994, J DRUG TARGET, V2, P357, DOI 10.3109/10611869408996810; Carrithers MD, 2007, J IMMUNOL, V178, P7822, DOI 10.4049/jimmunol.178.12.7822; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chen Y, 2012, ADV DRUG DELIVER REV, V64, P640, DOI 10.1016/j.addr.2011.11.010; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; DELEMARRE FGA, 1990, J LEUKOCYTE BIOL, V47, P251, DOI 10.1002/jlb.47.3.251; Diaz D, 2007, J CELL PHYSIOL, V210, P469, DOI 10.1002/jcp.20871; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dill RE, 1997, J PERIODONTOL, V68, P375, DOI 10.1902/jop.1997.68.4.375; DILL RE, 1993, J PERIODONTOL, V64, P169, DOI 10.1902/jop.1993.64.3.169; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Fraser SP, 2004, FEBS LETT, V569, P191, DOI 10.1016/j.febslet.2004.05.063; Gao F, 2011, CLIN EXP HYPERTENS, V33, P492, DOI 10.3109/10641963.2010.551795; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2012, CIRC RES, V110, P1546, DOI 10.1161/RES.0b013e31825ec26d; Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Kempf T, 2012, J MOL MED, V90, P361, DOI 10.1007/s00109-011-0847-y; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Liu HM, 2011, CARDIOVASC DRUG THER, V25, P203, DOI 10.1007/s10557-011-6294-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo WL, 2012, NAT IMMUNOL, V13, P880, DOI 10.1038/ni.2379; Luo YC, 2013, ACTA BIOCH BIOPH SIN, V45, P561, DOI 10.1093/abbs/gmt045; Luo Yuechen, 2013, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V29, P225; Majmudar MD, 2013, CIRCULATION, V127, P2038, DOI 10.1161/CIRCULATIONAHA.112.000116; Melgert BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045229; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890; NAKADE O, 1995, J DENT RES, V74, P331, DOI 10.1177/00220345950740010801; Rougier JS, 2012, J MOL CELL CARDIOL, V53, P589, DOI 10.1016/j.yjmcc.2012.08.011; Shaw J, 2007, BRIT J DERMATOL, V157, P997, DOI 10.1111/j.1365-2133.2007.08160.x; Steffens S, 2009, THROMB HAEMOSTASIS, V102, P240, DOI 10.1160/TH08-12-0837; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Turan M, 2004, INT J COLORECTAL DIS, V19, P250, DOI 10.1007/s00384-003-0533-9; WEIHRAUCH D, 1995, MOL CELL BIOCHEM, V147, P13, DOI 10.1007/BF00944778; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang XK, 2009, J DRUG TARGET, V17, P399, DOI 10.1080/10611860902795407; Zhou X, 2006, INT J CARDIOL, V107, P21, DOI 10.1016/j.ijcard.2004.12.098; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	50	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74390	10.1371/journal.pone.0074390	http://dx.doi.org/10.1371/journal.pone.0074390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069305	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300034
J	Currow, DC; Clark, K; Mitchell, GK; Johnson, MJ; Abernethy, AP				Currow, David C.; Clark, Katherine; Mitchell, Geoffrey K.; Johnson, Miriam J.; Abernethy, Amy P.			Prospectively Collected Characteristics of Adult Patients, Their Consultations and Outcomes as They Report Breathlessness When Presenting to General Practice in Australia	PLOS ONE			English	Article							PHYSICAL SYMPTOMS; DYSPNEA; PREVALENCE; EMERGENCY; DISEASE; VISITS	Introduction: Breathlessness is a subjective sensation, so understanding its impacts requires patients' reports, including prospective patient-defined breathlessness as a reason for presenting to general practitioners (GP). The aim of this study was to define the prevalence of breathlessness as a reason for GP consultations while defining the clinico-demographic factors of these patients and the characteristics and outcomes of those consultations. Methods: Using nine years of the Family Medicine Research Centre database of 100 consecutive encounters from 1,000 practices annually, the patient-defined reason for encounter 'breathlessness' was explored using prospectively collected data in people >= 18 years with clinical data coded using the International Classification for Primary Care V2. Dichotomous variables were analysed using chi square and 95% confidence intervals calculated using Kish's formula for a single stage clustered design. Results: Of all the 755,729 consultations collected over a nine year period from 1 April, 2000, 7255 included breathlessness as a reason for encounter (0.96%; 95% CI 0.93 to 0.99) most frequently attributed to chronic obstructive pulmonary disease. Only 48.3% of GPs saw someone reporting breathlessness. The proportion of consultations with breathlessness increased with age. Breathlessness trebled the likelihood that the consultation occurred in the community rather than the consulting room (p<0.0001) and increased 2.5 fold the likelihood of urgent referral to hospital (p<0.0001). Of those with breathlessness, 12% had undiagnosed breathlessness at the end of the consultation (873/7255) with higher likelihood of being younger females. Discussion: Breathlessness is a prevalent symptom in general practitioner. Such prevalence enables future research focused on understanding the temporal pattern of breathlessness and the longitudinal care offered to, and outcomes for these patients, including those who leave the consultation without a diagnosis.	[Currow, David C.; Abernethy, Amy P.] Flinders Univ S Australia, Discipline Serv, Bedford Pk, SA 5042, Australia; [Currow, David C.; Abernethy, Amy P.] Flinders Univ S Australia, Palliat Serv, Bedford Pk, SA 5042, Australia; [Currow, David C.; Abernethy, Amy P.] Flinders Univ S Australia, Support Serv, Bedford Pk, SA 5042, Australia; [Clark, Katherine] Univ Newcastle, Newcastle, NSW 2300, Australia; [Clark, Katherine] Calvary Mater Hosp, Hunter New England Area Palliat Care Serv, Waratah, NSW, Australia; [Mitchell, Geoffrey K.] Univ Queensland, Ipswich Clin Sch, Sch Med, Ipswich, Qld, Australia; [Johnson, Miriam J.] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Abernethy, Amy P.] Duke Univ, Med Ctr, Durham, NC USA	Flinders University South Australia; Flinders University South Australia; Flinders University South Australia; University of Newcastle; Calvary Mater Newcastle Hospital; University of Queensland; University of Hull; University of York - UK; Duke University	Currow, DC (corresponding author), Flinders Univ S Australia, Discipline Serv, Bedford Pk, SA 5042, Australia.	david.currow@flinders.edu.au	Mitchell, Geoffrey/F-1489-2010	Mitchell, Geoffrey/0000-0001-7817-6821; Johnson, Miriam/0000-0001-6204-9158; Currow, David/0000-0003-1988-1250	Discipline, Palliative and Supportive Services, Flinders University	Discipline, Palliative and Supportive Services, Flinders University	This study was supported by discretionary funding from the Discipline, Palliative and Supportive Services, Flinders University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy AP, 2003, BRIT MED J, V327, P523, DOI 10.1136/bmj.327.7414.523; ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; [Anonymous], 2010, ENZ NOUS AUSTR HLTH; Britt H, 2001, GEN PRACTICE SERIES, V30; Britt H, 2011, GEN PRACTICE SERIES, V31; Charles Janice, 2005, Aust Fam Physician, V34, P520; Currow DC, 2012, J PAIN SYMPTOM MANAG, V44, pE1, DOI 10.1016/j.jpainsymman.2012.07.005; Currow DC, 2011, J PAIN SYMPTOM MANAG, V42, P388, DOI 10.1016/j.jpainsymman.2010.11.021; Currow DC, 2009, J PAIN SYMPTOM MANAG, V38, P533, DOI 10.1016/j.jpainsymman.2009.01.006; Frese Thomas, 2011, J Clin Med Res, V3, P239, DOI 10.4021/jocmr642w; Gysels M, 2010, J PAIN SYMPTOM MANAG, V39, P555, DOI 10.1016/j.jpainsymman.2009.08.009; ICPC, ICPC 2 INT CLASS PRI; Johnson MJ, 2012, J PALLIAT MED, V15, P744, DOI 10.1089/jpm.2011.0430; Kish L, 1965, SURVEY SAMPLING; Mahler DA, 2012, COPD, V9, P522, DOI 10.3109/15412555.2012.701678; Morgan DD, 2012, J PALLIAT CARE, V6, P138; Nielsen LS, 2001, J INTERN MED, V250, P422, DOI 10.1046/j.1365-2796.2001.00901.x; Niska Richard, 2010, Natl Health Stat Report, P1; Parshall MB, 2001, HEART LUNG, V30, P47; Parshall MB, 1999, NURS RES, V48, P62, DOI 10.1097/00006199-199903000-00004; Pedersen F, 2007, INT J CLIN PRACT, V61, P1481, DOI 10.1111/j.1742-1241.2007.01428.x; Pratter MR, 2011, RESP MED, V105, P1014, DOI 10.1016/j.rmed.2010.12.009; van Wijk CMTG, 1999, SOC SCI MED, V49, P1061, DOI 10.1016/S0277-9536(99)00196-3; VanWijk CMTG, 1997, SOC SCI MED, V45, P231, DOI 10.1016/S0277-9536(96)00340-1; VERBRUGGE L M, 1980, Journal of Behavioral Medicine, V3, P327, DOI 10.1007/BF00845289; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wiseman R, 2013, AUST FAM PHYSICIAN, V42, P137; Zhang J, 2013, RESPIROLOGY, V18, P297, DOI 10.1111/j.1440-1843.2012.02282.x	28	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74814	10.1371/journal.pone.0074814	http://dx.doi.org/10.1371/journal.pone.0074814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219YJ	24069352	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300058
J	Ma, LN; Liu, XQ; Zhao, YY; Chen, BD; Li, XG; Qi, RM				Ma, Lina; Liu, Xueqing; Zhao, Yanyang; Chen, Beidong; Li, Xingguang; Qi, Ruomei			Ginkgolide B Reduces LOX-1 Expression by Inhibiting Akt Phosphorylation and Increasing Sirt1 Expression in Oxidized LDL-Stimulated Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; LECTIN-LIKE; ACTIVATION; ATHEROSCLEROSIS; NRF2; RECEPTOR; PATHWAY; ATHEROGENESIS; INFLAMMATION	Oxidized low-density lipoprotein (ox-LDL) is an important risk factor in the development of atherosclerosis. LOX-1, a lectin-like receptor for ox-LDL, is present primarily on endothelial cells and upregulated by ox-LDL, tumor necrosis factor a, shear stress, and cytokines in atherosclerosis. Recent studies demonstrated that ginkgolide B, a platelet-activating factor receptor antagonist, has antiinflammatory and antioxidant effects on endothelial and nerve cells. The present study investigated the effects of ginkgolide B on LOX-1 expression and the possible mechanism of action. Our results showed that ginkgolide B inhibited LOX-1 and intercellular cell adhesion molecule-1 (ICAM-1) expression in ox-LDL-stimulated endothelial cells through a mechanism associated with the attenuation of Akt activation. Similar data were obtained by silencing Akt and LY294002. We also evaluated Sirt1 and nuclear factor erythroid 2-related factor 2 (Nrf2) expression. These molecules play a protective role in endothelial cell injury. The results showed that ginkgolide B increased Sirt1 expression in ox-LDL-treated cells. The inhibitory effects of ginkgolide B on LOX-1 and ICAM-1 expression were reduced in Sirt1 siRNA-transfected cells. Nrf2 expression was increased in ox-LDL-treated cells, and ginkgolide B downregulated Nrf2 expression. These results suggest that ginkgolide B reduces Nrf2 expression by inhibiting LOX-1 expression, consequently reducing oxidative stress injury in ox-LDL-stimulated cells. Altogether, these results indicate that the protective effect of ginkgolide B on endothelial cells may be attributable to a decrease in LOX-1 expression and an increase in Sirt1 expression in ox-LDL-stimulated endothelial cells, the mechanism of which is linked to the inhibition of Akt activation. Ginkgolide B may be a multiple-target drug that exerts protective effects in ox-LDL-treated human umbilical vein endothelial cells.	[Ma, Lina; Liu, Xueqing; Zhao, Yanyang; Chen, Beidong; Qi, Ruomei] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Ma, Lina; Liu, Xueqing; Zhao, Yanyang; Chen, Beidong; Qi, Ruomei] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Ma, Lina; Li, Xingguang] Beijing Univ Chinese Med, Beijing, Peoples R China	Beijing Hospital; Beijing University of Chinese Medicine	Qi, RM (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	ruomeiqi@163.com			National Natural Science Foundation of China [81270379, 81070231, 81101859]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (grant no. 81270379, 81070231 and 81101859). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; Birukov Konstantin G, 2006, Curr Atheroscler Rep, V8, P223, DOI 10.1007/s11883-006-0077-x; Breitenstein A, 2011, CARDIOVASC RES, V89, P464, DOI 10.1093/cvr/cvq339; Carter S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035110; Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021; Daub K, 2010, SEMIN THROMB HEMOST, V36, P146, DOI 10.1055/s-0030-1251498; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fougerat A, 2009, CLIN SCI, V116, P791, DOI 10.1042/CS20080549; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kuhn AM, 2011, FREE RADICAL BIO MED, V50, P1382, DOI 10.1016/j.freeradbiomed.2011.02.036; Li B, 2012, EXP DIABETES RES, DOI 10.1155/2012/216512; Li DY, 2003, ARTERIOSCL THROM VAS, V23, P816, DOI 10.1161/01.ATV.0000066685.13434.FA; Li DY, 1999, CIRC RES, V84, P1043, DOI 10.1161/01.RES.84.9.1043; Li L, 2004, CIRC RES, V95, P877, DOI 10.1161/01.RES.0000147309.54227.42; Li L, 2011, ACTA BIOCH BIOPH SIN, V43, P103, DOI 10.1093/abbs/gmq104; Li R, 2009, J PHARMACOL SCI, V110, P362, DOI 10.1254/jphs.08275FP; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036237; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Navarra T, 2010, J ATHEROSCLER THROMB, V17, P317, DOI 10.5551/jat.3228; Rushworth SA, 2011, J IMMUNOL, V187, P702, DOI 10.4049/jimmunol.1004117; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Stein S, 2010, EUR HEART J, V31, P2301, DOI 10.1093/eurheartj/ehq107; Steinberg D, 1997, CIRCULATION, V95, P1062; Takabe W, 2011, ANTIOXID REDOX SIGN, V15, P1415, DOI 10.1089/ars.2010.3433; TANAKA M, 1993, BIOL PHARM BULL, V16, P538, DOI 10.1248/bpb.16.538; Wang L, 2008, INVEST OPHTH VIS SCI, V49, P1671, DOI 10.1167/iovs.07-1099; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Yoshimoto R, 2011, CARDIOVASC DRUG THER, V25, P379, DOI 10.1007/s10557-011-6324-6; Yuan Q, 2011, CAN J PHYSIOL PHARM, V89, P713, DOI [10.1139/Y11-069, 10.1139/y11-069]; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604; Zhang S, 2011, J CARDIOVASC PHARM, V57, P721, DOI 10.1097/FJC.0b013e31821a50a8	38	33	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74769	10.1371/journal.pone.0074769	http://dx.doi.org/10.1371/journal.pone.0074769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069345	gold, Green Submitted, Green Published			2022-12-27	WOS:000324547300057
J	Wu, F; Guo, YF; Kowal, P; Jiang, Y; Yu, M; Li, XJ; Zheng, Y; Xu, JY				Wu, Fan; Guo, Yanfei; Kowal, Paul; Jiang, Yong; Yu, Min; Li, Xinjian; Zheng, Yang; Xu, Jiying			Prevalence of Major Chronic Conditions among Older Chinese Adults: The Study on Global AGEing and Adult Health (SAGE) Wave 1	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; DIABETES PREVALENCE; NATIONAL NUTRITION; CHRONIC DISEASES; DEPRESSION; POPULATION; DEMENTIA; HYPERTENSION; AWARENESS; PEOPLE	Background: The likely corresponding increase in prevalence of chronic disease will be a major challenge for the health care system. Few nationwide epidemiological studies include a large enough sample of older adults to provide estimates of chronic conditions in the older adult population. This study aimed to estimate the prevalence of eight common chronic health conditions and examine socioeconomic inequalities in the diseases among older adults in China. Method: Data are from SAGE-China Wave 1, including 13,157 people aged 50-plus years. Respondents were asked if they had been diagnosed with any of the following chronic medical conditions: angina, arthritis, asthma, stroke, diabetes, depression, chronic lung disease and hypertension. A set of validated symptom-based questions and related diagnostic algorithms were also used to estimate disease prevalence for angina, arthritis, asthma and depression. Multivariate logistic regression was performed to examine the probability of developing chronic conditions in relation to sociodemographic variables such as gender, age, urban/rural setting and household wealth level. Results: Fifty percent of respondents reported having one of the selected chronic conditions, 18.9% two conditions, 5.8% three conditions, and 1.4% reported having four or more chronic conditions. Self-reported prevalence was generated for angina (8%), arthritis (22%), asthma (2%), stroke (3%), diabetes (7%), depression (0.3%), chronic lung disease (8%) and hypertension (27%). The symptom-based prevalence of angina, arthritis, asthma and depression was 10%, 20%, 4% and 2%, respectively. Conclusion: This study provides the best available prevalence estimates for major chronic health conditions among older Chinese adults. Findings from this study indicated that major chronic conditions were common, so prevention and early intervention targeting adults aged 50 years and older should be prioritized.	[Wu, Fan; Guo, Yanfei; Li, Xinjian; Zheng, Yang; Xu, Jiying] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Jiang, Yong] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [Kowal, Paul] WHO, Dept Hlth Stat & Informat Syst, CH-1211 Geneva, Switzerland; [Yu, Min] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Kowal, Paul] Univ Newcastle, Fac Hlth, Res Ctr Gender Hlth & Ageing, Newcastle, NSW 2300, Australia	Shanghai Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; World Health Organization; Zhejiang Provincial Center for Disease Control & Prevention; University of Newcastle	Wu, F (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China.	wufan68@gmail.com	JIANG, Yong/GYU-9887-2022	JIANG, Yong/0000-0001-7700-6054; Kowal, Paul/0000-0002-6314-8753	US National Institute on Aging [OGHA 04034785, YA1323-08-CN-0020, Y1-AG-1005-01, R01-AG034479]; Science and Technology Commission of Shanghai Municipality [10XD1403600]; Shanghai Municipal Organization Department; shanghai Bureau of Human Resource and Social Security; NATIONAL INSTITUTE ON AGING [R01AG034479] Funding Source: NIH RePORTER	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Organization Department; shanghai Bureau of Human Resource and Social Security; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the US National Institute on Aging through Interagency Agreements (OGHA 04034785; YA1323-08-CN-0020; Y1-AG-1005-01) and through a research grant (R01-AG034479); Science and Technology Commission of Shanghai Municipality (Grant No. 10XD1403600); Shanghai Municipal Organization Department & The shanghai Bureau of Human Resource and Social Security ("leading talents" project for Fan Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman ATF, 1997, PSYCHOL MED, V27, P1397, DOI 10.1017/S0033291797005734; Black HR, 1997, ARCH INTERN MED, V157, P2413; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; Chen R, 1999, INT J GERIATR PSYCH, V14, P821, DOI 10.1002/(SICI)1099-1166(199910)14:10<821::AID-GPS21>3.0.CO;2-0; Chen R, 2012, PREVALENCE ANGINA OL; Committee for Revision of Chinese Guidelines for Prevention and Treatment of Patients with Hypertension, 2005, CHIN J HYPERTENS, V134, P2; Llibre JD, 2011, MEDICC REV, V13, P30, DOI 10.37757/MR2011V13.N4.7; Ferguson B., 2003, HLTH SYSTEMS PERFORM, P747; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Imkampe AK, 2011, EUR J PUBLIC HEALTH, V21, P484, DOI 10.1093/eurpub/ckq106; KIVELA SL, 1988, ACTA PSYCHIAT SCAND, V78, P401, DOI 10.1111/j.1600-0447.1988.tb06358.x; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Li YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033881; Liu SQ, 2011, PREV CHRONIC DIS, V8; Liu ZR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-394; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; McCracken CFM, 1997, BRIT J PSYCHIAT, V171, P269, DOI 10.1192/bjp.171.3.269; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; National Center for Chronic and Non-communicable Disease Control and Prevention, 2007, REP CHRON DIS RISK F, P64; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Rabi DM, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-124; Rasch EK, 2003, ARTHRITIS RHEUM, V48, P917, DOI 10.1002/art.10897; Shi J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-277; UN Population Division, 2009, WORLD POP AG 2009; United Nations Educational Scientific and Cultural Organization, 1997, INT STAND CLASS ED I; Venketasubramanian N, 2005, STROKE, V36, P551, DOI 10.1161/01.STR.0000155687.18818.13; WHO, 2010, GLOB STAT REP NONC D; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	31	76	84	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74176	10.1371/journal.pone.0074176	http://dx.doi.org/10.1371/journal.pone.0074176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219YJ	24069278	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300030
J	Yasutaka, T; Naito, W; Nakanishi, J				Yasutaka, Tetsuo; Naito, Wataru; Nakanishi, Junko			Cost and Effectiveness of Decontamination Strategies in Radiation Contaminated Areas in Fukushima in Regard to External Radiation Dose	PLOS ONE			English	Article							POWER-PLANT ACCIDENT; REMEDIATION STRATEGIES; LONG-TERM; RADIONUCLIDES; MANAGEMENT	The objective of the present study is to evaluate the cost and effectiveness of decontamination strategies in the special decontamination areas in Fukushima in regard to external radiation dose. A geographical information system (GIS) was used to relate the predicted external dose in the affected areas to the number of potential inhabitants and the land use in the areas. A comprehensive review of the costs of various decontamination methods was conducted as part of the analysis. The results indicate that aerial decontamination in the special decontamination areas in Fukushima would be effective for reducing the air dose rate to the target level in a short period of time in some but not all of the areas. In a standard scenario, analysis of cost and effectiveness suggests that decontamination costs for agricultural areas account for approximately 80% of the total decontamination cost, of which approximately 60% is associated with storage. In addition, the costs of decontamination per person per unit area are estimated to vary greatly. Appropriate selection of decontamination methods may significantly decrease decontamination costs, allowing more meaningful decontamination in terms of the limited budget. Our analysis can help in examining the prioritization of decontamination areas from the viewpoints of cost and effectiveness in reducing the external dose. Decontamination strategies should be determined according to air dose rates and future land-use plans.	[Yasutaka, Tetsuo] Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm GREEN, Higashi Ku, Tsukuba, Ibaraki, Japan; [Naito, Wataru] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil RISS, Tsukuba, Ibaraki, Japan; [Nakanishi, Junko] Natl Inst Adv Ind Sci & Technol, AIST, Higashi Ku, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Naito, W (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil RISS, Tsukuba, Ibaraki, Japan.	w-naito@aist.go.jp	Naito, Wataru/M-1928-2018; Yasutaka, Tetsuo/N-6727-2016	Naito, Wataru/0000-0003-2064-7170; Yasutaka, Tetsuo/0000-0001-6000-663X	AIST Environment and Energy Unit	AIST Environment and Energy Unit	This work was supported by AIST Environment and Energy Unit. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIST, 2011, NAT I ADV IND SCI TE; [Anonymous], 2012, FUK PREF SURF DEC MO; Endo S, 2012, J ENVIRON RADIOACTIV, V111, P18, DOI 10.1016/j.jenvrad.2011.11.006; Fesenko S, 2013, J ENVIRON RADIOACTIV, V119, P39, DOI 10.1016/j.jenvrad.2010.08.012; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; IAEA, 2000, GEN PROC ASS RESP RA; Jacob P, 2009, SCI TOTAL ENVIRON, V408, P14, DOI 10.1016/j.scitotenv.2009.09.006; Jacob P, 2001, J ENVIRON RADIOACTIV, V56, P51, DOI 10.1016/S0265-931X(01)00047-9; JAEA, 2012, IMPL REP DEC REL FUK; JAEA, 2012, 2012020 JAEA; JAEA, 2012, RES DEC MOD PROJ 11; METI, 2012, RESTR AR AR WHICH EV, P2012; MEXT, 2011, DISTR MAP RAD DOS ET; MEXT (Ministry of Education Culture Sports Science and Technology), 2011, RES 4 AIRB MON SURV; MLIT, 2012, NAT LAND NUM INF DOW; MOE, 2012, PROV CALC STAND DEC; MOE, 2011, DEC GUID VER 1; MOE, 2012, BUDG REQ MIN ENV 201; MOE, 2012, POL DEC SPEC DEC AR; Morino Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048689; NAIIC, 2012, OFF REP FUK NUCL ACC; Nisbet A, 2000, J ENVIRON RADIOACTIV, V51, P239, DOI 10.1016/S0265-931X(00)00080-1; Oughton D, 2004, J ENVIRON RADIOACTIV, V74, P171, DOI 10.1016/j.jenvrad.2004.01.009; Statistics Bureau of Japan Ministry of Internal Affairs and Communications, 2014, RES PROD RES SPEC CR; Taira Y, 2012, RADIAT PROT DOSIM, V151, P537, DOI 10.1093/rpd/ncs040; UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation), 2000, UNSCEAR 2000 REP, VII; Yasutaka T, 2013, CHEMOSPHERE IN PRESS	27	29	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75308	10.1371/journal.pone.0075308	http://dx.doi.org/10.1371/journal.pone.0075308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069398	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300077
J	Delgado, G; Souza, V; Morales, R; Cerritos, R; Gonzalez-Gonzalez, A; Mendez, JL; Vazquez, V; Cravioto, A				Delgado, Gabriela; Souza, Valeria; Morales, Rosario; Cerritos, Rene; Gonzalez-Gonzalez, Andrea; Luis Mendez, Jose; Vazquez, Virginia; Cravioto, Alejandro			Genetic Characterization of Atypical Citrobacter freundii	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI O157; RIBOSOMAL-RNA GENES; SALMONELLA-ENTERICA; PHASE VARIATION; RRN OPERONS; STRAINS; DIVERSITY; LACTOSE; REARRANGEMENTS	The ability of a bacterial population to survive in different niches, as well as in stressful and rapidly changing environmental conditions, depends greatly on its genetic content. To survive such fluctuating conditions, bacteria have evolved different mechanisms to modulate phenotypic variations and related strategies to produce high levels of genetic diversity. Laboratories working in microbiological diagnosis have shown that Citrobacter freundii is very versatile in its colony morphology, as well as in its biochemical, antigenic and pathogenic behaviours. This phenotypic versatility has made C. freundii difficult to identify and it is frequently confused with both Salmonella enterica and Escherichia coli. In order to determine the genomic events and to explain the mechanisms involved in this plasticity, six C. freundii isolates were selected from a phenotypic variation study. An I-CeuI genomic cleavage map was created and eight housekeeping genes, including 16S rRNA, were sequenced. In general, the results showed a range of both phenotypes and genotypes among the isolates with some revealing a greater similarity to C. freundii and some to S. enterica, while others were identified as phenotypic and genotypic intermediary states between the two species. The occurrence of these events in natural populations may have important implications for genomic diversification in bacterial evolution, especially when considering bacterial species boundaries. In addition, such events may have a profound impact on medical science in terms of treatment, course and outcomes of infectious diseases, evading the immune response, and understanding host-pathogen interactions.	[Delgado, Gabriela; Morales, Rosario; Luis Mendez, Jose] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City 04510, DF, Mexico; [Souza, Valeria; Gonzalez-Gonzalez, Andrea] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolutiva, Mexico City 04510, DF, Mexico; [Cerritos, Rene] Univ Nacl Autonoma Mexico, Fac Med, Dept Cirugia Expt, Mexico City 04510, DF, Mexico; [Vazquez, Virginia] INP, Mexico City, DF, Mexico; [Cravioto, Alejandro] Int Vaccine Inst, Seoul, South Korea	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; International Vaccine Institute	Cravioto, A (corresponding author), Int Vaccine Inst, Seoul, South Korea.	Alejandro.Cravioto@ivi.int		Delgado, Gabriela/0000-0003-4577-4440; souza, valeria/0000-0002-2992-4229; Morales-Espinosa, Rosario/0000-0003-2110-4397	Direccion General de Apoyo al Personal Academico, UNAM [IN242602]; Consejo Nacional de Ciencia y Tecnologia [100343]	Direccion General de Apoyo al Personal Academico, UNAM(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research project was supported by grants from Direccion General de Apoyo al Personal Academico, UNAM (Pappitt project IN242602), URL:http://dgapa.unam.mx; and Consejo Nacional de Ciencia y Tecnologia (project 100343), URL: http://conacyt.gob.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperi A, 2008, INT MICROBIOL, V11, P185, DOI 10.2436/20.1501.01.59; AZNAR R, 1994, INT J SYST BACTERIOL, V44, P330, DOI 10.1099/00207713-44-2-330; Bai L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033054; Bayliss CD, 2009, FEMS MICROBIOL REV, V33, P504, DOI 10.1111/j.1574-6976.2009.00162.x; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BETTELHEIM KA, 1993, J CLIN MICROBIOL, V31, P760, DOI 10.1128/JCM.31.3.760-761.1993; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BRENNER DJ, 1993, INT J SYST BACTERIOL, V43, P777, DOI 10.1099/00207713-43-4-777; BULMASH JM, 1965, J BACTERIOL, V89, P259, DOI 10.1128/JB.89.1.259-259.1965; Canedo I, 1989, THESIS U NACL AUTONO; CHART H, 1993, J APPL BACTERIOL, V74, P583; Chen F, 2010, FEMS MICROBIOL LETT, V312, P126, DOI 10.1111/j.1574-6968.2010.02107.x; Chen F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-277; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; CRAVIOTO A, 1988, EPIDEMIOL INFECT, V101, P123, DOI 10.1017/S0950268800029289; CRAVIOTO A, 1990, AM J EPIDEMIOL, V131, P886, DOI 10.1093/oxfordjournals.aje.a115579; CROSA JH, 1974, J GEN MICROBIOL, V83, P271, DOI 10.1099/00221287-83-2-271; Cui LZ, 2012, P NATL ACAD SCI USA, V109, pE1647, DOI 10.1073/pnas.1204307109; DEHENESTROSA ARF, 1991, MOL GEN GENET, V226, P503, DOI 10.1007/BF00260664; den Bakker HC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-277; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; Doran TI, 1999, CLIN INFECT DIS, V28, P384, DOI 10.1086/515106; Eisenstark A, 2010, ANNU REV MICROBIOL, V64, P277, DOI 10.1146/annurev.micro.091208.073614; Ewing WH, 1986, ENTEROBACTERIACEAE, P341; Falush D, 2003, GENETICS, V164, P1567; Farmer III JJ, 1981, PROKARYOTES HDB HABI, P1140; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; FLORES M, 1988, J BACTERIOL, V170, P1191, DOI 10.1128/jb.170.3.1191-1196.1988; FLORES M, 1987, J BACTERIOL, V169, P5782, DOI 10.1128/jb.169.12.5782-5788.1987; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Garcia MM, 1985, ACTA PEDIAT MEX, V6, P68; Gilchrist Mary J. R., 1995, P457; Gilligan PH, 1992, CUMITECH A; Gong J, 2007, GENOMICS, V90, P542, DOI 10.1016/j.ygeno.2007.06.009; GONZALEZ AB, 1966, J BACTERIOL, V91, P1661, DOI 10.1128/JB.91.4.1661-1662.1966; GUARINO A, 1989, INFECT IMMUN, V57, P649, DOI 10.1128/IAI.57.2.649-652.1989; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallet B, 2001, CURR OPIN MICROBIOL, V4, P570, DOI 10.1016/S1369-5274(00)00253-8; Hanage WP, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-41; Helm RA, 2004, INFECT IMMUN, V72, P7338, DOI 10.1128/IAI.72.12.7338-7341.2004; Helm RA, 2003, GENETICS, V165, P951; Hess P, 2004, INFECT IMMUN, V72, P5298, DOI 10.1128/IAI.72.9.5298-5307.2004; HILL CW, 1981, P NATL ACAD SCI-BIOL, V78, P7069, DOI 10.1073/pnas.78.11.7069; Hill CW, 1999, RES MICROBIOL, V150, P665, DOI 10.1016/S0923-2508(99)00125-4; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Janion C, 2008, INT J BIOL SCI, V4, P338; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Khetawat G, 1999, INFECT IMMUN, V67, P148, DOI 10.1128/IAI.67.1.148-154.1999; Kothapalli S, 2005, J BACTERIOL, V187, P2638, DOI 10.1128/JB.187.8.2638-2650.2005; Kucerova E, 2010, PLOS ONE, V5, pA51, DOI 10.1371/journal.pone.0009556; Kumar S, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00120-12, DOI 10.1128/GEN0MEA.00120-12]; KUNZ LJ, 1965, J BACTERIOL, V89, P1629, DOI 10.1128/JB.89.6.1629-1629.1965; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; LEE JI, 1994, BIOCHEM BIOPH RES CO, V203, P1882, DOI 10.1006/bbrc.1994.2407; LEMINOR L, 1974, ANN INST PASTEUR MIC, VA125, P261; Liu GR, 2003, J BACTERIOL, V185, P2131, DOI 10.1128/JB.185.7.2131-2142.2003; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; Liu SL, 1998, FEMS MICROBIOL LETT, V164, P275, DOI 10.1016/S0378-1097(98)00225-0; LIU SL, 1993, P NATL ACAD SCI USA, V90, P6874, DOI 10.1073/pnas.90.14.6874; LIU SL, 1993, J BACTERIOL, V175, P4104, DOI 10.1128/JB.175.13.4104-4120.1993; LIU SL, 1995, J BACTERIOL, V177, P3355, DOI 10.1128/jb.177.11.3355-3357.1995; LIU SL, 1995, P NATL ACAD SCI USA, V92, P1018, DOI 10.1073/pnas.92.4.1018; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Liu SL, 1999, J BACTERIOL, V181, P6747, DOI 10.1128/JB.181.21.6747-6755.1999; Liu WQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004510; Makino K, 1999, GENES GENET SYST, V74, P227, DOI 10.1266/ggs.74.227; Matthews TD, 2011, MBIO, V2, DOI 10.1128/mBio.00060-11; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Murray MG, 1994, CURRENT PROTOCOLS MO, P241; Nandi S, 1997, INT J SYST BACTERIOL, V47, P858, DOI 10.1099/00207713-47-3-858; Nishiuchi Y, 2000, FEMS IMMUNOL MED MIC, V28, P163, DOI 10.1111/j.1574-695X.2000.tb01472.x; OCHMAN H, 1995, CURR OPIN GENET DEV, V5, P734, DOI 10.1016/0959-437X(95)80005-P; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; OU JT, 1988, P NATL ACAD SCI USA, V85, P4402, DOI 10.1073/pnas.85.12.4402; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pereira AL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-57; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Petty NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002018; Petty NK, 2010, J BACTERIOL, V192, P525, DOI 10.1128/JB.01144-09; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pruss BM, 1999, J BACTERIOL, V181, P2624; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Reid SD, 1999, J BACTERIOL, V181, P153, DOI 10.1128/JB.181.1.153-160.1999; Retchless AC, 2007, SCIENCE, V317, P1093, DOI 10.1126/science.1144876; Retchless AC, 2010, P NATL ACAD SCI USA, V107, P11453, DOI 10.1073/pnas.1001291107; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sacchi CT, 2002, J CLIN MICROBIOL, V40, P4520, DOI 10.1128/JCM.40.12.4520-4527.2002; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Samuel G, 2004, J BACTERIOL, V186, P6536, DOI 10.1128/JB.186.19.6536-6543.2004; Sanderson KE, 1998, ELECTROPHORESIS, V19, P569, DOI 10.1002/elps.1150190417; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Sedlak J, 1973, Curr Top Microbiol Immunol, V62, P41; SELANDER RK, 1986, APPL ENVIRON MICROB, V51, P873, DOI 10.1128/AEM.51.5.873-884.1986; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Shu SE, 2000, FEMS MICROBIOL LETT, V182, P93, DOI 10.1111/j.1574-6968.2000.tb08880.x; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teyssier C, 2003, J BACTERIOL, V185, P2901, DOI 10.1128/JB.185.9.2901-2909.2003; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Usera MA, 1996, EUR J EPIDEMIOL, V12, P377, DOI 10.1007/BF00145301; van der Woude MW, 2011, CURR OPIN MICROBIOL, V14, P205, DOI 10.1016/j.mib.2011.01.002; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Vickery MCL, 2007, J MICROBIOL METH, V68, P376, DOI 10.1016/j.mimet.2006.02.018; Vinogradov E, 2000, FEMS MICROBIOL LETT, V190, P157, DOI 10.1016/S0378-1097(00)00320-7; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Wu KY, 2005, J BACTERIOL, V187, P4720, DOI 10.1128/JB.187.14.4720-4727.2005; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Yap MN, 2004, APPL ENVIRON MICROB, V70, P3013, DOI 10.1128/AEM.70.5.3013-3023.2004	113	9	9	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74120	10.1371/journal.pone.0074120	http://dx.doi.org/10.1371/journal.pone.0074120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069274	Green Submitted, gold, Green Published			2022-12-27	WOS:000326240100086
J	Leger, MM; Gawryluk, RMR; Gray, MW; Roger, AJ				Leger, Michelle M.; Gawryluk, Ryan M. R.; Gray, Michael W.; Roger, Andrew J.			Evidence for a Hydrogenosomal-Type Anaerobic ATP Generation Pathway in Acanthamoeba castellanii	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SUCCINATE-COA-TRANSFERASE; FERREDOXIN OXIDOREDUCTASE; PYRUVATE METABOLISM; GENE-TRANSFER; PHYLOGENETIC DISTRIBUTIONS; TRICHOMONAS-VAGINALIS; TRITRICHOMONAS-FETUS; IRON HYDROGENASES; FE-HYDROGENASE	Diverse, distantly-related eukaryotic lineages have adapted to low-oxygen environments, and possess mitochondrion-related organelles that have lost the capacity to generate adenosine triphosphate (ATP) through oxidative phosphorylation. A subset of these organelles, hydrogenosomes, has acquired a set of characteristic ATP generation enzymes commonly found in anaerobic bacteria. The recipient of these enzymes could not have survived prior to their acquisition had it not still possessed the electron transport chain present in the ancestral mitochondrion. In the divergence of modern hydrogenosomes from mitochondria, a transitional organelle must therefore have existed that possessed both an electron transport chain and an anaerobic ATP generation pathway. Here, we report a modern analog of this organelle in the habitually aerobic opportunistic pathogen, Acanthamoeba castellanii. This organism possesses a complete set of enzymes comprising a hydrogenosome-like ATP generation pathway, each of which is predicted to be targeted to mitochondria. We have experimentally confirmed the mitochondrial localizations of key components of this pathway using tandem mass spectrometry. This evidence is the first supported by localization and proteome data of a mitochondrion possessing both an electron transport chain and hydrogenosome-like energy metabolism enzymes. Our work provides insight into the first steps that might have occurred in the course of the emergence of modern hydrogenosomes.	[Leger, Michelle M.; Gawryluk, Ryan M. R.; Gray, Michael W.; Roger, Andrew J.] Dalhousie Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS, Canada	Dalhousie University	Roger, AJ (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS, Canada.	aroger@dal.ca	Leger, Michelle M/M-4813-2016	Leger, Michelle M/0000-0001-5500-5480; Gawryluk, Ryan/0000-0003-1251-882X; Gray, Michael/0000-0001-7125-2625	Canadian Institutes of Health Research [MOP-62809, MOP-4124]; National Research Fund, Luxembourg; Nova Scotia Health Research Foundation; Killam Trusts; Tula Foundation; Canada Research Chairs Program; Canadian Institute for Advanced Research Program in Integrated Microbial Biodiversity; NIH/NHGRI [U01 HG02051]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Research Fund, Luxembourg(Luxembourg National Research Fund); Nova Scotia Health Research Foundation; Killam Trusts; Tula Foundation; Canada Research Chairs Program(Canada Research Chairs); Canadian Institute for Advanced Research Program in Integrated Microbial Biodiversity(Canadian Institute for Advanced Research (CIFAR)); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work and R. M. R. G. were supported by grant MOP-62809 awarded to A.J.R. by the Canadian Institutes of Health Research. M. M. L. is supported by the National Research Fund, Luxembourg, and by the Nova Scotia Health Research Foundation. R. M. R. G. was supported by a Predoctoral Scholarship from the Killam Trusts. Operating grant support to M. W. G. from the Canadian Institutes of Health Research (MOP-4124) as well as funding from the Tula Foundation is gratefully acknowledged. A.J.R. acknowledges support from the Canada Research Chairs Program, the Canadian Institute for Advanced Research Program in Integrated Microbial Biodiversity and the Tula Foundation. Preliminary sequence data was obtained from Baylor College of Medicine Human Genome Sequencing Center website at http://www.hgsc.bcm.tmc.edu. The DNA sequence of Acanthamoeba castellanii was supported by grant number U01 HG02051 from NIH/NHGRI to Richard Gibbs at the BCM-HGSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson JO, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-51; Andersson JO, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/27; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; Andersson Jan O., 2009, V532, P473, DOI [10.1007/978-1-60327-853-9-27, 10.1007/978-1-60327-853-9_27]; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Buetow D.E., 1989, P247; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cometa I, 2011, ACTA PROTOZOOL, V50, P33, DOI 10.4467/16890027AP.11.004.0004; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Ctrnacta V, 2006, J EUKARYOT MICROBIOL, V53, P225, DOI 10.1111/j.1550-7408.2006.00099.x; Dyall SD, 2004, NATURE, V431, P1103, DOI 10.1038/nature02990; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDWARDS SW, 1978, BIOCHEM J, V174, P203, DOI 10.1042/bj1740203; ELLIS JE, 1993, FEBS LETT, V325, P196, DOI 10.1016/0014-5793(93)81072-8; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Embley TM, 2006, PHILOS T R SOC B, V361, P1055, DOI 10.1098/rstb.2006.1844; Forestier M, 2003, EUR J BIOCHEM, V270, P2750, DOI 10.1046/j.1432-1033.2003.03656; Fritz-Laylin LK, 2010, CELL, V140, P631, DOI 10.1016/j.cell.2010.01.032; Gaffron Hans, 1942, JOUR GEN PHYSIOL, V26, P219, DOI 10.1085/jgp.26.2.219; Gaudet P, 2011, NUCLEIC ACIDS RES, V39, pD620, DOI 10.1093/nar/gkq1103; Gawryluk RMR, 2012, BBA-BIOENERGETICS, V1817, P2027, DOI 10.1016/j.bbabio.2012.06.005; Gawryluk RMR, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-176; Gelius-Dietrich G, 2004, J EUKARYOT MICROBIOL, V51, P456, DOI 10.1111/j.1550-7408.2004.tb00394.x; Hackstein JHP, 2005, BIOCHEM SOC T, V33, P47, DOI 10.1042/BST0330047; Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x; Horner DS, 2002, TRENDS BIOCHEM SCI, V27, P148, DOI 10.1016/S0968-0004(01)02053-9; Horner DS, 2000, MOL BIOL EVOL, V17, P1695, DOI 10.1093/oxfordjournals.molbev.a026268; Horner DS, 1999, MOL BIOL EVOL, V16, P1280, DOI 10.1093/oxfordjournals.molbev.a026218; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; HRDY I, 1995, J MOL EVOL, V41, P388, DOI 10.1007/BF01215186; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Lantsman Y, 2008, MICROBIOL-SGM, V154, P2757, DOI 10.1099/mic.0.2008/017897-0; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LINDMARK DG, 1973, J BIOL CHEM, V248, P7724; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MARVINSIKKEMA FD, 1993, ARCH MICROBIOL, V160, P388; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; O'Brien EA, 2007, NUCLEIC ACIDS RES, V35, pD445, DOI 10.1093/nar/gkl770; Oulton MM, 2003, EUR J BIOCHEM, V270, P4962, DOI 10.1046/j.1432-1033.2003.03898.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Putz S, 2006, EUKARYOT CELL, V5, P579, DOI 10.1128/EC.5.3.579-586.2006; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Rodriguez MA, 1996, MOL BIOCHEM PARASIT, V78, P273, DOI 10.1016/S0166-6851(96)02613-8; Rotte C, 2001, MOL BIOL EVOL, V18, P710, DOI 10.1093/oxfordjournals.molbev.a003853; Schneider G, 1998, PROTEINS, V30, P49, DOI 10.1002/(SICI)1097-0134(19980101)30:1<49::AID-PROT5>3.3.CO;2-P; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stairs CW, 2011, MOL BIOL EVOL, V28, P2087, DOI 10.1093/molbev/msr032; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2008, CURR BIOL, V18, P580, DOI 10.1016/j.cub.2008.03.037; STEINBUCHEL A, 1986, MOL BIOCHEM PARASIT, V20, P57, DOI 10.1016/0166-6851(86)90142-8; Takishita K, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-5; Tielens AGM, 2010, INT J PARASITOL, V40, P387, DOI 10.1016/j.ijpara.2009.12.006; Tsaousis AD, 2012, CELL ORIG LIFE EXTRE, V21, P53; Turner NA, 1997, FEMS MICROBIOL LETT, V157, P149, DOI 10.1111/j.1574-6968.1997.tb12766.x; van Grinsven KWA, 2008, J BIOL CHEM, V283, P1411, DOI 10.1074/jbc.M702528200; van Grinsven KWA, 2009, MOL BIOCHEM PARASIT, V164, P74, DOI 10.1016/j.molbiopara.2008.11.008; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Voncken FGJ, 2002, GENE, V284, P103, DOI 10.1016/S0378-1119(02)00388-8; WILLIAMS K, 1987, BIOCHEM J, V246, P529, DOI 10.1042/bj2460529	76	29	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e69532	10.1371/journal.pone.0069532	http://dx.doi.org/10.1371/journal.pone.0069532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086244	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900001
J	Jiao, X; Qin, YY; Li, GY; Zhao, SD; You, L; Ma, JL; Simpson, JL; Chen, ZJ				Jiao, Xue; Qin, Yingying; Li, Guangyu; Zhao, Shidou; You, Li; Ma, Jinlong; Simpson, Joe Leigh; Chen, Zi-Jiang			Novel NR5A1 Missense Mutation in Premature Ovarian Failure: Detection in Han Chinese Indicates Causation in Different Ethnic Groups	PLOS ONE			English	Article							STEROIDOGENIC FACTOR-I; ANTI-MULLERIAN HORMONE; SF-1 MUTATIONS; INSUFFICIENCY; GENE; FACTOR-1; WOMEN; PROMOTER; PROTEIN; INHIBIN	Background: The etiology of most premature ovarian failure (POF) cases is usually elusive. Although genetic causes clearly exist and a likely susceptible region of 8q22.3 has been discovered, no predominant explanation exists for POF. More recently, evidences have indicated that mutations in NR5A1 gene could be causative for POF. We therefore screened for mutations in the NR5A1 gene in a large cohort of Chinese women with non-syndromic POF. Methods: Mutation screening of NR5A1 gene was performed in 400 Han Chinese women with well-defined 46, XX idiopathic non-syndromic POF and 400 controls. Subsequently, functional characterization of the novel mutation identified was evaluated in vitro. Results: A novel heterozygous missense mutation [c.13T>G (p.Tyr5Asp)] in NR5A1 was identified in 1 of 384 patients (0.26%). This mutation impaired transcriptional activation on Amh, Inhibin-a, Cyp11a1 and Cyp19a1 gene, as shown by transactivation assays. However, no dominant negative effect was observed, nor was there impact on protein expression and nuclear localization. Conclusions: This novel mutation p.Tyr5Asp, in a novel non-domain region, is presumed to result in haploinsufficiency. Irrespectively, perturbation in NR5A1 is not a common explanation for POF in Chinese.	[Jiao, Xue; Qin, Yingying; Li, Guangyu; Zhao, Shidou; You, Li; Ma, Jinlong; Chen, Zi-Jiang] Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Shandong Prov Key Lab Reprod Med,Minist Educ, Ctr Reprod Med,Prov Hosp,Key Lab Reprod Endocrino, Jinan 250100, Peoples R China; [Simpson, Joe Leigh] Res & Global Programs March Dimes Fdn, White Plains, NY USA; [Simpson, Joe Leigh] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Shanghai Key Lab Assisted Reprod & Reprod Genet, Ctr Reprod Med, Renji Hosp,Sch Med, Shanghai 200030, Peoples R China	Shandong University; State University System of Florida; Florida International University; Shanghai Jiao Tong University	Chen, ZJ (corresponding author), Shandong Univ, Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Shandong Prov Key Lab Reprod Med,Minist Educ, Ctr Reprod Med,Prov Hosp,Key Lab Reprod Endocrino, Jinan 250100, Peoples R China.	chenzijiang@hotmail.com	Yan, Junhao/AAH-8310-2019; Chen, Zi-Jiang/GOE-6119-2022	Chen, Zi-Jiang/0000-0001-6637-6631; JIAO, XUE/0000-0002-2936-2166	National Basic Research Program of China [973 program] [2012CB944700]; National Natural Science Foundation of China [81000236, 81270662]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201078]; Independent Innovation Foundation of Shandong University, IIFSDU [2012TS130]	National Basic Research Program of China [973 program](National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Independent Innovation Foundation of Shandong University, IIFSDU	This work was supported by the National Basic Research Program of China [973 program-2012CB944700]; the National Natural Science Foundation of China [81000236,81270662]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201078); and Independent Innovation Foundation of Shandong University, IIFSDU (2012TS130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Bouilly J, 2011, HUM MUTAT, V32, P1108, DOI 10.1002/humu.21543; Camats N, 2012, J CLIN ENDOCR METAB, V97, pE1294, DOI 10.1210/jc.2011-3169; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Chand AL, 2010, HUM REPROD UPDATE, V16, P39, DOI 10.1093/humupd/dmp031; Ciaccio M, 2012, HORM RES PAEDIAT, V78, P119, DOI 10.1159/000338346; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Fan WQ, 2003, BIOCHEM BIOPH RES CO, V311, P987, DOI 10.1016/j.bbrc.2003.10.096; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; Ito M, 2000, MOL ENDOCRINOL, V14, P66, DOI 10.1210/me.14.1.66; Janse F, 2012, FERTIL STERIL, V97, P141, DOI 10.1016/j.fertnstert.2011.10.032; Jiao X, 2012, HUM REPROD, V27, P2201, DOI 10.1093/humrep/des104; Keri RA, 1996, J BIOL CHEM, V271, P10782, DOI 10.1074/jbc.271.18.10782; Laissue P, 2008, MOL CELL ENDOCRINOL, V282, P101, DOI 10.1016/j.mce.2007.11.005; Lakhal B, 2012, GENE, V509, P298, DOI 10.1016/j.gene.2012.08.007; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Mendelson CR, 2007, J STEROID BIOCHEM, V106, P62, DOI 10.1016/j.jsbmb.2007.05.001; Warman DM, 2011, HORM RES PAEDIAT, V75, P70, DOI 10.1159/000320029; Parker KL, 2002, RECENT PROG HORM RES, V57, P19, DOI 10.1210/rp.57.1.19; Pelusi C, 2008, BIOL REPROD, V79, P1074, DOI 10.1095/biolreprod.108.069435; Philibert P, 2013, FERTIL STERIL, V99, P484, DOI 10.1016/j.fertnstert.2012.10.026; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Qin YY, 2012, HUM MOL GENET, V21, P430, DOI 10.1093/hmg/ddr462; Rossetti R, 2009, HUM MUTAT, V30, P804, DOI 10.1002/humu.20961; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; Sugawara T, 1997, BIOCHEMISTRY-US, V36, P7249, DOI 10.1021/bi9628984; Suwanai AS, 2013, CLIN ENDOCRINOL, V78, P957, DOI 10.1111/cen.12054; TAKAYAMA K, 1995, J CLIN ENDOCR METAB, V80, P2815, DOI 10.1210/jc.80.9.2815; Voican A, 2013, J CLIN ENDOCR METAB, V98, pE1017, DOI 10.1210/jc.2012-4111; Zhao H, 2008, AM J HUM GENET, V82, P1342, DOI 10.1016/j.ajhg.2008.04.018	32	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74759	10.1371/journal.pone.0074759	http://dx.doi.org/10.1371/journal.pone.0074759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073220	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000029
J	Murdock, CC; Foufopoulos, J; Simon, CP				Murdock, Courtney C.; Foufopoulos, Johannes; Simon, Carl P.			A Transmission Model for the Ecology of an Avian Blood Parasite in a Temperate Ecosystem	PLOS ONE			English	Article							MALARIA PLASMODIUM-RELICTUM; SENSITIVITY ANALYSIS TECHNIQUES; WHITE-CROWNED SPARROWS; ST-LOUIS ENCEPHALITIS; 7 LARVAL INSTARS; LEUCOCYTOZOON-SIMONDI; REPRODUCTIVE SUCCESS; TEMPORAL VARIATION; PARENTAL EFFORT; DIPTERA	Most of our knowledge about avian haemosporidian parasites comes from the Hawaiian archipelago, where recently introduced Plasmodium relictum has contributed to the extinction of many endemic avian species. While the ecology of invasive malaria is reasonably understood, the ecology of endemic haemosporidian infection in mainland systems is poorly understood, even though it is the rule rather than the exception. We develop a mathematical model to explore and identify the ecological factors that most influence transmission of the common avian parasite, Leucocytozoon fringillinarum (Apicomplexa). The model was parameterized from White-crowned Sparrow (Zonotrichia leucophrys) and S. silvestre / craigi black fly populations breeding in an alpine ecosystem. We identify and examine the importance of altricial nestlings, the seasonal relapse of infected birds for parasite persistence across breeding seasons, and potential impacts of seasonal changes in black fly emergence on parasite prevalence in a high elevation temperate system. We also use the model to identify and estimate the parameters most influencing transmission dynamics. Our analysis found that relapse of adult birds and young of the year birds were crucial for parasite persistence across multiple seasons. However, distinguishing between nude nestlings and feathered young of the year was unnecessary. Finally, due to model sensitivity to many black fly parameters, parasite prevalence and sparrow recruitment may be most affected by seasonal changes in environmental temperature driving shifts in black fly emergence and gonotrophic cycles.	[Murdock, Courtney C.; Foufopoulos, Johannes] Univ Michigan, Sch Nat Resources, Ann Arbor, MI 48109 USA; [Murdock, Courtney C.; Foufopoulos, Johannes] Univ Michigan, Program Environm, Ann Arbor, MI 48109 USA; [Murdock, Courtney C.] Penn State Univ, Dept Entomol, Ctr Infect Dis, University Pk, PA 16802 USA; [Simon, Carl P.] Univ Michigan, Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Simon, Carl P.] Univ Michigan, Ctr Study Complex Syst, Dept Math, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Murdock, CC (corresponding author), Univ Michigan, Sch Nat Resources, Ann Arbor, MI 48109 USA.	ccm15@psu.edu		Foufopoulos, Johannes/0000-0002-8341-8271	NIH; School of Natural Resources, University of Michigan Alumni Incentive Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Natural Resources, University of Michigan Alumni Incentive Award	This research was funded by: NIH (http://sitemaker.umich.edu/macepid/ipid_training_program): Interdisciplinary Perspectives of Infectious Diseases Training Grant, and School of Natural Resources, University of Michigan Alumni Incentive Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PH, 2004, BLACK FLIES SIMULIID; Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2; ALLAN RA, 1989, AM MIDL NAT, V121, P341, DOI 10.2307/2426038; Allander K, 1997, FUNCT ECOL, V11, P358, DOI 10.1046/j.1365-2435.1997.00095.x; ALVERSON DR, 1977, J MED ENTOMOL, V14, P132, DOI 10.1093/jmedent/14.1.132; ANDERSON R M, 1991; [Anonymous], 2001, ERKELEY MADONNA MODE; APPLEGATE J E, 1971, Journal of Wildlife Diseases, V7, P91; APPLEGATE J E, 1970, Journal of Parasitology, V56, P8; APPLEGATE J E, 1971, Journal of Wildlife Diseases, V7, P37; APPLEGATE JE, 1970, J PARASITOL, V56, P439, DOI 10.2307/3277599; Aruch S, 2007, J WILDLIFE DIS, V43, P567, DOI 10.7589/0090-3558-43.4.567; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 2001, CONDOR, V103, P209, DOI 10.1650/0010-5422(2001)103[0209:PSRADO]2.0.CO;2; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; BAKER MC, 1981, ECOLOGY, V62, P636, DOI 10.2307/1937731; BALL GH, 1964, J PARASITOL, V50, P50; BEAUDOIN R L, 1971, Journal of Wildlife Diseases, V7, P5; BECKER CD, 1973, AM MIDL NAT, V89, P246, DOI 10.2307/2424158; BENNETT GF, 1992, CAN J ZOOL, V70, P2007, DOI 10.1139/z92-271; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bonier F, 2007, BEHAV ECOL, V18, P121, DOI 10.1093/beheco/arl050; BRIGGS N. THEODORE, 1960, PROC HELMINTHOL SOC WASHINGTON, V27, P151; CHERNIN E, 1952, AM J HYG, V56, P101, DOI 10.1093/oxfordjournals.aje.a119545; Chilton G, 1995, WHITECROWNED SPARROW; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; Cornet S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-179; Cornet S, 2013, ECOL LETT, V16, P323, DOI 10.1111/ele.12041; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DESSER SS, 1976, CAN J ZOOL, V54, P634, DOI 10.1139/z76-075; DESSER SS, 1968, CAN J ZOOLOG, V46, P281, DOI 10.1139/z68-041; Deviche P, 2010, PARASITOLOGY, V137, P261, DOI 10.1017/S003118200999134X; FIALHO RF, 1995, J ANIM ECOL, V64, P553, DOI 10.2307/5799; Finn DS, 2008, ARCT ANTARCT ALP RES, V40, P638, DOI 10.1657/1523-0430(07-072)[FINN]2.0.CO;2; FREDEEN FJH, 1981, CAN ENTOMOL, V113, P161, DOI 10.4039/Ent113161-2; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hellgren O, 2008, MOL ECOL, V17, P1605, DOI 10.1111/j.1365-294X.2007.03680.x; Hobbelen PHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049594; Huff CG, 1942, J INFECT DIS, V71, P18, DOI 10.1093/infdis/71.1.18; IMAN RL, 1988, RISK ANAL, V8, P71, DOI 10.1111/j.1539-6924.1988.tb01155.x; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P1749, DOI 10.1080/03610928008827996; Ishii Y, 2008, PARASITE, V15, P121, DOI 10.1051/parasite/2008152121; JACQUEZ JA, 1996, COMPARTMENTAL ANAL B; KHAN RA, 1970, J PROTOZOOL, V17, P642, DOI 10.1111/j.1550-7408.1970.tb04742.x; KHAN RA, 1970, CAN J ZOOLOG, V48, P451, DOI 10.1139/z70-077; Kilpatrick AM, 2006, AUK, V123, P764, DOI 10.1642/0004-8038(2006)123[764:EOCAMP]2.0.CO;2; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Lachish S, 2013, ECOGRAPHY, V36, P587, DOI 10.1111/j.1600-0587.2012.07801.x; Lachish S, 2011, J ANIM ECOL, V80, P1207, DOI 10.1111/j.1365-2656.2011.01893.x; Lack D., 1954, P343; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Lloyd AL, 2001, THEOR POPUL BIOL, V60, P59, DOI 10.1006/tpbi.2001.1525; Lord CC, 2001, VECTOR-BORNE ZOONOT, V1, P299, DOI 10.1089/15303660160025921; Lord CC, 2001, VECTOR-BORNE ZOONOT, V1, P317, DOI 10.1089/15303660160025930; Mackinnon MJ, 1999, EVOLUTION, V53, P689, DOI [10.2307/2640710, 10.1111/j.1558-5646.1999.tb05364.x]; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Marzal A, 2008, J EVOLUTION BIOL, V21, P979, DOI 10.1111/j.1420-9101.2008.01545.x; MERRITT RW, 1982, ECOLOGY, V63, P1322, DOI 10.2307/1938860; Millington OR, 2007, PLOS PATHOG, V3, P1380, DOI 10.1371/journal.ppat.0030143; Molaei G, 2006, J MED ENTOMOL, V43, P1088, DOI 10.1603/0022-2585(2006)43[1088:IOAAMB]2.0.CO;2; Morton ML., 2002, STUD AVIAN BIOL; Murdock C., 2009, THESIS U MICHIGAN; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; NORRIS K, 1994, J ANIM ECOL, V63, P601, DOI 10.2307/5226; Ots I, 1996, P ROY SOC B-BIOL SCI, V263, P1443, DOI 10.1098/rspb.1996.0210; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Press W. H., 1992, ART SCI COMPUTING; Ramenofsky M, 2007, BIOSCIENCE, V57, P135, DOI 10.1641/B570208; Rao RU, 2009, T ROY SOC TROP MED H, V103, P365, DOI 10.1016/j.trstmh.2008.07.012; Rock KS, 2012, ECOL MODEL, V235, P26, DOI 10.1016/j.ecolmodel.2012.04.004; Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6; ROLLER NF, 1973, CAN J ZOOL, V51, P1, DOI 10.1139/z73-001; ROSS DH, 1979, CAN J ZOOL, V57, P290, DOI 10.1139/z79-032; Ross DH, 1988, BLACKFLIES ECOLOGY P, P90; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; Stjernman M, 2004, P ROY SOC B-BIOL SCI, V271, P2387, DOI 10.1098/rspb.2004.2883; Tomas G, 2007, FUNCT ECOL, V21, P125, DOI 10.1111/j.1365-2435.2006.01214.x; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; Valkinas G., 2005, AVIAN MALARIA PARASI; van Riper C, 2001, STUD AVIAN BIOL-SER, P221; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Vieira JC, 2005, T ROY SOC TROP MED H, V99, P178, DOI 10.1016/j.trstmh.2004.03.012; Wingfield JC, 2003, GEN COMP ENDOCR, V131, P143, DOI 10.1016/S0016-6480(02)00648-2	86	14	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76126	10.1371/journal.pone.0076126	http://dx.doi.org/10.1371/journal.pone.0076126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073288	gold, Green Published, Green Submitted			2022-12-27	WOS:000324768000098
J	Pan, JC; Chen, JX; Zhang, B; Chen, X; Huang, B; Zhuang, JT; Mo, CQ; Qiu, SP				Pan, Jincheng; Chen, Junxing; Zhang, Bo; Chen, Xu; Huang, Bin; Zhuang, Jintao; Mo, Chengqiang; Qiu, Shaopeng			Association between RASSF1A Promoter Methylation and Prostate Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; DNA METHYLATION; MULTIPLE GENES; PROFILE; PATTERNS; INACTIVATION; STATISTICS; BREAST; GSTP1; LUNG	Prostate cancer (PCa) remains as one of the most common cause of cancer related death among men in the US. The widely used prostate specific antigen (PSA) screening is limited by low specificity. The diagnostic value of other biomarkers such as RAS association domain family protein 1 A (RASSF1A) promoter methylation in prostate cancer and the relationship between RASSF1A methylation and pathological features or tumor stage remains to be established. Therefore, a meta-analysis of published studies was performed to understand the association between RASSF1A methylation and prostate cancer. In total, 16 studies involving 1431 cases and 565 controls were pooled with a random effect model in this investigation. The odds ratio (OR) of RASSF1A methylation in PCa case, compared to controls, was 14.73 with 95% CI = 7.58-28.61. Stratified analyses consistently showed a similar risk across different sample types and, methylation detection methods. In addition, RASSF1A methylation was associated with high Gleason score OR=2.35, 95% CI: 1.56-3.53. Furthermore, the pooled specificity for all included studies was 0.87 (95% CI: 0.72-0.94), and the pooled sensitivity was 0.76 (95% CI: 0.55-0.89). The specificity in each subgroup stratified by sample type remained above 0.84 and the sensitivity also remained above 0.60. These results suggested that RASSF1A promoter methylation would be a potential biomarker in PCa diagnosis and therapy.	[Pan, Jincheng; Chen, Junxing; Chen, Xu; Huang, Bin; Zhuang, Jintao; Mo, Chengqiang; Qiu, Shaopeng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Bo] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Qiu, SP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.	qiushp@hotmail.com	ZHANG, BO/K-4561-2013	ZHANG, BO/0000-0002-6352-1757	China National Natural Science Foundation [81272809]; Science and Technology Planning Project of Guangdong [2011B050400021]; Guangdong Key Laboratory of Urology, The first affiliated Hospital of Guangzhou medical University [2010A060801016]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong; Guangdong Key Laboratory of Urology, The first affiliated Hospital of Guangzhou medical University	This work was supported by grants from the China National Natural Science Foundation (81272809); Supported by Science and Technology Planning Project of Guangdong (2011B050400021) and Guangdong Key Laboratory of Urology, The first affiliated Hospital of Guangzhou medical University (2010A060801016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathanggelou A, 2001, ONCOGENE, V20, P1509, DOI 10.1038/sj.onc.1204175; Alers JC, 2001, AM J PATHOL, V158, P399, DOI 10.1016/S0002-9440(10)63983-1; Allen NPC, 2007, ONCOGENE, V26, P6203, DOI 10.1038/sj.onc.1210440; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Barbieri CE, 2012, HISTOPATHOLOGY, V60, P187, DOI 10.1111/j.1365-2559.2011.04041.x; Bastian PJ, 2008, J UROLOGY, V179, P529, DOI 10.1016/j.juro.2007.09.038; Bastian PJ, 2005, CLIN CANCER RES, V11, P4097, DOI 10.1158/1078-0432.CCR-04-1832; Bastian PJ, 2004, EUR UROL, V46, P698, DOI 10.1016/j.eururo.2004.07.022; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Florl AL, 2004, BRIT J CANCER, V91, P985, DOI 10.1038/sj.bjc.6602030; Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009; Jeronimo C, 2004, CLIN CANCER RES, V10, P8472, DOI 10.1158/1078-0432.CCR-04-0894; Kang GH, 2004, J PATHOL, V202, P233, DOI 10.1002/path.1503; Kawamoto K, 2007, CLIN CANCER RES, V13, P2541, DOI 10.1158/1078-0432.CCR-06-2225; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Maruyama R, 2002, CLIN CANCER RES, V8, P514; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Roupret M, 2008, INT J CANCER, V122, P952, DOI 10.1002/ijc.23196; Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467; Roychowdhury S, 2013, J CLIN ONCOL, V31, P1866, DOI 10.1200/JCO.2012.45.3662; Roychowdhury S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003161; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singal R, 2004, ONCOL REP, V12, P631; Syeed N, 2010, MOL MED REP, V3, P883, DOI 10.3892/mmr.2010.348; van Leeuwen PJ, 2010, EUR J CANCER, V46, P377, DOI 10.1016/j.ejca.2009.09.008; Vasiljevic N, 2011, DIS MARKERS, V30, P151, DOI 10.3233/DMA-2011-0790; Woodson K, 2004, PROSTATE, V60, P25, DOI 10.1002/pros.20013; Wu T, 2011, BRIT J CANCER, V105, P65, DOI 10.1038/bjc.2011.143; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972	32	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75283	10.1371/journal.pone.0075283	http://dx.doi.org/10.1371/journal.pone.0075283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073258	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000067
J	Steinwand, MA; Young, HA; Bragg, JN; Tobias, CM; Vogel, JP				Steinwand, Michael A.; Young, Hugh A.; Bragg, Jennifer N.; Tobias, Christian M.; Vogel, John P.			Brachypodium sylvaticum, a Model for Perennial Grasses: Transformation and Inbred Line Development	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; FUNCTIONAL GENOMICS; WHEAT; ARABIDOPSIS; MUTAGENESIS; PROSPECTS; SECURITY; MARKERS; MAIZE; FOOD	Perennial species offer significant advantages as crops including reduced soil erosion, lower energy inputs after the first year, deeper root systems that access more soil moisture, and decreased fertilizer inputs due to the remobilization of nutrients at the end of the growing season. These advantages are particularly relevant for emerging biomass crops and it is projected that perennial grasses will be among the most important dedicated biomass crops. The advantages offered by perennial crops could also prove favorable for incorporation into annual grain crops like wheat, rice, sorghum and barley, especially under the dryer and more variable climate conditions projected for many grain-producing regions. Thus, it would be useful to have a perennial model system to test biotechnological approaches to crop improvement and for fundamental research. The perennial grass Brachypodium sylvaticum is a candidate for such a model because it is diploid, has a small genome, is self-fertile, has a modest stature, and short generation time. Its close relationship to the annual model Brachypodium distachyon will facilitate comparative studies and allow researchers to leverage the resources developed for B. distachyon. Here we report on the development of two keystone resources that are essential for a model plant: high-efficiency transformation and inbred lines. Using Agrobacterium tumefaciens-mediated transformation we achieved an average transformation efficiency of 67%. We also surveyed the genetic diversity of 19 accessions from the National Plant Germplasm System using SSR markers and created 15 inbred lines.	[Steinwand, Michael A.; Young, Hugh A.; Bragg, Jennifer N.; Tobias, Christian M.; Vogel, John P.] ARS, Western Reg Res Ctr, USDA, Albany, CA USA; [Young, Hugh A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Bragg, Jennifer N.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of California System; University of California Davis	Vogel, JP (corresponding author), ARS, Western Reg Res Ctr, USDA, Albany, CA USA.	john.vogel@ars.usda.gov	Tobias, Christian/B-6602-2009	Tobias, Christian/0000-0002-7881-750X; Vogel, John/0000-0003-1786-2689	Office of Science (BER), US Department of Energy; USDA-ARS CRIS [5325-21000-017-00]	Office of Science (BER), US Department of Energy(United States Department of Energy (DOE)); USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Office of Science (BER), US Department of Energy, and by USDA-ARS CRIS project 5325-21000-017-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj S, 2006, PLANT CELL REP, V25, P651, DOI 10.1007/s00299-005-0099-9; Bell LW, 2010, CROP PASTURE SCI, V61, P679, DOI 10.1071/CP10064; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Bragg JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041916; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Cao MX, 2006, PLANT CELL TISS ORG, V85, P307, DOI 10.1007/s11240-006-9081-7; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Ciampitti IA, 2012, FIELD CROP RES, V133, P48, DOI 10.1016/j.fcr.2012.03.008; Cox TS, 2010, CROP PASTURE SCI, V61, P513, DOI 10.1071/CP09201; Cox TS, 2006, BIOSCIENCE, V56, P649, DOI 10.1641/0006-3568(2006)56[649:PFDPGC]2.0.CO;2; Cox TS, 2002, CRIT REV PLANT SCI, V21, P59, DOI 10.1080/0735-260291044188; Doe, 2006, BREAKING BIOL BARRIE; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; Glover JD, 2010, SCIENCE, V328, P1638, DOI 10.1126/science.1188761; Glover JD, 2010, ISSUES SCI TECHNOL, V26, P41; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Han N, 2005, PLANT CELL TISS ORG, V81, P131, DOI 10.1007/s11240-004-4042-5; Hayes RC, 2012, FIELD CROP RES, V133, P68, DOI 10.1016/j.fcr.2012.03.014; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Khaleda L., 2006, Biotechnology, V5, P379; Khan MA, 1999, NORD J BOT, V19, P257, DOI 10.1111/j.1756-1051.1999.tb01108.x; Kim SJ, 2007, J PLANT BIOL, V50, P577, DOI 10.1007/BF03030712; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; LONG GM, 1989, MORPHOLOGICAL PHYSL; Luo H, 2004, PLANT CELL REP, V22, P645, DOI 10.1007/s00299-003-0734-2; PALMER JW, 1988, J APPL ECOL, V25, P569, DOI 10.2307/2403845; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Ramakrishnan AP, 2008, MOL ECOL RESOUR, V8, P1297, DOI 10.1111/j.1755-0998.2008.02174.x; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; SHI Y, 1993, PLANT SYST EVOL, V188, P125; Somleva MN, 2002, CROP SCI, V42, P2080, DOI 10.2135/cropsci2002.2080; Spielmeyer W, 2008, THEOR APPL GENET, V116, P481, DOI 10.1007/s00122-007-0684-0; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Van Tassel DL, 2010, EVOL APPL, V3, P434, DOI 10.1111/j.1752-4571.2010.00132.x; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Wang ZY, 2005, FUNCT PLANT BIOL, V32, P769, DOI 10.1071/FP05083; Young HA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-117; Zhang Peng, 2009, P365, DOI 10.1007/978-3-540-70581-9_32	45	22	23	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75180	10.1371/journal.pone.0075180	http://dx.doi.org/10.1371/journal.pone.0075180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073248	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000057
J	Yan, BC; Park, JH; Shin, BN; Ahn, H; Kim, IH; Lee, JC; Yoo, KY; Hwang, IK; Choi, JH; Park, JH; Lee, YL; Suh, HW; Jun, JG; Kwon, YG; Kim, YM; Kwon, SH; Her, S; Kim, JS; Hyun, BH; Kim, CK; Cho, JH; Lee, CH; Won, MH				Yan, Bing Chun; Park, Joon Ha; Shin, Bich Na; Ahn, Ji Hyeon; Kim, In Hye; Lee, Jae-Chul; Yoo, Ki-Yeon; Hwang, In Koo; Choi, Jung Hoon; Park, Jeong Ho; Lee, Yun Lyul; Suh, Hong-Won; Jun, Jong-Gab; Kwon, Young-Guen; Kim, Young-Myeong; Kwon, Seung-Hae; Her, Song; Kim, Jin Su; Hyun, Byung-Hwa; Kim, Chul-Kyu; Cho, Jun Hwi; Lee, Choong Hyun; Won, Moo-Ho			Neuroprotective Effect of a New Synthetic Aspirin-decursinol Adduct in Experimental Animal Models of Ischemic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; HIPPOCAMPAL CA1 REGION; OXYGEN-GLUCOSE DEPRIVATION; DELAYED NEURONAL DEATH; OXIDATIVE STRESS; CYTOCHROME-C; MICE; RAT; GERBIL; RELEASE	Stroke is the second leading cause of death. Experimental animal models of cerebral ischemia are widely used for researching mechanisms of ischemic damage and developing new drugs for the prevention and treatment of stroke. The present study aimed to comparatively investigate neuroprotective effects of aspirin (ASA), decursinol (DA) and new synthetic aspirin-decursinol adduct (ASA-DA) against transient focal and global cerebral ischemic damage. We found that treatment with 20 mg/kg, not 10 mg/kg, ASA-DA protected against ischemia-induced neuronal death after transient focal and global ischemic damage, and its neuroprotective effect was much better than that of ASA or DA alone. In addition, 20 mg/kg ASA-DA treatment reduced the ischemia-induced gliosis and maintained antioxidants levels in the corresponding injury regions. In brief, ASA-DA, a new synthetic drug, dramatically protected neurons from ischemic damage, and neuroprotective effects of ASA-DA may be closely related to the attenuation of ischemia-induced gliosis and maintenance of antioxidants.	[Yan, Bing Chun] Yangzhou Univ, Inst Integrat Tradit & Western Med, Coll Med, Yangzhou, Peoples R China; [Park, Joon Ha; Ahn, Ji Hyeon; Kim, In Hye; Lee, Jae-Chul; Lee, Yun Lyul; Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon, South Korea; [Shin, Bich Na] Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea; [Shin, Bich Na] Hallym Univ, Coll Med, Inst Neurodegenerat & Neuroregenerat, Chunchon, South Korea; [Yoo, Ki-Yeon] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Anat, Kangnung, South Korea; [Hwang, In Koo] Seoul Natl Univ, Dept Anat & Cell Biol, Coll Vet Med, Seoul, South Korea; [Hwang, In Koo] Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea; [Choi, Jung Hoon; Suh, Hong-Won] Kangwon Natl Univ, Dept Anat, Coll Vet Med, Chunchon, South Korea; [Park, Jeong Ho] Hanbat Natl Univ, Div Appl Chem & Biotechnol, Taejon, South Korea; [Suh, Hong-Won] Hallym Univ, Coll Med, Dept Pharmacol, Chunchon, South Korea; [Suh, Hong-Won] Hallym Univ, Coll Med, Inst Nat Med, Chunchon, South Korea; [Jun, Jong-Gab] Hallym Univ, Dept Chem, Chunchon, South Korea; [Jun, Jong-Gab] Hallym Univ, Inst Appl Chem, Chunchon, South Korea; [Kwon, Young-Guen] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Vasc Syst Res Ctr, Chunchon, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon, South Korea; [Kwon, Seung-Hae; Her, Song] Korea Basic Sci Inst, Chuncheon Ctr, Div Analyt Bioimaging, Chunchon, Kangwon, South Korea; [Kim, Jin Su] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea; [Hyun, Byung-Hwa; Kim, Chul-Kyu] OSONG Med Innovat Fdn, Lab Anim Ctr, Osong, South Korea; [Cho, Jun Hwi] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Sch Med, Dept Emergency Med, Chunchon, South Korea; [Cho, Jun Hwi] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Sch Med, Inst Med Sci, Chunchon, South Korea; [Lee, Choong Hyun] Dankook Univ, Coll Pharm, Dept Anat & Physiol, Cheonan, South Korea	Yangzhou University; Kangwon National University; Hallym University; Hallym University; Kangnung Wonju National University; Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Hanbat National University; Hallym University; Hallym University; Hallym University; Hallym University; Yonsei University; Yonsei University; Kangwon National University; Kangwon National University; Korea Basic Science Institute (KBSI); Korea Institute of Radiological & Medical Sciences; Osong Medical Innovation Foundation; Kangwon National University; Kangwon National University Hospital; Kangwon National University; Kangwon National University Hospital; Dankook University	Lee, CH (corresponding author), Dankook Univ, Coll Pharm, Dept Anat & Physiol, Cheonan, South Korea.	anaphy@dankook.ac.kr; mhwon@kangwon.ac.kr	KIM, JIN SU/U-2112-2019	KIM, JIN SU/0000-0001-8965-9538	Brain Research Center of the 21st Century Frontier Research Program [2010K000823]; Ministry of Education, Science and Technology, the Republic of Korea; National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0010580]; Osong Innovation Center [2010K000823]	Brain Research Center of the 21st Century Frontier Research Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Osong Innovation Center	This research was supported by a grant (2010K000823) from Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology, the Republic of Korea, by the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2010-0010580), and by a grant (2010K000823) from Osong Innovation Center funded by the Ministry of Education, Science and Technology, the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MB, 1997, BEHAV NEUROSCI, V111, P1205, DOI 10.1037/0735-7044.111.6.1205; Berger C, 2008, EXP NEUROL, V210, P543, DOI 10.1016/j.expneurol.2007.12.002; Berger C, 2004, BRAIN RES, V998, P237, DOI 10.1016/j.brainres.2003.11.049; Castillo J, 2003, NEUROSCI LETT, V339, P248, DOI 10.1016/S0304-3940(03)00029-6; Choi SS, 2003, LIFE SCI, V73, P471, DOI 10.1016/S0024-3205(03)00311-4; Crack PJ, 2003, J CEREBR BLOOD F MET, V23, P19, DOI 10.1097/01.WCB.0000035181.38851.71; Cuenca-Lopez MD, 2010, REV NEUROLOGIA, V51, P30, DOI 10.33588/rn.5101.2009667; De Cristobal J, 2002, STROKE, V33, P261, DOI 10.1161/hs0102.101299; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Fredduzzi S, 2001, NEUROSCI LETT, V302, P121, DOI 10.1016/S0304-3940(01)01672-X; Fujimura M, 2005, NEUROCRIT CARE, V2, P59, DOI 10.1385/NCC:2:1:059; Fujimura M, 1999, J NEUROSCI, V19, P3414; Guo RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049701; Hirvonen J, 2011, DIABETES, V60, P443, DOI 10.2337/db10-0940; Hsieh CH, 2009, J NUCL MED, V50, P2049, DOI 10.2967/jnumed.108.061234; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Hwang IK, 2006, NEUROCHEM RES, V31, P957, DOI 10.1007/s11064-006-9101-3; Ishiguro M, 2011, YAKUGAKU ZASSHI, V131, P513, DOI 10.1248/yakushi.131.513; Janac B, 2006, BEHAV BRAIN RES, V175, P362, DOI 10.1016/j.bbr.2006.09.008; Jung JE, 2009, J NEUROSCI, V29, P7003, DOI 10.1523/JNEUROSCI.1110-09.2009; Kang SY, 2007, J PHARM PHARMACOL, V59, P863, DOI 10.1211/jpp.59.6.0013; Kang SY, 2003, NEUROBIOL LEARN MEM, V79, P11, DOI 10.1016/S1074-7427(02)00007-2; Kang SY, 2001, J NAT PROD, V64, P683, DOI 10.1021/np000441w; Kim HH, 2008, J CEREBR BLOOD F MET, V28, P1285, DOI 10.1038/jcbfm.2008.24; Kim SW, 2010, NEUROTOX RES, V17, P39, DOI 10.1007/s12640-009-9075-4; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Lee CH, 2011, EXP NEUROL, V229, P450, DOI 10.1016/j.expneurol.2011.03.015; Lee H, 2003, FASEB J, V17, P1943, DOI 10.1096/fj.03-0057fje; Lee JK, 2003, PLANTA MED, V69, P230, DOI 10.1055/s-2003-38475; Li L, 2011, BIOSCI BIOTECH BIOCH, V75, P434, DOI 10.1271/bbb.100606; LIN CS, 1990, NEUROSCIENCE, V35, P289, DOI 10.1016/0306-4522(90)90083-G; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Mergenthaler P, 2012, DIS MODEL MECH, V5, P718, DOI 10.1242/dmm.010033; Murakami K, 1998, J NEUROSCI, V18, P205; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P557, DOI 10.1097/00004647-200105000-00010; Omote Y, 2012, STROKE, V43, P1639, DOI 10.1161/STROKEAHA.111.643098; Pu F, 2009, J PHARMACOL SCI, V109, P424, DOI 10.1254/jphs.08245FP; RICKELS E, 1993, NEUROSURGERY, V32, P479, DOI 10.1097/00006123-199303000-00030; Rosa AO, 2008, EXP NEUROL, V212, P93, DOI 10.1016/j.expneurol.2008.03.008; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011888; Whitehead SN, 2007, STROKE, V38, P381, DOI 10.1161/01.STR.0000254464.05561.72; Yan BC, 2011, BRAIN RES, V1425, P142, DOI 10.1016/j.brainres.2011.09.063; Yu HL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033584, 10.1371/journal.pone.0051239]	45	41	44	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74886	10.1371/journal.pone.0074886	http://dx.doi.org/10.1371/journal.pone.0074886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073226	gold, Green Submitted, Green Published			2022-12-27	WOS:000324768000035
J	Yehuda-Shnaidman, E; Nimri, L; Tarnovscki, T; Kirshtein, B; Rudich, A; Schwartz, B				Yehuda-Shnaidman, Einav; Nimri, Lili; Tarnovscki, Tanya; Kirshtein, Boris; Rudich, Assaf; Schwartz, Betty			Secreted Human Adipose Leptin Decreases Mitochondrial Respiration in HCT116 Colon Cancer Cells	PLOS ONE			English	Article							METABOLIC SYNDROME; PYRUVATE-KINASE; BREAST-CANCER; TUMOR-GROWTH; MOUSE MODEL; PROGRESSION; OBESITY; EXPRESSION; PROMOTES; TISSUE	Obesity is a key risk factor for the development of colon cancer; however, the endocrine/paracrine/metabolic networks mediating this connection are poorly understood. Here we hypothesize that obesity results in secreted products from adipose tissue that induce malignancy-related metabolic alterations in colon cancer cells. Human HCT116 colon cancer cells, were exposed to conditioned media from cultured human adipose tissue fragments of obese vs. non-obese subjects. Oxygen consumption rate (OCR, mostly mitochondrial respiration) and extracellular acidification rate (ECAR, mostly lactate production via glycolysis) were examined vis-a-vis cell viability and expression of related genes and proteins. Our results show that conditioned media from obese (vs. non-obese) subjects decreased basal (40%, p<0.05) and maximal (50%, p<0.05) OCR and gene expression of mitochondrial proteins and Bax without affecting cell viability or expression of glycolytic enzymes. Similar changes could be recapitulated by incubating cells with leptin, whereas, leptin-receptor specific antagonist inhibited the reduced OCR induced by conditioned media from obese subjects. We conclude that secreted products from the adipose tissue of obese subjects inhibit mitochondrial respiration and function in HCT116 colon cancer cells, an effect that is at least partly mediated by leptin. These results highlight a putative novel mechanism for obesity-associated risk of gastrointestinal malignancies, and suggest potential new therapeutic avenues.	[Yehuda-Shnaidman, Einav; Nimri, Lili; Schwartz, Betty] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel; [Tarnovscki, Tanya; Rudich, Assaf] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel; [Kirshtein, Boris] Soroka Acad Med Ctr, Dept Surg A, Beer Sheva, Israel	Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Yehuda-Shnaidman, E (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel.	yseinav@gmail.com		Kirshtein, Boris/0000-0001-5463-0065; Rudich, Assaf/0000-0002-1366-1444	Israel Science Foundation [134/06]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 134/06 to B. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; Anubhuti Arora S, 2008, DIABETES OBES METAB, V10, P973, DOI [10.1111/j.1463-1326.2008.00852.x, DOI 10.1111/J.1463-1326.2008.00852.X.PUBMED:18284436]; Bayley JP, 2012, CURR OPIN ONCOL, V24, P62, DOI 10.1097/CCO.0b013e32834deb9e; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; Bluemlein K, 2011, ONCOTARGET, V2, P393; Braun S, 2011, INT J BIOL SCI, V7, P1003, DOI 10.7150/ijbs.7.1003; BRESALIER RS, 1995, CANCER RES, V55, P2476; Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Collins S, MODERATION ALL THING; Collins S, 2012, PIGM CELL MELANOMA R, V25, P2, DOI 10.1111/j.1755-148X.2011.00937.x; Cook CC, 2012, BBA-GEN SUBJECTS, V1820, P652, DOI 10.1016/j.bbagen.2011.08.017; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Friedman JM, 1998, NUTR REV, V56, pS38; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Gertler A, 2006, TRENDS ENDOCRIN MET, V17, P372, DOI 10.1016/j.tem.2006.09.006; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Heather LC, 2011, J MOL CELL CARDIOL, V50, P598, DOI 10.1016/j.yjmcc.2011.01.007; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huysentruyt LC, 2010, INT J CANCER, V126, P65, DOI 10.1002/ijc.24649; Jaffe T, 2008, INT J CANCER, V123, P2543, DOI 10.1002/ijc.23821; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kalakonda S, 2007, CANCER RES, V67, P6212, DOI 10.1158/0008-5472.CAN-07-0031; Kovsan J, 2011, J CLIN ENDOCR METAB, V96, pE268, DOI 10.1210/jc.2010-1681; KUAN SF, 1987, CANCER RES, V47, P5715; Lavi I, 2010, APPL MICROBIOL BIOT, V85, P1977, DOI 10.1007/s00253-009-2296-x; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Park J, 2010, AM J PATHOL, V177, P3133, DOI 10.2353/ajpath.2010.100595; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; SCHMIDT H, 1991, EXP CELL RES, V194, P122, DOI 10.1016/0014-4827(91)90140-P; Schnabele K, 2009, EUR J NUTR, V48, P154, DOI 10.1007/s00394-009-0775-6; SCHWARTZ B, 1992, INT J CANCER, V52, P60, DOI 10.1002/ijc.2910520113; Smolkova K, 2011, INT J BIOCHEM CELL B, V43, P950, DOI 10.1016/j.biocel.2010.05.003; Sung MK, 2011, ANN NY ACAD SCI, V1229, P61, DOI 10.1111/j.1749-6632.2011.06094.x; Toyoshima Y, 2005, ENDOCRINOLOGY, V146, P4024, DOI 10.1210/en.2005-0087; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Zheng Q, 2011, ENDOCR-RELAT CANCER, V18, P491, DOI 10.1530/ERC-11-0102; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	49	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74843	10.1371/journal.pone.0074843	http://dx.doi.org/10.1371/journal.pone.0074843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073224	gold, Green Submitted, Green Published			2022-12-27	WOS:000324768000033
J	Malagnac, F; Fabret, C; Prigent, M; Rousset, JP; Namy, O; Silar, P				Malagnac, Fabienne; Fabret, Celine; Prigent, Magali; Rousset, Jean-Pierre; Namy, Olivier; Silar, Philippe			Rab-GDI Complex Dissociation Factor Expressed through Translational Frameshifting in Filamentous Ascomycetes	PLOS ONE			English	Article							PODOSPORA-ANSERINA; ESCHERICHIA-COLI; GAMMA-SUBUNIT; EEF1A GENE; SIGNAL; LIFE; DNA; PHYLOGENY; LONGEVITY; ACCURACY	In the model fungus Podospora anserina, the PaYIP3 gene encoding the orthologue of the Saccharomyces cerevisiae YIP3 Rab-GDI complex dissociation factor expresses two polypeptides, one of which, the long form, is produced through a programmed translation frameshift. Inactivation of PaYIP3 results in slightly delayed growth associated with modification in repartition of fruiting body on the thallus, along with reduced ascospore production on wood. Long and short forms of PaYIP3 are expressed in the mycelium, while only the short form appears expressed in the maturing fruiting body (perithecium). The frameshift has been conserved over the evolution of the Pezizomycotina, lasting for over 400 million years, suggesting that it has an important role in the wild.	[Malagnac, Fabienne; Fabret, Celine; Prigent, Magali; Rousset, Jean-Pierre; Namy, Olivier; Silar, Philippe] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Malagnac, Fabienne; Silar, Philippe] Univ Paris Diderot, IED, Sorbonne Paris Cite, Paris, France; [Fabret, Celine; Prigent, Magali; Rousset, Jean-Pierre; Namy, Olivier] CNRS, UMR8621, Inst Genet & Microbiol, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Silar, P (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France.	philippe.silar@igmors.u-psud.fr	Namy, olivier/B-8906-2008; Namy, Olivier/ABD-4379-2020	Namy, Olivier/0000-0002-1143-5961; silar, philippe/0000-0003-0104-987X; Malagnac, Fabienne/0000-0003-1139-7691	Agence Nationale de la Recherche [ANR-2011-BSV6-011]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work is supported by a grant from the Agence Nationale de la Recherche (ANR-2011-BSV6-011) to ON and an anonymous donator to PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; Kamei CLA, 2008, PLANT PHYSIOL, V147, P1735, DOI 10.1104/pp.108.122226; Ausubel FM, 1987, CURRENT PROTOCOLES M; BELCOUR L, 1991, P NATL ACAD SCI USA, V88, P3579, DOI 10.1073/pnas.88.9.3579; Bidou L, 2000, RNA, V6, P952, DOI 10.1017/S1355838200000443; BLINKOWA AL, 1990, NUCLEIC ACIDS RES, V18, P1725, DOI 10.1093/nar/18.7.1725; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; Brierley I, 2008, BIOCHEM SOC T, V36, P684, DOI 10.1042/BST0360684; BRYGOO Y, 1985, MOL GEN GENET, V200, P128, DOI 10.1007/BF00383325; Chung BYW, 2010, J MOL BIOL, V397, P448, DOI 10.1016/j.jmb.2010.01.044; Coppin-Raynal E, 1988, GENETICS TRANSLATION, P431; COPPINRAYNAL E, 1981, BIOCHEM GENET, V19, P729, DOI 10.1007/BF00484005; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; FLOWER AM, 1990, P NATL ACAD SCI USA, V87, P3713, DOI 10.1073/pnas.87.10.3713; Freitag J, 2012, NATURE, V485, P522, DOI 10.1038/nature11051; Geng JM, 2005, EUKARYOT CELL, V4, P1166, DOI 10.1128/EC.4.7.1166-1174.2005; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Houck-Loomis B, 2011, NATURE, V480, P561, DOI 10.1038/nature10657; Kicka S, 2006, P NATL ACAD SCI USA, V103, P13445, DOI 10.1073/pnas.0603693103; Kumar TKA, 2012, MYCOLOGIA, V104, P462, DOI 10.3852/11-213; Lalucque H, 2000, BMC Genet, V1, P3, DOI 10.1186/1471-2156-1-3; Lambou K, 2008, EUKARYOT CELL, V7, P1809, DOI 10.1128/EC.00149-08; LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Licznar P, 2003, EMBO J, V22, P4770, DOI 10.1093/emboj/cdg465; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; PICARDBENNOUN M, 1982, FEBS LETT, V149, P167, DOI 10.1016/0014-5793(82)81094-6; RIZET GEORGES, 1949, REV CYTOL ET BIOL VEG, V11, P201; RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51; Sekimoto S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-331; Silar P, 2000, BIOGERONTOLOGY, V1, P47, DOI 10.1023/A:1010029723081; Silar P, 1999, GENETICS, V151, P87; Silar P, 2000, MOL GEN GENET, V264, P354, DOI 10.1007/s004380000337; SILAR P, 1994, J MOL BIOL, V235, P231, DOI 10.1016/S0022-2836(05)80029-4; Silar P, 2001, GENETICS, V158, P1477; Silar P, 1995, FUNG GENET NEWSLETT, V42, P73, DOI DOI 10.4148/1941-4765.1353; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Wills NM, 2006, J BIOL CHEM, V281, P7082, DOI 10.1074/jbc.M511629200	48	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73772	10.1371/journal.pone.0073772	http://dx.doi.org/10.1371/journal.pone.0073772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069231	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300019
J	Marimpietri, D; Petretto, A; Raffaghello, L; Pezzolo, A; Gagliani, C; Tacchetti, C; Mauri, P; Melioli, G; Pistoia, V				Marimpietri, Danilo; Petretto, Andrea; Raffaghello, Lizzia; Pezzolo, Annalisa; Gagliani, Cristina; Tacchetti, Carlo; Mauri, Pierluigi; Melioli, Giovanni; Pistoia, Vito			Proteome Profiling of Neuroblastoma-Derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor Progression	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC STEM; METASTATIC NEUROBLASTOMA; CELL DIFFERENTIATION; MEMBRANE-VESICLES; PROGENITOR CELLS; CANCER CELLS; MICROENVIRONMENT; CARCINOMA; INVASION; CD133	Neuroblastoma (NB) is the most common extracranial solid tumor in childhood, with grim prognosis in a half of patients. Exosomes are nanometer-sized membrane vesicles derived from the multivesicular bodies (MVBs) of the endocytic pathway and released by normal and neoplastic cells. Tumor-derived exosomes have been shown in different model systems to carry molecules that promote cancer growth and dissemination. In this respect, we have here performed the first characterization and proteomic analysis of exosomes isolated from human NB cell lines by filtration and ultracentrifugation. Electron microscopy demonstrated that NB-derived exosomes exhibited the characteristic cup-shaped morphology. Dynamic light scattering studies showed a bell-shaped curve and a polydispersity factor consistent with those of exosomes. Zeta potential values suggested a good nanoparticle stability. We performed proteomic analysis of NB-derived exosomes by two dimension liquid chromatography separation and mass spectrometry analyses using the multidimensional protein identification technology strategy. We found that the large majority of the proteins identified in NB derived exosomes are present in Exocarta database including tetraspanins, fibronectin, heat shock proteins, MVB proteins, cytoskeleton-related proteins, prominin-1 (CD133), basigin (CD147) and B7-H3 (CD276). Expression of the CD9, CD63 and CD81 tetraspanins, fibronectin, CD133, CD147 and CD276 was validated by flow cytometry. Noteworthy, flow cytometric analysis showed that NB-derived exosomes expressed the GD2 disialoganglioside, the most specific marker of NB. In conclusion, this study shows that NB-derived exosomes express a discrete set of molecules involved in defense response, cell differentiation, cell proliferation and regulation of other important biological process. Thus, NB-derived exosomes may play an important role in the modulation of tumor microenvironment and represent potential tumor biomarkers.	[Marimpietri, Danilo; Raffaghello, Lizzia; Pezzolo, Annalisa; Pistoia, Vito] Ist Giannina Gaslini, Dept Translat Res & Lab Med, Lab Oncol, I-16148 Genoa, Italy; [Petretto, Andrea] Ist Giannina Gaslini, Dept Translat Res & Lab Med, Core Facil, I-16148 Genoa, Italy; [Melioli, Giovanni] Ist Giannina Gaslini, Dept Translat Res & Lab Med, Clin Pathol Labs, I-16148 Genoa, Italy; [Gagliani, Cristina] Univ Genoa, Dept Expt Med, Genoa, Italy; [Tacchetti, Carlo] Ist Sci San Raffaele, Expt Imaging Ctr, I-20132 Milan, Italy; [Mauri, Pierluigi] CNR, Inst Biomed Technol, I-20133 Milan, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Marimpietri, D (corresponding author), Ist Giannina Gaslini, Dept Translat Res & Lab Med, Lab Oncol, I-16148 Genoa, Italy.	danilomarimpietri@ospedale-gaslini.ge.it	Marimpietri, Danilo/AAA-7283-2020; Pezzolo, Annalisa/AAA-7424-2020; Mauri, Pietro Luigi/AAC-3095-2019; Marimpietri, Danilo/J-5975-2016; Petretto, Andrea/AAA-7342-2020	Marimpietri, Danilo/0000-0001-6360-1661; Mauri, Pietro Luigi/0000-0003-4364-0393; TACCHETTI, CARLO/0000-0003-4602-000X; Raffaghello, Lizzia/0000-0003-2357-0607; Petretto, Andrea/0000-0001-7811-8517	"Cinque per mille dell'IRPEF - Finanziamento della ricerca sanitaria"; Finanziamento Ricerca Corrente, Ministero Salute; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 13003]; Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione Compagnia San Paolo to Carlo Tacchetti	"Cinque per mille dell'IRPEF - Finanziamento della ricerca sanitaria"; Finanziamento Ricerca Corrente, Ministero Salute; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Compagnia San Paolo to Carlo Tacchetti(Compagnia di San Paolo)	This study was supported by: "Cinque per mille dell'IRPEF - Finanziamento della ricerca sanitaria", Finanziamento Ricerca Corrente, Ministero Salute and by Associazione Italiana per la Ricerca sul Cancro (AIRC) project IG 13003 to Vito Pistoia; funds from Associazione Italiana per la Ricerca sul Cancro (AIRC) and Fondazione Compagnia San Paolo to Carlo Tacchetti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal SM, 2011, BBA-MOL BASIS DIS, V1812, P213, DOI 10.1016/j.bbadis.2010.07.018; Ara T, 2006, CANCER METAST REV, V25, P645, DOI 10.1007/s10555-006-9028-9; Asgharzadeh S, 2012, J CLIN ONCOL, V30, P3525, DOI 10.1200/JCO.2011.40.9169; Bauer N, 2008, CELLS TISSUES ORGANS, V188, P127, DOI 10.1159/000112847; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Bogenmann E, 1996, INT J CANCER, V67, P379, DOI 10.1002/(SICI)1097-0215(19960729)67:3<379::AID-IJC12>3.0.CO;2-3; Bougatef F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012265; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Davidson B, 2003, CLIN EXP METASTAS, V20, P161, DOI 10.1023/A:1022696012668; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Graner MW, 2007, J NEUROSCI, V27, P11214, DOI 10.1523/JNEUROSCI.3588-07.2007; Gregorio A, 2008, HISTOPATHOLOGY, V53, P73, DOI 10.1111/j.1365-2559.2008.03070.x; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hathout Y, 2007, EXPERT REV PROTEOMIC, V4, P239, DOI 10.1586/14789450.4.2.239; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Kapp EA, 2005, PROTEOMICS, V5, P3475, DOI 10.1002/pmic.200500126; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Khan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046737; Kong Y, 1998, BBA-LIPID LIPID MET, V1394, P43, DOI 10.1016/S0005-2760(98)00096-4; Kshirsagar SK, 2012, PLACENTA, V33, P982, DOI 10.1016/j.placenta.2012.10.005; LADISCH S, 1994, P NATL ACAD SCI USA, V91, P1974, DOI 10.1073/pnas.91.5.1974; LADISCH S, 1987, INT J CANCER, V39, P73; Liang QC, 2005, CANCER BIOL THER, V4, P759, DOI 10.4161/cbt.4.7.1828; Liu FF, 2010, BREAST CANCER RES TR, V124, P677, DOI 10.1007/s10549-010-0790-6; Mallol R, 2012, ANAL BIOANAL CHEM, V402, P2407, DOI 10.1007/s00216-011-5705-9; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; Mbeunkui F, 2009, CANCER CHEMOTH PHARM, V63, P571, DOI 10.1007/s00280-008-0881-9; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; McKallip R, 1999, J IMMUNOL, V163, P3718; McPherson PS, 2010, PROTEOMICS, V10, P4025, DOI 10.1002/pmic.201000253; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Nurieva RI, 2009, IMMUNOL REV, V229, P88, DOI 10.1111/j.1600-065X.2009.00769.x; Pan YQ, 2012, ONCOL REP, V27, P2003, DOI 10.3892/or.2012.1729; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Riethdorf S, 2006, INT J CANCER, V119, P1800, DOI 10.1002/ijc.22062; Sartelet H, 2012, HISTOPATHOLOGY, V60, P1144, DOI 10.1111/j.1365-2559.2012.04191.x; Silva J, 2012, GENE CHROMOSOME CANC, V51, P409, DOI 10.1002/gcc.21926; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Swartz MA, 2012, CANCER RES, V72, P2473, DOI 10.1158/0008-5472.CAN-12-0122; Sweeny L, 2012, EXP CELL RES, V318, P1788, DOI 10.1016/j.yexcr.2012.04.022; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; THERY C, 2006, CURR PROTOC CELL BIO, V3; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; Welton JL, 2010, MOL CELL PROTEOMICS, V9, P1324, DOI 10.1074/mcp.M000063-MCP201; Witz IP, 2006, CANCER LETT, V242, P1, DOI 10.1016/j.canlet.2005.12.005; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yang CJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/842849; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang HG, 2011, CLIN CANCER RES, V17, P959, DOI 10.1158/1078-0432.CCR-10-1489; Zhang Y, 2010, INT J ONCOL, V36, P133, DOI 10.3892/ijo_00000484; Zhong WD, 2012, INT J CANCER, V130, P300, DOI 10.1002/ijc.25982; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	73	105	110	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75054	10.1371/journal.pone.0075054	http://dx.doi.org/10.1371/journal.pone.0075054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069378	Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300062
J	Muschol-Steinmetz, C; Friemel, A; Kreis, NN; Reinhard, J; Yuan, JP; Louwen, F				Muschol-Steinmetz, Cornelia; Friemel, Alexandra; Kreis, Nina-Naomi; Reinhard, Joscha; Yuan, Juping; Louwen, Frank			Function of Survivin in Trophoblastic Cells of the Placenta	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; PROTEIN-KINASE-A; GROWTH-FACTOR-I; WILD-TYPE P53; AURORA-B; INHIBITS APOPTOSIS; INNER CENTROMERE; CANCER-CELLS; EXPRESSION; PHOSPHORYLATION	Background: Preeclampsia is one of the leading causes of maternal and perinatal mortality and morbidity worldwide and its pathogenesis is not totally understood. As a member of the chromosomal passenger complex and an inhibitor of apoptosis, survivin is a well-characterized oncoprotein. Its roles in trophoblastic cells remain to be defined. Methods: The placental samples from 16 preeclampsia patients and 16 well-matched controls were included in this study. Real-time PCR, immunohistochemistry and Western blot analysis were carried out with placental tissues. Primary trophoblastic cells from term placentas were isolated for Western blot analysis. Cell proliferation, cell cycle analysis and immunofluorescence staining were performed in trophoblastic cell lines BeWo, JAR and HTR-8/SVneo. Results: The survivin gene is reduced but the protein amount is hardly changed in preeclamptic placentas, compared to control placentas. Upon stress, survivin in trophoblastic cells is phosphorylated on its residue serine 20 by protein kinase A and becomes stabilized, accompanied by increased heat shock protein 90. Depletion of survivin induces chromosome misalignment, abnormal centrosome integrity, and reduced localization and activity of Aurora B at the centromeres/kinetochores in trophoblastic metaphase cells. Conclusions: Our data indicate that survivin plays pivotal roles in cell survival and proliferation of trophoblastic cells. Further investigations are required to define the function of survivin in each cell type of the placenta in the context of proliferation, differentiation, apoptosis, angiogenesis, migration and invasion.	[Muschol-Steinmetz, Cornelia; Friemel, Alexandra; Kreis, Nina-Naomi; Yuan, Juping; Louwen, Frank] Goethe Univ Frankfurt, Sch Med, Dept Gynecol & Obstet, D-60054 Frankfurt, Germany; [Reinhard, Joscha] St Marien Hosp, Dept Gynecol & Obstet, Frankfurt, Germany	Goethe University Frankfurt; St. Marien Hospital	Yuan, JP (corresponding author), Goethe Univ Frankfurt, Sch Med, Dept Gynecol & Obstet, D-60054 Frankfurt, Germany.	yuan@em.uni-frankfurt.de	Kreis, Nina-Naomi/AAF-5407-2019	Kreis, Nina-Naomi/0000-0003-4304-0160; Yuan, Juping/0000-0003-0694-0565				Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Aris AK, 2007, CLIN BIOCHEM, V40, P94, DOI 10.1016/j.clinbiochem.2006.10.008; Barrett RMA, 2009, CELL CYCLE, V8, P278, DOI 10.4161/cc.8.2.7587; Chan KS, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.34; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; Colnaghi R, 2010, J BIOL CHEM, V285, P22592, DOI 10.1074/jbc.M109.065003; Connell CM, 2008, J BIOL CHEM, V283, P3289, DOI 10.1074/jbc.M704461200; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Fest S, 2008, AM J REPROD IMMUNOL, V59, P75, DOI 10.1111/j.1600-0897.2007.00557.x; Fortugno P, 2002, J CELL SCI, V115, P575; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Graham CH, 1997, PLACENTA, V18, P137, DOI 10.1016/S0143-4004(97)90085-0; Grill S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-70; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Guha M, 2009, CELL CYCLE, V8, P2708, DOI 10.4161/cc.8.17.9457; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Heazell AEP, 2008, REPROD SCI, V15, P1034, DOI 10.1177/1933719108322438; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Ka H, 2003, AM J PATHOL, V163, P413, DOI 10.1016/S0002-9440(10)63671-1; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Kreis NN, 2010, ONCOGENE, V29, P5591, DOI 10.1038/onc.2010.290; Lehner R, 2001, OBSTET GYNECOL, V97, P965, DOI 10.1016/S0029-7844(01)01131-0; Li CF, 2012, PLACENTA, V33, P47, DOI 10.1016/j.placenta.2011.10.008; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Louwen F, 2012, ONCOTARGET, V3, P759; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Oh SH, 2008, CLIN CANCER RES, V14, P1581, DOI 10.1158/1078-0432.CCR-07-0952; Ozkan S, 2008, J MATERN-FETAL NEO M, V21, P831, DOI 10.1080/14767050802251024; Petroff MG, 2006, METH MOLEC MED, V121, P203; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Sanhaji M, 2012, CELL CYCLE, V11, P543, DOI 10.4161/cc.11.3.19076; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shiozaki A, 2003, PLACENTA, V24, P65, DOI 10.1053/plac.2002.0860; Sommer KW, 2003, ONCOGENE, V22, P4266, DOI 10.1038/sj.onc.1206509; Vaira V, 2007, ONCOGENE, V26, P2678, DOI 10.1038/sj.onc.1210094; Van Antwerp DJ, 1998, TRENDS CELL BIOL, V8, P107, DOI 10.1016/S0962-8924(97)01215-4; Vaughan JE, 2012, HYPERTENS PREGNANCY, V31, P243, DOI 10.3109/10641955.2011.642436; Virdee K, 2000, CURR BIOL, V10, P1151, DOI 10.1016/S0960-9822(00)00702-8; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; von Versen-Hoynck F, 2009, PLACENTA, V30, P361, DOI 10.1016/j.placenta.2009.01.004; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wheatley SP, 2007, CELL CYCLE, V6, P1220, DOI 10.4161/cc.6.10.4179; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Yuan JP, 2011, AM J PATHOL, V179, P2091, DOI 10.1016/j.ajpath.2011.06.031; Zhao J, 2000, J CELL SCI, V113, P4363	60	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73337	10.1371/journal.pone.0073337	http://dx.doi.org/10.1371/journal.pone.0073337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069188	Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300010
J	Semple, MG; Myles, PR; Nicholson, KG; Lim, WS; Read, RC; Taylor, BL; Brett, SJ; Openshaw, PJM; Enstone, JE; McMenamin, J; Bannister, B; Nguyen-Van-Tam, JS				Semple, Malcolm G.; Myles, Puja R.; Nicholson, Karl G.; Lim, Wei Shen; Read, Robert C.; Taylor, Bruce L.; Brett, Stephen J.; Openshaw, Peter J. M.; Enstone, Joanne E.; McMenamin, James; Bannister, Barbara; Nguyen-Van-Tam, Jonathan S.			An Evaluation of Community Assessment Tools (CATs) in Predicting Use of Clinical Interventions and Severe Outcomes during the A(H1N1)pdm09 Pandemic	PLOS ONE			English	Article							INFLUENZA	During severe influenza pandemics healthcare demand can exceed clinical capacity to provide normal standards of care. Community Assessment Tools (CATs) could provide a framework for triage decisions for hospital referral and admission. CATs have been developed based on evidence that supports the recognition of severe influenza and pneumonia in the community (including resource limited settings) for adults, children and infants, and serious feverish illness in children. CATs use six objective criteria and one subjective criterion, any one or more of which should prompt urgent referral and admission to hospital. A retrospective evaluation of the ability of CATs to predict use of hospital-based interventions and patient outcomes in a pandemic was made using the first recorded routine clinical assessment on or shortly after admission from 1520 unselected patients (800 female, 480 children,16 years) admitted with PCR confirmed A(H1N1)pdm09 infection (the FLU-CIN cohort). Outcome measures included: any use of supplemental oxygen; mechanical ventilation; intravenous antibiotics; length of stay; intensive or high dependency care; death; and "severe outcome'' (combined: use of intensive or high dependency care or death during admission). Unadjusted and multivariable analyses were conducted for children (age,16 years) and adults. Each CATs criterion independently identified both use of clinical interventions that would in normal circumstances only be provided in hospital and patient outcome measures. "Peripheral oxygen saturation <= 92% breathing air, or being on oxygen'' performed well in predicting use of resources and outcomes for both adults and children; supporting routine measurement of peripheral oxygen saturation when assessing severity of disease. In multivariable analyses the single subjective criterion in CATs "other cause for clinical concern'' independently predicted death in children and in adults predicted length of stay, mechanical ventilation and "severe outcome''; supporting the role of clinical acumen as an important independent predictor of serious illness.	[Semple, Malcolm G.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Myles, Puja R.; Enstone, Joanne E.; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Nicholson, Karl G.] Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Infect Dis Unit, Leicester, Leics, England; [Lim, Wei Shen] Nottingham Univ Hosp NHS Trust, Dept Resp Med, Nottingham, England; [Read, Robert C.] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England; [Taylor, Bruce L.] Portsmouth Hosp NHS Trust, Dept Crit Care, Portsmouth, Hants, England; [Brett, Stephen J.] Imperial Coll Healthcare NHS Trust, Ctr Perioperat Med & Crit Care Res, London, England; [Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Ctr Resp Infect, London, England; [McMenamin, James] NHS Natl Serv, Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Bannister, Barbara] Royal Free Hampstead NHS Trust, Dept Infect Dis, London, England	University of Liverpool; University of Nottingham; University Hospitals of Leicester NHS Trust; University of Leicester; Nottingham University Hospital NHS Trust; University of Southampton; Portsmouth Hospitals NHS Trust; Imperial College London; Imperial College London; NHS National Services Scotland; University of London; University College London	Semple, MG (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	m.g.semple@liverpool.ac.uk	Openshaw, Peter/AAL-9442-2020; Nguyen-Van-Tam, Jonathan/I-2162-2019; Semple, Malcolm Gracie/A-8790-2008	Openshaw, Peter/0000-0002-7220-2555; Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Semple, Malcolm Gracie/0000-0001-9700-0418; Myles, Puja/0000-0002-8976-890X; Read, Robert/0000-0002-4297-6728	The Department of Health in England; The Scottish Government Chief Medical Officer and Public Health Directorate; NHS North West Strategic Health Authority; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; Medical Research Council [MC_G1001212, G1000758] Funding Source: researchfish; National Institute for Health Research [11/46/22] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish; MRC [MC_G1001212] Funding Source: UKRI	The Department of Health in England; The Scottish Government Chief Medical Officer and Public Health Directorate; NHS North West Strategic Health Authority; National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Department of Health in England was the main funder for FLU-CIN (United Kingdom Influenza Clinical Information Network). The Scottish Government Chief Medical Officer and Public Health Directorate supported the centre in Scotland. Chairmanship of the FLU-CIN Strategy Group (that includes MGS, KGN, WSL, RCR, BLT, SJB, PJMO, JEE, JM, BB and JSNVT as members) was provided by the Department of Health, England. The FLU-CIN Strategy Group had final responsibility for the interpretation of findings and decision to submit for publication. NHS North West Strategic Health Authority supported the development of the Community Assessment Tool for Children and the Alder Hey Children's Hospital NHS Foundation Trust Pandemic Influenza Group. PJMO and SJB were supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews A, 2001, COLUMN, V13, P7; [Anonymous], 2009, GUID IND PAT REP OUT; British Thoracic Society, 2002, THORAX, V57; British Thoracic Society, 2004, GUID MAN COMM ACQ PN; Challen K, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-33; Chief Medical Officer Great Britain Ministry of Health, 1920, REP PUBL HLTH MED SU; Department of Health, 2007, 8979 COI DEP HLTH GA; Department of Health, 2009, 11697 COI DEP HLTH G; Department of Health, 2007, 8443 COI DEP HLTH GA; Department of Health & NHS, 2009, 12368 COI DEP HLTH G; Lim WS, 2007, THORAX, V62, P1, DOI 10.1136/thx.2006.073080; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; Myles PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034428; *NAT COLL CTR CHRO, 2004, CHRON OBSTR PULM DIS; National Collaborating Centre for Women's and Children's Health, 2007, FEV ILLN CHILDR; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Scottish Intercollegiate Guidelines Network, 2006, BRONCH CHILDR; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; WHO, 2002, WHOFCHCAH0223; *WHO, 1991, WHOARI9120; World Health Organization, 2001, WHOFCHCAH0110 DEP CH; World Health Organization, 1994, WHOARI9431	23	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75384	10.1371/journal.pone.0075384	http://dx.doi.org/10.1371/journal.pone.0075384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069409	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000324777300077
J	Perdiguero, B; Gomez, CE; Di Pilato, M; Sorzano, COS; Delaloye, J; Roger, T; Calandra, T; Pantaleo, G; Esteban, M				Perdiguero, Beatriz; Elena Gomez, Carmen; Di Pilato, Mauro; Sorzano, Carlos Oscar S.; Delaloye, Julie; Roger, Thierry; Calandra, Thierry; Pantaleo, Giuseppe; Esteban, Mariano			Deletion of the Vaccinia Virus Gene A46R, Encoding for an Inhibitor of TLR Signalling, Is an Effective Approach to Enhance the Immunogenicity in Mice of the HIV/AIDS Vaccine Candidate NYVAC-C	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; PATTERN-RECOGNITION RECEPTORS; KAPPA-B KINASE; TIR-DOMAIN; CRYSTAL-STRUCTURE; PATHOGEN RECOGNITION; IMMUNE-RESPONSES; STRUCTURAL BASIS; INNATE IMMUNITY; I INTERFERON	Viruses have developed strategies to counteract signalling through Toll-like receptors (TLRs) that are involved in the detection of viruses and induction of proinflammatory cytokines and IFNs. Vaccinia virus (VACV) encodes A46 protein which disrupts TLR signalling by interfering with TLR: adaptor interactions. Since the innate immune response to viruses is critical to induce protective immunity, we studied whether deletion of A46R gene in a NYVAC vector expressing HIV-1 Env, Gag, Pol and Nef antigens (NYVAC-C) improves immune responses against HIV-1 antigens. This question was examined in human macrophages and in mice infected with a single A46R deletion mutant of the vaccine candidate NYVAC-C (NYVAC-C-.A46R). The viral gene A46R is not required for virus replication in primary chicken embryo fibroblast (CEF) cells and its deletion in NYVAC-C markedly increases TNF, IL-6 and IL-8 secretion by human macrophages. Analysis of the immune responses elicited in BALB/c mice after DNA prime/NYVAC boost immunization shows that deletion of A46R improves the magnitude of the HIV-1-specific CD4 and CD8 T cell immune responses during adaptive and memory phases, maintains the functional profile observed with the parental NYVAC-C and enhances anti-gp120 humoral response during the memory phase. These findings establish the immunological role of VACV A46R on innate immune responses of macrophages in vitro and antigen-specific T and B cell immune responses in vivo and suggest that deletion of viral inhibitors of TLR signalling is a useful approach for the improvement of poxvirus-based vaccine candidates.	[Perdiguero, Beatriz; Elena Gomez, Carmen; Di Pilato, Mauro; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain; [Delaloye, Julie; Roger, Thierry; Calandra, Thierry] CHU Vaudois, Dept Med, Infect Dis Serv, CH-1011 Lausanne, Switzerland; [Delaloye, Julie; Roger, Thierry; Calandra, Thierry; Pantaleo, Giuseppe] Univ Lausanne, Lausanne, Switzerland; [Pantaleo, Giuseppe] CHU Vaudois, Dept Med, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Esteban, M (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	mesteban@cnb.csic.es	Perdiguero, Beatriz/K-6587-2017; Pantaleo, Giuseppe/K-6163-2016; S. Sorzano, Carlos Oscar/ABE-4884-2021; Esteban, Mariano/ABG-5375-2020; Calandra, Thierry/D-9017-2015; Sorzano, Carlos Oscar S S./F-2639-2016; Gomez, Carmen Elena/K-1940-2014; Roger, Thierry/G-2007-2012	Perdiguero, Beatriz/0000-0001-6276-7766; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Esteban, Mariano/0000-0003-0846-2827; Calandra, Thierry/0000-0003-3051-1285; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; Gomez, Carmen Elena/0000-0002-5414-7935; Roger, Thierry/0000-0002-9358-0109; Di Pilato, Mauro/0000-0003-3902-7406	Ministry of Science and Innovation of Spain [SAF2008-02036]; Foundation FIPSE; PTVDC/CAVD program; Bill and Melinda Gates Foundation	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation FIPSE; PTVDC/CAVD program; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This investigation was supported by grants from the Ministry of Science and Innovation of Spain (SAF2008-02036), Foundation FIPSE and PTVDC/CAVD program with support from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Bowie AG, 2005, MOL IMMUNOL, V42, P859, DOI 10.1016/j.molimm.2004.11.007; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Gomez CE, 2012, HUM VACC IMMUNOTHER, V8, P1192, DOI 10.4161/hv.20778; Gomez CE, 2012, J VIROL, V86, P5026, DOI 10.1128/JVI.06684-11; Falivene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032220; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Garber DA, 2012, J VIROL, V86, P12605, DOI 10.1128/JVI.00246-12; Garber DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005445; Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Gay NJ, 2011, TRENDS IMMUNOL, V32, P104, DOI 10.1016/j.it.2010.12.005; Gomez CE, 2011, CURR GENE THER, V11, P189; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Guerra S, 2010, J VIROL, V84, P8141, DOI 10.1128/JVI.00749-10; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hutchens MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000153; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kibler KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025674; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Lysakova-Devine T, 2010, J IMMUNOL, V185, P4261, DOI 10.4049/jimmunol.1002013; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oda SI, 2011, MOL IMMUNOL, V48, P2144, DOI 10.1016/j.molimm.2011.07.014; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Paoletti E, 1996, P NATL ACAD SCI USA, V93, P11349, DOI 10.1073/pnas.93.21.11349; Perdiguero B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048524; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; PERKUS ME, 1995, J LEUKOCYTE BIOL, V58, P1; Quigley M, 2009, BLOOD, V113, P2256, DOI 10.1182/blood-2008-03-148809; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robinson HL, 2007, AIDS RES HUM RETROV, V23, P1555, DOI 10.1089/aid.2007.0165; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Sanchez-Sampedro L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038859; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stack J, 2012, J BIOL CHEM, V287, P22672, DOI 10.1074/jbc.M112.349225; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; TARTAGLIA J, 1992, AIDS RES HUM RETROV, V8, P1445, DOI 10.1089/aid.1992.8.1445; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zhu JG, 2007, BLOOD, V109, P619, DOI 10.1182/blood-2006-06-027136	71	21	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74831	10.1371/journal.pone.0074831	http://dx.doi.org/10.1371/journal.pone.0074831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069354	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300059
J	Redondo, BB; Bunz, M; Halder, P; Sadanandappa, MK; Muhlbauer, B; Erwin, F; Hofbauer, A; Rodrigues, V; VijayRaghavan, K; Ramaswami, M; Rieger, D; Wegener, C; Forster, C; Buchner, E				Redondo, Beatriz Blanco; Bunz, Melanie; Halder, Partho; Sadanandappa, Madhumala K.; Muehlbauer, Barbara; Erwin, Felix; Hofbauer, Alois; Rodrigues, Veronica; VijayRaghavan, K.; Ramaswami, Mani; Rieger, Dirk; Wegener, Christian; Foerster, Charlotte; Buchner, Erich			Identification and Structural Characterization of Interneurons of the Drosophila Brain by Monoclonal Antibodies of the Wurzburg Hybridoma Library	PLOS ONE			English	Article							PIGMENT-DISPERSING HORMONE; NERVOUS-SYSTEM; IMMUNOREACTIVE NEURONS; VISUAL-SYSTEM; OPTIC LOBE; MELANOGASTER; PROTEIN; LAMINA; GENE	Several novel synaptic proteins have been identified by monoclonal antibodies (mAbs) of the Wurzburg hybridoma library generated against homogenized Drosophila brains, e.g. cysteine string protein, synapse-associated protein of 47 kDa, and Bruchpilot. However, at present no routine technique exists to identify the antigens of mAbs of our library that label only a small number of cells in the brain. Yet these antibodies can be used to reproducibly label and thereby identify these cells by immunohistochemical staining. Here we describe the staining patterns in the Drosophila brain for ten mAbs of the Wurzburg hybridoma library. Besides revealing the neuroanatomical structure and distribution of ten different sets of cells we compare the staining patterns with those of antibodies against known antigens and GFP expression patterns driven by selected Gal4 lines employing regulatory sequences of neuronal genes. We present examples where our antibodies apparently stain the same cells in different Gal4 lines suggesting that the corresponding regulatory sequences can be exploited by the split-Gal4 technique for transgene expression exclusively in these cells. The detection of Gal4 expression in cells labeled by mAbs may also help in the identification of the antigens recognized by the antibodies which then in addition to their value for neuroanatomy will represent important tools for the characterization of the antigens. Implications and future strategies for the identification of the antigens are discussed.	[Redondo, Beatriz Blanco; Halder, Partho; Sadanandappa, Madhumala K.; Buchner, Erich] Univ Wurzburg, Inst Clin Neurobiol, D-97070 Wurzburg, Germany; [Bunz, Melanie; Halder, Partho; Muehlbauer, Barbara; Erwin, Felix; Rieger, Dirk; Wegener, Christian; Foerster, Charlotte; Buchner, Erich] Univ Wurzburg, Dept Neurobiol & Genet, Theodor Boveri Inst, Bioctr, D-97070 Wurzburg, Germany; [Hofbauer, Alois] Univ Regensburg, Inst Zool, D-93053 Regensburg, Germany; [Sadanandappa, Madhumala K.; Rodrigues, Veronica; VijayRaghavan, K.; Ramaswami, Mani] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Ramaswami, Mani] Univ Dublin Trinity Coll, Sch Genet & Microbiol, Dublin 2, Ireland; [Ramaswami, Mani] Univ Dublin Trinity Coll, Sch Nat Sci, Smurfit Inst Genet, Dublin 2, Ireland; [Ramaswami, Mani] Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland	University of Wurzburg; University of Wurzburg; University of Regensburg; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Buchner, E (corresponding author), Univ Wurzburg, Inst Clin Neurobiol, D-97070 Wurzburg, Germany.	buchner@biozentrum.uni-wuerzburg.de	Rieger, Dirk/X-8583-2019; Sadanandappa, Madhumala K/M-5375-2019	Rieger, Dirk/0000-0001-5597-5858; Sadanandappa, Madhumala K/0000-0001-6071-365X; Wegener, Christian/0000-0003-4481-3567; Ramaswami, Mani/0000-0001-7631-0468; Helfrich-Forster, Charlotte/0000-0002-0859-9092; Blanco Redondo, Beatriz/0000-0003-0246-2893	German Research Foundation (DFG); University of Wuerzburg; German Science Foundation [DFG-SFB554, DFG-SFB581, DFG-GRK1156, DFG-SFB1047]; Science Foundation Ireland; German Excellence Initiative; INSPIRE fellowship from Department of Science and Technology (DST), India; DAAD, Germany; NCBS-TIFR grants	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; German Science Foundation(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); German Excellence Initiative; INSPIRE fellowship from Department of Science and Technology (DST), India(Department of Science & Technology (India)); DAAD, Germany(Deutscher Akademischer Austausch Dienst (DAAD)); NCBS-TIFR grants	This publication was funded by the German Research Foundation (DFG, http://www.dfg.de/en/) and the University of Wuerzburg (http://www.uni-wuerzburg.de/) in the funding programme Open Access Publishing. The work was supported by the German Science Foundation, grants DFG-SFB554, -SFB581, and -GRK1156 (to E.B.) and -SFB1047 to C.F., C.W. and D.R., and by the Science Foundation Ireland (http://www.sfi.ie/) (to M.R.). B.B.R. and P.H. were supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg. M.K.S. was supported by INSPIRE fellowship from Department of Science and Technology (DST), India, (www.dst.gov.in/) and by a short-term fellowship of the DAAD, Germany (https://www.daad.de/en/). K.V.R's research was supported by the NCBS-TIFR (www.ncbs.res.in/) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; FUJITA SC, 1988, ANNU REV ENTOMOL, V33, P1, DOI 10.1146/annurev.en.33.010188.000245; Halder P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029352; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster Charlotte, 2007, Methods Mol Biol, V362, P533; HelfrichForster C, 1997, J COMP NEUROL, V380, P335, DOI 10.1002/(SICI)1096-9861(19970414)380:3<335::AID-CNE4>3.0.CO;2-3; HELFRICHFORSTER C, 1993, J COMP NEUROL, V337, P177, DOI 10.1002/cne.903370202; Hofbauer A, 1991, THESIS U WUERZBURG G; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; LOHR J, 1993, COMP BIOCHEM PHYS B, V104, P699, DOI 10.1016/0305-0491(93)90200-O; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; NASSEL DR, 1991, PROG NEUROBIOL, V37, P179, DOI 10.1016/0301-0082(91)90027-X; NASSEL DR, 1984, NEUROSCI LETT, V48, P203, DOI 10.1016/0304-3940(84)90020-X; NASSEL DR, 1985, J COMP NEUROL, V232, P190, DOI 10.1002/cne.902320205; NASSEL DR, 1983, BRAIN RES, V280, P361, DOI 10.1016/0006-8993(83)90068-9; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; REICHMUTH C, 1995, MOL BRAIN RES, V32, P45, DOI 10.1016/0169-328X(95)00058-Z; Siekhaus DE, 1999, J NEUROSCI, V19, P6942, DOI 10.1523/JNEUROSCI.19-16-06942.1999; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; Tuthill JC, 2013, NEURON, V79, P128, DOI 10.1016/j.neuron.2013.05.024; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wegener C, 2011, J NEUROCHEM, V118, P581, DOI 10.1111/j.1471-4159.2010.07130.x; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	29	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75420	10.1371/journal.pone.0075420	http://dx.doi.org/10.1371/journal.pone.0075420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069413	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300083
J	Zheng, JX; Li, Y; Zhang, H; Fan, HJ; Lu, CP				Zheng, Jun-xi; Li, Yue; Zhang, Hui; Fan, Hong-jie; Lu, Cheng-ping			Identification and Characterization of a Novel Hemolysis-Related Gene in Streptococcus suis Serotype 2	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; IV SECRETION SYSTEM; VIRULENCE; EXPRESSION; VECTORS; TYPE-2; VIRB6	Streptococcus suis serotype 2 (SS 2) is an important zoonotic pathogen that has caused two major infectious outbreaks of streptococcal toxic shock syndrome (STSS) in China. A novel gene located in the 89K pathogenicity island (PAI) encoding a putative hemolysin-III-related protein (Hhly3) has been previously characterized. In this study, the SS2 deletion mutant of the exogenous gene hhly3 was constructed by homologous recombination. This protein was found to exhibit cytolytic activity, and hemolytic activity of the hhly3 gene knockout mutant (Delta hhly3) was significantly lower than that in the wild-type strain ZY05719. In addition, qRT-PCR revealed that Hhly3 played an important role in the expression of the secreted hemolysin SLY, which may be the key reason for the decreased hemolytic activity. Consequently, compared with the WT strain, the infection and pathogenicity of Delta hhly3 was also decreased, as evidenced by in vitro bacterial growth in whole blood and by the in vivo zebrafish test, suggesting that hhly3 is a novel exogenous hemolysis-related gene in SS2 strains.	[Zheng, Jun-xi; Li, Yue; Zhang, Hui; Fan, Hong-jie; Lu, Cheng-ping] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China; [Fan, Hong-jie] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Fan, HJ (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China.	fhj@njau.edu.cn			National Basic Research Program (973) of China [2012CB518804]; National Natural Science Foundation of China [31172319]; Key Technology R&D Program of Jiangsu [BE2009388]; Fundamental Research Funds for the Central Universities [KYT 201003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technology R&D Program of Jiangsu; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the Program from the National Basic Research Program (973) of China (2012CB518804), the National Natural Science Foundation of China (31172319), the Key Technology R&D Program of Jiangsu (BE2009388), the Fundamental Research Funds for the Central Universities (KYT 201003), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampe F, 1998, LETT APPL MICROBIOL, V27, P270, DOI 10.1046/j.1472-765X.1998.00435.x; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Chen YC, 2004, CURR MICROBIOL, V49, P175, DOI 10.1007/s00284-004-4288-5; Feng YJ, 2010, TRENDS MICROBIOL, V18, P124, DOI 10.1016/j.tim.2009.12.003; Giraldo AMV, 2012, BIOCHEMISTRY-US, V51, P3881, DOI 10.1021/bi300298v; Higgins R, 2000, CAN VET J, V41, P414; Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052; Jiang H, 2009, VET MICROBIOL, V133, P309, DOI 10.1016/j.vetmic.2008.07.014; Li M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002080; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Sanchez-Vazquez FJ, 2011, CHRONOBIOL INT, V28, P109, DOI 10.3109/07420528.2010.538105; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Tan C, 2008, FEMS MICROBIOL LETT, V278, P108, DOI 10.1111/j.1574-6968.2007.00980.x; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Wu T, 2009, FEMS MICROBIOL LETT, V292, P170, DOI 10.1111/j.1574-6968.2008.01486.x; Xu LF, 2010, PROTEIN CELL, V1, P96, DOI 10.1007/s13238-010-0012-3; Zhang W, 2007, ZOONOSES PUBLIC HLTH, V54, P253, DOI 10.1111/j.1863-2378.2007.01056.x; Zheng F, 2011, INFECT IMMUN, V79, P1319, DOI 10.1128/IAI.00193-10; Zhu HD, 2011, MICROB PATHOGENESIS, V51, P442, DOI 10.1016/j.micpath.2011.08.002	21	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74674	10.1371/journal.pone.0074674	http://dx.doi.org/10.1371/journal.pone.0074674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069329	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300049
J	Henker, R; Scholz, M; Gaffling, S; Asano, N; Hampel, U; Garreis, F; Hornegger, J; Paulsen, F				Henker, Robert; Scholz, Michael; Gaffling, Simone; Asano, Nagayoshi; Hampel, Ulrike; Garreis, Fabian; Hornegger, Joachim; Paulsen, Friedrich			Morphological Features of the Porcine Lacrimal Gland and Its Compatibility for Human Lacrimal Gland Xenografting	PLOS ONE			English	Article							AUTOLOGOUS SUBMANDIBULAR-GLAND; SEVERE KERATOCONJUNCTIVITIS SICCA; TRANSPLANTATION; PIG; SEGMENTATION; MANAGEMENT; QUALITY; CELLS; RISK	In this study, we present first data concerning the anatomical structure, blood supply and location of the lacrimal gland of the pig. Our data indicate that the porcine lacrimal gland may serve as a potential xenograft candidate in humans or as an animal model for engineering of a bioartificial lacrimal gland tissue construct for clinical application. For this purpose, we used different macroscopic preparation techniques and digital reconstruction of the histological gland morphology to gain new insights and important information concerning the feasibility of a lacrimal gland transplantation from pig to humans in general. Our results show that the lacrimal gland of the pig reveals a lot of morphological similarities to the analogous human lacrimal gland and thus might be regarded as a xenograft in the future. This is true for a similar anatomical location within the orbit as well as for the feeding artery supply to the organ. Functional differences concerning the composition of the tear fluid, due to a different secretory unit distribution within the gland tissue will, however, be a challenge in future investigations.	[Henker, Robert; Scholz, Michael; Asano, Nagayoshi; Hampel, Ulrike; Garreis, Fabian; Paulsen, Friedrich] Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany; [Gaffling, Simone; Hornegger, Joachim] Univ Erlangen Nurnberg, Pattern Recognit Lab, D-91054 Erlangen, Germany; [Gaffling, Simone; Hornegger, Joachim] Univ Erlangen Nurnberg, Erlangen Grad Sch Adv Opt Technol SAOT, D-91054 Erlangen, Germany; [Asano, Nagayoshi] Santen Pharmaceut Co Ltd, Ctr Res & Dev, Nara, Japan	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Santen Pharmaceutical Co Ltd	Scholz, M (corresponding author), Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany.	michael.scholz@anatomie2.med.uni-erlangen.de	Hornegger, Joachim/H-2465-2017	Hornegger, Joachim/0000-0002-1834-8844; Scholz, Michael/0000-0001-8440-6785; Paulsen, Friedrich/0000-0002-0527-0953	Erlangen Graduate School in Advanced Optical Technologies (SAOT); German Research Foundation (DFG) within the framework of the German Excellence Initiative	Erlangen Graduate School in Advanced Optical Technologies (SAOT); German Research Foundation (DFG) within the framework of the German Excellence Initiative(German Research Foundation (DFG))	The authors gratefully acknowledge funding by the Erlangen Graduate School in Advanced Optical Technologies (SAOT) and by the German Research Foundation (DFG) within the framework of the German Excellence Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN ID, 1977, INT ARCH ALLER A IMM, V53, P62, DOI 10.1159/000231732; [Anonymous], 2007, OCUL SURF, V5, P179, DOI [10.1016/S1542-0124(12)70086-1, DOI 10.1016/51542-0124(12)700861, DOI 10.1016/S1542-0124(12)70086-1]; Blackie CA, 2010, CORNEA, V29, P1333, DOI 10.1097/ICO.0b013e3181d4f366; COOPER DKC, 1993, LANCET, V342, P682, DOI 10.1016/0140-6736(93)91791-J; CORDES J, 1989, PRAPARATOR, V35, P21; COZZI E, 1995, NAT MED, V1, P964, DOI 10.1038/nm0995-964; Ding C, 2011, J PROTEOME RES, V10, P2206, DOI 10.1021/pr100965q; Ekser B, 2010, EXPERT REV CLIN IMMU, V6, P219, DOI 10.1586/ECI.09.81; Erdogmus S, 2005, J CRANIOFAC SURG, V16, P957, DOI 10.1097/01.scs.0000179741.68294.1c; Fishman JA, 2012, XENOTRANSPLANTATION, V19, P72, DOI 10.1111/j.1399-3089.2012.00693.x; Ge XY, 2012, BRIT J ORAL MAX SURG, V50, P562, DOI 10.1016/j.bjoms.2011.10.004; Geerling G, 2000, GRAEF ARCH CLIN EXP, V238, P45, DOI 10.1007/s004170050008; Geerling G, 1998, OPHTHALMOLOGY, V105, P327, DOI 10.1016/S0161-6420(98)93406-6; Geerling G, 1998, OPHTHALMOLOGE, V95, P257, DOI 10.1007/s003470050272; Geerling G, 1999, GRAEF ARCH CLIN EXP, V237, P546, DOI 10.1007/s004170050277; Geerling Gerd, 2008, Dev Ophthalmol, V41, P255, DOI 10.1159/000131094; Getty R, 1975, SISSON GROSSMANS ANA; Hayreh S S, 1962, Br J Ophthalmol, V46, P165, DOI 10.1136/bjo.46.3.165; Jacobsen HC, 2008, J CRANIO MAXILL SURG, V36, P227, DOI 10.1016/j.jcms.2007.08.010; Kim MK, 2011, CURR OPIN ORGAN TRAN, V16, P231, DOI 10.1097/MOT.0b013e328344870c; King-Smith PE, 2011, OCUL SURF, V9, P197, DOI 10.1016/S1542-0124(11)70033-7; Kleckowska-Nawrot J, 2008, ANAT HISTOL EMBRYOL, V37, P74, DOI 10.1111/j.1439-0264.2007.00798.x; Kobayashi E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-8; Kuhnel WS, 1979, SCHWEINS ANAT ANZ, V145, P87; KUMAR PAV, 1990, BRIT J PLAST SURG, V43, P431; Lehmann KS, 2008, ANN SURG ONCOL, V15, P1899, DOI 10.1245/s10434-008-9934-x; Long C, 2009, TRANSFUSION, V49, P2418, DOI 10.1111/j.1537-2995.2009.02306.x; MACLEOD AM, 1992, AUST NZ J OPHTHALMOL, V20, P99, DOI 10.1111/j.1442-9071.1992.tb00719.x; Malandain G, 2004, NEUROIMAGE, V23, P111, DOI 10.1016/j.neuroimage.2004.04.038; Manji RA, 2012, AM HEART J, V164, P177, DOI 10.1016/j.ahj.2012.05.011; MURUBEDELCASTILLO J, 1986, SCAND J RHEUMATOL, P264; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patience C, 1998, LANCET, V352, P699, DOI 10.1016/S0140-6736(98)04369-4; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Popesko P, 1989, ATLAS TOPOGRAPHISCHE; Schaumberg DA, 2011, INVEST OPHTH VIS SCI, V52, P1994, DOI 10.1167/iovs.10-6997e; Streicher J, 1997, ANAT REC, V248, P583; Tamboli DA, 2011, OPHTHAL PLAST RECONS, V27, P453, DOI 10.1097/IOP.0b013e31821e9f5d; Tanaka Hozumi, 2006, J Artif Organs, V9, P136, DOI 10.1007/s10047-006-0343-2; Tong L, 2010, INVEST OPHTH VIS SCI, V51, P3449, DOI 10.1167/iovs.09-4445; van der Windt DJ, 2009, AM J TRANSPLANT, V9, P2716, DOI 10.1111/j.1600-6143.2009.02850.x; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	42	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74046	10.1371/journal.pone.0074046	http://dx.doi.org/10.1371/journal.pone.0074046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069265	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100083
J	Liu, WY; Wong, CF; Chung, KMK; Jiang, JW; Leung, FCC				Liu, Wing-Yee; Wong, Chi-Fat; Chung, Karl Ming-Kar; Jiang, Jing-Wei; Leung, Frederick Chi-Ching			Comparative Genome Analysis of Enterobacter cloacae	PLOS ONE			English	Article							VI SECRETION SYSTEM; ESCHERICHIA-COLI; IV SECRETION; BACILLUS-THURINGIENSIS; CHITINASE GENE; SEQUENCE; PLANT; BIOCONTROL; PURIFICATION; EXPRESSION	The Enterobacter cloacae species includes an extremely diverse group of bacteria that are associated with plants, soil and humans. Publication of the complete genome sequence of the plant growth-promoting endophytic E. cloacae subsp. cloacae ENHKU01 provided an opportunity to perform the first comparative genome analysis between strains of this dynamic species. Examination of the pan-genome of E. cloacae showed that the conserved core genome retains the general physiological and survival genes of the species, while genomic factors in plasmids and variable regions determine the virulence of the human pathogenic E. cloacae strain; additionally, the diversity of fimbriae contributes to variation in colonization and host determination of different E. cloacae strains. Comparative genome analysis further illustrated that E. cloacae strains possess multiple mechanisms for antagonistic action against other microorganisms, which involve the production of siderophores and various antimicrobial compounds, such as bacteriocins, chitinases and antibiotic resistance proteins. The presence of Type VI secretion systems is expected to provide further fitness advantages for E. cloacae in microbial competition, thus allowing it to survive in different environments. Competition assays were performed to support our observations in genomic analysis, where E. cloacae subsp. cloacae ENHKU01 demonstrated antagonistic activities against a wide range of plant pathogenic fungal and bacterial species.	[Liu, Wing-Yee; Wong, Chi-Fat; Chung, Karl Ming-Kar; Jiang, Jing-Wei; Leung, Frederick Chi-Ching] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Jiang, Jing-Wei; Leung, Frederick Chi-Ching] Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China	University of Hong Kong; Nanjing Agricultural University	Leung, FCC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	fcleung@hkucc.hku.hk			Strategic Research Theme of Infection and Immunology, Initiative of Clean Energy and Environment, The University of Hong Kong	Strategic Research Theme of Infection and Immunology, Initiative of Clean Energy and Environment, The University of Hong Kong	This project was partially supported by the Strategic Research Theme of Infection and Immunology, Initiative of Clean Energy and Environment, The University of Hong Kong and a start-up fund for Bioinformatics Center, Nanjing Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G.N., 2005, PLANT PATHOL, V5th, P26; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bhattacharya D, 2007, CRIT REV BIOTECHNOL, V27, P21, DOI 10.1080/07388550601168223; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bishop RE, 1998, J MOL BIOL, V280, P583, DOI 10.1006/jmbi.1998.1894; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Challacombe JF, 2007, J BACTERIOL, V189, P3680, DOI 10.1128/JB.00241-07; Chang WT, 2003, CURR MICROBIOL, V47, P102, DOI 10.1007/s00284-002-3955-7; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chernin LS, 1997, APPL ENVIRON MICROB, V63, P834, DOI 10.1128/AEM.63.3.834-839.1997; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Christie PJ, 2005, MOL MEMBR BIOL, V22, P51, DOI 10.1080/09687860500063316; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DeAngelis KM, 2011, STAND GENOMIC SCI, V5, P69, DOI 10.4056/sigs.2104875; DIENE SM, 2012, MOL BIOL EVOL; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; Frankowski J, 2001, ARCH MICROBIOL, V176, P421, DOI 10.1007/s002030100347; Garbeva P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027266; Gomaa EZ, 2012, J MICROBIOL, V50, P103, DOI 10.1007/s12275-012-1343-y; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; HINTON DM, 1995, MYCOPATHOLOGIA, V129, P117, DOI 10.1007/BF01103471; Hoffmann H, 2005, J CLIN MICROBIOL, V43, P3297, DOI 10.1128/JCM.43.7.3297-3303.2005; HUMANN JL, 2011, STANDARDS GENOMICS S, V5; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Jiang LQ, 2012, BIORESOURCE TECHNOL, V107, P405, DOI 10.1016/j.biortech.2011.12.083; JONES JDG, 1986, EMBO J, V5, P467, DOI 10.1002/j.1460-2075.1986.tb04235.x; Joseph S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049455; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Keller R, 1998, INFECT IMMUN, V66, P645, DOI 10.1128/IAI.66.2.645-649.1998; KLOEPPER JW, 1980, CURR MICROBIOL, V4, P317, DOI 10.1007/BF02602840; Leverstein-van Hall MA, 2006, J CLIN MICROBIOL, V44, P518, DOI 10.1128/JCM.44.2.518-524.2006; Li J, 2012, GENE, V494, P57, DOI 10.1016/j.gene.2011.11.051; Li YF, 2009, P NATL ACAD SCI USA, V106, P10793, DOI 10.1073/pnas.0812843106; Liu SY, 2007, MICROBIOL-SGM, V153, P3196, DOI 10.1099/mic.0.2006/005538-0; Liu WY, 2012, J BACTERIOL, V194, P5965, DOI 10.1128/JB.01394-12; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Manter DK, 2011, CURR MICROBIOL, V62, P1044, DOI 10.1007/s00284-010-9809-9; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mehmood MA, 2009, WORLD J MICROB BIOT, V25, P1955, DOI 10.1007/s11274-009-0094-3; Mela F, 2011, ISME J, V5, P1494, DOI 10.1038/ismej.2011.29; NELSON EB, 1988, PLANT DIS, V72, P140, DOI 10.1094/PD-72-0140; Norberg AL, 2011, FEBS LETT, V585, P2339, DOI 10.1016/j.febslet.2011.06.002; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Paauw A, 2007, J CLIN MICROBIOL, V45, P1420, DOI 10.1128/JCM.02242-06; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ren Y, 2010, J BACTERIOL, V192, P2463, DOI 10.1128/JB.00067-10; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sarris PF, 2011, INFECT GENET EVOL, V11, P157, DOI 10.1016/j.meegid.2010.09.006; Schroeder BK, 2010, PLANT DIS, V94, P236, DOI 10.1094/PDIS-94-2-0236; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shin SH, 2012, J BACTERIOL, V194, P2373, DOI 10.1128/JB.00028-12; Sisto A, 2010, ANTON LEEUW INT J G, V98, P505, DOI 10.1007/s10482-010-9468-7; Smits THM, 2010, FEMS MICROBIOL LETT, V308, P48, DOI 10.1111/j.1574-6968.2010.01994.x; Smits THM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-2; Suarez-Estrella F, 2007, CROP PROT, V26, P46, DOI 10.1016/j.cropro.2006.04.003; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsolis RM, 2002, P NATL ACAD SCI USA, V99, P12503, DOI 10.1073/pnas.212508599; van Dijk K, 2000, APPL ENVIRON MICROB, V66, P5340, DOI 10.1128/AEM.66.12.5340-5347.2000; WATANABE T, 1990, J BIOL CHEM, V265, P15659; Xu YQ, 2012, J BACTERIOL, V194, P897, DOI 10.1128/JB.06495-11; Xue QY, 2009, BIOL CONTROL, V48, P252, DOI 10.1016/j.biocontrol.2008.11.004; Zees AC, 2009, BBA-PROTEINS PROTEOM, V1794, P23, DOI 10.1016/j.bbapap.2008.09.018; Zhu B, 2011, INT J SYST EVOL MICR, V61, P2769, DOI 10.1099/ijs.0.028613-0	91	36	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74487	10.1371/journal.pone.0074487	http://dx.doi.org/10.1371/journal.pone.0074487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069314	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100107
J	Reyes, L; Eiler-McManis, E; Rodrigues, PH; Chadda, AS; Wallet, SM; Belanger, M; Barrett, AG; Alvarez, S; Akin, D; Dunn, WA; Progulske-Fox, A				Reyes, Leticia; Eiler-McManis, Eileen; Rodrigues, Paulo H.; Chadda, Amandeep S.; Wallet, Shannon M.; Belanger, Myriam; Barrett, Amanda G.; Alvarez, Sophie; Akin, Debra; Dunn, William A., Jr.; Progulske-Fox, Ann			Deletion of Lipoprotein PG0717 in Porphyromonas gingivalis W83 Reduces Gingipain Activity and Alters Trafficking in and Response by Host Cells	PLOS ONE			English	Article							C-TERMINAL-DOMAIN; BIOFILM FORMATION; IMMUNE-RESPONSE; VIRULENCE; EXPRESSION; AUTOPHAGY; SURVIVAL; INTERLEUKIN-8; INVASION; SEQUENCE	P. gingivalis (Pg), a causative agent of chronic generalized periodontitis, has been implicated in promoting cardiovascular disease. Expression of lipoprotein gene PG0717 of Pg strain W83 was found to be transiently upregulated during invasion of human coronary artery endothelial cells (HCAEC), suggesting this protein may be involved in virulence. We characterized the virulence phenotype of a PG0717 deletion mutant of pg W83. There were no differences in the ability of W83 Delta 717 to adhere and invade HCAEC. However, the increased proportion of internalized W83 at 24 hours post-inoculation was not observed with W83 Delta 717. Deletion of PG0717 also impaired the ability of W83 to usurp the autophagic pathway in HCAEC and to induce autophagy in Saos-2 sarcoma cells. HCAEC infected with W83 Delta 717 also secreted significantly greater amounts of MCP-1, IL-8, IL-6, GM-CSF, and soluble ICAM-1, VCAM-1, and E-selectin when compared to W83. Further characterization of W83 Delta 717 revealed that neither capsule nor lipid A structure was affected by deletion of PG0717. Interestingly, the activity of both arginine (Rgp) and lysine (Kgp) gingipains was reduced in whole-cell extracts and culture supernatant of W83 Delta 717. RT-PCR revealed a corresponding decrease in transcription of rgpB but not rgpA or kgp. Quantitative proteome studies of the two strains revealed that both RgpA and RgpB, along with putative virulence factors peptidylarginine deiminase and Clp protease were significantly decreased in the W83 Delta 717. Our results suggest that PG0717 has pleiotropic effects on W83 that affect microbial induced manipulation of host responses important for microbial clearance and infection control.	[Reyes, Leticia; Eiler-McManis, Eileen; Rodrigues, Paulo H.; Chadda, Amandeep S.; Wallet, Shannon M.; Belanger, Myriam; Barrett, Amanda G.; Progulske-Fox, Ann] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Reyes, Leticia; Eiler-McManis, Eileen; Rodrigues, Paulo H.; Chadda, Amandeep S.; Wallet, Shannon M.; Belanger, Myriam; Barrett, Amanda G.; Progulske-Fox, Ann] Ctr Mol Microbiol, Gainesville, FL USA; [Wallet, Shannon M.] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL USA; [Alvarez, Sophie] Donald Danforth Plant Sci Ctr, Prote & Mass Spectrometry Core, St Louis, MO USA; [Akin, Debra; Dunn, William A., Jr.] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Donald Danforth Plant Science Center; State University System of Florida; University of Florida	Reyes, L (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	lreyes@ufl.edu	Reyes, Leticia/H-7338-2019; Rodrigues, Paulo/O-2689-2017; Alvarez, Sophie/K-9231-2013	Rodrigues, Paulo/0000-0002-4646-6805; Alvarez, Sophie/0000-0001-8550-2832	National Institutes of Health [R01 DE13545, T90 DE021990]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants R01 DE13545 and T90 DE021990. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduse-Opoku J, 2006, INFECT IMMUN, V74, P449, DOI 10.1128/IAI.74.1.449-460.2006; Al-Qutub MN, 2006, INFECT IMMUN, V74, P4474, DOI 10.1128/IAI.01924-05; Allam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051345; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Aruni AW, 2013, MOL ORAL MICROBIOL, V28, P167, DOI 10.1111/omi.12017; BARTH K, 2012, J CELL PHYSL; BELANGER M, 2007, CURRENT PROTOCOLS MI; Belanger M, 2012, ANAEROBE, V18, P128, DOI 10.1016/j.anaerobe.2011.10.005; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Braunersreuther V, 2006, CELL MOL LIFE SCI, V63, P2079, DOI 10.1007/s00018-006-6127-2; Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-252; Brunner J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-5; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Chen T, 2004, J BACTERIOL, V186, P5473, DOI 10.1128/JB.186.16.5473-5479.2004; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Choi CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018499; Coats SR, 2009, CELL MICROBIOL, V11, P1587, DOI 10.1111/j.1462-5822.2009.01349.x; Curtis MA, 2001, CRIT REV ORAL BIOL M, V12, P192, DOI 10.1177/10454411010120030101; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Dorn BR, 2002, CELL MICROBIOL, V4, P1, DOI 10.1046/j.1462-5822.2002.00164.x; Dorn BR, 2001, INFECT IMMUN, V69, P5698, DOI 10.1128/IAI.69.9.5698-5708.2001; ENERSEN M, 2011, J ORAL MICROBIOL, P3; Fletcher J, 1998, CURR MICROBIOL, V36, P216, DOI 10.1007/s002849900297; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hasegawa Y, 2003, MICROBIOL IMMUNOL, V47, P849, DOI 10.1111/j.1348-0421.2003.tb03451.x; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; HAYASHI H, 1993, ORAL MICROBIOL IMMUN, V8, P386, DOI 10.1111/j.1399-302X.1993.tb00616.x; Hiratsuka K, 2008, MICROB PATHOGENESIS, V44, P320, DOI 10.1016/j.micpath.2007.10.006; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; James CE, 2006, INFECT IMMUN, V74, P3834, DOI 10.1128/IAI.01768-05; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kim KJ, 2003, CELL MICROBIOL, V5, P245, DOI 10.1046/j.1462-5822.2003.t01-1-00271.x; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kobayashi-Sakamoto M, 2003, CURR MICROBIOL, V46, P109, DOI 10.1007/s00284-002-3782-x; Kozarov E, 2000, INFECT IMMUN, V68, P732, DOI 10.1128/IAI.68.2.732-739.2000; Kurushima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038925; Laine ML, 1998, ORAL MICROBIOL IMMUN, V13, P322, DOI 10.1111/j.1399-302X.1998.tb00714.x; Lepine G, 1996, INFECT IMMUN, V64, P1467; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-26; Lin Li, 2006, Zhonghua Kou Qiang Yi Xue Za Zhi, V41, P734; Lo A, 2010, J BACTERIOL, V192, P1332, DOI 10.1128/JB.01211-09; Madrigal AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002723; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mikolajczyk-Pawlinska J, 1998, FEBS LETT, V440, P282, DOI 10.1016/S0014-5793(98)01461-6; Nassar H, 2002, INFECT IMMUN, V70, P268, DOI 10.1128/IAI.70.1.268-276.2002; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nishikawa K, 2010, J BACTERIOL, V192, P1975, DOI 10.1128/JB.01474-09; O'Brien-Simpson NM, 2003, CURR PROTEIN PEPT SC, V4, P409, DOI 10.2174/1389203033487009; Rivera FE, 2012, PROTEOMICS, V12, P263, DOI 10.1002/pmic.201100298; Rodrigues PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052606; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Sheets SA, 2005, INFECT IMMUN, V73, P1543, DOI 10.1128/IAI.73.3.1543-1552.2005; Sheets SM, 2008, FRONT BIOSCI-LANDMRK, V13, P3215; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Singh A, 2011, INFECT IMMUN, V79, P4533, DOI 10.1128/IAI.05016-11; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Tam V, 2009, INFECT IMMUN, V77, P1451, DOI 10.1128/IAI.01377-08; Tufano A, 2012, SEMIN THROMB HEMOST, V38, P515, DOI 10.1055/s-0032-1315759; Vanterpool E, 2005, INFECT IMMUN, V73, P1357, DOI 10.1128/IAI.73.3.1357-1366.2005; Walter C, 2004, INFECT IMMUN, V72, P5910, DOI 10.1128/IAI.72.10.5910-5918.2004; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WOO DDL, 1979, J INFECT DIS, V139, P534, DOI 10.1093/infdis/139.5.534; Yamatake K, 2007, INFECT IMMUN, V75, P2090, DOI 10.1128/IAI.01013-06; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; Yuan LH, 2007, FEMS IMMUNOL MED MIC, V51, P388, DOI 10.1111/j.1574-695X.2007.00326.x	77	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74230	10.1371/journal.pone.0074230	http://dx.doi.org/10.1371/journal.pone.0074230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069284	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100092
J	Godino, A; Pitra, S; Carrer, HF; Vivas, L				Godino, Andrea; Pitra, Soledad; Carrer, Hugo F.; Vivas, Laura			Body Sodium Overload Modulates the Firing Rate and Fos Immunoreactivity of Serotonergic Cells of Dorsal Raphe Nucleus	PLOS ONE			English	Article							PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; LATERAL PARABRACHIAL NUCLEUS; C-FOS; HYPERTONIC SALINE; SUBFORNICAL ORGAN; VOLUME EXPANSION; WATER-INTAKE; NEURONS; IDENTIFICATION; VASOPRESSIN	In order to determine whether serotonergic (5HT) dorsal raphe nucleus (DRN) cells are involved in body sodium status regulation, the effect of a s.c. infusion of either 2 M or 0.15 M NaCl on 5HT DRN neuron firing was studied using single unit extracellular recordings. In separate groups of 2 M and 0.15 M NaCl-infused rats, water intake, oxytocin (OT) plasma concentration, urine and plasma sodium and protein concentrations were also measured. Also, to determine the involvement of particular brain nuclei and neurochemical systems in body sodium overload (SO), animals from both groups were perfused for brain immunohistochemical detection of Fos, Fos-OT and Fos-5HT expression. SO produced a significant increase in serotonergic DRN neuron firing rate compared to baseline and 0.15 M NaCl-infused rats. As expected, 2 M NaCl s.c. infusion also induced a significant increase of water intake, diuresis and natriuresis, plasma sodium concentration and osmolality, even though plasma volume did not increase as indicated by changes in plasma protein concentration. The distribution of neurons along the forebrain and brainstem expressing Fos after SO showed the participation of the lamina terminalis, extended amygdala, supraoptic and paraventricular hypothalamic nuclei in the neural network that controls osmoregulatory responses. Both Fos-OT immunoreactive and plasma OT concentration increased after s.c. hypertonic sodium infusion. Finally, matching the "in vivo'' electrophysiological study, SO doubled the number of Fos-5HT immunolabeled cells within the DRN. In summary, the results characterize the behavioral, renal and endocrine responses after body sodium overload without volume expansion and specify the cerebral nuclei that participate at different CNS levels in the control of these responses. The electrophysiological approach also allows us to determine in an "in vivo" model that DRN 5HT neurons increase their firing frequency during an increase in systemic sodium concentration and osmolality, possibly to modulate sodium and water intake/excretion and avoid extracellular volume expansion.	[Godino, Andrea; Pitra, Soledad; Carrer, Hugo F.; Vivas, Laura] Univ Nacl Cordoba, CONICET, INIMEC, Inst Invest Med Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Godino, A (corresponding author), Univ Nacl Cordoba, CONICET, INIMEC, Inst Invest Med Mercedes & Martin Ferreyra, RA-5000 Cordoba, Argentina.	agodino@immf.uncor.edu			SECyT [05/1649]; CONICET [PIP 2561]; ANPCyT [PICT-2010-2072, 000113/2011, 140/12]; MYNCyT Cordoba grant [000113/2011]; Fundacion Roemmers; ISN (International Society for Neurochemistry)	SECyT(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT(ANPCyT); MYNCyT Cordoba grant; Fundacion Roemmers; ISN (International Society for Neurochemistry)	This work was supported in part by grants from: SECyT grant 2010-2011. N: 05/1649; CONICET grant 2010-2012. PIP 2561; ANPCyT grant 2011-2014. Bicentenario, PICT-2010-2072 (Resolution No 098/11); MYNCyT Cordoba grant 2011-2013. PID (Resolution 000113/2011); Fundacion Roemmers grant to novel investigators. 2011-2013; ANPCyT grant 2012-2014 for young investigators. PICT 2011-2014 (Resolution 140/12); and ISN (International Society for Neurochemistry) Research supplies for use in the applicant's home laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1978, BRAIN RES, V153, P169, DOI 10.1016/0006-8993(78)91140-X; Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; Badaue-Passos D, 2007, EXP NEUROL, V206, P86, DOI 10.1016/j.expneurol.2007.04.008; BARABAN JM, 1980, EUR J PHARMACOL, V66, P287, DOI 10.1016/0014-2999(80)90461-6; Bisset GW, 1996, BRIT J PHARMACOL, V117, P309, DOI 10.1111/j.1476-5381.1996.tb15192.x; Cheema-Dhadli S, 2002, J PHYSIOL-LONDON, V541, P929, DOI 10.1113/jphysiol.2002.019430; Colombari DSA, 1996, AM J PHYSIOL-REG I, V271, pR1470, DOI 10.1152/ajpregu.1996.271.6.R1470; Davern PJ, 2010, BRAIN RES, V1339, P41, DOI 10.1016/j.brainres.2010.04.022; Duan PG, 2008, BRAIN RES, V1198, P68, DOI 10.1016/j.brainres.2008.01.035; Franchini LF, 1999, AM J PHYSIOL-REG I, V276, pR1180, DOI 10.1152/ajpregu.1999.276.4.R1180; Franchini LF, 2002, AM J PHYSIOL-REG I, V282, pR235, DOI 10.1152/ajpregu.00766.2000; Godino A, 2005, NEUROSCIENCE, V133, P493, DOI 10.1016/j.neuroscience.2005.02.035; Godino A, 2007, AM J PHYSIOL-REG I, V293, pR1027, DOI 10.1152/ajpregu.00078.2007; Godino A, 2010, EXP NEUROL, V221, P275, DOI 10.1016/j.expneurol.2009.11.001; HAANWINCKEL MA, 1995, P NATL ACAD SCI USA, V92, P7902, DOI 10.1073/pnas.92.17.7902; Hajos M, 1998, NEUROSCIENCE, V87, P95, DOI 10.1016/S0306-4522(98)00157-2; Ho JM, 2007, AM J PHYSIOL-REG I, V292, pR1690, DOI 10.1152/ajpregu.00547.2006; HOCHSTENBACH SL, 1995, BRAIN RES, V674, P46, DOI 10.1016/0006-8993(94)01434-J; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; JOHNSON AK, 1993, FASEB J, V7, P678, DOI 10.1096/fasebj.7.8.8500693; Johnson AK, 1999, ANN NY ACAD SCI, V877, P258, DOI 10.1111/j.1749-6632.1999.tb09272.x; Kawano H, 2010, NEUROSCIENCE, V169, P1227, DOI 10.1016/j.neuroscience.2010.05.065; Kirby LG, 2003, NEUROSCIENCE, V116, P669, DOI 10.1016/S0306-4522(02)00584-5; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; KOVACS KJ, 1993, P NATL ACAD SCI USA, V90, P7681, DOI 10.1073/pnas.90.16.7681; LARSEN PJ, 1995, J NEUROSCI, V15, P2609; Li CS, 2006, AM J PHYSIOL-REG I, V291, pR914, DOI 10.1152/ajpregu.00750.2005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundy RF, 2001, J NEUROPHYSIOL, V85, P770, DOI 10.1152/jn.2001.85.2.770; Margatho LO, 2008, J NEUROSCI RES, V86, P3613, DOI 10.1002/jnr.21806; Margatho LO, 2002, BRAIN RES, V956, P103, DOI 10.1016/S0006-8993(02)03486-8; Margatho LO, 2007, AM J PHYSIOL-REG I, V293, P1190; McKinley MJ, 2004, J NEUROENDOCRINOL, V16, P340, DOI 10.1111/j.0953-8194.2004.01184.x; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; MCKINLEY MJ, 1994, BRAIN RES, V653, P305, DOI 10.1016/0006-8993(94)90405-7; Menani JV, 1998, AM J PHYSIOL-REG I, V274, pR555; Menani JV, 2004, BRAIN RES, V1030, P74, DOI 10.1016/j.brainres.2004.09.048; Menani JV, 1996, AM J PHYSIOL-REG I, V270, pR162, DOI 10.1152/ajpregu.1996.270.1.R162; Menani JV, 2000, AM J PHYSIOL-REG I, V279, pR126, DOI 10.1152/ajpregu.2000.279.1.R126; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MORRIS M, 1989, HYPERTENSION, V13, P110, DOI 10.1161/01.HYP.13.2.110; Noda M, 2005, CHEM SENSES, V30, pI44, DOI 10.1093/chemse/bjh105; OLDFIELD BJ, 1994, NEUROSCIENCE, V60, P255, DOI 10.1016/0306-4522(94)90219-4; Olivares EL, 2003, BRAZ J MED BIOL RES, V36, P1709, DOI 10.1590/S0100-879X2003001200013; OLSON BR, 1993, MOL CELL NEUROSCI, V4, P93, DOI 10.1006/mcne.1993.1011; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PETROV T, 1992, J COMP NEUROL, V318, P18, DOI 10.1002/cne.903180103; RICHARD D, 1992, NEUROENDOCRINOLOGY, V55, P609, DOI 10.1159/000126174; Rinaman L, 1997, NEUROSCIENCE, V79, P1165, DOI 10.1016/S0306-4522(97)00022-5; Schoorlemmer GHM, 2000, AM J PHYSIOL-REG I, V278, pR917, DOI 10.1152/ajpregu.2000.278.4.R917; Stricker EM, 2002, AM J PHYSIOL-REG I, V282, pR1710, DOI 10.1152/ajpregu.00548.2001; STRICKER EM, 1986, AM J PHYSIOL, V250, pR267, DOI 10.1152/ajpregu.1986.250.2.R267; Tanaka J, 2004, NEUROSCI LETT, V357, P41, DOI 10.1016/j.neulet.2003.12.040; Toney GM, 2003, ACTA PHYSIOL SCAND, V177, P43, DOI 10.1046/j.1365-201X.2003.01046.x; Verbalis J. G., 1995, CURR OPIN ENDOCRINOL, V2, P157; Vivas L., 2013, NEUROBIOLOGY BODY FL; Watanabe E, 2000, J NEUROSCI, V20, P7743	57	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74689	10.1371/journal.pone.0074689	http://dx.doi.org/10.1371/journal.pone.0074689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073217	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000026
J	Yeom, JH; Ryou, SM; Won, M; Park, M; Bae, J; Lee, K				Yeom, Ji-Hyun; Ryou, Sang-Mi; Won, Miae; Park, Mira; Bae, Jeehyeon; Lee, Kangseok			Inhibition of Xenograft Tumor Growth by Gold Nanoparticle-DNA Oligonucleotide Conjugates-Assisted Delivery of BAX mRNA	PLOS ONE			English	Article							GENE DELIVERY; PROTEIN EXPRESSION; IN-VITRO; CELLS; TRANSFECTION; PROSPECTS; VECTORS; LIPIDS	Use of non-biological agents for mRNA delivery into living systems in order to induce heterologous expression of functional proteins may provide more advantages than the use of DNA and/or biological vectors for delivery. However, the low efficiency of mRNA delivery into live animals, using non-biological systems, has hampered the use of mRNA as a therapeutic molecule. Here, we show that gold nanoparticle-DNA oligonucleotide (AuNP-DNA) conjugates can serve as universal vehicles for more efficient delivery of mRNA into human cells, as well as into xenograft tumors generated in mice. Injections of BAX mRNA loaded on AuNP-DNA conjugates into xenograft tumors resulted in highly efficient mRNA delivery. The delivered mRNA directed the efficient production of biologically functional BAX protein, a pro-apoptotic factor, consequently inhibiting tumor growth. These results demonstrate that mRNA delivery by AuNP-DNA conjugates can serve as a new platform for the development of safe and efficient gene therapy.	[Yeom, Ji-Hyun; Ryou, Sang-Mi; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Won, Miae; Park, Mira] CHA Univ, Dept Pharm, Songnam, South Korea; [Bae, Jeehyeon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Chung Ang University; Pochon Cha University; Chung Ang University	Bae, J (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	jeehyeon@cau.ac.kr; kangseok@cau.ac.kr	Won, Miae/AAL-9049-2020		National Research Foundation of Korea [2011-0021810, 2011-0013856]; Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ009025]	National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program (SSAC), Rural Development Administration, Republic of Korea	This research was supported by grants from the National Research Foundation of Korea (2011-0021810 and 2011-0013856) and the Next-Generation BioGreen 21 Program (SSAC, grant#: PJ009025), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettinger T, 2001, NUCLEIC ACIDS RES, V29, P3882, DOI 10.1093/nar/29.18.3882; Bragonzi A, 1999, GENE THER, V6, P1995, DOI 10.1038/sj.gt.3301039; Filion MC, 1998, INT J PHARM, V162, P159, DOI 10.1016/S0378-5173(97)00423-7; Filion MC, 1997, BBA-BIOMEMBRANES, V1329, P345, DOI 10.1016/S0005-2736(97)00126-0; Fisher KJ, 1997, BIOCHEM J, V321, P49, DOI 10.1042/bj3210049; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Hofland HEJ, 1997, PHARMACEUT RES, V14, P742, DOI 10.1023/A:1012146305040; Kariko K, 2001, J NEUROSCI METH, V105, P77, DOI 10.1016/S0165-0270(00)00355-1; Kim JH, 2011, J BIOTECHNOL, V155, P287, DOI 10.1016/j.jbiotec.2011.07.014; Kim JH, 2010, CHEM COMMUN, V46, P4151, DOI 10.1039/c0cc00103a; Kim JM, 2013, BIOTECHNOL BIOPROC E, V18, P637, DOI 10.1007/s12257-012-0546-8; Kim YJ, 2012, J MATER CHEM, V22, P25036, DOI 10.1039/c2jm34047j; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kreiter S, 2011, CURR OPIN IMMUNOL, V23, P399, DOI 10.1016/j.coi.2011.03.007; Kuhn AN, 2012, CURR GENE THER, V12, P347; LU D, 1994, CANCER GENE THER, V1, P245; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; Park S, 2010, ACS NANO, V4, P2555, DOI 10.1021/nn100362m; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Renault TT, 2011, BIOCHIMIE, V93, P1379, DOI 10.1016/j.biochi.2011.05.013; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Ryou SM, 2011, BIOCHEM BIOPH RES CO, V416, P178, DOI 10.1016/j.bbrc.2011.11.020; Ryou SM, 2010, BIOCHEM BIOPH RES CO, V398, P542, DOI 10.1016/j.bbrc.2010.06.115; Schott JW, 2011, CURR GENE THER, V11, P382; Strobel I, 2000, GENE THER, V7, P2028, DOI 10.1038/sj.gt.3301326; Su XF, 2011, MOL PHARMACEUT, V8, P774, DOI 10.1021/mp100390w; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; de Ilarduya CT, 2003, METHOD ENZYMOL, V373, P342; Yamamoto A, 2009, EUR J PHARM BIOPHARM, V71, P484, DOI 10.1016/j.ejpb.2008.09.016; Zhang X, 2012, J AM CHEM SOC, V134, P7266, DOI 10.1021/ja3014055; Zohra FT, 2009, BIOMATERIALS, V30, P4006, DOI 10.1016/j.biomaterials.2009.02.050	31	25	28	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75369	10.1371/journal.pone.0075369	http://dx.doi.org/10.1371/journal.pone.0075369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073264	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000073
J	Hraiech, S; Alingrin, J; Dizier, S; Brunet, J; Forel, JM; La Scola, B; Roch, A; Papazian, L; Pauly, V				Hraiech, Sami; Alingrin, Julie; Dizier, Stephanie; Brunet, Julie; Forel, Jean-Marie; La Scola, Bernard; Roch, Antoine; Papazian, Laurent; Pauly, Vanessa			Time to Intubation Is Associated with Outcome in Patients with Community-Acquired Pneumonia	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; INFECTIOUS-DISEASES-SOCIETY; NONINVASIVE VENTILATION; ACUTE PHYSIOLOGY; ADMISSION; SEVERITY; EPIDEMIOLOGY; VALIDATION; GUIDELINES; PROGNOSIS	Introduction: It has been suggested that delayed intensive care unit (ICU) transfer is associated with increased mortality for patients with community-acquired pneumonia (CAP). However, ICU admission policies and patient epidemiology vary widely across the world depending on local hospital practices and organizational constraints. We hypothesized that the time from the onset of CAP symptoms to invasive mechanical ventilation could be a relevant prognostic factor. Methods: One hundred patients with a CAP and necessitating invasive mechanical ventilation were included. Prospectively collected data were retrospectively analysed. Two study groups were identified based on the time of the initiation of invasive mechanical ventilation (rapid respiratory failure requiring mechanical ventilation within 72 h of the onset of CAP and progressive respiratory failure requiring invasive mechanical ventilation 4 or more days after the onset of CAP). Results: Excepting more COPD patients in the rapid respiratory failure group and more patients with diabetes in the progressive respiratory failure group, these patients had similar characteristics. The overall in-hospital mortality rate was 28% in the rapid respiratory failure group and 51% in the progressive respiratory failure group (P = 0.03). The ICU and the day 30 mortality rates were higher in the progressive respiratory failure group (47% vs. 23%, P = 0.02; and 37.7% vs. 21.3%, P = 0.03; respectively). After adjusting for the propensity score and other potential confounding factors, progressive respiratory failure remained associated with hospital mortality only after 12 days of invasive mechanical ventilation. Conclusions: This study suggested that the duration or delay in the time to intubation from the onset of CAP symptoms was associated with the outcomes in those patients who ultimately required invasive mechanical ventilation.	[Hraiech, Sami; Alingrin, Julie; Dizier, Stephanie; Forel, Jean-Marie; Roch, Antoine; Papazian, Laurent] Aix Marseille Univ, URMITE CNRS UMR 7278, Marseille, France; [Hraiech, Sami; Alingrin, Julie; Dizier, Stephanie; Forel, Jean-Marie; Roch, Antoine; Papazian, Laurent] Hop Nord Marseille, APHM, Marseille, France; [Brunet, Julie] Direct Rech Clin, Marseille, France; [La Scola, Bernard] Aix Marseille Univ, Fac Med, INSERM U1095, URMITE,UMR CNRS 7278,Inst Rech Dev 198, Marseille, France; [Pauly, Vanessa] Aix Marseille Univ, Lab Sante Publ EA3279, Marseille, France; [Pauly, Vanessa] Hop Sud, APHM, Serv Sante Publ & Informat Med, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Papazian, L (corresponding author), Aix Marseille Univ, URMITE CNRS UMR 7278, Marseille, France.	laurent.papazian@ap-hm.fr	LA SCOLA, Bernard/P-6477-2016	LA SCOLA, Bernard/0000-0001-8006-7704				Angus DC, 2002, AM J RESP CRIT CARE, V166, P717, DOI 10.1164/rccm.2102084; [Anonymous], 2000, MED MALADIES INFECT, V30, P566; Berger P, 2006, EMERG INFECT DIS, V12, P248; Carrillo A, 2012, INTENS CARE MED, V38, P458, DOI 10.1007/s00134-012-2475-6; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Coisel Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051340; Demoule A, 2006, INTENS CARE MED, V32, P1756, DOI 10.1007/s00134-006-0324-1; Yandiola PPE, 2009, CHEST, V135, P1572, DOI 10.1378/chest.08-2179; Ewig S, 1999, Monaldi Arch Chest Dis, V54, P250; Ewig S, 2004, THORAX, V59, P421, DOI 10.1136/thx.2003.008110; Ewig S, 1998, AM J RESP CRIT CARE, V158, P1102, DOI 10.1164/ajrccm.158.4.9803114; Georges H, 1999, INTENS CARE MED, V25, P198, DOI 10.1007/s001340050816; JACKSON GG, 1962, ARCH INTERN MED, V110, P663, DOI 10.1001/archinte.1962.03620230109016; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Kollef MH, 2000, CLIN INFECT DIS, V31, pS131, DOI 10.1086/314079; Labelle AJ, 2010, CHEST, V137, P1130, DOI 10.1378/chest.09-1652; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEROY O, 1995, INTENS CARE MED, V21, P24, DOI 10.1007/BF02425150; Leroy O, 1996, INTENS CARE MED, V22, P1307, DOI 10.1007/BF01709543; Liapikou A, 2009, CLIN INFECT DIS, V48, P377, DOI 10.1086/596307; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marrie TJ, 2007, MEDICINE, V86, P103, DOI 10.1097/MD.0b013e3180421c16; MOINE P, 1994, CHEST, V105, P1487, DOI 10.1378/chest.105.5.1487; Niederman MS, 2012, SEMIN RESP CRIT CARE, V33, P298, DOI 10.1055/s-0032-1315642; Niederman MS, 2004, CURR MED RES OPIN, V20, P969, DOI 10.1185/030079904125003944; Niederman MS, 2002, INTENS CARE MED, V28, P1003, DOI 10.1007/s00134-002-1324-4; Papazian L, N ENGL J MED, V363, P1107; Phua J, 2010, EUR RESPIR J, V36, P826, DOI 10.1183/09031936.00154209; Rello J, 2002, INTENS CARE MED, V28, P1030, DOI 10.1007/s00134-002-1325-3; Rello J, 1996, CLIN INFECT DIS, V23, P723, DOI 10.1093/clinids/23.4.723; Rello J, 2008, CRIT CARE, V12, DOI 10.1186/cc7025; Rello J, 2009, CRIT CARE MED, V37, P456, DOI 10.1097/CCM.0b013e318194b021; Renaud B, 2012, ACAD EMERG MED, V19, P294, DOI 10.1111/j.1553-2712.2012.01301.x; Restrepo MI, 2008, CHEST, V133, P610, DOI 10.1378/chest.07-1456; Restrepo MI, 2010, CHEST, V137, P552, DOI 10.1378/chest.09-1547; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P923, DOI 10.1164/ajrccm.160.3.9901107; TORRES A, 1991, AM REV RESPIR DIS, V144, P312, DOI 10.1164/ajrccm/144.2.312; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	40	14	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74937	10.1371/journal.pone.0074937	http://dx.doi.org/10.1371/journal.pone.0074937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069367	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300056
J	Li, M; Huang, L; Qiu, H; Fu, Q; Li, W; Yu, QQ; Sun, L; Zhang, LH; Hu, GY; Hu, JB; Yuan, XL				Li, Miao; Huang, Liu; Qiu, Hong; Fu, Qiang; Li, Wen; Yu, Qianqian; Sun, Li; Zhang, Lihong; Hu, Guangyuan; Hu, Junbo; Yuan, Xianglin			Helicobacter pylori Infection Synergizes with Three Inflammation-Related Genetic Variants in the GWASs to Increase Risk of Gastric Cancer in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; CYTOSOLIC PHOSPHOLIPASE A(2); PROSTAGLANDIN E-2 SYNTHESIS; SUSCEPTIBILITY LOCI; ENVIRONMENT INTERACTIONS; EPITHELIAL-CELLS; IN-VITRO; POLYMORPHISMS; EXPRESSION	Background: Three recent genome-wide association studies (GWASs) have reported that three SNPs (rs4072037, rs13361707 and rs2274223) located on genes related to host inflammatory response are significantly associated with susceptibility to gastric cancer (GC) in Chinese populations. Helicobacter pylori infection is also an important risk factor for GC through causing inflammatory response in the gastric mucosa. However, no study has established whether there are potential gene-environment interactions between these genetic variants and H. pylori infection to the risk of GC. Methods: We genotyped three polymorphisms (rs4072037 at 1q22, rs13361707 at 5p13, and rs2274223 at 10q23) in 335 Chinese gastric adenocarcinoma patients and 334 controls. H. pylori serology was examined by enzyme-linked immunosorbent assay. Multivariable logistic regression models were used to evaluate the association between the variables and GC risk. Results: We confirmed that the three SNPs (rs4072037, rs13361707 and rs2274223) were significantly associated with GC susceptibility. H. pylori infection also significantly increased the risk of GC. Furthermore, there were joint effects between H. pylori infection and the three SNPs on the risk of GC. The most elevated risk of GC was found in subjects with H. pylori seropositivity and AA genotypes for rs4072037 [ odds ratio (OR), 3.95; 95% confidence interval (CI), 2.29-6.79], H. pylori seropositivity and CT/CC genotypes for rs13361707 (OR, 2.68; 95% CI, 1.62-4.43), H. pylori seropositivity and AG/GG genotypes for rs2274223 (OR, 2.45; 95% CI, 1.55-3.88) compared with those with H. pylori seronegativity and other genotypes of each SNP. Significant interactions were observed between H. pylori seropositivity and the three SNPs (all P-Gx (E) < 0.05) to the risk of GC. Conclusion: These findings indicate that the three SNPs (rs4072037, rs13361707 and rs2274223) identified in the GWASs may interact with H. pylori infection to increase the risk of GC.	[Li, Miao; Huang, Liu; Qiu, Hong; Fu, Qiang; Li, Wen; Yu, Qianqian; Sun, Li; Zhang, Lihong; Hu, Guangyuan; Yuan, Xianglin] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan 430074, Hubei Province, Peoples R China; [Hu, Junbo] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Surg, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yuan, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan 430074, Hubei Province, Peoples R China.	yxl@medmail.com.cn			National Natural Science Foundation of China [81071832, 81272492]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81071832, N0. 81272492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Baccarelli A, 2006, INT J CANCER, V119, P1970, DOI 10.1002/ijc.22075; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Fu SD, 1999, GASTROENTEROLOGY, V116, P1319, DOI 10.1016/S0016-5085(99)70496-8; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029643, 10.1371/journal.pone.0045348]; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Linden S, 2004, BIOCHEM J, V384, P263, DOI 10.1042/BJ20040402; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Luo DW, 2011, J GASTROENTEROL, V46, P1260, DOI 10.1007/s00535-011-0445-3; Mcguckin MA, 2007, GASTROENTEROLOGY, V133, P1210, DOI 10.1053/j.gastro.2007.07.003; Nardone G, 2001, INFECT IMMUN, V69, P5857, DOI 10.1128/IAI.69.9.5857-5863.2001; Ng W, 2008, BRIT J CANCER, V99, P978, DOI 10.1038/sj.bjc.6604617; Obst B, 2000, CARCINOGENESIS, V21, P1111, DOI 10.1093/carcin/21.6.1111; Okuyama T, 2002, J LAB CLIN MED, V140, P92, DOI 10.1067/mlc.2002.125784; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pomorski T, 2001, J BIOL CHEM, V276, P804, DOI 10.1074/jbc.M003819200; Romano M, 1998, J BIOL CHEM, V273, P28560, DOI 10.1074/jbc.273.44.28560; Saeki N, 2011, GASTROENTEROLOGY, V140, P892, DOI 10.1053/j.gastro.2010.10.058; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Silva F, 2003, EUR J HUM GENET, V11, P380, DOI 10.1038/sj.ejhg.5200978; Silva F, 2001, EUR J HUM GENET, V9, P548, DOI 10.1038/sj.ejhg.5200677; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031932; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu HL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-276; Wu MS, 2005, CANCER EPIDEM BIOMAR, V14, P1878, DOI 10.1158/1055-9965.EPI-04-0792; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yang XX, 2012, ASIAN PAC J CANCER P, V13, P2519, DOI 10.7314/APJCP.2012.13.6.2519; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Zeng HM, 2011, CANCER EPIDEM BIOMAR, V20, P2594, DOI 10.1158/1055-9965.EPI-11-0702; Zhang HZ, 2011, CARCINOGENESIS, V32, P848, DOI 10.1093/carcin/bgr051	38	37	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74976	10.1371/journal.pone.0074976	http://dx.doi.org/10.1371/journal.pone.0074976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069371	Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300058
J	Meng, LZ; Martin, K; Weigel, A; Yang, XD				Meng, Ling-Zeng; Martin, Konrad; Weigel, Andreas; Yang, Xiao-Dong			Tree Diversity Mediates the Distribution of Longhorn Beetles (Coleoptera: Cerambycidae) in a Changing Tropical Landscape (Southern Yunnan, SW China)	PLOS ONE			English	Article							DORCADION-FULIGINATOR COLEOPTERA; SAPROXYLIC BEETLES; TEMPERATE FORESTS; SPECIES RICHNESS; BIODIVERSITY; IMPACT; FIRE; XISHUANGBANNA; COMMUNITIES; MANAGEMENT	Longhorn beetles (Coleoptera : Cerambycidae) have been used to identify sites of high biological diversity and conservation value in cultivated landscapes, but were rarely studied in changing landscapes of humid tropics. This study was conducted in a region of southern Yunnan, China, which was dominated by natural rainforest until 30 years ago, but is successively transformed into commercial rubber monoculture plantations since that time. The objectives were to investigate longhorn beetle species diversity and distribution in the major land use types of this landscape and to estimate the effects of an expected expansion of rubber plantations on the longhorn beetle assemblages. The results showed that tree species diversity (181 species in total) and longhorn beetle diversity (220 species in total) were closely related with no significant differences between the tree and longhorn beetles assemblages shown by similarity distance analysis. There was a highly positive relationship between the estimated species richness of longhorn beetles and the number of tree species. Individual numbers of longhorn beetles and trees were also highly positive related at the sampling sites. Non-metric multidimensional scaling revealed that the degree of canopy coverage, succession age and tree diversity explained 78.5% of the total variation in longhorn beetle assemblage composition. Natural forest sites had significantly higher numbers of species and individuals than any other type of habitat. Although young rubber plantations bear the highest longhorn beetle diversity outside forests (half of the total number of longhorn beetle species recorded in total), they can not provide permanent habitats for most of these species, because they develop into closed canopy plantations with less suitable habitat conditions. Therefore, along with an expected expansion of rubber cultivation which largely proceeds at the expense of forest areas, the habitat conditions for longhorn beetles in this region might decrease dramatically in future.	[Meng, Ling-Zeng; Yang, Xiao-Dong] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Yunnan, Peoples R China; [Meng, Ling-Zeng; Martin, Konrad] Univ Hohenheim, Agroecol Trop & Subtrop 380B, Stuttgart, Germany; [Weigel, Andreas] Rosalia Umweltmanagement, Wernburg, Germany	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; University Hohenheim	Meng, LZ (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Yunnan, Peoples R China.	mlz@xtbg.org.cn	Meng, Ling-Zeng/AAF-7916-2019		National Natural Science Foundation of China [NSFC-31200322]; Environment friendly rubber plantation project of Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences; project SURUMER (Sustainable Rubber Cultivation in the Mekong Region); German Federal Ministry of Education and Research (BMBF) program "Sustainable Land Management''	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environment friendly rubber plantation project of Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences; project SURUMER (Sustainable Rubber Cultivation in the Mekong Region); German Federal Ministry of Education and Research (BMBF) program "Sustainable Land Management''(Federal Ministry of Education & Research (BMBF))	This study was supported by National Natural Science Foundation of China (NSFC-31200322). Environment friendly rubber plantation project of Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences also partly funded this study. The work of the second author (K. Martin) was supported by the project SURUMER (Sustainable Rubber Cultivation in the Mekong Region), funded by the German Federal Ministry of Education and Research (BMBF) program "Sustainable Land Management''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga A, 2008, ECOGRAPHY, V31, P263, DOI 10.1111/j.0906-7590.2008.5335.x; Baur B, 2005, BIOL CONSERV, V124, P49, DOI 10.1016/j.biocon.2004.12.011; Baur B, 2002, BIOL CONSERV, V105, P133, DOI 10.1016/S0006-3207(01)00117-3; Bouget C, 2005, FOREST ECOL MANAG, V216, P1, DOI 10.1016/j.foreco.2005.05.037; Buse J, 2008, CONSERV BIOL, V22, P329, DOI 10.1111/j.1523-1739.2007.00880.x; Campbell JW, 2008, FOREST ECOL MANAG, V254, P134, DOI 10.1016/j.foreco.2007.07.032; Cao M, 2006, BIOTROPICA, V38, P306, DOI 10.1111/j.1744-7429.2006.00146.x; Collinge SK, 2001, BIOL CONSERV, V100, P103, DOI 10.1016/S0006-3207(00)00211-1; Colwell RK, 2013, ESTIMATES STAT ESTIM; Corona AM, 2007, J BIOGEOGR, V34, P1008, DOI 10.1111/j.1365-2699.2006.01666.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; HANKS LM, 1993, OECOLOGIA, V95, P22, DOI 10.1007/BF00649502; Hanks LM, 1999, ANNU REV ENTOMOL, V44, P483, DOI 10.1146/annurev.ento.44.1.483; HANSEN AJ, 1991, BIOSCIENCE, V41, P382, DOI 10.2307/1311745; Hjalten J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041100; Holland JD, 2007, BIODIVERS CONSERV, V16, P2599, DOI 10.1007/s10531-006-9066-1; Hu HB, 2008, ENVIRON MONIT ASSESS, V146, P147, DOI 10.1007/s10661-007-0067-7; JAMES FC, 1990, ANNU REV ECOL SYST, V21, P129, DOI 10.1146/annurev.es.21.110190.001021; Jansson N, 2009, J INSECT CONSERV, V13, P399, DOI 10.1007/s10841-008-9187-9; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Lu XT, 2010, J TROP FOR SCI, V22, P260; Maeto K, 2002, BIODIVERS CONSERV, V11, P1919, DOI 10.1023/A:1020849012649; Makino S, 2007, ECOL RES, V22, P372, DOI 10.1007/s11284-007-0359-y; Martikainen P, 2000, BIOL CONSERV, V94, P199, DOI 10.1016/S0006-3207(99)00175-5; McCune B., 2006, PC ORD MULTIVARIATE; Meng LZ, 2012, J INSECT CONSERV, V16, P423, DOI 10.1007/s10841-011-9428-1; Moretti M, 2004, FOREST ECOL MANAG, V187, P85, DOI 10.1016/S0378-1127(03)00314-1; Moretti M, 2004, ECOGRAPHY, V27, P173, DOI 10.1111/j.0906-7590.2004.03660.x; Moretti M, 2010, ECOGRAPHY, V33, P760, DOI 10.1111/j.1600-0587.2009.06172.x; MUONA J, 1994, ANN ZOOL FENN, V31, P109; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Okland B, 1996, BIODIVERS CONSERV, V5, P75, DOI 10.1007/BF00056293; Sugiura S, 2009, J INSECT CONSERV, V13, P377, DOI 10.1007/s10841-008-9185-y; Sugiura S, 2009, BIODIVERS CONSERV, V18, P2101, DOI 10.1007/s10531-009-9575-9; Taki H, 2010, FOREST ECOL MANAG, V259, P607, DOI 10.1016/j.foreco.2009.11.019; Talley TS, 2007, ECOLOGY, V88, P1476, DOI 10.1890/06-0555; TOWNES HENRY, 1962, PROC ENTOMOL SOC WASHINGTON, V64, P253; Ulyshen MD, 2004, FOREST ECOL MANAG, V199, P259, DOI 10.1016/j.foreco.2004.05.046; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; Wermelinger B, 2007, J APPL ENTOMOL, V131, P104, DOI 10.1111/j.1439-0418.2006.01128.x; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Zar J.H., 2010, BIOSTAT ANAL	43	27	31	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75481	10.1371/journal.pone.0075481	http://dx.doi.org/10.1371/journal.pone.0075481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069421	gold, Green Published			2022-12-27	WOS:000324777300082
J	Yin, J; Wang, LM; Yin, N; Tabuchi, A; Kuppe, H; Wolff, G; Kuebler, WM				Yin, Jun; Wang, Liming; Yin, Ning; Tabuchi, Arata; Kuppe, Hermann; Wolff, Gerhard; Kuebler, Wolfgang M.			Vasodilatory Effect of the Stable Vasoactive Intestinal Peptide Analog RO 25-1553 in Murine and Rat Lungs	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; TERM OXYGEN-THERAPY; GAS-EXCHANGE; RECEPTOR AGONIST; NATURAL-HISTORY; NITRIC-OXIDE; MICE LACKING; IN-VITRO; HYPERTENSION; VIP	Rationale: Stable analogs of vasoactive intestinal peptide (VIP) have been proposed as novel line of therapy in chronic obstructive pulmonary disease (COPD) based on their bronchodilatory and anti-inflammatory effects. We speculated that VIP analogs may provide additional benefits in that they exert vasodilatory properties in the lung, and tested this hypothesis in both ex vivo and in vivo models. Methods: In isolated perfused mouse lungs and in an in vivo rat model, pulmonary blood vessels were preconstricted by hypoxia and hemodynamic changes in response to systemic (ex vivo) or inhaled (in vivo) administration of the cyclic VIP analog RO 25-1553 were determined. Results: In mouse lungs, RO 25-1553 reduced intrinsic vascular resistance at normoxia, and attenuated the increase in pulmonary artery pressure in response to acute hypoxia. Consistently, inhalation of RO 25-1553 (1 mg.mL(-1) for 3 min) caused an extensive and sustained (> 60 min) inhibition of the pulmonary arterial pressure increase in response to hypoxia in vivo that was comparable to the effects of inhaled sildenafil. This effect was not attributable to systemic cardiovascular effects of RO 25-1553, but to a lung specific reduction in pulmonary vascular resistance, while cardiac output and systemic arterial hemodynamics remained unaffected. No adverse effects of RO 25-1553 inhalation on pulmonary gas exchange, ventilation-perfusion matching, or lung fluid content were detected. Conclusion: Our findings demonstrate that inhaled delivery of the stable VIP analog RO 25-1553 induces a potent and sustained vasodilatory effect in the pulmonary circulation with no detectable adverse effects. Therapeutic inhalation of RO 25-1553 may provide vascular benefits in addition to its reported anti-inflammatory and bronchodilatory effects in COPD, yet caution is warranted given the overall poor results of vasodilator therapies for pulmonary hypertension secondary to COPD in a series of recent clinical trials.	[Yin, Jun; Wang, Liming] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Jiangsu, Peoples R China; [Yin, Jun; Wang, Liming; Tabuchi, Arata; Kuebler, Wolfgang M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Yin, Jun; Wang, Liming; Yin, Ning; Kuppe, Hermann; Kuebler, Wolfgang M.] German Heart Inst, Inst Anesthesiol, Berlin, Germany; [Yin, Jun; Wang, Liming; Yin, Ning; Kuebler, Wolfgang M.] Charite, Inst Physiol, D-13353 Berlin, Germany; [Wolff, Gerhard] Hoffmann La Roche Ltd, Dept Translat Med, Nutley, NY USA; [Kuebler, Wolfgang M.] Univ Toronto, Dept Surg, Toronto, ON M5S 1A1, Canada; [Kuebler, Wolfgang M.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A1, Canada	Jiangsu University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; University of Toronto	Kuebler, WM (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	kueblerw@smh.ca		Wolff MD|PhD, Gerhard/0000-0002-4458-0700; Kuebler, Wolfgang/0000-0003-4100-2961	Hoffmann-La Roche Ltd.	Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	The present work was supported by Hoffmann-La Roche Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco I, 2013, EUR RESP J; Blanco I, 2010, AM J RESP CRIT CARE, V181, P270, DOI 10.1164/rccm.200907-0988OC; Boeck L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052248; BOLIN DR, 1995, BIOPOLYMERS, V37, P57, DOI 10.1002/bip.360370203; Bull T, 2012, COPD, V9, P211, DOI 10.3109/15412555.2012.683966; BURROWS B, 1972, NEW ENGL J MED, V286, P912, DOI 10.1056/NEJM197204272861703; Busto R, 2000, PEPTIDES, V21, P265, DOI 10.1016/S0196-9781(99)00202-8; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Chatila Wissam M, 2008, Proc Am Thorac Soc, V5, P549, DOI 10.1513/pats.200709-148ET; Christensen CC, 2004, EUR RESPIR J, V24, P580, DOI 10.1183/09031936.04.00118303; Cuttica MJ, 2010, RESP MED, V104, P1877, DOI 10.1016/j.rmed.2010.05.009; Dehler M, 2006, EUR RESPIR J, V27, P600, DOI 10.1183/09031936.06.00061505; Dernaika TA, 2010, RESPIRATION, V79, P377, DOI 10.1159/000242498; Dewit D, 1998, IMMUNOL LETT, V60, P57, DOI 10.1016/S0165-2478(97)00129-6; DEY RD, 1981, CELL TISSUE RES, V220, P231; DOMSCHKE S, 1978, GUT, V19, P1049, DOI 10.1136/gut.19.11.1049; Dreher M, 2009, RESPIRATION, V78, P154, DOI 10.1159/000187717; Falk Jeremy A, 2008, Proc Am Thorac Soc, V5, P543, DOI 10.1513/pats.200708-142ET; FENN WO, 1946, AM J PHYSIOL, V146, P637, DOI 10.1152/ajplegacy.1946.146.5.637; Galie N, 2010, AM J RESP CRIT CARE, V181, pA2516; GHATEI MA, 1982, ENDOCRINOLOGY, V111, P1248, DOI 10.1210/endo-111-4-1248; Groneberg DA, 2006, EUR J PHARMACOL, V533, P182, DOI 10.1016/j.ejphar.2005.12.055; HAMASAKI Y, 1983, T ASSOC AM PHYSICIAN, V96, P406; HASSAN M, 1994, NUCL MED BIOL, V21, P865, DOI 10.1016/0969-8051(94)90166-X; Hegewald MJ, 2009, CHEST, V135, P536, DOI 10.1378/chest.08-1515; Hentschel T, 2007, ANESTHESIOLOGY, V106, P124, DOI 10.1097/00000542-200701000-00021; Hurdman J, 2013, EUR RESPIR J, V41, P1292, DOI 10.1183/09031936.00079512; Ichinose F, 2001, CRIT CARE MED, V29, P1000, DOI 10.1097/00003246-200105000-00024; Kallstrom BL, 2001, EUR J PHARMACOL, V430, P335, DOI 10.1016/S0014-2999(01)01299-7; Kessler R, 2001, AM J RESP CRIT CARE, V164, P219, DOI 10.1164/ajrccm.164.2.2006129; Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191; Leuchte HH, 2008, EUR RESPIR J, V32, P1289, DOI 10.1183/09031936.00050008; Linden A, 2003, THORAX, V58, P217, DOI 10.1136/thorax.58.3.217; LINEHAN JH, 1992, J APPL PHYSIOL, V73, P987, DOI 10.1152/jappl.1992.73.3.987; Lovering AT, 2008, J APPL PHYSIOL, V104, P1418, DOI 10.1152/japplphysiol.00208.2007; LUNDBERG JM, 1984, PEPTIDES, V5, P593, DOI 10.1016/0196-9781(84)90090-1; Marino WD, 2006, CHEST, V130, p178S, DOI 10.1378/chest.130.4_MeetingAbstracts.178S-c; Minai OA, 2010, CHEST, V137, p39S, DOI 10.1378/chest.10-0087; MINKES RK, 1992, AM J PHYSIOL, V263, pH1659, DOI 10.1152/ajpheart.1992.263.6.H1659; MORICE A, 1983, LANCET, V2, P1225; NANDIWADA PA, 1985, J APPL PHYSIOL, V58, P1723, DOI 10.1152/jappl.1985.58.5.1723; ODONNELL M, 1994, J PHARMACOL EXP THER, V270, P1282; ODONNELL M, 1994, J PHARMACOL EXP THER, V270, P1289; Olschewski H, 2001, J LAB CLIN MED, V138, P287, DOI 10.1067/mlc.2001.119329; Onoue S, 2008, N-S ARCH PHARMACOL, V377, P579, DOI 10.1007/s00210-007-0232-0; Onoue S, 2007, PEPTIDES, V28, P1640, DOI 10.1016/j.peptides.2007.04.009; OSWALDMAMMOSSER M, 1991, RESPIRATION, V58, P304; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; PAUL S, 1987, J BIOL CHEM, V262, P158; PETERSON BT, 1982, J APPL PHYSIOL, V52, P1661, DOI 10.1152/jappl.1982.52.6.1661; Petkov V, 2003, J CLIN INVEST, V111, P1339, DOI 10.1172/JCI200317500; Rietema H, 2008, EUR RESPIR J, V31, P759, DOI 10.1183/09031936.00114207; SAGA T, 1984, T ASSOC AM PHYSICIAN, V97, P304; Said SI, 2007, CIRCULATION, V115, P1260, DOI 10.1161/CIRCULATIONAHA.106.681718; Said SI, 2006, AM J PHYSIOL-LUNG C, V291, pL547, DOI 10.1152/ajplung.00546.2005; Said SI, 2012, AM J RESP CRIT CARE, V185, P786, DOI 10.1164/ajrccm.185.7.786; Said SI, 2008, ANN NY ACAD SCI, V1144, P148, DOI 10.1196/annals.1418.014; SAID SI, 1991, ANN NY ACAD SCI, V629, P305; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; Schmidt DT, 2001, N-S ARCH PHARMACOL, V364, P314; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sims MW, 2009, CHEST, V136, P412, DOI 10.1378/chest.08-2739; Spohr F, 2007, ANESTHESIOLOGY, V107, P597; Stolz D, 2008, EUR RESPIR J, V32, P619, DOI 10.1183/09031936.00011308; Szema AM, 2006, AM J PHYSIOL-LUNG C, V291, pL880, DOI 10.1152/ajplung.00499.2005; Tabuchi A, 2008, J APPL PHYSIOL, V104, P338, DOI 10.1152/japplphysiol.00348.2007; Tannu SA, 2010, BRIT J PHARMACOL, V161, P1329, DOI 10.1111/j.1476-5381.2010.00975.x; Thabut G, 2005, CHEST, V127, P1531, DOI 10.1378/chest.127.5.1531; Urban N, 2012, CELL CALCIUM, V51, P194, DOI 10.1016/j.ceca.2012.01.001; USDIN TB, 1994, ENDOCRINOLOGY, V135, P2662, DOI 10.1210/en.135.6.2662; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507; Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420; Vizza CD, 1998, CHEST, V113, P576, DOI 10.1378/chest.113.3.576; WEITZENBLUM E, 1985, AM REV RESPIR DIS, V131, P493, DOI 10.1164/arrd.1985.131.4.493; WHAYNE TF, 1968, J APPL PHYSIOL, V25, P729, DOI 10.1152/jappl.1968.25.6.729; Yin N, 2009, CRIT CARE MED, V37, P980, DOI 10.1097/CCM.0b013e3181962ce6; Yoshida M, 1997, AM J RESP CRIT CARE, V155, P526, DOI 10.1164/ajrccm.155.2.9032189; Zhao L, 2001, CIRCULATION, V104, P424, DOI 10.1161/hc2901.093117	78	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75861	10.1371/journal.pone.0075861	http://dx.doi.org/10.1371/journal.pone.0075861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069452	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300099
J	Daniel, C; Roupioz, Y; Gasparutto, D; Livache, T; Buhot, A				Daniel, Camille; Roupioz, Yoann; Gasparutto, Didier; Livache, Thierry; Buhot, Arnaud			Solution-Phase vs Surface-Phase Aptamer-Protein Affinity from a Label-Free Kinetic Biosensor	PLOS ONE			English	Article							NONEQUILIBRIUM CAPILLARY-ELECTROPHORESIS; PLASMON RESONANCE; EQUILIBRIUM MIXTURES; HUMAN THROMBIN; DNA; BINDING; MOLECULES; LIGANDS; IMMOBILIZATION; HETEROGENEITY	Aptamers are selected DNA ligands that target biomolecules such as proteins. In recent years, they are showing an increasing interest as potential therapeutic agents or recognition elements in biosensor applications. In both cases, the need for characterizing the mating between the target and the aptamer either in solution or immobilized on a surface, is pressing. In this context, we have developed a kinetic biosensor made of micro-arrayed anti-thrombin aptamers to assess the kinetic parameters of this interaction. The binding of label-free thrombin on the biosensor was monitored in real-time by Surface Plasmon Resonance imaging. Remarkable performances were obtained for the quantification of thrombin without amplification (sub-nanomolar limit of detection and linear range of quantification to two orders of magnitude). The independent determinations of both the solution- and surface-phase affinities, respectively K-D(Sol) and K-D(Surf), revealed distinct values illustrating the importance of probes, targets or surface interactions in biosensors. Interestingly, K-D(Surf) values depend on the aptamer grafting density and linearly extrapolate towards K-D(Sol) for highly diluted probes. This suggests a lesser impact of the surface compared to the probe or target cooperativity interactions since the latter decrease with a reduced grafting density.	[Daniel, Camille; Roupioz, Yoann; Livache, Thierry; Buhot, Arnaud] UMR 5819 CEA CNRS UJF, Lab Struct & Proprietes Architectures Mol, Inst Nanosci & Cryogenie, Grenoble, France; [Gasparutto, Didier] UMR E3 CEA UJF, Serv Chim Inorgan & Biol, Inst Nanosci & Cryogenie, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Buhot, A (corresponding author), UMR 5819 CEA CNRS UJF, Lab Struct & Proprietes Architectures Mol, Inst Nanosci & Cryogenie, Grenoble, France.	arnaud.buhot@cea.fr	Buhot, Arnaud/O-5085-2019	Buhot, Arnaud/0000-0001-7643-4305	DSM-DRT/CEA Flagship Program; A3DN Project; Labex ARCANE program [ANR-11-LABX-0003-01]	DSM-DRT/CEA Flagship Program; A3DN Project; Labex ARCANE program	This work was partially supported by the DSM-DRT/CEA Flagship Program, "A3DN Project" and by the Labex ARCANE program (ANR-11-LABX-0003-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezovski M, 2005, J AM CHEM SOC, V127, P3165, DOI 10.1021/ja042394q; Berezovski M, 2003, ANAL CHEM, V75, P1382, DOI 10.1021/ac026214b; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; Daniel C, 2013, BIOSENS BIOELECTRON, V40, P186, DOI 10.1016/j.bios.2012.07.016; Drolet DW, 1996, NAT BIOTECHNOL, V14, P1021, DOI 10.1038/nbt0896-1021; Edwards PR, 1997, ANAL BIOCHEM, V246, P1, DOI 10.1006/abio.1996.9922; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; Ho HA, 2004, J AM CHEM SOC, V126, P1384, DOI 10.1021/ja037289f; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Jayasena SD, 1999, CLIN CHEM, V45, P1628; KARLSSON R, 1993, J IMMUNOL METHODS, V166, P75, DOI 10.1016/0022-1759(93)90330-A; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Lee Y, 2012, J AM CHEM SOC, V134, P17448, DOI 10.1021/ja308437h; Levicky R, 2005, TRENDS BIOTECHNOL, V23, P143, DOI 10.1016/j.tibtech.2005.01.004; Li YL, 2008, ELECTROPHORESIS, V29, P2570, DOI 10.1002/elps.200700798; Lin PH, 2011, COLLOID SURFACE B, V88, P552, DOI 10.1016/j.colsurfb.2011.07.032; Lubin AA, 2010, ACCOUNTS CHEM RES, V43, P496, DOI 10.1021/ar900165x; Milgram S, 2012, METHODS, V56, P326, DOI 10.1016/j.ymeth.2011.10.016; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Olmsted IR, 2011, ANAL CHEM, V83, P8867, DOI 10.1021/ac202823m; OShannessy DJ, 1996, ANAL BIOCHEM, V236, P275, DOI 10.1006/abio.1996.0167; Ostatna V, 2008, ANAL BIOANAL CHEM, V391, P1861, DOI 10.1007/s00216-008-2133-6; Potyrailo RA, 1998, ANAL CHEM, V70, P3419, DOI 10.1021/ac9802325; Rao AN, 2012, ANAL CHEM, V84, P9379, DOI 10.1021/ac302165h; Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164; Rotem D, 2012, J AM CHEM SOC, V134, P2781, DOI 10.1021/ja2105653; Salvi N, 2012, J AM CHEM SOC, V134, P11076, DOI 10.1021/ja303301w; Scarano S, 2010, BIOSENS BIOELECTRON, V25, P957, DOI 10.1016/j.bios.2009.08.039; Schuck P, 1997, CURR OPIN BIOTECH, V8, P498, DOI 10.1016/S0958-1669(97)80074-2; Song SP, 2008, TRAC-TREND ANAL CHEM, V27, P108, DOI 10.1016/j.trac.2007.12.004; Steel AB, 2000, BIOPHYS J, V79, P975, DOI 10.1016/S0006-3495(00)76351-X; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vijayendran RA, 2001, ANAL CHEM, V73, P471, DOI 10.1021/ac000523p; Wolf LK, 2007, J AM CHEM SOC, V129, P10503, DOI 10.1021/ja072401l; Zhang DP, 2011, J AM CHEM SOC, V133, P9188, DOI 10.1021/ja202141y; Zhao Q, 2008, ANAL CHEM, V80, P7586, DOI 10.1021/ac801206s; Zhu ZY, 2012, ANAL CHEM, V84, P7203, DOI 10.1021/ac301552e	40	35	34	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75419	10.1371/journal.pone.0075419	http://dx.doi.org/10.1371/journal.pone.0075419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069412	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300082
J	McLeod, DD; Beard, DJ; Parsons, MW; Levi, CR; Calford, MB; Spratt, NJ				McLeod, Damian D.; Beard, Daniel J.; Parsons, Mark W.; Levi, Christopher R.; Calford, Mike B.; Spratt, Neil J.			Inadvertent Occlusion of the Anterior Choroidal Artery Explains Infarct Variability in the Middle Cerebral Artery Thread Occlusion Stroke Model	PLOS ONE			English	Article							SUTURE; RATS	Intraluminal occlusion of the middle cerebral artery (MCAo) in rodents is perhaps the most widely used model of stroke, however variability of infarct volume and the ramifications of this on sample sizes remains a problem, particularly for preclinical testing of potential therapeutics. Our data and that of others, has shown a dichotomous distribution of infarct volumes for which there had previously been no clear explanation. When studying perfusion computed tomography cerebral blood volume (CBV) maps obtained during intraluminal MCAo in rats, we observed inadvertent occlusion of the anterior choroidal artery (AChAo) in a subset of animals. We hypothesized that the combined occlusion of the MCA and AChA may be a predictor of larger infarct volume following stroke. Thus, we aimed to determine the correlation between AChAo and final infarct volume in rats with either temporary or permanent MCA occlusion (1 h, 2 h, or permanent MCAo). Outbred Wistar rats (n = 28) were imaged prior to and immediately following temporary or permanent middle cerebral artery occlusion. Presence of AChAo on CBV maps was shown to be a strong independent predictor of 24 h infarct volume (beta = 0.732, p < 0.001). This provides an explanation for the previously observed dichotomous distribution of infarct volumes. Interestingly, cortical infarct volumes were also larger in rats with AChAo, although the artery does not supply cortex. This suggests an important role for perfusion of the MCA territory beyond the proximal occlusion through AChA-MCA anastomotic collateral vessels in animals with a patent AChAo. Identification of combined MCAo and AChAo will allow other investigators to tailor their stroke model to reduce variability in infarct volumes, improve statistical power and reduce sample sizes in preclinical stroke research.	[McLeod, Damian D.; Beard, Daniel J.; Parsons, Mark W.; Levi, Christopher R.; Calford, Mike B.; Spratt, Neil J.] Univ Newcastle, Callaghan, NSW 2308, Australia; [McLeod, Damian D.; Beard, Daniel J.; Parsons, Mark W.; Levi, Christopher R.; Calford, Mike B.; Spratt, Neil J.] Hunter Med Res Inst, Callaghan, NSW, Australia; [Parsons, Mark W.; Levi, Christopher R.; Spratt, Neil J.] Hunter New England Local Hlth Dist, New Lambton Hts, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	McLeod, DD (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Damian.McLeod@newcastle.edu.au	Parsons, Mark W./G-3750-2014; MCLEOD, DAMIAN/G-7704-2013; Spratt, Neil J/K-4208-2012; Beard, Daniel/AAP-1258-2020	MCLEOD, DAMIAN/0000-0002-1297-8984; Spratt, Neil J/0000-0002-9023-6177; Beard, Daniel/0000-0002-3720-7588; Levi, Christopher/0000-0002-9474-796X; Calford, Mike/0000-0002-5727-0234	National Health and Medical Research Council (NHMRC, Australia) [454417]; National Stroke Foundation (Australia) [2008-09/]; Hunter Medical Research Institute Stroke Research Project Grant [G0189810]; Greater Building Society; NHMRC [455632]	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Stroke Foundation (Australia); Hunter Medical Research Institute Stroke Research Project Grant; Greater Building Society; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC, Australia), Program Grant, #454417 (www.nhmrc.gov.au); the National Stroke Foundation (Australia), Small Project Grant (http://strokefoundation.com.au/research/research-grants-2008-09/); the Hunter Medical Research Institute Stroke Research Project Grant (Grant #G0189810) (www.newcastle.edu.au); and from funds donated by the Greater Building Society (http://www.greater.com.au). N. Spratt received a NHMRC training fellowship, #455632 (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham H, 2002, EXP BRAIN RES, V142, P131, DOI 10.1007/s00221-001-0909-4; COYLE P, 1984, STROKE, V15, P711, DOI 10.1161/01.STR.15.4.711; COYLE P, 1975, EXP NEUROL, V49, P671, DOI 10.1016/0014-4886(75)90051-5; GHIKA JA, 1990, ARCH NEUROL-CHICAGO, V47, P1097, DOI 10.1001/archneur.1990.00530100063014; Guan YJ, 2012, STROKE, V43, P888, DOI 10.1161/STROKEAHA.111.636456; He Z, 2000, J NEUROL SCI, V182, P16, DOI 10.1016/S0022-510X(00)00434-2; Letourneur A, 2011, J CEREBR BLOOD F MET, V31, P504, DOI 10.1038/jcbfm.2010.118; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Ma JY, 2006, J NEUROSCI METH, V156, P76, DOI 10.1016/j.jneumeth.2006.02.006; McLeod DD, 2011, INT J STROKE, V6, P284, DOI 10.1111/j.1747-4949.2010.00564.x; McLeod DD, 2013, INT J STROK IN PRESS; OLIFF HS, 1995, BRAIN RES, V675, P20, DOI 10.1016/0006-8993(95)00033-M; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Rewell SSJ, 2010, J CEREBR BLOOD F MET, V30, P729, DOI 10.1038/jcbfm.2009.273; Riva M, 2012, EXP NEUROL, V233, P815, DOI 10.1016/j.expneurol.2011.12.006; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; Spratt NJ, 2006, J NEUROSCI METH, V155, P285, DOI 10.1016/j.jneumeth.2006.01.020; Takano K, 1997, J NEUROL SCI, V153, P8, DOI 10.1016/S0022-510X(97)00184-6; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39	19	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75779	10.1371/journal.pone.0075779	http://dx.doi.org/10.1371/journal.pone.0075779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069448	Green Published, gold			2022-12-27	WOS:000324547300094
J	Yang, JN; Seluanov, A; Gorbunova, V				Yang, Jiang-Nan; Seluanov, Andrei; Gorbunova, Vera			Mitochondrial Inverted Repeats Strongly Correlate with Lifespan: mtDNA Inversions and Aging	PLOS ONE			English	Article							DNA MUTATIONS; SACCHAROMYCES-CEREVISIAE; PODOSPORA-ANSERINA; DELETIONS; MICE; ABUNDANT; GENE	Mitochondrial defects are implicated in aging and in a multitude of age-related diseases, such as cancer, heart failure, Parkinson's disease, and Huntington's disease. However, it is still unclear how mitochondrial defects arise under normal physiological conditions. Mitochondrial DNA (mtDNA) deletions caused by direct repeats (DRs) are implicated in the formation of mitochondrial defects, however, mitochondrial DRs show relatively weak (Pearson's r = -0.22, p<0.002; Spearman's rho = -0.12, p = 0.1) correlation with maximum lifespan (MLS). Here we report a stronger correlation (Pearson's r = -0.55, p<10(-16); Spearman's rho = -0.52, p<10(-14)) between mitochondrial inverted repeats (IRs) and lifespan across 202 species of mammals. We show that, in wild type mice under normal conditions, IRs cause inversions, which arise by replication-dependent mechanism. The inversions accumulate with age in the brain and heart. Our data suggest that IR-mediated inversions are more mutagenic than DR-mediated deletions in mtDNA, and impose stronger constraint on lifespan. Our study identifies IR-induced mitochondrial genome instability during mtDNA replication as a potential cause for mitochondrial defects.	[Yang, Jiang-Nan; Seluanov, Andrei; Gorbunova, Vera] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Seluanov, A (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	andrei.seluanov@rochester.edu; vera.gorbunova@rochester.edu		Gorbunova, Vera/0000-0001-8979-0333; Seluanov, Andrei/0000-0003-3400-538X	US National Institutes of Health [AG027237, AG031227]; Ellison Medical Foundation [AG-SS-2275-09]; NATIONAL INSTITUTE ON AGING [R01AG031227, R01AG027237] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the grants from the US National Institutes of Health AG027237, AG031227 (www.nih.gov) and Ellison Medical Foundation AG-SS-2275-09 (www.ellisonfoundation.org) to V. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028; Bi X, 1996, P NATL ACAD SCI USA, V93, P819, DOI 10.1073/pnas.93.2.819; Bodyak ND, 2001, HUM MOL GENET, V10, P17, DOI 10.1093/hmg/10.1.17; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006; Khaidakov M, 2006, MECH AGEING DEV, V127, P808, DOI 10.1016/j.mad.2006.07.008; Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434; Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445; Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x; Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007; Kovalenko SA, 1997, BIOCHEM BIOPH RES CO, V232, P147, DOI 10.1006/bbrc.1997.6251; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; KUCK U, 1985, CURR GENET, V9, P373, DOI 10.1007/BF00421608; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Lee HC, 2007, EXP BIOL MED, V232, P592; LINNANE AW, 1990, BIOCHEM INT, V22, P1067; Lobachev KS, 1998, GENETICS, V148, P1507; MADSEN CS, 1993, P NATL ACAD SCI USA, V90, P7671, DOI 10.1073/pnas.90.16.7671; Mammucari C, 2010, MECH AGEING DEV, V131, P536, DOI 10.1016/j.mad.2010.07.003; Osiewacz Heinz D, 2013, Methods Mol Biol, V965, P439, DOI 10.1007/978-1-62703-239-1_29; Osiewacz HD, 2011, BIOCHEM SOC T, V39, P1488, DOI 10.1042/BST0391488; Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Phadnis N, 2005, GENETICS, V171, P1549, DOI 10.1534/genetics.105.047092; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Samuels DC, 2004, TRENDS GENET, V20, P226, DOI 10.1016/j.tig.2004.03.003; SCHOFIELD MA, 1992, GENETICS, V132, P295; Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132; Thomas C A Jr, 1966, Prog Nucleic Acid Res Mol Biol, V5, P315, DOI 10.1016/S0079-6603(08)60237-8; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012	36	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73318	10.1371/journal.pone.0073318	http://dx.doi.org/10.1371/journal.pone.0073318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069185	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300008
J	Belghit, I; Panserat, S; Sadoul, B; Dias, K; Skiba-Cassy, S; Seiliez, I				Belghit, Ikram; Panserat, Stephane; Sadoul, Bastien; Dias, Karine; Skiba-Cassy, Sandrine; Seiliez, Iban			Macronutrient Composition of the Diet Affects the Feeding-Mediated Down Regulation of Autophagy in Muscle of Rainbow Trout (O. mykiss)	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; IN-VITRO ASSESSMENT; DEPENDENT PROTEOLYSIS; PROTEIN-TURNOVER; CELL-SURVIVAL; GLUCOSE; EXPRESSION; FOXO3; AMPK; VIVO	Autophagy functions as an important catabolic mechanism by mediating the turnover of intracellular organelles and protein complexes through a lysosome dependent degradative pathway. Although the induction of autophagy by starvation has been extensively studied, we still know very little about how autophagy is regulated under normal nutritional conditions. The purpose of the present study was to characterize both in vivo and in vitro the response of the autophagylysosomal degradative pathway to nutrient (amino acids and carbohydrates) availability in the muscle of the carnivorous rainbow trout. We report that meal feeding is accompanied by a rapid activation of Akt, FoxO1 and the Target of Rapamycin (TOR) signaling pathways and a concomitant decrease of autophagosome formation. We also show that this effect occurs only when the proportion of dietary proteins increases at the expense of carbohydrates. Concurrently, our in vitro study on primary culture of trout muscle cells demonstrates an opposite effect of amino acids and glucose on the regulation of autophagy-lysosomal pathways. More specifically, the addition of amino acids in cell culture medium inhibited the formation of autophagosomes, whereas the addition of glucose had an opposite effect. The effect of amino acids was accompanied by an activation of TOR, considered as an important regulator of autophagosomal formation. However, the mechanisms involved in the effect of glucose were independent of Akt, TOR and AMPK and remain to be determined. Together, these results demonstrated the specific role of macronutrients as well as that of their interactions in the regulation of autophagy and highlight the interest to consider the macronutrient composition of the diets in the control of this degradative pathway.	[Belghit, Ikram; Panserat, Stephane; Sadoul, Bastien; Dias, Karine; Skiba-Cassy, Sandrine; Seiliez, Iban] INRA, Nutr Metab Aquaculture UR1067, St Pee Sur Nivelle, France	INRAE; Universite de Pau et des Pays de l'Adour	Seiliez, I (corresponding author), INRA, Nutr Metab Aquaculture UR1067, St Pee Sur Nivelle, France.	seiliez@st-pee.inra.fr		Sadoul, Bastien/0000-0001-5968-3983; Panserat, Stephane/0000-0002-4479-9868	European Union [288925]	European Union(European Commission)	This study was supported by the European Union 7th Framework project (Project Call Identifier: FP7-KBBE-2011-5, Project Number: 288925, Advanced Research Initiatives for Nutrition & Aquaculture (ARRAINA)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attaix D, 1998, ADV MOL CEL, V27, P235, DOI 10.1016/S1569-2558(08)60463-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cuervo AM, 2012, MOL ASPECTS MED, V33, P2, DOI 10.1016/j.mam.2011.09.001; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Duan X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019532; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Moruno-Manchon JF, 2013, BIOCHEM J, V449, P497, DOI 10.1042/BJ20121122; Ghislat G, 2012, J BIOL CHEM, V287, P38625, DOI 10.1074/jbc.M112.365767; Grumati P, 2011, AUTOPHAGY, V7, P426, DOI 10.4161/auto.7.4.14392; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kamalam BS, 2012, J EXP BIOL, V215, P2567, DOI 10.1242/jeb.070581; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kawahito S, 2009, WORLD J GASTROENTERO, V15, P4137, DOI 10.3748/wjg.15.4137; Kee AJ, 2003, J PHYSIOL-LONDON, V546, P765, DOI 10.1113/jphysiol.2002.032367; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kobayashi S, 2012, AUTOPHAGY, V8, P577, DOI 10.4161/auto.18980; Kumamoto T, 2000, ACTA NEUROPATHOL, V100, P595, DOI 10.1007/s004010000229; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lee Youngjeon, 2012, Lab Anim Res, V28, P171, DOI 10.5625/lar.2012.28.3.171; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martinet W, 2005, BIOTECHNOL LETT, V27, P1157, DOI 10.1007/s10529-005-0007-y; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Moon TW, 2001, COMP BIOCHEM PHYS B, V129, P243, DOI 10.1016/S1096-4959(01)00316-5; MOORE S, 1968, J BIOL CHEM, V243, P6281; Mordier S, 2000, J BIOL CHEM, V275, P29900, DOI 10.1074/jbc.M003633200; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Polakof S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020228; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; Seiliez I, 2008, J NUTR, V138, P487, DOI 10.1093/jn/138.3.487; Seiliez I, 2012, AUTOPHAGY, V8, P364, DOI 10.4161/auto.18863; Seiliez I, 2011, GEN COMP ENDOCR, V172, P363, DOI 10.1016/j.ygcen.2011.03.026; Seiliez I, 2010, COMP BIOCHEM PHYS B, V157, P258, DOI 10.1016/j.cbpb.2010.06.011; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Vingtdeux V, 2011, FASEB J, V25, P219, DOI 10.1096/fj.10-167361; Yabu T, 2012, MAR BIOTECHNOL, V14, P491, DOI 10.1007/s10126-012-9432-9; Yan J, 2012, J NUTR BIOCHEM, V23, P716, DOI 10.1016/j.jnutbio.2011.03.014; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	60	17	19	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74308	10.1371/journal.pone.0074308	http://dx.doi.org/10.1371/journal.pone.0074308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069294	Green Published, gold			2022-12-27	WOS:000326240100100
J	Delatorre, E; Couto-Fernandez, JC; Guimaraes, ML; Cardoso, LPV; de Alcantara, KC; Stefani, MMD; Romero, H; Freire, CCM; Iamarino, A; Zanotto, PMD; Morgado, MG; Bello, G				Delatorre, Edson; Couto-Fernandez, Jose C.; Guimaraes, Monick Lindenmayer; Vaz Cardoso, Ludimila Paula; de Alcantara, Keila Correia; de Araujo Stefani, Mariane Martins; Romero, Hector; Freire, Caio C. M.; Iamarino, Atila; Zanotto, Paolo M. de A.; Morgado, Mariza G.; Bello, Gonzalo			Tracing the Origin and Northward Dissemination Dynamics of HIV-1 Subtype C in Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; ANTIRETROVIRAL DRUG-RESISTANCE; MODERATE PREVALENCE; PREGNANT-WOMEN; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; MATO-GROSSO; SAO-PAULO; TYPE-1	Previous studies indicate that the HIV-1 subtype C epidemic in southern Brazil was initiated by the introduction of a single founder strain probably originating from east Africa. However, the exact country of origin of such a founder strain as well as the origin of the subtype C viruses detected outside the Brazilian southern region remains unknown. HIV-1 subtype C pol sequences isolated in the southern, southeastern and central-western Brazilian regions (n = 209) were compared with a large number (n similar to 2,000) of subtype C pol sequences of African origin. Maximum-likelihood analyses revealed that most HIV-1 subtype C Brazilian sequences branched in a single monophyletic clade (CBR-I), nested within a larger monophyletic lineage characteristic of east Africa. Bayesian analyses indicate that the CBR-I clade most probably originated in Burundi and was introduced into the Parana state (southern region) around the middle 1970s, after which it rapidly disseminated to neighboring regions. The states of Parana and Santa Catarina have been the most important hubs of subtype C dissemination, and routine travel and spatial accessibility seems to have been the major driving forces of this process. Five additional introductions of HIV-1 subtype C strains probably originated in eastern (n = 2), southern (n = 2) and central (n = 1) African countries were detected in the Rio de Janeiro state (southeastern region). These results indicate a continuous influx of HIV-1 subtype C strains of African origin into Brazil and also unveil the existence of unrecognized transmission networks linking this country to east Africa.	[Delatorre, Edson; Couto-Fernandez, Jose C.; Guimaraes, Monick Lindenmayer; Morgado, Mariza G.; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil; [Vaz Cardoso, Ludimila Paula; de Alcantara, Keila Correia; de Araujo Stefani, Mariane Martins] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Romero, Hector] Univ Republica, Fac Ciencias, Secc Biomatemat, Lab Org & Evoluc Genoma, Montevideo, Uruguay; [Freire, Caio C. M.; Iamarino, Atila; Zanotto, Paolo M. de A.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Lab Evolucao Mol & Bioinformat, BR-05508 Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Goias; Universidad de la Republica, Uruguay; Universidade de Sao Paulo	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	gbellobr@gmail.com	de A. Zanotto, Paolo M./B-9286-2019; Freire, Caio/C-8248-2014; Bello, Gonzalo/E-6842-2013; Bentancor, Gonzalo Jose Bello/N-7377-2019; Delatorre, Edson/J-8330-2015	de A. Zanotto, Paolo M./0000-0002-8167-0625; Freire, Caio/0000-0002-7723-4230; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Delatorre, Edson/0000-0002-5746-0820; Iamarino, Atila/0000-0003-3904-0248; Couto-Fernandez, Jose Carlos/0000-0001-7091-9774; ALCANTARA, KEILA CORREIA/0000-0002-4477-2833	FAPERJ [E-26/111.758/2012]; CNPq [472896/2012-1]	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Public Health Service grants E-26/111.758/2012 from the FAPERJ and 472896/2012-1 from the CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara KC, 2013, J MED VIROL, V85, P396, DOI 10.1002/jmv.23474; Alcantara KC, 2012, J CLIN VIROL, V54, P15, DOI 10.1016/j.jcv.2012.01.011; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2014, TRACER V1 6; Archer J, 2007, AIDS, V21, P1693, DOI 10.1097/QAD.0b013e32825eabd0; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035649; Bello G, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/154945; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Brigido LFM, 2011, AIDS RES HUM RETROV, V27, P339, DOI 10.1089/aid.2010.0157; Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]; Veras NMC, 2011, J GEN VIROL, V92, P1698, DOI 10.1099/vir.0.028951-0; Couto-Fernandez JC, 2006, AIDS RES HUM RETROV, V22, P207, DOI 10.1089/aid.2006.22.207; Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014; da Silveira AA, 2012, AIDS RES HUM RETROV, V28, P304, DOI 10.1089/aid.2011.0128; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; de Sa DJ, 2008, AIDS RES HUM RETROV, V24, P347, DOI 10.1089/aid.2007.0203; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Delatorre EO, 2012, AIDS RES HUM RETROV, V28, P1369, DOI 10.1089/aid.2011.0381; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ferreira AS, 2011, J MED VIROL, V83, P1301, DOI 10.1002/jmv.22128; Fontella R, 2008, AIDS, V22, P2001, DOI 10.1097/QAD.0b013e3283108f69; FRANSEN S, 2010, PAPER SERIES MIGRATI; Graf T, 2013, VIROLOGY, V435, P170, DOI 10.1016/j.virol.2012.08.048; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Morgado MG, 1998, J ACQ IMMUN DEF SYND, V18, P488, DOI 10.1097/00042560-199808150-00011; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pilotto JH, 2013, AIDS RES HUM RETROV, V29, P681, DOI [10.1089/aid.2011.0333, 10.1089/AID.2011.0333]; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, FIGTREE V1 3 1 TREE; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Team RC, 2012, R LANG ENV STAT COMP; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Cardoso LPV, 2011, AIDS RES HUM RETROV, V27, P1349, DOI 10.1089/aid.2011.0153; Cardoso LPV, 2010, J MED VIROL, V82, P351, DOI 10.1002/jmv.21722; Cardoso LPV, 2009, J CLIN VIROL, V46, P134, DOI 10.1016/j.jcv.2009.07.009; de Castro CAV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-224; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	52	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74072	10.1371/journal.pone.0074072	http://dx.doi.org/10.1371/journal.pone.0074072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069269	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100084
J	Fernandes, TJ; Hodge, JM; Singh, PP; Eeles, DG; Collier, FM; Holten, I; Ebeling, PR; Nicholson, GC; Quinn, JMW				Fernandes, Tania J.; Hodge, Jason M.; Singh, Preetinder P.; Eeles, Damien G.; Collier, Fiona M.; Holten, Ian; Ebeling, Peter R.; Nicholson, Geoffrey C.; Quinn, Julian M. W.			Cord Blood-Derived Macrophage-Lineage Cells Rapidly Stimulate Osteoblastic Maturation in Mesenchymal Stem Cells in a Glycoprotein-130 Dependent Manner	PLOS ONE			English	Article							HUMAN BONE-MARROW; ADIPOSE-TISSUE; STROMAL CELLS; IN-VIVO; OSTEOCLAST DIFFERENTIATION; MULTIPLE ROLES; IDENTIFICATION; OSTEOGENESIS; GENERATION; RESORPTION	In bone, depletion of osteoclasts reduces bone formation in vivo, as does osteal macrophage depletion. How osteoclasts and macrophages promote the action of bone forming osteoblasts is, however, unclear. Since recruitment and differentiation of multi-potential stromal cells/mesenchymal stem cells (MSC) generates new active osteoblasts, we investigated whether human osteoclasts and macrophages (generated from cord blood-derived hematopoietic progenitors) induce osteoblastic maturation in adipose tissue-derived MSC. When treated with an osteogenic stimulus (ascorbate, dexamethasone and beta-glycerophosphate) these MSC form matrix-mineralising, alkaline phosphatase-expressing osteoblastic cells. Cord blood-derived progenitors were treated with macrophage colony stimulating factor (M-CSF) to form immature proliferating macrophages, or with M-CSF plus receptor activator of NF kappa B ligand (RANKL) to form osteoclasts; culture medium was conditioned for 3 days by these cells to study their production of osteoblastic factors. Both osteoclast-and macrophage-conditioned medium (CM) greatly enhanced MSC osteoblastic differentiation in both the presence and absence of osteogenic medium, evident by increased alkaline phosphatase levels within 4 days and increased mineralisation within 14 days. These CM effects were completely ablated by antibodies blocking gp130 or oncostatin M (OSM), and OSM was detectable in both CM. Recombinant OSM very potently stimulated osteoblastic maturation of these MSC and enhanced bone morphogenetic protein-2 (BMP-2) actions on MSC. To determine the influence of macrophage activation on this OSM-dependent activity, CM was collected from macrophage populations treated with M-CSF plus IL-4 (to induce alternative activation) or with GM-CSF, IFN gamma and LPS to cause classical activation. CM from IL-4 treated macrophages stimulated osteoblastic maturation in MSC, while CM from classically-activated macrophages did not. Thus, macrophage-lineage cells, including osteoclasts but not classically activated macrophages, can strongly drive MSC-osteoblastic commitment in OSM-dependent manner. This supports the notion that eliciting gp130-dependent signals in human MSC would be a useful approach to increase bone formation.	[Fernandes, Tania J.; Hodge, Jason M.; Ebeling, Peter R.; Nicholson, Geoffrey C.] Univ Melbourne, Dept Med, Northwest Acad Ctr, Melbourne, Vic 3010, Australia; [Fernandes, Tania J.; Hodge, Jason M.; Collier, Fiona M.] Geelong Hosp, Barwon Biomed Res, Geelong, Vic, Australia; [Hodge, Jason M.; Collier, Fiona M.] Deakin Univ, Sch Med, Barwon Hlth, Geelong, Vic 3217, Australia; [Singh, Preetinder P.; Eeles, Damien G.; Quinn, Julian M. W.] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Eeles, Damien G.] La Trobe Univ, Dept Human Biosci, Bundoora, Vic, Australia; [Holten, Ian] Barwon Hlth, Dept Plast Surg, Geelong, Vic, Australia; [Nicholson, Geoffrey C.] Univ Queensland, Rural Clin Sch, Toowoomba, Qld, Australia; [Quinn, Julian M. W.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	University of Melbourne; Geelong Hospital; Deakin University; Prince Henry's Institute of Medical Research; La Trobe University; University of Queensland; Monash University	Quinn, JMW (corresponding author), Prince Henrys Inst Med Res, Clayton, Vic, Australia.	julian.quinn@princehenrys.org	Nicholson, Geoffrey C/F-1901-2010	Nicholson, Geoffrey C/0000-0002-0152-1153; Ebeling, Peter/0000-0002-2921-3742	Australian National Health and Medical Research Council [611805]; Victorian Government	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by an Australian National Health and Medical Research Council Project Grant, number 611805 (http://www.nhmrc.gov.au) and by the Victorian Government Operational Infrastructure Support Program (http://www.vic.gov.au/business-industry/science-research.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CJ, 2004, J BONE MINER RES, V19, P2057, DOI 10.1359/JBMR.040913; Akagawa KS, 1996, BLOOD, V88, P4029, DOI 10.1182/blood.V88.10.4029.bloodjournal88104029; Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI 10.1359/JBMR.080324; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; DELMAS PD, 1995, BONE, V16, P603, DOI 10.1016/8756-3282(95)00113-R; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040; Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088; Hodge JM, 2007, J CELL BIOCHEM, V102, P759, DOI 10.1002/jcb.21331; Hodge JM, 2004, J BONE MINER RES, V19, P190, DOI 10.1359/JBMR.0301232; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410; Martin TJ, 2006, ANN NY ACAD SCI, V1068, P458, DOI 10.1196/annals.1346.043; Minehata K, 2006, INT J HEMATOL, V84, P319, DOI 10.1532/IJH97.06090; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Quinn JMW, 2008, J IMMUNOL, V181, P5720, DOI 10.4049/jimmunol.181.8.5720; Saleh H, 2011, ENDOCRINOLOGY, V152, P1911, DOI 10.1210/en.2010-1268; SCHEVEN BAA, 1986, NATURE, V321, P79, DOI 10.1038/321079a0; Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001; Sims NA, 2004, J CLIN INVEST, V113, P379, DOI 10.1172/JCI200419872; Sims NA, 2009, MOL CELL ENDOCRINOL, V310, P30, DOI 10.1016/j.mce.2008.08.025; Song HY, 2007, J CELL BIOCHEM, V101, P1238, DOI 10.1002/jcb.21245; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Walker EC, 2012, J BONE MINER RES, V27, P902, DOI 10.1002/jbmr.1506; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Walsh NC, 2009, J BONE MINER RES, V24, P1572, DOI [10.1359/jbmr.090320, 10.1359/JBMR.090320]; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534	39	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73266	10.1371/journal.pone.0073266	http://dx.doi.org/10.1371/journal.pone.0073266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069182	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100035
J	Lorente, L; Iceta, R; Martin, MM; Lopez-Gallardo, E; Sole-Violan, J; Blanquer, J; Labarta, L; Diaz, C; Borreguero-Leon, JM; Jimenez, A; Montoya, J; Ruiz-Pesini, E				Lorente, Leonardo; Iceta, Ruth; Martin, Maria M.; Lopez-Gallardo, Esther; Sole-Violan, Jordi; Blanquer, Jose; Labarta, Lorenzo; Diaz, Cesar; Maria Borreguero-Leon, Juan; Jimenez, Alejandro; Montoya, Julio; Ruiz-Pesini, Eduardo			Severe Septic Patients with Mitochondrial DNA Haplogroup JT Show Higher Survival Rates: A Prospective, Multicenter, Observational Study	PLOS ONE			English	Article							SEVERE SEPSIS; INTERLEUKIN-6	Objective: In a previous cohort study (n=96), we found an association between mitochondrial (mt) DNA haplogroup JT and increased survival of severe septic patients, after controlling for age and serum lactic acid levels. The aim of this research was to increase the predictive accuracy and to control for more confounder variables in a larger cohort (n=196) of severe septic patients, to confirm whether mtDNA haplogroup JT influences short and medium-term survival in these patients. Methods: We conducted a prospective, multicenter, observational study in six Spanish Intensive Care Units. We determined 30-day and 6-month survival and mtDNA haplogroup in this second cohort of 196 patients and in the global cohort (first and second cohorts combined) with 292 severe septic patients. Multiple logistic regression and Cox regression analyses were used to test for the association of mtDNA haplogroups JT with survival at 30-days and 6-months, controlling for age, sex, serum interleukin-6 levels and SOFA score. Results: Logistic and Cox regression analyses showed no differences in 30-day and 6-month survival between patients with mtDNA haplogroup JT and other haplogroups in the first cohort (n=96). In the second cohort (n=196), these analyses showed a trend to higher 30-day and 6-month survival in those with haplogroup JT. In the global cohort (n=292), logistic and Cox regression analyses showed higher 30-day and 6-month survival for haplogroup JT. There were no significant differences between J and T sub-haplogroups in 30-day and 6-month survival. Conclusions: The global cohort study (first and second cohorts combined), the largest to date reporting on mtDNA haplogroups in septic patients, confirmed that haplogroup JT patients showed increased 30-day and 6-month survival. This finding may be due to single nucleotide polymorphism defining the whole haplogroup JT and not separately for J or T sub-haplogroups.	[Lorente, Leonardo] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz De T, Spain; [Iceta, Ruth; Lopez-Gallardo, Esther; Montoya, Julio; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Zaragoza, Spain; [Martin, Maria M.] Hosp Univ Nuestra Senora de Candelaria, Intens Care Unit, Santa Cruz De Tenerife, Spain; [Sole-Violan, Jordi] Hosp Univ Dr, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Blanquer, Jose] Hosp Clin Univ, Intens Care Unit, Valencia, Spain; [Labarta, Lorenzo] Hosp San Jorge, Intens Care Unit, Huesca, Spain; [Diaz, Cesar] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria, Spain; [Maria Borreguero-Leon, Juan] Hosp Univ Canarias, Lab Deparment, San Cristobal la Laguna, Santa Cruz De T, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna, Santa Cruz De T, Spain; [Ruiz-Pesini, Eduardo] Fdn ARAID, Zaragoza, Spain	Universidad de la Laguna; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Zaragoza; Hospital Clinic Universitari de Valencia; Hospital Universidad San Jorge; Universidad de la Laguna; Universidad de la Laguna	Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna, Santa Cruz De T, Spain.	lorentemartin@msn.com	Martín, María/HDL-9512-2022; Borreguero León, Juan María/ABQ-2161-2022	Borreguero León, Juan María/0000-0001-7414-5278; Lopez Gallardo, Ester/0000-0002-3217-1424; Jimenez-Sosa, Alejandro/0000-0001-8732-2616	Instituto de Salud Carlos III (Madrid, Spain) [FIS-PI-10-00662, FIS-PI-10-01572, FIS-PI-11-01301, I3SNS-INT-11-063, I3SNS-INT-12-087]; Grupo de Trabajo de Enfermedades Infecciosas de la Sociedad Espanola de Medicina Intensiva; Critica y Unidades Coronarias (Madrid, Spain) [GTEI-SEMICYUC-2008]; Fundacion Rafael Clavijo para la Investigacion Biomedica (La Laguna, Spain); Diputacion General de Aragon (Grupos consolidados B33) (Zaragoza, Spain)	Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III); Grupo de Trabajo de Enfermedades Infecciosas de la Sociedad Espanola de Medicina Intensiva; Critica y Unidades Coronarias (Madrid, Spain); Fundacion Rafael Clavijo para la Investigacion Biomedica (La Laguna, Spain); Diputacion General de Aragon (Grupos consolidados B33) (Zaragoza, Spain)(Gobierno de Aragon)	This study was supported, in part, by a grant from Instituto de Salud Carlos III (FIS-PI-10-00662, FIS-PI-10-01572, FIS-PI-11-01301, I3SNS-INT-11-063 and I3SNS-INT-12-087) (Madrid, Spain), Grupo de Trabajo de Enfermedades Infecciosas de la Sociedad Espanola de Medicina Intensiva, Critica y Unidades Coronarias (GTEI-SEMICYUC-2008) (Madrid, Spain), Fundacion Rafael Clavijo para la Investigacion Biomedica (La Laguna, Spain), and Diputacion General de Aragon (Grupos consolidados B33) (Zaragoza, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Bellizzi D, 2006, GENES CELLS, V11, P883, DOI 10.1111/j.1365-2443.2006.00986.x; Canter JA, 2007, ANN SURG, V246, P406, DOI 10.1097/SLA.0b013e3181469955; Gomez R, 2009, J TRAUMA, V66, P850, DOI 10.1097/TA.0b013e3181991ac8; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; HACK CE, 1989, BLOOD, V74, P1704; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022116; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lichtenstern C, 2012, CURR OPIN INFECT DIS, V25, P328, DOI 10.1097/QCO.0b013e3283522038; Lorente L, 2012, CRIT CARE, V16, DOI 10.1186/cc11150; Lorente L, 2012, CRIT CARE MED, V40, P357, DOI 10.1097/CCM.0b013e318236e341; Lorente L, 2011, CRIT CARE MED, V39, P1289, DOI 10.1097/CCM.0b013e31820ee20c; Namath A, 2011, CRIT CARE NURS CLIN, V23, P181, DOI 10.1016/j.ccell.2010.12.011; PATEL RT, 1994, BRIT J SURG, V81, P1306, DOI 10.1002/bjs.1800810914; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yang Y, 2008, GENET MED, V10, P187, DOI 10.1097/GIM.0b013e318163c343; Yang Y, 2011, INTENS CARE MED, V37, P1613, DOI 10.1007/s00134-011-2319-9	23	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73320	10.1371/journal.pone.0073320	http://dx.doi.org/10.1371/journal.pone.0073320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069186	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100038
J	Witteveen, T; Zwart, JJ; Gast, KB; Bloemenkamp, KWM; van Roosmalen, J				Witteveen, Tom; Zwart, Joost J.; Gast, Karin B.; Bloemenkamp, Kitty W. M.; van Roosmalen, Jos			Overweight and Severe Acute Maternal Morbidity in a Low-Risk Pregnant Population in The Netherlands	PLOS ONE			English	Article							TRACHEAL INTUBATION; UTERINE RUPTURE; OBESITY; OUTCOMES; COMPLICATIONS; PREVALENCE; MORTALITY; BIRTH; CONSEQUENCES; METAANALYSIS	Objective: To investigate the association between overweight and severe acute maternal morbidity (SAMM) in a low-risk pregnant population. Design: Nationwide case-control study. Setting: The Netherlands, august 2004 to august 2006. Population: 1567 cases from initially primary care and 2994 women from primary care practices as controls, out of 371 012 women delivering in the Netherlands during the study period Methods: Cases were women with SAMM obtained from a nationwide prospective study. All women in this cohort who initially had low-risk pregnancies were compared with low-risk women without SAMM to calculate odd ratios (ORs) to develop SAMM by body mass index (BMI) category. We divided body mass index in three overweight categories and calculated the ORs (95% CI) of total SAMM and per specific endpoint by logistic regression, with normal weight as reference. We adjusted for age, parity and socio-economic status. Main Outcome Measures: SAMM, defined as Intensive Care Unit (ICU)-admission, Uterine Rupture, Eclampsia or Major Obstetric Haemorrhage (MOH) Results: SAMM was reported in 1567 cases which started as low-risk pregnancies. BMI was available in 1097 (70.0%) cases and 2994 control subjects were included. Analysis showed a dose response relation for overweight (aOR, 1.3; 95% CI, 1.0-1.5), obese (aOR, 1.4; 95% CI, 1.1-1.9) and morbidly obese (aOR, 2.1; 95% CI, 1.3-3.2) women to develop SAMM compared to normal weight. Sub analysis showed the same dose response relation for ICU-admission, Uterine Rupture and Eclampsia. We found no association for MOH. Conclusion: Overweight without pre-existent co-morbidity is an important risk-indicator for developing SAMM. This risk increases with an increasing body mass index.	[Witteveen, Tom; Bloemenkamp, Kitty W. M.; van Roosmalen, Jos] Leiden Univ Med Ctr, Dept Obstet, Leiden, Netherlands; [Zwart, Joost J.] Deventer Ziekenhuis, Dept Obstet & Gynaecol, Deventer, Netherlands; [Gast, Karin B.] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Gast, Karin B.] Leiden Univ Med Ctr, Dept Internal Med, Leiden, Netherlands; [van Roosmalen, Jos] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Dept Med Humanities, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Deventer Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Witteveen, T (corresponding author), Leiden Univ Med Ctr, Dept Obstet, Leiden, Netherlands.	tom.witteveen@gmail.com			Dutch Organisation for Health Research; Matty Brand Foundation	Dutch Organisation for Health Research; Matty Brand Foundation	The authors hereby state that no external funding was used for this study. The LEMMoN-study was supported by the Dutch Organisation for Health Research and the Matty Brand Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Barnardo PD, 2000, ANAESTHESIA, V55, P690, DOI 10.1046/j.1365-2044.2000.01536.x; Bryant AS, 2010, AM J OBSTET GYNECOL, V202, P335, DOI 10.1016/j.ajog.2009.10.864; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Dashe JS, 2009, OBSTET GYNECOL, V113, P1001, DOI 10.1097/AOG.0b013e3181a1d2f5; Denison FC, 2009, BJOG-INT J OBSTET GY, V116, P1467, DOI 10.1111/j.1471-0528.2009.02222.x; en College Verloskunde Commissievoor zorgverzekeringen, 2003, AD VERL LIST OBST RE; Guise JM, 2004, BMJ-BRIT MED J, V329, P19, DOI 10.1136/bmj.329.7456.19; Gunatilake RP, 2011, AM J OBSTET GYNECOL, V204, P106, DOI 10.1016/j.ajog.2010.10.002; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Heslehurst N, 2007, BJOG-INT J OBSTET GY, V114, P187, DOI 10.1111/j.1471-0528.2006.01180.x; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Juvin P, 2003, ANESTH ANALG, V97, P595, DOI 10.1213/01.ANE.0000072547.75928.B0; Kaczmarczyk M, 2007, BJOG-INT J OBSTET GY, V114, P1208, DOI 10.1111/j.1471-0528.2007.01484.x; Katzmarzyk PT, 2002, OBES RES, V10, P666, DOI 10.1038/oby.2002.90; Kiran TSU, 2005, BJOG-INT J OBSTET GY, V112, P768, DOI 10.1111/j.1471-0528.2004.00546.x; Lenz M, 2009, DTSCH ARZTEBL INT, V106, P641, DOI 10.3238/arztebl.2009.0641; Mills JL, 2010, AM J CLIN NUTR, V91, P1543, DOI 10.3945/ajcn.2009.28865; Neovius M, 2006, OBES REV, V7, P1, DOI 10.1111/j.1467-789x.2006.00190.x; Nohr EA, 2007, OBSTET GYNECOL, V110, P1083, DOI 10.1097/01.AOG.0000286760.46679.f8; Patel A, 2006, INT J GYNECOL OBSTET, V93, P220, DOI 10.1016/j.ijgo.2006.02.014; Pevzner L, 2009, OBSTET GYNECOL, V114, P1315, DOI 10.1097/AOG.0b013e3181bfb39f; Ramos GA, 2005, AM J OBSTET GYNECOL, V193, P1089, DOI 10.1016/j.ajog.2005.06.040; Rasmussen SA, 2008, AM J OBSTET GYNECOL, V198, P611, DOI 10.1016/j.ajog.2008.04.021; Reece EA, 2008, AM J OBSTET GYNECOL, V198, P23, DOI 10.1016/j.ajog.2007.06.076; Robinson HE, 2005, OBSTET GYNECOL, V106, P1357, DOI 10.1097/01.AOG.0000188387.88032.41; Rode L, 2005, OBSTET GYNECOL, V105, P537, DOI 10.1097/01.AOG.0000152304.39492.1c; Rosenberg TJ, 2005, AM J PUBLIC HEALTH, V95, P1545, DOI 10.2105/AJPH.2005.065680; Saravanakumar K, 2006, ANAESTHESIA, V61, P36, DOI 10.1111/j.1365-2044.2005.04433.x; Schokker DF, 2007, OBES REV, V8, P101, DOI 10.1111/j.1467-789X.2006.00273.x; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Statistics Netherlands (CBS), 2007, STATL; van Duin C, 2002, MAANDSTATISTIEK BEVO, V2, P32; Waller DK, 2007, ARCH PEDIAT ADOL MED, V161, P745, DOI 10.1001/archpedi.161.8.745; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x; Zwart JJ, 2010, TRANSFUSION MED, V20, P118, DOI 10.1111/j.1365-3148.2009.00967.x; Zwart JJ, 2011, EUR J PUBLIC HEALTH, V21, P229, DOI 10.1093/eurpub/ckq046	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74494	10.1371/journal.pone.0074494	http://dx.doi.org/10.1371/journal.pone.0074494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069316	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100108
J	Salpea, KD; Maubaret, CG; Kathagen, A; Ken-Dror, G; Gilroy, DW; Humphries, SE				Salpea, Klelia D.; Maubaret, Cecilia G.; Kathagen, Annegret; Ken-Dror, Gie; Gilroy, Derek W.; Humphries, Steve E.			The Effect of Pro-Inflammatory Conditioning and/or High Glucose on Telomere Shortening of Aging Fibroblasts	PLOS ONE			English	Article							OXIDATIVE STRESS; REPLICATIVE SENESCENCE; MITOCHONDRIAL-DNA; ENDOTHELIAL-CELLS; DISEASE-ACTIVITY; LENGTH; ASSOCIATION; INTERLEUKIN-1-BETA; ATHEROSCLEROSIS; MAINTENANCE	Cardiovascular disease and diabetes have been linked to shorter telomeres, but it is not yet clear which risk factors contribute to shorter telomeres in patients. Our aim was to examine whether pro-inflammatory conditioning, in combination or not with high glucose, result in a higher rate of telomere shortening during in vitro cellular ageing. Human fibroblasts from four donors were cultured for 90 days in: 1) medium lacking ascorbic acid only, 2) 10 mM buthionine sulphoximine (BSO) (pro-oxidant), 3) 25 mM D-glucose, 4) 1 ng/ml IL1B and 5) 25 mM D-glucose+1 ng/ml IL1B. Telomere length was measured with qPCR and intracellular reactive oxygen species (ROS) content and cell death with flow cytometry. Cultures treated with high glucose and BSO displayed a significantly lower growth rate, and cultures treated with IL1B showed a trend towards a higher growth rate, compared to the control [Glucose: 0.14 PD/day, p<0.001, BSO: 0.11 PD/day, p=0.006 and IL1B: 0.19 PD/day, p=0.093 vs. Control: 0.16 PD/day]. Telomere shortening with time was significantly accelerated in cultures treated with IL1B compared to the control [IL1B: 20.8%/day (95% CI: -1.1, -0.5) vs. Control: -0.6%/day (95% CI: -0.8, -0.3), p=0.012]. The hastening of telomere shortening by IL1B was only in part attenuated after adjustment for the number of cell divisions [IL1B: -4.1%/PD (95% CI: -5.7, -2.4) vs. Control: -2.5%/PD (95% CI: -4.4, -0.7), p=0.067]. The intracellular ROS content displayed 69% increase (p=0.033) in BSO compared to the control. In aging fibroblasts, pro-inflammatory conditioning aggravates the shortening of telomeres, an effect which was only in part driven by increased cell turnover. High glucose alone did not result in greater production of ROS or telomere shortening.	UCL, Ctr Cardiovasc Genet, Div Med, London WC1E 6BT, England; [Salpea, Klelia D.; Kathagen, Annegret; Ken-Dror, Gie; Humphries, Steve E.] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Athens, Greece; [Maubaret, Cecilia G.; Gilroy, Derek W.] UCL, Ctr Clin Pharmacol & Therapeut, Div Med, London, England	University of London; University College London; Alexander Fleming Biomedical Sciences Research Center; University of London; University College London	Salpea, KD (corresponding author), Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Athens, Greece.	salpea@fleming.gr; cecilia.maubaret@isped.u-bordeaux2.fr	Gilroy, Derek W/C-2588-2009; Gilroy, Derek/AAP-7227-2020	Gilroy, Derek/0000-0003-3476-0844; Humphries, Stephen E/0000-0002-8221-6547	British Heart Foundation [FS/06/053, RG2005/014]; Binks Trust; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Binks Trust; British Heart Foundation(British Heart Foundation)	Funding was provided by the British Heart Foundation for Klelia D. Salpea (FS/06/053) and Steve E. Humphries (RG2005/014) and by the Binks Trust for Cecilia G. Maubaret. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Chen W, 2009, ATHEROSCLEROSIS, V205, P620, DOI 10.1016/j.atherosclerosis.2009.01.021; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; De Boeck G, 2009, J PATHOL, V217, P327, DOI 10.1002/path.2500; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Huda N, 2007, AGING CELL, V6, P709, DOI 10.1111/j.1474-9726.2007.00330.x; Jeanclos E, 1998, DIABETES, V47, P482, DOI 10.2337/diabetes.47.3.482; Ksiazek K, 2008, BIOCHEM BIOPH RES CO, V366, P793, DOI 10.1016/j.bbrc.2007.12.021; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Maedler K, 2009, EXPERT OPIN BIOL TH, V9, P1177, DOI 10.1517/14712590903136688; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Morgan D, 2007, DIABETOLOGIA, V50, P359, DOI 10.1007/s00125-006-0462-6; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OYAMA Y, 1994, BRAIN RES, V635, P113, DOI 10.1016/0006-8993(94)91429-X; Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Piconi L, 2006, DIABETES-METAB RES, V22, P198, DOI 10.1002/dmrr.613; Salpea KD, 2008, J MOL MED, V86, P815, DOI 10.1007/s00109-008-0347-x; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P35, DOI 10.1016/j.atherosclerosis.2009.12.021; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; SCHONFELD P, 1990, FEBS LETT, V264, P246, DOI 10.1016/0014-5793(90)80259-L; Serra V, 2000, ANN NY ACAD SCI, V908, P327; Steer SE, 2007, ANN RHEUM DIS, V66, P476, DOI 10.1136/ard.2006.059188; Uziel O, 2007, EXP GERONTOL, V42, P971, DOI 10.1016/j.exger.2007.07.005; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Wu CH, 2007, LUPUS, V16, P265, DOI 10.1177/0961203307077155; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73756	10.1371/journal.pone.0073756	http://dx.doi.org/10.1371/journal.pone.0073756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086293	Green Published, gold, Green Submitted			2022-12-27	WOS:000326520200013
J	Garcia-Garcera, M; Garcia-Etxebarria, K; Coscolla, M; Latorre, A; Calafell, F				Garcia-Garcera, Marc; Garcia-Etxebarria, Koldo; Coscolla, Mireia; Latorre, Amparo; Calafell, Francesc			A New Method for Extracting Skin Microbes Allows Metagenomic Analysis of Whole-Deep Skin	PLOS ONE			English	Article							GUT MICROBIOTA; FAST PROGRAM; DIVERSITY; HEALTH; COMMUNITY	In the last decade, an extensive effort has been made to characterize the human microbiota, due to its clinical and economic interests. However, a metagenomic approach to the skin microbiota is hampered by the high proportion of host DNA that is recovered. In contrast with the burgeoning field of gut metagenomics, skin metagenomics has been hindered by the absence of an efficient method to avoid sequencing the host DNA. We present here a method for recovering microbial DNA from skin samples, based on a combination of molecular techniques. We have applied this method to mouse skin, and have validated it by standard, quantitative PCR and amplicon sequencing of 16S rRNA. The taxonomic diversity recovered was not altered by this new method, as proved by comparing the phylogenetic structure revealed by 16S rRNA sequencing in untreated vs. treated samples. As proof of concept, we also present the first two mouse skin metagenomes, which allowed discovering new taxa (not only prokaryotes but also viruses and eukaryots) not reachable by 16S rRNA sequencing, as well as to characterize the skin microbiome functional landscape. Our method paves the way for the development of skin metagenomics, which will allow a much deeper knowledge of the skin microbiome and its relationship with the host, both in a healthy state and in relation to disease.	[Garcia-Garcera, Marc; Garcia-Etxebarria, Koldo; Coscolla, Mireia; Calafell, Francesc] Univ Pompeu Fabra, CSIC, Inst Biol Evolutiva, Barcelona, Catalonia, Spain; [Garcia-Garcera, Marc; Latorre, Amparo] Univ Valencia, Ctr Publ Hlth Res CSISP, Joint Res Unit Genom & Hlth, Valencia, Spain; [Garcia-Garcera, Marc; Latorre, Amparo] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Coscolla, Mireia] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Valencia; University of Valencia; University of Basel; Swiss Tropical & Public Health Institute	Calafell, F (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolutiva, Barcelona, Catalonia, Spain.	francesc.calafell@upf.edu	Latorre, Amparo/E-4997-2015; Calafell, Francesc/C-8595-2014; Coscolla, Mireia/ABD-7942-2021; Garcia-Etxebarria, Koldo/AAQ-4638-2021	Latorre, Amparo/0000-0002-9146-7284; Calafell, Francesc/0000-0002-1083-9438; Garcia-Etxebarria, Koldo/0000-0002-6107-9416; Garcia-Garcera, Marc/0000-0001-6408-7561; Coscolla, Mireia/0000-0003-0752-0538	Spanish Ministry of Science and Innovation (MICINN) [SAF2010-16240, BFU2009-12895-CO2-01, BES-2008-006029]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Spanish Ministry of Science and Innovation (MICINN)[grant numbers SAF2010-16240 and BFU2009-12895-CO2-01]. MGG was supported by a predoctoral fellowship from the Spanish Ministry of Scienceand Innovation [Grant number BES-2008-006029]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bates JM, 2006, DEV BIOL, V297, P374, DOI 10.1016/j.ydbio.2006.05.006; BELDAFERRE P, 2011, ISME J, V6, P1, DOI DOI 10.1038/ISMEJ.2011.85.PUBMED:21716308; Bennett MF, 2008, J INVEST DERM SYMP P, V13, P15, DOI 10.1038/jidsymp.2008.3; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Blaser MJ, 2013, ISME J, V7, P85, DOI 10.1038/ismej.2012.81; Butler JE, 2000, IMMUNOLOGY, V100, P119, DOI 10.1046/j.1365-2567.2000.00013.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Docktor MJ, 2012, INFLAMM BOWEL DIS, V18, P935, DOI 10.1002/ibd.21874; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Garcia-Garcera M, 2012, ENVIRON MICROBIOL, V14, P2087, DOI 10.1111/j.1462-2920.2012.02756.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; MAKARENKOV V, 2002, ECOLOGY, V2, P1; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; NG KP, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GEN0MEA.00148-12.PUBMED:23409267; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Rogers GB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-49; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Zheng ZL, 2011, NAT PROTOC, V6, P1367, DOI 10.1038/nprot.2011.369	44	14	19	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74914	10.1371/journal.pone.0074914	http://dx.doi.org/10.1371/journal.pone.0074914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073227	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000324768000036
J	Liu, CS; Wang, Q; Xian, M; Ding, YM; Zhao, G				Liu, Changshui; Wang, Qi; Xian, Mo; Ding, Yamei; Zhao, Guang			Dissection of Malonyl-Coenzyme A Reductase of Chloroflexus aurantiacus Results in Enzyme Activity Improvement	PLOS ONE			English	Article							ESCHERICHIA-COLI; DEHYDROGENASE; PATHWAY; GENE; BIOSYNTHESIS; ACID	The formation of fusion protein in biosynthetic pathways usually improves metabolic efficiency either channeling intermediates and/or colocalizing enzymes. In the metabolic engineering of biochemical pathways, generating unnatural protein fusions between sequential biosynthetic enzymes is a useful method to increase system efficiency and product yield. Here, we reported a special case. The malonyl-CoA reductase (MCR) of Chloroflexus aurantiacus catalyzes the conversion of malonyl-CoA to 3-hydroxypropionate (3HP), and is a key enzyme in microbial production of 3HP, an important platform chemical. Functional domain analysis revealed that the N-terminal region of MCR (MCR-N; amino acids 1-549) and the C-terminal region of MCR (MCR-C; amino acids 550-1219) were functionally distinct. The malonyl-CoA was reduced into free intermediate malonate semialdehyde with NADPH by MCR-C fragment, and further reduced to 3HP by MCR-N fragment. In this process, the initial reduction of malonyl-CoA was rate limiting. Site-directed mutagenesis demonstrated that the TGXXXG(A)X(1-2) G and YXXXK motifs were important for enzyme activities of both MCR-N and MCR-C fragments. Moreover, the enzyme activity increased when MCR was separated into two individual fragments. Kinetic analysis showed that MCR-C fragment had higher affinity for malonyl-CoA and 4-time higher K-cat/K-m value than MCR. Dissecting MCR into MCR-N and MCR-C fragments also had a positive effect on the 3HP production in a recombinant Escherichia coli strain. Our study showed the feasibility of protein dissection as a new strategy in biosynthetic systems.	[Liu, Changshui; Wang, Qi; Xian, Mo; Zhao, Guang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China; [Xian, Mo; Zhao, Guang] Chinese Acad Sci, Key Lab Biobased Mat, Qingdao, Shandong, Peoples R China; [Liu, Changshui; Wang, Qi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ding, Yamei] Chinese Acad Sci, Inst Oceanol, Qingdao, Shandong, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhao, G (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Qingdao, Shandong, Peoples R China.	zhaoguang@qibebt.ac.cn	zhao, guang/E-4702-2013	zhao, guang/0000-0003-0002-5972; ding, yamei/0000-0002-8972-9468	CAS [Y112141105, KSCX2-EW-G-13]; Director Innovation Foundation of QIBEBT; National Natural Scientific Foundation of China [31200030]; National Science and Technology Program [2012BAD32B06-2]; National 863 Program of China [SS2013AA050703-2]	CAS(Chinese Academy of Sciences); Director Innovation Foundation of QIBEBT; National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Program; National 863 Program of China(National High Technology Research and Development Program of China)	This research was financially supported by the 100-Talent Project of CAS (for GZ), Director Innovation Foundation of QIBEBT, CAS (Y112141105), National Natural Scientific Foundation of China (31200030), Main Direction Program of Knowledge Innovation of CAS (KSCX2-EW-G-13), National Science and Technology Program (2012BAD32B06-2), and National 863 Program of China (SS2013AA050703-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao YJ, 2011, APPL MICROBIOL BIOT, V91, P1545, DOI 10.1007/s00253-011-3304-5; Chang HC, 2005, J MOL BIOL, V353, P397, DOI 10.1016/j.jmb.2005.08.052; Duax WL, 2000, VITAM HORM, V58, P121, DOI 10.1016/S0083-6729(00)58023-6; Hugler M, 2002, J BACTERIOL, V184, P2404, DOI 10.1128/JB.184.9.2404-2410.2002; Membrillo-Hernandez J, 2000, J BIOL CHEM, V275, P33869, DOI 10.1074/jbc.M005464200; Mendez-Perez D, 2012, METAB ENG, V14, P298, DOI 10.1016/j.ymben.2012.04.005; Mendez-Perez D, 2011, APPL ENVIRON MICROB, V77, P4264, DOI 10.1128/AEM.00467-11; NAIR RV, 1994, J BACTERIOL, V176, P871, DOI 10.1128/jb.176.3.871-885.1994; Rathnasingh C, 2012, J BIOTECHNOL, V157, P633, DOI 10.1016/j.jbiotec.2011.06.008; ROSSMANN MG, 1978, MOL CELL BIOCHEM, V21, P161; Wang Q, 2012, J MICROBIOL, V50, P693, DOI 10.1007/s12275-012-2234-y; Werpy T, 2004, TOP VALUE ADDED CHEM, VI, DOI [10.2172/15008859, DOI 10.2172/15008859]; Winkel BSJ, 2004, ANNU REV PLANT BIOL, V55, P85, DOI 10.1146/annurev.arplant.55.031903.141714; Zhang YS, 2006, J AM CHEM SOC, V128, P13030, DOI 10.1021/ja0622094; Zhou YJJ, 2012, J AM CHEM SOC, V134, P3234, DOI 10.1021/ja2114486	15	24	26	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75554	10.1371/journal.pone.0075554	http://dx.doi.org/10.1371/journal.pone.0075554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073271	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000081
J	Bryson, M; Johnson-Roberson, M; Murphy, RJ; Bongiorno, D				Bryson, Mitch; Johnson-Roberson, Matthew; Murphy, Richard J.; Bongiorno, Daniel			Kite Aerial Photography for Low-Cost, Ultra-high Spatial Resolution Multi-Spectral Mapping of Intertidal Landscapes	PLOS ONE			English	Article							MEIOBENTHIC COPEPODS; HABITAT STRUCTURE; PATTERNS; ECOLOGY; SCALE; CHLOROPHYLL; IMAGERY	Intertidal ecosystems have primarily been studied using field-based sampling; remote sensing offers the ability to collect data over large areas in a snapshot of time that could complement field-based sampling methods by extrapolating them into the wider spatial and temporal context. Conventional remote sensing tools (such as satellite and aircraft imaging) provide data at limited spatial and temporal resolutions and relatively high costs for small-scale environmental science and ecologically-focussed studies. In this paper, we describe a low-cost, kite-based imaging system and photogrammetric/mapping procedure that was developed for constructing high-resolution, three-dimensional, multi-spectral terrain models of intertidal rocky shores. The processing procedure uses automatic image feature detection and matching, structure-from-motion and photo-textured terrain surface reconstruction algorithms that require minimal human input and only a small number of ground control points and allow the use of cheap, consumer-grade digital cameras. The resulting maps combine imagery at visible and near-infrared wavelengths and topographic information at sub-centimeter resolutions over an intertidal shoreline 200 m long, thus enabling spatial properties of the intertidal environment to be determined across a hierarchy of spatial scales. Results of the system are presented for an intertidal rocky shore at Jervis Bay, New South Wales, Australia. Potential uses of this technique include mapping of plant (micro-and macro-algae) and animal (e.g. gastropods) assemblages at multiple spatial and temporal scales.	[Bryson, Mitch; Murphy, Richard J.; Bongiorno, Daniel] Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia; [Johnson-Roberson, Matthew] Univ Michigan, Dept Naval Architecture & Marine Engn, Ann Arbor, MI 48109 USA	University of Sydney; University of Michigan System; University of Michigan	Bryson, M (corresponding author), Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia.	m.bryson@acfr.usyd.edu.au			Faculty of Engineering and Information Technologies at the University of Sydney; Australian Research Council; New South Wales State Government	Faculty of Engineering and Information Technologies at the University of Sydney; Australian Research Council(Australian Research Council); New South Wales State Government	This work was supported through the Early Career Researcher Development Scheme through the Faculty of Engineering and Information Technologies at the University of Sydney, the Australian Research Council and the New South Wales State Government. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber J.S., 2001, T KANSAS ACAD SCI, V104, P18; Aber J.S., 1999, T KANSAS ACAD SCI, V102, P57, DOI DOI 10.2307/3628217; Agarwal S, 2010, EUR C COMP VIS; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Bajjouk T, 1998, REMOTE SENS ENVIRON, V64, P153, DOI 10.1016/S0034-4257(97)00175-2; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Beck MW, 1998, MAR ECOL PROG SER, V169, P165, DOI 10.3354/meps169165; Beis J.S., 2003, COMPUTER VISION PATT, P1000; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Bryson M, 2010, J FIELD ROBOT, V27, P632, DOI 10.1002/rob.20343; DECHO AW, 1988, J EXP MAR BIOL ECOL, V118, P229, DOI 10.1016/0022-0981(88)90075-5; Denny MW, 2004, ECOL MONOGR, V74, P513, DOI 10.1890/03-4043; Finlayson GD, 1998, SIXTH COLOR IMAGING CONFERENCE: COLOR SCIENCE, SYSTEMS AND APPLICATIONS, P90; Forster RM, 2006, INT J REMOTE SENS, V27, P3657, DOI 10.1080/01431160500500367; Frahm JM, 2010, ISPRS J PHOTOGRAMM, V65, P538, DOI 10.1016/j.isprsjprs.2010.08.009; Fraser WR, 1999, WATERBIRDS, V22, P435, DOI 10.2307/1522120; Furukawa Y, 2010, IEEE T PATTERN ANAL, V32, P1362, DOI 10.1109/TPAMI.2009.161; Guichard F, 2000, LIMNOL OCEANOGR, V45, P328, DOI 10.4319/lo.2000.45.2.0328; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Harwin S, 2012, REMOTE SENS-BASEL, V4, P1573, DOI 10.3390/rs4061573; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Johnson-Roberson M, 2010, J FIELD ROBOT, V27, P21, DOI 10.1002/rob.20324; Kita Y, 2008, INT C PATT RECOG, P319; Knudby A, 2007, PROG PHYS GEOG, V31, P421, DOI 10.1177/0309133307081292; Kromkamp JC, 2006, ESTUARIES COASTS, V29, P183, DOI 10.1007/BF02781988; Marzolff I, 2009, GEOMORPHOLOGY, V111, P48, DOI 10.1016/j.geomorph.2008.05.047; Meager JJ, 2011, MAR ECOL PROG SER, V428, P1, DOI 10.3354/meps09124; Meleder V, 2003, REMOTE SENS ENVIRON, V88, P386, DOI 10.1016/j.rse.2003.08.009; Mumby PJ, 1999, J ENVIRON MANAGE, V55, P157, DOI 10.1006/jema.1998.0255; Murphy RJ, 2008, MAR ECOL PROG SER, V365, P45, DOI 10.3354/meps07456; Murphy RJ, 2008, REMOTE SENS ENVIRON, V112, P3353, DOI 10.1016/j.rse.2007.09.016; Murphy RJ, 2009, J EXP MAR BIOL ECOL, V380, P68, DOI 10.1016/j.jembe.2009.09.002; Murphy RJ, 2009, J EXP MAR BIOL ECOL, V379, P77, DOI 10.1016/j.jembe.2009.08.005; Murray JC, 2013, J FIELD ROBOT, V30, P288, DOI 10.1002/rob.21448; Perkins RG, 2003, CONT SHELF RES, V23, P575, DOI 10.1016/S0278-4343(03)00006-2; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; Rango A, 2008, ENV PRACTICE, V8, P159; Sabuncu MR, 2008, IEEE T IMAGE PROCESS, V17, P788, DOI 10.1109/TIP.2008.918951; Saburova MA, 1995, MAR ECOL PROG SER, V129, P229, DOI 10.3354/meps129229; Sandulli R, 1999, J SEA RES, V41, P179, DOI 10.1016/S1385-1101(98)00048-3; Scoffin T.P., 1982, Coral Reefs, V1, P67, DOI 10.1007/BF00286542; Sklaver BA, 2006, INT J REMOTE SENS, V27, P4709, DOI 10.1080/01431160600784309; Smith MJ, 2009, EARTH SURF PROC LAND, V34, P155, DOI 10.1002/esp.1702; Snavely N, 2008, INT J COMPUT VISION, V80, P189, DOI 10.1007/s11263-007-0107-3; SUN B, 1993, J EXP MAR BIOL ECOL, V167, P73, DOI 10.1016/0022-0981(93)90185-Q; Thompson RC, 2004, ECOLOGY, V85, P1372, DOI 10.1890/03-0279; Torr PHS, 1997, INT J COMPUT VISION, V24, P271, DOI 10.1023/A:1007927408552; Turner D, 2012, REMOTE SENS-BASEL, V4, P1392, DOI 10.3390/rs4051392; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P51, DOI 10.1016/S0022-0981(00)00179-9; van der Wal D, 2008, MAR ECOL PROG SER, V367, P57, DOI 10.3354/meps07535; Vedaldi A., 2008, VLFEAT OPEN PORTABLE; Verhoeven GJJ, 2009, ARCHAEOL PROSPECT, V16, P233, DOI 10.1002/arp.354; Wang K, 2010, SENSORS-BASEL, V10, P9647, DOI 10.3390/s101109647; Wundram D, 2008, INT J REMOTE SENS, V29, P961, DOI 10.1080/01431160701352113; Xharde R, 2006, IEEE GEOSC REM SENS	57	63	64	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73550	10.1371/journal.pone.0073550	http://dx.doi.org/10.1371/journal.pone.0073550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069206	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300013
J	Gudiol, C; Ayats, J; Camoez, M; Dominguez, MA; Garcia-Vidal, C; Bodro, M; Ardanuy, C; Obed, M; Arnan, M; Antonio, M; Carratala, J				Gudiol, Carlota; Ayats, Josefina; Camoez, Mariana; Angeles Dominguez, M.; Garcia-Vidal, Carolina; Bodro, Marta; Ardanuy, Carmen; Obed, Mora; Arnan, Montserrat; Antonio, Maite; Carratala, Jordi			Increase in Bloodstream Infection Due to Vancomycin-Susceptible Enterococcus faecium in Cancer Patients: Risk Factors, Molecular Epidemiology and Outcomes	PLOS ONE			English	Article							RESISTANT ENTEROCOCCUS; BACTEREMIA; EMERGENCE; FAECALIS; VIRULENCE; MORTALITY	We conducted a prospective study to assess the risk factors, molecular epidemiology and outcome of bloodstream infection (BSI) due to Enterococcus faecium in hospitalized cancer patients. Between 2006 and 2012, a significant increase in vancomycin-susceptible E. faecium BSI was observed among cancer patients. Comparison of 54 episodes of BSI due to E. faecium with 38 episodes of BSI due to E. faecalis showed that previous use of carbapenems was the only independent risk factor for E. faecium acquisition (OR 10.24; 95% CI, 1.35-77.66). All E. faecium isolates were susceptible to glycopeptides, whereas 97% showed high-level resistance to ampicillin and ciprofloxacin. All 30 isolates available for genotyping belonged to the hospital-associated E. faecium lineages 17, 18 and 78. After 2009, most of the isolates belonged to ST117 (lineage 78). Patients with E. faecium BSI were more likely to receive inadequate initial empirical antibiotic therapy than patients with E. faecalis BSI, and time to adequate empirical antibiotic therapy was also longer in the former group. No significant differences were found between the two groups regarding early and overall case-fatality rates. Independent risk factors for overall case-fatality were current corticosteroids (OR 4.18; 95% CI, 1.34-13.01) and intensive care unit admission (OR 9.97; 95% CI, 1.96-50.63). The emergence of E. faecium among cancer patients is a concern since there are limited treatment options and it may presage the emergence of vancomycin-resistant enterococci. A rationale approach that combines infection control with antimicrobial stewardship.	[Gudiol, Carlota; Garcia-Vidal, Carolina; Bodro, Marta; Obed, Mora; Carratala, Jordi] Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain; [Gudiol, Carlota; Garcia-Vidal, Carolina; Bodro, Marta; Obed, Mora; Carratala, Jordi] Univ Barcelona, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Ayats, Josefina; Camoez, Mariana; Angeles Dominguez, M.; Ardanuy, Carmen] Univ Barcelona, Dept Microbiol, Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Arnan, Montserrat] Univ Barcelona, Dept Haematol, Hosp Duran & Reynals, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Antonio, Maite] Univ Barcelona, Dept Oncol, Hosp Duran & Reynals, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Gudiol, Carlota; Camoez, Mariana; Angeles Dominguez, M.; Garcia-Vidal, Carolina; Bodro, Marta; Carratala, Jordi] Inst Salud Carlos III, REIPI Spanish Network Res Infect Dis, Madrid, Spain; [Ayats, Josefina; Ardanuy, Carmen] Inst Salud Carlos III, CIBERes CIBER Enfermedades Resp, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Gudiol, C (corresponding author), Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain.	cgudiol@iconcologia.net; jcarratala@bellvitgehospital.cat	Bodro, Marta/D-7022-2019; Carratalà, Jordi/B-8410-2011; Ardanuy, Carmen/C-4463-2015; Carratala, Jordi/AAC-2639-2020; Camoez, Mariana/ACK-3178-2022; Bodro, Marta/AEN-0866-2022; Bodro, Marta/E-4199-2018	Carratalà, Jordi/0000-0003-3209-2563; Carratala, Jordi/0000-0003-3209-2563; Bodro, Marta/0000-0002-0520-8279; Camoez, Mariana/0000-0002-7517-6874; Antonio, Maite/0000-0002-7611-8529; Garcia-Vidal, Carolina/0000-0002-8915-0683; Dominguez, M. Angeles/0000-0003-3107-9586; Gudiol, Carlota/0000-0003-3095-4422; Ardanuy, Carmen/0000-0003-0225-607X; Ayats, Josefina/0000-0002-9998-1325	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), Barcelona, Spain	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Spanish Network for the Research in Infectious Diseases(Instituto de Salud Carlos III); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), Barcelona, Spain	This study was supported by research grant REIPI RD06/0008 from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Spanish Network for the Research in Infectious Diseases. MB is the recipient of a research grant from the Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), Barcelona, Spain. The funding sources had no role in the study design, the collection, analysis and interpretation of the data or the decision to submit the manuscript for publication. Only the authors had full access to the data files for the study. The authors do not have any relationship that may constitute a dual or conflicting interest.	Almyroudis NG, 2011, INFECT CONT HOSP EP, V32, P490, DOI 10.1086/659408; ARDUINO RC, 1994, INFECT IMMUN, V62, P5587, DOI 10.1128/IAI.62.12.5587-5594.1994; Arias CA, 2008, EXPERT REV ANTI-INFE, V6, P637, DOI 10.1586/14787210.6.5.637; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; BOYCE JM, 1992, ANTIMICROB AGENTS CH, V36, P1032, DOI 10.1128/AAC.36.5.1032; Cherif Honar, 2003, Hematol J, V4, P420, DOI 10.1038/sj.thj.6200334; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Conde-Estevez D, 2011, EUR J CLIN MICROBIOL, V30, P103, DOI 10.1007/s10096-010-1029-5; Coque TM, 2005, ANTIMICROB AGENTS CH, V49, P2693, DOI 10.1128/AAC.49.7.2693-2700.2005; DiazGranados CA, 2005, J INFECT DIS, V191, P588, DOI 10.1086/427512; DiazGranados CA, 2005, CLIN INFECT DIS, V41, P327, DOI 10.1086/430909; Fortun J, 2002, J ANTIMICROB CHEMOTH, V50, P1003, DOI 10.1093/jac/dkf216; Freitas AR, 2010, ANTIMICROB AGENTS CH, V54, P2660, DOI 10.1128/AAC.00134-10; Garbutt JM, 2000, CLIN INFECT DIS, V30, P466, DOI 10.1086/313694; Ghanem G, 2007, INFECT CONT HOSP EP, V28, P1054, DOI 10.1086/519932; Gudiol C, 2010, J ANTIMICROB CHEMOTH, V65, P333, DOI 10.1093/jac/dkp411; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Martinez-Odriozola P, 2007, ENFERM INFEC MICR CL, V25, P503, DOI 10.1157/13109986; McBride SJ, 2010, EUR J CLIN MICROBIOL, V29, P107, DOI 10.1007/s10096-009-0830-5; Mishra NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043958; Mundy LM, 2000, CLIN MICROBIOL REV, V13, P513, DOI 10.1128/CMR.13.4.513-522.2000; NOSKIN GA, 1995, CLIN INFECT DIS, V20, P296, DOI 10.1093/clinids/20.2.296; Pan SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047297; Prystowsky J, 2001, ANTIMICROB AGENTS CH, V45, P2154, DOI 10.1128/AAC.45.7.2154-2156.2001; Rice LB, 2003, J INFECT DIS, V187, P508, DOI 10.1086/367711; Rice LB, 2001, EMERG INFECT DIS, V7, P183, DOI 10.3201/eid0702.010205; Suppola JP, 1998, SCAND J INFECT DIS, V30, P153, DOI 10.1080/003655498750003546; Todeschini G, 2006, J INFECTION, V53, P266, DOI 10.1016/j.jinf.2005.11.012; Top J, 2008, J CLIN MICROBIOL, V46, P214, DOI 10.1128/JCM.01351-07; Treitman AN, 2005, J CLIN MICROBIOL, V43, P462, DOI 10.1128/JCM.43.1.462-463.2005; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Werner G, 2008, Euro Surveill, V13; Willems RJL, 2012, MBIO, V3, DOI 10.1128/mBio.00151-12; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]	35	40	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74734	10.1371/journal.pone.0074734	http://dx.doi.org/10.1371/journal.pone.0074734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069339	Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300040
J	Kiss-Toth, E; Harlock, E; Lath, D; Quertermous, T; Wilkinson, JM				Kiss-Toth, Endre; Harlock, Edward; Lath, Darren; Quertermous, Thomas; Wilkinson, J. Mark			A TNF Variant that Associates with Susceptibility to Musculoskeletal Disease Modulates Thyroid Hormone Receptor Binding to Control Promoter Activation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TOTAL HIP-ARTHROPLASTY; RHEUMATOID-ARTHRITIS; WEAR DEBRIS; OSTEOCLAST DIFFERENTIATION; PERIPROSTHETIC OSTEOLYSIS; FUNCTIONAL-ANALYSIS; ADHERENT ENDOTOXIN; GENE-EXPRESSION; BONE-RESORPTION	Tumor necrosis factor (TNF) is a powerful pro-inflammatory cytokine and immuno-regulatory molecule, and modulates susceptibility to musculoskeletal diseases. Several meta-analyses and replicated association studies have implicated the minor 'A' variant within the TNF promoter single nucleotide polymorphism (SNP) rs361525 (-238A/G) as a risk allele in joint related disorders, including psoriatic and juvenile idiopathic arthritis, and osteolysis after joint arthroplasty. Here we characterized the effect of this variant on TNF promoter function. A transcriptional reporter, encoding the -238A variant of the TNF promoter, resulted in 2.2 to 2.8 times greater transcriptional activation versus the 'G' variant in murine macrophages when stimulated with pro-inflammatory stimuli. Bioinformatic analysis predicted a putative binding site for thyroid hormone receptor (TR) for the -238A but not the -238G allele. Overexpression of TR-alpha induced promoter expression 1.8-fold in the presence of the 'A' allele only. TR-alpha expression both potentiated and sensitized the -238A response to LPS or a titanium particulate stimulus, whilst siRNA knockdown of either THRA or THRB impaired transcriptional activation for the -238A variant only. This effect was independent of receptor-ligand binding of triiodothyronine. Immunohistochemical analysis of osteolysis interface membranes from patients undergoing revision surgery confirmed expression of TR-alpha within osteoclast nuclei at the resorption surface. The 'A' allele at rs361525 confers increased transcriptional activation of the TNF promoter and influences susceptibility to several arthritic conditions. This effect is modulated, at least in part, by binding of TR, which both sensitizes and potentiates transcriptional activation of the 'A' variant independent of its endogenous ligand.	[Kiss-Toth, Endre] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Harlock, Edward; Lath, Darren; Wilkinson, J. Mark] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Quertermous, Thomas] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Quertermous, Thomas] Stanford Univ, Cardiovasc Res Inst, Stanford, CA 94305 USA	University of Sheffield; University of Sheffield; Stanford University; Stanford University	Kiss-Toth, E (corresponding author), Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	e.kiss-toth@sheffield.ac.uk	Kiss-Toth, Endre/AAC-4252-2020; Kiss-Toth, Endre/A-8596-2014	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017	Sheffield NIHR Bone BRU; Fondation Leducq	Sheffield NIHR Bone BRU; Fondation Leducq(Leducq Foundation)	This work was funded by the Sheffield NIHR Bone BRU and the Fondation Leducq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu EO, 1997, BONE, V21, P137, DOI 10.1016/S8756-3282(97)00097-5; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Bassett JHD, 2008, MOL ENDOCRINOL, V22, P501, DOI 10.1210/me.2007-0221; Bayley JP, 2001, CYTOKINE, V14, P316, DOI 10.1006/cyto.2001.0902; Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082; Childs LM, 2001, J BONE MINER RES, V16, P338, DOI 10.1359/jbmr.2001.16.2.338; Childs LM, 2001, J BONE JOINT SURG AM, V83A, P1789, DOI 10.2106/00004623-200112000-00004; FONG CLW, 1994, NUCLEIC ACIDS RES, V22, P1108, DOI 10.1093/nar/22.6.1108; Gallo J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-109; Gordon A, 2010, J ORTHOP RES, V28, P1127, DOI 10.1002/jor.21135; Greenfield EM, 2008, J AM ACAD ORTHOP SUR, V16, pS56, DOI 10.5435/00124635-200800001-00012; Hajeer AH, 2001, HUM IMMUNOL, V62, P1191, DOI 10.1016/S0198-8859(01)00322-6; Kaijzel EL, 1998, MOL MED, V4, P724, DOI 10.1007/BF03401767; Kaijzel EL, 2001, GENES IMMUN, V2, P135, DOI 10.1038/sj.gene.6363747; LEE ME, 1991, J BIOL CHEM, V266, P19034; Matthews JB, 2000, BIOMATERIALS, V21, P2033, DOI 10.1016/S0142-9612(00)00089-2; Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2; Monfoulet LE, 2011, J BONE MINER RES, V26, P2036, DOI 10.1002/jbmr.432; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603; Rahman P, 2006, ANN RHEUM DIS, V65, P919, DOI 10.1136/ard.2005.039164; Roux S, 2000, ARTHRITIS RES, V2, P451, DOI 10.1186/ar127; Sabokbar A, 2003, J ORTHOP RES, V21, P73, DOI 10.1016/S0736-0266(02)00106-7; Sapey E, 2010, AM J RESP CRIT CARE, V182, P192, DOI 10.1164/rccm.200912-1846OC; Schmeling H, 2006, CLIN EXP RHEUMATOL, V24, P103; Shastry BS, 2007, J HUM GENET, V52, P871, DOI 10.1007/s10038-007-0200-z; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Suttamanatwong S, 2009, J CELL BIOCHEM, V107, P284, DOI 10.1002/jcb.22124; Takagi M, 2011, J CLIN EXP HEMATOP, V51, P77, DOI 10.3960/jslrt.51.77; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100; Tatro JM, 2007, J ORTHOP RES, V25, P361, DOI 10.1002/jor.20289; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Touma Z, 2010, ARCH MED RES, V41, P142, DOI 10.1016/j.arcmed.2010.02.002; Tuan RS, 2008, J AM ACAD ORTHOP SUR, V16, pS42, DOI 10.5435/00124635-200800001-00010; Wilkinson JM, 2003, J BONE MINER RES, V18, P1995, DOI 10.1359/jbmr.2003.18.11.1995; Zou YF, 2010, AUTOIMMUNITY, V43, P264, DOI 10.3109/08916930903509049	36	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76034	10.1371/journal.pone.0076034	http://dx.doi.org/10.1371/journal.pone.0076034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069456	Green Accepted, Green Published, gold			2022-12-27	WOS:000324777300103
J	Dodd, PJ; Knight, GM; Lawn, SD; Corbett, EL; White, RG				Dodd, Peter J.; Knight, Gwenan M.; Lawn, Stephen D.; Corbett, Elizabeth L.; White, Richard G.			Predicting the Long-Term Impact of Antiretroviral Therapy Scale-Up on Population Incidence of Tuberculosis	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; HIV-ASSOCIATED TUBERCULOSIS; INFECTION; COUNTRIES; SETTINGS; EPIDEMIC; BURDEN; WILL; AIDS	Objective: To investigate the impact of antiretroviral therapy (ART) on long-term population-level tuberculosis disease (TB) incidence in sub-Saharan Africa. Methods: We used a mathematical model to consider the effect of different assumptions about life expectancy and TB risk during long-term ART under alternative scenarios for trends in population HIV incidence and ART coverage. Results: All the scenarios we explored predicted that the widespread introduction of ART would initially reduce population-level TB incidence. However, many modelled scenarios projected a rebound in population-level TB incidence after around 20 years. This rebound was predicted to exceed the TB incidence present before ART scale-up if decreases in HIV incidence during the same period were not sufficiently rapid or if the protective effect of ART on TB was not sustained. Nevertheless, most scenarios predicted a reduction in the cumulative TB incidence when accompanied by a relative decline in HIV incidence of more than 10% each year. Conclusions: Despite short-term benefits of ART scale-up on population TB incidence in sub-Saharan Africa, longer-term projections raise the possibility of a rebound in TB incidence. This highlights the importance of sustaining good adherence and immunologic response to ART and, crucially, the need for effective HIV preventive interventions, including early widespread implementation of ART.	[Dodd, Peter J.; Knight, Gwenan M.; White, Richard G.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England; [Dodd, Peter J.; Knight, Gwenan M.; Lawn, Stephen D.; Corbett, Elizabeth L.; White, Richard G.] London Sch Hyg & Trop Med, TB Ctr, London WC1, England; [Lawn, Stephen D.] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Corbett, Elizabeth L.] Malawi Liverpool Wellcome Trust Clin Res Programm, HIV & TB Grp, Blantyre, Malawi	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of Malawi	Dodd, PJ (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England.	peter.dodd@lshtm.ac.uk	Knight, Gwen/AAF-1176-2020; Knight, Gwen/AGE-2703-2022; White, Richard G/D-5407-2009	White, Richard G/0000-0003-4410-6635; Corbett, Elizabeth/0000-0002-3552-3181; Dodd, Pete/0000-0001-5825-9347; Knight, Gwenan/0000-0002-7263-9896	Bill and Melinda Gates Foundation [19790.01, 21675]; Wellcome Trust, London, UK; Medical Research Council (UK) [G0802414, MR/J005088/1]; Medical Research Council [MR/J005088/1, G0802414] Funding Source: researchfish; MRC [G0802414, MR/J005088/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust, London, UK(Wellcome Trust); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PJD is funded by the Consortium to Respond Effectively to the AIDS/TB Epidemic (19790.01) grant from the Bill and Melinda Gates Foundation. SDL and ELC are funded by the Wellcome Trust, London, UK. RGW is funded by a Medical Research Council (UK) Methodology Research Fellowship (G0802414), grant (MR/J005088/1), and the Consortium to Respond Effectively to the AIDS/TB Epidemic (19790.01) grant from the Bill and Melinda Gates Foundation (21675). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOB TUB CONTR WHO R; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, AM J RESP CRITICAL C, V170, P673; Cornell M, 2011, AIDS LONDON ENGLAND, V24, P2263; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Dimairo M, 2009, CROI; Espinal RA, 2000, LANCET, V355, P275, DOI 10.1016/S0140-6736(99)04402-5; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Middelkoop K, 2011, INT J TUBERC LUNG D, V15, P1714, DOI 10.5588/ijtld.11.0545; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; R Development Core Team R, 2009, R LANG ENV STAT COMP; Rangaka M, 2013, EFFECT TUBERCULIN SK; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107; Zaba B, 2007, AIDS, V21, pS87, DOI 10.1097/01.aids.0000299415.67646.26; Zachariah R, 2011, INT J TUBERC LUNG D, V15, P933, DOI 10.5588/ijtld.10.0666	31	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75466	10.1371/journal.pone.0075466	http://dx.doi.org/10.1371/journal.pone.0075466			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069418	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000324547300084
J	O'Connell, R; Chishinga, N; Kinyanda, E; Patel, V; Ayles, H; Weiss, HA; Seedat, S				O'Connell, Rebecca; Chishinga, Nathaniel; Kinyanda, Eugene; Patel, Vikram; Ayles, Helen; Weiss, Helen A.; Seedat, Soraya			Prevalence and Correlates of Alcohol Dependence Disorder among TB and HIV Infected Patients in Zambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; DSM-IV; ANTIRETROVIRAL THERAPY; DRINKING PATTERNS; MENTAL-DISORDERS; SEXUAL-BEHAVIOR; TUBERCULOSIS; RISK; ASSOCIATION	Objectives: To determine the prevalence and correlates of alcohol dependence disorders in persons receiving treatment for HIV and Tuberculosis (TB) at 16 Primary Health Care centres (PHC) across Zambia. Methods: 649 adult patients receiving treatment for HIV and/or TB at PHCs in Zambia (363 males, 286 females) were recruited between 1st December 2009 and 31st January 2010. Data on socio-demographic variables, clinical disease features (TB and HIV), and psychopathological status were collected. The Mini International Neuropsychiatric Interview (MINI) was used to diagnose alcohol dependence disorder. Correlates of alcohol dependence were analyzed for men only, due to low prevalence in women. Univariable and multivariable logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI), using general estimating equations to allow for within-PHC clustering. Results: The prevalence of alcohol dependence was 27.2% (95% CI: 17.7-39.5%) for men and 3.9% (95% CI: 1.4-0.1%) for women. Factors associated with alcohol dependence disorder in men included being single, divorced or widowed compared with married (adjusted OR = 1.47, 95% CI: 1.00-2.14) and being unemployed (adjusted OR = 1.30, 95% CI: 1.01-1.67). The highest prevalence of alcohol dependence was among HIV-test unknown TB patients (34.7%), and lowest was among HIV positive patients on treatment but without TB (14.1%), although the difference was not statistically significant (p = 0.38). Conclusions: Male TB/HIV patients in this population have high prevalence of alcohol dependence disorder, and prevalence differs by HIV/TB status. Further work is needed to explore interventions to reduce harmful drinking in this population.	[O'Connell, Rebecca; Chishinga, Nathaniel; Ayles, Helen] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Chishinga, Nathaniel; Ayles, Helen] Zambian Aids Related TB Project ZAMBART, Sch Med, Lusaka, Zambia; [Patel, Vikram] London Sch Hyg & Trop Med, Dept Nutr & Publ Hlth Intervent Res, London WC1, England; [Kinyanda, Eugene] Uganda Virus Res Inst, AIDS Unit, Med Res Council, Entebbe, Uganda; [Weiss, Helen A.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, MRC Trop Epidemiol Grp, London WC1, England; [Seedat, Soraya] Univ Stellenbosch, South African Res Chairs Program, ZA-7505 Tygerberg, Western Cape, South Africa; [Seedat, Soraya] Univ Stellenbosch, MRC Stress & Anxiety Disorders Unit, ZA-7505 Tygerberg, Western Cape, South Africa; [Seedat, Soraya] Univ Stellenbosch, Dept Psychiat, ZA-7505 Tygerberg, Western Cape, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; Stellenbosch University; Stellenbosch University; Stellenbosch University	O'Connell, R (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England.	rebecca.oconnell@bartshealth.nhs.uk	kinyanda, eugene/HGC-3554-2022; weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Seedat, Soraya/0000-0002-5118-786X; Ayles, Helen/0000-0003-4108-2842; Patel, Vikram/0000-0003-1066-8584	Evidence for Action on HIV treatment and care systems (EfA) research consortium; UK Department for International Development (DFID); MRC [MC_U950088495, G0700837] Funding Source: UKRI; Medical Research Council [G0700837, MC_U950088495] Funding Source: researchfish	Evidence for Action on HIV treatment and care systems (EfA) research consortium; UK Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by the Evidence for Action on HIV treatment and care systems (EfA) research consortium. EfA is funded by the UK Department for International Development (DFID), for the benefit of developing countries. The views expressed are not necessarily those of DFID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuda W, 2011, AM J ADDICTION, V20, P87, DOI 10.1111/j.1521-0391.2010.00111.x; APA, 2000, DIAGN STAT MAN MENT; APA, 2013, IAGN STAT MAN MENT D, V5; Azar MM, 2010, DRUG ALCOHOL DEPEND; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Bernards S, 2009, ADDICTION, V104, P1658, DOI 10.1111/j.1360-0443.2009.02667.x; Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI 10.1258/ijsa.2000.009432; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Clausen T, 2009, ADDICTION, V104, P1147, DOI 10.1111/j.1360-0443.2009.02559.x; Coldiron ME, 2008, AIDS BEHAV, V12, P594, DOI 10.1007/s10461-007-9304-x; CSO CSOCZaMII, 2009, AMB 2007 DEM HLTH SU; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Geis S, 2011, JAIDS-J ACQ IMM DEF, V56, P453, DOI 10.1097/QAI.0b013e3182118fa3; Greenfield SF, 2010, ALCOHOL CLIN EXP RES, V34, P317, DOI 10.1111/j.1530-0277.2009.01094.x; Greenfield TK, 2010, AIDS BEHAV, V14, P84, DOI 10.1007/s10461-010-9734-8; Hahn JA, 2010, AIDS BEHAV, V14, P1265, DOI 10.1007/s10461-010-9768-y; Hahn Judith A, 2010, Curr HIV/AIDS Rep, V7, P226, DOI 10.1007/s11904-010-0060-6; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hasin DS, 2004, ARCH GEN PSYCHIAT, V61, P891, DOI 10.1001/archpsyc.61.9.891; Jaquet A, 2010, ADDICTION, V105, P1416, DOI 10.1111/j.1360-0443.2010.02978.x; Joska JA, 2010, AIDS BEHAV, V14, P371, DOI 10.1007/s10461-009-9538-x; Kalichman SC, 2007, JAIDS-J ACQ IMM DEF, V44, P594, DOI 10.1097/QAI.0b013e3180415e07; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kalichman Seth C, 2011, Am J Public Health, V101, pe9, DOI 10.2105/AJPH.2011.300236; Kullgren G, 2009, AFR J PSYCHIATRY, V12, P52; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Li TK, 2007, ADDICTION, V102, P1522, DOI 10.1111/j.1360-0443.2007.01911.x; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Luchters S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-384; Mavedzenge SN, 2011, JAIDS-J ACQ IMM DEF, V58, P89, DOI 10.1097/QAI.0b013e3182254038; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; National AIDS Council Z NAC, 2008, AT STRAT PREV HIV AI; Olley BO, 2003, SAMJ S AFR MED J, V93, P928; Papas RK, 2011, ADDICTION, V106, P2156, DOI 10.1111/j.1360-0443.2011.03518.x; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2007, ANN EPIDEMIOL, V17, pS87, DOI 10.1016/j.annepidem.2007.01.019; Pithey A, 2009, SAHARA J-J SOC ASP H, V6, P155, DOI 10.1080/17290376.2009.9724944; Ray LA, 2009, ADDICT BEHAV, V34, P587, DOI 10.1016/j.addbeh.2009.03.028; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Schuckit MA, 2009, LANCET, V373, P492, DOI 10.1016/S0140-6736(09)60009-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Shuper PA, 2009, AIDS BEHAV, V13, P1021, DOI 10.1007/s10461-009-9589-z; Smit J, 2006, Afr Health Sci, V6, P215; Spies G, 2009, AIDS CARE, V21, P1163, DOI 10.1080/09540120902729965; Suliman S, 2010, J STUD ALCOHOL DRUGS, V71, P695, DOI 10.15288/jsad.2010.71.695; UNAIDS, 2010, UN COUNTR PROGR REP; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; WHO, 2007, IMPR DIAGN TREATM SM; WHO, 2008, WORLD HLTH SURV ZAMB; WHO, 2010, HO GLOB TUB CONTR; Woolf-King SE, 2011, ARCH SEX BEHAV, V40, P17, DOI 10.1007/s10508-009-9516-4; World Health Organization, 2008, GLOBAL BURDEN DIS; World Health Organization, 2007, INT CLASS DIS; Wu ES, 2011, JAIDS-J ACQ IMM DEF, V56, pE129, DOI 10.1097/QAI.0b013e31820dc1c8; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	61	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74406	10.1371/journal.pone.0074406	http://dx.doi.org/10.1371/journal.pone.0074406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219YJ	24069309	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000324547300040
J	Roubille, F; Delseny, D; Cristol, JP; Merle, D; Salvetat, N; Larue, C; Davy, JM; Leclercq, F; Pasquie, JL; Guerrier, L; Fareh, J; Dupuy, AM				Roubille, Francois; Delseny, Delphine; Cristol, Jean-Paul; Merle, Delphine; Salvetat, Nicolas; Larue, Catherine; Davy, Jean-Marc; Leclercq, Florence; Pasquie, Jean-Luc; Guerrier, Luc; Fareh, Jeannette; Dupuy, Anne-Marie			Depletion of proBNP(1-108) in Patients with Heart Failure Prevents Cross-Reactivity with Natriuretic Peptides	PLOS ONE			English	Article							GENERAL-POPULATION; NT-PROBNP; BNP; ASSAYS; DYSFUNCTION; PROHORMONE; PRECURSOR; BLOOD	Background: After synthesis by cardiomyocytes, precursor proBNP(1-108) is cleaved into NT-proBNP and BNP. Recently, cross-reactivity between these assays was discussed. The aim of this study was to characterize the cross-reactivities, through a new biochemical innovative approach consisting in the total depletion of the circulating proBNP1-108 in patients with heart failure (HF). Methods: This prospective study included 180 patients with chronic HF. BNP and NT-proBNP were dosed with commercial kits. ProBNP(1-108) was determined using an ELISA research assay specific to the precursor. ProBNP1-108 depletion was performed by immunocapture with a specific antibody targeting exclusively the ProBNP1-108 hinge region. ProBNP1-108, BNP and NT-proBNP levels were determined before and after depletion using this process in HF patients. Results: Mean age was 74.34 +/- 12.5 y, and 69% of patients were males. NYHA classes II and III were the most frequent (32% and 45% respectively). Before depletion, ProBNP1-108, NT-proBNP and BNP levels were 316.8+/-265.9 pg/ml; 6,054.0+/-11,539 pg/ml and 684.3+/-82.1 pg/ml respectively, and were closely correlated with NHYA classes. After immuno-depletion, proBNP1-108 was decreased in mean by 96% (p<0.0001), BNP by 53% (p<0.0001) and NT-proBNP by 5%. The relationship between BNP or NT-proBNP and NHYA classes remained unchanged. Conclusion: Current BNP and NT-proBNP assays measured as well proBNP molecule. This cross reactivity percentage has been controversial. Thanks to the removal of circulating proBNP1-108 with our immunodepletion process, we are now able to assess the remaining "true" BNP and NT-proBNP molecules and further evaluate their clinical relevance.	[Roubille, Francois; Delseny, Delphine; Davy, Jean-Marc; Leclercq, Florence; Pasquie, Jean-Luc] Univ Montpellier I, Dept Cardiol, Univ Hosp Montpellier, Montpellier, France; [Roubille, Francois] Univ Montreal, Montreal Heart Inst, Res Ctr, Montreal, PQ, Canada; [Cristol, Jean-Paul; Dupuy, Anne-Marie] Univ Montpellier I, Dept Biochem, Univ Hosp Montpellier, Montpellier, France; [Merle, Delphine; Salvetat, Nicolas; Fareh, Jeannette] SysDiag, CNRS Biorad UMR3145, Montpellier, France; [Larue, Catherine; Guerrier, Luc] Biorad Labs, Marnes La Coquette, France	Universite de Montpellier; CHU de Montpellier; Universite de Montreal; Universite de Montpellier; CHU de Montpellier	Roubille, F (corresponding author), Univ Montpellier I, Dept Cardiol, Univ Hosp Montpellier, Montpellier, France.	francois.roubille@gmail.com	Pasquié, Jean Luc/O-2216-2018	Pasquié, Jean Luc/0000-0003-3773-5804; LARUE, Catherine/0000-0002-5803-4671; dupuy, anne marie/0000-0001-6538-3944; SALVETAT, Nicolas/0000-0002-0759-5129	BIO-RAD; Federation Francaise de Cardiologie	BIO-RAD; Federation Francaise de Cardiologie	Both Association Calipso and Association Coeur et Recherche received grants for their research activities from BIO-RAD. Dr Roubille received grants for research from the Federation Francaise de Cardiologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargnoux AS, 2008, CLIN CHEM LAB MED, V46, P1019, DOI 10.1515/CCLM.2008.192; Choi EY, 2012, AM HEART J, V164, P251, DOI 10.1016/j.ahj.2012.05.010; Clerico A, 2006, AM J PHYSIOL-HEART C, V290, pH17, DOI 10.1152/ajpheart.00684.2005; Dries DL, 2010, CIRC-HEART FAIL, V3, P220, DOI 10.1161/CIRCHEARTFAILURE.109.903153; Emdin M, 2011, J AM COLL CARDIOL, V57, P1396, DOI 10.1016/j.jacc.2010.09.075; Giuliani I, 2006, CLIN CHEM, V52, P1054, DOI 10.1373/clinchem.2005.061770; Goetze JP, 2010, RESULTS PROBL CELL D, V50, P97, DOI 10.1007/400_2009_25; Hawkridge AM, 2005, P NATL ACAD SCI USA, V102, P17442, DOI 10.1073/pnas.0508782102; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Lam CSP, 2007, J AM COLL CARDIOL, V49, P1193, DOI 10.1016/j.jacc.2006.12.024; Liang FQ, 2007, J AM COLL CARDIOL, V49, P1071, DOI 10.1016/j.jacc.2006.10.063; Luckenbill KN, 2008, CLIN CHEM, V54, P619, DOI 10.1373/clinchem.2007.097998; Macheret F, 2011, J AM COLL CARDIOL, V57, P1386, DOI 10.1016/j.jacc.2011.01.005; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Miller WL, 2012, CLIN CHIM ACTA, V413, P920, DOI 10.1016/j.cca.2012.02.007; Mogelvang R, 2007, J AM COLL CARDIOL, V50, P1694, DOI 10.1016/j.jacc.2007.07.073; Nishikimi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053233; Savic-Radojevic A, 2013, J CLIN LAB ANAL; Schellenberger U, 2006, ARCH BIOCHEM BIOPHYS, V451, P160, DOI 10.1016/j.abb.2006.03.028; Seferian KR, 2008, CLIN CHEM, V54, P866, DOI 10.1373/clinchem.2007.100040; Seferian KR, 2007, CLIN CHEM, V53, P866, DOI 10.1373/clinchem.2006.076141; Semenov AG, 2009, CLIN CHEM, V55, P489, DOI 10.1373/clinchem.2008.113373; Waldo SW, 2008, J AM COLL CARDIOL, V51, P1874, DOI 10.1016/j.jacc.2007.12.051	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75174	10.1371/journal.pone.0075174	http://dx.doi.org/10.1371/journal.pone.0075174			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069392	Green Published, gold			2022-12-27	WOS:000324547300072
J	Ledesma-Garcia, L; Reyes-Ramirez, F; Santero, E				Ledesma-Garcia, Laura; Reyes-Ramirez, Francisca; Santero, Eduardo			The Ferredoxin ThnA3 Negatively Regulates Tetralin Biodegradation Gene Expression via ThnY, a Ferredoxin Reductase That Functions as a Regulator of the Catabolic Pathway	PLOS ONE			English	Article							NAPHTHALENE DIOXYGENASE; PURIFICATION; IDENTIFICATION; COMPONENT; SYSTEM; SITE	The genes for tetralin (thn) utilization in Sphingomonas macrogolitabida strain TFA are regulated at the transcriptional level by ThnR, ThnY and ThnA3. ThnR, a LysR-type transcriptional activator activates transcription specifically in response to tetralin, and ThnY is an iron-sulfur flavoprotein that may activate ThnR by protein-protein interaction. ThnA3, a Rieske-type ferredoxin that transfers electrons to the tetralin dioxygenase, prevents transcription of thn genes when the inducer molecule of the pathway is a poor substrate for the dioxygenase. The mechanism by which ThnA3 transduces this signal to the regulatory system is a major question concerning thn gene regulation. Here, we have confirmed the discriminatory function of ThnA3 and the negative role of its reduced form. We have generated ThnY variants with amino acid exchanges in the [2Fe-2S], FAD and NAD(P) H binding domains and their regulatory properties have been analyzed. Two variants, ThnY-C40S and ThnY-N201G, S206P have completely lost the discriminatory function of the regulatory system because they induced thn gene expression with different molecules such us cis-decalin, cyclohexane, trans-decalin, or benzene, which are not real inducers of the pathway. These results support a model in which ThnA3 exerts its negative modulation via the regulator ThnY.	[Ledesma-Garcia, Laura; Reyes-Ramirez, Francisca; Santero, Eduardo] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, CSIC, Seville, Spain; [Ledesma-Garcia, Laura; Reyes-Ramirez, Francisca; Santero, Eduardo] Univ Pablo de Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Universidad Pablo de Olavide	Reyes-Ramirez, F (corresponding author), Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, CSIC, Seville, Spain.	freyram@upo.es	Garcia, Laura Ledesma/AAA-6524-2021; Santero, Eduardo/K-6510-2014; Reyes-Ramirez, Francisca/L-3314-2014	Garcia, Laura Ledesma/0000-0003-3276-2192; Reyes-Ramirez, Francisca/0000-0002-5120-8931; Santero, Eduardo/0000-0002-6111-7160	Spanish Ministry of Science and Innovation grants [BIO2011-24003, CSD2007-00005]	Spanish Ministry of Science and Innovation grants(Ministry of Science and Innovation, Spain (MICINN))	This study was supported by Spanish Ministry of Science and Innovation grants BIO2011-24003 and CSD2007-00005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andujar E, 2000, J BACTERIOL, V182, P789, DOI 10.1128/JB.182.3.789-795.2000; Batie CJ, 1990, PHTHALATE DIOXYGENAS, P544; Crack JC, 2012, ANTIOXID REDOX SIGNA; DORN E, 1974, ARCH MICROBIOL, V99, P61, DOI 10.1007/BF00696222; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; HAIGLER BE, 1990, J BACTERIOL, V172, P457, DOI 10.1128/JB.172.1.457-464.1990; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Karlsson A, 2002, J MOL BIOL, V318, P261, DOI 10.1016/S0022-2836(02)00039-6; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Garcia LL, 2011, J BIOL CHEM, V286, P1709, DOI 10.1074/jbc.M110.184648; Lopez-Sanchez A, 2010, APPL ENVIRON MICROB, V76, P110, DOI 10.1128/AEM.01846-09; Lopez-Sanchez A, 2009, MOL MICROBIOL, V73, P1086, DOI 10.1111/j.1365-2958.2009.06834.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martinez-Perez O, 2004, J BACTERIOL, V186, P6101, DOI 10.1128/JB.186.18.6101-6109.2004; Martinez-Perez O, 2007, J BACTERIOL, V189, P3768, DOI 10.1128/JB.00057-07; Moreno-Ruiz E, 2003, J BACTERIOL, V185, P2026, DOI 10.1128/JB.185.6.2026-2030.2003; Nam JW, 2002, APPL ENVIRON MICROB, V68, P5882, DOI 10.1128/AEM.68.12.5882-5890.2002; Parales RE, 2000, J BACTERIOL, V182, P1641, DOI 10.1128/JB.182.6.1641-1649.2000; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; Sambrook J., 2001, MOL CLONING LAB MANU; YAMAGUCHI M, 1980, J BIOL CHEM, V255, P5058	25	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73910	10.1371/journal.pone.0073910	http://dx.doi.org/10.1371/journal.pone.0073910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069247	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100070
J	Nelson, CD; Sheng, M				Nelson, Christopher D.; Sheng, Morgan			GPR3 Stimulates A beta Production via Interactions with APP and beta-Arrestin2	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; ALPHA(1B)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; CLATHRIN ADAPTER; MEIOTIC ARREST; GENERATION; PRECURSOR; MUTATION	The orphan G protein-coupled receptor (GPCR) GPR3 enhances the processing of Amyloid Precursor Protein (APP) to the neurotoxic beta-amyloid (A beta) peptide via incompletely understood mechanisms. Through overexpression and shRNA knockdown experiments in HEK293 cells, we show that beta-arrestin2 (barr2), a GPCR-interacting scaffold protein reported to bind c-secretase, is an essential factor for GPR3-stimulated A beta production. For a panel of GPR3 receptor mutants, the degree of stimulation of A beta production correlates with receptor-beta-arrestin binding and receptor trafficking to endocytic vesicles. However, GPR3's recruitment of barr2 cannot be the sole explanation, because interaction with barr2 is common to most GPCRs, whereas GPR3 is relatively unique among GPCRs in enhancing A beta production. In addition to beta-arrestin, APP is present in a complex with GPR3 and stimulation of A beta production by GPR3 mutants correlates with their level of APP binding. Importantly, among a broader selection of GPCRs, only GPR3 and prostaglandin E receptor 2 subtype EP2 (PTGER2; another GPCR that increases A beta production) interact with APP, and PTGER2 does so in an agonist-stimulated manner. These data indicate that a subset of GPCRs, including GPR3 and PTGER2, can associate with APP when internalized via barr2, and thereby promote the cleavage of APP to generate A beta.	[Nelson, Christopher D.; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA	Roche Holding; Genentech	Sheng, M (corresponding author), Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA.	sheng.morgan@gene.com		Sheng, Morgan/0000-0002-8703-5366				Acharya S, 1996, J BIOL CHEM, V271, P25406, DOI 10.1074/jbc.271.41.25406; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Golde TE, 2010, EXP NEUROL, V223, P252, DOI 10.1016/j.expneurol.2009.07.035; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Greasley PJ, 2001, J BIOL CHEM, V276, P46485, DOI 10.1074/jbc.M105791200; GUAN XM, 1992, J BIOL CHEM, V267, P21995; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 2010, APP MUTATIONS TABLE; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; IISMAA TP, 1994, GENOMICS, V24, P391, DOI 10.1006/geno.1994.1635; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Konvicka K, 2000, PROTEIN ENG, V13, P395, DOI 10.1093/protein/13.6.395; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; Page RM, 2012, J NEUROSCI, V32, P18204, DOI 10.1523/JNEUROSCI.2681-12.2012; Pooler AM, 2004, NEUROSCI LETT, V362, P127, DOI 10.1016/j.neulet.2004.03.013; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Scheer A, 2000, MOL PHARMACOL, V57, P219; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Teng L, 2010, CELL RES, V20, P138, DOI 10.1038/cr.2010.3; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100	43	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74680	10.1371/journal.pone.0074680	http://dx.doi.org/10.1371/journal.pone.0074680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069330	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100115
J	Wu, GR; Stramaglia, S; Chen, HF; Liao, W; Marinazzo, D				Wu, Guo-Rong; Stramaglia, Sebastiano; Chen, Huafu; Liao, Wei; Marinazzo, Daniele			Mapping the Voxel-Wise Effective Connectome in Resting State fMRI	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY MRI; GRAPH-THEORETICAL ANALYSIS; BRAIN NETWORKS; GRANGER CAUSALITY; HEAD MOTION; ORGANIZATION; DECONVOLUTION; CRITICALITY; CORTEX; HUBS	A network approach to brain and dynamics opens new perspectives towards understanding of its function. The functional connectivity from functional MRI recordings in humans is widely explored at large scale, and recently also at the voxel level. The networks of dynamical directed connections are far less investigated, in particular at the voxel level. To reconstruct full brain effective connectivity network and study its topological organization, we present a novel approach to multivariate Granger causality which integrates information theory and the architecture of the dynamical network to efficiently select a limited number of variables. The proposed method aggregates conditional information sets according to community organization, allowing to perform Granger causality analysis avoiding redundancy and overfitting even for high-dimensional and short datasets, such as time series from individual voxels in fMRI. We for the first time depicted the voxel-wise hubs of incoming and outgoing information, called Granger causality density (GCD), as a complement to previous repertoire of functional and anatomical connectomes. Analogies with these networks have been presented in most part of default mode network; while differences suggested differences in the specific measure of centrality. Our findings could open the way to a new description of global organization and information influence of brain function. With this approach is thus feasible to study the architecture of directed networks at the voxel level and individuating hubs by investigation of degree, betweenness and clustering coefficient.	[Wu, Guo-Rong; Marinazzo, Daniele] Univ Ghent, Dept Data Anal, Fac Psychol & Educ Sci, B-9000 Ghent, Belgium; [Wu, Guo-Rong; Chen, Huafu] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Stramaglia, Sebastiano] Univ Bari, Dipartimento Fis, Bari, Italy; [Stramaglia, Sebastiano] Ist Nazl Fis Nucl, I-70126 Bari, Italy; [Liao, Wei] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liao, Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China	Ghent University; University of Electronic Science & Technology of China; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Hangzhou Normal University; Hangzhou Normal University	Marinazzo, D (corresponding author), Univ Ghent, Dept Data Anal, Fac Psychol & Educ Sci, B-9000 Ghent, Belgium.	weiliao.wl@gmail.com; daniele.marinazzo@ugent.be	Marinazzo, Daniele/H-4793-2019; stramaglia, sebastiano/H-7582-2015	Marinazzo, Daniele/0000-0002-9803-0122; stramaglia, sebastiano/0000-0002-5873-8564	China Scolarship Council [2011607033]; Natural Science Foundation of China [81201155]; Belgian Science Policy (IUAP VII) [CEREBNET P7 11]	China Scolarship Council; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Belgian Science Policy (IUAP VII)	This work was supported by the China Scolarship Council (grant number 2011607033 for G-RW), the Natural Science Foundation of China (grant number 81201155 for WL), and the Belgian Science Policy (IUAP VII project CEREBNET P7 11 for DM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carp J, 2013, NEUROIMAGE, V76, P436, DOI 10.1016/j.neuroimage.2011.12.061; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Davis B., 2013, CEREB CORTEX; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fallani FDV, 2007, HUM BRAIN MAPP, V28, P1334, DOI 10.1002/hbm.20353; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2011, NEUROIMAGE, V58, P303, DOI 10.1016/j.neuroimage.2009.09.031; Garg R, 2011, NEUROIMAGE, V58, P416, DOI 10.1016/j.neuroimage.2011.02.074; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Handwerker DA, 2012, NEUROIMAGE, V62, P1017, DOI 10.1016/j.neuroimage.2012.02.015; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Jiao Q, 2011, HUM BRAIN MAPP, V32, P154, DOI 10.1002/hbm.21065; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Marinazzo D, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/303601; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Moussa MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044428; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Petridou N., 2012, HUM BRAIN MAPP; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Richiardi J, 2011, NEUROIMAGE, V56, P616, DOI 10.1016/j.neuroimage.2010.05.081; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Roebroeck A, 2011, NEUROIMAGE, V58, P296, DOI 10.1016/j.neuroimage.2009.09.036; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Sepulcre J, 2012, J NEUROSCI, V32, P10649, DOI 10.1523/JNEUROSCI.0759-12.2012; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Tagliazucchi E, 2010, NEUROSCI LETT, V485, P26, DOI 10.1016/j.neulet.2010.08.053; Tang W, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002513; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wink AM, 2012, BRAIN CONNECT, V2, P265, DOI 10.1089/brain.2012.0087; Wu GR, 2013, BRAIN CONNECT, V3, P294, DOI 10.1089/brain.2013.0142; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Wu GR, 2012, LECT NOTES COMPUT SC, V7663, P226, DOI 10.1007/978-3-642-34475-6_28; Yan CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023460; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhou ZY, 2009, HUM BRAIN MAPP, V30, P2197, DOI 10.1002/hbm.20661; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	64	31	31	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73670	10.1371/journal.pone.0073670	http://dx.doi.org/10.1371/journal.pone.0073670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069220	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100053
J	Yang, Z; Garcia, A; Xu, SL; Powell, DR; Vertino, PM; Singh, S; Marcus, AI				Yang, Zhen; Garcia, Anapatricia; Xu, Songli; Powell, Doris R.; Vertino, Paula M.; Singh, Shivendra; Marcus, Adam I.			Withania somnifera Root Extract Inhibits Mammary Cancer Metastasis and Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							BREAST-CANCER; WITHAFERIN-A; PROGNOSTIC-SIGNIFICANCE; INTERMEDIATE-FILAMENTS; REGULATED EXPRESSION; VIMENTIN EXPRESSION; UP-REGULATION; CELL-CYCLE; CARCINOMA; APOPTOSIS	Though clinicians can predict which patients are at risk for developing metastases, traditional therapies often prove ineffective and metastatic disease is the primary cause of cancer patient death; therefore, there is a need to develop anti-metastatic therapies that can be administered over long durations to specifically inhibit the motility of cancer cells. Withania somnifera root extracts (WRE) have anti-proliferative activity and the active component, Withaferin A, inhibits the pro-metastatic protein, vimentin. Vimentin is an intermediate filament protein and is part of the epithelial to mesenchymal transition (EMT) program to promote metastasis. Here, we determined whether WRE standardized to Withaferin A (sWRE) possesses anti-metastatic activity and whether it inhibits cancer motility via inhibition of vimentin and the EMT program. Several formulations of sWRE were created to enrich for Withaferin A and a stock solution of sWRE in EtOH could recover over 90% of the Withaferin A found in the original extract powder. This sWRE formulation inhibited breast cancer cell motility and invasion at concentrations less than 1 mu M while having negligible cytotoxicity at this dose. sWRE treatment disrupted vimentin morphology in cell lines, confirming its vimentin inhibitory activity. To determine if sWRE inhibited EMT, TGF-beta was used to induce EMT in MCF10A human mammary epithelial cells. In this case, sWRE prevented EMT induction and inhibited 3-D spheroid invasion. These studies were taken into a human xenograft and mouse mammary carcinoma model. In both models, sWRE and Withaferin A showed dose-dependent inhibition of tumor growth and metastatic lung nodule formation with minimal systemic toxicity. Taken together, these data support the hypothesis that low concentrations of sWRE inhibit cancer metastasis potentially through EMT inhibition. Moreover, these doses of sWRE have nearly no toxicity in normal mouse organs, suggesting the potential for clinical use of orally administered WRE capsules.	[Yang, Zhen; Xu, Songli; Marcus, Adam I.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Garcia, Anapatricia] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Powell, Doris R.; Vertino, Paula M.] Emory Univ, Dept Radiat Oncol, Winship Canc Inst, Sch Med, Atlanta, GA USA; [Singh, Shivendra] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA USA; [Singh, Shivendra] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA	Emory University; Emory University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Marcus, AI (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA.	aimarcu@emory.edu			National Center for Complementary and Alternative Medicine [1R21AT005231]; Godfrey Charitable Trust; Golfer's Against Cancer; P30 CCSG [3P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292, R01CA077337] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT005231] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Godfrey Charitable Trust; Golfer's Against Cancer; P30 CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by an R21 from the National Center for Complementary and Alternative Medicine (1R21AT005231) awarded to AIM, the Godfrey Charitable Trust, and Golfer's Against Cancer. This work was also supported by a P30 CCSG awarded to the Winship Cancer Institute (3P30CA138292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Ali M, 1997, PHYTOCHEMISTRY, V44, P1163, DOI 10.1016/S0031-9422(96)00656-5; ANDREOLI JM, 1995, CELL MOTIL CYTOSKEL, V32, P10, DOI 10.1002/cm.970320103; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chen MHS, 2008, MODERN PATHOL, V21, P1183, DOI 10.1038/modpathol.2008.90; Choo Jennifer R, 2010, Cancers (Basel), V2, P1040, DOI 10.3390/cancers2021040; Christina AJM, 2004, J ETHNOPHARMACOL, V93, P359, DOI 10.1016/j.jep.2004.04.004; Chung BM, 2013, CURR OPIN CELL BIOL, V25, P600, DOI 10.1016/j.ceb.2013.06.008; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Das Chaurasiya N, 2008, PHYTOCHEM ANALYSIS, V19, P148, DOI 10.1002/pca.1029; Dauphin M, 2013, LUNG CANCER, V81, P117, DOI 10.1016/j.lungcan.2013.03.011; Domagala W, 1996, CLIN CANCER RES, V2, P147; Eckes B, 2000, J CELL SCI, V113, P2455; Fan LY, 2012, SCAND J RHEUMATOL, V41, P354, DOI 10.3109/03009742.2012.670263; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Grogan PT, 2013, INVEST NEW DRUG, V31, P545, DOI 10.1007/s10637-012-9888-5; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Holwell TA, 1997, J CELL SCI, V110, P1947; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Jones SE, 2008, CLIN BREAST CANCER, V8, P224, DOI 10.3816/CBC.2008.n.025; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Kusinska RU, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-118; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Leyon PV, 2004, PHYTOTHER RES, V18, P118, DOI 10.1002/ptr.1378; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Liu ZD, 1997, BIOCHEM BIOPH RES CO, V231, P283, DOI 10.1006/bbrc.1997.6083; Lund N, 2010, BIOCHEM BIOPH RES CO, V395, P401, DOI 10.1016/j.bbrc.2010.04.033; Mathur R, 2006, J ETHNOPHARMACOL, V105, P336, DOI 10.1016/j.jep.2005.11.020; Mayola E, 2011, APOPTOSIS, V16, P1014, DOI 10.1007/s10495-011-0625-x; Misra L, 2008, PHYTOCHEMISTRY, V69, P1000, DOI 10.1016/j.phytochem.2007.10.024; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Munagala R, 2011, CARCINOGENESIS, V32, P1697, DOI 10.1093/carcin/bgr192; Muralikrishnan G, 2010, IMMUNOL INVEST, V39, P688, DOI 10.3109/08820139.2010.487083; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Prakash J, 2002, NUTR CANCER, V42, P91, DOI 10.1207/S15327914NC421_12; Prakash J, 2001, PHYTOTHER RES, V15, P240, DOI 10.1002/ptr.779; Rodriguez Luis G., 2004, V294, P23; Roxanis I, 2013, J CLIN PATHOL, V66, P517, DOI 10.1136/jclinpath-2012-201348; SARRIA AJ, 1990, J CELL BIOL, V111, P553, DOI 10.1083/jcb.111.2.553; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Senthilnathan P, 2006, CHEM-BIOL INTERACT, V159, P180, DOI 10.1016/j.cbi.2005.11.003; Singh S, 2003, CANCER RES, V63, P2306; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Srinivasan S, 2007, CANCER RES, V67, P246, DOI 10.1158/0008-5472.CAN-06-2430; Stan SD, 2008, CANCER RES, V68, P7661, DOI 10.1158/0008-5472.CAN-08-1510; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Sun BC, 2008, CLIN CANCER RES, V14, P7050, DOI 10.1158/1078-0432.CCR-08-0520; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Thaiparambil JT, 2012, MOL CELL BIOL, V32, P3203, DOI 10.1128/MCB.00418-12; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Urn HJ, 2012, BIOCHEM BIOPH RES CO, V427, P24, DOI 10.1016/j.bbrc.2012.08.133; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Viale Giuseppe, 2009, Eur J Cancer, V45 Suppl 1, P5, DOI 10.1016/S0959-8049(09)70011-5; Wang JW, 2009, CANCER LETT, V281, P71, DOI 10.1016/j.canlet.2009.02.020; Wei JC, 2008, ANTICANCER RES, V28, P327; Yamashita N, 2013, J CANCER RES CLIN, V139, P739, DOI 10.1007/s00432-013-1376-6; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	67	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75069	10.1371/journal.pone.0075069	http://dx.doi.org/10.1371/journal.pone.0075069			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069380	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000326240100120
J	Liu, JX; Newby, G; Brackery, A; Gueye, CS; Candari, CJ; Escubil, LR; Vestergaard, LS; Baquilod, M				Liu, Jenny X.; Newby, Gretchen; Brackery, Aprielle; Gueye, Cara Smith; Candari, Christine J.; Escubil, Luz R.; Vestergaard, Lasse S.; Baquilod, Mario			Determinants of Malaria Program Expenditures during Elimination: Case Study Evidence from Select Provinces in the Philippines	PLOS ONE			English	Article								Even though eliminating malaria from the endemic margins is a part of the Global Malaria Action Plan, little guidance exists on what resources are needed to transition from controlling malaria to eliminating it. Using Philippines as an example, this study aimed to (1) estimate the financial resources used by sub-national malaria programs in different phases during elimination and (2) understand how different environmental and organizational factors may influence expenditure levels and spending proportions. The Philippines provides an opportunity to study variations in sub-national programs because its epidemiological and ecological diversity, devolved health system, and progressive elimination strategy all allow greater flexibility for lower-level governments to direct activities, but also create challenges for coordination and resource mobilization. Through key informant interviews and archival record retrieval in four selected provinces chosen based on eco-epidemiological variation, expenditures associated with provincial malaria programs were collected for selected years (mid-1990s to 2010). Results show that expenditures per person at risk per year decrease as programs progress from a state of controlled low-endemic malaria to elimination to prevention of reintroduction regardless of whether elimination was deliberately planned. However, wide variation across provinces were found: expenditures were generally higher if mainly financed with donor grants, but were moderated by the level of economic development, the level of malaria transmission and receptivity, and the capacity of program staff. Across all provinces, strong leadership appears to be a necessary condition for maintaining progress and is vital in controlling outbreaks. While sampled provinces and years may not be representative of other sub-national malaria programs, these findings suggest that the marginal yearly cost declines with each phase during elimination.	[Liu, Jenny X.; Newby, Gretchen; Gueye, Cara Smith] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Brackery, Aprielle] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Candari, Christine J.; Baquilod, Mario] Govt Philippines, Dept Hlth, Manila, Philippines; [Vestergaard, Lasse S.] WHO, Philippines Country Off, Manila, Philippines	University of California System; University of California San Francisco; Columbia University; Philippine Department Health; WHO Western Pacific Regional Office; World Health Organization	Liu, JX (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	liuj@globalhealth.ucsf.edu		Candari, Christine Joy/0000-0002-0168-0947	Bill and Melinda Gates Foundation; World Health Organization Philippines Country Office; Asia Pacific Malaria Elimination Network through the Australian Agency for International Development (AusAID)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); World Health Organization Philippines Country Office; Asia Pacific Malaria Elimination Network through the Australian Agency for International Development (AusAID)	This study was supported by grants from the Bill and Melinda Gates Foundation, the World Health Organization Philippines Country Office, and the Asia Pacific Malaria Elimination Network through a grant from the Australian Agency for International Development (AusAID). Technical assistance and in-kind contributions were provided by the Philippines Department of Health. Lasse S. Vestergaard is a staff member of the World Health Organization. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of the World Health Organization. Mario Bauquilod and Christine J. Candari are staff members of the Philippines Department of Health. Their views expressed in this publication do not necessarily represent the views of the Government of the Philippines. No individuals from the Bill and Melinda Gates Foundation and the Asia Pacific Malaria Elimination Network had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyasinghe RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043162; *BACK ROLL MAL PAR, 2008, GLOB MAL ACT PLAN MA; Beaver C., 2011, INT J GEOINFORMATICS, V7, P15; *CAV PROV HLTH TEA, 1998, MAL CAS; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; COTTER C, 2013, LANCET; Espino F, 2004, INT J HEALTH PLAN M, V19, pS155, DOI 10.1002/hpm.782; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; *INT REV SERV, 1987, REV PROC ACC COST RE; ISIDORO M, 2007, ENVIRON URBAN, V19, P191, DOI DOI 10.1177/0956247807076782; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Mills A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S11; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; *REP PHI DEP HLTH, 2004, EV MAL SIT PROV BENG; *REP PHIL DEP HLTH, 2005, EV MAL SIT PROV CAV; *REP PHIL DEP HLTH, 2011, MAL MED TERM DEV PLA, P2011; *REP PHIL DEP HLTH, 2012, MAL CAS DEATHS; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Smith DL, 2011, SCIENCE, V332, P1384, DOI 10.1126/science.1201398; Tatarsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023832; *WORLD BANK, 2012, WORLD DEV IND 2012 P; World Health Organization, 2007, MAL EL FIELD MAN LOW	23	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73352	10.1371/journal.pone.0073352	http://dx.doi.org/10.1371/journal.pone.0073352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086279	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900014
J	Baban, ST; Kuehne, SA; Barketi-Klai, A; Cartman, ST; Kelly, ML; Hardie, KR; Kansau, I; Collignon, A; Minton, NP				Baban, Soza T.; Kuehne, Sarah A.; Barketi-Klai, Amira; Cartman, Stephen T.; Kelly, Michelle L.; Hardie, Kim R.; Kansau, Imad; Collignon, Anne; Minton, Nigel P.			The Role of Flagella in Clostridium difficile Pathogenesis: Comparison between a Non-Epidemic and an Epidemic Strain	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; FIBRONECTIN-BINDING PROTEIN; TOXIN-B; MOTILITY; ADHERENCE; IDENTIFICATION; COLONIZATION; VIRULENCE; ADHESINS; GENOME	Clostridium difficile is a major cause of healthcare-associated infection and inflicts a considerable financial burden on healthcare systems worldwide. Disease symptoms range from self-limiting diarrhoea to fatal pseudomembranous colitis. Whilst C. difficile has two major virulence factors, toxin A and B, it is generally accepted that other virulence components of the bacterium contribute to disease. C. difficile colonises the gut of humans and animals and hence the processes of adherence and colonisation are essential for disease onset. Previously it has been suggested that flagella might be implicated in colonisation. Here we tested this hypothesis by comparing flagellated parental strains to strains in which flagella genes were inactivated using ClosTron technology. Our focus was on a UK-outbreak, PCR-ribotype 027 (B1/NAP1) strain, R20291. We compared the flagellated wild-type to a mutant with a paralyzed flagellum and also to mutants (fliC, fliD and flgE) that no longer produce flagella in vitro and in vivo. Our results with R20291 provide the first strong evidence that by disabling the motor of the flagellum, the structural components of the flagellum rather than active motility, is needed for adherence and colonisation of the intestinal epithelium during infection. Comparison to published data on 630 Delta erm and our own data on that strain revealed major differences between the strains: the R20291 flagellar mutants adhered less than the parental strain in vitro, whereas we saw the opposite in 630 Delta erm. We also showed that flagella and motility are not needed for successful colonisation in vivo using strain 630 Delta erm. Finally we demonstrated that in strain R20291, flagella do play a role in colonisation and adherence and that there are striking differences between C. difficile strains. The latter emphasises the overriding need to characterize more than just one strain before drawing general conclusions concerning specific mechanisms of pathogenesis.	[Baban, Soza T.; Kuehne, Sarah A.; Cartman, Stephen T.; Kelly, Michelle L.; Hardie, Kim R.; Minton, Nigel P.] Univ Nottingham, Ctr Biomol Sci, NIHR Biomed Res Unit GI Dis, Clostridia Res Grp, Nottingham NG7 2RD, England; [Barketi-Klai, Amira; Kansau, Imad; Collignon, Anne] Univ Paris 11, Fac Pharm, EA4043, F-92290 Chatenay Malabry, France	University of Nottingham; UDICE-French Research Universities; Universite Paris Saclay	Minton, NP (corresponding author), Univ Nottingham, Ctr Biomol Sci, NIHR Biomed Res Unit GI Dis, Clostridia Res Grp, Nottingham NG7 2RD, England.	nigel.minton@nottingham.ac.uk	Kuehne, Sarah/AAV-3481-2021; Kansau, Imad/GRX-4789-2022; Baban, Soza Tharwat/AAA-9981-2020	Kuehne, Sarah/0000-0001-6790-8433; Kansau, Imad/0000-0002-1893-6822; Baban, Soza Tharwat/0000-0003-3921-7496; Minton, Nigel/0000-0002-9277-1261; Hardie, Kim/0000-0002-4892-2739	UK Medical Research Council (MRC) [G0601176]; European Community [HEALTH-F3-2008-223585]; MRC [G0601176] Funding Source: UKRI; Medical Research Council [G0601176] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge the financial support of the UK Medical Research Council (MRC) Grant No. G0601176 and the European Community's Seventh Framework Programme 'HYPERDIFF' (HEALTH-F3-2008-223585). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora SK, 1998, INFECT IMMUN, V66, P1000, DOI 10.1128/IAI.66.3.1000-1007.1998; Aubry A, 2012, INFECT IMMUN, V80, P3521, DOI 10.1128/IAI.00224-12; Barketi-Klai A, 2011, J MED MICROBIOL, V60, P1155, DOI 10.1099/jmm.0.029553-0; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Calabi E, 2002, J BACTERIOL, V184, P3886, DOI 10.1128/JB.184.14.3886-3897.2002; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Cartman ST, 2010, INT J MED MICROBIOL, V300, P387, DOI 10.1016/j.ijmm.2010.04.008; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Dingle TC, 2011, INFECT IMMUN, V79, P4061, DOI 10.1128/IAI.05305-11; Duan QD, 2013, J BASIC MICROB, V53, P1, DOI [10.1002/jobm.201100335, 10.1002/jobm.201370001]; Eaton KA, 1996, INFECT IMMUN, V64, P2445, DOI 10.1128/IAI.64.7.2445-2448.1996; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Giron JA, 2002, MOL MICROBIOL, V44, P361, DOI 10.1046/j.1365-2958.2002.02899.x; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; LYERLY DM, 1991, J CLIN MICROBIOL, V29, P2639, DOI 10.1128/JCM.29.11.2639-2642.1991; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; O'Neil HS, 2006, INFECT IMMUN, V74, P6675, DOI 10.1128/IAI.00886-06; Ormonde P, 2000, J BACTERIOL, V182, P2326, DOI 10.1128/JB.182.8.2326-2328.2000; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Rashid MH, 2000, J BACTERIOL, V182, P225, DOI 10.1128/JB.182.1.225-227.2000; Sambrook J., 2001, MOL CLONING LAB MANU; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Tasteyre A, 2000, J CLIN MICROBIOL, V38, P3179, DOI 10.1128/JCM.38.9.3179-3186.2000; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Tasteyre A, 2001, J CLIN MICROBIOL, V39, P1178, DOI 10.1128/JCM.39.3.1178-1183.2001; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Wright KJ, 2005, INFECT IMMUN, V73, P7657, DOI 10.1128/IAI.73.11.7657-7668.2005	37	79	79	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73026	10.1371/journal.pone.0073026	http://dx.doi.org/10.1371/journal.pone.0073026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086268	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000326520200005
J	Ben Aharon, I; Bar Joseph, H; Tzabari, M; Shenkman, B; Farzam, N; Levi, M; Shalgi, R; Stemmer, SM; Savion, N				Ben Aharon, Irit; Bar Joseph, Hadas; Tzabari, Moran; Shenkman, Boris; Farzam, Nahid; Levi, Mattan; Shalgi, Ruth; Stemmer, Salomon M.; Savion, Naphtali			Doxorubicin-Induced Vascular Toxicity - Targeting Potential Pathways May Reduce Procoagulant Activity	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; ELEVATION MYOCARDIAL-INFARCTION; VENOUS THROMBOEMBOLISM; CANCER-PATIENTS; CHEMOTHERAPEUTIC-AGENTS; ENDOTHELIAL-CELLS; BREAST-CANCER; EPTIFIBATIDE; SURVIVAL; CARDIOMYOCYTE	Introduction: Previous study in mice using real-time intravital imaging revealed an acute deleterious effect of doxorubicin (DXR) on the gonadal vasculature, as a prototype of an end-organ, manifested by a reduction in blood flow and disintegration of the vessel wall. We hypothesized that this pattern may represent the formation of microthrombi. We aimed to further characterize the effect of DXR on platelets' activity and interaction with endothelial cells (EC) and to examine potential protectants to reduce DXR acute effect on the blood flow. Methods: The effect of DXR on platelet adhesion and aggregation were studied in vitro. For in vivo studies, mice were injected with either low molecular weight heparin (LMWH; Enoxaparin) or with eptifibatide (Integrilin (c)) prior to DXR treatment. Testicular arterial blood flow was examined in real-time by pulse wave Doppler ultrasound. Results: Platelet treatment with DXR did not affect platelet adhesion to a thrombogenic surface but significantly decreased ADP-induced platelet aggregation by up to 40% (p<0.001). However, there was a significant increase in GPIIbIIIa-mediated platelet adhesion to DXR-exposed endothelial cells (EC; 5.7-fold; p<0.001) reflecting the toxic effect of DXR on EC. The testicular arterial blood flow was preserved in mice pre-treated with LMWH or eptifibatide prior to DXR (P<0.01). Conclusions: DXR-induced acute vascular toxicity may involve increased platelet-EC adhesion leading to EC-bound microthrombi formation resulting in compromised blood flow. Anti-platelet/anti-coagulant agents are effective in reducing the detrimental effect of DXR on the vasculature and thus may serve as potential protectants to lessen this critical toxicity.	[Ben Aharon, Irit; Stemmer, Salomon M.] Davidoff Ctr, Inst Oncol, Petah Tiqwa, Israel; [Ben Aharon, Irit; Stemmer, Salomon M.] Rabin Med Ctr, Petah Tiqwa, Israel; [Ben Aharon, Irit; Stemmer, Salomon M.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Bar Joseph, Hadas; Tzabari, Moran; Levi, Mattan; Shalgi, Ruth] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Shenkman, Boris] Chaim Sheba Med Ctr, Amalia Biron Res Inst Thrombosis & Hemostasis, IL-52621 Tel Hashomer, Israel; [Farzam, Nahid] Tel Aviv Univ, Sackler Fac Med, Goldschleger Eye Res Inst, IL-69978 Tel Aviv, Israel; [Farzam, Nahid] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Ben Aharon, I (corresponding author), Davidoff Ctr, Inst Oncol, Petah Tiqwa, Israel.	iritbenaharon@gmail.com	Savion, Naphtali/K-1013-2019; Shenkman, Boris/AAB-1536-2020	Savion, Naphtali/0000-0001-8899-0624	Israel Cancer Association (ICA)	Israel Cancer Association (ICA)	This work was partially supported by a grant from the Israel Cancer Association (ICA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Arola OJ, 2000, CANCER RES, V60, P1789; Baltabaeva A, 2009, J HYPERTENS, V27, P2086, DOI 10.1097/HJH.0b013e32832f4f3d; Bar-Joseph H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023492; Beinert T, 1999, Eur J Med Res, V4, P43; Blom JW, 2004, J THROMB HAEMOST, V2, P1760, DOI 10.1111/j.1538-7836.2004.00928.x; Chaosuwannakit N, 2010, J CLIN ONCOL, V28, P166, DOI 10.1200/JCO.2009.23.8527; Chow AY, 2006, J CLIN ONCOL, V24, P925, DOI 10.1200/JCO.2005.03.5956; CLAHSEN PC, 1994, J CLIN ONCOL, V12, P1266, DOI 10.1200/JCO.1994.12.6.1266; Deepa PR, 2003, CHEM-BIOL INTERACT, V146, P201, DOI 10.1016/j.cbi.2003.08.003; Deepa PR, 2006, TOXICOLOGY, V16, P217; Deibele AJ, 2006, J THROMB THROMBOLYS, V22, P47, DOI 10.1007/s11239-006-7454-8; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Gibson CM, 2004, CIRCULATION, V110, P679, DOI 10.1161/01.CIR.0000137912.11655.F6; Goto S, 2004, J AM COLL CARDIOL, V44, P316, DOI 10.1016/j.jacc.2004.02.059; Hoshi A, 2011, BLOOD COAGUL FIBRIN, V22, P532, DOI 10.1097/MBC.0b013e328348629d; Hull R, 2003, THROMB HAEMOST S, p137a; Kakkar AK, 2004, J CLIN ONCOL, V22, P1944, DOI 10.1200/JCO.2004.10.002; Kaushal V, 2001, ENDOTHELIUM, V11, P253; Kim EJ, 2009, J THROMB HAEMOST, V7, P1172, DOI 10.1111/j.1538-7836.2009.03477.x; Kirwan CC, 2008, BRIT J CANCER, V99, P1000, DOI 10.1038/sj.bjc.6604620; Klerk CPW, 2005, J CLIN ONCOL, V23, P2130, DOI 10.1200/JCO.2005.03.134; Kuroda N, 2004, PATHOL INT, V54, P719, DOI 10.1111/j.1440-1827.2004.01685.x; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lee AYY, 2005, J CLIN ONCOL, V23, P2123, DOI 10.1200/JCO.2005.03.133; Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729; Moser M, 2003, J CARDIOVASC PHARM, V41, P586, DOI 10.1097/00005344-200304000-00011; Mousa SA, 2006, THROMB HAEMOSTASIS, V96, P816, DOI 10.1160/TH06-05-0289; Murata T, 2004, BRIT J PHARMACOL, V132, P1365; Nuver J, 2005, J CLIN ONCOL, V23, P9130, DOI 10.1200/JCO.2005.01.4092; Otten HMMB, 2004, ARCH INTERN MED, V164, P190, DOI 10.1001/archinte.164.2.190; Paredes N, 2003, BRIT J HAEMATOL, V120, P315, DOI 10.1046/j.1365-2141.2003.03971.x; Porat Y, 2006, BRIT J HAEMATOL, V135, P703, DOI 10.1111/j.1365-2141.2006.06344.x; SAVION N, 1987, J CELL PHYSIOL, V130, P77, DOI 10.1002/jcp.1041300112; SAVION N, 1989, EUR J BIOCHEM, V183, P363, DOI 10.1111/j.1432-1033.1989.tb14937.x; Shah I, 2009, CORE EVID, V4, P49; Shenkman B, 2008, PLATELETS, V19, P440, DOI 10.1080/09537100802082256; Smith BS, 2001, J THROMB THROMBOLYS, V11, P39, DOI 10.1023/A:1008904310194; Sohn S, 2002, ECHOCARDIOGR-J CARD, V19, P207, DOI 10.1046/j.1540-8175.2002.00207.x; Stevenson JL, 2005, CLIN CANCER RES, V11, P7003, DOI 10.1158/1078-0432.CCR-05-1131; Swystun LL, 2011, J THROMB HAEMOST, V9, P2313, DOI 10.1111/j.1538-7836.2011.04465.x; Swystun LL, 2009, J THROMB HAEMOST, V7, P619, DOI 10.1111/j.1538-7836.2009.03300.x; Tcheng JE, 2000, LANCET, V356, P2037; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Varon D, 1997, THROMB RES, V85, P283, DOI 10.1016/S0049-3848(97)00014-5; WALSH J, 1992, BRIT J HAEMATOL, V81, P480, DOI 10.1111/j.1365-2141.1992.tb02978.x; Woodley-Cook J, 2006, MOL CANCER THER, V5, P3303, DOI 10.1158/1535-7163.MCT-06-0154; Wu S, 2002, J MOL CELL CARDIOL, V34, P1595, DOI 10.1006/jmcc.2002.2110; Yamac D, 2006, ULTRASTRUCT PATHOL, V30, P103, DOI 10.1080/01913120500406335; Yatsu Y, 2008, ANESTH ANALG, V106, P530, DOI 10.1213/ane.0b013e31816071b0	49	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75157	10.1371/journal.pone.0075157	http://dx.doi.org/10.1371/journal.pone.0075157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073244	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000053
J	Dauer, JT; Jongejans, E				Dauer, Joseph T.; Jongejans, Eelke			Elucidating the Population Dynamics of Japanese Knotweed Using Integral Projection Models	PLOS ONE			English	Article							FALLOPIA-JAPONICA; REYNOUTRIA-JAPONICA; SEXUAL REPRODUCTION; BIOLOGICAL-CONTROL; CENTRAL DIEBACK; PERENNIAL HERB; GROWTH	Plant demographic studies coupled with population modeling are crucial components of invasive plant management because they inform managers when in a plant's life cycle it is most susceptible to control efforts. Providing land managers with appropriate data can be especially challenging when there is limited data on potentially important transitions that occur belowground. For 2 years, we monitored 4 clonal Japanese knotweed (Polygonum cuspidatum) infestations for emergence, survival, shoot height until leaf senescence, dry shoot biomass after senescence, and rhizome connections for 424 shoots. We developed an integral projection model using both final autumn shoot height and shoot biomass as predictors of survival between years, growth from year to year, and number of rhizomes produced by a shoot (fecundity). Numbers of new shoots within an infestation (population growth rate lambda) were projected to increase 13-233% in a year, with the greatest increase at the most frequently disturbed site. Elasticity analysis revealed population growth at 3 of the 4 sites was primarily due to ramet survival between years and to year-to-year growth in shoot height and shoot biomass. Population growth at the fourth site, the most disturbed, was due to the large production of new rhizomes and associated shoots. In contrast to previous studies, our excavation revealed that most of the shoots were not interconnected, suggesting rhizome production may be limited by the size or age of the plants, resource availability, disturbance frequency, or other factors. Future integration of plant population models with more data on belowground growth structures will clarify the critical stages in Japanese knotweed life cycle and support land managers in their management decisions.	[Dauer, Joseph T.] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA; [Jongejans, Eelke] Radboud Univ Nijmegen, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands	University of Nebraska System; University of Nebraska Lincoln; Radboud University Nijmegen	Dauer, JT (corresponding author), Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA.	jdauer@msu.edu	Jongejans, Eelke/B-4832-2008	Jongejans, Eelke/0000-0003-1148-7419	US Department of Agriculture [AFRI 2010-85320-30068]; Netherlands Organization for Scientific Research (NWO) [meerwaarde-840.11.001]	US Department of Agriculture(United States Department of Agriculture (USDA)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was partly funded by the US Department of Agriculture (AFRI 2010-85320-30068 to JD) and the Netherlands Organization for Scientific Research (NWO grant meerwaarde-840.11.001 to EJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 1996, ANN BOT-LONDON, V77, P477, DOI 10.1006/anbo.1996.0058; Adachi N, 1996, ANN BOT-LONDON, V78, P169, DOI 10.1006/anbo.1996.0110; Bailey J. P., 1994, Ecology and management of invasive riverside plants., P141; Barney JN, 2006, CAN J PLANT SCI, V86, P887, DOI 10.4141/P05-170; Bashtanova UB, 2009, WEED SCI, V57, P584, DOI 10.1614/WS-09-069.1; BEERLING DJ, 1991, BIOL CONSERV, V55, P329, DOI 10.1016/0006-3207(91)90036-9; BEERLING DJ, 1994, J ECOL, V82, P959, DOI 10.2307/2261459; Berg H, 2002, ECOGRAPHY, V25, P233, DOI 10.1034/j.1600-0587.2002.250211.x; Bram MR, 2004, WEED SCI, V52, P759, DOI 10.1614/P2002-053; Brock J, 1992, 9 C INT BIOL MAUV HE, P85; Bruno JF, 2011, ECOL MONOGR, V81, P123, DOI 10.1890/09-1178.1; CAIN ML, 1990, OECOLOGIA, V82, P201, DOI 10.1007/BF00323536; Dauer JT, 2012, J APPL ECOL, V49, P322, DOI 10.1111/j.1365-2664.2012.02117.x; Davis AS, 2006, ECOL APPL, V16, P2399, DOI 10.1890/1051-0761(2006)016[2399:DMISOB]2.0.CO;2; de Kroon H, 2000, ECOLOGY, V81, P607, DOI 10.1890/0012-9658(2000)081[0607:EAROMA]2.0.CO;2; DEKROON H, 1991, FUNCT ECOL, V5, P360; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Ellner SP, 2006, AM NAT, V167, P410, DOI 10.1086/499438; Eriksson O., 1990, CLONAL GROWTH PLANTS, P79; Grevstad F, 2013, BIOL CONTROL, V65, P53, DOI 10.1016/j.biocontrol.2013.01.001; Grimsby JL, 2007, AM J BOT, V94, P957, DOI 10.3732/ajb.94.6.957; Hay MJM, 2008, EVOL ECOL, V22, P461, DOI 10.1007/s10682-007-9193-5; Hegland SJ, 2010, OECOLOGIA, V163, P695, DOI 10.1007/s00442-010-1616-2; Hesse E, 2008, AM NAT, V172, pE196, DOI 10.1086/591683; Hollingsworth ML, 2000, BOT J LINN SOC, V133, P463, DOI 10.1111/j.1095-8339.2000.tb01589.x; Jongejans E, 2008, PLANT ECOL, V198, P225, DOI 10.1007/s11258-008-9397-y; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; LOCANDRO RR, 1973, THESIS RUTGERS U NEW; Lyngstad A, 2010, THESIS NTNU NORWAY, P179; Maerz JC, 2005, BIODIVERS CONSERV, V14, P2901, DOI 10.1007/s10531-004-0223-0; Metcalf CJE, 2013, METHODS ECOL EVOL, V4, P195, DOI 10.1111/2041-210x.12001; PITELKA LF, 1985, J ECOL, V73, P169, DOI 10.2307/2259776; Price E, 2005, EVOL ECOL, V15, P347; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; Seiger LA, 1997, NAT AREA J, V17, P341; Shaw RH, 2011, WEED RES, V51, P552, DOI 10.1111/j.1365-3180.2011.00880.x; Smith JMD, 2007, ECOL MODEL, V200, P421, DOI 10.1016/j.ecolmodel.2006.08.004; SUZUKI J, 1994, ANN BOT-LONDON, V73, P629, DOI 10.1006/anbo.1994.1079; Tickner DP, 2001, PROG PHYS GEOG, V25, P22, DOI 10.1191/030913301673178792; Wikberg S, 2006, PLANT ECOL, V183, P55, DOI 10.1007/s11258-005-9006-2	40	14	14	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75181	10.1371/journal.pone.0075181	http://dx.doi.org/10.1371/journal.pone.0075181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073249	Green Published, gold			2022-12-27	WOS:000324768000058
J	Fernandes, AM; Beddows, E; Filippi, A; Driever, W				Fernandes, Antonio M.; Beddows, Erin; Filippi, Alida; Driever, Wolfgang			Orthopedia Transcription Factor otpa and otpb Paralogous Genes Function during Dopaminergic and Neuroendocrine Cell Specification in Larval Zebrafish	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; IMPAIRED STRESS-RESPONSE; HOMEODOMAIN PROTEIN; HYPOTHALAMIC NEURONS; MICE LACKING; BRAIN; EXPRESSION; SYSTEMS; EVOLUTION; LINEAGES	The homeodomain transcription factor Orthopedia (Otp) is an important regulator for specification of defined subsets of neuroendocrine cells and dopaminergic neurons in vertebrates. In zebrafish, two paralogous otp genes, otpa and otpb, are present in the genome. Neither complete loss of Otp activity nor differential contributions of Otpa and Otpb to specification of defined neuronal populations have been analyzed in detail. We characterized zebrafish embryos and early larvae mutant for null alleles of otpa, otpb, or both genes to determine their individual contributions to the specification of th expressing dopaminergic neuronal populations as well as of crh, oxt, avp, trh or sst1.1 expressing neuroendocrine cells. otpa mutant larvae show an almost complete reduction of ventral diencephalic dopaminergic neurons, as reported previously. A small reduction in the number of trh cells in the preoptic region is detectable in otpa mutants, but no significant loss of crh, oxt and avp preoptic neuroendocrine cells. otpb single mutant larvae do not display a reduction in dopaminergic neurons or neuroendocrine cells in the otp expressing regions. In contrast, in otpa and otpb double mutant larvae specific groups of dopaminergic neurons as well as of crh, oxt, avp, trh and sst1.1-expressing neuroendocrine cells are completely lost. These observations suggest that the requirement for otpa and otpb function during development of the larval diencephalon is partially redundant. During evolutionary diversification of the paralogous otp genes, otpa maintained the prominent role in ventral diencephalic dopaminergic and neuroendocrine cell specification and is capable of partially compensating otpb loss of function. In addition, we identified a role of Otp in the development of a domain of somatostatin1-expressing cells in the rostral hindbrain, a region with strong otp expression but so far uncharacterized Otp function. Otp may thus be crucial for defined neuronal cell types also in the hindbrain.	[Driever, Wolfgang] Univ Freiburg, Fac Biol, Dev Biol Unit, D-79106 Freiburg, Germany; Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Driever, W (corresponding author), Univ Freiburg, Fac Biol, Dev Biol Unit, Hugstetter Str 55, D-79106 Freiburg, Germany.	driever@biologie.uni-freiburg.de		Driever, Wolfgang/0000-0002-9551-9141	Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government (Centre for Biological Signalling Studies) [EXC 294]; German Research Foundation [DFG-SFB780-B6]; EU ZF-HEALTH project [242048]	Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government (Centre for Biological Signalling Studies); German Research Foundation(German Research Foundation (DFG)); EU ZF-HEALTH project	The work was supported by the following grants to W. D.: Excellence Initiative of the German Federal and State Governments (Centre for Biological Signalling Studies EXC 294; www.dfg.de & www.bioss.uni-freiburg. de), the German Research Foundation (DFG-SFB780-B6; www.dfg.de), and the EU ZF-HEALTH project (Grant number 242048; http://cordis.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Amir-Zilberstein L, 2012, NEURON, V73, P279, DOI 10.1016/j.neuron.2011.11.019; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bardet SM, 2008, BRAIN RES BULL, V75, P231, DOI 10.1016/j.brainresbull.2007.10.037; Barraud Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013306; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blechman J, 2007, DEVELOPMENT, V134, P4417, DOI 10.1242/dev.011262; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Chandrasekar G, 2007, J COMP NEUROL, V505, P337, DOI 10.1002/cne.21496; Del Giacco L, 2008, DEV DYNAM, V237, P2295, DOI 10.1002/dvdy.21668; Del Giacco L, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-50; Devos N, 2002, MECH DEVELOP, V115, P133, DOI 10.1016/S0925-4773(02)00082-5; Eaton JL, 2008, DEV DYNAM, V237, P995, DOI 10.1002/dvdy.21503; Eaton JL, 2007, DEV GENES EVOL, V217, P149, DOI 10.1007/s00427-006-0123-2; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Filippi A, 2012, DEV BIOL, V369, P133, DOI 10.1016/j.ydbio.2012.06.010; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Gahete MD, 2010, ANN NY ACAD SCI, V1200, P43, DOI 10.1111/j.1749-6632.2010.05511.x; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Kettleborough RNW, 2011, METHOD CELL BIOL, V104, P121, DOI 10.1016/B978-0-12-374814-0.00006-9; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lin X, 1999, GENOMICS, V60, P96, DOI 10.1006/geno.1999.5882; Liu Y, 2010, GENE, V463, P21, DOI 10.1016/j.gene.2010.04.016; Lohr H, 2011, ANNU REV PHYSIOL, V73, P183, DOI 10.1146/annurev-physiol-012110-142320; Lohr H, 2009, DEVELOPMENT, V136, P1007, DOI 10.1242/dev.033878; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; Martin SC, 1998, J COMP NEUROL, V396, P253; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; Moret F, 2005, DEV BIOL, V277, P567, DOI 10.1016/j.ydbio.2004.11.004; Nair HP, 2006, PHYSIOLOGY, V21, P146, DOI 10.1152/physiol.00049.2005; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Onichtchouk D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.9; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Unger JL, 2003, GENE EXPR PATTERNS, V3, P105, DOI 10.1016/S1567-133X(02)00064-9; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolf A, 2013, DEVELOPMENT, V140, P1762, DOI 10.1242/dev.085357; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021	56	28	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75002	10.1371/journal.pone.0075002	http://dx.doi.org/10.1371/journal.pone.0075002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073233	Green Submitted, gold, Green Published			2022-12-27	WOS:000324768000042
J	Holler, Y; Thomschewski, A; Bergmann, J; Kronbichler, M; Crone, JS; Schmid, E; Butz, K; Holler, P; Trinka, E				Hoeller, Yvonne; Thomschewski, Aljoscha; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Schmid, Elisabeth; Butz, Kevin; Hoeller, Peter; Trinka, Eugen			EEG-Response Consistency across Subjects in an Active Oddball Task	PLOS ONE			English	Article							BRAIN ACTIVITY; BEDSIDE DETECTION; VEGETATIVE STATE; MOTOR IMAGERY; DISORDERS; AWARENESS; COMPONENTS; CONSCIOUSNESS; VARIABILITY; ARTIFACTS	The active oddball paradigm is a candidate task for voluntary brain activation. Previous research has focused on group effects, and has largely overlooked the potential problem of interindividual differences. Interindividual variance causes problems with the interpretation of group-level results. In this study we want to demonstrate the degree of consistency in the active oddball task across subjects, in order to answer the question of whether this task is able to reliably detect conscious target processing in unresponsive patients. We asked 18 subjects to count rare targets and to ignore frequent standards and rare distractors in an auditory active oddball task. Event-related-potentials (ERPs) and time-frequency data were analyzed with permutation-t-tests on a single subject level. We plotted the group-average ERPs and time-frequency data, and evaluated the numbers of subjects showing significant differences between targets and distractors in certain time-ranges. The distinction between targets/distractors and standards was found to be significant in the time-range of the P300 in all participants. In contrast, significant differences between targets and distractors in the time-range of the P3a/b were found in 8 subjects, only. By including effects in the N1 and in a late negative component there remained 2 subjects who did not show a distinction between targets and distractors in the ERP. While time-frequency data showed prominent effects for target/distractor vs. standard, significant differences between targets and distractors were found in 2 subjects, only. The results suggest that time-frequency-and ERP-analysis of the active oddball task may not be sensitive enough to detect voluntary brain activation in unresponsive patients. In addition, we found that time-frequency analysis was even less informative than ERPs about the subject's task performance. Despite suggesting the use of more sensitive paradigms and/or analysis techniques, the present results give further evidence that electroencephalographic research should rely more strongly on single-subject analysis because interpretations of group-effects may be misleading.	[Hoeller, Yvonne; Thomschewski, Aljoscha; Crone, Julia S.; Butz, Kevin; Hoeller, Peter; Trinka, Eugen] Paracelsus Med Univ, Dept Neurol, Salzburg, Austria; [Hoeller, Yvonne; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Schmid, Elisabeth; Trinka, Eugen] Paracelsus Med Univ, Inst Neurosci, Salzburg, Austria; [Hoeller, Yvonne; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Schmid, Elisabeth; Trinka, Eugen] Paracelsus Med Univ, Ctr Neurocognit Res, Salzburg, Austria; [Thomschewski, Aljoscha; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Butz, Kevin] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Thomschewski, Aljoscha; Bergmann, Juergen; Kronbichler, Martin; Crone, Julia S.; Butz, Kevin] Salzburg Univ, Ctr Neurocognit Res, A-5020 Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Salzburg University; Salzburg University	Holler, Y (corresponding author), Paracelsus Med Univ, Dept Neurol, Salzburg, Austria.	y.hoeller@salk.at	Kronbichler, Martin/AAY-1519-2021; Kronbichler, Martin/A-5599-2008; Höller, Yvonne/I-8928-2017	Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Höller, Yvonne/0000-0002-1727-8557; Trinka, Eugen/0000-0002-5950-2692; Thomschewski, Aljoscha/0000-0002-1811-5469; Butz, Kevin/0000-0001-8070-4128; Butz, Kevin/0000-0003-4502-2492; Crone, Julia Sophia/0000-0002-0787-7003	Jubilaumsfonds of the National Bank of Austria [14201]	Jubilaumsfonds of the National Bank of Austria	This research project is being supported by the Jubilaumsfonds of the National Bank of Austria (project no. 14201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekinschtein TA, 2008, J NEUROL NEUROSUR PS, V79, P826, DOI 10.1136/jnnp.2007.132738; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; CHILDERS DG, 1987, CRIT REV BIOMED ENG, V14, P185; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Damborska A, 2012, PHYSIOL RES, V61, P307, DOI 10.33549/physiolres.932237; Ebe M, 2002, LEITFADEN EEG PRAXIS; Fellinger R, 2011, CLIN NEUROPHYSIOL, V122, P2177, DOI 10.1016/j.clinph.2011.03.004; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Ferrari V, 2010, J COGNITIVE NEUROSCI, V22, P404, DOI 10.1162/jocn.2009.21244; Garcia-Larrea L, 1998, EVOKED POTENTIAL, V108, P260, DOI 10.1016/S0168-5597(97)00085-3; Goldfine AM, 2013, LANCET, V381, P289, DOI 10.1016/S0140-6736(13)60125-7; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Halder S, 2010, CLIN NEUROPHYSIOL, V121, P516, DOI 10.1016/j.clinph.2009.11.087; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; Hausfeld L, 2012, NEUROIMAGE, V59, P3641, DOI 10.1016/j.neuroimage.2011.11.056; Ho MC, 2012, NEUROSCI LETT, V507, P78, DOI 10.1016/j.neulet.2011.11.057; Holler Y, 2013, INT J PSYCHOPHYSIOL, V87, P35, DOI 10.1016/j.ijpsycho.2012.10.015; Holler Y, 2012, INT J PSYCHOPHYSIOL, V86, P206, DOI 10.1016/j.ijpsycho.2012.09.005; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P1744, DOI 10.1016/j.clinph.2011.02.009; Holler Y, 2011, INT J PSYCHOPHYSIOL, V80, P227, DOI 10.1016/j.ijpsycho.2011.03.012; John ER, 2011, BRAIN INJURY, V25, P426, DOI 10.3109/02699052.2011.558045; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Jung TP, 1998, ADV NEUR IN, V10, P894; Koenig T, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/938925; Kotchoubey B, 2004, BRAINWAVES MIND RECE, P75; Lechinger J, 2013, CLIN NEUROPHYSIOL, V124, P27, DOI 10.1016/j.clinph.2012.05.016; Liang XW, 2014, J NEUROIMAGING, V24, P31, DOI 10.1111/j.1552-6569.2012.00744.x; Makeig S, 1996, ADV NEUR IN, V8, P145; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Monti MM, 2009, PROG BRAIN RES, V177, P249, DOI 10.1016/S0079-6123(09)17717-8; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Saville CWN, 2012, BIOL PSYCHOL, V91, P275, DOI 10.1016/j.biopsycho.2012.07.006; Saville CWN, 2011, BIOL PSYCHOL, V87, P74, DOI 10.1016/j.biopsycho.2011.02.005; Schiff S, 2008, CLIN NEUROPHYSIOL, V119, P1795, DOI 10.1016/j.clinph.2008.04.007; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; Tzovara A, 2013, BRAIN, V136, P81, DOI 10.1093/brain/aws264; Tzovara A, 2012, DEV NEUROPSYCHOL, V37, P518, DOI 10.1080/87565641.2011.636851; Wronka E, 2012, ACTA NEUROBIOL EXP, V72, P51; Yordanova J, 2000, NEUROREPORT, V11, P1097, DOI 10.1097/00001756-200004070-00038	44	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74572	10.1371/journal.pone.0074572	http://dx.doi.org/10.1371/journal.pone.0074572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073216	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000025
J	Koberle, V; Pleli, T; Schmithals, C; Alonso, EA; Haupenthal, J; Bonig, H; Peveling-Oberhag, J; Biondi, RM; Zeuzem, S; Kronenberger, B; Waidmann, O; Piiper, A				Koeberle, Verena; Pleli, Thomas; Schmithals, Christian; Alonso, Eduardo Augusto; Haupenthal, Joerg; Boenig, Halvard; Peveling-Oberhag, Jan; Biondi, Ricardo M.; Zeuzem, Stefan; Kronenberger, Bernd; Waidmann, Oliver; Piiper, Albrecht			Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers	PLOS ONE			English	Article							SERUM; ENZYMES; RIBONUCLEASE; CANCER; QUANTITATION; DEGRADATION; SIRNAS; PLASMA; URINE; BLOOD	Background: MicroRNAs circulating in the blood, stabilized by complexation with proteins and/or additionally by encapsulation in lipid vesicles, are currently being evaluated as biomarkers. The consequences of their differential association with lipids/vesicles for their stability and use as biomarkers are largely unexplored and are subject of the present study. Methods: The levels of a set of selected microRNAs were determined by quantitative reverse-transcription PCR after extraction from sera or vesicle-and non-vesicle fractions prepared from sera. The stability of these microRNAs after incubation with RNase A or RNase inhibitor, an inhibitor of RNase A family enzymes was studied. Results: The levels of microRNA-1 and microRNA-122, but not those of microRNA-16, microRNA-21 and microRNA-142-3p, declined significantly during a 5-h incubation of the sera. RNase inhibitor prevented the loss of microRNAs in serum as well as the degradation of microRNA-122, a microRNA not expressed in blood cells, in whole blood. Stabilization of microRNA-122 was also achieved by hemolysis. Prolonged incubation of the sera led to enrichment of vesicle-associated relative to non-vesicle-associated microRNAs. Vesicle-associated microRNAs were more resistant to RNase A treatment than the respective microRNAs not associated with vesicles. Conclusions: Serum microRNAs showed differential stability upon prolonged incubation. RNase inhibitor might be useful to robustly preserve the pattern of cell-free circulating microRNAs. In the case of microRNAs not expressed in blood cells this can also be achieved by hemolysis. Vesicle-associated microRNAs appeared to be more stable than those not associated with vesicles, which might be useful to disclose additional biomarker properties of miRNAs.	[Koeberle, Verena; Pleli, Thomas; Schmithals, Christian; Alonso, Eduardo Augusto; Haupenthal, Joerg; Peveling-Oberhag, Jan; Biondi, Ricardo M.; Zeuzem, Stefan; Kronenberger, Bernd; Waidmann, Oliver; Piiper, Albrecht] Univ Hosp Frankfurt, Dept Med 1, Frankfurt, Germany; [Boenig, Halvard] Univ Hosp Frankfurt, Inst Transfus Med & Immunohematol, German Red Cross Blood Serv Baden Wurttemberg Hes, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Piiper, A (corresponding author), Univ Hosp Frankfurt, Dept Med 1, Frankfurt, Germany.	piiper@med.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Bönig, Halvard/AAG-3029-2021	Bönig, Halvard/0000-0003-0088-2675; Haupenthal, Jorg/0000-0003-3991-2800; Biondi, Ricardo/0000-0002-8873-7167	Paul und Ursula Klein-Stiftung; Deutsche Forschungsgemeinschaft [GRK1172]; Scholari Stiftung	Paul und Ursula Klein-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Scholari Stiftung	This work was supported in part by grants from the Paul und Ursula Klein-Stiftung (to VK) and the Deutsche Forschungsgemeinschaft (GRK1172) and the Scholari Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Haupenthal J, 2006, BIOCHEM PHARMACOL, V71, P702, DOI 10.1016/j.bcp.2005.11.015; Haupenthal J, 2007, INT J CANCER, V121, P206, DOI 10.1002/ijc.22665; Koberle V, 2013, J VIRAL HEPATITIS, V20, P530, DOI 10.1111/jvh.12075; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; MORITA T, 1986, J BIOCHEM-TOKYO, V99, P17, DOI 10.1093/oxfordjournals.jbchem.a135456; NADANO D, 1995, INT J BIOCHEM CELL B, V27, P971, DOI 10.1016/1357-2725(95)00063-U; Paris C, 2012, MOL PHARMACEUT, V9, P3464, DOI 10.1021/mp300278b; SORRENTINO S, 1989, BIOCHIM BIOPHYS ACTA, V998, P97, DOI 10.1016/0167-4838(89)90125-8; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Turner JJ, 2007, MOL BIOSYST, V3, P43, DOI 10.1039/b611612d; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; WEICKMANN JL, 1982, J BIOL CHEM, V257, P8705; Welker MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030796	30	141	146	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75184	10.1371/journal.pone.0075184	http://dx.doi.org/10.1371/journal.pone.0075184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073250	gold, Green Published, Green Submitted			2022-12-27	WOS:000324768000059
J	Li, SK; Zhou, JW; Yim, AKY; Leung, AKY; Tsui, SKW; Chan, TF; Lau, TCK				Li, Sai-Kam; Zhou, Jun-Wei; Yim, Aldrin Kay-Yuen; Leung, Alden King-Yung; Tsui, Stephen Kwok-Wing; Chan, Ting-Fung; Lau, Terrence Chi-Kong			Organism-Specific rRNA Capture System for Application in Next-Generation Sequencing	PLOS ONE			English	Article							MICROBIAL METATRANSCRIPTOMICS; GENE-EXPRESSION; HYBRIDIZATION	RNA-sequencing is a powerful tool in studying RNomics. However, the highly abundance of ribosomal RNAs (rRNA) and transfer RNA (tRNA) have predominated in the sequencing reads, thereby hindering the study of lowly expressed genes. Therefore, rRNA depletion prior to sequencing is often performed in order to preserve the subtle alteration in gene expression especially those at relatively low expression levels. One of the commercially available methods is to use DNA or RNA probes to hybridize to the target RNAs. However, there is always a concern with the non-specific binding and unintended removal of messenger RNA (mRNA) when the same set of probes is applied to different organisms. The degree of such unintended mRNA removal varies among organisms due to organism-specific genomic variation. We developed a computer-based method to design probes to deplete rRNA in an organism-specific manner. Based on the computation results, biotinylated-RNA-probes were produced by in vitro transcription and were used to perform rRNA depletion with subtractive hybridization. We demonstrated that the designed probes of 16S rRNAs and 23S rRNAs can efficiently remove rRNAs from Mycobacterium smegmatis. In comparison with a commercial subtractive hybridization-based rRNA removal kit, using organism-specific probes is better in preserving the RNA integrity and abundance. We believe the computer-based design approach can be used as a generic method in preparing RNA of any organisms for next-generation sequencing, particularly for the transcriptome analysis of microbes.	[Li, Sai-Kam; Lau, Terrence Chi-Kong] City Univ Hong Kong, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China; [Zhou, Jun-Wei; Tsui, Stephen Kwok-Wing] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Yim, Aldrin Kay-Yuen; Leung, Alden King-Yung; Chan, Ting-Fung] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, Ting-Fung] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Lau, TCK (corresponding author), City Univ Hong Kong, Dept Biol & Chem, Hong Kong, Hong Kong, Peoples R China.	chiklau@cityu.edu.hk	Tsui, Stephen Kwok-Wing/E-4385-2015; Chan, TingFung/A-6161-2013; Lau, Terrence/ABB-7900-2021	Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Chan, TingFung/0000-0002-0489-3884; Lau, Terrence/0000-0002-7505-7306; Leung, Alden/0000-0003-0559-2183	CityU [7200262]; City University of Hong Kong [7002753]; Research Fund for the Control of Infectious Diseases [9211027]; Hong Kong RGC Collaborative Research Fund [CUHK3/CRF/11G]; Lo Kwee-Seong Biomedical Research Fund; Lee Hysan Foundation; Research Fund for the Control of Infectious Diseases (RFCID) [11100282]	CityU(City University of Hong Kong); City University of Hong Kong(City University of Hong Kong); Research Fund for the Control of Infectious Diseases; Hong Kong RGC Collaborative Research Fund; Lo Kwee-Seong Biomedical Research Fund; Lee Hysan Foundation; Research Fund for the Control of Infectious Diseases (RFCID)	This work was supported by the CityU startup grant (7200262) the Strategic Research Grant (7002753) of the City University of Hong Kong, and the Research Fund for the Control of Infectious Diseases (9211027) granted to TCL. It was also supported by the Hong Kong RGC Collaborative Research Fund (CUHK3/CRF/11G), the Lo Kwee-Seong Biomedical Research Fund, and the Lee Hysan Foundation granted to TFC and the Research Fund for the Control of Infectious Diseases (RFCID) (11100282) granted to SKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; [Anonymous], BIOCHEM, V66, P173, DOI [10.1146/annurev.biochem.66.1.173, DOI 10.1146/ANNUREV.BI0CHEM.66.1.173.PUBMED:9242905]; Binder H, 2005, BIOPHYS J, V89, P337, DOI 10.1529/biophysj.104.055343; CAO GJ, 1992, P NATL ACAD SCI USA, V89, P7546, DOI 10.1073/pnas.89.16.7546; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Mao CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-72; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; PLUM G, 1994, INFECT IMMUN, V62, P476, DOI 10.1128/IAI.62.2.476-483.1994; ROBINSON KA, 1994, GENE, V148, P137, DOI 10.1016/0378-1119(94)90247-X; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Srisawat C, 2001, RNA, V7, P632, DOI 10.1017/S135583820100245X; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zhang AX, 2003, MOL MICROBIOL, V50, P1111, DOI 10.1046/j.1365-2958.2003.03734.x	18	5	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74286	10.1371/journal.pone.0074286	http://dx.doi.org/10.1371/journal.pone.0074286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073205	gold, Green Submitted, Green Published			2022-12-27	WOS:000324768000014
J	Mutti, E; Ruetz, M; Birn, H; Krautler, B; Nexo, E				Mutti, Elena; Ruetz, Markus; Birn, Henrik; Kraeutler, Bernhard; Nexo, Ebba			4-Ethylphenyl-Cobalamin Impairs Tissue Uptake of Vitamin B-12 and Causes Vitamin B-12 Deficiency in Mice	PLOS ONE			English	Article							COBALAMIN DEFICIENCY; HUMAN-PLASMA; SPINAL-CORD; PROTEINS; HAPTOCORRIN; HOMEOSTASIS; ANALOGS; SYSTEM; KIDNEY	Co-beta-4-ethylphenyl-cob(III) alamin (EtPhCbl) is an organometallic analogue of vitamin B-12 (CNCbl) which binds to transcobalamin (TC), a plasma protein that facilitates the cellular uptake of cobalamin (Cbl). In vitro assays with key enzymes do not convert EtPhCbl to the active coenzyme forms of Cbl suggesting that administration of EtPhCbl may cause cellular Cbl deficiency. Here, we investigate the in vivo effect of EtPhCbl in mice and its ability, if any, to induce Cbl deficiency. We show that EtPhCbl binds to mouse TC and we examined mice that received 3.5 nmol/24h EtPhCbl (n=6), 3.5 nmol/24h CNCbl (n=7) or NaCl (control group) (n=5) through osmotic mini-pumps for four weeks. We analyzed plasma, urine, liver, spleen, submaxillary glands and spinal cord for Cbl and markers of Cbl deficiency including methylmalonic acid (MMA) and homocysteine (tHcy). Plasma MMA (mean +/- SEM) was elevated in animals treated with EtPhCbl (1.01 +/- 0.12 mu mol/L) compared to controls (0.30 +/- 0.02 mu mol/L) and CNCbl (0.29 +/- 0.01 mu mol/L) treated animals. The same pattern was observed for tHcy. Plasma total Cbl concentration was higher in animals treated with EtPhCbl (128.82 +/- 1.87 nmol/L) than in CNCbl treated animals (87.64 +/- 0.93 nmol/L). However, the organ levels of total Cbl were significantly lower in animals treated with EtPhCbl compared to CNCbl treated animals or controls, notably in the liver (157.07 +/- 8.56 pmol/g vs. 603.85 +/- 20.02 pmol/g, and 443.09 +/- 12.32 pmol/g, respectively). Differences between the three groups was analysed using one-way ANOVA and, Bonferroni post-hoc test. EtPhCbl was present in all tissues, except the spinal cord, accounting for 35-90% of total Cbl. In conclusion, treatment with EtPhCbl induces biochemical evidence of Cbl deficiency. This may in part be caused by a compromised tissue accumulation of Cbl.	[Mutti, Elena; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Ruetz, Markus; Kraeutler, Bernhard] Univ Innsbruck, Inst Organ Chem, A-6020 Innsbruck, Austria; [Ruetz, Markus; Kraeutler, Bernhard] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Birn, Henrik] Aarhus Univ Hosp, Dept Nephrol, DK-8000 Aarhus, Denmark; [Birn, Henrik] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; University of Innsbruck; University of Innsbruck; Aarhus University; Aarhus University	Nexo, E (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	e.nexo@dadlnet.dk	Birn, Henrik/C-3931-2009; Mutti, Elena/M-8056-2016	Birn, Henrik/0000-0003-3715-7266; Mutti, Elena/0000-0001-5621-4786; Nexo, Ebba/0000-0001-9406-9081	Lundbeck Foundation	Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Lundbeck Foundation. The funders did not influence study design, data collection, or analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 1997, CHEM BIOL, V4, P175, DOI 10.1016/S1074-5521(97)90286-6; Birn H, 2003, NEPHROL DIAL TRANSPL, V18, P1095, DOI 10.1093/ndt/gfg089; Birn H, 2006, AM J PHYSIOL-RENAL, V291, pF22, DOI 10.1152/ajprenal.00385.2005; Chalasani KB, 2007, J CONTROL RELEASE, V122, P141, DOI 10.1016/j.jconrel.2007.05.019; Gruber K, 2011, CHEM SOC REV, V40, P4346, DOI 10.1039/c1cs15118e; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; KOLHOUSE JF, 1978, NEW ENGL J MED, V299, P785, DOI 10.1056/NEJM197810122991501; Kozyraki R, 2013, BIOCHIMIE, V95, P1002, DOI 10.1016/j.biochi.2012.11.004; Lakso HA, 2008, CLIN CHEM, V54, P2028, DOI 10.1373/clinchem.2007.101253; Lildballe DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046657; Mutti E, 2007, BRAIN RES, V1157, P92, DOI 10.1016/j.brainres.2007.04.055; Mutti E, 2013, BRAIN RES, V1503, P1, DOI 10.1016/j.brainres.2013.01.050; Peters HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040609; Ruetz M, 2013, ANGEW CHEM INT EDIT, V52, P2606, DOI 10.1002/anie.201209651; Scalabrino G, 1997, EXP NEUROL, V144, P258, DOI 10.1006/exnr.1996.6376; Scalabrino G, 2001, J NEUROPATH EXP NEUR, V60, P109, DOI 10.1093/jnen/60.2.109; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771	19	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75312	10.1371/journal.pone.0075312	http://dx.doi.org/10.1371/journal.pone.0075312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073261	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000070
J	Qiao, L; Yang, WZ; Fu, JZ; Song, ZB				Qiao, Liang; Yang, Weizhao; Fu, Jinzhong; Song, Zhaobin			Transcriptome Profile of the Green Odorous Frog (Odorrana margaretae)	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; RANA-CHENSINENSIS; SEQUENCE; GENOME; SKIN; ALIGNMENT; PROGRAM; PROTEIN	Transcriptome profiles provide a practical and inexpensive alternative to explore genomic data in non-model organisms, particularly in amphibians where the genomes are very large and complex. The odorous frog Odorrana margaretae (Anura: Ranidae) is a dominant species in the mountain stream ecosystem of western China. Limited knowledge of its genetic background has hindered research on this species, despite its importance in the ecosystem and as biological resources. Here we report the transcriptome of O. margaretae in order to establish the foundation for genetic research. Using an Illumina sequencing platform, 62,321,166 raw reads were acquired. After a de novo assembly, 37,906 transcripts were obtained, and 18,933 transcripts were annotated to 14,628 genes. We functionally classified these transcripts by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). A total of 11,457 unique transcripts were assigned to 52 GO terms, and 1,438 transcripts were assigned to 128 KEGG pathways. Furthermore, we identified 27 potential antimicrobial peptides (AMPs), 50,351 single nucleotide polymorphism (SNP) sites, and 2,574 microsatellite DNA loci. The transcriptome profile of this species will shed more light on its genetic background and provide useful tools for future studies of this species, as well as other species in the genus Odorrana. It will also contribute to the accumulation of amphibian genomic data.	[Qiao, Liang; Song, Zhaobin] Sichuan Univ, Sichuan Key Lab Conservat Biol Endangered Wildlif, Coll Life Sci, Chengdu 610064, Peoples R China; [Qiao, Liang; Yang, Weizhao; Fu, Jinzhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Fu, Jinzhong] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Song, Zhaobin] Sichuan Univ, Minist Educ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Chengdu 610064, Peoples R China	Sichuan University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; University of Guelph; Sichuan University	Fu, JZ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	jfu@uoguelph.ca; zbsong@scu.edu.cn			National Natural Science Foundation of China [31172061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by a National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm), grant number 31172061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullayev I, 2013, EXP CELL RES, V319, P1187, DOI 10.1016/j.yexcr.2013.02.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARRA D, 1995, TRENDS BIOTECHNOL, V13, P205, DOI 10.1016/S0167-7799(00)88947-7; Brelsford A, 2013, EVOLUTION, V67, P2434, DOI 10.1111/evo.12151; Cho JH, 2009, BBA-BIOMEMBRANES, V1788, P1564, DOI 10.1016/j.bbamem.2008.10.025; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Gao HY, 2013, CONSERV GENET RESOUR, V5, P935, DOI 10.1007/s12686-013-9936-2; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gregory T.R., 2005, ANIMAL GENOME SIZE D; Gregory TR, 2002, GENETICA, V115, P131, DOI 10.1023/A:1016032400147; Gruenheit N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-92; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu JY, 2012, J PROTEOMICS, V75, P5807, DOI 10.1016/j.jprot.2012.08.004; Liu R, 2011, J PROTEOME RES, V10, P1806, DOI 10.1021/pr101285n; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Looso M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r16; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; MOORE KS, 1991, J BIOL CHEM, V266, P19851; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Novkovic M, 2012, BIOINFORMATICS, V28, P1406, DOI 10.1093/bioinformatics/bts141; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Reilly BD, 2013, PHYSIOL GENOMICS, V45, P377, DOI 10.1152/physiolgenomics.00163.2012; Rosenblum EB, 2012, MOL ECOL, V21, P3110, DOI 10.1111/j.1365-294X.2012.05481.x; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stewart R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002936; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tan MH, 2013, GENOME RES, V23, P201, DOI 10.1101/gr.141424.112; Yang WZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-588; Yang XW, 2012, J PROTEOME RES, V11, P306, DOI 10.1021/pr200782u; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang M, 2013, J GENET GENOMICS, V40, P137, DOI 10.1016/j.jgg.2013.01.004	44	20	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75211	10.1371/journal.pone.0075211	http://dx.doi.org/10.1371/journal.pone.0075211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073255	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000064
J	Sousa, A; Dal Poz, MR; Boschi-Pinto, C				Sousa, Angelica; Dal Poz, Mario R.; Boschi-Pinto, Cynthia			Reducing Inequities in Neonatal Mortality through Adequate Supply of Health Workers: Evidence from Newborn Health in Brazil	PLOS ONE			English	Article							INFANT-MORTALITY; CHILD HEALTH; TRENDS; CARE; COUNTDOWN; COVERAGE; PROGRESS; PACKAGE; SECTOR	Introduction: Progress towards the MDG targets on maternal and child mortality is hindered worldwide by large differentials between poor and rich populations. Using the case of Brazil, we investigate the extent to which policies and interventions seeking to increase the accessibility of health services among the poor have been effective in decreasing neonatal mortality. Methods: With a panel data set for the 4,267 Minimum Comparable Areas (MCA) in Brazil in 1991 and 2000, we use a fixed effect regression model to evaluate the effect of the provision of physicians, nurse professionals, nurse associates and community health workers on neonatal mortality for poor and non-poor areas. We additionally forecasted the neonatal mortality rate in 2005. Results: We find that the provision of health workers is particularly important for neonatal mortality in poor areas. Physicians and especially nurse professionals have been essential in decreasing neonatal mortality: an increase of one nurse professional per 1000 population is associated with a 3.8% reduction in neonatal mortality while an increase of one physician per 1000 population is associated with a 2.3% reduction in neonatal mortality. We also find that nurse associates are less important for neonatal mortality (estimated reduction effect of 1.2%) and that community health workers are not important particularly among the poor. Differences in the provision of health workers explain a large proportion of neonatal mortality. Discussion: In this paper, we show new evidence to inform decision making on maternal and newborn health. Reductions in neonatal mortality in Brazil have been hampered by the unequal distribution of health workers between poor and non-poor areas. Thus, special attention to a more equitable health system is required to allocate the resources in order to improve the health of poor and ensure equitable access to health services to the entire population.	[Sousa, Angelica] World Hlth Org, Dept Hlth Syst Policies & Workforce, Geneva, Switzerland; [Dal Poz, Mario R.] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil; [Boschi-Pinto, Cynthia] World Hlth Org, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Boschi-Pinto, Cynthia] Univ Fed Fluminense, Rio De Janeiro, Brazil	World Health Organization; Universidade do Estado do Rio de Janeiro; World Health Organization; Universidade Federal Fluminense	Sousa, A (corresponding author), World Hlth Org, Dept Hlth Syst Policies & Workforce, Geneva, Switzerland.	sousaa@who.int	Pinto, Cynthia Boschi/AAA-6990-2020; , Dal Poz/D-3564-2009	Pinto, Cynthia Boschi/0000-0002-0069-7974; , Dal Poz/0000-0002-3005-3280; Sousa, Angelica/0000-0002-0006-9310				Allen SM, 2003, QUAL HEALTH RES, V13, P207, DOI 10.1177/1049732302239599; Anand S, 2010, MEASURING HLTH WORKF, P32; [Anonymous], LEV TRENDS CHILD MOR; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Barros AJD, 2005, REACHING POOR HLTH N; Barros FC, 2010, AM J PUBLIC HEALTH, V100, P1877, DOI 10.2105/AJPH.2010.196816; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Boschi-Pinto C, 2013, COMMUNICATION; Brasil. Rede Interagencial de Informacao para a Sau- de (Ripsa), 2008, INDICADORES BASICOS; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Cameron A.C., 2009, MICROECONOMETRICS US; Cardoso A, 2007, INT MICRODATA SCOPIN; Castro OJ, 2004, PROJECAO POPULACAO B; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Farahani M, 2009, SOC SCI MED, V68, P1918, DOI 10.1016/j.socscimed.2009.03.023; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2003, CENS DEM 2000 MICR A; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2002, CENS DEM 1991 MICR A; Instituto de Pesquisa Economica Aplicada (IPEA), 2008, DAD MACR MIC REG; Instituto de Pesquisa Economica Aplicada/Secretaria de Planejamento e Investimentos Estrategicos, 2007, OBJ DES MIL REL NAC; Matijasevich A, 2008, AM J PUBLIC HEALTH, V98, P692, DOI 10.2105/AJPH.2006.093492; Ministerio da Saude Departamento de Informatica do SUS (DATASUS), 2005, IND DAD BAS CONS PRO; Ministerio da Saude Departamento de Informatica do SUS (DATASUS), 2005, SIST INF AT BAS; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Duarte CMR, 2007, CAD SAUDE PUBLICA, V23, P1511, DOI 10.1590/S0102-311X2007000700002; Sergio L, 2011, CARTA CAPITAL, V651, P34; Sousa A, 2011, TRABALHO SAUDE ABORD, P319; Sousa A, 2006, MEASURING EFFICIENCY; Sousa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033399; Sousa A, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-21; StataCorp, 2005, STAT STAT SOFTW 9, V9; Szwarcwald Célia Landmann, 2002, Cad. Saúde Pública, V18, P1725, DOI 10.1590/S0102-311X2002000600027; de Andrade CLT, 2007, CAD SAUDE PUBLICA, V23, P1207, DOI 10.1590/S0102-311X2007000500022; UNICEF, 2012, COUNTD 2015 MAT NEWB; Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Volpe FM, 2009, REV PANAM SALUD PUBL, V26, P478, DOI 10.1590/S1020-49892009001200002; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; World Bank, 2008, WORLD DEV IND DAT 20; World Health Organisation, 2005, WORLD HLTH REP MAK E; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2006, WORLD HLTH REP WORK	47	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74772	10.1371/journal.pone.0074772	http://dx.doi.org/10.1371/journal.pone.0074772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	222YC	24073222	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000031
J	Kamijima, T; Sakashita, M; Miura, A; Nishimiya, Y; Tsuda, S				Kamijima, Tatsuro; Sakashita, Mami; Miura, Ai; Nishimiya, Yoshiyuki; Tsuda, Sakae			Antifreeze Protein Prolongs the Life-Time of Insulinoma Cells during Hypothermic Preservation	PLOS ONE			English	Article							MAMMALIAN-CELLS; GLYCOPROTEINS; TEMPERATURE; TIME	It is sometimes desirable to preserve mammalian cells by hypothermia rather than freezing during short term transplantation. Here we found an ability of hypothermic (+4 degrees C) preservation of fish antifreeze protein (AFP) against rat insulinoma cells denoted as RIN-5F. The preservation ability was compared between type I-III AFPs and antifreeze glycoprotein (AFGP), which could be recently mass-prepared by a developed technique utilizing the muscle homogenates, but not the blood serum, of cold-adapted fishes. For AFGP, whose molecular weight is distributed in the range from 2.6 to 34 kDa, only the proteins less than 10 kDa were examined. The viability rate was evaluated by counting of the preserved RIN-5F cells unstained with trypan blue. Significantly, either AFPI or AFPIII dissolved into Euro-Collins (EC) solution at a concentration of 10 mg/ml could preserve approximately 60% of the cells for 5 days at +4 degrees C. The 5-day preserved RIN-5F cells retained the ability to secrete insulin. Only 2% of the cells were, however, preserved for 5 days without AFP. Confocal photomicroscopy experiments further showed the significant binding ability of AFP to the cell surface. These results suggest that fish AFP enables 5-day quality storage of the insulinoma cells collected from a donor without freezing.	[Kamijima, Tatsuro; Sakashita, Mami; Miura, Ai; Nishimiya, Yoshiyuki; Tsuda, Sakae] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Tsuda, Sakae] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Hokkaido University	Tsuda, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan.	s.tsuda@aist.go.jp	Sakashita, Mami/M-2784-2018; Nishimiya, Yoshiyuki/M-4173-2018; Tsuda, Sakae/M-2756-2018	Sakashita, Mami/0000-0002-6726-4794; Nishimiya, Yoshiyuki/0000-0002-0701-7775; Tsuda, Sakae/0000-0002-1399-0619	Japan Society for the Promotion of Science (JSPS) [23310171]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for scientific research from the Japan Society for the Promotion of Science (JSPS) (No. 23310171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, EUR MAN; ARAV A, 1994, THERIOGENOLOGY, V41, P107, DOI 10.1016/S0093-691X(05)80055-X; Brockbank KGM, 2011, IN VITRO CELL DEV-AN, V47, P210, DOI 10.1007/s11626-010-9383-2; Celik Y, 2010, P NATL ACAD SCI USA, V107, P5423, DOI 10.1073/pnas.0909456107; CHAO H, 1993, PROTEIN SCI, V2, P1411, DOI 10.1002/pro.5560020906; Chen LB, 1997, P NATL ACAD SCI USA, V94, P3817, DOI 10.1073/pnas.94.8.3817; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Graether SP, 2004, EUR J BIOCHEM, V271, P3285, DOI 10.1111/j.1432-1033.2004.04256.x; Harding MM, 2003, EUR J BIOCHEM, V270, P1381, DOI 10.1046/j.1432-1033.2003.03488.x; Hirano Y, 2008, CRYOBIOLOGY, V57, P46, DOI 10.1016/j.cryobiol.2008.05.006; Hirano Y, 2008, ANAL CHEM, V80, P9349, DOI 10.1021/ac8018334; Ichii H, 2009, J HEPATO-BILIARY-PAN, V16, P101, DOI 10.1007/s00534-008-0021-2; LEE CY, 1992, CRYO-LETT, V13, P59; Nishimiya Y, 2005, FEBS J, V272, P482, DOI 10.1111/j.1742-4658.2004.04490.x; Nishimiya Y., 2008, SYNTHESIOLOGY, V1, P7, DOI [10.5571/syntheng.1.7, DOI 10.5571/SYNTHENG.1.7]; Ostrowska A, 2009, ARCH TOXICOL, V83, P493, DOI 10.1007/s00204-009-0419-x; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; RUBINSKY B, 1992, AM J PHYSIOL, V262, pR542, DOI 10.1152/ajpregu.1992.262.3.R542; RUBINSKY B, 1990, BIOCHEM BIOPH RES CO, V173, P1369, DOI 10.1016/S0006-291X(05)80939-8; RUBINSKY B, 1991, BIOCHEM BIOPH RES CO, V180, P566, DOI 10.1016/S0006-291X(05)81102-7; Rubinsky B, 2003, HEART FAIL REV, V8, P277, DOI 10.1023/A:1024734003814; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Takamichi M, 2007, FEBS J, V274, P6469, DOI 10.1111/j.1742-4658.2007.06164.x; Tomczak MM, 2002, BIOPHYS J, V82, P874, DOI 10.1016/S0006-3495(02)75449-0; Tsuda S, 2012, J JAPANESE SOC EXTRE, V11, P64; WAHLBERG JA, 1986, CRYOBIOLOGY, V23, P477, DOI 10.1016/0011-2240(86)90056-8; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006; Yasui M., 2008, CRYOBIOL CRYOTECH, V54, P1	28	29	30	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73643	10.1371/journal.pone.0073643	http://dx.doi.org/10.1371/journal.pone.0073643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069217	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300019
J	Liu, ZH; Wang, W; Jiang, JT; Bao, ED; Xu, DL; Zeng, YG; Tao, L; Qiu, JX				Liu, Zhihong; Wang, Wei; Jiang, Juntao; Bao, Erdun; Xu, Dongliang; Zeng, Yigang; Tao, Le; Qiu, Jianxin			Downregulation of GAS5 Promotes Bladder Cancer Cell Proliferation, Partly by Regulating CDK6	PLOS ONE			English	Article							LONG NONCODING RNA; BREAST-CANCER; GROWTH-ARREST; HUMAN CARCINOMAS; EXPRESSION; METASTASIS; MIR-34A; GENOME	Long non-coding RNAs (lncRNAs) play important roles in diverse biological processes, such as transcriptional regulation, cell growth and tumorigenesis. However, little is known about whether lncRNA-GAS5 (growth arrest-specific 5) regulates bladder cancer progression. In the present study, we found that the GAS5 expression is commonly downregulated in bladder cancer cell lines and human specimens. Knockdown of GAS5 promotes bladder cancer cell proliferation, whereas forced expression of GAS5 suppresses cell proliferation. We further demonstrated that knockdown of GAS5 increases CDK6 mRNA and protein levels in bladder cancer cells. Expectedly, GAS5 inhibition induces a significant decrease in G0/G1 phase and an obvious increase in S phase. Gain-of-function and loss-of-function studies showed that GAS5 inhibits bladder cancer cell proliferation, at least in part, by regulating CDK6 expression. Conclusions: Downregulated GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6, and thus may be helpful in the development of effective treatment strategies against bladder cancer.	[Liu, Zhihong; Wang, Wei; Jiang, Juntao; Bao, Erdun; Xu, Dongliang; Zeng, Yigang; Tao, Le; Qiu, Jianxin] Shanghai Jiao Tong Univ, Coll Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Qiu, JX (corresponding author), Shanghai Jiao Tong Univ, Coll Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China.	qiujason@sh163.net	Qiu, Jason/B-3502-2012	Qiu, Jason/0000-0003-1067-3199	Shanghai Municipal Health Bureau [XBR 2011038]	Shanghai Municipal Health Bureau	This work was supported by the Award Number XBR 2011038 from Shanghai Municipal Health Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Bo JJ, 2011, FEBS J, V278, P786, DOI 10.1111/j.1742-4658.2010.07997.x; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; Fellig Y, 2005, J CLIN PATHOL, V58, P1064, DOI 10.1136/jcp.2004.023648; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hirata H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051056; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Lacey JV, 2002, ENVIRON MOL MUTAGEN, V39, P82, DOI 10.1002/em.10062; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Luo M, 2013, FEBS J, V280, P1709, DOI 10.1111/febs.12185; Matouk IJ, 2010, BBA-MOL CELL RES, V1803, P443, DOI 10.1016/j.bbamcr.2010.01.010; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Pasin Erik, 2008, Rev Urol, V10, P31; Said N, 2012, J CLIN INVEST, V122, P1503, DOI 10.1172/JCI61392; Seiler R, 2010, J CLIN PATHOL, V63, P504, DOI 10.1136/jcp.2009.075077; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tano Keiko, 2012, Frontiers in Genetics, V3, P219, DOI 10.3389/fgene.2012.00219; Wang G, 2012, ONCOL LETT, V4, P43, DOI 10.3892/ol.2012.695; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Woo CJ, 2007, CELL, V129, P1257, DOI 10.1016/j.cell.2007.06.014; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	32	108	110	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73991	10.1371/journal.pone.0073991	http://dx.doi.org/10.1371/journal.pone.0073991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069260	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300027
J	Callegari, E; Elamin, BK; D'Abundo, L; Falzoni, S; Donvito, G; Moshiri, F; Milazzo, M; Altavilla, G; Giacomelli, L; Fornari, F; Hemminki, A; Di Virgilio, F; Gramantieri, L; Negrini, M; Sabbioni, S				Callegari, Elisa; Elamin, Bahaeldin K.; D'Abundo, Lucilla; Falzoni, Simonetta; Donvito, Giovanna; Moshiri, Farzaneh; Milazzo, Maddalena; Altavilla, Giuseppe; Giacomelli, Luciano; Fornari, Francesca; Hemminki, Akseli; Di Virgilio, Francesco; Gramantieri, Laura; Negrini, Massimo; Sabbioni, Silvia			Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus	PLOS ONE			English	Article							CONDITIONALLY REPLICATIVE ADENOVIRUS; PHASE-I TRIAL; HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; LIVER-TRANSPLANTATION; TRANSGENE EXPRESSION; ENDOGENOUS MICRORNA; COMBINATION; THERAPY; AD5-DELTA-24RGD	The down-regulation of miR-199 occurs in nearly all primary hepatocellular carcinomas (HCCs) and HCC cell lines in comparison with normal liver. We exploited this miR-199 differential expression to develop a conditionally replication-competent oncolytic adenovirus, Ad-199T, and achieve tumor-specific viral expression and replication. To this aim, we introduced four copies of miR-199 target sites within the 3' UTR of E1A gene, essential for viral replication. As consequence, E1A expression from Ad-199T virus was tightly regulated both at RNA and protein levels in HCC derived cell lines, and replication controlled by the level of miR-199 expression. Various approaches were used to asses in vivo properties of Ad-199T. Ad-199T replication was inhibited in normal, miR-199 positive, liver parenchyma, thus resulting in reduced hepatotoxicity. Conversely, the intrahepatic delivery of Ad-199T in newborn mice led to virus replication and fast removal of implanted HepG2 liver cancer cells. The ability of Ad-199T to control tumor growth was also shown in a subcutaneous xenograft model in nude mice and in HCCs arising in immune-competent mice. In summary, we developed a novel oncolytic adenovirus, Ad-199T, which could demonstrate a therapeutic potential against liver cancer without causing significant hepatotoxicity.	[Callegari, Elisa; Elamin, Bahaeldin K.; D'Abundo, Lucilla; Falzoni, Simonetta; Donvito, Giovanna; Moshiri, Farzaneh; Di Virgilio, Francesco; Negrini, Massimo] Univ Ferrara, Dipartimento Morfol Chirurg & Med Sperimentale, I-44100 Ferrara, Italy; [Elamin, Bahaeldin K.] Univ Khartoum, Dept Microbiol, Fac Med Lab Sci, Khartoum, Sudan; [Milazzo, Maddalena; Fornari, Francesca; Gramantieri, Laura] St Orsola Marcello Malpighi Hosp, Ctr Ric Biomed Applicata, Bologna, Italy; [Milazzo, Maddalena; Fornari, Francesca; Gramantieri, Laura] St Orsola Marcello Malpighi Hosp, Dipartimento Med Interna, Bologna, Italy; [Milazzo, Maddalena; Fornari, Francesca; Gramantieri, Laura] Univ Bologna, Bologna, Italy; [Altavilla, Giuseppe; Giacomelli, Luciano] Univ Padua, Dipartimento Sci Med Diagnost & Terapie Speciali, Padua, Italy; [Hemminki, Akseli] Univ Helsinki, Mol Canc Biol Program, Canc Gene Therapy Grp, Helsinki, Finland; [Hemminki, Akseli] Univ Helsinki, Transplantat Lab, Helsinki, Finland; [Hemminki, Akseli] Univ Helsinki, Haartman Inst, Helsinki, Finland; [Sabbioni, Silvia] Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy; [Moshiri, Farzaneh] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Mol Med, Tehran, Iran	University of Ferrara; University of Khartoum; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Padua; University of Helsinki; University of Helsinki; University of Helsinki; University of Ferrara; Tehran University of Medical Sciences	Negrini, M (corresponding author), Univ Ferrara, Dipartimento Morfol Chirurg & Med Sperimentale, I-44100 Ferrara, Italy.	ngm@unife.it; sbs@unife.it	Callegari, Elisa/Q-6135-2019; Callegari, Elisa/J-5763-2016; D'ABUNDO, LUCILLA/AAB-9816-2019; Gramantieri, Laura/K-8603-2016; Gramantieri, Laura/J-3862-2019; Negrini, Massimo/J-2377-2016; DI VIRGILIO, Francesco/O-4634-2019; Milazzo, Maddalena/K-7708-2016; Fornari, Francesca/K-6748-2016; Di Virgilio, Francesco/J-3754-2018	Callegari, Elisa/0000-0002-4969-5400; Callegari, Elisa/0000-0002-4969-5400; Gramantieri, Laura/0000-0002-5187-9559; Negrini, Massimo/0000-0002-0007-1920; DI VIRGILIO, Francesco/0000-0003-3566-1362; Milazzo, Maddalena/0000-0002-7060-7858; Di Virgilio, Francesco/0000-0003-3566-1362; Falzoni, Simonetta/0000-0002-6594-0357; D'Abundo, Lucilla/0000-0003-4196-0203; Elamin, Bahaeldin K./0000-0002-1136-4980; Fornari, Francesca/0000-0002-4302-4411; Moshiri, Farzaneh/0000-0003-0806-8651; GIACOMELLI, Laura/0000-0003-3598-7522	University of Ferrara; Associazione Italiana per la Ricerca sul Cancro	University of Ferrara; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the University of Ferrara and by Associazione Italiana per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany R, 2007, MOL ASPECTS MED, V28, P42, DOI 10.1016/j.mam.2006.12.002; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Bismuth H, 1999, SEMIN LIVER DIS, V19, P311, DOI 10.1055/s-2007-1007120; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Callegari E, 2012, HEPATOLOGY, V56, P1025, DOI 10.1002/hep.25747; Cawood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016152; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Chen W, 2011, CANCER LETT, V307, P93, DOI 10.1016/j.canlet.2011.03.021; Cormier JN, 2006, J GASTROINTEST SURG, V10, P761, DOI 10.1016/j.gassur.2005.10.006; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Forner A, 2006, CRIT REV ONCOL HEMAT, V60, P89, DOI 10.1016/j.critrevonc.2006.06.001; Freytag SO, 2007, MOL THER, V15, P1016, DOI 10.1038/mt.sj.6300120; Fu XP, 2012, MOL THER, V20, P339, DOI 10.1038/mt.2011.265; Ganly I, 2000, CLIN CANCER RES, V6, P798; HARDY B, 1973, CELL IMMUNOL, V9, P282, DOI 10.1016/0008-8749(73)90079-8; Harrach B, 2008, ENCY VIROLOGY, P1; Henry JC, 2010, BIOCHEM BIOPH RES CO, V403, P120, DOI 10.1016/j.bbrc.2010.10.130; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Jia XQ, 2012, CELL BIOCHEM BIOPHYS, V62, P237, DOI 10.1007/s12013-011-9263-8; Jin HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021307; Jonas S, 2001, TRANSPLANT P, V33, P3444, DOI 10.1016/S0041-1345(01)02484-8; Kawashima T, 2004, CLIN CANCER RES, V10, P285, DOI 10.1158/1078-0432.CCR-1075-3; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Lamfers MLM, 2007, CLIN CANCER RES, V13, P7451, DOI 10.1158/1078-0432.CCR-07-1265; Lamfers MLM, 2002, CANCER RES, V62, P5736; Leja J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008916; Li JL, 2009, GENE THER, V16, P376, DOI 10.1038/gt.2008.179; Li YH, 2001, CANCER RES, V61, P6428; Liu TC, 2008, GENE THER, V15, P877, DOI 10.1038/gt.2008.72; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mathis JM, 2005, ONCOGENE, V24, P7775, DOI 10.1038/sj.onc.1209044; Matsubara S, 2001, CANCER RES, V61, P6012; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Opyrchal Mateusz, 2009, V542, P705, DOI 10.1007/978-1-59745-561-9_35; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Post DE, 2003, HUM GENE THER, V14, P933, DOI 10.1089/104303403766682205; Rajecki M, 2007, MOL CANCER THER, V6, P742, DOI 10.1158/1535-7163.MCT-06-0403; Ranki T, 2007, INT J CANCER, V121, P165, DOI 10.1002/ijc.22627; Rodriguez R, 1997, CANCER RES, V57, P2559; Sebestyen Z, 2007, CANCER RES, V67, P11309, DOI 10.1158/0008-5472.CAN-07-0739; Ulasov IV, 2009, BRIT J CANCER, V100, P1154, DOI 10.1038/sj.bjc.6604969; Yamamoto M, 2003, GASTROENTEROLOGY, V125, P1203, DOI 10.1016/S0016-5085(03)01196-X; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08; Ylosmaki E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054506; Yu DC, 1999, CANCER RES, V59, P4200; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817	54	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73964	10.1371/journal.pone.0073964	http://dx.doi.org/10.1371/journal.pone.0073964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069256	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100078
J	Garcia-Rubies, A; Hereu, B; Zabala, M				Garcia-Rubies, Antoni; Hereu, Bernat; Zabala, Mikel			Long-Term Recovery Patterns and Limited Spillover of Large Predatory Fish in a Mediterranean MPA	PLOS ONE			English	Article							GROUPER EPINEPHELUS-MARGINATUS; MARINE PROTECTED AREAS; LARVAL EXPORT; CORAL-REEFS; 1834 PISCES; RESERVES; ISLANDS; POPULATIONS; SERRANIDAE; BIOMASS	Based on 19 y of visual census data from the Medes Islands MPA (NW Mediterranean), this study analyzes the carrying capacity (K) and population recovery time of six species of fish strongly affected by harvesting pressure along the Mediterranean coast. Three of these species (Epinephelus marginatus, Diplodus cervinus and Dicentrachus labrax) have practically reached carrying capacity in the Medes Islands MPA, while others are still approaching population stabilization (Sciaena umbra) or are still increasing in biomass (Dentex dentex). The one exception to these trends is S. aurata, which tended to decrease inside the MPA, probably due to fishing just outside its borders. These results confirm that fish populations may require decadal time scales to recover from exploitation, both in terms of total abundance (21 to 29 y to exceed 95% K) as well as total biomass (25 to 35 y), and that rates of recovery differ between species (13 to 31 y). The recovery and saturation observed within the no-take zone contrasts with results obtained in the partially protected buffer area and the peripheral area open for fishing, which show much lower biomass values. In general, the spillover from the MPA is very moderate, and its effects extend only to the partially protected area.	[Garcia-Rubies, Antoni] CEAB CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Hereu, Bernat; Zabala, Mikel] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona	Garcia-Rubies, A (corresponding author), CEAB CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain.	tonigr@ceab.csic.es	Hereu, Bernat/K-9150-2015; Zabala, Mikel/AAE-8977-2021	Hereu, Bernat/0000-0001-6247-7638; 	Direccio General de Pesca Maritima; "Departament de Medi Natural'' of the "Generalitat de Catalunya'; (COCONET) of the European Community's Seventh Framework Programme [87844, FP7/2007-2013]	Direccio General de Pesca Maritima; "Departament de Medi Natural'' of the "Generalitat de Catalunya'; (COCONET) of the European Community's Seventh Framework Programme	This study was mostly funded by the "Direccio General de Pesca Maritima", the "Departament de Medi Natural'' of the "Generalitat de Catalunya'and partially funded by the 87844 (COCONET) of the European Community's Seventh Framework Programme (FP7/2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; ABESAMIS RA, 2011, ECOLOGICAL APPL, V15, P1798; Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; BOEHLERT GW, 1992, DEEP-SEA RES, V39, P439, DOI 10.1016/0198-0149(92)90082-5; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; Chauvet C., 1991, ESPECES MARINES PROT, P277; Cheung WWL, 2005, BIOL CONSERV, V124, P97, DOI 10.1016/j.biocon.2005.01.017; CLAUDET J, 2008, ECOLOGICAL APPL, V20, P830; Coll J, 2004, FISH RES, V70, P97, DOI 10.1016/j.fishres.2004.05.004; Coll Josep, 1999, Bolleti de la Societat d'Historia Natural de les Balears, V42, P125; Coll J, 2013, ICES J MAR SCI, V70, P578, DOI 10.1093/icesjms/fst025; Coll J, 2012, SCI MAR, V76, P809, DOI 10.3989/scimar.03531.02H; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004140; CULIOLI JM, 1999, MEMOIRES I OCEANOGRA, P29; DEMARTINI EE, 1993, FISH B-NOAA, V91, P414; Diaz D, 2005, NEW ZEAL J MAR FRESH, V39, P447, DOI 10.1080/00288330.2005.9517324; *FAO, 2010, STAT WORLD FISH AQ; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; GARCIA-RUBIES A, 1990, Scientia Marina, V54, P317; GARCIARUBIES A, 1997, THESIS U BARCELONA S; Gerber LR, 2003, ECOL APPL, V13, pS47; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Harmelin Jean-Georges, 2002, Marine Life, V9, P11; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; Hereu B, 2006, MAR ECOL PROG SER, V325, P187, DOI 10.3354/meps325187; Hernandez-Leon S, 2001, J MARINE SYST, V30, P51, DOI 10.1016/S0924-7963(01)00037-9; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 2000, REV FISH BIOL FISHER, V10, P209, DOI 10.1023/A:1016619102955; Kelleher G., 1995, GLOBAL REPRESENTATIV, V1; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; LEBORGNE R, 1985, B MAR SCI, V37, P450; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Lopez-Sanz A, 2011, ESTUAR COAST SHELF S, V92, P521, DOI 10.1016/j.ecss.2011.02.006; Macpherson E, 1997, MAR ECOL PROG SER, V160, P135, DOI 10.3354/meps160135; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2009, MAR ECOL PROG SER, V396, P99, DOI 10.3354/meps08279; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Morey G, 2003, FISH RES, V62, P89, DOI 10.1016/S0165-7836(02)00250-3; Murawski SA, 2000, B MAR SCI, V66, P775; OROZCO MJ, 2011, SERIE ESTUDIOS BIOL; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; *PDT, 1990, NMFSSEFC261 PDT; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Renones Olga, 2002, Marine Life, V9, P45; Renones O, 2010, SCI MAR, V74, P523, DOI 10.3989/scimar.2010.74n3523; ROS J, 1984, ARCHIUS SECCIO CIENC; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Sala E, 1996, MAR ECOL PROG SER, V140, P71, DOI 10.3354/meps140071; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sasal P, 1996, J FISH BIOL, V49, P352, DOI 10.1111/j.1095-8649.1996.tb00029.x; Vacchi M, 1998, ITAL J ZOOL, V65, P281, DOI 10.1080/11250009809386833; Willis TJ, 2005, ECOL LETT, V8, P47, DOI 10.1111/j.1461-0248.2004.00692.x; Wood LJ, 2008, ORYX, V42, P340, DOI 10.1017/S003060530800046X; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zabala M, 1997, SCI MAR, V61, P79; Zabala M, 1997, SCI MAR, V61, P65	75	57	57	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73922	10.1371/journal.pone.0073922	http://dx.doi.org/10.1371/journal.pone.0073922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069251	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100074
J	Hu, J; Ma, XX; Tian, Y; Pang, L; Cui, LZ; Shang, H				Hu, Jian; Ma, Xiao Xue; Tian, Yuan; Pang, Long; Cui, Long Zhu; Shang, Hong			Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China	PLOS ONE			English	Article							MOLECULAR CHARACTERISTICS; AGR DYSFUNCTION; INTERMEDIATE; STRAINS; GLYCOPEPTIDES; BACTEREMIA; INFECTION; HETERORESISTANCE; IDENTIFICATION; SURVEILLANCE	Background: Strains of Staphylococcus aureus with an intermediate level of resistance to vancomycin (vancomycin-intermediate S. aureus, or VISA) or which contain subpopulations of mixed susceptibility (heterogeneous VISA, or hVISA) have been reported worldwide. However, the prevalence of VISA and hVISA infections in Northeast China is unknown. From 2007 through 2010, we surveyed the vancomycin susceptibility of methicillin-resistant and methicillin-sensitive S. aureus (MRSA and MSSA, respectively) clinical isolates in Northeast China. Methods: S. aureus clinical isolates (369 MRSA and 388 MSSA) were screened for hVISA and VISA on brain heart infusion agar containing 3 mu g/mL vancomycin, and their identity confirmed using a modified population analysis profile-area under the curve method and broth microdilution. All hVISA and VISA isolates were characterized genotypically and phenotypically. Results: Ten percent and 0.5 percent of the isolates were hVISA and VISA, respectively. The proportion of hVISA among MSSA isolates for the entire study period was 4.1%, but increased significantly year-by-year, from 1.2% in 2007 to 7.2% in 2010. The predominant sources of hVISA and VISA isolates were sputum (56.3%), pus (18.8%), and blood (8.8%). Molecular typing of hVISA and VISA strains revealed that, taken together, 80% contained the accessory gene regulator (agr) group II, and of these, 85.7% of the MR-hVISA and MR-VISA strains were staphylococcal cassette chromosome mec (SCCmec) type II. The adherence ability of all hVISA and VISA strains was reduced compared with that of vancomycin-susceptible strains, shown by biofilm assay. Conclusions: The percentage of hVISA strains was high and increased each year. The proportion of hVISA among MSSA specifically also increased significantly each year. In isolates collected from diverse infection sites, hVISA and VISA strains were found predominantly in sputum, pus, and blood, in descending order. Testing for vancomycin susceptibility should include both MRSA and MSSA isolates collected from different clinical sites.	[Hu, Jian; Ma, Xiao Xue; Tian, Yuan; Pang, Long] China Med Univ, Dept Med Microbiol & Parasitol, Coll Basic Med Sci, Shenyang, Peoples R China; [Cui, Long Zhu] Kitasato Univ, Res Ctr Antiinfect Drugs, Sagamihara, Kanagawa 228, Japan; [Shang, Hong] China Med Univ, Affiliated Hosp 1, Dept Clin Lab, Shenyang, Peoples R China; [Hu, Jian] Yixing Hosp Tradit Chinese Med, Dept Clin Lab, Yixing, Jiangsu, Peoples R China	China Medical University; Kitasato University; China Medical University	Shang, H (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Clin Lab, Shenyang, Peoples R China.	hongshang100@hotmail.com		cui (Cui), long zhu (Longzhu)/0000-0002-8909-3885	National Natural Science Foundation [30972520]; Ministry of Education in China [1001]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education in China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation (Grant No. 30972520) and the Ministry of Education in China (Grant No. [2009] 1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2010, ANTIMICROB AGENTS CH, V54, P945, DOI 10.1128/AAC.01316-09; Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Burnham CAD, 2010, J CLIN MICROBIOL, V48, P949, DOI 10.1128/JCM.02295-09; Campanile F, 2010, INT J ANTIMICROB AG, V36, P415, DOI 10.1016/j.ijantimicag.2010.06.044; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; CLSI, 2012, M100S22 CLSI; Davis SL, 2006, INFECT CONT HOSP EP, V27, P1025, DOI 10.1086/507918; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Garnier F, 2006, J ANTIMICROB CHEMOTH, V57, P146, DOI 10.1093/jac/dki413; Graber CJ, 2007, EMERG INFECT DIS, V13, P491, DOI 10.3201/eid1303.060960; Hageman JC, 2008, DIAGN MICR INFEC DIS, V62, P440, DOI 10.1016/j.diagmicrobio.2008.08.005; Han JH, 2012, J ANTIMICROB CHEMOTH, V67, P2346, DOI 10.1093/jac/dks255; Harigaya Y, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-287; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Howden BP, 2006, ANTIMICROB AGENTS CH, V50, P3039, DOI 10.1128/AAC.00422-06; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Howe RA, 2004, EMERG INFECT DIS, V10, P855, DOI 10.3201/eid1005.030556; Kawaguchiya M, 2011, MICROB DRUG RESIST, V17, P241, DOI 10.1089/mdr.2010.0136; Kirby A, 2010, J ANTIMICROB CHEMOTH, V65, P721, DOI 10.1093/jac/dkq009; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kosowska-Shick K, 2008, ANTIMICROB AGENTS CH, V52, P4510, DOI 10.1128/AAC.01073-08; Leonard SN, 2009, J ANTIMICROB CHEMOTH, V63, P489, DOI 10.1093/jac/dkn520; Li HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053341; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Liu C, 2003, ANTIMICROB AGENTS CH, V47, P3040, DOI 10.1128/AAC.47.10.3040-3045.2003; Lowy FD, 2011, NEW ENGL J MED, V364, P1987, DOI 10.1056/NEJMp1100251; Ludwig F, 2012, J CLIN MICROBIOL, V50, P3383, DOI 10.1128/JCM.01158-12; Ma XX, 2008, J CLIN MICROBIOL, V46, P3246, DOI 10.1128/JCM.00136-08; Ma XX, 2011, J MED MICROBIOL, V60, P1661, DOI 10.1099/jmm.0.034066-0; Ma XX, 2011, CAN J MICROBIOL, V57, P476, DOI [10.1139/W11-033, 10.1139/w11-033]; Ma XX, 2011, DIAGN MICR INFEC DIS, V70, P22, DOI 10.1016/j.diagmicrobio.2010.12.004; Maor Y, 2009, J INFECT DIS, V199, P619, DOI 10.1086/596629; Musta AC, 2009, J CLIN MICROBIOL, V47, P1640, DOI 10.1128/JCM.02135-08; Pillai SK, 2009, CLIN INFECT DIS, V49, P1169, DOI 10.1086/605636; Popovich KJ, 2009, INFECT CONT HOSP EP, V30, P9, DOI 10.1086/592709; Richter SS, 2011, J CLIN MICROBIOL, V49, P4203, DOI 10.1128/JCM.01152-11; Riederer K, 2011, J CLIN MICROBIOL, V49, P2147, DOI 10.1128/JCM.01435-10; Rijnders MIA, 2009, J CLIN MICROBIOL, V47, P4090, DOI 10.1128/JCM.00820-09; Rybak MJ, 2008, J CLIN MICROBIOL, V46, P2950, DOI 10.1128/JCM.00582-08; Sakoulas G, 2006, CLIN INFECT DIS, V42, pS40, DOI 10.1086/491713; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P4926, DOI 10.1128/AAC.48.12.4926-4928.2004; Sun WJ, 2009, ANTIMICROB AGENTS CH, V53, P3642, DOI 10.1128/AAC.00206-09; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; UNAL S, 1992, J CLIN MICROBIOL, V30, P1685, DOI 10.1128/JCM.30.7.1685-1691.1992; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; van Hal SJ, 2011, J CLIN MICROBIOL, V49, P1489, DOI 10.1128/JCM.02302-10; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399; Wootton M, 2007, J CLIN MICROBIOL, V45, P329, DOI 10.1128/JCM.01508-06	52	26	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73300	10.1371/journal.pone.0073300	http://dx.doi.org/10.1371/journal.pone.0073300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069184	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100037
J	Louros, NN; Iconomidou, VA; Giannelou, P; Hamodrakas, SJ				Louros, Nikolaos N.; Iconomidou, Vassiliki A.; Giannelou, Polina; Hamodrakas, Stavros J.			Structural Analysis of Peptide-Analogues of Human Zona Pellucida ZP1 Protein with Amyloidogenic Properties: Insights into Mammalian Zona Pellucida Formation	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; EGG EXTRACELLULAR COAT; SPERM RECEPTORS; SECONDARY STRUCTURE; DOMAIN; FIBRILS; IDENTIFICATION; SPECTROSCOPY; WATER; DIFFERENTIATION	Zona pellucida (ZP) is an extracellular matrix surrounding and protecting mammalian and fish oocytes, which is responsible for sperm binding. Mammalian ZP consists of three to four glycoproteins, called ZP1, ZP2, ZP3, ZP4. These proteins polymerize into long interconnected filaments, through a common structural unit, known as the ZP domain, which consists of two domains, ZP-N and ZP-C. ZP is related in function to silkmoth chorion and in an evolutionary fashion to the teleostean fish chorion, also fibrous structures protecting the oocyte and embryo, that both have been proven to be functional amyloids. Two peptides were predicted as 'aggregation-prone' by our prediction tool, AMYLPRED, from the sequence of the human ZP1-N domain. Here, we present results from transmission electron microscopy, X-ray diffraction, Congo red staining and attenuated total reflectance Fourier-transform infrared spectroscopy (ATR FT-IR), of two synthetic peptide-analogues of these predicted 'aggregation-prone' parts of the human ZP1-N domain, that we consider crucial for ZP protein polymerization, showing that they both self-assemble into amyloid-like fibrils. Based on our experimental data, we propose that human ZP (hZP) might be considered as a novel, putative, natural protective amyloid, in close analogy to silkmoth and teleostean fish chorions. Experiments are in progress to verify this proposal. We also attempt to provide insights into ZP formation, proposing a possible model for hZP1-N domain polymerization.	[Louros, Nikolaos N.; Iconomidou, Vassiliki A.; Giannelou, Polina; Hamodrakas, Stavros J.] Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece	National & Kapodistrian University of Athens	Hamodrakas, SJ (corresponding author), Univ Athens, Dept Cell Biol & Biophys, Fac Biol, Athens, Greece.	shamodr@biol.uoa.gr	Louros, Nikolaos/AAB-7443-2022; Louros, Nikolaos/AAR-5582-2021; Iconomidou, Vassiliki/AAM-2003-2020	Louros, Nikolaos/0000-0002-4030-1022; Louros, Nikolaos/0000-0002-4030-1022; Giannelou, Polina/0000-0003-0714-8940	University of Athens; SYNERGASIA PROGRAMME; European Regional Development Fund; National resources [Code 11SYN_1_1230]	University of Athens; SYNERGASIA PROGRAMME; European Regional Development Fund(European Commission); National resources	The authors thank the University of Athens for support. This work was funded by the SYNERGASIA 2011 PROGRAMME, co-funded by the European Regional Development Fund and National resources (Project Code 11SYN_1_1230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bely M, 2006, ACTA HISTOCHEM, V108, P175, DOI 10.1016/j.acthis.2006.03.017; BLEIL JD, 1980, DEV BIOL, V76, P185, DOI 10.1016/0012-1606(80)90371-1; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai SW, 1999, BIOPHYS CHEM, V80, P7, DOI 10.1016/S0301-4622(99)00060-5; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133; Choi S, 2010, J AM CHEM SOC, V132, P1359, DOI 10.1021/ja908562q; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Conner SJ, 2005, HUM REPROD, V20, P1148, DOI 10.1093/humrep/deh835; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Dean J, 2004, BIOESSAYS, V26, P29, DOI 10.1002/bies.10412; Diffraction O, 2009, CHRYSALIS PROMOTIONS; Divry P, 1927, CR SOC BIOL, V97, P1808; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dumont J N, 1985, Dev Biol (N Y 1985), V1, P235; Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Fraser RDB, 1973, PROTEINS; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; Goudet G, 2008, BIOL REPROD, V78, P796, DOI 10.1095/biolreprod.107.064568; GREVE JM, 1985, J MOL BIOL, V181, P253, DOI 10.1016/0022-2836(85)90089-0; Han L, 2010, CELL, V143, P404, DOI 10.1016/j.cell.2010.09.041; HARIS PI, 1995, BIOPOLYMERS, V37, P251, DOI 10.1002/bip.360370404; Hoodbhoy T, 2005, J BIOL CHEM, V280, P12721, DOI 10.1074/jbc.M413569200; Hoodbhoy T, 2004, REPRODUCTION, V127, P417, DOI 10.1530/rep.1.00181; Iconomidou VA, 2001, FEBS LETT, V499, P268, DOI 10.1016/S0014-5793(01)02510-8; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Iconomidou VA, 2008, CURR PROTEIN PEPT SC, V9, P291, DOI 10.2174/138920308784534041; Izquierdo-Rico MJ, 2009, J PROTEOME RES, V8, P926, DOI 10.1021/pr800568x; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jimenez-Movilla M, 2011, J CELL SCI, V124, P940, DOI 10.1242/jcs.079988; Jimenez-Movilla M, 2009, HISTOL HISTOPATHOL, V24, P599, DOI 10.14670/HH-24.599; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Jovine L, 2004, P NATL ACAD SCI USA, V101, P5922, DOI 10.1073/pnas.0401600101; Jovine Luca, 2006, BMC Biochem, V7, P11, DOI 10.1186/1471-2091-7-11; Kastritis PL, 2012, METHODS MOL BIOL, V819, P355, DOI 10.1007/978-1-61779-465-0_22; Kastritis PL, 2012, PROTEINS; Kelly JW, 2003, J CELL BIOL, V161, P461, DOI 10.1083/jcb.200304074; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kreplak L, 2006, ADV PROTEIN CHEM, V73, P217, DOI 10.1016/S0065-3233(06)73007-8; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lazo ND, 1998, BIOCHEMISTRY-US, V37, P1731, DOI 10.1021/bi971016d; Lefievre L, 2004, HUM REPROD, V19, P1580, DOI 10.1093/humrep/deh301; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Maury CPJ, 2009, J INTERN MED, V265, P329, DOI 10.1111/j.1365-2796.2008.02068.x; Mitraki A, 2010, ADV PROTEIN CHEM STR, V79, P89, DOI 10.1016/S1876-1623(10)79003-9; Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599; Monne M, 2006, SEMIN REPROD MED, V24, P204, DOI 10.1055/s-2006-948550; Monne M, 2011, BIOL REPROD, V85, P661, DOI 10.1095/biolreprod.111.092098; Pedersen JS, 2010, FEBS J, V277, P4591, DOI 10.1111/j.1742-4658.2010.07888.x; Pepys M.B., 1996, OXFORD TXB MED; Podrabsky JE, 2001, AM J PHYSIOL-REG I, V280, pR123, DOI 10.1152/ajpregu.2001.280.1.R123; Rankin TL, 2001, DEVELOPMENT, V128, P1119; Rankin TL, 2003, DEV CELL, V5, P33, DOI 10.1016/S1534-5807(03)00195-3; ROMHANYI G, 1971, VIRCHOWS ARCH A, V354, P209, DOI 10.1007/BF00544254; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Spargo SC, 2003, BIOL REPROD, V68, P358, DOI 10.1095/biolreprod.102.008086; Stetson I, 2012, J PROTEOMICS, V75, P5920, DOI 10.1016/j.jprot.2012.07.027; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uversky VN, 2008, CURR ALZHEIMER RES, V5, P260, DOI 10.2174/156720508784533312; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; Wassarman PM, 2009, J REPROD IMMUNOL, V83, P45, DOI 10.1016/j.jri.2009.06.259; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415, DOI 10.1146/annurev.bi.57.070188.002215; WASSARMAN PM, 1991, INT REV CYTOL, V130, P85, DOI 10.1016/S0074-7696(08)61502-8; Wassarman PM, 2002, MT SINAI J MED, V69, P148; Wassarman PM, 1996, J CELL SCI, V109, P2001; Wassarman PM, 1989, MAMMALIAN EGG COAT S, P49; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yanagimachi R., 1978, Current Topics in Developmental Biology, V12, P83, DOI 10.1016/S0070-2153(08)60594-3; Zhao M, 2003, MOL CELL BIOL, V23, P8982, DOI 10.1128/MCB.23.24.8982-8991.2003	84	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73258	10.1371/journal.pone.0073258	http://dx.doi.org/10.1371/journal.pone.0073258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069181	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100034
J	Oosterveld-Vlug, MG; Pasman, HRW; van Gennip, IE; Willems, DL; Onwuteaka-Philipsen, BD				Oosterveld-Vlug, Mariska G.; Pasman, H. Roeline W.; van Gennip, Isis E.; Willems, Dick L.; Onwuteaka-Philipsen, Bregje D.			Changes in the Personal Dignity of Nursing Home Residents: A Longitudinal Qualitative Interview Study	PLOS ONE			English	Article							OLDER-PEOPLE; CARE; VIEWS; LIFE; ILL	Background: Most nursing home residents spend the remainder of their life, until death, within a nursing home. As preserving dignity is an important aim of the care given here, insight into the way residents experience their dignity throughout their entire admission period is valuable. Aim: To investigate if and how nursing home residents' personal dignity changes over the course of time, and what contributes to this. Design: A longitudinal qualitative study. Methods: Multiple in-depth interviews, with an interval of six months, were carried out with 22 purposively sampled nursing home residents of the general medical wards of four nursing homes in The Netherlands. Transcripts were analyzed following the principles of thematic analysis. Results: From admission onwards, some residents experienced an improved sense of dignity, while others experienced a downward trend, a fluctuating one or no change at all. Two mechanisms were especially important for a nursing home resident to maintain or regain personal dignity: the feeling that one is in control of his life and the feeling that one is regarded as a worthwhile person. The acquirement of both feelings could be supported by 1) finding a way to cope with one's situation; 2) getting acquainted with the new living structures in the nursing home and therefore feeling more at ease; 3) physical improvement (with or without an electric wheelchair); 4) being socially involved with nursing home staff, other residents and relatives; and 5) being amongst disabled others and therefore less prone to exposures of disrespect from the outer world. Conclusion: Although the direction in which a resident's personal dignity develops is also dependent on one's character and coping capacities, nursing home staff can contribute to dignity by creating optimal conditions to help a nursing home resident recover feelings of control and of being regarded as a worthwhile person.	[Oosterveld-Vlug, Mariska G.; Pasman, H. Roeline W.; van Gennip, Isis E.; Onwuteaka-Philipsen, Bregje D.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Expertise Ctr Palliat Care,Med Ctr, Amsterdam, Netherlands; [Willems, Dick L.] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Sect Med Eth, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Oosterveld-Vlug, MG (corresponding author), Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Expertise Ctr Palliat Care,Med Ctr, Amsterdam, Netherlands.	eol@vumc.nl			Netherlands Organisation for Scientific Research (NWO, the Hague) [VICI 916.96.628]	Netherlands Organisation for Scientific Research (NWO, the Hague)(Netherlands Organization for Scientific Research (NWO))	This study is supported by a career award for Bregje Onwuteaka-Philipsen of the Netherlands Organisation for Scientific Research (NWO, the Hague; VICI 916.96.628). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers G, 2013, J PAIN SYMPTOM MANAG, V45, P1030, DOI 10.1016/j.jpainsymman.2012.06.012; Andersson I, 2007, J CLIN NURS, V16, P1712, DOI 10.1111/j.1365-2702.2007.01703.x; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Brooke V, 1989, Geriatr Nurs, V10, P66, DOI 10.1016/S0197-4572(89)80054-0; Chochinov HM, 2002, SOC SCI MED, V54, P433, DOI 10.1016/S0277-9536(01)00084-3; Dwyer LL, 2008, NURS ETHICS, V15, P97, DOI 10.1177/0969733007083938; FOLKMAN S, 1988, SOC SCI MED, V26, P309, DOI 10.1016/0277-9536(88)90395-4; Franklin LL, 2006, NURS ETHICS, V13, P130, DOI 10.1191/0969733006ne851oa; Goddard C, 2013, J ADV NURS, V69, P122, DOI 10.1111/j.1365-2648.2012.05999.x; Griffin-Heslin Vanessa Lynne, 2005, Accid Emerg Nurs, V13, P251, DOI 10.1016/j.aaen.2005.09.003; Hall S, 2009, AGE AGEING, V38, P411, DOI 10.1093/ageing/afp069; Iwasiw C, 1996, J CLIN NURS, V5, P381, DOI 10.1111/j.1365-2702.1996.tb00271.x; Jacelon CS, 2004, J ADV NURS, V48, P76, DOI 10.1111/j.1365-2648.2004.03170.x; Junger S, 2012, J PAIN SYMPTOM MANAG, V44, P192, DOI 10.1016/j.jpainsymman.2011.09.009; LAZARUS RS, 1975, AM PSYCHOL, V30, P553, DOI 10.1037/h0076649; Leget C, 2013, MED HEALTH CARE PHIL, V16, P945, DOI 10.1007/s11019-012-9427-3; Matiti MR, 2004, INT J NURS STUD, V41, P735, DOI 10.1016/j.ijnurstu.2004.02.008; Nordenfelt Lennart, 2003, Med Health Care Philos, V6, P103, DOI 10.1023/A:1024110810373; Oosterveld-Vlug MG, 2014, J ADV NURS, V70, P97, DOI 10.1111/jan.12171; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Pleschberger S, 2007, AGE AGEING, V36, P197, DOI 10.1093/ageing/afl152; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Thompson Genevieve N, 2008, Curr Opin Support Palliat Care, V2, P49, DOI 10.1097/SPC.0b013e3282f4cb15; van Gennip IE, 2013, INT J NURS STUD, V50, P1080, DOI 10.1016/j.ijnurstu.2012.12.014; Wilson SA, 1997, J ADV NURS, V26, P864, DOI 10.1046/j.1365-2648.1997.00636.x	26	23	24	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73822	10.1371/journal.pone.0073822	http://dx.doi.org/10.1371/journal.pone.0073822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069235	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100062
J	Roca, A; Dione, MM; Bojang, A; Townend, J; Egere, U; Darboe, O; Howie, SRC; Hill, PC; Adegbola, RA; Greenwood, BM; Antonio, M				Roca, Anna; Dione, Michel M.; Bojang, Abdoulie; Townend, John; Egere, Uzochukwu; Darboe, Ousainou; Howie, Stephen R. C.; Hill, Philip C.; Adegbola, Richard A.; Greenwood, Brian M.; Antonio, Martin			Nasopharyngeal Carriage of Pneumococci Four Years after Community-Wide Vaccination with PCV-7 in The Gambia: Long-Term Evaluation of a Cluster Randomized Trial	PLOS ONE			English	Article							DETERMINING CAPSULAR SEROTYPES; SEQUENTIAL MULTIPLEX PCR; CONJUGATE VACCINE; STREPTOCOCCUS-PNEUMONIAE; DISEASE; AZITHROMYCIN; TRACHOMA; CHILDREN; YOUNGER; IMPACT	Background: A village-randomized trial of a seven-valent pneumococcal-conjugate-vaccine (PCV-7) conducted in rural Gambia showed a decrease of vaccine-type (VT) and a non-significant increase in non-vaccine-type (NVT) nasopharyngeal carriage of pneumococci two years after vaccination. Here, we report findings four years after vaccination. Methods: PCV-7 was given to all children below 30 months of age enrolled in the trial and to those born during its course in all study villages. Villages were randomized (older children and adults) to receive PCV-7 (wholly vaccinated villages) or serogroup-C-meningococcal-conjugate-vaccine (partly vaccinated villages). Cross-sectional surveys (CSS) to collect nasopharyngeal swabs were conducted before and at various intervals after vaccination. Sixteen of these randomized villages (8 wholly vaccinated and 8 partly vaccinated) participated in a CSS conducted four years after vaccination started. Results: Four years after vaccination, the prevalence of VT pneumococcal carriage was slightly higher in partly than in wholly vaccinated villages [6.4% versus 3.9% (p = 0.120)] compared to 24.4% in the pre-vaccination CSS (p<0.001). Prevalence of NVT four years after vaccination was similar between study groups [32.7% versus 29.8% (p = 0.392), respectively] compared to 51.1% in the pre-vaccination CSS (p<0.001). Four years after vaccination started, lower prevalence of serotype 6A was detected in wholly vaccinated than in partly vaccinated villages (1.6% versus 3.5%, p = 0.093) whilst the prevalence of serotype 19A was similar between groups (2.9% versus 2.5%, p = 0.779). The most prevalent serotype 19A clone was ST 847. The most prevalent serotype 6A clone before vaccination was ST3324 whilst after vaccination ST913 and ST1737 predominated. Fourteen out of 26 STs detected among the serotype 6A isolates were new while no new 19A serotype ST was found. Conclusions: The decline in prevalence of VT pneumococci seen shortly after PCV-7 vaccination was sustained four years later with only a small difference between study arms. No significant serotype replacement was detected.	[Roca, Anna; Dione, Michel M.; Bojang, Abdoulie; Townend, John; Egere, Uzochukwu; Darboe, Ousainou; Howie, Stephen R. C.; Hill, Philip C.; Adegbola, Richard A.; Antonio, Martin] MRC Unit, Banjul, Gambia; [Hill, Philip C.] Univ Otago, Sch Med, Ctr Int Hlth, Dunedin, New Zealand; [Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium; [Greenwood, Brian M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of Otago; GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine	Roca, A (corresponding author), MRC Unit, Banjul, Gambia.	aroca@mrc.gm	Egere, Uzochukwu/AET-1704-2022	Dione, Michel/0000-0001-7812-5776	United Kingdom Medical Research Council; Medical Research Council [MC_U190085849] Funding Source: researchfish; MRC [MC_U190085849] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the United Kingdom Medical Research Council. Study vaccines were donated by Wyeth Lederle Vaccines (Pfizer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsola AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031050; Antonio M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-81; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Hanage WP, 2010, EPIDEMICS-NETH, V2, P80, DOI 10.1016/j.epidem.2010.03.005; Hanquet G, 2010, EMERG INFECT DIS, V16, P1428, DOI 10.3201/eid1609.100102; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Hsieh YC, 2009, VACCINE, V27, P5513, DOI 10.1016/j.vaccine.2009.06.091; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Saeland E, 2001, J INFECT DIS, V183, P253, DOI 10.1086/317934; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; van Gils EJM, 2010, JAMA-J AM MED ASSOC, V304, P1099, DOI 10.1001/jama.2010.1290; Vestrheim DF, 2012, CLIN VACCINE IMMUNOL, V19, P443, DOI 10.1128/CVI.05563-11; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2	28	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e72198	10.1371/journal.pone.0072198	http://dx.doi.org/10.1371/journal.pone.0072198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086259	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325223900007
J	Andre, I; Corn, J				Andre, Ingemar; Corn, Jacob			The RosettaCon 2012 Special Collection: Code Writ on Water, Documentation Writ in Stone	PLOS ONE			English	Editorial Material							COMPUTATIONAL DESIGN; BIOINFORMATICS; PREDICTION; REDESIGN; BIOLOGY; DOCKING		[Andre, Ingemar] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden; [Corn, Jacob] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Lund University; Roche Holding; Genentech	Corn, J (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA.	cornj@gene.com	André, Ingemar/O-4777-2014	André, Ingemar/0000-0002-4753-8233; Corn, Jacob/0000-0002-7798-5309				Adolf-Bryfogle J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066856; Alexander NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072851; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Der BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064363; Drew K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067051; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gentleman R, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1034; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kahraman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073411; Khar KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070661; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lemmon G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067536; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Morin A, 2012, SCIENCE, V336, P159, DOI 10.1126/science.1218263; Nguyen ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067302; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; Renfrew PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032637; Renfrew PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022431; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063090; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072096	34	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e73775	10.1371/journal.pone.0073775	http://dx.doi.org/10.1371/journal.pone.0073775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VP	24086295	Green Published, gold, Green Submitted			2022-12-27	WOS:000325220000003
J	Stamatakis, E; Chau, JY; Pedisic, Z; Bauman, A; Macniven, R; Coombs, N; Hamer, M				Stamatakis, Emmanuel; Chau, Josephine Y.; Pedisic, Zeljko; Bauman, Adrian; Macniven, Rona; Coombs, Ngaire; Hamer, Mark			Are Sitting Occupations Associated with Increased All-Cause, Cancer, and Cardiovascular Disease Mortality Risk? A Pooled Analysis of Seven British Population Cohorts	PLOS ONE			English	Article							TIME PHYSICAL-ACTIVITY; LEISURE-TIME; SEDENTARY BEHAVIORS; FINNISH SUBJECTS; HEALTH SURVEY; DEATH; NETHERLANDS; TRENDS; WORK; LIFE	Background: There is mounting evidence for associations between sedentary behaviours and adverse health outcomes, although the data on occupational sitting and mortality risk remain equivocal. The aim of this study was to determine the association between occupational sitting and cardiovascular, cancer and all-cause mortality in a pooled sample of seven British general population cohorts. Methods: The sample comprised 5380 women and 5788 men in employment who were drawn from five Health Survey for England and two Scottish Health Survey cohorts. Participants were classified as reporting standing, walking or sitting in their work time and followed up over 12.9 years for mortality. Data were modelled using Cox proportional hazard regression adjusted for age, waist circumference, self-reported general health, frequency of alcohol intake, cigarette smoking, nonoccupational physical activity, prevalent cardiovascular disease and cancer at baseline, psychological health, social class, and education. Results: In total there were 754 all-cause deaths. In women, a standing/walking occupation was associated with lower risk of all-cause (fully adjusted hazard ratio [HR] = 0.68, 95% CI 0.52-0.89) and cancer (HR = 0.60, 95% CI 0.43-0.85) mortality, compared to sitting occupations. There were no associations in men. In analyses with combined occupational type and leisure-time physical activity, the risk of all-cause mortality was lowest in participants with non-sitting occupations and high leisure-time activity. Conclusions: Sitting occupations are linked to increased risk for all-cause and cancer mortality in women only, but no such associations exist for cardiovascular mortality in men or women.	[Stamatakis, Emmanuel; Coombs, Ngaire; Hamer, Mark] UCL, Phys Act Res Grp, Div Populat Hlth, London, England; [Stamatakis, Emmanuel; Coombs, Ngaire; Hamer, Mark] UCL, Dept Epidemiol & Publ Hlth, London, England; [Stamatakis, Emmanuel; Chau, Josephine Y.; Pedisic, Zeljko; Bauman, Adrian; Macniven, Rona] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW 2006, Australia	University of London; University College London; University of London; University College London; University of Sydney	Stamatakis, E (corresponding author), UCL, Phys Act Res Grp, Div Populat Hlth, London, England.	e.stamatakis@ucl.ac.uk	Hamer, Mark/AAJ-6814-2021; Stamatakis, Emmanuel/C-4958-2009; Hamer, Mark/C-1602-2008	Hamer, Mark/0000-0002-8726-7992; Stamatakis, Emmanuel/0000-0001-7323-3225; Hamer, Mark/0000-0002-8726-7992; Pedisic, Zeljko/0000-0003-2886-3556; Macniven, Rona/0000-0002-2967-7977; Chau, Josephine/0000-0001-6261-2545	National Institute for Health Research (United Kingdom); British Heart Foundation; Scottish Health Survey; Scottish Executive; Health Survey for England by the Health and Social Care Information Centre; Australian National Health and Medical Research Council Program [569940]; National Institute for Health Research [CDF-2010-03-30] Funding Source: researchfish	National Institute for Health Research (United Kingdom)(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Scottish Health Survey; Scottish Executive; Health Survey for England by the Health and Social Care Information Centre; Australian National Health and Medical Research Council Program(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	This report is independent research arising from the first author's (ES) Career Development Fellowship supported by the National Institute for Health Research (United Kingdom). The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the National Institute for Health Research or the English Department of Health. MH receives funding from the British Heart Foundation, The Scottish Health Survey is funded by the Scottish Executive and the Health Survey for England by the Health and Social Care Information Centre. AB, JYC and ZP are funded by Australian National Health and Medical Research Council Program Grant (No. 569940). None of the funding organisations listed above had any involvement in the data analysis and interpretation or the preparation, review and approval of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Basner M, 2007, SLEEP, V30, P1085, DOI 10.1093/sleep/30.9.1085; Bureau of Labor Statistics, 2012, AM TIM US SURV 2011; Chau JY, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-76; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Friedenreich CM, 2010, CANCER CAUSE CONTROL, V21, P1105, DOI 10.1007/s10552-010-9538-1; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Holtermann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054548; Hu G, 2004, CIRCULATION, V110, P666, DOI 10.1161/01.CIR.0000138102.23783.94; Hu G, 2007, AM J HYPERTENS, V20, P1242, DOI 10.1016/j.amjhyper.2007.07.015; Hu GC, 2014, ASIA-PAC J PUBLIC HE, V26, P604, DOI 10.1177/1010539512471966; JOHANSSON S, 1988, European Heart Journal, V9, P8; Joint Health Surveys Unit, 2007, HLTH SURV ENGL PHYS; Joint Health Surveys Unit, 2009, HLTH SURV ENGL 2008; Jurakic D, 2010, SOCIOL PROST, V48, P113; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Kristal-Boneh E, 2000, J OCCUP ENVIRON MED, V42, P127, DOI 10.1097/00043764-200002000-00005; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V18, P11; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Messenger JC, 2011, CAMB J ECON, V35, P295, DOI 10.1093/cje/beq022; Miller R, 2004, INT J BEHAV MED, V11, P219, DOI 10.1207/s15327558ijbm1104_5; Moe B, 2013, OCCUP ENVIRON MED, V70, P86, DOI 10.1136/oemed-2012-100734; MORRIS JN, 1953, LANCET, V265, P1111; Ng SW, 2012, OBES REV, V13, P659, DOI 10.1111/j.1467-789X.2011.00982.x; Parent ME, 2011, CANCER EPIDEMIOL, V35, P151, DOI 10.1016/j.canep.2010.09.004; Pereira SMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031132; Proper KI, 2012, J OBES, V2012, DOI 10.1155/2012/607908; Pulsford RM, 2013, AM J PREV MED, V44, P132, DOI 10.1016/j.amepre.2012.10.009; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; SALONEN JT, 1988, AM J EPIDEMIOL, V127, P87, DOI 10.1093/oxfordjournals.aje.a114794; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Simons CCJM, 2013, AM J EPIDEMIOL, V177, P514, DOI 10.1093/aje/kws280; Spittaels H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-149; Stamatakis E, 2007, PREV MED, V45, P416, DOI 10.1016/j.ypmed.2006.12.014; Stephens BR, 2011, METABOLISM, V60, P941, DOI 10.1016/j.metabol.2010.08.014; SZRETER SRS, 1984, BRIT J SOCIOL, V35, P522, DOI 10.2307/590433; The Organisation for Economic Co-operation and Development, 2012, EMPL OUTL; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; van der Ploeg HP, 2013, AM J PREV MED, V44, P382, DOI 10.1016/j.amepre.2012.11.034; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Williams ED, 2011, J EPIDEMIOL COMMUN H, V65, P517, DOI 10.1136/jech.2009.102509; Williams ED, 2011, HEART, V97, P655, DOI 10.1136/hrt.2010.201012; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z	49	100	100	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2013	8	9							e73753	10.1371/journal.pone.0073753	http://dx.doi.org/10.1371/journal.pone.0073753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VP	24086292	Green Accepted, Green Published, gold			2022-12-27	WOS:000325220000002
J	Tanveer, SK; Wen, XX; Lu, XL; Zhang, JL; Liao, YC				Tanveer, Sikander Khan; Wen, Xiaoxia; Lu, Xing Li; Zhang, Junli; Liao, Yuncheng			Tillage, Mulch and N Fertilizer Affect Emissions of CO2 under the Rain Fed Condition	PLOS ONE			English	Article							CONTROLLING SOIL RESPIRATION; CARBON-DIOXIDE FLUXES; LAND-USE TYPES; ORGANIC-MATTER; CONSERVATION TILLAGE; MICROBIAL BIOMASS; LOESS PLATEAU; WATER-CONTENT; WHEAT FIELD; NITROGEN	A two year (2010-2012) study was conducted to assess the effects of different agronomic management practices on the emissions of CO2 from a field of non-irrigated wheat planted on China's Loess Plateau. Management practices included four tillage methods i.e. T-1: (chisel plow tillage), T-2: (zero-tillage), T-3: (rotary tillage) and T-4: (mold board plow tillage), 2 mulch levels i.e., M-0 (no corn residue mulch) and M-1 (application of corn residue mulch) and 5 levels of N fertilizer (0, 80, 160, 240, 320 kg N/ha). A factorial experiment having a strip split-split arrangement, with tillage methods in the main plots, mulch levels in the sub plots and N-fertilizer levels in the sub-sub plots with three replicates, was used for this study. The CO2 data were recorded three times per week using a portable GXH-3010E1 gas analyzer. The highest CO2 emissions were recorded following rotary tillage, compared to the lowest emissions from the zero tillage planting method. The lowest emissions were recorded at the 160 kg N/ha, fertilizer level. Higher CO2 emissions were recorded during the cropping year 2010-11 relative to the year 2011-12. During cropping year 2010-11, applications of corn residue mulch significantly increased CO2 emissions in comparison to the non-mulched treatments, and during the year 2011-12, equal emissions were recorded for both types of mulch treatments. Higher CO2 emissions were recorded immediately after the tillage operations. Different environmental factors, i.e., rain, air temperatures, soil temperatures and soil moistures, had significant effects on the CO2 emissions. We conclude that conservation tillage practices, i.e., zero tillage, the use of corn residue mulch and optimum N fertilizer use, can reduce CO2 emissions, give better yields and provide environmentally friendly options.	[Tanveer, Sikander Khan; Wen, Xiaoxia; Lu, Xing Li; Zhang, Junli; Liao, Yuncheng] Northwest A&F Univ Yangling, Coll Agron, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Liao, YC (corresponding author), Northwest A&F Univ Yangling, Coll Agron, Yangling, Shaanxi, Peoples R China.	yunchengliao@163.com			National Natural Science foundation of China [31071375, 31171506]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science foundation of China (31071375 and 31171506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi H., 2009, AGR ENG INT CIGR EJO, VXI, P1; Alvaro-Fuentes J, 2007, SOIL TILL RES, V96, P331, DOI 10.1016/j.still.2007.08.003; ANDERSON TH, 1994, BEYOND THE BIOMASS, P67; Bao S.D., 2008, SOIL AGR CHEM ANAL M, Vthird ed; Bauer J, 2008, GEODERMA, V145, P17, DOI 10.1016/j.geoderma.2008.01.026; BEARE MH, 1994, SOIL SCI SOC AM J, V58, P787, DOI 10.2136/sssaj1994.03615995005800030021x; Bowden RD, 1998, SOIL BIOL BIOCHEM, V30, P1591, DOI 10.1016/S0038-0717(97)00228-9; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Calderon FJ, 2001, SOIL SCI SOC AM J, V65, P118, DOI 10.2136/sssaj2001.651118x; Chapin III FS, 1991, INTEGRATED RESPONSES, P67; Cole CV, 1997, NUTR CYCL AGROECOSYS, V49, P221, DOI 10.1023/A:1009731711346; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Ding WX, 2007, SOIL BIOL BIOCHEM, V39, P669, DOI 10.1016/j.soilbio.2006.09.024; Ding WX, 2006, ATMOS ENVIRON, V40, P3294, DOI 10.1016/j.atmosenv.2006.01.045; Drury CF, 1999, AGRON J, V91, P101, DOI 10.2134/agronj1999.00021962009100010016x; Edmeades DC, 2003, NUTR CYCL AGROECOSYS, V66, P165, DOI 10.1023/A:1023999816690; Fisk MC, 2001, BIOGEOCHEMISTRY, V53, P201, DOI 10.1023/A:1010693614196; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; FRANZLUEBBERS AJ, 1995, SOIL TILL RES, V34, P41, DOI 10.1016/0167-1987(94)00450-S; Galantini J, 2006, SOIL TILL RES, V34, P41; Gao ChengDa, 2008, Journal of Beijing Forestry University, V30, P102; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Haynes RJ, 2000, SOIL BIOL BIOCHEM, V32, P211, DOI 10.1016/S0038-0717(99)00148-0; Houghton R, 1990, EARTH TRANSFORMED HU, P393; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Hutchinson JJ, 2007, AGR FOREST METEOROL, V142, P288, DOI 10.1016/j.agrformet.2006.03.030; Iqbal J, 2008, SOIL BIOL BIOCHEM, V40, P2324, DOI 10.1016/j.soilbio.2008.05.010; Iqbal J, 2009, AGR ECOSYST ENVIRON, V131, P292, DOI 10.1016/j.agee.2009.02.001; Jacinthe PA, 2002, SOIL TILL RES, V67, P147, DOI 10.1016/S0167-1987(02)00058-2; JOHNSON MG, 1995, WATER AIR SOIL POLL, V82, P593, DOI 10.1007/BF00479414; KERN JS, 1993, SOIL SCI SOC AM J, V57, P200, DOI 10.2136/sssaj1993.03615995005700010036x; Kladivko EJ, 2001, SOIL TILL RES, V61, P61, DOI 10.1016/S0167-1987(01)00179-9; Koga N, 2003, AGR ECOSYST ENVIRON, V99, P213, DOI 10.1016/S0167-8809(03)00132-4; KOWALENKO CG, 1978, SOIL BIOL BIOCHEM, V10, P417, DOI 10.1016/0038-0717(78)90068-8; La Scala N, 2005, SOIL TILL RES, V84, P222, DOI 10.1016/j.still.2004.11.004; LADD JN, 1994, SOIL BIOL BIOCHEM, V26, P821, DOI 10.1016/0038-0717(94)90298-4; Lal R, 1997, NUTR CYCL AGROECOSYS, V49, P243, DOI 10.1023/A:1009794514742; Lal R, 1999, J SOIL WATER CONSERV, V54, P374; Lal R, 1997, SOIL TILL RES, V42, P145, DOI 10.1016/S0167-1987(97)00006-8; Lal R., 1998, POTENTIAL US CROP LA; Lee DK, 2007, SOIL BIOL BIOCHEM, V39, P178, DOI 10.1016/j.soilbio.2006.07.004; Li H, 2010, AGR ECOSYST ENVIRON, V135, P24, DOI 10.1016/j.agee.2009.08.003; LIANG BC, 1992, SOIL SCI, V153, P307, DOI 10.1097/00010694-199204000-00007; Liu H, 2008, AGR ECOSYST ENVIRON, V124, P125, DOI 10.1016/j.agee.2007.09.002; Lou YZ, 2006, SOIL RESP ENV, P110; Paustian K, 1997, SOIL USE MANAGE, V13, P230, DOI 10.1111/j.1475-2743.1997.tb00594.x; Paustian K., 1997, SOIL ORGANIC MATTER; POST WM, 1990, AM SCI, V78, P310; Raich JW, 1992, SOIL SCI SOC AM J, V56, P476; Reeves DW, 1997, SOIL TILL RES, V43, P131, DOI 10.1016/S0167-1987(97)00038-X; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Reicosky DC, 2002, AGRICULTURAL PRACTICES AND POLICIES FOR CARBON SEQUESTRATION IN SOIL, P87; Reicosky DC, 1997, SOIL TILL RES, V41, P105, DOI 10.1016/S0167-1987(96)01080-X; REICOSKY DC, 1993, AGRON J, V85, P1237, DOI 10.2134/agronj1993.00021962008500060027x; Ren XE, 2007, CHINESE SCI BULL, V52, P2722, DOI 10.1007/s11434-007-0346-2; Saiz G, 2007, GEODERMA, V139, P79, DOI 10.1016/j.geoderma.2006.12.005; Schlesinger W.H., 1986, CHANGES SOIL CARBON, P194, DOI DOI 10.1007/978-1-4757-1915-4_11; Schlesinger WH, 2006, SCIENCE, V314, P1217, DOI 10.1126/science.1137177; Smith P, 1998, GLOB CHANGE BIOL, V4, P679, DOI 10.1046/j.1365-2486.1998.00185.x; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Wang XB, 2007, SOIL TILL RES, V93, P239, DOI 10.1016/j.still.2006.05.005; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Xiao Y, 2005, AGR ECOSYST ENVIRON, V109, P273, DOI 10.1016/j.agee.2005.03.016; Zhang HX, 2011, ECOL RES, V26, P735, DOI 10.1007/s11284-011-0832-5; Zhang HX, 2011, J ENVIRON SCI-CHINA, V23, P79, DOI 10.1016/S1001-0742(10)60376-2; Zou JW, 2004, CHINESE SCI BULL, V49, P381, DOI 10.1360/03wd0270	69	26	26	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e72140	10.1371/journal.pone.0072140	http://dx.doi.org/10.1371/journal.pone.0072140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086256	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700004
J	Sanchez-Santos, MT; Mesa-Frias, M; Choi, M; Nuesch, E; Asunsolo-Del Barco, A; Amuzu, A; Smith, GD; Ebrahim, S; Prieto-Merino, D; Casas, JP				Sanchez-Santos, Maria T.; Mesa-Frias, Marco; Choi, Minkyoung; Nueesch, Eveline; Asunsolo-Del Barco, Angel; Amuzu, Antoinette; Smith, George Davey; Ebrahim, Shah; Prieto-Merino, David; Casas, Juan P.			Area-Level Deprivation and Overall and Cause-Specific Mortality: 12 Years' Observation on British Women and Systematic Review of Prospective Studies	PLOS ONE			English	Review							COURSE SOCIOECONOMIC POSITION; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; HEALTH BEHAVIORS; RISK-FACTORS; NEIGHBORHOODS; METAANALYSIS; ASSOCIATION; SMOKING	Background: Prospective studies have suggested a negative impact of area deprivation on overall mortality, but its effect on cause-specific mortality and the mechanisms that account for this association remain unclear. We investigate the association of area deprivation, using Index of Multiple deprivation (IMD), with overall and cause-specific mortality, contextualising findings within a systematic review. Methods And Findings: We used data from 4,286 women from the British Women's Heart Health Study (BWHHS) recruited at 1999-2001 to examine the association of IMD with overall and cause-specific mortality using Cox regression models. One standard deviation (SD) increase in the IMD score had a hazard ratio (HR) of 1.21 (95% CI: 1.13-1.30) for overall mortality after adjustment for age and lifecourse individual deprivation, which was attenuated to 1.15 (95% CI: 1.04-1.26) after further inclusion of mediators (health behaviours, biological factors and use of statins and blood pressure-lowering medications). A more pronounced association was observed for respiratory disease and vascular deaths. The meta-analysis, based on 20 published studies plus the BWHHS (n=21), yielded a summary relative risk (RR) of 1.15 (95% CI: 1.11-1.19) for area deprivation (top [least deprived; reference] vs. bottom tertile) with overall mortality in an age and sex adjusted model, which reduced to 1.06 (95% CI: 1.04-1.08) in a fully adjusted model. Conclusions: Health behaviours mediate the association between area deprivation and cause-specific mortality. Efforts to modify health behaviours may be more successful if they are combined with measures that tackle area deprivation.	[Sanchez-Santos, Maria T.; Asunsolo-Del Barco, Angel] Univ Alcala, Fac Med, Dept Surg Med & Social Sci, Madrid, Spain; [Sanchez-Santos, Maria T.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford NIHR Musculoskeletal Biomed Res Unit, Oxford, England; [Mesa-Frias, Marco; Choi, Minkyoung; Nueesch, Eveline; Amuzu, Antoinette; Ebrahim, Shah; Prieto-Merino, David; Casas, Juan P.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Mesa-Frias, Marco] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Social & Environm Hlth Res, London WC1, England; [Smith, George Davey] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [Ebrahim, Shah] Publ Hlth Fdn India, South Asia Network Chron Dis, New Delhi, India; [Casas, Juan P.] UCL, Inst Cardiovasc Sci, London, England	Universidad de Alcala; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; Public Health Foundation of India; University of London; University College London	Sanchez-Santos, MT (corresponding author), Univ Alcala, Fac Med, Dept Surg Med & Social Sci, Madrid, Spain.	maytesanchezsantos@gmail.com; Juan.Pablo-Casas@lshtm.ac.uk	Mesa-Frias, Marco/E-4756-2014; Davey Smith, George/A-7407-2013; Asúnsolo, Ángel/D-8050-2018	Davey Smith, George/0000-0002-1407-8314; Asúnsolo, Ángel/0000-0001-7898-4685; Sanchez-Santos, Maria Teresa/0000-0003-1908-8623; Prieto-Merino, David/0000-0001-5001-0061	Department of Health [009/0049]; British Heart Foundation [EPNCCD08]; Marie Curie Intra-European Fellowship for Career Development [FP7-PEOPLE-2010-IEF-273673]; British Heart Foundation [PG/09/022/26739] Funding Source: researchfish	Department of Health; British Heart Foundation(British Heart Foundation); Marie Curie Intra-European Fellowship for Career Development; British Heart Foundation(British Heart Foundation)	This work was supported by grants from the Department of Health (grant 009/0049) and the British Heart Foundation (grant EPNCCD08). EN was recipient of a Marie Curie Intra-European Fellowship for Career Development (Grant FP7-PEOPLE-2010-IEF-273673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Boffetta P, 2006, CANCER EPIDEM BIOMAR, V15, P1184, DOI 10.1158/1055-9965.EPI-06-0032; Bosma H, 2001, AM J EPIDEMIOL, V153, P363, DOI 10.1093/aje/153.4.363; Brunekreef Bert, 2009, Res Rep Health Eff Inst, P5; de Hollander EL, 2012, INT J EPIDEMIOL, V41, P805, DOI 10.1093/ije/dys008; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Ebrahim S, 2012, LANCET, V380, P545, DOI 10.1016/S0140-6736(12)60694-1; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Fox J., 2002, R S PLUS COMPANION A; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Jefferis BJ, 2010, HEART, V96, P854, DOI 10.1136/hrt.2009.191148; Khaw Kay-Tee, 2008, PLoS Med, V5, pe12, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Knottnerus A, 2008, J CLIN EPIDEMIOL, V61, P323, DOI 10.1016/j.jclinepi.2007.11.006; Lawlor DA, 2003, AM J PUBLIC HEALTH, V93, P266, DOI 10.2105/AJPH.93.2.266; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P91, DOI 10.2105/AJPH.2003.035592; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; Li FZ, 2009, PREV MED, V48, P237, DOI 10.1016/j.ypmed.2009.01.005; Major JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015538; Malmstrom M, 1999, PUBLIC HEALTH, V113, P279, DOI 10.1016/S0033-3506(99)00180-8; Marinacci C, 2004, J EPIDEMIOL COMMUN H, V58, P199, DOI 10.1136/jech.2003.014928; McCartney D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000737; Meijer M, 2012, SOC SCI MED, V74, P1204, DOI 10.1016/j.socscimed.2011.11.034; National Assembly for Wales, 2005, WELSH IND MULT DEPR; Noble M, 2004, NGLISH INDICES DEPRI; Office of the Chief Statistician Scottish Executive, 2004, SCOTT IND MULT DEPR; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Sandford A, 2003, RESPIROLOGY, V8, P7, DOI 10.1046/j.1440-1843.2003.00436.x; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Terry Therneau, 2012, PACKAGE SURVIVAL ANA; Turrell G, 2007, J EPIDEMIOL COMMUN H, V61, P13, DOI 10.1136/jech.2006.046094; van Hooijdonk C, 2008, INT J EPIDEMIOL, V37, P1384, DOI 10.1093/ije/dyn181; Wall M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-207; Watt HC, 2009, AM J PUBLIC HEALTH, V99, P320, DOI 10.2105/AJPH.2007.129288; Yao Li, 2011, J Aging Res, V2011, P132073, DOI 10.4061/2011/132073	39	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e72656	10.1371/journal.pone.0072656	http://dx.doi.org/10.1371/journal.pone.0072656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	226HG	24086262	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000325025200006
J	Ahn, J; Hogan, N				Ahn, Jooeun; Hogan, Neville			Long-Range Correlations in Stride Intervals May Emerge from Non-Chaotic Walking Dynamics	PLOS ONE			English	Article							HUMAN GAIT; FRACTAL DYNAMICS; MOVEMENT VARIABILITY; STABILITY; DISEASE; NOISE; PATTERNS; CHAOS; MODEL	Stride intervals of normal human walking exhibit long-range temporal correlations. Similar to the fractal-like behaviors observed in brain and heart activity, long-range correlations in walking have commonly been interpreted to result from chaotic dynamics and be a signature of health. Several mathematical models have reproduced this behavior by assuming a dominant role of neural central pattern generators (CPGs) and/or nonlinear biomechanics to evoke chaos. In this study, we show that a simple walking model without a CPG or biomechanics capable of chaos can reproduce long-range correlations. Stride intervals of the model revealed long-range correlations observed in human walking when the model had moderate orbital stability, which enabled the current stride to affect a future stride even after many steps. This provides a clear counterexample to the common hypothesis that a CPG and/or chaotic dynamics is required to explain the long-range correlations in healthy human walking. Instead, our results suggest that the long-range correlation may result from a combination of noise that is ubiquitous in biological systems and orbital stability that is essential in general rhythmic movements.	[Ahn, Jooeun; Hogan, Neville] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Hogan, Neville] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ahn, J (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	aje@mit.edu		Ahn, Jooeun/0000-0002-7964-5148	DARPA's Warrior Web program [BAA-11-72]; Eric P. and Evelyn E. Newman Fund; Gloria Blake Fund	DARPA's Warrior Web program; Eric P. and Evelyn E. Newman Fund; Gloria Blake Fund	This work was supported in part by DARPA's Warrior Web program, BAA-11-72, the Eric P. and Evelyn E. Newman Fund, and by the Gloria Blake Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047963; Ashkenazy Y, 2002, PHYSICA A, V316, P662, DOI 10.1016/S0378-4371(02)01453-X; BABLOYANTZ A, 1986, P NATL ACAD SCI USA, V83, P3513, DOI 10.1073/pnas.83.10.3513; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Coleman MJ, 1997, DYNAM STABIL SYST, V12, P139, DOI 10.1080/02681119708806242; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Frenkel-Toledo S, 2005, MOVEMENT DISORD, V20, P1109, DOI 10.1002/mds.20507; Garcia M, 1998, J BIOMECH ENG-T ASME, V120, P281, DOI 10.1115/1.2798313; Gates DH, 2007, PHYSICA A, V380, P259, DOI 10.1016/j.physa.2007.02.061; Gerasimenko Y, 2010, J NEUROSCI, V30, P3700, DOI 10.1523/JNEUROSCI.4751-09.2010; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBERGER AL, 1990, SCI AM, V262, P43; Gurfinkel VS, 1998, EUR J NEUROSCI, V10, P1608, DOI 10.1046/j.1460-9568.1998.00179.x; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; Ivanenko YP, 2005, J NEUROPHYSIOL, V94, P754, DOI 10.1152/jn.00088.2004; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Nayfeh A.H., 2008, APPL NONLINEAR DYNAM; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; POOL R, 1989, SCIENCE, V243, P604, DOI 10.1126/science.2916117; SKINNER JE, 1990, BIO-TECHNOL, V8, P1018, DOI 10.1038/nbt1190-1018; Su JLS, 2007, J BIOMECH ENG-T ASME, V129, P802, DOI 10.1115/1.2800760; Terrier P, 2003, EUR J APPL PHYSIOL, V90, P554, DOI 10.1007/s00421-003-0906-3; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Torre K, 2007, BRIT J MATH STAT PSY, V60, P85, DOI 10.1348/000711005X89513; Usatenko OV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.110601; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; West BJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051917; West Bruce J, 2005, J Neuroeng Rehabil, V2, P24, DOI 10.1186/1743-0003-2-24; WINTER DA, 1984, HUM MOVEMENT SCI, V3, P51, DOI 10.1016/0167-9457(84)90005-8; XU N, 1988, B MATH BIOL, V50, P559; Yang JF, 2006, NEUROSCIENTIST, V12, P379, DOI 10.1177/1073858406292151	38	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73239	10.1371/journal.pone.0073239	http://dx.doi.org/10.1371/journal.pone.0073239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086274	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200007
J	Dufour, N; Redcay, E; Young, L; Mavros, PL; Moran, JM; Triantafyllou, C; Gabrieli, JDE; Saxe, R				Dufour, Nicholas; Redcay, Elizabeth; Young, Liane; Mavros, Penelope L.; Moran, Joseph M.; Triantafyllou, Christina; Gabrieli, John D. E.; Saxe, Rebecca			Similar Brain Activation during False Belief Tasks in a Large Sample of Adults with and without Autism	PLOS ONE			English	Article							ASPERGER-SYNDROME; FUNCTIONAL CONNECTIVITY; SPECTRUM DISORDERS; NEURAL BASIS; MIND; COMPREHENSION; CHILDREN; FMRI; REPRESENTATIONS; ADOLESCENTS	Reading about another person's beliefs engages 'Theory of Mind' processes and elicits highly reliable brain activation across individuals and experimental paradigms. Using functional magnetic resonance imaging, we examined activation during a story task designed to elicit Theory of Mind processing in a very large sample of neurotypical (N = 462) individuals, and a group of high-functioning individuals with autism spectrum disorders (N = 31), using both region-of-interest and whole-brain analyses. This large sample allowed us to investigate group differences in brain activation to Theory of Mind tasks with unusually high sensitivity. There were no differences between neurotypical participants and those diagnosed with autism spectrum disorder. These results imply that the social cognitive impairments typical of autism spectrum disorder can occur without measurable changes in the size, location or response magnitude of activity during explicit Theory of Mind tasks administered to adults.	[Dufour, Nicholas; Mavros, Penelope L.; Triantafyllou, Christina; Gabrieli, John D. E.; Saxe, Rebecca] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Redcay, Elizabeth] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Young, Liane] Boston Coll, Dept Psychol, Boston, MA USA; [Moran, Joseph M.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Triantafyllou, Christina; Gabrieli, John D. E.; Saxe, Rebecca] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park; Boston College; Harvard University; Massachusetts Institute of Technology (MIT)	Saxe, R (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	saxe@mit.edu	Gabrieli, John/AAJ-2869-2020		Simons Foundation; National Science Foundation [095518, 0645960]; Dana Foundation; John Merck Scholars Grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096914] Funding Source: NIH RePORTER	Simons Foundation; National Science Foundation(National Science Foundation (NSF)); Dana Foundation; John Merck Scholars Grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Simons Foundation, the National Science Foundation (grant number 095518), the Dana Foundation, a National Science Foundation Graduate Research Fellowship (grant number 0645960), and a John Merck Scholars Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Belsley D.A., 2005, REGRESSION DIAGNOSTI; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P215, DOI 10.1093/scan/nsp017; Dodell-Feder D, 2011, NEUROIMAGE, V55, P705, DOI 10.1016/j.neuroimage.2010.12.040; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gilbert SJ, 2008, NEUROPSYCHOLOGIA, V46, P2281, DOI 10.1016/j.neuropsychologia.2008.03.025; Groen WB, 2010, CEREB CORTEX, V20, P1937, DOI 10.1093/cercor/bhp264; Hasson U, 2009, AUTISM RES, V2, P220, DOI 10.1002/aur.89; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kennedy DP, 2008, SOC COGN AFFECT NEUR, V3, P177, DOI 10.1093/scan/nsn011; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Kliemann D, 2008, NEUROPSYCHOLOGIA, V46, P2949, DOI 10.1016/j.neuropsychologia.2008.06.010; Koster-Hale J, 2013, P NATL ACAD SCI USA, V110, P5648, DOI 10.1073/pnas.1207992110; Lombardo MV, 2011, NEUROIMAGE, V56, P1832, DOI 10.1016/j.neuroimage.2011.02.067; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; Moran JM, 2011, P NATL ACAD SCI USA, V108, P2688, DOI 10.1073/pnas.1011734108; Nieminen-von Wendt T, 2003, EUR CHILD ADOLES PSY, V12, P178, DOI 10.1007/s00787-003-0337-z; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Redcay E, 2012, HUM BRAIN MAPP; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2006, SOC NEUROSCI-UK, V1, P284, DOI 10.1080/17470910601000446; Senju A, 2009, SCIENCE, V325, P883, DOI 10.1126/science.1176170; Sommer M, 2007, NEUROIMAGE, V35, P1378, DOI 10.1016/j.neuroimage.2007.01.042; Triantafyllou C, 2011, NEUROIMAGE, V55, P597, DOI 10.1016/j.neuroimage.2010.11.084; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Wellman HM, 2002, AUTISM, V6, P343, DOI 10.1177/1362361302006004003; Wolf I, 2010, NEUROIMAGE, V49, P894, DOI 10.1016/j.neuroimage.2009.08.060; Young L, 2010, REV PHILOS PSYCHOL, V1, P333, DOI 10.1007/s13164-010-0027-y; Young L, 2011, SOC NEUROSCI-UK, V6, P302, DOI 10.1080/17470919.2010.529712; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137; Younga L, 2008, NEUROIMAGE, V40, P1912, DOI 10.1016/j.neuroimage.2008.01.057	45	99	99	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75468	10.1371/journal.pone.0075468	http://dx.doi.org/10.1371/journal.pone.0075468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	222YC	24073267	gold, Green Submitted, Green Published			2022-12-27	WOS:000324768000077
J	Kiderlen, TR; Conteh, M; Roll, S; Seeling, S; Weinmann, S				Kiderlen, Til R.; Conteh, Michael; Roll, Stephanie; Seeling, Stefanie; Weinmann, Stefan			Cross-Sectional Study Assessing HIV Related Knowledge, Attitudes and Behavior in Namibian Public Sector Employees in Capital and Regional Settings	PLOS ONE			English	Article							STEPPING STONES; PREVENTION; RISK	The study objective was to assess the current status of HIV knowledge, attitudes and behavior (KAB) among employees of Namibian ministries. As most HIV campaigning takes place in the capital of Windhoek, an additional aim was to compare Windhoek to four regions (Hardap, Erongo, Oshana, and Caprivi). Between January and March 2011 a cross-sectional survey was conducted in two Namibian ministries, with participants selected randomly from the workforce. Data collection was based on questionnaires. 832 participants were included in the study (51.6% male). Nearly 90% of participants reported to have been tested for HIV before. Knowledge about HIV transmission ranged from 67% to 95% of correct answers, with few differences between the capital and regions. However, a knowledge gap regarding HIV transmission and prevention was seen. In particular, we found significantly lower knowledge regarding transmission from mother-to-child during pregnancy and higher rate of belief in a supernatural role in HIV transmission. In addition, despite many years of HIV prevention activities, a substantial proportion of employees had well-known HIV risk factors including multiple concurrent partnership rates (21%), intergenerational sex (19%), and lower testing rates for men (82% compared to women with 91%).	[Kiderlen, Til R.] Goethe Univ Frankfurt, Dept Med, D-60054 Frankfurt, Germany; [Kiderlen, Til R.] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Conteh, Michael] Univ Namibia, Multidisciplinary Res Ctr, Windhoek, Namibia; [Conteh, Michael] Namibia Inst Publ Adm & Management, Windhoek, Namibia; [Roll, Stephanie; Weinmann, Stefan] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Seeling, Stefanie] Charite, Berlin Sch Publ Hlth, D-13353 Berlin, Germany; [Weinmann, Stefan] Deutsch Gesell Int Zusammenarbeit, Berlin, Germany	Goethe University Frankfurt; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Namibia; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kiderlen, TR (corresponding author), Goethe Univ Frankfurt, Dept Med, D-60054 Frankfurt, Germany.	t.kiderlen@yahoo.com		Roll, Stephanie/0000-0003-1191-3289; Seeling, Stefanie/0000-0002-1597-7258	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	The study has been funded by the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) in their interest of assessing running programmes for cooperating partners. The study design respected the funders interests, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study is also part of the "Namibian HIV Research and Evaluation Agenda" and stated as a study to be conducted during the period of the "National Strategic Framework for HIV/AIDS response in Namibia" (NSF) 2010/11 and 2015/16. Study design, conduction and analysis was monitored by cooperating partners like UNDP, UNAIDS, Pharmaccess, Namibian Business Coalition on AIDS (NABCOA), Ministry of Health and Social Services (MoHSS), Office of the Prime Minister (OPM) and the University of Namibia (UNAM).	Bradley JE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-496; Carey M.P., 1997, AIDS BEHAV, V1, P61, DOI [DOI 10.1023/A:1026218005943, 10.1023/A:1026218005943]; Colvin M, 2007, AIDS, V21, pS13, DOI 10.1097/01.aids.0000279690.69276.c9; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; *JOINT UN PROGR HI, 2008, PID FACT SHEETS HIV; *MIN HLTH SOC SERV, 2000, ATL DEM HLTH SURV 20; *MIN HLTH SOC SERV, 2010, EP 2010 NAT HIV SENT; *MIN HLTH SOC SERV, 2008, IV AIDS NAM BEH CONT; *MIN HLTH SOC SERV, 2006, AT DEM HLTH SURV; *MIN HLTH SOC SERV, 2010, AT STRAT FRAM HIV AI; *NAW LIF TRUST JOH, 2007, AMIBIA HIV AIDS COMM; *OFF PRIM MIN NAM, 2009, PUBL SERV WORKPL POL; *OPM, 2009, AM PUBL SERV SECT RE; RUGG D, 2010, NAIDS BASIC TERMINOL; Shepherd J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14070; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; The World Health Organization, DEATH DALY EST CAUS; Tournoud M, 2008, TROP MED INT HEALTH, V13, P310, DOI 10.1111/j.1365-3156.2008.02004.x; *WHO, 2008, DVOC COMM SOC MOB TB; *WHO, 2011, MOTH TO CHILD TRANSM	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75593	10.1371/journal.pone.0075593	http://dx.doi.org/10.1371/journal.pone.0075593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073273	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000083
J	Bao, JJ; Huck, D; Gunther, LK; Sellers, JR; Sakamoto, T				Bao, Jianjun; Huck, Daniel; Gunther, Laura K.; Sellers, James R.; Sakamoto, Takeshi			Actin Structure-Dependent Stepping of Myosin 5a and 10 during Processive Movement	PLOS ONE			English	Article							MOLECULE FLUORESCENCE POLARIZATION; HAND-OVER-HAND; F-ACTIN; BUNDLED ACTIN; COILED-COIL; NECK LENGTH; V MOLECULES; FILOPODIA; MOTOR; PROTEINS	How myosin 10, an unconventional myosin, walks processively along actin is still controversial. Here, we used single molecule fluorescence techniques, TIRF and FIONA, to study the motility and the stepping mechanism of dimerized myosin 10 heavy-meromyosin-like fragment on both single actin filaments and two-dimensional F-actin rafts crosslinked by fascin or a-actinin. As a control, we also tracked and analyzed the stepping behavior of the well characterized processive motor myosin 5a. We have shown that myosin 10 moves processively along both single actin filaments and F-actin rafts with a step size of 31 nm. Moreover, myosin 10 moves more processively on fascin-F-actin rafts than on a-actinin-F-actin rafts, whereas myosin 5a shows no such selectivity. Finally, on fascin-F-actin rafts, myosin 10 has more frequent side steps to adjacent actin filaments than myosin 5a in the F-actin rafts. Together, these results reveal further single molecule features of myosin 10 on various actin structures, which may help to understand its cellular functions.	[Bao, Jianjun; Huck, Daniel; Gunther, Laura K.; Sakamoto, Takeshi] Wayne State Univ, Dept Phys & Astron, Detroit, MI 48202 USA; [Sakamoto, Takeshi] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48202 USA; [Sellers, James R.] NHLBI, NIH, Bethesda, MD 20892 USA	Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sakamoto, T (corresponding author), Wayne State Univ, Dept Phys & Astron, Detroit, MI 48202 USA.	ee4243@wayne.edu		Huck, Daniel/0000-0003-4221-8078; Gunther, Laura/0000-0003-4588-2572	National Institutes of Health [HL089350]; Department of Physics and Astronomy, Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL089350, ZIAHL004232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Physics and Astronomy, Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (career development grant HL089350 to TS), the start-up fund from the Department of Physics and Astronomy, Wayne State University (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MY, 2007, P NATL ACAD SCI USA, V104, P4332, DOI 10.1073/pnas.0611471104; Ali MY, 2013, TRAFFIC, V14, P70, DOI 10.1111/tra.12017; Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Forkey JN, 2000, PROG BIOPHYS MOL BIO, V74, P1, DOI 10.1016/S0079-6107(00)00015-8; Ishikawa K, 2003, J CELL BIOL, V160, P887, DOI 10.1083/jcb.200210139; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Khurana S, 2011, CELL ADHES MIGR, V5, P409, DOI 10.4161/cam.5.5.17644; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Lu Q, 2011, MOL BIOL CELL, V22, P4268, DOI 10.1091/mbc.E11-04-0354; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Nagy A, 2009, BIOPHYS J, V97, P3123, DOI 10.1016/j.bpj.2009.09.033; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Oke OA, 2010, P NATL ACAD SCI USA, V107, P2509, DOI 10.1073/pnas.0906907107; Ono S, 1997, J BIOL CHEM, V272, P2527; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Plantard L, 2010, J CELL SCI, V123, P3525, DOI 10.1242/jcs.069609; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Ricca BL, 2010, BIOPHYS J, V99, P1818, DOI 10.1016/j.bpj.2010.06.066; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; Snyder GE, 2004, BIOPHYS J, V87, P1776, DOI 10.1529/biophysj.103.036897; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sukow C, 2003, BIOPHYS J, V85, P525, DOI 10.1016/S0006-3495(03)74497-X; Sukow C, 1998, J MOL BIOL, V284, P1039, DOI 10.1006/jmbi.1998.2211; Sun Y, 2010, NAT STRUCT MOL BIOL, V17, P485, DOI 10.1038/nsmb.1785; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; TAYLOR KA, 1992, J STRUCT BIOL, V108, P140, DOI 10.1016/1047-8477(92)90013-Z; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Watanabe TM, 2010, J BIOL CHEM, V285, P19605, DOI 10.1074/jbc.M109.093864; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036988; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	53	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74936	10.1371/journal.pone.0074936	http://dx.doi.org/10.1371/journal.pone.0074936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069366	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300055
J	Broeckx, BJG; Coopman, F; Verhoeven, GEC; Van Haeringen, W; van de Goor, L; Bosmans, T; Gielen, I; Saunders, JH; Soetaert, SSA; Van Bree, H; Van Neste, C; Van Nieuwerburgh, F; Van Ryssen, B; Verelst, E; Van Steendam, K; Deforce, D				Broeckx, Bart J. G.; Coopman, Frank; Verhoeven, Geert E. C.; Van Haeringen, Wim; van de Goor, Leanne; Bosmans, Tim; Gielen, Ingrid; Saunders, Jimmy H.; Soetaert, Sandra S. A.; Van Bree, Henri; Van Neste, Christophe; Van Nieuwerburgh, Filip; Van Ryssen, Bernadette; Verelst, Elien; Van Steendam, Katleen; Deforce, Dieter			The Prevalence of Nine Genetic Disorders in a Dog Population from Belgium, the Netherlands and Germany	PLOS ONE			English	Article							CANINE DEGENERATIVE MYELOPATHY; EXERCISE-INDUCED COLLAPSE; HIP-DYSPLASIA; CENTRONUCLEAR MYOPATHY; MISSENSE MUTATION; ARYLSULFATASE-G; DNM1 MUTATION; BREEDS; FREQUENCY; SULFATASE	The objective of this study was to screen a dog population from Belgium, the Netherlands and Germany for the presence of mutant alleles associated with hip dysplasia (HD), degenerative myelopathy (DM), exercise-induced collapse (EIC), neuronal ceroid lipofuscinosis 4A (NCL), centronuclear myopathy (HMLR), mucopolysaccharidosis VII (MPS VII), myotonia congenita (MG), gangliosidosis (GM1) and muscular dystrophy (Duchenne type) (GRMD). Blood samples (K3EDTA) were collected for genotyping with Kompetitive Allele Specific PCR (n = 476). Allele and genotype frequencies were calculated in those breeds with at least 12 samples (n = 8). Hardy-Weinberg equilibrium was tested. Genetic variation was identified for 4 out of 9 disorders: mutant alleles were found in 49, 15, 3 and 2 breeds for HD, DM, EIC and NCL respectively. Additionally, mutant alleles were identified in crossbreeds for both HD and EIC. For HD, DM, EIC and NCL mutant alleles were newly discovered in 43, 13, 2 and 1 breed(s), respectively. In 9, 2 and 1 breed(s) for DM, EIC and NCL respectively, the mutant allele was detected, but the respective disorder has not been reported in those breeds. For 5 disorders (HMLR, MPS VII, MG, GM1, GRMD), the mutant allele could not be identified in our population. For the other 4 disorders (HD, DM, EIC, NCL), prevalence of associated mutant alleles seems strongly breed dependent. Surprisingly, mutant alleles were found in many breeds where the disorder has not been reported to date.	[Broeckx, Bart J. G.; Soetaert, Sandra S. A.; Van Neste, Christophe; Van Nieuwerburgh, Filip; Van Steendam, Katleen; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Coopman, Frank] Holbigenet NV, Waarschoot, Belgium; [Verhoeven, Geert E. C.; Gielen, Ingrid; Saunders, Jimmy H.; Van Bree, Henri; Van Ryssen, Bernadette] Univ Ghent, Fac Vet Med, Dept Med Imaging & Small Anim Orthopaed, Merelbeke, Belgium; [Van Haeringen, Wim; van de Goor, Leanne] Dr Van Haeringen Lab bv, Wageningen, Netherlands; [Bosmans, Tim] Univ Ghent, Fac Vet Med, Dept Med & Clin Biol Small Anim, Merelbeke, Belgium; [Verelst, Elien] Univ Coll Ghent, Fac Appl Bioengn, Melle, Belgium	Ghent University; Ghent University; Ghent University; HOGENT University College of Applied Sciences & Arts	Deforce, D (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium.	Dieter.Deforce@Ugent.be	Broeckx, Bart/AAH-3940-2021; Van Ryssen, Bernadette/ABI-5258-2020; Deforce, Dieter LD/J-4725-2013; Coopman, Frank/ABB-8083-2021; Van Neste, Christophe/AAE-5505-2020; Van Nieuwerburgh, Filip/H-9697-2015	Broeckx, Bart/0000-0001-6742-3911; Deforce, Dieter LD/0000-0002-0635-661X; Van Nieuwerburgh, Filip/0000-0001-8815-5485; Van Neste, Christophe/0000-0002-5958-5731	Agency for Innovation by Science and Technology in Flanders (IWT); Royal Canin	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Royal Canin	The authors would like to thank the Agency for Innovation by Science and Technology in Flanders (IWT, http://www.iwt.be/) for their financial support and Royal Canin for their financial support to aid sample collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol M, 2010, P NATL ACAD SCI USA, V107, P14775, DOI 10.1073/pnas.0914206107; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Coates JR, 2010, VET CLIN N AM-SMALL, V40, P929, DOI 10.1016/j.cvsm.2010.05.001; COLEMAN DL, 1973, DIABETOLOGIA, V9, P287, DOI 10.1007/BF01221856; Coopman F, 2008, VET REC, V163, P654, DOI 10.1136/vr.163.22.654; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; Friedenberg SG, 2011, AM J VET RES, V72, P530, DOI 10.2460/ajvr.72.4.530; Gentilini F, 2011, J VET DIAGN INVEST, V23, P124, DOI 10.1177/104063871102300122; Gould D, 2011, VET OPHTHALMOL, V14, P378, DOI 10.1111/j.1463-5224.2011.00892.x; GREGORIUS HR, 1980, BIOMETRICS, V36, P643, DOI 10.2307/2556116; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Hytonen MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040281; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Karmi N, 2010, J VET INTERN MED, V24, P1337, DOI 10.1111/j.1939-1676.2010.0631.x; Mellersh C, 2012, MAMM GENOME, V23, P109, DOI 10.1007/s00335-011-9365-z; Minor KM, 2011, VET J, V189, P214, DOI 10.1016/j.tvjl.2011.06.022; Olby N, 2004, J VET INTERN MED, V18, P201, DOI 10.1892/0891-6640(2004)18&lt;201:CCDIAA&gt;2.0.CO;2; Patterson EE, 2008, NAT GENET, V40, P1235, DOI 10.1038/ng.224; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Ramirez F, 2007, J CELL PHYSIOL, V213, P326, DOI 10.1002/jcp.21189; Ray J, 1998, GENOMICS, V48, P248, DOI 10.1006/geno.1997.5189; Rettenmaier JL, 2002, VET RADIOL ULTRASOUN, V43, P313, DOI 10.1111/j.1740-8261.2002.tb01010.x; Rhodes TH, 1999, FEBS LETT, V456, P54, DOI 10.1016/S0014-5793(99)00926-6; Schnell G, 1935, AM KENNEL GAZ, V52, P25; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Wininger FA, 2011, J VET INTERN MED, V25, P1166, DOI [10.1111/j.1939-1676.2011.00760.x, 10.1111/j.1939-1676.2011.0760.x]; Yamato O, 2002, J INHERIT METAB DIS, V25, P525, DOI 10.1023/A:1021280007739	28	13	13	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74811	10.1371/journal.pone.0074811	http://dx.doi.org/10.1371/journal.pone.0074811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069350	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300048
J	El Moussi, A; Pozo, F; Kacem, MAB; Ledesma, J; Cuevas, MT; Casas, I; Slim, A				El Moussi, Awatef; Pozo, Francisco; Kacem, Mohamed Ali Ben Hadj; Ledesma, Juan; Teresa Cuevas, Maria; Casas, Inmaculada; Slim, Amine			Virological Surveillance of Influenza Viruses during the 2008-09, 2009-10 and 2010-11 Seasons in Tunisia	PLOS ONE			English	Article							A(H1N1) VIRUS; HEMAGGLUTININ; D222G; H1N1	Background: The data contribute to a better understanding of the circulation of influenza viruses especially in North-Africa. Objective: The objective of this surveillance was to detect severe influenza cases, identify their epidemiological and virological characteristics and assess their impact on the healthcare system. Method: We describe in this report the findings of laboratory-based surveillance of human cases of influenza virus and other respiratory viruses' infection during three seasons in Tunisia. Results: The 2008-09 winter influenza season is underway in Tunisia, with co-circulation of influenza A/H3N2 (56.25%), influenza A(H1N1) (32.5%), and a few sporadic influenza B viruses (11.25%). In 2010-11 season the circulating strains are predominantly the 2009 pandemic influenza A(H1N1) pdm09 (70%) and influenza B viruses (22%). And sporadic viruses were sub-typed as A/H3N2 and unsubtyped influenza A, 5% and 3%, respectively. Unlike other countries, highest prevalence of influenza B virus Yamagata-like lineage has been reported in Tunisia (76%) localised into the clade B/Bangladesh/3333/2007. In the pandemic year, influenza A(H1N1) pdm09 predominated over other influenza viruses (95%). Amino acid changes D222G and D222E were detected in the HA gene of A(H1N1) pdm09 virus in two severe cases, one fatal case and one mild case out of 50 influenza A(H1N1) pdm09 viruses studied. The most frequently reported respiratory virus other than influenza in three seasons was RSV (45.29%). Conclusion: This article summarises the surveillance and epidemiology of influenza viruses and other respiratory viruses, showing how rapid improvements in influenza surveillance were feasible by connecting the existing structure in the health care system for patient records to electronic surveillance system for reporting ILI cases.	[El Moussi, Awatef; Kacem, Mohamed Ali Ben Hadj; Slim, Amine] Charles Nicolles Hosp, Natl Influenza Ctr, Microbiol Lab, Virol Unit, Tunis, Tunisia; [Pozo, Francisco; Ledesma, Juan; Teresa Cuevas, Maria; Casas, Inmaculada] Inst Salud Carlos III, Ctr Nacl Microbiol, Natl Influenza Ctr, Influenza & Resp Viruses Unit, Madrid, Spain	Universite de Tunis-El-Manar; Hopital Charles Nicolle; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	El Moussi, A (corresponding author), Charles Nicolles Hosp, Natl Influenza Ctr, Microbiol Lab, Virol Unit, Tunis, Tunisia.	awatefbio@ymail.com	Pozo, Francisco/F-4426-2012; gonzalez-nico, maria teresa cuevas/E-2001-2014; Casas, Inmaculada/X-7579-2019; Ledesma, Juan/GMX-3345-2022; Casas, Inmaculada/H-9442-2015; Ledesma, Juan/GMX-0948-2022	Pozo, Francisco/0000-0003-1828-733X; gonzalez-nico, maria teresa cuevas/0000-0002-4195-1975; Casas, Inmaculada/0000-0003-1840-1198; Ledesma, Juan/0000-0002-0871-5065; Casas, Inmaculada/0000-0003-1840-1198; Ledesma, Juan/0000-0002-0871-5065	Unit Virology, Microbiology Laboratory Charles Nicolle's Hospital as National Influenza Centre-Tunis; Influenza and Respiratory Laboratory, Instituto de Salud Carlos III as National Influenza Centre-Madrid	Unit Virology, Microbiology Laboratory Charles Nicolle's Hospital as National Influenza Centre-Tunis; Influenza and Respiratory Laboratory, Instituto de Salud Carlos III as National Influenza Centre-Madrid	This research was supported by Unit Virology, Microbiology Laboratory Charles Nicolle's Hospital as National Influenza Centre-Tunis and Influenza and Respiratory Laboratory, Instituto de Salud Carlos III as National Influenza Centre-Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It is just an informal statement of the study and the members of the ethic committee of Charles Nicolle's hospital have previously always approved the work of the NIC.	Adnane Berdai Mohamed, 2012, Pan Afr Med J, V11, P36; [Anonymous], INFL VIR CHAR SURV R; Barakat A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024579; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; El Moussi A, 2012, ARCH VIROL, V157, P1813, DOI 10.1007/s00705-012-1349-0; European Surveillance Centre for Disease Prevention and Control, 2011, SURV REP WEEKL INFL; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Ledesma J, 2012, J CLIN VIROL, V53, P16, DOI 10.1016/j.jcv.2011.09.032; Ledesma J, 2011, J CLIN VIROL, V51, P75, DOI 10.1016/j.jcv.2011.01.020; Liu SL, 2013, REV MED VIROL, V23, P3, DOI 10.1002/rmv.1712; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Puzelli S, 2010, EMERG INFECT DIS, V16, P863, DOI [10.3201/eid1605.091858, 10.3201/eid1605.091815]; Schoub Barry D, 2010, Expert Rev Respir Med, V4, P167, DOI 10.1586/ers.10.10; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Steffen C, 2012, B WORLD HEALTH ORGAN, V90, P301, DOI 10.2471/BLT.11.098244; Steffen C, 2011, VACCINE, V29, P363, DOI 10.1016/j.vaccine.2010.11.029; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WHO, WHO REC POSTP PER; World Health Organization, 2011, WEEKLY EPIDEMIOLOGIC; World Health Organization, 2011, EP VIR SIT UPD 2010; World Health Organization, 2009, CDC PROT REALT RTPCR; World Health Organization, 2009, CLIN MAN HUM INF PAN; Wurapa Frederick, 2011, Pan Afr Med J, V10 Supp 1, P6; Yang JR, 2011, VIRUS RES, V155, P163, DOI 10.1016/j.virusres.2010.09.015; Yazdanbakhsh M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000182	27	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74064	10.1371/journal.pone.0074064	http://dx.doi.org/10.1371/journal.pone.0074064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069267	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300026
J	Gordoa, A; Acuna, JL; Farres, R; Bacher, K				Gordoa, Ana; Luis Acuna, Jose; Farres, Roser; Bacher, Kathrin			Burst Feeding of Pelagia noctiluca ephyrae on Atlantic Bluefin Tuna (Thunnus thynnus) Eggs	PLOS ONE			English	Article							LONG-TERM FLUCTUATIONS; AURELIA-AURITA; NORTHEAST ATLANTIC; MEDITERRANEAN-SEA; JELLYFISH BLOOMS; FISH LARVAE; RATES; MORTALITY; ZOOPLANKTON; PREDATION	This study investigates the predation of P. noctiluca ephyrae on Atlantic Bluefin tuna (ABFT) eggs under different experimental conditions. The specific factors considered in the experimental design were: a) water mix conditions to explore predation under two-dimensional (2D) and three-dimensional (3D) prey distributions, b) prey density to investigate the ingestion rate capacity, and c) incubation time to inspect gut saturation. The eggs and jellyfish ephyrae were collected during the 2012 ABFT spawning survey off Ibiza (Balearic Isl., Western Mediterranean). The results showed that the proportion of feeding ephyrae increased with size. The mean clearance rate of feeding ephyrae, 4.14 L h(-1), was the highest ever recorded for ephyrae. Under calm conditions the eggs floated at the surface (2D spatial arrangement) and the clearance rates, at low prey densities, were at least twice those under mixed conditions (3D spatial arrangement). At high prey density, clearance rate did not differ between mix conditions, probably due to the fast gut saturation, which was reached in c.a. 15 min, as revealed by time series observations of gut contents. The fast saturation of ephyrae and their slow digestion time of approximately 18 h suggest the existence of a diel feeding periodicity. We conclude that in the Western Mediterranean, P. noctiluca ephyrae are capable of predating on ABFT eggs, a highly pulsed and spatially restricted resource that potentially switches from a 3D to a 2D configuration in the absence of wind-generated turbulence. The P. noctiluca and Atlantic Bluefin tuna egg system might represent an example of a general mechanism linking pelagic and neustonic food webs.	[Gordoa, Ana; Farres, Roser; Bacher, Kathrin] CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Gerona, Spain; [Luis Acuna, Jose] Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Asturias, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Oviedo	Gordoa, A (corresponding author), CSIC, Ctr Estudios Avanzados Blanes, Dept Marine Ecol, Blanes, Gerona, Spain.	gordoa@ceab.csic.es	Gordoa, Ana/A-1470-2013; Fernández, José Luis Acuña/I-7482-2016	Gordoa, Ana/0000-0003-1822-8196; Fernández, José Luis Acuña/0000-0003-3306-7212	Spanish Ministry of the Economy and Competitiveness	Spanish Ministry of the Economy and Competitiveness(Spanish Government)	This study is part of the project "Spatio-temporal overlap and trophic interactions between Atlantic Bluefin Tuna spawning and jellyfish in the Balearic spawning grounds" funded by the Spanish Ministry of the Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; BAILEY KM, 1984, MAR BIOL, V79, P303, DOI 10.1007/BF00393262; BAILEY KM, 1984, MAR BIOL, V83, P287, DOI 10.1007/BF00397461; Bernard P., 2011, ZOOPLANKTON SPATIAL, V4, P1; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Brodeur RD, 2002, MAR ECOL PROG SER, V233, P89, DOI 10.3354/meps233089; Browman HI, 2003, ESTUARIES, V26, P30, DOI 10.1007/BF02691691; Cameron P, 1997, MAR POLLUT BULL, V34, P129, DOI 10.1016/S0025-326X(96)00069-0; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Compte J, 2010, MAR ECOL PROG SER, V402, P147, DOI 10.3354/meps08453; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Duclerc J., 1973, Revue Trav Inst Peches Marit, V37, P163; Duffy JT, 1997, J EXP MAR BIOL ECOL, V212, P123, DOI 10.1016/S0022-0981(96)02741-4; Fancett Jenkins GP, 1988, J EXP MAR BIOL ECOL, V116, P63, DOI [10.1016/0022-0981(88)90246-8, DOI 10.1016/0022-0981(88)90246-8]; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; FRANQUEVILLE C, 1971, Tethys, V3, P11; Giorgi R, 1991, JELLYFISH BLOOMS MED, P102; Gordoa A, 2013, COL ICCAT V IN PRESS, V69; Gordoa A, 2010, ICCAT COL VOL SCI PA, V65, P828; Gordoa A, 2009, ICES J MAR SCI, V66, P2205, DOI 10.1093/icesjms/fsp211; GOY J, 1989, DEEP-SEA RES, V36, P269, DOI 10.1016/0198-0149(89)90138-6; Graham WM, 2001, J PLANKTON RES, V23, P67, DOI 10.1093/plankt/23.1.67; Hansson LJ, 2006, J PLANKTON RES, V28, P937, DOI 10.1093/plankt/fbl030; HUNTER JR, 1976, FISH B-NOAA, V74, P81; Hunter JR, 1975, C LARV FISH MORT STU, P1; LARSON RJ, 1991, HYDROBIOLOGIA, V216, P311, DOI 10.1007/BF00026480; LASKER R, 1985, CAN J FISH AQUAT SCI, V42, P31, DOI 10.1139/f85-260; Licandro P, 2010, BIOL LETTERS, V6, P688, DOI 10.1098/rsbl.2010.0150; Acuna JL, 2011, SCIENCE, V333, P1627, DOI 10.1126/science.1205134; de Puelles MLF, 2007, PROG OCEANOGR, V74, P329, DOI 10.1016/j.pocean.2007.04.009; Lynam CP, 2005, MAR ECOL PROG SER, V298, P157, DOI 10.3354/meps298157; MacKenzie BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039998; Malej A, 1989, NOVA THALASSIA, V10, P89; Mariottini GL, 2008, MAR DRUGS, V6, P496, DOI 10.3390/md20080025; Mather FJ, 1995, NMFSSEFSC370 NOAA; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; Medina A, 2007, MAR ECOL PROG SER, V337, P221, DOI 10.3354/meps337221; Meneses I, 2003, J PLANKTON RES, V25, P1177, DOI 10.1093/plankt/25.9.1177; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Miyake P, 2003, COLLECTIVE VOLUME SC, V55, P114; Moller LF, 2010, HYDROBIOLOGIA, V645, P167, DOI 10.1007/s10750-010-0219-6; MORAND P, 1992, ANN I OCEANOGR PARIS, V68, P151; Pawar S, 2012, NATURE, V486, P485, DOI 10.1038/nature11131; PURCELL JE, 1994, MAR ECOL PROG SER, V114, P47, DOI 10.3354/meps114047; Purcell JE, 2001, MAR ECOL PROG SER, V210, P67, DOI 10.3354/meps210067; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ravier C, 2001, ICES J MAR SCI, V58, P1299, DOI 10.1006/jmsc.2001.1119; Richards WJ, 1976, ICCAT COLL VOL SCI P, V5, P267; Riisgard HU, 2011, J SEA RES, V65, P51, DOI 10.1016/j.seares.2010.07.002; Rodriguez-Roda J, 1981, COLLECTIVE VOLUME SC, V15, P278; Russell F. S., 1970, MEDUSAE BRIT ISLES; Sabates A, 2010, HYDROBIOLOGIA, V645, P153, DOI 10.1007/s10750-010-0221-z; SANDRINI LR, 1989, MAR BIOL, V102, P49, DOI 10.1007/BF00391322; Sissenwine MP, 1984, WORKSH EXPL MAR COMM, P59; THEILACKER GH, 1986, FISH B-NOAA, V84, P1; Titelman J, 2006, MAR BIOL, V149, P297, DOI 10.1007/s00227-005-0200-5; Vucetic T, 1983, P WORKSH JELL BLOOMS, P167; Worm B, 2011, P NATL ACAD SCI USA, V108, P11942, DOI 10.1073/pnas.1102353108; [No title captured]	59	17	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74721	10.1371/journal.pone.0074721	http://dx.doi.org/10.1371/journal.pone.0074721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069335	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300038
J	Jacobelli, J; Matthews, ME; Chen, S; Krummel, MF				Jacobelli, Jordan; Matthews, Miriam Estin; Chen, Stephanie; Krummel, Matthew F.			Activated T Cell Trans-Endothelial Migration Relies on Myosin-IIA Contractility for Squeezing the Cell Nucleus through Endothelial Cell Barriers	PLOS ONE			English	Article							MOTILITY; ICAM-1; INFLAMMATION; ADHESION	Following activation, T cells are released from lymph nodes to traffic via the blood to effector sites. The re-entry of these activated T cells into tissues represents a critical step for them to carry out local effector functions. Here we have assessed defects in effector T cells that are acutely depleted in Myosin-IIA (MyoIIA) and show a T cell intrinsic requirement for this motor to facilitate the diapedesis step of extravasation. We show that MyoIIA accumulates at the rear of T cells undergoing trans-endothelial migration. T cells can extend protrusions and project a substantial portion of their cytoplasm through the endothelial wall in the absence of MyoIIA. However, this motor protein plays a crucial role in allowing T cells to complete the movement of their relatively rigid nucleus through the endothelial junctions. In vivo, this defect manifests as poor entry into lymph nodes, tumors and into the spinal cord, during tissue-specific autoimmunity, but not the spleen. This suggests that therapeutic targeting of this molecule may allow for differential attenuation of tissue-specific inflammatory responses.	[Jacobelli, Jordan; Matthews, Miriam Estin] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Jacobelli, Jordan; Matthews, Miriam Estin] Univ Colorado, Denver, CO 80202 USA; [Chen, Stephanie; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	National Jewish Health; University of Colorado System; University of Colorado Denver; University of California System; University of California San Francisco	Jacobelli, J (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA.	jacobellij@njhealth.org; matthew.krummel@ucsf.edu		Chen, Stephanie/0000-0002-9004-3682	National Institutes of Health [RO1 AI52116]; National Multiple Sclerosis Society [PP1775]; NATIONAL CANCER INSTITUTE [U54CA163123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007405, R01AI052116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health (RO1 AI52116 to MFK) and JJ was was supported (in part) by a Pilot Research Award (PP1775) from the National Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Carman CV, 2008, CURR OPIN CELL BIOL, V20, P533, DOI 10.1016/j.ceb.2008.05.007; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LAHM HW, 1985, J CHROMATOGR, V326, P357, DOI 10.1016/S0021-9673(01)87461-6; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Manes TD, 2013, J IMMUNOL, V190, P3079, DOI 10.4049/jimmunol.1201817; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Soriano SF, 2011, J IMMUNOL, V187, P2356, DOI 10.4049/jimmunol.1100935; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853	24	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75151	10.1371/journal.pone.0075151	http://dx.doi.org/10.1371/journal.pone.0075151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069389	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300069
J	Liesz, A; Ruger, H; Purrucker, J; Zorn, M; Dalpke, A; Mohlenbruch, M; Englert, S; Nawroth, PP; Veltkamp, R				Liesz, Arthur; Rueger, Holger; Purrucker, Jan; Zorn, Markus; Dalpke, Alexander; Moehlenbruch, Markus; Englert, Stefan; Nawroth, Peter P.; Veltkamp, Roland			Stress Mediators and Immune Dysfunction in Patients with Acute Cerebrovascular Diseases	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INDUCED IMMUNODEPRESSION; POSTSTROKE INFECTION; ACTIVATION; INJURY; IMMUNODEFICIENCY; COMPLICATIONS; RISK	Background: Post-stroke immune depression contributes to the development of infections which are major complications after stroke. Previous experimental and clinical studies suggested that humoral stress mediators induce immune dysfunction. However, prospective clinical studies testing this concept are missing and no data exists for other cerebrovascular diseases including intracerebral hemorrhage (ICH) and TIA. Methods: We performed a prospective clinical study investigating 166 patients with TIA, ischemic and hemorrhagic stroke. We measured a broad panel of stress mediators, leukocyte subpopulations, cytokines and infection markers from hospital admission to day 7 and on follow-up after 2-3 months. Multivariate regression analyses detected independent predictors of immune dysfunction and bacterial infections. ROC curves were used to test the diagnostic value of these parameters. Results: Only severe ischemic strokes and ICH increased some catecholamine metabolites, ACTH and cortisol levels. Immunodysfunction was eminent already on hospital admission after large brain lesions with lymphocytopenia as a key feature. None of the stress mediators was an independent predictor of lymphocytopenia or infections. However, lymphocytopenia on hospital admission was detected as an independent explanatory variable of later infections. NIHSSS and lymphocytopenia on admission were excellent predictors of infection. Conclusions: Our results question the present pathophysiological concept of stress-hormone mediated immunodysfunction after stroke. Early lymphocytopenia was identified as an early independent predictor of post-stroke infections. Absence of lymphocytopenia may serve as a negative predictive marker for stratification for early antibiotic treatment.	[Liesz, Arthur; Rueger, Holger; Purrucker, Jan; Veltkamp, Roland] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [Zorn, Markus; Nawroth, Peter P.] Heidelberg Univ, Dept Internal Med, Heidelberg, Germany; [Dalpke, Alexander] Heidelberg Univ, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany; [Moehlenbruch, Markus] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Englert, Stefan] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Liesz, A (corresponding author), Heidelberg Univ, Dept Neurol, Heidelberg, Germany.	Arthur.Liesz@med.uni-heidelberg.de	Liesz, Arthur/AAT-7147-2021	Liesz, Arthur/0000-0002-9069-2594	Deutsche Forschungsgemeinschaft [VE196/3-1]; Else Kroner-Fresenius foundation [2012-A118]; Daimler-Benz foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius foundation; Daimler-Benz foundation	This work was supported by grants from the Deutsche Forschungsgemeinschaft (VE196/3-1) and the Else Kroner-Fresenius foundation (2012-A118) and by a fellowship of the Daimler-Benz foundation to A. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P1410, DOI 10.1161/01.STR.24.9.1410; Ajmo CT, 2009, EXP NEUROL, V218, P47, DOI 10.1016/j.expneurol.2009.03.044; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chamorro A, 2007, J NEUROL SCI, V252, P29, DOI 10.1016/j.jns.2006.10.001; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; CRUSE JM, 1992, IMMUNOL RES, V11, P104, DOI 10.1007/BF02918615; Davenport RJ, 1996, STROKE, V27, P415, DOI 10.1161/01.STR.27.3.415; Diamond B, 2011, P NATL ACAD SCI USA, V108, P3461, DOI 10.1073/pnas.1100329108; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Emsley HCA, 2003, J NEUROIMMUNOL, V139, P93, DOI 10.1016/S0165-5728(03)00134-6; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Emsley HCA, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-5; Gumbinger C, 2012, J NEUROL SCI; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Harms H, 2011, CEREBROVASC DIS, V32, P552, DOI 10.1159/000331922; Hug A, 2010, NEUROCRIT CARE; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Illanes S, 2011, NEUROSCI LETT, V490, P170, DOI 10.1016/j.neulet.2010.11.065; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; Smith CJ, 2006, J NEUROL SCI, V251, P77, DOI 10.1016/j.jns.2006.09.011; Smith CJ, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-2; TARKOWSKI E, 1995, STROKE, V26, P57, DOI 10.1161/01.STR.26.1.57; Urra X, 2009, NEUROSCIENCE, V158, P1174, DOI 10.1016/j.neuroscience.2008.06.014; Urra X, 2009, CURR MOL MED, V9, P195, DOI 10.2174/156652409787581574; Urra X, 2009, STROKE, V40, P1262, DOI 10.1161/STROKEAHA.108.532085; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Walter U, 2013, EUR J NEUROL, V20, P153, DOI 10.1111/j.1468-1331.2012.03818.x; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110	34	44	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74839	10.1371/journal.pone.0074839	http://dx.doi.org/10.1371/journal.pone.0074839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069356	gold, Green Submitted, Green Published			2022-12-27	WOS:000324777300051
J	Oeda, T; Umemura, A; Tomita, S; Hayashi, R; Kohsaka, M; Sawada, H				Oeda, Tomoko; Umemura, Atsushi; Tomita, Satoshi; Hayashi, Ryutaro; Kohsaka, Masayuki; Sawada, Hideyuki			Clinical Factors Associated with Abnormal Postures in Parkinson's Disease	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; REVERSIBLE PISA SYNDROME; MULTIPLE SYSTEM ATROPHY; DEEP BRAIN-STIMULATION; DROPPED HEAD SYNDROME; MOVEMENT-DISORDERS; INDUCED ANTECOLLIS; PERIPHERAL TRAUMA; CAMPTOCORMIA; PATHOGENESIS	Background: Abnormal posture (AP) is often seen in Parkinson's disease (PD), and marked forms known as dropped head syndrome and camptocormia encumber daily living activities. Unlike other motor disabilities such as bradykinesia or muscular rigidity, AP is not always improved but rather deteriorated by PD medication. Purpose: To clarify factors associated with neck and thoracolumbar AP. Methods: Neck flexion (NF) and thoracolumbar (TL) angles were measured in 216 consecutive PD patients and 175 elderly healthy controls. The differences in NF and TL angles between PD patients and controls were designated as Delta NFA and Delta TLA, respectively. The association of Delta NFA or Delta TLA and predictable factors such as age, sex, duration of PD, Hoehn Yahr (H-Y) stage, Unified Parkinson's Disease Rating Scale Part 3 (UPDRS-3), daily dose of dopamine agonists, and comorbid orthopedic spinal lesions was investigated in PD patients. Patients were divided into quartiles according to Delta NFA or Delta TLA. The association between predictable factors and Delta NFA or Delta TLA was estimated as odds ratio (OR), comparing with the lowest quartile as the reference by multivariate regression analysis. Results: Compared with controls, distributions of all three posture angles were significantly shifted rightward in PD patients. Although there were no difference in UPDRS-3 scores in the quartiles of Delta NFA, the highest quartile was associated with H-Y stage >= 3 [OR 2.99, 95% confidence interval (CI) 1.33-6.70, p = 0.008] after adjustment for age, sex and comorbid orthopedic spinal lesions. The highest quartile of Delta TLA was associated with comorbid orthopedic spinal lesions [OR 5.83 (1.42-23.8), p = 0.014], and UPDRS-3 score [OR 3.04 (1.80-5.15)/10 points, p < 0.0001]. Conclusion: Thoraco-lumbar AP was associated with UPDRS-3 scores and orthopedic spinal lesions, and in contrast, neck AP was not associated with these factors, suggesting that they had different pathomechanisms.	[Sawada, Hideyuki] Natl Hosp Org, Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan; Natl Hosp Org, Natl Utano Hosp, Dept Neurol, Kyoto, Japan		Sawada, H (corresponding author), Natl Hosp Org, Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan.	sawada@unh.hosp.go.jp	Umemura, Atsushi/ABC-4716-2021	Umemura, Atsushi/0000-0001-8557-6014; Tomita, Satoshi/0000-0003-4410-6539; Sawada, Hideyuki/0000-0002-5909-3366	National Hospital Organization	National Hospital Organization	Drs. Hayashi, Tomita, and Kousaka report no disclosures. Drs. Umemura, Oeda and Sawada are funded by grants-in-aid from the National Hospital Organization. This does not alter the authors' adherence to all the neurology policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Raya S, 2009, AGE AGEING, V38, P675, DOI 10.1093/ageing/afp137; Bloch F, 2006, J NEUROL NEUROSUR PS, V77, P1223, DOI 10.1136/jnnp.2006.087908; Bonanni L, 2007, MOVEMENT DISORD, V22, P2097, DOI 10.1002/mds.21694; Broussolle E, 2007, MOVEMENT DISORD, V22, P909, DOI 10.1002/mds.21484; Cannas A, 2005, CLIN NEUROPHARMACOL, V28, P252, DOI 10.1097/01.wnf.0000183449.04271.05; Cannas A, 2009, J NEUROL, V256, P390, DOI 10.1007/s00415-009-0072-6; Charpentier P, 2005, REV NEUROL-FRANCE, V161, P459, DOI 10.1016/S0035-3787(05)85077-5; Christenson E S, 2012, Minerva Ginecol, V64, P181; Djaldetti R, 1999, MOVEMENT DISORD, V14, P443, DOI 10.1002/1531-8257(199905)14:3<443::AID-MDS1009>3.0.CO;2-G; Fasano A, 2011, MOVEMENT DISORD, V26, P2578, DOI 10.1002/mds.23918; Finsterer J, 2011, DISABIL REHABIL, V33, P1702, DOI 10.3109/09638288.2010.543750; Fujimoto K, 2006, J NEUROL, V253, P21, DOI 10.1007/s00415-006-7006-3; Gerton BK, 2010, MOVEMENT DISORD, V25, P247, DOI 10.1002/mds.22909; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; JANKOVIC J, 1988, J NEUROL NEUROSUR PS, V51, P1512, DOI 10.1136/jnnp.51.12.1512; Jankovic J, 2009, NEUROL CLIN, V27, P821, DOI 10.1016/j.ncl.2009.04.005; Jobst EE, 1997, ARCH NEUROL-CHICAGO, V54, P450, DOI 10.1001/archneur.1997.00550160080020; Kashihara K, 2006, MOVEMENT DISORD, V21, P1213, DOI 10.1002/mds.20948; Kataoka H, 2011, CLIN NEUROPHARMACOL, V34, P48, DOI 10.1097/WNF.0b013e318204d35c; Konczak J, 2007, J NEUROL, V254, P655, DOI 10.1007/s00415-006-0426-2; Lepoutre AC, 2006, J NEUROL NEUROSUR PS, V77, P1229, DOI 10.1136/jnnp.2005.083998; Litvan I, 1996, NEUROLOGY, V46, P922, DOI 10.1212/WNL.46.4.922; Margraf NG, 2010, MOVEMENT DISORD, V25, P542, DOI 10.1002/mds.22780; Parkinson J, 2002, J NEUROPSYCH CLIN N, V14, P223, DOI 10.1176/appi.neuropsych.14.2.223; Sako W, 2009, MOVEMENT DISORD, V24, P1076, DOI 10.1002/mds.22529; Seki M, 2011, MOVEMENT DISORD, V26, P2567, DOI 10.1002/mds.23955; Sipila S, 2003, SCAND J MED SCI SPOR, V13, P19, DOI 10.1034/j.1600-0838.2003.20210.x; Slawek J, 2006, CLIN NEUROL NEUROSUR, V108, P699, DOI 10.1016/j.clineuro.2005.07.004; Solla P, 2012, J CLIN NEUROSCI, V19, P922, DOI 10.1016/j.jocn.2012.01.018; Solla P, 2008, J NEUROL SCI, V275, P154, DOI 10.1016/j.jns.2008.07.017; Spuler S, 2010, MOVEMENT DISORD, V25, P552, DOI 10.1002/mds.22913; Suzuki M, 2008, J NEUROL SCI, V264, P195, DOI 10.1016/j.jns.2007.08.008; Taguchi Y, 2008, INTERNAL MED, V47, P2011, DOI 10.2169/internalmedicine.47.1579; Tiple D, 2009, J NEUROL NEUROSUR PS, V80, P145, DOI 10.1136/jnnp.2008.150011; Umemura A, 2010, J NEUROSURG, V112, P1283, DOI 10.3171/2009.10.JNS09917; Uzawa A, 2009, MOVEMENT DISORD, V24, P2408, DOI 10.1002/mds.22779; van Rooijen DE, 2011, J NEUROL NEUROSUR PS, V82, P892, DOI 10.1136/jnnp.2010.232504; Vaugoyeau M, 2010, J NEUROL SCI, V289, P66, DOI 10.1016/j.jns.2009.08.019; Wright WG, 2007, EXP NEUROL, V208, P38, DOI 10.1016/j.expneurol.2007.07.002	40	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73547	10.1371/journal.pone.0073547	http://dx.doi.org/10.1371/journal.pone.0073547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069205	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300012
J	Ghazvini, M; Sonneveld, P; Kremer, A; Franken, P; Sacchetti, A; Atlasi, Y; Roth, S; Joosten, R; Smits, R; Fodde, R				Ghazvini, Mehrnaz; Sonneveld, Petra; Kremer, Andreas; Franken, Patrick; Sacchetti, Andrea; Atlasi, Yaser; Roth, Sabrina; Joosten, Rosalie; Smits, Ron; Fodde, Riccardo			Cancer Stemness in Apc- vs. Apc/KRAS-Driven Intestinal Tumorigenesis	PLOS ONE			English	Article							EPITHELIAL-CELL LINE; COLORECTAL-CANCER; TUMOR PROGRESSION; CARCINOMA SEQUENCE; BETA-CATENIN; MOUSE MODEL; ADENOMA; COLON; GENE; MUTATION	Constitutive activation of the Wnt pathway leads to adenoma formation, an obligatory step towards intestinal cancer. In view of the established role of Wnt in regulating stemness, we attempted the isolation of cancer stem cells (CSCs) from Apc- and Apc/KRAS-mutant intestinal tumours. Whereas CSCs are present in Apc/KRAS tumours, they appear to be very rare (<10(-6)) in the Apc-mutant adenomas. In contrast, the Lin(-)CD24(hi)CD29(+) subpopulation of adenocarcinoma cells appear to be enriched in CSCs with increased levels of active beta-catenin. Expression profiling analysis of the CSC-enriched subpopulation confirmed their enhanced Wnt activity and revealed additional differential expression of other signalling pathways, growth factor binding proteins, and extracellular matrix components. As expected, genes characteristic of the Paneth cell lineage (e. g. defensins) are co-expressed together with stem cell genes (e. g. Lgr5) within the CSC-enriched subpopulation. This is of interest as it may indicate a cancer stem cell niche role for tumor-derived Paneth-like cells, similar to their role in supporting Lgr5(+) stem cells in the normal intestinal crypt. Overall, our results indicate that oncogenic KRAS activation in Apc-driven tumours results in the expansion of the CSCs compartment by increasing (R)-catenin intracellular stabilization.	[Ghazvini, Mehrnaz; Sonneveld, Petra; Franken, Patrick; Sacchetti, Andrea; Atlasi, Yaser; Roth, Sabrina; Joosten, Rosalie; Fodde, Riccardo] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands; [Kremer, Andreas] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Smits, Ron] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Fodde, R (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands.	r.fodde@erasmusmc.nl	Atlasi, Yaser/F-2885-2018; Atlasi, Yaser/AAI-5396-2021; Sacchetti, Andrea/H-8763-2019; Fodde, Riccardo/AAW-9394-2021	Atlasi, Yaser/0000-0002-7350-1784; Fodde, Riccardo/0000-0001-9839-4324; Ghazvini, Mehrnaz/0000-0001-7859-6930; Kremer, Andreas/0000-0003-1466-0600	Dutch Cancer Society [EMCR 2001-2482]; Netherlands Organisation for Scientific Research [NWO/Vici 016.036.636]; BSIK (Kennisinfrastructuur) program of the Dutch Government [03038]; Netherlands Institute for Regenerative Medicine (NIRM); EU; TuMIC (integrated concept of tumor metastasis)	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BSIK (Kennisinfrastructuur) program of the Dutch Government; Netherlands Institute for Regenerative Medicine (NIRM); EU(European Commission); TuMIC (integrated concept of tumor metastasis)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These studies were supported by grants from the Dutch Cancer Society (EMCR 2001-2482), the Netherlands Organisation for Scientific Research (NWO/Vici 016.036.636), the BSIK (Kennisinfrastructuur) program of the Dutch Government grant 03038 (www.stemcells.nl) and the Netherlands Institute for Regenerative Medicine (NIRM; www.nirm.nl), and the EU FP6 and FP7 consortia Migrating Cancer Stem Cells program (MCSCs; www.mcscs.eu) and TuMIC (integrated concept of tumor metastasis (http://itgmv1.fzk.de/www/tumic/tumic_main.htm).	Allen M, 2010, J PATHOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Buczacki SJ, 2013, NATURE; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feng Y, 2011, GASTROENTEROLOGY; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Janssen KP, 2002, GASTROENTEROLOGY, V123, P492, DOI 10.1053/gast.2002.34786; KAWAGUCHI T, 1991, JPN J CANCER RES, V82, P138, DOI 10.1111/j.1349-7006.1991.tb01820.x; Kirchner T, 2000, AM J PATHOL, V157, P1113, DOI 10.1016/S0002-9440(10)64626-3; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; PARASKEVA C, 1988, INT J CANCER, V41, P908; PARASKEVA C, 1984, INT J CANCER, V34, P49, DOI 10.1002/ijc.2910340109; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Roth S, 2011, EMBO REP, V12, P483, DOI 10.1038/embor.2011.97; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Smits R, 1998, GASTROENTEROLOGY, V114, P275, DOI 10.1016/S0016-5085(98)70478-0; Smits R, 1997, CARCINOGENESIS, V18, P321, DOI 10.1093/carcin/18.2.321; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WILLIAMS AC, 1990, CANCER RES, V50, P4724	37	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73872	10.1371/journal.pone.0073872	http://dx.doi.org/10.1371/journal.pone.0073872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069241	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300023
J	Kushnick, G				Kushnick, Geoff			Access to Resources Shapes Maternal Decision Making: Evidence from a Factorial Vignette Experiment	PLOS ONE			English	Article							PARENTAL INVESTMENT; TERMINAL INVESTMENT; NATURAL-SELECTION; SEX-RATIO; AGE; PREFERENCES; EVOLUTION; ECOLOGY; OPTIMIZATION; REPRODUCTION	The central assumption of behavioral ecology is that natural selection has shaped individuals with the capacity to make decisions that balance the fitness costs and benefits of behavior. A number of factors shape the fitness costs and benefits of maternal care, but we lack a clear understanding how they, taken together, play a role in the decision-making process. In animal studies, the use of experimental methods has allowed for the tight control of these factors. Standard experimentation is inappropriate in human behavioral ecology, but vignette experiments may solve the problem. I used a confounded factorial vignette experiment to gather 640 third-party judgments about the maternal care decisions of hypothetical women and their children from 40 female karo Batak respondents in rural Indonesia. This allowed me to test hypotheses derived from parental investment theory about the relative importance of five binary factors in shaping maternal care decisions with regard to two distinct scenarios. As predicted, access to resources-measured as the ability of a woman to provide food for her children-led to increased care. A handful of other factors conformed to prediction, but they were inconsistent across scenarios. The results suggest that mothers may use simple heuristics, rather than a full accounting for costs and benefits, to make decisions about maternal care. Vignettes have become a standard tool for studying decision making, but have made only modest inroads to evolutionarily informed studies of human behavior.	[Kushnick, Geoff] Univ Washington, Henry M Jackson Sch Int Studies, Dept Anthropol, Seattle, WA 98195 USA; [Kushnick, Geoff] Univ Washington, Henry M Jackson Sch Int Studies, Southeast Asia Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kushnick, G (corresponding author), Univ Washington, Henry M Jackson Sch Int Studies, Dept Anthropol, Seattle, WA 98195 USA.	kushnick@u.washington.edu		Kushnick, Geoff/0000-0001-9280-0213	Arts & Humanities Research Council's (United Kingdom)	Arts & Humanities Research Council's (United Kingdom)(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	The fieldwork was funded by the Arts & Humanities Research Council's (United Kingdom) "Culture and Mind" Project (http://www.philosophy.dept.shef.ac.uk/culture&mind/). Other than providing funding for fieldwork, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER CS, 1978, PUBLIC OPIN QUART, V42, P93, DOI 10.1086/268432; [Anonymous], 2011, RES METHODS ANTHR; Atzmuller C, 2010, METHODOLOGY-EUR, V6, P128, DOI 10.1027/1614-2241/a000014; Barrett HC, 2008, FDN EVOLUTIONARY PSY, P173; Borgerhoff Mulder M, 2007, EVOLUTION MIND FUNDA, P78; Borgerhoff Mulder M, 2000, EVOL HUM BEHAV, V21, P371, DOI [10.1016/S1090-5138(00)00053-2, DOI 10.1016/S1090-5138(00)00053-2.PUBMED:11146304]; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; BRASPENNING J, 1994, J CLIN EPIDEMIOL, V47, P1365, DOI 10.1016/0895-4356(94)90080-9; Braza F, 2004, HUM ECOL, V32, P163, DOI 10.1023/B:HUEC.0000019761.98723.af; Broad KD, 2006, PHILOS T R SOC B, V361, P2199, DOI 10.1098/rstb.2006.1940; CARLISLE TR, 1982, ANIM BEHAV, V30, P824, DOI 10.1016/S0003-3472(82)80156-5; CLARK AB, 1978, SCIENCE, V201, P163, DOI 10.1126/science.201.4351.163; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Collins WA, 2000, AM PSYCHOL, V55, P218, DOI 10.1037/0003-066X.55.2.218; CRONK L, 1991, J BIOSOC SCI, V23, P229, DOI 10.1017/S0021932000019246; Cronk L, 2007, REPROD BIOMED ONLINE, V15, P23, DOI 10.1016/S1472-6483(10)60546-9; Davis JN, 1999, P ROY SOC B-BIOL SCI, V266, P1791, DOI 10.1098/rspb.1999.0848; Dochtermann NA, 2011, BEHAV ECOL SOCIOBIOL, V65, P37, DOI 10.1007/s00265-010-1039-4; El-Mouden C., 2012, EVOLUTION RATIONALIT, P23, DOI [10.1017/CBO9780511792601.003, DOI 10.1017/CBO9780511792601.003]; Fessler DMT, 2005, AM J PHYS ANTHROPOL, V127, P95, DOI 10.1002/ajpa.20039; Fisher RA, 1935, DESIGN EXPT; Furlow FB, 1997, EVOL HUM BEHAV, V18, P175, DOI 10.1016/S1090-5138(97)00006-8; Gibson MA, 2010, CURR ANTHROPOL, V51, P693, DOI 10.1086/655954; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; GOWATY PA, 1985, AM NAT, V126, P347, DOI 10.1086/284421; Hadley C, 2006, AM J HUM BIOL, V18, P359, DOI 10.1002/ajhb.20505; Helle S, 2008, HUM REPROD, V23, P2387, DOI 10.1093/humrep/den305; HILBORN R, 1982, ACTA BIOTHEOR, V31, P145, DOI 10.1007/BF01857238; HRDY SB, 1992, ETHOL SOCIOBIOL, V13, P409, DOI 10.1016/0162-3095(92)90011-R; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; Institute SAS. Inc, 2008, JMP 8 DES EXP GUID; Jeon J, 2008, BEHAV ECOL, V19, P344, DOI 10.1093/beheco/arm136; Kaplan Hillard S., 2000, ADAPTATION HUMAN BEH, P283; Kushnick G, 2010, HUM NATURE-INT BIOS, V21, P62, DOI 10.1007/s12110-010-9082-4; Kushnick G, 2009, J BIOSOC SCI, V41, P183, DOI 10.1017/S0021932008002988; Lawson DW, 2011, PHILOS T R SOC B, V366, P333, DOI 10.1098/rstb.2010.0297; Low Bobbi S., 2000, WHY SEX MATTERS DARW; Low BS, 2005, EVOL HUM BEHAV, V26, P64, DOI 10.1016/j.evolhumbehav.2004.08.011; Low BS, 2003, BIODEMOGRAPHY OF HUMAN REPRODUCTION AND FERTILITY, P105; Lycett JE, 1999, P ROY SOC B-BIOL SCI, V266, P2355, DOI 10.1098/rspb.1999.0931; Mann J., 1992, ADAPTED MIND EVOLUTI, P367; Norenzayan A, 2005, PSYCHOL BULL, V131, P763, DOI 10.1037/0033-2909.131.5.763; Pigliucci M, 2006, MAKING SENSE EVOLUTI, P150; Pillsworth EG, 2008, EVOL HUM BEHAV, V29, P256, DOI 10.1016/j.evolhumbehav.2008.01.005; Quinlan RJ, 2005, CURR ANTHROPOL, V46, P471, DOI 10.1086/430017; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Rickard IJ, 2010, ECOLOGY, V91, P3515, DOI 10.1890/10-0019.1; ROSSI PH, 1974, AM SOCIOL REV, V39, P224, DOI 10.2307/2094234; Royle N, 2012, EVOLUTION OF PARENTAL CARE, pXIV; Schlomer GL, 2012, J FAM PSYCHOL, V26, P443, DOI 10.1037/a0027859; Shenk MK, 2004, RES ECON AN, V23, P307, DOI 10.1016/S0190-1281(04)23013-X; Singarimbun Masri, 1975, KINSHIP DESCENT ALLI; Smith EA, 2005, BEHAV BRAIN SCI, V28, P832, DOI 10.1017/S0140525X0540014X; Statistik BP, 2012, KAB KAR DAL ANGK, P2011; Ting TF, 2004, POPUL ENVIRON, V25, P281; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Voland E, 1998, ANNU REV ANTHROPOL, V27, P347, DOI 10.1146/annurev.anthro.27.1.347; VOLAND E, 1995, HUM NATURE-INT BIOS, V6, P33, DOI 10.1007/BF02734134; West SA, 2009, MONOGR POPUL BIOL, V44, P162; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson M., 1994, INFANTICIDE PARENTAL, P73; Winterhalder B, 2000, EVOL ANTHROPOL, V9, P51; Ydenberg Ron, 2010, P131	65	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75539	10.1371/journal.pone.0075539	http://dx.doi.org/10.1371/journal.pone.0075539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219YJ	24069427	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300088
J	Mathison, A; Grzenda, A; Lomberk, G; Velez, G; Buttar, N; Tietz, P; Hendrickson, H; Liebl, A; Xiong, YNY; Gores, G; Fernandez-Zapico, M; LaRusso, NF; Faubion, W; Shah, VH; Urrutia, R				Mathison, Angela; Grzenda, Adrienne; Lomberk, Gwen; Velez, Gabriel; Buttar, Navtej; Tietz, Pamela; Hendrickson, Helen; Liebl, Ann; Xiong, Yuning Y.; Gores, Gregory; Fernandez-Zapico, Martin; LaRusso, Nicholas F.; Faubion, William; Shah, Vijay H.; Urrutia, Raul			Role for Kruppel-Like Transcription Factor 11 in Mesenchymal Cell Function and Fibrosis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; INDUCED LIVER FIBROSIS; CANCER; EXPRESSION; PATHWAY; KLF6; TRANSPLANTATION; BIOSYNTHESIS; REGENERATION; RECRUITMENT	Kruppel-like factor 11 (KLF11) and the highly homologous KLF10 proteins are transcription factors originating from duplication of the Drosophila melanogaster ancestor cabut. The function of these proteins in epithelial cells has been previously characterized. In the current study, we report a functional role for KLF11 in mesenchymal cells and in mesenchymal cell dysfunction, namely, fibrosis, and subsequently perform a detailed cellular, molecular, and in vivo characterization of this phenomenon. We find that, in cultured mesenchymal cells, enhanced expression of KLF11 results in activated extracellular matrix pathways, including collagen gene silencing and matrix metalloproteinases activation without changes in tissue inhibitors of metalloproteinases. Combined, reporter and chromatin immunoprecipitation assays demonstrate that KLF11 interacts directly with the collagen 1a2 (COL1A2) promoter in mesenchymal cells to repress its activity. Mechanistically, KLF11 regulates collagen gene expression through the heterochromatin protein 1 gene-silencing pathway as mutants defective for coupling to this epigenetic modifier lose the ability to repress COL1A2. Expression studies reveal decreased levels of KLF11 during liver fibrogenesis after chemically induced injury in vivo. Congruently, KLF11(-/-) mice, which should be deficient in the hypothesized anti-fibrogenic brake imposed by this transcription factor, display an enhanced response to liver injury with increased collagen fibril deposition. Thus, KLFs expands the repertoire of transcription factors involved in the regulation of extracellular matrix proteins in mesenchymal cells and define a novel pathway that modulates the fibrogenic response during liver injury.	[Mathison, Angela; Grzenda, Adrienne; Lomberk, Gwen; Velez, Gabriel; Liebl, Ann; Xiong, Yuning Y.; Faubion, William; Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Mathison, Angela; Grzenda, Adrienne; Lomberk, Gwen; Buttar, Navtej; Tietz, Pamela; Hendrickson, Helen; Liebl, Ann; Xiong, Yuning Y.; Gores, Gregory; LaRusso, Nicholas F.; Faubion, William; Shah, Vijay H.; Urrutia, Raul] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Fernandez-Zapico, Martin] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN USA; [Urrutia, Raul] Mayo Clin, Translat Epigen Program, Ctr Individualized Med, Rochester, MN USA; [Urrutia, Raul] Mayo Clin, Dept Biophys, Rochester, MN USA; [Urrutia, Raul] Mayo Clin, Dept Med, Rochester, MN USA; [Urrutia, Raul] Mayo Clin, Dept Biochem, Rochester, MN USA; [Urrutia, Raul] Mayo Clin, Dept Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Urrutia, R (corresponding author), Mayo Clin, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu	Grzenda, Adrienne L/K-4421-2019; Lomberk, Gwen/AAL-8490-2020	Grzenda, Adrienne L/0000-0001-5952-6953; Lomberk, Gwen/0000-0001-5463-789X; Velez, Gabriel/0000-0003-0819-5933; Mathison, Angela/0000-0002-6763-2710	National Institutes of Health [DK52913]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567]; Translational Epigenomic Program, Center for Individualized Medicine, Mayo Clinic; NIH Training Grant in Tumor Microenvironment [T32CA148073]; NATIONAL CANCER INSTITUTE [T32CA148073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK052913, R56DK052913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021171, R37AA021171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Cell Signaling in Gastroenterology; Translational Epigenomic Program, Center for Individualized Medicine, Mayo Clinic; NIH Training Grant in Tumor Microenvironment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health (DK52913); the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567); the Translational Epigenomic Program, Center for Individualized Medicine, Mayo Clinic (RU); and NIH (T32CA148073) Training Grant in Tumor Microenvironment (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; Botella LM, 2009, BIOCHEM J, V419, P485, DOI 10.1042/BJ20081434; Buttar NS, 2010, J BIOL CHEM, V285, P11433, DOI 10.1074/jbc.M109.077065; Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009; Das A, 2010, AM J PHYSIOL-GASTR L, V298, pG908, DOI 10.1152/ajpgi.00510.2009; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Grunewald M, 2012, J BIOL CHEM, V287, P24195, DOI 10.1074/jbc.M112.373936; Hedin KE, 2000, SURGERY, V128, P1, DOI 10.1067/msy.2000.106426; Jiao JJ, 2009, CURR OPIN GASTROEN, V25, P223, DOI 10.1097/MOG.0b013e3283279668; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2008, CURR OPIN GASTROEN, V24, P597, DOI 10.1097/MOG.0b013e32830b111d; Lomberk G, 2012, J BIOL CHEM, V287, P13026, DOI 10.1074/jbc.M112.342634; Ma XR, 2009, LAB INVEST, V89, P903, DOI 10.1038/labinvest.2009.51; Mathison A, 2010, PANCREATOLOGY, V10, P505, DOI [10.1016/S1424-3903(10)80035-3, 10.1159/000320540]; Miele L, 2008, GASTROENTEROLOGY, V135, P282, DOI 10.1053/j.gastro.2008.04.004; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Seo S, 2013, J PAIN, V14, P549, DOI 10.1016/j.jpain.2013.01.772; Seo S, 2012, J BIOL CHEM, V287, P12723, DOI 10.1074/jbc.M112.351395; Starkel P, 2003, J HEPATOL, V39, P538, DOI 10.1016/S0168-8278(03)00360-X; Watanabe A, 2007, HEPATOLOGY, V46, P1509, DOI 10.1002/hep.21867; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang KL, 2008, BIOCHEM BIOPH RES CO, V373, P219, DOI 10.1016/j.bbrc.2008.05.192; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Zhang HB, 2013, J HEPATOL, V58, P763, DOI 10.1016/j.jhep.2012.11.024; Zhao XY, 2008, PATHOL INT, V58, P580, DOI 10.1111/j.1440-1827.2008.02274.x	34	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75311	10.1371/journal.pone.0075311	http://dx.doi.org/10.1371/journal.pone.0075311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069400	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300078
J	Yang, SM; Hua, KF; Lin, YC; Chen, A; Chang, JM; Chao, LK; Ho, CL; Ka, SM				Yang, Shun-Min; Hua, Kuo-Feng; Lin, Yu-Chuan; Chen, Ann; Chang, Jia-Ming; Chao, Louis Kuoping; Ho, Chen-Lung; Ka, Shuk-Man			Citral Is Renoprotective for Focal Segmental Glomerulosclerosis by Inhibiting Oxidative Stress and Apoptosis and Activating Nrf2 Pathway in Mice	PLOS ONE			English	Article							NF-KAPPA-B; DIABETIC-NEPHROPATHY; BARDOXOLONE METHYL; INFLAMMATORY RESPONSE; PROTEIN-KINASES; KIDNEY; PROGRESSION; EXPRESSION; INJURY; FIBROSIS	The pathogenesis of focal segmental glomerulosclerosis (FSGS) is considered to be associated with oxidative stress, mononuclear leukocyte recruitment and infiltration, and matrix production and/or matrix degradation, although the exact etiology and pathogenic pathways remain to be determined. Establishment of a pathogenesis-based therapeutic strategy for the disease is clinically warranted. Citral (3,7-dimethyl-2,6-octadienal), a major active compound in Litsea cubeba, a traditional Chinese herbal medicine, can inhibit oxidant activity, macrophage and NF-kappa B activation. In the present study, first, we used a mouse model of FSGS with the features of glomerular epithelial hyperplasia lesions (EPHLs), a key histopathology index of progression of FSGS, peri-glomerular inflammation, and progressive glomerular hyalinosis/sclerosis. When treated with citral for 28 consecutive days at a daily dose of 200 mg/kg of body weight by gavage, the FSGS mice showed greatly reduced EPHLs, glomerular hyalinosis/sclerosis and peri-glomerular mononuclear leukocyte infiltration, suggesting that citral may be renoprotective for FSGS and act by inhibiting oxidative stress and apoptosis and early activating the Nrf2 pathway. Meanwhile, a macrophage model involved in anti-oxidative and anti-inflammatory activities was employed and confirmed the beneficial effects of citral on the FSGS model.	[Yang, Shun-Min; Lin, Yu-Chuan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Yang, Shun-Min; Chen, Ann] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei, Taiwan; [Hua, Kuo-Feng] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Chang, Jia-Ming] Dev Ctr Biotechnol, Inst Drug Evaluat Platform, Dept Pharmacol, Taipei, Taiwan; [Chao, Louis Kuoping] China Med Univ, Dept Cosmeceut, Taichung, Taiwan; [Ho, Chen-Lung] Taiwan Forestry Res Inst, Div Wood Cellulose, Taipei, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Ilan University; China Medical University Taiwan; National Defense Medical Center	Ka, SM (corresponding author), Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan.	mariaka@ndmctsgh.edu.tw	Chang, Jia-Ming/P-4010-2019		Ministry of Economic Affairs [101-EC-17-A-19-S1-161]; National Science Council, Taiwan, ROC [NSC 100-2313-B-197-002, NSC 101-2321-B-016-003, NSC 102-2628-B-197-001-MY3]	Ministry of Economic Affairs; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Ministry of Economic Affairs (101-EC-17-A-19-S1-161) and National Science Council (NSC 100-2313-B-197-002; NSC 101-2321-B-016-003; NSC 102-2628-B-197-001-MY3), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes MM, 2006, PEDIATR NEPHROL, V21, P1003, DOI 10.1007/s00467-006-0138-y; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Bachiega TF, 2011, J ETHNOPHARMACOL, V137, P909, DOI 10.1016/j.jep.2011.07.021; Barroso MF, 2011, J AGR FOOD CHEM, V59, P5062, DOI 10.1021/jf1048244; Benchimol C, 2003, CURR OPIN PEDIATR, V15, P171, DOI 10.1097/00008480-200304000-00006; Benz K, 2010, PEDIATR NEPHROL, V25, P1291, DOI 10.1007/s00467-010-1507-0; Braun N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003233.pub2; Bruschi M, 2011, J CHROMATOGR B, V879, P1338, DOI 10.1016/j.jchromb.2010.11.030; Cheel J, 2005, J AGR FOOD CHEM, V53, P2511, DOI 10.1021/jf0479766; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cravedi P, 2013, AM J TRANSPLANT, V13, P266, DOI 10.1111/ajt.12045; D'Agati VD, 2012, CLIN J AM SOC NEPHRO; Erkan E, 2005, J AM SOC NEPHROL, V16, P398, DOI 10.1681/ASN.2003100861; Goumenos DS, 2006, NEPHRON CLIN PRACT, V104, pC75, DOI 10.1159/000093993; Grande MT, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-19; Ka SM, 2012, DIABETOLOGIA, V55, P509, DOI 10.1007/s00125-011-2364-5; Ka SM, 2011, AM J PHYSIOL-RENAL, V301, pF1218, DOI 10.1152/ajprenal.00050.2011; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kim JH, 2012, FREE RADICAL BIO MED, V53, P629, DOI 10.1016/j.freeradbiomed.2012.04.019; Korbet SM, 2000, RENAL FAILURE, V22, P685, DOI 10.1081/JDI-100101956; Korbet SM, 2012, J AM SOC NEPHROL, V23, P1769, DOI 10.1681/ASN.2012040389; Lee HJ, 2008, ARCH PHARM RES, V31, P342, DOI 10.1007/s12272-001-1162-0; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Lin CT, 2008, BIORESOURCE TECHNOL, V99, P8783, DOI 10.1016/j.biortech.2008.04.041; Liu GC, 2012, DIABETOLOGIA, V55, P2522, DOI 10.1007/s00125-012-2586-1; Liu S, 2013, AM J PHYSIOL-RENAL; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Munoz M, 2011, J RENIN-ANGIO-ALDO S, V12, P404, DOI 10.1177/1470320311410092; Musante L, 2007, J AM SOC NEPHROL, V18, P799, DOI 10.1681/ASN.2006090965; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Oh CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045870; Ortiz MI, 2010, PHYTOMEDICINE, V18, P74, DOI 10.1016/j.phymed.2010.05.009; Ory V, 2012, AM J PATHOL, V180, P2284, DOI 10.1016/j.ajpath.2012.02.008; Ozbek E, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/465897; Pani A, 2012, AUTOIMMUN REV; Passerini P, 2009, G Ital Nefrol, V26, P563; Pedruzzi LM, 2012, BIOCHIMIE, V94, P2461, DOI 10.1016/j.biochi.2012.07.015; Pergola PE, 2011, AM J NEPHROL, V33, P469, DOI 10.1159/000327599; Pouchert CJ, 1974, ALDRICH LIB NMR SPEC; Queisser N, 2012, FREE RADICAL BIO MED, V53, P314, DOI 10.1016/j.freeradbiomed.2012.05.011; Reisman SA, 2012, J AM SOC NEPHROL, V23, P1663, DOI 10.1681/ASN.2012050457; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Rojas-Rivera J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/321714; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Schachter AD, 2000, TRANSPLANTATION, V70, P1107, DOI 10.1097/00007890-200010150-00021; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Shui HA, 2006, NEPHROL DIAL TRANSPL, V21, P1794, DOI 10.1093/ndt/gfl113; Shui HA, 2007, TRANSL RES, V150, P216, DOI 10.1016/j.trsl.2007.04.003; Sozeri B, 2010, SAUDI J KIDNEY DIS T, V21, P87; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Stirling CM, 2006, NEPHRON CLIN PRACT, V104, pC83, DOI 10.1159/000093994; Su SC, 2006, CLIN CHIM ACTA, V374, P106, DOI 10.1016/j.cca.2006.05.045; Therrien FJ, 2012, AM J NEPHROL, V36, P151, DOI 10.1159/000340033; Thornalley PJ, 2012, J RENAL NUTR, V22, P195, DOI 10.1053/j.jrn.2011.10.012; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Tsai PY, 2011, FREE RADICAL BIO MED, V50, P1503, DOI 10.1016/j.freeradbiomed.2011.02.029; Wang Y, 2001, KIDNEY INT, V59, P941, DOI 10.1046/j.1523-1755.2001.00577.x; Wang Y, 2008, AM J PATHOL, V172, P1491, DOI 10.2353/ajpath.2008.070825; Wang YP, 2001, KIDNEY INT, V59, P975, DOI 10.1046/j.1523-1755.2001.059003975.x; Wasilewska A, 2011, SCAND J UROL NEPHROL, V45, P52, DOI 10.3109/00365599.2010.526140; Watson D, 2009, INT J BIOCHEM CELL B, V41, P729, DOI 10.1016/j.biocel.2008.04.028; Wilmes A, 2011, TOXICOL IN VITRO, V25, P613, DOI 10.1016/j.tiv.2010.12.009; Wyburn KR, 2013, AM J PHYSIOL-RENAL, V304, pF68, DOI 10.1152/ajprenal.00669.2011; Yang B, 2002, KIDNEY INT, V62, P1301, DOI 10.1111/j.1523-1755.2002.kid587.x; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33; Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807; Zoja C, 2013, AM J PHYSIOL-RENAL, V304, pF808, DOI 10.1152/ajprenal.00376.2012	74	28	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74871	10.1371/journal.pone.0074871	http://dx.doi.org/10.1371/journal.pone.0074871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069362	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300064
J	Bacon, S; Kyithar, MP; Schmid, J; Pozza, AC; Handberg, A; Byrne, MM				Bacon, Siobhan; Kyithar, Ma P.; Schmid, Jasmin; Pozza, Andre Costa; Handberg, Aase; Byrne, Maria M.			Circulating CD36 Is Reduced in HNF1A-MODY Carriers	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; SCAVENGER RECEPTOR CD36; INSULIN-RESISTANCE; SOLUBLE CD36; CARDIOVASCULAR MORTALITY; SENSITIVITY; MUTATIONS; SECRETION; MARKERS	Introduction: Premature atherosclerosis is a significant cause of morbidity and mortality in type 2 diabetes mellitus. Maturity onset diabetes of the young (MODY) accounts for approximately 2% of all diabetes, with mutations in the transcription factor; hepatocyte nuclear factor 1 alpha (HNF1A) accounting for the majority of MODY cases. There is somewhat limited data available on the prevalence of macrovascular disease in HNF1A-MODY carriers with diabetes. Marked insulin resistance and the associated dyslipidaemia are not clinical features of HNF1A-MODY carriers. The scavenger protein CD36 has been shown to play a substantial role in the pathogenesis of atherosclerosis, largely through its interaction with oxidised LDL. Higher levels of monocyte CD36 and plasma CD36(sCD36) are seen to cluster with insulin resistance and diabetes. The aim of this study was to determine levels of sCD36 in participants with HNF1A-MODY diabetes and to compare them with unaffected normoglycaemic family members and participants with type 2 diabetes mellitus. Methods: We recruited 37 participants with HNF1A-MODY diabetes and compared levels of sCD36 with BMI-matched participants with type 2 diabetes mellitus and normoglycaemic HNF1A-MODY negative family controls. Levels of sCD36 were correlated with phenotypic and biochemical parameters. Results: HNF1A-MODY participants were lean, normotensive, with higher HDL and lower triglyceride levels when compared to controls and participants with type 2 diabetes mellitus. sCD36 was also significantly lower in HNF1A-MODY participants when compared to both the normoglycaemic family controls and to lean participants with type 2 diabetes mellitus. Conclusion: In conclusion, sCD36 is significantly lower in lean participants with HNF1A-MODY diabetes when compared to weight-matched normoglycaemic familial HNF1A-MODY negative controls and to lean participants with type 2 diabetes mellitus. Lower levels of this pro-atherogenic marker may result from the higher HDL component in the lipid profile of HNF1A-MODY participants.	[Bacon, Siobhan; Kyithar, Ma P.; Pozza, Andre Costa; Byrne, Maria M.] Mater Misericordiae Univ Hosp, Dept Endocrinol, Dublin, Ireland; [Schmid, Jasmin] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Handberg, Aase] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark	Mater Misericordiae University Hospital; University College Dublin; Royal College of Surgeons - Ireland; Aalborg University; Aalborg University Hospital	Byrne, MM (corresponding author), Mater Misericordiae Univ Hosp, Dept Endocrinol, Dublin, Ireland.	mbyrne@mater.ie	Byrne, Maria/A-8310-2017; Schmid, Jasmin/C-3393-2012	Byrne, Maria/0000-0002-9394-8698; Schmid, Jasmin/0000-0001-5384-2242; Handberg, Aase/0000-0001-5719-203X	Mater College Foundation; Metabolic Research Unit	Mater College Foundation; Metabolic Research Unit	This research was funded in association with the Mater College Foundation and the Metabolic Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806; Brundert M, 2011, J LIPID RES, V52, P745, DOI 10.1194/jlr.M011981; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Chmielewski M, 2010, CLIN CHIM ACTA, V411, P2079, DOI 10.1016/j.cca.2010.09.009; Eitzman DT, 2000, ARTERIOSCL THROM VAS, V20, P1831, DOI 10.1161/01.ATV.20.7.1831; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Glintborg D, 2008, DIABETES CARE, V31, P328, DOI 10.2337/dc07-1424; Handberg A, 2012, J INTERN MED, V271, P294, DOI 10.1111/j.1365-2796.2011.02442.x; Handberg A, 2010, J CLIN ENDOCR METAB, V95, P1939, DOI 10.1210/jc.2009-2002; Handberg A, 2008, STROKE, V39, P3092, DOI 10.1161/STROKEAHA.108.517128; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; McDonald TJ, 2011, DIABETES CARE, V34, P1860, DOI 10.2337/dc11-0323; Owen KR, 2010, DIABETES CARE, V33, P1919, DOI 10.2337/dc10-0288; Owen KR, 2002, DIABETIC MED, V19, P758, DOI 10.1046/j.1464-5491.2002.00766.x; Pearson ER, 2004, DIABETES CARE, V27, P1102, DOI 10.2337/diacare.27.5.1102; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Steele AM, 2010, DIABETIC MED, V27, P157, DOI 10.1111/j.1464-5491.2009.02913.x; Stride A, 2005, DIABETES CARE, V28, P1751, DOI 10.2337/diacare.28.7.1751; Tripathy D, 2000, DIABETOLOGIA, V43, P1476, DOI 10.1007/s001250051558; Yue P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009906	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74577	10.1371/journal.pone.0074577	http://dx.doi.org/10.1371/journal.pone.0074577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069322	gold, Green Submitted, Green Published			2022-12-27	WOS:000326240100112
J	Song, S; Cheong, LZ; Falkeborg, M; Liu, L; Dong, MD; Jensen, HM; Bertelsen, K; Thorsen, M; Tan, TW; Xu, XB; Guo, Z				Song, Shuang; Cheong, Ling-Zhi; Falkeborg, Mia; Liu, Lei; Dong, Mingdong; Jensen, Henrik Max; Bertelsen, Kresten; Thorsen, Michael; Tan, Tianwei; Xu, Xuebing; Guo, Zheng			Facile Synthesis of Phosphatidyl Saccharides for Preparation of Anionic Nanoliposomes with Enhanced Stability	PLOS ONE			English	Article							GENE DELIVERY; LIPOSOMES; CRYOPROTECTANTS; INTERNALIZATION; VITRIFICATION; COMPLEXES; SUGARS	Physical stability during storage and against processing such as dehyration/rehydration are the cornerstone in designing delivery vehicles. In this work, mono-, di- and tri-saccharides were enzymatically conjugated to phosphatidyl group through a facile approach namely phospholipase D (PLD) mediated transphosphatidylation in a biphasic reaction system. The purified products were structurally identified and the connectivities of carbohydrate to phosphatidyl moiety precisely mapped by H-1, P-31, C-13 NMR pulse sequences and LC-ESI-FTMS. The synthetic phosphatidyl saccharides were employed as the sole biomimetic component for preparation of nanoliposomes. It was found that the critical micelle concentration (CMC) of phosphatidyl saccharides increases as more bulky sugar moiety (mono- to tri-) is introduced. Phosphatidyl di- saccharide had the largest membrane curvature. In comparison to the zwitterionic phosphatidylcholine liposome, all phosphatidyl saccharides liposomes are anionic and demonstrated significantly enhanced stability during storage. According to the confocal laser scan microscopy (CLSM) and atom force microscopy (AFM) analyses, the nanoliposomes formed by the synthetic phosphatidyl saccharides also show excellent stability against dehydration/rehydration process in which most of the liposomal structures remained intact. The abundance hydroxyl groups in the saccharide moieties might provide sufficient H-bondings for stabilization. This work demonstrated the synthesized phosphatidyl saccharides are capable of functioning as enzymatically liable materials which can form stable nanoliposomes without addition of stabilizing excipients.	[Song, Shuang; Cheong, Ling-Zhi; Falkeborg, Mia; Xu, Xuebing; Guo, Zheng] Aarhus Univ, Dept Engn, Aarhus, Denmark; [Tan, Tianwei] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China; [Liu, Lei; Dong, Mingdong] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Jensen, Henrik Max; Bertelsen, Kresten; Thorsen, Michael] DuPont Nutr & Hlth, Adv Anal, Brabrand, Denmark	Aarhus University; Beijing University of Chemical Technology; Aarhus University	Tan, TW (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China.	twtan@mail.buct.edu.cn; guo@mb.au.dk	Thorsen, Michael/GQI-1726-2022; Dong, Mingdong/AAC-3023-2020; Cheong, Ling-Zhi/F-5092-2015; Dong, Mingdong/B-3341-2010; dong, mingdong/AAK-9315-2020; Xu, Xuebing/GLQ-7148-2022	Dong, Mingdong/0000-0002-2025-2171; Cheong, Ling-Zhi/0000-0001-6760-8553; Dong, Mingdong/0000-0002-2025-2171; 	"Innovationskonsortiet"; Danish Technological Institute; 973 program [2011CB710800, 2009CB724703, 2011CB200905]; National Nature Science Foundation of China [21076017, 21106005]; Key Projects in the National Science & Technology Pillar Program during the 12th Five-Year Plan Period [2011BAD22B04]; DuPont; Marine Bioproducts; Altlantic Biotechnology; University of Southern Denmark; Villum Fonden [00007194] Funding Source: researchfish	"Innovationskonsortiet"; Danish Technological Institute; 973 program(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program during the 12th Five-Year Plan Period; DuPont; Marine Bioproducts; Altlantic Biotechnology; University of Southern Denmark; Villum Fonden(Villum Fonden)	This project was funded by "Innovationskonsortiet" and in collaboration with Danish Technological Institute, DuPont, Marine Bioproducts, Altlantic Biotechnology and University of Southern Denmark. This work was also supported by 973 program (2011CB710800, 2009CB724703, 2011CB200905), the National Nature Science Foundation of China (21076017, 21106005), and Key Projects in the National Science & Technology Pillar Program during the 12th Five-Year Plan Period (2011BAD22B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2012, BIOMATERIALS, V33, P7858, DOI 10.1016/j.biomaterials.2012.07.004; ANANTHAPADMANABHAN KP, 1985, LANGMUIR, V1, P352, DOI 10.1021/la00063a015; AUSBORN M, 1994, J CONTROL RELEASE, V30, P105, DOI 10.1016/0168-3659(94)90257-7; Chen CJ, 2010, J CONTROL RELEASE, V142, P299, DOI 10.1016/j.jconrel.2009.10.024; Crowe JH, 1996, BBA-BIOMEMBRANES, V1280, P187, DOI 10.1016/0005-2736(95)00287-1; CROWE LM, 1985, ARCH BIOCHEM BIOPHYS, V242, P240, DOI 10.1016/0003-9861(85)90498-9; FISHER K, 2000, FORMATION SELF ASSEM; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Hsu CYM, 2012, BIOMATERIALS, V33, P7834, DOI 10.1016/j.biomaterials.2012.06.093; Huang Z, 2008, J AM CHEM SOC, V130, P15702, DOI 10.1021/ja8065557; Ingvarsson PT, 2011, EXPERT OPIN DRUG DEL, V8, P375, DOI 10.1517/17425247.2011.553219; KOSTER KL, 1994, BBA-BIOMEMBRANES, V1193, P143, DOI 10.1016/0005-2736(94)90343-3; Latxague L, 2011, CHEM COMMUN, V47, P12598, DOI 10.1039/c1cc13948g; Li L. L., 2012, ANGEW CHEM INT EDIT, V51, P1, DOI DOI 10.1002/ANIE.201106864; Liu SC, 2002, J AM CHEM SOC, V124, P6037, DOI 10.1021/ja0123507; Ma MM, 2011, CHEM COMMUN, V47, P2853, DOI 10.1039/c0cc05137c; Mady MM, 2011, AFR J PHARM PHARMACO, V5, P1898, DOI 10.5897/AJPP11.462; Maitani Y, 2008, INT J PHARM, V356, P69, DOI 10.1016/j.ijpharm.2007.12.033; Miniadis-Meimaroglou S, 2008, CHEM PHYS LIPIDS, V152, P104, DOI 10.1016/j.chemphyslip.2008.01.003; Murthy BN, 2012, RSC ADV, V2, P1329, DOI 10.1039/c2ra01192a; Perttu EK, 2012, J AM CHEM SOC, V134, P4485, DOI 10.1021/ja210989h; Qi W, 2010, J MATER CHEM, V20, P2121, DOI 10.1039/b920469p; SANTAELLA C, 1991, ANGEW CHEM INT EDIT, V30, P567, DOI 10.1002/anie.199105671; Schafer J, 2010, BIOMATERIALS, V31, P6892, DOI 10.1016/j.biomaterials.2010.05.043; SHINODA K, 1959, J PHYS CHEM-US, V63, P648, DOI 10.1021/j150575a003; Song S, 2012, FOOD CHEM, V135, P373, DOI 10.1016/j.foodchem.2012.05.020; Stark B, 2010, EUR J PHARM SCI, V41, P546, DOI 10.1016/j.ejps.2010.08.010; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; vanHal DA, 1996, J COLLOID INTERF SCI, V178, P263, DOI 10.1006/jcis.1996.0114	29	14	14	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73891	10.1371/journal.pone.0073891	http://dx.doi.org/10.1371/journal.pone.0073891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069243	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100067
J	Martire, S; Fuso, A; Rotili, D; Tempera, I; Giordano, C; De Zottis, I; Muzi, A; Vernole, P; Graziani, G; Lococo, E; Faraldi, M; Maras, B; Scarpa, S; Mosca, L; d'Erme, M				Martire, Sara; Fuso, Andrea; Rotili, Dante; Tempera, Italo; Giordano, Cesare; De Zottis, Ivana; Muzi, Alessia; Vernole, Patrizia; Graziani, Grazia; Lococo, Emanuela; Faraldi, Martina; Maras, Bruno; Scarpa, Sigfrido; Mosca, Luciana; d'Erme, Maria			PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage	PLOS ONE			English	Article							NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE-1; OXIDATIVE STRESS; A-BETA; DNA-BINDING; SIGNAL-TRANSDUCTION; CELL-DEATH; ACTIVATION; BRAIN; TARGET	Amyloid beta peptide (A beta) causes neurodegeneration by several mechanisms including oxidative stress, which is known to induce DNA damage with the consequent activation of poly (ADP-ribose) polymerase (PARP-1). To elucidate the role of PARP-1 in the neurodegenerative process, SH-SY5Y neuroblastoma cells were treated with A beta(25-35) fragment in the presence or absence of MC2050, a new PARP-1 inhibitor. A beta(25-35) induces an enhancement of PARP activity which is prevented by cell pre-treatment with MC2050. These data were confirmed by measuring PARP-1 activity in CHO cells transfected with amylod precursor protein and in vivo in brains specimens of TgCRND8 transgenic mice overproducing the amyloid peptide. Following A beta(25-35) exposure a significant increase in intracellular ROS was observed. These data were supported by the finding that A beta(25-35) induces DNA damage which in turn activates PARP-1. Challenge with A beta(25-35) is also able to activate NF-kB via PARP-1, as demonstrated by NF-kB impairment upon MC2050 treatment. Moreover, A beta(25-35) via PARP-1 induces a significant increase in the p53 protein level and a parallel decrease in the anti-apoptotic Bcl-2 protein. These overall data support the hypothesis of PARP-1 involvment in cellular responses induced by A beta and hence a possible rationale for the implication of PARP-1 in neurodegeneration is discussed.	[Martire, Sara; De Zottis, Ivana; Faraldi, Martina; Maras, Bruno; Mosca, Luciana; d'Erme, Maria] Sapienza Univ, Dept Biochem Sci, Rome, Italy; [Fuso, Andrea] Sapienza Univ, Dept Psychol Sec Neurosci, Rome, Italy; [Rotili, Dante; Giordano, Cesare] Sapienza Univ, Dept Pharmaceut Studies, Rome, Italy; [Tempera, Italo] Temple Univ, Fels Inst Canc Res & Mol Biol, Philadelphia, PA USA; [Muzi, Alessia; Graziani, Grazia] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Vernole, Patrizia] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Rome, Italy; [Lococo, Emanuela] Sapienza Univ, Dept Expt Med, Rome, Italy; [Scarpa, Sigfrido] Sapienza Univ, Dept Surg P Valdoni, Rome, Italy; [d'Erme, Maria] Sapienza Univ, Fdn Cenci Bolognetti, Inst Pasteur, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Rome Tor Vergata; University of Rome Tor Vergata; Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	d'Erme, M (corresponding author), Sapienza Univ, Dept Biochem Sci, Rome, Italy.	maria.derme@uniroma1.it	Graziani, Grazia/G-5747-2012; Martire, Sara/AAH-2808-2020; Rotili, Dante/J-9157-2016; Faraldi, Martina/B-1378-2017; Tempera, Italo/N-2495-2019; Mosca, Luciana/K-8101-2015	Graziani, Grazia/0000-0002-0221-768X; Martire, Sara/0000-0002-1570-3476; Faraldi, Martina/0000-0003-2047-7255; Tempera, Italo/0000-0001-7893-2914; Mosca, Luciana/0000-0003-2748-9021; Muzi, Alessia/0000-0001-6946-3888; d'erme, maria/0000-0001-7160-570X; Fuso, Andrea/0000-0001-9467-5671; Rotili, Dante/0000-0002-8428-8763	MIUR; Istituto Pasteur, Fondazione Cenci Bolognetti, Roma, Italy	MIUR(Ministry of Education, Universities and Research (MIUR)); Istituto Pasteur, Fondazione Cenci Bolognetti, Roma, Italy(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by funds from MIUR and from Istituto Pasteur, Fondazione Cenci Bolognetti, Roma, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Abeti R, 2012, NEUROCHEM RES, V37, P2589, DOI 10.1007/s11064-012-0895-x; Abeti R, 2011, BRAIN, V134, P1658, DOI 10.1093/brain/awr104; Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; de la Lastra CA, 2007, CURR PHARM DESIGN, V13, P933; Atherton E, 1989, SOLID PHASE PEPTIDE, P203; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Beneke Sascha, 2012, Frontiers in Genetics, V3, P169, DOI 10.3389/fgene.2012.00169; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Butterfield DA, 2002, FREE RADICAL RES, V36, P1307, DOI 10.1080/1071576021000049890; Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Chen Jiao-Jiao, 2008, Neurosci Bull, V24, P183, DOI 10.1007/s12264-008-0183-6; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Czapski GA, 2006, NEUROCHEM INT, V49, P751, DOI 10.1016/j.neuint.2006.06.006; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; d'Avila JC, 2012, J NEUROINFLAMM, V15, P9; Datki Z, 2003, BRAIN RES BULL, V62, P223, DOI 10.1016/j.brainresbull.2003.09.011; Dutta C, 2012, CANCER RES, V72, P4193, DOI 10.1158/0008-5472.CAN-11-4204; Frozza RL, 2009, NEUROCHEM RES, V34, P295, DOI 10.1007/s11064-008-9776-8; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hayashi M, 2009, NEUROPATHOLOGY, V29, P1, DOI 10.1111/j.1440-1789.2008.00888.x; Ji YBA, 2010, CURR OPIN GENET DEV, V20, P512, DOI 10.1016/j.gde.2010.06.001; Kaminsky YG, 2010, EXP NEUROL, V221, P26, DOI 10.1016/j.expneurol.2009.09.005; Kang YH, 2004, CANCER RES, V64, P8960, DOI 10.1158/0008-5472.CAN-04-1830; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Love S, 1999, BRAIN, V122, P247, DOI 10.1093/brain/122.2.247; Maki CG, 1996, CANCER RES, V56, P2649; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Millucci L, 2009, J BIOSCIENCES, V34, P293, DOI 10.1007/s12038-009-0033-3; Mosca L, 2011, CHEMMEDCHEM, V6, P606, DOI 10.1002/cmdc.201000536; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V51, P1774, DOI 10.1016/j.freeradbiomed.2011.08.006; Olivieri G, 2001, J NEUROCHEM, V76, P224, DOI 10.1046/j.1471-4159.2001.00090.x; Pacher P, 2005, ANTIOXID REDOX SIGN, V7, P1568, DOI 10.1089/ars.2005.7.1568; Paradis E, 1996, J NEUROSCI, V16, P7533; Patel JR, 2008, EXP NEUROL, V213, P93, DOI 10.1016/j.expneurol.2008.05.007; Pellicciari R, 2004, PROGR MED CHEM, V42, P125, DOI 10.1016/S0079-6468(04)42003-7; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Poojari C, 2012, BIOCHIM BIOPHYS ACTA, P327; Shall S, 2000, MUTAT RES-DNA REPAIR, V460, P1, DOI 10.1016/S0921-8777(00)00016-1; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Song YS, 2004, NEUROSCI RES, V49, P69, DOI 10.1016/j.neures.2004.01.010; Strosznajder JB, 2000, ACTA BIOCHIM POL, V47, P847, DOI 10.18388/abp.2000_4003; Strosznajder JB, 2012, MOL NEUROBIOL, V46, P78, DOI 10.1007/s12035-012-8258-9; Strosznajder RP, 2005, MOL NEUROBIOL, V31, P149, DOI 10.1385/MN:31:1-3:149; Szabo C, 1996, SHOCK, V6, P79, DOI 10.1097/00024382-199608000-00001; Tempera I, 2010, J VIROL, V84, P4988, DOI 10.1128/JVI.02333-09; Tofoleanu F, 2012, J MOL BIOL, V421, P572, DOI 10.1016/j.jmb.2011.12.063; Valenzuela MT, 2002, ONCOGENE, V21, P1108, DOI 10.1038/sj.onc.1205169; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Wesierska-Gadek J, 2001, CELL MOL BIOL LETT, V6, P117; Wieler S, 2003, J BIOL CHEM, V278, P18914, DOI 10.1074/jbc.M211641200; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Yang N, 2010, J CELL BIOCHEM, V110, P1208, DOI 10.1002/jcb.22635; ZABEL U, 1991, J BIOL CHEM, V266, P252; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646	66	47	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e72169	10.1371/journal.pone.0072169	http://dx.doi.org/10.1371/journal.pone.0072169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086258	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200005
J	Fang, XL; Sittadjody, S; Gyabaah, K; Opara, EC; Balaji, KC				Fang, Xiaolan; Sittadjody, Sivanandane; Gyabaah, Kenneth; Opara, Emmanuel C.; Balaji, Kethandapatti C.			Novel 3D Co-Culture Model for Epithelial-Stromal Cells Interaction in Prostate Cancer	PLOS ONE			English	Article							SOLUBLE E-CADHERIN; IN-VITRO; RECIPROCAL INTERACTIONS; EXTRACELLULAR-MATRIX; ALGINATE HYDROGELS; GROWTH; DIFFERENTIATION; PROLIFERATION; PROGRESSION; INHIBITION	Paracrine function is a major mechanism of cell-cell communication within tissue microenvironment in normal development and disease. In vitro cell culture models simulating tissue or tumor microenvironment are necessary tools to delineate epithelial-stromal interactions including paracrine function, yet an ideal three-dimensional (3D) tumor model specifically studying paracrine function is currently lacking. In order to fill this void we developed a novel 3D co-culture model in double-layered alginate hydrogel microspheres, incorporating prostate cancer epithelial and stromal cells in separate compartments of the microspheres. The cells remained confined and viable within their respective spheres for over 30 days. As a proof of principle regarding paracrine function of the model, we measured shedded component of E-cadherin (sE-cad) in the conditioned media, a major membrane bound cell adhesive molecule that is highly dysregulated in cancers including prostate cancer. In addition to demonstrating that sE-cad can be reliably quantified in the conditioned media, the time course experiments also demonstrated that the amount of sE-cad is influenced by epithelial-stromal interaction. In conclusion, the study establishes a novel 3D in vitro co-culture model that can be used to study cell-cell paracrine interaction.	[Fang, Xiaolan; Sittadjody, Sivanandane; Gyabaah, Kenneth; Opara, Emmanuel C.; Balaji, Kethandapatti C.] Wake Forest Univ Hlth Sci, Inst Regenerat Med, Winston Salem, NC USA; [Fang, Xiaolan; Balaji, Kethandapatti C.] Wake Forest Univ Hlth Sci, Ctr Comprehens Canc, Dept Canc Biol, Winston Salem, NC USA; [Balaji, Kethandapatti C.] Wake Forest Univ Hlth Sci, Dept Urol, Winston Salem, NC USA	Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Balaji, KC (corresponding author), Wake Forest Univ Hlth Sci, Inst Regenerat Med, Winston Salem, NC USA.	kbalaji@wakehealth.edu			Wake Forest University; NIH [CA079448]; NATIONAL CANCER INSTITUTE [T32CA079448, P30CA012197] Funding Source: NIH RePORTER	Wake Forest University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Wake Forest University institutional funds to KC Balaji and by NIH grant CA079448 to X. Fang. Funder's website is http://www.wakehealth.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Bhadriraju K, 2002, DRUG DISCOV TODAY, V7, P612, DOI 10.1016/S1359-6446(02)02273-0; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040; Choi DS, 2007, J PROTEOME RES, V6, P4646, DOI 10.1021/pr070192y; Chung LWK, 2003, CANCER-AM CANCER SOC, V97, P772, DOI 10.1002/cncr.11140; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372; Giatromanolaki A, 2012, CANCER BIOL THER, V13, P1284, DOI 10.4161/cbt.21785; Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Henke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042516; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Hwang RF, 2012, MOL CANCER RES, V10, P1147, DOI 10.1158/1541-7786.MCR-12-0022; Jaggi M, 2003, BIOCHEM BIOPH RES CO, V307, P254, DOI 10.1016/S0006-291X(03)01161-6; Jiang HJ, 2009, DIABETES-METAB RES, V25, P232, DOI 10.1002/dmrr.940; Kassen A, 1996, PROSTATE, V28, P89, DOI 10.1002/(SICI)1097-0045(199602)28:2<89::AID-PROS3>3.0.CO;2-I; Khanna O, 2010, J BIOMED MATER RES A, V95A, P632, DOI 10.1002/jbm.a.32883; Kuefer R, 2003, CLIN CANCER RES, V9, P6447; Lelievre SA, 1998, P NATL ACAD SCI USA, V95, P14711, DOI 10.1073/pnas.95.25.14711; Matsumoto K, 2003, J UROLOGY, V170, P2248, DOI 10.1097/01.ju.0000094189.93805.17; Okugawa Y, 2012, J SURG RES, V175, pE67, DOI 10.1016/j.jss.2011.11.009; Olumi AF, 1999, CANCER RES, V59, P5002; Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542; Rajashekhar G, 2008, STEM CELLS, V26, P2674, DOI 10.1634/stemcells.2008-0277; Rhee HW, 2001, IN VITRO CELL DEV-AN, V37, P127; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I; Spancake KM, 1999, CANCER RES, V59, P6042; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Syed V, 2008, J CELL BIOCHEM, V104, P82, DOI 10.1002/jcb.21603; Tendulkar S, 2012, BIOMED MICRODEVICES, V14, P461, DOI 10.1007/s10544-011-9623-6; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; WEAVER VM, 1995, SEMIN CANCER BIOL, V6, P175, DOI 10.1006/scbi.1995.0021; Weiss JV, 2011, INT J CANCER, V128, P1384, DOI 10.1002/ijc.25438; Yates CC, 2007, BRIT J CANCER, V96, P1246, DOI 10.1038/sj.bjc.6603700; Zhau HE, 1997, IN VITRO CELL DEV-AN, V33, P375	43	41	41	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75187	10.1371/journal.pone.0075187	http://dx.doi.org/10.1371/journal.pone.0075187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073251	gold, Green Published, Green Submitted			2022-12-27	WOS:000324768000060
J	Farhy, C; Elgart, M; Shapira, Z; Oron-Karni, V; Yaron, O; Menuchin, Y; Rechavi, G; Ashery-Padan, R				Farhy, Chen; Elgart, Michael; Shapira, Zehavit; Oron-Karni, Varda; Yaron, Orly; Menuchin, Yotam; Rechavi, Gideon; Ashery-Padan, Ruth			Pax6 Is Required for Normal Cell-Cycle Exit and the Differentiation Kinetics of Retinal Progenitor Cells	PLOS ONE			English	Article							SONIC HEDGEHOG; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; FATE SPECIFICATION; KINASE INHIBITORS; NUCLEAR RECEPTOR; AMACRINE CELLS; GANGLION-CELL; EXPRESSION; PROLIFERATION	The coupling between cell-cycle exit and onset of differentiation is a common feature throughout the developing nervous system, but the mechanisms that link these processes are mostly unknown. Although the transcription factor Pax6 has been implicated in both proliferation and differentiation of multiple regions within the central nervous system (CNS), its contribution to the transition between these successive states remains elusive. To gain insight into the role of Pax6 during the transition from proliferating progenitors to differentiating precursors, we investigated cell-cycle and transcriptomic changes occurring in Pax6-retinal progenitor cells (RPCs). Our analyses revealed a unique cell-cycle phenotype of the Pax6-deficient RPCs, which included a reduced number of cells in the S phase, an increased number of cells exiting the cell cycle, and delayed differentiation kinetics of Pax6-precursors. These alterations were accompanied by coexpression of factors that promote (Ccnd1, Ccnd2, Ccnd3) and inhibit (P27(kip1) and P27(kip2)) the cell cycle. Further characterization of the changes in transcription profile of the Pax6-deficient RPCs revealed abrogated expression of multiple factors which are known to be involved in regulating proliferation of RPCs, including the transcription factors Vsx2, Nr2e1, Plagl1 and Hedgehog signaling. These findings provide novel insight into the molecular mechanism mediating the pleiotropic activity of Pax6 in RPCs. The results further suggest that rather than conveying a linear effect on RPCs, such as promoting their proliferation and inhibiting their differentiation, Pax6 regulates multiple transcriptional networks that function simultaneously, thereby conferring the capacity to proliferate, assume multiple cell fates and execute the differentiation program into retinal lineages.	[Farhy, Chen; Elgart, Michael; Shapira, Zehavit; Oron-Karni, Varda; Yaron, Orly; Menuchin, Yotam; Ashery-Padan, Ruth] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Farhy, Chen; Elgart, Michael; Shapira, Zehavit; Oron-Karni, Varda; Yaron, Orly; Menuchin, Yotam; Ashery-Padan, Ruth] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Rechavi, Gideon] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Ashery-Padan, R (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	ruthash@post.tau.ac.il		Menuchin-Lasowski, Yotam/0000-0002-0756-6889	Israel Science Foundation [610/10]; Israel Ministry of Science [36494]; Ziegler Foundation; Binational Science Foundation; German Israeli Foundation; Israel Ministry of Health; Israel-Italy foundation	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Ziegler Foundation; Binational Science Foundation(US-Israel Binational Science Foundation); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Ministry of Health; Israel-Italy foundation	R.A.-P.'s research is supported by the Israel Science Foundation (grant number 610/10), the Israel Ministry of Science (grant number 36494), the Ziegler Foundation, the Binational Science Foundation, the German Israeli Foundation, the Israel Ministry of Health and the Israel-Italy foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Asami M, 2011, DEVELOPMENT, V138, P5067, DOI 10.1242/dev.074591; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Barton KM, 2008, DEV DYNAM, V237, P672, DOI 10.1002/dvdy.21449; Bassett EA, 2007, MOL CELL BIOL, V27, P7497, DOI 10.1128/MCB.00687-07; Baumer N, 2002, DEVELOPMENT, V129, P4535; Bel-Vialar S, 2007, DEV BIOL, V305, P659, DOI 10.1016/j.ydbio.2007.02.012; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Bilitou A, 2010, DEV DYNAM, V239, P727, DOI 10.1002/dvdy.22223; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Carthon BC, 2005, MOL CELL BIOL, V25, P1081, DOI 10.1128/MCB.25.3.1081-1088.2005; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Coutinho P, 2011, GENOME RES, V21, P1349, DOI 10.1101/gr.124115.111; Cvekl A, 1999, INVEST OPHTH VIS SCI, V40, P1343; Cwinn MA, 2011, J NEUROSCI, V31, P5169, DOI 10.1523/JNEUROSCI.5495-10.2011; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Das G, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-15; Duparc RH, 2007, DEV BIOL, V301, P374, DOI 10.1016/j.ydbio.2006.11.006; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Fujitani Y, 2006, DEVELOPMENT, V133, P4439, DOI 10.1242/dev.02598; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; GERDES J, 1984, J IMMUNOL, V133, P1710; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Green ES, 2003, DEVELOPMENT, V130, P539, DOI 10.1242/dev.00275; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gui HX, 2007, DEV BIOL, V301, P14, DOI 10.1016/j.ydbio.2006.10.035; HARMAN AM, 1987, ANAT EMBRYOL, V177, P123, DOI 10.1007/BF00572536; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Heatley MK, 2002, HISTOPATHOLOGY, V40, P483, DOI 10.1046/j.1365-2559.2002.01390.x; Hollemann T, 1998, DEVELOPMENT, V125, P2425; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Hsieh YW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-32; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Inoue T, 2002, DEVELOPMENT, V129, P831; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jusuf PR, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-34; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Lacomme M, 2012, MOL CELL BIOL, V32, P2596, DOI 10.1128/MCB.06745-11; Le TT, 2006, DEV BIOL, V295, P764, DOI 10.1016/j.ydbio.2006.03.055; Lee J, 1997, DEVELOPMENT, V124, P2537; Li SG, 2004, NEURON, V43, P795, DOI 10.1016/j.neuron.2004.08.041; Lin YP, 2009, INVEST OPHTH VIS SCI, V50, P68, DOI 10.1167/iovs.07-1619; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Ma L, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-11; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Miyawaki T, 2004, J NEUROSCI, V24, P8124, DOI 10.1523/JNEUROSCI.2235-04.2004; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Pacal M, 2012, DEV DYNAM, V241, P1525, DOI 10.1002/dvdy.23840; Philips GT, 2005, DEV BIOL, V279, P308, DOI 10.1016/j.ydbio.2004.12.018; Psarros M, 2005, NUCLEIC ACIDS RES, V33, pW638, DOI 10.1093/nar/gki490; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; RAO SS, 1994, MOL CELL BIOL, V14, P5259, DOI 10.1128/MCB.14.8.5259; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Riesenberg AN, 2009, J NEUROSCI, V29, P12865, DOI 10.1523/JNEUROSCI.3382-09.2009; Riesenberg AN, 2009, GENESIS, V47, P175, DOI 10.1002/dvg.20479; Roy K, 2004, J NEUROSCI, V24, P8333, DOI 10.1523/JNEUROSCI.1148-04.2004; Rungger-Brandle E, 2010, DEV NEUROBIOL, V70, P764, DOI 10.1002/dneu.20816; Sakagami K, 2009, J NEUROSCI, V29, P6932, DOI 10.1523/JNEUROSCI.0289-09.2009; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shaham O, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003357; Shaham O, 2012, PROG RETIN EYE RES, V31, P351, DOI 10.1016/j.preteyeres.2012.04.002; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sigulinsky CL, 2008, DEV BIOL, V317, P560, DOI 10.1016/j.ydbio.2008.02.055; Skapek SX, 2001, ONCOGENE, V20, P6742, DOI 10.1038/sj.onc.1204876; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Tamai H, 2007, GENES CELLS, V12, P983, DOI 10.1111/j.1365-2443.2007.01113.x; Tang XM, 2000, J CELL BIOCHEM, V76, P270, DOI 10.1002/(SICI)1097-4644(20000201)76:2<270::AID-JCB10>3.0.CO;2-6; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyas DA, 2003, CEREB CORTEX, V13, P612, DOI 10.1093/cercor/13.6.612; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Warren N, 1999, CEREB CORTEX, V9, P627, DOI 10.1093/cercor/9.6.627; Warren N, 1997, DEVELOPMENT, V124, P1573; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Zaccarini R, 2007, INVEST OPHTH VIS SCI, V48, P5408, DOI 10.1167/iovs.07-0413; Zhang CL, 2006, GENE DEV, V20, P1308, DOI 10.1101/gad.1413606; Zheng MH, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-38; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	91	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76489	10.1371/journal.pone.0076489	http://dx.doi.org/10.1371/journal.pone.0076489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073291	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000101
J	Beaufort, N; Corvazier, E; Mlanaoindrou, S; de Bentzmann, S; Pidard, D				Beaufort, Nathalie; Corvazier, Elisabeth; Mlanaoindrou, Saouda; de Bentzmann, Sophie; Pidard, Dominique			Disruption of the Endothelial Barrier by Proteases from the Bacterial Pathogen Pseudomonas aeruginosa: Implication of Matrilysis and Receptor Cleavage	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; TIGHT JUNCTION PROTEINS; VE-CADHERIN; EXTRACELLULAR-MATRIX; CELL-SURVIVAL; VIRULENCE FACTORS; PROTEOLYSIS; APOPTOSIS; METALLOPROTEINASE; ADHESION	Within the vasculature, uncontrolled pericellular proteolysis can lead to disruption of cell-to-cell and cell-to-matrix interactions and subsequent detachment-induced cell apoptosis, or anoikis, contributing to inflammatory vascular diseases, with the endothelium as the major target. Most studies so far have focused on endogenous proteinases. However, during bloodstream infections, bacterial proteinases may also trigger endothelial anoikis. We thus investigated the potential apoptotic activity of the proteinases secreted by the haematotropic opportunistic pathogen, Pseudomonas aeruginosa, and particularly its predominant metalloproteinase, LasB. For this, we used the secretome of the LasB-expressing pseudomonal strain, PAO1, and compared it with that from the isogenic, LasB-deficient strain (PAO1 Delta lasB), as well as with purified LasB. Secretomes were tested for apoptotic activity on cultured human endothelial cells derived from the umbilical vein or from the cerebral microvasculature. We found that the PAO1 secretome readily induced endothelial cell anoikis, as did secretomes of LasB-positive clinical pseudomonal isolates, while the PAO1 Delta lasB secretome had only a limited impact on endothelial adherence and viability. Notably, purified LasB reproduced most of the effects of the LasB-containing secretomes, and these were drastically reduced in the presence of the LasB-selective inhibitor, phosphoramidon. A precocious and extensive LasB-dependent degradation of several proteins associated with the endothelial extracellular matrix, fibronectin and von Willebrand factor, was observed by immunofluorescence and/or immunoblotting analysis of cell cultures. Moreover, the PAO1 secretome, but not that from PAO1 Delta lasB, specifically induced rapid endoproteolysis of two major interendothelial junction components, VE-cadherin and occludin, as well as of the anti-anoikis, integrin-associated urokinase receptor, uPAR. Taken as a prototype for exogenous haemorrhagic proteinases, pseudomonal LasB thus appears to induce endothelial anoikis not only via matrilysis, as observed for many pro-apoptotic proteinases, but also via cleavage of some essential cell-to-cell and cell-to-matrix adhesion receptors implicated in the maintenance of the endothelial barrier.	[Beaufort, Nathalie; Corvazier, Elisabeth; Mlanaoindrou, Saouda; Pidard, Dominique] INSERM, U698, Paris, France; [Beaufort, Nathalie; Corvazier, Elisabeth; Mlanaoindrou, Saouda; Pidard, Dominique] Univ Paris 07, UMR S698, Paris, France; [de Bentzmann, Sophie] CNRS, UMR LISM 7255, Marseille, France; [de Bentzmann, Sophie] Aix Marseille Univ, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Pidard, D (corresponding author), INSERM, U698, Paris, France.	dominique.pidard@inserm.fr		Pidard, Dominique/0000-0002-5732-3279; Beaufort, Nathalie/0000-0002-7088-4206	Fondation Lefoulon-Delalande/Institut de France, Paris, France; Vaincre la Mucoviscidose, Paris, France; Fondation Bettencourt-Schueller, Paris, France; Centre National de la Recherche Scientifique (CNRS); Agence Nationale pour la Recherche (ANR), Paris, France	Fondation Lefoulon-Delalande/Institut de France, Paris, France; Vaincre la Mucoviscidose, Paris, France; Fondation Bettencourt-Schueller, Paris, France; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche (ANR), Paris, France(French National Research Agency (ANR))	This work was supported by a fellowship from the Fondation Lefoulon-Delalande/Institut de France (http://lefoulon-delalande.institut-defrance.fr/), Paris, France (to NB), and by Vaincre la Mucoviscidose (http://www.vaincrelamuco.org/), Paris, France, the Fondation Bettencourt-Schueller (http://www.fondationbs.org/), Paris, France, and grants from Centre National de la Recherche Scientifique (CNRS; http://www.cnrs.fr/) and Agence Nationale pour la Recherche (ANR; http://www.agence-nationale-recherche.fr/), Paris, France (to SdB). DP is Charge de Recherche at the Institut National des Sciences du Vivant within the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Alfano D, 2006, J BIOL CHEM, V281, P17758, DOI 10.1074/jbc.M601812200; Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Basire A, 2006, THROMB HAEMOSTASIS, V95, P678, DOI 10.1160/TH05-07-0511; Beaufort N, 2011, CELL MICROBIOL, V13, P1149, DOI 10.1111/j.1462-5822.2011.01606.x; Beaufort N, 2010, BIOCHEM J, V428, P473, DOI 10.1042/BJ20091806; Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; Boehme MWJ, 2002, IMMUNOLOGY, V107, P340, DOI 10.1046/j.1365-2567.2002.01469.x; Bojarski C, 2004, J CELL SCI, V117, P2097, DOI 10.1242/jcs.01071; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Caballero AR, 2001, ANAL BIOCHEM, V290, P330, DOI 10.1006/abio.2001.4999; Cabrol SN, 2003, J BACTERIOL, V185, P7222, DOI 10.1128/JB.185.24.7222-7230.2003; CAREY DJ, 1991, ANNU REV PHYSIOL, V53, P161, DOI 10.1146/annurev.physiol.53.1.161; Chung MC, 2008, J BIOL CHEM, V283, P9531, DOI 10.1074/jbc.M705871200; Colman RW, 2010, THROMB HAEMOSTASIS, V104, P875, DOI 10.1160/TH10-01-0017; Davis GE, 2001, J CELL SCI, V114, P917; de Bentzmann S, 2000, LAB INVEST, V80, P209, DOI 10.1038/labinvest.3780024; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Giraud C, 2010, ENV MICROBIOL REP, V2, P343, DOI 10.1111/j.1758-2229.2009.00070.x; Guillot L, 2002, J IMMUNOL, V168, P5989, DOI 10.4049/jimmunol.168.12.5989; Hermant B, 2003, J BIOL CHEM, V278, P14002, DOI 10.1074/jbc.M300351200; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Hippenstiel S, 2003, THROMB HAEMOSTASIS, V89, P18; Houard X, 2006, J AM COLL CARDIOL, V48, pA3, DOI 10.1016/j.jacc.2006.04.098; Hsu SL, 2001, CANCER LETT, V167, P193, DOI 10.1016/S0304-3835(01)00479-7; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Jyot J, 2011, J INFECT DIS, V203, P1369, DOI 10.1093/infdis/jir045; Komori Y, 2001, TOXICON, V39, P1327, DOI 10.1016/S0041-0101(01)00084-8; Koolwijk P, 2001, BLOOD, V97, P3123, DOI 10.1182/blood.V97.10.3123; Leduc D, 2007, INFECT IMMUN, V75, P3848, DOI 10.1128/IAI.00015-07; Lemichez E, 2010, NAT REV MICROBIOL, V8, P93, DOI 10.1038/nrmicro2269; Lindstedt KA, 2004, ARTERIOSCL THROM VAS, V24, P1350, DOI 10.1161/01.ATV.0000135322.78008.55; Matsumoto K, 2004, BIOL CHEM, V385, P1007, DOI 10.1515/BC.2004.131; Mattos Saliba A, 2009, MICROB PATHOG, V33, P153; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; McCarty SM, 2012, WOUND REPAIR REGEN, V20, P125, DOI 10.1111/j.1524-475X.2012.00763.x; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Moura-Da-Silva AM, 2007, CURR PHARM DESIGN, V13, P2893, DOI 10.2174/138161207782023711; OKAJIMA K, 1995, J LAB CLIN MED, V126, P377; Pier GB, 2005, MANDELL DOUGLAS BENN, V6th, P2587; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210; Rand JH, 1997, THROMB HAEMOSTASIS, V78, P445; Ray MJ, 1997, THROMB HAEMOSTASIS, V78, P1021; Ruggeri ZM, 1999, THROMB HAEMOSTASIS, V82, P576; Sahni SK, 2007, THROMB RES, V119, P531, DOI 10.1016/j.thromres.2006.06.006; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Sheets SA, 2005, INFECT IMMUN, V73, P1543, DOI 10.1128/IAI.73.3.1543-1552.2005; Sidibe A, 2012, ARTHRITIS RHEUM-US, V64, P77, DOI 10.1002/art.33336; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stepinska M, 2008, MICROB PATHOGENESIS, V44, P448, DOI 10.1016/j.micpath.2007.11.008; Strateva T, 2011, ANN MICROBIOL, V61, P717, DOI 10.1007/s13213-011-0273-y; Supuran CT, 2002, MED RES REV, V22, P329, DOI 10.1002/med.10007; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Takii R, 2005, INFECT IMMUN, V73, P883, DOI 10.1128/IAI.73.2.883-893.2005; TOURNIER JM, 1985, AM REV RESPIR DIS, V132, P524; Valbuena G, 2006, ANNU REV PATHOL-MECH, V1, P171, DOI 10.1146/annurev.pathol.1.110304.100031; Valente E, 2000, MICROB PATHOGENESIS, V29, P345, DOI 10.1006/mpat.2000.0400; van Delden C, 2007, INT J ANTIMICROB AG, V30, pS71, DOI 10.1016/j.ijantimicag.2007.06.015; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Vasil ML, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000420; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; WAGNER DD, 1984, P NATL ACAD SCI-BIOL, V81, P471, DOI 10.1073/pnas.81.2.471; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Xiao KY, 2003, J BIOL CHEM, V278, P19199, DOI 10.1074/jbc.M211746200; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zulianello L, 2006, INFECT IMMUN, V74, P3134, DOI 10.1128/IAI.01772-05	73	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75708	10.1371/journal.pone.0075708	http://dx.doi.org/10.1371/journal.pone.0075708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069438	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300091
J	Belham, FS; Satler, C; Garcia, A; Tomaz, C; Gasbarri, A; Rego, A; Tavares, MCH				Belham, Flavia Schechtman; Satler, Corina; Garcia, Ana; Tomaz, Carlos; Gasbarri, Antonella; Rego, Artur; Tavares, Maria Clotilde H.			Age-Related Differences in Cortical Activity during a Visuo-Spatial Working Memory Task with Facial Stimuli	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; SEX-DIFFERENCES; BRAIN ACTIVITY; GENDER-DIFFERENCES; COGNITIVE CONTROL; FACE PERCEPTION; EMOTION; ATTENTION; CORTEX; EXPRESSIONS	Emotion, importantly displayed by facial expressions, is one of the most significant memory modulators. The interaction between memory and the different emotional valences change across lifespan, while young adults (YA) are expected to better recall negative events (Negativity Bias Hypothesis), older adults (OA) tend to focus on positive stimuli (Positivity Effect Hypothesis). This research work aims at verifying whether cortical electrical activity of these two age groups would also be differently influenced by emotional valences in a visuo-spatial working memory task. 27 YA (13 males) and 25 OA (14 males), all healthy volunteers, underwent electroencephalographic recordings (21 scalp electrodes montage), while performing the Spatial Delayed Recognition Span Task using a touch screen with different stimuli categories: neutral, positive and negative faces and geometric pictures. YA obtained higher scores than OA, and showed higher activation of theta and alpha bands in the frontal and midline regions, besides a more evident right-hemispheric asymmetry on alpha band when compared to OA. For both age groups, performance in the task was worse for positive faces than to negative and to neutral faces. Facial stimuli induced a better performance and higher alpha activation on the pre-frontal region for YA, and on the midline, occipital and left temporal regions for OA when compared to geometric figures. The superior performance of YA was expected due to the natural cognitive deficits connected to ageing, as was a better performance with facial stimuli due to the evolutionary importance of faces. These results were related to cortical activity on areas of importance for action-planning, decision making and sustained attention. Taken together, they are in accordance with the Negativity Bias but do not support the Positivity Effect. The methodology used was able to identify age-related differences in cortical activity during emotional mnemonic processing and may be interesting to future investigations.	[Belham, Flavia Schechtman; Garcia, Ana; Tomaz, Carlos; Rego, Artur; Tavares, Maria Clotilde H.] Univ Brasilia, Dept Physiol Sci, Lab Neurosci & Behav, Brasilia, DF, Brazil; [Satler, Corina] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil; [Gasbarri, Antonella] Univ Aquila, Dept Biomed Sci & Technol, I-67100 Laquila, Italy	Universidade de Brasilia; Universidade de Brasilia; University of L'Aquila	Tavares, MCH (corresponding author), Univ Brasilia, Dept Physiol Sci, Lab Neurosci & Behav, Brasilia, DF, Brazil.	mchtavares@unb.br	Tomaz, Carlos A B/F-8626-2012; Satler, Corina/F-5870-2012; Costa, Artur/K-7996-2015; Satler, Corina/AAZ-3003-2021	Satler, Corina/0000-0001-7821-2183; Costa, Artur/0000-0001-9604-4208; Belham, Flavia/0000-0003-2986-4171; Gasbarri, Antonella/0000-0003-0708-6524				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Baddeley A. D, 1986, WORKING MEMORY; Baddeley AD, 2002, EUR PSYCHOL, V7, P85, DOI 10.1027//1016-9040.7.2.85; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Beason-Held LL, 1999, HIPPOCAMPUS, V9, P562, DOI 10.1002/(SICI)1098-1063(1999)9:5<562::AID-HIPO10>3.0.CO;2-X; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bergado JA, 2011, PROG NEUROBIOL, V94, P64, DOI 10.1016/j.pneurobio.2011.03.004; Berlingeri M, 2013, EXP BRAIN RES, V224, P393, DOI 10.1007/s00221-012-3319-x; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Bourne VJ, 2010, NEUROPSYCHOLOGIA, V48, P1289, DOI 10.1016/j.neuropsychologia.2009.12.032; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Buckmaster CA, 2004, J NEUROSCI, V24, P9811, DOI 10.1523/JNEUROSCI.1532-04.2004; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; Carp J, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00217; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Daffner KR, 2011, J COGNITIVE NEUROSCI, V23, P1298, DOI 10.1162/jocn.2010.21540; Damasio A, 2000, FEELING WHAT HAPPENS; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dudchenko PA, 2013, NEUROSCI BIOBEHAV R, V37, P2111, DOI 10.1016/j.neubiorev.2012.03.003; Duzel E, 2010, CURR OPIN NEUROBIOL, V20, P143, DOI 10.1016/j.conb.2010.01.004; Ekman P, 2011, EMOT REV, V3, P364, DOI 10.1177/1754073911410740; Estes Z, 2008, EMOTION, V8, P453, DOI 10.1037/a0012887; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Feredoes E, 2011, P NATL ACAD SCI USA, V108, P17510, DOI 10.1073/pnas.1106439108; Folstein M.F., 2010, MMSE 2 MINIMENTAL ST; Frank JE, 2000, BRAZ J MED BIOL RES, V33, P1483, DOI 10.1590/S0100-879X2000001200013; Galli G, 2011, J NEUROSCI, V31, P12364, DOI 10.1523/JNEUROSCI.1619-11.2011; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Garcia A, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00082; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gilboa-Schechtman E, 1999, COGNITION EMOTION, V13, P305, DOI 10.1080/026999399379294; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Gruhn D, 2005, PSYCHOL AGING, V20, P579, DOI 10.1037/0882-7974.20.4.579; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; Hamann S, 2003, NAT NEUROSCI, V6, P106, DOI 10.1038/nn0203-106; Haut KM, 2006, NEUROIMAGE, V32, P411, DOI 10.1016/j.neuroimage.2006.01.044; Haxby JV, 1995, HUM BRAIN MAPP, V3, P68, DOI 10.1002/hbm.460030204; Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jonides J, 2005, CURR DIR PSYCHOL SCI, V14, P2, DOI 10.1111/j.0963-7214.2005.00323.x; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keuker JIH, 2003, NEUROBIOL AGING, V24, P157, DOI 10.1016/S0197-4580(02)00062-3; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; La Cerra P, 1998, P NATL ACAD SCI USA, V95, P11290; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lacreuse A, 2002, NEUROBIOL AGING, V23, P589, DOI 10.1016/S0197-4580(02)00002-7; Lacreuse A, 2005, BEHAV NEUROSCI, V119, P118, DOI 10.1037/0735-7044.119.1.118; Lenardt MH, 2009, ACTA PAUL ENFERM, V22, P638, DOI 10.1590/S0103-21002009000500007; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; McIntyre CK, 2012, NEUROSCI BIOBEHAV R, V36, P1750, DOI 10.1016/j.neubiorev.2011.11.001; Mikels JA, 2005, PSYCHOL AGING, V20, P542, DOI 10.1037/0882-7974.20.4.542; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Nahm FKD, 1997, J COGNITIVE NEUROSCI, V9, P611, DOI 10.1162/jocn.1997.9.5.611; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Palmer K, 2002, AM J PSYCHIAT, V159, P436, DOI 10.1176/appi.ajp.159.3.436; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pereira DA, 2012, ARQ NEURO-PSIQUIAT, V70, P175, DOI 10.1590/S0004-282X2012005000003; Petrican R, 2008, PSYCHOL AGING, V23, P585, DOI 10.1037/a0013176; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Santesso DL, 2008, NEUROPSYCHOLOGIA, V46, P1338, DOI 10.1016/j.neuropsychologia.2007.12.013; Sarmiento ELP, 2007, BRASILIA MED, V44, P24; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Satler C, 2011, DEMENT GER COGN D EX, V1, P124, DOI 10.1159/000329155; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Simon HA, 1990, F COGNITIVE SCI, P1; Sousa Rilva Lopes de, 2007, J. bras. psiquiatr., V56, P102, DOI 10.1590/S0047-20852007000200005; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Squire LR, 2009, J NEUROSCI, V29, P12711, DOI 10.1523/JNEUROSCI.3575-09.2009; Storey J., 2010, INT ENCY STAT SCI, V1, P1; Sutton SK, 2000, NEUROPSYCHOLOGIA, V38, P1723, DOI 10.1016/S0028-3932(00)00076-2; SUZUKI S, 1995, J EXP PSYCHOL HUMAN, V21, P901, DOI 10.1037/0096-1523.21.4.901; Thomas RC, 2006, PSYCHOL AGING, V21, P821, DOI 10.1037/0882-7974.21.4.821; Tisserand DJ, 2003, CORTEX, V39, P1107, DOI 10.1016/S0010-9452(08)70880-3; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272	98	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75778	10.1371/journal.pone.0075778	http://dx.doi.org/10.1371/journal.pone.0075778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069447	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300097
J	Mehta, D; Satyanarayana, T				Mehta, Deepika; Satyanarayana, Tulasi			Dimerization Mediates Thermo-Adaptation, Substrate Affinity and Transglycosylation in a Highly Thermostable Maltogenic Amylase of Geobacillus thermoleovorans	PLOS ONE			English	Article							N-TERMINAL DOMAIN; ALPHA-AMYLASE; ENZYMATIC CHARACTERIZATION; DEGRADING ENZYMES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BETA-AMYLASE; SWISS-MODEL; CYCLODEXTRINS; PURIFICATION	Background: Maltogenic amylases belong to a subclass of cyclodextrin-hydrolyzing enzymes and hydrolyze cyclodextrins more efficiently than starch unlike typical alpha-amylases. Several bacterial malto-genic amylases with temperature optima of 40-60 degrees C have been previously characterized. The thermo-adaption, substrate preferences and transglycosylation aspects of extremely thermostable bacterial maltogenic amylases have not yet been reported. Methodology/Principal Findings: The recombinant monomeric and dimeric forms of maltogenic a-amylase (Gt-Mamy) of the extremely thermophilic bacterium Geobacillus thermoleovorans are of 72.5 and 145 kDa, which are active optimally at 80 degrees C. Extreme thermostability of this enzyme has been explained by analyzing far-UV CD spectra. Dimerization increases T-1/2 of Gt-Mamy from 8.2 h to 12.63 h at 90 degrees C and mediates its enthalpy-driven conformational thermostabilization. Furthermore, dime-rization regulates preferential substrate binding of the enzyme. The substrate preference switching of Gt-Mamy upon dimerization has been confirmed from the substrate-binding affinities of the enzyme for various high and low molecular weight substrates. There is an alteration in Km and substrate hydrolysis efficiency (V-max/K-m) of the enzyme (for cyclodex-trins/starch) upon dimerization. N-terminal truncation indicated the role of N-terminal 128 amino acids in the thermostabilization and modulation of substrate-binding affinity. This has been confirmed by molecular docking of beta-cyclodextrin to Gt-Mamy that indicated the requirement of homodimer formation by the interaction of a few N-terminal residues of chain A with the catalytic residues of (alpha/beta)(8) barrel of chain B and vice-versa for stable cyclodextrin binding. Site directed mutagenesis provided evidence for the role of N-terminal D109 at the dimeric interface in substrate affinity modulation and thermostabilization. The dimeric Gt-Mamy transglycosylates hydrolytic products of G4/G5 and acarbose, while the truncated form does not because of the lack of extra sugar-binding space formed due to dimerization. Conclusion/Significance: N-terminal domain controls enthalpy-driven thermostabilization, substrate-binding affinity and transglycosylation activity of Gt-Mamy by homodimer formation.	[Mehta, Deepika; Satyanarayana, Tulasi] Univ Delhi, Dept Microbiol, New Delhi, India	University of Delhi	Satyanarayana, T (corresponding author), Univ Delhi, Dept Microbiol, South Campus, New Delhi, India.	tsnarayana@gmail.com			CSIR (Council of Scientific and Industrial Research), New Delhi, India [37(1394)/10/EMR-II]	CSIR (Council of Scientific and Industrial Research), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	The work is funded by CSIR (Council of Scientific and Industrial Research), New Delhi, India. The grant no. is 37(1394)/10/EMR-II. The URL of the funder is www.csir.res.in/home.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bazzicalupo M., 1996, SPECIES DIAGNOSTICS, P155, DOI [10.1385/0-89603-323-6:155, DOI 10.1385/0-89603-323-6:155]; Bikadi Z, 2006, J CHEMINFORMATICS, V1, P15; Bruins ME, 2001, APPL BIOCHEM BIOTECH, V90, P155, DOI 10.1385/ABAB:90:2:155; Cha HJ, 1998, EUR J BIOCHEM, V253, P251, DOI 10.1046/j.1432-1327.1998.2530251.x; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Derde LJ, 2012, FOOD CHEM, V135, P713, DOI 10.1016/j.foodchem.2012.05.031; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kamitori S, 1999, J MOL BIOL, V287, P907, DOI 10.1006/jmbi.1999.2647; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Kim JW, 2007, BBA-PROTEINS PROTEOM, V1774, P661, DOI 10.1016/j.bbapap.2007.03.010; Kim TJ, 2001, BIOCHEMISTRY-US, V40, P14182, DOI 10.1021/bi015531u; Kolcuoglu Y, 2010, PROCESS BIOCHEM, V45, P821, DOI 10.1016/j.procbio.2010.02.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li D, 2010, NEW BIOTECHNOL, V27, P300, DOI 10.1016/j.nbt.2010.04.001; Li F, 2011, ACTA BIOCH BIOPH SIN, V43, P324, DOI 10.1093/abbs/gmr013; Li XL, 2010, APPL MICROBIOL BIOT, V85, P1821, DOI 10.1007/s00253-009-2190-6; Li X, 2012, FEMS MICROBIOL LETT, V329, P204, DOI 10.1111/j.1574-6968.2012.02522.x; Liu B, 2006, ENZYME MICROB TECH, V39, P805, DOI 10.1016/j.enzmictec.2006.01.003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Mehta D, 2013, J MOL CATAL B-ENZYM, V85-86, P229, DOI 10.1016/j.molcatb.2012.08.017; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Oh KW, 2005, FEMS MICROBIOL LETT, V252, P175, DOI 10.1016/j.femsle.2005.08.050; Park KH, 2002, BIOLOGIA, V57, P87; Park SH, 2007, BIOSCI BIOTECH BIOCH, V71, P1564, DOI 10.1271/bbb.70017; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Rao JLUM, 2007, APPL BIOCHEM BIOTECH, V142, P179, DOI 10.1007/s12010-007-0017-4; SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19; VANGRYSPERRE W, 1989, BIOCHEM J, V260, P163, DOI 10.1042/bj2600163; Yang SJ, 2004, APPL ENVIRON MICROB, V70, P5988, DOI 10.1128/AEM.70.10.5988-5995.2004	32	25	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73612	10.1371/journal.pone.0073612	http://dx.doi.org/10.1371/journal.pone.0073612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069213	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300014
J	Yu, J; Wang, L; Weng, SJ; Yang, XL; Zhang, DQ; Zhong, YM				Yu, Jun; Wang, Lu; Weng, Shi-Jun; Yang, Xiong-Li; Zhang, Dao-Qi; Zhong, Yong-Mei			Hyperactivity of ON-Type Retinal Ganglion Cells in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; OSCILLATORY POTENTIALS; MAINTAINED ACTIVITY; JUVENILE DIABETICS; DARK-ADAPTATION; GLIAL CHANGES; MOUSE RETINA; RETINOPATHY; RATS; ELECTRORETINOGRAM	Impairment of visual function has been detected in the early stage of diabetes but the underlying neural mechanisms involved are largely unknown. Morphological and functional alterations of retinal ganglion cells, the final output neurons of the vertebrate retina, are thought to be the major cause of visual defects in diabetes but direct evidence to support this notion is limited. In this study we investigated functional changes of retinal ganglion cells in a type 1-like diabetic mouse model. Our results demonstrated that the spontaneous spiking activity of ON-type retinal ganglion cells was increased in streptozotocin-diabetic mice after 3 to 4 months of diabetes. At this stage of diabetes, no apoptotic signals or cell loss were detected in the ganglion cell layer of the retina, suggesting that the functional alterations in ganglion cells occur prior to massive ganglion cell apoptosis. Furthermore, we found that the increased activity of ON-type ganglion cells was mainly a result of reduced inhibitory signaling to the cells in diabetes. This novel mechanism provides insight into how visual function is impaired in diabetic retinopathy.	[Yu, Jun; Wang, Lu; Weng, Shi-Jun; Yang, Xiong-Li; Zhong, Yong-Mei] Fudan Univ, Inst Neurobiol, Inst Brain Sci, Shanghai 200433, Peoples R China; [Yu, Jun; Wang, Lu; Weng, Shi-Jun; Yang, Xiong-Li; Zhong, Yong-Mei] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Zhang, Dao-Qi] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA	Fudan University; Fudan University; Oakland University	Zhang, DQ (corresponding author), Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA.	zhang@oakland.edu; ymzhong@fudan.edu.cn			National Program of Basic Research; Ministry of Science and Technology of China [2011CB504602]; National Natural Science Foundation of China [31070967, 31171055, 30930034, 31121061]; 211 Project; Ministry of Education of China; U.S. Midwest Eye-Banks Research Award	National Program of Basic Research(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 211 Project(Anhui UniversityMinistry of Education, China); Ministry of Education of China(Ministry of Education, China); U.S. Midwest Eye-Banks Research Award	This work was supported by grants from the National Program of Basic Research sponsored by the Ministry of Science and Technology of China (2011CB504602), the National Natural Science Foundation of China (31070967, 31171055, 30930034, 31121061), the 211 Project sponsored by the Ministry of Education of China, and a U.S. Midwest Eye-Banks Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Relevant URLs: 1) http://www.most.gov.cn/eng/ 2)http://www.nsfc.gov.cn/Portal0/default152.htm 3)http://www.moe.gov.cn/publicfiles/business/htmlfiles/moe/moe_2792/index.html 4)http://www.mebtc.org/	Asnaghi V, 2003, DIABETES, V52, P506, DOI 10.2337/diabetes.52.2.506; Atkinson CL, 2013, J NEUROPHYSIOL, V109, P1589, DOI 10.1152/jn.00786.2012; Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BLOODWORTH JMB, 1962, DIABETES, V11, P1; Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; BRESNICK GH, 1987, ARCH OPHTHALMOL-CHIC, V105, P810; Bui BV, 2009, EXP EYE RES, V88, P1076, DOI 10.1016/j.exer.2009.01.009; CAPUTO S, 1990, DIABETES CARE, V13, P412, DOI 10.2337/diacare.13.4.412; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Ewing FME, 1998, ENDOCR REV, V19, P462, DOI 10.1210/er.19.4.462; Farajian R, 2011, J PHYSIOL-LONDON, V589, P4473, DOI 10.1113/jphysiol.2011.213371; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Gastinger MJ, 2008, INVEST OPHTH VIS SCI, V49, P2635, DOI 10.1167/iovs.07-0683; GLICKMAN RD, 1982, BRAIN RES, V234, P81, DOI 10.1016/0006-8993(82)90474-7; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRUNWALD JE, 1995, BRIT J OPHTHALMOL, V79, P735, DOI 10.1136/bjo.79.8.735; Han Y, 2004, INVEST OPHTH VIS SCI, V45, P948, DOI 10.1167/iovs.03-1101; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; Hardikar AA, 1999, DIABETES RES CLIN PR, V46, P203, DOI 10.1016/S0168-8227(99)00098-4; IKEDA H, 1992, EUR J PHARMACOL, V210, P53; JUEN S, 1990, ARCH OPHTHALMOL-CHIC, V108, P372, DOI 10.1001/archopht.1990.01070050070033; Kern TS, 2008, J PHYSIOL-LONDON, V586, P4401, DOI 10.1113/jphysiol.2008.156695; Kern TS, 1996, ARCH OPHTHALMOL-CHIC, V114, P986, DOI 10.1001/archopht.1996.01100140194013; Kizawa J, 2006, JPN J OPHTHALMOL, V50, P367, DOI 10.1007/s10384-006-0326-0; Klein R, 1995, DIABETES AM; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; KUFFLER SW, 1957, J GEN PHYSIOL, V40, P683, DOI 10.1085/jgp.40.5.683; Layton CJ, 2007, GRAEF ARCH CLIN EXP, V245, P1335, DOI 10.1007/s00417-006-0506-0; Li Q, 2002, EXP EYE RES, V74, P615, DOI 10.1006/exer.2002.1170; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Mahamed DA, 2005, DIABETES, V54, P1477, DOI 10.2337/diabetes.54.5.1477; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MERIMEE TJ, 1990, NEW ENGL J MED, V322, P978, DOI 10.1056/NEJM199004053221406; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Phipps JA, 2006, INVEST OPHTH VIS SCI, V47, P3187, DOI 10.1167/iovs.05-1493; PRAGER TC, 1990, AM J OPHTHALMOL, V109, P279, DOI 10.1016/S0002-9394(14)74550-7; RERUP C C, 1970, Pharmacological Reviews, V22, P485; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; SAKAI H, 1995, OPHTHALMIC RES, V27, P57, DOI 10.1159/000267571; Sato Sakura, 2006, Nihon Rinsho, VSuppl 3, P161; Seki M, 2004, DIABETES, V53, P2412, DOI 10.2337/diabetes.53.9.2412; Shinoda K, 2007, CLIN EXP OPHTHALMOL, V35, P847, DOI 10.1111/j.1442-9071.2007.01607.x; SIMONSEN SE, 1980, ACTA OPHTHALMOL, V58, P865; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Strang CE, 2005, AM J PHYSIOL-CELL PH, V289, pC644, DOI 10.1152/ajpcell.00633.2004; Strang CE, 2003, VISUAL NEUROSCI, V20, P651, DOI 10.1017/S0952523803206076; Sugimoto M, 2005, OPHTHALMOLOGICA, V219, P379, DOI 10.1159/000088382; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Tzekov R, 1999, SURV OPHTHALMOL, V44, P53, DOI 10.1016/S0039-6257(99)00063-6; WACHTMEISTER L, 1980, ACTA OPHTHALMOL, V58, P712; WOLTER JR, 1961, AM J OPHTHALMOL, V51, P1123; Xiao CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030343; Yang Y, 2012, MOL VIS, V18, P1411	60	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76049	10.1371/journal.pone.0076049	http://dx.doi.org/10.1371/journal.pone.0076049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069457	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300104
J	Zhao, YL; Shen, LP; Ma, JC; Gao, Z; Han, X; Qi, SX; Li, Q				Zhao, Yuliang; Shen, Liping; Ma, Jingchen; Gao, Zhao; Han, Xu; Qi, Shunxiang; Li, Qi			Epidemiology of Hepatitis C Virus Infection and Risk Factor Analysis in the Hebei Province, China	PLOS ONE			English	Article							POPULATION	Background: In 1985, a hepatitis C virus (HCV) outbreak caused by plasmapheresis donation was reported in the Hebei Province, China. However, studies assessing the epidemic features and risk factors of HCV in the general population of Hebei have been limited until now. Methods: The multicenter cluster sampling method was used to collect samples. The participants were interviewed. Relevant information was obtained from the general population using a standardized questionnaire, and association and logistic regression analyses were conducted. Serum samples were taken to test anti-HCV by enzyme immunoassays. Results: A total of 4562 participants from 11 cities of the Hebei Province were enrolled. The average anti-HCV positive rate was 0.62% (29/4562), which was 1.07% in the rural population, compared with 0.22% in the urban population. The anti-HCV positive rate in the 40-59-year age group was higher than in those aged <40 years. History of blood transfusion and transmission in families were the main risk factors for HCV infection in this area. Conclusion: The anti-HCV positive rate in Hebei has decreased significantly from that two decades ago. Safety of blood products and health education about HCV still need to be improved.	[Zhao, Yuliang; Ma, Jingchen; Gao, Zhao; Han, Xu; Qi, Shunxiang; Li, Qi] Ctr Dis Control & Prevent Hebei Prov, Shijiazhuang, Peoples R China; [Shen, Liping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Li, Q (corresponding author), Ctr Dis Control & Prevent Hebei Prov, Shijiazhuang, Peoples R China.	liqinew67@163.com			Important Program for Hebei Committee of Science and Technology named 'Study on Viral Hepatitis Control and Prevention [10276102D]	Important Program for Hebei Committee of Science and Technology named 'Study on Viral Hepatitis Control and Prevention	This study was supported by the Important Program for Hebei Committee of Science and Technology named 'Study on Viral Hepatitis Control and Prevention(10276102D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, WKLY EPIDEMIOL REC, V72, P341; Chandra Madhavi, 2003, Trop Gastroenterol, V24, P193; Chen Yuan-Ding, 2002, Hepatobiliary Pancreat Dis Int, V1, P194; Dai Z QG, 1995, VIRAL HEPATITIS CHIN; KANG LY, 1997, CHIN J INFECT DIS, V15, P71; Li D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054815; Liu FF, 2009, EMERG INFECT DIS, V15, P1819, DOI [10.3201/eid1511.0900263, 10.3201/eid1511.090263]; MENG ZD, 1991, CHINESE MED J-PEKING, V104, P494; Peng JS, 2008, VIRUS RES, V135, P191, DOI 10.1016/j.virusres.2008.01.017; Prati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SUN YD, 1991, CHINESE MED J-PEKING, V104, P975; Uhanova J, 2012, J HEPATOL, V57, P736, DOI 10.1016/j.jhep.2012.05.018; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3	15	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75586	10.1371/journal.pone.0075586	http://dx.doi.org/10.1371/journal.pone.0075586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069430	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300086
J	Frikke-Schmidt, H; Pedersen, TA; Fledelius, C; Olsen, GS; Hellerstein, M				Frikke-Schmidt, Henriette; Pedersen, Thomas Askov; Fledelius, Christian; Olsen, Grith Skytte; Hellerstein, Marc			Adipose Weight Gain during Chronic Insulin Treatment of Mice Results from Changes in Lipid Storage without Affecting De Novo Synthesis of Palmitate	PLOS ONE			English	Article							DIABETIC RATS; IN-VIVO; GLUCOSE; TISSUE; TRANSCRIPTION; LIPOGENESIS; EXPRESSION; TRANSPORT; TURNOVER; THERAPY	Insulin treatment is associated with increased adipose mass in both humans and mice. However, the underlying dynamic basis of insulin induced lipid accumulation in adipose tissue remains elusive. To assess this, young female C57BL6/J mice were fed a low fat diet for 3 weeks, treated subsequently with 7 days of constant subcutaneous insulin infusion by osmotic minipumps and compared to mice with only buffer infused. To track changes in lipid deposition during insulin treatment, metabolic labeling was conducted with heavy water for the final 4 days. Blood glucose was significantly lowered within one hour after implantation of insulin loaded mini pumps and remained lower throughout the study. Insulin treated animals gained significantly more weight during treatment and the mean weight of the subcutaneous adipose depots was significantly higher with the highest dose of insulin. Surprisingly, de novo palmitate synthesis within the subcutaneous and the gonadal depots was not affected significantly by insulin treatment. In contrast insulin treatment caused accumulation of triglycerides in both depots due to either deposition of newly synthesised triglycerides (subcutaneous depot) or inhibition of lipolysis (gonadal depot).	[Frikke-Schmidt, Henriette; Hellerstein, Marc] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Frikke-Schmidt, Henriette; Pedersen, Thomas Askov; Olsen, Grith Skytte] Novo Nordisk AS, Dept Insulin Biol, Malov, Denmark; [Fledelius, Christian] Novo Nordisk AS, Dept Insulin Pharmacol, Malov, Denmark; [Hellerstein, Marc] KineMed Inc, Emeryville, CA USA	University of California System; University of California Berkeley; Novo Nordisk; Novo Nordisk	Hellerstein, M (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	march@berkeley.edu			Novo Nordisk A/S	Novo Nordisk A/S(Novo Nordisk)	The authors declare that the study was funded by Novo Nordisk A/S through which the authors HF-S, TAP, GSO, and CF all are employees and stakeholders. The insulin used for the experiments has been provided by Novo Nordisk A/S. All Intellectual Property Rights of the current study are owned by University of California Berkeley and there has been no compromise of the objectivity or validity of the data in the manuscript. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chen M, 2006, PEDIATR SURG INT, V22, P647, DOI 10.1007/s00383-006-1704-x; DANI C, 1989, MOL CELL ENDOCRINOL, V63, P199, DOI 10.1016/0303-7207(89)90096-8; Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6; FRIEDMAN MI, 1994, PHYSIOL BEHAV, V56, P373, DOI 10.1016/0031-9384(94)90209-7; Giorgino F, 2005, ACTA PHYSIOL SCAND, V183, P13, DOI 10.1111/j.1365-201X.2004.01385.x; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Heller S, 2004, DIABETES RES CLIN PR, V65, pS23, DOI 10.1016/j.diabres.2004.07.005; HELLERSTEIN MK, 1993, AM J PHYSIOL, V265, pE814, DOI 10.1152/ajpendo.1993.265.5.E814; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Kahn BB, 1996, DIABETES, V45, P1644, DOI 10.2337/diabetes.45.11.1644; Pu QH, 2009, AM J PHYSIOL-HEART C, V296, pH132, DOI 10.1152/ajpheart.00370.2008; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scherer T, 2011, REV ENDOCR METAB DIS, V12, P235, DOI 10.1007/s11154-011-9190-4; Sorisky A, 1999, CRIT REV CL LAB SCI, V36, P1, DOI 10.1080/10408369991239169; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Tobin BW, 2000, CAN J PHYSIOL PHARM, V78, P622, DOI 10.1139/cjpp-78-8-622; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298	20	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e76060	10.1371/journal.pone.0076060	http://dx.doi.org/10.1371/journal.pone.0076060			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069458	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300097
J	Miao, RZ; Guo, XB; Zhi, QM; Shi, YL; Li, LP; Mao, XH; Zhang, L; Li, CS				Miao, Ruizhen; Guo, Xiaobo; Zhi, Qiaoming; Shi, Yulong; Li, Leping; Mao, Xuehui; Zhang, Li; Li, Chensheng			VEZT, a Novel Putative Tumor Suppressor, Suppresses the Growth and Tumorigenicity of Gastric Cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CPG ISLAND METHYLATION; PROMOTER METHYLATION; GENE-EXPRESSION; EPIGENETIC MECHANISMS; TRANSCRIPTION FACTOR; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; DNA METHYLATION; DOWN-REGULATION	Vezatin (VEZT), an adherens junctions transmembrane protein, was identified as a putative tumor suppressor in our previous study. However, the role of VEZT in tumorigenesis remains elusive. We aimed to clarify its epigenetic regulation and biological functions in gastric cancer. In this study, we show that the expression level of VEZT is involved in lymphatic metastasis, depth of cancer invasion and TNM stage in 104 gastric cancer patients. Bisulfate sequencing polymerase chain reaction (BSP) methods showed that VEZT was hypermethylated in tissues and corresponding blood of gastric cancer patients compared with healthy controls. Helicobacter pylori (H. pylori) infection induces the methylation and silencing of VEZT in GES-1 cells. Restoring VEZT expression in MKN-45 and NCI-N87 gastric cancer cells inhibited growth, invasion and tumorigenesis in vitro and in vivo. Global microarray analysis was applied to analyze the molecular basis of the biological functions of VEZT after VEZT transfection combined with real-time PCR and chromatin immunoprecipitation assay. G protein-coupled receptor 56(GPR56), cell growth, cell division cycle 42(CDC42), migration/invasion and transcription factor 19(TCF19), cell cycle progression, were identified as direct VEZT target genes. TCF19, a novel target of VEZT, was functionally validated. Overexpression of TCF19 in MKN-45 cells increased cell cycle progress and growth ability. This study provides novel insight into the regulation of the VEZT gene, which could represent a potential target for therapeutic anti-cancer strategies.	[Miao, Ruizhen; Guo, Xiaobo; Shi, Yulong; Li, Leping; Mao, Xuehui; Zhang, Li; Li, Chensheng] Shandong Univ, Prov Hosp, Dept Gastrointestinal Surg, Jinan 250100, Shandong, Peoples R China; [Zhi, Qiaoming] Soochow Univ, Affiliated Hosp 1, Dept Gen Surg, Suzhou, Jiangsu, Peoples R China	Shandong University; Soochow University - China	Guo, XB (corresponding author), Shandong Univ, Prov Hosp, Dept Gastrointestinal Surg, Jinan 250100, Shandong, Peoples R China.	guo992352@hotmail.com; shiyl9889@126.com; lileping@medmail.com.cn		Li, Leping/0000-0003-2329-6791	National Youthful Science Foundation of China [81101858]; Natural Science Foundation of Shandong Province of China [ZR2011HM041, Y2007C102, ZR2011HM076]; Shandong Science and Technology Commission [2011GGB14158, 2007H2071]; Youthful Science Foundation of Shandong Province of China [BS2010YY060]	National Youthful Science Foundation of China; Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province); Shandong Science and Technology Commission; Youthful Science Foundation of Shandong Province of China	This work was supported in part by grants from the National Youthful Science Foundation of China (81101858), the Natural Science Foundation of Shandong Province of China (ZR2011HM041, Y2007C102, ZR2011HM076), Key Research Project from Shandong Science and Technology Commission (2011GGB14158, 2007H2071), the Youthful Science Foundation of Shandong Province of China (BS2010YY060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahloul A, 2009, EMBO MOL MED, V1, P125, DOI 10.1002/emmm.200900015; Banham AH, 2001, CANCER RES, V61, P8820; Becker KF, 2000, SURG ONCOL, V9, P5, DOI 10.1016/S0960-7404(00)00016-5; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Chan AOO, 2003, GUT, V52, P502, DOI 10.1136/gut.52.4.502; Chemin K, 2012, J IMMUNOL, V189, P2159, DOI 10.4049/jimmunol.1200156; Choi IS, 2005, CELL RES, V15, P247, DOI 10.1038/sj.cr.7290293; Danglot L, 2012, J NEUROSCI, V32, P9007, DOI 10.1523/JNEUROSCI.3084-11.2012; Ding SZ, 2010, FUTURE ONCOL, V6, P851, DOI [10.2217/fon.10.37, 10.2217/FON.10.37]; Dong CX, 2009, INT J CANCER, V124, P434, DOI 10.1002/ijc.23891; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Elbediwy A, 2012, J CELL BIOL, V198, P677, DOI 10.1083/jcb.201202094; Eslick GD, 1999, AM J GASTROENTEROL, V94, P2373, DOI 10.1111/j.1572-0241.1999.01360.x; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Garinis GA, 2002, HUM GENET, V111, P115, DOI 10.1007/s00439-002-0783-6; Gigek CO, 2012, EPIGENOMICS-UK, V4, P279, DOI [10.2217/EPI.12.22, 10.2217/epi.12.22]; GRAHAM DY, 1992, ANN INTERN MED, V116, P705, DOI 10.7326/0003-4819-116-9-705; Guo W, 2009, EUR J MED RES, V14, P453; Guo X, 2010, ONCOGENE, V29, P3908, DOI 10.1038/onc.2010.143; Guo XB, 2011, J GASTROEN HEPATOL, V26, P1685, DOI 10.1111/j.1440-1746.2011.06808.x; Guo XB, 2011, WORLD J GASTROENTERO, V17, P1895, DOI 10.3748/wjg.v17.i14.1895; Guo XB, 2011, BIOCHEM BIOPH RES CO, V404, P622, DOI 10.1016/j.bbrc.2010.12.026; Guo XB, 2010, BIOCHEM BIOPH RES CO, V398, P1, DOI 10.1016/j.bbrc.2010.05.082; Hyenne V, 2005, DEV BIOL, V287, P180, DOI 10.1016/j.ydbio.2005.09.004; Hyenne V, 2007, MECH DEVELOP, V124, P449, DOI 10.1016/j.mod.2007.03.004; Hyenne V, 2007, REPRODUCTION, V133, P563, DOI 10.1530/REP-06-0271; Jiang J, 2011, ONCOGENE, V30, P4498, DOI 10.1038/onc.2011.154; Jones PA, 2003, ANN NY ACAD SCI, V983, P213, DOI 10.1111/j.1749-6632.2003.tb05976.x; Kang GH, 2003, LAB INVEST, V83, P519, DOI 10.1097/01.LAB.0000064704.53132.65; Katayama Y, 2009, BIOCHEM BIOPH RES CO, V388, P496, DOI 10.1016/j.bbrc.2009.08.003; Kitajima Y, 2008, ONCOL REP, V19, P197; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; KU DH, 1991, CELL GROWTH DIFFER, V2, P179; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Lee JH, 2004, ONCOGENE, V23, P4646, DOI 10.1038/sj.onc.1207588; Liu ZF, 2006, J MED MICROBIOL, V55, P1009, DOI 10.1099/jmm.0.46456-0; Luo DY, 2006, LAB INVEST, V86, P591, DOI 10.1038/labinvest.3700415; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Mirshahi P, 2009, LEUKEMIA, V23, P1039, DOI 10.1038/leu.2009.10; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Perez-Diez A, 2007, ADV EXP MED BIOL, V593, P74; Peterson AJ, 2010, GASTROENTEROLOGY, V139, P2005, DOI 10.1053/j.gastro.2010.08.043; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Resende C, 2011, HELICOBACTER, V16, P38, DOI 10.1111/j.1523-5378.2011.00879.x; TELFORD JL, 1994, TRENDS BIOTECHNOL, V12, P420, DOI 10.1016/0167-7799(94)90031-0; Thiel A, 2012, HELICOBACTER, V17, P26, DOI 10.1111/j.1523-5378.2012.00979.x; Tsuji S, 2006, WORLD J GASTROENTERO, V12, P1671, DOI 10.3748/wjg.v12.i11.1671; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Ushijima T, 2006, J GASTROENTEROL, V41, P401, DOI 10.1007/s00535-006-1846-6; Xu L, 2010, ADV EXP MED BIOL, V706, P98; Xu L, 2010, CLIN EXP METASTAS, V27, P241, DOI 10.1007/s10585-010-9322-3; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yang LQ, 2012, FUTURE ONCOL, V8, P431, DOI [10.2217/FON.12.27, 10.2217/fon.12.27]	55	25	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74409	10.1371/journal.pone.0074409	http://dx.doi.org/10.1371/journal.pone.0074409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069310	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300041
J	Nishi, H; Sakaguchi, T; Miyagawa, S; Yoshikawa, Y; Fukushima, S; Saito, S; Ueno, T; Kuratani, T; Sawa, Y				Nishi, Hiroyuki; Sakaguchi, Taichi; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Saito, Shunsuke; Ueno, Takayoshi; Kuratani, Toru; Sawa, Yoshiki			Impact of microRNA Expression in Human Atrial Tissue in Patients with Atrial Fibrillation Undergoing Cardiac Surgery	PLOS ONE			English	Article							HEART-FAILURE; FIBROSIS; CONTRIBUTES; MIR-21	Background: Although microRNA (miRNA) regulates initiation and/or progression of atrial fibrillation (AF) in canine AF models, the underlying mechanism in humans remains unclear. We speculated that certain miRNAs in atrial tissue are related to AF, and evaluated the relationship of miRNA expression in human atrial tissue in cardiac surgery patients. Methods: Right atrial tissues from 29 patients undergoing cardiovascular surgery were divided into 3 groups [A: chronic AF or unsuccessful maze, n=6; B: successful maze, n=10; C: sinus rhythm (SR) n=13]. miRNA expression was determined using high density microarrays and with Reverse transcriptase-polymerase chain reaction (RT-PCR). Fibrosis was examined using Masson trichrome staining. Results: miRNA microarray analysis showed elevated miRNA-21, miRNA-23b, miRNA-199b, and miRNA-208b in AF as compared to SR groups. RT-PCR showed elevated miRNA-21 (1.9-fold) and miRNA-208b (4.2-fold) in AF as compared to the SR groups. miRNA-21 expression increased from Group C to A (A: 2.1-fold, B: 1.8-fold, C: 1.0-fold). Fibrosis increased from C to A (A: 43.0 +/- 12.9%, B: 21.3 +/- 6.1%, C: 11.9 +/- 3.1%). Percent fibrosis and miRNA-21 expression were correlated (r=0.508, p<0.05). The plasma levels of miRNA-21 in AF patients was significantly decreased as compared to the healthy volunteers (p<0.05). Conclusion: The expression of miRNA-21 in human atrial tissue was found to be related to atrial fibrosis and might affect AF occurrence, indicating its usefulness as a biomarker for cardiac surgery management.	[Nishi, Hiroyuki; Sakaguchi, Taichi; Miyagawa, Shigeru; Yoshikawa, Yasushi; Fukushima, Satsuki; Saito, Shunsuke; Ueno, Takayoshi; Kuratani, Toru; Sawa, Yoshiki] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Osaka, Japan	Osaka University	Sawa, Y (corresponding author), Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Osaka, Japan.	sawa-p@surg1.osaka-u.med.ac.jp	Fukushima, Satsuki/ABE-6582-2020; Sakaguchi, Taichi/ABF-7767-2020	Fukushima, Satsuki/0000-0002-9481-8860; Sakaguchi, Taichi/0000-0002-8733-0533; Miyagawa, Shigeru/0000-0003-0015-6569	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23659668]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded in part by a grant-in-aid for Scientific Research (23659668) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0278-0; Bauer A, 2004, CARDIOVASC RES, V61, P764, DOI 10.1016/j.cardiores.2003.12.013; Cardin S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1027, DOI 10.1161/CIRCEP.112.973214; Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644; COX JL, 1995, J THORAC CARDIOV SUR, V110, P485, DOI 10.1016/S0022-5223(95)70245-8; Damiano RJ, 2011, J THORAC CARDIOV SUR, V141, P113, DOI 10.1016/j.jtcvs.2010.08.067; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gaudino M, 2003, CIRCULATION, V108, P195, DOI 10.1161/01.cir.0000087441.48566.0d; Goette A, 2002, CARDIOVASC RES, V54, P390, DOI 10.1016/S0008-6363(02)00251-1; Kainuma S, 2011, EUR J CARDIO-THORAC, V40, P61, DOI 10.1016/j.ejcts.2010.11.008; Latronico MVG, 2007, CIRC RES, V101, P1225, DOI 10.1161/CIRCRESAHA.107.163147; Latronico MVG, 2008, PHYSIOL GENOMICS, V34, P239, DOI 10.1152/physiolgenomics.90254.2008; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044906; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Murphy NF, 2007, HEART, V93, P606, DOI 10.1136/hrt.2006.107573; Nakai T, 2007, CARDIOLOGY, V108, P90, DOI 10.1159/000095936; Oakes RS, 2009, CIRCULATION, V119, P1758, DOI 10.1161/CIRCULATIONAHA.108.811877; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Wang ZG, 2011, CARDIOVASC RES, V89, P710, DOI 10.1093/cvr/cvq350; Xiao JJ, 2011, PHYSIOL GENOMICS, V43, P655, DOI 10.1152/physiolgenomics.00139.2010; Yang B, 2007, NAT MED, V212, P358	25	42	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73397	10.1371/journal.pone.0073397	http://dx.doi.org/10.1371/journal.pone.0073397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069193	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100042
J	Zhang, PJ; Li, CH; Zhu, L; Su, XR; Li, Y; Jin, CH; Li, TW				Zhang, Pengjuan; Li, Chenghua; Zhu, Lin; Su, Xiurong; Li, Ye; Jin, Chunhua; Li, Taiwu			De Novo Assembly of the Sea Cucumber Apostichopus japonicus Hemocytes Transcriptome to Identify miRNA Targets Associated with Skin Ulceration Syndrome	PLOS ONE			English	Article							RNA-SEQ; EXPRESSION ANALYSIS; MANNOSE RECEPTOR; MICRORNAS; GENE; LIPOPOLYSACCHARIDE; IDENTIFICATION; PROTEIN; TOPHAT; CELLS	Background: De novo transcriptome sequencing is a robust method of predicting miRNA target genes, especially samples without reference genomes. Differentially expressed miRNAs have been previously identified in hemocytes collected from healthy skin and from skin affected by skin ulceration syndrome (SUS) in Apostichopus japonicus. Target identification for these differentially expressed miRNAs is a major challenge for this non-model organism. Methodology/Principal Findings: To thoroughly understand the function of miRNAs, a normalized cDNA library was sequenced with the Illumina Hiseq2000 technology. A total of 91,098,474 clean reads corresponding to 251,148 unigenes, each with an average length of 494bp, were obtained. Blastx analysis against a nonredundant (nr) NCBI protein database revealed that in this set, 52,680 unigenes coded for 3,893 annotated proteins. Two digital gene expression (DGE) libraries from healthy and SUS samples showed that 4,858 of the unigenes were expressed at significantly different levels; 2,163 were significantly up-regulated, while 2,695 were significantly down-regulated. The computational prediction of miRNA targets from these differentially expressed genes identified 732 unigenes as the targets of 57 conserved and 8 putative novel miRNA families, including spu-miRNA-31 and spu-miRNA-2008. Conclusion: This study demonstrates the feasibility of identifying miRNA targets by transcriptome analysis. The DGE assembly data represent a substantial increase in the genomic resources available for this species and will provide insights into the gene expression profile analysis and the miRNAs function annotations of further studies.	[Zhang, Pengjuan; Li, Chenghua; Zhu, Lin; Su, Xiurong; Li, Ye; Jin, Chunhua] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China; [Li, Taiwu] Ningbo City Coll Vocat Technol, Ningbo, Zhejiang, Peoples R China	Ningbo University; Ningbo City College of Vocational Technology	Li, CH (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.	chli@yic.ac.cn	Li, Chenghua/L-9825-2019	Li, Chenghua/0000-0003-2978-8762	NSFC [31101919, 41216120]; K. C. Wong Magna Fund at Ningbo University	NSFC(National Natural Science Foundation of China (NSFC)); K. C. Wong Magna Fund at Ningbo University	This work was financially supported by NSFC grant (31101919 and 41216120), and K. C. Wong Magna Fund at Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandiera S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054791; Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/803069; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; CAO LQ, 1994, GENE, V139, P163, DOI 10.1016/0378-1119(94)90750-1; Cong LN, 2009, J BIOSCI BIOENG, V107, P583, DOI 10.1016/j.jbiosc.2009.01.016; Deng H, 2009, AQUACULTURE, V287, P18, DOI 10.1016/j.aquaculture.2008.10.015; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Enright AJ, 2004, GENOME BIOL, V5; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graveley BR, 2008, NATURE, V453, P1197, DOI 10.1038/4531197b; Han LL, 2012, IMMUNOL LETT, V143, P137, DOI 10.1016/j.imlet.2011.12.004; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Liu HZ, 2010, J INVERTEBR PATHOL, V105, P236, DOI 10.1016/j.jip.2010.05.016; Ma HM, 2010, DEV COMP IMMUNOL, V34, P677, DOI 10.1016/j.dci.2010.01.014; Ma Yue-xin, 2006, Dalian Shuichan Xueyuan Xuebao, V21, P13; Mader U, 2011, CURR OPIN BIOTECH, V22, P32, DOI 10.1016/j.copbio.2010.10.003; Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032; Moseley P, 2000, IMMUNOPHARMACOLOGY, V48, P299, DOI 10.1016/S0162-3109(00)00227-7; Muniategui A, 2013, BRIEF BIOINFORM, V14, P263, DOI 10.1093/bib/bbs028; Nazarov PV, 2013, NUCLEIC ACIDS RES, V41, P2817, DOI 10.1093/nar/gks1471; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Qin CJ, 2010, FISH SHELLFISH IMMUN, V29, P195, DOI 10.1016/j.fsi.2010.03.010; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; SHEPHERD VL, 1990, J IMMUNOL, V145, P1530; Sun L, 2011, COMP BIOCHEM PHYS D, V6, P195, DOI 10.1016/j.cbd.2011.03.002; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; van Iterson M, 2013, NUCLEIC ACIDS RES, V41, P2013, DOI [10.1093/nar/gkt525, DOI 10.1093/NAR/GKT525.PUBMED:23771142]; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wieten L, 2007, FEBS LETT, V581, P3716, DOI 10.1016/j.febslet.2007.04.082; Witkos TM, 2011, CURR MOL MED, V11, P93; Xu XL, 2010, EUR J PHARMACOL, V641, P229, DOI 10.1016/j.ejphar.2010.05.021; Yang AF, 2010, FISH SHELLFISH IMMUN, V29, P839, DOI 10.1016/j.fsi.2010.07.023; Zhang Chun-yun, 2006, Journal of Fisheries of China, V30, P118; Zheng FR, 2012, AQUACULTURE, V334, P24, DOI 10.1016/j.aquaculture.2011.11.009; Zhou ZC, 2011, FISH SHELLFISH IMMUN, V31, P540, DOI 10.1016/j.fsi.2011.06.023	44	50	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73506	10.1371/journal.pone.0073506	http://dx.doi.org/10.1371/journal.pone.0073506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069201	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100047
J	Brait, M; Maldonado, L; Noordhuis, M; Begum, S; Loyo, M; Poeta, ML; Barbosa, A; Fazio, V; Angioli, R; Rabitti, C; Marchionni, L; de Graeff, P; van der Zee, AGJ; Wisman, GBA; Sidransky, D; Hoque, MO				Brait, Mariana; Maldonado, Leonel; Noordhuis, Maartje; Begum, Shahnaz; Loyo, Myriam; Poeta, Maria Luana; Barbosa, Alvaro; Fazio, Vitom.; Angioli, Roberto; Rabitti, Carla; Marchionni, Luigi; de Graeff, Pauline; van der Zee, Ate G. J.; Wisman, G. Bea A.; Sidransky, David; Hoque, Mohammad O.			Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression	PLOS ONE			English	Article							PROGNOSTIC-FACTOR; DNA METHYLATION; MULTIPLE GENES; HYPERMETHYLATION; EXPRESSION; TUMORS; IDENTIFICATION; INACTIVATION; EPIGENOMICS; MECHANISMS	Purpose: To elucidate the role of biological and clinical impact of aberrant promoter hypermethylation (PH) in ovarian cancer (OC). Experimental Design: PH of PGP9.5, HIC1, AIM1, APC, PAK3, MGMT, KIF1A, CCNA1, ESR1, SSBP2, GSTP1, FKBP4 and VGF were assessed by quantitative methylation specific PCR (QMSP) in a training set. We selected two genes (VGF and PGP9.5) for further QMSP analysis in a larger independent validation (IV) set with available clinical data. Biologic relevance of VGF gene was also evaluated. Results: PH frequency for PGP9.5 and VGF were 85% (316/372) and 43% (158/366) respectively in the IV set of samples while no PH was observed in controls. In 372 OC cases with available follow up, PGP9.5 and VGF PH were correlated with better patient survival [Hazard Ratios (HR) for overall survival (OS) were 0.59 (95% Confidence Intervals (CI) = 0.42-0.84, p = 0.004), and 0.73 (95% CI = 0.55-0.97, p = 0.028) respectively, and for disease specific survival (DSS) were 0.57 (95% CI 0.39-0.82, p = 0.003) and 0.72 (95% CI 0.54-0.96, p = 0.027). In multivariate analysis, VGF PH remained an independent prognostic factor for OS (HR 0.61, 95% CI 0.43-0.86, p < 0.005) and DSS (HR 0.58, 95% CI 0.41-0.83, p < 0.003). Furthermore, PGP9.5 PH was significantly correlated with lower grade, early stage tumors, and with absence of residual disease. Forced expression of VGF in OC cell lines inhibited cell growth. Conclusions: Our results indicate that VGF and PGP9.5 PH are potential biomarkers for ovarian carcinoma. Confirmatory cohorts with longitudinal follow-up are required in future studies to define the clinical impact of VGF and PGP9.5 PH before clinical application.	[Brait, Mariana; Maldonado, Leonel; Noordhuis, Maartje; Loyo, Myriam; Sidransky, David; Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Brait, Mariana] Brazilian Natl Canc Inst, Inst Nacl Canc INCA, Rio De Janeiro, Brazil; [Noordhuis, Maartje; de Graeff, Pauline; van der Zee, Ate G. J.; Wisman, G. Bea A.] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol Oncol, Groningen, Netherlands; [Begum, Shahnaz] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Poeta, Maria Luana] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Barbosa, Alvaro] Hosp San Jose Tec Monterrey, Dept Pathol, Monterrey, Nuevo Leon, Mexico; [Fazio, Vitom.] Univ Campus Biomed Rome, Mol Med Lab, Rome, Italy; [Fazio, Vitom.] Univ Campus Biomed Rome, Biotechnol Ctr Integrated Res, Rome, Italy; [Angioli, Roberto] Univ Campus Biomed Rome, Dept Gynecol, Rome, Italy; [Rabitti, Carla] Univ Campus Biomed Rome, Dept Pathol, Rome, Italy; [Marchionni, Luigi; Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; National Cancer Institute (Inca); University of Groningen; Johns Hopkins University; Johns Hopkins Medicine; Universita degli Studi di Bari Aldo Moro; Tecnologico de Monterrey; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; Johns Hopkins University; Johns Hopkins University	Hoque, MO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	mhoque1@jhmi.edu	Marchionni, Luigi/S-6774-2017; Fazio, Vito Michele VMF/H-3007-2016; angioli, roberto/K-4172-2016	Marchionni, Luigi/0000-0002-7336-8071; Fazio, Vito Michele VMF/0000-0002-7751-1867; angioli, roberto/0000-0002-8528-4318; Brait, Mariana/0000-0002-1652-8921; POETA, Maria Luana/0000-0002-6364-727X; Hoque, Mohammad Obaidul/0000-0001-6701-9978	Career development award from Specialized Program of Research Excellence [P50 CA098252]; Flight Attendant Medical Research Institute; National Institutes of Health-National Cancer Institute [P30CA006973]; Dutch Cancer Society; Jo Kolk studiefonds; NATIONAL CANCER INSTITUTE [P30CA006973, P50CA098252] Funding Source: NIH RePORTER	Career development award from Specialized Program of Research Excellence; Flight Attendant Medical Research Institute; National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dutch Cancer Society(KWF Kankerbestrijding); Jo Kolk studiefonds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Career development award to Dr. Hoque from Specialized Program of Research Excellence grant P50 CA098252 (PI: T-C Wu). Dr. Hoque and Dr. Begum are supported by a Young Clinical Scientist Award from the Flight Attendant Medical Research Institute. Dr. Marchionni is supported by National Institutes of Health-National Cancer Institute grant P30CA006973. M. G. Noordhuis is a recipient of grants from the Dutch Cancer Society and Jo Kolk studiefonds. The funding agencies had no role in the design of the study, data collection, analysis, interpretation of the results, preparation of the manuscript, or the decision to submit the manuscript for publication.	Akhoondi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2788; [Anonymous], 1971, Acta Obstet Gynecol Scand, V50, P1; Bartolomucci A, 2007, GENES NUTR, V2, P169, DOI 10.1007/s12263-007-0047-0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brait M, 2012, BRIT J CANCER, V106, P414, DOI 10.1038/bjc.2011.468; Brait M, 2008, CANCER EPIDEM BIOMAR, V17, P2786, DOI 10.1158/1055-9965.EPI-08-0192; Brown R, 1997, ONCOGENE, V15, P45, DOI 10.1038/sj.onc.1201167; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Dai W, 2011, CLIN CANCER RES, V17, P4052, DOI 10.1158/1078-0432.CCR-10-3021; de Caceres Inmaculada Ibanez, 2004, Cancer Research, V64, P6476, DOI 10.1158/0008-5472.CAN-04-1529; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fiegl H, 2008, INT J CANCER, V123, P725, DOI 10.1002/ijc.23563; Hahm S, 1999, NEURON, V23, P537, DOI 10.1016/S0896-6273(00)80806-5; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Holloway RW, 2002, GYNECOL ONCOL, V87, P8, DOI 10.1006/gyno.2002.6797; Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009; Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913; Hoque MO, 2008, J UROLOGY, V179, P743, DOI 10.1016/j.juro.2007.09.019; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Liu JW, 2008, CLIN CANCER RES, V14, P3754, DOI 10.1158/1078-0432.CCR-07-4763; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loyo M, 2011, INT J CANCER, V128, P1393, DOI 10.1002/ijc.25443; Makarla PB, 2005, CLIN CANCER RES, V11, P5365, DOI 10.1158/1078-0432.CCR-04-2455; Maldonado L, 2010, BIOMARK MED, V4, P543, DOI 10.2217/BMM.10.72; Mastoraki A, 2009, ARCH DERMATOL RES, V301, P653, DOI 10.1007/s00403-009-0962-6; Mizukami H, 2008, ANTICANCER RES, V28, P2697; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Ostrow KL, 2009, CLIN CANCER RES, V15, P1184, DOI 10.1158/1078-0432.CCR-08-1304; Ozdemir F, 2012, EXP THER MED, V4, P1092, DOI 10.3892/etm.2012.715; Pils D, 2013, CANCER-AM CANCER SOC, V119, P946, DOI 10.1002/cncr.27850; Rathi A, 2002, CLIN CANCER RES, V8, P3324; Rosas SLB, 2001, CANCER LETT, V170, P73, DOI 10.1016/S0304-3835(01)00449-9; Rosenbaum E, 2012, PROSTATE, V72, P1133, DOI 10.1002/pros.22461; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Strathdee G, 2001, AM J PATHOL, V158, P1121, DOI 10.1016/S0002-9440(10)64059-X; Su HY, 2009, INT J CANCER, V124, P387, DOI 10.1002/ijc.23957; Tam KF, 2007, J CANCER RES CLIN, V133, P331, DOI 10.1007/s00432-006-0178-5; Teodoridis JM, 2005, CANCER RES, V65, P8961, DOI 10.1158/0008-5472.CAN-05-1187; Tokumaru Y, 2008, INT J CANCER, V123, P753, DOI 10.1002/ijc.23354; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wegiel B, 2008, JNCI-J NATL CANCER I, V100, P1022, DOI 10.1093/jnci/djn214; Wiley A, 2006, INT J GYNECOL CANCER, V16, P210, DOI 10.1111/j.1525-1438.2006.00299.x; Wiley A, 2006, CANCER-AM CANCER SOC, V107, P299, DOI 10.1002/cncr.21992; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yamashita K, 2006, CANCER RES, V66, P3921, DOI 10.1158/0008-5472.CAN-05-1511; Zeller C, 2013, AM J PATHOL, V182, P668, DOI 10.1016/j.ajpath.2012.11.040	53	29	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e70878	10.1371/journal.pone.0070878	http://dx.doi.org/10.1371/journal.pone.0070878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086249	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900004
J	Razak, SRA; Ueno, K; Takayama, N; Nariai, N; Nagasaki, M; Saito, R; Koso, H; Lai, CY; Murakami, M; Tsuji, K; Michiue, T; Nakauchi, H; Otsu, M; Watanabe, S				Razak, Siti Razila Abdul; Ueno, Kazuko; Takayama, Naoya; Nariai, Naoki; Nagasaki, Masao; Saito, Rika; Koso, Hideto; Lai, Chen-Yi; Murakami, Miyako; Tsuji, Koichiro; Michiue, Tatsuo; Nakauchi, Hiromitsu; Otsu, Makoto; Watanabe, Sumiko			Profiling of MicroRNA in Human and Mouse ES and iPS Cells Reveals Overlapping but Distinct MicroRNA Expression Patterns	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; DIFFERENTIATION; LINES; GENERATION; NAIVE	Using quantitative PCR-based miRNA arrays, we comprehensively analyzed the expression profiles of miRNAs in human and mouse embryonic stem (ES), induced pluripotent stem (iPS), and somatic cells. Immature pluripotent cells were purified using SSEA-1 or SSEA-4 and were used for miRNA profiling. Hierarchical clustering and consensus clustering by nonnegative matrix factorization showed two major clusters, human ES/iPS cells and other cell groups, as previously reported. Principal components analysis (PCA) to identify miRNAs that segregate in these two groups identified miR-187, 299-3p, 499-5p, 628-5p, and 888 as new miRNAs that specifically characterize human ES/iPS cells. Detailed direct comparisons of miRNA expression levels in human ES and iPS cells showed that several miRNAs included in the chromosome 19 miRNA cluster were more strongly expressed in iPS cells than in ES cells. Similar analysis was conducted with mouse ES/iPS cells and somatic cells, and several miRNAs that had not been reported to be expressed in mouse ES/iPS cells were suggested to be ES/iPS cell-specific miRNAs by PCA. Comparison of the average expression levels of miRNAs in ES/iPS cells in humans and mice showed quite similar expression patterns of human/mouse miRNAs. However, several mouse-or human-specific miRNAs are ranked as high expressers. Time course tracing of miRNA levels during embryoid body formation revealed drastic and different patterns of changes in their levels. In summary, our miRNA expression profiling encompassing human and mouse ES and iPS cells gave various perspectives in understanding the miRNA core regulatory networks regulating pluripotent cells characteristics.	[Razak, Siti Razila Abdul; Ueno, Kazuko; Saito, Rika; Koso, Hideto; Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan; [Ueno, Kazuko; Nariai, Naoki; Nagasaki, Masao] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Div Biomed Informat Anal, Sendai, Miyagi 980, Japan; [Takayama, Naoya; Lai, Chen-Yi; Murakami, Miyako; Nakauchi, Hiromitsu; Otsu, Makoto] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Tokyo, Japan; [Takayama, Naoya; Otsu, Makoto] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Stem Cell Bank, Tokyo, Japan; [Tsuji, Koichiro] Univ Tokyo, Inst Med Sci, Res Hosp, Div Pediat Hematol Oncol, Tokyo, Japan; [Michiue, Tatsuo] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Tokyo, Japan	University of Tokyo; Tohoku University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Watanabe, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Tokyo, Japan.	sumiko@ims.u-tokyo.ac.jp	Razak, Siti Razila Abdul/R-2298-2016; Abdul Razak, Siti Razila/P-2754-2014	Razak, Siti Razila Abdul/0000-0003-1398-7652; Abdul Razak, Siti Razila/0000-0002-9197-1982; Nagasaki, Masao/0000-0002-4292-8785; KOSO, HIDETO/0000-0002-8986-7617; Otsu, Makoto/0000-0002-9769-0217; xing zhi, shi zhi/0000-0003-3289-5681	Project for Realization of Regenerative Medicine; MEXT of Japan	Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The project was supported by "the Project for Realization of Regenerative Medicine" and "the grants-in-aid for scientific research" by a Grant-in-Aid for Scientific Research from MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002820; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chao A, 2012, ONCOGENE, V31, P764, DOI 10.1038/onc.2011.269; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Favreau AJ, 2012, LEUKEMIA RES, V36, P334, DOI 10.1016/j.leukres.2011.09.027; GEY GO, 1952, CANCER RES, V12, P264; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hirst M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r113; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Jong HL, 2013, PHYSIOL GENOMICS, V45, P256, DOI 10.1152/physiolgenomics.00071.2012; Jouneau A, 2012, RNA, V18, P253, DOI 10.1261/rna.028878.111; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim KS, 2009, FEBS J, V276, P2140, DOI 10.1111/j.1742-4658.2009.06932.x; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Neveu P, 2010, CELL STEM CELL, V7, P671, DOI 10.1016/j.stem.2010.11.012; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Watson JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053417; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094	57	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73532	10.1371/journal.pone.0073532	http://dx.doi.org/10.1371/journal.pone.0073532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086284	Green Submitted, Green Published, gold			2022-12-27	WOS:000326520200010
J	Tao, T; Zhao, L; Lv, YD; Chen, JD; Hu, Y; Zhang, TZ; Zhou, BL				Tao, Tao; Zhao, Liang; Lv, Yuanda; Chen, Jiedan; Hu, Yan; Zhang, Tianzhen; Zhou, Baoliang			Transcriptome Sequencing and Differential Gene Expression Analysis of Delayed Gland Morphogenesis in Gossypium australe during Seed Germination	PLOS ONE			English	Article							RNA-SEQ DATA; (+)-DELTA-CADINENE SYNTHASE; GENOME SEQUENCE; MOLECULAR-BIOLOGY; PIGMENT GLANDS; COTTON PLANTS; ANNOTATION; ALIGNMENT; HIRSUTUM; CLONING	The genus Gossypium is a globally important crop that is used to produce textiles, oil and protein. However, gossypol, which is found in cultivated cottonseed, is toxic to humans and non-ruminant animals. Efforts have been made to breed improved cultivated cotton with lower gossypol content. The delayed gland morphogenesis trait possessed by some Australian wild cotton species may enable the widespread, direct usage of cottonseed. However, the mechanisms about the delayed gland morphogenesis are still unknown. Here, we sequenced the first Australian wild cotton species (Gossypium australe) and a diploid cotton species (Gossypium arboreum) using the Illumina Hiseq 2000 RNA-seq platform to help elucidate the mechanisms underlying gossypol synthesis and gland development. Paired-end Illumina short reads were de novo assembled into 226,184, 213,257 and 275,434 transcripts, clustering into 61,048, 47,908 and 72,985 individual clusters with N50 lengths of 1,710 bp, 1544 BP and 1,743 bp, respectively. The clustered Unigenes were searched against three public protein databases (TrEMBL, SwissProt and RefSeq) and the nucleotide and protein sequences of Gossypium raimondii using BLASTx and BLASTn. A total of 21,987, 17,209 and 25,325 Unigenes were annotated. Of these, 18,766 (85.4%), 14,552 (84.6%) and 21,374 (84.4%) Unigenes could be assigned to GO-term classifications. We identified and analyzed 13,884 differentially expressed Unigenes by clustering and functional enrichment. Terpenoid-related biosynthesis pathways showed differentially regulated expression patterns between the two cotton species. Phylogenetic analysis of the terpene synthases family was also carried out to clarify the classifications of TPSs. RNA-seq data from two distinct cotton species provide comprehensive transcriptome annotation resources and global gene expression profiles during seed germination and gland and gossypol formation. These data may be used to further elucidate various mechanisms and help promote the usage of cottonseed.	[Tao, Tao; Zhao, Liang; Lv, Yuanda; Chen, Jiedan; Hu, Yan; Zhang, Tianzhen; Zhou, Baoliang] Nanjing Agr Univ, MOE Hybrid Cotton R&D Engn Res Ctr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, BL (corresponding author), Nanjing Agr Univ, MOE Hybrid Cotton R&D Engn Res Ctr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	baoliangzhou@njau.edu.cn		LV, Yuanda/0000-0001-6576-7999; Lv, Yuanda/0000-0002-6640-5989	National Natural Science Foundation of China [31271771, 30571184]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was financially supported in part by grants from the National Natural Science Foundation of China (31271771, 30571184) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamidi C, 2011, GENOME RES, V21, P1193, DOI 10.1101/gr.113779.110; ADAMS R, 1960, CHEM REV, V60, P555, DOI 10.1021/cr60208a002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BELL AA, 1978, PHYTOCHEMISTRY, V17, P1297, DOI 10.1016/S0031-9422(00)94578-3; Benedict CR, 2006, PHYTOCHEMISTRY, V67, P356, DOI 10.1016/j.phytochem.2005.11.015; Blackstaffe L, 1997, MELANOMA RES, V7, P364, DOI 10.1097/00008390-199710000-00002; BOTTGER GT, 1964, J ECON ENTOMOL, V57, P283, DOI 10.1093/jee/57.2.283; Brubaker CL, 1996, AUST J BOT, V44, P601, DOI 10.1071/BT9960601; Cai YingFan, 2003, Journal of Beijing Forestry University, V25, P6; Carvalho L. P. de, 2000, Revista de Oleaginosas e Fibrosas, V4, P39; CHAPPELL J, 1995, ANNU REV PLANT PHYS, V46, P521, DOI 10.1146/annurev.pp.46.060195.002513; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Chen XY, 1996, J NAT PROD, V59, P944, DOI 10.1021/np960344w; Chen XY, 1995, ARCH BIOCHEM BIOPHYS, V324, P255, DOI 10.1006/abbi.1995.0038; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Davis EM, 1996, PHYTOCHEMISTRY, V41, P1047, DOI 10.1016/0031-9422(95)00771-7; DAVIS EM, 1998, PLANT PHYSIOL, V116, P1192; DILDAY RH, 1986, CROP SCI, V26, P639, DOI 10.2135/cropsci1986.0011183X002600030046x; Ding Liang, 2004, Acta Agronomica Sinica, V30, P100; Dong CG, 2007, CHINESE SCI BULL, V52, P3105, DOI 10.1007/s11434-007-0468-6; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FRYXELL P. A., 1965, AUSTRALIAN J BOT, V13, P71, DOI 10.1071/BT9650071; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; GORDON A., 2011, FASTX TOOLKIT COMPUT; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grover CE, 2007, PLANT J, V50, P995, DOI 10.1111/j.1365-313X.2007.03102.x; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hong GJ, 2012, PLANT CELL, V24, P2635, DOI 10.1105/tpc.112.098749; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang J-X, 2003, J COTTON SCI, V15, P2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo P, 2001, PLANT J, V28, P95, DOI 10.1046/j.1365-313X.2001.01133.x; Martin GS, 2003, PHYTOCHEMISTRY, V62, P31, DOI 10.1016/S0031-9422(02)00432-6; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; McFadden H, 2004, EUPHYTICA, V138, P61, DOI 10.1023/B:EUPH.0000047076.38747.81; MCMICHAEL SC, 1960, AGRON J, V52, P385, DOI 10.2134/agronj1960.00021962005200070005x; McMICHAEL SCOTT C., 1959, AGRON JOUR, V51, P630; Meng YL, 1999, J NAT PROD, V62, P248, DOI 10.1021/np980314o; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scheffler JA, 2008, J COTTON SCI, V12, P202; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; SMITH FH, 1961, NATURE, V192, P888, DOI 10.1038/192888a0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Threlfall D, 1991, ECOL CHEM BIOCH PLAN, V31; Townsend BJ, 2005, PLANT PHYSIOL, V138, P516, DOI 10.1104/pp.104.056010; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uniprot, 2012, SWISSPROT UT; Wang K, 2012, NAT GENET; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Xie YF, 2007, COLLOID SURFACE B, V60, P258, DOI 10.1016/j.colsurfb.2007.06.020; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xu YH, 2004, PLANT PHYSIOL, V135, P507, DOI 10.1104/pp.104.038612; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhu S.J., 1998, COTTON SCI, V10, P81; Zhu ShuiJin, 1999, Acta Gossypii Sinica, V11, P169; Zhu SJ, 2001, CHINESE SCI BULL, V46, P1168, DOI 10.1007/BF02900595	76	22	26	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75323	10.1371/journal.pone.0075323	http://dx.doi.org/10.1371/journal.pone.0075323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073262	gold, Green Published, Green Submitted			2022-12-27	WOS:000324768000071
J	Klinger, M; Kong, K; Moorhead, M; Weng, L; Zheng, JB; Faham, M				Klinger, Mark; Kong, Katherine; Moorhead, Martin; Weng, Li; Zheng, Jianbiao; Faham, Malek			Combining Next-Generation Sequencing and Immune Assays: A Novel Method for Identification of Antigen-Specific T Cells	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EPITOPE SPECIFICITIES; FULL REPERTOIRE; INFLUENZA-A; CD8+T CELLS; RESPONSES; CANCER; EXPRESSION; RECOGNITION; PEPTIDE	In this study, we combined a novel sequencing method, which can identify individual clonotypes based on their unique T cell receptor (TCR) rearrangement, with existing immune assays to characterize antigen-specific T cell responses. We validated this approach using three types of assays routinely used to measure antigen-specific responses: pentamers which enable identification of T cells bearing specific TCRs, activation marker expression following antigen stimulation and antigen-induced proliferation to identify cytomegalovirus (CMV) specific clonotypes. In one individual, 8 clonotypes were identified using a pentamer reagent derived from the CMV pp65 protein. The same 8 clonotypes were also identified following sequencing of cells that upregulated an activation marker following incubation with an identical peptide derived from pp65. These 8 and an additional 8 clonotypes were identified using a more sensitive CFSE-based proliferation assay. We found clear sequence homology among some of the clonotypes identified, and the CDR3 region in one clonotype was identical to a previously published pp65-specific clonotype sequence. Many of these CMV-specific clonotypes were present at frequencies below 10 25 which are undetectable using standard flow-cytometric methods. These studies suggest that an immune response is comprised of a diverse set of clones, many of which are present at very low frequencies. Thus, the combination of immune assays and sequencing depicts the richness and diversity of an immune response at a level that is not possible using standard immune assays alone. The methods articulated in this work provide an enhanced understanding of T cell-mediated immune responses at the clonal level.	[Klinger, Mark; Kong, Katherine; Moorhead, Martin; Weng, Li; Zheng, Jianbiao; Faham, Malek] Sequenta Inc, Res, San Francisco, CA USA		Faham, M (corresponding author), Sequenta Inc, Res, San Francisco, CA USA.	Malek.Faham@sequenta.com			Sequenta Inc.	Sequenta Inc.	Sequenta Inc. funded this research and had a role in the study design, data collection, analysis, decision to publish and preparation of the manuscript.	Babel N, 2009, J AM SOC NEPHROL, V20, P344, DOI 10.1681/ASN.2007111225; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Campbell JD, 2010, CLIN EXP ALLERGY, V40, P1025, DOI 10.1111/j.1365-2222.2010.03505.x; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Derre L, 2008, P NATL ACAD SCI USA, V105, P15010, DOI 10.1073/pnas.0807954105; Faham M, 2012, BLOOD, V120, P5173, DOI 10.1182/blood-2012-07-444042; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Gawad C, 2012, BLOOD IN PRESS; Gawad C, 2012, BLOOD, V120, P4407, DOI 10.1182/blood-2012-05-429811; Gratama JW, 2008, CYTOM PART A, V73A, P971, DOI 10.1002/cyto.a.20655; Janetzki Sylvia, 2005, Methods Mol Biol, V302, P51; Keilhoz U, 2006, CLIN CANCER RES, V12, p2346S, DOI 10.1158/1078-0432.CCR-05-2540; Kern F, 2005, TRENDS IMMUNOL, V26, P477, DOI 10.1016/j.it.2005.07.005; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Lim A, 2000, J IMMUNOL, V165, P2001, DOI 10.4049/jimmunol.165.4.2001; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; Meier S, 2008, CYTOMETRY A; Moodie Z, 2010, CANCER IMMUNOL IMMUN, V59, P1489, DOI 10.1007/s00262-010-0875-4; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Pira GL, 2007, CYTOM PART B-CLIN CY, V72B, P77, DOI 10.1002/cyto.b.20186; Retiere C, 2000, J VIROL, V74, P3948, DOI 10.1128/JVI.74.9.3948-3952.2000; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Rudd BD, 2010, J IMMUNOL, V184, P2958, DOI 10.4049/jimmunol.0903493; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Sherwood AM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002536; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Venturi V, 2008, J IMMUNOL, V181, P7853, DOI 10.4049/jimmunol.181.11.7853; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Wolfl M, 2008, CYTOM PART A, V73A, P1043, DOI 10.1002/cyto.a.20594; Wolfl M, 2007, BLOOD, V110, P201, DOI 10.1182/blood-2006-11-056168	34	25	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74231	10.1371/journal.pone.0074231	http://dx.doi.org/10.1371/journal.pone.0074231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069285	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300030
J	Bretherick, KL; Schuetz, JM; Morton, LM; Purdue, MP; Conde, L; Gallagher, RP; Connors, JM; Gascoyne, RD; Berry, BR; Armstrong, B; Kricker, A; Vajdic, CM; Grulich, A; Hjalgrim, H; Smedby, KE; Skibola, CF; Rothman, N; Spinelli, JJ; Brooks-Wilson, AR				Bretherick, Karla L.; Schuetz, Johanna M.; Morton, Lindsay M.; Purdue, Mark P.; Conde, Lucia; Gallagher, Richard P.; Connors, Joseph M.; Gascoyne, Randy D.; Berry, Brian R.; Armstrong, Bruce; Kricker, Anne; Vajdic, Claire M.; Grulich, Andrew; Hjalgrim, Henrik; Smedby, Karin E.; Skibola, Christine F.; Rothman, Nathaniel; Spinelli, John J.; Brooks-Wilson, Angela R.			Sex- and Subtype-Specific Analysis of H2AFX Polymorphisms in Non-Hodgkin Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; DOUBLE-STRAND BREAKS; YIN YANG 1; HISTONE H2AX; REPRODUCTIVE FACTORS; GENETIC-VARIANTS; RISK; CANCER; PROGRESSION; WOMEN	H2AFX encodes a histone variant involved in signaling sites of DNA damage and recruiting repair factors. Genetic variants in H2AFX may influence risk of non-Hodgkin lymphoma (NHL), a heterogeneous group of lymphoid tumors that are characterized by chromosomal translocations. We previously reported that rs2509049, a common variant in the promoter of H2AFX, was associated with risk for NHL in the British Columbia population. Here we report results for 13 single nucleotide polymorphisms (SNPs) in 100 Kb surrounding H2AFX in an expanded collection of 568 NHL cases and 547 controls. After correction for multiple testing, significant associations were present for mantle cell lymphoma (p = 0.007 for rs604714) and all B-cell lymphomas (p = 0.046 for rs2509049). Strong linkage disequilibrium in the 5 Kb upstream of H2AFX limited the ability to determine which specific SNP (rs2509049, rs7759, rs8551, rs643788, rs604714, or rs603826), if any, was responsible. There was a significant interaction between sex and rs2509049 in the all B-cell lymphomas group (p = 0.002); a sex-stratified analysis revealed that the association was confined to females (p = 0.001). Neither the overall nor the female-specific association with rs2509049 was replicated in any of four independent NHL sample sets. Meta-analysis of all five study populations (3,882 B-cell NHL cases and 3,718 controls) supported a weak association with B-cell lymphoma (OR = 0.92, 95% CI = 0.86-0.99, p = 0.034), although this association was not significant after exclusion of the British Columbia data. Further research into the potential sex-specificity of the H2AFX-NHL association may identify a subset of NHL cases that are influenced by genotype at this locus.	[Bretherick, Karla L.; Schuetz, Johanna M.; Brooks-Wilson, Angela R.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Bretherick, Karla L.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Morton, Lindsay M.; Purdue, Mark P.; Rothman, Nathaniel] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Conde, Lucia; Skibola, Christine F.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Gallagher, Richard P.; Spinelli, John J.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Connors, Joseph M.] BC Canc Agcy, Div Med Oncol, Vancouver, BC, Canada; [Connors, Joseph M.; Gascoyne, Randy D.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada; [Gascoyne, Randy D.] BC Canc Agcy, Dept Pathol, Vancouver, BC, Canada; [Berry, Brian R.] Royal Jubilee Hosp, Dept Pathol, Victoria, BC, Canada; [Armstrong, Bruce; Kricker, Anne] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Vajdic, Claire M.] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Adult Canc Program,Lowy Canc Res Ctr, Sydney, NSW, Australia; [Grulich, Andrew] Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW 2052, Australia; [Hjalgrim, Henrik] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Smedby, Karin E.] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Spinelli, John J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Brooks-Wilson, Angela R.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	British Columbia Cancer Agency; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Berkeley; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; Statens Serum Institut; Karolinska Institutet; University of British Columbia; Simon Fraser University	Brooks-Wilson, AR (corresponding author), BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	abrooks-wilson@bcgsc.ca	Morton, Lindsay/AAE-7495-2022; Spinelli, John J./B-6210-2013; Hjalgrim, Henrik/AAG-4973-2021; Conde, Lucia/D-9295-2011; Brooks-Wilson, Angela/E-9399-2012; Purdue, Mark P/C-9228-2016; Gascoyne, Randy D/A-6009-2013; Armstrong, Bruce K/K-9464-2015; Connors, Joseph/AAF-5284-2019; Vajdic, Claire/AAP-5940-2020; Morton, Lindsay M/B-5234-2015	Morton, Lindsay/0000-0001-9767-2310; Spinelli, John J./0000-0002-9119-3287; Brooks-Wilson, Angela/0000-0003-1009-6408; Purdue, Mark P/0000-0003-1177-3108; Gascoyne, Randy D/0000-0002-2610-5690; Armstrong, Bruce K/0000-0001-8940-7525; Connors, Joseph/0000-0002-1361-7531; Morton, Lindsay M/0000-0001-9767-2310; Vajdic, Claire/0000-0002-3612-8298; Bretherick, Karla/0000-0002-6606-802X; Conde, Lucia/0000-0001-5180-543X	Michael Smith Foundation for Health Research; Canadian Institutes of Health Research (CIHR) [MOP86528]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	KLB is funded by postdoctoral fellowships from the Michael Smith Foundation for Health Research (http://www.msfhr.org/) and the Canadian Institutes of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html). This study was funded by a grant from CIHR (MOP86528) to ARB-W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, WORLD POP PROSP 2010; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Castellano G, 2010, CELL CYCLE, V9, P557, DOI 10.4161/cc.9.3.10554; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Choudhury A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-69; Costas L, 2012, CANCER CAUSE CONTROL, V23, P195, DOI 10.1007/s10552-011-9869-6; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fan WW, 2011, J NEURO-ONCOL, V105, P211, DOI 10.1007/s11060-011-0586-5; Fernberg P, 2010, CANCER CAUSE CONTROL, V21, P759, DOI 10.1007/s10552-010-9504-y; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Hughes AM, 2004, INT J CANCER, V110, P429, DOI 10.1002/ijc.20128; Jin XM, 2011, DNA CELL BIOL, V30, P1039, DOI 10.1089/dna.2010.1130; Kane EV, 2012, ANN ONCOL, V24, P433, DOI [10.1093/annonc/mds340, DOI 10.1093/ANN0NC/MDS340.PUBMED:22967995]; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lossos IS, 2005, J CLIN ONCOL, V23, P6351, DOI 10.1200/JCO.2005.05.012; Lu JC, 2008, BREAST CANCER RES TR, V110, P357, DOI 10.1007/s10549-007-9717-2; Lu YL, 2011, INT J CANCER, V129, P974, DOI 10.1002/ijc.25730; Lumley T, 2009, RMETA METAANALYSIS R, P16; MAYER PJ, 1991, ANN HUM BIOL, V18, P405, DOI 10.1080/03014469100001702; Morton LM, 2009, INT J CANCER, V124, P2737, DOI 10.1002/ijc.24248; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; Naidoo K, 2011, J CLIN PATHOL, V64, P125, DOI 10.1136/jcp.2010.078188; Nelson RA, 2001, J CLIN ONCOL, V19, P1381, DOI 10.1200/JCO.2001.19.5.1381; Norgaard M, 2006, BRIT J CANCER, V94, P1339, DOI 10.1038/sj.bjc.6603123; Novik KL, 2007, CANCER EPIDEM BIOMAR, V16, P1098, DOI 10.1158/1055-9965.EPI-06-0639; Prescott J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008135; R Core Team, 2018, R LANG ENV STAT COMP; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Sakhinia E, 2007, BLOOD, V109, P3922, DOI 10.1182/blood-2006-09-046391; Schuetz JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031560; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Sipahimalani P, 2007, INT J CANCER, V121, P1967, DOI 10.1002/ijc.22888; Skibola CF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002816; Slaby O, 2009, ONCOL REP, V21, P1235, DOI 10.3892/or_00000346; Smedby KE, 2005, JNCI-J NATL CANCER I, V97, P199, DOI 10.1093/jnci/dji022; Spinelli JJ, 2007, INT J CANCER, V121, P2767, DOI 10.1002/ijc.23005; Stojadinovic A, 2007, MED SCI MONITOR, V13, pBR231; Swerdlow SH, 2008, WHO CLASSIFICATION T; Vose JM, 2012, AM J HEMATOL, V87, P605, DOI 10.1002/ajh.23176; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yin B, 2009, J EXP MED, V206, P2625, DOI 10.1084/jem.20091320; Zinzani PL, 2012, HEMATOL-AM SOC HEMAT, P426, DOI 10.1182/asheducation-2012.1.426	49	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74619	10.1371/journal.pone.0074619	http://dx.doi.org/10.1371/journal.pone.0074619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069324	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300046
J	Corsetti, PP; de Almeida, LA; Carvalho, NB; Azevedo, V; Silva, TMA; Teixeira, HC; Faria, AC; Oliveira, SC				Corsetti, Patricia P.; de Almeida, Leonardo A.; Carvalho, Natalia B.; Azevedo, Vasco; Silva, Teane M. A.; Teixeira, Henrique C.; Faria, Ana C.; Oliveira, Sergio C.			Lack of Endogenous IL-10 Enhances Production of Proinflammatory Cytokines and Leads to Brucella abortus Clearance in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; IN-VIVO; IFN-GAMMA; TH1 CELLS; INFECTION; RESISTANCE; RESPONSES; INFLAMMATION; IMMUNITY; DISEASE	IL-10 is a cytokine that regulates the balance between pathogen clearance and immunopathology. Brucella abortus is an intracellular bacterium that causes chronic disease in humans and domestic animals. Here we evaluated the contribution of IL-10 in host immune response and pathology during B. abortus infection. To assess the role of IL-10 in vivo, IL-10 knockout (KO) or 129 Sv/Ev (wild-type) mice were infected with B. abortus and the number of viable bacteria from the spleen was determined at 1, 2, 3, 6 and 14-weeks postinfection. IL-10 KO mice showed reduced bacterial loads in the spleen when compared to wild-type mice during all time points studied. Additionally, at 14-weeks postinfection IL-10 KO mice had totally cleared the infection. This clearance was preceded by an enhanced IFN-gamma, TNF-alpha and IL-17 responses in both the serum and the spleen of IL-10 KO mice. Additionally, dendritic cells from infected IL-10 KO mice produced elevated levels of IL-12 and TNF-a compared to wild-type animals. Histopathology analysis was performed and both KO and wild-type mice developed multifocal granulomas and necrosis in the liver. However, at six-weeks postinfection reduced numbers of granulomas was detected in IL-10 KO mice compared to wild-type animals. This reduced liver pathology at later stage of infection was accompanied by increased numbers of CD4+CD25+foxp3+T cells and expression of TGF-beta in IL-10 KO splenocytes. Taken together, our findings demonstrate that IL-10 modulates the proinflammatory immune response to B. abortus infection and the lack of IL-10 increases resistance to Brucella infection.	[Corsetti, Patricia P.; de Almeida, Leonardo A.; Carvalho, Natalia B.; Faria, Ana C.; Oliveira, Sergio C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Azevedo, Vasco] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Silva, Teane M. A.] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Belo Horizonte, MG, Brazil; [de Almeida, Leonardo A.; Teixeira, Henrique C.] Univ Fed Juiz de Fora, Dept Microbiol Imunol & Parasitol, Juiz De Fora, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Juiz de Fora	Oliveira, SC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.	scozeus@icb.ufmg.br	de Almeida, Leonardo A/G-2482-2012; Azevedo, Vasco/B-1556-2019; Oliveira, Sergio Costa/AAG-5408-2021; Azevedo, Vasco A.C/F-4315-2011; Faria, Ana Maria/AAK-8688-2021; Corsetti, Patrícia Paiva/A-5748-2019; Carvalho, Natalia/H-3977-2015; Teixeira, Henrique C/R-2133-2019; Gomes, Teane Milagres Augusto/AAP-2686-2021	de Almeida, Leonardo A/0000-0003-1886-5080; Azevedo, Vasco/0000-0002-4775-2280; Oliveira, Sergio Costa/0000-0003-4062-5577; Azevedo, Vasco A.C/0000-0002-4775-2280; Corsetti, Patrícia Paiva/0000-0002-7037-4484; Carvalho, Natalia/0000-0003-2586-7877; Teixeira, Henrique C/0000-0002-0172-9720; Gomes, Teane Milagres Augusto/0000-0002-3752-8613; Faria, Ana Maria/0000-0002-0604-8510	CNPq; CNPq/CONICET; FAPEMIG; FAPEMIG/CNPq (PRONEX); CAPES/PNPD; CNPq/MAPA; CNPq/REPENSA; INCT-Vacinas	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/CONICET(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG/CNPq (PRONEX); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/MAPA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/REPENSA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT-Vacinas	This work was supported by grants from CNPq, CNPq/CONICET, FAPEMIG, FAPEMIG/CNPq (PRONEX), CAPES/PNPD, CNPq/MAPA, CNPq/REPENSA and INCT-Vacinas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranovich I, 1999, INFECT IMMUN, V67, P4418, DOI 10.1128/IAI.67.9.4418-4426.1999; Anitescu M, 1997, J INTERF CYTOK RES, V17, P781, DOI 10.1089/jir.1997.17.781; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Brandao APMS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/589494; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Clapp B, 2011, INFECT IMMUN, V79, P4165, DOI 10.1128/IAI.05080-11; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; FERNANDES DM, 1995, INFECT IMMUN, V63, P1130, DOI 10.1128/IAI.63.3.1130-1133.1995; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Goenka R, 2011, J INFECT DIS, V203, P1136, DOI 10.1093/infdis/jiq171; Gomes MTR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00130; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Huang LY, 2001, J IMMUNOL, V167, P1423, DOI 10.4049/jimmunol.167.3.1423; Hunter CA, 1997, J IMMUNOL, V158, P3311; JIANG XS, 1993, INFECT IMMUN, V61, P124, DOI 10.1128/IAI.61.1.124-134.1993; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; Macedo GC, 2008, J IMMUNOL, V180, P1080, DOI 10.4049/jimmunol.180.2.1080; MOVAT HZ, 1987, FASEB J, V46, P97; Murphy EA, 2001, IMMUNOLOGY, V103, P511, DOI 10.1046/j.1365-2567.2001.01258.x; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Rasouli M, 2013, CYTOKINE, V61, P297, DOI 10.1016/j.cyto.2012.10.012; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shimmi O, 2013, J BIOCH; SVETIC A, 1993, INT IMMUNOL, V5, P877, DOI 10.1093/intimm/5.8.877; Trant CGMC, 2010, INFECT IMMUN, V78, P2283, DOI 10.1128/IAI.01433-09; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Xavier MN, 2009, J COMP PATHOL, V140, P149, DOI 10.1016/j.jcpa.2008.10.004; Xavier MN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003454; ZHAN YF, 1993, INFECT IMMUN, V61, P4899, DOI 10.1128/IAI.61.11.4899-4901.1993	35	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74729	10.1371/journal.pone.0074729	http://dx.doi.org/10.1371/journal.pone.0074729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069337	gold, Green Submitted, Green Published			2022-12-27	WOS:000324547300054
J	Hu, ZY; Kong, F; Si, MF; Tian, KL; Yu, LX; Young, CYF; Yuan, HQ; Lou, HX				Hu, Zhongyi; Kong, Feng; Si, Manfei; Tian, Keli; Yu, Lin Xi; Young, Charles Y. F.; Yuan, Huiqing; Lou, Hongxiang			Riccardin D Exerts Its Antitumor Activity by Inducing DNA Damage in PC-3 Prostate Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DEPENDENT MANNER; BREAK REPAIR; CHECKPOINT; ATR; POISONS; MITOXANTRONE; PREDNISONE; MECHANISMS; DOCETAXEL	We recently reported that Riccardin D (RD) was able to induce apoptosis by targeting Topo II. Here, we found that RD induced cell cycle arrest in G2/M phase in PC-3 cells, and caused remarkable DNA damage as evidenced by induction of gamma H2AX foci, micronuclei, and DNA fragmentation in Comet assay. Time kinetic and dose-dependent studies showed that ATM/Chk2 and ATR/Chk1 signaling pathways were sequentially activated in response to RD. Blockage of ATM/ATR signaling led to the attenuation of RD-induced gamma H2AX, and to the partial recovery of cell proliferation. Furthermore, RD exposure resulted in the inactivation of BRCA1, suppression of HR and NHEJ repair activity, and downregulation of the expressions and DNA-end binding activities of Ku70/86. Consistent with the observations, microarray data displayed that RD triggered the changes in genes responsible for cell proliferation, cell cycle, DNA damage and repair, and apoptosis. Administration of RD to xenograft mice reduced tumor growth, and coordinately caused alterations in the expression of genes involved in DNA damage and repair, along with cell apoptosis. Thus, this finding identified a novel mechanism by which RD affects DNA repair and acts as a DNA damage agent in prostate cancer.	[Hu, Zhongyi; Kong, Feng; Si, Manfei; Tian, Keli; Yu, Lin Xi; Yuan, Huiqing] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250100, Peoples R China; [Hu, Zhongyi; Lou, Hongxiang] Shandong Univ, Sch Pharmaceut Sci, Dept Nat Prod Chem, Jinan 250100, Peoples R China; [Yu, Lin Xi] Univ Toronto, Dept Human Biol, Toronto, ON M5S 1A1, Canada; [Young, Charles Y. F.] Mayo Clin, Mayo Clin Coll Med, Dept Urol, Rochester, MN USA	Shandong University; Shandong University; University of Toronto; Mayo Clinic	Yuan, HQ (corresponding author), Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250100, Peoples R China.	lyuanhq@sdu.edu.cn; louhongxiang@sdu.edu.cn	hu, zhongyi/E-6103-2015	Hu, Zhongyi/0000-0002-9249-9720	National Natural Science Foundation of China [30772594, 30973551, 30925038]; Natural Science Foundation of Shandong Province [2009ZRB01346]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the National Natural Science Foundation of China (30772594, 30973551, 30925038) and the Natural Science Foundation of Shandong Province (2009ZRB01346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2001, CANCER RES, V61, P4112; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Fan R, 2004, CANCER RES, V64, P8526, DOI 10.1158/0008-5472.CAN-04-1601; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Fleck O, 2004, J CELL SCI, V117, P515, DOI 10.1242/jcs.00952; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Houtgraaf JH, 2006, CARDIOVASC REVASCULA, V7, P165, DOI 10.1016/j.carrev.2006.02.002; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu YG, 2012, MUTAT RES-FUND MOL M, V731, P140, DOI 10.1016/j.mrfmmm.2011.12.003; Lu ZQ, 2006, J ASIAN NAT PROD RES, V8, P187, DOI 10.1080/1028602042000325537; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Mao ZY, 2009, NEOPLASIA, V11, P683, DOI 10.1593/neo.09312; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Robison JG, 2005, J BIOL CHEM, V280, P12927, DOI 10.1074/jbc.M414391200; Singh RP, 2002, CELL CYCLE, V1, P156, DOI 10.4161/cc.1.3.117; Siu WY, 2004, MOL CANCER THER, V3, P621; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; So A, 2005, WORLD J UROL, V23, P1, DOI 10.1007/s00345-004-0473-1; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Wang HC, 2006, CANCER RES, V66, P1391, DOI 10.1158/0008-5472.CAN-05-3270; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wu JX, 2010, PROTEIN CELL, V1, P117, DOI 10.1007/s13238-010-0010-5; Xue X, 2012, LUNG CANCER, V76, P300, DOI 10.1016/j.lungcan.2011.12.013; Xue X, 2012, INVEST NEW DRUG, V30, P212, DOI 10.1007/s10637-010-9554-8; Yan Y, 2010, ONCOGENE, V29, P4317, DOI 10.1038/onc.2010.187; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zuco V, 2010, CANCER LETT, V292, P186, DOI 10.1016/j.canlet.2009.12.001	34	5	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74387	10.1371/journal.pone.0074387	http://dx.doi.org/10.1371/journal.pone.0074387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069304	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300038
J	Rai, S; Bhaskar; Goel, SK; Dwivedi, UN; Sundar, S; Goyal, N				Rai, Smita; Bhaskar; Goel, Sudhir K.; Dwivedi, Upendra Nath; Sundar, Shyam; Goyal, Neena			Role of Efflux Pumps and Intracellular Thiols in Natural Antimony Resistant Isolates of Leishmania donovani	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; GENE-EXPRESSION ANALYSIS; INCREASED TRYPANOTHIONE LEVELS; AQUAGLYCEROPORIN AQP1 GENE; MULTIDRUG-RESISTANCE; ABC TRANSPORTER; DRUG-RESISTANCE; PENTAVALENT ANTIMONY; PHOSPHOLIPID TRAFFICKING; ORNITHINE-DECARBOXYLASE	Background: In view of the recent upsurge in the phenomenon of therapeutic failure, drug resistance in Leishmania, developed under natural field conditions, has become a great concern yet little understood. Accordingly, the study of determinants of antimony resistance is urgently warranted. Efflux transporters have been reported in Leishmania but their role in clinical resistance is still unknown. The present study was designed to elucidate the mechanism of natural antimony resistance in L. donovani field isolates by analyzing the functionality of efflux pump(s) and expression profiles of known genes involved in transport and thiol based redox metabolism Methodology/Principal Findings: We selected 7 clinical isolates (2 sensitive and 5 resistant) in addition to laboratory sensitive reference and SbIII resistant mutant strains for the present study. Functional characterization using flow cytometry identified efflux pumps that transported substrates of both P-gp and MRPA and were inhibited by the calmodulin antagonist trifluoperazine. For the first time, verapamil sensitive efflux pumps for rhodamine 123 were observed in L. donovani that were differentially active in resistant isolates. RT-PCR confirmed the overexpression of MRPA in isolates with high resistance index only. Resistant isolates also exhibited consistent down regulation of AQP1 and elevated intracellular thiol levels which were accompanied with increased expression of ODC and TR genes. Interestingly, gamma-GCS is not implicated in clinical resistance in L. donovani isolates. Conclusions/Significance: Here we demonstrate for the first time, the role of P-gp type plasma membrane efflux transporter(s) in antimony resistance in L. donovani field isolates. Further, decreased levels of AQP1 and elevated thiols levels have emerged as biomarkers for clinical resistance.	[Rai, Smita; Bhaskar; Goyal, Neena] CSIR Cent Drug Res Inst, Div Biochem, Lucknow, Uttar Pradesh, India; [Goel, Sudhir K.] All India Inst Med Sci, Dept Biochem, Bhopal, India; [Dwivedi, Upendra Nath] Univ Lucknow, Dept Biochem, Lucknow 226007, Uttar Pradesh, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); All India Institute of Medical Sciences (AIIMS) Bhopal; Lucknow University; Banaras Hindu University (BHU)	Goyal, N (corresponding author), CSIR Cent Drug Res Inst, Div Biochem, Lucknow, Uttar Pradesh, India.	neenacdri@yahoo.com	Dwivedi, Upendra/AAM-7657-2021	Dwivedi, Upendra/0000-0002-4053-2795; , Bhaskar/0000-0002-5055-121X	Department of Science and technology, India [SR/SO/BB-037/2009]; Department of Biotechnology, India [BT/PR2792/Med/14/383/2001]; ICMR	Department of Science and technology, India(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); ICMR(Indian Council of Medical Research (ICMR))	The work is supported by Department of Science and technology, India (SR/SO/BB-037/2009) and Department of Biotechnology, India (BT/PR2792/Med/14/383/2001) grants. ICMR is gratefully acknowledged for financial support to SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo M G, 2003, East Mediterr Health J, V9, P837; Adaui V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001021; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; [Anonymous], 1990, World Health Organ Tech Rep Ser, V793, P1; Araujo-Santos JM, 2005, BIOCHEM BIOPH RES CO, V330, P349, DOI 10.1016/j.bbrc.2005.02.176; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Basselin M, 2002, ANTIMICROB AGENTS CH, V46, P3731, DOI 10.1128/AAC.46.12.3731-3738.2002; Benerjee C, 1999, CA CALMODULIN DEPEND, V118, P567; Chiquero MJ, 1998, BIOCHEM PHARMACOL, V55, P131, DOI 10.1016/S0006-2952(97)00385-7; Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023; CHOW LMC, 1993, MOL BIOCHEM PARASIT, V60, P195, DOI 10.1016/0166-6851(93)90131-G; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Coelho AC, 2003, MOL BIOCHEM PARASIT, V130, P83, DOI 10.1016/S0166-6851(03)00162-2; COHEN BE, 1986, BIOCHIM BIOPHYS ACTA, V860, P57, DOI 10.1016/0005-2736(86)90498-0; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; CUNNINGHAM ML, 1995, EUR J BIOCHEM, V230, P460, DOI 10.1111/j.1432-1033.1995.tb20583.x; Decuypere S, 2008, PARASITOLOGY, V135, P183, DOI 10.1017/S0031182007003782; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Dey S, 1996, P NATL ACAD SCI USA, V93, P2192, DOI 10.1073/pnas.93.5.2192; Essodaigui M, 1999, MOL BIOCHEM PARASIT, V100, P73, DOI 10.1016/S0166-6851(99)00036-5; Ferreira CD, 2003, BIOMETALS, V16, P441, DOI 10.1023/A:1022823605068; Frezard F, 2001, ANTIMICROB AGENTS CH, V45, P913, DOI 10.1128/AAC.45.3.913-916.2001; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gourbal B, 2004, J BIOL CHEM, V279, P31010, DOI 10.1074/jbc.M403959200; Grondin K, 1997, EMBO J, V16, P3057, DOI 10.1093/emboj/16.11.3057; Gueiros FJ, 1995, EXP PARASITOL, V81, P480, DOI 10.1006/expr.1995.1141; Hadighi R, 2006, PLOS MED, V3, P659, DOI 10.1371/journal.pmed.0030162; Haimeur A, 1999, MOL MICROBIOL, V34, P726, DOI 10.1046/j.1365-2958.1999.01634.x; Haimeur A, 2000, MOL BIOCHEM PARASIT, V108, P131, DOI 10.1016/S0166-6851(00)00187-0; Hamilton CJ, 2003, BIOCHEM J, V369, P529, DOI 10.1042/BJ20021298; HENDERSON DM, 1992, MOL CELL BIOL, V12, P2855, DOI 10.1128/MCB.12.6.2855; Hendricks O, 2003, INT J ANTIMICROB AG, V22, P262, DOI 10.1016/S0924-8579(03)00205-X; Hidaka H, 1998, Tanpakushitsu Kakusan Koso, V43, P1732; Homolya L, 2003, BIOFACTORS, V17, P103, DOI 10.1002/biof.5520170111; Kaatz GW, 2003, ANTIMICROB AGENTS CH, V47, P719, DOI 10.1128/AAC.47.2.719-726.2003; Katakura K, 1999, BIOCHEM BIOPH RES CO, V255, P289, DOI 10.1006/bbrc.1999.0209; Kedzierski L, 2009, CURR MED CHEM, V16, P599, DOI 10.2174/092986709787458489; Legare D, 1997, EXP PARASITOL, V87, P275, DOI 10.1006/expr.1997.4222; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Leprohon P, 2009, ANTIMICROB AGENTS CH, V53, P2646, DOI 10.1128/AAC.01474-08; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizumi K, 2006, BIOCHIM BIOPHYS ACTA, V1978, P738; Maharjan M, 2008, AM J TROP MED HYG, V79, P69, DOI 10.4269/ajtmh.2008.79.69; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mandal G, 2009, INDIAN J BIOCHEM BIO, V46, P86; Mandal S, 2010, J ANTIMICROB CHEMOTH, V65, P496, DOI 10.1093/jac/dkp468; Marquis N, 2005, MOL MICROBIOL, V57, P1690, DOI 10.1111/j.1365-2958.2005.04782.x; Mary C, 2010, Int J Microbiol, V2010, DOI 10.1155/2010/819060; Messaritakis I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065467; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Mittal MK, 2007, AM J TROP MED HYG, V76, P681, DOI 10.4269/ajtmh.2007.76.681; Molnar J, 1997, ANTICANCER RES, V17, P481; Molnar J, 2010, CURR TOP MED CHEM, V10, P1757; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Mukherjee A, 2006, MOL BIOCHEM PARASIT, V145, P1, DOI 10.1016/j.molbiopara.2005.08.016; Mukherjee A, 2007, J ANTIMICROB CHEMOTH, V59, P204, DOI 10.1093/jac/dkl494; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; NEAL RA, 1989, T ROY SOC TROP MED H, V83, P197, DOI 10.1016/0035-9203(89)90642-1; Ouellette M, 1998, DRUG RESIST UPDATE, V1, P43, DOI 10.1016/S1368-7646(98)80213-6; Ouellette M, 2004, DRUG RESIST UPDATE, V7, P257, DOI 10.1016/j.drup.2004.07.002; Parodi-Talice A, 2003, BBA-BIOMEMBRANES, V1612, P195, DOI 10.1016/S0005-2736(03)00131-7; POOT M, 1991, CYTOMETRY, V12, P184, DOI 10.1002/cyto.990120214; Prasad V, 2000, PARASITOL RES, V86, P661, DOI 10.1007/PL00008548; Rojas R, 2006, J INFECT DIS, V193, P1375, DOI 10.1086/503371; SANCHEZ A, 1994, BIOCHEM BIOPH RES CO, V199, P855, DOI 10.1006/bbrc.1994.1307; Sarkar A, 2009, EXP PARASITOL, V122, P299, DOI 10.1016/j.exppara.2009.04.012; SEELIG GF, 1985, METHOD ENZYMOL, V113, P379; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Singh N, 2007, PARASITOLOGY, V134, P777, DOI 10.1017/S0031182007002284; Sinha S, 2011, BIOINFORMATION, V6, P107, DOI 10.6026/97320630006107; Sodre CL, 2000, ARCH BIOCHEM BIOPHYS, V380, P85, DOI 10.1006/abbi.2000.1899; Sundar S, 2005, B WORLD HEALTH ORGAN, V83, P394; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Torres DC, 2010, INFECT GENET EVOL, V10, P727, DOI 10.1016/j.meegid.2010.05.006; URBINA JA, 1988, MOL BIOCHEM PARASIT, V30, P185, DOI 10.1016/0166-6851(88)90111-9; Valiathan R, 2006, EXP PARASITOL, V114, P103, DOI 10.1016/j.exppara.2006.02.015; WHO, 2006, CONTR LEISHM; Yamey G, 2002, BRIT MED J, V325, P176, DOI 10.1136/bmj.325.7357.176; Yan SC, 2003, CHEM COMMUN, P266, DOI 10.1039/b210240d; Yan SC, 2003, J BIOL INORG CHEM, V8, P689, DOI 10.1007/s00775-003-0468-1; Yardley V, 2006, J INFECT DIS, V194, P1168, DOI 10.1086/507710	85	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74862	10.1371/journal.pone.0074862	http://dx.doi.org/10.1371/journal.pone.0074862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069359	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300062
J	Shivaram, P; Ahmed, MI; Kariyanna, PT; Sabbineni, H; Avula, UMR				Shivaram, Pushpa; Ahmed, Molla Imaduddin; Kariyanna, Pramod Theetha; Sabbineni, Harika; Avula, Uma Mahesh R.			Doppler Echocardiography Imaging in Detecting Multi-Valvular Lesions: A Clinical Evaluation in Children with Acute Rheumatic Fever	PLOS ONE			English	Article							A STREPTOCOCCAL INFECTIONS; HEART-DISEASE; MITRAL REGURGITATION; PREVALENCE	Rationale: Doppler echocardiography has been demonstrated to be accurate in diagnosing valvular lesions in rheumatic heart disease (RHD) when compared to clinical evaluation alone. Objective: To perform Doppler echocardiography in children clinically diagnosed by the Jones criteria to have acute rheumatic fever (ARF), and to then compare the effectiveness of echo in detecting single/multi-valvular lesions with that of the initial clinical evaluation. Methods and Results: We enrolled 93 children who were previously diagnosed with ARF by clinical examination. Presence of valvular lesions were enlisted, first by clinical auscultation, and then by performing Doppler echocardiography. We found that Doppler echocardiography was a sensitive technique, capable of detecting valvular lesions that were missed by clinical auscultation alone. Echocardiography of patients with carditis revealed mitral regurgitation to be the most common lesion present (53 patients, 56.98%), followed by aortic regurgitation in 21 patients (22.6%). The difference between clinical and echocardiographic diagnosis in ARF children with carditis was statistically significant for mitral regurgitation, aortic regurgitation and tricuspid regurgitation. Clinical auscultation alone revealed 4 cases of mitral stenosis, 39 mitral regurgitation, 14 aortic regurgitation, 9 tricuspid regurgitation; in contrast, echo revealed 5 cases of mitral stenosis, 53 mitral regurgitation, 21 aortic regurgitation, 18 tricuspid regurgitation. Conclusion: Doppler echocardiography is a more sensitive technique for detecting valvular lesions. In the setting of ARF, echo enables a 46.9% higher detection level of carditis, as compared to the clinical examination alone. Echo was very significant in detecting regurgitation lesions, especially for cases of tricuspid regurgitation in the setting of multivalvular involvement. The results of our study are in accordance with previous clinical studies, all of which clearly demonstrate the advantages of Doppler echocardiography, paving the way for its probable inclusion as one of the Jones major criteria for diagnosing ARF.	[Shivaram, Pushpa] Marshfield Clin Fdn Med Res & Educ, Dept Pediat, Marshfield, WI USA; [Ahmed, Molla Imaduddin] Chesterfield Royal Hosp, Dept Pediat, Chesterfield, Derby, England; [Shivaram, Pushpa; Ahmed, Molla Imaduddin] Bangalore Med Coll & Res Inst, Vanivilas Children Hosp, Bangalore, Karnataka, India; [Kariyanna, Pramod Theetha; Avula, Uma Mahesh R.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [Sabbineni, Harika] Univ Georgia, Coll Pharm, Augusta, GA USA	Marshfield Clinic; Bangalore Medical College & Research Institute (BMCRI); University of Michigan System; University of Michigan; University System of Georgia; University of Georgia	Avula, UMR (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA.	umamahes@med.umich.edu	Shivaram, Pushpa/W-8449-2019; avula, uma mahesh/B-8047-2014	Shivaram, Pushpa/0000-0003-3661-8059; avula, uma mahesh/0000-0002-4786-3722				Anabwani GM, 1996, E AFR MED J, V73, P215; Aurakzai Hamza Arslan, 2009, J Ayub Med Coll Abbottabad, V21, P122; Beaton A, 2012, CIRCULATION, V125, P3127, DOI 10.1161/CIRCULATIONAHA.112.092312; BISNO AL, 1991, NEW ENGL J MED, V325, P783, DOI 10.1056/NEJM199109123251106; BRAND A, 1992, AM HEART J, V123, P177, DOI 10.1016/0002-8703(92)90763-L; Carapetis JR, 2008, NAT CLIN PRACT CARD, V5, P411, DOI 10.1038/ncpcardio1185; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 1999, CLIN INFECT DIS, V28, P205, DOI 10.1086/515114; Doocy Shannon, 2006, World Health Popul, V8, P32; Essien I O, 2008, Niger Postgrad Med J, V15, P175; Ferrieri P, 2002, CIRCULATION, V105, P2115, DOI 10.1161/01.CIR.0000013073.22415.90; Fever WHOECoR Rheumatic Heart D, 2004, RHEUM FEV RHEUM HEAR; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; Jones TD, 1944, J AMER MED ASSOC, V126, P481, DOI 10.1001/jama.1944.02850430015005; King Alexandra, 2012, Nat Rev Cardiol, V9, P433, DOI 10.1038/nrcardio.2012.89; Marijon E, 2008, NAT CLIN PRACT CARD, V5, DOI 10.1038/ncpcardio1300; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Marijon E, 2009, CIRCULATION, V120, P663, DOI 10.1161/CIRCULATIONAHA.109.849190; MARTIN RP, 1979, AM J CARDIOL, V43, P560, DOI 10.1016/0002-9149(79)90014-6; Padmavati S, 2001, HEART, V86, P127, DOI 10.1136/heart.86.2.127; Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7; SAHN DJ, 1988, CIRCULATION, V78, P1075, DOI 10.1161/01.CIR.78.4.1075; STEINFELD L, 1986, CIRCULATION, V74, P385; Stevenson J G, 1989, J Am Soc Echocardiogr, V2, P1; Vasan RS, 1996, CIRCULATION, V94, P73, DOI 10.1161/01.CIR.94.1.73; WHO J, 1994, JOINT WHO ISFC M RHE; WU YT, 1993, AM J CARDIOL, V71, P727, DOI 10.1016/0002-9149(93)91018-D	28	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74114	10.1371/journal.pone.0074114	http://dx.doi.org/10.1371/journal.pone.0074114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069273	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300029
J	Heuss, SF; Tarantino, N; Fantini, J; Ndiaye-Lobry, D; Moretti, J; Israel, A; Logeat, F				Heuss, Sara Farrah; Tarantino, Nadine; Fantini, Jacques; Ndiaye-Lobry, Delphine; Moretti, Julien; Israel, Alain; Logeat, Frederique			A Glycosphingolipid Binding Domain Controls Trafficking and Activity of the Mammalian Notch Ligand Delta-Like 1	PLOS ONE			English	Article							LIPID RAFTS; CELL FATE; CHOLESTEROL; RECEPTOR; PATHWAY; INTERNALIZATION; DEPLETION; AUXILIN; ADAM10	The activity of Notch ligands is tightly regulated by trafficking events occurring both before and after ligand-receptor interaction. In particular endocytosis and recycling have been shown to be required for full signaling activity of the ligands before they encounter the Notch receptor. However little is known about the precise endocytic processes that contribute to ligand internalization. Here we demonstrate that endocytosis contributes to Dll1 signaling activity by preserving the ligand from shedding and degradation. We further show that the glycosphingolipid-binding motif originally identified in Drosophila Notch ligands is conserved in mammals and is necessary for Dll1 internalization. Mutation of its conserved tryptophan residue results in a Dll1 molecule which is rapidly inactivated by shedding and degradation, does not recycle to the cell surface and does not activate Notch signaling. Finally, silencing in the signal-sending cells of glucosylceramide synthase, the enzyme implicated in the initial phase of glycosphingolipid synthesis, down-regulates Notch activation. Our data indicate that glycosphingolipids, by interacting with Dll1, may act as functional co-factors to promote its biological activity.	[Heuss, Sara Farrah; Tarantino, Nadine; Ndiaye-Lobry, Delphine; Moretti, Julien; Israel, Alain; Logeat, Frederique] Inst Pasteur, CNRS, URA 2582, Unite Signalisat Mol & Activat Cellulaire, Paris, France; [Fantini, Jacques] Univ Aix Marseille, Fac Sci St Jerome, CNRS, Lab Interact Mol & Syst Membranaires,UMR 6231, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Israel, A (corresponding author), Inst Pasteur, CNRS, URA 2582, Unite Signalisat Mol & Activat Cellulaire, Paris, France.	aisrael@pasteur.fr		Fantini, Jacques/0000-0001-8653-5521; Moretti, Julien/0000-0002-3415-9058	Ligue Nationale Contre le Cancer; Association pour la Recherche sur le Cancer; European Community (Rubicon FP6 Network of Excellence)	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); European Community (Rubicon FP6 Network of Excellence)	SFH received a doctoral fellowship from Ligue Nationale Contre le Cancer and Association pour la Recherche sur le Cancer. This work was supported in part by a grant from the European Community (Rubicon FP6 Network of Excellence) to AI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Banks SML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018259; Benhra N, 2010, MOL BIOL CELL, V21, P2078, DOI 10.1091/mbc.E09-11-0926; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2009, EXP CELL RES, V315, P1549, DOI 10.1016/j.yexcr.2008.09.010; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Eun SH, 2008, DEVELOPMENT, V135, P1089, DOI 10.1242/dev.009530; Fantini J, 2006, BIOCHEMISTRY-US, V45, P10957, DOI 10.1021/bi060762s; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Gil C, 2007, FEBS LETT, V581, P1851, DOI 10.1016/j.febslet.2007.03.080; Gonzalez-Gaitan M, 2008, DEV CELL, V15, P172, DOI 10.1016/j.devcel.2008.07.001; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Hamel S, 2010, J CELL BIOL, V188, P581, DOI 10.1083/jcb.200907116; Harris B, 2009, BRAIN RES, V1296, P203, DOI 10.1016/j.brainres.2009.07.105; Heuss SF, 2008, P NATL ACAD SCI USA, V105, P11212, DOI 10.1073/pnas.0800695105; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Jin GX, 2011, EMBO J, V30, P2281, DOI 10.1038/emboj.2011.136; Kandachar V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-50; Katic I, 2005, GENETICS, V171, P1605, DOI 10.1534/genetics.105.048041; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Meloty-Kapella L, 2012, DEV CELL, V22, P1299, DOI 10.1016/j.devcel.2012.04.005; Miljan Erik A, 2002, Sci STKE, V2002, pre15, DOI 10.1126/stke.2002.160.re15; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Okamoto Y, 2000, J BIOL CHEM, V275, P6439, DOI 10.1074/jbc.275.9.6439; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Rajan A, 2009, NAT CELL BIOL, V11, P815, DOI 10.1038/ncb1888; Shergill B, 2012, DEV CELL, V22, P1313, DOI 10.1016/j.devcel.2012.04.007; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049	47	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74392	10.1371/journal.pone.0074392	http://dx.doi.org/10.1371/journal.pone.0074392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069306	gold, Green Published, Green Submitted			2022-12-27	WOS:000326240100104
J	Balasubramaniam, VRMT; Wai, TH; Tejo, BA; Omar, AR; Hassan, SS				Balasubramaniam, Vinod R. M. T.; Wai, Tham Hong; Tejo, Bimo Ario; Omar, Abdul Rahman; Hassan, Sharifah Syed			Highly Pathogenic Avian Influenza Virus Nucleoprotein Interacts with TREX Complex Adaptor Protein Aly/REF	PLOS ONE			English	Article							MESSENGER-RNA EXPORT; NUCLEAR EXPORT; CAENORHABDITIS-ELEGANS; ORF57 PROTEIN; BINDING; UAP56; IDENTIFICATION; TRANSCRIPTION; ACCUMULATION; REPLICATION	We constructed a novel chicken (Gallus gallus) lung cDNA library fused inside yeast acting domain vector (pGADT7). Using yeast two-hybrid screening with highly pathogenic avian influenza (HPAI) nucleoprotein (NP) from the strain (A/chicken/Malaysia/5858/2004(H5N1)) as bait, and the Gallus gallus lung cDNA library as prey, a novel interaction between the Gallus gallus cellular RNA export adaptor protein Aly/REF and the viral NP was identified. This interaction was confirmed and validated with mammalian two hybrid studies and co-immunoprecipitation assay. Cellular localization studies using confocal microscopy showed that NP and Aly/REF co-localize primarily in the nucleus. Further investigations by mammalian two hybrid studies into the binding of NP of other subtypes of influenza virus such as the swine A/New Jersey/1976/H1N1 and pandemic A/Malaysia/854/2009(H1N1) to human Aly/REF, also showed that the NP of these viruses interacts with human Aly/REF. Our findings are also supported by docking studies which showed tight and favorable binding between H5N1 NP and human Aly/REF, using crystal structures from Protein Data Bank. siRNA knockdown of Aly/REF had little effect on the export of HPAI NP and other viral RNA as it showed no significant reduction in virus titer. However, UAP56, another component of the TREX complex, which recruits Aly/REF to mRNA was found to interact even better with H5N1 NP through molecular docking studies. Both these proteins also co-localizes in the nucleus at early infection similar to Aly/REF. Intriguingly, knockdown of UAP56 in A549 infected cells shows significant reduction in viral titer (close to 10 fold reduction). Conclusively, our study have opened new avenues for research of other cellular RNA export adaptors crucial in aiding viral RNA export such as the SRSF3, 9G8 and ASF/SF2 that may play role in influenza virus RNA nucleocytoplasmic transport.	[Balasubramaniam, Vinod R. M. T.; Wai, Tham Hong; Hassan, Sharifah Syed] Monash Univ, Sch Med & Hlth Sci, Infect Dis Lab MR3, Virus Host Interact Grp, Selangor, Malaysia; [Tejo, Bimo Ario] Univ Putra Malaysia UPM Serdang, Fac Sci, Dept Chem, Selangor, Malaysia; [Omar, Abdul Rahman] Univ Putra Malaysia UPM Serdang, Inst Biosci, Selangor, Malaysia	Monash University; Monash University Sunway; Universiti Putra Malaysia; Universiti Putra Malaysia	Hassan, SS (corresponding author), Monash Univ, Sch Med & Hlth Sci, Infect Dis Lab MR3, Virus Host Interact Grp, Sunway Campus, Selangor, Malaysia.	sharifah.syedhassan@med.monash.edu.my	Tejo, Bimo A/I-2929-2012; RMT Balasubramaniam, Vinod/B-6957-2017	Tejo, Bimo A/0000-0002-2890-0938; RMT Balasubramaniam, Vinod/0000-0001-9583-307X	Ministry of Science, Technology and Innovation [MED2009-INI(GG)-001-SH, 5140028-000-00]	Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	The source of the funding is Ministry of Science, Technology and Innovation, Project No: MED2009-INI(GG)-001-SH Grant No: 5140028-000-00.	Boyne JR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000194; Chen IHB, 2005, J VIROL, V79, P3949, DOI 10.1128/JVI.79.7.3949-3961.2005; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; DAVEY J, 1985, CELL, V40, P667, DOI 10.1016/0092-8674(85)90215-6; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Hiriart E, 2003, J BIOL CHEM, V278, P335, DOI 10.1074/jbc.M208656200; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Katahira J, 2012, BBA-GENE REGUL MECH, V1819, P507, DOI 10.1016/j.bbagrm.2011.12.001; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Lei HX, 2011, P NATL ACAD SCI USA, V108, P17985, DOI 10.1073/pnas.1113076108; Li DJ, 2012, J VIROL, V86, P9866, DOI 10.1128/JVI.01190-12; Lischka P, 2006, MOL CELL BIOL, V26, P1631, DOI 10.1128/MCB.26.5.1631-1643.2006; Longman D, 2003, RNA, V9, P881, DOI 10.1261/rna.5420503; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; MacMorris M, 2003, RNA, V9, P847, DOI 10.1261/rna.5480803; Malik P, 2004, J BIOL CHEM, V279, P33001, DOI 10.1074/jbc.M313008200; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; Nojima T, 2007, J BIOL CHEM, V282, P15645, DOI 10.1074/jbc.M700629200; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Ohno M, 2002, MOL CELL, V9, P659, DOI 10.1016/S1097-2765(02)00454-9; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	33	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e72429	10.1371/journal.pone.0072429	http://dx.doi.org/10.1371/journal.pone.0072429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073193	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000324768000002
J	Clayson, PE; Larson, MJ				Clayson, Peter E.; Larson, Michael J.			Adaptation to Emotional Conflict: Evidence from a Novel Face Emotion Paradigm	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; DEPTH-RECORDED POTENTIALS; EVENT-RELATED POTENTIALS; WORD FORM AREA; COGNITIVE CONTROL; GENERALIZED ANXIETY; SPATIOTEMPORAL STAGES; IMPLICIT REGULATION; RESOLVE CONFLICT; ANGRY FACES	The preponderance of research on trial-by-trial recruitment of affective control (e.g., conflict adaptation) relies on stimuli wherein lexical word information conflicts with facial affective stimulus properties (e.g., the face-Stroop paradigm where an emotional word is overlaid on a facial expression). Several studies, however, indicate different neural time course and properties for processing of affective lexical stimuli versus affective facial stimuli. The current investigation used a novel task to examine control processes implemented following conflicting emotional stimuli with conflict-inducing affective face stimuli in the absence of affective words. Forty-one individuals completed a task wherein the affective-valence of the eyes and mouth were either congruent (happy eyes, happy mouth) or incongruent (happy eyes, angry mouth) while high-density event-related potentials (ERPs) were recorded. There was a significant congruency effect and significant conflict adaptation effects for error rates. Although response times (RTs) showed a significant congruency effect, the effect of previous-trial congruency on current-trial RTs was only present for current congruent trials. Temporospatial principal components analysis showed a P3-like ERP source localized using FieldTrip software to the medial cingulate gyrus that was smaller on incongruent than congruent trials and was significantly influenced by the recruitment of control processes following previous-trial emotional conflict (i.e., there was significant conflict adaptation in the ERPs). Results show that a face-only paradigm may be sufficient to elicit emotional conflict and suggest a system for rapidly detecting conflicting emotional stimuli and subsequently adjusting control resources, similar to cognitive conflict detection processes, when using conflicting facial expressions without words.	[Clayson, Peter E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Clayson, Peter E.; Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA	University of California System; University of California Los Angeles; Brigham Young University; Brigham Young University	Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	michael_larson@byu.edu	Clayson, Peter E/F-5438-2011; Larson, Michael J/C-8543-2012; Clayson, Peter E/AAC-9207-2019	Clayson, Peter E/0000-0003-4437-6598; Larson, Michael J/0000-0002-8199-8065; Clayson, Peter E/0000-0003-4437-6598	Brigham Young University College of Family, Home, and Social Sciences	Brigham Young University College of Family, Home, and Social Sciences	Funding for this study was provided by the Brigham Young University College of Family, Home, and Social Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2012, HUM BRAIN MAPP, V33, P2147, DOI 10.1002/hbm.21347; Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; BENTIN S, 1988, J EXP PSYCHOL GEN, V117, P148, DOI 10.1037/0096-3445.117.2.148; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Clayson PE, 2013, PSYCHOPHYSIOLOGY, V50, P174, DOI 10.1111/psyp.12001; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dichter GS, 2010, SCHIZOPHRENIA BULL, V36, P595, DOI 10.1093/schbul/sbn118; Dien J, 2006, BRAIN LANG, V97, P91, DOI 10.1016/j.bandl.2005.08.002; Dien J, 2005, CLIN NEUROPHYSIOL, V116, P1808, DOI 10.1016/j.clinph.2004.11.025; Dien J, 2003, COGNITIVE BRAIN RES, V17, P637, DOI 10.1016/S0926-6410(03)00188-5; Dien J., 2005, EVENT RELATED POTENT; Dien J, 2007, HUM BRAIN MAPP, V28, P742, DOI 10.1002/hbm.20304; Dien J, 2010, BRAIN RES, V1355, P126, DOI 10.1016/j.brainres.2010.07.099; Dien J, 2010, J NEUROSCI METH, V187, P138, DOI 10.1016/j.jneumeth.2009.12.009; Dien J, 2010, PSYCHOPHYSIOLOGY, V47, P170, DOI 10.1111/j.1469-8986.2009.00885.x; Dien J, 2009, NEUROPSYCHOLOGIA, V47, P1, DOI 10.1016/j.neuropsychologia.2008.08.024; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Ernst M, 2010, AM J PSYCHIAT, V167, P489, DOI 10.1176/appi.ajp.2010.10010234; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Etkin A, 2011, AM J PSYCHIAT, V168, P968, DOI 10.1176/appi.ajp.2011.10091290; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Foti D, 2011, HUM BRAIN MAPP, V32, P2207, DOI 10.1002/hbm.21182; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fox E, 2006, EMOTION, V6, P534, DOI 10.1037/1528-3542.6.3.534; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P51, DOI 10.1016/0928-4257(94)90093-0; HALGREN E, 1994, J PHYSIOL-PARIS, V88, P1, DOI 10.1016/0928-4257(94)90092-2; Hofstetter C, 2012, NEUROIMAGE, V60, P1734, DOI 10.1016/j.neuroimage.2012.01.110; Isaac L, 2012, BRAIN BEHAV, V2, P74, DOI 10.1002/brb3.38; Jackson MC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00437; Jarcho JM, 2013, BIOL PSYCHOL, V92, P306, DOI 10.1016/j.biopsycho.2012.09.008; Junghofer M, 1999, CLIN NEUROPHYSIOL, V110, P1149, DOI 10.1016/S1388-2457(99)00044-9; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Keselman HJ, 2003, PSYCHOPHYSIOLOGY, V40, P586, DOI 10.1111/1469-8986.00060; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; LeDoux J, 1996, PROG BRAIN RES, V107, P437; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Lutkenhoner B, 1998, ELECTROEN CLIN NEURO, V106, P314, DOI 10.1016/S0013-4694(97)00140-5; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Ovaysikia S, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00234; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Raccuglia RA, 1997, BRIT J PSYCHOL, V88, P93, DOI 10.1111/j.2044-8295.1997.tb02623.x; Reeck C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00232; Rellecke J, 2011, BRAIN COGNITION, V77, P23, DOI 10.1016/j.bandc.2011.07.001; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1111/1469-8986.3820343; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Young AW, 2002, FACIAL EXPRESSIONS E; ZHANG LJ, 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0051110.PUBMED:23227242; Zhu XR, 2010, NEUROSCI LETT, V478, P1, DOI 10.1016/j.neulet.2010.04.036	66	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75776	10.1371/journal.pone.0075776	http://dx.doi.org/10.1371/journal.pone.0075776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	222YC	24073278	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000088
J	Dumez, ME; Herman, J; Campisi, V; Bouaziz, A; Rosu, F; Luxen, A; Vandenberghe, I; de Pauw, E; Frere, JM; Matagne, A; Chevigne, A; Galleni, M				Dumez, Marie-Eve; Herman, Julie; Campisi, Vincenzo; Bouaziz, Ahlem; Rosu, Frederic; Luxen, Andre; Vandenberghe, Isabel; de Pauw, Edwin; Frere, Jean-Marie; Matagne, Andre; Chevigne, Andy; Galleni, Moreno			The Proline-Rich Motif of the proDer p 3 Allergen Propeptide Is Crucial for Protease-Protease Interaction	PLOS ONE			English	Article							DUST-MITE ALLERGEN; ZYMOGEN ACTIVATION; INTRAMOLECULAR CHAPERONE; ACTIVE-SITE; TRYPSIN; RECOMBINANT; IGE; SUBTILISIN; PEPTIDES; GLYCOSYLATION	The majority of proteases are synthesized in an inactive form, termed zymogen, which consists of a propeptide and a protease domain. The propeptide is commonly involved in the correct folding and specific inhibition of the enzyme. The propeptide of the house dust mite allergen Der p 3, NPILPASPNAT, contains a proline-rich motif (PRM), which is unusual for a trypsin-like protease. By truncating the propeptide or replacing one or all of the prolines in the non-glycosylated zymogen with alanine(s), we demonstrated that the full-length propeptide is not required for correct folding and thermal stability and that the PRM is important for the resistance of proDer p 3 to undesired proteolysis when the protein is expressed in Pichia pastoris. Additionally, we followed the maturation time course of proDer p 3 by coupling a quenched-flow assay to mass spectrometry analysis. This approach allowed to monitor the evolution of the different species and to determine the steady-state kinetic parameters for activation of the zymogen by the major allergen Der p 1. This experiment demonstrated that prolines 5 and 8 are crucial for proDer p 3-Der p 1 interaction and for activation of the zymogen.	[Dumez, Marie-Eve; Herman, Julie; Campisi, Vincenzo; Bouaziz, Ahlem; Frere, Jean-Marie; Chevigne, Andy; Galleni, Moreno] Univ Liege, Ctr Prot Engn, Liege, Belgium; [Campisi, Vincenzo; Chevigne, Andy] Ctr Rech Publ Sante, Lab Retrovirol, Luxembourg, Luxembourg; [Rosu, Frederic; de Pauw, Edwin] Univ Liege, GIGA R, LSM, Liege, Belgium; [Luxen, Andre] Univ Liege, Ctr Rech Cyclotron, Liege, Belgium; [Vandenberghe, Isabel] Lab Prot Biochem & Prot Engn, Ghent, Belgium; [Frere, Jean-Marie; Matagne, Andre] Univ Liege, Ctr Prot Engn, Lab Enzymol & Repliement Prot, Liege, Belgium	University of Liege; Luxembourg Institute of Health; University of Liege; University of Liege; University of Liege	Galleni, M (corresponding author), Univ Liege, Ctr Prot Engn, Liege, Belgium.	mgalleni@ulg.ac.be	Rosu, Frédéric/E-6403-2011	Rosu, Frédéric/0000-0003-3674-7539; De Pauw, Edwin/0000-0003-3475-1315; Chevigne, Andy/0000-0003-4768-6743; Matagne, Andre/0000-0001-6417-6791	Belgian Fonds de la Recherche Scientifique (F.R.S.-FNRS); Fonds de la Recherche Fondamentale et Collective [2.4.511.06, 2.4561.07, 2.4.548.10]; Interuniversity Attraction Pole (IAP) [P6/19]; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) (Brussels, Belgium); FRIA (Brussels, Belgium); F.R.S.-FNRS (Brussels, Belgium); "Centre de Recherche Public-Sante'', Luxembourg [20100708]	Belgian Fonds de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Fondamentale et Collective(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole (IAP)(Belgian Federal Science Policy Office); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) (Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); FRIA (Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); F.R.S.-FNRS (Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); "Centre de Recherche Public-Sante'', Luxembourg	This work was supported by the Belgian Fonds de la Recherche Scientifique (F.R.S.-FNRS), the Fonds de la Recherche Fondamentale et Collective (2.4.511.06, 2.4561.07, 2.4.548.10), and Interuniversity Attraction Pole (IAP) P6/19. MED was supported by the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) (Brussels, Belgium). JH and VC are supported by the FRIA (Brussels, Belgium). FR is supported by F.R.S.-FNRS (Brussels, Belgium). AC was an Aspirant of the F.R.S.-FNRS (Brussels, Belgium) and is now supported by the "Centre de Recherche Public-Sante'', Luxembourg (grant 20100708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Jeffrey, 2009, V189, P85; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Borgono CA, 2004, MOL CANCER RES, V2, P257; BRUNGER AT, 1987, BIOCHEMISTRY-US, V26, P5153; Cheong N, 2003, ALLERGY, V58, P352, DOI 10.1034/j.1398-9995.2003.00033.x; Chevigne A, 2007, J MOL BIOL, V374, P170, DOI 10.1016/j.jmb.2007.08.025; Chevigne A, 2010, BBA-GEN SUBJECTS, V1800, P937, DOI 10.1016/j.bbagen.2010.05.011; CHUA KY, 1992, J ALLERGY CLIN IMMUN, V89, P95, DOI 10.1016/S0091-6749(05)80045-4; Consalvi V, 2000, PROTEIN ENG, V13, P501, DOI 10.1093/protein/13.7.501; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; Dumez ME, 2008, J BIOL CHEM, V283, P30606, DOI 10.1074/jbc.M803041200; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; Fu X, 2000, J BIOL CHEM, V275, P16871, DOI 10.1074/jbc.275.22.16871; GREENE WK, 1991, J IMMUNOL, V147, P3768; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; Harris J, 2004, CHEM BIOL, V11, P1361, DOI 10.1016/j.chembiol.2004.08.008; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; HIGAKI JN, 1989, BIOCHEMISTRY-US, V28, P9256, DOI 10.1021/bi00450a004; Jacquet A, 2011, CLIN EXP ALLERGY, V41, P305, DOI 10.1111/j.1365-2222.2010.03661.x; Jacquet A, 2011, INT ARCH ALLERGY IMM, V155, P95, DOI 10.1159/000320375; Kikuchi Y, 2006, J IMMUNOL, V177, P1609, DOI 10.4049/jimmunol.177.3.1609; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Lazure C, 2002, CURR PHARM DESIGN, V8, P511, DOI 10.2174/1381612023395691; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Maruo K, 1997, J ALLERGY CLIN IMMUN, V100, P253, DOI 10.1016/S0091-6749(97)70233-1; Meno K, 2005, J IMMUNOL, V175, P3835, DOI 10.4049/jimmunol.175.6.3835; Ohshima Y, 2008, J BIOSCI BIOENG, V106, P345, DOI 10.1263/jbb.106.345; Potter PC, 2009, WORLD ALLERGY ORGAN, V2, P150, DOI 10.1097/WOX.0b013e3181b055f3; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Reshetniak Ia K, 1997, BIOFIZIKA, V42, P785; Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0; Sauter NK, 1998, NAT STRUCT BIOL, V5, P945, DOI 10.1038/2919; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCOBIE G, 1994, BIOCHEM SOC T, V22, pS448, DOI 10.1042/bst022448s; Shakib F, 2002, EUROPEAN RESP MONOGR, P153; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Subbian E, 2005, J MOL BIOL, V347, P367, DOI 10.1016/j.jmb.2005.01.028; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Takai T, 2006, INT ARCH ALLERGY IMM, V139, P181, DOI 10.1159/000091163; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; VASQUEZ JR, 1989, J CELL BIOCHEM, V39, P265, DOI 10.1002/jcb.240390306; Vliagoftis Harissios, 2008, Inflammation & Allergy Drug Targets, V7, P288, DOI 10.2174/187152808786848379; Wan H, 2001, CLIN EXP ALLERGY, V31, P279, DOI 10.1046/j.1365-2222.2001.00970.x; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3	46	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e68014	10.1371/journal.pone.0068014	http://dx.doi.org/10.1371/journal.pone.0068014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073192	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000001
J	Horwood, C; Butler, LM; Haskins, L; Phakathi, S; Rollins, N				Horwood, Christiane; Butler, Lisa M.; Haskins, Lyn; Phakathi, Sifiso; Rollins, Nigel			HIV-Infected Adolescent Mothers and Their Infants: Low Coverage of HIV Services and High Risk of HIV Transmission in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							PREGNANCY; WOMEN; AGE	Objectives: Rates of pregnancy and HIV infection are high among South African adolescents, yet little is known about rates of mother-to-child transmission of HIV (MTCT) in this group. We report a comparison of the characteristics of adolescent mothers and adult mothers, including HIV prevalence and MTCT rates. Methods: We examined patterns of health service utilization during the antenatal and early postnatal period, HIV prevalence and MTCT amongst adolescent (<20-years-old) and adult (20 to 39-years-old) mothers with infants aged <= 16 weeks attending immunization clinics in six districts of KwaZulu-Natal between May 2008 and April 2009. Findings: Interviews were conducted with 19,093 mothers aged between 12 and 39 years whose infants were aged <= 16 weeks. Most mothers had attended antenatal care four or more times during their last pregnancy (80.3%), and reported having an HIV test (98.2%). A greater proportion of HIV-infected adult mothers, compared to adolescent mothers, reported themselves as HIV-positive (41.2% vs. 15.9%, p<0.0001), reported having a CD4 count taken during their pregnancy (81.0% vs. 66.5%, p<0.0001), and having received the CD4 count result (84.4% vs. 75.7%, p<0.0001). Significantly fewer adolescent mothers received the recommended PMTCT regimen. HIV antibody was detected in 40.4% of 7,800 infants aged 4-8 weeks tested for HIV, indicating HIV exposure. This was higher among infants of adult mothers (47.4%) compared to adolescent mothers (17.9%, p<0.0001). The MTCT rate at 4-8 weeks of age was significantly higher amongst infants of adolescent mothers compared to adult mothers (35/325 [10.8%] vs. 185/2,800 [6.1%], OR 1.7, 95% CI 1.2-2.4). Conclusion: Despite high levels of antenatal clinic attendance among pregnant adolescents in KwaZulu-Natal, the MTCT risk is higher among infants of HIV-infected adolescent mothers compared to adult mothers. Access to adolescent-friendly family planning and PMTCT services should be prioritised for this vulnerable group.	[Horwood, Christiane; Haskins, Lyn; Phakathi, Sifiso] Univ KwaZulu Natal, Ctr Rural Hlth, Durban, Kwazulu Natal, South Africa; [Butler, Lisa M.] Univ Calif San Francisco, Dept Epidemiol & Biostat & Global Hlth Sci, San Francisco, CA 94143 USA; [Rollins, Nigel] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland; [Rollins, Nigel] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Durban, Kwazulu Natal, South Africa	University of Kwazulu Natal; University of California System; University of California San Francisco; World Health Organization; University of Kwazulu Natal	Horwood, C (corresponding author), Univ KwaZulu Natal, Ctr Rural Hlth, Durban, Kwazulu Natal, South Africa.	horwoodc@ukzn.ac.za	Horwood, Christiane Marianne/GRF-4446-2022	Horwood, Christiane Marianne/0000-0003-4395-1423	Global Fund to Fight AIDS, Tuberculosis and Malaria; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	Global Fund to Fight AIDS, Tuberculosis and Malaria; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All funding for the study was provided by the Global Fund to Fight AIDS, Tuberculosis and Malaria. (http://www.theglobalfund.org/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Horwood C, 2012, B WORLD HEALTH ORGAN, V90, P168, DOI 10.2471/BLT.11.092056; Jewkes R, 2012, SOC SCI MED, V74, P1729, DOI 10.1016/j.socscimed.2011.05.020; Jewkes R, 2001, SOC SCI MED, V52, P733, DOI 10.1016/S0277-9536(00)00177-5; Jewkes R, 2009, CULT HEALTH SEX, V11, P675, DOI 10.1080/13691050902846452; Kelly RJ, 2003, JAIDS-J ACQ IMM DEF, V32, P446, DOI 10.1097/00126334-200304010-00016; Moultrie TA, 2007, SAMJ S AFR MED J, V97, P442; Panday S., 2009, TEENAGE PREGNANCY S; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; SA Department of Health Medical Research Council, 2007, S AFR DEM HLTH SURV; Steffenson AE, 2011, SEX TRANSM DIS, V38, P459, DOI 10.1097/OLQ.0b013e3182080860; United Nations, 2000, UN MILL DECL; United Nations secretary-general BK-M, 2010, GLOB STRAT WOM CHILD; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	14	43	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74568	10.1371/journal.pone.0074568	http://dx.doi.org/10.1371/journal.pone.0074568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	222YC	24073215	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000024
J	Breiderhoff, T; Christiansen, GB; Pallesen, LT; Vaegter, C; Nykjaer, A; Holm, MM; Glerup, S; Willnow, TE				Breiderhoff, Tilman; Christiansen, Gitte B.; Pallesen, Lone T.; Vaegter, Christian; Nykjaer, Anders; Holm, Mai Marie; Glerup, Simon; Willnow, Thomas E.			Sortilin-Related Receptor SORCS3 Is a Postsynaptic Modulator of Synaptic Depression and Fear Extinction	PLOS ONE			English	Article							LONG-TERM DEPRESSION; AMYLOID PRECURSOR PROTEIN; AMPA RECEPTORS; PDZ DOMAIN; PICK1; HIPPOCAMPUS; CA1; IDENTIFICATION; PLASTICITY; DELETION	SORCS3 is an orphan receptor of the VPS10P domain receptor family, a group of sorting and signaling receptors central to many pathways in control of neuronal viability and function. SORCS3 is highly expressed in the CA1 region of the hippocampus, but the relevance of this receptor for hippocampal activity remained absolutely unclear. Here, we show that SORCS3 localizes to the postsynaptic density and that loss of receptor activity in gene-targeted mice abrogates NMDA receptor-dependent and -independent forms of long-term depression (LTD). Consistent with a loss of synaptic retraction, SORCS3-deficient mice suffer from deficits in behavioral activities associated with hippocampal LTD, particularly from an accelerated extinction of fear memory. A possible molecular mechanism for SORCS3 in synaptic depression was suggested by targeted proteomics approaches that identified the ability of SORCS3 to functionally interact with PICK1, an adaptor that sorts glutamate receptors at the postsynapse. Faulty localization of PICK1 in SORCS3-deficient neurons argues for altered glutamate receptor trafficking as the cause of altered synaptic plasticity in the SORCS3-deficient mouse model. In conclusion, our studies have identified a novel function for VPS10P domain receptors in control of synaptic depression and suggest SORCS3 as a novel factor modulating aversive memory extinction.	[Breiderhoff, Tilman; Willnow, Thomas E.] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Christiansen, Gitte B.; Pallesen, Lone T.; Vaegter, Christian; Nykjaer, Anders; Holm, Mai Marie; Glerup, Simon] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Pallesen, Lone T.; Vaegter, Christian; Nykjaer, Anders; Glerup, Simon] Aarhus Univ, Lundbeck Fdn Res Ctr MIND, Aarhus, Denmark; [Pallesen, Lone T.; Vaegter, Christian; Nykjaer, Anders; Glerup, Simon] Aarhus Univ, Danish Res Inst Translat Neurosci, Aarhus, Denmark	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Aarhus University; Aarhus University; Lundbeckfonden; Aarhus University	Willnow, TE (corresponding author), Max Delbrueck Ctr Mol Med, Berlin, Germany.	willnow@mdcberlin.de	Breiderhoff, Tilman/X-9364-2019; Vægter, Christian Bjerggaard/AFW-0912-2022	Breiderhoff, Tilman/0000-0002-1676-7498; Vægter, Christian Bjerggaard/0000-0001-6573-146X; Willnow, Thomas/0000-0001-9515-7921; Nykjaer, Anders/0000-0001-6422-6736; Holm, Mai/0000-0001-7347-8724	Lundbeck Foundation; German Research Foundation; Helmholtz Association of German Research Centers (iCEMED); Lundbeck Foundation [R77-2010-6802] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); German Research Foundation(German Research Foundation (DFG)); Helmholtz Association of German Research Centers (iCEMED); Lundbeck Foundation(Lundbeckfonden)	Funding was provided by the Lundbeck Foundation, the German Research Foundation, and the Helmholtz Association of German Research Centers (iCEMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bajor LA, 2013, J AFFECT DISORDERS, V145, P232, DOI 10.1016/j.jad.2012.08.005; Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Fjorback AW, 2012, J NEUROSCI, V32, P1467, DOI 10.1523/JNEUROSCI.2272-11.2012; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Hampe W, 2001, HUM GENET, V108, P529, DOI 10.1007/s004390100504; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hermey G, 2004, J NEUROCHEM, V88, P1470, DOI 10.1046/j.1471-4159.2004.02286.x; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kemp N, 2000, EUR J NEUROSCI, V12, P360, DOI 10.1046/j.1460-9568.2000.00903.x; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Lane RF, 2013, J NEUROSCI, V33, P7099, DOI 10.1523/JNEUROSCI.5270-12.2013; Lane RF, 2010, J NEUROSCI, V30, P13110, DOI 10.1523/JNEUROSCI.3872-10.2010; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Ryu J, 2008, J NEUROSCI, V28, P8178, DOI 10.1523/JNEUROSCI.1944-08.2008; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Takahashi T, 1998, J NEUROSCI, V18, P3138; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Thorsen TS, 2010, P NATL ACAD SCI USA, V107, P413, DOI 10.1073/pnas.0902225107; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Volk L, 2010, P NATL ACAD SCI USA, V107, P21784, DOI 10.1073/pnas.1016103107; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	46	42	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75006	10.1371/journal.pone.0075006	http://dx.doi.org/10.1371/journal.pone.0075006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069373	Green Published, gold, Green Accepted			2022-12-27	WOS:000324777300060
J	Mizuno, CM; Kimes, NE; Lopez-Perez, M; Auso, E; Rodriguez-Valera, F; Ghai, R				Megumi Mizuno, Carolina; Kimes, Nikole E.; Lopez-Perez, Mario; Auso, Eva; Rodriguez-Valera, Francisco; Ghai, Rohit			A Hybrid NRPS-PKS Gene Cluster Related to the Bleomycin Family of Antitumor Antibiotics in Alteromonas macleodii Strains	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; STREPTOMYCES-VERTICILLUS ATCC15003; POLYKETIDE SYNTHASE; NATURAL-PRODUCTS; TYROCIDINE SYNTHETASE; PHYLOGENETIC ANALYSES; CONDENSATION DOMAINS; SEQUENCE-ANALYSIS; ORGANIC-MATTER; BIOSYNTHESIS	Although numerous marine bacteria are known to produce antibiotics via hybrid NRPS-PKS gene clusters, none have been previously described in an Alteromonas species. In this study, we describe in detail a novel hybrid NRPS-PKS cluster identified in the plasmid of the Alteromonas macleodii strain AltDE1 and analyze its relatedness to other similar gene clusters in a sequence-based characterization. This is a mobile cluster, flanked by transposase-like genes, that has even been found inserted into the chromosome of some Alteromonas macleodii strains. The cluster contains separate genes for NRPS and PKS activity. The sole PKS gene appears to carry a novel acyltransferase domain, quite divergent from those currently characterized. The predicted specificities of the adenylation domains of the NRPS genes suggest that the final compound has a backbone very similar to bleomycin related compounds. However, the lack of genes involved in sugar biosynthesis indicates that the final product is not a glycopeptide. Even in the absence of these genes, the presence of the cluster appears to confer complete or partial resistance to phleomycin, which may be attributed to a bleomycin-resistance-like protein identified within the cluster. This also suggests that the compound still shares significant structural similarity to bleomycin. Moreover, transcriptomic evidence indicates that the NRPS-PKS cluster is expressed. Such sequence-based approaches will be crucial to fully explore and analyze the diversity and potential of secondary metabolite production, especially from increasingly important sources like marine microbes.	[Megumi Mizuno, Carolina; Kimes, Nikole E.; Lopez-Perez, Mario; Auso, Eva; Rodriguez-Valera, Francisco; Ghai, Rohit] Univ Miguel Hernandez, Evolutionary Genom Grp, Dept Prod Vegetal & Microbiol, Alicante, Spain	Universidad Miguel Hernandez de Elche	Rodriguez-Valera, F (corresponding author), Univ Miguel Hernandez, Evolutionary Genom Grp, Dept Prod Vegetal & Microbiol, Alicante, Spain.	frvalera@umh.es	Mizuno, Carolina Megumi/G-8246-2012; Eva, Ausó/AAD-8448-2022; Auso-Monreal, Eva/J-3264-2017; Rodriguez-Valera, Francisco/M-2782-2013; López-Pérez, Mario/ABG-1904-2020; Ghai, Rohit/E-7086-2012	Mizuno, Carolina Megumi/0000-0001-8016-7561; Auso-Monreal, Eva/0000-0003-2991-7659; Rodriguez-Valera, Francisco/0000-0002-9809-2059; López-Pérez, Mario/0000-0002-3996-6780; Ghai, Rohit/0000-0002-0591-6152	Spanish Ministerio de Ciencia e Innovacion [BIO2008-02444, CDS2009-00006, CGL2009-12651-C02-01]; Generalitat Valenciana [PROMETEO/2010/089, ACOMP/2009/155]; European Community [FP7-KBBE-2012-6-311975]; Juan de la Cierva from Spanish Ministerio de Ciencia e Innovacion	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Community(European Commission); Juan de la Cierva from Spanish Ministerio de Ciencia e Innovacion	This work was supported by projects MAGYK (BIO2008-02444), MICROGEN (Programa CONSOLIDER-INGENIO 2010 CDS2009-00006), and CGL2009-12651-C02-01 from the Spanish Ministerio de Ciencia e Innovacion and by projects DIMEGEN (PROMETEO/2010/089) and ACOMP/2009/155 from the Generalitat Valenciana. FEDER funds and MaCuMBA funds from the European Community (Ref. FP7-KBBE-2012-6-311975) supported this project. R. G. was supported by a Juan de la Cierva scholarship from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; BAUMANN L, 1972, J BACTERIOL, V110, P402, DOI 10.1128/JB.110.1.402-429.1972; Bergendahl V, 2002, EUR J BIOCHEM, V269, P620, DOI 10.1046/j.0014-2956.2001.02691.x; Blunt JW, 2009, NAT PROD REP, V26, P170, DOI 10.1039/b805113p; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cho JY, 2012, BIOSCI BIOTECH BIOCH, V76, P1452, DOI 10.1271/bbb.120102; Clugston SL, 2003, BIOCHEMISTRY-US, V42, P12095, DOI 10.1021/bi035090+; Devi CS, 2011, J PHARM RES, V4; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Du LH, 2001, METAB ENG, V3, P78, DOI 10.1006/mben.2000.0171; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fewer DP, 2011, APPL ENVIRON MICROB, V77, P8034, DOI 10.1128/AEM.05993-11; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fukuda D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018031; Galm U, 2011, J NAT PROD, V74, P526, DOI 10.1021/np1008152; Galm U, 2009, MOL BIOSYST, V5, P77, DOI 10.1039/b814075h; Garbeva P, 2011, ISME J, V5, P973, DOI 10.1038/ismej.2010.196; Garcia I, 2012, CHEM BIOL, V19, P399, DOI 10.1016/j.chembiol.2012.01.014; Garcia-Martinez J, 2002, ENVIRON MICROBIOL, V4, P42, DOI 10.1046/j.1462-2920.2002.00255.x; Gontang EA, 2010, APPL ENVIRON MICROB, V76, P2487, DOI 10.1128/AEM.02852-09; Gonzaga A, 2012, GENOME BIOL EVOL, V4, P1360, DOI 10.1093/gbe/evs112; Gulder TAM, 2009, CURR OPIN MICROBIOL, V12, P252, DOI 10.1016/j.mib.2009.05.002; Hoffmann D, 2003, GENE, V311, P171, DOI 10.1016/S0378-1119(03)00587-0; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee BK, 2008, J MICROBIOL, V46, P274, DOI 10.1007/s12275-007-0238-9; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lopez-Perez M, 2013, GENOME BIOL IN PRESS, DOI [10.1093/gbe/evt1089, DOI 10.1093/GBE/EVT1089]; Lopez-Perez M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00696; Lu YW, 2008, J BACTERIOL, V190, P6903, DOI 10.1128/JB.00865-08; Luo LS, 2002, BIOCHEMISTRY-US, V41, P9184, DOI 10.1021/bi026047+; MAEDA K, 1956, J ANTIBIOT, V9, P82; Mansson M, 2011, MAR DRUGS, V9, P1440, DOI 10.3390/md9091440; Martens T, 2007, MICROB ECOL, V54, P31, DOI 10.1007/s00248-006-9165-2; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Minowa Y, 2007, J MOL BIOL, V368, P1500, DOI 10.1016/j.jmb.2007.02.099; Murphy AC, 2011, ANGEW CHEM INT EDIT, V50, P3271, DOI 10.1002/anie.201007029; Olano C, 2009, MAR DRUGS, V7, P210, DOI 10.3390/md7020210; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Sanchez S, 2010, J ANTIBIOT, V63, P442, DOI 10.1038/ja.2010.78; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Sass AM, 2001, APPL ENVIRON MICROB, V67, P5392, DOI 10.1128/AEM.67.12.5392-5402.2001; Schafer H, 2001, FEMS MICROBIOL ECOL, V34, P243, DOI 10.1016/S0168-6496(00)00102-1; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Shen B, 2002, J NAT PROD, V65, P422, DOI 10.1021/np010550q; SHIGEMORI H, 1992, J ORG CHEM, V57, P4317, DOI 10.1021/jo00041a053; SHIOZAWA H, 1993, J ANTIBIOT, V46, P1834, DOI 10.7164/antibiotics.46.1834; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tao MF, 2007, MOL BIOSYST, V3, P60, DOI 10.1039/b615284h; Tomprefa N, 2011, BIOCONTROL SCI TECHN, V21, P721, DOI 10.1080/09583157.2011.575211; Uzair B, 2012, SCI WORLD J, V10; Walsh CT, 2008, ACCOUNTS CHEM RES, V41, P4, DOI 10.1021/ar7000414; Wietz M, 2011, ENV MICROBIOL REP, V3, P559, DOI 10.1111/j.1758-2229.2011.00259.x; Yadav G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000351; Zhang JH, 1997, APPL ENVIRON MICROB, V63, P2771, DOI 10.1128/AEM.63.7.2771-2778.1997; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu P, 2009, CAN J MICROBIOL, V55, P219, DOI [10.1139/W08-125, 10.1139/w08-125]; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	67	19	19	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e76021	10.1371/journal.pone.0076021	http://dx.doi.org/10.1371/journal.pone.0076021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069455	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300102
J	Yang, S; Kuang, Y; Li, HB; Liu, YH; Hui, XY; Li, P; Jiang, ZW; Zhou, YL; Wang, Y; Xu, AM; Li, SW; Liu, PT; Wu, DH				Yang, Song; Kuang, Ye; Li, Hongbo; Liu, Yuehong; Hui, Xiaoyan; Li, Peng; Jiang, Zhiwu; Zhou, Yulai; Wang, Yu; Xu, Aimin; Li, Shiwu; Liu, Pentao; Wu, Donghai			Enhanced Production of Recombinant Secretory Proteins in Pichia pastoris by Optimizing Kex2 P1' site	PLOS ONE			English	Article							STEM-CELL FACTOR; C-KIT; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; SPECIFICITY; PROTEASE; LIGAND; OVEREXPRESSION; ENDOPROTEASE; SELECTION	Pichia pastoris is one of the most widely used expression systems for the production of recombinant secretory proteins. Its universal application is, however, somewhat hampered by its unpredictable yields for different heterologous proteins, which is now believed to be caused in part by their varied efficiencies to traffic through the host secretion machinery. The yeast endoprotease Kex2 removes the signal peptides from pre-proteins and releases the mature form of secreted proteins, thus, plays a pivotal role in the yeast secretory pathways. In this study, we found that the yields of many recombinant proteins were greatly influenced by Kex2 P1' site residues and the optimized P1's amino acid residue could largely determine the final amount of secretory proteins synthesized and secreted. A further improvement of secretory yield was achieved by genomic integration of additional Kex2 copies, which again highlighted the importance of Kex2 cleavage to the production of recombinant secretory proteins in Pichia yeast.	[Yang, Song; Kuang, Ye; Li, Hongbo; Liu, Yuehong; Li, Peng; Jiang, Zhiwu; Wang, Yu; Xu, Aimin; Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Yang, Song; Kuang, Ye; Li, Hongbo; Liu, Yuehong; Li, Peng; Jiang, Zhiwu; Wang, Yu; Xu, Aimin; Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China; [Kuang, Ye; Liu, Yuehong; Zhou, Yulai] Jilin Univ, Sch Pharmaceut Sci, Dept Biomed Engn, Changchun 130023, Peoples R China; [Li, Hongbo] Huaihua Coll, Dept Life Sci, Key Lab Res & Utilizat Ethnomed Plant Resources H, Huaihua, Peoples R China; [Hui, Xiaoyan; Wang, Yu; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Li, Shiwu] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge, England	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Jilin University; Huaihua University; University of Hong Kong; State University System of Florida; University of Florida; Wellcome Trust Sanger Institute	Wu, DH (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	dhwu2001@gmail.com	Li, Peng/AER-7520-2022; HUI, Xiaoyan Hannah/M-5175-2019	HUI, Xiaoyan Hannah/0000-0002-7525-5812; Jiang, Zhiwu/0000-0002-9359-7779; wang, yu/0000-0001-8697-2940	National Basic Research Program of China [2011CB504004, 2010CB945500]; Strategic Exploration Grant of Stem Cells from the Chinese Academy of Sciences [XDA01020303]; Science and Technology Planning Project of Guangdong Province [2011A060901019]	National Basic Research Program of China(National Basic Research Program of China); Strategic Exploration Grant of Stem Cells from the Chinese Academy of Sciences; Science and Technology Planning Project of Guangdong Province	This work was supported in part by funds from the National Basic Research Program of China (2011CB504004 and 2010CB945500), the Strategic Exploration Grant of Stem Cells from the Chinese Academy of Sciences (XDA01020303) and Science and Technology Planning Project of Guangdong Province (2011A060901019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRAHAM H, 1992, BLOOD, V79, P365; Bader O, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-116; Barnard GC, 2010, J IND MICROBIOL BIOT, V37, P961, DOI 10.1007/s10295-010-0746-1; Bevan A, 1998, P NATL ACAD SCI USA, V95, P10384, DOI 10.1073/pnas.95.18.10384; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Cereghino GPL, 2002, CURR OPIN BIOTECH, V13, P329, DOI 10.1016/S0958-1669(02)00330-0; Cos O, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-17; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dragosits M, 2009, J PROTEOME RES, V8, P1380, DOI 10.1021/pr8007623; FULLER RS, 1988, ANNU REV PHYSIOL, V50, P345, DOI 10.1146/annurev.ph.50.030188.002021; FULLER RS, 1989, SCIENCE, V246, P482, DOI 10.1126/science.2683070; FULLER RS, 1989, P NATL ACAD SCI USA, V86, P1434, DOI 10.1073/pnas.86.5.1434; Gasser B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-179; Gasser B, 2007, APPL ENVIRON MICROB, V73, P6499, DOI 10.1128/AEM.01196-07; Gasser B, 2006, BIOTECHNOL BIOENG, V94, P353, DOI 10.1002/bit.20851; GERMAIN D, 1992, FEBS LETT, V299, P283, DOI 10.1016/0014-5793(92)80132-Z; GERMAIN D, 1992, EUR J BIOCHEM, V204, P121, DOI 10.1111/j.1432-1033.1992.tb16613.x; Goodman M, 2009, NAT REV DRUG DISCOV, V8, P837, DOI 10.1038/nrd3040; Graf A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-390; Guerfal M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-49; Hartner FS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn369; HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007; Inan M, 2006, BIOTECHNOL BIOENG, V93, P771, DOI 10.1002/bit.20762; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; Kent D, 2008, CLIN CANCER RES, V14, P1926, DOI 10.1158/1078-0432.CCR-07-5134; Kliman RM, 2003, J MOL EVOL, V57, P98, DOI 10.1007/s00239-003-2459-9; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Li PZ, 2007, APPL BIOCHEM BIOTECH, V142, P105, DOI 10.1007/s12010-007-0003-x; Love KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037915; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; MEKORI YA, 1995, INT ARCH ALLERGY IMM, V107, P136, DOI 10.1159/000236955; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Potgieter TI, 2009, J BIOTECHNOL, V139, P318, DOI 10.1016/j.jbiotec.2008.12.015; Resina D, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-21; RHOLAM M, 1995, EUR J BIOCHEM, V227, P707, DOI 10.1111/j.1432-1033.1995.tb20192.x; Rockwell NC, 1997, BIOCHEMISTRY-US, V36, P1912, DOI 10.1021/bi961779l; Rockwell NC, 2004, TRENDS BIOCHEM SCI, V29, P80, DOI 10.1016/j.tibs.2003.12.006; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Rockwell NC, 1998, BIOCHEMISTRY-US, V37, P3386, DOI 10.1021/bi972534r; ROMANOS M, 1995, CURR OPIN BIOTECH, V6, P527, DOI 10.1016/0958-1669(95)80087-5; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Rosenfeld SA, 1999, METHOD ENZYMOL, V306, P154; Rossi P, 2000, J ENDOCRINOL INVEST, V23, P609, DOI 10.1007/BF03343784; Sheridan C, 2010, NAT BIOTECHNOL, V28, P307, DOI 10.1038/nbt0410-307; Stadheim TA, 2008, NAT PROTOC, V3, P1026, DOI 10.1038/nprot.2008.76; Stadlmayr G, 2010, BIOTECHNOL BIOENG, V105, P543, DOI 10.1002/bit.22573; Sumi A, 1999, BIOSEPARATION, V8, P195, DOI 10.1023/A:1008081314112; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Weis R, 2004, FEMS YEAST RES, V5, P179, DOI 10.1016/j.femsyr.2004.06.016; Werten MWT, 1999, YEAST, V15, P1087, DOI 10.1002/(SICI)1097-0061(199908)15:11<1087::AID-YEA436>3.0.CO;2-F; Xuan YJ, 2009, FEMS YEAST RES, V9, P1271, DOI 10.1111/j.1567-1364.2009.00571.x	54	41	43	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75347	10.1371/journal.pone.0075347	http://dx.doi.org/10.1371/journal.pone.0075347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069404	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300073
J	Zhu, R; Wang, SC; Sun, C; Tao, Y; Piao, HL; Wang, XQ; Du, MR; Li, DJ				Zhu, Rui; Wang, Song-Cun; Sun, Chan; Tao, Yu; Piao, Hai-Lan; Wang, Xiao-Qiu; Du, Mei-Rong; Li, Da-Jin			Hyaluronan-CD44 Interaction Promotes Growth of Decidual Stromal Cells in Human First-Trimester Pregnancy	PLOS ONE			English	Article							T-CELLS; EXTRACELLULAR-MATRIX; TH2 BIAS; EXPRESSION; CD44; IMPLANTATION; INTERFACE; INFLAMMATION; TROPHOBLASTS; MAINTENANCE	Hyaluronan (HA) and its receptor CD44 are expressed at the maternal-fetal interface, but its role in early pregnancy remains unclear. Here, we found that primary decidual stromal cells (DSCs) continuously secreted HA and expressed its receptor CD44. Pregnancy-associated hormones up-regulated HA synthetase (HAS) 2 transcription and HA release from DSCs. High molecular weight-HA (HMW-HA), but not medium molecular weight (MMW-HA) or low molecular weight (LMW-HA), promoted proliferation and inhibited apoptosis of DSCs in a CD44-dependent manner. The in-cell Western analysis revealed HMW-HA activated PI3K/AKT and mitogen-activated protein kinase (MAPK)/ERK1/2 signaling pathways time-dependently. Blocking these pathways by specific inhibitor LY294002 or U0126 abrogated HMW-HA-regulated DSc proliferation and apoptosis. Finally, we have found that HA content, HA molecular weight, HAS2 mRNA level, and CD44 expression were significantly decreased in DSCs from unexplained miscarriage compared with the normal pregnancy. Collectively, our results indicate that higher level and greater molecular mass of HA at maternal-fetal interface contributes to DSc growth and maintenance of DSCs in human early pregnancy.	[Zhu, Rui; Wang, Song-Cun; Sun, Chan; Tao, Yu; Piao, Hai-Lan; Wang, Xiao-Qiu; Du, Mei-Rong; Li, Da-Jin] Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol, Hosp & Inst Obstet & Gynecol,IBS, Shanghai 200433, Peoples R China; [Zhu, Rui] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou, Peoples R China	Fudan University; Soochow University - China	Du, MR (corresponding author), Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol, Hosp & Inst Obstet & Gynecol,IBS, Shanghai 200433, Peoples R China.	dmrlq1973@sina.cn; djli@shmu.edu.cn			Key Project of Shanghai Basic Research [12JC1401600]; Shanghai Shenkang Foundation [SHDC12010122]; Shanghai PuJiang Talent Program [10PJ1401600]; National Nature Science Foundation of China [NSFC30910103909, NSFC31270969, NSFC81070537, NSFC31171437]; Natural Science Research Program for Colleges and Universities of Jiangsu Province [10KJB320021]	Key Project of Shanghai Basic Research; Shanghai Shenkang Foundation; Shanghai PuJiang Talent Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Research Program for Colleges and Universities of Jiangsu Province	This work was supported by the Key Project of Shanghai Basic Research [12JC1401600 to D-JL]; Shanghai Shenkang Foundation [SHDC12010122 to D-JL]; Shanghai PuJiang Talent Program [10PJ1401600 to M-RD]; and National Nature Science Foundation of China [NSFC30910103909 and NSFC31270969 to D-JL, NSFC81070537 and NSFC31171437 to M-RD]; and the Natural Science Research Program for Colleges and Universities of Jiangsu Province [10KJB320021 to RZ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz L, 2006, GLYCOBIOLOGY, V16, P359, DOI 10.1093/glycob/cwj085; Bhilocha S, 2011, ANAL BIOCHEM, V417, P41, DOI 10.1016/j.ab.2011.05.026; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Campo GM, 2010, INNATE IMMUN-LONDON, V16, P48, DOI 10.1177/1753425909340419; Chang CC, 2012, CARBOHYD POLYM, V90, P1168, DOI 10.1016/j.carbpol.2012.06.071; Cordo-Russo R, 2009, PLACENTA, V30, P88, DOI 10.1016/j.placenta.2008.10.013; Dekel N, 2010, AM J REPROD IMMUNOL, V63, P17, DOI 10.1111/j.1600-0897.2009.00792.x; Du MR, 2012, HUM REPROD, V27, P1955, DOI 10.1093/humrep/des111; Egorina EM, 2006, J THROMB HAEMOST, V4, P614, DOI 10.1111/j.1538-7836.2005.01781.x; Godbole G, 2011, FERTIL STERIL, V95, P1278, DOI 10.1016/j.fertnstert.2010.09.045; Goshen R, 1996, MOL HUM REPROD, V2, P685, DOI 10.1093/molehr/2.9.685; Guo PF, 2010, BLOOD, V116, P2061, DOI 10.1182/blood-2009-11-252940; Hambiliki F, 2010, FERTIL STERIL, V94, P1669, DOI 10.1016/j.fertnstert.2009.10.019; Hao JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040716; He YY, 2012, CLIN IMMUNOL, V145, P161, DOI 10.1016/j.clim.2012.07.017; Herishanu Y, 2011, LEUKEMIA LYMPHOMA, V52, P1758, DOI 10.3109/10428194.2011.569962; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006; Jung T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208421; King AE, 2010, J STEROID BIOCHEM, V120, P116, DOI 10.1016/j.jsbmb.2010.01.003; Ledee N, 2011, J PATHOL, V225, P554, DOI 10.1002/path.2948; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; Lockwood CJ, 2009, REPROD SCI, V16, P162, DOI 10.1177/1933719108325758; Marzioni D, 2001, EUR J HISTOCHEM, V45, P131; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Nagamatsu T, 2009, HUM REPROD, V24, P3160, DOI 10.1093/humrep/dep308; Nakagawa K, 2012, J ASSIST REPROD GEN, V29, P679, DOI 10.1007/s10815-012-9758-2; Olivares EG, 1997, BIOL REPROD, V57, P609, DOI 10.1095/biolreprod57.3.609; Patriarca MT, 2013, MENOPAUSE, V20, P336, DOI [10.1097/GME.0b013e318269898c, 10.1097/gme.0b013e318269898c]; Piao HL, 2012, CELL MOL IMMUNOL, V9, P423, DOI 10.1038/cmi.2012.23; Ruiz C, 1997, J REPROD IMMUNOL, V33, P15, DOI 10.1016/S0165-0378(96)01009-1; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Silasi M, 2012, AM J REPROD IMMUNOL, V68, P279, DOI 10.1111/aji.12006; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Stock AE, 2002, ENDOCRINOLOGY, V143, P4375, DOI 10.1210/en.2002-220563; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Xu BF, 2012, FERTIL STERIL, V98, P389, DOI 10.1016/j.fertnstert.2012.04.032; Zhou WH, 2008, HUM REPROD, V23, P2669, DOI 10.1093/humrep/den308	41	27	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74812	10.1371/journal.pone.0074812	http://dx.doi.org/10.1371/journal.pone.0074812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069351	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300049
J	Yamagishi, N; Anderson, SJ				Yamagishi, Noriko; Anderson, Stephen J.			The Relationship between Self-Awareness of Attentional Status, Behavioral Performance and Oscillatory Brain Rhythms	PLOS ONE			English	Article							CINGULATE MOTOR AREAS; NEURONAL SYNCHRONIZATION; VOLUNTARY MOVEMENT; VISUAL-ATTENTION; NEURAL BASIS; CORTEX; TASK; EEG; GAMMA; DESYNCHRONIZATION	High-level cognitive factors, including self-awareness, are believed to play an important role in human visual perception. The principal aim of this study was to determine whether oscillatory brain rhythms play a role in the neural processes involved in self-monitoring attentional status. To do so we measured cortical activity using magnetoencephalography (MEG) and functional magnetic resonance imaging (fMRI) while participants were asked to self-monitor their internal status, only initiating the presentation of a stimulus when they perceived their attentional focus to be maximal. We employed a hierarchical Bayesian method that uses fMRI results as soft-constrained spatial information to solve the MEG inverse problem, allowing us to estimate cortical currents in the order of millimeters and milliseconds. Our results show that, during self-monitoring of internal status, there was a sustained decrease in power within the 7-13 Hz (alpha) range in the rostral cingulate motor area (rCMA) on the human medial wall, beginning approximately 430 msec after the trial start (p < 0.05, FDR corrected). We also show that gamma-band power (41-47 Hz) within this area was positively correlated with task performance from 40-640 msec after the trial start (r = 0.71, p < 0.05). We conclude: (1) the rCMA is involved in processes governing self-monitoring of internal status; and (2) the qualitative differences between alpha and gamma activity are reflective of their different roles in self-monitoring internal states. We suggest that alpha suppression may reflect a strengthening of top-down interareal connections, while a positive correlation between gamma activity and task performance indicates that gamma may play an important role in guiding visuomotor behavior.	[Yamagishi, Noriko] Dept Cognit Neurosci, ATR Cognit Mech Labs, Kyoto, Japan; [Yamagishi, Noriko] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Yamagishi, Noriko] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Brain Networks & Commun Lab, Osaka, Japan; [Anderson, Stephen J.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Japan Science & Technology Agency (JST); National Institute of Information & Communications Technology (NICT) - Japan; Aston University	Yamagishi, N (corresponding author), Dept Cognit Neurosci, ATR Cognit Mech Labs, Kyoto, Japan.	n.yamagishi@nict.go.jp			JST PRESTO program	JST PRESTO program	This work was supported by the JST PRESTO program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkal D, 2002, EUR J NEUROSCI, V15, P887, DOI 10.1046/j.1460-9568.2002.01920.x; Bisley JW, 2011, J PHYSIOL-LONDON, V589, P49, DOI 10.1113/jphysiol.2010.192666; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; de Jong R, 2006, BRAIN RES, V1105, P73, DOI 10.1016/j.brainres.2006.03.030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fincham JM, 2002, P NATL ACAD SCI USA, V99, P3346, DOI 10.1073/pnas.052703399; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2008, J NEUROSCI, V28, P4823, DOI 10.1523/JNEUROSCI.4499-07.2008; Habas C, 2010, NEURORADIOLOGY, V52, P47, DOI 10.1007/s00234-009-0572-1; Haegens S, 2012, J COGNITIVE NEUROSCI, V24, P677, DOI 10.1162/jocn_a_00164; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Hoshi E, 2005, J NEUROPHYSIOL, V94, P640, DOI 10.1152/jn.01201.2004; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Leocani L, 1997, EVOKED POTENTIAL, V104, P199, DOI 10.1016/S0168-5597(96)96051-7; Leocani L, 2001, CLIN NEUROPHYSIOL, V112, P923, DOI 10.1016/S1388-2457(01)00530-2; Morgan HM, 2011, J NEUROPHYSIOL, V106, P3185, DOI 10.1152/jn.00246.2011; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Nam CS, 2011, CLIN NEUROPHYSIOL, V122, P567, DOI 10.1016/j.clinph.2010.08.002; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Pashler HE., 1998, PSYCHOL ATTENTION, DOI [10.7551/mitpress/5677.001.0001, DOI 10.7551/MITPRESS/5677.001.0001]; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Qin PM, 2012, HUM BRAIN MAPP, V33, P154, DOI 10.1002/hbm.21201; Richardson AG, 2008, J NEUROPHYSIOL, V99, P1253, DOI 10.1152/jn.01096.2007; Roux F, 2012, J NEUROSCI, V32, P12411, DOI 10.1523/JNEUROSCI.0421-12.2012; Sato M, 2004, NEUROIMAGE, V23, P806, DOI 10.1016/j.neuroimage.2004.06.037; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Shaw JC, 2003, BRAINS ALPHA PHYTHMS; Shibata K, 2008, CEREB CORTEX, V18, P1664, DOI 10.1093/cercor/bhm194; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Smith EL, 2008, CURR BIOL, V18, pR414, DOI 10.1016/j.cub.2008.03.009; Szurhaj W, 2003, CLIN NEUROPHYSIOL, V114, P107, DOI 10.1016/S1388-2457(02)00333-4; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Worden MS, 2000, J NEUROSCI, V20; Yamagishi N, 2003, NEUROIMAGE, V20, P98, DOI 10.1016/S1053-8119(03)00341-0; Yamagishi N, 2005, COGNITIVE BRAIN RES, V25, P799, DOI 10.1016/j.cogbrainres.2005.09.006; Yamagishi N, 2008, BRAIN RES, V1197, P115, DOI 10.1016/j.brainres.2007.12.063; Yamagishi N, 2010, P ROY SOC B-BIOL SCI, V277, P3421, DOI 10.1098/rspb.2010.0891; Yoshioka T, 2008, NEUROIMAGE, V42, P1397, DOI 10.1016/j.neuroimage.2008.06.013	54	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74962	10.1371/journal.pone.0074962	http://dx.doi.org/10.1371/journal.pone.0074962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069368	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000324547300066
J	Barclay, P; Benard, S				Barclay, Pat; Benard, Stephen			Who Cries Wolf, and When? Manipulation of Perceived Threats to Preserve Rank in Cooperative Groups	PLOS ONE			English	Article							INTERGROUP CONFLICT; GROUP COMPETITION; VOLUNTARY PROVISION; MORTALITY SALIENCE; POWER; LEADERSHIP; EVOLUTION; DILEMMA; HETEROGENEITY; SACRIFICE	People perform greater within-group cooperation when their groups face external threats, such as hostile outgroups or natural disasters. Researchers and social commentators suggest that high-ranking group members manipulate this "threatdependent'' cooperation by exaggerating threats in order to promote cooperation and suppress competition for their position. However, little systematic research tests this claim or possible situational moderators. In three studies, we use a cooperative group game to show that participants pay to increase others' perceptions of group threats, and spend more on manipulation when holding privileged positions. This manipulation cost-effectively elicits cooperation and sustains privilege, and is fostered by competition over position, not only position per se. Less cooperative people do more manipulation than more cooperative people do. Furthermore, these effects generalize to broader definitions of privilege. Conceptually, these results offer new insights into an understudied dimension of group behavior. Methodologically, the research extends cooperative group games to allow for analyzing more complex group dynamics.	[Barclay, Pat] Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada; [Benard, Stephen] Indiana Univ, Dept Sociol, Bloomington, IN USA	University of Guelph; Indiana University System; Indiana University Bloomington	Barclay, P (corresponding author), Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada.	barclayp@uoguelph.ca		Barclay, Pat/0000-0002-7905-9069	National Science Foundation (NSF) [0904312]; Minerva Initiative of the U.S. Department of Defense; Cornell University Institute for Social Sciences; Division Of Behavioral and Cognitive Sci [0904312] Funding Source: National Science Foundation; Division of Behavioral and Cognitive Sciences [0904622] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Minerva Initiative of the U.S. Department of Defense(United States Department of Defense); Cornell University Institute for Social Sciences; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division of Behavioral and Cognitive Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This material is based upon work supported by the National Science Foundation under Grant No.(NSF grant 0904312) in conjunction with the Minerva Initiative of the U.S. Department of Defense, as well by the Cornell University Institute for Social Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or other sponsors.	Anderson C, 2002, J PERS SOC PSYCHOL, V83, P1362, DOI 10.1037//0022-3514.83.6.1362; ANDREONI J, 1995, AM ECON REV, V85, P891; Axelrod R., 1984, THE EVOLUTION OF COO; Barclay P, 2004, EVOL HUM BEHAV, V25, P209, DOI 10.1016/j.evolhumbehav.2004.04.002; Barclay P, 2013, EVOL HUM BEHAV, V34, P164, DOI 10.1016/j.evolhumbehav.2013.02.002; BARGH JA, 1995, J PERS SOC PSYCHOL, V68, P768, DOI 10.1037/0022-3514.68.5.768; Barker JL, 2012, BEHAV ECOL, V23, P735, DOI 10.1093/beheco/ars020; BEKKERS F, 1977, J PEACE RES, V14, P223, DOI 10.1177/002234337701400302; Benard Stephen, 2011, ADV GROUP PROCESS, V28, P189; Boehm C., 1999, HIERARCHY IN THE FOR; Bornstein G, 2003, PERS SOC PSYCHOL REV, V7, P129, DOI 10.1207/S15327957PSPR0702_129-145; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Brewer M.B., 2001, SOCIAL IDENTITY INTE, P17; Buckley E, 2006, J PUBLIC ECON, V90, P935, DOI 10.1016/j.jpubeco.2005.06.002; Chagnon NA, 1997, YANOMAMO; Chan K. S., 1999, Experimental Economics, V2, P5; Chan KS, 1997, J ECON BEHAV ORGAN, V32, P349, DOI 10.1016/S0167-2681(96)00025-X; Cherry TL, 2005, J ECON BEHAV ORGAN, V57, P357, DOI 10.1016/j.jebo.2003.11.010; Cinrincione J, 2004, WMD IN IRAQ EVIDENCE; Coser LA, 1956, THE FUNCTIONS OF SOC; Davis D. D., 1993, EXPERIMENTAL ECONOMI; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; DAWKINS MS, 1991, ANIM BEHAV, V41, P865, DOI 10.1016/S0003-3472(05)80353-7; Diamond J., 2005, COLLAPSE HOW SOCIETI; DIEKMANN A, 1993, INT J GAME THEORY, V22, P75, DOI 10.1007/BF01245571; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fordham B, 1998, INT STUD QUART, V42, P567, DOI 10.1111/0020-8833.00096; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Galinsky AD, 2006, PSYCHOL SCI, V17, P1068, DOI 10.1111/j.1467-9280.2006.01824.x; Gambetta D, 2009, CODES OF THE UNDERWORLD: HOW CRIMINALS COMMUNICATE, P1; Gould R.V., 2003, COLLISION WILLS AMBI, DOI 10.7208/chicago/9780226305516.001.0001; Gruenfeld DH, 2008, J PERS SOC PSYCHOL, V95, P111, DOI 10.1037/0022-3514.95.1.111; Guinote A, 2007, EUR REV SOC PSYCHOL, V18, P256, DOI 10.1080/10463280701692813; Halevy N, 2008, PSYCHOL SCI, V19, P405, DOI 10.1111/j.1467-9280.2008.02100.x; Hardy CL, 2006, PERS SOC PSYCHOL B, V32, P1402, DOI 10.1177/0146167206291006; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; JOHNSON RH, 1986, INT SECURITY, V10, P32; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; Jonas E, 2002, PERS SOC PSYCHOL B, V28, P1342, DOI 10.1177/014616702236834; KERR NL, 1993, PERS SOC PSYCHOL B, V19, P432, DOI 10.1177/0146167293194008; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Lahti DC, 2005, EVOL HUM BEHAV, V26, P47, DOI 10.1016/j.evolhumbehav.2004.09.004; Landau MJ, 2004, PERS SOC PSYCHOL B, V30, P1136, DOI 10.1177/0146167204267988; LAWLER EJ, 1975, SOCIOMETRY, V38, P163, DOI 10.2307/2786598; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Levati MV, 2007, J CONFLICT RESOLUT, V51, P793, DOI 10.1177/0022002707302796; Luke DA, 2019, MULTILEVEL MODELING; Magaloni B, 2010, ANNU REV POLIT SCI, V13, P123, DOI 10.1146/annurev.polisci.031908.220529; Magee JC, 2005, LEAS ORG MAN SERIES, P275; Maner JK, 2010, J PERS SOC PSYCHOL, V99, P482, DOI 10.1037/a0018559; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Milinski M, 2002, P ROY SOC B-BIOL SCI, V269, P881, DOI 10.1098/rspb.2002.1964; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; MUNN CA, 1986, NATURE, V319, P143, DOI 10.1038/319143a0; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Pickering J, 2005, INT STUD QUART, V49, P23, DOI 10.1111/j.0020-8833.2005.00333.x; PRUITT DG, 1977, ANNU REV PSYCHOL, V28, P363, DOI 10.1146/annurev.ps.28.020177.002051; Puurtinen M, 2009, P ROY SOC B-BIOL SCI, V276, P355, DOI 10.1098/rspb.2008.1060; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Radford AN, 2008, P ROY SOC B-BIOL SCI, V275, P2787, DOI 10.1098/rspb.2008.0787; RAPOPORT A, 1993, ORGAN BEHAV HUM DEC, V55, P171, DOI 10.1006/obhd.1993.1029; Reeve HK, 2007, P NATL ACAD SCI USA, V104, P9736, DOI 10.1073/pnas.0703466104; Reeve HK, 2006, P NATL ACAD SCI USA, V103, P8430, DOI 10.1073/pnas.0603005103; Roberts G, 2005, ANIM BEHAV, V70, P901, DOI 10.1016/j.anbehav.2005.02.006; Sherif M, 1966, IN COMMON PREDICAMEN; SHILS E, 1965, AM SOCIOL REV, V30, P199, DOI 10.2307/2091564; SHORT JF, 1963, AM J SOCIOL, V68, P571, DOI 10.1086/223429; Simmel Georg, 1955, CONFLICT; Sober E., 1998, UNTO OTHERS THE EVOL; Svolik MW, 2009, AM J POLIT SCI, V53, P477, DOI 10.1111/j.1540-5907.2009.00382.x; Tisdall S, 2010, THE GUARDIAN; Tsebelis G., 1990, NESTED GAMES RATIONA; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Vasi IB, 2003, SOC FORCES, V81, P979, DOI 10.1353/sof.2003.0047; Watts DP, 2010, MIND THE GAP: TRACING THE ORIGINS OF HUMAN UNIVERSALS, P109, DOI 10.1007/978-3-642-02725-3_5; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2006, CURR BIOL, V16, P1103, DOI 10.1016/j.cub.2006.03.069; Willer R., 2004, CURRENT RES SOCIAL P, V10, P1; Willer R, 2009, AM SOCIOL REV, V74, P23, DOI 10.1177/000312240907400102; WILSON W, 1971, J CONFLICT RESOLUT, V15, P167, DOI 10.1177/002200277101500205; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110; Zelmer J., 2003, Experimental Economics, V6, P299, DOI 10.1023/A:1026277420119	84	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73863	10.1371/journal.pone.0073863	http://dx.doi.org/10.1371/journal.pone.0073863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069239	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100064
J	Hamre, LA; Eichner, C; Caipang, CMA; Dalvin, ST; Bron, JE; Nilsen, F; Boxshall, G; Skern-Mauritzen, R				Hamre, Lars A.; Eichner, Christiane; Caipang, Christopher Marlowe A.; Dalvin, Sussie T.; Bron, James E.; Nilsen, Frank; Boxshall, Geoff; Skern-Mauritzen, Rasmus			The Salmon Louse Lepeophtheirus salmonis (Copepoda: Caligidae) Life Cycle Has Only Two Chalimus Stages	PLOS ONE			English	Article							DEVELOPMENTAL-STAGES; SEA LICE; CALIGUS; GROWTH; SURVIVAL; WATERS; SALAR	Each year the salmon louse (Lepeophtheirus salmonis Kroyer, 1838) causes multi-million dollar commercial losses to the salmon farming industry world-wide, and strict lice control regimes have been put in place to reduce the release of salmon louse larvae from aquaculture facilities into the environment. For half a century, the Lepeophtheirus life cycle has been regarded as the only copepod life cycle including 8 post-nauplius instars as confirmed in four different species, including L. salmonis. Here we prove that the accepted life cycle of the salmon louse is wrong. By observations of chalimus larvae molting in incubators and by morphometric cluster analysis, we show that there are only two chalimus instars: chalimus 1 (comprising the former chalimus I and II stages which are not separated by a molt) and chalimus 2 (the former chalimus III and IV stages which are not separated by a molt). Consequently the salmon louse life cycle has only six post-nauplius instars, as in other genera of caligid sea lice and copepods in general. These findings are of fundamental importance in experimental studies as well as for interpretation of salmon louse biology and for control and management of this economically important parasite.	[Hamre, Lars A.; Eichner, Christiane; Dalvin, Sussie T.; Nilsen, Frank] Univ Bergen, Sea Lice Res Ctr, Bergen, Norway; [Caipang, Christopher Marlowe A.; Dalvin, Sussie T.; Skern-Mauritzen, Rasmus] Inst Marine Res, N-5024 Bergen, Norway; [Bron, James E.] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Boxshall, Geoff] Nat Hist Museum, London SW7 5BD, England	University of Bergen; Institute of Marine Research - Norway; University of Stirling; Natural History Museum London	Skern-Mauritzen, R (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	rasmus@imr.no	Dalvin, Sussie/AAL-6893-2021; Bron, James E/B-6231-2018	Dalvin, Sussie/0000-0002-6092-4710; Bron, James E/0000-0003-3544-0519; Boxshall, Geoffrey/0000-0001-8170-7734; Hamre, Lars Are/0000-0002-9546-921X; Caipang, Christopher Marlowe/0000-0001-6356-9753	Research Council of Norway (RCN); Norwegian Seafood Research Fund (FHF) through the SFI-Sea Lice Research Centre (RCN) [203513]; PrevenT project (FHF) [900416]; PrevenT project (RCN) [199778]	Research Council of Norway (RCN)(Research Council of Norway); Norwegian Seafood Research Fund (FHF) through the SFI-Sea Lice Research Centre (RCN); PrevenT project (FHF); PrevenT project (RCN)	This research has been funded by the Research Council of Norway (RCN) and the Norwegian Seafood Research Fund (FHF) through the SFI-Sea Lice Research Centre (RCN grant number 203513) and the PrevenT project (FHF grant number 900416 and RCN grant number 199778). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSTENSRUD M, 1990, J MAR BIOL ASSOC UK, V70, P269, DOI 10.1017/S0025315400035396; Bjorn PA, 2001, AQUAC RES, V32, P947, DOI 10.1046/j.1365-2109.2001.00627.x; Boxshall GA, 1998, PHILOS T ROY SOC B, V353, P765, DOI 10.1098/rstb.1998.0242; BOXSHALL GA, 1974, J NAT HIST, V8, P681, DOI 10.1080/00222937400770581; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Dalvin S, 2011, DIS AQUAT ORGAN, V94, P211, DOI 10.3354/dao02331; Eichner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-126; Glover KA, 2011, MAR ECOL PROG SER, V427, P161, DOI 10.3354/meps09045; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Ho JS., 2004, SEA LICE TAIWAN COPE; Izawa K., 1969, Report of the Faculty of Fisheries Prefectural University of Mie, V6, P127; JOHNSON SC, 1991, CAN J ZOOL, V69, P929, DOI 10.1139/z91-138; JOHNSON SC, 1991, J MAR BIOL ASSOC UK, V71, P425, DOI 10.1017/S0025315400051687; KABATA Z, 1972, J FISH RES BOARD CAN, V29, P1571, DOI 10.1139/f72-245; Kim Il-Hoi, 1993, P16; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Lees F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001549; LEWIS ALAN G., 1963, PACIFIC SCI, V17, P195; Liddy GC, 2003, AQUACULT INT, V11, P53, DOI 10.1023/A:1024100110378; Lin CL, 1996, J NAT HIST, V30, P661, DOI 10.1080/00222939600770371; Madinabeitia I, 2011, J PARASITOL, V97, P221, DOI 10.1645/GE-2615.1; Maran BAV, 2013, PARASITE, V20, DOI 10.1051/parasite/2013015; Mennerat A, 2012, J EVOLUTION BIOL, V25, P856, DOI 10.1111/j.1420-9101.2012.02474.x; Ohtsuka S, 2009, J NAT HIST, V43, P1779, DOI 10.1080/00222930902993757; Piasecki W, 1996, CAN J ZOOL, V74, P1459, DOI 10.1139/z96-161; Price MHH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016851; Schram Thomas A., 1993, P30; Skern-Mauritzen R, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-44; Tucker CS, 2002, FISH PATHOL, V37, P107, DOI 10.3147/jsfp.37.107; Voth DR, 1972, THESIS OREGON STATE	30	168	170	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73539	10.1371/journal.pone.0073539	http://dx.doi.org/10.1371/journal.pone.0073539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069203	Green Published, gold			2022-12-27	WOS:000326240100049
J	Madouasse, A; Marceau, A; Lehebel, A; Brouwer-Middelesch, H; van Schaik, G; Van der Stede, Y; Fourichon, C				Madouasse, Aurelien; Marceau, Alexis; Lehebel, Anne; Brouwer-Middelesch, Henriette; van Schaik, Gerdien; Van der Stede, Yves; Fourichon, Christine			Evaluation of a Continuous Indicator for Syndromic Surveillance through Simulation. Application to Vector Borne Disease Emergence Detection in Cattle Using Milk Yield	PLOS ONE			English	Article							VIRUS SEROTYPE 8; BLUETONGUE VIRUS; OUTBREAKS; EPIDEMIC; EUROPE	Two vector borne diseases, caused by the Bluetongue and Schmallenberg viruses respectively, have emerged in the European ruminant populations since 2006. Several diseases are transmitted by the same vectors and could emerge in the future. Syndromic surveillance, which consists in the routine monitoring of indicators for the detection of adverse health events, may allow an early detection. Milk yield is routinely measured in a large proportion of dairy herds and could be incorporated as an indicator in a surveillance system. However, few studies have evaluated continuous indicators for syndromic surveillance. The aim of this study was to develop a framework for the quantification of both disease characteristics and model predictive abilities that are important for a continuous indicator to be sensitive, timely and specific for the detection of a vector-borne disease emergence. Emergences with a range of spread characteristics and effects on milk production were simulated. Milk yields collected monthly in 48 713 French dairy herds were used to simulate 576 disease emergence scenarios. First, the effect of disease characteristics on the sensitivity and timeliness of detection were assessed: Spatio-temporal clusters of low milk production were detected with a scan statistic using the difference between observed and simulated milk yields as input. In a second step, the system specificity was evaluated by running the scan statistic on the difference between observed and predicted milk yields, in the absence of simulated emergence. The timeliness of detection depended mostly on how easily the disease spread between and within herds. The time and location of the emergence or adding random noise to the simulated effects had a limited impact on the timeliness of detection. The main limitation of the system was the low specificity i.e. the high number of clusters detected from the difference between observed and predicted productions, in the absence of disease.	[Madouasse, Aurelien; Marceau, Alexis; Lehebel, Anne; Fourichon, Christine] INRA, UMR1300, F-44026 Nantes, France; [Madouasse, Aurelien; Marceau, Alexis; Lehebel, Anne; Fourichon, Christine] LUNAM Univ, Agroalimentaire & Alimentat Nantes Atlantique, Ecole Natl Vet, Oniris,UMR BioEpAR, Nantes, France; [Brouwer-Middelesch, Henriette; van Schaik, Gerdien] GD Anim Hlth Serv, Deventer, Netherlands; [Van der Stede, Yves] Unit Coordinat Vet Diagnost Epidemiol & Risk Anal, Brussels, Belgium; [Van der Stede, Yves] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Ghent University	Madouasse, A (corresponding author), INRA, UMR1300, BP 40706, F-44026 Nantes, France.	Aurelien.Madouasse@oniris-nantes.fr	Van der Stede, Yves/I-4626-2016; Madouasse, Aurélien/AAC-2814-2019; Fourichon, Christine/B-1265-2010; van Schaik, Gerdien/AAD-7771-2020	Van der Stede, Yves/0000-0001-7294-3698; Madouasse, Aurélien/0000-0002-9254-5707; Fourichon, Christine/0000-0002-7079-0955; van Schaik, Gerdien/0000-0002-0460-2629	European Union; French National Research Agency (ANR); Veterinary and Agrochemical Research Centre (CODA-CERVA); Netherlands Food and Consumer Product Safety Authority	European Union(European Commission); French National Research Agency (ANR)(French National Research Agency (ANR)); Veterinary and Agrochemical Research Centre (CODA-CERVA); Netherlands Food and Consumer Product Safety Authority	Funding comes from the European Union, the French National Research Agency (ANR), the Veterinary and Agrochemical Research Centre (CODA-CERVA) and the Netherlands Food and Consumer Product Safety Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2011, PACKAGE LME4 LINEAR; Buckeridge DL, 2007, J BIOMED INFORM, V40, P370, DOI 10.1016/j.jbi.2006.09.003; Buehler JW, 2003, EMERG INFECT DIS, V9, P1197, DOI 10.3201/eid0910.030231; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; Drewe JA, 2012, EPIDEMIOL INFECT, V140, P575, DOI 10.1017/S0950268811002160; Ducheyne E, 2011, PREV VET MED, V99, P48, DOI 10.1016/j.prevetmed.2011.01.003; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; Gerbier G, 2008, PREV VET MED, V87, P119, DOI 10.1016/j.prevetmed.2008.06.012; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Kleinman KP, 2005, EPIDEMIOL INFECT, V133, P409, DOI 10.1017/S0950268804003528; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff Martin, 2004, MMWR Suppl, V53, P144; Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58; Lucy MC, 2001, J DAIRY SCI, V84, P1277, DOI 10.3168/jds.S0022-0302(01)70205-6; Mellor PS, 2002, VET J, V164, P20, DOI 10.1053/tvjl.2002.0713; Nusinovici S, 2013, J DAIRY SCI, V96, P877, DOI 10.3168/jds.2012-5800; Perrin JB, 2010, EPIDEMICS-NETH, V2, P207, DOI 10.1016/j.epidem.2010.10.002; Pioz M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-60; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; R Core Team, 2012, R LANG ENV STAT COMP; Santman-Berends IMGA, 2011, J DAIRY SCI, V94, P1347, DOI 10.3168/jds.2010-3792; Szmaragd C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007741; Tarlinton R, 2012, VET J, V194, P10, DOI 10.1016/j.tvjl.2012.08.017; Unkel S, 2012, J R STAT SOC A STAT, V175, P49, DOI 10.1111/j.1467-985X.2011.00714.x	25	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73726	10.1371/journal.pone.0073726	http://dx.doi.org/10.1371/journal.pone.0073726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069227	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100058
J	Huang, SF; Wang, DN; Chen, P; Yang, P; Cao, J; Zhang, LP				Huang Shifeng; Wang Danni; Chen Pu; Yang Ping; Cao Ju; Zhang Liping			Circulating Liver-Specific miR-122 as a Novel Potential Biomarker for Diagnosis of Cholestatic Liver Injury	PLOS ONE			English	Article							HEPATITIS-C VIRUS; PLASMA MICRORNAS; IDENTIFICATION; MIR-29	Background: Circulating microRNA-122 (miR-122) has been increasingly reported to be a potential biomarker for drug-, viral-, alcohol-and chemical-induced liver injury. The present study was initiated to determine the potential of circulating miR-122 as a biomarker for cholestatic liver injury. Methods: Both bile-duct ligation (BDL) mice and patients with biliary calculi were employed as cholestatic liver injury models, and serum miR-122 level was determined by stem-loop real-time reverse-transcription PCR (SLqRT-PCR). All quantitative PCR values were normalized to those for U6 RNA and calculated with the 2(-Delta Ct) method. Results: Serum miR-122 increased significantly after BDL-induced cholestatic injury and showed a similar time course to ALT concentrations. Compared with the sham controls, BDL mice had increased serum levels of miR-122 by 24.36+/-12.86, 423.63+/-322.89, 4.43+/-2.02 and 12.23+/-8.92 folds after 1, 3, 7 and 14 days, respectively. Moreover, serum miR-122 level was substantially higher in patients with biliary calculi than that in the healthy control group. In addition, patients with severe liver injury showed significantly higher levels of serum miR-122 when compared with healthy controls or patients with mild or moderate liver injury. Furthermore, serum miR-122 was found to show significant diagnostic value for biliary calculi by yielding an AUC (the areas under the receiver operating characteristic curve) of 0.931 with 77.4% sensitivity and 96.4% specificity in discriminating biliary calculi from healthy controls. Conclusion: Collectively, these data suggest that serum miR-122 has strong potential as a novel, specific and noninvasive biomarker for diagnosis of cholestasis-induced liver injury.	[Huang Shifeng; Wang Danni; Chen Pu; Yang Ping; Cao Ju; Zhang Liping] Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University	Zhang, LP (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China.	liuzhangcq@yahoo.com		Huang, Shifeng/0000-0001-7641-8823	National Science Foundation of China [81071621, 30973378]; Natural Science Foundation of Chongqing, China [CSTC, 2010BB5390]; Science Foundation of Chongqing Municipal Bureau of Health [2010-2-090]; Medical Science Foundation of the First Affiliated Hospital of Chongqing Medical University [YXJJ 2009-12]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing); Science Foundation of Chongqing Municipal Bureau of Health; Medical Science Foundation of the First Affiliated Hospital of Chongqing Medical University	This work was supported in part by the National Science Foundation of China (Grant No. 81071621 and 30973378), the Natural Science Foundation of Chongqing, China (Grant No. CSTC, 2010BB5390), the Science Foundation of Chongqing Municipal Bureau of Health (Grant No. 2010-2-090) and the Medical Science Foundation of the First Affiliated Hospital of Chongqing Medical University (Grant No. YXJJ 2009-12). The authors thank Erding Hu for the revision of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Dufour DR, 2000, CLIN CHEM, V46, P2050; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jiang JX, 2008, HEPATOLOGY, V48, P1497, DOI 10.1002/hep.22515; Kanda T, 2010, HEPATO-GASTROENTEROL, V57, P1013; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lebovitz HE, 2002, DIABETES CARE, V25, P815, DOI 10.2337/diacare.25.5.815; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Qin X, 2012, EUR J CLIN NUTR, V66, P541, DOI 10.1038/ejcn.2011.192; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	29	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73133	10.1371/journal.pone.0073133	http://dx.doi.org/10.1371/journal.pone.0073133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086271	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900010
J	Ben-Pazi, H; Stoner, JA; Cunningham, MW				Ben-Pazi, Hilla; Stoner, Julie A.; Cunningham, Madeleine W.			Dopamine Receptor Autoantibodies Correlate with Symptoms in Sydenham's Chorea	PLOS ONE			English	Article							AUTOIMMUNE NEUROPSYCHIATRIC DISORDERS; OBSESSIVE-COMPULSIVE DISORDER; ANTIBODIES; DISEASE; MODEL; DYSKINESIA; LEVODOPA; PRIMATES; CHILDREN; BEHAVIOR	Background: Sydenham chorea (SC), a neuropsychiatric sequela of group-A streptococcal infection, is associated with basal ganglia autoantibodies. Although autoantibodies have been proposed in neuropsychiatric disorders, little evidence has been shown to link autoimmunity and clinical symptoms. We hypothesized that dopamine receptor-autoantibody interactions may be the basis of neuropsychiatric symptoms in SC. Methods: Sera from 22 children with SC (age 10.7 +/- 64.5 years) and 22 age-matched controls were studied. Clinical neuropsychiatric symptoms were measured in SC at sample collection using the UFMG-Sydenham's-Chorea-Rating-Scale (USCRS). Anti-dopamine D1 receptor (D1R) and anti-dopamine D2 receptor (D2R) autoantibodies were measured by the enzyme linked immunosorbent assay (ELISA) and were correlated with clinical symptoms. Results: Anti-D1R and anti-D2R autoantibodies were significantly higher in SC compared to controls (n = 44; p = 0.010 and p = 0.017, respectively). We found that the ratio (anti-D2R/D1R) of the two anti-dopaminergic receptor antibodies correlated with neuropsychiatric symptoms as determined by USCRS measurements (n = 18; r = 0.53, p = 0.024). In addition, anti-D2R titers correlated with antistreptolysin-O titers (n = 43; r = 0.49, p = 0.0008). Interpretation: Our report linked, for the first time, autoimmunity with neuropsychiatric symptoms. The significant correlation was found using ratios of autoantibodies against dopamine receptors (anti-D2R/D1R) rather than the absolute elevated individual anti-D1R or anti-D2R titers. We suggest that autoantibodies may lead to a receptor imbalance and induce greater sensitivity to dopamine signaling potentially leading to neuropsychiatric symptoms in SC. Our novel findings suggesting altered balance in the dopaminergic system may provide a new approach in understanding autoimmune neuropsychiatric disorders with possible implications for diagnosis and treatment.	[Ben-Pazi, Hilla] Shaare Zedek Med Ctr, Neuropediat Unit, Jerusalem, Israel; [Stoner, Julie A.] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Cunningham, Madeleine W.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA	Hebrew University of Jerusalem; Shaare Zedek Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ben-Pazi, H (corresponding author), Shaare Zedek Med Ctr, Neuropediat Unit, Jerusalem, Israel.	benpazi@gmail.com		benpazi, hilla/0000-0002-8039-4761	Mirski Fund (Shaare Zedek Medical Center); National Heart; Lung and Blood Institute [R01HL56267, HL56267, HL35280]; David Judah Fund from Dr. Michael Jenike at Harvard University; Pepsico /Global Giving grants; PANDAS Research Fund at the University of Oklahoma Health Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035280, R37HL035280, R01HL056267, R56HL056267] Funding Source: NIH RePORTER	Mirski Fund (Shaare Zedek Medical Center); National Heart; Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); David Judah Fund from Dr. Michael Jenike at Harvard University; Pepsico /Global Giving grants; PANDAS Research Fund at the University of Oklahoma Health Sciences Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by the Mirski Fund (Shaare Zedek Medical Center); R01HL56267 from the National Heart; Lung and Blood Institute (HL56267, HL35280); David Judah Fund from Dr. Michael Jenike at Harvard University; Pepsico /Global Giving grants to MWC and the PANDAS Research Fund at the University of Oklahoma Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Ben-Pazi H, 2011, J MOL NEUROSCI, P1; BOYCE S, 1990, NEUROLOGY, V40, P927, DOI 10.1212/WNL.40.6.927; Brimberg L, 2012, NEUROPSYCHOPHARMACOL; BROOKS DJ, 1991, ANN NEUROL, V30, P166, DOI 10.1002/ana.410300207; Cardoso F, 1999, MOVEMENT DISORD, V14, P805, DOI 10.1002/1531-8257(199909)14:5<805::AID-MDS1013>3.0.CO;2-P; Church AJ, 2002, NEUROLOGY, V59, P227, DOI 10.1212/WNL.59.2.227; Dale RC, 2005, BRIT J PSYCHIAT, V187, P314, DOI 10.1192/bjp.187.4.314; Dale RC, 2012, BRAIN IN PRESS; DANEK A, 1994, NEUROLOGY, V44, P117, DOI 10.1212/WNL.44.1.117; Esmaeilzadeh M, 2011, HUM BRAIN MAPP, V32, P1626, DOI 10.1002/hbm.21134; Garvey MA, 2005, J CHILD NEUROL, V20, P424, DOI 10.1177/08830738050200050601; Hasbi A, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-26; Hoffman KL, 2012, BEHAV BRAIN RES, V230, P1, DOI 10.1016/j.bbr.2012.01.041; HUSBY G, 1977, LANCET, V1, P1208; Iravani MM, 2006, J PHARMACOL EXP THER, V319, P1225, DOI 10.1124/jpet.106.110429; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; Kirvan CA, 2007, J IMMUNOL, V178, P7412, DOI 10.4049/jimmunol.178.11.7412; Kirvan CA, 2006, J NEUROIMMUNOL, V179, P173, DOI 10.1016/j.jneuroim.2006.06.017; Leckman JF, 2011, J AM ACAD CHILD PSY, V50, P108, DOI 10.1016/j.jaac.2010.10.011; Olver JS, 2010, PSYCHIAT RES-NEUROIM, V183, P85, DOI 10.1016/j.pscychresns.2010.04.004; Pena J, 2002, ARQ NEURO-PSIQUIAT, V60, P374, DOI 10.1590/S0004-282X2002000300006; Rascol O, 2001, ARCH NEUROL-CHICAGO, V58, P249, DOI 10.1001/archneur.58.2.249; SWEDO SE, 1994, JAMA-J AM MED ASSOC, V272, P1788, DOI 10.1001/jama.272.22.1788; Teixeira AL, 2005, MOVEMENT DISORD, V20, P585, DOI 10.1002/mds.20377; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Yaddanapudi K, 2010, MOL PSYCHIATR, V15, P712, DOI 10.1038/mp.2009.77	27	55	58	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73516	10.1371/journal.pone.0073516	http://dx.doi.org/10.1371/journal.pone.0073516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073196	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000005
J	Czeisler, C; Mikawa, T				Czeisler, Catherine; Mikawa, Takashi			Microtubules Coordinate VEGFR2 Signaling and Sorting	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE-ACTIVITY; RECEPTOR; KDR; DOMAIN; AUTOPHOSPHORYLATION; LETHALITY; BINDING	VEGF signaling is a key regulator of vessel formation and function. In vascular endothelial cells, this signaling is mediated through its cognate receptor VEGFR2, which is dynamically sorted in response to ligand. Little is known about the underlying mechanism of this intracellular sorting. Here we examined the role of different components of the cytoskeleton in this process. We found that VEGFR2 mainly associates with microtubule fibers and to a lesser extent with intermediate filaments and actin. Microtubule disruption leads to accumulation of VEGFR2 protein in the membrane and cytoplasm leading to defects in VEGF signaling. In contrast, inhibition of actin filaments results in no accumulation of VEGFR2 total protein or apparent changes in microtubule association. Instead, actin inhibition leads to a more global signaling disruption of the ERK1/2 pathway. This is the first report demonstrating that VEGFR2 associates closely with microtubules in modulating the subcellular sorting and signaling of VEGFR2.	[Czeisler, Catherine; Mikawa, Takashi] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Czeisler, Catherine] Ohio State Univ, Med Ctr, Dept Neuropathol, Columbus, OH 43210 USA	University of California System; University of California San Francisco; University System of Ohio; Ohio State University	Mikawa, T (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA.	Takashi.Mikawa@ucsf.edu		Czeisler, Catherine/0000-0001-7895-6449	National Institutes of Health (NIH) [R37HL08921, R01HL92429]; NIH [T32 HL007731]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112268, R01HL092429, R37HL078921, T32HL007731] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by grants from the National Institutes of Health (NIH) (R37HL08921 and R01HL92429 to TM; CC was also supported by NIH T32 HL007731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fox SB, 2004, J PATHOL, V202, P313, DOI 10.1002/path.1520; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Kendall RL, 1999, J BIOL CHEM, V274, P6453, DOI 10.1074/jbc.274.10.6453; Lu HY, 2006, MOL PHARMACOL, V69, P1207, DOI 10.1124/mol.105.019075; Meissner M, 2008, J INVEST DERMATOL, V128, P2084, DOI 10.1038/jid.2008.37; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047	16	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75833	10.1371/journal.pone.0075833	http://dx.doi.org/10.1371/journal.pone.0075833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073279	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000089
J	Gonzalez-Serrano, AF; Pirro, V; Ferreira, CR; Oliveri, P; Eberlin, LS; Heinzmann, J; Lucas-Hahn, A; Niemann, H; Cooks, RG				Gonzalez-Serrano, Andres Felipe; Pirro, Valentina; Ferreira, Christina R.; Oliveri, Paolo; Eberlin, Livia S.; Heinzmann, Julia; Lucas-Hahn, Andrea; Niemann, Heiner; Cooks, Robert Graham			Desorption Electrospray Ionization Mass Spectrometry Reveals Lipid Metabolism of Individual Oocytes and Embryos	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; FATTY-ACID-COMPOSITION; BOVINE-OOCYTES; DAIRY-COWS; DNA METHYLATION; SINGLE EMBRYO; CULTURE; FERTILIZATION; SQUALENE; SHEEP	Alteration of maternal lipid metabolism early in development has been shown to trigger obesity, insulin resistance, type 2 diabetes and cardiovascular diseases later in life in humans and animal models. Here, we set out to determine (i) lipid composition dynamics in single oocytes and preimplantation embryos by high mass resolution desorption electrospray ionization mass spectrometry (DESI-MS), using the bovine species as biological model, (ii) the metabolically most relevant lipid compounds by multivariate data analysis and (iii) lipid upstream metabolism by quantitative real-time PCR (qRT-PCR) analysis of several target genes (ACAT1, CPT 1b, FASN, SREBP1 and SCAP). Bovine oocytes and blastocysts were individually analyzed by DESI-MS in both positive and negative ion modes, without lipid extraction and under ambient conditions, and were profiled for free fatty acids (FFA), phospholipids (PL), cholesterol-related molecules, and triacylglycerols (TAG). Principal component analysis (PCA) and linear discriminant analysis (LDA), performed for the first time on DESI-MS fused data, allowed unequivocal discrimination between oocytes and blastocysts based on specific lipid profiles. This analytical approach resulted in broad and detailed lipid annotation of single oocytes and blastocysts. Results of DESI-MS and transcript regulation analysis demonstrate that blastocysts produced in vitro and their in vivo counterparts differed significantly in the homeostasis of cholesterol and FFA metabolism. These results should assist in the production of viable and healthy embryos by elucidating in vivo embryonic lipid metabolism.	[Gonzalez-Serrano, Andres Felipe; Heinzmann, Julia; Lucas-Hahn, Andrea; Niemann, Heiner] Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt, Germany; [Pirro, Valentina] Univ Turin, Dept Chem, Turin, Italy; [Ferreira, Christina R.; Eberlin, Livia S.; Cooks, Robert Graham] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Oliveri, Paolo] Univ Genoa, Dept Pharm, Genoa, Italy	Friedrich Loeffler Institute; University of Turin; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Genoa	Niemann, H (corresponding author), Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt, Germany.	heiner.niemann@fli.bund.de; cooks@purdue.edu	Pirro, Valentina/M-5678-2014; Ferreira, Christina Ramires/F-4744-2012; Cooks, R Graham/G-1051-2015; Oliveri, Paolo/K-4359-2015	Ferreira, Christina Ramires/0000-0003-3988-6454; Cooks, R Graham/0000-0002-9581-9603; Oliveri, Paolo/0000-0002-3722-9461	German Academic Exchange Service (DAAD); Fundacion Gran Mariscal Ayacucho (FUNDAYACUCHO); L'Oreal/UNESCO Italia per le Donne e la Scienza grant; Purdue University Center for Cancer Research; Brazilian National Council for Scientific and Technological Development (CNPq); NSF IDBR [0852740]; Direct For Biological Sciences [0852740] Funding Source: National Science Foundation	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Fundacion Gran Mariscal Ayacucho (FUNDAYACUCHO); L'Oreal/UNESCO Italia per le Donne e la Scienza grant; Purdue University Center for Cancer Research; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSF IDBR(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AFGS was supported from the German Academic Exchange Service (DAAD) and the Fundacion Gran Mariscal Ayacucho (FUNDAYACUCHO); VP was supported from the "L'Oreal/UNESCO Italia per le Donne e la Scienza 2013" grant; CF was supported from the Purdue University Center for Cancer Research Small Grants and from the Brazilian National Council for Scientific and Technological Development (CNPq); RGC by NSF IDBR 0852740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aardema H, 2011, BIOL REPROD, V85, P62, DOI 10.1095/biolreprod.110.088815; Adamiak SJ, 2006, REPRODUCTION, V131, P247, DOI 10.1530/rep.1.00871; Blanchet L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-254; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BUNGARTZ L, 1995, THERIOGENOLOGY, V43, P667, DOI 10.1016/0093-691X(94)00072-3; Campbell BK, 2003, REPRODUCTION, P429; Chen MX, 2011, CURR DIABETES REV, V7, P426, DOI 10.2174/157339911797579151; Dabelea D, 2011, DIABETES, V60, P1849, DOI 10.2337/db11-0400; Diederich M, 2012, REPRODUCTION, V144, P319, DOI 10.1530/REP-12-0134; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Eberlin LS, 2013, P NATL ACAD SCI USA, V110, P1611, DOI 10.1073/pnas.1215687110; Eberlin LS, 2011, CHEMBIOCHEM, V12, P2129, DOI 10.1002/cbic.201100411; ECKERT J, 1995, THERIOGENOLOGY, V43, P1211, DOI 10.1016/0093-691X(95)00093-N; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Ferreira CR, 2012, J MASS SPECTROM, V47, P29, DOI 10.1002/jms.2022; Ferreira CR, 2012, ANAL BIOANAL CHEM, V404, P2915, DOI 10.1007/s00216-012-6426-4; Ferreira CR, 2010, J LIPID RES, V51, P1218, DOI 10.1194/jlr.D001768; Fouladi-Nashta AA, 2009, REPRODUCTION, V138, P771, DOI 10.1530/REP-08-0391; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Garcia-Reyes JF, 2009, ANAL CHEM, V81, P820, DOI 10.1021/ac802166v; Gulliver CE, 2012, ANIM REPROD SCI, V131, P9, DOI 10.1016/j.anireprosci.2012.02.002; Haaf T, 2006, CURR TOP MICROBIOL, V310, P13; Heinzmann J, 2011, MOL REPROD DEV, V78, P188, DOI 10.1002/mrd.21281; Jackson AU, 2011, ANAL BIOANAL CHEM, V399, P367, DOI 10.1007/s00216-010-4349-5; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Jungheim ES, 2011, BIOL REPROD, V85, P678, DOI 10.1095/biolreprod.111.092148; Kennedy JH, 2010, ANAL CHEM, V82, P7502, DOI 10.1021/ac101295g; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim SK, 2012, ADV FOOD NUTR RES, V65, P223, DOI 10.1016/B978-0-12-416003-3.00014-7; Konigsdorf CAI, 2012, OBESITY FACTS, V5, P575, DOI 10.1159/000342583; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; Lazzari G, 2002, BIOL REPROD, V67, P767, DOI 10.1095/biolreprod.102.004481; Leroy JLMR, 2010, HUM REPROD, V25, P768, DOI 10.1093/humrep/dep420; Leroy JLMR, 2005, REPRODUCTION, V130, P485, DOI 10.1530/rep.1.00735; Leroy JLMR, 2005, THERIOGENOLOGY, V64, P2022, DOI 10.1016/j.theriogenology.2005.05.003; LOEWENSTEIN JE, 1964, J EMBRYOL EXP MORPH, V12, P113; Marei WF, 2012, REPROD FERT DEVELOP, V24, P679, DOI 10.1071/RD11204; Marei WF, 2010, REPRODUCTION, V139, P979, DOI 10.1530/REP-09-0503; Marei WF, 2009, BIOL REPROD, V81, P1064, DOI 10.1095/biolreprod.109.076851; Matorras R, 1998, HUM REPROD, V13, P2227, DOI 10.1093/humrep/13.8.2227; McEvoy TG, 2000, J REPROD FERTIL, V118, P163, DOI 10.1530/reprod/118.1.163; McKeegan PJ, 2012, REPROD FERT DEVELOP, V24, P59, DOI 10.1071/RD11907; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Niemann H, 2010, CELL REPROGRAM, V12, P33, DOI 10.1089/cell.2009.0063; Pereira RM, 2008, CELL TISSUE BANK, V9, P267, DOI 10.1007/s10561-008-9075-2; Pirro V, 2012, ANALYST, V137, P2374, DOI 10.1039/c2an35122f; Prates EG, 2013, IN VITRO CELL DEV-AN, V49, P335, DOI 10.1007/s11626-013-9624-2; Rienzi L, 2012, HUM REPROD, V27, P1606, DOI 10.1093/humrep/des088; Seal JR, 2003, J AM SOC MASS SPECTR, V14, P872, DOI 10.1016/S1044-0305(03)00339-8; Sinclair KD, 2000, HUM REPROD, V15, P68, DOI 10.1093/humrep/15.suppl_5.68; Spanova M, 2012, BBA-MOL CELL BIOL L, V1821, P647, DOI 10.1016/j.bbalip.2012.01.015; Ta MT, 2012, FEBS J, V279, P4231, DOI 10.1111/febs.12015; Van Hoeck V, 2013, REPRODUCTION, V145, P33, DOI 10.1530/REP-12-0174; Van Hoeck V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023183; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; WALKER SK, 1992, THERIOGENOLOGY, V37, P111, DOI 10.1016/0093-691X(92)90250-U; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Wrenzycki C, 2007, THERIOGENOLOGY, V68, pS77, DOI 10.1016/j.theriogenology.2007.04.028; Wrenzycki C, 2000, J REPROD FERTIL, V118, P69, DOI 10.1530/reprod/118.1.69; Wrenzycki Christine, 2005, Birth Defects Res C Embryo Today, V75, P1, DOI 10.1002/bdrc.20035; Wu LDL, 2012, MOL ENDOCRINOL, V26, P562, DOI 10.1210/me.2011-1362; Wu LLY, 2012, REPROD FERT DEVELOP, V24, P29, DOI 10.1071/RD11904; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; 2013, FERTIL STERIL, V99, P37, DOI DOI 10.1016/J.FERTNSTERT.2012.09.028.PUBMED:23083924	64	54	57	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74981	10.1371/journal.pone.0074981	http://dx.doi.org/10.1371/journal.pone.0074981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073231	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000040
J	O'Donoghue, AJ; Jin, Y; Knudsen, GM; Perera, NC; Jenne, DE; Murphy, JE; Craik, CS; Hermiston, TW				O'Donoghue, Anthony J.; Jin, Ye; Knudsen, Giselle M.; Perera, Natascha C.; Jenne, Dieter E.; Murphy, John E.; Craik, Charles S.; Hermiston, Terry W.			Global Substrate Profiling of Proteases in Human Neutrophil Extracellular Traps Reveals Consensus Motif Predominantly Contributed by Elastase	PLOS ONE			English	Article							SERINE PROTEASES; PROTEINASE-3; SPECIFICITY; INHIBITION; ACTIVATION; STRATEGY; NETOSIS	Neutrophil extracellular traps (NETs) consist of antimicrobial molecules embedded in a web of extracellular DNA. Formation of NETs is considered to be a defense mechanism utilized by neutrophils to ensnare and kill invading pathogens, and has been recently termed NETosis. Neutrophils can be stimulated to undergo NETosis ex vivo, and are predicted to contain high levels of serine proteases, such as neutrophil elastase (NE), cathepsin G (CG) and proteinase 3 (PR3). Serine proteases are important effectors of neutrophil-mediated immunity, which function directly by degrading pathogenic virulent factors and indirectly via proteolytic activation or deactivation of cytokines, chemokines and receptors. In this study, we utilized a diverse and unbiased peptide library to detect and profile protease activity associated with NETs induced by phorbol-12-myristate-13-acetate (PMA). We obtained a "proteolytic signature" from NETs derived from healthy donor neutrophils and used proteomics to assist in the identification of the source of this proteolytic activity. In addition, we profiled each neutrophil serine protease and included the newly identified enzyme, neutrophil serine protease 4 (NSP4). Each enzyme had overlapping yet distinct endopeptidase activities and often cleaved at unique sites within the same peptide substrate. The dominant proteolytic activity in NETs was attributed to NE; however, cleavage sites corresponding to CG and PR3 activity were evident. When NE was immunodepleted, the remaining activity was attributed to CG and to a lesser extent PR3 and NSP4. Our results suggest that blocking NE activity would abrogate the major protease activity associated with NETs. In addition, the newly identified substrate specificity signatures will guide the design of more specific probes and inhibitors that target NET-associated proteases.	[Jin, Ye; Murphy, John E.; Hermiston, Terry W.] Bayer Healthcare Pharmaceut, US Innovat Ctr, San Francisco, CA USA; [O'Donoghue, Anthony J.; Knudsen, Giselle M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Perera, Natascha C.; Jenne, Dieter E.] Helmholtz Zentrum Munchen, ILBD, Comprehens Pneumol Ctr, Munich, Germany; [Jenne, Dieter E.] Max Planck Inst Neurobiol, Planegg Martinsried, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; University of California System; University of California San Francisco; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society	Hermiston, TW (corresponding author), Bayer Healthcare Pharmaceut, US Innovat Ctr, San Francisco, CA USA.	Terry.Hermiston@bayer.com	Jenne, Dieter Erich/AAP-1414-2020		Bayer HealthCare; NIH [R01CA128765]; Biomedical Technology Research Centers program, NIH NIGMS [8P41GM103481]; NATIONAL CANCER INSTITUTE [R01CA128765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, P50GM082250] Funding Source: NIH RePORTER	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Research Centers program, NIH NIGMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by Bayer HealthCare and by NIH grant R01CA128765 (CSC). Mass spectrometry was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at UCSF supported by the Biomedical Technology Research Centers program, NIH NIGMS 8P41GM103481 (AL Burlingame). Bayer HealthCare authors were involved in study design, decision to publish, and preparation of the manuscript.	Barrientos L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00166; Bianchi M, 2011, J ALLERGY CLIN IMMUN, V127, P1243, DOI 10.1016/j.jaci.2011.01.021; Brea D, 2012, BIOCHEM J, V447, P363, DOI 10.1042/BJ20120818; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Choi KY, 2012, THERANOSTICS, V2, P156, DOI 10.7150/thno.4068; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dubois AV, 2012, AM J RESP CELL MOL, V47, P80, DOI 10.1165/rcmb.2011-0380OC; Dworski R, 2011, J ALLERGY CLIN IMMUN, V127, P1260, DOI 10.1016/j.jaci.2010.12.1103; Edgington LE, 2011, CURR OPIN CHEM BIOL, V15, P798, DOI 10.1016/j.cbpa.2011.10.012; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Jonsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019340; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Lu T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00365; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Meyer-Hoffert U, 2010, CURR OPIN HEMATOL; O'Donoghue AJ, 2008, J BIOL CHEM, V283, P29186, DOI 10.1074/jbc.M802366200; O'Donoghue AJ, 2012, NAT METHODS, V9, P1095, DOI [10.1038/NMETH.2182, 10.1038/nmeth.2182]; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rada B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054205; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Robertson SE, 2006, EUR J IMMUNOL, V36, P722, DOI 10.1002/eji.200535402; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	40	93	96	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75141	10.1371/journal.pone.0075141	http://dx.doi.org/10.1371/journal.pone.0075141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073241	Green Published, gold			2022-12-27	WOS:000324768000050
J	Pascoe, SJS; Hargreaves, JR; Langhaug, LF; Hayes, RJ; Cowan, FM				Pascoe, Sophie J. S.; Hargreaves, James R.; Langhaug, Lisa F.; Hayes, Richard J.; Cowan, Frances M.			'How Poor Are You?' - A Comparison of Four Questionnaire Delivery Modes for Assessing Socio-Economic Position in Rural Zimbabwe	PLOS ONE			English	Article							SOCIAL DESIRABILITY BIAS; FACE-TO-FACE; SEXUAL-BEHAVIOR; VALIDITY; ADOLESCENTS; WEALTH	Background: Assessing socio-economic position can be difficult, particularly in developing countries. Collection of socioeconomic data usually relies on interviewer-administered questionnaires, but there is little research exploring how questionnaire delivery mode (QDM) influences reporting of these indicators. This paper reports on results of a trial of four QDMs, and the effect of mode on poverty reporting. Methods: This trial was nested within a community-randomised trial of an adolescent reproductive health intervention conducted in rural Zimbabwe. Participants were randomly allocated to one of four QDMs (three different self-administered modes and one interviewer-administered mode); a subset was randomly selected to complete the questionnaire twice. Questions covered three socio-economic domains: i) ownership of sellable and fixed assets; ii) ability to afford essential items; and iii) food sufficiency. Statistical analyses assessed the association between QDM and reporting of poverty, and compared the extent of response agreement between questionnaire rounds. Results: 96% (n = 1483) of those eligible took part; 395 completed the questionnaire twice. Reported levels of poverty were high. Respondents using self-administered modes were more likely to report being unable to afford essential items and having insufficient food. Among those completing the questionnaire twice using different modes, higher levels of poverty and food insufficiency were reported when they completed the questionnaire using a self-administered mode. Conclusion: These data suggest that QDM plays a significant role in how different socio-economic indicators are reported, and reminds us to consider the mode of collection when identifying indicators to determine socio-economic position.	[Pascoe, Sophie J. S.; Hargreaves, James R.; Hayes, Richard J.] London Sch Hyg & Trop Med, London WC1, England; [Langhaug, Lisa F.; Cowan, Frances M.] Royal Free & Univ Coll Med Sch, London WC1E 6BT, England; [Cowan, Frances M.] Univ Zimbabwe, Dept Community Med, Harare, Zimbabwe	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Zimbabwe	Cowan, FM (corresponding author), Royal Free & Univ Coll Med Sch, London WC1E 6BT, England.	f.cowan@ucl.ac.uk		Pascoe, Sophie/0000-0002-9199-8333; Langhaug, Lisa/0000-0002-9131-8158; Hargreaves, James/0000-0002-3509-3572; Hayes, Richard/0000-0002-1729-9892; Cowan, Frances/0000-0003-3087-4422	National Institutes of Mental Health (NIMH) [RO1 MH 65570]; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065570] Funding Source: NIH RePORTER	National Institutes of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The funding for this study was provided through a grant plus a competitively awarded supplement from National Institutes of Mental Health (NIMH) RO1 MH 65570, "Randomised trial of HIV/STI prevention in Zimbabwean Youth." (URL: www.nimh.nih.gov/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Central Statistical Office [Zimbabwe] and Macro International Inc, 2000, ZIMB DEM HLTH SURV 1; Cohen D, 1998, SEPED C PAPER SERIES, P1; Cowan FM, 2008, TROP MED INT HEALTH, V13, P1235, DOI 10.1111/j.1365-3156.2008.02137.x; Durant LE, 2000, ARCH SEX BEHAV, V29, P309, DOI 10.1023/A:1001930202526; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Health CftSDo, 2008, CLOS GAP GEN HLTH EQ; Howe LD, 2012, INT J EPIDEMIOLOGY; Klimes-Dougan B, 1998, J ADOLESCENCE, V21, P435, DOI 10.1006/jado.1998.0166; Kreuter F, 2008, PUBLIC OPIN QUART, V72, P847, DOI 10.1093/poq/nfn063; Langhaug LF, 2007, C P 17 BIENN M INT S; Langhaug LF, 2010, J COMMUN HEALTH, V35, P355, DOI 10.1007/s10900-010-9261-6; Langhaug LF, 2009, J AFFECT DISORDERS, V118, P220, DOI 10.1016/j.jad.2009.02.003; [Macro International Inc Central Statistical Office (CSO) [Zimbabwe]], 2007, ZIMB DEM HLTH SURV 2; Mavhu W, 2008, CULT HEALTH SEX, V10, P563, DOI 10.1080/13691050801948102; Ministry of Health and Child Welfare (Zimbabwe) Zimbabwe National Family Planning Council National AIDS Council (Zimbabwe) US Centers for Disease Control and Prevention, 2004, ZIMB YOUNG AD SURV Y; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Moum T, 1998, SOC INDIC RES, V45, P279, DOI 10.1023/A:1006958100504; Newman JC, 2002, AM J PUBLIC HEALTH, V92, P294, DOI 10.2105/AJPH.92.2.294; Rollins N, 2007, PLOS MED, V4, P1576, DOI 10.1371/journal.pmed.0040301; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; *UNAIDS, 2008, 2008 REP GLOB AIDS E; United nations Development Programme (UNDP), 2007, NAT HUM DEV REP RUSS; Weinhardt LS, 1998, ARCH SEX BEHAV, V27, P155, DOI 10.1023/A:1018682530519; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Willis GB, 2004, COGNITIVE INTERVIEWI; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534	32	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74977	10.1371/journal.pone.0074977	http://dx.doi.org/10.1371/journal.pone.0074977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	222YC	24073230	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000324768000039
J	Sato, M; Nakai, Y; Nakata, W; Yoshida, T; Hatano, K; Kawashima, A; Fujita, K; Uemura, M; Takayama, H; Nonomura, N				Sato, Mototaka; Nakai, Yasutomo; Nakata, Wataru; Yoshida, Takahiro; Hatano, Koji; Kawashima, Atsunari; Fujita, Kazutoshi; Uemura, Motohide; Takayama, Hitoshi; Nonomura, Norio			EMMPRIN Promotes Angiogenesis, Proliferation, Invasion and Resistance to Sunitinib in Renal Cell Carcinoma, and Its Level Predicts Patient Outcome	PLOS ONE			English	Article							COMPUTERIZED IMAGE-ANALYSIS; MICROVESSEL DENSITY; TUMOR ANGIOGENESIS; MATRIX METALLOPROTEINASES; RECOGNITION MOLECULE; PROGNOSTIC-FACTOR; SURFACE INDUCER; GROWTH-FACTOR; CANCER-CELLS; EXPRESSION	Purpose: Extracellular matrix metalloproteinase inducer (EMMPRIN) has been reported to play crucial roles, including in angiogenesis, in several carcinomas. However, the correlation between EMMPRIN levels and angiogenesis expression profile has not been reported, and the role of EMMPRIN in renal cell carcinoma (RCC) is unclear. In the present study, we evaluated the association of EMMPRIN with angiogenesis, its value in prognosis, and its roles in RCC. Experimental Design: EMMPRIN expression was examined in 50 RCC patients treated with radical nephrectomy. Angiogenesis, proliferation, and invasion activity were evaluated using EMMPRIN knockdown RCC cell lines. The size of EMMPRIN-overexpressing xenografts was measured and the degree of angiogenesis was quantified. EMMPRIN expression was evaluated in RCC patients who received sunitinib therapy and in sunitinib-resistant cells. Further, the relation between EMMPRIN expression and sensitivity to sunitinib was examined. Results: EMMPRIN score was significantly associated with clinicopathological parameters in RCC patients, as well as being significantly correlated with microvessel area (MVA) in immature vessels and with prognosis. Downregulation of EMMPRIN by siRNA led to decreased VEGF and bFGF expression, cell proliferation, and invasive potential. EMMPRIN over-expressing xenografts showed accelerated growth and MVA of immature vessels. EMMPRIN expression was significantly increased in patients who received sunitinib therapy as well as in sunitinib-resistant 786-O cells (786-suni). EMMPRIN-overexpressing RCC cells were resistant to sunitinib. Conclusion: Our findings indicate that high expression of EMMPRIN in RCC plays important roles in tumor progression and sunitinib resistance. Therefore, EMMPRIN could be a novel target for the treatment of RCC.	[Sato, Mototaka; Nakai, Yasutomo; Nakata, Wataru; Yoshida, Takahiro; Hatano, Koji; Kawashima, Atsunari; Fujita, Kazutoshi; Uemura, Motohide; Takayama, Hitoshi; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Osaka, Japan	Osaka University	Nakai, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Urol, Osaka, Japan.	nakai@uro.med.osaka-u.ac.jp	Nakata, Wataru/N-2484-2019; Fujita, Kazutoshi/AAQ-4428-2020; uemura, motohide/G-6101-2011	Nakata, Wataru/0000-0003-3953-6534; Fujita, Kazutoshi/0000-0002-6774-7497; Hatano, Koji/0000-0002-8409-5152				BISWAS C, 1995, CANCER RES, V55, P434; Bordador LC, 2000, INT J CANCER, V85, P347, DOI 10.1002/(SICI)1097-0215(20000201)85:3<347::AID-IJC9>3.3.CO;2-R; Brawer MK, 1996, CANCER, V78, P345, DOI 10.1002/(SICI)1097-0142(19960715)78:2<345::AID-CNCR25>3.0.CO;2-V; Brower V, 2009, J NATL CANCER I, V101, P846, DOI 10.1093/jnci/djp171; Brower V, 2009, J NATL CANCER I, V101, P780, DOI 10.1093/jnci/djp150; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chen X, 2006, CANCER RES, V66, P11323, DOI 10.1158/0008-5472.CAN-06-1536; Delahunt B, 1997, BRIT J UROL, V80, P401, DOI 10.1046/j.1464-410X.1997.00374.x; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; FADOOL JM, 1993, DEV DYNAM, V196, P252, DOI 10.1002/aja.1001960406; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fukuoka M, 2012, VIRCHOWS ARCH, V461, P457, DOI 10.1007/s00428-012-1302-3; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Guo HM, 1998, GENE, V220, P99, DOI 10.1016/S0378-1119(98)00400-4; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Herbst C, 1998, J CANCER RES CLIN, V124, P141; HOLLINGSWORTH HC, 1995, AM J PATHOL, V147, P33; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Itou Masaya, 2013, Int J Evol Biol, V2013, P406209, DOI 10.1155/2013/406209; JAEGER TM, 1995, J UROLOGY, V154, P69, DOI 10.1016/S0022-5347(01)67230-6; Jin JS, 2006, INT J GYNECOL PATHOL, V25, P140, DOI 10.1097/01.pgp.0000189244.57145.84; Kanekura T, 2002, INT J CANCER, V99, P520, DOI 10.1002/ijc.10390; Lee JS, 2000, ANAL QUANT CYTOL, V22, P469; Li Y, 2009, HISTOPATHOLOGY, V54, P677, DOI 10.1111/j.1365-2559.2009.03280.x; Liang YX, 2009, CANCER INVEST, V27, P788, DOI 10.1080/07357900802709167; Lim M, 1998, FEBS LETT, V441, P88, DOI 10.1016/S0014-5793(98)01474-4; LIOTTA LA, 1974, CANCER RES, V34, P997; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; MATSUDA M, 1979, CANCER RES, V39, P4694; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Nakamura K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-191; OBERMAIR A, 1995, INT J CANCER, V62, P126, DOI 10.1002/ijc.2910620203; Pantuck AJ, 2003, CLIN CANCER RES, V9, P4641; Pertega-Gomes N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-312; Reimers N, 2004, CLIN CANCER RES, V10, P3422, DOI 10.1158/1078-0432.CCR-03-0610; Sameshima T, 2000, INT J CANCER, V88, P21, DOI 10.1002/1097-0215(20001001)88:1<21::AID-IJC4>3.0.CO;2-S; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tan H, 2008, TRANSL RES, V152, P143, DOI 10.1016/j.trsl.2008.07.005; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Wang B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-61; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; Zhang Q, 2007, EUR J CANCER PREV, V16, P196, DOI 10.1097/01.cej.0000236245.40619.c3; Zheng HC, 2006, BRIT J CANCER, V95, P1371, DOI 10.1038/sj.bjc.6603425; Zhu P, 2005, ARTHRITIS RES THER, V7, pR1023, DOI 10.1186/ar1778	50	40	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74313	10.1371/journal.pone.0074313	http://dx.doi.org/10.1371/journal.pone.0074313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073208	gold, Green Published, Green Submitted			2022-12-27	WOS:000324768000017
J	Shoghi, KI; Xu, JB; Su, Y; He, J; Rowland, D; Yan, Y; Garbow, JR; Tu, ZD; Jones, LA; Higashikubo, R; Wheeler, KT; Lubet, RA; Mach, RH; You, M				Shoghi, Kooresh I.; Xu, Jinbin; Su, Yi; He, June; Rowland, Douglas; Yan, Ying; Garbow, Joel R.; Tu, Zhude; Jones, Lynne A.; Higashikubo, Ryuji; Wheeler, Kenneth T.; Lubet, Ronald A.; Mach, Robert H.; You, Ming			Quantitative Receptor-Based Imaging of Tumor Proliferation with the Sigma-2 Ligand [F-18]ISO-1	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PERFORMANCE EVALUATION; ENDOCRINE THERAPY; IN-VIVO; FDG PET; CANCER; EXPRESSION; RECRUITMENT; MANAGEMENT; EFFICACY	The sigma-2 receptor is expressed in higher density in proliferating (P) tumor cells versus quiescent (Q) tumor cells, thus providing an attractive target for imaging the proliferative status (i.e., P:Q ratio) of solid tumors. Here we evaluate the utility of the sigma-2 receptor ligand 2-(2-[F-18]fluoroethoxy)-N-(4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl)-5-methyl-benzamide, [F-18]ISO-1, in two different rodent models of breast cancer. In the first study, small animal Positron Emission Tomography (PET) imaging studies were conducted with [F-18]ISO-1 and (18)FDG in xenografts of mouse mammary tumor 66 and tracer uptake was correlated with the in vivo P: Q ratio determined by flow cytometric measures of BrdU-labeled tumor cells. The second model utilized a chemically-induced (N-methyl-N-nitrosourea [MNU]) model of rat mammary carcinoma to correlate measures of [F-18]ISO-1 and FDG uptake with MR-based volumetric measures of tumor growth. In addition, [F-18]ISO-1 and FDG were used to assess the response of MNU-induced tumors to bexarotene and Vorozole therapy. In the mouse mammary 66 tumors, a strong linear correlation was observed between the [F-18]ISO-1 tumor: background ratio and the proliferative status (P: Q ratio) of the tumor (R = 0.87). Similarly, measures of [F-18]ISO-1 uptake in MNU-induced tumors significantly correlated (R = 0.68, P<0.003) with changes in tumor volume between consecutive MR imaging sessions. Our data suggest that PET studies of [F-18]ISO-1 provide a measure of both the proliferative status and tumor growth rate, which would be valuable in designing an appropriate treatment strategy.	[Shoghi, Kooresh I.; Xu, Jinbin; Su, Yi; Garbow, Joel R.; Tu, Zhude; Jones, Lynne A.; Mach, Robert H.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Shoghi, Kooresh I.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO USA; [He, June; Yan, Ying; Higashikubo, Ryuji; You, Ming] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Mach, Robert H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Mach, Robert H.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Shoghi, Kooresh I.; Mach, Robert H.] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO USA; [Rowland, Douglas] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA; [Wheeler, Kenneth T.] Wake Forest Univ, Hlth Sci Ctr, Dept Radiol, Winston Salem, NC 27109 USA; [Lubet, Ronald A.] NIH, Bethesda, MD 20892 USA; [You, Ming] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA; [You, Ming] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Davis; Wake Forest University; National Institutes of Health (NIH) - USA; Medical College of Wisconsin; Medical College of Wisconsin	Shoghi, KI (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	shoghik@wustl.edu	Xu, Jinbin/ABG-1280-2020; Rowland, Douglas J/F-3104-2014; Shoghi, Kooresh/H-7398-2014	Xu, Jinbin/0000-0002-2120-8287; Rowland, Douglas J/0000-0001-8059-6905; Shoghi, Kooresh/0000-0003-3204-457X; Mach, Robert/0000-0002-7645-2869; Su, Yi/0000-0002-1946-8063; Jones, Lynne/0000-0003-0235-9538	NIH/NCI [N01-CN-43308]; Siteman Cancer Center [P30CA091842]; NIH [CA102869]; NATIONAL CANCER INSTITUTE [P30CA091842, R33CA102869, R21CA102869] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Siteman Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by NIH/NCI contract N01-CN-43308, Siteman Cancer Center support grant P30CA091842, NIH grant CA102869 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nabulsi I, 1999, BRIT J CANCER, V81, P925, DOI 10.1038/sj.bjc.6690789; Alves FA, 2004, INT J ORAL MAX SURG, V33, P593, DOI 10.1016/j.ijom.2004.01.010; Avril N, 2001, J NUCL MED, V42, P9; BEM WT, 1991, CANCER RES, V51, P6558; Christov K, 2000, BREAST CANCER RES TR, V60, P117, DOI 10.1023/A:1006384026252; Christov K, 2007, CLIN CANCER RES, V13, P5488, DOI 10.1158/1078-0432.CCR-07-0404; Collins I, 2005, CURR OPIN PHARMACOL, V5, P366, DOI 10.1016/j.coph.2005.04.009; Dehdashti F, 2013, J NUCL MED, V54, P350, DOI 10.2967/jnumed.112.111948; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Endo Keigo, 2006, Int J Clin Oncol, V11, P286, DOI 10.1007/s10147-006-0595-0; Eubank WB, 2005, SEMIN NUCL MED, V35, P84, DOI 10.1053/j.semnuclmed.2004.11.001; Fornace A. J., 2001, MOL BASIS CANC, P423; GULLINO PM, 1975, J NATL CANCER I, V54, P401; HABERKORN U, 1994, NUCL MED BIOL, V21, P827, DOI 10.1016/0969-8051(94)90162-7; HUGGINS C, 1965, CANCER RES, V25, P1163; Kashiwagi H, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-48; Kumar R, 2004, RADIOL CLIN N AM, V42, P1113, DOI 10.1016/j.rcl.2004.08.005; Laforest R, 2007, IEEE T NUCL SCI, V54, P42, DOI 10.1109/TNS.2006.889312; Loddo M, 2009, BRIT J CANCER, V100, P959, DOI 10.1038/sj.bjc.6604924; Lubet RA, 2005, CARCINOGENESIS, V26, P441, DOI 10.1093/carcin/bgh338; Lubet RA, 1998, CARCINOGENESIS, V19, P1345, DOI 10.1093/carcin/19.8.1345; Mach R.H., 2013, J MED CHEM; Mach RH, 1997, CANCER RES, V57, P156; Miele E, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-52; Rosen EL, 2007, RADIOGRAPHICS, V27, pS215, DOI 10.1148/rg.27si075517; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sun HH, 2005, J NUCL MED, V46, P292; Tai YC, 2005, J NUCL MED, V46, P455; Tu ZD, 2005, NUCL MED BIOL, V32, P423, DOI 10.1016/j.nucmedbio.2005.03.008; Tu ZD, 2007, J MED CHEM, V50, P3194, DOI 10.1021/jm0614883; van Waarde A, 2004, J NUCL MED, V45, P1939; VILNER BJ, 1995, CANCER RES, V55, P408; WALLEN CA, 1984, CELL TISSUE KINET, V17, P65, DOI 10.1111/j.1365-2184.1984.tb00569.x; WALLEN CA, 1984, CELL TISSUE KINET, V17, P79, DOI 10.1111/j.1365-2184.1984.tb00570.x; Wheeler KT, 2000, BRIT J CANCER, V82, P1223, DOI 10.1054/bjoc.1999.1067; Xu JB, 2005, EUR J PHARMACOL, V525, P8, DOI 10.1016/j.ejphar.2005.09.063	39	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74188	10.1371/journal.pone.0074188	http://dx.doi.org/10.1371/journal.pone.0074188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073202	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000011
J	de Souza, WF; Fortunato-Miranda, N; Robbs, BK; de Araujo, WM; de-Freitas, JC; Bastos, LG; Viola, JPB; Morgado-Diaz, JA				de Souza, Waldemir F.; Fortunato-Miranda, Natalia; Robbs, Bruno K.; de Araujo, Wallace M.; de-Freitas-Junior, Julio C.; Bastos, Lilian G.; Viola, Joao P. B.; Morgado-Diaz, Jose A.			Claudin-3 Overexpression Increases the Malignant Potential of Colorectal Cancer Cells: Roles of ERK1/2 and PI3K-Akt as Modulators of EGFR signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TIGHT JUNCTION; E-CADHERIN; EXPRESSION; PROTEIN; TRANSFORMATION; ACTIVATION; FAMILY; TRANSDUCTION; PERMEABILITY	The altered expressions of claudin proteins have been reported during the tumorigenesis of colorectal cancer. However, the molecular mechanisms that regulate these events in this cancer type are poorly understood. Here, we report that epidermal growth factor (EGF) increases the expression of claudin-3 in human colorectal adenocarcinoma HT-29 cells. This increase was related to increased cell migration and the formation of anchorage-dependent and anchorage-independent colonies. We further showed that the ERK1/2 and PI3K-Akt pathways were involved in the regulation of these effects because specific pharmacological inhibition blocked these events. Genetic manipulation of claudin-1 and claudin-3 in HT-29 cells showed that the overexpression of claudin-1 resulted in decreased cell migration; however, migration was not altered in cells that overexpressed claudin-3. Furthermore, the overexpression of claudin-3, but not that of claudin-1, increased the tight junction-related paracellular flux of macromolecules. Additionally, an increased formation of anchorage-dependent and anchorage-independent colonies were observed in cells that overexpressed claudin-3, while no such changes were observed when claudin-1 was overexpressed. Finally, claudin-3 silencing alone despite induce increase proliferation, and the formation of anchoragedependent and -independent colonies, it was able to prevent the EGF-induced increased malignant potential. In conclusion, our results show a novel role for claudin-3 overexpression in promoting the malignant potential of colorectal cancer cells, which is potentially regulated by the EGF-activated ERK1/2 and PI3K-Akt pathways.	[de Souza, Waldemir F.; Fortunato-Miranda, Natalia; de Araujo, Wallace M.; de-Freitas-Junior, Julio C.; Bastos, Lilian G.; Morgado-Diaz, Jose A.] Inst Nacl Canc, Ctr Pesquisas, Programa Biol Celular, Grp Biol Estrutural, Rio De Janeiro, Brazil; [Robbs, Bruno K.; Viola, Joao P. B.] Inst Nacl Canc, Ctr Pesquisas, Programa Biol Celular, Grp Regulacao Genica, Rio De Janeiro, Brazil	Centro Brasileiro de Pesquisas Fisicas; National Cancer Institute (Inca); Centro Brasileiro de Pesquisas Fisicas; National Cancer Institute (Inca)	Morgado-Diaz, JA (corresponding author), Inst Nacl Canc, Ctr Pesquisas, Programa Biol Celular, Grp Biol Estrutural, Rio De Janeiro, Brazil.	jmorgado@inca.gov.br	Araujo, Wallace/O-7736-2015; Viola, Joao P.B./AAP-4125-2020; Fortunato de Miranda, Natalia/O-7750-2015; de Souza, Waldemir/B-3612-2015; de Freitas Junior, Julio Cesar/M-5754-2013; Morgado-Diaz, Jose A./A-9649-2010	Viola, Joao P.B./0000-0002-0698-3146; de Souza, Waldemir/0000-0003-3258-6758; de Freitas Junior, Julio Cesar/0000-0002-2070-1432; DE ARAUJO, WALLACE/0000-0003-2979-4070; Robbs, Bruno Kaufmann/0000-0002-3972-5530	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Ministerio da Saude - Brasil; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ); Instituto nacional de Ciencia e Tecnologia em Cancer [573806/2008-0, 170.026/2008]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio da Saude - Brasil; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto nacional de Ciencia e Tecnologia em Cancer	This study was sponsored by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Ministerio da Saude - Brasil, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado de Rio de Janeiro (FAPERJ) and Instituto nacional de Ciencia e Tecnologia em Cancer (573806/2008-0 and 170.026/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036; Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Asaka M, 2011, AM J PHYSIOL-CELL PH, V300, pC87, DOI 10.1152/ajpcell.00565.2010; Barbosa LA, 2003, CELL TISSUE RES, V312, P319, DOI 10.1007/s00441-003-0727-z; Bezdekova M, 2012, INT J MOL SCI, V13, P1632, DOI 10.3390/ijms13021632; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; CHANTRET I, 1988, CANCER RES, V48, P1936; Chicaybam L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060298; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Contreras RG, 2004, J MEMBRANE BIOL, V198, P147, DOI 10.1007/s00232-004-0670-2; de Araujo WM, 2010, J CANCER RES CLIN, V136, P1773, DOI 10.1007/s00432-010-0836-5; de Oliveira SS, 2005, FEBS LETT, V579, P6179, DOI 10.1016/j.febslet.2005.09.091; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Ersoz S, 2011, PATHOL RES PRACT, V207, P285, DOI 10.1016/j.prp.2011.01.011; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hashimoto K, 2008, BIOCHEM BIOPH RES CO, V376, P154, DOI 10.1016/j.bbrc.2008.08.140; Ikari A, 2012, BBA-MOL CELL RES, V1823, P1110, DOI 10.1016/j.bbamcr.2012.04.005; Ikari A, 2011, J CELL PHYSIOL, V226, P2448, DOI 10.1002/jcp.22590; Ikari A, 2011, J CELL PHYSIOL, V226, P1471, DOI 10.1002/jcp.22386; Kinugasa T, 2012, ANTICANCER RES, V32, P2309; Kwon MJ, 2010, CARCINOGENESIS, V31, P974, DOI 10.1093/carcin/bgp336; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; Leve F, 2011, EUR J PHARMACOL, V671, P7, DOI 10.1016/j.ejphar.2011.09.006; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; de Freitas JCM, 2011, CANCER CHEMOTH PHARM, V68, P227, DOI 10.1007/s00280-010-1477-8; De-Freitas JCM, 2012, J CELL BIOCHEM, V113, P2957, DOI 10.1002/jcb.24173; MARCIAL MA, 1987, LAB INVEST, V56, P424; Mariadason JM, 2000, J CELL PHYSIOL, V183, P347, DOI 10.1002/(SICI)1097-4652(200006)183:3<347::AID-JCP7>3.0.CO;2-W; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Mitchell LA, 2011, AM J PHYSIOL-LUNG C, V301, pL40, DOI 10.1152/ajplung.00299.2010; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Ogawa M, 2012, HISTOCHEM CELL BIOL, V138, P323, DOI 10.1007/s00418-012-0956-x; Ohmori K, 2009, FOOD ADDIT CONTAM A, V26, P568, DOI 10.1080/02652030802471221; Oliveira SS, 2007, CELL MOL LIFE SCI, V64, P17, DOI 10.1007/s00018-006-6314-1; Peter Y, 2009, MOL CARCINOGEN, V48, P488, DOI 10.1002/mc.20485; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Resnick MB, 2005, MODERN PATHOL, V18, P511, DOI 10.1038/modpathol.3800301; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Singh AB, 2004, J BIOL CHEM, V279, P3543, DOI 10.1074/jbc.M308682200; Singh AB, 2007, AM J PHYSIOL-CELL PH, V293, pC1660, DOI 10.1152/ajpcell.00274.2007; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Takizawa Y, 2012, INT J PHARMACEUT, V426, P82, DOI 10.1016/j.ijpharm.2012.01.023; Vidal F, 2011, INT J ONCOL, V38, P1365, DOI 10.3892/ijo.2011.955; Vivekanand P, 2006, ANNU REV GENET, V40, P139, DOI 10.1146/annurev.genet.40.110405.090555; Weber CR, 2012, ANN NY ACAD SCI, V1257, P77, DOI 10.1111/j.1749-6632.2012.06528.x; Yoon CH, 2010, J BIOL CHEM, V285, P226, DOI 10.1074/jbc.M109.054189; Yoon YK, 2009, MOL CANCER THER, V8, P2526, DOI 10.1158/1535-7163.MCT-09-0300	50	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74994	10.1371/journal.pone.0074994	http://dx.doi.org/10.1371/journal.pone.0074994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069372	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300059
J	Friman, VP; Ghoul, M; Molin, S; Johansen, HK; Buckling, A				Friman, Ville-Petri; Ghoul, Melanie; Molin, Soren; Johansen, Helle Krogh; Buckling, Angus			Pseudomonas aeruginosa Adaptation to Lungs of Cystic Fibrosis Patients Leads to Lowered Resistance to Phage and Protist Enemies	PLOS ONE			English	Article							EVOLUTION; VIRULENCE; BACTERIA; HOST; PREDATION; DYNAMICS; COEVOLUTION; MULTIPLE; SURVIVAL; PROTOZOA	Pathogenic life styles can lead to highly specialized interactions with host species, potentially resulting in fitness trade-offs in other ecological contexts. Here we studied how adaptation of the environmentally transmitted bacterial pathogen, Pseudomonas aeruginosa, to cystic fibrosis (CF) patients affects its survival in the presence of natural phage (14/1, Phi KZ, PNM and PT7) and protist (Tetrahymena thermophila and Acanthamoebae polyphaga) enemies. We found that most of the bacteria isolated from relatively recently intermittently colonised patients (1-25 months), were innately phage-resistant and highly toxic for protists. In contrast, bacteria isolated from long time chronically infected patients (2-23 years), were less efficient in both resisting phages and killing protists. Moreover, chronic isolates showed reduced killing of wax moth larvae (Galleria mellonella) probably due to weaker in vitro growth and protease expression. These results suggest that P. aeruginosa long-term adaptation to CF-lungs could trade off with its survival in aquatic environmental reservoirs in the presence of microbial enemies, while lowered virulence could reduce pathogen opportunities to infect insect vectors; factors that are both likely to result in poorer environmental transmission. From an applied perspective, phage therapy could be useful against chronic P. aeruginosa lung infections that are often characterized by multidrug resistance: chronic isolates were least resistant to phages and their poor growth will likely slow down the emergence of beneficial resistance mutations.	[Friman, Ville-Petri; Ghoul, Melanie] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Friman, Ville-Petri; Buckling, Angus] Univ Exeter, Penryn, England; [Molin, Soren] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Johansen, Helle Krogh] Rigshosp, Dept Clin Microbiol, Copenhagen, Denmark	University of Oxford; University of Exeter; Technical University of Denmark; Rigshospitalet; University of Copenhagen	Friman, VP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Silwood Pk Campus, Ascot, Berks, England.	vifriman@gmail.com		Friman, Ville-Petri/0000-0002-1592-157X; Molin, Soren/0000-0002-7973-2639; Buckling, Angus/0000-0003-1170-4604	Marie-Curie Intra-European Fellowship within the 7th European Community Framework Programme; Wellcome Trust Institutional Strategic Support Fund fellowship; Novo Nordisk Foundation; Danish Research Agency; European Research Council; NERC; BBSRC; Royal Society Wolfson Research Merit award; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Marie-Curie Intra-European Fellowship within the 7th European Community Framework Programme(European Commission); Wellcome Trust Institutional Strategic Support Fund fellowship(Wellcome Trust); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Research Agency; European Research Council(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Wolfson Research Merit award(Royal Society of London); Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by Marie-Curie Intra-European Fellowship within the 7th European Community Framework Programme and Wellcome Trust Institutional Strategic Support Fund fellowship (V. F.). H.K.J. was supported by a Novo Nordisk Foundation clinical research stipend and S. M. was funded by the Danish Research Agency. A. B. acknowledges support from the European Research Council, NERC, BBSRC, and a Royal Society Wolfson Research Merit award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu D, 2012, MBIO, V3, DOI 10.1128/mBio.00029-12; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Buckling A, 2012, ADV EXP MED BIOL, V751, P347, DOI 10.1007/978-1-4614-3567-9_16; Casadevall A, 2007, EUKARYOT CELL, V6, P2169, DOI 10.1128/EC.00308-07; Cigana C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852513; Cirillo JD, 1999, INFECT IMMUN, V67, P4427, DOI 10.1128/IAI.67.9.4427-4434.1999; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; de Bentzmann Sophie, 2011, Environ Microbiol, V13, P1655, DOI 10.1111/j.1462-2920.2011.02469.x; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; ELLIOTT AM, 1959, ANNU REV MICROBIOL, V13, P79, DOI 10.1146/annurev.mi.13.100159.000455; Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Friman VP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006761; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gama JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002503; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; Hauer G, 2005, HYDROBIOLOGIA, V549, P33, DOI 10.1007/s10750-005-2210-1; HOLLSING AE, 1987, J CLIN MICROBIOL, V25, P1868, DOI 10.1128/JCM.25.10.1868-1874.1987; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P2862, DOI 10.1128/AEM.03817-12; James CE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-216; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Johansen HK, 2004, PEDIATR PULM, V37, P427, DOI 10.1002/ppul.10457; Jousset A, 2012, ENVIRON MICROBIOL, V14, P1830, DOI 10.1111/j.1462-2920.2011.02627.x; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; Malone JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000804; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Matz C, 2004, ENVIRON MICROBIOL, V6, P218, DOI 10.1111/j.1462-2920.2004.00556.x; Steinberg KM, 2007, P ROY SOC B-BIOL SCI, V274, P1921, DOI 10.1098/rspb.2007.0245; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Mikonranta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043801; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; OJENIYI B, 1991, APMIS, V99, P925, DOI 10.1111/j.1699-0463.1991.tb01280.x; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; Price P W, 1980, Monogr Popul Biol, V15, P1; Rau MH, 2012, ENVIRON MICROBIOL, V14, P2200, DOI 10.1111/j.1462-2920.2012.02795.x; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Selezska K, 2012, ENVIRON MICROBIOL, V14, P1952, DOI 10.1111/j.1462-2920.2012.02719.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Tan MW, 2002, ANNU REV MICROBIOL, V56, P539, DOI 10.1146/annurev.micro.56.012302.161110; Thompson JN, 2005, CURR BIOL, V15, pR992, DOI 10.1016/j.cub.2005.11.046; Thompson JN, 1994, COEVOLUTIONARY PROCE, Vxi; Willner D, 2012, AM J RESP CELL MOL, V46, P127, DOI 10.1165/rcmb.2011-0253OC; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Zaborin A, 2009, P NATL ACAD SCI USA, V106, P6327, DOI 10.1073/pnas.0813199106	59	31	31	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75380	10.1371/journal.pone.0075380	http://dx.doi.org/10.1371/journal.pone.0075380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069407	gold, Green Published			2022-12-27	WOS:000324777300075
J	Martin, V; Ratel, S; Siracusa, J; Le Ruyet, P; Savary-Auzeloux, I; Combaret, L; Guillet, C; Dardevet, D				Martin, Vincent; Ratel, Sebastien; Siracusa, Julien; Le Ruyet, Pascale; Savary-Auzeloux, Isabelle; Combaret, Lydie; Guillet, Christelle; Dardevet, Dominique			Whey Proteins Are More Efficient than Casein in the Recovery of Muscle Functional Properties following a Casting Induced Muscle Atrophy	PLOS ONE			English	Article							RAT SOLEUS MUSCLE; SKELETAL-MUSCLE; BED REST; UBIQUITIN-PROTEASOME; ELECTRICAL-STIMULATION; RESISTANCE EXERCISE; HINDLIMB SUSPENSION; APOPTOTIC PATHWAYS; BODY-COMPOSITION; DISUSE ATROPHY	The purpose of this study was to investigate the effect of whey supplementation, as compared to the standard casein diet, on the recovery of muscle functional properties after a casting-induced immobilization period. After an initial (I0) evaluation of the contractile properties of the plantarflexors (isometric torque-frequency relationship, concentric power-velocity relationship and a fatigability test), the ankle of 20 male adult rats was immobilized by casting for 8 days. During this period, rats were fed a standard diet with 13% of casein (CAS). After cast removal, rats received either the same diet or a diet with 13% of whey proteins (WHEY). A control group (n = 10), non-immobilized but pair-fed to the two other experimental groups, was also studied and fed with the CAS diet. During the recovery period, contractile properties were evaluated 7 (R7), 21 (R21) and 42 days (R42) after cast removal. The immobilization procedure induced a homogeneous depression of average isometric force at R7 (CAS: - 19.0 +/- 8.2%; WHEY: - 21.7 +/- 8.4%; P<0.001) and concentric power (CAS: - 26.8 +/- 16.4%, P<0.001; WHEY: - 13.5 +/- 21.8%, P<0.05) as compared to I0. Conversely, no significant alteration of fatigability was observed. At R21, isometric force had fully recovered in WHEY, especially for frequencies above 50 Hz, whereas it was still significantly depressed in CAS, where complete recovery occurred only at R42. Similarly, recovery of concentric power was faster at R21 in the 500-700 degrees/s range in the WHEY group. These results suggest that recovery kinetics varied between diets, the diet with the whey proteins promoting a faster recovery of isometric force and concentric power output as compared to the casein diet. These effects were more specifically observed at force level and movement velocities that are relevant for functional abilities, and thus natural locomotion.	[Martin, Vincent; Ratel, Sebastien; Siracusa, Julien] Univ Blaise Pascal, Clermont Univ, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533,CRNH Auvergne, Clermont Ferrand, France; [Le Ruyet, Pascale] Lactalis Rech & Dev, Retiers, France; [Savary-Auzeloux, Isabelle; Combaret, Lydie; Guillet, Christelle; Dardevet, Dominique] CRNH Auvergne, Unite Nutr Humaine, UMR 1019, INRA, Clermont Ferrand, France; [Guillet, Christelle] Univ Auvergne, Clermont Univ, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); INRAE; Universite Clermont Auvergne (UCA)	Martin, V (corresponding author), Univ Blaise Pascal, Clermont Univ, Lab Adaptat Metab Exercice Condit Physiol & Patho, EA 3533,CRNH Auvergne, Clermont Ferrand, France.	vincent.martin@univ-bpclermont.fr	Martin, Vincent/ABF-7135-2020; SIRACUSA, Julien/I-4344-2016	Martin, Vincent/0000-0002-6681-1610; SIRACUSA, Julien/0000-0001-7715-5199; Dardevet, Dominique/0000-0001-7320-9970; Combaret, Lydie/0000-0001-6550-8700; Savary-Auzeloux, Isabelle/0000-0002-3298-9787	Lactalis Recherche et Developpement	Lactalis Recherche et Developpement	Lactalis Recherche et Developpement funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JC, 2000, J NUTR, V130, P139, DOI 10.1093/jn/130.2.139; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Atherton PJ, 2010, AM J CLIN NUTR, V92, P1080, DOI 10.3945/ajcn.2010.29819; BAKER JH, 1988, MUSCLE NERVE, V11, P231, DOI 10.1002/mus.880110308; Baptista IL, 2010, MUSCLE NERVE, V41, P800, DOI 10.1002/mus.21578; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; BUSE MG, 1975, J CLIN INVEST, V56, P1250, DOI 10.1172/JCI108201; Clark BC, 2009, MED SCI SPORT EXER, V41, P1869, DOI 10.1249/MSS.0b013e3181a645a6; Crameri RM, 2004, MATRIX BIOL, V23, P259, DOI 10.1016/j.matbio.2004.05.009; Dangin M, 2001, AM J PHYSIOL-ENDOC M, V280, pE340, DOI 10.1152/ajpendo.2001.280.2.E340; Dardevet D, 2000, J NUTR, V130, P2630, DOI 10.1093/jn/130.11.2630; Dardevet D, 2012, SCI WORLD J, DOI 10.1100/2012/269531; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; Ferrando AA, 1997, J APPL PHYSIOL, V82, P807, DOI 10.1152/jappl.1997.82.3.807; Ferrando AA, 2010, CLIN NUTR, V29, P18, DOI 10.1016/j.clnu.2009.03.009; GIBSON JNA, 1988, LANCET, V2, P767; GIBSON JNA, 1987, CLIN SCI, V72, P503, DOI 10.1042/cs0720503; Gillette PD, 1996, J APPL PHYSIOL, V81, P724, DOI 10.1152/jappl.1996.81.2.724; Glover EI, 2010, APPL PHYSIOL NUTR ME, V35, P125, DOI 10.1139/H09-137; Gorassini M, 2000, J NEUROPHYSIOL, V83, P2002, DOI 10.1152/jn.2000.83.4.2002; Groskreutz JJ, 2002, AGING CLIN EXP RES, V14, P347; Hoang PD, 2007, MED SCI SPORT EXER, V39, P849, DOI 10.1249/MSS.0b013e318033499b; Ikemoto M, 2001, FASEB J, V15, P1279, DOI 10.1096/fj.00-0629fje; Ishihara A, 1997, AVIAT SPACE ENVIR MD, V68, P421; Jacobsen DE, 2007, MATURITAS, V58, P7, DOI 10.1016/j.maturitas.2007.04.012; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lynn R, 1998, J APPL PHYSIOL, V85, P98, DOI 10.1152/jappl.1998.85.1.98; Magne H, 2012, J PHYSIOL-LONDON, V590, P2035, DOI 10.1113/jphysiol.2011.226266; Magne H, 2011, J PHYSIOL-LONDON, V589, P511, DOI 10.1113/jphysiol.2010.201707; MCDONALD KS, 1992, J APPL PHYSIOL, V73, P1135, DOI 10.1152/jappl.1992.73.3.1135; MERCIER C, 1993, MECH AGEING DEV, V68, P117, DOI 10.1016/0047-6374(93)90144-G; MORGAN DL, 1990, BIOPHYS J, V57, P209, DOI 10.1016/S0006-3495(90)82524-8; Paddon-Jones D, 2004, J CLIN ENDOCR METAB, V89, P4351, DOI 10.1210/jc.2003-032159; Paddon-Jones D, 2006, J CLIN ENDOCR METAB, V91, P4836, DOI 10.1210/jc.2006-0651; Papadakis MA, 1996, ANN INTERN MED, V124, P708, DOI 10.7326/0003-4819-124-8-199604150-00002; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Slimani L, 2012, AM J PHYSIOL-ENDOC M, V303, pE1335, DOI 10.1152/ajpendo.00379.2012; Snih SA, 2004, AGING CLIN EXP RES, V16, P481, DOI 10.1007/BF03327406; Taillandier D, 1996, BIOCHEM J, V316, P65, DOI 10.1042/bj3160065; Tang JE, 2009, J APPL PHYSIOL, V107, P987, DOI 10.1152/japplphysiol.00076.2009; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Varejao ASP, 2002, MUSCLE NERVE, V26, P630, DOI 10.1002/mus.10242; Vazeille E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1181, DOI 10.1152/ajpendo.90532.2008; Warren GL, 2004, EUR J APPL PHYSIOL, V93, P130, DOI 10.1007/s00421-004-1185-3; Washington TA, 2004, J APPL PHYSIOL, V97, P1424, DOI 10.1152/japplphysiol.00222.2004	49	17	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75408	10.1371/journal.pone.0075408	http://dx.doi.org/10.1371/journal.pone.0075408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069411	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300078
J	Tabrizi, GA; Bose, K; Reimann, Y; Kessel, M				Tabrizi, Golnaz A.; Boese, Kerstin; Reimann, Yvonne; Kessel, Michael			Geminin Is Required for the Maintenance of Pluripotency	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CHROMATIN REMODELING COMPLEX; SELF-RENEWAL; TRANSCRIPTION FACTORS; NEURAL PLATE; ES CELLS; MOUSE; CYCLE; DIFFERENTIATION; SOX2	Pluripotency requires the expression of the three core transcriptions factors Oct4, Sox2 and Nanog, as well as further, complementary proteins. The geminin protein is part of this network, and was shown to play a role in the regulation of DNA replication, the control of the cell cycle, and the acquisition of neural fate. It is highly expressed in the early embryo, in particular the epiblast and the early neural ectoderm, and also in pluripotent embryonic stem cells. The genetic inactivation of geminin resulted in lethality after the first few cell divisions, and thus prohibited the outgrowth of pluripotent cells. We established embryonic stem cells allowing the deletion of the geminin gene by induction of of Cre-recombinase with tamoxifen. Here, we show that geminin deficiency quickly leads to a loss of pluripotency, and to differentiation into the mesendodermal direction with high Oct4/low Sox2 levels. Simultaneous loss of geminin and induction of the neural lineage resulted in immediate apoptosis. These results suggested that in early development geminin functions via the co-expressed Sox2 gene. We found that the stem cell enhancer SRR2 of Sox2 is occupied by the activating esBAF complex in the presence of geminin, but becomes epigenetically repressed in its absence by the Polycomb repressive complex PRC2. The importance of geminin for Sox2 expression also explains the absolute requirement for geminin during the induction of pluripotency by OSKM viruses. In summary, geminin is required for Sox2 expression, and thus for the maintenance of totipotency, pluripotency and the early neural lineage.	[Tabrizi, Golnaz A.; Boese, Kerstin; Reimann, Yvonne; Kessel, Michael] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Kessel, M (corresponding author), Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.	mkessel1@gwdg.de			Max-Planck Society	Max-Planck Society(Max Planck Society)	This work was supported by the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Ballabeni A, 2011, P NATL ACAD SCI USA, V108, P19252, DOI 10.1073/pnas.1116794108; Barry KA, 2012, DEV BIOL, V371, P35, DOI 10.1016/j.ydbio.2012.07.031; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Boos A, 2006, BIOL CELL, V98, P363, DOI 10.1042/BC20060007; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Dejosez M, 2012, ANNU REV BIOCHEM, V81, P737, DOI 10.1146/annurev-biochem-052709-104948; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Fujii-Yamamoto H, 2005, J BIOL CHEM, V280, P12976, DOI 10.1074/jbc.M412224200; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Hara K, 2006, GENES CELLS, V11, P1281, DOI 10.1111/j.1365-2443.2006.01019.x; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Karamitros D, 2010, J IMMUNOL, V184, P2432, DOI 10.4049/jimmunol.0901983; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kulartz M, 2004, J BIOL CHEM, V279, P41686, DOI 10.1074/jbc.M405798200; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li VC, 2012, P NATL ACAD SCI USA, V109, P12550, DOI 10.1073/pnas.1206740109; Lim JW, 2011, DEVELOPMENT, V138, P33, DOI 10.1242/dev.059824; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Luo LF, 2007, MOL CELL BIOL, V27, P4737, DOI 10.1128/MCB.00123-07; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Menchon C, 2011, CELL CYCLE, V10, P1435, DOI 10.4161/cc.10.9.15421; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Petropoulou C, 2008, FRONT BIOSCI, V13, P4485, DOI 10.2741/3018; Pitulescu ME, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-16; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Schultz KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017736; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Shinnick KM, 2010, J CLIN INVEST, V120, P4303, DOI 10.1172/JCI43556; Spella M, 2011, STEM CELLS, V29, P1269, DOI 10.1002/stem.678; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Uerlings Y, 2008, FUNKTION GEMININ BEI; Voss AK, 1997, EXP CELL RES, V230, P45, DOI 10.1006/excr.1996.3418; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Wiese C, 2006, METH MOL B, V325, P181; Yang VS, 2011, CURR BIOL, V21, P692, DOI 10.1016/j.cub.2011.03.026; Yellajoshyula D, 2012, MOL CELL BIOL, V32, P4549, DOI 10.1128/MCB.00737-12; Yellajoshyula D, 2011, P NATL ACAD SCI USA, V108, P3294, DOI 10.1073/pnas.1012053108; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559	58	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73826	10.1371/journal.pone.0073826	http://dx.doi.org/10.1371/journal.pone.0073826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069236	Green Published, Green Submitted			2022-12-27	WOS:000324777300021
J	Garcia-Vedrenne, AE; Groner, M; Page-Karjian, A; Siegmund, GF; Singhal, S; Sziklay, J; Roberts, S				Garcia-Vedrenne, Ana Elisa; Groner, Maya; Page-Karjian, Annie; Siegmund, Gregor-Fausto; Singhal, Sonia; Sziklay, Jamie; Roberts, Steven			Development of Genomic Resources for a thraustochytrid Pathogen and Investigation of Temperature Influences on Gene Expression	PLOS ONE			English	Article							MERCENARIA-MERCENARIA IMMUNITY; PARASITE UNKNOWN DISEASE; HARD CLAMS; ULTRASTRUCTURAL OBSERVATIONS; LINEAR GRAMICIDIN; WASTING DISEASE; QPX DISEASE; QUAHOG; STRAINS; METALLOPROTEINASE	Understanding how environmental changes influence the pathogenicity and virulence of infectious agents is critical for predicting epidemiological patterns of disease. Thraustochytrids, part of the larger taxonomic class Labyrinthulomycetes, contain several highly pathogenic species, including the hard clam pathogen quahog parasite unknown (QPX). QPX has been associated with large-scale mortality events along the northeastern coast of North America. Growth and physiology of QPX is temperature-dependent, and changes in local temperature profiles influence pathogenicity. In this study we characterize the partial genome of QPX and examine the influence of temperature on gene expression. Genes involved in several biological processes are differentially expressed upon temperature change, including those associated with altered growth and metabolism and virulence. The genomic and transcriptomic resources developed in this study provide a foundation for better understanding virulence, pathogenicity and life history of thraustochytrid pathogens.	[Garcia-Vedrenne, Ana Elisa] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Groner, Maya] Univ Prince Edward Isl, Ctr Vet Epidemiol Res, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Page-Karjian, Annie] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA; [Siegmund, Gregor-Fausto] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Singhal, Sonia] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Sziklay, Jamie] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Roberts, Steven] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of California System; University of California Santa Barbara; University of Prince Edward Island; University System of Georgia; University of Georgia; University of Chicago; University of Washington; University of Washington Seattle; University of Hawaii System; University of Washington; University of Washington Seattle	Roberts, S (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	sr320@uw.edu	Page-Karjian, Annie/AAX-5668-2021; Groner, Maya L/J-4261-2014	Page-Karjian, Annie/0000-0001-6279-529X; Groner, Maya L/0000-0002-3381-6415; Roberts, Steven/0000-0001-8302-1138; Siegmund, Gregor-Fausto/0000-0002-8967-8816; Sziklay, Jamie/0000-0002-6220-918X; Garcia-Vedrenne, Ana/0000-0002-3518-1564	National Science Foundation [OCE-1215977]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation (OCE-1215977 - RCN: Evaluating the Impacts of a Changing Ocean on Management and Ecology of Infectious Marine Disease) to D. Harvell, C. Friedman, E. Hofmann, K. Lafferty and K. McComas. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson Robert S., 2002, Journal of Shellfish Research, V21, P404; Anderson RS, 2006, J SHELLFISH RES, V25, P708; Azevedo C, 1997, DIS AQUAT ORGAN, V31, P73, DOI 10.3354/dao031073; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Bongiorni L, 2005, AQUAT MICROB ECOL, V41, P299, DOI 10.3354/ame041299; Bower S. M., 2010, SYNOPSIS INFECT DIS; BOWER SM, 1987, CAN J ZOOL, V65, P2013, DOI 10.1139/z87-306; Brothers C, 2000, BIOL BULL, V199, P200, DOI 10.2307/1542897; Burge CA, 2012, DIS AQUAT ORGAN, V101, P1, DOI 10.3354/dao02487; Calvo LMR, 1998, DIS AQUAT ORGAN, V33, P209, DOI 10.3354/dao033209; Chen RQ, 2003, BIOCHEM BIOPH RES CO, V310, P182, DOI 10.1016/j.bbrc.2003.09.009; Coceres VM, 2012, EXP PARASITOL, V132, P274, DOI 10.1016/j.exppara.2012.08.003; Craven KD, 2005, MYCOLOGIA, V97, P160, DOI 10.3852/mycologia.97.1.160; Dahl SF, 2011, J INVERTEBR PATHOL, V106, P314, DOI 10.1016/j.jip.2010.11.005; Dahl SF, 2010, J SHELLFISH RES, V29, P83, DOI 10.2983/035.029.0131; Davies BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001295; Decker Christie-Sue, 2002, Journal of Shellfish Research, V21, P404; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dove ADM, 2004, J AQUAT ANIM HEALTH, V16, P246, DOI 10.1577/H03-052.1; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Ford SE, 2002, AQUACULTURE, V208, P23, DOI 10.1016/S0044-8486(01)00795-5; Gast RJ, 2008, DIS AQUAT ORGAN, V81, P219, DOI 10.3354/dao01948; Gomez-Chiarri M, 2012, J SHELLFISH RES, V31, P583, DOI 10.2983/035.031.0219; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Holt R. A., 1989, Journal of Aquatic Animal Health, V1, P94, DOI 10.1577/1548-8667(1989)001&lt;0094:ROWTTB&gt;2.3.CO;2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JONES GM, 1983, J PARASITOL, V69, P903, DOI 10.2307/3281055; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kleinschuster SJ, 1998, J SHELLFISH RES, V17, P75; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Liu K.-J., 2007, J CANC MOL, V3, P45; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lyons MM, 2006, DIS AQUAT ORGAN, V72, P45, DOI 10.3354/dao072045; MacCallum GS, 2000, DIS AQUAT ORGAN, V77, P159; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; MANDL J, 1985, ARCH MICROBIOL, V143, P248, DOI 10.1007/BF00411244; MCLEAN N, 1987, J INVERTEBR PATHOL, V49, P223, DOI 10.1016/0022-2011(87)90165-0; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Montagna GN, 2012, J BIOL CHEM, V287, P2410, DOI 10.1074/jbc.M111.302109; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUEHLSTEIN LK, 1988, MAR BIOL, V99, P465, DOI 10.1007/BF00392553; MUEHLSTEIN LK, 1991, MYCOLOGIA, V83, P180, DOI 10.2307/3759933; Ostersetzer O, 1996, PLANT MOL BIOL, V31, P673, DOI 10.1007/BF00042238; Perrigault M, 2011, J INVERTEBR PATHOL, V106, P322, DOI 10.1016/j.jip.2010.11.004; Perrigault M, 2010, J INVERTEBR PATHOL, V104, P83, DOI 10.1016/j.jip.2010.02.005; Perrigault M, 2009, PARASITOLOGY, V136, P1281, DOI 10.1017/S0031182009990606; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Rahimian H, 1996, DIS AQUAT ORGAN, V27, P187, DOI 10.3354/dao027187; RISTOW H, 1975, BIOCHIM BIOPHYS ACTA, V390, P246, DOI 10.1016/0005-2787(75)90345-7; Roberts SB, 2013, QPX GENOME BROWSER F, DOI DOI 10.6084/M9.FIGSHARE.701214; Robold AV, 2005, CURR GENET, V47, P307, DOI 10.1007/s00294-004-0559-8; Santos ED, 2011, ISME J, V5, P1471, DOI 10.1038/ismej.2011.19; SINDERMANN CJ, 1956, MAINE DEP SEA SHORE, V25, P1; Singer S, 1997, J IND MICROBIOL BIOT, V18, P226, DOI 10.1038/sj.jim.2900371; Smolowitz R, 1998, J INVERTEBR PATHOL, V71, P9, DOI 10.1006/jipa.1997.4706; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Wan SG, 2006, TOXICON, V47, P480, DOI 10.1016/j.toxicon.2006.01.006; WHYTE SK, 1994, DIS AQUAT ORGAN, V19, P129, DOI 10.3354/dao019129	63	16	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74196	10.1371/journal.pone.0074196	http://dx.doi.org/10.1371/journal.pone.0074196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069279	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300031
J	Krieg, SM; Sollmann, N; Hauck, T; Ille, S; Foerschler, A; Meyer, B; Ringel, F				Krieg, Sandro M.; Sollmann, Nico; Hauck, Theresa; Ille, Sebastian; Foerschler, Annette; Meyer, Bernhard; Ringel, Florian			Functional Language Shift to the Right Hemisphere in Patients with Language-Eloquent Brain Tumors	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TEMPORAL-LOBE EPILEPSY; DIRECT CORTICAL STIMULATION; GRADE-II GLIOMAS; DOMINANT HEMISPHERE; WORD RETRIEVAL; CLINICAL ARTICLE; VIRTUAL LESION; AWAKE SURGERY; NAMING ERRORS	Objectives: Language function is mainly located within the left hemisphere of the brain, especially in right-handed subjects. However, functional MRI (fMRI) has demonstrated changes of language organization in patients with left-sided perisylvian lesions to the right hemisphere. Because intracerebral lesions can impair fMRI, this study was designed to investigate human language plasticity with a virtual lesion model using repetitive navigated transcranial magnetic stimulation (rTMS). Experimental design: Fifteen patients with lesions of left-sided language-eloquent brain areas and 50 healthy and purely right-handed participants underwent bilateral rTMS language mapping via an object-naming task. All patients were proven to have left-sided language function during awake surgery. The rTMS-induced language errors were categorized into 6 different error types. The error ratio (induced errors/number of stimulations) was determined for each brain region on both hemispheres. A hemispheric dominance ratio was then defined for each region as the quotient of the error ratio (left/right) of the corresponding area of both hemispheres (ratio >1 = left dominant; ratio <1 = right dominant). Results: Patients with language-eloquent lesions showed a statistically significantly lower ratio than healthy participants concerning "all errors'' and "all errors without hesitations'', which indicates a higher participation of the right hemisphere in language function. Yet, there was no cortical region with pronounced difference in language dominance compared to the whole hemisphere. Conclusions: This is the first study that shows by means of an anatomically accurate virtual lesion model that a shift of language function to the non-dominant hemisphere can occur.	[Krieg, Sandro M.; Sollmann, Nico; Hauck, Theresa; Ille, Sebastian; Meyer, Bernhard; Ringel, Florian] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, D-80290 Munich, Germany; [Foerschler, Annette] Tech Univ Munich, Klinikum Rechts Isar, Sect Neuroradiol, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich	Ringel, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, D-80290 Munich, Germany.	Florian.Ringel@lrz.tum.de	Meyer, Bernhard/Q-9413-2016; Krieg, Sandro M./L-8902-2016; TUM, Forschung Neurorad/C-1202-2014; Ringel, Florian/E-4933-2014; Meyer, Bernhard/AAH-3329-2019; Forschler, Annette/O-9390-2015	Krieg, Sandro M./0000-0003-4050-1531; Meyer, Bernhard/0000-0001-6486-7955; Forschler, Annette/0000-0001-9665-5228; Sollmann, Nico/0000-0002-8120-2223	Department of Neurosurgery; Section of Neuroradiology; TU Munich	Department of Neurosurgery; Section of Neuroradiology; TU Munich	The study was mostly financed by institutional grants from the Department of Neurosurgery and the Section of Neuroradiology, TU Munich, and the authors declare that they have no conflict of interest affecting this study. Moreover, SK received a grant of the "Stiftung Neurochirurgische Forschung" of the German Neurosurgical Society (DGNC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum SH, 2012, NEUROIMAGE; Baumgaertner A, 2012, HUM BRAIN MAPP; Billingsley RL, 2001, BRAIN, V124, P1218, DOI 10.1093/brain/124.6.1218; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Bonelli SB, 2012, EPILEPSIA, V53, P639, DOI 10.1111/j.1528-1167.2012.03433.x; Brennan J, 2012, NEUROIMAGE, V60, P1139, DOI 10.1016/j.neuroimage.2012.01.030; Briganti C, 2012, AJNR AM J NEURORADIO; Candidi M, 2008, SOC NEUROSCI-UK, V3, P388, DOI 10.1080/17470910701676269; Chang EF, 2011, J NEUROSURG, V114, P893, DOI 10.3171/2010.11.JNS10888; Corina DP, 2010, BRAIN LANG, V115, P101, DOI 10.1016/j.bandl.2010.04.001; Corina DP, 2005, HUM BRAIN MAPP, V24, P1, DOI 10.1002/hbm.20063; Cousin E, 2007, EUR J RADIOL, V63, P274, DOI 10.1016/j.ejrad.2007.01.030; Cousin Emilie, 2008, Neuropsychiatr Dis Treat, V4, P235; Davidson DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00219; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Devlin JT, 2007, BRAIN, V130, P610, DOI 10.1093/brain/awl331; Epstein CM, 1996, NEUROLOGY, V47, P1590, DOI 10.1212/WNL.47.6.1590; FitzGerald DB, 1997, AM J NEURORADIOL, V18, P1529; Galluzzi S, 2008, J NEUROL SCI, V273, P3, DOI 10.1016/j.jns.2008.06.023; Geva S, 2012, J COGNITIVE NEUROSCI, V24, P2135, DOI 10.1162/jocn_a_00278; Giussani C, 2010, NEUROSURGERY, V66, P113, DOI 10.1227/01.NEU.0000360392.15450.C9; Goldmann RE, 2005, EPILEPSY BEHAV, V6, P473, DOI 10.1016/j.yebeh.2005.03.012; Griffiths JD, 2012, CEREB CORTEX; Hickok G, 2009, PHYS LIFE REV, V6, P121, DOI 10.1016/j.plrev.2009.06.001; Hund-Georgiadis M, 2001, J MAGN RESON IMAGING, V13, P668, DOI 10.1002/jmri.1094; Ilmoniemi RJ, 1999, CRIT REV BIOMED ENG, V27, P241; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Ius T, 2011, NEUROIMAGE, V56, P992, DOI 10.1016/j.neuroimage.2011.03.022; Knops A, 2006, NEUROPSYCHOLOGIA, V44, P2270, DOI 10.1016/j.neuropsychologia.2006.05.011; Krieg SM, 2012, J NEUROSURG, V116, P994, DOI 10.3171/2011.12.JNS111524; Krieg SM, 2012, CLIN NEUROPHYSIOL; Lioumis P, 2012, J NEUROSCI METH, V204, P349, DOI 10.1016/j.jneumeth.2011.11.003; McGraw P, 2001, NEUROIMAG CLIN N AM, V11, P343; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; OJEMANN GA, 1978, BRAIN LANG, V6, P239, DOI 10.1016/0093-934X(78)90061-5; Orosz A, 2012, NEUROIMAGE, V61, P599, DOI 10.1016/j.neuroimage.2012.03.084; PASCUALLEONE A, 1991, NEUROLOGY, V41, P697, DOI 10.1212/WNL.41.5.697; Pellicciari MC, 2009, NEUROSCIENCE, V163, P266, DOI 10.1016/j.neuroscience.2009.06.013; Perrone-Bertolotti M, 2012, EPILEPSY BEHAV, V23, P81, DOI 10.1016/j.yebeh.2011.11.011; Picht T, 2013, NEUROSURGERY, V72, P808, DOI 10.1227/NEU.0b013e3182889e01; Picht T, 2009, NEUROSURGERY, V65, P93, DOI 10.1227/01.NEU.0000348009.22750.59; Robles SG, 2008, J NEUROSURG, V109, P615, DOI 10.3171/JNS/2008/109/10/0615; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Roux FE, 2003, NEUROSURGERY, V52, P1335, DOI 10.1227/01.NEU.0000064803.05077.40; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; Ruohonen J, 1999, EEG CL N SU, P30; Salmelin R, 2000, J CLIN NEUROPHYSIOL, V17, P163, DOI 10.1097/00004691-200003000-00005; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Sarubbo S, 2012, ACTA NEUROCHIR, V154, P1653, DOI 10.1007/s00701-012-1416-z; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schuhmann T, 2012, CEREB CORTEX, V22, P701, DOI 10.1093/cercor/bhr155; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Shafto MA, 2010, J COGNITIVE NEUROSCI, V22, P1530, DOI 10.1162/jocn.2009.21321; Smith AE, 2009, EXP BRAIN RES, V198, P489, DOI 10.1007/s00221-009-1945-8; Sollmann N, 2013, J NEUROSURG, V118, P175, DOI 10.3171/2012.9.JNS121053; Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496; Thiel A, 2006, BRAIN LANG, V98, P57, DOI 10.1016/j.bandl.2006.01.007; Thiel A, 2005, ANN NEUROL, V57, P128, DOI 10.1002/ana.20342; Thivard L, 2005, NEUROIMAGE, V24, P841, DOI 10.1016/j.neuroimage.2004.10.001; Tracy JI, 2009, CORTEX, V45, P1178, DOI 10.1016/j.cortex.2009.01.007; van de Meerendonk N, 2011, NEUROIMAGE, V54, P2350, DOI 10.1016/j.neuroimage.2010.10.022; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Wang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059657; Wassermann EM, 1999, NEUROPSYCHOLOGIA, V37, P537, DOI 10.1016/S0028-3932(98)00102-X; Wheat KL, 2012, BRAIN LANG; Yordanova YN, 2011, J NEUROSURG, V115, P232, DOI 10.3171/2011.3.JNS101333	66	66	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75403	10.1371/journal.pone.0075403	http://dx.doi.org/10.1371/journal.pone.0075403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069410	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300081
J	Shieh, AWY; Chalker, DL				Shieh, Annie Wan Yi; Chalker, Douglas L.			LIA5 Is Required for Nuclear Reorganization and Programmed DNA Rearrangements Occurring during Tetrahymena Macronuclear Differentiation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; GENOME-WIDE CHARACTERIZATION; DICER-LIKE PROTEIN; CHROMOSOME BREAKAGE; CHROMODOMAIN PROTEIN; THERMOPHILA; ELIMINATION; HETEROCHROMATIN; REPAIR	During macronuclear differentiation of the ciliate Tetrahymena thermophila, genome-wide DNA rearrangements eliminate nearly 50 Mbp of germline derived DNA, creating a streamlined somatic genome. The transposon-like and other repetitive sequences to be eliminated are identified using a piRNA pathway and packaged as heterochromatin prior to their removal. In this study, we show that LIA5, which encodes a zinc-finger protein likely of transposon origin, is required for both chromosome fragmentation and DNA elimination events. Lia5p acts after the establishment of RNAi-directed heterochromatin modifications, but prior to the excision of the modified sequences. In Delta LIA5 cells, DNA elimination foci, large nuclear sub-structures containing the sequences to be eliminated and the essential chromodomain protein Pdd1p, do not form Lia5p, unlike Pdd1p, is not stably associated with these structures, but is required for their formation. In the absence of Lia5p, we could recover foci formation by ectopically inducing DNA damage by UV treatment. Foci in both wild-type or UV-treated Delta LIA5 cells contain dephosphorylated Pdd1p. These studies of LIA5 reveal that DNA elimination foci form after the excision of germ-line limited sequences occurs and indicate that Pdd1p reorganization is likely mediated through a DNA damage response.	[Shieh, Annie Wan Yi; Chalker, Douglas L.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Chalker, DL (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	dchalker@biology2.wustl.edu		Chalker, Douglas/0000-0002-0285-3344	National Institutes of Health [GM069593]; Biology Department of Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biology Department of Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a National Institutes of Health research grant (GM069593) to D.L.C. A.W.Y.S. was also supported by funds provided by the Biology Department of Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SL, 1967, GENETICS, V55, P797; AUSTERBERRY CF, 1988, MOL CELL BIOL, V8, P3947, DOI 10.1128/MCB.8.9.3947; Ayoub N, 2009, CELL CYCLE, V8, P2945; Ball AR, 2009, J CELL BIOL, V185, P573, DOI 10.1083/jcb.200904033; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Baudry C, 2009, GENE DEV, V23, P2478, DOI 10.1101/gad.547309; Bruns PJ, 2000, METHOD CELL BIOL, V62, P501; Cassidy-Hanley D, 2005, GENETICS, V170, P1623, DOI 10.1534/genetics.104.031435; CassidyHanley D, 1997, GENETICS, V146, P135; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chalker DL, 2008, BBA-MOL CELL RES, V1783, P2130, DOI 10.1016/j.bbamcr.2008.07.012; Chalker DL, 2011, ANNU REV GENET, V45, P227, DOI 10.1146/annurev-genet-110410-132432; Chalker DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-224; Cheng CY, 2010, MOL BIOL CELL, V21, P1753, DOI 10.1091/mbc.E09-12-1079; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Coyne RS, 1999, MOL CELL, V4, P865, DOI 10.1016/S1097-2765(00)80396-2; De Palmenaer D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-18; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Fan QC, 2000, METHOD CELL BIOL, V62, P533; Fass JN, 2011, G3-GENES GENOM GENET, V1, P515, DOI 10.1534/g3.111.000927; GAERTIG J, 1994, NUCLEIC ACIDS RES, V22, P5391, DOI 10.1093/nar/22.24.5391; Hamilton E, 2005, GENETICS, V170, P1611, DOI 10.1534/genetics.104.031401; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Kanaar R, 2008, EMBO J, V27, P581, DOI 10.1038/emboj.2008.11; Kapusta A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002049; Karrer KM, 2000, METHOD CELL BIOL, V62, P127; Kataoka K, 2011, ADV EXP MED BIOL, V722, P156, DOI 10.1007/978-1-4614-0332-6_10; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Lin IT, 2012, MOL BIOL CELL, V23, P2213, DOI 10.1091/mbc.E11-11-0952; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Matsuda A, 2010, EUKARYOT CELL, V9, P1087, DOI 10.1128/EC.00379-09; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Motl JA, 2011, EUKARYOT CELL, V10, P1648, DOI 10.1128/EC.05216-11; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nikiforov MA, 2000, MOL CELL BIOL, V20, P4128, DOI 10.1128/MCB.20.11.4128-4134.2000; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Orias E, 2000, METHOD CELL BIOL, V62, P189; Orias E, 2011, RES MICROBIOL, V162, P578, DOI 10.1016/j.resmic.2011.05.001; Rexer CH, 2007, EUKARYOT CELL, V6, P1320, DOI 10.1128/EC.00157-07; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shang YH, 2002, P NATL ACAD SCI USA, V99, P3734, DOI 10.1073/pnas.052016199; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Smothers JF, 1997, DEVELOPMENT, V124, P4537; Smothers JF, 1997, J EUKARYOT MICROBIOL, V44, P79, DOI 10.1111/j.1550-7408.1997.tb05942.x; Song XY, 2007, MOL CELL BIOL, V27, P2648, DOI 10.1128/MCB.01910-06; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; YAO M, 1974, CHROMOSOMA, V48, P1; YAO MC, 1994, NUCLEIC ACIDS RES, V22, P5702, DOI 10.1093/nar/22.25.5702; YAO MC, 1990, CELL, V63, P763, DOI 10.1016/0092-8674(90)90142-2; YAO MC, 1984, CELL, V36, P433, DOI 10.1016/0092-8674(84)90236-8; Yao MC, 2007, J CELL SCI, V120, P1978, DOI 10.1242/jcs.006502	59	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75337	10.1371/journal.pone.0075337	http://dx.doi.org/10.1371/journal.pone.0075337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069402	Green Submitted, gold, Green Published			2022-12-27	WOS:000324547300079
J	Zheng, Q; Zeng, TT; Chen, J; Liu, H; Zhang, H; Su, J				Zheng, Qin; Zeng, Ting-ting; Chen, Jiao; Liu, Hua; Zhang, He; Su, Jun			Association between DNA Methyltransferases 3B Gene Polymorphisms and the Susceptibility to Acute Myeloid Leukemia in Chinese Han Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; T PROMOTER POLYMORPHISM; LUNG-CANCER; DNMT3B POLYMORPHISMS; EPIGENETIC CHANGES; BREAST-CANCER; RISK; METHYLATION; MALIGNANCIES; ADENOCARCINOMA	DNMT3B plays a crucial role in the generation of aberrant methylation during carcinogenesis. Polymorphisms in the DNMT3B gene may influence the DNA methylation enzymatic activity of DNMT3B, thereby modulating the susceptibility to AML. Thus, we investigated the association between SNPs in the DNMT3B gene and their haplotypes with the risk of AML in the Chinese Han population. The DNMT3B genotype was determined by HRM in 317 de novo AML patients and 406 healthy control subjects matched for age and gender. Among the 5 SNPs investigated in this study, rs2424913 demonstrated no polymorphisms in the Chinese Han populations, rs1569686 and rs2424908 were significantly associated with AML risk. The GG genotype of rs1569686 was associated with increased AML risk (OR: 5.76; 95% CI: 2.60-12.73; P<0.01) compared with the TT genotype, and individuals with a G allele had a significantly increased risk (OR: 1.89; 95% CI: 1.41-2.52; P<0.01) for AML compared with those harboring a C allele, this polymorphism can predict the risk of AML in a minority of patients. While the CC genotype of rs2424908 appeared to reduce the AML risk (OR: 0.57; 95% CI: 0.36-0.91; P=0.01) compared with the TT genotype, individuals with a C allele were associated with a lower risk (OR: 0.79, 95% CI: 0.64-0.97, P=0.03) for developing AML compared with those harboring a T allele. The other 2 SNPs, rs6087990 and rs6119954, had no significant association with AML risk in the study population. The CGGT, CTAT, TGAT, and CGAT haplotypes of rs6087990, rs1569686, rs6119954, and rs2424908 appeared to significantly increase the AML risk, and the TTGC haplotype appeared to significantly reduce the risk. These results suggest that DNMT3B polymorphisms may contribute to the genetic susceptibility to AML; in particular, the G allele of rs1569686 serves as a risk factor for AML, whereas the C allele of rs2424908 represents a potential protective factor.	[Zheng, Qin; Zeng, Ting-ting; Chen, Jiao; Liu, Hua; Zhang, He; Su, Jun] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China	Sichuan University	Su, J (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610064, Peoples R China.	sjhuaxi1667@163.com	chen, JJ/HGB-6029-2022; CHEN, JIAO/GZA-5784-2022		National Natural Science Foundation of China [81201343]; science and technology project of Sichuan Province of China [2011SZ0206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); science and technology project of Sichuan Province of China	This work received financial support from the National Natural Science Foundation of China (Grant no. 81201343) and the science and technology project of Sichuan Province of China (Grant no. 2011SZ0206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung PP, 2005, ONCOL REP, V14, P1151; Bao Q, 2011, INT J COLORECTAL DIS, V26, P1107, DOI 10.1007/s00384-011-1199-3; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; Chang KP, 2007, ORAL ONCOL, V43, P345, DOI 10.1016/j.oraloncology.2006.04.006; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fan H, 2008, WORLD J GASTROENTERO, V14, P2230, DOI 10.3748/wjg.14.2230; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Greif PA, 2012, BLOOD, V120, P395, DOI 10.1182/blood-2012-01-403220; Gronbaek K, 2012, HAEMATOL-HEMATOL J, V97, P1380, DOI 10.3324/haematol.2011.058305; Hong YS, 2007, BIOCHEM GENET, V45, P155, DOI 10.1007/s10528-006-9047-9; Juhl-Christensen C, 2012, PEDIATR BLOOD CANCER, V58, P525, DOI 10.1002/pbc.23397; Khalade A, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-31; Khandanpour C, 2012, BLOOD, V120, P4006, DOI 10.1182/blood-2011-02-334722; Khorshied MM, 2012, GENE, V511, P34, DOI 10.1016/j.gene.2012.09.024; Lee ST, 2012, NUCLEIC ACIDS RES, V40, P11339, DOI 10.1093/nar/gks957; Lee SJ, 2005, CARCINOGENESIS, V26, P403, DOI 10.1093/carcin/bgh307; Liu H, 2012, EXP THER MED, V3, P525, DOI 10.3892/etm.2011.420; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; McCabe DC, 2005, NUTR REV, V63, P183, DOI [10.1301/nr.2005.Jun.183-195, 10.1111/j.1753-4887.2005.tb00136.x]; Montgomery KG, 2004, BREAST CANCER RES, V6, pR390, DOI 10.1186/bcr807; Rithidech KN, 2007, EXP HEMATOL, V35, P117, DOI 10.1016/j.exphem.2007.01.019; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Schoofs T, 2013, BLOOD, V121, P178, DOI 10.1182/blood-2012-08-448860; Shen HB, 2002, CANCER RES, V62, P4992; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Sun MY, 2012, GENET MOL RES, V11, P4330, DOI 10.4238/2012.September.26.1; Thomas A, 2012, BLOOD, V119, P2731, DOI 10.1182/blood-2011-12-381426; Wang J, 2006, CANCER RES, V66, P8361, DOI 10.1158/0008-5472.CAN-06-2031; Wang YM, 2005, WORLD J GASTROENTERO, V11, P3623, DOI 10.3748/wjg.v11.i23.3623; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; Yan P, 2012, BLOOD, V120, P2466, DOI 10.1182/blood-2012-05-429175	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74626	10.1371/journal.pone.0074626	http://dx.doi.org/10.1371/journal.pone.0074626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069326	Green Submitted, gold, Green Published			2022-12-27	WOS:000324547300047
J	Chang, TS; Chang, CM; Hsu, TW; Lin, YS; Lai, NS; Su, YC; Huang, KY; Lin, HL; Lee, CC				Chang, Ting-Shou; Chang, Chun-Ming; Hsu, Ta-Wen; Lin, Yaoh-Shiang; Lai, Ning-Sheng; Su, Yu-Chieh; Huang, Kuang-Yung; Lin, Hung-Lung; Lee, Ching-Chih			The Combined Effect of Individual and Neighborhood Socioeconomic Status on Nasopharyngeal Cancer Survival	PLOS ONE			English	Article							RISK-FACTORS; CARCINOMA; RADIOTHERAPY; POPULATION; IMPACT; INEQUALITIES; DEPRIVATION; DISPARITIES; MORTALITY; DIAGNOSIS	Background: The relationship between individual and neighborhood socioeconomic status (SES) and mortality rates in patients with nasopharyngeal carcinoma (NPC) is unknown. This population-based study aimed to examine the association between SES and survival of patients with NPC in Taiwan. Materials and Methods: A population-based follow-up study was conducted of 4691 patients diagnosed with NPC between 2002 and 2006. Each patient was traced to death or for 5 years. Individual SES was defined by enrollee job category. Neighborhood SES was based on household income dichotomized into advantaged and disadvantaged areas. Cox proportional hazards model was used to compare the death-free survival rates between the different SES groups after adjusting for possible confounding factors and risk factors. Results: In NPC patients below the age of 65 years, 5-year overall survival rates were worst for those with low individual SES living in disadvantaged neighborhoods. After adjusting for patient characteristics (age, gender, Charlson Comorbidity Index Score), NPC patients with low individual SES residing in disadvantaged neighborhoods were found to have a 2-fold higher risk of mortality than patients with high individual SES residing in advantaged neighborhoods. We found no significant difference in mortality rates between different SES groups in NPC patients aged 65 and above. Conclusions: Our findings indicate that NPC patients with low individual SES who live in disadvantaged neighborhoods have the higher risk of mortality than their more privileged counterparts. Public health strategies and welfare policies would be well advised to try to offset the inequalities in health care and pay more attention to addressing the needs of this vulnerable group.	[Chang, Ting-Shou; Lin, Yaoh-Shiang] Kaohsiung Vet Gen Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Chang, Chun-Ming; Hsu, Ta-Wen] Buddhist Dalin Tzu Chi Gen Hosp, Dept Surg, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lai, Ning-Sheng; Su, Yu-Chieh; Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Lin, Hung-Lung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Res, Chiayi, Taiwan; [Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Rheumatol, Chiayi, Taiwan; [Chang, Chun-Ming; Hsu, Ta-Wen; Lai, Ning-Sheng; Su, Yu-Chieh; Huang, Kuang-Yung; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Educ, Chiayi, Taiwan	Kaohsiung Veterans General Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Lee, CC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan.	hematcd@hotmail.com		Su, Yu-Chieh/0000-0002-1771-9017; Lin, Hung-Lung/0000-0001-8904-7750				Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; [Anonymous], 2008, NHI PROFILE; Berglund A, 2010, THORAX, V65, P327, DOI 10.1136/thx.2009.125914; Braaten T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-178; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brown AF, 2013, NEUROLOGY, V80, P520, DOI 10.1212/WNL.0b013e31828154ae; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; Cheng SH, 1997, CANCER J SCI AM, V3, P100; Chu KP, 2011, CANCER-AM CANCER SOC, V117, P1935, DOI 10.1002/cncr.25723; Chung NN, 2004, HEAD NECK-J SCI SPEC, V26, P241, DOI 10.1002/hed.10378; Conway DI, 2010, BRIT J ORAL MAX SURG, V48, P11, DOI 10.1016/j.bjoms.2009.03.020; Cutrona CE, 2006, CURR DIR PSYCHOL SCI, V15, P188, DOI 10.1111/j.1467-8721.2006.00433.x; Department of heath TEY, 2001, CANCER REGISTRY ANNU; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Erkal HS, 2001, RADIOTHER ONCOL, V61, P247, DOI 10.1016/S0167-8140(01)00448-0; Fang FM, 2002, INT J RADIAT ONCOL, V53, P959, DOI 10.1016/S0360-3016(02)02838-9; Guo XC, 2009, INT J CANCER, V124, P2942, DOI 10.1002/ijc.24293; Hollingshead AdB, 1975, FOUR FACTOR INDEX OF; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; Kawachi I, 2003, NEIGHBORHOODS AND HE, Vxiii; Kim JY, 2007, SOC SCI MED, V65, P2489, DOI 10.1016/j.socscimed.2007.07.022; Koopman C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-617; Kwok J, 2010, CANCER-AM CANCER SOC, V116, P476, DOI 10.1002/cncr.24774; Le H, 2008, CANCER EPIDEM BIOMAR, V17, P1950, DOI 10.1158/1055-9965.EPI-07-2774; Lee CC, 2012, ORAL ONCOL, V48, P253, DOI 10.1016/j.oraloncology.2011.10.002; Lee CC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-92; Lin JC, 2001, J CLIN ONCOL, V19, P2607, DOI 10.1200/JCO.2001.19.10.2607; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Munck K, 2005, LARYNGOSCOPE, V115, P1283, DOI 10.1097/01.MLG.0000165382.83891.92; Palmer JR, 2012, AM J EPIDEMIOL, V176, P1141, DOI 10.1093/aje/kws211; Reitzel LR, 2012, HEALTH PLACE, V18, P861, DOI 10.1016/j.healthplace.2012.03.005; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Sanderson M, 2006, ANN EPIDEMIOL, V16, P901, DOI 10.1016/j.annepidem.2006.02.006; Sundquist J, 1999, INT J EPIDEMIOL, V28, P841, DOI 10.1093/ije/28.5.841; Sze HCK, 2012, ORAL ONCOL, V48, P162, DOI 10.1016/j.oraloncology.2011.08.019; Teo PML, 2000, INT J RADIAT ONCOL, V48, P1311, DOI 10.1016/S0360-3016(00)00786-0; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605; Turkoz FP, 2011, ASIAN PAC J CANCER P, V12, P3017; van Jaarsveld CHM, 2007, J CLIN EPIDEMIOL, V60, P712, DOI 10.1016/j.jclinepi.2006.10.005; Yu XQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-364	41	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73889	10.1371/journal.pone.0073889	http://dx.doi.org/10.1371/journal.pone.0073889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069242	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100066
J	Liu, NM; Yokota, T; Maekawa, S; Lu, P; Tei, I; Taniguchi, H; Yokoyama, U; Kato, T; Minamisawa, S				Liu, Norika Mengchia; Yokota, Tomohiro; Maekawa, Shun; Lue, Ping; Tei, Inbun; Taniguchi, Hideki; Yokoyama, Utako; Kato, Takashi; Minamisawa, Susumu			Transcription Profiles of Endothelial Cells in the Rat Ductus Arteriosus during a Perinatal Period	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; VITAMIN-A; PULMONARY-ARTERY; PROGENITOR CELLS; EXPRESSION; CLOSURE; MATURATION; PLASTICITY; PATENCY; SYSTEM	Endothelial cells (ECs) lining the blood vessels serve a variety of functions and play a central role in the homeostasis of the circulatory system. Since the ductus arteriosus (DA) has different arterial characteristics from its connecting vessels, we hypothesized that ECs of the DA exhibited a unique gene profile involved in the regulation of DA-specific morphology and function. Using a fluorescence-activated cell sorter, we isolated ECs from pooled tissues from the DA or the descending aorta of Wistar rat fetuses at full-term of gestation (F group) or neonates 30 minutes after birth (N group). Using anti-CD31 and anti-CD45 antibodies as cell surface markers for ECs and hematopoietic derived cells, respectively, cDNAs from the CD31-positive and CD45-negative cells were hybridized to the Affymetrix GeneChip (R) Rat Gene 1.0 ST Array. Among 26,469 gene-level probe sets, 82 genes in the F group and 81 genes in the N group were expressed at higher levels in DA ECs than in aortic ECs (p<0.05, fold change>2.0). In addition to well-known endothelium-enriched genes such as Tgfb2 and Vegfa, novel DA endothelium-dominant genes including Slc38a1, Capn6, and Lrat were discovered. Enrichment analysis using GeneGo MetaCore software showed that DA endothelium-related biological processes were involved in morphogenesis and development. We identified many overlapping genes in each process including neural crest-related genes (Hoxa1, Hoxa4, and Hand2, etc) and the second heart field-related genes (Tbx1, Isl1, and Fgf10, etc). Moreover, we found that regulation of epithelial-to-mesenchymal transition, cell adhesion, and retinol metabolism are the active pathways involved in the network via potential interactions with many of the identified genes to form DA-specific endothelia. In conclusion, the present study uncovered several significant differences of the transcriptional profile between the DA and aortic ECs. Newly identified DA endothelium-dominant genes may play an important role in DA-specific functional and morphologic characteristics.	[Liu, Norika Mengchia; Yokota, Tomohiro; Lue, Ping; Minamisawa, Susumu] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Maekawa, Shun; Kato, Takashi] Waseda Univ, Sch Educ, Dept Biol, Tokyo, Japan; [Lue, Ping; Minamisawa, Susumu] Jikei Univ, Dept Cell Physiol, Tokyo, Japan; [Tei, Inbun; Taniguchi, Hideki] Yokohama City Univ, Dept Regenerat Med, Yokohama, Kanagawa 232, Japan; [Yokoyama, Utako] Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan	Waseda University; Waseda University; Jikei University; Yokohama City University; Yokohama City University	Minamisawa, S (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan.	sminamis@jikei.ac.jp	Maekawa, Shun/AAL-2657-2020; Zheng, Yun-Wen/R-2874-2019; Kato, Takashi/AFO-2557-2022; Yokoyama, Utako/AAD-1404-2022	Maekawa, Shun/0000-0002-2406-2201; Zheng, Yun-Wen/0000-0001-9002-3190; Kato, Takashi/0000-0003-0384-7971; Yokoyama, Utako/0000-0003-1803-0155; Yokota, Tomohiro/0000-0003-2540-3810; Minamisawa, Susumu/0000-0003-4728-2116; Liu, Norika/0000-0002-0033-9253	Ministry of Education, Culture, Sports, Science and Technology of Japan; Yokohama Foundation for Advanced Medical Science; "High-Tech Research Center" Project for Private Universities: MEXT; MEXT; Vehicle Racing Commemorative Foundation; Miyata Cardiology Research Promotion Funds; Takeda Science Foundation; Shimabara Science Promotion Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Foundation for Advanced Medical Science; "High-Tech Research Center" Project for Private Universities: MEXT; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Miyata Cardiology Research Promotion Funds; Takeda Science Foundation(Takeda Science Foundation (TSF)); Shimabara Science Promotion Foundation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (U.Y., S. M.), a Grant-in-Aid for Scientific Research on Innovative Areas (U.Y.,), the Yokohama Foundation for Advanced Medical Science (U.Y., S. M.), the "High-Tech Research Center" Project for Private Universities: MEXT (T. K., S. M.), MEXT-Supported Program for the Strategic Research Foundation at Private Universities (T. K., S. M.), the Vehicle Racing Commemorative Foundation (U.Y., S. M.), Miyata Cardiology Research Promotion Funds (U.Y.), the Takeda Science Foundation (U.Y., S. M.), and the Shimabara Science Promotion Foundation (S. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren P, 2008, J PHYSIOL PHARMACOL, V59, P55; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Akaike T, 2009, J BIOL CHEM, V284, P24025, DOI 10.1074/jbc.M109.017061; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Arciniegas E, 2005, ENDOTHELIUM-J ENDOTH, V12, P193, DOI 10.1080/10623320500227283; Baragatti B, 2007, BRIT J PHARMACOL, V151, P54, DOI 10.1038/sj.bjp.0707211; Bergwerff M, 1999, ANAT EMBRYOL, V200, P559, DOI 10.1007/s004290050304; Bergwerff M, 1998, CIRC RES, V82, P221; Bessarabova M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S13; Bokenkamp R, 2006, PEDIATR RES, V60, P407, DOI 10.1203/01.pdr.0000238243.37116.a6; Bokenkamp R, 2010, NEONATOLOGY, V98, P6, DOI 10.1159/000262481; Bosley TM, 2008, AM J MED GENET A, V146A, P1235, DOI 10.1002/ajmg.a.32262; BOUDREAU N, 1992, LAB INVEST, V67, P350; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; COBURN RF, 1986, CIRC RES, V58, P341, DOI 10.1161/01.RES.58.3.341; Colbert MC, 1996, CIRC RES, V78, P790, DOI 10.1161/01.RES.78.5.790; Costa M, 2006, PHYSIOL GENOMICS, V25, P250, DOI 10.1152/physiolgenomics.00231.2005; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; DEREEDER EG, 1988, AM J PATHOL, V132, P574; Diez M, 2010, CARDIOVASC RES, V88, P502, DOI 10.1093/cvr/cvq236; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Fox JJ, 1996, AM J PHYSIOL-HEART C, V271, pH2638, DOI 10.1152/ajpheart.1996.271.6.H2638; Golzio C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030677; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Ivey KN, 2008, CIRC RES, V103, P388, DOI 10.1161/CIRCRESAHA.108.180661; Jin MH, 2011, J PHYSIOL SCI, V61, P167, DOI 10.1007/s12576-011-0133-3; Lacorre DA, 2004, BLOOD, V103, P4164, DOI 10.1182/blood-2003-10-3537; Makki N, 2012, HUM MOL GENET, V21, P26, DOI 10.1093/hmg/ddr434; Momma K, 1998, PEDIATR RES, V43, P629, DOI 10.1203/00006450-199805000-00011; Moonen JRAJ, 2010, CARDIOVASC RES, V86, P506, DOI 10.1093/cvr/cvq012; RANA MS, 2013, AM J MED GENETICS A; Ravishankar C, 2003, J PEDIATR-US, V143, P644, DOI 10.1067/S0022-3476(03)00501-8; Smith GCS, 1998, PHARMACOL REV, V50, P35; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Meeteren LA, 2012, CELL TISSUE RES, V347, P177, DOI 10.1007/s00441-011-1222-6; WALDO KL, 1993, ANAT RECORD, V237, P385, DOI 10.1002/ar.1092370312; Watanabe Y, 2012, P NATL ACAD SCI USA, V109, P18273, DOI 10.1073/pnas.1215360109; Watanabe Y, 2010, ANN NY ACAD SCI, V1188, P15, DOI 10.1111/j.1749-6632.2009.05078.x; Weber SC, 2011, PEDIATR RES, V70, P236, DOI 10.1203/PDR.0b013e318225f748; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Wu GR, 2001, PEDIATR RES, V49, P747, DOI 10.1203/00006450-200106000-00006; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2007, PHYSIOL GENOMICS, V31, P139, DOI 10.1152/physiolgenomics.00007.2006; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; Yokoyama Utako, 2010, Journal of Smooth Muscle Research, V46, P77; Zhou B, 1998, PEDIATR RES, V44, P865, DOI 10.1203/00006450-199812000-00007; Zile MH, 2010, NUTRIENTS, V2, P532, DOI 10.3390/nu2050532	49	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73685	10.1371/journal.pone.0073685	http://dx.doi.org/10.1371/journal.pone.0073685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086288	gold, Green Submitted, Green Published			2022-12-27	WOS:000325223900018
J	Schwartz, HA; Eichstaedt, JC; Kern, ML; Dziurzynski, L; Ramones, SM; Agrawal, M; Shah, A; Kosinski, M; Stillwell, D; Seligman, MEP; Ungar, LH				Schwartz, H. Andrew; Eichstaedt, Johannes C.; Kern, Margaret L.; Dziurzynski, Lukasz; Ramones, Stephanie M.; Agrawal, Megha; Shah, Achal; Kosinski, Michal; Stillwell, David; Seligman, Martin E. P.; Ungar, Lyle H.			Personality, Gender, and Age in the Language of Social Media: The Open-Vocabulary Approach	PLOS ONE			English	Article							WORDS; LIFE; REGRESSION; POSITIONS; TAXONOMY; MODEL; POWER; WEB	We analyzed 700 million words, phrases, and topic instances collected from the Facebook messages of 75,000 volunteers, who also took standard personality tests, and found striking variations in language with personality, gender, and age. In our open-vocabulary technique, the data itself drives a comprehensive exploration of language that distinguishes people, finding connections that are not captured with traditional closed-vocabulary word-category analyses. Our analyses shed new light on psychosocial processes yielding results that are face valid (e.g., subjects living in high elevations talk about the mountains), tie in with other research (e.g., neurotic people disproportionately use the phrase 'sick of' and the word 'depressed'), suggest new hypotheses (e.g., an active life implies emotional stability), and give detailed insights (males use the possessive 'my' when mentioning their 'wife' or 'girlfriend' more often than females use 'my' with 'husband' or 'boyfriend'). To date, this represents the largest study, by an order of magnitude, of language and personality.	[Schwartz, H. Andrew; Eichstaedt, Johannes C.; Kern, Margaret L.; Dziurzynski, Lukasz; Ramones, Stephanie M.; Agrawal, Megha; Seligman, Martin E. P.] Univ Penn, Posit Psychol Ctr, Philadelphia, PA 19104 USA; [Schwartz, H. Andrew; Agrawal, Megha; Shah, Achal; Ungar, Lyle H.] Univ Penn, Philadelphia, PA 19104 USA; [Kosinski, Michal; Stillwell, David] Univ Cambridge, Psychometr Ctr, Cambridge, England	University of Pennsylvania; University of Pennsylvania; University of Cambridge	Schwartz, HA (corresponding author), Univ Penn, Posit Psychol Ctr, Philadelphia, PA 19104 USA.	hansens@sas.upenn.edu	Schwartz, H. Andrew/AAE-7276-2021; Kern, Margaret L./T-3661-2018; Kosinski, Michal/AAH-7375-2019	Kern, Margaret L./0000-0003-4300-598X; Kosinski, Michal/0000-0003-2936-4775; Eichstaedt, Johannes/0000-0002-3220-2972	Robert Wood Johnson Foundation's Pioneer Portfolio	Robert Wood Johnson Foundation's Pioneer Portfolio(Robert Wood Johnson Foundation (RWJF))	Support for this research was provided by the Robert Wood Johnson Foundation's Pioneer Portfolio, through a grant to Martin Seligman, "Exploring Concept of Positive Health". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aim CO, 2005, P C HUM LANG TECHN E, P579, DOI DOI 10.3115/1220575.1220648; ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; Argamon S, 2003, TEXT IN PRESS, V23, P3; Argamon S., 2003, ACM SIGKDD, V9, P475, DOI DOI 10.1145/956750.956805; Argamon S, 2009, COMMUN ACM, V52, P119, DOI 10.1145/1461928.1461959; Argamon Shlomo, 2005, P JOINT ANN M INT CL; Baccianella S, 2010, LREC 2010 - SEVENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION; Bachrach Y, 2012, PERSONALITY PATTERNS; Back MD, 2010, PSYCHOL SCI, V21, P372, DOI 10.1177/0956797609360756; Bamman D, 2012, ARXIV12104567; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Burger John D., 2011, P C EMP METH NAT LAN, P1301, DOI DOI 10.1007/S00256-005-0933-8; Chung C, 2007, FRONT SOC PSYCHOL, P343; Chung CK, 2008, J RES PERS, V42, P96, DOI 10.1016/j.jrp.2007.04.006; CHURCH KW, 1990, 27TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P76; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Costa P., 2008, SAGE HDB PERSONALITY, V2, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9]; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Eckert P, 2008, J SOCIOLING, V12, P453, DOI 10.1111/j.1467-9841.2008.00374.x; EISENSTEIN J., 2011, P 49 ANN M ASS COMP, V1, P1365; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fast LA, 2008, J PERS SOC PSYCHOL, V94, P334, DOI 10.1037/0022-3514.94.2.334; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Gilbert E., P ACM 2012 C COMP SU, P1037, DOI 10.1145/2145204.2145359; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Golbeck J., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P149, DOI 10.1109/PASSAT/SocialCom.2011.33; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Grimmer Justin, 2013, POLITICAL ANAL; Haig BD, 2005, PSYCHOL METHODS, V10, P371, DOI 10.1037/1082-989X.10.4.371; Harris J., 2011, WORD CLOUDS CONSIDER; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; HOLMES DI, 1994, COMPUT HUMANITIES, V28, P87, DOI 10.1007/BF01830689; Holtgraves T, 2011, J RES PERS, V45, P92, DOI 10.1016/j.jrp.2010.11.015; Hoyle rh, 2009, HDB INDIVIDUAL DIFFE, P257, DOI DOI 10.1007/S00018-010-0311-0; Huffaker DA, 2005, J COMPUT-MEDIAT COMM, V10; Iacobelli F, 2011, LECT NOTES COMPUT SC, V6975, P568, DOI 10.1007/978-3-642-24571-8_71; Ireland ME, 2012, OXFORD HDB IN PRESS; Jurafsky D., 2009, P HUM LANG TECHN 200, P638, DOI DOI 10.3115/1620754.1620847; Kim S.M., 2004, 20 INT C COMP LING G, P1; Kosinski M, 2013, P NATL ACAD SCI PNAS; Kramer A.D., 2011, P 5 INT AAAI C WEBL, P169; Kramer ADI, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P287; Laver M, 2003, AM POLIT SCI REV, V97, P311; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lin Dekang, 1998, P 1 WORKSHOP COMPUTA, P57; Mairesse F., P HUM LANG TECHN C N, P85; Mairesse F, 2007, J ARTIF INTELL RES, V30, P457, DOI 10.1613/jair.2349; McCallum, 2002, MALLET MACHINE LEARN; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; Mehl MR, 2006, J PERS SOC PSYCHOL, V90, P862, DOI 10.1037/0022-3514.90.5.862; Mehl MR, 2003, J PERS SOC PSYCHOL, V84, P857, DOI 10.1037/0022-3514.84.4.857; Meyer GJ, 2001, AM PSYCHOL, V56, P128, DOI 10.1037//0003-066X.56.2.128; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Mihalcea R., 2006, P AAAI SPRING S COMP, P19; Miller G, 2011, SCIENCE, V333, P1814, DOI 10.1126/science.333.6051.1814; Monroe BL, 2004, 21 ANN M SOC POL MET, P29; Monroe BL, 2008, POLIT ANAL, V16, P372, DOI 10.1093/pan/mpn018; Mukherjee A., 2010, P 2010 C EMPIRICAL M, P207, DOI DOI 10.5555/1870658.1870679; MULAC A, 1986, COMMUN MONOGR, V53, P115, DOI 10.1080/03637758609376131; MULAC A, 1990, SEX ROLES, V23, P439, DOI 10.1007/BF00289762; Newman ML, 2008, DISCOURSE PROCESS, V45, P211, DOI 10.1080/01638530802073712; Noah A.Smith, 2010, EMNLP; NORMAN WT, 1963, J ABNORM PSYCHOL, V66, P574, DOI 10.1037/h0040291; OConnor B, 2011, COMPUTATIONAL TEXT A, V41, P43; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Pennebaker JW, 2003, J PERS SOC PSYCHOL, V85, P291, DOI 10.1037/0022-3514.85.2.291; Pennebaker JW, 2003, ANNU REV PSYCHOL, V54, P547, DOI 10.1146/annurev.psych.54.101601.145041; Pennebaker JW, 1999, J PERS SOC PSYCHOL, V77, P1296, DOI 10.1037/0022-3514.77.6.1296; Pennebaker JW, 2007, DEVELOPMENT, V1, P1; Ranganath R, 2009, P 2009 C EMP METH NA, V1, P334; Rao Delip, 2010, P 2 INT WORKSH SEARC, P37, DOI DOI 10.1145/1871985.1871993; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Schler J., 2006, AAAI SPRING S COMP A, VVolume 6, P199; Slapin JB, 2008, AM J POLIT SCI, V52, P705, DOI 10.1111/j.1540-5907.2008.00338.x; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Steyvers M, 2007, HDB LATENT SEMANTIC; Stone P.J., 1966, GEN INQUIRER COMPUTE; Sumner C, 2012, PREDICTING DARK TRIA; Sumner C, 2011, BLACK HAT BRIEF, V11, P197; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Thomson R, 2001, BRIT J SOC PSYCHOL, V40, P193, DOI 10.1348/014466601164812; Weinberger S, 2011, NATURE, V471, P566, DOI 10.1038/471566a; Wilson T, 2009, COMPUT LINGUIST, V35, P399, DOI 10.1162/coli.08-012-R1-06-90; Yarkoni T, 2010, J RES PERS, V44, P363, DOI 10.1016/j.jrp.2010.04.001	94	762	794	27	275	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73791	10.1371/journal.pone.0073791	http://dx.doi.org/10.1371/journal.pone.0073791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	228VC	24086296	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700012
J	Gigandet, X; Griffa, A; Kober, T; Daducci, A; Gilbert, G; Connelly, A; Hagmann, P; Meuli, R; Thiran, JP; Krueger, G				Gigandet, Xavier; Griffa, Alessandra; Kober, Tobias; Daducci, Alessandro; Gilbert, Guillaume; Connelly, Alan; Hagmann, Patric; Meuli, Reto; Thiran, Jean-Philippe; Krueger, Gunnar			A Connectome-Based Comparison of Diffusion MRI Schemes	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; BRAIN CONNECTIVITY; MOTION CORRECTION; FIBER PATHWAYS; TENSOR; TRACTOGRAPHY; TRACKING; ROBUST; OPTIMIZATION; VALIDATION	Diffusion MRI has evolved towards an important clinical diagnostic and research tool. Though clinical routine is using mainly diffusion weighted and tensor imaging approaches, Q-ball imaging and diffusion spectrum imaging techniques have become more widely available. They are frequently used in research-oriented investigations in particular those aiming at measuring brain network connectivity. In this work, we aim at assessing the dependency of connectivity measurements on various diffusion encoding schemes in combination with appropriate data modeling. We process and compare the structural connection matrices computed from several diffusion encoding schemes, including diffusion tensor imaging, q-ball imaging and high angular resolution schemes, such as diffusion spectrum imaging with a publically available processing pipeline for data reconstruction, tracking and visualization of diffusion MR imaging. The results indicate that the high angular resolution schemes maximize the number of obtained connections when applying identical processing strategies to the different diffusion schemes. Compared to the conventional diffusion tensor imaging, the added connectivity is mainly found for pathways in the 50-100mm range, corresponding to neighboring association fibers and long-range associative, striatal and commissural fiber pathways. The analysis of the major associative fiber tracts of the brain reveals striking differences between the applied diffusion schemes. More complex data modeling techniques (beyond tensor model) are recommended 1) if the tracts of interest run through large fiber crossings such as the centrum semi-ovale, or 2) if non-dominant fiber populations, e. g. the neighboring association fibers are the subject of investigation. An important finding of the study is that since the ground truth sensitivity and specificity is not known, the comparability between results arising from different strategies in data reconstruction and/or tracking becomes implausible to understand.	[Gigandet, Xavier; Griffa, Alessandra; Daducci, Alessandro; Hagmann, Patric; Thiran, Jean-Philippe] Ecole Polytech Fed Lausanne, Signal Proc Labs LTS5, Lausanne, Switzerland; [Kober, Tobias; Krueger, Gunnar] Siemens Schweiz AG CIBM, Adv Clin Imaging Technol, Lausanne, Switzerland; [Gilbert, Guillaume] CHU Montreal, Dept Radiol, Montreal, PQ, Canada; [Connelly, Alan] Florey Neurosci Inst Austin, Brain Res Inst, Melbourne, Vic, Australia; [Connelly, Alan] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Hagmann, Patric; Meuli, Reto; Thiran, Jean-Philippe] CHU Vaudois, Dept Radiol, CH-1011 Lausanne, Switzerland; [Hagmann, Patric; Meuli, Reto; Thiran, Jean-Philippe] Univ Lausanne, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Siemens AG; Universite de Montreal; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Gigandet, X (corresponding author), Ecole Polytech Fed Lausanne, Signal Proc Labs LTS5, Lausanne, Switzerland.	xavier.gigandet@epfl.ch	Connelly, Alan/A-9065-2013	Connelly, Alan/0000-0001-7159-8079; Griffa, Alessandra/0000-0003-1923-1653; Thiran, Jean-Philippe/0000-0003-2938-9657	Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards Foundation; Jeantet Foundation	Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL); Swiss Federal Institute of Technology Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); Leenaards Foundation; Jeantet Foundation	This work was supported by the Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Swiss Federal Institute of Technology Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG) and the Leenaards and the Jeantet Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2010, MAGN RESON MED, V64, P554, DOI 10.1002/mrm.22365; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gilbert G, 2007, IEEE T MED IMAGING, V26, P1428, DOI 10.1109/TMI.2007.907699; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Granziera C, 2011, P INT SOC MAGN RESON, V19; Granziera C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005101; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hagmann P., 2005, DIFFUSION MRI BRAIN; Hagmann P, 2004, P INT SOC MAGN RESON, V12; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Jack CR, 2010, ALZHEIMERS DEMENT, V6, P212, DOI 10.1016/j.jalz.2010.03.004; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jones DK, 2005, MAGNET RESON MED, V53, P1143, DOI 10.1002/mrm.20466; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; Khachaturian MH, 2007, MAGN RESON MED, V57, P289, DOI 10.1002/mrm.21090; Kober T, 2012, NEUROIMAGE, V59, P389, DOI 10.1016/j.neuroimage.2011.07.004; Kuo LW, 2008, NEUROIMAGE, V41, P7, DOI 10.1016/j.neuroimage.2008.02.016; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Menzel MI, 2011, MAGN RESON MED, V66, P1226, DOI 10.1002/mrm.23064; Michailovich O, 2011, IEEE T MED IMAGING, V30, P1100, DOI 10.1109/TMI.2011.2142189; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; O'Brien KR, 2013, IEEE T MED IN PRESS; Papadakis NG, 2000, MAGN RESON IMAGING, V18, P671, DOI 10.1016/S0730-725X(00)00151-X; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reese TG, 2009, J MAGN RESON IMAGING, V29, P517, DOI 10.1002/jmri.21497; Robson PM, 2008, MAGN RESON MED, V60, P895, DOI 10.1002/mrm.21728; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Thottakara P, 2006, NEUROIMAGE, V29, P868, DOI 10.1016/j.neuroimage.2005.08.051; Toosy AT, 2004, NEUROIMAGE, V21, P1452, DOI 10.1016/j.neuroimage.2003.11.022; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tristan-Vega A, 2009, NEUROIMAGE, V47, P638, DOI 10.1016/j.neuroimage.2009.04.049; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wang R, 2007, P INT SOC MAGN RESON, V15; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wedeen VJ, 2000, P INT SOC MAGN RESON, V8; Wedeen VJ, 1996, 2 INT C FUNCT MAPP H, V2, P146; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Yo TS, 2009, LECT NOTES COMPUT SC, V5761, P886	59	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75061	10.1371/journal.pone.0075061	http://dx.doi.org/10.1371/journal.pone.0075061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073235	Green Published			2022-12-27	WOS:000324768000044
J	Imamura, T; Suzuki, A; Lupisan, S; Okamoto, M; Aniceto, R; Egos, RJ; Daya, EE; Tamaki, R; Saito, M; Fuji, N; Roy, CN; Opinion, JM; Santo, AV; Macalalad, NG; Tandoc, A; Sombrero, L; Olveda, R; Oshitani, H				Imamura, Tadatsugu; Suzuki, Akira; Lupisan, Socorro; Okamoto, Michiko; Aniceto, Rapunzel; Egos, Rutchie J.; Daya, Edgardo E.; Tamaki, Raita; Saito, Mariko; Fuji, Naoko; Roy, Chandra Nath; Opinion, Jaime M.; Santo, Arlene V.; Macalalad, Noel G.; Tandoc, Amado, III; Sombrero, Lydia; Olveda, Remigio; Oshitani, Hitoshi			Molecular Evolution of Enterovirus 68 Detected in the Philippines	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; HOSPITALIZED CHILDREN; RECOMBINATION; RHINOVIRUS; EMERGENCE; DYNAMICS	Background: Detection of Enterovirus 68 (EV68) has recently been increased. However, underlying evolutionary mechanism of this increasing trend is not fully understood. Methods: Nasopharyngeal swabs were collected from 5,240 patients with acute respiratory infections in the Philippines from June 2009 to December 2011. EV68 was detected by polymerase chain reaction (PCR) targeting for 5' untranslated region (5' UTR), viral protein 1 (VP1), and VP4/VP2. Phylogenetic trees were generated using the obtained sequences. Results: Of the 5,240 tested samples, 12 EV68 positive cases were detected between August and December in 2011 (detection rate, 0.23%). The detection rate was higher among inpatients than outpatients (p<0.0001). Among VP1 sequences detected from 7 patients in 2011, 5 in lineage 2 were diverged from those detected in the Philippines in 2008, however, 2 in lineage 3 were not diverged from strains detected in the Philippines in 2008 but closely associated with strains detected in the United States. Combined with our previous report, EV68 occurrences were observed twice in the Philippines within the last four years. Conclusions: EV68 detections might be occurring in cyclic patterns, and viruses might have been maintained in the community while some strains might have been newly introduced.	[Imamura, Tadatsugu; Suzuki, Akira; Okamoto, Michiko; Fuji, Naoko; Roy, Chandra Nath; Oshitani, Hitoshi] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Aniceto, Rapunzel; Tamaki, Raita; Saito, Mariko] Tohoku RITM Res Ctr Emerging & Reemerging Infect, Muntinlupa, Philippines; [Aniceto, Rapunzel; Egos, Rutchie J.] Eastern Visayas Reg Med Ctr, Tacloban City, Philippines; [Daya, Edgardo E.] Leyte Prov Hosp, Palo City, Philippines; [Opinion, Jaime M.] Tacloban City Hlth Catchment Ctr, Tacloban City, Philippines; [Santo, Arlene V.] Tanuan Rural Hlth Unit, Tanuan City, Philippines; [Lupisan, Socorro; Macalalad, Noel G.; Tandoc, Amado, III; Sombrero, Lydia; Olveda, Remigio] Res Inst Trop Med, Muntinlupa, Philippines	Tohoku University; Research Institute for Tropical Medicine - Philippines	Oshitani, H (corresponding author), Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan.	oshitanih@med.tohoku.ac.jp	Oshitani, Hitoshi/AAE-4349-2019; Roy, Chandra Nath/X-5769-2019; Okamoto, Michiko/AAE-4373-2019	Roy, Chandra Nath/0000-0001-6667-1550; Okamoto, Michiko/0000-0002-3505-5939; Suzuki, Akira/0000-0002-8223-0314; Tandoc, Amado III/0000-0002-2186-4989	Japan Initiative for Global research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Society for the Promotion of Science (JSPS), Japan	Japan Initiative for Global research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid from the Japan Initiative for Global research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Science and Technology Research Partnership for Sustainable Development (SATREPS) from Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA), and Research Fellowships for Young Scientists from Japan Society for the Promotion of Science (JSPS), Japan. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fouzas S, 2011, PEDIATRICS, V128, P740, DOI 10.1542/peds.2011-0271; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Imamura Tadatsugu, 2011, Morbidity and Mortality Weekly Report, V60, P1301; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08; Kiang D, 2007, J CLIN VIROL, V38, P227, DOI 10.1016/j.jcv.2006.12.016; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Lauinger IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036005; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Piralla A, 2011, J CLIN MICROBIOL, V49, P373, DOI 10.1128/JCM.01814-10; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Suzuki A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-267; Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10	23	30	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74221	10.1371/journal.pone.0074221	http://dx.doi.org/10.1371/journal.pone.0074221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073203	gold, Green Published, Green Submitted			2022-12-27	WOS:000324768000012
J	Mwansa-Kambafwile, J; McCarthy, K; Gharbaharan, V; Venter, FWD; Maitshotlo, B; Black, A				Mwansa-Kambafwile, Judith; McCarthy, Kerrigan; Gharbaharan, Varanna; Venter, Francois W. D.; Maitshotlo, Boitumelo; Black, Andrew			Tuberculosis Case Finding: Evaluation of a Paper Slip Method to Trace Contacts	PLOS ONE			English	Article							PREVALENCE; TB	Setting: South Africa has the third highest tuberculosis (TB) burden in the world. Intensified case finding, recommended by WHO, is one way to control TB. Objective: To evaluate the effectiveness and acceptability of a paper slip method for TB contact tracing. Method: TB patients were offered paper slips to give to their contacts, inviting them for TB screening. The number of contacts screened and the proportion diagnosed with TB was calculated. Contacts that returned to the clinic after receiving the slips were interviewed. A focus group discussion (FGD) with TB patients was held to determine their acceptability. Results: From 718 paper slips issued, a 26% TB contact tracing rate was found, with a 12% case detection rate. The majority (68%) of contacts were screened within 2 weeks of receiving the slip. Age and gender were not significantly associated with time to screening. 16% of the contacts screened did not reside with the TB patients. 98% of the contacts said the method was acceptable. FGD findings show that this method is acceptable and may prevent stigma associated with TB/HIV. Conclusion: This simple, inexpensive method yields high contact tracing and case detection rates and potentially would yield additional benefits outside households.	[Mwansa-Kambafwile, Judith; Gharbaharan, Varanna; Venter, Francois W. D.; Maitshotlo, Boitumelo; Black, Andrew] Wits Reprod Hlth & HIV Inst, TB HIV Unit, Johannesburg, Gauteng Provinc, South Africa; [Mwansa-Kambafwile, Judith; Gharbaharan, Varanna; Venter, Francois W. D.; Black, Andrew] Univ Witwatersrand, Dept Clin Med, Johannesburg, Gauteng Provinc, South Africa; [McCarthy, Kerrigan] Aurum Inst, Epidemiol Unit, Johannesburg, Gauteng Provinc, South Africa	University of Witwatersrand	Mwansa-Kambafwile, J (corresponding author), Wits Reprod Hlth & HIV Inst, TB HIV Unit, Johannesburg, Gauteng Provinc, South Africa.	judy.mwansa@gmail.com		Venter, Willem/0000-0002-4157-732X; McCarthy, Kerrigan/0000-0001-8958-9795	United States Agency for International Development; President's Emergency Plan for AIDS Relief [674-A-00-08-00005-00]	United States Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the United States Agency for International Development and the President's Emergency Plan for AIDS Relief (674-A-00-08-00005-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR 2010; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Dodd PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029130; Irani L, 2007, Tanzan Health Res Bull, V9, P169; Kwazulu-Natal Department of Health, 2012, LOB TB AMB BRINGS TB; Mathee A, 2009, DEV SO AFR, V26, P721, DOI 10.1080/03768350903303266; Meidany F, 2011, INNOVATIVE TB SCREEN; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; Oni T, 2011, THORAX, V66, P669, DOI 10.1136/thx.2011.160168; Radhakrishna S, 2007, INT J TUBERC LUNG D, V11, P282; South African National Department of Health, 2011, GUID COND C IN PRESS; StataCorp, 2011, STAT STAT SOFTW; Thulesius Hans, 2004, Lakartidningen, V101, P3066; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587; World Health Organization, 2008, WHO 3 IS M GEN SWITZ; Wright A, 2002, SEX TRANSM INFECT, V78, P422, DOI 10.1136/sti.78.6.422; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	23	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75757	10.1371/journal.pone.0075757	http://dx.doi.org/10.1371/journal.pone.0075757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073277	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000087
J	Oshima, T; Shan, J; Okugawa, T; Chen, X; Hori, K; Tomita, T; Fukui, H; Watari, J; Miwa, H				Oshima, Tadayuki; Shan, Jing; Okugawa, Takuya; Chen, Xin; Hori, Kazutoshi; Tomita, Toshihiko; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto			Down-Regulation of Claudin-18 Is Associated with the Proliferative and Invasive Potential of Gastric Cancer at the Invasive Front	PLOS ONE			English	Article							TIGHT JUNCTION; REDUCED EXPRESSION; GENE; IMMUNOHISTOCHEMISTRY; METASTASIS; CARCINOMA; PROTEINS; STOMACH; STRANDS	Background: Claudins are known as tight junction proteins, and their expression pattern in gastric cancer is still controversial. The relationship between the expression patterns of tight junction proteins and tumor proliferation in early gastric cancer is still far from clear. Aims: To investigate the expression patterns of claudin-18 and Ki-67 in early gastric cancer at the invasive front and surrounding normal gastric mucosa and to investigate the biological function of claudin-18 in the proliferation and invasion of cancer cells. Methods: Seventy-five early gastric cancer lesions removed via endoscopic mucosal resection or endoscopic submucosal resection were evaluated. All gastric cancer lesions were diagnosed as differentiated adenocarcinoma using the Japanese Classification of Gastric Carcinoma. To assess epithelial proliferation, immunostaining with Ki-67 was performed, and the labeling index was calculated. To assess the expression of epithelial tight junction proteins, immunofluorescent staining of claudin-18 was performed. The immunoreactivity of claudin-18 was graded according to the number of stained cells. Correlation analysis was performed by Spearman's rank correlation coefficient. Transfection of claudin-18 small interfering RNA (siRNA) was accomplished in MKN74, a claudin-18-positive gastric cancer cell line, to investigate the effect of claudin-18 on proliferation and invasion of cancer cells. Results: Claudin-18 was significantly down-regulated in gastric cancer compared to surrounding gastric normal mucosa or intestinal metaplasia. The Ki-67 labeling index of gastric cancer at the invasive front was inversely correlated with the claudin-18 level, but that at the mucosal lesion was not correlated. Claudin-18 knockdown significantly promoted the proliferation of MKN74 compared with control siRNA-transfected cells. MKN74 invasion increased significantly with claudin-18 siRNA transfection compared with control siRNA transfection. Conclusions: Down-regulation of claudin-18 is associated with the proliferative potential at the invasive front of gastric cancer, suggesting that it has a pivotal role in gastric cancer progression.	[Oshima, Tadayuki; Shan, Jing; Okugawa, Takuya; Chen, Xin; Hori, Kazutoshi; Tomita, Toshihiko; Fukui, Hirokazu; Watari, Jiro; Miwa, Hiroto] Hyogo Coll Med, Dept Internal Med, Div Upper Gastroenterol, Nishinomiya, Hyogo 6638501, Japan	Hyogo College of Medicine	Oshima, T (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Upper Gastroenterol, Nishinomiya, Hyogo 6638501, Japan.	t-oshima@hyo-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22590691]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan through a Grant-in-Aid for Scientific Research (C) 2010-2012 (No. 22590691). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008002; Al Moustafa AE, 2002, ONCOGENE, V21, P2634, DOI 10.1038/sj.onc.1205351; Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126; Cui JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017819; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Zavala-Zendejas VE, 2011, CANCER INVEST, V29, P1, DOI 10.3109/07357907.2010.512594; Endoh Y, 2000, AM J PATHOL, V157, P717, DOI 10.1016/S0002-9440(10)64584-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Hayashi D, 2012, GASTROENTEROLOGY, V142, P292, DOI 10.1053/j.gastro.2011.10.040; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Hollande F, 2001, AM J PHYSIOL-GASTR L, V280, pG910, DOI 10.1152/ajpgi.2001.280.5.G910; Jalava P, 2006, HISTOPATHOLOGY, V48, P674, DOI 10.1111/j.1365-2559.2006.02402.x; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kamata I, 2009, J GASTROEN HEPATOL, V24, P1527, DOI 10.1111/j.1440-1746.2009.05810.x; Matsuda Y, 2007, CANCER SCI, V98, P1014, DOI 10.1111/j.1349-7006.2007.00490.x; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morohashi S, 2007, INT J MOL MED, V20, P139; Nagano Hideki, 2005, Gastric Cancer, V8, P149, DOI 10.1007/s10120-005-0328-5; Okugawa T, 2012, DIGEST DIS SCI, V57, P1562, DOI 10.1007/s10620-012-2043-5; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Oshima T, 2008, J GASTROEN HEPATOL, V23, pS146, DOI 10.1111/j.1440-1746.2008.05405.x; Ouban A, 2010, HISTOL HISTOPATHOL, V25, P83, DOI 10.14670/HH-25.83; Resnick MB, 2005, MODERN PATHOL, V18, P511, DOI 10.1038/modpathol.3800301; Sanada Y, 2006, J PATHOL, V208, P633, DOI 10.1002/path.1922; Sauer T, 2005, CYTOPATHOLOGY, V16, P193, DOI 10.1111/j.1365-2303.2005.00257.x; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; TATEMATSU M, 1990, ACTA PATHOL JAPON, V40, P494; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Turksen K, 2011, STEM CELL REV REP, V7, P797, DOI 10.1007/s12015-011-9267-1; Ueda J, 2007, PATHOBIOLOGY, V74, P32, DOI 10.1159/000101049; Usami Y, 2006, HUM PATHOL, V37, P569, DOI 10.1016/j.humpath.2005.12.018	37	38	39	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74757	10.1371/journal.pone.0074757	http://dx.doi.org/10.1371/journal.pone.0074757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073219	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000028
J	Planes, R; Bahraoui, E				Planes, Remi; Bahraoui, Elmostafa			HIV-1 Tat Protein Induces the Production of IDO in Human Monocyte Derived-Dendritic Cells through a Direct Mechanism: Effect on T Cells Proliferation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD MONOCYTES; TYPE-1 CLADE B; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; CYTOKINE EXPRESSION; QUINOLINIC ACID; INHIBITION	During HIV-1 infection, an increase of indoleamine 2,3 dioxygenase (IDO) expression, and dendritic cells (DC) dysfunction were often associated with AIDS disease progression. In this work, we investigated the effect of HIV-1 Tat protein on the expression of IDO, in MoDCs. We show that Tat induces IDO protein expression and activity in a dose dependent manner by acting at the cell membrane. Using Tat-mutants, we show that the N-Terminal domain, Tat 1-45, but not the central region, Tat 30-72, is sufficient to induce the expression of active IDO. Tat protein is also able to induce several cytokines in MoDCs, including IFN-gamma, a strong inducer of IDO. In order to understand whether IDO is induced directly by Tat protein or indirectly following IFN-gamma production, complementary experiments were performed and showed that: i) at the kinetic level, Tat induced IDO expression before the production of IFN-gamma ii) treatment of MoDCs with Tat-conditioned medium was unable to stimulate IDO expression, iii) coculture of MoDCs in a transwell cell system did not allow IDO expression in MoDCs not previously treated by Tat, iv) direct contact between Tat-treated and untreated MoDCs was not sufficient to induce IDO expression in a Tat-independent manner, and v) treatment of MoDCs in the presence of IFN-gamma pathway inhibitors, Jak I and Ly294002, inhibited IFN-gamma-induced IDO but had no effect on Tat-induced IDO. At the functional level, our data showed that treatment of MoDCs with Tat led to the inhibition of their capacity to stimulate T cell proliferation. This impairement was totally abolished when the stimulation was performed in the presence of 1MT, an inhibitor of IDO activity, arguing for the implication of the kynurenine pathway. By inducing IDO, Tat protein may be considered, as a viral pathogenic factor, in the dysregulation of the DC functions during HIV-1 infection.	[Planes, Remi; Bahraoui, Elmostafa] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Planes, Remi; Bahraoui, Elmostafa] CNRS, U5282, Toulouse, France; [Planes, Remi; Bahraoui, Elmostafa] Univ Toulouse 3, EA 3038, F-31062 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bahraoui, E (corresponding author), Fac Med Toulouse, INSERM, U1043, U317, F-31073 Toulouse, France.	bahraoui@cict.fr		BAHRAOUI, ELMOSTAFA/0000-0003-1852-389X	Agence Nationale de Recherche sur le Sida (ANRS); SIDACTION; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre national de la recherche scientifique (CNRS); ministere de la recherche et des technologies	Agence Nationale de Recherche sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); SIDACTION; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ministere de la recherche et des technologies	This work was supported by the Agence Nationale de Recherche sur le Sida (ANRS), SIDACTION, Institut National de la Sante et de la Recherche Medicale (INSERM), Centre national de la recherche scientifique (CNRS) and ministere de la recherche et des technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 1998, P NATL ACAD SCI USA, V95, P13153, DOI 10.1073/pnas.95.22.13153; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Bennasser Y, 2002, FASEB J, V16, P546, DOI 10.1096/fj.01-0775com; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Boasso A, 2011, BLOOD, V118, P5152, DOI 10.1182/blood-2011-03-344218; Boasso A, 2009, J IMMUNOL, V182, P4313, DOI 10.4049/jimmunol.0803314; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; BRAKE DA, 1990, J CELL BIOL, V111, P1275, DOI 10.1083/jcb.111.3.1275; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Bukovsky AA, 1997, J VIROL, V71, P1013, DOI 10.1128/JVI.71.2.1013-1018.1997; Buscemi L, 2007, NEUROBIOL DIS, V26, P661, DOI 10.1016/j.nbd.2007.03.004; Che KF, 2010, EUR J IMMUNOL, V40, P2248, DOI 10.1002/eji.201040377; Chuenchitra Thippawan, 2012, J Med Assoc Thai, V95 Suppl 5, pS116; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; CLERICI M, 1994, IMMUNOL TODAY, V15, P575, DOI 10.1016/0167-5699(94)90220-8; CLERICI M, 1994, J CLIN INVEST, V93, P768, DOI 10.1172/JCI117031; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Contreras X, 2005, VIROLOGY, V332, P316, DOI 10.1016/j.virol.2004.11.032; Dang YH, 2000, FREE RADICAL BIO MED, V28, P615, DOI 10.1016/S0891-5849(99)00272-5; Debin A, 2002, VACCINE, V20, P2752, DOI 10.1016/S0264-410X(02)00191-3; Dunham RM, 2013, AIDS RES HUM RETROV, V29, P207, DOI [10.1089/AID.2012.0162, 10.1089/aid.2012.0162]; EMILIE D, 1994, RES IMMUNOL, V145, P595, DOI 10.1016/S0923-2494(05)80039-2; Fairman P, 2012, CLIN EXP IMMUNOL, V170, P101, DOI 10.1111/j.1365-2249.2012.04628.x; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Favre D, SCI TRANSL MED, V2; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Frankel AD, 1992, CURR OPIN GENET DEV, V2, P293, DOI 10.1016/S0959-437X(05)80287-4; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Gendelman HE, 1997, AIDS, V11, pS35; Granelli-Piperno A, 2006, J IMMUNOL, V176, P991, DOI 10.4049/jimmunol.176.2.991; Grant RS, 2000, J VIROL, V74, P4110, DOI 10.1128/JVI.74.9.4110-4115.2000; GRAZIOSI C, 1994, RES IMMUNOL, V145, P602, DOI 10.1016/S0923-2494(05)80040-9; GUTHEIL WG, 1994, P NATL ACAD SCI USA, V91, P6594, DOI 10.1073/pnas.91.14.6594; Heyes MP, 2001, BRAIN, V124, P1033, DOI 10.1093/brain/124.5.1033; Hill M, 2007, EUR J IMMUNOL, V37, P3054, DOI 10.1002/eji.200636704; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Johri MK, 2011, EXPERT OPIN BIOL TH, V11, P269, DOI 10.1517/14712598.2011.546339; Jurgens B, 2009, BLOOD, V114, P3235, DOI 10.1182/blood-2008-12-195073; Leghmari K, 2008, CELL IMMUNOL, V253, P45, DOI 10.1016/j.cellimm.2008.04.015; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; Li JC, AIDS, V24, P1609; Li JCB, 2005, FEBS LETT, V579, P3055, DOI 10.1016/j.febslet.2005.04.060; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lob S, 2008, LANGENBECK ARCH SURG, V393, P995, DOI 10.1007/s00423-007-0245-7; Martinson JA, 2010, ANTIMICROB AGENTS CH, V54, P871, DOI 10.1128/AAC.01246-09; MASOOD R, 1994, BIOCHEM BIOPH RES CO, V202, P374, DOI 10.1006/bbrc.1994.1938; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2002, J IMMUNOL, V168, P3771, DOI 10.4049/jimmunol.168.8.3771; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Monini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048781; Morini M, 2000, BIOCHEM BIOPH RES CO, V273, P267, DOI 10.1006/bbrc.2000.2941; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Noonan D, 2000, Adv Pharmacol, V48, P229; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Potula R, 2005, BLOOD, V106, P2382, DOI 10.1182/blood-2005-04-1403; Presicce P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042802; Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Rizzardi GP, 1996, AIDS, V10, pF45, DOI 10.1097/00002030-199611000-00001; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Samikkannu T, 2010, J NEUROVIROL, V16, P255, DOI 10.3109/13550284.2010.497809; Samikkannu T, 2009, AIDS RES HUM RETROV, V25, P329, DOI 10.1089/aid.2008.0225; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; Secchiero P, 1999, J IMMUNOL, V162, P2427; Smith DG, 2001, J NEUROVIROL, V7, P56; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; vanBaalen CA, 1997, J GEN VIROL, V78, P1913, DOI 10.1099/0022-1317-78-8-1913; Wang Xi-cheng, 2010, Zhonghua Yi Xue Za Zhi, V90, P588; WERNER ER, 1988, BIOL CHEM H-S, V369, P337, DOI 10.1515/bchm3.1988.369.1.337; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Williams A, 2013, CYTOKINE, V61, P521, DOI 10.1016/j.cyto.2012.11.006; Wong JK, 2010, J BIOL CHEM, V285, P18319, DOI 10.1074/jbc.M110.120840; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yang YB, 2010, J MED VIROL, V82, P735, DOI 10.1002/jmv.21720; ZAULI G, 1993, MICROBIOLOGICA, V16, P115; Zheng Lin, 2005, J Zhejiang Univ Sci B, V6, P668, DOI 10.1631/jzus.2005.B0668; Zocchi MR, 1998, J IMMUNOL, V161, P2938	87	38	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74551	10.1371/journal.pone.0074551	http://dx.doi.org/10.1371/journal.pone.0074551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073214	Green Published, gold			2022-12-27	WOS:000324768000023
J	Alamilla, J; Gillespie, DC				Alamilla, Javier; Gillespie, Deda C.			Maturation of Calcium-Dependent GABA, Glycine, and Glutamate Release in the Glycinergic MNTB-LSO Pathway	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; LATERAL SUPERIOR OLIVE; SHORT-TERM PLASTICITY; TRANSMITTER RELEASE; TEMPERATURE-DEPENDENCE; MULTIPLE TYPES; SYNAPTIC-TRANSMISSION; CHANNEL CURRENTS; OMEGA-CONOTOXINS; CA2+ CHANNELS	The medial nucleus of the trapezoid body (MNTB) is a key nucleus in high-fidelity temporal processing that underlies sound localization in the auditory brainstem. While the glycinergic principal cells of the MNTB project to all primary nuclei of the superior olive, during development the projection from MNTB to the lateral superior olive (LSO) is of interest because this immature inhibitory projection is known to undergo tonotopic refinement during an early postnatal period, and because during this period individual MNTB terminals in the LSO transiently release glycine GABA and glutamate. Developmental changes in calcium-dependent release are understood to be required to allow various auditory nuclei to follow high frequency activity; however, little is known about maturation of calcium-dependent release in the MNTB-LSO pathway, which has been presumed to have less stringent requirements for high-fidelity temporal following. In acute brainstem slices of rats age postnatal day 1 to 15 we recorded whole-cell responses in LSO principal neurons to electrical stimulation in the MNTB in order to measure sensitivity to external calcium, the contribution of different voltage-gated calcium channel subtypes to vesicular release, and the maturation of these measures for both GABA/glycine and glutamate transmission. Our results establish that release of glutamate at MNTB-LSO synapses is calcium-dependent. Whereas no significant developmental changes were evident for glutamate release, GABA/glycine release underwent substantial changes over the first two postnatal weeks: soon after birth L-type, N-type, and P/Q-type voltage-gated calcium channels (VGCCs) together mediated release, but after hearing onset P/Q-type VGCCs predominated. Blockade of P/Q-type VGCCs reduced the estimated quantal number for GABA/gly and glutamate transmission at P5-8 and the frequency of evoked miniature glycinergic events at P12-15, without apparent effects on spontaneous release of neurotransmitter, supporting a model in which P/Q-type VGCCs are required for mature synchronous synaptic transmission, but not for spontaneous vesicle release.	[Alamilla, Javier; Gillespie, Deda C.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University	Alamilla, J (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	alamill@mcmaster.ca			CIHR; NSERC; CONACyT	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by a CIHR operating grant and an NSERC discovery grant (to DCG), and a CONACyT postdoctoral fellowship (to JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Barnes-Davies M, 2001, HEARING RES, V162, P134, DOI 10.1016/S0378-5955(01)00378-1; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; CAIRD D, 1983, EXP BRAIN RES, V52, P385; CANT NB, 1986, J COMP NEUROL, V247, P457, DOI 10.1002/cne.902470406; Case DT, 2011, J NEUROPHYSIOL, V106, P2570, DOI 10.1152/jn.00644.2010; Cooper AP, 2011, J COMP NEUROL, V519, P2417, DOI 10.1002/cne.22634; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Ene FA, 2003, J NEUROPHYSIOL, V90, P2581, DOI 10.1152/jn.00238.2003; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; Giugovaz-Tropper B, 2011, NEUROSCIENCE, V192, P219, DOI 10.1016/j.neuroscience.2011.06.021; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hirtz JJ, 2011, J NEUROSCI, V31, P8280, DOI 10.1523/JNEUROSCI.5098-10.2011; Iftinca M, 2006, NEUROSCIENCE, V142, P1031, DOI 10.1016/j.neuroscience.2006.07.010; Inchauspe CG, 2004, J NEUROSCI, V24, P10379, DOI 10.1523/JNEUROSCI.2104-04.2004; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; KANDLER K, 1995, J NEUROSCI, V15, P6890; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kim G, 2010, NEUROSCIENCE, V171, P924, DOI 10.1016/j.neuroscience.2010.09.054; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kotak VC, 1998, J NEUROSCI, V18, P4646; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; MCALLISTERWILLIAMS RH, 1995, NEUROPHARMACOLOGY, V34, P1479, DOI 10.1016/0028-3908(95)00130-X; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; Peloquin JB, 2008, NEUROSCIENCE, V151, P1066, DOI 10.1016/j.neuroscience.2007.11.053; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rosen AD, 1996, AM J PHYSIOL-CELL PH, V271, pC863, DOI 10.1152/ajpcell.1996.271.3.C863; Salgado H, 2005, J NEUROPHYSIOL, V94, P3771, DOI 10.1152/jn.00455.2005; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Stocker JW, 1997, J NEUROSCI, V17, P3002; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; Wang LY, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-36; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; WU SH, 1992, J NEUROSCI, V12, P3084, DOI 10.1523/JNEUROSCI.12-08-03084.1992; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024	45	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75688	10.1371/journal.pone.0075688	http://dx.doi.org/10.1371/journal.pone.0075688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069436	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300089
J	Song, YZ; Zhang, ZH; Lin, WX; Zhao, XJ; Ma, MDYL; Ma, YL; Guo, L; Chen, FP; Long, XL; He, XL; Sunada, Y; Soneda, S; Nakatomi, A; Dateki, S; Ngu, LH; Kobayashi, K; Saheki, T				Song, Yuan-Zong; Zhang, Zhan-Hui; Lin, Wei-Xia; Zhao, Xin-Jing; Deng, Mei; Ma, Yan-Li; Guo, Li; Chen, Feng-Ping; Long, Xiao-Ling; He, Xiang-Ling; Sunada, Yoshihide; Soneda, Shun; Nakatomi, Akiko; Dateki, Sumito; Ngu, Lock-Hock; Kobayashi, Keiko; Saheki, Takeyori			SLC25A13 Gene Analysis in Citrin Deficiency: Sixteen Novel Mutations in East Asian Patients, and the Mutation Distribution in a Large Pediatric Cohort in China	PLOS ONE			English	Article							NEONATAL INTRAHEPATIC CHOLESTASIS; II CITRULLINEMIA; LIVER-DISEASE; IDENTIFICATION; NICCD; POPULATIONS; FREQUENCY; DIAGNOSIS; SIBLINGS; PROTEIN	Background: The human SLC25A13 gene encodes citrin, the liver-type mitochondrial aspartate/glutamate carrier isoform 2 (AGC2), and SLC25A13 mutations cause citrin deficiency (CD), a disease entity that encompasses different age-dependant clinical phenotypes such as Adult-onset Citrullinemia Type II (CTLN2) and Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency (NICCD). The analyses of SLC25A13 gene and its protein/mRNA products remain reliable tools for the definitive diagnoses of CD patients, and so far, the SLC25A13 mutation spectrum in Chinese CD patients has not been well-characterized yet. Methods and Results: By means of direct DNA sequencing, cDNA cloning and SNP analyses, 16 novel pathogenic mutations, including 9 missense, 4 nonsense, 1 splice-site, 1 deletion and 1 large transposal insertion IVS4ins6kb (GenBank accession number KF425758), were identified in CTLN2 or NICCD patients from China, Japan and Malaysia, respectively, making the SLC25A13 variations worldwide reach the total number of 81. A large NICCD cohort of 116 Chinese cases was also established, and the 4 high-frequency mutations contributed a much larger proportion of the mutated alleles in the patients from south China than in those from the north (chi(2) = 14.93, P<0.01), with the latitude of 30uN as the geographic dividing line in mainland China. Conclusions: This paper further enriched the SLC25A13 variation spectrum worldwide, and formed a substantial contribution to the in-depth understanding of the genotypic feature of Chinese CD patients.	[Song, Yuan-Zong; Zhang, Zhan-Hui; Lin, Wei-Xia; Zhao, Xin-Jing; Deng, Mei; Ma, Yan-Li; Guo, Li] Jinan Univ, Dept Pediat, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Chen, Feng-Ping] Jinan Univ, Dept Lab Sci, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Long, Xiao-Ling] Zhongshan Boai Hosp, Dept Pediat, Zhongshan, Peoples R China; [He, Xiang-Ling] Hunan Prov Peoples Hosp, Children Med Ctr, Changsha, Hunan, Peoples R China; [Sunada, Yoshihide] Kawasaki Med Sch, Dept Neurol, Kawasaki, Kanagawa, Japan; [Soneda, Shun] St Marianna Univ, Dept Pediat, Sch Med, Kanagawa, Japan; [Nakatomi, Akiko; Dateki, Sumito] Nagasaki Univ Hosp, Dept Pediat, Nagasaki, Japan; [Ngu, Lock-Hock] Hosp Kuala Lumpur, Dept Clin Genet, Kuala Lumpur, Malaysia; [Kobayashi, Keiko] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol Metab & Biochem Genet, Kagoshima 890, Japan; [Saheki, Takeyori] Kumamoto Univ, Inst Resource Dev & Anal, Kumamoto, Japan	Jinan University; Jinan University; Kawasaki Medical School; Saint Marianna University; Nagasaki University; Kagoshima University; Kumamoto University	Song, YZ (corresponding author), Jinan Univ, Dept Pediat, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	songyuanzong@vip.tom.com	Ngu, Lock Hock/R-4473-2019; Ngu, Lock-Hock/Y-6055-2019	Ngu, Lock Hock/0000-0002-2396-1686	Fundamental Research Funds for the Central Universities [21612430]; National Natural Science Foundation of China (NSFC) [81070279, 81270957]; Japan Society for the Promotion of Science	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Fundamental Research Funds for the Central Universities (No. 21612430), the projects supported by the National Natural Science Foundation of China (NSFC, Nos. 81070279 and 81270957), and Grants-in-Aid for Asia-Africa Scientific Platform Program from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ben-Shalom E, 2002, MOL GENET METAB, V77, P202, DOI 10.1016/S1096-7192(02)00167-1; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Dimmock D, 2009, MOL GENET METAB, V96, P44, DOI 10.1016/j.ymgme.2008.10.007; Dimmock D, 2007, PEDIATRICS, V119, pE773, DOI 10.1542/peds.2006-1950; Fiermonte G, 2011, MOL GENET METAB, V104, P501, DOI 10.1016/j.ymgme.2011.08.022; Fu HY, 2011, J GASTROENTEROL, V46, P510, DOI 10.1007/s00535-010-0329-y; Hayasaka K, 2012, JIMD REP, V2, P37, DOI 10.1007/8904_2011_42; Hutchin T, 2006, J INHERIT METAB DIS, V29, P112; Hutchin T, 2009, J INHERIT METAB DIS, V32, pS151, DOI 10.1007/s10545-009-1116-x; Kikuchi A, 2012, MOL GENET METAB, V105, P553, DOI 10.1016/j.ymgme.2011.12.024; Ko JM, 2007, INT J MOL MED, V20, P809; Kobayashi K, 1999, NAT GENET, V22, P159, DOI 10.1038/9667; Kobayashi K, 1993, GENEREVIEWS; Kobayashi K., 2008, J APPL CLIN PEDIAT, V23, P1553; Komatsu M, 2008, J HEPATOL, V49, P810, DOI 10.1016/j.jhep.2008.05.016; Kuhara T, 2011, ANAL BIOANAL CHEM, V400, P1881, DOI 10.1007/s00216-011-4766-0; Lee BH, 2010, J PEDIATR GASTR NUTR, V50, P682, DOI 10.1097/MPG.0b013e3181d67fbf; Lin JT, 2011, CLIN CHIM ACTA, V412, P460, DOI 10.1016/j.cca.2010.11.027; Lin S, 1987, ACTA ANTHR SINICA, V6, P190; Lin WX, 2012, GENE, V505, P269, DOI 10.1016/j.gene.2012.06.012; Lu YB, 2005, J HUM GENET, V50, P338, DOI 10.1007/s10038-005-0262-8; Luder AS, 2006, J INHERIT METAB DIS, V29, P59; MATSUMOTO H, 1988, HUM GENET, V80, P207, DOI 10.1007/BF01790088; Nagasaka H, 2009, MOL GENET METAB, V97, P21, DOI 10.1016/j.ymgme.2009.01.009; Ohura T, 2007, J INHERIT METAB DIS, V30, P139, DOI 10.1007/s10545-007-0506-1; Ohura T, 2001, HUM GENET, V108, P87, DOI 10.1007/s004390000448; Okano Y, 2013, MOL GENET METAB, V109, P9, DOI 10.1016/j.ymgme.2013.01.020; Saheki T, 2002, METAB BRAIN DIS, V17, P335, DOI 10.1023/A:1021961919148; Saheki T, 2002, J HUM GENET, V47, P333, DOI 10.1007/s100380200046; Saheki T, 2011, MOL GENET METAB, V104, P492, DOI 10.1016/j.ymgme.2011.08.015; Sheng JS, 2006, J INHERIT METAB DIS, V29, P163; Song YZ, 2009, DIGEST LIVER DIS, V41, P683, DOI 10.1016/j.dld.2008.11.014; Song YZ, 2011, INT J MOL MED, V28, P33, DOI 10.3892/ijmm.2011.653; Song Yuan-zong, 2008, Zhonghua Er Ke Za Zhi, V46, P411; Tabata A, 2008, J HUM GENET, V53, P534, DOI 10.1007/s10038-008-0282-2; Takahashi Y, 2012, INTERNAL MED, V51, P2131, DOI 10.2169/internalmedicine.51.7644; Takaya J, 2005, METABOLISM, V54, P1615, DOI 10.1016/j.metabol.2005.06.009; Tazawa Y, 2001, J PEDIATR-US, V138, P735, DOI 10.1067/mpd.2001.113264; Thong MK, 2010, SINGAP MED J, V51, pE12; Tokuhara D, 2007, MOL GENET METAB, V90, P30, DOI 10.1016/j.ymgme.2006.09.009; Tomomasa T, 2001, J PEDIATR-US, V138, P741, DOI 10.1067/mpd.2001.113361; Wen Peng-Qiang, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P303; Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721; Wongkittichote P, 2012, J INHERIT METAB DIS; Xing Ya-zhi, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P180, DOI 10.3760/cma.j.issn.1003-9406.2010.02.014; Yamaguchi N, 2002, HUM MUTAT, V19, P122, DOI 10.1002/humu.10022; Yasuda T, 2000, HUM GENET, V107, P537, DOI 10.1007/s004390000430; Zhang ZH, 2012, GENE, V511, P227, DOI 10.1016/j.gene.2012.09.049; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699; Zhao XJ, 2011, TOHOKU J EXP MED, V225, P273, DOI 10.1620/tjem.225.273	51	37	60	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74544	10.1371/journal.pone.0074544	http://dx.doi.org/10.1371/journal.pone.0074544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069319	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300036
J	Wanner, SP; Yoshida, K; Kulchitsky, VA; Ivanov, AI; Kanosue, K; Romanovsky, AA				Wanner, Samuel P.; Yoshida, Kyoko; Kulchitsky, Vladimir A.; Ivanov, Andrei I.; Kanosue, Kazuyuki; Romanovsky, Andrej A.			Lipopolysaccharide-Induced Neuronal Activation in the Paraventricular and Dorsomedial Hypothalamus Depends on Ambient Temperature	PLOS ONE			English	Article							COLD-SEEKING BEHAVIOR; SYMPATHETIC OUTFLOW; FEVER; NUCLEUS; HYPOTHERMIA; MEDIATOR	Systemic inflammatory response syndrome is associated with either fever or hypothermia, but the mechanisms responsible for switching from one to the other are unknown. In experimental animals, systemic inflammation is often induced by bacterial lipopolysaccharide (LPS). To identify the diencephalic and brainstem structures involved in the fever-hypothermia switch, we studied the expression of c-Fos protein, a marker of neuronal activation, in rats treated with the same high dose of LPS (0.5 mg/kg, intravenously) either in a thermoneutral (30 degrees C) or cool (24 degrees C) environment. At 30 degrees C, LPS caused fever; at 24 degrees C, the same dose caused profound hypothermia. Both fever and hypothermia were associated with the induction of c-Fos in many brain areas, including several structures of the anterior preoptic, paraventricular, lateral, and dorsal hypothalamus, the bed nucleus of the stria terminalis, the posterior pretectal nucleus, ventrolateral periaqueductal gray, lateral parabrachial nucleus, area postrema, and nucleus of the solitary tract. Every brain area studied showed a comparable response to LPS at the two different ambient temperatures used, with the exception of two areas: the dorsomedial hypothalamic nucleus (DMH), which we studied together with the adjacent dorsal hypothalamic area (DA), and the paraventricular hypothalamic nucleus (PVH). Both structures had much stronger c-Fos expression during LPS hypothermia than during fever. We propose that PVH and DMH/DA neurons are involved in a circuit, which - depending on the ambient temperature - determines whether the thermoregulatory response to bacterial LPS will be fever or hypothermia.	[Wanner, Samuel P.; Kulchitsky, Vladimir A.; Ivanov, Andrei I.; Romanovsky, Andrej A.] St Josephs Hosp, System Inflammat Lab, FeverLab, Phoenix, AZ USA; [Wanner, Samuel P.] Univ Fed Minas Gerais, Sch Phys Educ Physiotherapy & Occupat Therapy, Belo Horizonte, MG, Brazil; [Yoshida, Kyoko; Kanosue, Kazuyuki] Osaka Univ, Fac Med, Sch Allied Hlth Sci, Dept Physiol, Osaka, Japan; [Kulchitsky, Vladimir A.] Natl Acad Sci, Inst Physiol, Minsk, BELARUS; [Ivanov, Andrei I.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA; [Ivanov, Andrei I.] Virginia Commonwealth Univ, Virginia Inst Mol Med, Richmond, VA USA; [Kanosue, Kazuyuki] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan; [Romanovsky, Andrej A.] Arizona State Univ, Interdisciplinary Grad Program Neurosci, Tempe, AZ USA	St. Joseph's Hospital and Medical Center; Universidade Federal de Minas Gerais; Osaka University; National Academy of Sciences of Belarus (NASB); Institute of Physiology of the National Academy of Sciences of Belarus; Virginia Commonwealth University; Virginia Commonwealth University; Waseda University; Arizona State University; Arizona State University-Tempe	Romanovsky, AA (corresponding author), St Josephs Hosp, System Inflammat Lab, FeverLab, Phoenix, AZ USA.	aromano@chw.edu	Ivanov, Andrei/V-1672-2019; Wanner, Samuel P./F-9654-2012; Kulchitsky, Vladimir/AAS-1322-2021	Wanner, Samuel P./0000-0002-4659-1032; Yoshida-Court, Kyoko/0000-0002-7558-9943; Romanovsky, Andrej/0000-0003-3772-8575	National Institutes of Health [R01NS41233]; Ministry of Education, Science and Culture of Japan [12307001, 11557003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research has been supported in part by the National Institutes of Health (grant R01NS41233 to A.A.R.) and by the Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (grants 12307001 and 11557003 to K.K.). S.P.W. was a fellow of the National Council for Scientific and Technological Development, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MC, 2012, J NEUROSCI, V32, P2086, DOI 10.1523/JNEUROSCI.5606-11.2012; Almeida MC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000001; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Belevych N, 2010, BRAIN BEHAV IMMUN, V24, P1137, DOI 10.1016/j.bbi.2010.05.007; DiMicco JA, 2007, AM J PHYSIOL-REG I, V292, pR47, DOI 10.1152/ajpregu.00498.2006; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; Furuyashiki T, 2011, NAT REV ENDOCRINOL, V7, P163, DOI 10.1038/nrendo.2010.194; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; Ivanov AI, 2003, J PHYSIOL-LONDON, V553, P221, DOI 10.1113/jphysiol.2003.055616; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Liu E, 2012, AM J PHYSIOL-REG I, V302, pR1372, DOI 10.1152/ajpregu.00023.2012; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; Morrison SF, 2012, FRONT ENDOCRINOL LAU, V3; Muckart DJJ, 1997, CRIT CARE MED, V25, P1789, DOI 10.1097/00003246-199711000-00014; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Rivest S, 2000, P SOC EXP BIOL MED, V223, P22, DOI 10.1046/j.1525-1373.2000.22304.x; Romanovsky AA, 1998, MED HYPOTHESES, V50, P219, DOI 10.1016/S0306-9877(98)90022-6; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V271, pR244, DOI 10.1152/ajpregu.1996.271.1.R244; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Romanovsky AA, 2002, J APPL PHYSIOL, V92, P2667, DOI 10.1152/japplphysiol.01173.2001; Romanovsky AA, 1996, AM J PHYSIOL-REG I, V270, pR693, DOI 10.1152/ajpregu.1996.270.4.R693; Romanovsky AA, 1998, AM J PHYSIOL-REG I, V275, pR323, DOI 10.1152/ajpregu.1998.275.1.R323; Romanovsky AA, 1998, AM J PHYSIOL-REG I, V275, pR332, DOI 10.1152/ajpregu.1998.275.1.R332; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Saper CB, 2012, NAT NEUROSCI, V15, P1088, DOI 10.1038/nn.3159; Smith JE, 1998, BRAIN RES, V786, P153, DOI 10.1016/S0006-8993(97)01437-6; Steiner AA, 2005, AM J PHYSIOL-REG I, V289, pR1253, DOI 10.1152/ajpregu.00371.2005; Steiner AA, 2007, PROG LIPID RES, V46, P89, DOI 10.1016/j.plipres.2006.11.001; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Steiner AA, 2009, AM J PHYSIOL-REG I, V297, pR485, DOI 10.1152/ajpregu.91026.2008; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; Yoshida K, 2009, J NEUROSCI, V29, P11954, DOI 10.1523/JNEUROSCI.2643-09.2009; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529	36	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75733	10.1371/journal.pone.0075733	http://dx.doi.org/10.1371/journal.pone.0075733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069444	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300095
J	Crouzin, N; Baranger, K; Cavalier, M; Marchalant, Y; Cohen-Solal, C; Roman, FS; Khrestchatisky, M; Rivera, S; Feron, F; Vignes, M				Crouzin, Nadine; Baranger, Kevin; Cavalier, Melanie; Marchalant, Yannick; Cohen-Solal, Catherine; Roman, Francois S.; Khrestchatisky, Michel; Rivera, Santiago; Feron, Francois; Vignes, Michel			Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer's Disease: Dissociation between Somatosensory Cortex and Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TRANSGENIC MICE; MEMORY; IMPAIRMENT; PATHOLOGY; PLAQUE; TRANSMISSION; STIMULATION; SYNAPSES; FAILURES	Transgenic mouse models of Alzheimer's disease (AD) that overproduce the amyloid beta peptide (A beta) have highlighted impairments of hippocampal long-term synaptic plasticity associated with the progression of the disease. Here we examined whether the characteristics of one of the hallmarks of AD, i.e. A beta deposition, in both the somatosensory cortex and the hippocampus, correlated with specific losses of synaptic plasticity in these areas. For this, we evaluated the occurrence of long-term potentiation (LTP) in the cortex and the hippocampus of 6-month old 5xFAD transgenic mice that exhibited massive A beta deposition in both regions but with different features: in cortical areas a majority of A beta deposits comprised a dense core surrounded by a diffuse corona while such kind of A beta deposition was less frequently observed in the hippocampus. In order to simultaneously monitor synaptic changes in both areas, we developed a method based on the use of Multi-Electrode Arrays (MEA). When compared with wild-type (WT) mice, basal transmission was significantly reduced in both areas in 5xFAD mice, while short-term synaptic plasticity was unaffected. The induction of long-term changes of synaptic transmission by different protocols revealed that in 5xFAD mice, LTP in the layer 5 of the somatosensory cortex was more severely impaired than LTP triggered in the CA1 area of the hippocampus. We conclude that cortical plasticity is deficient in the 5xFAD model and that this deficit could be correlated with the proportion of diffuse plaques in 5xFAD mice.	[Crouzin, Nadine; Baranger, Kevin; Marchalant, Yannick; Roman, Francois S.; Khrestchatisky, Michel; Rivera, Santiago; Feron, Francois] Aix Marseille Univ, Lab Neurobiol Interact Cellulaires & Neurophysiop, Marseille, France; [Crouzin, Nadine; Baranger, Kevin; Marchalant, Yannick; Roman, Francois S.; Khrestchatisky, Michel; Rivera, Santiago; Feron, Francois] CNRS, Lab Neurobiol Interact Cellulaires & Neurophysiop, Marseille, France; [Cavalier, Melanie; Cohen-Solal, Catherine; Vignes, Michel] Univ Montpellier 2, Univ Montpellier 1, CNRS, Lab Inst Biomol Max Mousseron UMR5247, Montpellier, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Montpellier	Vignes, M (corresponding author), Univ Montpellier 2, Univ Montpellier 1, CNRS, Lab Inst Biomol Max Mousseron UMR5247, Montpellier, France.	Michel.Vignes@univ-montp2.fr	Vignes, Michel/AAA-7693-2019; Feron, Francois/J-5639-2014	Vignes, Michel/0000-0003-0969-2966; 	Centre National de la Recherche Scientifique, Aix-Marseille University; University of Montpellier 2; French National Agency for Research ANR; "Fonds Europeen de Developpement Regional" FEDER in PACA; French Alzheimer's Plan	Centre National de la Recherche Scientifique, Aix-Marseille University; University of Montpellier 2; French National Agency for Research ANR(French National Research Agency (ANR)); "Fonds Europeen de Developpement Regional" FEDER in PACA; French Alzheimer's Plan	This work was supported in part by the Centre National de la Recherche Scientifique, Aix-Marseille University and University of Montpellier 2 and by grants from the French National Agency for Research ANR funding to NC, SR and MK (ADHOC, TIMPAD and PREVENTAD projects, respectively) within the frame of the French Alzheimer's Plan. The work was also supported by grants to SR and MK from "Fonds Europeen de Developpement Regional" FEDER in PACA. KB was granted a research associate fellowship by the French Alzheimer's Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour SB, 2010, NEUROCHEM INT, V57, P440, DOI 10.1016/j.neuint.2010.02.013; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Battaglia F, 2007, BIOL PSYCHIAT, V62, P1405, DOI 10.1016/j.biopsych.2007.02.027; Bell KFS, 2006, NEUROBIOL AGING, V27, P1644, DOI 10.1016/j.neurobiolaging.2005.09.034; Bell KFS, 2006, EUR J PHARMACOL, V545, P11, DOI 10.1016/j.ejphar.2006.06.045; Bozzao A, 2001, AM J NEURORADIOL, V22, P1030; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CARLESIMO GA, 1992, NEUROPSYCHOL REV, V3, P119, DOI 10.1007/BF01108841; CastroAlamancos MA, 1996, P NATL ACAD SCI USA, V93, P1335, DOI 10.1073/pnas.93.3.1335; Chang PKY, 2012, EUR J NEUROSCI, V35, P1908, DOI 10.1111/j.1460-9568.2012.08165.x; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Delatour B, 2004, NEUROBIOL DIS, V16, P41, DOI 10.1016/j.nbd.2004.01.008; Devi L, 2010, EUR J NEUROSCI, V31, P110, DOI 10.1111/j.1460-9568.2009.07031.x; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Eriksen JL, 2007, BEHAV GENET, V37, P79, DOI 10.1007/s10519-006-9118-z; Esiri MM, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P79; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gerlai R, 2002, HIPPOCAMPUS, V12, P657, DOI 10.1002/hipo.10101; Girard SD, 2013, J ALZHEIMERS DIS, V33, P781, DOI 10.3233/JAD-2012-120982; GONATAS NK, 1967, J NEUROPATH EXP NEUR, V26, P25, DOI 10.1097/00005072-196701000-00003; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hernandez RV, 2005, BRAIN RES PROTOC, V15, P6, DOI 10.1016/j.brainresprot.2005.02.003; Heuschkel MO, 2002, J NEUROSCI METH, V114, P135, DOI 10.1016/S0165-0270(01)00514-3; HOM J, 1992, ARCH CLIN NEUROPSYCH, V7, P121, DOI 10.1016/0887-6177(92)90006-9; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Johnson Micah A., 2012, Yale Journal of Biology and Medicine, V85, P481; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Koliatsos VE, 2006, ACTA NEUROPATHOL, V112, P147, DOI 10.1007/s00401-006-0068-6; Kopanitsa MV, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-61; Lante Fabien, 2008, Journal of Integrative Neuroscience, V7, P249, DOI 10.1142/S0219635208001800; Leon-Espinosa G, 2012, J ALZHEIMERS DIS, V29, P841, DOI 10.3233/JAD-2012-112036; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Marchetti C, 2011, REV NEUROSCIENCE, V22, P373, DOI 10.1515/RNS.2011.035; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Nguyen PV, 2006, J EXP BIOL, V209, P2293, DOI 10.1242/jeb.01985; Nguyen PV, 2000, LEARN MEMORY, V7, P170, DOI 10.1101/lm.7.3.170; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, REV NEUROSCIENCE, V17, P429; Ohno M, 2009, NEUROBIOL LEARN MEM, V92, P455, DOI 10.1016/j.nlm.2009.05.001; Ondrejcak T, 2010, NEUROMOL MED, V12, P13, DOI 10.1007/s12017-009-8091-0; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Ramos B, 2006, NEUROBIOL AGING, V27, P1658, DOI 10.1016/j.neurobiolaging.2005.09.022; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Spires Tara L, 2005, NeuroRx, V2, P423, DOI 10.1602/neurorx.2.3.423; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Stephen JM, 2010, J NEURAL TRANSM, V117, P217, DOI 10.1007/s00702-009-0343-5; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	57	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74667	10.1371/journal.pone.0074667	http://dx.doi.org/10.1371/journal.pone.0074667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069328	gold, Green Published			2022-12-27	WOS:000324547300048
J	Niedworok, C; Kretschmer, I; Rock, K; vom Dorp, F; Szarvas, T; Hess, J; Freudenberger, T; Melchior-Becker, A; Rubben, H; Fischer, JW				Niedworok, Christian; Kretschmer, Inga; Roeck, Katharina; vom Dorp, Frank; Szarvas, Tibor; Hess, Jochen; Freudenberger, Till; Melchior-Becker, Ariane; Ruebben, Herbert; Fischer, Jens W.			The Impact of the Receptor of Hyaluronan-Mediated Motility (RHAMM) on Human Urothelial Transitional Cell Cancer of the Bladder	PLOS ONE			English	Article							URINARY-BLADDER; OVER-EXPRESSION; PROSTATE-CANCER; FOCAL ADHESIONS; CARCINOMA; CD44; ACID; GROWTH; PROGRESSION; OLIGOSACCHARIDES	Hyaluronan (HA) is a carbohydrate of the extracellular matrix with tumor promoting effects in a variety of cancers. The present study addressed the role of HA matrix for progression and prognosis of human bladder cancer by studying the expression and function of HA-related genes. Methods: Tissue samples of 120 patients with different stages of transitional cell bladder cancer, who underwent surgical treatment for bladder cancer at the University Hospital of Essen were analysed. mRNA-expression levels of HA synthases (HAS1-3) and HA-receptors (RHAMM and CD44) were evaluated by real time RT-PCR in comparison to healthy bladder tissue as control. In uni- and multivariate cox proportional hazard survival regression analysis, the impact of the gene expression levels on survival was assessed. In vitro knock-down of RHAMM, CD44 and HAS isoenzymes was achieved by siRNA and lentiviral shRNA in J82 bladder cancer cells. Transfected cells were analysed in vitro with regard to proliferation, cell cycle and apoptosis. J82 cells after knock-down of RHAMM were xenografted into male nu/nu athymic mice to monitor tumor progression in vivo. Results: In invasive tumor stages RHAMM-, HAS1 and HAS2 mRNA-expression levels were elevated whereas HAS3v1 was reduced as compared to non-invasive tumors. Subsequently, Kaplan-Meier analysis revealed reduced bladder cancer specific survival in patients with high RHAMM mRNA and low HAS3v1 expression. Elevated RHAMM in invasive tumors was confirmed by RHAMM immunohistochemistry. Furthermore, multivariate analysis revealed that only RHAMM expression was associated with poor prognosis independent from other survival factors (HR=2.389, 95% CI 1.227-4.651, p=0.01). Lentiviral RHAMM knock-down revealed reduced J82 cell proliferation in vitro and reduced xenograft tumor growth in vivo. Conclusion: The data suggest that RHAMM plays a crucial role in mediating progression of muscle-invasive bladder cancer and recommends RHAMM for further evaluation as a prognostic marker or therapeutic target in bladder cancer therapy.	[Niedworok, Christian; vom Dorp, Frank; Hess, Jochen; Ruebben, Herbert] Univ Duisburg Essen, Dept Urol, Essen Med Sch, Essen, Germany; [Kretschmer, Inga; Roeck, Katharina; Freudenberger, Till; Melchior-Becker, Ariane; Fischer, Jens W.] Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany; [Szarvas, Tibor] Med Univ Vienna, Dept Urol, Vienna Gen Hosp, Vienna, Austria	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Medical University of Vienna	Fischer, JW (corresponding author), Univ Dusseldorf, Inst Pharmakol & Klin Pharmakol, Univ Klinikum Dusseldorf, D-40225 Dusseldorf, Germany.	Jens.Fischer@uni-duesseldorf.de	Hess, Jochen/AAA-2388-2020; SZARVAS, t./L-4422-2017	Hess, Jochen/0000-0002-9902-5368; SZARVAS, t./0000-0002-6321-0799	DFG [Fi682/4-1]; IFORES Program of the University of Essen	DFG(German Research Foundation (DFG)); IFORES Program of the University of Essen	The study was supported by DFG Fi682/4-1 and the IFORES Program of the University of Essen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAND M, 1991, CHEM-BIOL INTERACT, V77, P97, DOI 10.1016/0009-2797(91)90008-U; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Eissa S, 2005, CANCER-AM CANCER SOC, V103, P1356, DOI 10.1002/cncr.20902; Golshani R, 2008, CANCER RES, V68, P483, DOI 10.1158/0008-5472.CAN-07-2140; Golshani R, 2007, INT J CANCER, V120, P1712, DOI 10.1002/ijc.22222; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Goueffic Y, 2006, CARDIOVASC RES, V72, P339, DOI 10.1016/j.cardiores.2006.07.017; Greiner J, 2010, HAEMATOL-HEMATOL J, V95, P1191, DOI 10.3324/haematol.2009.014704; Gust KM, 2009, NEOPLASIA, V11, P956, DOI 10.1593/neo.09694; HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575; Hall CL, 2002, CELL COMMUN ADHES, V9, P273, DOI 10.1080/15419060216306; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Herr HW, 1998, J CLIN ONCOL, V16, P1298, DOI 10.1200/JCO.1998.16.4.1298; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Kong QY, 2003, ONCOL REP, V10, P51; Kosaki R, 1999, CANCER RES, V59, P1141; Kramer MW, 2011, CANCER-AM CANCER SOC, V117, P1197, DOI 10.1002/cncr.25565; Kramer MW, 2010, EUR UROL, V57, P86, DOI 10.1016/j.eururo.2009.03.057; Liberman D, 2011, BJU INT, V107, P905, DOI 10.1111/j.1464-410X.2010.09590.x; Lokeshwar VB, 2000, J UROLOGY, V163, P348, DOI 10.1016/S0022-5347(05)68050-0; Lokeshwar VB, 2002, CANCER-AM CANCER SOC, V95, P61, DOI 10.1002/cncr.10652; Lokeshwar VB, 2005, CANCER RES, V65, P2243, DOI 10.1158/0008-5472.CAN-04-2805; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Millan-Rodriguez F, 2000, J UROLOGY, V164, P680, DOI 10.1016/S0022-5347(05)67280-1; Miyake H, 2002, J UROLOGY, V167, P1282, DOI 10.1016/S0022-5347(05)65282-2; Muramaki M, 2004, J UROLOGY, V171, P426, DOI 10.1097/01.ju.0000093446.54115.b6; Nagel S, 2010, EXP HEMATOL, V38, P38, DOI 10.1016/j.exphem.2009.10.010; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; OTOOLE C, 1978, BRIT J CANCER, V38, P64, DOI 10.1038/bjc.1978.164; Passerotti CC, 2011, UROL ONCOL-SEMIN ORI, V29, P710, DOI 10.1016/j.urolonc.2009.10.006; Passerotti CC, 2006, EUR UROL, V49, P71, DOI 10.1016/j.eururo.2005.09.015; Pectasides D, 2009, CRIT REV ONCOL HEMAT, V70, P114, DOI 10.1016/j.critrevonc.2008.07.018; Ploeg M, 2009, WORLD J UROL, V27, P289, DOI 10.1007/s00345-009-0383-3; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rock K, 2012, J BIOL CHEM, V287, P20056, DOI 10.1074/jbc.M112.353151; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; SKINNER DG, 1988, EUR UROL, V14, P30; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Tolg C, 2010, J BIOL CHEM, V285, P26461, DOI 10.1074/jbc.M110.121491; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Twarock S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-30; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146	48	31	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75681	10.1371/journal.pone.0075681	http://dx.doi.org/10.1371/journal.pone.0075681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069434	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300090
J	Petta, S; Valenti, L; Marchesini, G; Di Marco, V; Licata, A; Camma, C; Barcellona, MR; Cabibi, D; Donati, B; Fracanzani, A; Grimaudo, S; Parrinello, G; Pipitone, RM; Torres, D; Fargion, S; Licata, G; Craxi, A				Petta, Salvatore; Valenti, Luca; Marchesini, Giulio; Di Marco, Vito; Licata, Anna; Camma, Calogero; Barcellona, Maria Rosa; Cabibi, Daniela; Donati, Benedetta; Fracanzani, Anna; Grimaudo, Stefania; Parrinello, Gaspare; Pipitone, Rosaria Maria; Torres, Daniele; Fargion, Silvia; Licata, Giuseppe; Craxi, Antonio			PNPLA3 GG Genotype and Carotid Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; WALL THICKNESS; CARDIOVASCULAR-DISEASE; RISK; ASSOCIATION; HEPATITIS; EVENTS; HEART	Background and Aim: To evaluate if the presence of carotid atherosclerosis in patients with NAFLD, could be related to gene variants influencing hepatic fat accumulation and the severity of liver damage. Methods: We recorded anthropometric, metabolic and histological data(Kleiner score) of 162 consecutive, biopsy-proven Sicilian NAFLD patients. Intima-media thickness(IMT), IMT thickening(IMT >= 1 mm) and carotid plaques(focal thickening of >1.3 mm at the level of common carotid artery) were evaluated using ultrasonography. IL28B rs12979860 C>T, PNPLA3 rs738409 C>G, GCKR rs780094 C>T, LYPLAL1 rs12137855 C>T, and NCAN rs2228603 C>T single nucleotide polymorphisms were also assessed. The results were validated in a cohort of 267 subjects with clinical or histological diagnosis of NAFLD from Northern Italy, 63 of whom had follow-up examinations. Results: Carotid plaques, IMT thickening and mean maximum IMT were similar in the two cohorts, whereas the prevalence of diabetes, obesity, NASH, and PNPLA3 GG polymorphism(21% vs. 13%, p = 0.02) were significantly higher in the Sicilian cohort. In this cohort, the prevalence of carotid plaques and IMT thickening was higher in PNPLA3 GG compared to CC/CG genotype(53% vs. 32%, p = 0.02; 62% vs. 28%, p < 0.001, respectively). These associations were confirmed at multivariate analyses (OR2.94; 95% C. I. 1.12-7.71, p = 0.02, and OR4.11; 95% C. I. 1.69-9.96, p = 0.002, respectively), although have been observed only in patients <50years. Also in the validation cohort, PNPLA3 GG genotype was independently associated with IMT thickening in younger patients only (OR: 6.00,95% C. I. 1.36-29, p = 0.01), and to IMT progression (p = 0.05) in patients with follow-up examinations. Conclusion: PNPLA3 GG genotype is associated with higher severity of carotid atherosclerosis in younger patients with NAFLD. Mechanisms underlying this association, and its clinical relevance need further investigations.	[Petta, Salvatore; Di Marco, Vito; Licata, Anna; Camma, Calogero; Barcellona, Maria Rosa; Grimaudo, Stefania; Pipitone, Rosaria Maria; Craxi, Antonio] Univ Palermo, Di Bi MIS, Sez Gastroenterol, Palermo, Italy; [Valenti, Luca; Donati, Benedetta; Fracanzani, Anna; Fargion, Silvia] Univ Milan, Fdn Ca Granda IRCCS Osped Maggiore Policlin, Sect Internal Med, Dept Pathophysiol & Transplantat, Milan, Italy; [Parrinello, Gaspare; Torres, Daniele; Licata, Giuseppe] Univ Palermo, Dipartimento Biomed Med Interna & Specialist Di B, Palermo, Italy; [Cabibi, Daniela] Univ Palermo, Dipartimento Patol Umana, Palermo, Italy; [Marchesini, Giulio] Univ Bologna, Dipartimento Med & Gastroenterol, Bologna, Italy	University of Palermo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Palermo; University of Palermo; University of Bologna	Petta, S (corresponding author), Univ Palermo, Di Bi MIS, Sez Gastroenterol, Palermo, Italy.	petsa@inwind.it	cabibi, daniela/D-7438-2013; Di Marco, Vito/AAC-4612-2022; Fracanzani, Anna Ludovica/J-8986-2018; Donati, Benedetta/AAA-7779-2022; Valenti, Luca/B-3695-2009; Craxi, Antonio/K-9529-2016	cabibi, daniela/0000-0001-6571-6577; Fracanzani, Anna Ludovica/0000-0001-5918-0171; Donati, Benedetta/0000-0002-9163-8194; CAMMA', CALOGERO/0000-0002-9224-1914; DI MARCO, VITO/0000-0001-6397-4206; Licata, Anna/0000-0003-0383-6121; Valenti, Luca/0000-0001-8909-0345; PIPITONE, Rosaria Maria/0000-0002-6721-3962; PARRINELLO, Gaspare/0000-0002-3594-7232; Grimaudo, Stefania/0000-0003-3225-4112; Craxi, Antonio/0000-0002-4480-9544; Marchesini, Giulio/0000-0003-2407-9860; Petta, Salvatore/0000-0002-0822-9673	PRIN [2010C4JJWB_001]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was funded by grants from PRIN 2010-2011 (Prot. N. 2010C4JJWB_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18; Carulli L, 2011, INTERN EMERG MED; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dunn W, 2008, AM J GASTROENTEROL, V103, P2263, DOI 10.1111/j.1572-0241.2008.02034.x; Fracanzani AL, 2008, AM J MED, V121, P72, DOI 10.1016/j.amjmed.2007.08.041; Fraser A, 2007, ARTERIOSCL THROM VAS, V27, P2729, DOI 10.1161/ATVBAHA.107.152298; Gavin JR, 2000, DIABETES CARE, V23, pS4; Goland S, 2006, J CLIN GASTROENTEROL, V40, P949, DOI 10.1097/01.mcg.0000225668.53673.e6; Holliday EG, 2012, NAT GENET, V44, P1147, DOI 10.1038/ng.2397; Kim D, 2012, HEPATOLOGY, V56, P605, DOI 10.1002/hep.25593; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kozakova M, 2012, HEPATOLOGY, V55, P1406, DOI 10.1002/hep.25555; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Pare G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001374; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Petta S, 2012, J HEPATOL, V56, P1356, DOI 10.1016/j.jhep.2012.01.007; Petta S, 2012, HEPATOLOGY, V55, P1317, DOI 10.1002/hep.25508; *SAS I INC, 1992, SAS STAT SOFTW CHANG; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Targher G, 2006, DIABETES CARE, V29, P1325, DOI 10.2337/dc06-0135; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Valenti L, 2011, NUTR METAB CARDIOVAS, V21, P568, DOI 10.1016/j.numecd.2010.01.003; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Van Vre EA, 2012, ARTERIOSCL THROM VAS, V32, P887, DOI 10.1161/ATVBAHA.111.224873; Yilmaz Y, 2010, ATHEROSCLEROSIS, V211, P182, DOI 10.1016/j.atherosclerosis.2010.01.049	32	55	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74089	10.1371/journal.pone.0074089	http://dx.doi.org/10.1371/journal.pone.0074089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069270	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300028
J	Seifert, L; Harbeck, M; Thomas, A; Hoke, N; Zoller, L; Wiechmann, I; Grupe, G; Scholz, HC; Riehm, JM				Seifert, Lisa; Harbeck, Michaela; Thomas, Astrid; Hoke, Nadja; Zoeller, Lothar; Wiechmann, Ingrid; Grupe, Gisela; Scholz, Holger C.; Riehm, Julia M.			Strategy for Sensitive and Specific Detection of Yersinia pestis in Skeletons of the Black Death Pandemic	PLOS ONE			English	Article							ANCIENT DNA EXTRACTION; REAL-TIME PCR; GENOME SEQUENCE; PLAGUE; BONE; AMPLIFICATION; PRESERVATION; AGENT; CONTAMINATION; VICTIMS	Yersinia pestis has been identified as the causative agent of the Black Death pandemic in the 14th century. However, retrospective diagnostics in human skeletons after more than 600 years are critical. We describe a strategy following a modern diagnostic algorithm and working under strict ancient DNA regime for the identification of medieval human plague victims. An initial screening and DNA quantification assay detected the Y. pestis specific pla gene of the high copy number plasmid pPCP1. Results were confirmed by conventional PCR and sequence analysis targeting both Y. pestis specific virulence plasmids pPCP1 and pMT1. All assays were meticulously validated according to human clinical diagnostics requirements (ISO 15189) regarding efficiency, sensitivity, specificity, and limit of detection (LOD). Assay specificity was 100% tested on 41 clinically relevant bacteria and 29 Y. pseudotuberculosis strains as well as for DNA of 22 Y. pestis strains and 30 previously confirmed clinical human plague samples. The optimized LOD was down to 4 gene copies. 29 individuals from three different multiple inhumations were initially assessed as possible victims of the Black Death pandemic. 7 samples (24%) were positive in the pPCP1 specific screening assay. Confirmation through second target pMT1 specific PCR was successful for 4 of the positive individuals (14%). A maximum of 700 and 560 copies per mu l aDNA were quantified in two of the samples. Those were positive in all assays including all repetitions, and are candidates for future continuative investigations such as whole genome sequencing. We discuss that all precautions taken here for the work with aDNA are sufficient to prevent external sample contamination and fulfill the criteria of authenticity. With regard to retrospective diagnostics of a human pathogen and the uniqueness of ancient material we strongly recommend using a careful strategy and validated assays as presented in our study.	[Seifert, Lisa; Hoke, Nadja; Grupe, Gisela] Univ Munich, Dept Biol 1, Martinsried, Germany; [Harbeck, Michaela; Grupe, Gisela] State Collect Anthropol & Palaeoanat, Munich, Germany; [Thomas, Astrid; Zoeller, Lothar; Scholz, Holger C.; Riehm, Julia M.] Bundeswehr Inst Microbiol, Munich, Germany; [Wiechmann, Ingrid] Univ Munich, Dept Vet Sci, Inst Palaeoanat Domesticat Res & Hist Vet Med, Munich, Germany	University of Munich; Bundeswehr Institute of Microbiology (IMB); University of Munich	Riehm, JM (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	juliariehm@bundeswehr.org			Bavarian State Ministry of Sciences	Bavarian State Ministry of Sciences	This work was supported by a grant of the Bavarian State Ministry of Sciences according to the Bavarian Elite Aid Act (BayEFG) and regarding the collagen preservation experiments by the Deutsche Forschungsgemeinschaft (DFG Ha 5979). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Benedictow OJ, 2004, BLACK DEATH 1346 135, VXVI; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Campos PF, 2012, ANN ANAT, V194, P7, DOI 10.1016/j.aanat.2011.07.003; Cohn SK, 2002, BLACK DEATH TRANSFOR, Vx; Cooper A, 2000, SCIENCE, V289, P1139; Dalitz S, 2012, HIST VEREIN BRANDENB, V2011-2012, P67; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; Drancourt M, 2011, LANCET INFECT DIS, V11, P894, DOI 10.1016/S1473-3099(11)70292-4; Duncan CJ, 2005, POSTGRAD MED J, V81, P315, DOI 10.1136/pgmj.2004.024075; Eurogentec, 2004, YOUR ON STOP SHOP RE; Fulton TL, 2012, METHODS MOL BIOL, V840, P111, DOI 10.1007/978-1-61779-516-9_15; Garrelt Christina, 2003, DOC ARCHAEOBIOL, P247; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Gotherstrom A, 2002, ARCHAEOMETRY, V44, P395, DOI 10.1111/1475-4754.00072; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Harbeck M, 2009, ARCHAEOL ANTHROP SCI, V1, P43, DOI 10.1007/s12520-009-0004-5; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoke N, 2011, PALAEOGEOGR PALAEOCL, V310, P23, DOI 10.1016/j.palaeo.2011.03.021; Janse I, 2013, EMERG INFECT DIS, V19, P342, DOI 10.3201/eid1902.120659; Kemp BM, 2010, HUM BIOL, V82, P227, DOI 10.3378/027.082.0207; Little LK, 2007, PLAGUE END ANTIQUITY, Vxiv; LONGO MC, 1990, GENE, V93, P125, DOI 10.1016/0378-1119(90)90145-H; Matt CP, 2008, JAHRESBERICHT 2006 A, P37; Mohammadi T, 2004, TRANSFUSION, V44, P1314, DOI 10.1111/j.0041-1132.2004.04114.x; Nguyen-Hieu T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015405; Nolte FS, 2011, MOL DIAGNOSTIC METHO; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Poinar HN, 2003, INT CONGR SER, V1239, P575, DOI 10.1016/S0531-5131(02)00624-6; Pruvost M, 2005, BIOTECHNIQUES, V38, P569, DOI 10.2144/05384ST03; Rabenau HF, 2007, J CLIN VIROL, V40, P93, DOI 10.1016/j.jcv.2007.07.009; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Riehm JM, 2011, EMERG INFECT DIS, V17, P1320, DOI 10.3201/eid1707.100740; Riehm JM, 2011, MOL CELL PROBE, V25, P8, DOI 10.1016/j.mcp.2010.09.002; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2007, BIOTECHNIQUES, V42, P343, DOI 10.2144/000112383; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; Tomaso H, 2003, FEMS IMMUNOL MED MIC, V38, P117, DOI 10.1016/S0928-8244(03)00184-6; Tran TNN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016735; Tsangaras K, 2012, ANN ANAT, V194, P58, DOI 10.1016/j.aanat.2011.04.003; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; WHO, 2010, EEKLY EPIDEMIOLOGICA, V85, P37; Wiechmann I, 2005, AM J PHYS ANTHROPOL, V126, P48, DOI 10.1002/ajpa.10276; Wiechmann I, 2013, DOCUMENTA A IN PRESS, V10; Wiechmann I, 2010, EMERG INFECT DIS, V16, P1806, DOI 10.3201/eid1611.100598; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; World Health Organization, 2009, OP GUID PLAG SURV DI; Xu Z, 2009, ELECTROPHORESIS, V30, P1282, DOI 10.1002/elps.200800473; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	64	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75742	10.1371/journal.pone.0075742	http://dx.doi.org/10.1371/journal.pone.0075742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069445	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300093
J	Agam, Y; Carey, C; Barton, JJS; Dyckman, KA; Lee, AKC; Vangel, M; Manoach, DS				Agam, Yigal; Carey, Caitlin; Barton, Jason J. S.; Dyckman, Kara A.; Lee, Adrian K. C.; Vangel, Mark; Manoach, Dara S.			Network Dynamics Underlying Speed-Accuracy Trade-Offs in Response to Errors	PLOS ONE			English	Article							EVENT-RELATED FMRI; POSTERIOR CINGULATE CORTEX; DEFAULT MODE NETWORK; FRONTAL EYE FIELD; FUNCTIONAL CONNECTIVITY; DECISION-MAKING; REACTION-TIME; HUMAN BRAIN; ATTENTION; TASKS	The ability to dynamically and rapidly adjust task performance based on its outcome is fundamental to adaptive, flexible behavior. Over trials of a task, responses speed up until an error is committed and after the error responses slow down. These dynamic adjustments serve to optimize performance and are well-described by the speed-accuracy trade-off (SATO) function. We hypothesized that SATOs based on outcomes reflect reciprocal changes in the allocation of attention between the internal milieu and the task-at-hand, as indexed by reciprocal changes in activity between the default and dorsal attention brain networks. We tested this hypothesis using functional MRI to examine the pattern of network activation over a series of trials surrounding and including an error. We further hypothesized that these reciprocal changes in network activity are coordinated by the posterior cingulate cortex (PCC) and would rely on the structural integrity of its white matter connections. Using diffusion tensor imaging, we examined whether fractional anisotropy of the posterior cingulum bundle correlated with the magnitude of reciprocal changes in network activation around errors. As expected, reaction time (RT) in trials surrounding errors was consistent with predictions from the SATO function. Activation in the default network was: (i) inversely correlated with RT, (ii) greater on trials before than after an error and (iii) maximal at the error. In contrast, activation in the right intraparietal sulcus of the dorsal attention network was (i) positively correlated with RT and showed the opposite pattern: (ii) less activation before than after an error and (iii) the least activation on the error. Greater integrity of the posterior cingulum bundle was associated with greater reciprocity in network activation around errors. These findings suggest that dynamic changes in attention to the internal versus external milieu in response to errors underlie SATOs in RT and are mediated by the PCC.	[Agam, Yigal; Manoach, Dara S.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Agam, Yigal; Vangel, Mark; Manoach, Dara S.] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Carey, Caitlin] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Barton, Jason J. S.] Univ British Columbia, Dept Neurol, Vancouver, BC V5Z 1M9, Canada; [Barton, Jason J. S.] Univ British Columbia, Dept Ophthalmol, Vancouver, BC, Canada; [Barton, Jason J. S.] Univ British Columbia, Dept Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Dyckman, Kara A.] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Lee, Adrian K. C.] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; University of British Columbia; University of British Columbia; University of British Columbia; University System of Georgia; University of Georgia; University of Washington; University of Washington Seattle	Agam, Y (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA.	yigal@nmr.mgh.harvard.edu	Barton, Jason JS/A-6362-2012	Lee, Adrian KC/0000-0002-7611-0500; Carey, Caitlin/0000-0002-4953-5351	National Institute for Mental Health [F32 MH088081, F32 MH082514, R01 MH67720]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH082514, F32MH088081, R01MH067720] Funding Source: NIH RePORTER	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding came from the National Institute for Mental Health F32 MH088081 (YA); F32 MH082514 (KD); R01 MH67720 (DSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2011, P NATL ACAD SCI USA, V108, P17556, DOI 10.1073/pnas.1103475108; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BOGACZ R, 2010, TRENDS NEUROSCI, V33, P10, DOI DOI 10.1016/J.TINS.2009.09.002; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Eichele T, 2008, P NATL ACAD SCI USA, V105, P6173, DOI 10.1073/pnas.0708965105; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Ford KA, 2009, NEUROIMAGE, V45, P470, DOI 10.1016/j.neuroimage.2008.12.009; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Heitz RP, 2012, NEURON, V76, P616, DOI 10.1016/j.neuron.2012.08.030; Ivanoff J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002635; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Li CSR, 2007, NEUROIMAGE, V38, P640, DOI 10.1016/j.neuroimage.2007.07.021; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Manoach DS, 2007, J NEUROSCI, V27, P1791, DOI 10.1523/JNEUROSCI.3662-06.2007; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Padilla ML, 2006, J COGNITIVE NEUROSCI, V18, P1477, DOI 10.1162/jocn.2006.18.9.1477; Pierrot-Deseilligny C, 2003, PROG BRAIN RES, V142, P3; Polli FE, 2006, SCHIZOPHR RES, V82, P191, DOI 10.1016/j.schres.2005.10.003; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ridderinkhof KR, 2003, NEUROSCI LETT, V348, P1, DOI 10.1016/S0304-3940(03)00566-4; Ross M, 2011, NEUROSCIENCE, V196, P168, DOI 10.1016/j.neuroscience.2011.08.006; Teipel SJ, 2010, NEUROIMAGE, V49, P2021, DOI 10.1016/j.neuroimage.2009.10.067; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tu P, 2010, BRAIN, V133, P625, DOI 10.1093/brain/awp317; Vallesi A, 2012, HUM BRAIN MAPP, V33, P1677, DOI 10.1002/hbm.21312; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; van Veen V, 2008, J COGNITIVE NEUROSCI, V20, P1952, DOI 10.1162/jocn.2008.20146; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	52	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73692	10.1371/journal.pone.0073692	http://dx.doi.org/10.1371/journal.pone.0073692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069223	Green Published, gold			2022-12-27	WOS:000326240100055
J	Buttner, K; Krieter, J; Traulsen, A; Traulsen, I				Buettner, Kathrin; Krieter, Joachim; Traulsen, Arne; Traulsen, Imke			Efficient Interruption of Infection Chains by Targeted Removal of Central Holdings in an Animal Trade Network	PLOS ONE			English	Article							POTENTIAL EPIDEMIC SIZE; COMMUNITY STRUCTURE; SOCIAL NETWORKS; DISEASE-CONTROL; PIG-MOVEMENTS; PATTERNS; CATTLE; SPREAD; INTERNET; ONTARIO	Centrality parameters in animal trade networks typically have right-skewed distributions, implying that these networks are highly resistant against the random removal of holdings, but vulnerable to the targeted removal of the most central holdings. In the present study, we analysed the structural changes of an animal trade network topology based on the targeted removal of holdings using specific centrality parameters in comparison to the random removal of holdings. Three different time periods were analysed: the three-year network, the yearly and the monthly networks. The aim of this study was to identify appropriate measures for the targeted removal, which lead to a rapid fragmentation of the network. Furthermore, the optimal combination of the removal of three holdings regardless of their centrality was identified. The results showed that centrality parameters based on ingoing trade contacts, e. g. in-degree, ingoing infection chain and ingoing closeness, were not suitable for a rapid fragmentation in all three time periods. More efficient was the removal based on parameters considering the outgoing trade contacts. In all networks, a maximum percentage of 7.0% (on average 5.2%) of the holdings had to be removed to reduce the size of the largest component by more than 75%. The smallest difference from the optimal combination for all three time periods was obtained by the removal based on out-degree with on average 1.4% removed holdings, followed by outgoing infection chain and outgoing closeness. The targeted removal using the betweenness centrality differed the most from the optimal combination in comparison to the other parameters which consider the outgoing trade contacts. Due to the pyramidal structure and the directed nature of the pork supply chain the most efficient interruption of the infection chain for all three time periods was obtained by using the targeted removal based on out-degree.	[Buettner, Kathrin; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany; [Buettner, Kathrin; Krieter, Joachim; Traulsen, Imke] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Max Planck Society; University of Kiel	Buttner, K (corresponding author), Max Planck Inst Evolutionary Biol, Evolutionary Theory Grp, Plon, Germany.	buettner@evolbio.mpg.de	Traulsen, Arne/A-4955-2009	Traulsen, Arne/0000-0002-0669-5267	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; ben Avraham D., 2000, DIFFUSION REACTIONS; Bigras-Poulin M, 2006, PREV VET MED, V76, P11, DOI 10.1016/j.prevetmed.2006.04.004; Bigras-Poulin M, 2007, PREV VET MED, V80, P143, DOI 10.1016/j.prevetmed.2007.02.004; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Buttner K, 2013, PREV VET MED, V110, P418, DOI 10.1016/j.prevetmed.2013.01.008; Buttner K, 2013, TRANSBOUND IN PRESS; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Cohen R, 2001, PHYS REV LETT, V86, P3682, DOI 10.1103/PhysRevLett.86.3682; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Dube C, 2011, PREV VET MED, V99, P102, DOI 10.1016/j.prevetmed.2011.01.013; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gross T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.208701; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Havlin S, 2010, COMPLEX NETWORKS STR; Heckathorn DD, 1999, SOCIOL FOCUS, V32, P159, DOI [DOI 10.1080/00380237.1999.10571133, 10.1080/00380237.1999.10571133]; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Kao RR, 2006, P ROY SOC B-BIOL SCI, V273, P1999, DOI 10.1098/rspb.2006.3505; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; Kiss IZ, 2006, J R SOC INTERFACE, V3, P55, DOI 10.1098/rsif.2005.0079; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lurette A, 2011, PREV VET MED, V102, P30, DOI 10.1016/j.prevetmed.2011.06.007; Martinez-Lopez B, 2009, PREV VET MED, V91, P29, DOI 10.1016/j.prevetmed.2009.05.007; Masuda Naoki, 2013, F1000Prime Rep, V5, P6, DOI 10.12703/P5-6; Masuda N, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123018; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; MORRIS M, 1993, SOCIOL METHOD RES, V22, P99, DOI 10.1177/0049124193022001005; Natale F, 2009, PREV VET MED, V92, P341, DOI 10.1016/j.prevetmed.2009.08.026; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Ribbens S, 2009, PREV VET MED, V88, P57, DOI 10.1016/j.prevetmed.2008.08.002; Sahimi M, 1994, APPL PERCOLATION THE; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; SAS&REG;Institute Inc, 2008, US GUID REL 9 2; STAUFFER D, 1994, INTRO PERCOLATION TH; Ueno T, 2008, J THEOR BIOL, V254, P655, DOI 10.1016/j.jtbi.2008.07.001; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Webb CR, 2006, EPIDEMIOL INFECT, V134, P31, DOI 10.1017/S095026880500467X; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661	47	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74292	10.1371/journal.pone.0074292	http://dx.doi.org/10.1371/journal.pone.0074292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069293	gold, Green Published			2022-12-27	WOS:000326240100099
J	Czigler, I; Intraub, H; Stefanics, G				Czigler, Istvan; Intraub, Helene; Stefanics, Gabor			Prediction Beyond the Borders: ERP Indices of Boundary Extension-Related Error	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MEMORY; P300; REPRESENTATION; LAYOUT; SCENES; BRAIN; ATTENTION; COMPONENT; LOOKING	Boundary extension (BE) is a rapidly occurring memory error in which participants incorrectly remember having seen beyond the boundaries of a view. However, behavioral data has provided no insight into how quickly after the onset of a test picture the effect is detected. To determine the time course of BE from neural responses we conducted a BE experiment while recording EEG. We exploited a diagnostic response asymmetry to mismatched views (a closer and wider view of the same scene) in which the same pair of views is rated as more similar when the closer item is shown first than vice versa. On each trial, a closer or wider view was presented for 250 ms followed by a 250-ms mask and either the identical view or a mismatched view. Boundary ratings replicated the typical asymmetry. We found a similar asymmetry in ERP responses in the 265-285 ms interval where the second member of the close-then-wide pairs evoked less negative responses at left parieto-temporal sites compared to the wide-then-close condition. We also found diagnostic ERP effects in the 500-560 ms range, where ERPs to wide-then-close pairs were more positive at centro-parietal sites than in the other three conditions, which is thought to be related to participants' confidence in their perceptual decision. The ERP effect in the 265-285 ms range suggests the falsely remembered region beyond the view-boundaries of S1 is rapidly available and impacts assessment of the test picture within the first 265 ms of viewing, suggesting that extrapolated scene structure may be computed rapidly enough to play a role in the integration of successive views during visual scanning.	[Czigler, Istvan] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Intraub, Helene] Univ Delaware, Dept Psychol, Newark, DE USA; [Stefanics, Gabor] Univ Zurich, Inst Biomed Engn, TNU, Zurich, Switzerland; [Stefanics, Gabor] Swiss Fed Inst Technol, Zurich, Switzerland; [Stefanics, Gabor] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Delaware; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Stefanics, G (corresponding author), Univ Zurich, Inst Biomed Engn, TNU, Zurich, Switzerland.	stefanics@biomed.ee.ethz.ch	Stefanics, Gabor/M-9955-2019	Stefanics, Gabor/0000-0002-0324-0996; Czigler, Istvan/0000-0003-1661-3808	University of Zurich; ETH Zurich; Hungarian National Research Fund (OTKA) [104462]	University of Zurich; ETH Zurich(ETH Zurich); Hungarian National Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was supported by the University of Zurich and ETH Zurich, and a grant from the Hungarian National Research Fund (OTKA), grant number 104462. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Chadwick MJ, 2013, CORTEX, V49, P2067, DOI 10.1016/j.cortex.2012.11.010; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dickinson CA, 2008, J EXP PSYCHOL HUMAN, V34, P543, DOI 10.1037/0096-1523.34.3.543; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2005, J COGNITIVE NEUROSCI, V17, P73, DOI 10.1162/0898929052879987; Epstein RA, 2011, CURR BIOL, V21, pR437, DOI 10.1016/j.cub.2011.04.037; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fu SM, 2003, PSYCHOPHYSIOLOGY, V40, P770, DOI 10.1111/1469-8986.00077; Gottesman CV, 2011, J EXP PSYCHOL HUMAN, V37, P382, DOI 10.1037/a0021434; Gottesman CV, 2002, J EXP PSYCHOL HUMAN, V28, P589, DOI 10.1037//0096-1523.28.3.589; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Hubbard TL, 2010, Q J EXP PSYCHOL, V63, P1467, DOI 10.1080/17470210903511236; Intraub H, 1996, J MEM LANG, V35, P118, DOI 10.1006/jmla.1996.0007; Intraub H, 2002, VIS COGN, V9, P93, DOI 10.1080/13506280143000340; INTRAUB H, 1989, J EXP PSYCHOL LEARN, V15, P179, DOI 10.1037/0278-7393.15.2.179; Intraub H, 1998, J EXP PSYCHOL LEARN, V24, P186, DOI 10.1037/0278-7393.24.1.186; INTRAUB H, 1992, J EXP PSYCHOL LEARN, V18, P180, DOI 10.1037/0278-7393.18.1.180; Intraub H, 2008, PSYCHOL SCI, V19, P1007, DOI 10.1111/j.1467-9280.2008.02192.x; Intraub H, 2008, PERCEPT PSYCHOPHYS, V70, P1337, DOI 10.3758/PP.70.7.1337; Intraub H, 2006, PERCEPT PSYCHOPHYS, V68, P759, DOI 10.3758/BF03193699; Intraub H, 2012, WIRES COGN SCI, V3, P117, DOI 10.1002/wcs.149; Intraub H, 2010, PSYCHOL LEARN MOTIV, V52, P231, DOI 10.1016/S0079-7421(10)52006-1; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1111/1469-8986.3510023; Kimura M, 2006, PSYCHOPHYSIOLOGY, V43, P180, DOI 10.1111/j.1469-8986.2006.00388.x; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Koriat A, 2000, ANNU REV PSYCHOL, V51, P481, DOI 10.1146/annurev.psych.51.1.481; Kotchoubey B, 1997, BIOL PSYCHOL, V46, P25, DOI 10.1016/S0301-0511(96)05236-2; Luck S.J., 2005, INTRO EVENT RELATED; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; Mullally SL, 2012, CURR BIOL, V22, P261, DOI 10.1016/j.cub.2012.01.001; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Park S, 2007, NEURON, V54, P335, DOI 10.1016/j.neuron.2007.04.006; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Previc FH, 1997, NEUROPSYCHOLOGIA, V35, P1513, DOI 10.1016/S0028-3932(97)00091-2; Roediger HL, 1996, J MEM LANG, V35, P76, DOI 10.1006/jmla.1996.0005; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Wang YP, 2003, EXP BRAIN RES, V148, P451, DOI 10.1007/s00221-002-1319-y; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207	50	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74245	10.1371/journal.pone.0074245	http://dx.doi.org/10.1371/journal.pone.0074245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069286	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326240100093
J	Uddin, SMZ; Qin, YX				Uddin, Sardar M. Z.; Qin, Yi-Xian			Enhancement of Osteogenic Differentiation and Proliferation in Human Mesenchymal Stem Cells by a Modified Low Intensity Ultrasound Stimulation under Simulated Microgravity	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MECHANICAL STRAIN; PULSED ULTRASOUND; CYCLOOXYGENASE-2 EXPRESSION; OSTEOBLASTS; GENES; INTEGRIN; PATHWAY; ACTIVATION; EXPOSURE	Adult stem cells can differentiate into multiple lineages depending on their exposure to differing biochemical and biomechanical inductive factors. Lack of mechanical signals due to disuse can inhibit osteogenesis and induce adipogenesis of mesenchymal stem cells (MSCs). Long-term bed rest due to both brain/spinal cord injury and space travel can lead to disuse osteoporosis that is in part caused by a reduced number of osteoblasts. Thus, it is essential to provide proper mechanical stimulation for cellular viability and osteogenesis, particularly under disuse conditions. The objective of this study was to examine the effects of low intensity pulsed ultrasound (LIPUS) on the osteogenic differentiation of adipose-derived human stem cells (Ad-hMSC) in simulated microgravity conditions. Cells were cultured in a 1D clinostat to simulate microgravity (SMG) and treated with LIPUS at 30mW/cm2 for 20 min/day. It was hypothesized that the application of LIPUS to SMG cultures would restore osteogenesis in Ad-hMSCs. The results showed significant increases in ALP, OSX, RANKL, RUNX2, and decreases in OPG in LIPUS treated SMG cultures of Ad-MSC compared to non-treated cultures. LIPUS also restored OSX, RUNX2 and RANKL expression in osteoblast cells. SMG significantly reduced ALP positive cells by 70% (p<0.01) and ALP activity by 22% (p<0.01), while LIPUS treatment restored ALP positive cell number and activity to equivalence with normal gravity controls. Extracellular matrix collagen and mineralization was assessed by Sirius red and Alizarin red staining, respectively. SMG cultures showed little or no collagen or mineralization, but LIPUS treatment restored collagen content to 50% (p<0.001) and mineralization by 45% (p<0.001) in LIPUS treated-SMG cultures relative to SMG-only cultures. The data suggest that LIPUS treatment can restore normal osteogenic differentiation of MSCs from disuse by daily short duration stimulation.	[Uddin, Sardar M. Z.; Qin, Yi-Xian] SUNY Stony Brook, Dept Biomed Engn, Orthopaed Bioengn Res Lab, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Qin, YX (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Orthopaed Bioengn Res Lab, Stony Brook, NY 11794 USA.	Yi-Xian.Qin@stonybrook.edu	Uddin, Sardar M Z/AAO-9222-2020		National Institutes of Health [AR52379, AR61821]; National Space Biomedical Research Institute through NASA Cooperative Agreement [NCC 958]; United States Army Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061821, R01AR052379, R01AR049286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Space Biomedical Research Institute through NASA Cooperative Agreement; United States Army Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study is supported by the National Institutes of Health AR52379 and AR61821, and the National Space Biomedical Research Institute through NASA Cooperative Agreement NCC 9-58, and United States Army Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker KG, 2001, PHYS THER, V81, P1351, DOI 10.1093/ptj/81.7.1351; Bhang SH, 2010, BIOTECHNOL APPL BIOC, V55, P191, DOI 10.1042/BA20090307; BINDERMAN I, 1988, CALCIFIED TISSUE INT, V42, P261, DOI 10.1007/BF02553753; BINDERMAN I, 1984, CALCIFIED TISSUE INT, V36, pS82, DOI 10.1007/BF02406139; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; BUCKLEY MJ, 1988, BONE MINER, V4, P225; CHAPMAN IV, 1980, ULTRASOUND MED BIOL, V6, P47, DOI 10.1016/0301-5629(80)90063-0; Guignandon A, 2003, CELL COMMUN ADHES, V10, P69, DOI 10.1080/cac.10.2.69.83; Hsu HC, 2007, CELL SIGNAL, V19, P2317, DOI 10.1016/j.cellsig.2007.07.006; Huang Y, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-87; Hundt W, 2008, EUR RADIOL, V18, P993, DOI 10.1007/s00330-007-0848-y; Jansen JH, 2006, J ORTHOP RES, V24, P1480, DOI 10.1002/jor.20186; Kaneko T, 2002, PANCREATOLOGY, V2, P61, DOI 10.1159/000049450; Khayat G, 2012, DIFFERENTIATION, V83, P179, DOI 10.1016/j.diff.2011.12.004; Kobayashi Y, 2009, EUR CELLS MATER, V17, P15; Lai CH, 2010, ULTRASOUND MED BIOL, V36, P1022, DOI 10.1016/j.ultrasmedbio.2010.03.014; Li JK, 2003, BIOMATERIALS, V24, P2379, DOI 10.1016/S0142-9612(03)00033-4; Liu J, 2009, ANN BIOMED ENG, V37, P794, DOI 10.1007/s10439-009-9638-9; Lu HB, 2009, BIOCHEM BIOPH RES CO, V378, P569, DOI 10.1016/j.bbrc.2008.11.074; Luu YK, 2010, INT J OBESITY, V34, P401, DOI 10.1038/ijo.2009.240; Meyers VE, 2004, J CELL BIOCHEM, V93, P697, DOI 10.1002/jcb.20229; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; Nolte PA, 2001, J ORTHOP RES, V19, P301, DOI 10.1016/S0736-0266(00)00027-9; Olkku A, 2010, BONE, V47, P320, DOI 10.1016/j.bone.2010.04.604; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Pelaez D, 2009, STEM CELLS DEV, V18, P93, DOI 10.1089/scd.2008.0030; Plotkin LI, 2005, AM J PHYSIOL-CELL PH, V289, pC633, DOI 10.1152/ajpcell.00278.2004; Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008; Rubin J, 2000, AM J PHYSIOL-CELL PH, V278, pC1126, DOI 10.1152/ajpcell.2000.278.6.C1126; Rubin J, 1997, J CELL PHYSIOL, V170, P81, DOI 10.1002/(SICI)1097-4652(199701)170:1<81::AID-JCP9>3.0.CO;2-H; Sheyn D, 2010, TISSUE ENG PT A, V16, P3403, DOI 10.1089/ten.tea.2009.0834; SILVER IL, 1976, J THEOR BIOL, V61, P353; Tabuchi Y, 2002, BIOCHEM BIOPH RES CO, V290, P498, DOI 10.1006/bbrc.2001.6203; Takeuchi R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2451; Tang CH, 2007, J BIOL CHEM, V282, P25406, DOI 10.1074/jbc.M701001200; Tang CH, 2006, MOL PHARMACOL, V69, P2047, DOI 10.1124/mol.105.022160; Tang L, 2006, BIOCHEM BIOPH RES CO, V344, P122, DOI 10.1016/j.bbrc.2006.03.123; Uddin SMZ, 2013, ULTRASOUND MED BIOL, V39, P804, DOI 10.1016/j.ultrasmedbio.2012.11.016; Vico L, 2001, CALCIFIED TISSUE INT, V68, P1, DOI 10.1007/BF02684996; Yamazaki S, 2011, J ARTIF ORGANS, V14, P310, DOI 10.1007/s10047-011-0580-x; Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518; Yang RS, 2005, BONE, V36, P276, DOI 10.1016/j.bone.2004.10.009; Yang XM, 2010, ARCH MED SCI, V6, P152, DOI 10.5114/aoms.2010.13886	43	68	75	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73914	10.1371/journal.pone.0073914	http://dx.doi.org/10.1371/journal.pone.0073914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069248	Green Submitted, gold, Green Published			2022-12-27	WOS:000326240100071
J	Smaniotto, S; Schneider, E; Goudin, N; Bricard-Rignault, R; Machavoine, F; Dardenne, M; Dy, M; Savino, W				Smaniotto, Salete; Schneider, Elke; Goudin, Nicolas; Bricard-Rignault, Rachel; Machavoine, Francois; Dardenne, Mireille; Dy, Michel; Savino, Wilson			Mouse Basophils Reside in Extracellular Matrix-Enriched Bone Marrow Niches Which Control Their Motility	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; IN-VIVO; MIGRATION; SURVIVAL; IL-4	Basophils co-express Fc epsilon RI alpha and CD49b, the alpha-2 chain of integrin-type receptor VLA-2 (alpha 2 beta 1), which recognizes type-1 collagen as a major natural ligand. The physiological relevance of this integrin for interactions with extracellular bone marrow matrix remains unknown. Herein, we examined the expression of several receptors of this family by bone marrow-derived basophils sorted either ex-vivo or after culture with IL-3. Having established that both populations display CD49d, CD49e and CD49f (alpha-4, alpha-5 and alpha-6 integrins subunits, respectively), we addressed receptor functions by measuring migration, adhesion, proliferation and survival after interacting with matched natural ligands. Type I collagen, laminin and fibronectin promoted basophil migration/adhesion, the former being the most effective. None of these ligands affected basophil viability and expansion. Interactions between basophils and extracellular matrix are likely to play a role in situ, as supported by confocal 3D cell imaging of femoral bone marrow sections, which revealed basophils exclusively in type-1 collagen-enriched niches that contained likewise laminin and fibronectin. This is the first evidence for a structure/function relationship between basophils and extracellular matrix proteins inside the mouse bone marrow.	[Smaniotto, Salete] Univ Fed Alagoas, Inst Biol & Hlth Sci, Cell Biol Lab, Maceio, Brazil; [Schneider, Elke; Bricard-Rignault, Rachel; Machavoine, Francois; Dardenne, Mireille; Dy, Michel] Univ Paris 05, Hop Necker, CNRS, UMR 8147, Paris, France; [Goudin, Nicolas] Univ Paris 05, Hop Necker, Paris, France; [Savino, Wilson] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil	Universidade Federal de Alagoas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Fundacao Oswaldo Cruz	Savino, W (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Thymus Res, Rio De Janeiro, Brazil.	savino@fiocruz.br	Smaniotto, Salete/AAT-4056-2020; Smaniotto, Salete/T-3796-2017	Smaniotto, Salete/0000-0003-1527-5894	Capes/Cofecub French/Brazilian conjoint program; CNRS (France); Fiocruz (Brazil); CNPq (Brazil); Faperj (Brazil); Fapeal (Brazil)	Capes/Cofecub French/Brazilian conjoint program; CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Fiocruz (Brazil); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fapeal (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL))	This work was developed in the context of the CNRS-Fiocruz Associated Laboratory of Immunology and Immunopathology, being funded by the Capes/Cofecub French/Brazilian conjoint program, as well as CNRS (France), Fiocruz, CNPq, Faperj and Fapeal (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Bochner BS, 2001, IMMUNOL REV, V179, P5, DOI 10.1034/j.1600-065X.2001.790101.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; ERLE DJ, 1992, AM J RESP CELL MOL, V6, P459, DOI 10.1165/ajrcmb/6.5.459; Heinemann A, 2005, J ALLERGY CLIN IMMUN, V116, P820, DOI 10.1016/j.jaci.2005.06.008; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Pinto-Mariz F, 2010, J NEUROIMMUNOL, V223, P128, DOI 10.1016/j.jneuroim.2010.03.006; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAGHOW R, 1994, FASEB J, V8, P823, DOI 10.1096/fasebj.8.11.8070631; Savino W, 2004, J LEUKOCYTE BIOL, V75, P951, DOI 10.1189/jlb.1003455; Schneider E, 1999, EXP HEMATOL, V27, P1010, DOI 10.1016/S0301-472X(99)00039-9; Schneider E, 2011, J ALLERGY CLIN IMMUN, V128, P864, DOI 10.1016/j.jaci.2011.04.043; Schneider E, 2010, EUR CYTOKINE NETW, V21, P142, DOI 10.1684/ecn.2010.0197; Schneider E, 2009, J IMMUNOL, V183, P3591, DOI 10.4049/jimmunol.0900328; Smaniotto S, 2005, ENDOCRINOLOGY, V146, P3005, DOI 10.1210/en.2004-0709; Smaniotto S, 2010, BRAIN BEHAV IMMUN, V24, P451, DOI 10.1016/j.bbi.2009.11.014; SONE KD, 2010, J ALLERGY CLIN IM S2, V125, pS73; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639	25	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e70292	10.1371/journal.pone.0070292	http://dx.doi.org/10.1371/journal.pone.0070292			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086246	Green Submitted, Green Published, gold			2022-12-27	WOS:000325223900002
J	Askovich, PS; Sanders, CJ; Rosenberger, CM; Diercks, AH; Dash, P; Navarro, G; Vogel, P; Doherty, PC; Thomas, PG; Aderem, A				Askovich, Peter S.; Sanders, Catherine J.; Rosenberger, Carrie M.; Diercks, Alan H.; Dash, Pradyot; Navarro, Garnet; Vogel, Peter; Doherty, Peter C.; Thomas, Paul G.; Aderem, Alan			Differential Host Response, Rather Than Early Viral Replication Efficiency, Correlates with Pathogenicity Caused by Influenza Viruses	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; A H1N1 VIRUS; PANDEMIC INFLUENZA; IMMUNE-RESPONSE; BINDING-SITES; HUMAN AIRWAY; TNF-ALPHA; INFECTION; RECEPTOR; MICE	Influenza viruses exhibit large, strain-dependent differences in pathogenicity in mammalian hosts. Although the characteristics of severe disease, including uncontrolled viral replication, infection of the lower airway, and highly inflammatory cytokine responses have been extensively documented, the specific virulence mechanisms that distinguish highly pathogenic strains remain elusive. In this study, we focused on the early events in influenza infection, measuring the growth rate of three strains of varying pathogenicity in the mouse airway epithelium and simultaneously examining the global host transcriptional response over the first 24 hours. Although all strains replicated equally rapidly over the first viral life-cycle, their growth rates in both lung and tracheal tissue strongly diverged at later times, resulting in nearly 10-fold differences in viral load by 24 hours following infection. We identified separate networks of genes in both the lung and tracheal tissues whose rapid up-regulation at early time points by specific strains correlated with a reduced viral replication rate of those strains. The set of early-induced genes in the lung that led to viral growth restriction is enriched for both NF-kappa B binding site motifs and members of the TREM1 and IL-17 signaling pathways, suggesting that rapid, NF-kappa B -mediated activation of these pathways may contribute to control of viral replication. Because influenza infection extending into the lung generally results in severe disease, early activation of these pathways may be one factor distinguishing high- and low-pathogenicity strains.	[Askovich, Peter S.; Rosenberger, Carrie M.; Diercks, Alan H.; Navarro, Garnet; Doherty, Peter C.; Aderem, Alan] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Sanders, Catherine J.; Dash, Pradyot; Vogel, Peter; Doherty, Peter C.; Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Center for Infectious Disease Research; St Jude Children's Research Hospital	Aderem, A (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	alan.aderem@seattlebiomed.org	Thomas, Paul G./H-1063-2018; Vogel, Peter/N-2490-2018; Doherty, Peter Charles/C-4185-2013	Thomas, Paul G./0000-0001-7955-0256; Vogel, Peter/0000-0002-7535-0545; Dash, Pradyot/0000-0001-5467-0657; Doherty, Peter Charles/0000-0002-5028-3489	NIAID [HHSN272200800058C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL099168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007610, U19AI100627] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID's Systems Influenza contract (HHSN272200800058C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulou A, 2012, INT J INFECT DIS, V16, pE204, DOI 10.1016/j.ijid.2011.11.012; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Behrens G, 2006, INFLUENZA REPORT; Belisle SE, 2010, J VIROL, V84, P12576, DOI 10.1128/JVI.01310-10; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Crapo J D, 1982, Am Rev Respir Dis, V125, P740; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; Dash P, 2010, J VIROL, V84, P9149, DOI 10.1128/JVI.00642-10; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Faruqui F, 2010, CURR OPIN PEDIATR, V22, P530, DOI 10.1097/MOP.0b013e32833bb81a; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Fornek JL, 2009, J VIROL, V83, P11102, DOI 10.1128/JVI.00994-09; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Garigliany MM, 2010, EMERG INFECT DIS, V16, P595, DOI 10.3201/eid1604.091061; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Gibot S, 2007, EUR J IMMUNOL, V37, P456, DOI 10.1002/eji.200636387; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Ivan FX, 2012, FUNCT INTEGR GENOMIC, V12, P105, DOI 10.1007/s10142-011-0247-y; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; LaRussa P, 2011, SEMIN RESP CRIT CARE, V32, P393, DOI 10.1055/s-0031-1283279; Li CG, 2012, CELL RES, V22, P528, DOI 10.1038/cr.2011.165; Loeffelholz MJ, 2010, CLIN LAB MED, V30, P1, DOI 10.1016/j.cll.2009.10.005; Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Neumann G, 2004, CURR TOP MICROBIOL, V283, P43; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Nordhoff C, 2012, CELL MICROBIOL, V14, P1135, DOI 10.1111/j.1462-5822.2012.01787.x; Nordmann A, 2012, FASEB J, V26, P1290, DOI 10.1096/fj.11-189886; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Pommerenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041169; Rahman MS, 2005, CLIN IMMUNOL, V115, P268, DOI 10.1016/j.clim.2005.01.014; Reading PC, 2010, IMMUNOL CELL BIOL, V88, P641, DOI 10.1038/icb.2010.11; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8183; Rothberg MB, 2010, CRIT CARE MED, V38, pE91, DOI 10.1097/CCM.0b013e3181c92eeb; Rutigliano JA, 2010, J VIROL, V84, P1047, DOI 10.1128/JVI.01535-09; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Seo SU, 2010, J VIROL, V84, P12713, DOI 10.1128/JVI.01675-10; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith JH, 2011, VIRAL IMMUNOL, V24, P131, DOI 10.1089/vim.2010.0085; Stertz S, 2011, MICROBES INFECT, V13, P516, DOI 10.1016/j.micinf.2011.01.012; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Van Stry M, 2012, J VIROL, V86, P4151, DOI 10.1128/JVI.05303-11; Vasilescu DM, 2012, P NATL ACAD SCI USA, V109, P17105, DOI 10.1073/pnas.1215112109; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; World Health Organization (WHO), 2009, INFLUENZA; Wu HY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-172	64	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74863	10.1371/journal.pone.0074863	http://dx.doi.org/10.1371/journal.pone.0074863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073225	Green Published, gold			2022-12-27	WOS:000324768000034
J	Chen, LY; Zhong, NS; Lai, KF				Chen, Liyan; Zhong, Nanshan; Lai, Kefang			Re-Challenge with Ovalbumin Failed to Induce Bronchial Asthma in Mice with Eosinophilic Bronchitis	PLOS ONE			English	Article							TOLERANCE	Objective: To investigate whether eosinophilic bronchitis without airway hyperresponsiveness will develop bronchial asthma in allergic mice. Methods: Mice were sensitized with OVA on days 0, 7, and 14, challenged on days 21 to 23 (1st OVA challenge), and re-challenged on days 46 to 48 (2nd OVA challenge), intranasally with 10 (the EB group) and 200 (the AS group) mu g OVA. Lung resistance (R-L) was assessed 24 h after each challenge and on day 45 followed by analysis of leukocyte distribution in the bronchoalveolar lavage (BAL) fluid and histological examination. Results: Twenty-four hours after the 1st OVA challenge, aerosolized methacholine caused a dose-dependent increase in R-L in all groups. At doses >= 1.56 mg/mL, R-L in the AS group was significantly higher than that of the NS-1 group (P<0.01 or 0.05) and at doses >= 12.5 mg/mL, R-L was markedly higher in the AS group than that of the EB group (P<0.01). The percentage of eosinophils in both the EB group and the AS group was markedly higher than that of the control group. Twenty-four hours after the 2nd OVA challenge, at doses >= 12.5 mg/mL, there was no significant difference in R-L among all groups (P>0.05). At doses >= 12.5 mg/mL, R-L in the AS group was significantly higher than that of the control group and EB group (P<0.01 or 0.05). The percentage of eosinophils in the AS group was noticeably higher than that of the EB group(P<0.05). Furthermore, there was apparent infiltration by inflammatory cells, predominantly eosinophils, into the sub-epithelial region of the bronchus and the bronchioles and around the vessels in the EB and AS group. Conclusion: Re-challenge with low doses of ovalbumin did not increase airway reactivity and failed to induce bronchial asthma in mice with ovalbumin-induced EB.	[Chen, Liyan; Zhong, Nanshan; Lai, Kefang] Guangzhou Med Univ, Affiliated Hosp 1, Dept Resp Med, Guangzhou, Guangdong, Peoples R China; [Chen, Liyan; Zhong, Nanshan; Lai, Kefang] Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China; [Chen, Liyan; Zhong, Nanshan; Lai, Kefang] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Lai, KF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	klai@163.com			National Natural Science Foundation of China [81100009, 30670934]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants of the National Natural Science Foundation of China (No. 81100009 and No. 30670934). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry MA, 2005, CLIN EXP ALLERGY, V35, P598, DOI 10.1111/j.1365-2222.2005.02222.x; Chen LY, 2011, CLIN EXP MED, V11, P19, DOI 10.1007/s10238-010-0106-5; Chung Y, 2002, IMMUNOBIOLOGY, V206, P408, DOI 10.1078/0171-2985-00190; GIBSON PG, 1989, LANCET, V1, P1346; Glaab T, 2001, AM J PHYSIOL-LUNG C, V280, pL565, DOI 10.1152/ajplung.2001.280.3.L565; Natarajan S, 2012, INT ARCH ALLERGY IMM, V158, P120, DOI 10.1159/000330896; Park SW, 2004, CHEST, V125, P1998, DOI 10.1378/chest.125.6.1998; Tournoy KG, 2006, CURR ALLERGY ASTHM R, V6, P437, DOI 10.1007/s11882-996-0018-3; Van Hove CL, 2007, AM J RESP CELL MOL, V36, P573, DOI 10.1165/rcmb.2006-0385OC; Vanoirbeek JAJ, 2009, TOXICOLOGY, V257, P144, DOI 10.1016/j.tox.2008.12.020	10	5	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75195	10.1371/journal.pone.0075195	http://dx.doi.org/10.1371/journal.pone.0075195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073252	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000061
J	Garcia-Martinez, V; Villanueva, J; Torregrosa-Hetland, CJ; Bittman, R; Higdon, A; Darley-Usmar, VM; Davletov, B; Gutierrez, LM				Garcia-Martinez, Virginia; Villanueva, Jose; Torregrosa-Hetland, Cristina J.; Bittman, Robert; Higdon, Ashlee; Darley-Usmar, Victor M.; Davletov, Bazbek; Gutierrez, Luis M.			Lipid Metabolites Enhance Secretion Acting on SNARE Microdomains and Altering the Extent and Kinetics of Single Release Events in Bovine Adrenal Chromaffin Cells	PLOS ONE			English	Article							SYNAPTOSOME-ASSOCIATED PROTEIN; ARACHIDONIC-ACID; C-TERMINUS; VESICLE DOCKING; T-SNARE; SNAP-25; FUSION; MEMBRANE; EXOCYTOSIS; SYNAPTOBREVIN	Lipid molecules such as arachidonic acid (AA) and sphingolipid metabolites have been implicated in modulation of neuronal and endocrine secretion. Here we compare the effects of these lipids on secretion from cultured bovine chromaffin cells. First, we demonstrate that exogenous sphingosine and AA interact with the secretory apparatus as confirmed by FRET experiments. Examination of plasma membrane SNARE microdomains and chromaffin granule dynamics using total internal reflection fluorescent microscopy (TIRFM) suggests that sphingosine production promotes granule tethering while arachidonic acid promotes full docking. Our analysis of single granule release kinetics by amperometry demonstrated that both sphingomyelinase and AA treatments enhanced drastically the amount of catecholamines released per individual event by either altering the onset phase of or by prolonging the off phase of single granule catecholamine release kinetics. Together these results demonstrate that the kinetics and extent of the exocytotic fusion pore formation can be modulated by specific signalling lipids through related functional mechanisms.	[Garcia-Martinez, Virginia; Villanueva, Jose; Torregrosa-Hetland, Cristina J.; Gutierrez, Luis M.] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain; [Bittman, Robert] CUNY, Queens Coll, Dept Chem & Biochem, Flushing, NY USA; [Higdon, Ashlee; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Davletov, Bazbek] MRC Lab Mol Biol, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); City University of New York (CUNY) System; Queens College NY (CUNY); University of Alabama System; University of Alabama Birmingham; MRC Laboratory Molecular Biology	Gutierrez, LM (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain.	luisguti@umh.es	Villanueva, José/K-4448-2014; Gutierrez, Luis/K-8633-2014; Davletov, Bazbek/ABA-8569-2021	Villanueva, José/0000-0002-4057-2113; Gutierrez, Luis/0000-0002-0512-7858; Darley-Usmar, Victor/0000-0001-8921-7086; Torregrosa, Jose-Vicente/0000-0001-5160-3248; Davletov, Bazbek/0000-0003-4658-3275	Spanish Ministry of Science and Innovation (MICINN) [BFU2011-25095]; FPU program of Ministry of Education and Culture of Spain; MRC [MC_U105178791] Funding Source: UKRI; Medical Research Council [MC_U105178791] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPU program of Ministry of Education and Culture of Spain; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant from the Spanish Ministry of Science and Innovation (MICINN, BFU2011-25095) to LMG. C T-H is recipient of a fellowship from the FPU program of Ministry of Education and Culture of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandhuvula P, 2009, BIOCHEM BIOPH RES CO, V380, P366, DOI 10.1016/j.bbrc.2009.01.106; BARK IC, 1994, GENE, V139, P291, DOI 10.1016/0378-1119(94)90773-0; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; Bode C, 2010, J CELL BIOCHEM, V109, P1232, DOI 10.1002/jcb.22507; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Criado M, 1999, P NATL ACAD SCI USA, V96, P7256, DOI 10.1073/pnas.96.13.7256; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024; Davletov B, 2007, CELL MOL LIFE SCI, V64, P1597, DOI 10.1007/s00018-007-6557-5; Fang QH, 2008, P NATL ACAD SCI USA, V105, P15388, DOI 10.1073/pnas.0805377105; Gil A, 1998, EUR J NEUROSCI, V10, P3369, DOI 10.1046/j.1460-9568.1998.00341.x; Gil A, 2002, J BIOL CHEM, V277, P9904, DOI 10.1074/jbc.M110182200; Gutierrez LM, 1997, J BIOL CHEM, V272, P2634, DOI 10.1074/jbc.272.5.2634; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Henkel AW, 2006, J CELL BIOCHEM, V97, P1393, DOI 10.1002/jcb.20751; Higdon AN, 2009, FREE RADICAL BIO MED, V47, P201, DOI 10.1016/j.freeradbiomed.2009.05.009; Hu K, 2002, NATURE, V415, P646, DOI 10.1038/415646a; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Lang T, 2008, PROG LIPID RES, V47, P461, DOI 10.1016/j.plipres.2008.08.002; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Lopez I, 2009, TRAFFIC, V10, P172, DOI 10.1111/j.1600-0854.2008.00861.x; Lopez-Font I, 2010, J NEUROCHEM, V114, P1550, DOI 10.1111/j.1471-4159.2010.06872.x; Mosharov EV, 2005, NAT METHODS, V2, P651, DOI 10.1038/nmeth782; Neco P, 2004, J BIOL CHEM, V279, P27450, DOI 10.1074/jbc.M311462200; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; RINDLISBACHER B, 1990, J NEUROCHEM, V54, P1247, DOI 10.1111/j.1471-4159.1990.tb01955.x; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Torregrosa-Hetland CJ, 2013, INT J BIOCHEM CELL B, V45, P583, DOI 10.1016/j.biocel.2012.11.021; Uchiyama Y, 2007, BRAIN RES, V1151, P46, DOI 10.1016/j.brainres.2007.03.012; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Xu T, 1999, EMBO J, V18, P3293, DOI 10.1093/emboj/18.12.3293; ZIMMERBERG J, 1991, ANN NY ACAD SCI, V635, P307, DOI 10.1111/j.1749-6632.1991.tb36501.x	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75845	10.1371/journal.pone.0075845	http://dx.doi.org/10.1371/journal.pone.0075845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073281	gold, Green Published, Green Accepted			2022-12-27	WOS:000324768000091
J	Liu, W; Zhang, B; Zhang, ZW; Zhou, XH				Liu, Wei; Zhang, Bo; Zhang, Zhiwei; Zhou, Xiao-Hua			Joint Modeling of Transitional Patterns of Alzheimer's Disease	PLOS ONE			English	Article							LONGITUDINAL BINARY DATA; DATA SET UDS; DEMENTIA; EDUCATION; OUTCOMES; ONSET	While the experimental Alzheimer's drugs recently developed by pharmaceutical companies failed to stop the progression of Alzheimer's disease, clinicians strive to seek clues on how the patients would be when they visit back next year, based upon the patients' current clinical and neuropathologic diagnosis results. This is related to how to precisely identify the transitional patterns of Alzheimer's disease. Due to the complexities of the diagnosis of Alzheimer's disease, the condition of the disease is usually characterized by multiple clinical and neuropathologic measurements, including Clinical Dementia Rating (CDRGLOB), Mini-Mental State Examination (MMSE), a score derived from the clinician judgement on neuropsychological tests (COGSTAT), and Functional Activities Questionnaire (FAQ). In this research article, we investigate a class of novel joint random-effects transition models that are used to simultaneously analyze the transitional patterns of multiple primary measurements of Alzheimer's disease and, at the same time, account for the association between the measurements. The proposed methodology can avoid the bias introduced by ignoring the correlation between primary measurements and can predict subject-specific transitional patterns.	[Liu, Wei] Harbin Inst Technol, Dept Math, Harbin 150006, Peoples R China; [Zhang, Bo] Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Biostat Core, Corvallis, OR 97331 USA; [Zhang, Zhiwei] US FDA, Div Biostat, Off Surveillance & Biometr, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Zhou, Xiao-Hua] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, HSR&D Ctr Excellence,US Dept Vet Affairs Puget So, Seattle, WA 98195 USA	Harbin Institute of Technology; Oregon State University; US Food & Drug Administration (FDA); University of Washington; University of Washington Seattle	Zhang, B (corresponding author), Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Biostat Core, Corvallis, OR 97331 USA.	Bo.Zhang@oregonstate.edu		Zhou, Xiaohua/0000-0001-7935-1222	Fundamental Research Funds for the Central Universities [HIT.NSRIF.2012063]; National Institute on Aging [U01 AG016976]; NATIONAL INSTITUTE ON AGING [U01AG016976] Funding Source: NIH RePORTER	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Wei Liu's research was partially supported by "the Fundamental Research Funds for the Central Universities" through Grant HIT.NSRIF.2012063. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Alzheimer's Coordinating Center database is funded by National Institute on Aging Grant U01 AG016976.	Albert PS, 2000, BIOMETRICS, V56, P602, DOI 10.1111/j.0006-341X.2000.00602.x; Albert PS, 2003, STAT NEERL, V57, P100, DOI 10.1111/1467-9574.00223; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Berchtold NC, 1998, NEUROBIOL AGING, V19, P173, DOI 10.1016/S0197-4580(98)00052-9; Bermejo-Pareja F, 2008, J NEUROL SCI, V264, P63, DOI 10.1016/j.jns.2007.07.021; Dawson JD, 2009, NEUROLOGY, V72, P521, DOI 10.1212/01.wnl.0000341931.35870.49; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Faes C, 2008, STAT MED, V27, P4408, DOI 10.1002/sim.3314; Fieuws S, 2006, BIOMETRICS, V62, P424, DOI 10.1111/j.1541-0420.2006.00507.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gao X, 2010, J AM STAT ASSOC, V105, P1531, DOI 10.1198/jasa.2010.tm09414; Geys H, 1999, J AM STAT ASSOC, V94, P734, DOI 10.2307/2669986; Hebert LE, 2013, NEUROLOGY IN PRESS; Ilk O, 2007, CAN J STAT, V35, P105, DOI 10.1002/cjs.5550350110; Johnson V.E., 1999, ORDINAL DATA MODELIN; Koepsell TD, 2008, NEUROLOGY, V70, P1732, DOI 10.1212/01.wnl.0000284603.85621.aa; Lee K, 2007, BIOMETRICS, V63, P1060, DOI 10.1111/j.1541-0420.2007.00800.x; Lee K, 2009, STAT MED, V28, P1284, DOI 10.1002/sim.3534; Lindsay B., 1988, CONTEMP MATH, V80, P220; Molenberghs G., 2005, MODELS DISCRETE LONG; Morris JC, 1997, ALZ DIS ASSOC DIS, V11, P1, DOI 10.1097/00002093-199706001-00001; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Pinheiro J, 2001, MIXED EFFECTS MODELS; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P108, DOI 10.1001/archneurol.2007.11; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Varin C, 2005, BIOMETRIKA, V92, P519, DOI 10.1093/biomet/92.3.519; Varin C, 2011, STAT SINICA, V21, P5; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; WONG WH, 1986, ANN STAT, V14, P88, DOI 10.1214/aos/1176349844; ZEGER SL, 1988, BIOMETRICS, V44, P1019, DOI 10.2307/2531732; Zeng LL, 2007, J AM STAT ASSOC, V102, P211, DOI 10.1198/016214506000000889	35	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75487	10.1371/journal.pone.0075487	http://dx.doi.org/10.1371/journal.pone.0075487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073268	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000078
J	Wang, YR; Qin, S; Han, R; Wu, JC; Liang, ZQ; Qin, ZH; Wang, Y				Wang, Yan-Ru; Qin, Shu; Han, Rong; Wu, Jun-Chao; Liang, Zhong-Qin; Qin, Zheng-Hong; Wang, Yan			Cathepsin L Plays a Role in Quinolinic Acid- Induced NF-Kb Activation and Excitotoxicity in Rat Striatal Neurons	PLOS ONE			English	Article							KAPPA-B ACTIVATION; RADICAL SCAVENGER OPC-14117; CELL-DEATH; KAINIC ACID; INDUCED APOPTOSIS; MEMBRANE PERMEABILIZATION; MITOCHONDRIA DYSFUNCTION; AUTOPHAGOSOME FORMATION; SELECTIVE AUTOPHAGY; STRUCTURAL BASIS	The present study seeks to investigate the role of cathepsin L in glutamate receptor-induced transcription factor nuclear factor-kappa B (NF-kappa B) activation and excitotoxicity in rats striatal neurons. Stereotaxic administration of the N-methyl-d-aspartate (NMDA) receptor agonist Quinolinic acid (QA) into the unilateral striatum was used to produce the in vivo excitotoxic model. Co-administration of QA and the cathepsin L inhibitor Z-FF-FMK or 1-Naphthalenesulfonyl-IW-CHO (NaphthaCHO) was used to assess the contribution of cathepsin L to QA-induced striatal neuron death. Western blot analysis and cathepsin L activity assay were used to assess the changes in the levels of cathepsin L after QA treatment. Western blot analysis was used to assess the changes in the protein levels of inhibitor of NF-kappa B alpha isoform (I kappa B-alpha) and phospho-I kappa B alpha (p-I kappa B alpha) after QA treatment. Immunohistochemical analysis was used to detect the effects of Z-FF-FMK or NaphthaCHO on QA-induced NF-kappa B. Western blot analysis was used to detect the effects of Z-FF-FMK or NaphthaCHO on QA-induced I kappa B-alpha phosphorylation and degradation, changes in the levels of IKK alpha, p-IKK alpha, TP53, caspase-3, beclin1, p62, and LC3II/LC3I. The results show that QA-induced loss of striatal neurons were strongly inhibited by Z-FF-FMK or NaphthaCHO. QA-induced degradation of I kappa B-alpha, NF-kappa B nuclear translocation, up-regulation of NF-kappa B responsive gene TP53, and activation of caspase-3 was strongly inhibited by Z-FF-FMK or NaphthaCHO. QA-induced increases in beclin 1, LC3II/LC3I, and down-regulation of p62 were reduced by Z-FF-FMK or NaphthaCHO. These results suggest that cathepsin L is involved in glutamate receptor-induced NF-kB activation. Cathepsin L inhibitors have neuroprotective effects by inhibiting glutamate receptor-induced I kappa B-alpha degradation and NF-kappa B activation.	[Wang, Yan] Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Suzhou, Peoples R China; Soochow Univ, Sch Pharmaceut Sci, Lab Aging & Nervous Dis SZS0703, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Wang, Y (corresponding author), Soochow Univ, Sch Pharmaceut Sci, Dept Pharmacol, Wen Jing Rd, Suzhou, Peoples R China.	yanwang@suda.edu.cn			National Natural Science Foundation of China [81000547, 30930035, 81072656]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Natural Science Foundation of China (No 81000547; 30930035; 81072656) and by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleyasin H, 2004, J NEUROSCI, V24, P2963, DOI 10.1523/JNEUROSCI.0155-04.2004; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2004, NEUROBIOL AGING, V25, P83, DOI 10.1016/S0197-4580(03)00034-4; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Collette J, 2004, INT REV CYTOL, V241, P1, DOI 10.1016/S0074-7696(04)41001-8; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dai C, 2011, P NATL ACAD SCI USA, V108, P18937, DOI 10.1073/pnas.1110988108; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Dong XX, 2012, NEUROSCIENCE, V207, P52, DOI 10.1016/j.neuroscience.2012.01.018; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Fei XF, 2009, BRAIN RES, V1264, P85, DOI 10.1016/j.brainres.2009.01.057; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Funkelstein L, 2010, NEUROPEPTIDES, V44, P457, DOI 10.1016/j.npep.2010.08.003; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gonzalez-Suarez I, 2011, EMBO J, V30, P3383, DOI 10.1038/emboj.2011.225; GOTO T, 1994, HISTOCHEMISTRY, V101, P33, DOI 10.1007/BF00315829; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Haik KL, 2000, EXP NEUROL, V163, P430, DOI 10.1006/exnr.2000.7384; Henkels KM, 1999, CANCER RES, V59, P3077; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishidoh K, 2002, BIOL CHEM, V383, P1827, DOI 10.1515/BC.2002.206; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x; Lankelma JM, 2010, LIFE SCI, V86, P225, DOI 10.1016/j.lfs.2009.11.016; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu CL, 2010, J NEUROCHEM, V115, P68, DOI 10.1111/j.1471-4159.2010.06905.x; Miyoshi N, 2005, BIOCHEM BIOPH RES CO, V334, P466, DOI 10.1016/j.bbrc.2005.06.113; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakai M, 2000, BRAIN RES, V859, P207, DOI 10.1016/S0006-8993(00)01959-4; Nakai M, 1999, MOL BRAIN RES, V64, P59, DOI 10.1016/S0169-328X(98)00310-6; Nakai M, 2000, J NEUROCHEM, V74, P647, DOI 10.1046/j.1471-4159.2000.740647.x; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pan JA, 2013, J BIOL CHEM, V288, P2952, DOI 10.1074/jbc.M112.441063; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qin ZH, 1996, BRAIN RES, V725, P166, DOI 10.1016/S0006-8993(96)00200-4; Qin ZH, 1999, J NEUROSCI, V19, P4023; Qin ZH, 1998, MOL PHARMACOL, V53, P33, DOI 10.1124/mol.53.1.33; Ryvnyak VV, 2004, B EXP BIOL MED+, V137, P90, DOI 10.1023/B:BEBM.0000024396.17895.77; Sevenich L, 2006, BIOL CHEM, V387, P885, DOI 10.1515/BC.2006.112; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shen H, 2010, BRIT J PHARMACOL, V161, P127, DOI 10.1111/j.1476-5381.2010.00894.x; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; WAGURI S, 1995, EUR J CELL BIOL, V67, P308; Wang N, 2011, BRIT J PHARMACOL, V164, P731, DOI 10.1111/j.1476-5381.2011.01349.x; Wang Y, 2006, BRAIN RES, V1071, P245, DOI 10.1016/j.brainres.2005.10.074; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wang Y, 2013, ACTA PHARMACOL SIN, V34, P585, DOI 10.1038/aps.2012.194; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Waxman EA, 2005, NEUROSCIENTIST, V11, P37, DOI 10.1177/1073858404269012; Xiang B, 2011, BRAIN RES, V1387, P29, DOI 10.1016/j.brainres.2011.02.092; Yamakura T, 1999, PROG NEUROBIOL, V59, P279, DOI 10.1016/S0301-0082(99)00007-6; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; YOKOTA S, 1988, HISTOCHEMISTRY, V90, P277, DOI 10.1007/BF00495971; Yue ZY, 2009, BBA-MOL CELL RES, V1793, P1496, DOI 10.1016/j.bbamcr.2009.01.016; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174	66	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75702	10.1371/journal.pone.0075702	http://dx.doi.org/10.1371/journal.pone.0075702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073275	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000085
J	Wu, WL; Wu, BY; Ye, T; Huang, HG; Dai, CJ; Yuan, JJ; Wang, W				Wu, Wenlin; Wu, Bingyan; Ye, Ting; Huang, Huagen; Dai, Congjie; Yuan, Jianjun; Wang, Wei			TCTP Is a Critical Factor in Shrimp Immune Response to Virus Infection	PLOS ONE			English	Article							CONTROLLED TUMOR PROTEIN; INDUCED CELL-DEATH; ANTIAPOPTOTIC ACTIVITY; GTPASE; SURVIVAL; STRESS; GROWTH; GENES; PHAGOCYTOSIS; EXPRESSION	The translationally controlled tumor protein (TCTP) is an abundant, ubiquitous, and conserved protein which plays important roles in a number of biological processes. In the present study, the TCTP in shrimp Litopenaeus vannamei was analyzed. The TCTP of L. vannamei, a 168-amino-acid polypeptide, shares a high degree of similarity with TCTPs from other species, having two TCTP protein signatures at the 45-55 aa and 123-145 aa motif. The mRNA and protein levels from different tissues were detected with the highest in muscle and the lowest in heart among all examined tissues. In addition, temporal TCTP expression was significantly up-regulated at 16 h and 48 h following infection with white spot syndrome virus (WSSV). Lastly, silencing of TCTP with dsRNA led to a significant increase of WSSV loads. These results provide new insights into the importance of TCTP as an evolutionarily conserved molecule for shrimp innate immunity against virus infection.	[Wu, Wenlin; Wu, Bingyan; Huang, Huagen; Dai, Congjie; Yuan, Jianjun] Quanzhou Normal Univ, Dept Biol, Quanzhou, Peoples R China; [Ye, Ting] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Wei] State Ocean Adm, Inst Oceanog 3, Xiamen, Peoples R China	Quanzhou Normal University; Zhejiang Sci-Tech University; State Oceanic Administration	Wu, WL (corresponding author), Quanzhou Normal Univ, Dept Biol, Quanzhou, Peoples R China.	wenlinw@hotmail.Com; wangw.sz@gmail.com	ye, ting/HGC-5924-2022		National Natural Science Foundation of China [31072236]; Education Office of Fujian Province [JK2009043]; Haixi Project of Fujian [A101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Office of Fujian Province; Haixi Project of Fujian	This research was supported by the National Natural Science Foundation of China (31072236), the Education Office of Fujian Province (JK2009043) and Haixi Project of Fujian (A101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Bonnet C, 2000, YEAST, V16, P23, DOI 10.1002/(SICI)1097-0061(20000115)16:1<23::AID-YEA503>3.0.CO;2-A; Burgents JE, 2005, DEV COMP IMMUNOL, V29, P681, DOI 10.1016/j.dci.2005.01.004; Cans C, 2003, P NATL ACAD SCI USA, V100, P13892, DOI 10.1073/pnas.2335950100; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chitpatima ST, 1998, NUCLEIC ACIDS RES, V16, P23; Gachet Y, 1999, J CELL SCI, V112, P1257; Gnanasekar M, 2002, MOL BIOCHEM PARASIT, V121, P107, DOI 10.1016/S0166-6851(02)00027-0; Gnanasekar M, 2009, BIOCHEM BIOPH RES CO, V386, P333, DOI 10.1016/j.bbrc.2009.06.028; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Huang TZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050581; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049711; Li CH, 2010, FISH SHELLFISH IMMUN, V29, P530, DOI 10.1016/j.fsi.2010.04.018; Lightner DV, 2011, J INVERTEBR PATHOL, V106, P110, DOI 10.1016/j.jip.2010.09.012; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Lucibello M, 2011, EXP CELL RES, V317, P2479, DOI 10.1016/j.yexcr.2011.07.012; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; Martin GG, 2000, J CRUSTACEAN BIOL, V20, P209, DOI 10.1651/0278-0372(2000)020[0209:EOSMFT]2.0.CO;2; Mulenga A, 2005, EXP APPL ACAROL, V37, P215, DOI 10.1007/s10493-005-3261-8; Nagano-Ito M, 2009, FEBS LETT, V583, P1363, DOI 10.1016/j.febslet.2009.03.045; PAY A, 1992, PLANT MOL BIOL, V19, P501, DOI 10.1007/BF00023399; RASMUSSEN SW, 1994, YEAST, V10, pS63, DOI 10.1002/yea.320100008; Sirois I, 2011, CELL DEATH DIFFER, V18, P549, DOI 10.1038/cdd.2010.126; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Thiele H, 1998, EUR J BIOCHEM, V257, P62, DOI 10.1046/j.1432-1327.1998.2570062.x; THOMAS G, 1981, P NATL ACAD SCI-BIOL, V78, P5712, DOI 10.1073/pnas.78.9.5712; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Wang Q, 2011, BIOL BULL-US, V221, P290, DOI 10.1086/BBLv221n3p290; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Wu WL, 2007, FISH SHELLFISH IMMUN, V23, P438, DOI 10.1016/j.fsi.2007.01.001; Xu AM, 1999, BIOCHEM J, V342, P683, DOI 10.1042/0264-6021:3420683; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; YENOFSKY R, 1983, MOL CELL BIOL, V3, P1197, DOI 10.1128/MCB.3.7.1197; Zhang D, 2002, J BIOL CHEM, V277, P37430, DOI 10.1074/jbc.M207413200	36	14	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74460	10.1371/journal.pone.0074460	http://dx.doi.org/10.1371/journal.pone.0074460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073212	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000021
J	Minnery, M; Contreras, C; Perez, R; Solorzano, N; Tintaya, K; Jimenez, J; Soto, S; Lecca, L				Minnery, Mark; Contreras, Carmen; Perez, Rosa; Solorzano, Ninfa; Tintaya, Karen; Jimenez, Judith; Soto, Silvia; Lecca, Leonid			A Cross Sectional Study of Knowledge and Attitudes Towards Tuberculosis amongst Front-Line Tuberculosis Personnel in High Burden Areas of Lima, Peru	PLOS ONE			English	Article							STAFF	Introduction: Tuberculosis, reported as the second most common infectious cause of death worldwide, is a key mortality contributor in developing countries and globally. The disease is endemic in Peru and while relative success was achieved during the 1990s in its control, this slowed as new complications, such as multi drug resistant TB arose. Health centre workers participating in the national DOTS program, create the front-line TB work-force in Peru meaning their knowledge and attitudes about the disease are key in its control. Methods: A Spanish language, multiple choice knowledge and attitudes survey was designed based on previous successful studies and the national Peruvian TB control guidelines. It was applied to two health networks in Lima, Peru amongst 301health workers participating in the national TB control program from 66 different health centres. The study results were analysed to test mean knowledge scores amongst different groups, overall gaps in key areas of TB treatment and control knowledge, and attitudes towards the disease and the national TB control program. Results: A mean knowledge score of 10.1 (+/- 1.7) out of 15 or 67.3% correct was shown. Demographics shown to have an effect on knowledge score were age and level of education. Major knowledge gaps were noted primarily in themes relating to treatment and diagnostics. Greater community involvement including better patient education about TB was seen as important in implementing the national TB control program. Participants were in disagreement about the current distribution of health resources throughout the study area. Discussion Serious knowledge gaps were identified from the survey; these reflect findings from a previous study in Lima and other studies from TB endemic areas throughout the world. Understanding these gaps and observations made by front-line TB workers in Lima may help to improve the national TB control program and other control efforts globally.	[Minnery, Mark] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Contreras, Carmen; Tintaya, Karen; Jimenez, Judith; Soto, Silvia; Lecca, Leonid] Socios Salud Surcusal Peru, Lima, Peru; [Perez, Rosa; Solorzano, Ninfa] Minist Salud Lima, Direcc Salud Lima Ciudad 5, Lima, Peru	University of Queensland	Lecca, L (corresponding author), Socios Salud Surcusal Peru, Lima, Peru.	llecca_ses@pih.org	Soto, Silvia/HGB-5950-2022	Lecca, Leonid/0000-0003-1363-3985				Aguilar-Najera MJ, 2008, MED UNAB, V11, P213; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Ayaya S O, 2003, East Afr Med J, V80, P83; Chakaya JM, 2005, INT J TUBERC LUNG D, V9, P403; Cruz Martínez Óscar Andrés, 2011, av.enferm., V29, P143; Dussault Gilles, 2003, Hum Resour Health, V1, P1, DOI 10.1186/1478-4491-1-1; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; Farmer P, 1997, ANN C GLOB LUNG HLTH; Hashim D S, 2003, East Mediterr Health J, V9, P718; Hoa NP, 2005, HEALTH POLICY, V72, P1, DOI 10.1016/j.healthpol.2004.02.013; Kiefer E, 2009, J INFECT DEV COUNTR, V3, P783, DOI 10.3855/jidc.335; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Minsa Peru, 2012, SIT PREV CONTR UNPUB; PAHO, 2006, EG PLAN TUB CONTR 20, P2006; Peru Minsa, 2011, IMP SOC TUB PER 2010; Peru Minsa, 2006, NORM TECN SAL UNPUB; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; Watkins RE, 2005, PATIENT EDUC COUNS, V56, P340, DOI 10.1016/j.pec.2004.03.009; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, 4 WHO; WHO, 2009, TUB PROF	22	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75698	10.1371/journal.pone.0075698	http://dx.doi.org/10.1371/journal.pone.0075698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223BC	24069437	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300090
J	Person, B; Schilling, K; Owuor, M; Ogange, L; Quick, R				Person, Bobbie; Schilling, Katharine; Owuor, Mercy; Ogange, Lorraine; Quick, Rob			A Qualitative Evaluation of Hand Drying Practices among Kenyans	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; HYGIENE; DISEASE; RISK	Background: Recommended disease prevention behaviors of hand washing, hygienic hand drying, and covering one's mouth and nose in a hygienic manner when coughing and sneezing appear to be simple behaviors but continue to be a challenge to successfully promote and sustain worldwide. We conducted a qualitative inquiry to better understand current hand drying behaviors associated with activities of daily living, and mouth and nose covering practices, among Kenyans. Methods and Findings: We conducted 7 focus group discussions; 30 in-depth interviews; 10 structured household observations; and 75 structured observations in public venues in the urban area of Kisumu; rural communities surrounding Kisumu; and a peri-urban area outside Nairobi, Kenya. Using a grounded theory approach, we transcribed and coded the narrative data followed by thematic analysis of the emergent themes. Hand drying, specifically on a clean towel, was not a common practice among our participants. Most women dried their hands on their waist cloth, called a leso, or their clothes whether they were cooking, eating or cleaning the nose of a young child. If men dried their hands, they used their trousers or a handkerchief. Children rarely dried their hands; they usually just wiped them on their clothes, shook them, or left them wet as they continued with their activities. Many people sneezed into their hands and wiped them on their clothes. Men and women used a handkerchief fairly often when they had a runny nose, cold, or the flu. Most people coughed into the air or their hand. Conclusions: Drying hands on dirty clothes, rags and lesos can compromise the benefits of handwashing. Coughing and sneezing in to an open hand can contribute to spread of disease as well. Understanding these practices can inform health promotion activities and campaigns for the prevention and control of diarrheal disease and influenza.	[Person, Bobbie] Ctr Dis Control & Prevent, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA; [Schilling, Katharine; Quick, Rob] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Owuor, Mercy; Ogange, Lorraine] Kenya Govt Med Res Ctr, Kisumu, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Person, B (corresponding author), Ctr Dis Control & Prevent, Off Director, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA.	bperson@cdc.gov			Vestergaard Frandsen SA	Vestergaard Frandsen SA	This qualitative inquiry was funded by Vestergaard Frandsen SA(http://www.vestergaard-frandsen.com/) as part of a larger hand hygiene investigation but they had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Burt RS, 2005, BROKERAGE CLOSURE IN; *CDCP, 2009, COUGH SNEEZ; *CDCP, 2011, HANDW CLEAN HANDS SA; Dewalt K., 2002, PARTICIPANT OBSERVAT; Glaser B.G., 1968, DISCOV GROUNDED THEO; *GLOB PUBL PRIV PA, 2011, PARTN; Gulis G, 2004, ENVIRON RES, V96, P219, DOI 10.1016/j.envres.2004.01.016; Gustafson DR, 2000, MAYO CLIN PROC, V75, P705; Jumaa PA, 2005, INT J INFECT DIS, V9, P3, DOI 10.1016/j.ijid.2004.05.005; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MERCY KJ, 2008, THESIS METROPOLIA U; Miles M., 1994, EARLY STEPS ANAL QUA, P50; Patrick DR, 1997, EPIDEMIOL INFECT, V119, P319, DOI 10.1017/S0950268897008261; Patton M. Q, 2002, QUALITATIVE RES EVAL, P431; Ray Sandip Kumar, 2010, Indian J Public Health, V54, P126, DOI 10.4103/0019-557X.75734; Suchdev PS, 2010, FOOD NUTR BULL, V31, pS168, DOI 10.1177/15648265100312S209; Todd ECD, 2010, J FOOD PROTECT, V73, P1937, DOI 10.4315/0362-028X-73.10.1937; *WHO, 2010, KEN HLTH PROF	20	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74370	10.1371/journal.pone.0074370	http://dx.doi.org/10.1371/journal.pone.0074370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069302	Green Published, gold			2022-12-27	WOS:000324777300033
J	Schwammle, V; Jensen, ON				Schwammle, Veit; Jensen, Ole Norregaard			A Computational Model for Histone Mark Propagation Reproduces the Distribution of Heterochromatin in Different Human Cell Types	PLOS ONE			English	Article							H3 LYSINE 9; CHROMATIN DOMAINS; GENE-EXPRESSION; HUMAN GENOME; PERICENTRIC HETEROCHROMATIN; NUCLEOSOME MODIFICATION; METHYLATION STATES; EPIGENETIC CONTROL; CHIP-SEQ; HP1	Chromatin is a highly compact and dynamic nuclear structure that consists of DNA and associated proteins. The main organizational unit is the nucleosome, which consists of a histone octamer with DNA wrapped around it. Histone proteins are implicated in the regulation of eukaryote genes and they carry numerous reversible post-translational modifications that control DNA-protein interactions and the recruitment of chromatin binding proteins. Heterochromatin, the transcriptionally inactive part of the genome, is densely packed and contains histone H3 that is methylated at Lys 9 (H3K9me). The propagation of H3K9me in nucleosomes along the DNA in chromatin is antagonizing by methylation of H3 Lysine 4 (H3K4me) and acetylations of several lysines, which is related to euchromatin and active genes. We show that the related histone modifications form antagonized domains on a coarse scale. These histone marks are assumed to be initiated within distinct nucleation sites in the DNA and to propagate bi-directionally. We propose a simple computer model that simulates the distribution of heterochromatin in human chromosomes. The simulations are in agreement with previously reported experimental observations from two different human cell lines. We reproduced different types of barriers between heterochromatin and euchromatin providing a unified model for their function. The effect of changes in the nucleation site distribution and of propagation rates were studied. The former occurs mainly with the aim of (de-) activation of single genes or gene groups and the latter has the power of controlling the transcriptional programs of entire chromosomes. Generally, the regulatory program of gene transcription is controlled by the distribution of nucleation sites along the DNA string.	[Schwammle, Veit; Jensen, Ole Norregaard] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	University of Southern Denmark	Schwammle, V (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	veits@bmb.sdu.dk	Jensen, Ole N/J-1763-2012	Jensen, Ole N/0000-0003-1862-8528; Schwammle, Veit/0000-0002-9708-6722	Danish Council for Independent Research, Natural Sciences; Danish National Research Foundation (Center for Epigenetics)	Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation (Center for Epigenetics)	VS and ONJ acknowledge generous financial support from the Danish Council for Independent Research, Natural Sciences (FNU), and the Danish National Research Foundation (Center for Epigenetics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bock C, 2007, PLOS COMPUT BIOL, V3, P1055, DOI 10.1371/journal.pcbi.0030110; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chiu YH, 2003, GENETICS, V165, P115; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Czvitkovich S, 2001, MECH DEVELOP, V107, P141, DOI 10.1016/S0925-4773(01)00464-6; de Wit E, 2009, CHROMOSOMA, V118, P25, DOI 10.1007/s00412-008-0186-0; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Donze D, 2002, BIOESSAYS, V24, P344, DOI 10.1002/bies.10072; Douarin BL, 1996, EMBO J, V15, P6701; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Finelli P, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-16; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gils C, 2009, ARXIV09124465; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hatano A, 2010, BIOCHEM BIOPH RES CO, V397, P93, DOI 10.1016/j.bbrc.2010.05.074; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Jenuwein T, 2001, TRENDS CELL BIOL, V11, P266, DOI 10.1016/S0962-8924(01)02001-3; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimura A, 2004, GENES CELLS, V9, P499, DOI 10.1111/j.1356-9597.2004.00740.x; Kondo Y, 2003, J BIOL CHEM, V278, P27658, DOI 10.1074/jbc.M304072200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Leroy G, 2009, MOL CELL PROTEOMICS, V8, P2432, DOI 10.1074/mcp.M900160-MCP200; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; Micheelsen MA, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/2/026010; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Norwood LE, 2006, J BIOL CHEM, V281, P18668, DOI 10.1074/jbc.M512454200; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Sedighi M, 2007, PHYS BIOL, V4, P246, DOI 10.1088/1478-3975/4/4/002; Sidoli S, 2012, J PROTEOMICS, V75, P3419, DOI 10.1016/j.jprot.2011.12.029; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Smit A, 1996, REPEATMASKER OPEN 30; Sneppen K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.21; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang JR, 2012, NUCLEIC ACIDS RES, V40, P511, DOI 10.1093/nar/gkr750; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002	74	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73818	10.1371/journal.pone.0073818	http://dx.doi.org/10.1371/journal.pone.0073818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069233	Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300020
J	Yu, WB; Huang, PH; Li, DZ; Wang, H				Yu, Wen-Bin; Huang, Pan-Hui; Li, De-Zhu; Wang, Hong			Incongruence between Nuclear and Chloroplast DNA Phylogenies in Pedicularis Section Cyathophora (Orobanchaceae)	PLOS ONE			English	Article							BAYESIAN POSTERIOR PROBABILITIES; POLLINATION ECOLOGY; INFERRING PHYLOGENY; QUATERNARY CLIMATE; POLLEN MORPHOLOGY; GENE TREES; BOOTSTRAP; EVOLUTION; PHYLOGEOGRAPHY; ASTERACEAE	Pedicularis section Cyathophora is a monophyletic group characterized by perfoliate leaf and/or bract bases at each node. This section comprises four series, corresponding to four general corolla types of Pedicularis, i.e. toothless, toothed, beaked and long-tubed corollas. In this study, we aim to reconstruct a comprehensive phylogeny of section Cyathophora, and compare phylogenetic incongruence between nuclear and chloroplast datasets. Sixty-seven accessions belonging to section Cyathophora and 9 species for other Pedicularis were sampled, and one nuclear gene (nrITS) and four chloroplast genes (matK, rbcL, trnH-psbA and trnL-F) were sequenced. Phylogenetic analyses show that the topologies and networks inferred from nrITS and the concatenated chloroplast datasets were incongruent, and the nrITS phylogenies and network agreed with the morphology-based taxonomy to some degree. The chloroplast genome of two Sichuan samples of P. cyathophylloides (E4 and E5) may show introgression from an ancestor of P. cyathophylla. Neither the nrITS dataset nor the concatenated chloroplast dataset were able to adequately resolve relationships among species in the series Reges; this is most likely due to incomplete lineage sorting and/or introgression/hybridization. The nrITS phylogeny indicates the beakless (toothed and toothless) and beaked galeas may have evolved independently within section Cyathophora, and the chloroplast phylogeny reveals that the long corolla tube with beaked galea is derived from the short one.	[Yu, Wen-Bin; Huang, Pan-Hui; Li, De-Zhu; Wang, Hong] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Yu, Wen-Bin; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Yunnan, Peoples R China; [Yu, Wen-Bin; Huang, Pan-Hui] Chinese Acad Sci, Grad Univ, Beijing, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	dzl@mail.kib.ac.cn; wanghong@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011; Yu, Wen-Bin/H-8339-2014	Li, De-Zhu/0000-0002-4990-724X; Yu, Wen-Bin/0000-0002-7643-2112	National Natural Science Foundation of China [31200185]; West Light Foundation of the Chinese Academy of Sciences; National High-tech Research & Development Program of China [2012AA021801]; National Science and Technology on Basic Research Program [2013FY112600]; Key Research Program of the Chinese Academy of Sciences [KJZD-EW-L07]; Large-Scale Scientific Facilities of the Chinese Academy of Sciences [2009-LSF-GBOWS-01]; National Key Basic Research Program of China [2014CB954100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); National High-tech Research & Development Program of China(National High Technology Research and Development Program of China); National Science and Technology on Basic Research Program; Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Large-Scale Scientific Facilities of the Chinese Academy of Sciences; National Key Basic Research Program of China(National Basic Research Program of China)	This study is supported by grants from the National Natural Science Foundation of China (31200185), the West Light Foundation of the Chinese Academy of Sciences, the National High-tech Research & Development Program of China (2012AA021801), the National Science and Technology on Basic Research Program (2013FY112600), the Key Research Program of the Chinese Academy of Sciences (KJZD-EW-L07), the Large-Scale Scientific Facilities of the Chinese Academy of Sciences (2009-LSF-GBOWS-01), and the National Key Basic Research Program of China (2014CB954100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MC, 2010, MOL PHYLOGENET EVOL, V54, P235, DOI 10.1016/j.ympev.2009.08.008; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Bonati G., 1910, B SOC BOT FRANCE, V57, P1; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Doyle J. J., 1987, PHYTOCHEM B, P11; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kolaczkowski B, 2007, MOL BIOL EVOL, V24, P2108, DOI 10.1093/molbev/msm141; Li H-L, 1948, P ACAD NAT SCI PHILA, V100, P205; LI HL, 1951, EVOLUTION, V5, P158, DOI 10.1111/j.1558-5646.1951.tb02771.x; Limpricht W, 1924, REPERT SPEC NOV REGN, V20, P161, DOI DOI 10.1002/FEDR.19240200612; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Lu L, 2010, MOL PHYLOGENET EVOL, V57, P364, DOI 10.1016/j.ympev.2010.06.002; Macior L.W., 1982, P29; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maximovicz CJ, 1888, B ACAD SCI ST PETERS, P477; McKinnon GE, 2010, MOL ECOL, V19, P1367, DOI 10.1111/j.1365-294X.2010.04579.x; Nishimoto Y, 2003, GENES GENET SYST, V78, P139, DOI 10.1266/ggs.78.139; Okuyama Y, 2005, MOL BIOL EVOL, V22, P285, DOI 10.1093/molbev/msi016; P-C Tsoong, 1955, ACTA PHYTOTAX SINICA, V4, P71; P-C Tsoong, 1965, ACTA PHYTOTAX SINICA, V10, P357; Pelser PB, 2010, AM J BOT, V97, P856, DOI 10.3732/ajb.0900287; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prain D., 1890, ANN ROYAL BOT GARDEN, V3, P1; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Ree RH, 2005, INT J PLANT SCI, V166, P595, DOI 10.1086/430191; REE RH, 2001, THESIS HAVARD U CAMB; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt-Lebuhn AN, 2012, MOL PHYLOGENET EVOL, V65, P23, DOI 10.1016/j.ympev.2012.05.015; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tang Y, 2007, FLORA, V202, P209, DOI 10.1016/j.flora.2006.09.001; Tang Y, 2006, ARCT ANTARCT ALP RES, V38, P446, DOI 10.1657/1523-0430(2006)38[446:APESOP]2.0.CO;2; Tsitrone A, 2003, EVOLUTION, V57, P1776, DOI 10.1111/j.0014-3820.2003.tb00585.x; Tsoong P-C., 1963, FLORA REIPUBLICAE PO, V68, P1; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; VanRaamsdonk LWD, 1997, BOT J LINN SOC, V123, P91, DOI 10.1006/bojl.1996.0075; Wang H, 1998, ACTA BOT SIN, V40, P781; Wang H, 2009, PLANT SYST EVOL, V277, P153, DOI 10.1007/s00606-008-0112-1; Wang S, 2004, CHINA SPECIES RED LI, VI; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; Wu ZY., 2003, FAMILIES GENERA ANGI; Yang FS, 2007, PLANT SYST EVOL, V264, P251, DOI 10.1007/s00606-006-0510-1; Yang FS, 2003, PLANT SYST EVOL, V240, P91, DOI 10.1007/s00606-003-0005-2; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang H.-P., 1990, ACTA PHYTOTAX SINICA, V28, P136; Yang ZY, 2012, J SYST EVOL, V50, P316, DOI 10.1111/j.1759-6831.2012.00199.x; Yoo KO, 2002, AM J BOT, V89, P966, DOI 10.3732/ajb.89.6.966; Yu W-B, 2011, THESIS CHINESE ACAD; Yu WB, 2008, J INTEGR PLANT BIOL, V50, P244, DOI 10.1111/j.1744-7909.2007.00364.x; Yu WB, 2013, J SYST EVOL, V51, P435, DOI 10.1111/jse.12018; Yu WB, 2011, J SYST EVOL, V49, P507, DOI 10.1111/j.1759-6831.2011.00159_3.x; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang YX, 2012, MOL PHYLOGENET EVOL, V63, P777, DOI 10.1016/j.ympev.2012.02.023; Zou XH, 2008, J SYST EVOL, V46, P795, DOI 10.3724/SP.J.1002.2008.08081	63	38	38	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74828	10.1371/journal.pone.0074828	http://dx.doi.org/10.1371/journal.pone.0074828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069353	gold, Green Published			2022-12-27	WOS:000324777300050
J	Becherelli, M; Prachi, P; Viciani, E; Biagini, M; Fiaschi, L; Chiarot, E; Nosari, S; Brettoni, C; Marchi, S; Biancucci, M; Fontana, MR; Montagnani, F; Bagnoli, F; Barocchi, MA; Manetti, AGO				Becherelli, Marco; Prachi, Prachi; Viciani, Elisa; Biagini, Massimiliano; Fiaschi, Luigi; Chiarot, Emiliano; Nosari, Sarah; Brettoni, Cecilia; Marchi, Sara; Biancucci, Marco; Fontana, Maria Rita; Montagnani, Francesca; Bagnoli, Fabio; Barocchi, Michele A.; Manetti, Andrea G. O.			Protective Activity of the CnaBE3 Domain Conserved among Staphylococcus aureus Sdr Proteins	PLOS ONE			English	Article							STABILIZING ISOPEPTIDE; SURFACE-PROTEINS; NASAL-CARRIAGE; VACCINE; ADHESIN; GENES; BONDS; IDENTIFICATION; POPULATIONS; ANTIBODIES	Staphylococcus aureus is an opportunistic pathogen, commensal of the human skin and nares, but also responsible for invasive nosocomial as well as community acquired infections. Staphylococcus aureus adheres to the host tissues by means of surface adhesins, such as SdrC, SdrD, and SdrE proteins. The Sdr family of proteins together with a functional A domain, contain respectively two, three or five repeated sequences called B motifs which comprise the CnaB domains. SdrD and SdrE proteins were reported to be protective in animal models against invasive diseases or lethal challenge with human clinical S. aureus isolates. In this study we identified a 126 amino acid sequence containing a CnaB domain, conserved among the three Sdr proteins. The three fragments defined here as CnaBC2, D5 and E3 domains even though belonging to phylogenetically distinct strains, displayed high sequence similarity. Based on the sequence conservation data, we selected the CnaBE3 domain for further analysis and characterization. Polyclonal antibodies raised against the recombinant CnaBE3 domain recognized SdrE, SdrC and SdrD proteins of different S. aureus lineages. Moreover, we demonstrated that the CnaBE3 domain was expressed in vivo during S. aureus infections, and that immunization of this domain alone significantly reduces the bacterial load in mice challenged with S. aureus. Furthermore, we show that the reduction of bacteria by CnaBE3 vaccination is due to functional antibodies. Finally, we demonstrated that the region of the SdrE protein containing the CnaBE3 domain was resistant to trypsin digestion, a characteristic often associated with the presence of an isopeptide bond.	[Becherelli, Marco; Prachi, Prachi; Viciani, Elisa; Biagini, Massimiliano; Fiaschi, Luigi; Chiarot, Emiliano; Nosari, Sarah; Brettoni, Cecilia; Marchi, Sara; Biancucci, Marco; Fontana, Maria Rita; Bagnoli, Fabio; Barocchi, Michele A.; Manetti, Andrea G. O.] Novartis Vaccines & Diagnost, Siena, Italy; [Montagnani, Francesca] Univ Siena, Dept Med Biotechnol, I-53100 Siena, Italy	Novartis; University of Siena	Manetti, AGO (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	Andrea_guido.manetti@novartis.com	Montagnani, Francesca/R-3334-2016	Montagnani, Francesca/0000-0002-2267-1337	Univerity of Siena; Novartis Vaccines and Diagnostics	Univerity of Siena; Novartis Vaccines and Diagnostics	EV is a recipient of a Novartis Fellowship from the PhD program in cellular biology and physiology of the Univerity of Siena. This work was funded by Novartis Vaccines and Diagnostics. The funders had a role in study design, data collection and analysis, preparation of the manuscript and decision to publish.	Barbu EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000726; Bartlett John G, 2008, Top HIV Med, V16, P151; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; El Mortaji L, 2012, BIOCHEM J, V441, P833, DOI 10.1042/BJ20111397; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Foster TJ, 2004, J CLIN INVEST, V114, P1693, DOI 10.1172/JCI200423825; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hagan RM, 2010, ANGEW CHEM INT EDIT, V49, P8421, DOI 10.1002/anie.201004340; Jensen SO, 2009, FUTURE MICROBIOL, V4, P565, DOI 10.2217/FMB.09.30; Josefsson E, 1998, J BIOL CHEM, V273, P31145, DOI 10.1074/jbc.273.47.31145; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kabanova A, 2010, VACCINE, V29, P104, DOI 10.1016/j.vaccine.2010.09.018; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kim HK, 2011, FASEB J, V25, P3605, DOI 10.1096/fj.11-187963; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Krause M, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-11; Lamers RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016426; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Mishra A, 2011, MOL MICROBIOL, V81, P1205, DOI 10.1111/j.1365-2958.2011.07745.x; Mishra RPN, 2012, J INFECT DIS, V206, P1041, DOI 10.1093/infdis/jis463; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Moschioni M, 2010, INFECT IMMUN, V78, P5033, DOI 10.1128/IAI.00601-10; Niall H D, 1973, Methods Enzymol, V27, P942; Nuccitelli A, 2011, P NATL ACAD SCI USA, V108, P10278, DOI 10.1073/pnas.1106590108; Panula-Perala J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-31; PATTI JM, 1994, CURR OPIN CELL BIOL, V6, P752, DOI 10.1016/0955-0674(94)90104-X; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005; Sabat A, 2006, J CLIN MICROBIOL, V44, P1135, DOI 10.1128/JCM.44.3.1135-1138.2006; Schaffer AC, 2008, INT J ANTIMICROB AG, V32, pS71, DOI 10.1016/j.ijantimicag.2008.06.009; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sitkiewicz I, 2011, ANTON LEEUW INT J G, V99, P409, DOI 10.1007/s10482-010-9476-7; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Stapleton MR, 2012, J MED MICROBIOL, V61, P766, DOI 10.1099/jmm.0.040915-0; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tchernychev B, 1997, P NATL ACAD SCI USA, V94, P6335, DOI 10.1073/pnas.94.12.6335; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Xue HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020332	58	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74718	10.1371/journal.pone.0074718	http://dx.doi.org/10.1371/journal.pone.0074718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069334	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300052
J	Cano, LM; Raffaele, S; Haugen, RH; Saunders, DGO; Leonelli, L; MacLean, D; Hogenhout, SA; Kamoun, S				Cano, Liliana M.; Raffaele, Sylvain; Haugen, Riston H.; Saunders, Diane G. O.; Leonelli, Lauriebeth; MacLean, Dan; Hogenhout, Saskia A.; Kamoun, Sophien			Major Transcriptome Reprogramming Underlies Floral Mimicry Induced by the Rust Fungus Puccinia monoica in Boechera stricta	PLOS ONE			English	Article							HOMEOBOX GENES PENNYWISE; ARABIDOPSIS-THALIANA; INFLORESCENCE ARCHITECTURE; SCENT PRODUCTION; ZINC-FINGER; LEAF SHAPE; PROTEIN; MERISTEM; FLOWER; BIOSYNTHESIS	Puccinia monoica is a spectacular plant parasitic rust fungus that triggers the formation of flower-like structures (pseudoflowers) in its Brassicaceae host plant Boechera stricta. Pseudoflowers mimic in shape, color, nectar and scent co-occurring and unrelated flowers such as buttercups. They act to attract insects thereby aiding spore dispersal and sexual reproduction of the rust fungus. Although much ecological research has been performed on P. monoica-induced pseudoflowers, this system has yet to be investigated at the molecular or genomic level. To date, the molecular alterations underlying the development of pseudoflowers and the genes involved have not been described. To address this, we performed gene expression profiling to reveal 256 plant biological processes that are significantly altered in pseudoflowers. Among these biological processes, plant genes involved in cell fate specification, regulation of transcription, reproduction, floral organ development, anthocyanin (major floral pigments) and terpenoid biosynthesis (major floral volatile compounds) were down-regulated in pseudoflowers. In contrast, plant genes involved in shoot, cotyledon and leaf development, carbohydrate transport, wax biosynthesis, cutin transport and L-phenylalanine metabolism (pathway that results in phenylethanol and phenylacetaldehyde volatile production) were up-regulated. These findings point to an extensive reprogramming of host genes by the rust pathogen to induce floral mimicry. We also highlight 31 differentially regulated plant genes that are enriched in the biological processes mentioned above, and are potentially involved in the formation of pseudoflowers. This work illustrates the complex perturbations induced by rust pathogens in their host plants, and provides a starting point for understanding the molecular mechanisms of pathogen-induced floral mimicry.	[Cano, Liliana M.; Raffaele, Sylvain; Saunders, Diane G. O.; MacLean, Dan; Kamoun, Sophien] Sainsbury Lab, Norwich, Norfolk, England; [Raffaele, Sylvain] INRA, CNRS, Lab Interact Plantes Microorganismes, UMR441,UMR2594, F-31326 Castanet Tolosan, France; [Haugen, Riston H.] Black Hills State Univ, Integrat Genom Program, Spearfish, SD 57799 USA; [Leonelli, Lauriebeth] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Hogenhout, Saskia A.] John Innes Ctr, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Black Hills State University; University of California System; University of California Berkeley; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Kamoun, S (corresponding author), Sainsbury Lab, Norwich, Norfolk, England.	sophien.kamoun@tsl.ac.uk	Kamoun, Sophien/B-3529-2009; Leonelli, Lauriebeth/GYU-8762-2022; Saunders, Diane GO/N-1916-2015; Raffaele, Sylvain/K-6673-2019; Cano, Liliana M/O-7041-2016; Hogenhout, Saskia A/D-9266-2012; Raffaele, Sylvain/F-7187-2012; MacLean, Dan/C-7046-2013	Kamoun, Sophien/0000-0002-0290-0315; Leonelli, Lauriebeth/0000-0001-7536-523X; Raffaele, Sylvain/0000-0002-2442-9632; Cano, Liliana M/0000-0002-7996-4181; Hogenhout, Saskia A/0000-0003-1371-5606; Raffaele, Sylvain/0000-0002-2442-9632; MacLean, Dan/0000-0003-1032-0887	Gatsby Charitable Foundation; Marie Curie IEF Fellowship [255104]; Leverhulme Early Career Fellowship	Gatsby Charitable Foundation; Marie Curie IEF Fellowship(European Commission); Leverhulme Early Career Fellowship(Leverhulme Trust)	The Gatsby Charitable Foundation provided funding for this work. S.R. received support from Marie Curie IEF Fellowship contract 255104 and D.G.O.S. from a Leverhulme Early Career Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Bertaccini A, 2007, FRONT BIOSCI-LANDMRK, V12, P673, DOI 10.2741/2092; Bohlmann J, 2000, ARCH BIOCHEM BIOPHYS, V375, P261, DOI 10.1006/abbi.1999.1669; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bondada BR, 1996, ENVIRON EXP BOT, V36, P61, DOI 10.1016/0098-8472(96)00128-1; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cheng YF, 2008, P NATL ACAD SCI USA, V105, P21017, DOI 10.1073/pnas.0809761106; Colasanti J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-158; Conway LJ, 1997, P NATL ACAD SCI USA, V94, P10209, DOI 10.1073/pnas.94.19.10209; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Deng Jian-yu, 2004, Journal of Zhejiang University Science, V5, P1577, DOI 10.1631/jzus.2004.1577; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Eriksson S, 2010, CURR BIOL, V20, P527, DOI 10.1016/j.cub.2010.01.039; Farr D. F., 1989, Fungi on plants and plant products in the United States.; Fotopoulos V, 2003, PLANT PHYSIOL, V132, P821, DOI 10.1104/pp.103.021428; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Giurfa M, 1999, INT J PLANT SCI, V160, pS41, DOI 10.1086/314214; Gorai M., 2010, Emirates Journal of Food and Agriculture, V22, P1; Gutensohn M, 2011, PLANT J, V66, P591, DOI 10.1111/j.1365-313X.2011.04515.x; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Joubes J, 2008, PLANT MOL BIOL, V67, P547, DOI 10.1007/s11103-008-9339-z; Kammenga JE, 2007, TRENDS ECOL EVOL, V22, P273, DOI 10.1016/j.tree.2007.01.013; Kanrar S, 2008, PLANT J, V54, P924, DOI 10.1111/j.1365-313X.2008.03458.x; Kanrar S, 2006, PLANTA, V224, P1163, DOI 10.1007/s00425-006-0298-9; KOLATTUKUDY PE, 1995, P NATL ACAD SCI USA, V92, P4080, DOI 10.1073/pnas.92.10.4080; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; MOLLER AP, 1995, P NATL ACAD SCI USA, V92, P2288, DOI 10.1073/pnas.92.6.2288; Narita NN, 2004, PLANT J, V38, P699, DOI 10.1111/j.1365-313X.2004.02078.x; Ochando I, 2006, PLANT PHYSIOL, V141, P607, DOI 10.1104/pp.106.077149; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Panikashvili D, 2011, NEW PHYTOL, V190, P113, DOI 10.1111/j.1469-8137.2010.03608.x; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; Raguso RA, 1998, MOL ECOL, V7, P1127, DOI 10.1046/j.1365-294x.1998.00426.x; Roy BA, 1998, MYCOLOGIA, V90, P846, DOI 10.2307/3761326; ROY BA, 1993, EVOLUTION, V47, P111, DOI 10.1111/j.1558-5646.1993.tb01203.x; Roy BA, 1996, ECOLOGY, V77, P2445, DOI 10.2307/2265745; ROY BA, 1993, NATURE, V362, P56, DOI 10.1038/362056a0; Roy BA, 1997, OECOLOGIA, V109, P414, DOI 10.1007/s004420050101; ROY BA, 1994, ECOLOGY, V75, P352, DOI 10.2307/1939539; Ruhlmann JM, 2010, J EXP BOT, V61, P395, DOI 10.1093/jxb/erp309; Rushworth CA, 2011, MOL ECOL, V20, P4843, DOI 10.1111/j.1365-294X.2011.05340.x; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Schranz ME, 2007, PLANT PHYSIOL, V144, P286, DOI 10.1104/pp.107.096685; Scofield S, 2008, PLANT SIGNAL BEHAV, V3, P257, DOI 10.4161/psb.3.4.5194; Seo PJ, 2011, PLANT J, V65, P418, DOI 10.1111/j.1365-313X.2010.04432.x; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; Sidler M, 1998, PLANT CELL, V10, P1623, DOI 10.1105/tpc.10.10.1623; Simpson B.B., 1983, P142; Smit MA, 2006, FIELD CROP RES, V98, P91, DOI 10.1016/j.fcr.2005.12.009; Smith HMS, 2004, CURR BIOL, V14, P812, DOI 10.1016/j.cub.2004.04.032; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Tholl D, 2005, PLANT J, V42, P757, DOI 10.1111/j.1365-313X.2005.02417.x; Trigueros M, 2009, PLANT CELL, V21, P1394, DOI 10.1105/tpc.109.065508; Tsukaya H, 2005, INT J DEV BIOL, V49, P547, DOI 10.1387/ijdb.041921ht; Venglat SP, 2002, P NATL ACAD SCI USA, V99, P4730, DOI 10.1073/pnas.072626099; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Weiss J, 2005, INT J DEV BIOL, V49, P513, DOI 10.1387/ijdb.051998jw; Wen JQ, 2004, PLANT J, V37, P668, DOI 10.1111/j.1365-313X.2003.01994.x; Windsor AJ, 2006, PLANT PHYSIOL, V140, P1169, DOI 10.1104/pp.105.073981; Zhang JH, 2004, PHYTOPATHOLOGY, V94, P842, DOI 10.1094/PHYTO.2004.94.8.842	71	17	17	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75293	10.1371/journal.pone.0075293	http://dx.doi.org/10.1371/journal.pone.0075293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069397	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300076
J	Piccinato, CA; Rosa, GJM; N'Jai, AU; Jefcoate, CR; Wiltbank, MC				Piccinato, Carla A.; Rosa, Guilherme J. M.; N'Jai, Alhaji U.; Jefcoate, Colin R.; Wiltbank, Milo C.			Estradiol and Progesterone Exhibit Similar Patterns of Hepatic Gene Expression Regulation in the Bovine Model	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; MAMMARY-GLAND; OVARIECTOMIZED MICE; ANDROGEN METABOLISM; CELL-PROLIFERATION; DAIRY-COWS; HORMONE; ALPHA; MOUSE; LIVER	Female sex steroid hormones, estradiol-17 beta (E2-17 beta) and progesterone (P4) regulate reproductive function and gene expression in a broad range of tissues. Given the central role of the liver in regulating homeostasis including steroid hormone metabolism, we sought to understand how E2-17 beta and P4 interact to affect global gene expression in liver. Ovariectomized cows (n = 8) were randomly assigned to 4 treatment groups applied in a replicated Latin Square design: 1) No hormone supplementation, 2) E2-17 beta treatment (ear implant), 3) P4 treatment (intravaginal inserts), and 4) E2-17 beta combined with P4. After 14 d of treatment, liver biopsies were collected, allowing 28 d intervals between periods. Changes in gene expression in the liver biopsies were monitored using bovine-specific arrays. Treatment with E2-17 beta altered expression of 479 genes, P4 472 genes, and combined treatment significantly altered expression of 468 genes. In total, 578 genes exhibited altered expression including a remarkable number (346 genes) that responded similarly to E2-17 beta, P4, or combined treatment. Additional evidence for similar gene expression actions of E2-17 beta and/or P4 were: principal component analysis placed almost every treatment array at a substantial distance from controls; Venn diagrams indicated overall treatment effects for most regulated genes; clustering analysis indicated the two major clusters had all treatments up-regulating (172 genes) or down-regulating (173 genes) expression. Thus, unexpectedly, common biological pathways were regulated by E2-17 beta and/or P4 in liver. This indicates that the mechanism of action of these steroid hormones in the liver might be either indirect or might occur through non-genomic pathways. This unusual pattern of gene expression in response to steroid hormones is consistent with the idea that there are classical and non-classical tissue-specific responses to steroid hormone actions. Future studies are needed to elucidate putative mechanism(s) responsible for overlapping actions of E2-17 beta and P4 on the liver transcriptome.	[Piccinato, Carla A.; Jefcoate, Colin R.; Wiltbank, Milo C.] Univ Wisconsin, Endocrinol Reprod Physiol Program, Madison, WI 53706 USA; [Rosa, Guilherme J. M.] Univ Wisconsin, Dept Anim Sci, Madison, WI USA; [Rosa, Guilherme J. M.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [N'Jai, Alhaji U.] Univ Wisconsin, Dept Pathobiol Sci & Mol & Environm Toxicol, Madison, WI USA; [Jefcoate, Colin R.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; [Wiltbank, Milo C.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wiltbank, MC (corresponding author), Univ Wisconsin, Endocrinol Reprod Physiol Program, Madison, WI 53706 USA.	wiltbank@wisc.edu	Piccinato, Carla/J-8168-2015; Rosa, Guilherme J. M. J. M./G-3862-2011; Wiltbank, Milo C/B-1506-2010	Piccinato, Carla/0000-0002-2872-5957; Rosa, Guilherme J. M. J. M./0000-0001-9172-6461; Wiltbank, Milo C/0000-0001-8188-0991	CAPES-Fellowship from Brazil; Pfizer Global Academic Consortium on Reproduction in Dairy Cattle; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	CAPES-Fellowship from Brazil; Pfizer Global Academic Consortium on Reproduction in Dairy Cattle; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a CAPES-Fellowship from Brazil to CAP and the Pfizer Global Academic Consortium on Reproduction in Dairy Cattle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Blouin K, 2009, MOL CELL ENDOCRINOL, V301, P97, DOI 10.1016/j.mce.2008.10.035; Boada LD, 2002, ARCH TOXICOL, V75, P707, DOI 10.1007/s00204-001-0297-3; Boverhof DR, 2004, CARCINOGENESIS, V25, P1277, DOI 10.1093/carcin/bgh114; Cheng XL, 2006, LIFE SCI, V79, P1988, DOI 10.1016/j.lfs.2006.06.044; Clark J.H., 1988, P675; Cohen C, 1998, HUM PATHOL, V29, P1428, DOI 10.1016/S0046-8177(98)90011-9; Colak M, 2011, REPROD DOMEST ANIM, V46, P854, DOI 10.1111/j.1439-0531.2011.01754.x; Conley AJ, 1997, BIOL REPROD, V56, P789, DOI 10.1095/biolreprod56.4.789; Ellmann S, 2009, CELL MOL LIFE SCI, V66, P2405, DOI 10.1007/s00018-009-0017-3; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Follettie MT, 2006, ENDOCRINOLOGY, V147, P714, DOI 10.1210/en.2005-0600; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Ginger MR, 2001, MOL ENDOCRINOL, V15, P1993, DOI 10.1210/me.15.11.1993; Glaser S, 2008, AM J PHYSIOL-GASTR L, V295, pG124, DOI 10.1152/ajpgi.00536.2007; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Granata OM, 2009, J STEROID BIOCHEM, V113, P290, DOI 10.1016/j.jsbmb.2009.01.013; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hanifi-Moghaddam P, 2005, J CLIN ENDOCR METAB, V90, P973, DOI 10.1210/jc.2004-1423; Hewitt SC, 2000, STEROIDS, V65, P551, DOI 10.1016/S0039-128X(00)00113-6; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hsieh YC, 2007, AM J PATHOL, V170, P1210, DOI 10.2353/ajpath.2007.060883; Ing NH, 2005, BIOL REPROD, V72, P1290, DOI 10.1095/biolreprod.105.040014; Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278; JORGE AD, 1993, HEPATOLOGY, V18, P1108; KATZENELLENBOGEN BS, 1980, ANNU REV PHYSIOL, V42, P17, DOI 10.1146/annurev.ph.42.030180.000313; Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; KRAUS WL, 1993, ENDOCRINOLOGY, V132, P2371, DOI 10.1210/en.132.6.2371; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Li RW, 2008, FUNCT INTEGR GENOMIC, V8, P55, DOI 10.1007/s10142-007-0055-6; Li RW, 2006, PHYSIOL GENOMICS, V27, P42, DOI 10.1152/physiolgenomics.00032.2006; Lindberg MK, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740167; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; *NAT RES COUNC, 2001, NUTR REQ DAIR COW; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Quinkler M, 2003, J CLIN ENDOCR METAB, V88, P2803, DOI 10.1210/jc.2002-021970; Reddy AP, 2005, PSYCHOPHARMACOLOGY, V180, P125, DOI 10.1007/s00213-005-2154-1; Shao RJ, 2006, J ENDOCRINOL, V190, P857, DOI 10.1677/joe.1.06896; Shimizu T, 2010, PHYSIOL GENOMICS, V42A, P290, DOI 10.1152/physiolgenomics.00107.2010; SPENCER TE, 1995, BIOL REPROD, V53, P1527, DOI 10.1095/biolreprod53.6.1527; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suzuki T, 2006, INVEST OPHTH VIS SCI, V47, P158, DOI 10.1167/iovs.05-1003; Suzuki T, 2008, INVEST OPHTH VIS SCI, V49, P1797, DOI 10.1167/iovs.07-1458; Tong W, 1999, MOL CELL BIOL, V19, P2251; VAZQUEZANON M, 1994, J DAIRY SCI, V77, P1521, DOI 10.3168/jds.S0022-0302(94)77092-2; Whitlock BK, 2008, NEUROENDOCRINOLOGY, V88, P212, DOI 10.1159/000146242; Wiltbank M, 2006, THERIOGENOLOGY, V65, P17, DOI 10.1016/j.theriogenology.2005.10.003; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Xu JW, 2004, WORLD J GASTROENTERO, V10, P250	52	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73552	10.1371/journal.pone.0073552	http://dx.doi.org/10.1371/journal.pone.0073552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069207	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300014
J	Wu, S; Kanda, T; Nakamoto, S; Jiang, X; Miyamura, T; Nakatani, SM; Ono, SK; Takahashi-Nakaguchi, A; Gonoi, T; Yokosuka, O				Wu, Shuang; Kanda, Tatsuo; Nakamoto, Shingo; Jiang, Xia; Miyamura, Tatsuo; Nakatani, Sueli M.; Ono, Suzane Kioko; Takahashi-Nakaguchi, Azusa; Gonoi, Tohru; Yokosuka, Osamu			Prevalence of Hepatitis C Virus Subgenotypes 1a and 1b in Japanese Patients: Ultra-Deep Sequencing Analysis of HCV NS5B Genotype-Specific Region	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; INFECTION; THERAPY; COUNTRIES; RIBAVIRIN; VARIANTS	Background: Hepatitis C virus (HCV) subgenotypes 1a and 1b have different impacts on the treatment response to peginterferon plus ribavirin with direct-acting antivirals (DAAs) against patients infected with HCV genotype 1, as the emergence rates of resistance mutations are different between these two subgenotypes. In Japan, almost all of HCV genotype 1 belongs to subgenotype 1b. Methods and Findings: To determine HCV subgenotype 1a or 1b in Japanese patients infected with HCV genotype 1, real-time PCR-based method and Sanger method were used for the HCV NS5B region. HCV subgenotypes were determined in 90% by real-time PCR-based method. We also analyzed the specific probe regions for HCV subgenotypes 1a and 1b using ultra-deep sequencing, and uncovered mutations that could not be revealed using direct-sequencing by Sanger method. We estimated the prevalence of HCV subgenotype 1a as 1.2-2.5% of HCV genotype 1 patients in Japan. Conclusions: Although real-time PCR-based HCV subgenotyping method seems fair for differentiating HCV subgenotypes 1a and 1b, it may not be sufficient for clinical practice. Ultra-deep sequencing is useful for revealing the resistant strain(s) of HCV before DAA treatment as well as mixed infection with different genotypes or subgenotypes of HCV.	[Wu, Shuang; Kanda, Tatsuo; Nakamoto, Shingo; Jiang, Xia; Miyamura, Tatsuo; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan; [Nakamoto, Shingo] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba, Japan; [Nakatani, Sueli M.; Ono, Suzane Kioko] Univ Sao Paulo, Sch Med, Dept Gastroenterol, Sao Paulo, Brazil; [Takahashi-Nakaguchi, Azusa; Gonoi, Tohru] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan	Chiba University; Chiba University; Universidade de Sao Paulo; Chiba University	Kanda, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba, Japan.	kandat@aol.com	Ono, Suzane K/I-3107-2012; Jiang, Xia/P-4220-2014; gonoi, tohru/AAC-5181-2021; , gonoi/GRS-0648-2022	Jiang, Xia/0000-0003-4572-0039; gonoi, tohru/0000-0003-3655-7911; , gonoi/0000-0003-3655-7911; Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (TK, SN, and OY) and a grant of Postdoctoral Fellowships for Foreign Researchers, Japan Society for the Promotion of Science (SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2013, J MED VIROL, V85, P1028, DOI 10.1002/jmv.23579; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Brownell J, 2013, CLIN CANCER RES, V19, P1347, DOI 10.1158/1078-0432.CCR-12-0928; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Chevaliez S, 2012, GASTROENTEROLOGY, V142, P1303, DOI 10.1053/j.gastro.2012.02.027; Di Bisceglie AM, 1997, HEPATOLOGY S1, V26, p34S; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Hayashi K, 2012, J MED VIROL, V84, P438, DOI 10.1002/jmv.23207; Kanda T, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-9; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Kieffer TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034372; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Nakatani SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010150; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Ninomiya M, 2012, J CLIN MICROBIOL, V50, P857, DOI 10.1128/JCM.05715-11; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Soriano V, 2011, J ANTIMICROB CHEMOTH, V66, P1673, DOI 10.1093/jac/dkr215; Stedman CAM, 2013, J GASTROEN HEPATOL, V28, P38, DOI 10.1111/jgh.12028; TAKADA N, 1993, J HEPATOL, V17, P277, DOI 10.1016/S0168-8278(05)80205-3; TANAKA T, 1994, HEPATOLOGY, V19, P1347, DOI 10.1016/0270-9139(94)90226-7; Thomas LB, 2012, ANN CLIN LAB SCI, V42, P355; Thomas XV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041191; TSUKIYAMAKOHARA K, 1993, VIROLOGY, V192, P430, DOI 10.1006/viro.1993.1058; Vispo E, 2012, J CLIN VIROL, V55, P58, DOI 10.1016/j.jcv.2012.05.012; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wu SA, 2011, J HEPATOL, V54, P19, DOI 10.1016/j.jhep.2010.06.018	28	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73615	10.1371/journal.pone.0073615	http://dx.doi.org/10.1371/journal.pone.0073615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069214	Green Submitted, gold, Green Published			2022-12-27	WOS:000324547300018
J	Luo, JY; Matthews, KRW				Luo, Jingyuan; Matthews, Kirstin R. W.			Globalization of Stem Cell Science: An Examination of Current and Past Collaborative Research Networks	PLOS ONE			English	Article							PATTERNS; CITATION; CHINA; REGULATIONS; SINGLE	Science and engineering research has becoming an increasingly international phenomenon. Traditional bibliometric studies have not captured the evolution of collaborative partnerships between countries, particularly in emerging technologies such as stem cell science, in which an immense amount of investment has been made in the past decade. Analyzing over 2,800 articles from the top journals that include stem cell research in their publications, this study demonstrates the globalization of stem cell science. From 2000 to 2010, international collaborations increased from 20.9% to 36% of all stem cell publications analyzed. The United States remains the most prolific and the most dominant country in the field in terms of publications in high impact journals. But Asian countries, particularly China are steadily gaining ground. Exhibiting the largest relative growth, the percent of Chinese-authored stem cell papers grew more than ten-fold, while the percent of Chinese-authored international papers increased over seven times from 2000 to 2010. And while the percent of total stem cell publications exhibited modest growth for European countries, the percent of international publications increased more substantially, particularly in the United Kingdom. Overall, the data indicated that traditional networks of collaboration extant in 2000 still predominate in stem cell science. Although more nations are becoming involved in international collaborations and undertaking stem cell research, many of these efforts, with the exception of those in certain Asian countries, have yet to translate into publications in high impact journals.	[Luo, Jingyuan] Univ London London Sch Econ & Polit Sci, Dept Law, London WC2A 2AE, England; [Luo, Jingyuan; Matthews, Kirstin R. W.] Rice Univ, Sci & Technol Policy Program, James A Baker Inst Publ Policy 3, Houston, TX 77251 USA	University of London; London School Economics & Political Science; Rice University	Matthews, KRW (corresponding author), Rice Univ, Sci & Technol Policy Program, James A Baker Inst Publ Policy 3, Houston, TX 77251 USA.	krwm@rice.edu	Matthews, Kirstin RW/D-2496-2017	Matthews, Kirstin RW/0000-0002-3702-0414	Baker Institute; State of Qatar Endowment for International Stem Cell Policy	Baker Institute; State of Qatar Endowment for International Stem Cell Policy	Support for the project was provided by the Baker Institute and the State of Qatar Endowment for International Stem Cell Policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABT HA, 1984, PUBL ASTRON SOC PAC, V96, P746, DOI 10.1086/131415; Amin  M., 2000, IMPACT FACTORS USE A; Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Ben-David U, 2012, CELL STEM CELL, V10, P666, DOI 10.1016/j.stem.2012.05.003; Carlstein S, 2010, DATABASES BIBLIOMETR; CNN, 2001, GW BUSHS ADDR STEM C; Cyranoski D, 2012, NATURE NEWS; de Solla Price Derek J., 1986, LITTLE SCI BIG SCI; Doring O, 2004, KENNEDY INST ETHIC J, V14, P39, DOI 10.1353/ken.2004.0014; Doring O, 2003, NAT REV GENET, V4, P233, DOI 10.1038/nrg1022; *EUR COMM, 2005, PROP COUNC DEC CONC, P440; European Commission, 2002, WORK PROGR SPEC EXTR; Flynn JM, 2010, STEM CELL REV REP, V6, P143, DOI 10.1007/s12015-010-9133-6; Garfield E., 1994, THOMSON REUTERS IMPA; Glanzel W, 2005, SCIENTOMETRICS, V65, P323, DOI 10.1007/s11192-005-0277-0; Glanzel W, 2002, LIBR TRENDS, V50, P461; Goldfinch S, 2003, SCIENTOMETRICS, V57, P321, DOI 10.1023/A:1025048516769; HERBERTZ H, 1995, SCIENTOMETRICS, V33, P117, DOI 10.1007/BF02020777; Herrmann I, 2008, GERMANY PARLIAMENT P; Ho YS, 2003, SCIENTOMETRICS, V57, P369, DOI 10.1023/A:1025004701748; Isasi RM, 2006, HUM REPROD, V21, P2474, DOI 10.1093/humrep/del235; KATZ JS, 1994, SCIENTOMETRICS, V31, P31, DOI 10.1007/BF02018100; Katz JS, 1997, SCIENTOMETRICS, V40, P541, DOI 10.1007/BF02459299; Li LL, 2009, SCIENTOMETRICS, V80, P39, DOI 10.1007/s11192-008-1939-5; Liao LM, 2007, PHILOS T R SOC B, V362, P1107, DOI 10.1098/rstb.2007.2037; Loser P, 2010, STEM CELLS, V28, P240, DOI 10.1002/stem.286; Luo JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017684; LUUKKONEN T, 1992, SCI TECHNOL HUM VAL, V17, P101, DOI 10.1177/016224399201700106; MATTHEWS KR, 2009, STEM CELL RES SCI PO; McMahon DS, 2010, REGEN MED, V5, P35, DOI [10.2217/rme.09.78, 10.2217/RME.09.78]; Ministry of Health of the People's Republic of China, 2009, CLIN APPL TECHN MAN; NARIN F, 1991, SCIENTOMETRICS, V21, P313, DOI 10.1007/BF02093973; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; O ffi ce of the President of the United States, 2009, FEG REG 4 FEG REG 4, V74, P10667; Salter B, 2006, REGEN MED, V1, P671, DOI 10.2217/17460751.1.5.671; Schuldt BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052068; SMART JC, 1986, SCIENTOMETRICS, V10, P297, DOI 10.1007/BF02016776; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tansey B, 2008, SAN FRANCISCO CHRONI; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; United Kingdom Human Tissue Authority, 2008, STEM CELL SCI UK KEY; US National Institutes of Health, 2010, STEM CELLS DIS; US National Institutes of Health, 2009, STEM CELL BAS WHAT A; US National Science Foundation, 2010, SCI ENG IND 2010; US National Science Foundation, 2012, SCI ENG IND 2012; Wallace ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033339; WIDERMANN P, 2004, EMBO REP, V5, P927; Zweig D, 2012, CHINA Q	48	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73598	10.1371/journal.pone.0073598	http://dx.doi.org/10.1371/journal.pone.0073598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069210	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326240100051
J	Stang, AS; Wingert, AS; Hartling, L; Plint, AC				Stang, Antonia S.; Wingert, Aireen S.; Hartling, Lisa; Plint, Amy C.			Adverse Events Related to Emergency Department Care: A Systematic Review	PLOS ONE			English	Review							FOCUSED TRIGGER TOOL; PATIENT SAFETY; HOSPITALIZED-PATIENTS; HEALTH-CARE; EXPERIENCE; ERRORS; HARM; US	Objective: To systematically review the literature regarding the prevalence, preventability, severity and types of adverse events (AE) in the Emergency Department (ED). Methods: We systematically searched major bibliographic databases, relevant journals and conference proceedings, and completed reference reviews of primary articles. Observational studies (cohort and case-control), quasi-experimental (e.g. before/after) studies and randomized controlled trials, were considered for inclusion if they examined a broad demographic group reflecting a significant proportion of ED patients and described the proportion of AE. Studies conducted outside of the ED setting, those examining only a subpopulation of patients (e.g. a specific entrance complaint or receiving a specific intervention), or examining only adverse drug events, were excluded. Two independent reviewers assessed study eligibility, completed data extraction, and assessed study quality with the Newcastle Ottawa Scale. Results: Our search identified 11,624 citations. Ten articles, representing eight observational studies, were included. Methodological quality was low to moderate with weaknesses in study group comparability, follow-up, and outcome ascertainment and reporting. There was substantial variation in the proportion of patients with AE related to ED care, ranging from 0.16% (n = 9308) to 6.0% (n = 399). Similarly, the reported preventability of AE ranged from 36% (n = 250) to 71% (n = 24). The most common types of events were related to management (3 studies), diagnosis (2 studies) and medication (2 studies). Conclusions: The variability in findings and lack of high quality studies on AE in the high risk ED setting highlights the need for research in this area. Further studies with rigorous, standardized outcome assessment and reporting are required.	[Stang, Antonia S.] Univ Calgary, Dept Pediat & Community Hlth Sci, Calgary, AB, Canada; [Wingert, Aireen S.] Univ Alberta, Dept Pediat, Cochrane Child Hlth Field, Edmonton, AB, Canada; [Plint, Amy C.] Univ Ottawa, Dept Pediat & Emergency Med, Ottawa, ON, Canada; [Hartling, Lisa] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada	University of Calgary; University of Alberta; University of Ottawa; University of Alberta	Stang, AS (corresponding author), Univ Calgary, Dept Pediat & Community Hlth Sci, Calgary, AB, Canada.	antonia.stang@albertahealthservices.ca	Plint, Amy/AAE-2250-2020		Canadian Institute of Health Research, CIHR	Canadian Institute of Health Research, CIHR(Canadian Institutes of Health Research (CIHR))	Amy Plint received support for this project from the Canadian Institute of Health Research, CIHR(http://www.cihr-irsc.gc.ca). Lisa Hartling holds a New Investigator Salary Award from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroyd-Stolarz S, 2011, QUAL SAF HLTH CARE; Agarwal S, 2010, PEDIATR CRIT CARE ME, V11, P568, DOI 10.1097/PCC.0b013e3181d8e405; [Anonymous], CAN I HLTH INF B; [Anonymous], GLOSS TERMS; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Baker GR, 2004, CAN MED ASSOC J, V170, P353; Barata IA, 2007, PEDIATR EMERG CARE, V23, P412, DOI 10.1097/01.pec.0000278393.32752.9f; Bigham B, 2008, PATIENT SAFETY EMERG; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Calder LA, 2010, CAN J EMERG MED, V12, P421; Classen DC, 2008, J PATIENT SAF, V4; de Vries EN, 2008, QUAL SAF HEALTH CARE, V17, P216, DOI 10.1136/qshc.2007.023622; Fordyce J, 2003, ANN EMERG MED, V42, P324, DOI 10.1016/S0196-0644(03)00398-6; Forster AJ, 2004, CAN MED ASSOC J, V170, P1235, DOI 10.1503/cmaj.1030683; Forster AJ, 2007, QUAL SAF HEALTH CARE, V16, P17, DOI 10.1136/qshc.2005.017384; Friedman SM, 2008, CAN J EMERG MED, V10, P421; Griffin FA, 2008, QUAL SAF HEALTH CARE, V17, P253, DOI 10.1136/qshc.2007.025080; Hall KK, 2010, QUAL SAF HEALTH CARE, V19, pI20, DOI 10.1136/qshc.2010.040246; Hendrie J, 2007, EMERG MED AUSTRALAS, V19, P16, DOI 10.1111/j.1742-6723.2006.00896.x; Hendrie J, 2007, EMERG MED AUSTRALAS, V19, P9, DOI 10.1111/j.1742-6723.2006.00897.x; Henneman P. L., 2005, J PATIENT SAF, V1, P126, DOI DOI 10.1097/01.JPS.0000175694.39559.12; Institute of Medicine, 2000, ERR IS HUMAN BUILDIN; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Matlow AG, 2011, QUAL SAF HLTH CARE; Matlow AG, 2012, CAN MED ASSOC J, V184, pE709, DOI 10.1503/cmaj.112153; Miller MR, 2003, PEDIATRICS, V111, P1358, DOI 10.1542/peds.111.6.1358; Resar RK, 2006, JT COMM J QUAL PATIE, V32, P585, DOI 10.1016/S1553-7250(06)32076-4; Sharek PJ, 2006, PEDIATRICS, V118, P1332, DOI 10.1542/peds.2006-0565; Smyth RMD, 2012, PLOS MED, V7, P24; Takata GS, 2008, PEDIATRICS, V121, pE927, DOI 10.1542/peds.2007-1779; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Wells G.A., NEWCASTLE OTTAWA SCA; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x; Wolff AM, 2002, EMERG MED J, V19, P35, DOI 10.1136/emj.19.1.35; Wolff AM, 2001, MED J AUSTRALIA, V174, P621, DOI 10.5694/j.1326-5377.2001.tb143469.x	36	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74214	10.1371/journal.pone.0074214	http://dx.doi.org/10.1371/journal.pone.0074214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069281	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100089
J	Steinbach, S; Reindl, W; Dempfle, A; Schuster, A; Wolf, P; Hundt, W; Huber, W				Steinbach, Silke; Reindl, Wolfgang; Dempfle, Astrid; Schuster, Anna; Wolf, Petra; Hundt, Walter; Huber, Wolfgang			Smell and Taste in Inflammatory Bowel Disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CROHNS-DISEASE; NUTRITIONAL-STATUS; DIETARY-INTAKE; QUANTITATIVE ASSESSMENT; OLFACTORY DYSFUNCTION; FLAVOR ENHANCEMENT; SUGAR CONSUMPTION; DISORDERS; IDENTIFICATION	Objective: To investigate the olfactory/gustatory functions of patients with inflammatory bowel disease (IBD) by smell/taste tests, and to determine if disease activity or medication might influence the olfactory/gustatory functions of patients. Patients and Methods: In total, 59 IBD patients (37 Crohn's disease (CD) and 22 ulcerative colitis (UC) patients) were studied using "Sniffin' sticks" and "taste strips" for olfactory and gustatory tests, respectively, and compared to healthy controls and published normative data. Results: Among IBD (CD and UC) patients, the values for odor threshold, but not for odor identification or discrimination, were significantly lower than that of the normative data. Further, these patients showed lower values than the normative taste values and the control group for all tastes, except sour; 57.6% of the IBD patients were hyposmic, while 30.5% were hypogeusic. Subjective self-assessments showed that the patients were not aware of their reduced olfactory/gustatory functions. There were no relevant differences in taste and smell abilities between the CD and UC patients. Disease activity and treatment did not influence the olfactory/gustatory functions. Conclusion: IBD (CD and UC) patients exhibited significant reductions in the olfactory and gustatory functions. Therefore, patients should be tested by smell/taste tests, in order to be adequately informed of their olfactory/gustatory functions and provided an understanding of how to overcome their limitations, and thus improve their quality of life.	[Steinbach, Silke] Univ Marburg, Dept Otorhinolaryngol, Marburg, Germany; [Reindl, Wolfgang; Schuster, Anna; Huber, Wolfgang] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, Dept Gastroenterol, D-80290 Munich, Germany; [Dempfle, Astrid] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Wolf, Petra] Tech Univ Munich, Klinikum Rechts Isar, Dept Med Stat & Epidemiol, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Hundt, Walter] Univ Marburg, Dept Radiol, Marburg, Germany	Philipps University Marburg; Technical University of Munich; Philipps University Marburg; Technical University of Munich; Philipps University Marburg	Steinbach, S (corresponding author), Univ Marburg, Dept Otorhinolaryngol, Marburg, Germany.	silkesteinbach@hotmail.com	Dempfle, Astrid/ABB-8889-2020; Dempfle, Astrid/D-1513-2012	Dempfle, Astrid/0000-0002-2618-3920				Adams DH, 2006, NAT REV IMMUNOL, V6, P244, DOI 10.1038/nri1784; Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; AUVIN S, 2003, GUT, V35, pA53; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; DUFFY VB, 1995, J AM DIET ASSOC, V95, P879, DOI 10.1016/S0002-8223(95)00244-8; Ellul P, 2007, AM J GASTROENTEROL, V102, P689, DOI 10.1111/j.1572-0241.2007.01040_6.x; Eloy P, 2007, EUR ARCH OTO-RHINO-L, V264, P103, DOI 10.1007/s00405-006-0146-3; Fasunla JA, 2012, EUR ARCH OTO-RHINO-L, V269, P179, DOI 10.1007/s00405-011-1691-y; Gilat T, 1986, FRONT GASTROINTEST R, V11, P158; Griffiths A., 2000, PAEDIAT GASTROINTEST, V3rd ed., P613; Hartman C, 2009, WORLD J GASTROENTERO, V15, P2570, DOI 10.3748/wjg.15.2570; Heckmann SM, 2005, J DENT RES, V84, P35, DOI 10.1177/154405910508400105; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; JONESGOTMAN M, 1988, NEUROPSYCHOLOGIA, V26, P387, DOI 10.1016/0028-3932(88)90093-0; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Katz J, 2003, ORAL DIS, V9, P34, DOI 10.1034/j.1601-0825.2003.00879.x; Kidd M, 2008, AM J PHYSIOL-GASTR L, V295, pG260, DOI 10.1152/ajpgi.00056.2008; Lambert B, 2012, DIGEST DIS SCI, V57, P2171, DOI 10.1007/s10620-012-2232-2; Landis BN, 2010, ORL-J OTO-RHIN-LARYN, V72, P252, DOI 10.1159/000317024; Landis BN, 2009, J NEUROL, V256, P242, DOI 10.1007/s00415-009-0088-y; LEDERER PC, 1985, Z GASTROENTEROL, V23, P470; Mahmud N, 2001, EUR J GASTROEN HEPAT, V13, P93, DOI 10.1097/00042737-200102000-00001; MARTINI GA, 1976, KLIN WOCHENSCHR, V54, P367, DOI 10.1007/BF01469792; Mathey MFAM, 2001, J GERONTOL A-BIOL, V56, pM200, DOI 10.1093/gerona/56.4.M200; MAYBERRY JF, 1980, DIGESTION, V20, P323, DOI 10.1159/000198454; MAYBERRY JF, 1981, DIGEST DIS SCI, V26, P444, DOI 10.1007/BF01313588; MILLER B, 1976, Verhandlungen der Deutschen Gesellschaft fuer Innere Medizin, V82, P922; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Mueller C, 2003, RHINOLOGY, V41, P2; MURCH SH, 1991, GUT, V32, P913, DOI 10.1136/gut.32.8.913; MURPHY C, 1977, SENS PROCESS, V1, P204; O'Sullivan M, 2006, BEST PRACT RES CL GA, V20, P561, DOI 10.1016/j.bpg.2006.03.001; PENNY WJ, 1983, GUT, V24, P288, DOI 10.1136/gut.24.4.288; Perricone C, 2013, CLIN REV ALLERG IMMU, V45, P87, DOI 10.1007/s12016-012-8343-x; Prescott J, 2004, APPETITE, V42, P143, DOI 10.1016/j.appet.2003.08.013; Reden J, 2007, EUR ARCH OTO-RHINO-L, V264, P139, DOI 10.1007/s00405-006-0157-0; Reif S, 1997, GUT, V40, P754, DOI 10.1136/gut.40.6.754; Rowland M, 2010, INFLAMM BOWEL DIS, V16, P332, DOI 10.1002/ibd.20983; Sakagami M, 2009, ACTA OTO-LARYNGOL, V129, P1115, DOI 10.1080/00016480802552550; Sari S, 2007, DIGEST DIS SCI, V52, P1285, DOI 10.1007/s10620-006-9584-4; Schiffman SS, 2007, J NUTR HEALTH AGING, V11, P439; Schutz T, 2003, DIGEST DIS, V21, P252, DOI 10.1159/000073343; Shoda R, 1996, AM J CLIN NUTR, V63, P741, DOI 10.1093/ajcn/63.5.741; Steinbach S, 2011, SCAND J RHEUMATOL, V40, P169, DOI 10.3109/03009742.2010.517547; Steinbach S, 2008, Laryngorhinootologie, V87, P657, DOI 10.1055/s-2008-1077547; Steinbach S, 2012, AM J RHINOL ALLERGY, V26, P463, DOI 10.2500/ajra.2012.26.3824; Steinbach S, 2010, EUR ARCH OTO-RHINO-L, V267, P1081, DOI 10.1007/s00405-009-1181-7; Steinbach S, 2009, J CLIN ONCOL, V27, P1899, DOI 10.1200/JCO.2008.19.2690; Szczeklik K, 2012, POL ARCH MED WEWN, V122, P200, DOI 10.20452/pamw.1256; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Turner JH, 2010, AM J RHINOL ALLERGY, V24, P336, DOI 10.2500/ajra.2010.24.3498; Yamamoto T, 2009, ALIMENT PHARM THER, V30, P99, DOI 10.1111/j.1365-2036.2009.04035.x; Yeomans MR, 2008, PHYSIOL BEHAV, V93, P958, DOI 10.1016/j.physbeh.2007.12.009; Yoshida H, 2011, INFLAMM BOWEL DIS, V17, P2217, DOI 10.1002/ibd.21593; Zopf Y, 2009, J CLIN GASTROENTEROL, V43, P617, DOI 10.1097/MCG.0b013e31818acf91	58	20	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73454	10.1371/journal.pone.0073454	http://dx.doi.org/10.1371/journal.pone.0073454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086282	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700010
J	Arumugam, G; Nair, AG; Hariharaputran, S; Ramanathan, S				Arumugam, Gandhimathi; Nair, Anu G.; Hariharaputran, Sridhar; Ramanathan, Sowdhamini			Rebelling for a Reason: Protein Structural "Outliers''	PLOS ONE			English	Article							ASPARTATE-ALPHA-DECARBOXYLASE; RAY CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DOMAIN SUPERFAMILIES; FOLD SPACE; HOMOLOGOUS PROTEINS; BETA-ALANINE; DATABASE; ALIGNMENTS; SEQUENCE	Analysis of structural variation in domain superfamilies can reveal constraints in protein evolution which aids protein structure prediction and classification. Structure-based sequence alignment of distantly related proteins, organized in PASS2 database, provides clues about structurally conserved regions among different functional families. Some superfamily members show large structural differences which are functionally relevant. This paper analyses the impact of structural divergence on function for multi-member superfamilies, selected from the PASS2 superfamily alignment database. Functional annotations within superfamilies, with structural outliers or 'rebels', are discussed in the context of structural variations. Overall, these data reinforce the idea that functional similarities cannot be extrapolated from mere structural conservation. The implication for fold-function prediction is that the functional annotations can only be inherited with very careful consideration, especially at low sequence identities.	[Arumugam, Gandhimathi; Nair, Anu G.; Hariharaputran, Sridhar; Ramanathan, Sowdhamini] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Ramanathan, S (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Gandhi Krishi Vigyana Kendra Campus, Bangalore, Karnataka, India.	mini@ncbs.res.in	mo, qin/O-7877-2014	Nair, Anu/0000-0002-1952-9583; Hariharaputran, Sridhar/0000-0002-9979-3244	Council of Scientific and Industrial Research (CSIR); Centre for Excellence; Department of Biotechnology, India; National Centre for Biological Sciences (NCBS)	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Centre for Excellence; Department of Biotechnology, India(Department of Biotechnology (DBT) India); National Centre for Biological Sciences (NCBS)(Tata Institute of Fundamental Research (TIFR))	Gandhimathi Arumugam is supported by Senior Research Fellowship from the Council of Scientific and Industrial Research (CSIR). The work is supported by Centre for Excellence Grant by Department of Biotechnology, India and The National Centre for Biological Sciences (NCBS) for financial and infrastructural support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Bennett MJ, 2004, STRUCTURE, V12, P1339, DOI 10.1016/j.str.2004.07.004; Bhaduri A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-35; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Castillo RM, 1999, STRUCTURE, V7, P227, DOI 10.1016/S0969-2126(99)80028-8; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Cuff A, 2009, STRUCTURE, V17, P1051, DOI 10.1016/j.str.2009.06.015; Dessailly BH, 2009, CURR OPIN STRUC BIOL, V19, P349, DOI 10.1016/j.sbi.2009.03.009; Devedjiev Y, 2004, J MOL BIOL, V343, P395, DOI 10.1016/j.jmb.2004.08.037; Du ZD, 2009, NUCLEIC ACIDS RES, V37, pW345, DOI 10.1093/nar/gkp463; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furnham N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002403; Gandhimathi A, 2012, NUCLEIC ACIDS RES, V40, pD531, DOI 10.1093/nar/gkr1096; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Gupta K, 2004, J MOL BIOL, V335, P503, DOI 10.1016/j.jmb.2003.10.073; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HUBBARD TJP, 1987, PROTEIN ENG, V1, P159, DOI 10.1093/protein/1.3.159; Kanagarajadurai K, 2011, IJKDB IN PRESS; Kolodny R, 2006, CURR OPIN STRUC BIOL, V16, P393, DOI 10.1016/j.sbi.2006.04.007; Lee B, 2004, J MOL BIOL, V340, P1, DOI 10.1016/j.jmb.2004.04.049; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Mallika V, 2002, NUCLEIC ACIDS RES, V30, P284, DOI 10.1093/nar/30.1.284; Mayr G, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-50; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MURZIN AG, 1994, CURR OPIN STRUC BIOL, V4, P441, DOI 10.1016/S0959-440X(94)90114-7; Murzin AG, 1998, CURR OPIN STRUC BIOL, V8, P380, DOI 10.1016/S0959-440X(98)80073-0; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Park JE, 2010, CELL MOL LIFE SCI, V67, P1957, DOI 10.1007/s00018-010-0279-9; Pershad HR, 1999, BBA-BIOENERGETICS, V1412, P262, DOI 10.1016/S0005-2728(99)00066-3; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Pirovano W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-556; POULOS TL, 1980, J BIOL CHEM, V255, P8199; PTITSYN OB, 1980, Q REV BIOPHYS, V13, P339, DOI 10.1017/S0033583500001724; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; Sowdhamini R, 1998, STRUCTURE, V6, P1087, DOI 10.1016/S0969-2126(98)00110-5; SUTCLIFFE MJ, 1987, PROTEIN ENG, V1, P377, DOI 10.1093/protein/1.5.377; Taylor WR, 2007, CURR OPIN STRUC BIOL, V17, P354, DOI 10.1016/j.sbi.2007.06.002; Teng ZX, 2013, BIOINFORMATICS, V29, P1424, DOI 10.1093/bioinformatics/btt160; WASTERNACK C, 1980, PHARMACOL THERAPEUT, V8, P629, DOI 10.1016/0163-7258(80)90079-0; Webb Edwin C., 1992, ENZYME NOMENCLATURE; WILLIAMSON JM, 1979, J BIOL CHEM, V254, P8074; Wright GD, 1999, CURR OPIN MICROBIOL, V2, P499, DOI 10.1016/S1369-5274(99)00007-7; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	54	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74416	10.1371/journal.pone.0074416	http://dx.doi.org/10.1371/journal.pone.0074416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073209	Green Submitted, gold, Green Published			2022-12-27	WOS:000324768000018
J	Vorimore, F; Hsia, RC; Huot-Creasy, H; Bastian, S; Deruyter, L; Passet, A; Sachse, K; Bavoil, P; Myers, G; Laroucau, K				Vorimore, Fabien; Hsia, Ru-ching; Huot-Creasy, Heather; Bastian, Suzanne; Deruyter, Lucie; Passet, Anne; Sachse, Konrad; Bavoil, Patrik; Myers, Garry; Laroucau, Karine			Isolation of a New Chlamydia species from the Feral Sacred Ibis (Threskiornis aethiopicus): Chlamydia ibidis	PLOS ONE			English	Article							CHLAMYDOPHILA-PSITTACI INFECTIONS; EMPHASIS; PIGEONS; HUMANS; BIRDS; PCR	Investigations conducted on feral African Sacred Ibises (Threskiornis aethiopicus) in western France led to the isolation of a strain with chlamydial genetic determinants. Ultrastructural analysis, comparative sequence analysis of the 16S rRNA gene, ompA, and of a concatenate of 31 highly conserved genes, as well as determination of the whole genome sequence confirmed the relatedness of the new isolate to members of the Chlamydiaceae, while, at the same time demonstrating a unique position outside the currently recognized species of this family. We propose to name this new chlamydial species Chlamydia ibidis.	[Vorimore, Fabien; Deruyter, Lucie; Laroucau, Karine] Univ Paris Est, Anses, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France; [Hsia, Ru-ching] Univ Maryland, Core Imaging Facil, Baltimore, MD 21201 USA; [Huot-Creasy, Heather; Myers, Garry] Univ Maryland, Inst Genome Sci, Baltimore, MD 21201 USA; [Bastian, Suzanne; Passet, Anne] Univ Nantes Angers, Nantes, France; [Bastian, Suzanne] ONIRIS, UMR1300, Nantes, France; [Bastian, Suzanne] INRA, UMR1300, F-44026 Nantes, France; [Passet, Anne] ONIRIS, Ctr Wildlife & Ecosyst Hlth, Nantes, France; [Sachse, Konrad] Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany; [Bavoil, Patrik] Univ Maryland, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; University System of Maryland; University of Maryland Baltimore	Laroucau, K (corresponding author), Univ Paris Est, Anses, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France.	karine.laroucau@anses.fr	Sachse, Konrad/GWC-4999-2022; Laroucau, Karine/GSO-1980-2022; Myers, Garry/E-7708-2011	Sachse, Konrad/0000-0003-1230-1786; Laroucau, Karine/0000-0001-7605-8602; Myers, Garry/0000-0002-4756-4810; Bastian, Suzanne/0000-0003-4903-9742	NIH [U19 AI084044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI084044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Patrik Bavoil was supported by NIH U19 AI084044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BERGEYS MANUAL SYSTE; Barret J, 2010, REV SCI TECH OIE, V29, P113, DOI 10.20506/rst.29.1.1968; Bastian S, 2010, 9 EWDA C DUTCH ISL V; Christerson L, 2010, ENV MICROBIOL REP, V2, P605, DOI 10.1111/j.1758-2229.2010.00174.x; Clergeau P, 2006, BIOL INVASIONS, V8, P1381, DOI 10.1007/s10530-006-0002-9; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Gaede W, 2008, ZOONOSES PUBLIC HLTH, V55, P184, DOI 10.1111/j.1863-2378.2008.01108.x; Gasparini J, 2011, ENVIRON MICROBIOL, V13, P3186, DOI 10.1111/j.1462-2920.2011.02575.x; Guerin JL, 2006, P 7 JOURN RECH PALM, P37; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; HENRY MC, 1977, B SOC PATHOL EXOT, V70, P144; Herrmann B, 2000, APPL ENVIRON MICROB, V66, P3654, DOI 10.1128/AEM.66.8.3654-3656.2000; Kaleta EF, 2003, AVIAN PATHOL, V32, P435, DOI 10.1080/03079450310001593613; Laroucau K, 2009, INFECT GENET EVOL, V9, P1240, DOI 10.1016/j.meegid.2009.08.005; Laroucau K, 2009, VET MICROBIOL, V135, P82, DOI 10.1016/j.vetmic.2008.09.048; Lemus JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013512; Leon O, 2004, 6 JOURN RECH PALM FO; MATSUMOTO A, 1991, J ELECTRON MICROSC, V40, P356; Matsumoto A., 1988, MICROBIOLOGY CHLAMYD, P21; Menard A, 2006, J MED MICROBIOL, V55, P471, DOI 10.1099/jmm.0.46335-0; Myers GSA, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P27, DOI 10.1128/9781555817329.ch2; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Prukner-Radovcic E, 2009, P 1 EUR M AN CHLAM Z; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Sachse K, 2012, VET MICROBIOL, V157, P476, DOI 10.1016/j.vetmic.2012.01.002; Sachse K, 2009, VET MICROBIOL, V135, P2, DOI 10.1016/j.vetmic.2008.09.040; SPENCER WN, 1983, VET REC, V113, P535; Travnicek M, 2002, ANN AGR ENV MED, V9, P253; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Vicari N, 2009, P 1 EUR M AN CHLAM Z; Wilson DP, 2006, B MATH BIOL, V68, P161, DOI 10.1007/s11538-005-9024-1; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Zocevic A, 2012, ENVIRON MICROBIOL, V14, P2212, DOI 10.1111/j.1462-2920.2012.02800.x	34	69	71	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74823	10.1371/journal.pone.0074823	http://dx.doi.org/10.1371/journal.pone.0074823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073223	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000032
J	Yen, TA; Yang, HI; Hsieh, WS; Chou, HC; Chen, CY; Tsou, KI; Tsao, PN				Yen, Ting-An; Yang, Hwai-I; Hsieh, Wu-Shiun; Chou, Hung-Chieh; Chen, Chien-Yi; Tsou, Kuo-Inn; Tsao, Po-Nien		Taiwan Premature Infant Dev Collab	Preeclampsia and the Risk of Bronchopulmonary Dysplasia in VLBW Infants: A Population Based Study	PLOS ONE			English	Article							CHRONIC LUNG-DISEASE; RESPIRATORY-DISTRESS-SYNDROME; GROWTH-FACTOR; TYROSINE KINASE-1; MATERNAL PREECLAMPSIA; ANGIOGENIC FACTORS; PRETERM DELIVERY; CORD BLOOD; HYPERTENSION; PATHOGENESIS	Background: Preeclampsia remains a leading cause of maternal mortality and preterm delivery. Both preeclampsia and bronchopulmonary dysplasia (BPD) of prematurity are associated with impaired angiogenesis. However, the relationship between maternal preeclampsia and BPD remains controversial. This study aims to test whether or not preeclampsia is associated with development of BPD in a cohort of premature infants. Materials and Methods: We conducted a retrospective cohort study assessing the association between preeclampsia and the risk of developing BPD in very-low-birth-weight (VLBW) infants registered in the Premature Baby Foundation of Taiwan from 1997 through 2006. All 21 neonatal departments in Taiwan participated in the data collection. A total of 8,653 VLBW infants were registered in the database. The exclusion criteria included congenital anomalies, chromosome anomalies, infants that died before 36 weeks post-conceptual (PCA), and those whose BPD status were unavailable. BPD was defined as oxygen dependence at 36 weeks postmenstrual age. The association between maternal preeclampsia and BPD was assessed using a multivariate-adjusted logistic regression model. Results: In the end, a total of 5,753 cases were enrolled in this study. The incidence of preeclampsia was 14.7% (n=847) and the overall incidence of BPD was 34.9%. Infants with maternal preeclampsia had a higher gestational age, higher incidence of cesarean section and being small for their gestational age, lower incidence of respiratory distress syndrome, patent ductus arteriosus, and sepsis. BPD occurred significantly less frequently in the maternal preeclampsia group (24.1% vs. 36.7%; adjusted odds ratio: 0.78; 95% confidence interval, 0.62-0.98). Subgroup analysis showed that the association between preeclampsia and BPD was significant only in those VLBW infants with a gestational age between 31-34 weeks. Conclusion: This data supports the association between fetal exposure to maternal preeclampsia and a reduced risk of BPD in relatively mature VLBW infants.	[Yen, Ting-An; Hsieh, Wu-Shiun; Chou, Hung-Chieh; Chen, Chien-Yi; Tsao, Po-Nien] Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yang, Hwai-I] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Yang, Hwai-I] China Med Univ Hosp, Mol & Genom Epidemiol Ctr, Taichung, Taiwan; [Yang, Hwai-I] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Tsou, Kuo-Inn] Cardinal Tien Hosp, Dept Pediat, New Taipei City, Taiwan; [Tsou, Kuo-Inn] Fu Jen Catholic Univ, Coll Med, New Taipei City, Taiwan; [Tsao, Po-Nien] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Academia Sinica - Taiwan; Cardinal Tien Hospital; Fu Jen Catholic University; National Taiwan University	Tsao, PN (corresponding author), Natl Taiwan Univ, Coll Med, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan.	tsaopn@ntu.edu.tw	Yang, Hwai-I/A-9470-2008; Chen, Chien-Yi/A-9680-2015; Chou, Hung-Chieh/AGZ-5161-2022	Yang, Hwai-I/0000-0002-3433-942X; Chen, Chien-Yi/0000-0002-6030-2655; Hsieh, Kai-Sheng/0000-0002-0294-9872; TSAO, PO-NIEN/0000-0002-6114-1769; CHOU, HUNG-CHIEH/0000-0002-8932-9472; YEN, TING-AN/0000-0002-2288-6784; HSIEH, WU-SHIUN/0000-0002-0609-3311; Huang, Chao-Ching/0000-0003-2799-7181; Tsou, Kuo-inn/0000-0002-5986-7624	National Science Council [NSC 101-2628-B-002 -002 -MY4]; National Taiwan University [102R7751]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by grant awards from National Science Council (NSC 101-2628-B-002 -002 -MY4) and National Taiwan University (102R7751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abman SH, 2010, ADV EXP MED BIOL, V661, P323, DOI 10.1007/978-1-60761-500-2_21; ACOG, 2002, OBSTET GYNECOL, V99, P869; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bose C, 2009, PEDIATRICS, V124, pE450, DOI 10.1542/peds.2008-3249; BOWEN JR, 1988, AUST NZ J OBSTET GYN, V28, P109, DOI 10.1111/j.1479-828X.1988.tb01635.x; BRAZY JE, 1982, J PEDIATR-US, V100, P265, DOI 10.1016/S0022-3476(82)80653-7; Cetinkaya M, 2010, J MATERN-FETAL NEO M, V23, P425, DOI [10.3109/14767050903184173, 10.1080/14767050903184173]; Cheng SL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-115; Cheng SW, 2004, EARLY HUM DEV, V76, P39, DOI 10.1016/j.earlhumdev.2003.10.004; CHISWICK ML, 1976, ARCH DIS CHILD, V51, P674, DOI 10.1136/adc.51.9.674; Durrmeyer X, 2012, J PEDIATR-US, V160, P578, DOI 10.1016/j.jpeds.2011.09.025; FRIEDMAN SA, 1995, AM J OBSTET GYNECOL, V172, P1785, DOI 10.1016/0002-9378(95)91412-9; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Gyamfi-Bannerman C, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.08.007; Hansen AR, 2010, J PEDIATR-US, V156, P532, DOI 10.1016/j.jpeds.2009.10.018; Hsieh T T, 1991, J Formos Med Assoc, V90, P382; Jelin AC, 2010, J MATERN-FETAL NEO M, V23, P389, DOI [10.1080/14767050903168416, 10.3109/14767050903168416]; Kim CR, 1996, ARCH PEDIAT ADOL MED, V150, P686, DOI 10.1001/archpedi.1996.02170320032005; Korhonen P, 1999, EARLY HUM DEV, V54, P245, DOI 10.1016/S0378-3782(98)00101-7; Kurkinen-Raty M, 2000, BRIT J OBSTET GYNAEC, V107, P648, DOI 10.1111/j.1471-0528.2000.tb13308.x; Lal MK, 2003, PEDIATRICS, V111, P483, DOI 10.1542/peds.111.3.483; Langenveld J, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.003; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lindheimer MD, 2006, NEW ENGL J MED, V355, P1056, DOI 10.1056/NEJMe068161; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; O'Shea JE, 2012, PEDIATR RES, V71, P210, DOI 10.1038/pr.2011.27; Redline RW, 2002, PEDIATR RES, V52, P713, DOI 10.1203/00006450-200211000-00017; Reiss Irwin, 2003, Archives of Gynecology and Obstetrics, V269, P40, DOI 10.1007/s00404-003-0486-9; Schlapbach LJ, 2010, ACTA PAEDIATR, V99, P1504, DOI 10.1111/j.1651-2227.2010.01861.x; Sharma Puneet, 2004, BMC Pediatr, V4, P9, DOI 10.1186/1471-2431-4-9; Staff AC, 2005, EUR J OBSTET GYN R B, V122, P33, DOI 10.1016/j.ejogrb.2004.11.015; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Tang JR, 2012, AM J PHYSIOL-LUNG C, V302, pL36, DOI 10.1152/ajplung.00294.2011; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Tsao PN, 2005, PEDIATRICS, V116, P468, DOI 10.1542/peds.2004-2240; Tsao PN, 2004, PEDIATRICS, V113, P1348, DOI 10.1542/peds.113.5.1348; Tsao PN, 2004, AM J RESP CRIT CARE, V169, P505, DOI 10.1164/rccm.200306-774OC; Tsao PN, 1999, J PEDIATR-US, V135, P56, DOI 10.1016/S0022-3476(99)70327-6; TUBMAN TRJ, 1991, ARCH DIS CHILD-FETAL, V66, P52, DOI 10.1136/adc.66.1_Spec_No.52; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Withagen MIJ, 2001, EUR J OBSTET GYN R B, V94, P211, DOI 10.1016/S0301-2115(00)00332-8; WOLF EJ, 1993, AM J OBSTET GYNECOL, V169, P1233, DOI 10.1016/0002-9378(93)90288-T; YOON JJ, 1980, PEDIATRICS, V65, P735; Zeitlin J, 2010, J PEDIATR-US, V157, P733, DOI 10.1016/j.jpeds.2010.05.002	50	39	45	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75168	10.1371/journal.pone.0075168	http://dx.doi.org/10.1371/journal.pone.0075168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073247	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000056
J	Barthels, C; Puchalka, J; Racek, T; Klein, C; Brocker, T				Barthels, Christian; Puchalka, Jacek; Racek, Tomas; Klein, Christoph; Brocker, Thomas			Novel Spontaneous Deletion of Artemis Exons 10 and 11 in Mice Leads to T- and B-Cell Deficiency	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; DEPENDENT PROTEIN-KINASE; DNA-LIGASE IV; COMBINED IMMUNE-DEFICIENCY; LEAKY SCID PHENOTYPE; V(D)J RECOMBINATION; GENE-MUTATIONS; NUCLEIC-ACIDS; BONE-MARROW; MOUSE	Here we describe a novel, spontaneous, 4035 basepairs long deletion in the DNA cross-link repair 1C (Dclre1c)-locus in C57BL/6-mice, which leads to loss of exons 10 and 11 of the gene encoding for Artemis, a protein involved into V(D) J-recombination of antigen receptors of T and B cells. While several spontaneous mutations of Artemis have been described to cause SCID in humans, in mice, only targeted deletions by knockout technology are known to cause the same phenotype so far. The deletion we observed causes a loss of Artemis function in the C57BL/6 strain and, consequently, the absence of T and B cells, in presence of normal numbers of NK cells and cells of the myeloid lineage. Thus, for the first time we present T-B-NK+ severe combined immunodeficiency (SCID) phenotype after spontaneously occurring modification of Artemis gene in mice. Our mouse model may serve as a valuable tool to study mechanisms as well as potential therapies of SCID in humans.	[Barthels, Christian; Brocker, Thomas] Univ Munich, Inst Immunol, D-80539 Munich, Germany; [Puchalka, Jacek; Racek, Tomas; Klein, Christoph] Univ Munich, Dept Pediat, Dr von Hauner Childrens Hosp, Munich, Germany	University of Munich; University of Munich	Brocker, T (corresponding author), Univ Munich, Inst Immunol, Goethestr 31, D-80539 Munich, Germany.	tbrocker@med.uni-muenchen.de		Brocker, Thomas/0000-0001-7060-5433	Deutsche Forschungsgemeinschaft [SFB 1054/B03, SFB 1054/A05]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft SFB 1054/B03 (TB) and SFB 1054/A05 (CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOYD RL, 1993, IMMUNOL TODAY, V14, P445, DOI 10.1016/0167-5699(93)90248-J; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Chistiakov DA, 2009, EUR J MED GENET, V52, P373, DOI 10.1016/j.ejmg.2009.05.009; Cossu F, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-76; de Villartay JP, 2003, CURR OPIN IMMUNOL, V15, P592, DOI 10.1016/S0952-7915(03)00101-8; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Farr AG, 2002, IMMUNOL REV, V189, P20, DOI 10.1034/j.1600-065X.2002.18903.x; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; Fischer A, 2005, IMMUNOL REV, V203, P98, DOI 10.1111/j.0105-2896.2005.00223.x; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Huang Y, 2009, J EXP MED, V206, P893, DOI 10.1084/jem.20082396; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; Kobayashi N, 2003, HUM GENET, V112, P348, DOI 10.1007/s00439-002-0897-x; Laurent J, 2004, INT IMMUNOL, V16, P1069, DOI 10.1093/intimm/dxh108; Li LY, 2005, J IMMUNOL, V174, P2420, DOI 10.4049/jimmunol.174.4.2420; Li LY, 2002, J IMMUNOL, V168, P6323, DOI 10.4049/jimmunol.168.12.6323; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Noordzij JG, 2003, BLOOD, V101, P1446, DOI 10.1182/blood-2002-01-0187; Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pannicke U, 2010, HUM MUTAT, V31, P197, DOI 10.1002/humu.21168; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Rivera-Munoz P, 2009, BLOOD, V114, P3601, DOI 10.1182/blood-2008-11-188383; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Rucci F, 2010, P NATL ACAD SCI USA, V107, P3024, DOI 10.1073/pnas.0914865107; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; van der Burg M, 2009, CURR OPIN ALLERGY CL, V9, P503, DOI 10.1097/ACI.0b013e3283327e41; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; Van der Burg M, 2007, EUR J IMMUNOL, V37, P3522, DOI 10.1002/eji.200737624; van Zelm MC, 2008, AM J HUM GENET, V82, P320, DOI 10.1016/j.ajhg.2007.10.011; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Xiao Z, 2009, BIOL BLOOD MARROW TR, V15, P1, DOI 10.1016/j.bbmt.2008.10.026	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74838	10.1371/journal.pone.0074838	http://dx.doi.org/10.1371/journal.pone.0074838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069355	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300060
J	Chevaleyre, J; Duchez, P; Rodriguez, L; Vlaski, M; Villacreces, A; Conrad-Lapostolle, V; Praloran, V; Ivanovic, Z; de la Grange, PB				Chevaleyre, Jean; Duchez, Pascale; Rodriguez, Laura; Vlaski, Marija; Villacreces, Arnaud; Conrad-Lapostolle, Veronique; Praloran, Vincent; Ivanovic, Zoran; de la Grange, Philippe Brunet			Busulfan Administration Flexibility Increases the Applicability of Scid Repopulating Cell Assay in NSG Mouse Model	PLOS ONE			English	Article							TAIL VEIN; ENGRAFTMENT; MICE; EFFICIENT; PROGENITORS	Background: Xenotransplantation models allowing the identification and quantification of human Hematopoietic stem cells (HSC) in immunodeficient mice remain the only way to appropriately address human HSC function despite the recent progress in phenotypic characterization. However, these in vivo experiments are technically demanding, time consuming and expensive. Indeed, HSCs engraftment in mouse requires pre-conditioning of animals either by irradiation or cytotoxic drugs to allow homing of injected cells in specific stem cell niches and their subsequent expansion and differentiation in bone marrow. Recently, the development of busulfan pre-conditioning of animals improved the flexibility of experimentation in comparison with irradiation. Design and Methods: In order to further facilitate the organization of these complex experiments we investigated the effect of extending the period between mice pre-conditioning and cell injection on the engraftment efficiency. In the meantime, we also explored the role of busulfan doses, mouse gender and intravenous injection route (caudal or retro orbital) on engraftment efficiency. Results and Conclusion: We showed that a period of up to 7 days did not modify engraftment efficiency of human HSCs in NSG model. Moreover, retro orbital cell injection to female mice pre-conditioned with 2x25 mg/kg of busulfan seems to be the best adapted schema to detect the human HSC in xenotransplantation experiments.	[Chevaleyre, Jean; Duchez, Pascale; Rodriguez, Laura; Vlaski, Marija; Ivanovic, Zoran; de la Grange, Philippe Brunet] EFS AqLi, Bordeaux, France; [Chevaleyre, Jean; Duchez, Pascale; Rodriguez, Laura; Vlaski, Marija; Villacreces, Arnaud; Conrad-Lapostolle, Veronique; Praloran, Vincent; Ivanovic, Zoran; de la Grange, Philippe Brunet] CNRS, UMR 5164, Bordeaux, France; [Chevaleyre, Jean; Duchez, Pascale; Rodriguez, Laura; Vlaski, Marija; Villacreces, Arnaud; Conrad-Lapostolle, Veronique; Praloran, Vincent; Ivanovic, Zoran; de la Grange, Philippe Brunet] Univ Bordeaux Segalen, UMR 5164, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	de la Grange, PB (corresponding author), EFS AqLi, Bordeaux, France.	philippe.brunet-de-la-grange@efs.sante.fr	Ivanovic, Zoran/ABC-7667-2020; Lafarge, Marija Vlaski/ABD-8047-2020; Rodriguez, Laura/ABC-8732-2020	Ivanovic, Zoran/0000-0001-6158-0270; Lafarge, Marija Vlaski/0000-0002-1961-1157; Rodriguez, Laura/0000-0001-8968-8873; VILLACRECES, Arnaud/0000-0002-2868-2264; BRUNET DE LA GRANGE, Philippe/0000-0001-5002-6012; DUCHEZ, PASCALE/0000-0003-1474-3764	French Blood Institute	French Blood Institute	The source of funding for this work is the French Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Bueno C, 2010, CYTOTHERAPY, V12, P45, DOI 10.3109/14653240903377052; DOWN JD, 1993, EXP HEMATOL, V21, P913; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Ivanovic Z, 2004, STEM CELLS, V22, P716, DOI 10.1634/stemcells.22-5-716; Lowry P A, 1996, Biol Blood Marrow Transplant, V2, P15; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; McDermott SP, 2010, BLOOD, V116, P193, DOI 10.1182/blood-2010-02-271841; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; PRICE JE, 1984, P SOC EXP BIOL MED, V177, P347; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Robert-Richard E, 2006, HAEMATOLOGICA, V91, P1384; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Steel CD, 2008, LAB ANIMAL, V37, P26, DOI 10.1038/laban0108-26; Sugimoto K, 2001, GROWTH FACTORS, V19, P219, DOI 10.3109/08977190109001088; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155	17	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74361	10.1371/journal.pone.0074361	http://dx.doi.org/10.1371/journal.pone.0074361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069300	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300036
J	Gueguen, P; Rouault, K; Chen, JM; Raguenes, O; Fichou, Y; Hardy, E; Gobin, E; Pan-petesch, B; Kerbiriou, M; Trouve, P; Marcorelles, P; Abgrall, JF; Le Marechal, C; Ferec, C				Gueguen, Paul; Rouault, Karen; Chen, Jian-Min; Raguenes, Odile; Fichou, Yann; Hardy, Elisabeth; Gobin, Eric; Pan-petesch, Brigitte; Kerbiriou, Mathieu; Trouve, Pascal; Marcorelles, Pascale; Abgrall, Jean-francois; Le Marechal, Cedric; Ferec, Claude			A Missense Mutation in the Alpha-Actinin 1 Gene (ACTN1) Is the Cause of Autosomal Dominant Macrothrombocytopenia in a Large French Family	PLOS ONE			English	Article							GRAY PLATELET SYNDROME; CONGENITAL MACROTHROMBOCYTOPENIA; THROMBOCYTOPENIA; NBEAL2; LEUKEMIA; DISEASE; ITGA2B; MYH9	Inherited thrombocytopenia is a heterogeneous group of disorders characterized by a reduced number of blood platelets. Despite the identification of nearly 20 causative genes in the past decade, approximately half of all subjects with inherited thrombocytopenia still remain unexplained in terms of the underlying pathogenic mechanisms. Here we report a six-generation French pedigree with an autosomal dominant mode of inheritance and the identification of its genetic basis. Of the 55 subjects available for analysis, 26 were diagnosed with isolated macrothrombocytopenia. Genome-wide linkage analysis mapped a 10.9 Mb locus to chromosome 14 (14q22) with a LOD score of 7.6. Candidate gene analysis complemented by targeted next-generation sequencing identified a missense mutation (c.137GA; p.Arg46Gln) in the alpha-actinin 1 gene (ACTN1) that segregated with macrothrombocytopenia in this large pedigree. The missense mutation occurred within actin-binding domain of alpha-actinin 1, a functionally critical domain that crosslinks actin filaments into bundles. The evaluation of cultured mutation-harboring megakaryocytes by electron microscopy and the immunofluorescence examination of transfected COS-7 cells suggested that the mutation causes disorganization of the cellular cytoplasm. Our study concurred with a recently published whole-exome sequence analysis of six small Japanese families with congenital macrothrombocytopenia, adding ACTN1 to the growing list of thrombocytopenia genes.	[Gueguen, Paul; Rouault, Karen; Chen, Jian-Min; Fichou, Yann; Kerbiriou, Mathieu; Trouve, Pascal; Le Marechal, Cedric; Ferec, Claude] INSERM, U1078, Brest, France; [Gueguen, Paul; Rouault, Karen; Chen, Jian-Min; Kerbiriou, Mathieu; Trouve, Pascal; Marcorelles, Pascale; Abgrall, Jean-francois; Le Marechal, Cedric; Ferec, Claude] UBO, Fac Med & Sci Sante, Brest, France; [Gueguen, Paul; Rouault, Karen; Raguenes, Odile; Le Marechal, Cedric; Ferec, Claude] Hop Morvan, CHU Brest, Lab Genet Mol & Histocompatibil, Brest, France; [Chen, Jian-Min; Fichou, Yann; Hardy, Elisabeth; Le Marechal, Cedric; Ferec, Claude] Hop Cavale Blanche, CHU Brest, Hematol Lab, Brest, France; [Gobin, Eric; Marcorelles, Pascale] Etab Francais Sang EFS Bretagne, Brest, France; [Pan-petesch, Brigitte; Abgrall, Jean-francois] Hop Morvan, CHU Brest, Serv Anat Pathol, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale	Gueguen, P (corresponding author), INSERM, U1078, Brest, France.	paul.gueguen@chu-brest.fr	Ferec, Claude/ABG-9699-2020; Fichou, Yann/AAJ-9179-2020	Ferec, Claude/0000-0002-2325-0710; Fichou, Yann/0000-0002-5104-9125; PAN-PETESCH, Brigitte/0000-0001-9853-2635; GUEGUEN, Paul/0000-0003-2533-3226; ROUAULT, Karen/0000-0001-7586-3212; Chen, Jian-Min/0000-0002-2424-3969	Institut National de la Sante et de la Recherche Medicale (INSERM), France	Institut National de la Sante et de la Recherche Medicale (INSERM), France(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was partly supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), France. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, NAT GENET, V43, P735, DOI 10.1038/ng.885; Balduini CL, 2012, HUM GENET, V131, P1821, DOI 10.1007/s00439-012-1215-x; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; Cooper DN, 2011, HUM MUTAT, V32, P1075, DOI 10.1002/humu.21557; Dawood BB, 2007, PLATELETS, V18, P329, DOI 10.1080/09537100601024111; DEBILI N, 1993, BLOOD, V82, P84, DOI 10.1182/blood.V82.1.84.bloodjournal82184; Gunay-Aygun M, 2011, NAT GENET, V43, P732, DOI 10.1038/ng.883; Hart A, 2000, IMMUNITY, V13, P167, DOI 10.1016/S1074-7613(00)00017-0; Johnson HJ, 2009, EXP HEMATOL, V37, P901, DOI 10.1016/j.exphem.2009.05.005; Kahr WHA, 2011, NAT GENET, V43, P738, DOI 10.1038/ng.884; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Kunishima S, 2013, AM J HUM GENET, V92, P431, DOI 10.1016/j.ajhg.2013.01.015; Kunishima S, 2011, BLOOD, V117, P5479, DOI 10.1182/blood-2010-12-323691; Kunishima S, 2009, BLOOD, V113, P458, DOI 10.1182/blood-2008-06-162610; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; Noris P, 2011, BLOOD, V117, P6673, DOI 10.1182/blood-2011-02-336537; Nurden AT, 2011, BLOOD, V118, P5996, DOI 10.1182/blood-2011-07-365635; Nurden P, 2011, BLOOD, V118, P5928, DOI 10.1182/blood-2011-07-365601; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; Seri M, 2000, NAT GENET, V26, P103; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793	24	38	42	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74728	10.1371/journal.pone.0074728	http://dx.doi.org/10.1371/journal.pone.0074728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069336	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300053
J	Guo, CC; Lu, HB; Gao, W; Wang, L; Lu, KH; Wu, SH; Pataer, A; Huang, MS; El-Zein, R; Lin, TY; Roth, JA; Mehran, R; Hofstetter, W; Swisher, SG; Wu, XF; Fang, BL				Guo, Chengcheng; Lu, Haibo; Gao, Wen; Wang, Li; Lu, Kaihua; Wu, Shuhong; Pataer, Apar; Huang, Maosheng; El-Zein, Randa; Lin, Tongyu; Roth, Jack A.; Mehran, Reza; Hofstetter, Wayne; Swisher, Stephen G.; Wu, Xifeng; Fang, Bingliang			Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival	PLOS ONE			English	Article							FACTOR BINDING-PROTEIN-2; CANDIDATE BIOMARKER; HIGH EXPRESSION; MESSENGER-RNA; IGF-I; SERUM; DIAGNOSIS; IGFBP-2; MARKER; ANGIOGENESIS	Background: We recently showed that IGFBP2 is overexpressed in primary lung cancer tissues. This study aims to determine whether IGFBP2 is elevated in blood samples of lung cancer patients and whether its level is associated with clinical outcomes. Methodology/Principal Findings: Plasma IGFBP2 levels were determined blindly by enzyme-linked immunosorbent assay in 80 lung cancer patients and 80 case-matched healthy controls for comparison. We analyzed blood samples for IGFBP2 levels from an additional 84 patients with lung cancer and then tested for associations between blood IGFBP2 levels and clinical parameters in all 164 lung cancer patients. All statistical tests were two-sided and differences with p<0.05 were considered significant. The mean plasma concentration of IGFBP2 in lung cancer patients was significantly higher than that in healthy controls (388.12 +/- 261.00 ng/ml vs 219.30 +/- 172.84 ng/ml, p<0.001). IGFBP2 was increased in all types of lung cancer, including adenocarcinoma, squamous cell cancer, and small-cell cancer, regardless of patients' age, sex, or smoking status. IGFBP2 levels were mildly but significantly associated with tumor size and were significantly higher in stage IV than stage I or III disease. A multivariate analysis showed that lung cancer patients whose blood IGFBP2 was higher than 160.9 ng/ml had a poor survival outcome, with a hazard ratio of 8.76 (95% CI 1.12-68.34, p=0.038 after adjustment for tumor size, pathology, and stage). The median survival time for patients with blood IGFBP2 > 160.9 ng/ml is 15.1 months; whereas median survival time was 128.2 months for the patients whose blood IGFBP2 was <= 160.9 ng/ml (p =0.0002). Conclusions/Significance: Blood IGFBP2 is significantly increased in lung cancer patients. A high circulating level of IGFBP2 is significantly associated with poor survival, suggesting that blood IGFBP2 levels could be a prognostic biomarker for lung cancer.	[Guo, Chengcheng; Lu, Haibo; Gao, Wen; Wang, Li; Lu, Kaihua; Wu, Shuhong; Pataer, Apar; Roth, Jack A.; Mehran, Reza; Hofstetter, Wayne; Swisher, Stephen G.; Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Huang, Maosheng; El-Zein, Randa; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Guo, Chengcheng] Sun Yat Sen Univ, Ctr Canc, Dept Neurosurg Neurooncol, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Tongyu] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Haibo] Harbin Med Univ, Affiliated Hosp 3, Dept Internal Med 8, Harbin, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University; Sun Yat Sen University; Harbin Medical University	Fang, BL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	bfang@mdanderson.org			National Institutes of Health [R01 CA092481, R01 CA124951]; Specialized Program of Research Excellence (SPORE) Grant [CA070907]; University of Texas MD Anderson Cancer Center [CA-016672]; Lung Program, DNA Analysis and Flow Cytometry, and Cellular Imaging Core Facility; Homer Flower Gene Therapy Research Fund; Charles Rogers Gene Therapy Fund; Flora & Stuart Mason Lung Cancer Research Fund; Charles B. Swank Memorial Fund for Esophageal Cancer Research; George O. Sweeney Fund for Esophageal Cancer Research; Phalan Thoracic Gene Therapy Fund; M. W. Elkins Endowed Fund for Thoracic Surgical Oncology; Chapman Foundation; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA070907, R01CA124951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Program of Research Excellence (SPORE) Grant; University of Texas MD Anderson Cancer Center; Lung Program, DNA Analysis and Flow Cytometry, and Cellular Imaging Core Facility; Homer Flower Gene Therapy Research Fund; Charles Rogers Gene Therapy Fund; Flora & Stuart Mason Lung Cancer Research Fund; Charles B. Swank Memorial Fund for Esophageal Cancer Research; George O. Sweeney Fund for Esophageal Cancer Research; Phalan Thoracic Gene Therapy Fund; M. W. Elkins Endowed Fund for Thoracic Surgical Oncology; Chapman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health through R01 CA092481 and R01 CA124951 to B. Fang, Specialized Program of Research Excellence (SPORE) Grant CA070907, The University of Texas MD Anderson Cancer Center, Support Grant CA-016672, Lung Program, DNA Analysis and Flow Cytometry, and Cellular Imaging Core Facility, and the Homer Flower Gene Therapy Research Fund, the Charles Rogers Gene Therapy Fund, the Flora & Stuart Mason Lung Cancer Research Fund, the Charles B. Swank Memorial Fund for Esophageal Cancer Research, the George O. Sweeney Fund for Esophageal Cancer Research, the Phalan Thoracic Gene Therapy Fund, and the M. W. Elkins Endowed Fund for Thoracic Surgical Oncology, and Chapman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ambrosini-Spaltro A, 2011, APPL IMMUNOHISTO M M, V19, P318, DOI 10.1097/PAI.0b013e3128052936; Azar WJ, 2011, ENDOCRINOLOGY, V152, P3332, DOI 10.1210/en.2011-1121; Baron-Hay S, 2004, CLIN CANCER RES, V10, P1796, DOI 10.1158/1078-0432.CCR-0672-2; Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967, DOI 10.1152/ajpendo.2000.278.6.E967; Becher OJ, 2008, J CHILD NEUROL, V23, P1205, DOI 10.1177/0883073808321766; Busund LT, 2005, J CLIN PATHOL, V58, P361, DOI 10.1136/jcp.2004.020834; CLEMMONS DR, 1991, J CLIN ENDOCR METAB, V73, P727, DOI 10.1210/jcem-73-4-727; COHEN P, 1993, J CLIN ENDOCR METAB, V76, P1031, DOI 10.1210/jc.76.4.1031; Dunlap SM, 2007, P NATL ACAD SCI USA, V104, P11736, DOI 10.1073/pnas.0703145104; Goulart BHL, 2012, J NATL COMPR CANC NE, V10, P267, DOI 10.6004/jnccn.2012.0023; He Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031087; Ho PJ, 1997, CLIN ENDOCRINOL, V46, P333; Holdenrieder S, 2010, CANCER BIOMARK, V6, P179, DOI 10.3233/CBM-2009-0128; Holmes KM, 2012, P NATL ACAD SCI USA, V109, P3475, DOI 10.1073/pnas.1120375109; Hsieh D, 2010, BIOCHEM BIOPH RES CO, V397, P367, DOI 10.1016/j.bbrc.2010.05.145; Inman BA, 2005, EUR UROL, V47, P695, DOI 10.1016/j.eururo.2004.12.015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kuhnl A, 2011, LEUKEMIA RES, V35, P1585, DOI 10.1016/j.leukres.2011.08.006; Ladd JJ, 2012, CANCER PREV RES, V5, P655, DOI 10.1158/1940-6207.CAPR-11-0412; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1529, DOI 10.1111/j.1525-1438.2006.00623.x; Lee HY, 2002, CANCER RES, V62, P3530; Lin Y, 2009, NEURO-ONCOLOGY, V11, P468, DOI 10.1215/15228517-2008-114; Liou JM, 2010, J CLIN ENDOCR METAB, V95, P1717, DOI 10.1210/jc.2009-2668; Mattsson A, 2008, GROWTH HORM IGF RES, V18, P506, DOI 10.1016/j.ghir.2008.04.005; Matuschek C, 2011, EUR J MED RES, V16, P451; Mehrian-Shai R, 2007, P NATL ACAD SCI USA, V104, P5563, DOI 10.1073/pnas.0609139104; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Mishra L, 1998, GROWTH HORM IGF RES, V8, P473, DOI 10.1016/S1096-6374(98)80300-6; Moore LM, 2009, P NATL ACAD SCI USA, V106, P16675, DOI 10.1073/pnas.0900807106; Patz EF, 2007, J CLIN ONCOL, V25, P5578, DOI 10.1200/JCO.2007.13.5392; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Probst-Hensch NM, 2010, CLIN CANCER RES, V16, P1025, DOI 10.1158/1078-0432.CCR-09-0957; Russo VC, 2005, ENDOCRINOLOGY, V146, P4445, DOI 10.1210/en.2005-0467; Salgia R, 2011, CANCER-AM CANCER SOC, V117, P3889, DOI 10.1002/cncr.25935; Schneider J, 2006, ADV CLIN CHEM, V42, P1, DOI 10.1016/S0065-2423(06)42001-1; STIEBER P, 1993, CANCER, V72, P707, DOI 10.1002/1097-0142(19930801)72:3<707::AID-CNCR2820720313>3.0.CO;2-X; Uzoh CC, 2011, BRIT J CANCER, V104, P1587, DOI 10.1038/bjc.2011.127; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; Zhang LH, 2007, DIGEST DIS SCI, V52, P248, DOI 10.1007/s10620-006-9358-z; Zhang Y, 2013, INT J ONCOL, V42, P93, DOI 10.3892/ijo.2012.1699; Zheng SC, 2011, NEURO-ONCOLOGY, V13, P280, DOI 10.1093/neuonc/noq190	42	32	32	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74973	10.1371/journal.pone.0074973	http://dx.doi.org/10.1371/journal.pone.0074973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069370	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300067
J	Malizia, A; Easdale, TA; Grau, HR				Malizia, Agustina; Easdale, Tomas A.; Grau, H. Ricardo			Rapid Structural and Compositional Change in an Old-Growth Subtropical Forest: Using Plant Traits to Identify Probable Drivers	PLOS ONE			English	Article							TROPICAL FORESTS; FUNCTIONAL-GROUPS; TREE GROWTH; RESPONSES; DYNAMICS; TEMPERATE; SUCCESSION; PATTERNS; SHIFTS	Recent studies have shown directional changes in old-growth tropical forests, but changes are complex and diverse, and their drivers unclear. Here, we report rapid net structural and compositional changes in an old-growth subtropical forest and we assess the functional nature of these changes to test hypothetical drivers including recovery from past disturbances, reduction in ungulate browsing, CO2 fertilization, and increases in rainfall and temperature. The study relies on 15 years of demographic monitoring within 8 ha of subtropical montane forest in Argentina. Between 1992 and 2007, stem density markedly increased by 50% (12 stems ha(-1) y(-1)) and basal area by 6% (0.13 m(2) ha(-1) y(-1)). Increased stem density resulted from enhanced recruitment of understory treelets (Piper tucumanum, Eugenia uniflora, Allophylus edulis) into small size classes. Among 27 common tree species, net population growth was negatively correlated with maximum tree size and longevity, and positively correlated with leaf size and leaf nutrient content, especially so when initial population size was controlled for. Changes were inconsistent with predictions derived from past disturbances (no increase in shade-tolerant or long-lived late-succesional species), rainfall or temperature increase (no increase in evergreen or deciduous species, respectively). However, the increase in nutrient-rich soft-leaved species was consistent with exclusion of large herbivores two decades before monitoring started; and CO2 fertilization could help explain the disproportionate increase in small stems. Reductions in populations of large vertebrates have been observed in many otherwise undisturbed tropical forests, and our results suggest they can have important structural and functional repercussions in these forests.	[Malizia, Agustina; Grau, H. Ricardo] Univ Nacl Tucuman, IER, CONICET, San Miguel De Tucuman, Argentina; [Easdale, Tomas A.] Landcare Res, Lincoln, New Zealand	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Landcare Research - New Zealand	Malizia, A (corresponding author), Univ Nacl Tucuman, IER, CONICET, San Miguel De Tucuman, Argentina.	agustinamalizia@yahoo.com		Easdale, Tomas A./0000-0001-5086-8527	CIUNT; PIP-CONICET [968]	CIUNT; PIP-CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Support for this research was provided by CIUNT and PIP-CONICET 968. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; BROWN A, 2001, BOSQUES NUBLADOS NEO, P623; CHAVE J, 2008, PLOS BIOL, V6, P455, DOI DOI 10.1371/journal.pbio.0060045; Chazdon RL, 2010, BIOTROPICA, V42, P31, DOI 10.1111/j.1744-7429.2009.00566.x; Chesson PL., 1986, COMMUNITY ECOL; Clark DA, 2003, P NATL ACAD SCI USA, V100, P5852, DOI 10.1073/pnas.0935903100; Clark DA, 2007, BIOTROPICA, V39, P4, DOI 10.1111/j.1744-7429.2006.00227.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 1998, CLIMATIC CHANGE, V39, P413, DOI 10.1023/A:1005395806800; Connell JH, 1997, AUST J ECOL, V22, P163, DOI 10.1111/j.1442-9993.1997.tb00655.x; Cunningham SC, 2003, NEW PHYTOL, V157, P55, DOI 10.1046/j.1469-8137.2003.00652.x; Cunningham SC, 2002, OECOLOGIA, V133, P112, DOI 10.1007/s00442-002-1034-1; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; Easdale TA, 2007, J ECOL, V95, P1234, DOI 10.1111/j.1365-2745.2007.01290.x; Easdale TA, 2009, PERSPECT PLANT ECOL, V11, P203, DOI 10.1016/j.ppees.2009.03.001; Enquist BJ, 2011, GLOBAL CHANGE BIOL, V17, P1408, DOI 10.1111/j.1365-2486.2010.02326.x; Fauset S, 2012, ECOL LETT, V15, P1120, DOI 10.1111/j.1461-0248.2012.01834.x; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Finegan B, 1996, TRENDS ECOL EVOL, V11, P119, DOI 10.1016/0169-5347(96)81090-1; Gotelli NJ, 2013, ECOSIMR 1 00; Grau HR, 2008, ECOL SOC, V13; Grau HR, 2002, ECOLOGY, V83, P2591, DOI 10.1890/0012-9658(2002)083[2591:SDRBTA]2.0.CO;2; Grau HR, 1998, MAN BIOSPH, V21, P715; Grau HR, 2010, ECOLOGIA INTERFASE N, P33; Grime J. P., 2001, PLANT STRATEGIES VEG; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Gunderson CA, 2010, GLOBAL CHANGE BIOL, V16, P2272, DOI 10.1111/j.1365-2486.2009.02090.x; Hunzinger H, 1997, MT RES DEV, V17, P299, DOI 10.2307/3674020; Korner C, 2009, ANNU REV ECOL EVOL S, V40, P61, DOI 10.1146/annurev.ecolsys.110308.120217; Laurance WF, 2004, NATURE, V428, P171, DOI 10.1038/nature02383; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lewis SL, 2004, PHILOS T ROY SOC B, V359, P421, DOI 10.1098/rstb.2003.1431; Lewis SL, 2004, PHILOS T R SOC B, V359, P437, DOI 10.1098/rstb.2003.1432; Mason NWH, 2010, J ECOL, V98, P1422, DOI 10.1111/j.1365-2745.2010.01714.x; Minetti J.L., 2006, SER CONSERV NAT, V17, P1; Minetti JL, 2003, ATMOSFERA, V16, P119; Nunez Montellano MG, 2010, ECOLOGIA INTERFASE N, P51, DOI DOI 10.25260/EA.15.25.1; Oliver C.D., 1996, FOREST STAND DYNAMIC; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Roldan AI, 2001, CONSERV BIOL, V15, P617, DOI 10.1046/j.1523-1739.2001.015003617.x; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Silvertown J., 2001, INTRO PLANT POPULATI; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Thompson K, 2011, TRENDS ECOL EVOL, V26, P155, DOI 10.1016/j.tree.2011.01.007; Valencia R, 2009, J TROP ECOL, V25, P473, DOI 10.1017/S0266467409990095; van Ommen Kloeke AEE, 2012, GLOBAL ECOL BIOGEOGR, V21, P224, DOI 10.1111/j.1466-8238.2011.00667.x; VILLALBA R, 1992, J BIOGEOGR, V19, P631, DOI 10.2307/2845706; Wardle D., 2002, COMMUNITIES ECOSYSTE; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]; [No title captured]	54	12	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73546	10.1371/journal.pone.0073546	http://dx.doi.org/10.1371/journal.pone.0073546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069204	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300013
J	Dobson, R; Burgess, MI; Banks, M; Pritchard, DM; Vora, J; Valle, JW; Wong, C; Chadwick, C; George, K; Keevil, B; Adaway, J; Ardill, JES; Anthoney, A; Hofmann, U; Poston, GJ; Cuthbertson, DJ				Dobson, Rebecca; Burgess, Malcolm I.; Banks, Melissa; Pritchard, D. Mark; Vora, Jiten; Valle, Juan W.; Wong, Christopher; Chadwick, Carrie; George, Keith; Keevil, Brian; Adaway, Joanne; Ardill, Joy E. S.; Anthoney, Alan; Hofmann, Uschi; Poston, Graeme J.; Cuthbertson, Daniel J.			The Association of a Panel of Biomarkers with the Presence and Severity of Carcinoid Heart Disease: A Cross-Sectional Study	PLOS ONE			English	Article							ENETS CONSENSUS GUIDELINES; BRAIN NATRIURETIC PEPTIDE; CHROMOGRANIN-A; NEUROENDOCRINE NEOPLASMS; GROWTH-FACTOR; DIAGNOSIS; ECHOCARDIOGRAPHY; DISCONTINUATION; PROGRESSION; MANAGEMENT	Purpose: Metastatic neuroendocrine tumors secrete serotonin and other vasoactive substances that are responsible for carcinoid syndrome and carcinoid heart disease. We sought to evaluate the discriminatory utility of diagnostic biomarkers in determining the presence and severity of carcinoid heart disease in patients with metastatic neuroendocrine tumors. Patients and methods: A cross-sectional study of patients with neuroendocrine tumors with documented liver metastases and/or carcinoid syndrome between April 2009-October 2012 in 5 tertiary referral centers. Serum was analyzed for Chromogranin A, Chromogranin B and N-terminal pro Brain Natriuretic Peptide (NT-proBNP). Plasma was analyzed for Neurokinin A and 5-Hydroxyindoleacetic acid (5HIAA). Echocardiography was used to determine the presence and severity of carcinoid heart disease. Non-parametric receiver operating characteristic curves were constructed for biomarkers, and the area under the curve determined. The severity of cardiac involvement was correlated with the concentration of each biomarker. Results: A total of 187 patients were identified of whom 37 (20%) had carcinoid heart disease. Significantly higher median values of all biomarkers were found in the patients with cardiac involvement. NT-proBNP and plasma 5HIAA had the highest areas under the curve for the prediction of carcinoid heart disease [NT-proBNP 0.82 (95% confidence interval 0.74-0.90, p<0.0001) and 5HIAA 0.85 (95% confidence interval 0.78-0.92, p<0.0001]. NT-proBNP was moderately correlated (r = 0.48, p<0.001) whereas plasma 5HIAA was only weakly correlated (r = 0.34, p<0.001) with the echocardiographic severity score. Conclusion: NT-proBNP and plasma 5HIAA are both sensitive and specific biomarkers for the presence of carcinoid heart disease whereas only NT-proBNP is moderately correlated with disease severity.	[Dobson, Rebecca; Burgess, Malcolm I.; Banks, Melissa; Wong, Christopher; Chadwick, Carrie; Poston, Graeme J.; Cuthbertson, Daniel J.] Aintree Univ Hosp NHS Fdn Trust, Neuroendocrine Tumour Grp, Liverpool L9 7AL, Merseyside, England; [Burgess, Malcolm I.; Wong, Christopher] Aintree Univ Hosp NHS Fdn Trust, Dept Cardiol, Liverpool L9 7AL, Merseyside, England; [Pritchard, D. Mark] Univ Liverpool, Inst Translat Med, Dept Gastroenterol, Liverpool L69 3BX, Merseyside, England; [Pritchard, D. Mark; Vora, Jiten] Royal Liverpool Univ Hosp, Neuroendocrine Tumour Grp, Liverpool, Merseyside, England; [Valle, Juan W.] Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Dept Med Oncol, Manchester, Lancs, England; [George, Keith] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Keevil, Brian; Adaway, Joanne] Univ S Manchester Hosp, Dept Clin Chem, Manchester M20 8LR, Lancs, England; [Ardill, Joy E. S.] Royal Victoria Hosp, Reg Peptide Lab, Belfast BT12 6BA, Antrim, North Ireland; [Anthoney, Alan] St James Univ Hosp, CRUK Clin Canc Ctr, Leeds LS9 7TF, Yorks, England; [Hofmann, Uschi] Huddersfield Royal Infirm, Huddersfield, Yorks, England; [Dobson, Rebecca; Cuthbertson, Daniel J.] Univ Liverpool, Dept Obes & Endocrinol, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England	Aintree University Hospitals NHS Foundation Trust; Aintree University Hospitals NHS Foundation Trust; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Christie NHS Foundation Trust; University of Manchester; Liverpool John Moores University; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Saint James's University Hospital; University of Liverpool	Dobson, R (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Neuroendocrine Tumour Grp, Liverpool L9 7AL, Merseyside, England.	rebecca.dobson@liverpool.ac.uk	keevil, brian/AAP-6147-2020; Adaway, Joanne/AAF-3737-2021; Valle, Juan/J-3571-2015	Valle, Juan/0000-0002-1999-0863; Adaway, Joanne/0000-0003-4352-3410; Cuthbertson, Daniel/0000-0002-6128-0822; Pritchard, David Mark/0000-0001-7971-3561	Ipsen	Ipsen(Ipsen)	Senior author Dr. DJ Cuthbertson received an investigator-initiated award from a commercial source, Ipsen. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bergestuen DS, 2010, NEUROENDOCRINOLOGY, V92, P168, DOI 10.1159/000318014; Bergestuen DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-6; Bhattacharyya S, 2008, AM J CARDIOL, V102, P938, DOI 10.1016/j.amjcard.2008.05.047; Bhattacharyya S, 2010, CIRC-CARDIOVASC IMAG, V3, P103, DOI 10.1161/CIRCIMAGING.109.886846; Bhattacharyya S, 2009, LANCET, V374, P577, DOI 10.1016/S0140-6736(09)60252-X; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Denney WD, 1998, J AM COLL CARDIOL, V32, P1017, DOI 10.1016/S0735-1097(98)00354-4; Heidrich FM, 2008, CIRC RES, V102, P1230, DOI 10.1161/CIRCRESAHA.107.166033; Hess G, 2005, CLIN CHIM ACTA, V360, P187, DOI 10.1016/j.cccn.2005.04.031; HOWARD RJ, 1982, CIRCULATION, V66, P1059, DOI 10.1161/01.CIR.66.5.1059; Jackson LN, 2009, CLIN CANCER RES, V15, P2747, DOI 10.1158/1078-0432.CCR-08-2346; Korse CM, 2011, BRIT J CANCER, V105, P1173, DOI 10.1038/bjc.2011.380; Korse CM, 2009, J CLIN ONCOL, V27, P4293, DOI 10.1200/JCO.2008.18.7047; Lillegard JB, 2011, J AM COLL SURGEONS, V213, P130, DOI 10.1016/j.jamcollsurg.2011.03.029; Mamikunian P, 2011, PANCREAS, V40, P1000, DOI 10.1097/MPA.0b013e318232b6a2; Miller AG, 2010, J CHROMATOGR B, V878, P695, DOI 10.1016/j.jchromb.2010.01.010; Moller JE, 2003, NEW ENGL J MED, V348, P1005, DOI 10.1056/NEJMoa021451; Mosli HH, 2012, J CLIN ENDOCR METAB, V97, pE1731, DOI 10.1210/jc.2012-1548; Pape UF, 2012, NEUROENDOCRINOLOGY, V95, P135, DOI 10.1159/000335629; Plockinger U, 2009, NEUROENDOCRINOLOGY, V90, P190, DOI 10.1159/000225947; Ramachandran R, 2012, CLIN ENDOCRINOL, V76, P831, DOI 10.1111/j.1365-2265.2011.04319.x; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; SEKIYA K, 1989, J CLIN INVEST, V83, P1834, DOI 10.1172/JCI114089; Stridsberg M, 2007, REGUL PEPTIDES, V139, P80, DOI 10.1016/j.regpep.2006.10.008; Tellez MR, 2012, PANCREAS, V42, P45; Turner GB, 2006, GUT, V55, P1586, DOI 10.1136/gut.2006.092320; Vinik AI, 2010, PANCREAS, V39, P713, DOI 10.1097/MPA.0b013e3181ebaffd; Zuetenhorst J, 2004, BRIT J CANCER, V90, P2073, DOI 10.1038/sj.bjc.6601816; Zuetenhorst JM, 2003, CANCER, V97, P1609, DOI 10.1002/cncr.11226	29	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73679	10.1371/journal.pone.0073679	http://dx.doi.org/10.1371/journal.pone.0073679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069222	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100054
J	Hawlitschek, O; Nagy, ZT; Berger, J; Glaw, F				Hawlitschek, Oliver; Nagy, Zoltan T.; Berger, Johannes; Glaw, Frank			Reliable DNA Barcoding Performance Proved for Species and Island Populations of Comoran Squamate Reptiles	PLOS ONE			English	Article							WESTERN INDIAN-OCEAN; DAY GECKOS; PHYLOGENETIC-RELATIONSHIPS; MAXIMUM-LIKELIHOOD; IDENTIFICATION; DIVERSITY; CRYPTOBLEPHARUS; ARCHIPELAGO; SCINCIDAE; ALIGNMENT	In the past decade, DNA barcoding became increasingly common as a method for species identification in biodiversity inventories and related studies. However, mainly due to technical obstacles, squamate reptiles have been the target of few barcoding studies. In this article, we present the results of a DNA barcoding study of squamates of the Comoros archipelago, a poorly studied group of oceanic islands close to and mostly colonized from Madagascar. The barcoding dataset presented here includes 27 of the 29 currently recognized squamate species of the Comoros, including 17 of the 18 endemic species. Some species considered endemic to the Comoros according to current taxonomy were found to cluster with non-Comoran lineages, probably due to poorly resolved taxonomy. All other species for which more than one barcode was obtained corresponded to distinct clusters useful for species identification by barcoding. In most species, even island populations could be distinguished using barcoding. Two cryptic species were identified using the DNA barcoding approach. The obtained barcoding topology, a Bayesian tree based on COI sequences of 5 genera, was compared with available multigene topologies, and in 3 cases, major incongruences between the two topologies became evident. Three of the multigene studies were initiated after initial screening of a preliminary version of the barcoding dataset presented here. We conclude that in the case of the squamates of the Comoros Islands, DNA barcoding has proven a very useful and efficient way of detecting isolated populations and promising starting points for subsequent research.	[Hawlitschek, Oliver; Berger, Johannes; Glaw, Frank] Zool Staatssammlung Munchen, Munich, Germany; [Nagy, Zoltan T.] JEMU, Royal Belgian Inst Nat Sci, Brussels, Belgium	Royal Belgian Institute of Natural Sciences	Hawlitschek, O (corresponding author), Zool Staatssammlung Munchen, Munich, Germany.	oliver.hawlitschek@gmx.de	Nagy, Zoltan T./C-6737-2011	Nagy, Zoltan T./0000-0002-8455-040X; Hawlitschek, Oliver/0000-0001-8010-4157	Mohamed bin Zayed Species Conservation Fund [0925157]; DAAD [D/09/49634]; "Deutsche Forschungsgemeinschaft" DFG [GL 314/1]; Freunde der Zoologischen Staatssammlung Munchen; Society of the University of Munich; EES of the University of Munich; Synthesys grant [FR-TAF-2988]	Mohamed bin Zayed Species Conservation Fund; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); "Deutsche Forschungsgemeinschaft" DFG(German Research Foundation (DFG)); Freunde der Zoologischen Staatssammlung Munchen; Society of the University of Munich; EES of the University of Munich; Synthesys grant	The research was financially supported by the Mohamed bin Zayed Species Conservation Fund (project 0925157), by DAAD grant D/09/49634 to O. Hawlitschek, and the "Deutsche Forschungsgemeinschaft" DFG (GL 314/1) to F. Glaw. The "Freunde der Zoologischen Staatssammlung Munchen", the Society of the University of Munich and EES funding program of the University of Munich provided additional financial support. The work at MNHN was financially supported by Synthesys grant FR-TAF-2988 to O. Hawlitschek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Ball SL, 2006, CAN J FOREST RES, V36, P337, DOI 10.1139/X05-276; EMERICK CM, 1982, EARTH PLANET SC LETT, V60, P415, DOI 10.1016/0012-821X(82)90077-2; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Haszprunar Gerhard, 2009, Nachrichtenblatt der Bayerischen Entomologen, V58, P45; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hawlitschek O, 2008, THESIS U MUNICH; Hawlitschek O, 2013, ZOOL SCR, V42, P135, DOI 10.1111/zsc.12001; Hawlitschek O, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.144.1648; Hawlitschek O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042970; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hey J, 2012, EVOLUTION, V66, P1413, DOI 10.1111/j.1558-5646.2011.01542.x; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Horner Paul, 2007, Beagle, P21; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Louette M, 2004, STUDIES AFROTROPICAL, V293; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Maddison WP, 2009, MESQUITE MODULAR SYS; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller M.A., 2010, P GAT COMP ENV WORKS; Murphy RW, 2013, MOL ECOL RESOUR, V13, P161, DOI 10.1111/1755-0998.12050; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; OTA H, 1991, Amphibia-Reptilia, V12, P181, DOI 10.1163/156853891X00158; Posada D, 2004, COLLAPSE DESCRIBING; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 4; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Rocha S, 2006, J BIOGEOGR, V33, P13, DOI 10.1111/j.1365-2699.2005.01375.x; Rocha S, 2005, BELG J ZOOL, V135, P39; Rocha S, 2005, MOL PHYLOGENET EVOL, V35, P292, DOI 10.1016/j.ympev.2004.11.023; Rocha S, 2009, MOL PHYLOGENET EVOL, V52, P530, DOI 10.1016/j.ympev.2009.03.032; Rocha S, 2007, MOL PHYLOGENET EVOL, V43, P685, DOI 10.1016/j.ympev.2006.07.010; Rocha S, 2010, AMPHIBIA-REPTILIA, V31, P375, DOI 10.1163/156853810791769473; Rocha S, 2010, HERPETOL J, V20, P83; Rocha Sara, 2010, Zootaxa, V2429, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P204, DOI 10.1603/0013-8746(2006)099[0204:DBATIL]2.0.CO;2; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vences M., 2012, METHODS MOL BIOL, V858, P79, DOI [10.1007/978, DOI 10.1007/978-1-61779-591-6_]; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615	54	25	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73368	10.1371/journal.pone.0073368	http://dx.doi.org/10.1371/journal.pone.0073368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069192	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100041
J	Pardo-Seco, J; Amigo, J; Gonzalez-Manteiga, W; Salas, A				Pardo-Seco, Jacobo; Amigo, Jorge; Gonzalez-Manteiga, Wenceslao; Salas, Antonio			A Generalized Model to Estimate the Statistical Power in Mitochondrial Disease Studies Involving 2 x k Tables	PLOS ONE			English	Article							DETECT DEPENDENCE; DNA POLYMORPHISMS; HAPLOGROUPS; RISK; POPULATION; TREE	Background: Mitochondrial DNA (mtDNA) variation (i.e. haplogroups) has been analyzed in regards to a number of multifactorial diseases. The statistical power of a case-control study determines the a priori probability to reject the null hypothesis of homogeneity between cases and controls. Methods/Principal Findings: We critically review previous approaches to the estimation of the statistical power based on the restricted scenario where the number of cases equals the number of controls, and propose a methodology that broadens procedures to more general situations. We developed statistical procedures that consider different disease scenarios, variable sample sizes in cases and controls, and variable number of haplogroups and effect sizes. The results indicate that the statistical power of a particular study can improve substantially by increasing the number of controls with respect to cases. In the opposite direction, the power decreases substantially when testing a growing number of haplogroups. We developed mitPower (http://bioinformatics.cesga.es/mitpower/), a web-based interface that implements the new statistical procedures and allows for the computation of the a priori statistical power in variable scenarios of case-control study designs, or e. g. the number of controls needed to reach fixed effect sizes. Conclusions/Significance: The present study provides with statistical procedures for the computation of statistical power in common as well as complex case-control study designs involving 2 x k tables, with special application (but not exclusive) to mtDNA studies. In order to reach a wide range of researchers, we also provide a friendly web-based tool - mitPower - that can be used in both retrospective and prospective case-control disease studies.	[Pardo-Seco, Jacobo; Amigo, Jorge; Salas, Antonio] Univ Santiago Compostela, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Fac Med, Galicia, Spain; [Pardo-Seco, Jacobo; Amigo, Jorge; Salas, Antonio] Univ Santiago Compostela, GMX, Inst Ciencias Forenses, Fac Med, Galicia, Spain; [Gonzalez-Manteiga, Wenceslao] Univ Santiago Compostela, Dept Estadist & Invest Operat, Santiago De Compostela, A Coruna, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Salas, A (corresponding author), Univ Santiago Compostela, Unidade Xenet, Dept Anat Patolox & Ciencias Forenses, Fac Med, Galicia, Spain.	antonio.salas@usc.es	Amigo Lechuga, Jorge/A-4892-2010; Pardo-Seco, Jacobo J/G-3752-2016; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Manteiga, Wenceslao González/E-4253-2012	Amigo Lechuga, Jorge/0000-0002-1362-2605; Pardo-Seco, Jacobo J/0000-0002-8059-8908; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Manteiga, Wenceslao González/0000-0002-3555-4623	Ministerio de Ciencia e Innovacion [SAF2008-02971]; Plan Galego IDT, Xunta de Galicia [EM 2012/045]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT, Xunta de Galicia	The research leading to these results has received funding from the "Ministerio de Ciencia e Innovacion" (SAF2008-02971) and from the Plan Galego IDT, Xunta de Galicia (EM 2012/045) given to A. S. There are no conflicts of interest in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021029; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Armitage P., 2002, STAT METHODS MED RES; Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bacchetti P, 2002, BRIT MED J, V324, P1271, DOI 10.1136/bmj.324.7348.1271; Bandelt HJ, 2007, EUR J HUM GENET, V15, P400, DOI 10.1038/sj.ejhg.5201781; Bandelt HJ, 2012, INT J LEGAL MED, V126, P901, DOI 10.1007/s00414-012-0762-y; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; Baudouin SV, 2005, LANCET, V366, P2118, DOI 10.1016/S0140-6736(05)67890-7; Bishop YM., 2007, DISCRETE MULTIVARIAT; Bowman AW, 1997, APPL SMOOTHING TECHN; Boyett JM, 1979, J ROYAL STAT SOC C, V28, P329; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cochran WG, 1957, EXPT DESING; Covarrubias D, 2008, J HUM GENET; Dai JL, 2007, BIOMETRICS, V63, P1245, DOI 10.1111/j.1541-0420.2007.00801.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Good P, 2000, PERMUTATION TESTS PR; Haneuse S, 2011, J STAT SOFTW, V43, P1; Hintze J., 2013, PASS 12; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385; Mosquera-Miguel A, 2012, AM J MED GENET B, V159B, P414, DOI 10.1002/ajmg.b.32044; PAGANO M, 1981, J AM STAT ASSOC, V76, P931, DOI 10.2307/2287590; Patefield W.M., 1981, J R STAT SOC C-APPL, V30, P91, DOI 10.2307/2346669; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Sanchez MS, 2006, THEOR POPUL BIOL, V69, P111, DOI 10.1016/j.tpb.2005.11.001; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Ueno H, 2009, MITOCHONDRION, V9, P385, DOI 10.1016/j.mito.2009.06.003; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Zhang AM, 2012, PLOS ONE, V6; Zou GH, 2006, GENETICS, V172, P687, DOI 10.1534/genetics.105.049536; Zumbo BD, 1998, J ROY STAT SOC D-STA, V47, P385, DOI 10.1111/1467-9884.00139; Zuo YJ, 2006, GENETICS, V173, P1747, DOI 10.1534/genetics.105.042648	46	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73567	10.1371/journal.pone.0073567	http://dx.doi.org/10.1371/journal.pone.0073567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086285	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900016
J	Combaz, A; Chatelle, C; Robben, A; Vanhoof, G; Goeleven, A; Thijs, V; Van Hulle, MM; Laureys, S				Combaz, Adrien; Chatelle, Camille; Robben, Arne; Vanhoof, Gertie; Goeleven, Ann; Thijs, Vincent; Van Hulle, Marc M.; Laureys, Steven			A Comparison of Two Spelling Brain-Computer Interfaces Based on Visual P3 and SSVEP in Locked-In Syndrome	PLOS ONE			English	Article							STEADY-STATE; EVOKED-POTENTIALS; MENTAL PROSTHESIS; EEG; PEOPLE; COMMUNICATION; ATTENTION; RESPONSES; BCI; ALS	Objectives: We study the applicability of a visual P3-based and a Steady State Visually Evoked Potentials (SSVEP)-based Brain-Computer Interfaces (BCIs) for mental text spelling on a cohort of patients with incomplete Locked-In Syndrome (LIS). Methods: Seven patients performed repeated sessions with each BCI. We assessed BCI performance, mental workload and overall satisfaction for both systems. We also investigated the effect of the quality of life and level of motor impairment on the performance. Results: All seven patients were able to achieve an accuracy of 70% or more with the SSVEP-based BCI, compared to 3 patients with the P3-based BCI, showing a better performance with the SSVEP BCI than with the P3 BCI in the studied cohort. Moreover, the better performance of the SSVEP-based BCI was accompanied by a lower mental workload and a higher overall satisfaction. No relationship was found between BCI performance and level of motor impairment or quality of life. Conclusion: Our results show a better usability of the SSVEP-based BCI than the P3-based one for the sessions performed by the tested population of locked-in patients with respect to all the criteria considered. The study shows the advantage of developing alternative BCIs with respect to the traditional matrix-based P3 speller using different designs and signal modalities such as SSVEPs to build a faster, more accurate, less mentally demanding and more satisfying BCI by testing both types of BCIs on a convenience sample of LIS patients.	[Combaz, Adrien; Robben, Arne; Van Hulle, Marc M.] Katholieke Univ Leuven, Computat Neurosci Grp, Lab Neuro & Psychophysiol, Louvain, Belgium; [Chatelle, Camille; Laureys, Steven] Univ Liege, Coma Sci Grp, Cyclotron Res Centerp, Liege, Belgium; [Vanhoof, Gertie; Goeleven, Ann] Univ Hosp Leuven, Dept Speech Language Pathol ENT Head & Neck Surg, Louvain, Belgium; [Thijs, Vincent] Univ Hosp Leuven, Dept Neurol, Louvain, Belgium; [Thijs, Vincent] VIB, Vesalius Res Ctr, Louvain, Belgium; [Laureys, Steven] Liege Univ Hosp, Dept Neurol, Liege, Belgium	KU Leuven; University of Liege; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); University of Liege	Combaz, A (corresponding author), Katholieke Univ Leuven, Computat Neurosci Grp, Lab Neuro & Psychophysiol, Louvain, Belgium.	Adrien.Combaz@med.kuleuven.be	Thijs, Vincent/C-3647-2009; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Thijs, Vincent/0000-0002-6614-8417; Laureys, Steven/0000-0002-3096-3807; Chatelle, Camille/0000-0002-7526-2107; Van Hulle, Marc/0000-0003-1060-7044	Agentschap voor Innovatie door Wetenschap en Technologie (IWT, Flemish Agency for Innovation through Science and Technology); Belgian Fund for Scientific Research (FNRS); European Commission [FP7-247919 DECODER]; James S. McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action [ARC-06/11-340]; Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO, Funds for Scientific Research - Flanders); K.U. Leuven, the Belgian Fund for Scientific Research - Flanders [PFV/10/008, CREA/07/027, G.0588.09]; Interuniversity Attraction Poles Programme - Belgian Science Policy [IUAP P7/21]; Flemish Regional Ministry of Education (Belgium) [GOA 10/019]; Flemish Agency for Innovation by Science and Technology (TETRA project Spellbinder); SWIFT prize of the King Baudouin Foundation of Belgium	Agentschap voor Innovatie door Wetenschap en Technologie (IWT, Flemish Agency for Innovation through Science and Technology); Belgian Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); James S. McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action; Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO, Funds for Scientific Research - Flanders)(FWO); K.U. Leuven, the Belgian Fund for Scientific Research - Flanders; Interuniversity Attraction Poles Programme - Belgian Science Policy(Belgian Federal Science Policy Office); Flemish Regional Ministry of Education (Belgium)(FWO); Flemish Agency for Innovation by Science and Technology (TETRA project Spellbinder); SWIFT prize of the King Baudouin Foundation of Belgium	AC and AR are supported by the Agentschap voor Innovatie door Wetenschap en Technologie (IWT, Flemish Agency for Innovation through Science and Technology). CC and SL are supported by the Belgian Fund for Scientific Research (FNRS), the European Commission (FP7-247919 DECODER), the James S. McDonnell Foundation, the Mind Science Foundation and the French Speaking Community Concerted Research Action (ARC-06/11-340). VT holds a Senior Clinical Investigator grant from the Fonds Wetenschappelijk Onderzoek - Vlaanderen (FWO, Funds for Scientific Research - Flanders). MMVH is supported by research grants received from the program Financing program (PFV/10/008), the CREA Financing program (CREA/07/027) of the K.U. Leuven, the Belgian Fund for Scientific Research - Flanders (G.0588.09), the Interuniversity Attraction Poles Programme - Belgian Science Policy (IUAP P7/21), the Flemish Regional Ministry of Education (Belgium) (GOA 10/019), the Flemish Agency for Innovation by Science and Technology (TETRA project Spellbinder) and by the SWIFT prize of the King Baudouin Foundation of Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2010, HUM-COMPUT INT-SPRIN, P35, DOI 10.1007/978-1-84996-272-8_3; Aloise F, 2012, ERGONOMICS, V55, P538, DOI 10.1080/00140139.2012.661084; Andersen SK, 2011, J COGNITIVE NEUROSCI, V23, P238, DOI 10.1162/jocn.2009.21328; BAUER G, 1979, J NEUROL, V221, P77, DOI 10.1007/BF00313105; Bennys K, 2007, J CLIN NEUROPHYSIOL, V24, P405, DOI 10.1097/WNP.0b013e31815068d5; Bernheim JL, 1999, BIOETHICS, V13, P272, DOI 10.1111/1467-8519.00156; Bianchi L, 2010, BRAIN TOPOGR, V23, P180, DOI 10.1007/s10548-010-0143-0; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Byers J.C., 1989, ADV IND ERGONOMICS S, P481; Casanova E, 2003, ARCH PHYS MED REHAB, V84, P862, DOI 10.1016/S0003-9993(03)00008-X; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chatelle C, 2012, BRAIN INJURY, V8, P447; Choularton S., 2004, 10 AUSTR INT C SPEEC, P457; Chumerin N., 2011, Proceedings of the 2011 IEEE 6th International Conference on Intelligent Data Acquisition and Advanced Computing Systems: Technology and Applications (IDAACS 2011), P369, DOI 10.1109/IDAACS.2011.6072776; Combaz A, 2012, NEUROCOMPUTING, V80, P73, DOI 10.1016/j.neucom.2011.09.013; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Cristianini N, 2000, INTRO SUPPORT VECTOR; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai R, 2011, CLIN EEG NEUROSCI, V42, P209, DOI 10.1177/155005941104200404; Field A, 2013, DISCOVERING STAT USI; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Gray M, 2003, NEUROIMAGE, V20, P975, DOI 10.1016/S1053-8119(03)00401-4; Guan C, 2004, IEEE WORKSH BIOM CIR; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; HART S G, 1988, P139; HAYASHI H, 1989, J NEUROL SCI, V93, P19, DOI 10.1016/0022-510X(89)90158-5; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Jin J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036006; Kaufmann T, 2011, 5 INT BRAIN COMP INT, P49; Keerthi SS, 2005, J MACH LEARN RES, V6, P341; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Legendre P, 2000, J STAT COMPUT SIM, V67, P37, DOI 10.1080/00949650008812035; Lesenfants D, 2011, P 5 INT BRAIN COMP I, P1; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Luck S.J., 2005, INTRO EVENT RELATED; Mak JN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025003; Manyakov NV, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/519868; McFarland DJ, 2003, BIOL PSYCHOL, V63, P237, DOI 10.1016/S0301-0511(03)00073-5; MORONEY WF, 1992, PROC NAECON IEEE NAT, P734, DOI 10.1109/NAECON.1992.220513; Nam CS, 2012, ERGONOMICS, V55, P581, DOI 10.1080/00140139.2011.647095; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Nijboer F, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00055; NYGREN TE, 1991, HUM FACTORS, V33, P17, DOI 10.1177/001872089103300102; Ortner R, 2011, CLIN EEG NEUROSCI, V42, P214, DOI 10.1177/155005941104200405; Papaliagkas VT, 2011, CLIN NEUROPHYSIOL, V122, P1322, DOI 10.1016/j.clinph.2010.12.036; Parini Sergio, 2009, Comput Intell Neurosci, P864564, DOI 10.1155/2009/864564; Pastor MA, 2007, CEREB CORTEX, V17, P1899, DOI 10.1093/cercor/bhl098; Pastor MA, 2003, J NEUROSCI, V23, P11621; PATTERSON JR, 1986, STROKE, V17, P758, DOI 10.1161/01.STR.17.4.758; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Perlstein WM, 2003, NEUROSCI LETT, V342, P191, DOI 10.1016/S0304-3940(03)00226-X; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Pires G, 2012, CLIN NEUROPHYSIOL, V123, P1168, DOI 10.1016/j.clinph.2011.10.040; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Rakotomamonjy A, 2005, LECT NOTES COMPUT SC, V3696, P45, DOI 10.1007/11550822_8; REGAN D, 1966, ELECTROEN CLIN NEURO, V20, P238, DOI 10.1016/0013-4694(66)90088-5; Schnakers C, 2008, J NEUROL, V255, P323, DOI 10.1007/s00415-008-0544-0; Segers H, 2011, IFMBE PROC, V34, P164; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; Silvoni S, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.20.001.2009; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; Tsai ML, 2012, PEDIATR NEONATOL, V53, P118, DOI 10.1016/j.pedneo.2012.01.009; Vazquez-Marrufo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062523; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Volosyak I, 2010, IEEE ENG MED BIO, P4201, DOI 10.1109/IEMBS.2010.5627390; Volosyak I, 2009, LECT NOTES COMPUT SC, V5517, P706, DOI 10.1007/978-3-642-02478-8_88; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yazicioglu RF, 2006, PROC EUR SOLID-STATE, P247	81	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73691	10.1371/journal.pone.0073691	http://dx.doi.org/10.1371/journal.pone.0073691			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086289	Green Published, Green Submitted, gold			2022-12-27	WOS:000325218700011
J	Tyler, AD; Knox, N; Kabakchiev, B; Milgrom, R; Kirsch, R; Cohen, Z; McLeod, RS; Guttman, DS; Krause, DO; Silverberg, MS				Tyler, Andrea D.; Knox, Natalie; Kabakchiev, Boyko; Milgrom, Raquel; Kirsch, Richard; Cohen, Zane; McLeod, Robin S.; Guttman, David S.; Krause, Denis O.; Silverberg, Mark S.			Characterization of the Gut-Associated Microbiome in Inflammatory Pouch Complications Following Ileal Pouch-Anal Anastomosis	PLOS ONE			English	Article							MUCOSA-ASSOCIATED MICROBIOTA; CROHNS-DISEASE; ULCERATIVE-COLITIS; FECAL MICROBIOTA; BOWEL-DISEASE; RISK-FACTORS; COMMENSAL; MARKERS; NUMBER; TWIN	Introduction: Inflammatory complications following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC) are common and thought to arise through mechanisms similar to de novo onset inflammatory bowel disease. The aim of this study was to determine whether specific organisms in the tissue-associated microbiota are associated with inflammatory pouch complications. Methods: Patients having previously undergone IPAA were recruited from Mount Sinai Hospital. Clinical and demographic information were collected and a pouchoscopy with biopsy of both the pouch and afferent limb was performed. Patients were classified based on post-surgical phenotype into four outcome groups: familial adenomatous polyposis controls (FAP), no pouchitis, pouchitis, and Crohn's disease-like (CDL). Pyrosequencing of the 16S rRNA V1-V3 hypervariable region, and quantitative PCR for bacteria of interest, were used to identify organisms present in the afferent limb and pouch. Associations with outcomes were evaluated using exact and non-parametric tests of significance. Results: Analysis at the phylum level indicated that Bacteroidetes were detected significantly less frequently (P<0.0001) in the inflammatory outcome groups (pouchitis and CDL) compared to both FAP and no pouchitis. Conversely, Proteobacteria were detected more frequently in the inflammatory groups (P=0.01). At the genus level, organisms associated with outcome were detected less frequently among the inflammatory groups compared to those without inflammation. Several of these organisms, including Bacteroides (P<0.0001), Parabacteroides (P <= 2.2x10(-3)), Blautia (P <= 3.0x10(-3)) and Sutterella (P <= 2.5x10(-3)), were associated with outcome in both the pouch and afferent limb. These associations remained significant even following adjustment for antibiotic use, smoking, country of birth and gender. Individuals with quiescent disease receiving antibiotic therapy displayed similar reductions in these organisms as those with active pouch inflammation. Conclusions: Specific genera are associated with inflammation of the ileal pouch, with a reduction of typically ubiquitous organisms characterizing the inflammatory phenotypes.	[Tyler, Andrea D.; Kabakchiev, Boyko; Cohen, Zane; Silverberg, Mark S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Tyler, Andrea D.; Kabakchiev, Boyko; Milgrom, Raquel; Cohen, Zane; McLeod, Robin S.; Silverberg, Mark S.] Mt Sinai Hosp, Zane Cohen Ctr Digest Dis, Inflammatory Bowel Dis Grp, Toronto, ON M5G 1X5, Canada; [Knox, Natalie; Krause, Denis O.] Univ Manitoba, Dept Anim Sci, Winnipeg, MB R3T 2N2, Canada; [Krause, Denis O.] Univ Manitoba, Winnipeg, MB, Canada; [Kirsch, Richard] Mt Sinai Hosp, Lab Med & Pathol, Toronto, ON M5G 1X5, Canada; [Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Manitoba; University of Manitoba; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto	Silverberg, MS (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	msilverberg@mtsinai.on.ca	Guttman, David S/A-7839-2011; Silverberg, Mark/B-4183-2008; McLeod, Robin/K-1476-2013; Kirsch, Richard/J-2335-2016	Guttman, David S/0000-0001-8479-3869; Knox, Natalie/0000-0001-6133-7799	Crohn's and Colitis Foundation of Canada (CCFC)	Crohn's and Colitis Foundation of Canada (CCFC)	This research was funded through a grant from the Crohn's and Colitis Foundation of Canada (CCFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2008, INFLAMM BOWEL DIS, V14, P401, DOI 10.1002/ibd.20276; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andoh A, 2012, J GASTROENTEROL, V47, P1298, DOI 10.1007/s00535-012-0605-0; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Carlier JP, 2007, INT J SYST EVOL MICR, V57, P725, DOI 10.1099/ijs.0.64705-0; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; FARMER RG, 1993, DIGEST DIS SCI, V38, P1137, DOI 10.1007/BF01295733; Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043; Fleshner P, 2008, CLIN GASTROENTEROL H, V6, P561, DOI 10.1016/j.cgh.2008.01.002; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Heuschen UA, 2002, DIS COLON RECTUM, V45, P776, DOI 10.1007/s10350-004-6297-7; Hviid A, 2011, GUT, V60, P49, DOI 10.1136/gut.2010.219683; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kuisma J, 2004, SCAND J GASTROENTERO, V39, P544, DOI 10.1080/00365520410004668; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Mangin I, 2004, FEMS MICROBIOL ECOL, V50, P25, DOI 10.1016/j.femsec.2004.05.005; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Manuzak J, 2012, CLIN VACCINE IMMUNOL, V19, P1207, DOI 10.1128/CVI.00282-12; McLaughlin SD, 2010, ANN SURG, V252, P90, DOI 10.1097/SLA.0b013e3181e3dc8b; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; SANDBORN WJ, 1994, MAYO CLIN PROC, V69, P409, DOI 10.1016/S0025-6196(12)61634-6; Savino F, 2011, ACTA PAEDIATR, V100, P75, DOI 10.1111/j.1651-2227.2010.01988.x; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon CE, 1997, M D COMPUT, V14, P306; Shea MK, 2008, AM J EPIDEMIOL, V167, P313, DOI 10.1093/aje/kwm306; Shen B, 2008, INFLAMM BOWEL DIS, V14, P942, DOI 10.1002/ibd.20409; SHEPHERD NA, 1993, GUT, V34, P101, DOI 10.1136/gut.34.1.101; Simchuk EJ, 2000, WORLD J SURG, V24, P851, DOI 10.1007/s002680010136; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyler AD, 2013, GUT, V62, P1433, DOI 10.1136/gutjnl-2011-301957; Tyler AD, 2012, CLIN GASTROENTEROL H, V10, P507, DOI 10.1016/j.cgh.2011.09.016; Verma R, 2010, J CLIN MICROBIOL, V48, P4279, DOI 10.1128/JCM.01360-10; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Zella GC, 2011, INFLAMM BOWEL DIS, V17, P1092, DOI 10.1002/ibd.21460	49	63	64	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e66934	10.1371/journal.pone.0066934	http://dx.doi.org/10.1371/journal.pone.0066934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086242	Green Submitted, Green Published, gold			2022-12-27	WOS:000325025200001
J	Ban, KC; Peng, ZL; Kozar, RA				Ban, Kechen; Peng, Zhanglong; Kozar, Rosemary A.			Inhibition of ERK1/2 Worsens Intestinal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INFLAMMATORY RESPONSES; CELL-DEATH; KINASE; MTOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION; PATHWAY; IDENTIFICATION	Background: The role of extracellular signal-regulated protein kinase (ERK) in intestinal ischemia/reperfusion (I/R) injury has not been well investigated. The aim of the current study was to examine the effect of inhibition of the ERK pathway in an in vitro and in vivo model of intestinal I/R injury. Methods: ERK1/2 activity was inhibited using the specific inhibitor, U0126, in intestinal epithelial cells under hypoxia/reoxygenation conditions and in mice subjected to 1 hour of intestinal ischemia followed by 6 hours reperfusion. In vitro, cell proliferation was assessed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay, apoptosis by DNA fragmentation, and migration using an in vitro model of intestinal wound healing. Cells were also transfected with a p70S6K plasmid and the effects of overexpression similarly analyzed. In vivo, the effects of U0126 on intestinal cell proliferation and apoptosis, intestinal permeability, lung and intestinal neutrophil infiltration and injury, and plasma cytokine levels were measured. Survival was also assessed after U0126. Activity of p70S6 kinase (p70S6K) was measured by Western blot. Results: In vitro, inhibition of ERK1/2 by U0126 significantly decreased cell proliferation and migration but enhanced cell apoptosis. Overexpression of p70S6K promoted cell proliferation and decreased cell apoptosis. In vivo, U0126 significantly increased cell apoptosis and decreased cell proliferation in the intestine, increased intestinal permeability, intestinal and lung neutrophil infiltration, and injury, as well as systemic pro-inflammatory cytokines, TNF-alpha, IL-6 and IL-1 beta. Mortality was also significantly increased by U0126. Inhibition of ERK1/2 by U0126 also abolished activity of p70S6K both in vitro and in vivo models. Conclusion: Pharmacologic inhibition of ERK1/2 by U0126 worsens intestinal IR injury. The detrimental effects are mediated, at least in part, by inhibition of p70S6K, the major effector of mammalian target of rapamycin pathway.	[Ban, Kechen; Peng, Zhanglong; Kozar, Rosemary A.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Ban, KC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA.	Kechen.Ban@uth.tmc.edu			National Institutes of Health [R01 GM077282]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01 GM077282. http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Alderliesten M, 2007, AM J PATHOL, V171, P452, DOI 10.2353/ajpath.2007.060805; Ban KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041584; Bellingan GJ, 2002, THORAX, V57, P540, DOI 10.1136/thorax.57.6.540; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Deng ZH, 2012, J TRAUMA ACUTE CARE, V72, P143, DOI 10.1097/TA.0b013e3182222f67; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Gorelik G, 2010, AUTOIMMUNITY, V43, P17, DOI 10.3109/08916930903374832; Grishin A, 2004, SURGERY, V136, P329, DOI 10.1016/j.surg.2004.05.008; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Jeong S, 2012, J NEUROSURG ANESTH, V24, P51, DOI 10.1097/ANA.0b013e3182368d70; Leseux L, 2008, BLOOD, V111, P285, DOI 10.1182/blood-2007-04-085092; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Lu K, 2010, J NEUROCHEM, V114, P237, DOI 10.1111/j.1471-4159.2010.06747.x; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Marampon F, 2011, MOL CANCER THER, V10, P159, DOI 10.1158/1535-7163.MCT-10-0631; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Noh KT, 2012, J BIOL CHEM, V287, P14226, DOI 10.1074/jbc.M111.308841; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Rocker GM, 1997, THORAX, V52, P841, DOI 10.1136/thx.52.10.841; Rocourt DV, 2007, J SURG RES, V139, P269, DOI 10.1016/j.jss.2006.10.047; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sato N, 2006, AM J PHYSIOL-GASTR L, V290, pG616, DOI 10.1152/ajpgi.00248.2005; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Souza DG, 2004, J IMMUNOL, V173, P4137, DOI 10.4049/jimmunol.173.6.4137; Tamion F, 1997, AM J PHYSIOL-GASTR L, V273, pG314, DOI 10.1152/ajpgi.1997.273.2.G314; Wang H, 2012, BIOSCI TRENDS, V6, P325, DOI 10.5582/bst.2012.v6.6.325; Wattanasirichaigoon S, 1999, SHOCK, V11, P269, DOI 10.1097/00024382-199904000-00008; Yamnik RL, 2010, FEBS LETT, V584, P124, DOI 10.1016/j.febslet.2009.11.041; Yang RK, 2005, INTENS CARE MED, V31, P709, DOI 10.1007/s00134-005-2601-9; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zhua YM, 2013, BRAIN RES, V1494, P1, DOI 10.1016/j.brainres.2012.11.047	39	23	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76790	10.1371/journal.pone.0076790	http://dx.doi.org/10.1371/journal.pone.0076790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073294	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000104
J	Duka, V; Lee, JH; Credle, J; Wills, J; Oaks, A; Smolinsky, C; Shah, K; Mash, DC; Masliah, E; Sidhu, A				Duka, Valeriy; Lee, Jae-Hoon; Credle, Joel; Wills, Jonathan; Oaks, Adam; Smolinsky, Ciaran; Shah, Ketul; Mash, Deborah C.; Masliah, Eliezer; Sidhu, Anita			Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer's Diseases	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; MOUSE MODEL; PHOSPHORYLATION; NEURODEGENERATION; TAUOPATHY; PATHOLOGY; PATHWAYS; BRAIN	Objective: Most neurodegenerative diseases contain hyperphosphorylated Tau [p-Tau]. We examined for the first time epitopes at which Tau is hyperphosphorylated in Parkinson's disease, dementia with Lewy bodies and Alzheimer's disease, and also select Tau kinases. Methods: Postmortem frontal cortex from Parkinson's disease, dementia with Lewy bodies, Alzheimer's disease and striata from Parkinson's disease, were analyzed by immunoblots using commercially available antibodies against 20 different phospho-epitopes of Tau. Major Tau kinases were also screened. Results in diseased tissues were compared to nondiseased controls. Results: In Alzheimer's disease, Tau was hyperphosphorylated at all the 20 epitopes of p-Tau. In dementia with Lewy bodies, p-Tau formation occurred at 6 sites sharing 30% overlap with Alzheimer's disease, while in Parkinson's frontal cortex, an area which does not degenerate, Tau hyperphosphorylation was seen at just 3 epitopes, indicating 15% overlap with Alzheimer's disease. In Parkinson's disease striatum, an area which undergoes considerable neurodegeneration, Tau was hyperphosphorylated at 10 epitopes, sharing 50% overlap with Alzheimer's disease. Between frontal cortex of Parkinson's disease and dementia with Lewy bodies, there were only two p-Tau epitopes in common. In striata of Parkinson's disease, there were 3 clusters of Tau hyperphosphorylated at 3 contiguous sites, while two such clusters were detected in dementia with Lewy bodies; such clusters disrupt axonal transport of mitochondria, cause microtubule remodeling and result in cell death. p-GSK-3 beta, a major Tau kinase, was activated in all brain regions examined, except in dementia with Lewy bodies. Activation of other Tau kinases was seen in all brain regions, with no clear pattern of activation. Interpretation: Our studies suggest that the three neurodegenerative diseases each have a signature-specific profile of p-Tau formation which may be useful in understanding the genesis of the diseases and for the development of a panel of specific biomarkers.	[Duka, Valeriy; Lee, Jae-Hoon; Credle, Joel; Wills, Jonathan; Oaks, Adam; Smolinsky, Ciaran; Shah, Ketul; Sidhu, Anita] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA; [Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Neurol & Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Georgetown University; University of Miami; University of California System; University of California San Diego	Sidhu, A (corresponding author), Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA.	sidhua@georgetown.edu		Lipton, Stuart/0000-0002-3490-1259	National Institutes of Health [R01AGO28108]; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from National Institutes of Health R01AGO28108 [AS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Ando K, 2011, J BIOL CHEM, V286, P7619, DOI 10.1074/jbc.M110.158477; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2006, NEUROTOX RES, V10, P1, DOI 10.1007/BF03033329; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Echeverria V, 2004, NEUROSCIENCE, V129, P583, DOI 10.1016/j.neuroscience.2004.07.036; Forlenza OV, 2011, BRIT J PSYCHIAT, V198, P351, DOI 10.1192/bjp.bp.110.080044; Gilley J, 2011, BIOCHEM SOC T, V39, P933, DOI 10.1042/BST0390933; Goedert M, 1998, MOL PSYCHIATR, V3, P462, DOI 10.1038/sj.mp.4000458; HAGGERTY T, 2011, EUR J NEUROSCI, P1; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hashimoto M, 2004, J BIOL CHEM, V279, P23622, DOI 10.1074/jbc.M313784200; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kaul T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-79; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; Kozikowski AP, 2006, CHEMMEDCHEM, V1, P256, DOI 10.1002/cmdc.200500039; Lippens G, 2012, BIOCHEM SOC T, V40, P698, DOI 10.1042/BST20120050; Lovestone S, 1997, NEUROSCIENCE, V78, P309; Muntane G, 2008, NEUROSCIENCE, V152, P913, DOI 10.1016/j.neuroscience.2008.01.030; Ninkina N, 2009, HUM MOL GENET, V18, P1779, DOI 10.1093/hmg/ddp090; Papapetropoulos S, 2005, ACTA NEUROL SCAND, V111, P353, DOI 10.1111/j.1600-0404.2005.00411.x; Qureshi HY, 2011, J BIOL CHEM, V286, P5055, DOI 10.1074/jbc.M110.178905; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Troquier L, 2012, CURR ALZHEIMER RES, V9, P397, DOI 10.2174/156720512800492503; Wills J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030745; Wills J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017953; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	37	67	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75025	10.1371/journal.pone.0075025	http://dx.doi.org/10.1371/journal.pone.0075025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073234	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000043
J	Xiong, CH; Wang, DM; Wang, Q; Benton, MJ; Xue, JZ; Meng, MC; Zhao, Q; Zhang, J				Xiong, Conghui; Wang, Deming; Wang, Qi; Benton, Michael J.; Xue, Jinzhuang; Meng, Meicen; Zhao, Qi; Zhang, Jing			Diversity Dynamics of Silurian-Early Carboniferous Land Plants in South China	PLOS ONE			English	Article							FAMENNIAN MASS EXTINCTION; EARLY EVOLUTION; BIODIVERSITY; ARTHROPOD; EVENTS	New megafossil and microfossil data indicate four episodes in the diversification of Silurian-Early Carboniferous land plants of South China, a relatively continuous regional record. Plant diversity increased throughout, but the rising curve was punctuated by three major falls. There were peaks of origination in the Ludlow-Pragian, Givetian, late Famennian and Visean and peaks of extinction in the Pragian-Emsian, Givetian and early Tournaisian. Speciation and extinction rates were highest in the Lochkovian-Pragian and became progressively lower in subsequent stages. High correlation coefficients indicate that these events are associated with the availability of land habitat contingent on eustatic variations and increasing numbers of cosmopolitan genera. Meanwhile, proportions of endemic genera declined gradually. Due to less endemism and more migrations, both speciation and species extinction rates reduced. The changes of diversity and the timing of the three extinctions of land plants in South China are similar to those known already from Laurussia. However, the largest events in the Lochkovian-Pragian and subsequent smaller ones have not been seen in the global pattern of plant evolution. These land plant events do not correspond well temporally with those affecting land vertebrates or marine invertebrates. In South China, the diversity curve of land plants is generally opposite to that of marine faunas, showing a strong effect of eustatic variations. The increasing diversity of both land vertebrates and plants was punctuated above the Devonian-Carboniferous boundary, known as Romer's Gap, implying common underlying constraints on macroevolution of land animals and plants.	[Xiong, Conghui; Wang, Deming; Xue, Jinzhuang; Meng, Meicen] Peking Univ, Dept Geol, Minist Educ, Key Lab Orogen Belts & Crustal Evolut, Beijing 100871, Peoples R China; [Wang, Qi; Zhang, Jing] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Benton, Michael J.; Zhao, Qi] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Zhao, Qi] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Botany, CAS; University of Bristol; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wang, DM (corresponding author), Peking Univ, Dept Geol, Minist Educ, Key Lab Orogen Belts & Crustal Evolut, Beijing 100871, Peoples R China.	dmwang@pku.edu.cn; happyking@ibcas.ac.cn	Xue, Jinzhuang/D-3331-2009; Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824; Xue, Jinzhuang/0000-0003-4397-4641	National Basic Research Program of China (973 Program) [2012CB821900]; National Natural Science Foundation of China [40830211, 41172007, 40972015]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [123106]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences)	This study is supported by the National Basic Research Program of China (973 Program, Grant no. 2012CB821900), the National Natural Science Foundation of China (Grant nos. 40830211, 41172007, 40972015), and State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) (No. 123106) to DW and QW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton MJ, 2011, GEOL SOC SPEC PUBL, V358, P63, DOI 10.1144/SP358.6; Benton MJ, 2010, PHILOS T R SOC B, V365, P3667, DOI 10.1098/rstb.2010.0269; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; BENTON MJ, 1993, FOSS REC, V2, P845; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Bond D, 2004, GEOL MAG, V141, P173, DOI 10.1017/S0016756804008866; Cascales-Minana B, 2013, EARTH SCI R IN PRESS, DOI [10.1016/j.earscirev.2013.05.013, DOI 10.1016/J.EARSCIREV.2013.05.013)]; Cascales-Minana B, 2012, LETHAIA, V45, P71, DOI 10.1111/j.1502-3931.2011.00262.x; Chen DZ, 2003, PALAEOGEOGR PALAEOCL, V193, P87, DOI 10.1016/S0031-0182(02)00716-2; Coates Michael I., 1995, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V17, P373; COPPER P, 1986, GEOLOGY, V14, P835, DOI 10.1130/0091-7613(1986)14<835:FMEACO>2.0.CO;2; Copper P, 2002, PALAEOGEOGR PALAEOCL, V181, P27, DOI 10.1016/S0031-0182(01)00472-2; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Gutak JM, 2011, PALAEOGEOGR PALAEOCL, V299, P240, DOI 10.1016/j.palaeo.2010.11.005; Hao S.-G., 2013, EARLY DEVONIAN POSON, P366; Haq BU, 2008, SCIENCE, V322, P64, DOI 10.1126/science.1161648; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; Joachimski MM, 2009, EARTH PLANET SC LETT, V284, P599, DOI 10.1016/j.epsl.2009.05.028; JOACHIMSKI MM, 1993, GEOLOGY, V21, P675, DOI 10.1130/0091-7613(1993)021<0675:AEITLF>2.3.CO;2; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Ma XP, 2002, PALAEOGEOGR PALAEOCL, V181, P325, DOI 10.1016/S0031-0182(01)00484-9; Ma XPP, 2009, GEOL SOC SPEC PUBL, V314, P241, DOI 10.1144/SP314.13; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Niklas K.J., 1997, EVOLUTIONARY BIOL PL, P449; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; RAYMOND A, 1985, PALEOBIOLOGY, V11, P293, DOI 10.1017/S009483730001160X; RAYMOND A, 1995, PALEOBIOLOGY, V21, P74, DOI 10.1017/S0094837300013087; Rees PM, 2002, GEOLOGY, V30, P827; Rong JY, 2007, GEOL J, V42, P431, DOI 10.1002/gj.1073; Ruban Dmitry A., 2008, Geologos, V14, P37; Sallan LC, 2010, P NATL ACAD SCI USA, V107, P10131, DOI 10.1073/pnas.0914000107; Sandberg CA, 2002, GEOL SOC AM SPEC PAP, V356, P473; Scotese CR, 2004, J GEOL, V112, P729, DOI 10.1086/424867; Simon L, 2007, CHEM GEOL, V246, P19, DOI 10.1016/j.chemgeo.2007.08.014; Smithson TR, 2012, P NATL ACAD SCI USA, V109, P4532, DOI 10.1073/pnas.1117332109; Tiffney, 1985, GEOLOGICAL FACTORS E, P169; WANG Y, 1984, GEOL SOC AM BULL, V95, P265; Wang Y, 2007, GEOL J, V42, P339, DOI 10.1002/gj.1082; Wang Y, 2010, SCI CHINA EARTH SCI, V53, P1828, DOI 10.1007/s11430-010-4079-8; Ward P, 2006, P NATL ACAD SCI USA, V103, P16818, DOI 10.1073/pnas.0607824103; Xiong CH, 2011, PALEOBIOLOGY, V37, P157, DOI 10.1666/09029.1	42	19	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75706	10.1371/journal.pone.0075706	http://dx.doi.org/10.1371/journal.pone.0075706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073276	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000086
J	Fradet, A; Sorel, H; Depalle, B; Serre, CM; Farlay, D; Turtoi, A; Bellahcene, A; Follet, H; Castronovo, V; Clezardin, P; Bonnelye, E				Fradet, Anais; Sorel, Helene; Depalle, Baptiste; Serre, Claire Marie; Farlay, Delphine; Turtoi, Andrei; Bellahcene, Akeila; Follet, Helene; Castronovo, Vincent; Clezardin, Philippe; Bonnelye, Edith			A New Murine Model of Osteoblastic/Osteolytic Lesions from Human Androgen-Resistant Prostate Cancer	PLOS ONE			English	Article							CARCINOMA CELL-LINE; BONE METASTASIS; OSTEOBLAST DIFFERENTIATION; ENDOTHELIN AXIS; BREAST-CANCER; ERR-ALPHA; IN-VITRO; ESTABLISHMENT; EXPRESSION; SIALOPROTEIN	Background: Up to 80% of patients dying from prostate carcinoma have developed bone metastases that are incurable. Castration is commonly used to treat prostate cancer. Although the disease initially responds to androgen blockade strategies, it often becomes castration-resistant (CRPC for Castration Resistant Prostate Cancer). Most of the murine models of mixed lesions derived from prostate cancer cells are androgen sensitive. Thus, we established a new model of CRPC (androgen receptor (AR) negative) that causes mixed lesions in bone. Methods: PC3 and its derived new cell clone PC3c cells were directly injected into the tibiae of SCID male mice. Tumor growth was analyzed by radiography and histology. Direct effects of conditioned medium of both cell lines were tested on osteoclasts, osteoblasts and osteocytes. Results: We found that PC3c cells induced mixed lesions 10 weeks after intratibial injection. In vitro, PC3c conditioned medium was able to stimulate tartrate resistant acid phosphatase (TRAP)-positive osteoclasts. Osteoprotegerin (OPG) and endothelin-1 (ET1) were highly expressed by PC3c while dikkopf-1 (DKK1) expression was decreased. Finally, PC3c highly expressed bone associated markers osteopontin (OPN), Runx2, alkaline phosphatase (ALP), bone sialoprotein (BSP) and produced mineralized matrix in vitro in osteogenic conditions. Conclusions: We have established a new CRPC cell line as a useful system for modeling human metastatic prostate cancer which presents the mixed phenotype of bone metastases that is commonly observed in prostate cancer patients with advanced disease. This model will help to understand androgen-independent mechanisms involved in the progression of prostate cancer in bone and provides a preclinical model for testing the effects of new treatments for bone metastases.	[Fradet, Anais; Sorel, Helene; Depalle, Baptiste; Serre, Claire Marie; Farlay, Delphine; Follet, Helene; Clezardin, Philippe; Bonnelye, Edith] INSERM, U1033, F-69008 Lyon, France; [Fradet, Anais; Sorel, Helene; Depalle, Baptiste; Serre, Claire Marie; Farlay, Delphine; Follet, Helene; Clezardin, Philippe; Bonnelye, Edith] Univ Lyon, Lyon, France; [Turtoi, Andrei; Bellahcene, Akeila; Castronovo, Vincent] Univ Liege, Metastasis Res Lab, GIGA CANC, Liege, Belgium	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Liege	Bonnelye, E (corresponding author), INSERM, U1033, F-69008 Lyon, France.	edith.bonnelye@inserm.fr	Turtoi, Andrei/ABD-1271-2021; Bonnelye, Edith/AAT-9134-2021; FARLAY, Delphine/AGF-1234-2022; Clezardin, Philippe/M-8071-2014; Follet, Hélène/E-5536-2010; Depalle, Baptiste/J-6068-2019	Turtoi, Andrei/0000-0003-3813-6635; FARLAY, Delphine/0000-0001-6487-0337; Clezardin, Philippe/0000-0003-0149-4463; Follet, Hélène/0000-0002-3290-2899; Depalle, Baptiste/0000-0002-5789-0636	CNRS; Inserm; University of Lyon; "Ligue Regionale contre le Cancer" (Isere); "Association pour la Recherche sur les Tumeurs de la Prostate (ARTP)"; Ligue Nationale contre le Cancer; Region Rhone Alpes "Cible" program	CNRS(Centre National de la Recherche Scientifique (CNRS)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Lyon; "Ligue Regionale contre le Cancer" (Isere); "Association pour la Recherche sur les Tumeurs de la Prostate (ARTP)"; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Region Rhone Alpes "Cible" program(Region Auvergne-Rhone-Alpes)	This work was supported by the CNRS (Edith Bonnelye), Inserm, the University of Lyon, "Ligue Regionale contre le Cancer" (Isere) (EB) http://www.ligue-cancer.net/ and "Association pour la Recherche sur les Tumeurs de la Prostate (ARTP)" (Edith Bonnelye) http://www.artp.org/. Anais Fradet is supported by the Ligue Nationale contre le Cancer, http://www.ligue-cancer.net/ Baptiste Depalle by a grant from the Region Rhone Alpes "Cible" program and Akeila Bellahcene is a Senior Research Associate from the National Fund for Scientific Research, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbalagan Muralidharan, 2012, Nucl Recept Signal, V10, pe001, DOI 10.1621/nrs.10001; Bagnato A, 2011, BRIT J PHARMACOL, V163, P220, DOI 10.1111/j.1476-5381.2011.01217.x; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Carlinfante G, 2003, CLIN EXP METASTAS, V20, P437, DOI 10.1023/A:1025419708343; Chauchereau A, 2011, EXP CELL RES, V317, P262, DOI 10.1016/j.yexcr.2010.10.012; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Coleman R, 2012, JNCI-J NATL CANCER I, V104, P1059, DOI 10.1093/jnci/djs263; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Flajollet S, 2011, MOL CANCER RES, V9, P914, DOI 10.1158/1541-7786.MCR-10-0537; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Harris S. E., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P313; Huang WC, 2005, CANCER RES, V65, P2303, DOI 10.1158/0008-5472.CAN-04-3448; Jimeno A, 2004, EXPERT OPIN INV DRUG, V13, P1631, DOI 10.1517/13543784.13.12.1631; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kamiya N, 2011, INT J CLIN ONCOL, V16, P366, DOI 10.1007/s10147-011-0193-7; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Keller ET, 2004, J CELL BIOCHEM, V91, P718, DOI 10.1002/jcb.10662; Korenchuk S, 2001, IN VIVO, V15, P163; LeRoy BE, 2006, PROSTATE, V66, P1213, DOI 10.1002/pros.20408; Li ZG, 2008, J CLIN INVEST, V118, P2697, DOI 10.1172/JCI33093; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Navone NM, 1997, CLIN CANCER RES, V3, P2493; NELSON JB, 1995, NAT MED, V1, P944, DOI 10.1038/nm0995-944; Roudier MP, 2008, J UROLOGY, V180, P1154, DOI 10.1016/j.juro.2008.04.140; Saraon P, 2011, CLIN CHEM, V57, P1366, DOI 10.1373/clinchem.2011.165977; Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Theriault RL, 2012, CANCER CONTROL, V19, P92, DOI 10.1177/107327481201900203; Tian TV, 2013, ONCOGENE, DOI [10.1038/onc.2013.176, DOI 10.1038/0NC.2013.176.PUBMED:23708657]; Vela I, 2007, BJU INT, V99, P735, DOI 10.1111/j.1464-410X.2006.06670.x; von Schroeder HP, 2003, BONE, V33, P673, DOI 10.1016/S8756-3282(03)00215-1; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055	39	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75092	10.1371/journal.pone.0075092	http://dx.doi.org/10.1371/journal.pone.0075092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069383	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000324777300064
J	Gubert, P; Aguiar, GC; Mourao, T; Bridi, JC; Barros, AG; Soares, FA; Romano-Silva, MA				Gubert, Priscila; Aguiar, Gabriel Costa; Mourao, Tacito; Bridi, Jessika Cristina; Barros, Alexandre Guimaraes; Soares, Felix Alexandre; Romano-Silva, Marco Aurelio			Behavioral and Metabolic Effects of the Atypical Antipsychotic Ziprasidone on the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							SEROTONIN; FAT; DAF-16; DOPAMINE; SCHIZOPHRENIA; MECHANISMS; OCTOPAMINE; LONGEVITY; NEURONS; PATHWAY	Atypical antipsychotics are associated with metabolic syndrome, primarily associated with weight gain. The effects of Ziprasidone, an atypical antipsychotic, on metabolic syndrome has yet to be evaluated. Here in, we evaluated lipid accumulation and behavioral changes in a new experimental model, the nematode Caenorhabditis elegans (C. elegans). Behavioral parameters in the worms were evaluated 24 h after Ziprasidone treatment. Subsequently, lipid accumulation was examined using Nile red, LipidTox green and BODIPY labeling. Ziprasidone at 40 mu M for 24 h effectively decreased the fluorescence labeling of all markers in intestinal cells of C. elegans compared to control (0.16% dimethyl sulfoxide). Ziprasidone did not alter behaviors related to energetic balance, such as pharynx pumping, defecation cycles and movement. There was, however, a reduction in egg-production, egg-laying and body-length in nematodes exposed to Ziprasidone without any changes in the progression of larval stages. The serotoninergic pathway did not appear to modulate Ziprasidone's effects on Nile red fluorescence. Additionally, Ziprasidone did not alter lipid accumulation in daf-16 or crh-1 deletion mutants (orthologous of the transcription factors DAF-16 and CREB, respectively). These results suggest that Ziprasidone alters reproductive behavior, morphology and lipid reserves in the intestinal cells of C. elegans. Our results highlight that the DAF-16 and CREB transcription factors are essential for Ziprasidone-induced fat store reduction.	[Bridi, Jessika Cristina; Romano-Silva, Marco Aurelio] Univ Fed Minas Gerais, Dept Saude Mental, Fac Med, Belo Horizonte, MG, Brazil; [Soares, Felix Alexandre] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Quim, BR-97119900 Santa Maria, RS, Brazil; [Gubert, Priscila; Aguiar, Gabriel Costa; Mourao, Tacito; Barros, Alexandre Guimaraes; Romano-Silva, Marco Aurelio] Univ Fed Minas Gerais, INCT Med Mol, Fac Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Santa Maria (UFSM); Universidade Federal de Minas Gerais	Romano-Silva, MA (corresponding author), Univ Fed Minas Gerais, Dept Saude Mental, Fac Med, Belo Horizonte, MG, Brazil.	romanosilva@gmail.com	Soares, Félix/AAE-6251-2020; Gubert, Priscila/ABC-1059-2020; Romano-Silva, Marco Aurelio/A-1790-2008; Romano-Silva, Marco Aurelio/T-8321-2019; Soares, Félix AA/K-7611-2012	Soares, Félix/0000-0002-6453-7902; Gubert, Priscila/0000-0002-3598-8050; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Soares, Félix AA/0000-0002-6453-7902; Bridi, Jessika/0000-0002-7692-9866	INCT; CAPES; CNPQ (The National Council for Scientific and Technological Development); FAPEMIG	INCT; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ (The National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by INCT, CAPES, CNPQ (The National Council for Scientific and Technological Development), and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitlhadj L, 2011, ENVIRON HEALTH PERSP, V119, P20, DOI 10.1289/ehp.1002522; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BRENNER S, 1974, GENETICS, V77, P71; Donohoe DR, 2006, PHARMACOL RES, V54, P361, DOI 10.1016/j.phrs.2006.07.002; Haupt DW, 2006, EUR NEUROPSYCHOPHARM, V16, pS149, DOI 10.1016/j.euroneuro.2006.06.003; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Hyman SE, 1996, NEURON, V16, P901, DOI 10.1016/S0896-6273(00)80111-7; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Karmacharya R, 2009, NEUROPSYCHOPHARMACOL, V34, P1968, DOI 10.1038/npp.2009.35; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Kubagawa HM, 2006, NAT CELL BIOL, V8, P1143, DOI 10.1038/ncb1476; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Mamo D, 2004, AM J PSYCHIAT, V161, P818, DOI 10.1176/appi.ajp.161.5.818; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P20; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ren XC, 1999, J NEUROBIOL, V39, P107, DOI 10.1002/(SICI)1097-4695(199904)39:1&lt;107::AID-NEU9&gt;3.0.CO;2-7; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Stimmel GL, 2002, CLIN THER, V24, P21, DOI 10.1016/S0149-2918(02)85003-2; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wang PW, 2011, J PSYCHIATR RES, V45, P1128, DOI 10.1016/j.jpsychires.2011.01.019; Watanabe H, 2010, ENDOCRINOLOGY, V151, P4776, DOI 10.1210/en.2009-1349; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002	36	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74780	10.1371/journal.pone.0074780	http://dx.doi.org/10.1371/journal.pone.0074780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069346	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300044
J	Kim, MK; Cho, JH; Lee, JJ; Cheong, YH; Son, MH; Lee, KJ				Kim, Mi-Kyung; Cho, Jin-Hwan; Lee, Jae-Jin; Cheong, Ye-Hwang; Son, Moon-Ho; Lee, Kong-Joo			Differential Protective Effects of Exenatide, an Agonist of GLP-1 Receptor and Piragliatin, a Glucokinase Activator in Beta Cell Response to Streptozotocin-Induced and Endoplasmic Reticulum Stresses	PLOS ONE			English	Article							FREE FATTY-ACIDS; OXIDATIVE STRESS; POSTTRANSLATIONAL MODIFICATIONS; MEDIATED APOPTOSIS; COLORIMETRIC ASSAY; INSULIN-RESISTANCE; DIABETES-MELLITUS; PANCREATIC-ISLETS; 14-3-3 PROTEINS; GLUCOSE	Background: Agonists of glucagon-like peptide-1 receptor (GLP-1R) and glucokinase activators (GKA) act as antidiabetic agents by their ability protect beta cells, and stimulate insulin secretion. Oxidative and endoplasmic reticulum (ER) stresses aggravate type 2 diabetes by causing beta cell loss. It was shown that GLP-1R agonists protect beta cells from oxidative and ER stresses. On the other hand, little is known regarding how GKAs protect beta cells. We hypothesized that GKAs protect beta cells by mechanisms distinct from those underlying GLP-1R agonist and tested our hypothesis by comparing the molecular effects of exenatide, a GLP-1R agonist, and piragliatin, a GKA, on INS-1 cells under oxidative and ER-induced stresses. Methods: Beta cells were treated with streptozotocin (STZ) to induce oxidative stress and with palmitate or thapsigargin (Tg) to induce ER stress respectively, and the effects of exenatide and piragliatin on these cells were investigated by: a) characterizing the kinases involved employing specific kinase inhibitors, and b) by identifying the differentially regulated proteins in response to stresses with proteomic analysis. Results: Exenatide protected INS-1 cells from both ER and STZ-induced death. In contrast, piragliatin rescued the cells only from STZ-induced stress. Akt activation by exenatide appeared to contribute to its protective effects of beta cells while enhanced glucose utilization was the contributing factor in the case of piragliatin. Also, exenatide, not piragliatin, blocked changes in proteins 14-3-3 beta, epsilon and theta, and preserved the 14-3-3 theta levels under the ER stress. Isoform-specific modifications of 14-3-3, and the reduction of 14-3-3 theta, commonly associated with beta cell death were assessed. Conclusions: Exenatide and piragliatin exert distinct effects on beta cell survival and thus on type 2 diabetes. This study which confirmed our hypothesis is also the first to observe specific modulation of 14-3-3 isoform in stress-induced beta cell death associated with progressive deterioration of type 2 diabetes.	[Kim, Mi-Kyung; Cho, Jin-Hwan; Lee, Jae-Jin; Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Seoul, South Korea; [Kim, Mi-Kyung; Cho, Jin-Hwan; Lee, Jae-Jin; Lee, Kong-Joo] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Kim, Mi-Kyung; Cheong, Ye-Hwang; Son, Moon-Ho] Dong A ST Res Inst, Yongin, Gyeonggi Do, South Korea	Ewha Womans University; Ewha Womans University	Lee, KJ (corresponding author), Ewha Womans Univ, Coll Pharm, Seoul, South Korea.	kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020	Global Research Lab Program [2012045441]; 3 Proteogenomics Research Program [2012036680]; WCU project of the National Research Foundation of Korea [R31-2008-000-410010-0]	Global Research Lab Program; 3 Proteogenomics Research Program; WCU project of the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Global Research Lab Program (No. 2012045441), the 3 Proteogenomics Research Program (No. 2012036680) and WCU project (R31-2008-000-410010-0) of the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Bonadonna RC, 2010, J CLIN ENDOCR METAB, V95, P5028, DOI 10.1210/jc.2010-1041; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cho JM, 2011, DIABETES RES CLIN PR, V91, P72, DOI 10.1016/j.diabres.2010.10.012; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Dalle S, 2011, CELL SIGNAL, V23, P522, DOI 10.1016/j.cellsig.2010.09.014; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Fan R, 2010, DIABETES OBES METAB, V12, P815, DOI 10.1111/j.1463-1326.2010.01238.x; Fehse F, 2005, J CLIN ENDOCR METAB, V90, P5991, DOI 10.1210/jc.2005-1093; Futamura M, 2012, DIABETOLOGIA, V55, P1071, DOI 10.1007/s00125-011-2439-3; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Kim JY, 2010, J KOREAN MED SCI, V25, P1626, DOI 10.3346/jkms.2010.25.11.1626; Kim M, 2012, DIABETES RES CLIN PR, V98, P132, DOI 10.1016/j.diabres.2012.04.013; Kim S, 2006, NUCLEIC ACIDS RES, V34, pW258, DOI 10.1093/nar/gkl245; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Kwon DY, 2009, J PHARMACOL SCI, V111, P361, DOI 10.1254/jphs.09178FP; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Memos N, 2011, J NEUROSCI RES, V89, P1409, DOI 10.1002/jnr.22673; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy N, 2008, J NEUROCHEM, V106, P978, DOI 10.1111/j.1471-4159.2008.05447.x; Na S, 2008, MOL CELL PROTEOMICS, V7, P2452, DOI 10.1074/mcp.M800101-MCP200; Nakamura A, 2012, DIABETOLOGIA, V55, P1745, DOI 10.1007/s00125-012-2521-5; Nakamura A, 2009, ENDOCRINOLOGY, V150, P1147, DOI 10.1210/en.2008-1183; Nielsen MD, 2008, AGING CELL, V7, P688, DOI 10.1111/j.1474-9726.2008.00420.x; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-5; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Saini KS, 1996, BIOCHEM MOL BIOL INT, V39, P1229; Sari FR, 2010, J PHARMACOL SCI, V113, P325, DOI 10.1254/jphs.10047FP; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Tonnesen MF, 2009, ENDOCRINOLOGY, V150, P4094, DOI 10.1210/en.2009-0029; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; UNGER RH, 1985, DIABETOLOGIA, V28, P119; Wei P, 2009, DIABETOLOGIA, V52, P2142, DOI 10.1007/s00125-009-1446-0; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	49	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73340	10.1371/journal.pone.0073340	http://dx.doi.org/10.1371/journal.pone.0073340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069189	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300011
J	Lin, TW; Wu, JW; Chang, DTH				Lin, Tzu-Wen; Wu, Jian-Wei; Chang, Darby Tien-Hao			Combining Phylogenetic Profiling-Based and Machine Learning-Based Techniques to Predict Functional Related Proteins	PLOS ONE			English	Article							FUSION EVENTS; SEQUENCES; LINKAGES; GENOMES; INFORMATION; DATABASE; SYSTEMS	Annotating protein functions and linking proteins with similar functions are important in systems biology. The rapid growth rate of newly sequenced genomes calls for the development of computational methods to help experimental techniques. Phylogenetic profiling (PP) is a method that exploits the evolutionary co-occurrence pattern to identify functional related proteins. However, PP-based methods delivered satisfactory performance only on prokaryotes but not on eukaryotes. This study proposed a two-stage framework to predict protein functional linkages, which successfully enhances a PP-based method with machine learning. The experimental results show that the proposed two-stage framework achieved the best overall performance in comparison with three PP-based methods.	[Lin, Tzu-Wen; Wu, Jian-Wei; Chang, Darby Tien-Hao] Natl Cheng Kung Univ, Dept Elect Engn, Tainan 70101, Taiwan	National Cheng Kung University	Chang, DTH (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, 1 Univ Rd, Tainan 70101, Taiwan.	darby@mail.ncku.edu.tw	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Science Council of the Republic of China, Taiwan [NSC 101-2221-E-006-264-]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council of the Republic of China, Taiwan, for financially supporting this research under Contract No. NSC 101-2221-E-006-264-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artin E, 1964, GAMMA FUNCTION; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Chang DTH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S3; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Enault F, 2003, BIOINFORMATICS, V19, pi105, DOI 10.1093/bioinformatics/btg1013; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Oyang YJ, 2005, IEEE T NEURAL NETWOR, V16, P225, DOI 10.1109/TNN.2004.836229; Pellegrini M, 2003, GOOGLE PATENTS; Ruano-Rubio V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-383; Salgado H, 2000, P NATL ACAD SCI USA, V97, P6652, DOI 10.1073/pnas.110147297; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Snitkin ES, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-420; Strong M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r59; Sun JC, 2005, BIOINFORMATICS, V21, P3409, DOI 10.1093/bioinformatics/bti532; Vapnik V., 1998, STAT LEARNING THEORY; Witten IH, 2005, DATA MINING PRACTICA, Vxxxi; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298; Yu CY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-167	25	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75940	10.1371/journal.pone.0075940	http://dx.doi.org/10.1371/journal.pone.0075940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069454	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300101
J	Monz, D; Tutdibi, E; Mildau, C; Shen, J; Kasoha, M; Laschke, MW; Roolfs, T; Schmiedl, A; Tschernig, T; Bieback, K; Gortner, L				Monz, Dominik; Tutdibi, Erol; Mildau, Celine; Shen, Jie; Kasoha, Mariz; Laschke, Matthias W.; Roolfs, Torge; Schmiedl, Andreas; Tschernig, Thomas; Bieback, Karen; Gortner, Ludwig			Human Umbilical Cord Blood Mononuclear Cells in a Double-Hit Model of Bronchopulmonary Dysplasia in Neonatal Mice	PLOS ONE			English	Article							INDUCED LUNG INJURY; MESENCHYMAL STEM-CELLS; REAL-TIME PCR; MOUSE MODEL; TRANSFORMING GROWTH-FACTOR-BETA-1; MTOR; PREVENTION; THERAPY; HYPOXIA; INFANTS	Background: Bronchopulmonary dysplasia (BPD) presents a major threat of very preterm birth and treatment options are still limited. Stem cells from different sources have been used successfully in experimental BPD, induced by postnatal hyperoxia. Objectives: We investigated the effect of umbilical cord blood mononuclear cells (MNCs) in a new double-hit mouse model of BPD. Methods: For the double-hit, date mated mice were subjected to hypoxia and thereafter the offspring was exposed to hyperoxia. Human umbilical cord blood MNCs were given intraperitoneally by day P7. As outcome variables were defined: physical development (auxology), lung structure (histomorphometry), expression of markers for lung maturation and inflammation on mRNA and protein level. Pre- and postnatal normoxic pups and sham treated double-hit pups served as control groups. Results: Compared to normoxic controls, sham treated double-hit animals showed impaired physical and lung development with reduced alveolarization and increased thickness of septa. Electron microscopy revealed reduced volume density of lamellar bodies. Pulmonary expression of mRNA for surfactant proteins B and C, Mtor and Crabp1 was reduced. Expression of Igf1 was increased. Treatment with umbilical cord blood MNCs normalized thickness of septa and mRNA expression of Mtor to levels of normoxic controls. Tgfb3 mRNA expression and pro-inflammatory IL-1 beta protein concentration were decreased. Conclusion: The results of our study demonstrate the therapeutic potential of umbilical cord blood MNCs in a new double-hit model of BPD in newborn mice. We found improved lung structure and effects on molecular level. Further studies are needed to address the role of systemic administration of MNCs in experimental BPD.	[Monz, Dominik; Tutdibi, Erol; Mildau, Celine; Shen, Jie; Kasoha, Mariz; Gortner, Ludwig] Univ Saarland, Dept Pediat & Neonatol, Homburg, Saar, Germany; [Shen, Jie] Third Mil Med Univ, Daping Hosp, Dept Pediat, Chongqing, Peoples R China; [Laschke, Matthias W.] Univ Saarland, Inst Clin & Expt Surg, Homburg, Saar, Germany; [Roolfs, Torge; Schmiedl, Andreas] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Tschernig, Thomas] Univ Saarland, Inst Anat & Cell Biol, Homburg, Saar, Germany; [Bieback, Karen] Heidelberg Univ, Inst Transfus Med & Immunol, Mannheim, Germany	Saarland University; Army Medical University; Saarland University; Hannover Medical School; Saarland University; Ruprecht Karls University Heidelberg	Gortner, L (corresponding author), Univ Saarland, Dept Pediat & Neonatol, Homburg, Saar, Germany.	ludwig.gortner@uks.eu			Sino-German Center for Research Promotion	Sino-German Center for Research Promotion	This work was in part supported by the Sino-German Center for Research Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahlfeld SK, 2012, BIRTH DEFECTS RES A, V94, P3, DOI 10.1002/bdra.22869; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; Baker CD, 2013, THORAX, V68, P402, DOI 10.1136/thoraxjnl-2012-202661; Bassler D, 2009, PEDIATRICS, V123, P313, DOI 10.1542/peds.2008-0377; Bry K, 2010, SEMIN PERINATOL, V34, P211, DOI 10.1053/j.semperi.2010.02.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cerny L, 2008, LUNG, V186, P75, DOI 10.1007/s00408-007-9069-z; Chang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052419; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Deakins KM, 2009, RESP CARE, V54, P1252; Fehrenbach H, 1998, METHODS PULMONARY RE, P429, DOI DOI 10.1007/978-3-0348-8855-4_17; Fielhaber JA, 2012, J IMMUNOL, V188, P4535, DOI 10.4049/jimmunol.1003655; Gauldie J, 2003, AM J PATHOL, V163, P2575, DOI 10.1016/S0002-9440(10)63612-7; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Goncharova EA, 2013, FASEB J, V27, P1796, DOI 10.1096/fj.12-222224; Gortner L, 2005, BIOL NEONATE, V88, P129, DOI 10.1159/000085895; Gortner L, 2013, ANN ANAT, V195, P351, DOI 10.1016/j.aanat.2013.02.010; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Heimfeld S, 2003, LEUKEMIA, V17, P856, DOI 10.1038/sj.leu.2402893; Hochberg Ze'ev, 2011, Front Endocrinol (Lausanne), V2, P41, DOI 10.3389/fendo.2011.00041; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hwang SK, 2011, BMB REP, V44, P506, DOI 10.5483/BMBRep.2011.44.8.506; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kogler G, 2009, BONE MARROW TRANSPL, V44, P683, DOI 10.1038/bmt.2009.287; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Maritz GS, 2001, PEDIATR PULM, V32, P201, DOI 10.1002/ppul.1109; Mayani H, 2003, ARCH MED RES, V34, P476, DOI 10.1016/j.arcmed.2003.08.004; O'Reilly M, 2013, CLIN EXP PHARM PHYSL; Pereira-Cunha FG, 2013, TRANSFUSION, V53, P2034, DOI 10.1111/trf.12078; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pierro M, 2013, THORAX, V68, P475, DOI 10.1136/thoraxjnl-2012-202323; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rosner M, 2008, MUTAT RES-REV MUTAT, V659, P284, DOI 10.1016/j.mrrev.2008.06.001; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Sng J, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/521343; Tutdibi E, 2012, J PERINAT MED, V40, P527, DOI 10.1515/jpm-2011-0204; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Van Marter LJ, 2011, ARCH DIS CHILD-FETAL, V96, pF20, DOI 10.1136/adc.2010.183012; Vicencio AG, 2004, AM J RESP CELL MOL, V31, P650, DOI 10.1165/rcmb.2004-0092OC; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Warburton D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S2; Wright RJ, 2010, BIOL PSYCHOL, V84, P46, DOI 10.1016/j.biopsycho.2010.01.007; Yeh TF, 2004, NEW ENGL J MED, V350, P1304, DOI 10.1056/NEJMoa032089; Zeitlin J, 2010, J PEDIATR-US, V157, P733, DOI 10.1016/j.jpeds.2010.05.002; Zhang XY, 2012, CELL BIOL INT, V36, P589, DOI 10.1042/CBI20110447	48	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74740	10.1371/journal.pone.0074740	http://dx.doi.org/10.1371/journal.pone.0074740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069341	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300042
J	Auner, HW; Moody, AM; Ward, TH; Kraus, M; Milan, E; May, P; Chaidos, A; Driessen, C; Cenci, S; Dazzi, F; Rahemtulla, A; Apperley, JF; Karadimitris, A; Dillon, N				Auner, Holger W.; Moody, Anne Marie; Ward, Theresa H.; Kraus, Marianne; Milan, Enrico; May, Philippa; Chaidos, Aristeidis; Driessen, Christoph; Cenci, Simone; Dazzi, Francesco; Rahemtulla, Amin; Apperley, Jane F.; Karadimitris, Anastasios; Dillon, Niall			Combined Inhibition of p97 and the Proteasome Causes Lethal Disruption of the Secretory Apparatus in Multiple Myeloma Cells	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; SIGNAL INTEGRATION; MAMMALIAN-CELLS; DEGRADATION; BORTEZOMIB; APOPTOSIS; ATPASE; ER; RETROTRANSLOCATION	Inhibition of the proteasome is a widely used strategy for treating multiple myeloma that takes advantage of the heavy secretory load that multiple myeloma cells (MMCs) have to deal with. Resistance of MMCs to proteasome inhibition has been linked to incomplete disruption of proteasomal endoplasmic-reticulum (ER)-associated degradation (ERAD) and activation of non-proteasomal protein degradation pathways. The ATPase p97 (VCP/Cdc48) has key roles in mediating both ERAD and non-proteasomal protein degradation and can be targeted pharmacologically by small molecule inhibition. In this study, we compared the effects of p97 inhibition with Eeyarestatin 1 and DBeQ on the secretory apparatus of MMCs with the effects induced by the proteasome inhibitor bortezomib, and the effects caused by combined inhibition of p97 and the proteasome. We found that p97 inhibition elicits cellular responses that are different from those induced by proteasome inhibition, and that the responses differ considerably between MMC lines. Moreover, we found that dual inhibition of both p97 and the proteasome terminally disrupts ER configuration and intracellular protein metabolism in MMCs. Dual inhibition of p97 and the proteasome induced high levels of apoptosis in all of the MMC lines that we analysed, including bortezomib-adapted AMO-1 cells, and was also effective in killing primary MMCs. Only minor toxicity was observed in untransformed and non-secretory cells. Our observations highlight non-redundant roles of p97 and the proteasome in maintaining secretory homeostasis in MMCs and provide a preclinical conceptual framework for dual targeting of p97 and the proteasome as a potential new therapeutic strategy in multiple myeloma.	[Auner, Holger W.; Moody, Anne Marie; Dillon, Niall] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Gene Regulat & Chromatin Grp, London, England; [Auner, Holger W.; May, Philippa; Chaidos, Aristeidis; Dazzi, Francesco; Rahemtulla, Amin; Apperley, Jane F.; Karadimitris, Anastasios] Univ London Imperial Coll Sci Technol & Med, Dept Med, Ctr Haematol, London, England; [Ward, Theresa H.] London Sch Hyg & Trop Med, Immunol & Infect Dept, London WC1, England; [Kraus, Marianne; Driessen, Christoph] Kantonsspital, St Gallen, Switzerland; [Milan, Enrico; Cenci, Simone] Ist Sci San Raffaele, Div Genet & Cell Biol, Age Related Dis Grp, I-20132 Milan, Italy	Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Auner, HW (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Gene Regulat & Chromatin Grp, London, England.	holger.auner04@imperial.ac.uk; niall.dillon@csc.mrc.ac.uk	Cenci, Simone/J-7700-2016; Ward, Theresa H./E-9650-2013; Dazzi, Francesco/ABD-6171-2021; May, Philippa/G-4496-2010; Milan, Enrico/J-8343-2016; Driessen, C/F-7061-2016; Milan, Enrico/AAH-3354-2021	Cenci, Simone/0000-0003-1215-7518; Ward, Theresa H./0000-0002-9881-8649; Dazzi, Francesco/0000-0003-2407-236X; May, Philippa/0000-0002-9033-4041; Milan, Enrico/0000-0003-3094-4275; Driessen, C/0000-0002-1124-7303; Milan, Enrico/0000-0003-3094-4275; Chaidos, Aristeidis/0000-0003-1453-8576; Auner, Holger/0000-0003-4040-0642	Medical Research Council UK; Cancer Research UK; Leuka (registered UK charity) [286231]; Wellcome Trust/Imperial College London; Cancer Research UK [15448] Funding Source: researchfish; Medical Research Council [G0400373, MC_U120036884] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10275] Funding Source: researchfish; MRC [MC_U120036884, G0400373] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Leuka (registered UK charity); Wellcome Trust/Imperial College London; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research in ND's lab was supported by the Medical Research Council UK. Part of this work was funded by a Cancer Research UK Clinician Scientist Fellowship to HWA. HWA was supported by Leuka (registered UK charity no. 286231) and a Wellcome Trust/Imperial College London Value in People Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Aronson LI, 2012, HAEMATOL-HEMATOL J, V97, P1119, DOI 10.3324/haematol.2012.064923; Auner HW, 2010, BLOOD, V116, P3445, DOI 10.1182/blood-2009-10-250423; Avet-Loiseau H, 2012, J CLIN ONCOL, V30, P1949, DOI 10.1200/JCO.2011.36.5726; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Cenci S, 2006, EMBO J, V25, P1104, DOI 10.1038/sj.emboj.7601009; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; David E, 2010, BLOOD, V116, P5285, DOI 10.1182/blood-2010-03-272393; Dimopoulos MA, 2011, EUR J HAEMATOL, V86, P1, DOI 10.1111/j.1600-0609.2010.01542.x; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fessart D, 2013, CANCER LETT, V337, P26, DOI 10.1016/j.canlet.2013.05.030; Hideshima T, 2005, ONCOGENE, V24, P3121, DOI 10.1038/sj.onc.1208522; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; Hyun T, 2000, BLOOD, V96, P3560, DOI 10.1182/blood.V96.10.3560.h8003560_3560_3568; Kharaziha P, 2012, CANCER RES, V72, P5348, DOI 10.1158/0008-5472.CAN-12-0658; Kirk SJ, 2010, J LEUKOCYTE BIOL, V87, P245, DOI 10.1189/jlb.1208774; Kraus M, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.2; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mannava S, 2012, BLOOD, V119, P1450, DOI 10.1182/blood-2011-04-346676; Marissen WE, 2000, J BIOL CHEM, V275, P9314, DOI 10.1074/jbc.275.13.9314; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Meyer H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-48; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Morley SJ, 2005, CELL DEATH DIFFER, V12, P571, DOI 10.1038/sj.cdd.4401591; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Parlati F, 2009, BLOOD, V114, P3439, DOI 10.1182/blood-2009-05-223677; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruckrich T, 2009, LEUKEMIA, V23, P1098, DOI 10.1038/leu.2009.8; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Steinbrunn T, 2011, BLOOD, V117, P1998, DOI 10.1182/blood-2010-05-284422; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Vij N, 2011, EXPERT OPIN THER TAR, V15, P233, DOI 10.1517/14728222.2011.553610; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Ward Theresa H., 2007, V390, P281; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yi P, 2012, MOL CANCER THER, V11, P2610, DOI 10.1158/1535-7163.MCT-12-0516	57	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74415	10.1371/journal.pone.0074415	http://dx.doi.org/10.1371/journal.pone.0074415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069311	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000324547300042
J	Eastwood, SV; Tillin, T; Wright, A; Heasman, J; Willis, J; Godsland, IF; Forouhi, N; Whincup, P; Hughes, AD; Chaturvedi, N				Eastwood, Sophie V.; Tillin, Therese; Wright, Andrew; Heasman, John; Willis, Joseph; Godsland, Ian F.; Forouhi, Nita; Whincup, Peter; Hughes, Alun D.; Chaturvedi, Nishi			Estimation of CT-Derived Abdominal Visceral and Subcutaneous Adipose Tissue Depots from Anthropometry in Europeans, South Asians and African Caribbeans	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; METABOLIC RISK-FACTORS; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; WHITE ADULTS; MEN; WOMEN; ACCUMULATION; ASSOCIATION; OBESITY	Background: South Asians and African Caribbeans experience more cardiometabolic disease than Europeans. Risk factors include visceral (VAT) and subcutaneous abdominal (SAT) adipose tissue, which vary with ethnicity and are difficult to quantify using anthropometry. Objective: We developed and cross-validated ethnicity and gender-specific equations using anthropometrics to predict VAT and SAT. Design: 669 Europeans, 514 South Asians and 227 African Caribbeans (70 +/- 7 years) underwent anthropometric measurement and abdominal CT scanning. South Asian and African Caribbean participants were first-generation migrants living in London. Prediction equations were derived for CT-measured VAT and SAT using stepwise regression, then cross-validated by comparing actual and predicted means. Results: South Asians had more and African Caribbeans less VAT than Europeans. For basic VAT prediction equations (age and waist circumference), model fit was better in men (R-2 range 0.59-0.71) than women (range 0.35-0.59). Expanded equations (+ weight, height, hip and thigh circumference) improved fit for South Asian and African Caribbean women (R-2 0.35 to 0.55, and 0.43 to 0.56 respectively). For basic SAT equations, R2 was 0.69-0.77, and for expanded equations it was 0.72-0.86. Cross-validation showed differences between actual and estimated VAT of <7%, and SAT of <8% in all groups, apart from VAT in South Asian women which disagreed by 16%. Conclusion: We provide ethnicity-and gender-specific VAT and SAT prediction equations, derived from a large tri-ethnic sample. Model fit was reasonable for SAT and VAT in men, while basic VAT models should be used cautiously in South Asian and African Caribbean women. These equations will aid studies of mechanisms of cardiometabolic disease in later life, where imaging data are not available.	[Eastwood, Sophie V.; Tillin, Therese; Willis, Joseph; Hughes, Alun D.; Chaturvedi, Nishi] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Wright, Andrew; Heasman, John] Imperial Coll Healthcare NHS Trust, Dept Med, London, England; [Godsland, Ian F.] Univ London Imperial Coll Sci Technol & Med, Dept Endocrinol & Metab Med, London, England; [Forouhi, Nita] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; [Whincup, Peter] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England	Imperial College London; Imperial College London; Imperial College London; University of Cambridge; St Georges University London	Eastwood, SV (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	s.eastwood@imperial.ac.uk	Hughes, Alun David/N-3781-2013; Wright, Andrew/HDM-9615-2022	Hughes, Alun David/0000-0001-5432-5271; Tillin, Therese/0000-0003-1590-9826; Whincup, Peter/0000-0002-5589-4107; Forouhi, Nita/0000-0002-5041-248X; Eastwood, Sophie/0000-0002-1883-8771	Medical Research Council; Diabetes UK; British Heart Foundation [SP/07/001/23603]; Wellcome Trust [082464/Z/07/Z]; MRC [MC_UU_12015/5, MC_UP_A100_1003] Funding Source: UKRI; Medical Research Council [MC_UU_12015/5, MC_UP_A100_1003] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded at baseline by the Medical Research Council (www.mrc.ac.uk), Diabetes UK (www.diabetes.org.uk) and British Heart Foundation (www.bhf.org.uk), and at follow-up by the Wellcome Trust (grant number: 082464/Z/07/Z, www.wellcome.ac.uk) and British Heart Foundation (grant number: SP/07/001/23603). The funders played no role in the study design and conduct or in these analyses or the decision to submit the manuscript for publication. The SABRE study group is entirely independent from the funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWELL M, 1985, BRIT MED J, V290, P1692, DOI 10.1136/bmj.290.6483.1692; Bonora E, 1995, METABOLISM, V44, P1617, DOI 10.1016/0026-0495(95)90084-5; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Brundavani V, 2006, EUR J CLIN NUTR, V60, P658, DOI 10.1038/sj.ejcn.1602366; Carroll JF, 2008, OBESITY, V16, P600, DOI 10.1038/oby.2007.92; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Conway JM, 1997, AM J CLIN NUTR, V66, P1345, DOI 10.1093/ajcn/66.6.1345; CONWAY JM, 1995, AM J CLIN NUTR, V61, P765, DOI 10.1093/ajcn/61.4.765; DESPRES JP, 1991, AM J CLIN NUTR, V54, P471, DOI 10.1093/ajcn/54.3.471; FERLAND M, 1989, BRIT J NUTR, V61, P139, DOI 10.1079/BJN19890104; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Forouhi NG, 2001, INT J OBESITY, V25, P1327, DOI 10.1038/sj.ijo.0801723; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Gavin JR, 1997, DIABETES CARE, V20, P1183; Goel K, 2008, OBESITY, V16, P451, DOI 10.1038/oby.2007.55; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Gupta R, 2008, HEART, V94, P16, DOI 10.1136/hrt.2007.132951; Kekes-Szabo T, 1994, Obes Res, V2, P450; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; LARSSON B, 1992, AM J EPIDEMIOL, V135, P266, DOI 10.1093/oxfordjournals.aje.a116280; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; LEMIEUX S, 1994, DIABETOLOGIA, V37, P757, DOI 10.1007/BF00404332; Maislin G, 2012, OBESITY, V20, P2124, DOI 10.1038/oby.2012.53; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Misra A, 2011, INT J OBESITY, V35, P167, DOI 10.1038/ijo.2010.135; Pascot A, 1999, DIABETES CARE, V22, P1471, DOI 10.2337/diacare.22.9.1471; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; ROSS R, 1992, J APPL PHYSIOL, V72, P787, DOI 10.1152/jappl.1992.72.2.787; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEIDELL JC, 1987, AM J CLIN NUTR, V45, P7, DOI 10.1093/ajcn/45.1.7; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Springer F, 2012, EUR J RADIOL, V81, P1488, DOI 10.1016/j.ejrad.2011.04.006; Stanforth PR, 2004, INT J OBESITY, V28, P925, DOI 10.1038/sj.ijo.0802563; Tillin T, 2013, J AM COLL CARDIOL, V61, P1777, DOI 10.1016/j.jacc.2012.12.046; Tillin T, 2013, DIABETES CARE, V36, P383, DOI 10.2337/dc12-0544; Tillin T, 2012, INT J EPIDEMIOL, V41, P33, DOI 10.1093/ije/dyq175; Wild SH, 2007, J PUBLIC HEALTH-UK, V29, P191, DOI 10.1093/pubmed/fdm010	41	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75085	10.1371/journal.pone.0075085	http://dx.doi.org/10.1371/journal.pone.0075085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069381	Green Published, Green Submitted, gold			2022-12-27	WOS:000324547300069
J	Eom, JS; Kim, JS; Jang, JI; Kim, BH; Yoo, SY; Choi, JH; Bang, IS; Lee, IS; Park, YK				Eom, Jeong Seon; Kim, Jin Seok; Jang, Jung Im; Kim, Bae-Hoon; Yoo, So Young; Choi, Ji Hyeon; Bang, Iel-Soo; Lee, In Soo; Park, Yong Keun			Enhancement of Host Immune Responses by Oral Vaccination to Salmonella enterica serovar Typhimurium Harboring Both FliC and FljB Flagella	PLOS ONE			English	Article							FACTOR-KAPPA-B; PHASE VARIATION; BACTERIAL FLAGELLIN; GENE-EXPRESSION; IN-VIVO; ACTIVATION; CELLS; INTERLEUKIN-1-BETA; MACROPHAGES; IPAF	Flagellin, the structural component of the flagellar filament in various motile bacteria, can contribute to the activation of NF-kappa B and proinflammatory cytokine expression during the innate immune response in host cells. Thus, flagellin proteins represent a particularly attractive target for the development of vaccine candidates. In this study, we investigated the immune response by increasing the flagella number in the iacP mutant strain and the adjuvant activity of the flagellin component FljB of Salmonella enterica serovar Typhimurium. We found that the iacP mutant strain expresses two flagellin proteins (FliC and FljB), which result in increased NF-kappa B-dependent gene expression in bone marrow derived macrophages. Using an oral immunization mouse model, we observed that the administration of a live attenuated S. typhimurium BRD509 strain expressing the FliC and FljB flagellins induced significantly enhanced flagellin-specific IgG responses in the systemic compartment. The mice immunized with the recombinant attenuated S. typhimurium strain that has two types of flagella were protected from lethal challenge with the Salmonella SL1344 strain. These results indicate that overexpression of flagella in the iacP mutant strain enhance the induction of an antigen-specific immune responses in macrophage cell, and both the FliC and FljB flagellar filament proteins-producing S. typhimurium can induce protective immune responses against salmonellosis.	[Eom, Jeong Seon; Kim, Jin Seok; Jang, Jung Im; Kim, Bae-Hoon; Yoo, So Young; Choi, Ji Hyeon; Park, Yong Keun] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Bang, Iel-Soo] Chosun Univ, Sch Dent, Dept Microbiol & Immunol, Kwangju, South Korea; [Lee, In Soo] Hannam Univ, Dept Biotechnol, Taejon, South Korea	Korea University; Chosun University; Hannam University	Park, YK (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea.	ykpark@korea.ac.kr	Kim, Bae-Hoon/A-8847-2014; Kim, Bae-Hoon/F-3289-2012	Kim, Bae-Hoon/0000-0001-6866-7248	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0012804]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0012804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhaya A, 2008, MICROB PATHOGENESIS, V44, P524, DOI 10.1016/j.micpath.2008.01.004; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BLAIR DF, 1995, ANNU REV MICROBIOL, V49, P489, DOI 10.1146/annurev.mi.49.100195.002421; CHATFIELD SN, 1992, BIO-TECHNOL, V10, P888, DOI 10.1038/nbt0892-888; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Jong HK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002933; Dunstan SJ, 1998, INFECT IMMUN, V66, P732, DOI 10.1128/IAI.66.2.732-740.1998; Ehrbar K, 2006, MOL MICROBIOL, V59, P248, DOI 10.1111/j.1365-2958.2005.04931.x; Eom JS, 2012, J BACTERIOL, V194, P4332, DOI 10.1128/JB.00076-12; Foley S L, 2008, J Anim Sci, V86, pE173; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gauley J, 2010, J LEUKOCYTE BIOL, V87, P1115, DOI 10.1189/jlb.0709465; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hur J, 2011, CLIN VACCINE IMMUNOL, V18, P203, DOI 10.1128/CVI.00407-10; Kim JS, 2011, INFECT IMMUN, V79, P1440, DOI 10.1128/IAI.01231-10; Kutsukake K, 2006, J BACTERIOL, V188, P950, DOI 10.1128/JB.188.3.950-957.2006; Liang HY, 2010, LETT APPL MICROBIOL, V50, P181, DOI 10.1111/j.1472-765X.2009.02768.x; Lyons S, 2004, J CELL SCI, V117, P5771, DOI 10.1242/jcs.01500; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mireles JR, 2001, J BACTERIOL, V183, P5848, DOI 10.1128/JB.183.20.5848-5854.2001; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moreno M, 2000, J MOL MICROB BIOTECH, V2, P245; Nalbantsoy A, 2010, ANN MICROBIOL, V60, P565, DOI 10.1007/s13213-010-0093-5; Olusesan AG, 2010, AFR J PHARM PHARMACO, V4, P151; Pieper GM, 2001, ANTIOXID REDOX SIGN, V3, P81, DOI 10.1089/152308601750100542; Pietila TE, 2005, J LEUKOCYTE BIOL, V78, P909, DOI 10.1189/jlb.1204721; Rosu V, 2006, J BACTERIOL, V188, P4497, DOI 10.1128/JB.01552-05; Scharf B, 2002, J BACTERIOL, V184, P5979, DOI 10.1128/JB.184.21.5979-5986.2002; Simon R, 2008, J INTERF CYTOK RES, V28, P661, DOI 10.1089/jir.2008.0022; Simon R, 2007, BIOCHEM BIOPH RES CO, V355, P280, DOI 10.1016/j.bbrc.2007.01.148; Sun YH, 2007, J BIOL CHEM, V282, P33897, DOI 10.1074/jbc.C700181200; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; Uchiya K, 2008, MICROBIOL-SGM, V154, P3491, DOI 10.1099/mic.0.2008/021667-0; Wang SW, 2002, BIOCHEM J, V367, P729, DOI 10.1042/BJ20020752; Yamamoto S, 2006, J BACTERIOL, V188, P958, DOI 10.1128/JB.188.3.958-967.2006; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046828; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194	40	14	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74850	10.1371/journal.pone.0074850	http://dx.doi.org/10.1371/journal.pone.0074850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069357	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300061
J	Akiyama, LF; Richards, TR; Imada, T; Dager, SR; Wroblewski, L; Kuhl, PK				Akiyama, Lisa F.; Richards, Todd R.; Imada, Toshiaki; Dager, Stephen R.; Wroblewski, Liv; Kuhl, Patricia K.			Age-Specific Average Head Template for Typically Developing 6-Month-Old Infants	PLOS ONE			English	Article							MAGNETIC-RESONANCE IMAGES; SPATIAL NORMALIZATION; HUMAN BRAIN; PROBABILISTIC ATLAS; WHITE-MATTER; MR-IMAGES; SEGMENTATION; REGISTRATION; ROBUST; OPTIMIZATION	Due to the rapid anatomical changes that occur within the brain structure in early human development and the significant differences between infant brains and the widely used standard adult templates, it becomes increasingly important to utilize appropriate age- and population-specific average templates when analyzing infant neuroimaging data. In this study we created a new and highly detailed age-specific unbiased average head template in a standard MNI152-like infant coordinate system for healthy, typically developing 6-month-old infants by performing linear normalization, diffeomorphic normalization and iterative averaging processing on 60 subjects' structural images. The resulting age-specific average templates in a standard MNI152-like infant coordinate system demonstrate sharper anatomical detail and clarity compared to existing infant average templates and successfully retains the average head size of the 6-month-old infant. An example usage of the average infant templates transforms magnetoencephalography (MEG) estimated activity locations from MEG's subject-specific head coordinate space to the standard MNI152-like infant coordinate space. We also created a new atlas that reflects the true 6- month-old infant brain anatomy. Average templates and atlas are publicly available on our website (http://ilabs.washington.edu/6-m-templates-atlas).	[Akiyama, Lisa F.; Imada, Toshiaki; Wroblewski, Liv; Kuhl, Patricia K.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Richards, Todd R.; Dager, Stephen R.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Dager, Stephen R.] Univ Washington, Autism Ctr, Seattle, WA 98195 USA; [Dager, Stephen R.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kuhl, PK (corresponding author), Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA.	pkkuhl@u.washington.edu			National Institutes of Health [ARRA-HD37954-0951, HD55741]; Infant Brain Imaging Study (IBIS) [HD55741]; University of Washington's Science of Learning Center (The LIFE Center) [SMA-0835854]; NIH UW Research Core Grant; University of Washington [P30 DC04661]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055741] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037954, R01HD065283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infant Brain Imaging Study (IBIS); University of Washington's Science of Learning Center (The LIFE Center); NIH UW Research Core Grant; University of Washington(University of Washington); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support for the research was provided by the Santa Fe Institute Consortium and National Institutes of Health grants to P.K.K. (HD37954 and ARRA-HD37954-0951) and SRD (ARRA-HD065283 and HD55741). We acknowledge the support of the Infant Brain Imaging Study (IBIS), supported by HD55741, for acquiring 3T 6 month old imaging data. This work was also supported by the University of Washington's Science of Learning Center (The LIFE Center, SMA-0835854, PI, P.K.K.) and an NIH UW Research Core Grant, University of Washington P30 DC04661. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli CR, 2007, NEUROIMAGE, V35, P308, DOI 10.1016/j.neuroimage.2006.08.058; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Choe M, 2012, CEREB CORTEX, V3; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Einarson D, 2006, 12 ANN M ORG HUM MAP; Evans AC, 2006, NEUROIMAGE, V30, P184, DOI 10.1016/j.neuroimage.2005.09.068; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Gaillard WD, 2001, NEUROIMAGE, V13, P239, DOI 10.1006/nimg.2000.0681; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Hoeksma MR, 2005, CLIN NEUROPHYSIOL, V116, P1188, DOI 10.1016/j.clinph.2004.12.021; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kazemi K, 2007, NEUROIMAGE, V37, P463, DOI 10.1016/j.neuroimage.2007.05.004; Klein A, 2010, NEUROIMAGE, V51, P214, DOI 10.1016/j.neuroimage.2010.01.091; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Kochunov P, 2001, J COMPUT ASSIST TOMO, V25, P805, DOI 10.1097/00004728-200109000-00023; Kochunov P, 2005, HUM BRAIN MAPP, V24, P325, DOI 10.1002/hbm.20090; Leow AD, 2006, NEUROIMAGE, V31, P627, DOI 10.1016/j.neuroimage.2005.12.013; Matsuzawa J, 2001, CEREB CORTEX, V11, P335, DOI 10.1093/cercor/11.4.335; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McAuliffe MJ, 2001, COMP MED SY, P381; Murgasova M, 2007, ACAD RADIOL, V14, P1350, DOI 10.1016/j.acra.2007.07.020; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Pfefferbaum A, 2012, NEUROIMAGE, V60, P940, DOI 10.1016/j.neuroimage.2012.01.092; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Senjem ML, 2005, NEUROIMAGE, V26, P600, DOI 10.1016/j.neuroimage.2005.02.005; Shi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018746; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wilke M, 2003, NEUROREPORT, V14, P1887, DOI 10.1097/00001756-200310270-00001; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Woods RP, 2003, NEUROIMAGE, V18, P769, DOI 10.1016/S1053-8119(03)00019-3; Yoon U, 2009, NEUROIMAGE, V45, P769, DOI 10.1016/j.neuroimage.2008.12.046; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	42	17	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73821	10.1371/journal.pone.0073821	http://dx.doi.org/10.1371/journal.pone.0073821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069234	Green Submitted, gold, Green Published			2022-12-27	WOS:000326240100061
J	Pace, E; Zhang, JS				Pace, Edward; Zhang, Jinsheng			Noise-Induced Tinnitus Using Individualized Gap Detection Analysis and Its Relationship with Hyperacusis, Anxiety, and Spatial Cognition	PLOS ONE			English	Article							SALICYLATE-INDUCED TINNITUS; INDUCED HEARING-LOSS; NEURAL ACTIVITY; PSYCHIATRIC-DISORDERS; BEHAVIORAL PARADIGM; SLEEP COMPLAINTS; AUDITORY-CORTEX; C57BL/6J MICE; ANIMAL-MODEL; C-FOS	Tinnitus has a complex etiology that involves auditory and non-auditory factors and may be accompanied by hyperacusis, anxiety and cognitive changes. Thus far, investigations of the interrelationship between tinnitus and auditory and non-auditory impairment have yielded conflicting results. To further address this issue, we noise exposed rats and assessed them for tinnitus using a gap detection behavioral paradigm combined with statistically-driven analysis to diagnose tinnitus in individual rats. We also tested rats for hearing detection, responsivity, and loss using prepulse inhibition and auditory brainstem response, and for spatial cognition and anxiety using Morris water maze and elevated plus maze. We found that our tinnitus diagnosis method reliably separated noise-exposed rats into tinnitus((+)) and tinnitus((-)) groups and detected no evidence of tinnitus in tinnitus((-)) and control rats. In addition, the tinnitus((+)) group demonstrated enhanced startle amplitude, indicating hyperacusis-like behavior. Despite these results, neither tinnitus, hyperacusis nor hearing loss yielded any significant effects on spatial learning and memory or anxiety, though a majority of rats with the highest anxiety levels had tinnitus. These findings showed that we were able to develop a clinically relevant tinnitus((+)) group and that our diagnosis method is sound. At the same time, like clinical studies, we found that tinnitus does not always result in cognitive-emotional dysfunction, although tinnitus may predispose subjects to certain impairment like anxiety. Other behavioral assessments may be needed to further define the relationship between tinnitus and anxiety, cognitive deficits, and other impairments.	[Pace, Edward; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA; [Zhang, Jinsheng] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI USA	Wayne State University; Wayne State University	Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA.	jinzhang@med.wayne.edu	张, 锦胜/GXF-8167-2022		Tinnitus Research Consortium; Wayne State University	Tinnitus Research Consortium; Wayne State University	This work was supported by the Tinnitus Research Consortium and the Wayne State University President's Enhancement Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P F, 1995, Vital Health Stat 10, P1; Andersson G, 2000, J SPEECH LANG HEAR R, V43, P1168, DOI 10.1044/jslhr.4305.1168; Andersson G, 2005, CYBERPSYCHOL BEHAV, V8, P32, DOI 10.1089/cpb.2005.8.32; Andersson G, 2009, SCAND J PSYCHOL, V50, P517, DOI 10.1111/j.1467-9450.2009.00752.x; Ang ET, 2006, BRAIN RES, V1113, P186, DOI 10.1016/j.brainres.2006.07.023; Attias J., 2005, Journal of Basic and Clinical Physiology and Pharmacology, V16, P117; Bartels H, 2008, EAR HEARING, V29, P947, DOI 10.1097/AUD.0b013e3181888f83; Bauer CA, 1999, OTOLARYNG HEAD NECK, V121, P457, DOI 10.1016/S0194-5998(99)70237-8; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; Blaesing L, 2012, INT J AUDIOL, V51, P611, DOI 10.3109/14992027.2012.664290; BRANDY WT, 1995, AMJ AUDIOL, V4, P5; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Chung JW, 2007, ANESTH ANALG, V104, P1404, DOI 10.1213/01.ane.0000261508.24083.6c; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; Dauman R, 2005, ACTA OTO-LARYNGOL, V125, P503, DOI 10.1080/00016480510027565; Dehmel S, 2012, J NEUROSCI, V32, P1660, DOI 10.1523/JNEUROSCI.4608-11.2012; Evans KC, 2008, DEPRESS ANXIETY, V25, P496, DOI 10.1002/da.20347; FALKENBERG E, 2012, J OTOLARYNGOL, V2012, P75460; GABR TA, 2011, AURIS NASUS LARYNX; Goble TJ, 2009, HEARING RES, V253, P52, DOI 10.1016/j.heares.2009.03.002; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gopinath B, 2010, ANN EPIDEMIOL, V20, P129, DOI 10.1016/j.annepidem.2009.09.002; Guitton Matthieu J., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/80904; Guitton MJ, 2005, EUR J NEUROSCI, V22, P2675, DOI 10.1111/j.1460-9568.2005.04436.x; Guitton MJ, 2003, J NEUROSCI, V23, P3944; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; HALLBERG LRM, 1993, BRIT J AUDIOL, V27, P19, DOI 10.3109/03005369309077885; Hardoy MC, 2005, SOC PSYCH PSYCH EPID, V40, P24, DOI 10.1007/s00127-005-0837-x; Harker KT, 2002, BEHAV BRAIN RES, V134, P467; Hasson D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-130; Hebert S, 2004, HEARING RES, V190, P1, DOI 10.1016/S0378-5955(04)00021-8; Hebert S, 2007, EAR HEARING, V28, P649; Hebert S, 2007, NEUROSCI LETT, V411, P138, DOI 10.1016/j.neulet.2006.10.028; Hebert S, 2011, J SLEEP RES, V20, P38, DOI 10.1111/j.1365-2869.2010.00860.x; Heffner HE, 2002, HEARING RES, V170, P83, DOI 10.1016/S0378-5955(02)00343-X; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Holgers KM, 2005, INT J AUDIOL, V44, P584, DOI 10.1080/14992020500190235; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; HUMPHREYS MS, 1984, PSYCHOL REV, V91, P153, DOI 10.1037/0033-295X.91.2.153; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Ison JR, 2003, JARO-J ASSOC RES OTO, V4, P495, DOI 10.1007/s10162-002-3046-2; JAKES S, 1988, ADV BEHAV RES THER, V10, P53, DOI 10.1016/0146-6402(88)90016-1; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1988, LARYNGOSCOPE, V98, P280; Juris L, 2013, INT J AUDIOL, V52, P230, DOI 10.3109/14992027.2012.743043; Kim JU, 2005, LARYNGOSCOPE, V115, P1996, DOI 10.1097/01.mlg.0000180173.81034.4d; Kraemer PJ, 1996, BRAIN RES BULL, V39, P17, DOI 10.1016/0361-9230(95)02028-4; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; LEWIS JE, 1994, CLIN OTOLARYNGOL, V19, P50, DOI 10.1111/j.1365-2273.1994.tb01147.x; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; LOBARINAS E, 2008, ACOUSTIC OVERSTIMULA; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Lu J, 2011, NEUROSCIENCE, V189, P187, DOI 10.1016/j.neuroscience.2011.04.073; Luo H, 2012, NEUROSCI LETT, V522, P16, DOI 10.1016/j.neulet.2012.05.072; Lyche P, 2011, CLIN NEUROPSYCHOL, V25, P359, DOI 10.1080/13854046.2010.547518; Mahlke C, 2004, HEARING RES, V195, P17, DOI 10.1016/j.heares.2004.03.005; Mahoney CJ, 2011, J NEUROL NEUROSUR PS, V82, P1274, DOI 10.1136/jnnp.2010.235473; MAO J, 2011, JNEUROTRAUMA; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Moon IS, 2011, J OCCUP ENVIRON HYG, V8, P618, DOI 10.1080/15459624.2011.609013; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Nelson Jeffrey J, 2004, Ear Nose Throat J, V83, P472; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nobre MJ, 2011, BRAIN RES, V1421, P20, DOI 10.1016/j.brainres.2011.09.013; Norman M, 2012, HEARING RES, V290, P64, DOI 10.1016/j.heares.2012.03.015; Nowotny M, 2011, J ACOUST SOC AM, V130, P2827, DOI 10.1121/1.3646902; Oishi N, 2010, AUDIOL NEURO-OTOL, V15, P187, DOI 10.1159/000251916; Pan T, 2009, INT J AUDIOL, V48, P277, DOI 10.1080/14992020802581974; Quintanilla-Dieck MD, 2009, J PEDIATR-US, V155, P550, DOI 10.1016/j.jpeds.2009.04.053; Rizzardo R, 1998, J OTOLARYNGOL, V27, P21; Rosow DE, 2013, CASE REP OTOLARYNGOL, V2013, DOI 10.1155/2013/480676; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Rybalko N, 2011, PHYSIOL BEHAV, V102, P453, DOI 10.1016/j.physbeh.2010.12.010; Salonen J, 2007, GEN HOSP PSYCHIAT, V29, P431, DOI 10.1016/j.genhosppsych.2007.05.002; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Shulman, 1995, Int Tinnitus J, V1, P13; SOOD SK, 1998, BRIT J AUDIOL, V22, P1; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Sun W, 2012, BRAIN RES, V1485, P108, DOI 10.1016/j.brainres.2012.02.008; Tambs K, 2004, PSYCHOSOM MED, V66, P776, DOI 10.1097/01.psy.0000133328.03596.fb; Test T, 2011, SLEEP, V34, P25, DOI 10.1093/sleep/34.1.25; TURNER J, 2012, J NEUROSCI RES; Turner J, 2012, J NEUROSCI RES, V90, P1480, DOI 10.1002/jnr.22827; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Uran SL, 2010, BRAIN RES, V1361, P102, DOI 10.1016/j.brainres.2010.09.022; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang H, 2000, Zhonghua Er Bi Yan Hou Ke Za Zhi, V35, P420; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z; Zhang JS, 2003, EXP BRAIN RES, V153, P655, DOI 10.1007/s00221-003-1612-4; ZHENG Y, 2011, NEUROSCIENCE; Zoger S, 2001, AUDIOLOGY, V40, P133; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	105	37	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75011	10.1371/journal.pone.0075011	http://dx.doi.org/10.1371/journal.pone.0075011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069375	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100119
J	Schiarea, S; Arnoldi, L; Fanelli, R; De Combarieu, E; Chiabrando, C				Schiarea, Silvia; Arnoldi, Lolita; Fanelli, Roberto; De Combarieu, Eric; Chiabrando, Chiara			In-Depth Glycoproteomic Characterization of gamma-Conglutin by High-Resolution Accurate Mass Spectrometry	PLOS ONE			English	Article							N-LINKED OLIGOSACCHARIDES; LUPIN SEED; 2-DIMENSIONAL ELECTROPHORESIS; PROTEIN GLYCOSYLATION; STRUCTURAL-ANALYSIS; GLYCANS; ALLERGENS; TRYPSIN; GLUCOSE; LEGUME	The molecular characterization of bioactive food components is necessary for understanding the mechanisms of their beneficial or detrimental effects on human health. This study focused on gamma-conglutin, a well-known lupin seed N-glycoprotein with health-promoting properties and controversial allergenic potential. Given the importance of N-glycosylation for the functional and structural characteristics of proteins, we studied the purified protein by a mass spectrometry-based glycoproteomic approach able to identify the structure, micro-heterogeneity and attachment site of the bound N-glycan(s), and to provide extensive coverage of the protein sequence. The peptide/N-glycopeptide mixtures generated by enzymatic digestion (with or without N-deglycosylation) were analyzed by high-resolution accurate mass liquid chromatography-multi-stage mass spectrometry. The four main micro-heterogeneous variants of the single N-glycan bound to gamma-conglutin were identified as Man(2)(Xyl) (Fuc) GlcNAc(2), Man(3)(Xyl) (Fuc) GlcNAc(2), GlcNAcMan(3)(Xyl) (Fuc) GlcNAc(2) and GlcNAc (2)Man(3)(Xyl) (Fuc) GlcNAc(2). These carry both core beta 1,2-xylose and core alpha 1-3-fucose (well known Cross-Reactive Carbohydrate Determinants), but corresponding fucose-free variants were also identified as minor components. The N-glycan was proven to reside on Asn(131), one of the two potential N-glycosylation sites. The extensive coverage of the gamma-conglutin amino acid sequence suggested three alternative N-termini of the small subunit, that were later confirmed by direct-infusion Orbitrap mass spectrometry analysis of the intact subunit.	[Schiarea, Silvia; Fanelli, Roberto; Chiabrando, Chiara] IRCCS Ist Ric Farmacol Mario Negri, Dept Environm Hlth Sci, Milan, Italy; [Arnoldi, Lolita; De Combarieu, Eric] INDENA SpA, Res & Dev Labs, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Chiabrando, C (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Environm Hlth Sci, Milan, Italy.	chiara.chiabrando@marionegri.it	Schiarea, Silvia/ABA-6351-2020	Schiarea, Silvia/0000-0001-7569-4762				Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Bateman KP, 1998, J CHROMATOGR A, V794, P327, DOI 10.1016/S0021-9673(97)00937-0; Bertoglio JC, 2011, FITOTERAPIA, V82, P933, DOI 10.1016/j.fitote.2011.05.007; Boja ES, 2001, ANAL CHEM, V73, P3576, DOI 10.1021/ac0103423; BOUWSTRA JB, 1990, EUR J BIOCHEM, V190, P113, DOI 10.1111/j.1432-1033.1990.tb15553.x; Brandsch C, 2010, PLANT FOOD HUM NUTR, V65, P410, DOI 10.1007/s11130-010-0201-5; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Cooper CA, 2001, NUCLEIC ACIDS RES, V29, P332, DOI 10.1093/nar/29.1.332; Dooper MMBW, 2009, J INVEST ALLERG CLIN, V19, P283; DURANTI M, 1995, EUR J BIOCHEM, V230, P886, DOI 10.1111/j.1432-1033.1995.tb20632.x; Duranti M, 1997, FIELD CROP RES, V53, P31, DOI 10.1016/S0378-4290(97)00021-X; Duranti M, 2008, TRENDS FOOD SCI TECH, V19, P624, DOI 10.1016/j.tifs.2008.07.002; Fiocchi A, 2009, CLIN EXP ALLERGY, V39, P1045, DOI 10.1111/j.1365-2222.2009.03199.x; Foley RC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-59; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Guillamon E, 2010, MOL NUTR FOOD RES, V54, P1668, DOI 10.1002/mnfr.200900452; Hall RS, 2005, ASIA PAC J CLIN NUTR, V14, P91; Hemmer W., 2012, ANTICARBOHYDRATE ANT, P181; Jappe U, 2010, MOL NUTR FOOD RES, V54, P113, DOI 10.1002/mnfr.200900365; Kaulfurst-Soboll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017800; Kim JS, 2013, J PROTEOME RES, V12, P910, DOI 10.1021/pr300955f; Kimura Y, 2000, BIOSCI BIOTECH BIOCH, V64, P562, DOI 10.1271/bbb.64.562; Kolarich D, 2005, FEBS J, V272, P5182, DOI 10.1111/j.1742-4658.2005.04841.x; Kolarich D, 2006, BBA-GEN SUBJECTS, V1760, P715, DOI 10.1016/j.bbagen.2005.11.012; Kolarich D, 2012, NAT PROTOC, V7, P1285, DOI 10.1038/nprot.2012.062; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Leymarie N, 2012, ANAL CHEM, V84, P3040, DOI 10.1021/ac3000573; Lovati MR, 2012, BRIT J NUTR, V107, P67, DOI 10.1017/S0007114511002601; Magni C, 2005, J AGR FOOD CHEM, V53, P2275, DOI 10.1021/jf0491512; Magni C, 2004, J NUTR BIOCHEM, V15, P646, DOI 10.1016/j.jnutbio.2004.06.009; Magni C, 2007, PHYTOCHEMISTRY, V68, P997, DOI 10.1016/j.phytochem.2007.01.003; MARCHESI M, 2008, BR J NUTR, V4, P1; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; Matsui T, 2011, GLYCOBIOLOGY, V21, P994, DOI 10.1093/glycob/cwq198; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Ohsuga H, 1996, J BIOL CHEM, V271, P26653, DOI 10.1074/jbc.271.43.26653; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Olczak M, 2000, BBA-GEN SUBJECTS, V1523, P236, DOI 10.1016/S0304-4165(00)00128-8; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; Sanz ML, 2010, CLIN EXP ALLERGY, V40, P1461, DOI 10.1111/j.1365-2222.2010.03590.x; Scarafoni A, 2001, BBA-GENE STRUCT EXPR, V1519, P147, DOI 10.1016/S0167-4781(01)00225-1; Schiarea S, 2010, J PROTEOME RES, V9, P4376, DOI 10.1021/pr1001109; Sirtori CR, 2004, J NUTR, V134, P18, DOI 10.1093/jn/134.1.18; Sirtori E, 2011, FOOD CHEM, V126, P902, DOI 10.1016/j.foodchem.2010.11.073; Terruzzi I, 2011, NUTR METAB CARDIOVAS, V21, P197, DOI 10.1016/j.numecd.2009.09.004; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Verma AK, 2013, CLIN REV ALLERG IMMU, V45, P30, DOI 10.1007/s12016-012-8310-6; Wait R, 2005, J AGR FOOD CHEM, V53, P4599, DOI 10.1021/jf050021i; Weisse K, 2010, EUR J NUTR, V49, P65, DOI 10.1007/s00394-009-0049-3; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Wuhrer M, 2007, J CHROMATOGR B, V849, P115, DOI 10.1016/j.jchromb.2006.09.041; Yang BY, 1996, CARBOHYD RES, V287, P203, DOI 10.1016/0008-6215(96)00073-0	53	12	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73906	10.1371/journal.pone.0073906	http://dx.doi.org/10.1371/journal.pone.0073906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069245	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100069
J	van der Wath, RC; Gardiner, BS; Burgess, AW; Smith, DW				van der Wath, Richard C.; Gardiner, Bruce S.; Burgess, Antony W.; Smith, David W.			Cell Organisation in the Colonic Crypt: A Theoretical Comparison of the Pedigree and Niche Concepts	PLOS ONE			English	Article							STEM-CELL; SMALL-INTESTINE; COMPUTATIONAL MODEL; COMPREHENSIVE MODEL; SELF-RENEWAL; LARGE-BOWEL; IN-VIVO; MIGRATION; PROLIFERATION; EPITHELIUM	The intestinal mucosa is a monolayer of rapidly self-renewing epithelial cells which is not only responsible for absorption of water and nutrients into the bloodstream but also acts as a protective barrier against harmful microbes entering the body. New functional epithelial cells are produced from stem cells, and their proliferating progeny. These stem cells are found within millions of crypts (tubular pits) spaced along the intestinal tract. The entire intestinal epithelium is replaced every 2-3 days in mice (3-5 days in humans) and hence cell production, differentiation, migration and turnover need to be tightly regulated. Malfunctions in this regulation are strongly linked to inflammatory bowel diseases and to the formation of adenomas and ultimately cancerous tumours. Despite a great deal of biological experimentation and observation, precisely how colonic crypts are regulated to produce mature colonocytes remains unclear. To assist in understanding how cell organisation in crypts is achieved, two very different conceptual models of cell behaviour are developed here, referred to as the 'pedigree' and the 'niche' models. The pedigree model proposes that crypt cells are largely preprogrammed and receive minimal prompting from the environment as they move through a routine of cell differentiation and proliferation to become mature colonocytes. The niche model proposes that crypt cells are primarily influenced by the local microenvironments along the crypt, and that predetermined cell behaviour plays a negligible role in their development. In this paper we present a computational model of colonic crypts in the mouse, which enables a comparison of the quality and controllability of mature coloncyte production by crypts operating under these two contrasting conceptual models of crypt regulation.	[van der Wath, Richard C.; Gardiner, Bruce S.; Smith, David W.] Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia; [Burgess, Antony W.] Royal Melbourne Hosp, Ludwig Inst Canc Res, Melbourne, Vic, Australia; [Burgess, Antony W.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	University of Western Australia; Ludwig Institute for Cancer Research; Royal Melbourne Hospital; Walter & Eliza Hall Institute	van der Wath, RC (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia.	rvanderwath@gmail.com	Gardiner, Bruce/C-8593-2012; Smith, David W/H-5856-2014	Smith, David W/0000-0003-4864-0288; Gardiner, Bruce/0000-0001-8770-5908	National Health and Medical Research Council, Australia [542531, 487922]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. This work was supported by the National Health and Medical Research Council, Australia (Project Grant 542531 and Program Grant 487922). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bellis J, 2012, J CELL BIOL, V198, P331, DOI 10.1083/jcb.201204086; BLEIBERG H, 1976, CANCER RES, V36, P325; Boman BM, 2008, CANCER RES, V68, P3304, DOI 10.1158/0008-5472.CAN-07-2061; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Davies PS, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-57; Drasdo D, 2000, PHYS REV LETT, V84, P4244, DOI 10.1103/PhysRevLett.84.4244; Drasdo D, 2001, NONLINEAR ANAL-THEOR, V47, P245, DOI 10.1016/S0362-546X(01)00173-0; Edwards CM, 2007, B MATH BIOL, V69, P1927, DOI 10.1007/s11538-007-9199-8; Fletcher AG, 2012, J THEOR BIOL, V300, P118, DOI 10.1016/j.jtbi.2012.01.021; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gardiner BS, 2000, J NON-NEWTON FLUID, V92, P151, DOI 10.1016/S0377-0257(00)00102-6; Gibson PR, 1996, INFLAMM BOWEL DIS, V2, P279, DOI 10.1002/ibd.3780020412; HAGEMANN RF, 1977, CELL TISSUE KINET, V10, P3, DOI 10.1111/j.1365-2184.1977.tb00278.x; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Itzkovitz S, 2012, CELL, V148, P608, DOI 10.1016/j.cell.2011.12.025; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; KARNAVAS WJ, 1993, IEEE T SYST MAN CYB, V23, P488, DOI 10.1109/21.229461; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Kellett M, 1992, Epithelial Cell Biol, V1, P147; Kim KM, 2002, ONCOGENE, V21, P5441, DOI 10.1038/sj.onc.1205604; Leedham SJ, 2013, GUT, V62, P83, DOI 10.1136/gutjnl-2011-301601; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; LOEFFLER M, 1987, VIRCHOWS ARCH B, V53, P286, DOI 10.1007/BF02890255; LOEFFLER M, 1993, J THEOR BIOL, V160, P471, DOI 10.1006/jtbi.1993.1031; LOEFFLER M, 1988, CELL TISSUE KINET, V21, P247, DOI 10.1111/j.1365-2184.1988.tb00784.x; LOEFFLER M, 1986, CELL TISSUE KINET, V19, P627, DOI 10.1111/j.1365-2184.1986.tb00763.x; Loeffler Markus, 1997, P1, DOI 10.1016/B978-012563455-7/50002-7; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; MAGNEY JE, 1986, AM J ANAT, V177, P43, DOI 10.1002/aja.1001770106; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; MEINZER HP, 1992, CELL PROLIFERAT, V25, P125, DOI 10.1111/j.1365-2184.1992.tb01486.x; North MJ, 2007, ADVANCING SOCIAL SIMULATION: THE FIRST WORLD CONGRESS, P129, DOI 10.1007/978-4-431-73167-2_13; Pin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037115; Potten C, 1983, STEM CELLS THEIR IDE, V155-99; Potten C, 1983, CYTOTOXIC INSULT TIS, V105-52; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; POTTEN CS, 1992, GUT, V33, P71, DOI 10.1136/gut.33.1.71; POTTEN CS, 1982, CELL TISSUE KINET, V15, P351, DOI 10.1111/j.1365-2184.1982.tb01053.x; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; POTTEN CS, 1987, J THEOR BIOL, V127, P381, DOI 10.1016/S0022-5193(87)80136-4; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; QIU JM, 1994, EPITHELIAL CELL BIOL, V3, P137; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; RODRIGUEZ MSBD, 1979, VIRCHOWS ARCH B, V29, P351; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; Smith E. D, 2008, OPEN CYBERNETICS SYS, V2, P39, DOI DOI 10.2174/1874110X00802010039; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; SUNTER JP, 1979, J ANAT, V129, P833; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Wath RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006972; van der Wath RC, 2008, LECT N BIOINFORMAT, V5307, P387, DOI 10.1007/978-3-540-88562-7_26; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; van Leeuwen IMM, 2006, CELL PROLIFERAT, V39, P157, DOI 10.1111/j.1365-2184.2006.00378.x; Walter AC, 2009, THESIS U NOTTINGHAM; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Wong SY, 2010, J R SOC INTERFACE, V7, pS351, DOI 10.1098/rsif.2010.0018.focus; Wright N, 1984, BIOL EPITHELIAL CELL; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998	74	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73204	10.1371/journal.pone.0073204	http://dx.doi.org/10.1371/journal.pone.0073204			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069177	Green Published, gold			2022-12-27	WOS:000326240100032
J	Weijts, BGMW; van Impel, A; Schulte-Merker, S; de Bruin, A				Weijts, Bart G. M. W.; van Impel, Andreas; Schulte-Merker, Stefan; de Bruin, Alain			Atypical E2fs Control Lymphangiogenesis through Transcriptional Regulation of Ccbe1 and Flt4	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; LARGE GENE LISTS; VASCULAR DEVELOPMENT; PLC-GAMMA; FACTOR-C; IN-VIVO; CELLS; ZEBRAFISH; ACTIVATION; ANGIOGENESIS	Lymphatic vessels are derived from venous endothelial cells and their formation is governed by the Vascular endothelial growth factor C (VegfC)/Vegf receptor 3 (Vegfr3; Flt4) signaling pathway. Recent studies show that Collagen and Calcium Binding EGF domains 1 protein (Ccbe1) enhances VegfC-dependent lymphangiogenesis. Both Ccbe1 and Flt4 have been shown to be indispensable for lymphangiogenesis. However, how these essential players are transcriptionally regulated remains poorly understood. In the case of angiogenesis, atypical E2fs (E2f7 and E2f8) however have been recently shown to function as transcriptional activators for VegfA. Using a genome-wide approach we here identified both CCBE1 and FLT4 as direct targets of atypical E2Fs. E2F7/8 directly bind and stimulate the CCBE1 promoter, while recruitment of E2F7/8 inhibits the FLT4 promoter. Importantly, inactivation of e2f7/8 in zebrafish impaired venous sprouting and lymphangiogenesis with reduced ccbe1 expression and increased flt4 expression. Remarkably, over-expression of e2f7/8 rescued Ccbe1- and Flt4-dependent lymphangiogenesis phenotypes. Together these results identified E2f7/8 as novel in vivo transcriptional regulators of Ccbe1 and Flt4, both essential genes for venous sprouting and lymphangiogenesis.	[Weijts, Bart G. M. W.; de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [van Impel, Andreas; Schulte-Merker, Stefan] Hubrecht Inst KNAW, Utrecht, Netherlands; [van Impel, Andreas; Schulte-Merker, Stefan] UMC Utrecht, Utrecht, Netherlands; [Schulte-Merker, Stefan] Wageningen Univ, EZO Dept, NL-6700 AP Wageningen, Netherlands	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Wageningen University & Research	de Bruin, A (corresponding author), Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands.	a.debruin@uu.nl	de Bruin, Alain/AAL-9195-2020; Weijts, Bart/O-7107-2019; van Impel, Andreas/G-7284-2014	Weijts, Bart/0000-0003-4843-3019; van Impel, Andreas/0000-0002-4737-3547; de Bruin, Alain/0000-0001-8579-2649				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Bos FL, 2011, CIRC RES, V109, P486, DOI 10.1161/CIRCRESAHA.111.250738; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kazenwadel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040497; Korenjak M, 2012, MOL CELL BIOL, V32, P4375, DOI 10.1128/MCB.00536-12; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Lu Z, 2006, ONCOGENE, V25, P230, DOI 10.1038/sj.onc.1209025; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Pandit SK, 2012, NAT CELL BIOL, V14, P1181, DOI 10.1038/ncb2585; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Rojas DA, 2007, GENE EXPR PATTERNS, V7, P339, DOI 10.1016/j.modgep.2006.08.002; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Weijts BGMW, 2012, EMBO J, V31, P3871, DOI 10.1038/emboj.2012.231; Westendorp B, 2012, NUCLEIC ACIDS RES, V40, P3511, DOI 10.1093/nar/gkr1203	35	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73693	10.1371/journal.pone.0073693	http://dx.doi.org/10.1371/journal.pone.0073693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069224	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100056
J	Yoshida, M; Jochems, A; Hasselmo, ME				Yoshida, Motoharu; Jochems, Arthur; Hasselmo, Michael E.			Comparison of Properties of Medial Entorhinal Cortex Layer II Neurons in Two Anatomical Dimensions with and without Cholinergic Activation	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; AFTER-HYPERPOLARIZATION; STELLATE CELLS; GRID CELLS; SUBTHRESHOLD OSCILLATIONS; SPATIAL PERIODICITY; CELLULAR PROPERTIES; PRINCIPAL NEURONS; PATH-INTEGRATION; FREQUENCY	Mechanisms underlying grid cell firing in the medial entorhinal cortex (MEC) still remain unknown. Computational modeling studies have suggested that cellular properties such as spike frequency adaptation and persistent firing might underlie the grid cell firing. Recent in vivo studies also suggest that cholinergic activation influences grid cell firing. Here we investigated the anatomical distribution of firing frequency adaptation, the medium spike after hyperpolarization potential (mAHP), subthreshold membrane potential oscillations, sag potential, input resistance and persistent firing, in MEC layer II principal cells using in vitro whole-cell patch clamp recordings in rats. Anatomical distributions of these properties were compared along both the dorso-ventral and medio-lateral axes, both with and without the cholinergic receptor agonist carbachol. We found that spike frequency adaptation is significantly stronger in ventral than in dorsal neurons both with and without carbachol. Spike frequency adaptation was significantly correlated with the duration of the mAHP, which also showed a gradient along the dorso-ventral axis. In carbachol, we found that about 50% of MEC layer II neurons show persistent firing which lasted more than 30 seconds. Persistent firing of MEC layer II neurons might contribute to grid cell firing by providing the excitatory drive. Dorso-ventral differences in spike frequency adaptation we report here are opposite from previous predictions by a computational model. We discuss an alternative mechanism as to how dorso-ventral differences in spike frequency adaptation could contribute to different scales of grid spacing.	[Yoshida, Motoharu] Ruhr Univ Bochum, Fac Psychol, Mercator Res Grp Struct Memory, Bochum, Germany; [Yoshida, Motoharu; Jochems, Arthur] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany; [Yoshida, Motoharu; Hasselmo, Michael E.] Boston Univ, Dept Psychol, Ctr Memory & Brain, Boston, MA 02215 USA; [Yoshida, Motoharu; Hasselmo, Michael E.] Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA	Ruhr University Bochum; Ruhr University Bochum; Boston University; Boston University	Yoshida, M (corresponding author), Ruhr Univ Bochum, Fac Psychol, Mercator Res Grp Struct Memory, Univ Str 150, Bochum, Germany.	motoharu.yoshida@rub.de		Hasselmo, Michael/0000-0002-9925-6377	National Institute of Mental Health (NIMH) [R01 MH61492, MH60013]; ONR MURI [N00014-10-1-0936]; JSPS; International Graduate School of Neuroscience, Ruhr University Bochum; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061492] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ONR MURI(MURIOffice of Naval Research); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); International Graduate School of Neuroscience, Ruhr University Bochum; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health (NIMH) R01 MH61492, MH60013, ONR MURI N00014-10-1-0936, JSPS Postdoctoral Fellowship for Research Abroad and International Graduate School of Neuroscience, Ruhr University Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKAI E, 1994, J NEUROPHYSIOL, V72, P644, DOI 10.1152/jn.1994.72.2.644; Boehlen A, 2010, J NEUROSCI, V30, P4585, DOI 10.1523/JNEUROSCI.4939-09.2010; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burak Y., 2009, PLOS COMPUTATIONAL B, V5; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Canto CB, 2012, HIPPOCAMPUS, V22, P1256, DOI 10.1002/hipo.20997; Canto CB, 2012, HIPPOCAMPUS, V22, P1277, DOI 10.1002/hipo.20993; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Dodson PD, 2011, J PHYSIOL-LONDON, V589, P2993, DOI 10.1113/jphysiol.2011.205021; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Garden DLF, 2008, NEURON, V60, P875, DOI 10.1016/j.neuron.2008.10.044; Giocomo LM, 2008, J NEUROSCI, V28, P9414, DOI 10.1523/JNEUROSCI.3196-08.2008; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Giocomo LM, 2009, J NEUROSCI, V29, P7625, DOI 10.1523/JNEUROSCI.0609-09.2009; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Gu N, 2008, J NEUROPHYSIOL, V100, P2589, DOI 10.1152/jn.90433.2008; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hamlin AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053472; Hasselmo ME, 2012, FRONTIERS NEURAL CIR, V6; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Heys JG, 2010, J NEUROPHYSIOL, V104, P258, DOI 10.1152/jn.00492.2009; Khawaja FA, 2007, HIPPOCAMPUS, V17, P1143, DOI 10.1002/hipo.20365; Klink R, 1997, J NEUROPHYSIOL, V77, P1813, DOI 10.1152/jn.1997.77.4.1813; Klink R, 1997, HIPPOCAMPUS, V7, P571; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Magistretti J, 2004, J NEUROPHYSIOL, V92, P1644, DOI 10.1152/jn.00036.2004; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Navratilova Z, 2012, HIPPOCAMPUS, V22, P772, DOI 10.1002/hipo.20939; Pastoll H, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00017; Schmidt-Hieber C, 2013, NAT NEUROSCI, V16, P325, DOI 10.1038/nn.3340; Shay CF, 2012, HIPPOCAMPUS, V22, P1733, DOI 10.1002/hipo.22008; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; Yoshida M, 2011, J NEUROSCI, V31, P12683, DOI 10.1523/JNEUROSCI.1654-11.2011; ZHANG L, 1994, PFLUG ARCH EUR J PHY, V426, P247, DOI 10.1007/BF00374778	40	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73904	10.1371/journal.pone.0073904	http://dx.doi.org/10.1371/journal.pone.0073904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069244	Green Published, gold			2022-12-27	WOS:000326240100068
J	Nesbitt, SJ; Butler, RJ; Gower, DJ				Nesbitt, Sterling J.; Butler, Richard J.; Gower, David J.			A New Archosauriform (Reptilia: Diapsida) from the Manda Beds (Middle Triassic) of Southwestern Tanzania	PLOS ONE			English	Article							VANCLEAVEA-CAMPI; REDESCRIPTION; PHYLOGENY; DINOSAUR; ARIZONA; ORIGIN	Background: Archosauria and their closest relatives, the non-archosaurian archosauriforms, diversified in the Early and Middle Triassic, soon after the end-Permian extinction. This diversification is poorly documented in most Lower and Middle Triassic rock sequences because fossils of early groups of archosauriforms are relatively rare compared to those of other amniotes. The early Middle Triassic (? late Anisian) Manda beds of southwestern Tanzania form an exception, with early archosaur skeletons being relatively common and preserved as articulated or associated specimens. The Manda archosaur assemblage is exceptionally diverse for the Middle Triassic. However, to date, no non-archosaurian archosauriforms have been reported from these rocks. Methodology/Principal Findings: Here, we name a new taxon, Asperoris mnyama gen. et sp. nov., from the Manda beds and thoroughly describe the only known specimen. The specimen consists of a well-preserved partial skull including tooth-bearing elements (premaxilla, maxilla), the nasal, partial skull roof, and several incomplete elements. All skull elements are covered in an autapomorphic highly rugose sculpturing. A unique combination of character states indicates that A. mnyama lies just outside Archosauria as a stem archosaur within Archosauriformes, but more precise relationships of A. mnyama relative to other early archosauriform clades (e. g., Erythrosuchidae) cannot be determined currently. Conclusions/Significance: Asperoris mnyama is the first confirmed non-archosaurian archosauriform from the Manda beds and increases the morphological and taxonomic diversity of early archosauriforms known from the Middle Triassic. The direct association of A. mnyama with species referable to Archosauria demonstrates that non-archosaurian archosauriforms were present during the rise and early diversification of Archosauria. Non-archosaurian archosauriforms and archosaurs co-occur in fossil reptile assemblages across Pangaea from the late Early Triassic to the end of the Late Triassic.	[Nesbitt, Sterling J.] Univ Washington, Burke Museum, Seattle, WA 98195 USA; [Nesbitt, Sterling J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Butler, Richard J.] Univ Munich, GeoBioctr, Munich, Germany; [Gower, David J.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Munich; Natural History Museum London	Nesbitt, SJ (corresponding author), Univ Washington, Burke Museum, Seattle, WA 98195 USA.	sjn2104@uw.edu	Butler, Richard J./A-5239-2011	Butler, Richard J./0000-0003-2136-7541; Nesbitt, Sterling/0000-0002-7017-1652	National Science Foundation EAR (Division of Earth Sciences) [1024036]; Natural History Museum (United Kingdom); DFG Emmy Noether Programme award [BU 2587/3-1]	National Science Foundation EAR (Division of Earth Sciences); Natural History Museum (United Kingdom); DFG Emmy Noether Programme award(German Research Foundation (DFG))	This work was supported by National Science Foundation EAR (Division of Earth Sciences)-1024036 (to Christian Sidor) and a Natural History Museum (United Kingdom) collections improvement grant to curate Manda beds fossils (to P. Barrett). RJB was supported by a DFG Emmy Noether Programme award (BU 2587/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTRIDGE J, 1964, NATURE, V201, P445, DOI 10.1038/201445a0; Bennett SC, 1996, ZOOL J LINN SOC-LOND, V118, P261, DOI 10.1111/j.1096-3642.1996.tb01267.x; Benton M.J., 1988, Systematics Association Special Volume Series, P295; Benton M.J., 1990, P11; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Butler RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025693; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Charig A, 1967, FOSS REC, P708; Charig AJ, 1956, NEW TRIASSIC ARCHOSA; Charig AJ, 1957, ABSTR DISS U CAMBR, V1955-56, P28; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; COX CB, 1991, PALAEONTOLOGY, V34, P767; Desojo JB, 2011, ZOOL J LINN SOC-LOND, V161, P839, DOI 10.1111/j.1096-3642.2010.00655.x; Dilkes DW, 1998, PHILOS T ROY SOC B, V353, P501, DOI 10.1098/rstb.1998.0225; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2010, J VERTEBR PALEONTOL, V30, P1433, DOI 10.1080/02724634.2010.501446; Ezcurra MD, 2013, GEOL SOC LOND SPEC P, DOI [10.1144/SP379.11, DOI 10.1144/SP379.11)]; Fraser NC., 2006, DAWN DINOSAURS LIFE; Galton PM, STUTTGARTER BEITRAGE, V116, P1; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gauthier J.A., 1988, Systematics Association Special Volume Series, P103; Gauthier J.A., 1984, CLADISTIC ANAL HIGHE; Gebauer E. V. I., 2004, NEUES JB GEOLOGIE PA, V231, P1; Gottmann-Quesada A, 2009, PALAEONTOGR ABT A, V287, P123; Gower David J., 2000, P140; Gower David J., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V280, P1; Gower David John, 2003, Annals of the South African Museum, V110, P1; Huene F.v., 1938, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie Stuttgart, V80, P264; HUENE FRIEDRICH V., 1939, NEUES JAHRB MINERAL GEOL U PALAONT ABT B BEILAGE BD, V81, P61; HUNT A.P., 2002, NEW MEXICO MUSEUM NA, V21, P269; Hunt Adrian P., 2005, Bulletin of the New Mexico Museum of Natural History and Science, P59; Juul Lars, 1994, Palaeontologia Africana, V31, P1; Kalandadze NN, 1985, PALEONTOL J, V1995, P73; Lautenschlager S, 2011, PALAEONTOL Z, V85, P357, DOI 10.1007/s12542-011-0105-1; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Modesto SP, 2004, SYST BIOL, V53, P815, DOI 10.1080/10635150490503026; Nesbitt SJ, 2005, NEUES JAHRB GEOL P-M, P332; Nesbitt SJ, 2003, P ROY SOC B-BIOL SCI, V270, pS234, DOI 10.1098/rsbl.2003.0066; Nesbitt SJ, EARTH ENV S IN PRESS; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2013, GEOL MAG, V150, P225, DOI 10.1017/S0016756812000362; Nesbitt SJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0949; Nesbitt SJ, 2010, EARTH ENV SCI T R SO, V101, P271, DOI 10.1017/S1755691011020044; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2010, NATURE, V464, P95, DOI 10.1038/nature08718; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; OCHEV VG, 1958, DOKL AKAD NAUK SSSR+, V123, P749; Parker WG, 2005, P ROY SOC B-BIOL SCI, V272, P963, DOI 10.1098/rspb.2004.3047; Parrish J.M., 1992, Journal of Vertebrate Paleontology, V12, P93; Parrish J. Michael, 1993, Journal of Vertebrate Paleontology, V13, P287; Romer A. S., 1971, Breviora, VNo. 379, P1; Romer A.S., 1972, Breviora, VNo. 389, P1; Sennikov A.G., 1988, Paleontologicheskii Zhurnal, V1988, P124; Sookias RB, 2013, SPECIAL PUBLICATIONS, DOI [10.1144/SP379.6, DOI 10.1144/SP379.6)]; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Stockley G.M., 1932, Q J GEOL SOC LOND, V88, P610, DOI DOI 10.1016/S0031-0182(03)00230-X; Sues HD., 2010, TRIASSIC LIFE LAND G; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Weinbaum Jonathan C., 2011, Paleobios, V30, P18; WELLES S. P., 1947, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V27, P241; Young C. C., 1964, Palaeontologia Sinica No 151 NS G, VNo. 19, P1; Young C-C, 1973, MEMOIRS I VERTEBRATE, V10, P38	64	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e72753	10.1371/journal.pone.0072753	http://dx.doi.org/10.1371/journal.pone.0072753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086264	gold, Green Published, Green Submitted			2022-12-27	WOS:000325223900008
J	Rosso, C; Valabregue, R; Attal, Y; Vargas, P; Gaudron, M; Baronnet, F; Bertasi, E; Humbert, F; Peskine, A; Perlbarg, V; Benali, H; Lehericy, S; Samson, Y				Rosso, Charlotte; Valabregue, Romain; Attal, Yohan; Vargas, Patricia; Gaudron, Marie; Baronnet, Flore; Bertasi, Eric; Humbert, Frederic; Peskine, Anne; Perlbarg, Vincent; Benali, Habib; Lehericy, Stephane; Samson, Yves			Contribution of Corticospinal Tract and Functional Connectivity in Hand Motor Impairment after Stroke	PLOS ONE			English	Article							DIFFUSION TENSOR TRACTOGRAPHY; CORTICAL ACTIVATION; UPPER-LIMB; RECOVERY; BRAIN; REORGANIZATION; STIMULATION; DAMAGE; FMRI; CEREBELLAR	Background: Motor outcome after stroke is associated with reorganisation of cortical networks and corticospinal tract (CST) integrity. However, the relationships between motor severity, CST damage, and functional brain connectivity are not well understood. Here, the main objective was to study the effect of CST damage on the relationship between functional motor network connectivity and hand motor function in two groups of stroke patients: the severely (n=8) and the mildly impaired (n=14). Methods: Twenty-two carotid stroke patients with motor deficits were studied with magnetic resonance imaging (MRI) at 3 weeks, at 3 and 6 months. Healthy subjects (n=28) were scanned once. The CST injury was assessed by fractional anisotropy values. Functional connectivity was studied from a whole-hand grip task fMRI in a cortical and cerebellar motor network. Functional connectivity indexes were computed between these regions at each time point. The relationship between hand motor strength, ipsilesional CST damage and functional connectivity from the primary motor cortex (M1) was investigated using global and partial correlations. Findings: In mildly impaired patients, cortico-cortical connectivity was disturbed at three weeks but returned to a normal pattern after 3 months. Cortico-cerebellar connectivity was still decreased at 6 months. In severely impaired patients, the cortico-cortical connectivity tended to return to a normal pattern, but the cortico-cerebellar connectivity was totally abolished during the follow-up. In the entire group of patients, the hand motor strength was correlated to the ipsilesional functional connectivity from M1. Partial correlations revealed that these associations were not anymore significant when the impact of CST damage was removed, except for the ipsilesional M1-contralateral cerebellum connectivity. Conclusion: Functional brain connectivity changes can be observed, even in severely impaired patients with no recovery. Upper limb function is mainly explained by the CST damage and by the ipsilesional cortico-cerebellar connectivity.	[Rosso, Charlotte; Valabregue, Romain; Attal, Yohan; Vargas, Patricia; Gaudron, Marie; Bertasi, Eric; Humbert, Frederic; Perlbarg, Vincent; Benali, Habib; Lehericy, Stephane; Samson, Yves] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM, Paris, France; [Rosso, Charlotte; Valabregue, Romain; Attal, Yohan; Vargas, Patricia; Gaudron, Marie; Bertasi, Eric; Humbert, Frederic; Lehericy, Stephane; Samson, Yves] CNRS, INSERM, U975, UMR 7225, Paris, France; [Rosso, Charlotte; Attal, Yohan; Vargas, Patricia; Gaudron, Marie; Samson, Yves] CRICM, COGIMAGE, Paris, France; [Rosso, Charlotte; Baronnet, Flore; Samson, Yves] Hop La Pitie Salpetriere, APHP, Paris, France; [Rosso, Charlotte] Univ Paris 11, IFR49, DSV NeuroSpin I2BM, Gif Sur Yvette, France; [Valabregue, Romain; Bertasi, Eric; Humbert, Frederic] Ctr Neuroimagerie Rech CENIR, Inst Cerveau & Moelle Epiniere, Paris, France; [Gaudron, Marie] CHU Tours, Serv Neurol, Tours, France; [Baronnet, Flore] CEA NEUROSPIN, INSERM, U562, Saclay, France; [Peskine, Anne] Hop La Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, Paris, France; [Perlbarg, Vincent; Benali, Habib] Hop La Pitie Salpetriere, Lab Imagerie Fonct, INSERM, UMR S678, Paris, France; [Lehericy, Stephane] Hop La Pitie Salpetriere, AP HP, Serv Neuroradiol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; CHU Tours; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Rosso, C (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM, Paris, France.	charlotte.rosso@gmail.com	samson, yves/C-5647-2013; valabregue, romain/GWQ-7484-2022	valabregue, romain/0000-0002-1814-9570; Peskine, Anne/0000-0003-0083-493X; samson, yves/0000-0002-8080-1427	IFR 49 institute (Institut Federatif de Recherche, Gif sur Yvette, France) [49]; program "Investissements d'avenir" [ANR-10-IAIHU-06]	IFR 49 institute (Institut Federatif de Recherche, Gif sur Yvette, France); program "Investissements d'avenir"(French National Research Agency (ANR))	This work was partially supported by the IFR 49 institute (Institut Federatif de Recherche no 49, Gif sur Yvette, France). The research leading to these results has received funding from the program "Investissements d'avenir" ANR-10-IAIHU-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN D, 1991, SCIENCE, V266, P458; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Binkofski F, 2004, NEUROLOGY, V63, P1223, DOI 10.1212/01.WNL.0000140468.92212.BE; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Buma FE, 2010, NEUROREHAB NEURAL RE, V24, P589, DOI 10.1177/1545968310364058; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Calautti C, 2010, J NEUROL NEUROSUR PS, V81, P788, DOI 10.1136/jnnp.2009.190512; Carter AR, 2012, NEUROIMAGE, V62, P2271, DOI 10.1016/j.neuroimage.2012.02.070; Carter AR, 2012, NEUROREHAB NEURAL RE, V26, P7, DOI 10.1177/1545968311411054; Catano A, 1996, ELECTROMYOGR MOTOR C, V101, P233, DOI 10.1016/0924-980X(96)95656-8; Cho SH, 2007, NEUROSCI LETT, V426, P123, DOI 10.1016/j.neulet.2007.08.049; Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Deen Ben, 2012, Nature, V491, pS20; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Jaillard A, 2005, BRAIN, V128, P1122, DOI 10.1093/brain/awh456; Jang SH, 2004, NEUROREPORT, V15, P395, DOI 10.1097/00001756-200403010-00002; Jang SH, 2003, NEUROREPORT, V14, P1305, DOI 10.1097/01.wnr.0000078700.79393.09; Johansen-Berg H, 2009, BRAIN STRUCT FUNCT, V213, P499, DOI 10.1007/s00429-009-0220-x; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; Kokotilo KJ, 2009, J NEUROL PHYS THER, V33, P45, DOI 10.1097/NPT.0b013e31819824f0; Kwon YH, 2011, J REHABIL MED, V43, P430, DOI 10.2340/16501977-0793; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Loubinoux I, 2007, CEREB CORTEX, V17, P2980, DOI 10.1093/cercor/bhm023; Lu J, 2011, J NEUROSCI, V31, P15065, DOI 10.1523/JNEUROSCI.2364-11.2011; Lu MK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00260; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Mintzopoulos D, 2009, NEUROIMAGE, V47, pT90, DOI 10.1016/j.neuroimage.2009.03.007; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; Noskin O, 2008, J NEUROL NEUROSUR PS, V79, P401, DOI 10.1136/jnnp.2007.118463; Pannek K, 2009, J MAGN RESON IMAGING, V29, P529, DOI 10.1002/jmri.21627; PANTANO P, 1986, BRAIN, V109, P677, DOI 10.1093/brain/109.4.677; Perlbarg V, 2007, MAGN RESON IMAGING, V25, P35, DOI 10.1016/j.mri.2006.09.042; Puig J, 2010, AM J NEURORADIOL, V31, P1324, DOI 10.3174/ajnr.A2038; Radlinska B, 2010, NEUROLOGY, V75, P1048, DOI 10.1212/WNL.0b013e3181f39aa0; Rehme AK, 2013, J PHYSIOL-LONDON, V591, P17, DOI 10.1113/jphysiol.2012.243469; Rehme AK, 2012, NEUROIMAGE, V59, P2771, DOI 10.1016/j.neuroimage.2011.10.023; Rehme AK, 2011, CEREB CORTEX, V21, P756, DOI 10.1093/cercor/bhq140; Rehme AK, 2011, NEUROIMAGE, V55, P1147, DOI 10.1016/j.neuroimage.2011.01.014; Riley JD, 2011, STROKE, V42, P421, DOI 10.1161/STROKEAHA.110.599340; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Seitz RJ, 2010, NEUROLOGY, V74, P276, DOI 10.1212/WNL.0b013e3181ccc758; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Small SL, 2002, BRAIN, V125, P1544, DOI 10.1093/brain/awf148; Stagg CJ, 2012, BRAIN, V135, P276, DOI 10.1093/brain/awr313; Sterr A, 2010, NEUROREHAB NEURAL RE, V24, P413, DOI 10.1177/1545968309348310; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Talelli P, 2012, NEUROREHAB NEURAL RE, V26, P976, DOI 10.1177/1545968312437940; Tombari D, 2004, NEUROIMAGE, V23, P827, DOI 10.1016/j.neuroimage.2004.07.058; Vargas P, 2013, J MAGN RESON IMAGING, V37, P836, DOI 10.1002/jmri.23870; Wang LE, 2012, HUM BRAIN MAPP, V33, P2941, DOI 10.1002/hbm.21417; Ward NS, 2006, NEUROREHAB NEURAL RE, V20, P398, DOI 10.1177/1545968306286322; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Westlake KP, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00008; Zhu LL, 2010, STROKE, V41, P910, DOI 10.1161/STROKEAHA.109.577023	60	38	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73164	10.1371/journal.pone.0073164	http://dx.doi.org/10.1371/journal.pone.0073164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086272	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900011
J	Hoffman, MT; Gunatilaka, MK; Wijeratne, K; Gunatilaka, L; Arnold, AE				Hoffman, Michele T.; Gunatilaka, Malkanthi K.; Wijeratne, Kithsiri; Gunatilaka, Leslie; Arnold, A. Elizabeth			Endohyphal Bacterium Enhances Production of Indole-3-Acetic Acid by a Foliar Fungal Endophyte	PLOS ONE			English	Article							COLLETOTRICHUM-GLOEOSPORIOIDES; PLANT-GROWTH; GEOGRAPHIC STRUCTURE; SALKOWSKI REAGENT; USTILAGO-MAYDIS; PESTALOTIOPSIS; HOST; IDENTIFICATION; BIOSYNTHESIS; DIVERSITY	Numerous plant pathogens, rhizosphere symbionts, and endophytic bacteria and yeasts produce the important phytohormone indole-3-acetic acid (IAA), often with profound effects on host plants. However, to date IAA production has not been documented among foliar endophytes - the diverse guild of primarily filamentous Ascomycota that live within healthy, above-ground tissues of all plant species studied thus far. Recently bacteria that live within hyphae of endophytes (endohyphal bacteria) have been detected, but their effects have not been studied previously. Here we show not only that IAA is produced in vitro by a foliar endophyte (here identified as Pestalotiopsis aff. neglecta, Xylariales), but that IAA production is enhanced significantly when the endophyte hosts an endohyphal bacterium (here identified as Luteibacter sp., Xanthomonadales). Both the endophyte and the endophyte/bacterium complex appear to rely on an L-tryptophan dependent pathway for IAA synthesis. The bacterium can be isolated from the fungus when the symbiotic complex is cultivated at 36 degrees C. In pure culture the bacterium does not produce IAA. Culture filtrate from the endophyte-bacterium complex significantly enhances growth of tomato in vitro relative to controls and to filtrate from the endophyte alone. Together these results speak to a facultative symbiosis between an endophyte and endohyphal bacterium that strongly influences IAA production, providing a new framework in which to explore endophyte-plant interactions.	[Hoffman, Michele T.; Gunatilaka, Malkanthi K.; Arnold, A. Elizabeth] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Wijeratne, Kithsiri; Gunatilaka, Leslie] Sch Nat Resources & Environm, Southwest Ctr Nat Prod Res & Commercializat, Tucson, AZ USA	University of Arizona	Arnold, AE (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	Arnold@ag.arizona.edu	Hoffman, Michele T/D-2537-2011		Division of Plant Pathology and Microbiology; School of Plant Sciences; College of Agriculture and Life Sciences at The University of Arizona; National Science Foundation [NSF-0626520, 0702825]	Division of Plant Pathology and Microbiology; School of Plant Sciences; College of Agriculture and Life Sciences at The University of Arizona; National Science Foundation(National Science Foundation (NSF))	We thank the Division of Plant Pathology and Microbiology, the School of Plant Sciences, and the College of Agriculture and Life Sciences at The University of Arizona for logistical and financial support. Additional support from the National Science Foundation (NSF-0626520 and 0702825 to AEA; NSF-IGERT to MTH) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2009, SYST BIOL, V58, P283, DOI 10.1093/sysbio/syp001; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; Bajo J, 2008, FOREST PATHOL, V38, P263, DOI 10.1111/j.1439-0329.2008.00545.x; Barash I, 2009, ANNU REV PHYTOPATHOL, V47, P133, DOI 10.1146/annurev-phyto-080508-081803; Barbieri E, 2000, APPL ENVIRON MICROB, V66, P5035, DOI 10.1128/AEM.66.11.5035-5042.2000; Bertaux J, 2003, APPL ENVIRON MICROB, V69, P4243, DOI 10.1128/AEM.69.7.4243-4248.2003; Bianciotto V, 1996, APPL ENVIRON MICROB, V62, P3005, DOI 10.1128/AEM.62.8.3005-3010.1996; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; CARROLL G, 1983, MYCOLOGIA, V75, P53, DOI 10.2307/3792923; Chague V, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-173; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; EHMANN A, 1977, J CHROMATOGR, V132, P267, DOI 10.1016/S0021-9673(00)89300-0; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; GRUEN HE, 1959, ANNU REV PLANT PHYS, V10, P405, DOI 10.1146/annurev.pp.10.060159.002201; Herre EA, 2007, ECOLOGY, V88, P550, DOI 10.1890/05-1606; Higgins KL, 2007, MOL PHYLOGENET EVOL, V42, P543, DOI 10.1016/j.ympev.2006.07.012; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Hoffman MT, 2010, APPL ENVIRON MICROB, V76, P4063, DOI 10.1128/AEM.02928-09; HOFFMAN MT, 2010, THESIS U ARIZONA TUC; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeewon R, 2004, FUNGAL DIVERS, V17, P39; Jeewon R, 2003, MOL PHYLOGENET EVOL, V27, P372, DOI 10.1016/S1055-7903(03)00010-1; Kobayashi DY, 2009, ANNU REV PHYTOPATHOL, V47, P63, DOI 10.1146/annurev-phyto-080508-081729; KOGA J, 1995, BBA-PROTEIN STRUCT M, V1249, P1, DOI 10.1016/0167-4838(95)00011-I; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Levy A, 2003, APPL ENVIRON MICROB, V69, P6250, DOI 10.1128/AEM.69.10.6250-6256.2003; Lindow SE, 1998, PHYTOPATHOLOGY, V88, P1149, DOI 10.1094/PHYTO.1998.88.11.1149; Lodge DJ, 1996, MYCOLOGIA, V88, P733, DOI 10.2307/3760967; Maddison WP, 2019, MESQUITE MODULAR SYS; Maor R, 2004, APPL ENVIRON MICROB, V70, P1852, DOI 10.1128/AEM.70.3.1852-1854.2004; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Miller M.A., 2010, P GAT COMP ENV WORKS; Nassar AH, 2005, BIOL FERT SOILS, V42, P97, DOI 10.1007/s00374-005-0008-y; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; Robinson M, 1998, APPL ENVIRON MICROB, V64, P5030; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Salkowski E., 1885, Z PHYSL CHEM, V9, P23; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Sharma M, 2008, CELL MICROBIOL, V10, P2235, DOI 10.1111/j.1462-5822.2008.01202.x; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Sosa-Morales ME, 1997, APPL MICROBIOL BIOT, V48, P726, DOI 10.1007/s002530051123; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; STEYAERT R. L., 1953, TRANS BRIT MYCOL SOC, V36, P81; Strack D, 2003, J CHEM ECOL, V29, P1955, DOI 10.1023/A:1025695032113; Suwannarach N, 2013, J GEN PLANT PATHOL, V79, P277, DOI 10.1007/s10327-013-0453-7; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tudzynski B, 2002, MYCOTA, V10, P183; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; Watanabe K, 2010, MYCOSCIENCE, V51, P182, DOI 10.1007/s10267-009-0025-z; Wei JG, 2007, FUNGAL DIVERS, V24, P55; Xin G, 2009, MYCOL RES, V113, P973, DOI 10.1016/j.mycres.2009.06.001; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; Zwickl D. J, 2006, GENETIC ALGORITHM AP	62	89	112	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e73132	10.1371/journal.pone.0073132	http://dx.doi.org/10.1371/journal.pone.0073132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086270	Green Published, gold, Green Submitted			2022-12-27	WOS:000325025200007
J	Ping, LH; Jabara, CB; Rodrigo, AG; Hudelson, SE; Piwowar-Manning, E; Wang, L; Eshleman, SH; Cohen, MS; Swanstrom, R				Ping, Li-Hua; Jabara, Cassandra B.; Rodrigo, Allen G.; Hudelson, Sarah E.; Piwowar-Manning, Estelle; Wang, Lei; Eshleman, Susan H.; Cohen, Myron S.; Swanstrom, Ronald			HIV-1 Transmission during Early Antiretroviral Therapy: Evaluation of Two HIV-1 Transmission Events in the HPTN 052 Prevention Study	PLOS ONE			English	Article							HETEROSEXUAL TRANSMISSION; INFECTION; INITIATION; COUPLES	In the HPTN 052 study, transmission between HIV-discordant couples was reduced by 96% when the HIV-infected partner received suppressive antiretroviral therapy (ART). We examined two transmission events where the newly infected partner was diagnosed after the HIV-infected partner (index) initiated therapy. We evaluated the sequence complexity of the viral populations and antibody reactivity in the newly infected partner to estimate the dates of transmission to the newly infected partners. In both cases, transmission most likely occurred significantly before HIV-1 diagnosis of the newly infected partner, and either just before the initiation of therapy or before viral replication was adequately suppressed by therapy of the index. This study further strengthens the conclusion about the efficacy of blocking transmission by treating the infected partner of discordant couples. However, this study does not rule out the potential for HIV-1 transmission to occur shortly after initiation of ART, and this should be recognized when antiretroviral therapy is used for HIV-1 prevention.	[Ping, Li-Hua] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Jabara, Cassandra B.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Rodrigo, Allen G.] Natl Evolutionary Synth Ctr, Durham, NC USA; [Hudelson, Sarah E.; Piwowar-Manning, Estelle; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Wang, Lei] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Cohen, Myron S.] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA; [Cohen, Myron S.; Swanstrom, Ronald] Univ N Carolina, UNC Ctr AIDS Res, Chapel Hill, NC 27515 USA; [Swanstrom, Ronald] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; The National Evolutionary Synthesis Center; Johns Hopkins University; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Swanstrom, R (corresponding author), Univ N Carolina, UNC Ctr AIDS Res, Chapel Hill, NC 27515 USA.	risunc@med.unc.edu	Rodrigo, Allen/E-8905-2015	Rodrigo, Allen/0000-0002-8327-7317	National Institutes of Health [U01-AI068619/UM1-AI068619]; HPTN Network Laboratory [U01-AI068613/UM1-AI068613]; HPTN Statistical and Data Management Center [U01-AI068617/UM1-AI068617]; Center For HIV/AIDS Vaccine Immunology [U19-AI067854]; University of North Carolina Center For AIDS Research [P30-AI50410, R37-AI44667, R37-DK49381]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617, U01AI068617, U19AI067854, UM1AI068613, UM1AI068619, R37AI044667, P30AI050410, U01AI068619, U01AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HPTN Network Laboratory; HPTN Statistical and Data Management Center; Center For HIV/AIDS Vaccine Immunology; University of North Carolina Center For AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants to the HIV Prevention Trials Network (HPTN) (U01-AI068619/UM1-AI068619), the HPTN Network Laboratory (U01-AI068613/UM1-AI068613), the HPTN Statistical and Data Management Center (U01-AI068617/UM1-AI068617), the Center For HIV/AIDS Vaccine Immunology (U19-AI067854), the University of North Carolina Center For AIDS Research (P30-AI50410), and to R. S. (R37-AI44667) and M. S. C. (R37-DK49381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Giorgi EE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-532; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006	15	19	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2013	8	9							e71557	10.1371/journal.pone.0071557	http://dx.doi.org/10.1371/journal.pone.0071557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226HG	24086252	Green Published, Green Submitted, gold			2022-12-27	WOS:000325025200004
J	Talaei, N; Cheung, YH; Landolt-Marticorena, C; Noamani, B; Li, T; Wither, JE				Talaei, Nafiseh; Cheung, Yui-Ho; Landolt-Marticorena, Carolina; Noamani, Babak; Li, Timothy; Wither, Joan E.			T Cell and Dendritic Cell Abnormalities Synergize to Expand Pro-Inflammatory T Cell Subsets Leading to Fatal Autoimmunity in B6.NZBc1 Lupus-Prone Mice	PLOS ONE			English	Article							FOLLICULAR-HELPER-CELLS; B-CELL; SUSCEPTIBILITY; RECEPTOR; IL-21; GENERATION; T-HELPER-1; LY108; TH1	We have previously shown that B6 congenic mice with a New Zealand Black chromosome 1 (c1) 96-100 cM interval produce anti-nuclear Abs and that at least two additional genetic loci are required to convert this subclinical disease to fatal glomerulonephritis in mice with a c1 70-100 cM interval (c1(70-100)). Here we show that the number of T follicular helper and IL-21-, IFN-gamma-, and IL-17-secreting CD4(+) T cells parallels disease severity and the number of susceptibility loci in these mice. Immunization of pre-autoimmune mice with OVA recapitulated these differences. Differentiation of nave T cells in-vitro under polarizing conditions and in-vivo following adoptive transfer of OVA-specific TCR transgenic cells into c1(70-100) or B6 recipient mice, revealed T cell functional defects leading to increased differentiation of IFN-gamma- and IL-17-producing cells in the 96-100 cM and 88-96 cM intervals, respectively. However, in-vivo enhanced differentiation of pro-inflammatory T cell subsets was predominantly restricted to c1(70-100) recipient mice, which demonstrated altered dendritic cell function, with increased production of IL-6 and IL-12. The data provide support for the role of pro-inflammatory T cells in the conversion of subclinical disease to fatal autoimmunity and highlight the importance of synergistic interactions between individual susceptibility loci in this process.	[Talaei, Nafiseh; Cheung, Yui-Ho; Noamani, Babak; Li, Timothy; Wither, Joan E.] Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Arthrit Ctr Excellence, Toronto, ON, Canada; [Talaei, Nafiseh; Cheung, Yui-Ho; Wither, Joan E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Landolt-Marticorena, Carolina; Wither, Joan E.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wither, Joan E.] Univ Hlth Network, Div Rheumatol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Wither, JE (corresponding author), Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Arthrit Ctr Excellence, Toronto, ON, Canada.	jwither@uhnres.utoronto.ca		Wither, Joan/0000-0001-5961-9228	Canadian Institutes of Health Research; Arthritis Centre of Excellence; Arthritis and Autoimmunity Research Foundation; Government of Ontario Scholarship; Government of Ontario/Edward Dunlop Scholarship in Science and Technology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Arthritis Centre of Excellence; Arthritis and Autoimmunity Research Foundation; Government of Ontario Scholarship; Government of Ontario/Edward Dunlop Scholarship in Science and Technology	This work was supported by a research grant from the Canadian Institutes of Health Research awarded to JW. JW receives salary support from The Arthritis Centre of Excellence and The Arthritis and Autoimmunity Research Foundation. NT is the recipient of a Government of Ontario Scholarship and a Government of Ontario/Edward Dunlop Scholarship in Science and Technology. Y-HC was supported by a studentship from The Arthritis Centre of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Cheung YH, 2011, GENES IMMUN, V12, P251, DOI 10.1038/gene.2010.71; Cheung YH, 2005, J IMMUNOL, V175, P8154, DOI 10.4049/jimmunol.175.12.8154; Cuda CM, 2012, J IMMUNOL, V188, P604, DOI 10.4049/jimmunol.1002362; Du X, 2005, EUR J IMMUNOL, V35, P3414, DOI 10.1002/eji.200535366; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Jacob N, 2009, J IMMUNOL, V182, P2532, DOI 10.4049/jimmunol.0802948; Kang HK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2682; Keszei M, 2013, FASEB J, V27, P3123, DOI 10.1096/fj.12-226951; Keszei M, 2011, J EXP MED, V208, P811, DOI 10.1084/jem.20101653; Kim CH, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/416910; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Linterman MA, 2010, PROG MOL BIOL TRANSL, V92, P207, DOI 10.1016/S1877-1173(10)92009-7; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Loh C, 2011, J IMMUNOL, V186, P5845, DOI 10.4049/jimmunol.1003426; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Mohan C, 1999, J CLIN INVEST, V103, P1685, DOI 10.1172/JCI5827; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Pau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036761; Pau E, 2011, CLIN IMMUNOL, V139, P215, DOI 10.1016/j.clim.2011.02.005; Peck SR, 2000, IMMUNOGENETICS, V52, P63, DOI 10.1007/s002510000252; Shin MS, 2011, CURR OPIN RHEUMATOL, V23, P444, DOI 10.1097/BOR.0b013e328349a255; Spilianakis CG, 2005, EUR J IMMUNOL, V35, P3400, DOI 10.1002/eji.200535588; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	37	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75166	10.1371/journal.pone.0075166	http://dx.doi.org/10.1371/journal.pone.0075166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073245	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000054
J	Chuang, C; Pan, J; Hawke, DH; Lin, SH; Yu-Lee, LY				Chuang, Carol; Pan, Jing; Hawke, David H.; Lin, Sue-Hwa; Yu-Lee, Li-yuan			NudC Deacetylation Regulates Mitotic Progression	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; LYSINE-ACETYLATION; NUCLEAR MIGRATION; HISTONE ACETYLATION; AURORA-B; KINETOCHORE; PROTEIN; DYNEIN; INHIBITORS; MITOSIS	Mitosis is largely driven by posttranslational modifications of proteins. Recent studies suggest that protein acetylation is prevalent in mitosis, but how protein acetylation/deacetylation regulates mitotic progression remains unclear. Nuclear distribution protein C (NudC), a conserved protein that regulates cell division, was previously shown to be acetylated. We found that NudC acetylation was decreased during mitosis. Using mass spectrometry analysis, we identified K39 to be an acetylation site on NudC. Reconstitution of NudC-deficient cells with wild-type or K39R acetylation-defective NudC rescued mitotic phenotypes, including chromosome misalignment, chromosome missegregation, and reduced spindle width, observed after NudC protein knockdown. In contrast, the K39Q acetylation-mimetic NudC was unable to rescue these mitotic phenotypes, suggesting that NudC deacetylation is important for mitotic progression. To examine proteins that may play a role in NudC deacetylation during mitosis, we found that NudC co-localizes on the mitotic spindle with the histone deacetylase HDAC3, an HDAC shown to regulate mitotic spindle stability. Further, NudC co-immunoprecipitates with HDAC3 and loss of function of HDAC3 either by protein knockdown or inhibition with a small molecule inhibitor increased NudC acetylation. These observations suggest that HDAC3 may be involved in NudC deacetylation during mitosis. Cells with NudC or HDAC3 knockdown exhibited overlapping mitotic abnormalities, including chromosomes arranged in a "dome-like'' configuration surrounding a collapsed mitotic spindle. Our studies suggest that NudC acetylation/deacetylation regulates mitotic progression and NudC deacetylation, likely through HDAC3, is critical for spindle function and chromosome congression.	[Chuang, Carol; Yu-Lee, Li-yuan] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Pan, Jing; Yu-Lee, Li-yuan] Baylor Coll Med, Dept Med, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Yu-Lee, Li-yuan] Baylor Coll Med, Houston, TX 77030 USA; [Hawke, David H.; Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Yu-Lee, LY (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	yulee@bcm.edu		Hawke, David/0000-0002-6102-7843	National Institutes of Health (NIH) [T32 DK07696, P50-CA140388, RO1 DK4564, RO1 DK53176, AI071130]; Department of Defense (DOD) [PC080847, PC093132]; Cancer Prevention and Research Institute of Texas [RP110327]; Dan L. Duncan Cancer Center; Alkek Award in Experimental Therapeutics; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI071130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007696, R01DK053176] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012304] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); Cancer Prevention and Research Institute of Texas; Dan L. Duncan Cancer Center; Alkek Award in Experimental Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) training grant T32 DK07696 and grants from the NIH (P50-CA140388, RO1 DK4564, RO1 DK53176, and AI071130), Department of Defense (DOD) (PC080847 and PC093132), Cancer Prevention and Research Institute of Texas (RP110327), Dan L. Duncan Cancer Center, and Alkek Award in Experimental Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; Cappello S, 2011, DEV BIOL, V357, P326, DOI 10.1016/j.ydbio.2011.07.001; Chiu YH, 1997, GENETICS, V145, P707; Choi E, 2012, DEV CELL, V22, P295, DOI 10.1016/j.devcel.2012.01.009; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuang Carol, 2012, Methods Mol Biol, V909, P181, DOI 10.1007/978-1-61779-959-4_13; Chuang C, 2010, J PROTEOME RES, V9, P4554, DOI 10.1021/pr100281h; Cunniff J, 1997, MECH DEVELOP, V66, P55, DOI 10.1016/S0925-4773(97)00085-3; Dawe AL, 2001, DEV GENES EVOL, V211, P434, DOI 10.1007/s004270100176; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dowling M, 2005, CANCER BIOL THER, V4, P197, DOI 10.4161/cbt.4.2.1441; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Eot-Houllier G, 2008, GENE DEV, V22, P2639, DOI 10.1101/gad.484108; Fadri-Moskwik M, 2012, FASEB J, V26, P4057, DOI 10.1096/fj.12-206656; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; Gabrielli B, 2012, ADV CANCER RES, V116, P1, DOI 10.1016/B978-0-12-394387-3.00001-X; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ishii S, 2008, P NATL ACAD SCI USA, V105, P4179, DOI 10.1073/pnas.0710140105; Iwabata H, 2005, PROTEOMICS, V5, P4653, DOI 10.1002/pmic.200500042; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson DG, 2013, CELL, V152, P685, DOI 10.1016/j.cell.2013.01.017; Kelly AE, 2010, SCIENCEXPRESS; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kurasawa Y, 2010, MOL BIOL CELL, V21, P1188, DOI 10.1091/mbc.E09-11-0950; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; LOPEZRODAS G, 1992, FEBS LETT, V296, P82, DOI 10.1016/0014-5793(92)80408-9; Ma Y, 2008, CELL MOL LIFE SCI, V65, P3100, DOI 10.1007/s00018-008-8237-5; Magnaghi-Jaulin L, 2007, CANCER RES, V67, P6360, DOI 10.1158/0008-5472.CAN-06-3012; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Moreau N, 2001, INT J DEV BIOL, V45, P839; Nishino M, 2006, CURR BIOL, V16, P1414, DOI 10.1016/j.cub.2006.05.052; OSMANI AH, 1990, J CELL BIOL, V111, P543, DOI 10.1083/jcb.111.2.543; de Castro IP, 2011, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00050; Robbins AR, 2005, CELL CYCLE, V4, P717, DOI 10.4161/cc.4.5.1690; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Toba S, 2012, NEUROPATHOLOGY, V32, P432, DOI 10.1111/j.1440-1789.2012.01301.x; Wang F, 2010, SCIENCEXPRESS; Warrener R, 2010, MOL PHARMACOL, V78, P384, DOI 10.1124/mol.109.062976; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yamada M, 2010, EMBO J, V29, P517, DOI 10.1038/emboj.2009.378; Yang FK, 2012, CELL CYCLE, V11, P797, DOI 10.4161/cc.11.4.19307; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhang MY, 2002, EXP CELL RES, V273, P73, DOI 10.1006/excr.2001.5414; Zhang QH, 2000, P NATL ACAD SCI USA, V97, P14323, DOI 10.1073/pnas.011283598; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2	55	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73841	10.1371/journal.pone.0073841	http://dx.doi.org/10.1371/journal.pone.0073841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069238	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300022
J	Donnelly, JM; Chawla, A; Houghton, J; Zavros, Y				Donnelly, Jessica M.; Chawla, Ambreesh; Houghton, JeanMarie; Zavros, Yana			Sonic Hedgehog Mediates the Proliferation and Recruitment of Transformed Mesenchymal Stem Cells to the Stomach	PLOS ONE			English	Article							BONE-MARROW; HELICOBACTER-PYLORI; CONDITIONED MEDIUM; GENE-EXPRESSION; IFN-GAMMA; MODEL; GASTRITIS; GROWTH; CANCER; MICE	Studies using Helicobacter-infected mice show that bone marrow-derived mesenchymal stem cells (MSCs) can repopulate the gastric epithelium and promote gastric cancer progression. Within the tumor microenvironment of the stomach, pro-inflammatory cytokine interferon-gamma (IFN gamma) and Sonic hedgehog (Shh) are elevated. IFN gamma is implicated in tumor proliferation via activation of the Shh signaling pathway in various tissues but whether a similar mechanism exists in the stomach is unknown. We tested the hypothesis that IFN gamma drives MSC proliferation and recruitment, a response mediated by Shh signaling. The current study uses transplantation of an in vitro transformed mesenchymal stem cell line (stMSC(vect)), that over-expresses hedgehog signaling, in comparison to non-transformed wild-type MSCs (wtMSCs), wtMSCs transfected to over-express Shh (wtMSC(Shh)), and stMSCs transduced with lentiviral constructs containing shRNA targeting the Shh gene (stMSC(ShhKO)). The effect of IFN gamma on MSC proliferation was assessed by cell cycle analysis in vitro using cells treated with recombinant IFN gamma (rmIFN gamma) alone, or in combination with anti-Shh 5E1 antibody, and in vivo using mice transplanted with MSCs treated with PBS or rmIFN gamma. In vitro, IFN gamma significantly increased MSC proliferation, a response mediated by Shh that was blocked by 5E1 antibody. The MSC population collected from bone marrow of PBS- or IFN gamma-treated mice showed that IFN gamma significantly increased the percentage of all MSC cell lines in S phase, with the exception of the stMSCs(ShhKO) cells. While the MSC cell lines with intact Shh expression were recruited to the gastric mucosa in response to IFN gamma, stMSCs(ShhKO) were not. Hedgehog signaling is required for MSC proliferation and recruitment to the stomach in response to IFN gamma.	[Donnelly, Jessica M.; Chawla, Ambreesh; Zavros, Yana] Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45221 USA; [Houghton, JeanMarie] Univ Massachusetts, Sch Med, Dept Med, Div Gastroenterol, Worcester, MA USA; [Houghton, JeanMarie] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; University of Cincinnati	Zavros, Y (corresponding author), Univ Cincinnati, Coll Med, Dept Mol & Cellular Physiol, Cincinnati, OH 45221 USA.	yana.zavros@uc.edu		Houghton, JeanMarie/0000-0002-1727-373X	American Cancer Society [119072-RSG-10-167-01-MPC]; Albert J. Ryan Foundation Fellowship; Digestive Health Center Cincinnati Children's Medical Health Center (DHC: Bench to Bedside Research in Pediatric Digestive Disease) [CHTF/SUB DK078392]; National Institutes of Health (NIH) [AR-47363]; NIH [AR-47363]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Albert J. Ryan Foundation Fellowship; Digestive Health Center Cincinnati Children's Medical Health Center (DHC: Bench to Bedside Research in Pediatric Digestive Disease); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Cancer Society Research Scholar Award 119072-RSG-10-167-01-MPC (Y. Zavros), Albert J. Ryan Foundation Fellowship (J. Donnelly) and in part by the Digestive Health Center Cincinnati Children's Medical Health Center (DHC: Bench to Bedside Research in Pediatric Digestive Disease) CHTF/SUB DK078392. The authors would like to acknowledge the assistance of Monica DeLay manager of the Research Flow Cytometry Core in the Division of Rheumatology at Cincinnati Children's Hospital Medical Center, supported in part by National Institutes of Health (NIH) AR-47363. All flow cytometric data were acquired using equipment maintained by the Research Flow Cytometry Core in the Division of Rheumatology at Cincinnati Children's Hospital Medical Center, supported in part by NIH AR-47363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; CORREA P, 1975, LANCET, V2, P58; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Li HC, 2006, WORLD J GASTROENTERO, V12, P363, DOI 10.3748/wjg.v12.i3.363; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Houghton J, 2010, STEM CELLS DEV, V19, P1153, DOI 10.1089/scd.2009.0439; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Lin N, 2008, BIOCHEM BIOPH RES CO, V372, P260, DOI 10.1016/j.bbrc.2008.05.029; Menon LG, 2007, STEM CELLS, V25, P520, DOI 10.1634/stemcells.2006-0257; MOSS SF, 1994, GUT, V35, P1567, DOI 10.1136/gut.35.11.1567; Okumura T, 2009, LAB INVEST, V89, P1410, DOI 10.1038/labinvest.2009.88; Padol IT, 2004, GUT, V53, P1075, DOI 10.1136/gut.2003.026435; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Sawai N, 1999, INFECT IMMUN, V67, P279, DOI 10.1128/IAI.67.1.279-285.1999; Schumacher MA, 2012, GASTROENTEROLOGY, V142, P1150, DOI 10.1053/j.gastro.2012.01.029; Shibata W, 2013, GUT, V62, P192, DOI 10.1136/gutjnl-2011-301824; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Son SM, 2006, VET IMMUNOL IMMUNOP, V112, P284, DOI 10.1016/j.vetimm.2006.02.005; Stewart GA, 2003, J PATHOL, V199, P488, DOI 10.1002/path.1295; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004; Wang JP, 2003, J CLIN INVEST, V112, P535, DOI 10.1172/JCI200318637; Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1; Zavros Y, 2003, P NATL ACAD SCI USA, V100, P12944, DOI 10.1073/pnas.2135193100; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407; Zavros Y, 2007, J BIOL CHEM, V282, P33265, DOI 10.1074/jbc.M707090200	30	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75225	10.1371/journal.pone.0075225	http://dx.doi.org/10.1371/journal.pone.0075225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069395	Green Published, gold			2022-12-27	WOS:000324777300070
J	Ghorashian, N; Gokce, SK; Guo, SX; Everett, WN; Ben-Yakar, A				Ghorashian, Navid; Goekce, Sertan Kutal; Guo, Sam Xun; Everett, William Neil; Ben-Yakar, Adela			An Automated Microfluidic Multiplexer for Fast Delivery of C. elegans Populations from Multiwells	PLOS ONE			English	Article							LARGE-SCALE INTEGRATION; CAENORHABDITIS-ELEGANS; HIGH-THROUGHPUT; SYSTEM; IMMOBILIZATION; REGENERATION; CHEMISTRY; VERSATILE; ORGANISM; PLATFORM	Automated biosorter platforms, including recently developed microfluidic devices, enable and accelerate high-throughput and/or high-resolution bioassays on small animal models. However, time-consuming delivery of different organism populations to these systems introduces a major bottleneck to executing large-scale screens. Current population delivery strategies rely on suction from conventional well plates through tubing periodically exposed to air, leading to certain disadvantages: 1) bubble introduction to the sample, interfering with analysis in the downstream system, 2) substantial time drain from added bubble-cleaning steps, and 3) the need for complex mechanical systems to manipulate well plate position. To address these concerns, we developed a multiwell-format microfluidic platform that can deliver multiple distinct animal populations from on-chip wells using multiplexed valve control. This Population Delivery Chip could operate autonomously as part of a relatively simple setup that did not require any of the major mechanical moving parts typical of plate-handling systems to address a given well. We demonstrated automatic serial delivery of 16 distinct C. elegans worm populations to a single outlet without introducing any bubbles to the samples, causing cross-contamination, or damaging the animals. The device achieved delivery of more than 90% of the population preloaded into a given well in 4.7 seconds; an order of magnitude faster than delivery modalities in current use. This platform could potentially handle other similarly sized model organisms, such as zebrafish and drosophila larvae or cellular micro-colonies. The device's architecture and microchannel dimensions allow simple expansion for processing larger numbers of populations.	[Ghorashian, Navid; Goekce, Sertan Kutal; Guo, Sam Xun; Everett, William Neil; Ben-Yakar, Adela] Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Ben-Yakar, A (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	ben-yakar@mail.utexas.edu	Everett, William Neil/AAE-2101-2021	Ghorashian, Navid/0000-0002-5783-4933	National Institutes of Health [NIH R01 AG041135, NIH R21 NS067340, NIH R01 NS060129]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060129, R21NS067340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to thank the National Institutes of Health (www.nih.gov) for its generous support of this research. Specifically, the grants that made this work possible are the NIH Director's Transformative Award (NIH R01 AG041135), NIH R21 NS067340, and NIH R01 NS060129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Caceres ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035037; Carr JA, 2011, LAB CHIP, V11, P2385, DOI 10.1039/c1lc20170k; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Chung K, 2011, LAB CHIP, V11, P3689, DOI 10.1039/c1lc20400a; Chung K, 2009, LAB CHIP, V9, P2764, DOI 10.1039/b910703g; Crane MM, 2012, NAT METHODS, V9, P977, DOI [10.1038/NMETH.2141, 10.1038/nmeth.2141]; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Gilleland CL, 2010, NAT PROTOC, V5, P1888, DOI 10.1038/nprot.2010.143; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Guo SX, 2008, NAT METHODS, V5, P531, DOI 10.1038/NMETH.1203; Han M, 2010, DEV DYNAM, V239, P1263, DOI 10.1002/dvdy.22291; Hardy BS, 2009, LAB CHIP, V9, P935, DOI 10.1039/b813061b; Hua ZS, 2006, J MICROMECH MICROENG, V16, P1433, DOI 10.1088/0960-1317/16/8/001; Hulme SE, 2007, LAB CHIP, V7, P1515, DOI 10.1039/b707861g; Hulme SE, 2011, ANGEW CHEM INT EDIT, V50, P4774, DOI 10.1002/anie.201005461; Hulme SE, 2010, LAB CHIP, V10, P589, DOI 10.1039/b919265d; JOHNSON TE, 1982, P NATL ACAD SCI-BIOL, V79, P6603, DOI 10.1073/pnas.79.21.6603; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kim N, 2007, SENSOR ACTUAT B-CHEM, V122, P511, DOI 10.1016/j.snb.2006.06.026; Lockery SR, 2012, LAB CHIP, V12, P2211, DOI 10.1039/c2lc00001f; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Nguyen NT, 2002, FUNDAMENTALS APPL MI, P35; Pulak R, 2001, INT C EL M; Qin JH, 2007, LAB CHIP, V7, P186, DOI 10.1039/b613414a; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Samara C, 2010, P NATL ACAD SCI USA, V107, P18342, DOI 10.1073/pnas.1005372107; Singhal A, 2010, ANAL CHEM, V82, P8671, DOI 10.1021/ac101956e; Stirman JN, 2010, J NEUROSCI METH, V191, P90, DOI 10.1016/j.jneumeth.2010.05.019; Suiban B, 2012, J VIS EXP, V60; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wang JY, 2006, ANGEW CHEM INT EDIT, V45, P5276, DOI 10.1002/anie.200601677; Zeng F, 2008, LAB CHIP, V8, P653, DOI 10.1039/b804808h	35	14	14	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74480	10.1371/journal.pone.0074480	http://dx.doi.org/10.1371/journal.pone.0074480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069313	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300043
J	Shigematsu, M; Ogawa, T; Tanaka, W; Takahashi, K; Kitamoto, HK; Hidaka, M; Masaki, H				Shigematsu, Megumi; Ogawa, Tetsuhiro; Tanaka, Wataru; Takahashi, Kazutoshi; Kitamoto, Hiroko K.; Hidaka, Makoto; Masaki, Haruhiko			Evidence for DNA Cleavage Caused Directly by a transfer RNA-Targeting Toxin	PLOS ONE			English	Article							LACTIS GAMMA-TOXIN; KLUYVEROMYCES-LACTIS; KILLER TOXIN; SACCHAROMYCES-CEREVISIAE; PICHIA-ACACIAE; CYTOTOXIC RIBONUCLEASE; ANTICODON NUCLEASE; PHASE ARREST; YEAST; DAMAGE	The killer yeast species Pichia acaciae produces a heteromeric killer protein, PaT, that causes DNA damage and arrests the cell cycle of sensitive Saccharomyces cerevisiae in the S phase. However, the mechanism by which DNA damage occurs remains elusive. A previous study has indicated that Orf2p, a subunit of PaT, specifically cleaves an anticodon loop of an S. cerevisiae transfer RNA (tRNA(mcm5s2UUG)(Gln)). This finding raised a question about whether the DNA damage is a result of the tRNA cleavage or whether Orf2p directly associates with and cleaves the genomic DNA of sensitive yeast cells. We showed that Orf2p cleaves genomic DNA in addition to cleaving tRNA in vitro. This DNA cleavage requires the same Orf2p residue as that needed for tRNA cleavage, His299. The expression of Orf2p, in which His299 was substituted to alanine, abolished the cell cycle arrest of the host cell. Moreover, the translation impairment induced by tRNA cleavage enabled Orf2p to enter the nucleus, thereby inducing histone phosphorylation.	[Shigematsu, Megumi; Ogawa, Tetsuhiro; Tanaka, Wataru; Takahashi, Kazutoshi; Hidaka, Makoto; Masaki, Haruhiko] Univ Tokyo, Dept Biotechnol, Tokyo, Japan; [Kitamoto, Hiroko K.] Natl Inst Agroenvironm Sci, Ibaraki, Japan	University of Tokyo; National Institute for Agro-Environmental Sciences (NIAES) Japan	Ogawa, T (corresponding author), Univ Tokyo, Dept Biotechnol, Tokyo, Japan.	atetsu@mail.ecc.u-tokyo.ac.jp; amasaki@mail.ecc.u-tokyo.ac.jp	Ogawa, Tetsuhiro/AAO-2961-2021	Takahashi, Kazutoshi/0000-0003-3275-4109	Japan Society for the Promotion of Science [21658029]; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No.21658029, HM), and by Takeda Science Foundation to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUTLER AR, 1991, J GEN MICROBIOL, V137, P1749, DOI 10.1099/00221287-137-7-1749; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Jablonowski D, 2007, BIOCHEM SOC T, V35, P1533, DOI 10.1042/BST0351533; Jablonowski D, 2002, J BIOL CHEM, V277, P26276, DOI 10.1074/jbc.M203354200; Jones SJ, 1996, J MOL BIOL, V264, P1154, DOI 10.1006/jmbi.1996.0703; KAMIMURA K, 1981, CURR MICROBIOL, V6, P175, DOI 10.1007/BF01642394; Keppetipola N, 2009, RNA, V15, P1036, DOI 10.1261/rna.1637809; Klassen R, 2006, FEMS YEAST RES, V6, P404, DOI 10.1111/j.1567-1364.2005.00006.x; Klassen R, 2005, CELL MICROBIOL, V7, P393, DOI 10.1111/j.1462-5822.2004.00469.x; Klassen R, 2004, MOL MICROBIOL, V53, P263, DOI 10.1111/j.1365-2958.2004.04119.x; Klassen R, 2008, MOL MICROBIOL, V69, P681, DOI 10.1111/j.1365-2958.2008.06319.x; Klassen R, 2007, DNA REPAIR, V6, P1864, DOI 10.1016/j.dnarep.2007.07.010; Klassen R, 2011, MOL GENET GENOMICS, V285, P185, DOI 10.1007/s00438-010-0597-5; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; Meineke B, 2012, RNA, V18, P1716, DOI 10.1261/rna.034132.112; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Ogawa T, 1999, SCIENCE, V283, P2097, DOI 10.1126/science.283.5410.2097; Ogawa T, 2006, NUCLEIC ACIDS RES, V34, P6065, DOI 10.1093/nar/gkl629; PARKER MW, 1992, J MOL BIOL, V224, P639, DOI 10.1016/0022-2836(92)90550-4; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Shigematsu M, 2012, BIOCHEM BIOPH RES CO, V420, P750, DOI 10.1016/j.bbrc.2012.03.061; Shigematsu M, 2009, YEAST, V26, P663, DOI 10.1002/yea.1725; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; WILKINSON CRM, 1995, NUCLEIC ACIDS RES, V23, P203, DOI 10.1093/nar/23.2.203	26	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75512	10.1371/journal.pone.0075512	http://dx.doi.org/10.1371/journal.pone.0075512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069426	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300087
J	Altaner, C; Altanerova, V; Cihova, M; Hunakova, L; Kaiserova, K; Klepanec, A; Vulev, I; Madaric, J				Altaner, Cestmir; Altanerova, Veronika; Cihova, Marina; Hunakova, Lubica; Kaiserova, Katarina; Klepanec, Andrej; Vulev, Ivan; Madaric, Juraj			Characterization of Mesenchymal Stem Cells of "No-Options" Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells	PLOS ONE			English	Article							THERAPEUTIC ANGIOGENESIS; TRANSPLANTATION; TRIAL; EFFICACY; PLACEBO; SAFETY	Background: Application of autologous bone marrow mononuclear cells to "no option" patients with advanced critical limb ischemia (CLI) prevented major limb amputation in 73% patients during the 6-month follow-up. We examined which properties of bone marrow stromal cells also known as bone-marrow derived mesenchymal stem cells of responding and non-responding patients are important for amputation-free survival. Methods and Findings: Mesenchymal stem cells of 41 patients with CLI unsuitable for revascularisation were isolated from mononuclear bone marrow concentrate used for their treatment. Based on the clinical outcome of the treatment, we divided patients into two groups: responders and non-responders. Biological properties of responders' and non-responders' mesenchymal stem cells were characterized according to their ability to multiply, to differentiate in vitro, quantitative expression of cell surface markers, secretion of 27 cytokines, chemokines and growth factors, and to the relative expression of 15 mesenchymal stem cells important genes. Secretome comparison between responders (n=27) and non-responders (n=14) revealed significantly higher secretion values of IL-4, IL-6 and MIP-1b in the group of responders. The expression of cell markers CD44 and CD90 in mesenchymal stem cells from responders was significantly higher compared to non-responders (p< 0.01). The expression of mesenchymal stem cells surface markers that was analyzed in 22 patients did not differ between diabetic (n=13) and non-diabetic (n=9) patient groups. Statistically significant higher expression of E-cadherin and PDX-1/IPF1 genes was found in non-responders, while expression of Snail was higher in responders. Conclusions: The quality of mesenchymal stem cells shown in the expression of cell surface markers, secreted factors and stem cell genes plays an important role in therapeutic outcome. Paracrine mechanisms are main drivers in the induction of reparatory processes in CLI patients. Differences in mesenchymal stem cells properties are discussed in relation to their involvement in the reparatory process.	[Altaner, Cestmir; Altanerova, Veronika; Cihova, Marina; Hunakova, Lubica] Slovak Acad Sci, Canc Res Inst, Bratislava, Slovakia; [Altaner, Cestmir; Altanerova, Veronika; Kaiserova, Katarina] St Elisabeth Canc Inst, Bratislava, Slovakia; [Klepanec, Andrej; Vulev, Ivan; Madaric, Juraj] Natl Cardiovasc Inst, Bratislava, Slovakia; [Madaric, Juraj] Slovak Med Univ, Bratislava, Slovakia	Slovak Academy of Sciences; Slovak Medical University Bratislava	Altaner, C (corresponding author), Slovak Acad Sci, Canc Res Inst, Bratislava, Slovakia.	exonalt@savba.sk; madaricjuraj@gmail.com	Hunakova, Luba/E-4523-2015; Altaner, Cestmir/AGG-6981-2022; Klepanec, Andrej/AAD-7197-2020; Altaner, Cestmir/F-7057-2018	Altaner, Cestmir/0000-0001-6998-0885; Hunakova, Luba/0000-0003-2159-0807; Klepanec, Andrej/0000-0002-7460-2974; Madaric, Juraj/0000-0003-1326-2336	Slovak League against Cancer; VEGA - Grant Funding Agency of the Slovak Academy of Sciences [2/0177/11]; European Regional Development Funding (ITMS) [26240220023]	Slovak League against Cancer; VEGA - Grant Funding Agency of the Slovak Academy of Sciences; European Regional Development Funding (ITMS)	Laboratory part of the study was supported by grants from the Slovak League against Cancer, and VEGA - Grant Funding Agency of the Slovak Academy of Sciences (2/0177/11). Clinical study was sponsored by a grant from European Regional Development Funding (ITMS code: 26240220023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Altanerova V, 2012, INT J CANCER, V130, P2455, DOI 10.1002/ijc.26278; Amann B, 2009, CELL TRANSPLANT, V18, P371, DOI 10.3727/096368909788534942; Belch J, 2011, LANCET, V377, P1929, DOI 10.1016/S0140-6736(11)60394-2; Benoit E, 2013, CELL TRANSPLANT, V22, P545, DOI 10.3727/096368912X636777; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Cihova M, 2011, MOL PHARMACEUT, V8, P1480, DOI 10.1021/mp200151a; DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020; Idei N, 2011, CIRC-CARDIOVASC INTE, V4, P15, DOI 10.1161/CIRCINTERVENTIONS.110.955724; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kirana S, 2012, INT J CLIN PRACT, V66, P384, DOI 10.1111/j.1742-1241.2011.02886.x; Klepanec A, 2012, CELL TRANSPLANT, V21, P1909, DOI 10.3727/096368912X636948; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Kusumanto YH, 2006, HUM GENE THER, V17, P683, DOI 10.1089/hum.2006.17.683; Lara-Hernandez R, 2010, ANN VASC SURG, V24, P287, DOI 10.1016/j.avsg.2009.10.012; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee HC, 2012, CIRC J, V76, P1750, DOI 10.1253/circj.CJ-11-1135; Lu DB, 2011, DIABETES RES CLIN PR, V92, P26, DOI 10.1016/j.diabres.2010.12.010; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Otsuru S, 2012, BLOOD, V120, P1933, DOI 10.1182/blood-2011-12-400085; Schiavetta A, 2012, STEM CELL TRANSL MED, V1, P572, DOI 10.5966/sctm.2012-0021; Shen WC, 2013, STEM CELLS DEV, V22, P1408, DOI 10.1089/scd.2012.0445; Sprengers RW, 2010, J VASC SURG, V52, P843, DOI 10.1016/j.jvs.2010.04.057; Tang Y, 2012, LIFE SCI, V91, P951, DOI 10.1016/j.lfs.2012.09.005; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tongeren R, 2008, J CARDIOVASC SURG, V49, P51; Walter DH, 2011, CIRC-CARDIOVASC INTE, V4, P26, DOI 10.1161/CIRCINTERVENTIONS.110.958348	30	27	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73722	10.1371/journal.pone.0073722	http://dx.doi.org/10.1371/journal.pone.0073722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069226	Green Submitted, gold, Green Published			2022-12-27	WOS:000326240100057
J	Zang, XF; Zhou, Y; Huang, ZF; Zhang, CY				Zang, Xiaofang; Zhou, Yong; Huang, Zufa; Zhang, Chaoyue			Endothelin-1 Single Nucleotide Polymorphisms and Risk of Pulmonary Metastatic Osteosarcoma	PLOS ONE			English	Article							BLOOD-PRESSURE RESPONSES; GENETIC-VARIANTS; ASSOCIATION; SYSTEM	Pulmonary metastases are the major cause of death of osteosarcoma (OS) patients. Endothelin-1 (ET-1) reportedly plays an important role in OS metastasis. In the present study, we for the first time explored the association of ET-1 SNPs with the risk of pulmonary metastatic OS. We genotyped three SNPs (rs1800541, rs2070699 and rs5370) in the ET-1 gene in a case-control study, using 260 pairs of age-, sex-, residence area-and tumor location-matched subjects. Patients with pulmonary metastatic OS and patients with localized high-grade (stage IIB) OS were enrolled as cases and controls, respectively. The G allele at rs1800541 was found associated with reduced risk of pulmonary metastatic OS after adjustment for body mass index, systolic blood pressure, diastolic blood pressure and the plasma ET-1 level (P=10(-4); adjusted OR, 0.55; 95% CI, 0.42-0.70), while the G allele at rs2070699 was not significantly associated with the risk of pulmonary metastatic OS (P=0.15; adjusted OR, 1.15; 95% CI, 0.87-1.50). The mRNA and the secreted protein levels of ET-1 in primary OS cell cultures (POCCs) established from surgically resected primary OS in the rs1800541 TT homozygotes were higher than those from the TG heterozygotes (P<0.05), who in turn showed higher ET-1 mRNA and secreted ET-1 levels than the GG homozygotes (P<0.05). In the control subjects, the rs1800541 TT homozygotes showed an 18.4% relapse rate, significantly higher than that of the GG homozygotes (0%) (P<0.01). On the other hand, the GG homozygotes showed a 71.4% complete recovery rate, significantly higher than that of the TG heterozygotes (7.3%) and the TT homozygotes (0%) (P<0.01). This study provides the first evidence of an association between the ET-1 gene SNPs and the risk of pulmonary metastatic OS.	[Zang, Xiaofang; Zhou, Yong; Huang, Zufa; Zhang, Chaoyue] Cent S Univ, Xiangya Hosp 3, Dept Orthopaed, Changsha, Hunan, Peoples R China	Central South University	Huang, ZF (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Orthopaed, Changsha, Hunan, Peoples R China.	zcy1958@medmail.com.cn			Hunan Provincial Natural Science Foundation, Hunan, P.R. China [07B2697, 10C6833]	Hunan Provincial Natural Science Foundation, Hunan, P.R. China	This work was supported by Hunan Provincial Natural Science Foundation (grants #07B2697 and #10C6833), Hunan, P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba A. I., 2007, COMP ONCOLOGY, P119; Bacci G, 2003, ANN ONCOL, V14, P1126, DOI 10.1093/annonc/mdg286; Caronia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026091; Charu R, 2006, THORAX, V61, P1011, DOI 10.1136/thx.2006.066019; Felx M, 2006, CLIN SCI, V110, P645, DOI 10.1042/CS20050286; Gorlick R, 2003, CLIN CANCER RES, V9, P5442; Hu YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-169; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Li Y, 2012, MOL MED REP, V5, P1391, DOI 10.3892/mmr.2012.842; Munajat I, 2008, J Orthop Surg (Hong Kong), V16, P182; Muratli HH, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-49; Panoulas VF, 2008, ENDOTHELIUM-J ENDOTH, V15, P203, DOI 10.1080/10623320802228708; Rankinen T, 2007, HYPERTENSION, V50, P1120, DOI 10.1161/HYPERTENSIONAHA.107.093609; Ta H, 2009, CANCER METAST REV, V28, P247, DOI 10.1007/s10555-009-9186-7; Wittig JC, 2002, AM FAM PHYSICIAN, V65, P1123; Wolf RE, 1996, ORTHOP CLIN N AM, V27, P473; Zhao Q, 2010, AM J HYPERTENS, V23, P606, DOI 10.1038/ajh.2010.36; Zhao Q, 2010, J HYPERTENS, V28, P756, DOI 10.1097/HJH.0b013e3283370d32; Zhao YT, 2011, CLIN ORTHOP RELAT R, V469, P3190, DOI 10.1007/s11999-011-1939-2; Zhu G, 2008, GENES IMMUN, V9, P23, DOI 10.1038/sj.gene.6364441	20	12	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73349	10.1371/journal.pone.0073349	http://dx.doi.org/10.1371/journal.pone.0073349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069190	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100040
J	Sathitsuksanoh, N; Xu, B; Zhao, BY; Zhang, YHP				Sathitsuksanoh, Noppadon; Xu, Bin; Zhao, Bingyu; Zhang, Y-H. Percival			Overcoming Biomass Recalcitrance by Combining Genetically Modified Switchgrass and Cellulose Solvent-Based Lignocellulose Pretreatment	PLOS ONE			English	Article							DILUTE-ACID PRETREATMENT; FERMENTABLE SUGAR YIELDS; ENZYMATIC-HYDROLYSIS; LIGNIN; FRACTIONATION; SACCHARIFICATION; MANIPULATION; IMPROVEMENT; DEPOSITION	Decreasing lignin content of plant biomass by genetic engineering is believed to mitigate biomass recalcitrance and improve saccharification efficiency of plant biomass. In this study, we compared two different pretreatment methods (i.e., dilute acid and cellulose solvent) on transgenic plant biomass samples having different lignin contents and investigated biomass saccharification efficiency. Without pretreatment, no correlation was observed between lignin contents of plant biomass and saccharification efficiency. After dilute acid pretreatment, a strong negative correlation between lignin content of plant samples and overall glucose release was observed, wherein the highest overall enzymatic glucan digestibility was 70% for the low-lignin sample. After cellulose solvent- and organic solvent-based lignocellulose fractionation pretreatment, there was no strong correlation between lignin contents and high saccharification efficiencies obtained (i.e., 80-90%). These results suggest that the importance of decreasing lignin content in plant biomass to saccharification was largely dependent on pretreatment choice and conditions.	[Sathitsuksanoh, Noppadon; Zhang, Y-H. Percival] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA; [Xu, Bin; Zhao, Bingyu] Virginia Tech, Dept Hort, Blacksburg, VA USA; [Sathitsuksanoh, Noppadon; Zhang, Y-H. Percival] Virginia Tech, ICTAS, Blacksburg, VA USA; [Zhang, Y-H. Percival] DOE BioEnergy Sci Ctr BESC, Oak Ridge, TN USA; [Zhang, Y-H. Percival] Gate Fuels Inc, Blacksburg, VA USA; [Zhang, Y-H. Percival] Cell Free Bioinnovat Inc, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Sathitsuksanoh, N (corresponding author), Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA 24061 USA.	sathino@vt.edu	sathitsuksanoh, noppadon/O-6305-2014	sathitsuksanoh, noppadon/0000-0003-1521-9155	Institute of Critical Technology and Applied Sciences (ICTAS) of Virginia Tech; Biological Systems Engineering Department of Virginia Tech; Bioprocess and Biodesign Research Center of the Agricultural and Life Science College of Virginia Tech; U.S. Department of Energy [DE-FG02-08ER64629]	Institute of Critical Technology and Applied Sciences (ICTAS) of Virginia Tech; Biological Systems Engineering Department of Virginia Tech; Bioprocess and Biodesign Research Center of the Agricultural and Life Science College of Virginia Tech; U.S. Department of Energy(United States Department of Energy (DOE))	This project was partly supported by a grant from the Institute of Critical Technology and Applied Sciences (ICTAS) of Virginia Tech, the Biological Systems Engineering Department of Virginia Tech, the Bioprocess and Biodesign Research Center of the Agricultural and Life Science College of Virginia Tech, and the U.S. Department of Energy (under contract number DE-FG02-08ER64629). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes V, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-3; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Coleman HD, 2008, P NATL ACAD SCI USA, V105, P4501, DOI 10.1073/pnas.0706537105; DeMartini JD, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-52; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Guo DG, 2001, TRANSGENIC RES, V10, P457, DOI 10.1023/A:1012278106147; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Moxley G, 2007, ENERG FUEL, V21, P3684, DOI 10.1021/ef7003893; Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x; Rolando C., 1992, METHODS LIGNIN CHEM, P334, DOI DOI 10.1007/978-3-642-74065-7_23; Rollin JA, 2011, BIOTECHNOL BIOENG, V108, P22, DOI 10.1002/bit.22919; Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416; Saha BC, 2005, BIOTECHNOL PROGR, V21, P816, DOI 10.1021/bp049564n; Sathitsuksanoh N, 2013, J CHEM TECHNOL BIOT, V88, P169, DOI 10.1002/jctb.3959; Sathitsuksanoh N, 2012, BIORESOURCE TECHNOL, V117, P228, DOI 10.1016/j.biortech.2012.04.088; Sathitsuksanoh N, 2011, BIOTECHNOL BIOENG, V108, P521, DOI 10.1002/bit.22964; Selig MJ, 2007, BIOTECHNOL PROGR, V23, P1333, DOI 10.1021/bp0702018; Shi J, 2011, BIORESOURCE TECHNOL, V102, P8930, DOI 10.1016/j.biortech.2011.07.042; Shi J, 2011, BIORESOURCE TECHNOL, V102, P5952, DOI 10.1016/j.biortech.2011.03.027; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Sluiter A., 2008, NREL, P1; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Zhang YHP, 2011, PROCESS BIOCHEM, V46, P2091, DOI 10.1016/j.procbio.2011.08.005; Zhu ZG, 2009, BIOTECHNOL BIOENG, V103, P715, DOI 10.1002/bit.22307	26	19	19	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73523	10.1371/journal.pone.0073523	http://dx.doi.org/10.1371/journal.pone.0073523			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086283	Green Published, gold			2022-12-27	WOS:000325223900015
J	Gallagher, N; Fear, EC; Byrd, IA; Vigmond, EJ				Gallagher, Neal; Fear, Elise C.; Byrd, Israel A.; Vigmond, Edward J.			Contact Geometry Affects Lesion Formation in Radio-Frequency Cardiac Catheter Ablation	PLOS ONE			English	Article							THERMAL-CONDUCTIVITY; ATRIAL-FIBRILLATION; TISSUE TEMPERATURE; ELECTRODE; BIOMATERIALS; DIFFUSIVITY; IMPEDANCE; DENSITY; MUSCLE; MODEL	One factor which may be important for determining proper lesion creation during atrial ablation is catheter-endocardial contact. Little information is available that relates geometric contact, depth and angle, to ablation lesion formation. We present an electrothermal computer model of ablation that calculated lesion volume and temperature development over time. The Pennes bioheat equation was coupled to a quasistatic electrical problem to investigate the effect of catheter penetration depth, as well as incident catheter angle as may occur in practice. Biological experiments were performed to verify the modelling of electrical phenomena. Results show that for deeply penetrating tips, acute catheter angles reduced the rate of temperature buildup, allowing larger lesions to form before temperatures elevated excessively. It was also found that greater penetration did not lead to greater transmurality of lesions. We conclude that catheter contact angle plays a significant role in lesion formation, and the time course must be considered. This is clinically relevant because proper identification and prediction of geometric contact variables could improve ablation efficacy.	[Gallagher, Neal; Fear, Elise C.; Vigmond, Edward J.] Univ Calgary, Dept Elect & Comp Engn, Calgary, AB, Canada; [Byrd, Israel A.] St Jude Med, Atrial Fibrillat Technol Dev, St Paul, MN USA; [Vigmond, Edward J.] Univ Bordeaux 1, Lab Inst Modelisat, LIRYC Electrophysiol & Heart Modeling Inst, Pessac, France	University of Calgary; St. Jude Medical; UDICE-French Research Universities; Universite de Bordeaux	Vigmond, EJ (corresponding author), Univ Calgary, Dept Elect & Comp Engn, Calgary, AB, Canada.	edward.vigmond@u-bordeaux1.fr		Fear, Elise/0000-0002-9984-8188	Natural Sciences and Engineering Research Councils of Canada; French Government through the Agence National de la Recherche programme A"Investissements d'AvenirA [ANR-10-IAHU-04]	Natural Sciences and Engineering Research Councils of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); French Government through the Agence National de la Recherche programme A"Investissements d'AvenirA(French National Research Agency (ANR))	This research was partly supported by a grant from the Natural Sciences and Engineering Research Councils of Canada (http://www.nserc-crsng.gc.ca/), and the French Government through the Agence National de la Recherche (http://www.agence-nationale-recherche.fr/) programme A "Investissements d'AvenirA with grant ANR-10-IAHU-04. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, J BIOMECH ENG T ASME, DOI DOI 10.1115/1.3426282; Berjano EJ, 2004, IEEE T BIO-MED ENG, V51, P1348, DOI 10.1109/TBME.2004.827545; Berjano EJ, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-24; Bruce GK, 2005, CIRCULATION, V112, P954, DOI 10.1161/CIRCULATIONAHA.104.492439; Calkins H, 2007, EUROPACE, V9, P335, DOI 10.1093/europace/eum120; Cao H, 2002, IEEE T BIO-MED ENG, V49, P247, DOI 10.1109/10.983459; CHURCHILL SW, 1977, J HEAT TRANS-T ASME, V99, P300, DOI 10.1115/1.3450685; COOPER TE, 1971, AEROSPACE MED, V42, P24; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; Gaita F, 2010, CIRCULATION, V122, P1667, DOI 10.1161/CIRCULATIONAHA.110.937953; Gallagher N, 2011, INT J BIOELECTROMAGN, V13, P190; Gopalakrishnan J, 2002, ANN BIOMED ENG, V30, P884, DOI 10.1114/1.1507845; HAINES DE, 1990, CIRC RES, V67, P124, DOI 10.1161/01.RES.67.1.124; HINGHOFERSZALKAY H, 1987, J APPL PHYSIOL, V63, P1003, DOI 10.1152/jappl.1987.63.3.1003; Ho SY, 1999, J CARDIOVASC ELECTR, V10, P1525; Houben RPM, 2004, HEART RHYTHM, V1, P639, DOI 10.1016/j.hrthm.2004.08.015; Kongsgaard E, 1997, PACE, V20, P1252, DOI 10.1111/j.1540-8159.1997.tb06778.x; MENDLOWITZ M, 1948, SCIENCE, V107, P97, DOI 10.1126/science.107.2769.97; NAKAGAWA H, 1995, CIRCULATION, V91, P2264, DOI 10.1161/01.CIR.91.8.2264; NATH S, 1993, CIRCULATION, V88, P1826, DOI 10.1161/01.CIR.88.4.1826; PANESCU D, 1995, IEEE T BIO-MED ENG, V42, P879, DOI 10.1109/10.412649; Peyman A, 2007, BIOELECTROMAGNETICS, V28, P264, DOI 10.1002/bem.20271; Schutt D, 2009, INT J HYPERTHER, V25, P99, DOI 10.1080/02656730802563051; SHAHIDI AV, 1994, IEEE T BIO-MED ENG, V41, P963, DOI 10.1109/10.324528; Suarez Ana Gonzalez, 2010, Open Biomed Eng J, V4, P47, DOI 10.2174/1874120701004020047; Tangwongsan C, 2004, IEEE T BIO-MED ENG, V51, P1478, DOI 10.1109/TBME.2004.828035; Tungjitkusolmun S, 2001, IEEE T BIO-MED ENG, V48, P194, DOI 10.1109/10.909640; VALVANO JW, 1985, INT J THERMOPHYS, V6, P301, DOI 10.1007/BF00522151; Wittkampf FHM, 2006, PACE, V29, P1285, DOI 10.1111/j.1540-8159.2006.00533.x; Wood MA, 2009, J CARDIOVASC ELECTR, V20, P1262, DOI 10.1111/j.1540-8167.2009.01538.x; YIPINTSOI T, 1972, P SOC EXP BIOL MED, V141, P1032; Zheng XS, 2000, J INTERV CARD ELECTR, V4, P645, DOI 10.1023/A:1026586119600	32	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73242	10.1371/journal.pone.0073242	http://dx.doi.org/10.1371/journal.pone.0073242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086275	gold, Green Published			2022-12-27	WOS:000326520200008
J	Minati, L; Sigala, N				Minati, Ludovico; Sigala, Natasha			Effective Connectivity Reveals Strategy Differences in an Expert Calculator	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; TERM WORKING-MEMORY; PROGRESSIVE MATRICES; CALENDAR CALCULATION; CALENDRICAL SAVANTS; EPISODIC RETRIEVAL; MENTAL CALCULATION; PARIETAL CORTEX; FUNCTIONAL MRI; ACTIVATION	Mathematical reasoning is a core component of cognition and the study of experts defines the upper limits of human cognitive abilities, which is why we are fascinated by peak performers, such as chess masters and mental calculators. Here, we investigated the neural bases of calendrical skills, i.e. the ability to rapidly identify the weekday of a particular date, in a gifted mental calculator who does not fall in the autistic spectrum, using functional MRI. Graph-based mapping of effective connectivity, but not univariate analysis, revealed distinct anatomical location of "cortical hubs" supporting the processing of well-practiced close dates and less-practiced remote dates: the former engaged predominantly occipital and medial temporal areas, whereas the latter were associated mainly with prefrontal, orbitofrontal and anterior cingulate connectivity. These results point to the effect of extensive practice on the development of expertise and long term working memory, and demonstrate the role of frontal networks in supporting performance on less practiced calculations, which incur additional processing demands. Through the example of calendrical skills, our results demonstrate that the ability to perform complex calculations is initially supported by extensive attentional and strategic resources, which, as expertise develops, are gradually replaced by access to long term working memory for familiar material.	[Minati, Ludovico; Sigala, Natasha] Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9RH, E Sussex, England; [Minati, Ludovico] Fdn IRCCS Ist Neurol Carlo Besta, Dept Sci, Milan, Italy; [Sigala, Natasha] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton BN1 9RH, E Sussex, England	University of Brighton; University of Sussex; IRCCS Istituto Neurologico Besta; Italfarmaco; University of Sussex	Sigala, N (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 9RH, E Sussex, England.	N.Sigala@sussex.ac.uk	Sigala, Natasha/K-1750-2013; Minati, Ludovico/R-1076-2017; Sigala, Natasha/ABH-3181-2020	Sigala, Natasha/0000-0002-9456-6093; Minati, Ludovico/0000-0002-2532-1674; Sigala, Natasha/0000-0002-9456-6093	Brighton and Sussex Medical School	Brighton and Sussex Medical School	This work was supported by Brighton and Sussex Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bilalic M, 2009, COGNITIVE SCI, V33, P1117, DOI 10.1111/j.1551-6709.2009.01030.x; Boddaert N, 2005, BRIT J PSYCHIAT, V187, P83, DOI 10.1192/bjp.187.1.83; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bor D, 2007, CEREB CORTEX, V17, P778, DOI 10.1093/cercor/bhk035; Bor D, 2007, CURR BIOL, V17, pR95, DOI 10.1016/j.cub.2007.01.019; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; BURBAUD P, 1995, J NEUROPHYSIOL, V74, P2194, DOI 10.1152/jn.1995.74.5.2194; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Butterworth B, 2001, NAT NEUROSCI, V4, P11, DOI 10.1038/82841; Butterworth B, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P553; Campitelli G, 2007, INT J NEUROSCI, V117, P1641, DOI 10.1080/00207450601041955; Campitelli G, 2011, CURR DIR PSYCHOL SCI, V20, P280, DOI 10.1177/0963721411421922; Coricelli G, 2009, P NATL ACAD SCI USA, V106, P9163, DOI 10.1073/pnas.0807721106; Cowan R, 2006, COGNITION, V100, pB1, DOI 10.1016/j.cognition.2005.08.001; Cowan R, 2009, PHILOS T R SOC B, V364, P1417, DOI 10.1098/rstb.2008.0323; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; DORMAN C, 1991, BRAIN COGNITION, V15, P26, DOI 10.1016/0278-2626(91)90013-X; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; ERICSSON KA, 1980, SCIENCE, V208, P1181, DOI 10.1126/science.7375930; Fehr T, 2011, NEUROCASE, V17, P360, DOI 10.1080/13554794.2010.532135; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Galton F., 1908, MEMORIES MY LIFE; Gobet F, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P523; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Guida A, 2012, BRAIN COGNITION, V79, P221, DOI 10.1016/j.bandc.2012.01.010; Hambrick DZ, 2011, CURR DIR PSYCHOL SCI, V20, P275, DOI 10.1177/0963721411422061; Heavey L, 2012, DEV MED CHILD NEUROL, V54, P507, DOI 10.1111/j.1469-8749.2012.04250.x; Hermelin B., 2001, BRIGHT SPLINTERS MIN; Hon N, 2009, NEUROPSYCHOLOGIA, V47, P1721, DOI 10.1016/j.neuropsychologia.2009.02.011; HUNTER IML, 1962, BRIT J PSYCHOL, V53, P243, DOI 10.1111/j.2044-8295.1962.tb00831.x; HUNTER IML, 1977, BRIT J PSYCHOL, V68, P155, DOI 10.1111/j.2044-8295.1977.tb01571.x; Kalbfleisch M Layne, 2004, Anat Rec B New Anat, V277, P21, DOI 10.1002/ar.b.20010; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; LeFevre JA, 1996, J EXP PSYCHOL GEN, V125, P284, DOI 10.1037/0096-3445.125.3.284; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Machielsen WCM, 2000, HUM BRAIN MAPP, V9, P156, DOI 10.1002/(SICI)1097-0193(200003)9:3<156::AID-HBM4>3.0.CO;2-Q; McIntosh AR, 1998, ANN NY ACAD SCI, V855, P556, DOI 10.1111/j.1749-6632.1998.tb10625.x; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Miller LK, 1999, PSYCHOL BULL, V125, P31, DOI 10.1037/0033-2909.125.1.31; Minati L, 2012, NEUROIMAGE, V60, P2191, DOI 10.1016/j.neuroimage.2012.02.048; Nigri A, 2013, NEUROREPORT, V24, P171, DOI 10.1097/WNR.0b013e32835d5d2b; OCONNOR N, 1984, PSYCHOL MED, V14, P801, DOI 10.1017/S0033291700019772; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Pesenti M, 2001, NAT NEUROSCI, V4, P103, DOI 10.1038/82831; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Raven JC, 1941, BRIT J MED PSYCHOL, V19, P137, DOI 10.1111/j.2044-8341.1941.tb00316.x; Rosenberg-Lee M, 2011, NEUROPSYCHOLOGIA, V49, P2592, DOI 10.1016/j.neuropsychologia.2011.04.035; Rosenberg-Lee M, 2009, COGN AFFECT BEHAV NE, V9, P270, DOI 10.3758/CABN.9.3.270; SIEGLER RS, 1987, J EXP PSYCHOL GEN, V116, P250, DOI DOI 10.1037/0096-3445.116.3.250; Staszewski J., 1988, NATURE EXPERTISE, P71; Treffert DA, 2009, PHILOS T R SOC B, V364, P1351, DOI 10.1098/rstb.2008.0326; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Viera Y, 2012, BASIC COURSE MENTAL; Ward J, 2013, ANNU REV PSYCHOL, V64, P49, DOI 10.1146/annurev-psych-113011-143840; Zago L, 2008, NEUROPSYCHOLOGIA, V46, P2403, DOI 10.1016/j.neuropsychologia.2008.03.001	61	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73746	10.1371/journal.pone.0073746	http://dx.doi.org/10.1371/journal.pone.0073746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	246EK	24086291	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326520200012
J	te Pas, MFW; Koopmans, SJ; Kruijt, L; Calus, MPL; Smits, MA				te Pas, Marinus F. W.; Koopmans, Sietse-Jan; Kruijt, Leo; Calus, Mario P. L.; Smits, Mari A.			Plasma Proteome Profiles Associated with Diet-Induced Metabolic Syndrome and the Early Onset of Metabolic Syndrome in a Pig Model	PLOS ONE			English	Article							EARLY ATHEROSCLEROSIS; BIOMARKER DISCOVERY; GENE-EXPRESSION; STREPTOZOTOCIN; FAT; DYSFUNCTION; OBESITY; LEPTIN; SENSOR	Obesity and related diabetes are important health threatening multifactorial metabolic diseases and it has been suggested that 25% of all diabetic patients are unaware of their patho-physiological condition. Biomarkers for monitoring and control are available, but early stage predictive biomarkers enabling prevention of these diseases are still lacking. We used the pig as a model to study metabolic disease because humans and pigs share a multitude of metabolic similarities. Diabetes was chemically induced and control and diabetic pigs were either fed a high unsaturated fat (Mediterranean) diet or a high saturated fat/cholesterol/sugar (cafeteria) diet. Physiological parameters related to fat metabolism and diabetes were measured. Diabetic pigs' plasma proteome profiles differed more between the two diets than control pigs plasma proteome profiles. The expression levels of several proteins correlated well with (patho) physiological parameters related to the fat metabolism (cholesterol, VLDL, LDL, NEFA) and diabetes (Glucose) and to the diet fed to the animals. Studying only the control pigs as a model for metabolic syndrome when fed the two diets showed correlations to the same parameters but now more focused on insulin, glucose and abdominal fat depot parameters. We conclude that proteomic profiles can be used as a biomarker to identify pigs with developing metabolic syndrome (prediabetes) and diabetes when fed a cafeteria diet. It could be developed into a potential biomarkers for the early recognition of metabolic diseases.	[te Pas, Marinus F. W.; Kruijt, Leo; Calus, Mario P. L.; Smits, Mari A.] Wageningen UR Livestock Res, ABGC, Lelystad, Netherlands; [Koopmans, Sietse-Jan] Wageningen Univ, Adaptat Physiol Grp, Dept Anim Sci, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	te Pas, MFW (corresponding author), Wageningen UR Livestock Res, ABGC, Lelystad, Netherlands.	marinus.tepas@wur.nl	smits, mari/J-4892-2013; Calus, Mario/H-7627-2019	smits, mari/0000-0002-3493-291X; Calus, Mario/0000-0002-3213-704X	Dutch ministry ELI [KB 15-011-003-ASG-V-1]	Dutch ministry ELI	The proteomics work has been funded by a grant from the Dutch ministry EL&I, grant no. KB 15-011-003-ASG-V-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell LN, 2010, AM J PHYSIOL-GASTR L, V298, pG746, DOI 10.1152/ajpgi.00485.2009; Doherty MK, 2008, PROTEOM CLIN APPL, V2, P135, DOI 10.1002/prca.200780085; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koopmans SJ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-64; Koopmans SJ, 2006, METABOLISM, V55, P960, DOI 10.1016/j.metabol.2006.03.004; Kussmann M, 2006, J BIOTECHNOL, V124, P758, DOI 10.1016/j.jbiotec.2006.02.014; Lam QLK, 2007, CELL MOL IMMUNOL, V4, P1; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Mach N, 2010, J ANIM SCI, V88, P1522, DOI 10.2527/jas.2009-2256; MANSFORD KR, 1968, LANCET, V1, P670; Merks JWM., 2000, CHALLENGE GENETIC CH, V27, P8, DOI 10.1017/S1463981500040498; Moore RE, 2007, BIOMARK INSIGHTS, V2, P185; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Rao PV, 2009, J PROTEOME RES, V8, P239, DOI 10.1021/pr8003776; RERUP C C, 1970, Pharmacological Reviews, V22, P485; ROSSINI AA, 1977, P NATL ACAD SCI USA, V74, P2485, DOI 10.1073/pnas.74.6.2485; Sundsten T, 2009, MOL CELL ENDOCRINOL, V297, P93, DOI 10.1016/j.mce.2008.06.018; Szkudelski T, 2001, PHYSIOL RES, V50, P537; van den Heuvel M, 2012, AM J PHYSIOL-HEART C, V302, pH85, DOI 10.1152/ajpheart.00311.2011; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Zhang YY, 2002, AM J PHYSIOL-REG I, V282, pR226, DOI 10.1152/ajpregu.00392.2001	26	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e73087	10.1371/journal.pone.0073087	http://dx.doi.org/10.1371/journal.pone.0073087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086269	gold, Green Published, Green Submitted			2022-12-27	WOS:000326520200006
J	Andrew, DW; Cochrane, M; Schripsema, JH; Ramsey, KH; Dando, SJ; O'Meara, CP; Timms, P; Beagley, KW				Andrew, Dean W.; Cochrane, Melanie; Schripsema, Justin H.; Ramsey, Kyle H.; Dando, Samantha J.; O'Meara, Connor P.; Timms, Peter; Beagley, Kenneth W.			The Duration of Chlamydia muridarum Genital Tract Infection and Associated Chronic Pathological Changes Are Reduced in IL-17 Knockout Mice but Protection Is Not Increased Further by Immunization	PLOS ONE			English	Article							CHRONIC DISEASE MANIFESTATIONS; MOUSE PNEUMONITIS BIOVAR; T-CELL; HOST-DEFENSE; MATRIX METALLOPROTEINASES; TRACHOMATIS INFECTION; TRANSCUTANEOUS IMMUNIZATION; UROGENITAL INFECTION; ACQUIRED-IMMUNITY; FEMALE MICE	IL-17 is believed to be important for protection against extracellular pathogens, where clearance is dependent on neutrophil recruitment and local activation of epithelial cell defences. However, the role of IL-17 in protection against intracellular pathogens such as Chlamydia is less clear. We have compared (i) the course of natural genital tract C. muridarum infection, (ii) the development of oviduct pathology and (iii) the development of vaccine-induced immunity against infection in wild type (WT) BALB/c and IL-17 knockout mice (IL-17-/-) to determine if IL-17-mediated immunity is implicated in the development of infection-induced pathology and/or protection. Both the magnitude and duration of genital infection was significantly reduced in IL-17-/- mice compared to BALB/c. Similarly, hydrosalpinx was also greatly reduced in IL-17-/- mice and this correlated with reduced neutrophil and macrophage infiltration of oviduct tissues. Matrix metalloproteinase (MMP) 9 and MMP2 were increased in WT oviducts compared to IL-17-/- animals at day 7 post-infection. In contrast, oviducts from IL-17-/- mice contained higher MMP9 and MMP2 at day 21. Infection also elicited higher levels of Chlamydia-neutralizing antibody in serum of IL-17-/- mice than WT mice. Following intranasal immunization with C. muridarum Major Outer Membrane Protein (MOMP) and cholera toxin plus CpG adjuvants, significantly higher levels of chlamydial MOMP-specific IgG and IgA were found in serum and vaginal washes of IL-17-/- mice. T cell proliferation and IFN gamma production by splenocytes was greater in WT animals following in vitro re-stimulation, however vaccination was only effective at reducing infection in WT, not IL-17-/- mice. Intranasal or transcutaneous immunization protected WT but not IL-17-/- mice against hydrosalpinx development. Our data show that in the absence of IL-17, the severity of C. muridarum genital infection and associated oviduct pathology are significantly attenuated, however neither infection or pathology can be reduced further by vaccination protocols that effectively protect WT mice.	[Andrew, Dean W.; Cochrane, Melanie; Dando, Samantha J.; O'Meara, Connor P.; Timms, Peter; Beagley, Kenneth W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Schripsema, Justin H.; Ramsey, Kyle H.] Midwestern Univ, Chicago Coll Osteopath Med, Dept Microbiol & Immunol, Downers Grove, IL 60515 USA	Queensland University of Technology (QUT); Midwestern University; Midwestern University - Chicago College of Osteopathic Medicine	Beagley, KW (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia.	k2.beagley@qut.edu.au	Beagley, Kenneth/J-1129-2012	Beagley, Kenneth/0000-0003-3112-6557; Timms, Peter/0000-0002-1682-0025; O'Meara, Connor/0000-0002-2007-8126; Dando, Samantha/0000-0002-5119-1711	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The project was supported by a grant from the National Health and Medical Research Council (PT and KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew DW, 2011, J REPROD IMMUNOL, V91, P9, DOI 10.1016/j.jri.2011.06.100; Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Beagley KW, 2009, MUCOSAL IMMUNOL, V2, P278, DOI 10.1038/mi.2009.11; Beagley KW, 2000, J REPROD IMMUNOL, V48, P47, DOI 10.1016/S0165-0378(00)00069-3; Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Benagiano M, 2012, P NATL ACAD SCI USA, V109, P1222, DOI 10.1073/pnas.1111833109; Berry LJ, 2004, INFECT IMMUN, V72, P1019, DOI 10.1128/IAI.72.2.1019-1028.2004; Carey A, 2011, VACCINE, V29, P6505, DOI 10.1016/j.vaccine.2011.07.012; Carey AJ, 2009, IMMUNOL CELL BIOL, V87, P337, DOI 10.1038/icb.2009.3; Chen Z, 2008, CYTOKINE, V41, P71, DOI 10.1016/j.cyto.2007.09.009; Cochrane M, 2010, FUTURE MICROBIOL, V5, P1833, DOI [10.2217/fmb.10.148, 10.2217/FMB.10.148]; Cunningham KA, 2009, J REPROD IMMUNOL, V81, P34, DOI 10.1016/j.jri.2009.04.002; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Fazio G, 2009, WORLD J CARDIOL, V1, P31, DOI 10.4330/wjc.v1.i1.31; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Fling SP, 2001, P NATL ACAD SCI USA, V98, P1160, DOI 10.1073/pnas.98.3.1160; Frazer LC, 2011, INFECT IMMUN, V79, P4029, DOI 10.1128/IAI.05535-11; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gopal R, 2012, EUR J IMMUNOL, V42, P364, DOI 10.1002/eji.201141569; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Haudenschild D, 2002, J BIOL CHEM, V277, P4309, DOI 10.1074/jbc.M109372200; Hickey DK, 2009, VACCINE, V27, P6983, DOI 10.1016/j.vaccine.2009.09.078; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hvid M, 2007, CELL MICROBIOL, V9, P2795, DOI 10.1111/j.1462-5822.2007.00996.x; Imtiaz MT, 2007, MICROBES INFECT, V9, P1561, DOI 10.1016/j.micinf.2007.08.010; Imtiaz MT, 2006, INFECT IMMUN, V74, P5513, DOI 10.1128/IAI.00730-06; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jiang XZ, 2010, IMMUNOLOGY, V129, P556, DOI 10.1111/j.1365-2567.2009.03157.x; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Koenders MI, 2011, ARTHRITIS RHEUM-US, V63, P2329, DOI 10.1002/art.30418; Kohyama S, 2007, J IMMUNOL, V179, P3917, DOI 10.4049/jimmunol.179.6.3917; Lampe MF, 1998, INFECT IMMUN, V66, P5457, DOI 10.1128/IAI.66.11.5457-5461.1998; Lee HY, 2010, FEMS IMMUNOL MED MIC, V59, P108, DOI 10.1111/j.1574-695X.2010.00668.x; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Lu CX, 2012, VACCINE, V30, P475, DOI 10.1016/j.vaccine.2011.10.059; Marwaha AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00129; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; PAL S, 1994, INFECT IMMUN, V62, P3354, DOI 10.1128/IAI.62.8.3354-3362.1994; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Prantner D, 2009, INFECT IMMUN, V77, P5334, DOI 10.1128/IAI.00883-09; Prause O, 2004, THORAX, V59, P313, DOI 10.1136/thx.2003.008854; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Ramsey KH, 2005, INFECT IMMUN, V73, P6962, DOI 10.1128/IAI.73.10.6962-6973.2005; Rudner XL, 2007, INFECT IMMUN, V75, P3055, DOI 10.1128/IAI.01329-06; Rupp J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006020; Sadik CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026342; Schulte S, 2008, AM J PATHOL, V172, P1500, DOI 10.2353/ajpath.2008.070776; Scurlock AM, 2011, INFECT IMMUN, V79, P1349, DOI 10.1128/IAI.00984-10; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Skelding KA, 2006, VACCINE, V24, P355, DOI 10.1016/j.vaccine.2005.07.104; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; van Zandbergen G, 2004, J IMMUNOL, V172, P1768, DOI 10.4049/jimmunol.172.3.1768; Yu H, 2010, INFECT IMMUN, V78, P2272, DOI 10.1128/IAI.01374-09; Zhang QZ, 2013, CLIN CANCER RES, V19, P3176, DOI 10.1158/1078-0432.CCR-13-0042; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zygmunt BM, 2009, J IMMUNOL, V183, P6933, DOI 10.4049/jimmunol.0901144	73	56	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76664	10.1371/journal.pone.0076664	http://dx.doi.org/10.1371/journal.pone.0076664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073293	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000103
J	Gaiottino, J; Norgren, N; Dobson, R; Topping, J; Nissim, A; Malaspina, A; Bestwick, JP; Monsch, AU; Regeniter, A; Lindberg, RL; Kappos, L; Leppert, D; Petzold, A; Giovannoni, G; Kuhle, J				Gaiottino, Johanna; Norgren, Niklas; Dobson, Ruth; Topping, Joanne; Nissim, Ahuva; Malaspina, Andrea; Bestwick, Jonathan P.; Monsch, Andreas U.; Regeniter, Axel; Lindberg, Raija L.; Kappos, Ludwig; Leppert, David; Petzold, Axel; Giovannoni, Gavin; Kuhle, Jens			Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBROSPINAL-FLUID NEUROFILAMENT; AXONAL DAMAGE MARKERS; SUBUNIT PNF-H; HEAVY-CHAIN; NF-H; CSF; PROTEIN; BIOMARKERS; DIAGNOSIS	Objective: Neuronal damage is the morphological substrate of persisting neurological disability. Neurofilaments (Nf) are cytoskeletal proteins of neurons and their release into cerebrospinal fluid has shown encouraging results as a biomarker for neurodegeneration. This study aimed to validate the quantification of the Nf light chain (NfL) in blood samples, as a biofluid source easily accessible for longitudinal studies. Methods: We developed and applied a highly sensitive electrochemiluminescence (ECL) based immunoassay for quantification of NfL in blood and CSF. Results: Patients with Alzheimer's disease (AD) (30.8 pg/ml, n=20), Guillain-Barre-syndrome (GBS) (79.4 pg/ml, n=19) or amyotrophic lateral sclerosis (ALS) (95.4 pg/ml, n=46) had higher serum NfL values than a control group of neurological patients without evidence of structural CNS damage (control patients, CP) (4.4 pg/ml, n=68, p<0.0001 for each comparison, p=0.002 for AD patients) and healthy controls (HC) (3.3 pg/ml, n=67, p<0.0001). Similar differences were seen in corresponding CSF samples. CSF and serum levels correlated in AD (r=0.48, p=0.033), GBS (r=0.79, p<0.0001) and ALS (r=0.70, p<0.0001), but not in CP (r=0.11, p=0.3739). The sensitivity and specificity of serum NfL for separating ALS from healthy controls was 91.3% and 91.0%. Conclusions: We developed and validated a novel ECL based sandwich immunoassay for the NfL protein in serum (NfL(Umea47:3)); levels in ALS were more than 20-fold higher than in controls. Our data supports further longitudinal studies of serum NfL in neurodegenerative diseases as a potential biomarker of on-going disease progression, and as a potential surrogate to quantify effects of neuroprotective drugs in clinical trials.	[Gaiottino, Johanna; Dobson, Ruth; Topping, Joanne; Malaspina, Andrea; Giovannoni, Gavin; Kuhle, Jens] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Gaiottino, Johanna; Nissim, Ahuva; Kuhle, Jens] Queen Mary Univ London, John Vane Sci Ctr, Bone & Joint Res Unit, London, England; [Norgren, Niklas] UmanDiagnostics, Umea, Sweden; [Malaspina, Andrea] North East London & Essex Reg MND Care Ctr, London, England; [Bestwick, Jonathan P.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England; [Monsch, Andreas U.] Univ Basel Hosp, Dept Geriatr, Memory Clin, CH-4031 Basel, Switzerland; [Regeniter, Axel] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Lindberg, Raija L.; Kappos, Ludwig; Leppert, David; Kuhle, Jens] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Petzold, Axel] UCL Inst Neurol, Dept Neuroinflammat, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Basel; University of Basel; University of Basel; University of London; University College London	Kuhle, J (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England.	j.kuhle@qmul.ac.uk	Kuhle, Jens/AGE-3474-2022; Petzold, Axel/C-1090-2009; Monsch, Andreas U/C-8309-2019; Monsch, Andreas/HGU-8171-2022	Petzold, Axel/0000-0002-0344-9749; Monsch, Andreas U/0000-0003-1692-1560; 	ECTRIMS Research Fellowship Programme; "Forschungsfonds" of the University of Basel, Switzerland; ABN/MS Society of Great Britain Clinical Research Fellowship	ECTRIMS Research Fellowship Programme; "Forschungsfonds" of the University of Basel, Switzerland; ABN/MS Society of Great Britain Clinical Research Fellowship	J. Kuhle's work is supported by an ECTRIMS Research Fellowship Programme and by the "Forschungsfonds" of the University of Basel, Switzerland. R. Dobson is funded by an ABN/MS Society of Great Britain Clinical Research Fellowship.	Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; Boylan KB, 2013, J NEUROL NEUROSUR PS, V84, P467, DOI 10.1136/jnnp-2012-303768; Brettschneider J, 2006, MULT SCLER J, V12, P143, DOI 10.1191/135248506ms1263oa; Brettschneider J, 2006, NEUROLOGY, V66, P852, DOI 10.1212/01.wnl.0000203120.85850.54; Brettschneider J, 2006, DEMENT GERIATR COGN, V21, P291, DOI 10.1159/000091436; Deisenhammer F, 2009, EUR J NEUROL, V16, P760, DOI 10.1111/j.1468-1331.2009.02595.x; Dujmovic I, 2013, MUSCLE NERVE, V48, P132, DOI 10.1002/mus.23752; Ganesalingam J, 2011, J NEUROCHEM, V117, P528, DOI 10.1111/j.1471-4159.2011.07224.x; Giovannoni G, 2010, MULT SCLER J, V16, P285, DOI 10.1177/1352458510361358; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; KHALIL M, 2012, MULT SCLER, V19, P58010; Kuhle J, 2011, NEUROLOGY, V76, P1206, DOI 10.1212/WNL.0b013e31821432ff; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Kuhle J, 2010, J NEUROIMMUNOL, V220, P114, DOI 10.1016/j.jneuroim.2010.01.004; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Lu CH, 2011, J NEUROSCI METH, V195, P143, DOI 10.1016/j.jneumeth.2010.11.026; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Norgren N, 2005, BRAIN RES BULL, V67, P264, DOI 10.1016/j.brainresbull.2005.06.031; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Norgren N, 2002, HYBRIDOMA HYBRIDOM, V21, P53, DOI 10.1089/15368590252917647; Otto M, 2012, AMYOTROPH LATERAL SC, V13, P1, DOI 10.3109/17482968.2011.627589; Petzold A, 2007, NEURODEGENER DIS, V4, P185, DOI 10.1159/000101843; Petzold A, 2006, NEUROLOGY, V67, P1071, DOI 10.1212/01.wnl.0000237334.69665.92; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2004, J NEUROL NEUROSUR PS, V75, P1178, DOI 10.1136/jnnp.2003.017236; Petzold A, 2004, MULT SCLER J, V10, P281, DOI 10.1191/1352458504ms1021sr; Petzold A, 2003, J IMMUNOL METHODS, V278, P179, DOI 10.1016/S0022-1759(03)00189-3; Petzold A, 2009, MUSCLE NERVE, V40, P42, DOI 10.1002/mus.21239; Petzold A, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/217802; Petzold A, 2010, ANN NEUROL, V68, P806, DOI 10.1002/ana.22169; Rana OR, 2013, INT J CARDIOL, V168, P1322, DOI 10.1016/j.ijcard.2012.12.016; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Ross MA, 1998, NEUROLOGY, V50, P768, DOI 10.1212/WNL.50.3.768; Rundgren M, 2012, CRIT CARE, V16, DOI 10.1186/cc11244; Sellner J, 2011, NEUROCHEM RES, V36, P2287, DOI 10.1007/s11064-011-0553-8; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Singh P, 2011, J NEUROL SCI, V304, P117, DOI 10.1016/j.jns.2011.01.025; Teunissen CE, 2009, NEUROLOGY, V72, P1322, DOI 10.1212/WNL.0b013e3181a0fe3f; Tisdall M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004403; Zetterberg H, 2007, EUR J NEUROL, V14, P1329, DOI 10.1111/j.1468-1331.2007.01972.x	42	287	298	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75091	10.1371/journal.pone.0075091	http://dx.doi.org/10.1371/journal.pone.0075091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073237	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000046
J	Jaramillo, J; Torto, B; Mwenda, D; Troeger, A; Borgemeister, C; Poehling, HM; Francke, W				Jaramillo, Juliana; Torto, Baldwyn; Mwenda, Dickson; Troeger, Armin; Borgemeister, Christian; Poehling, Hans-Michael; Francke, Wittko			Coffee Berry Borer Joins Bark Beetles in Coffee Klatch	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; DENDROCTONUS-PONDEROSAE HOPKINS; HYPOTHENEMUS-HAMPEI FERRARI; REDBAY AMBROSIA BEETLE; SLAVE-MAKING ANT; COLEOPTERA-CURCULIONIDAE; CHEMICAL ECOLOGY; SECONDARY ATTRACTION; PHEROMONE PRODUCTION; ANTENNAL RESPONSES	Unanswered key questions in bark beetle-plant interactions concern host finding in species attacking angiosperms in tropical zones and whether management strategies based on chemical signaling used for their conifer-attacking temperate relatives may also be applied in the tropics. We hypothesized that there should be a common link in chemical signaling mediating host location by these Scolytids. Using laboratory behavioral assays and chemical analysis we demonstrate that the yellow-orange exocarp stage of coffee berries, which attracts the coffee berry borer, releases relatively high amounts of volatiles including conophthorin, chalcogran, frontalin and sulcatone that are typically associated with Scolytinae chemical ecology. The green stage of the berry produces a much less complex bouquet containing small amounts of conophthorin but no other compounds known as bark beetle semiochemicals. In behavioral assays, the coffee berry borer was attracted to the spiroacetals conophthorin and chalcogran, but avoided the monoterpenes verbenone and a-pinene, demonstrating that, as in their conifer-attacking relatives in temperate zones, the use of host and non-host volatiles is also critical in host finding by tropical species. We speculate that microorganisms formed a common basis for the establishment of crucial chemical signals comprising inter-and intraspecific communication systems in both temperate-and tropical-occurring bark beetles attacking gymnosperms and angiosperms.	[Jaramillo, Juliana; Poehling, Hans-Michael] Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, D-30167 Hannover, Germany; [Jaramillo, Juliana; Torto, Baldwyn; Mwenda, Dickson; Borgemeister, Christian] Icipe, Nairobi, Kenya; [Troeger, Armin; Francke, Wittko] Univ Hamburg, Inst Organ Chem, Hamburg, Germany	Leibniz University Hannover; International Centre of Insect Physiology & Ecology (ICIPE); University of Hamburg	Jaramillo, J (corresponding author), Leibniz Univ Hannover, Inst Plant Dis & Plant Protect, D-30167 Hannover, Germany.	jjaramillo@icipe.org			German Research Foundation - Deutsche Forschungsgemeinschaft (DFG)	German Research Foundation - Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was funded by the German Research Foundation - Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS MD, 1966, CAN ENTOMOL, V98, P285, DOI 10.4039/Ent98285-3; Beck JJ, 2012, J AGR FOOD CHEM, V60, P11869, DOI 10.1021/jf304157q; Berenbaum MR, 2008, SCIENCE, V322, P52, DOI 10.1126/science.1164873; Blomquist GJ, 2010, INSECT BIOCHEM MOLEC, V40, P699, DOI 10.1016/j.ibmb.2010.07.013; Borbon-Martinez MO, 1989, THESIS U P SABATIER; Borden JH, 2003, FOREST CHRON, V79, P685, DOI 10.5558/tfc79685-3; BORDEN JH, 1979, J CHEM ECOL, V5, P79, DOI 10.1007/BF00987689; Borden JH, 1997, INSECT PHEROMONE RESEARCH, P421; Borden JH, 1998, CHEMOECOLOGY, V8, P69, DOI 10.1007/PL00001806; Broberg CL, 2005, CAN ENTOMOL, V137, P716; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Brun L. O., 1997, P714; BUHRING M, 1976, Z NATURFORSCH C, V31, P748, DOI 10.1515/znc-1976-11-1223; Burbano EG, 2012, ENVIRON ENTOMOL, V41, P133, DOI 10.1603/EN11112; Byers JA, 2000, NATURWISSENSCHAFTEN, V87, P503, DOI 10.1007/s001140050768; BYERS JA, 1989, EXPERIENTIA, V45, P271, DOI 10.1007/BF01951813; Cantergiani E, 2001, EUR FOOD RES TECHNOL, V212, P648, DOI 10.1007/s002170100305; Castracani C, 2008, INSECT SOC, V55, P137, DOI 10.1007/s00040-008-0981-x; Citron CA, 2012, J NAT PROD, V75, P1765, DOI 10.1021/np300468h; COULSON RN, 1979, ANNU REV ENTOMOL, V24, P417, DOI 10.1146/annurev.en.24.010179.002221; Davis AP, 2006, BOT J LINN SOC, V152, P465, DOI 10.1111/j.1095-8339.2006.00584.x; Dicke M, 2000, BIOCHEM SYST ECOL, V28, P601, DOI 10.1016/S0305-1978(99)00106-4; Dodds KJ, 2011, J ECON ENTOMOL, V104, P879, DOI 10.1603/EC10358; Dufour BP, 2008, J APPL ENTOMOL, V132, P591, DOI 10.1111/j.1439-0418.2008.01291.x; FRANCKE W, 1995, J CHEM ECOL, V21, P1043, DOI 10.1007/BF02033807; Francke W, 2001, CURR ORG CHEM, V5, P233, DOI 10.2174/1385272013375652; Francke W, 1999, CURR ORG CHEM, V3, P407; Francke-Grosmann H., 1967, P141; Goodwin TE, 2006, J CHEM ECOL, V32, P1849, DOI 10.1007/s10886-006-9094-z; Greenberg L, 2007, J CHEM ECOL, V33, P935, DOI 10.1007/s10886-007-9269-2; Hanula JL, 2011, J ECON ENTOMOL, V104, P501, DOI 10.1603/EC10263; HARDIE J, 1994, J CHEM ECOL, V20, P2847, DOI 10.1007/BF02098393; Harrington Thomas C., 2005, P257; Huber DPW, 2001, AGR FOREST ENTOMOL, V3, P225, DOI 10.1046/j.1461-9555.2001.00111.x; Huber DPW, 1999, J CHEM ECOL, V25, P805, DOI 10.1023/A:1020892700653; Huber DPW, 2001, ENTOMOL EXP APPL, V99, P131, DOI 10.1023/A:1018979916210; Huber DPW, 2001, J CHEM ECOL, V27, P217, DOI 10.1023/A:1005668019434; Huber DPW, 2000, CHEMOECOLOGY, V10, P103, DOI 10.1007/PL00001811; Jaramillo J, 2009, ENTOMOL EXP APPL, V130, P275, DOI 10.1111/j.1570-7458.2008.00820.x; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Kendra PE, 2011, J CHEM ECOL, V37, P932, DOI 10.1007/s10886-011-9998-0; Khan ZR, 2000, PEST MANAG SCI, V56, P957, DOI 10.1002/1526-4998(200011)56:11<957::AID-PS236>3.0.CO;2-T; Khan ZR, 1997, NATURE, V388, P631, DOI 10.1038/41681; Krokene P, 1998, PHYTOPATHOLOGY, V88, P39, DOI 10.1094/PHYTO.1998.88.1.39; Liu SS, 2005, ECOL LETT, V8, P722, DOI 10.1111/j.1461-0248.2005.00776.x; Mathieu F, 1998, J AGR FOOD CHEM, V46, P1106, DOI 10.1021/jf970851z; Mathieu F, 1999, J APPL ENTOMOL, V123, P535, DOI 10.1046/j.1439-0418.1999.00400.x; Mendesil E, 2009, J CHEM ECOL, V35, P944, DOI 10.1007/s10886-009-9685-6; MILLER JR, 1990, J CHEM ECOL, V16, P3197, DOI 10.1007/BF00979619; Nijholt W. W., 1976, Bi-monthly Research Notes, V32, P31; Ortiz A, 2004, J AGR FOOD CHEM, V52, P5914, DOI 10.1021/jf049537c; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Pureswaran DS, 2000, CHEMOECOLOGY, V10, P153, DOI 10.1007/PL00001818; Pureswaran DS, 2004, CHEMOECOLOGY, V14, P59, DOI 10.1007/s00049-003-0261-1; Raffa KF, 2001, CHEMOECOLOGY, V11, P49, DOI 10.1007/PL00001833; Rappaport NG, 2001, ENVIRON ENTOMOL, V30, P837, DOI 10.1603/0046-225X-30.5.837; Rasmussen LEL, 2003, CHEM SENSES, V28, P433, DOI 10.1093/chemse/28.5.433; Reding ME, 2011, J ECON ENTOMOL, V104, P2017, DOI 10.1603/EC11119; Rochat D, 2000, J CHROMATOGR A, V885, P433, DOI 10.1016/S0021-9673(99)01049-3; Ruiz-Cardenas R, 2010, SCI AGR, V67, P658, DOI 10.1590/S0103-90162010000600007; SAS Institute, 1999, SAS STAT US GUID; SCHROEDER LM, 1989, J CHEM ECOL, V15, P807, DOI 10.1007/BF01015179; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Sequeira AS, 2000, P ROY SOC B-BIOL SCI, V267, P2359, DOI 10.1098/rspb.2000.1292; Six DL, 2011, ANNU REV ENTOMOL, V56, P255, DOI 10.1146/annurev-ento-120709-144839; Six DL, 2004, SYMBIOSIS, V37, P207; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Wood Stephen L., 1992, Great Basin Naturalist Memoirs, V13, P835; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x; Zhang QH, 1999, J CHEM ECOL, V25, P1923, DOI 10.1023/A:1020994119019; Zhang QH, 2000, CHEMOECOLOGY, V10, P69, DOI 10.1007/s000490050010; Zhang QH, 2002, J CHEM ECOL, V28, P1839, DOI 10.1023/A:1020569303433	73	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74277	10.1371/journal.pone.0074277	http://dx.doi.org/10.1371/journal.pone.0074277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073204	Green Submitted, gold, Green Published			2022-12-27	WOS:000324768000013
J	Lalmansingh, AS; Arora, K; DeMarco, RA; Hager, GL; Nagaich, AK				Lalmansingh, Avin S.; Arora, Kamalpreet; DeMarco, Richard A.; Hager, Gordon L.; Nagaich, Akhilesh K.			High-Throughput RNA FISH Analysis by Imaging Flow Cytometry Reveals That Pioneer Factor Foxa1 Reduces Transcriptional Stochasticity	PLOS ONE			English	Article							TUMOR VIRUS PROMOTER; GENE-EXPRESSION; GLUCOCORTICOID-RECEPTOR; LIVING CELLS; NATURAL PROMOTER; CHROMATIN; BINDING; MODES	Genes are regulated at the single-cell level. Here, we performed RNA FISH of thousands of cells by flow cytometry (flow-RNA FISH) to gain insight into transcriptional variability between individual cells. These experiments utilized the murine adenocarcinoma 3134 cell line with 200 copies of the MMTV-Ras reporter integrated at a single genomic locus. The MMTV array contains approximately 800-1200 binding sites for the glucocorticoid receptor (GR) and 600 binding sites for the pioneer factor Foxa1. Hormone activation of endogenous GR by dexamethasone treatment resulted in highly variable changes in the RNA FISH intensity (25-300 pixel intensity units) and size (1.25-15 mu m), indicative of probabilistic or stochastic mechanisms governing GR and cofactor activation of the MMTV promoter. Exogenous expression of the pioneer factor Foxa1 increased the FISH signal intensity and size as expected for a chromatin remodeler that enhances transcriptional competence through increased chromatin accessibility. In addition, specific analysis of Foxa1-enriched cell sub-populations showed that low and high Foxa1 levels substantially lowered the cell-to-cell variability in the FISH intensity as determined by a noise calculation termed the % coefficient of variation. These results suggest that an additional function of the pioneer factor Foxa1 may be to decrease transcriptional noise.	[Lalmansingh, Avin S.; Arora, Kamalpreet; Nagaich, Akhilesh K.] US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA; [DeMarco, Richard A.] EMD Millipore Corp, Amnis, Seattle, WA USA; [Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Merck KGaA; MilliporeSigma; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nagaich, AK (corresponding author), US FDA, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	akhilesh.nagaich@fda.hhs.gov			United States Food and Drug Administration (FDA) within the Center for Drug Evaluation and Research (CDER); United States Department of Energy; FDA; NATIONAL CANCER INSTITUTE [ZIABC005450] Funding Source: NIH RePORTER	United States Food and Drug Administration (FDA) within the Center for Drug Evaluation and Research (CDER); United States Department of Energy(United States Department of Energy (DOE)); FDA(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the United States Food and Drug Administration (FDA) within the Center for Drug Evaluation and Research (CDER). This project was supported in part by an appointment to the Research Participation Program at CDER administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the United States Department of Energy and FDA [to A.S.L.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Belikov S, 2012, EXP CELL RES, V318, P61, DOI 10.1016/j.yexcr.2011.09.016; Belikov S, 2009, MOL CELL BIOL, V29, P5413, DOI 10.1128/MCB.00368-09; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gandhi SJ, 2011, NAT STRUCT MOL BIOL, V18, P27, DOI 10.1038/nsmb.1934; Georgel PT, 2003, GENE DEV, V17, P1617, DOI 10.1101/gad.1097603; Holmqvist PH, 2005, EXP CELL RES, V304, P593, DOI 10.1016/j.yexcr.2004.12.002; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kramer PR, 1999, J BIOL CHEM, V274, P28590, DOI 10.1074/jbc.274.40.28590; Lalmansingh AS, 2012, BBA-GENE REGUL MECH, V1819, P707, DOI 10.1016/j.bbagrm.2012.02.018; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; OSTROWSKI MC, 1983, MOL CELL BIOL, V3, P2045, DOI 10.1128/MCB.3.11.2045; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; Voss TC, 2009, J CELL SCI, V122, P345, DOI 10.1242/jcs.035865; Zaret KS, 2010, COLD SH Q B, V75, P219, DOI 10.1101/sqb.2010.75.061; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	31	7	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e76043	10.1371/journal.pone.0076043	http://dx.doi.org/10.1371/journal.pone.0076043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073287	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000097
J	Struijk, EA; May, AM; Beulens, JWJ; de Wit, GA; Boer, JMA; Onland-Moret, NC; van der Schouw, YT; Bueno-de-Mesquita, HB; Hoekstra, J; Peeters, PHM				Struijk, Ellen A.; May, Anne M.; Beulens, Joline W. J.; de Wit, G. Ardine; Boer, Jolanda M. A.; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Bueno-de-Mesquita, H. Bas; Hoekstra, Jeljer; Peeters, Petra H. M.			Development of Methodology for Disability-Adjusted Life Years (DALYs) Calculation Based on Real-Life Data	PLOS ONE			English	Article							GLOBAL BURDEN; SYSTEMATIC ANALYSIS; DISEASE	Background: Disability-Adjusted Life Years (DALYs) have the advantage that effects on total health instead of on a specific disease incidence or mortality can be estimated. Our aim was to address several methodological points related to the computation of DALYs at an individual level in a follow-up study. Methods: DALYs were computed for 33,507 men and women aged 20-70 years when participating in the EPIC-NL study in 1993-7. DALYs are the sum of the Years Lost due to Disability (YLD) and the Years of Life Lost (YLL) due to premature mortality. Premature mortality was defined as death before the estimated date of individual Life Expectancy (LE). Different methods to compute LE were compared as well as the effect of different follow-up periods using a two-part model estimating the effect of smoking status on health as an example. Results: During a mean follow-up of 12.4 years, there were 69,245 DALYs due to years lived with a disease or premature death. Current-smokers had lost 1.28 healthy years of their life (1.28 DALYs 95%CI 1.10; 1.46) compared to never-smokers. The outcome varied depending on the method used for estimating LE, completeness of disease and mortality ascertainment and notably the percentage of extinction (duration of follow-up) of the cohort. Conclusion: We conclude that the use of DALYs in a cohort study is an appropriate way to assess total disease burden in relation to a determinant. The outcome is sensitive to the LE calculation method and the follow-up duration of the cohort.	[Struijk, Ellen A.; May, Anne M.; Beulens, Joline W. J.; de Wit, G. Ardine; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Struijk, Ellen A.; de Wit, G. Ardine; Boer, Jolanda M. A.; Bueno-de-Mesquita, H. Bas; Hoekstra, Jeljer] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Struijk, EA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	e.struijk-2@umcutrecht.nl	van der Schouw, Yvonne T./F-8327-2014; Onland-Moret, N. Charlotte/G-9185-2011; May, Anne M/G-9183-2011	van der Schouw, Yvonne T./0000-0002-4605-435X; Onland-Moret, N. Charlotte/0000-0002-2360-913X; , jeljer/0000-0001-8252-8906; Struijk, Ellen/0000-0002-9302-9616; Beulens, Joline/0000-0002-4181-0937; de Wit, G. Ardine/0000-0002-1375-7657	European Commission (SANCO); Dutch Ministry of Health; Dutch Cancer Society; Netherlands Organisation for Health research and Development (ZonMW); World Cancer Research Fund (WCRF); Dutch research council (NWO-ZonMW) [40-00812-98-10040]	European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Health; Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organisation for Health research and Development (ZonMW)(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); Dutch research council (NWO-ZonMW)	The EPIC-NL study was funded by the "Europe against Cancer'' Program of the European Commission (SANCO), the Dutch Ministry of Health, the Dutch Cancer Society, the Netherlands Organisation for Health research and Development (ZonMW), and World Cancer Research Fund (WCRF). The analysis was also supported by a grant of the Dutch research council (NWO-ZonMW; grant no 40-00812-98-10040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, KANK NED 2020 TRENDS; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Duan N., 1983, J BUS STAT, V1, P115, DOI DOI 10.2307/1391852; Hoekstra J, 2012, FOOD CHEM TOXICOL, V50, pS684, DOI 10.1016/j.fct.2010.05.049; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Statistics Netherlands, LEV GESL LEEFT VAN 1; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; Streppel MT, 2007, TOB CONTROL, V16, P107, DOI 10.1136/tc.2006.017715; Tijhuis MJ, 2012, FOOD CHEM TOXICOL, V50, P5, DOI 10.1016/j.fct.2011.06.010; Vaartjes I, 2011, HART VAATZIEKTEN NED; van Baal Pieter H M, 2006, Popul Health Metr, V4, P1, DOI 10.1186/1478-7954-4-1; Victorian Burden of Disease Study, 1999, MORB; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; *WORLD BANK, 1993, WORLD DEV REP 1993 I	18	18	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74294	10.1371/journal.pone.0074294	http://dx.doi.org/10.1371/journal.pone.0074294			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	222YC	24073206	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000015
J	Xu, ST; Zhang, Y; Zhu, Z; Liu, CY; Mao, NY; Ji, YX; Wang, HL; Jiang, XH; Li, CS; Tang, W; Feng, DX; Wang, CY; Zheng, L; Lei, Y; Ling, H; Zhao, CF; Ma, Y; He, JL; Wang, Y; Li, P; Guan, RH; Zhou, SJ; Zhou, JH; Wang, S; Zhang, H; Zheng, HY; Liu, L; Ma, HMT; Guan, J; Lu, PS; Feng, Y; Zhang, YJ; Zhou, SD; Xiong, Y; Ba, ZM; Chen, H; Yang, XH; Bo, F; Ma, YJ; Liang, Y; Lei, YK; Gu, SY; Liu, W; Chen, M; Featherstone, D; Jee, Y; Bellini, WJ; Rota, PA; Xu, W				Xu, Songtao; Zhang, Yan; Zhu, Zhen; Liu, Chunyu; Mao, Naiying; Ji, Yixin; Wang, Huiling; Jiang, Xiaohong; Li, Chongshan; Tang, Wei; Feng, Daxing; Wang, Changyin; Zheng, Lei; Lei, Yue; Ling, Hua; Zhao, Chunfang; Ma, Yan; He, Jilan; Wang, Yan; Li, Ping; Guan, Ronghui; Zhou, Shujie; Zhou, Jianhui; Wang, Shuang; Zhang, Hong; Zheng, Huanying; Liu, Leng; Ma, Hemuti; Guan, Jing; Lu, Peishan; Feng, Yan; Zhang, Yanjun; Zhou, Shunde; Xiong, Ying; Ba, Zhuoma; Chen, Hui; Yang, Xiuhui; Bo, Fang; Ma, Yujie; Liang, Yong; Lei, Yake; Gu, Suyi; Liu, Wei; Chen, Meng; Featherstone, David; Jee, Youngmee; Bellini, William J.; Rota, Paul A.; Xu, Wenbo			Genetic Characterization of the Hemagglutinin Genes of Wild-Type Measles Virus Circulating in China, 1993-2009	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; RECEPTOR; IDENTIFICATION; ANTIGENICITY; EVOLUTION; GENOTYPES; SOFTWARE; RESIDUES; EPITOPES; BINDING	Background: China experienced several large measles outbreaks in the past two decades, and a series of enhanced control measures were implemented to achieve the goal of measles elimination. Molecular epidemiologic surveillance of wild-type measles viruses (MeV) provides valuable information about the viral transmission patterns. Since 1993, virologic surveillnace has confirmed that a single endemic genotype H1 viruses have been predominantly circulating in China. A component of molecular surveillance is to monitor the genetic characteristics of the hemagglutinin (H) gene of MeV, the major target for virus neutralizing antibodies. Principal Findings: Analysis of the sequences of the complete H gene from 56 representative wild-type MeV strains circulating in China during 1993-2009 showed that the H gene sequences were clustered into 2 groups, cluster 1 and cluster 2. Cluster1 strains were the most frequently detected cluster and had a widespread distribution in China after 2000. The predicted amino acid sequences of the H protein were relatively conserved at most of the functionally significant amino acid positions. However, most of the genotype H1 cluster1 viruses had an amino acid substitution (Ser240Asn), which removed a predicted N-linked glycosylation site. In addition, the substitution of Pro397Leu in the hemagglutinin noose epitope (HNE) was identified in 23 of 56 strains. The evolutionary rate of the H gene of the genotype H1 viruses was estimated to be approximately 0.76x10(-3) substitutions per site per year, and the ratio of dN to dS (dN/dS) was <1 indicating the absence of selective pressure. Conclusions: Although H genes of the genotype H1 strains were conserved and not subjected to selective pressure, several amino acid substitutions were observed in functionally important positions. Therefore the antigenic and genetic properties of H genes of wild-type MeVs should be monitored as part of routine molecular surveillance for measles in China.	[Xu, Songtao; Zhang, Yan; Zhu, Zhen; Mao, Naiying; Ji, Yixin; Wang, Huiling; Jiang, Xiaohong; Xu, Wenbo] China Ctr Dis Control & Prevent, Reg Reference Measles Lab WHO Western Pacific Reg, Key Lab Med Virol, Minist Hlth,Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Liu, Chunyu; Bellini, William J.; Rota, Paul A.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Li, Chongshan; Tang, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Feng, Daxing] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan Province, Peoples R China; [Wang, Changyin] Shandong Ctr Dis Control & Prevent, Jinan, Shandong, Peoples R China; [Zheng, Lei] Shanxi Ctr Dis Control & Prevent, Taiyuan, Shanxi Province, Peoples R China; [Lei, Yue] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Ling, Hua; Zhao, Chunfang] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Ma, Yan] Hainan Ctr Dis Control & Prevent, Haikou, Hainan Province, Peoples R China; [He, Jilan] Sichuan Ctr Dis Control & Prevent, Chengdu, Sichuan Provinc, Peoples R China; [Wang, Yan] Liaoning Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China; [Li, Ping; Guan, Ronghui] Shaanxi Ctr Dis Control & Prevent, Xian, Shannxi Provinc, Peoples R China; [Zhou, Shujie] Anhui Ctr Dis Control & Prevent, Hefei, Anhui, Peoples R China; [Zhou, Jianhui; Wang, Shuang] Jilin Ctr Dis Control & Prevent, Changchun, Jilin Province, Peoples R China; [Zhang, Hong] Hunan Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Zheng, Huanying; Liu, Leng] Guangdong Ctr Dis Control & Prevent, Guangzhou, Guangzhou Provi, Peoples R China; [Ma, Hemuti; Guan, Jing] Xinjiang Ctr Dis Control & Prevent, Urumchi City, Xinjiang Provin, Peoples R China; [Lu, Peishan] Jiangsu Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Feng, Yan; Zhang, Yanjun] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Zhou, Shunde; Xiong, Ying] Jiangxi Ctr Dis Control & Prevent, Nanchang City, Jiangxi, Peoples R China; [Ba, Zhuoma] Qinghai Ctr Dis Control & Prevent, Xining, Qinghai Provinc, Peoples R China; [Chen, Hui] Ningxia Ctr Dis Control & Prevent, Yinchuan City, Ningxia Provinc, Peoples R China; [Yang, Xiuhui] Fujian Ctr Dis Control & Prevent, Fuzhou, Fujian Province, Peoples R China; [Bo, Fang; Ma, Yujie] Heilongjiang Ctr Dis Control & Prevent, Harbin, Heilongjiang Pr, Peoples R China; [Liang, Yong] Hebei Ctr Dis Control & Prevent, Shijiazhuang, Hebei Province, Peoples R China; [Lei, Yake] Hubei Ctr Dis Control & Prevent, Wuhan, Hunan, Peoples R China; [Gu, Suyi] Inner Mongolia Ctr Dis Control & Prevent, Hohhot City, Inner Mongolia, Peoples R China; [Liu, Wei] Guangxi Ctr Dis Control & Prevent, Nanning, Guangxi Provinc, Peoples R China; [Chen, Meng] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Featherstone, David] WHO, CH-1211 Geneva, Switzerland; [Jee, Youngmee] WHO, Western Pacific Reg Off, Manila, Philippines	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA; Shanghai Center for Disease Control & Prevention; Tianjin Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention; World Health Organization; WHO Western Pacific Regional Office; World Health Organization	Xu, W (corresponding author), China Ctr Dis Control & Prevent, Reg Reference Measles Lab WHO Western Pacific Reg, Key Lab Med Virol, Minist Hlth,Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn	ma, yujie/GYA-3957-2022; Jee, Youngmee/AGW-0164-2022	Jee, Youngmee/0000-0001-5369-6628	Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004215, 2013ZX10004-101, 2012ZX10004401, 2012ZX10004201-003]; WHO Measles Regional Reference Laboratory; WHO [WP CHN AAA 011 XZ 08]	Key Technologies R&D Program of National Ministry of Science; WHO Measles Regional Reference Laboratory; WHO(World Health Organization)	This work is supported by the Key Technologies R&D Program of National Ministry of Science (2013ZX10004-202, 2012ZX10004215, 2013ZX10004-101, 2012ZX10004401, 2012ZX10004201-003), WHO Measles Regional Reference Laboratory funding and WHO funding (number WP CHN AAA 011 XZ 08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHATIB G, 1986, VIROLOGY, V150, P479, DOI 10.1016/0042-6822(86)90312-0; Bolt G, 1999, VIRUS RES, V61, P43, DOI 10.1016/S0168-1702(99)00025-8; Bouche FB, 2002, VIRAL IMMUNOL, V15, P451, DOI 10.1089/088282402760312331; Ertl OT, 2003, ARCH VIROL, V148, P2195, DOI 10.1007/s00705-003-0159-9; Finsterbusch T, 2009, J GEN VIROL, V90, P2739, DOI 10.1099/vir.0.013524-0; Griffin D., 1996, FIELDS VIROLOGY, V3rd ed., P1267; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; HU AH, 1994, J GEN VIROL, V75, P1043, DOI 10.1099/0022-1317-75-5-1043; HU AH, 1994, J GEN VIROL, V75, P2173, DOI 10.1099/0022-1317-75-9-2173; HU AZ, 1993, VIROLOGY, V192, P351, DOI 10.1006/viro.1993.1042; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Ji YX, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-105; Ji Yixin, 2009, Virol J, V6, P135, DOI 10.1186/1743-422X-6-135; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Liffick SL, 2001, VIRUS RES, V77, P81, DOI 10.1016/S0168-1702(01)00268-4; MAKELA MJ, 1989, SCAND J IMMUNOL, V30, P225, DOI 10.1111/j.1365-3083.1989.tb01205.x; Masse N, 2004, J VIROL, V78, P9051, DOI 10.1128/JVI.78.17.9051-9063.2004; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Rima BK, 1997, J GEN VIROL, V78, P97, DOI 10.1099/0022-1317-78-1-97; ROTA JS, 1992, VIROLOGY, V188, P135, DOI 10.1016/0042-6822(92)90742-8; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; SAITO H, 1995, MOL CELL PROBE, V9, P1, DOI 10.1016/S0890-8508(95)90902-8; Santibanez S, 2005, J GEN VIROL, V86, P365, DOI 10.1099/vir.0.80467-0; Shi JW, 2011, VIRUS GENES, V43, P319, DOI 10.1007/s11262-011-0638-0; Tahara M, 2013, J VIROL, V87, P3583, DOI 10.1128/JVI.03029-12; Tahara M, 2013, J VIROL, V87, P666, DOI 10.1128/JVI.02033-12; TAMIN A, 1994, J INFECT DIS, V170, P795, DOI 10.1093/infdis/170.4.795; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vongpunsawad S, 2004, J VIROL, V78, P302, DOI 10.1128/JVI.78.1.302-313.2004; World Health Organization (WHO), 2012, WKLY EPIDEMIOL REC, V87, P73; Xu WB, 1998, VIRUS RES, V54, P147, DOI 10.1016/S0168-1702(98)00020-3; Zhang Y, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-14; Zhang Y, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-120; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034401; Zhang Y, 2010, EMERG INFECT DIS, V16, P943, DOI 10.3201/eid1606.100089; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Ziegler D, 1996, J GEN VIROL, V77, P2479, DOI 10.1099/0022-1317-77-10-2479	39	14	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73374	10.1371/journal.pone.0073374	http://dx.doi.org/10.1371/journal.pone.0073374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073194	Green Published, gold			2022-12-27	WOS:000324768000003
J	Katzir, T; Hershko, S; Halamish, V				Katzir, Tami; Hershko, Shirley; Halamish, Vered			The Effect of Font Size on Reading Comprehension on Second and Fifth Grade Children: Bigger Is Not Always Better	PLOS ONE			English	Article							FLUENCY; MEMORY; TEXT; DIFFICULTY; ILLUSIONS; JUDGMENTS; COMPETENCE; RETENTION; WORDS	Research on reading development has focused on the linguistic, cognitive, and recently, metacognitive skills children must master in order to learn to read. Less focus has been devoted to how the text itself, namely the perceptual features of the words, affects children's learning and comprehension. In this study, we manipulated perceptual properties of text by presenting reading passages in different font sizes, line lengths, and line spacing to 100 children in the second and fifth grades. For second graders (Experiment 1), decreasing font size, as well as increasing line length, yielded significantly lower comprehension scores. Line spacing had no effect on performance. For fifth graders (Experiment 2), decreasing font size yielded higher comprehension scores, yet there were no effects for line length and line spacing. Results are discussed within a "desirable difficulty" approach to reading development.	[Katzir, Tami; Hershko, Shirley] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel; [Katzir, Tami; Hershko, Shirley] Univ Haifa, Dept Learning Disabil & Special Educ, IL-31999 Haifa, Israel; [Halamish, Vered] Univ Haifa, Inst Informat Proc & Decis Making, IL-31999 Haifa, Israel	University of Haifa; University of Haifa; University of Haifa	Katzir, T (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel.	katzirta@gmail.com	/AAA-4542-2022; Katzir, Tami/AAI-9916-2021; l, y/AAN-7397-2020					Alter AL, 2007, J EXP PSYCHOL GEN, V136, P569, DOI 10.1037/0096-3445.136.4.569; Alter AL, 2009, PSYCHOL SCI, V20, P1414, DOI 10.1111/j.1467-9280.2009.02461.x; [Anonymous], READ RAND READ STUD; Bjork E. L., 2011, PSYCHOL REAL WORLD E, P56, DOI DOI 10.1017/CBO9781107415324.004; Bjork R., 1994, METACOGNITION KNOWIN, P185; Breznitz Z., 2006, FLUENCY READING SYNC; Cain K, 2004, J EDUC PSYCHOL, V96, P31, DOI 10.1037/0022-0663.96.1.31; Castel AD, 2007, PSYCHON B REV, V14, P107, DOI 10.3758/BF03194036; Chall JS, 1991, STAGES READING DEV; Conlon EG, 2006, J RES READ, V29, P11, DOI 10.1111/j.1467-9817.2006.00290.x; Corley M, 2007, COGNITION, V105, P658, DOI 10.1016/j.cognition.2006.10.010; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Diemand-Yauman C, 2011, COGNITION, V118, P111, DOI 10.1016/j.cognition.2010.09.012; Lonsdale MD, 2006, J RES READ, V29, P433, DOI 10.1111/j.1467-9817.2006.00317.x; Dunn L.M., 1981, PEABODY PICTURE VOCA; French MMJ, 2013, J ED RES IN PRESS; Hughes L. E., 2000, J RES READ, V23, P314, DOI [10.1111/1467-9817.00126, DOI 10.1111/1467-9817.00126]; Hughes LE, 2002, BRIT J EDUC PSYCHOL, V72, P213, DOI 10.1348/000709902158856; Jenkins JR, 2003, J EDUC PSYCHOL, V95, P719, DOI 10.1037/0022-0663.95.4.719; Joshi RM, 1998, READING AND SPELLING, P319; Katzir T, 2008, J LEARN DISABIL-US, V41, P47, DOI 10.1177/0022219407311325; Katzir T, 2006, ANN DYSLEXIA, V56, P51, DOI 10.1007/s11881-006-0003-5; Katzir T, 2009, READ WRIT, V22, P261, DOI 10.1007/s11145-007-9112-8; Kelley CM, 2002, PSYCHOL LEARN MOTIV, V41, P293, DOI 10.1016/S0079-7421(02)80010-X; LABERGE D, 1974, COGNITIVE PSYCHOL, V6, P293, DOI 10.1016/0010-0285(74)90015-2; McDaniel MA, 2002, J MEM LANG, V46, P544, DOI 10.1006/jmla.2001.2819; Nelson T.O., 1990, PSYCHOL LEARNING MOT, V26, P125, DOI [10.1016/S0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5, 10.1016/s0079-7421(08)60053-5]; O'Brien BA, 2005, J RES READ, V28, P332, DOI 10.1111/j.1467-9817.2005.00273.x; Oppenheimer DM, 2008, TRENDS COGN SCI, V12, P237, DOI 10.1016/j.tics.2008.02.014; Perfetti C., 1995, J RES READ, V18, P106, DOI [DOI 10.1111/J.1467-9817.1995.TB00076.X, 10.1111/j.1467-9817.1995.tb00076.x]; Perfetti CA, 2005, BL HBK DEV PSYCHOL, P227, DOI 10.1002/9780470757642.ch13; Pikulski JJ, 2005, READ TEACH, V58, P510, DOI 10.1598/RT.58.6.2; Primor L, 2011, ANN DYSLEXIA, V61, P242, DOI 10.1007/s11881-011-0059-8; Reber R, 1999, CONSCIOUS COGN, V8, P338, DOI 10.1006/ccog.1999.0386; Rhodes MG, 2008, J EXP PSYCHOL GEN, V137, P615, DOI 10.1037/a0013684; Rhodes MG, 2009, PSYCHON B REV, V16, P550, DOI 10.3758/PBR.16.3.550; Shany M., 2006, ALEF AD TAF SYSTEM D; SHEA JB, 1979, J EXP PSYCHOL-HUM L, V5, P179, DOI 10.1037/0278-7393.5.2.179; Snellings P, 2009, J LEARN DISABIL-US, V42, P291, DOI 10.1177/0022219408331038; Song HJ, 2008, SOC COGNITION, V26, P791, DOI 10.1521/soco.2008.26.6.791; Stecker S.K., 1998, 47 YB NAT READ C CHI, P295; Sungkhasettee VW, 2011, PSYCHON B REV, V18, P973, DOI 10.3758/s13423-011-0114-9; SWEET AP, 2002, IMPROVING COMPREHENS, P17; SWELLER J, 1994, COGNITION INSTRUCT, V12, P185, DOI 10.1207/s1532690xci1203_1; Werth L, 2003, MEMORY, V11, P411, DOI 10.1080/09658210244000586; Wigfield, 1999, SCI STUD READ, V3, P231, DOI DOI 10.1207/S1532799XSSR0303_3; Wolf M, 2000, J LEARN DISABIL-US, V33, P375, DOI 10.1177/002221940003300408; Wolf M., 2001, SCIENT STUD READ, V5, P211, DOI DOI 10.1207/S1532799XSSR0503_2; Yue CL, 2013, MEM COGNITION, V41, P229, DOI 10.3758/s13421-012-0255-8; Zorzi M, 2012, P NATL ACAD SCI USA, V109, P11455, DOI 10.1073/pnas.1205566109	50	27	29	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74061	10.1371/journal.pone.0074061	http://dx.doi.org/10.1371/journal.pone.0074061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223BC	24069266	Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300025
J	Plesnar-Bielak, A; Skrzynecka, AM; Prokop, ZM; Kolasa, M; Dzialo, M; Radwan, J				Plesnar-Bielak, Agata; Skrzynecka, Anna M.; Prokop, Zofia M.; Kolasa, Michal; Dzialo, Maciej; Radwan, Jacek			No Evidence for Reproductive Isolation through Sexual Conflict in the Bulb Mite Rhizoglyphus robini	PLOS ONE			English	Article							ANTAGONISTIC COEVOLUTION; DROSOPHILA-MELANOGASTER; SELECTION; SPECIATION; EVOLUTION; ADAPTATION; MANIPULATION; ASSOCIATION; POPULATIONS; RESISTANCE	Sexual conflict leading to sexual antagonistic coevolution has been hypothesized to drive reproductive isolation in allopatric populations and hence lead to speciation. However, the generality of this speciation mechanism is under debate. We used experimental evolution in the bulb mite Rhizoglyphus robini to investigate whether sexual conflict promotes reproductive isolation measured comprehensively to include all possible pre- and post-zygotic mechanisms. We established replicate populations in which we either enforced monogamy, and hence removed sexual conflict by making male and female evolutionary interests congruent, or allowed promiscuity. After 35 and 45 generations of experimental evolution, we found no evidence of reproductive isolation between the populations in any of the mating systems. Our results indicate that sexual conflict does not necessarily drive fast reproductive isolation and it may not be a ubiquitous mechanism leading to speciation.	[Plesnar-Bielak, Agata; Skrzynecka, Anna M.; Prokop, Zofia M.; Kolasa, Michal; Dzialo, Maciej; Radwan, Jacek] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Radwan, Jacek] Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Poznan, Poland	Jagiellonian University; Adam Mickiewicz University	Plesnar-Bielak, A (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	agata.plesnar@uj.edu.pl	PLESNAR-BIELAK, Agata/F-3391-2015; Kolasa, Michał/AAB-6336-2020	PLESNAR-BIELAK, Agata/0000-0002-7806-8908; Kolasa, Michał/0000-0003-2143-429X; Dzialo, Maciej/0000-0002-3632-8572; Radwan, Jacek/0000-0001-8503-5701	Polish Ministry of Science and Higher Education [N303 529438]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The project was supported by grant number N303 529438 from the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2000, P NATL ACAD SCI USA, V97, P10460, DOI 10.1073/pnas.97.19.10460; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist Goran, 2005, pUnpaginated; Bacigalupe LD, 2007, J EVOLUTION BIOL, V20, P1763, DOI 10.1111/j.1420-9101.2007.01389.x; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bonduriansky R, 2011, AM NAT, V178, P729, DOI 10.1086/662665; Candolin U, 2008, TRENDS ECOL EVOL, V23, P446, DOI 10.1016/j.tree.2008.04.008; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Coyne J.A., 2004, SPECIATION; Fisher RA, 1930, GENETICAL THEORY NAT; Fricke C, 2007, EVOLUTION, V61, P440, DOI 10.1111/j.1558-5646.2007.00038.x; Gage MJG, 2002, P ROY SOC B-BIOL SCI, V269, P2309, DOI 10.1098/rspb.2002.2154; Gavrilets S, 2005, EVOL ECOL, V19, P167, DOI 10.1007/s10682-004-7916-4; Gavrilets S, 2001, P ROY SOC B-BIOL SCI, V268, P531, DOI 10.1098/rspb.2000.1382; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Gay L, 2009, BIOL LETTERS, V5, P693, DOI 10.1098/rsbl.2009.0072; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kolodziejczyk M, 2003, BEHAV ECOL SOCIOBIOL, V53, P110, DOI 10.1007/s00265-002-0557-0; Konior M, 2006, P ROY SOC B-BIOL SCI, V273, P309, DOI 10.1098/rspb.2005.3302; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lorch PD, 2003, EVOL ECOL RES, V5, P867; Martin OY, 2003, NATURE, V423, P979, DOI 10.1038/nature01752; Michalczyk L, 2008, THESIS U E ANGLIA; Michalczyk L, 2011, SCIENCE, V333, P1739, DOI 10.1126/science.1207314; Morrow EH, 2003, ECOL LETT, V6, P228, DOI 10.1046/j.1461-0248.2003.00418.x; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Parker GA, 1979, SEXUAL SELECTION REP, P126; Plesnar-Bielak A, 2012, P ROY SOC B-BIOL SCI, V279, P4661, DOI 10.1098/rspb.2012.1867; Radwan J, 1996, ANIM BEHAV, V52, P651, DOI 10.1006/anbe.1996.0209; Radwan J, 1997, ETHOL ECOL EVOL, V9, P373, DOI 10.1080/08927014.1997.9522879; Radwan J, 2000, ETHOLOGY, V106, P53, DOI 10.1046/j.1439-0310.2000.00498.x; Radwan J, 2007, EXP APPL ACAROL, V42, P151, DOI 10.1007/s10493-007-9086-x; RICE WR, 1984, EVOLUTION, V38, P1251, DOI 10.1111/j.1558-5646.1984.tb05647.x; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Rowe L, 2006, PHILOS T R SOC B, V361, P277, DOI 10.1098/rstb.2005.1788; Tilszer M, 2006, EVOLUTION, V60, P1868, DOI 10.1111/j.0014-3820.2006.tb00530.x; Wigby S, 2006, J EVOLUTION BIOL, V19, P1033, DOI 10.1111/j.1420-9101.2006.01107.x; Wigby S, 2004, EVOLUTION, V58, P1028	43	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74971	10.1371/journal.pone.0074971	http://dx.doi.org/10.1371/journal.pone.0074971			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069369	Green Published, gold			2022-12-27	WOS:000324777300057
J	Al-Sammak, F; Kalinski, T; Weinert, S; Link, A; Wex, T; Malfertheiner, P				Al-Sammak, Fadi; Kalinski, Thomas; Weinert, Soenke; Link, Alexander; Wex, Thomas; Malfertheiner, Peter			Gastric Epithelial Expression of IL-12 Cytokine Family in Helicobacter pylori Infection in Human: Is it Head or Tail of the Coin?	PLOS ONE			English	Article							HETERODIMERIC CYTOKINE; T-CELLS; GENE-EXPRESSION; HOST-CELL; RECEPTOR; INTERLEUKIN-12; PROTEIN; SUBUNIT; DISEASE; CLONING	Recently, there has been a growing interest in an expanding group of cytokines known as "IL-12 family". The so far gained knowledge about these cytokines, as crucial playmakers in mucosal immunity, has not yet been sufficiently investigated in the context of Helicobacter pylori infection. All genes encoding the monomeric components of these cytokines and their corresponding receptors were examined in gastric epithelial cell lines (AGS and MKN-28) after being infected with 4 H. pylori strains: BCM-300, P1 wild-type, and P1-derived isogenic mutants lacking cytotoxin-associated gene A (cagA) or virulence gene virB7 (multiplicity of infection=50). Both infected and uninfected samples were analyzed after 24h and 48h using real-time quantitative polymerase chain reaction (RT-qPCR). Gene expression analysis demonstrated a strong upregulation of IL23A (encodes p19) by infection, whereas IL23R, Epstein-Barr virus-induced gene 3 (EBI3), IL6ST, IL12A, and IL27RA were found to be expressed, but not regulated, or to a lesser extent. Transcripts of IL12RB2, IL12B, IL12RB1, and IL27A were not detected. Interestingly, P1 resulted in stronger alterations of expression than CagA mutant and BCM-300, particularly for IL23A (59.7-fold versus 32.4- and 6.7-fold, respectively in AGS after 48h, P<.05), whereas no changes were seen with VirB7 mutant. In a proof-of-principle experiment, we demonstrated epithelial-derived expression of IL-12, p19, and Ebi3 in gastric mucosa of gastritis patients using immunohistochemistry (IHC). Unlike IL-12 and Ebi3, increased immunostaining of p19 was observed in H. pylori gastritis. Herein, we highlight the potential role of gastric epithelial cells in mucosal immunity, not only because they are predominant cell type in mucosa and initial site of host-bacterial interaction, but also as a major contributor to molecules that are thought to be primarily expressed by immune cells so far. Of these molecules, p19 was the most relevant one to H. pylori infection in terms of expression and localization.	[Al-Sammak, Fadi; Link, Alexander; Wex, Thomas; Malfertheiner, Peter] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Kalinski, Thomas] Otto Von Guericke Univ, Dept Pathol, Magdeburg, Germany; [Weinert, Soenke] Otto Von Guericke Univ, Dept Cardiol Angiol & Pneumol, Magdeburg, Germany; [Wex, Thomas] Dept Mol Genet, Med Lab Clin Chem Microbiol & Infect Dis, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University	Wex, T (corresponding author), Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany.	t.wex@schenk-ansorge.de	Al-Sammak, Fadi F./ABD-8552-2020	Link, Alexander/0000-0002-9514-4562; Al-Sammak, Fadi F./0000-0001-7765-6612; Weinert, Sonke/0000-0002-7201-0836	German Academic Exchange Service (DAAD); Iraqi Ministry of Higher Education and Scientific Research in Baghdad (MoHESR); Al-Nahrain University, College of Medicine; BMBF [BMBF-0315905D]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Iraqi Ministry of Higher Education and Scientific Research in Baghdad (MoHESR); Al-Nahrain University, College of Medicine; BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by a joint scholarship program between the German Academic Exchange Service (DAAD) and the Iraqi Ministry of Higher Education and Scientific Research in Baghdad (MoHESR); Al-Nahrain University, College of Medicine. This work was also supported in part by a grant from the BMBF (BMBF-0315905D) in the frame of ERA-Net PathoGenoMics project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi I, 2002, HAEMATOLOGICA, V87, P434; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bliss SK, 2000, J IMMUNOL, V165, P4515, DOI 10.4049/jimmunol.165.8.4515; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; CHIZZONITE R, 1992, J IMMUNOL, V148, P3117; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Core R Team, 2012, R LANG ENV STAT COMP; Covacci A, 2000, J EXP MED, V191, P587, DOI 10.1084/jem.191.4.587; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; CRABTREE JE, 1994, J CLIN PATHOL, V47, P945, DOI 10.1136/jcp.47.10.945; DESAI BB, 1992, J IMMUNOL, V148, P3125; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 2001, AM J PATHOL, V159, P1763, DOI 10.1016/S0002-9440(10)63023-4; Eckmann L, 2000, J BIOL CHEM, V275, P14084, DOI 10.1074/jbc.275.19.14084; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Li XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029350, 10.1371/journal.pone.0051199]; Liu Jianguo, 2005, Curr Immunol Rev, V1, P119, DOI 10.2174/1573395054065115; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; Maaser C, 2004, IMMUNOLOGY, V112, P437, DOI 10.1111/j.1365-2567.2004.01895.x; Malfertheiner P, 2012, GASTROENTEROLOGY S1, V142, pS; Matthias Kohl, 2007, SLQPCR FUNCTIONS ANA; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; Maul J, 2012, LANGENBECK ARCH SURG, V397, P1, DOI 10.1007/s00423-011-0789-4; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Muller-Newen Gerhard, 2003, Sci STKE, V2003, pPE40, DOI 10.1126/stke.2003.201.pe40; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Rho HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-240; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; STERN AS, 1990, P NATL ACAD SCI USA, V87, P6808, DOI 10.1073/pnas.87.17.6808; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; WOLF SF, 1991, J IMMUNOL, V146, P3074; Wu CY, 1997, EUR J IMMUNOL, V27, P147, DOI 10.1002/eji.1830270122	50	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75192	10.1371/journal.pone.0075192	http://dx.doi.org/10.1371/journal.pone.0075192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069393	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300073
J	Cao, Y; Zhang, Y; Yu, ZF; Mi, F; Liu, CL; Tang, XZ; Long, YX; He, XX; Wang, PF; Xu, JP				Cao, Yang; Zhang, Ying; Yu, Zefen; Mi, Fei; Liu, Chunli; Tang, Xiaozhao; Long, Yunxian; He, Xiaoxia; Wang, Pengfei; Xu, Jianping			Structure, Gene Flow, and Recombination among Geographic Populations of a Russula virescens Ally from Southwestern China	PLOS ONE			English	Article							DNA; DIVERSITY; MUSHROOM; GENOME	Mushrooms that are morphologically indistinguishable from Russula virescens (Schaeff.) Fr. are among the most popular wild edible mushrooms in Yunnan province, southwestern China. However, almost nothing is known about their biology. This study investigated the diversity and population genetics of a R. virescens ally from Yunnan. A total of 210 samples were collected from 13 geographical locations throughout the main distribution range in Yunnan. The patterns of genetic variation within and among these geographic populations were analyzed using sequences from three nuclear and two mitochondrial DNA fragments. Analysis of the ITS sequences revealed that samples from Yunnan showed 3-6% sequence difference from R. virescens samples from North America and Europe and formed a distinct clade. Our multilocus population genetic analyses suggested frequent gene flow among geographic populations of the R. virescens ally in Yunnan. Interestingly, the nuclear and mitochondrial genes exhibited different levels of gene flow and recombination. We discuss the implications of our results for understanding speciation, reproduction and conservation of this important biological resource.	[Cao, Yang; Zhang, Ying; Yu, Zefen; Mi, Fei; Liu, Chunli; Tang, Xiaozhao; Long, Yunxian; He, Xiaoxia; Wang, Pengfei; Xu, Jianping] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; [Cao, Yang; Zhang, Ying; Yu, Zefen; Mi, Fei; Liu, Chunli; Tang, Xiaozhao; Long, Yunxian; He, Xiaoxia; Wang, Pengfei; Xu, Jianping] Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Yunnan University; Yunnan University; McMaster University	Xu, JP (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China.	jpxu@mcmaster.ca			Yunnan Province High-Profile Talents Program [2010CI106]; National Natural Science Foundation Program of PR China [31100018]; Yunnan University [2010C04Z]	Yunnan Province High-Profile Talents Program; National Natural Science Foundation Program of PR China(National Natural Science Foundation of China (NSFC)); Yunnan University	This project was supported by grants from Yunnan Province High-Profile Talents Program (2010CI106) to J. Xu, National Natural Science Foundation Program of PR China (31100018), and from Yunnan University (2010C04Z) to Y. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcik S, 2011, CRYPTOGAMIE MYCOL, V32, P63, DOI 10.7872/crym.v32.iss1.2012.063; Adamcik S, 2010, CRYPTOGAMIE MYCOL, V31, P119; Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Brundrett M, 2004, BIOL REV, V79, P473, DOI 10.1017/S1464793103006316; Comeron JM, 1995, J MOL EVOL, V41, P1152, DOI 10.1007/BF00173196; Hughes KW, 2009, NEW PHYTOL, V182, P795, DOI 10.1111/j.1469-8137.2009.02802.x; Ishida TA, 2008, NEW PHYTOL, V180, P491, DOI 10.1111/j.1469-8137.2008.02572.x; Klironomos JN, 2001, NATURE, V410, P651, DOI 10.1038/35070643; Lan M, 2009, MAT MED YUNNAN; Li MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010684; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pujol C, 2005, EVOL GENET, P149; Roy M, 2008, MOL ECOL, V17, P2825, DOI 10.1111/j.1365-294X.2008.03790.x; Saari SK, 2005, NEW PHYTOL, V165, P295, DOI 10.1111/j.1469-8137.2004.01213.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sha T, 2008, MICROBIOL-SGM, V154, P3460, DOI 10.1099/mic.0.2008/020495-0; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang HM, 2007, FUNGAL GENET BIOL, V44, P991, DOI 10.1016/j.fgb.2007.03.005; Wang XH, 2004, COLOR ATLAS WILD COM; Wang XH, 2009, NOVA HEDWIGIA, V88, P269, DOI 10.1127/0029-5035/2009/0088-0269; [王向华 Wang Xianghua], 2002, [生物多样性, Chinese Biodiversity], V10, P318; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilson A. J., 2012, Mycology - An International Journal on Fungal Biology, V3, P158; Xu J, 2005, EVOL GENET, P189; Xu JP, 2009, MOL ECOL, V18, P2628, DOI 10.1111/j.1365-294X.2009.04227.x; XU JP, 1994, TRENDS GENET, V10, P226, DOI 10.1016/0168-9525(94)90158-9; Xu JP, 1999, MOL ECOL, V8, P59, DOI 10.1046/j.1365-294X.1999.00523.x; [杨祝良 Yang Zhuliang], 2002, [自然资源学报, Journal of Natural Resources], V17, P463	36	20	25	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73174	10.1371/journal.pone.0073174	http://dx.doi.org/10.1371/journal.pone.0073174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069176	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300006
J	Galatola, M; Izzo, V; Cielo, D; Morelli, M; Gambino, G; Zanzi, D; Strisciuglio, C; Sperandeo, MP; Greco, L; Auricchio, R				Galatola, Martina; Izzo, Valentina; Cielo, Donatella; Morelli, Marinita; Gambino, Giuseppina; Zanzi, Delia; Strisciuglio, Caterina; Sperandeo, Maria Pia; Greco, Luigi; Auricchio, Renata			Gene Expression Profile of Peripheral Blood Monocytes: A Step towards the Molecular Diagnosis of Celiac Disease?	PLOS ONE			English	Article							INTRAEPITHELIAL LYMPHOCYTES; MULTIPLE COMMON; LPP EXPRESSION; T(H)17 CELLS; KAPPA-B; DIFFERENTIATION; ASSOCIATION; VARIANTS; IL-21	Aim: Celiac disease (CD) is a multifactorial autoimmune disease induced by ingestion of gluten in genetically predisposed individuals. Despite technological progress, the diagnosis of CD is still based on duodenal biopsy as it was 50 years ago. In this study we analysed the expression of CD-associated genes in small bowel biopsies of patients and controls in order to explore the multivariate pathway of the expression profile of CD patients. Then, using multivariant discriminant analysis, we evaluated whether the expression profiles of these genes in peripheral blood monocytes (PBMs) differed between patients and controls. Participants: Thirty-seven patients with active and 11 with treated CD, 40 healthy controls and 9 disease controls (Crohn's disease patients) were enrolled. Results: Several genes were differentially expressed in CD patients versus controls, but the analysis of each single gene did not provided a comprehensive picture. A multivariate discriminant analysis showed that the expression of 5 genes in intestinal mucosa accounted for 93% of the difference between CD patients and controls. We then applied the same approach to PBMs, on a training set of 20 samples. The discriminant equation obtained was validated on a testing cohort of 10 additional cases and controls, and we obtained a correct classification of all CD cases and of 91% of the control samples. We applied this equation to treated CD patients and to disease controls and obtained a discrimination of 100%. Conclusions: The combined expression of 4 genes allows one to discriminate between CD patients and controls, and between CD patients on a gluten-free diet and disease controls. Our results contribute to the understanding of the complex interactions among CD-associated genes, and they may represent a starting point for the development of a molecular diagnosis of celiac disease.	[Galatola, Martina; Izzo, Valentina; Cielo, Donatella; Morelli, Marinita; Gambino, Giuseppina; Zanzi, Delia; Strisciuglio, Caterina; Sperandeo, Maria Pia; Greco, Luigi; Auricchio, Renata] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Galatola, Martina; Cielo, Donatella; Zanzi, Delia; Sperandeo, Maria Pia; Greco, Luigi; Auricchio, Renata] Univ Naples Federico II, ELFID, Naples, Italy; [Galatola, Martina] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Greco, L (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	ydongre@unina.it	Strisciuglio, Caterina/ABD-2466-2020; AURICCHIO, RENATA/AAC-7718-2022	STRISCIUGLIO, Caterina/0000-0002-9005-6571	PREVENT-CD project [036383]	PREVENT-CD project	This work was funded by the PREVENT-CD project: EU-FP6-2005-FOOD4B-contract no. 036383. The authors thank Associazione Italiana Celiachia (AIC), European Laboratory for food induced disease (ELFID) and the Italian Ministry of Health, International Affairs, (EUROMED action - MEDICEL project) for a supporting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Beitnes ACR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033556; Bragde H, 2011, PEDIATR RES, V69, P530, DOI 10.1203/PDR.0b013e318217ecec; Capuano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029094; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882; Gibbons DL, 2011, J IMMUNOL, V187, P2067, DOI 10.4049/jimmunol.1100833; Gorenne I, 2006, CIRC RES, V98, P378, DOI 10.1161/01.RES.0000202802.34727.fd; Greco L, 2011, WORLD J GASTROENTERO, V17, P4971, DOI 10.3748/wjg.v17.i45.4971; Grunewald TGP, 2009, TRANSL ONCOL, V2, P107, DOI 10.1593/tlo.09112; Harris KM, 2010, CLIN IMMUNOL, V135, P430, DOI 10.1016/j.clim.2010.01.003; Hollis-Moffatt JE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3053; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; IRVINE EJ, 1995, J CLIN GASTROENTEROL, V20, P27; Izzo V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026920; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Maiuri MC, 2003, J MOL MED-JMM, V81, P373, DOI 10.1007/s00109-003-0440-0; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Oberhuber G, 2001, Z GASTROENTEROL, V39, P157, DOI 10.1055/s-2001-11147; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Plaza-Izurieta L, 2011, J MED GENET, V48, P493, DOI 10.1136/jmg.2011.089714; Qu ZL, 2012, J HUAZHONG U SCI-MED, V32, P459, DOI 10.1007/s11596-012-0080-0; Raki M, 2006, GASTROENTEROLOGY, V131, P428, DOI 10.1053/j.gastro.2006.06.002; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Sperandeo MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021281; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; VECCHI M, 1992, GASTROENTEROLOGY, V102, P1499, DOI 10.1016/0016-5085(92)91707-B; Verhelst K, 2012, EMBO J, V31, P3845, DOI 10.1038/emboj.2012.240; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang MM, 2012, MOL VIS, V18, P1865	33	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74747	10.1371/journal.pone.0074747	http://dx.doi.org/10.1371/journal.pone.0074747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069342	gold, Green Published			2022-12-27	WOS:000324547300055
J	Cuppini, L; Calleri, A; Bruzzone, MG; Prodi, E; Anghileri, E; Pellegatta, S; Mancuso, P; Porrati, P; Di Stefano, AL; Ceroni, M; Bertolini, F; Finocchiaro, G; Eoli, M				Cuppini, Lucia; Calleri, Angelica; Bruzzone, Maria Grazia; Prodi, Elena; Anghileri, Elena; Pellegatta, Serena; Mancuso, Patrizia; Porrati, Paola; Di Stefano, Anna Luisa; Ceroni, Mauro; Bertolini, Francesco; Finocchiaro, Gaetano; Eoli, Marica			Prognostic Value of CD109+Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan	PLOS ONE			English	Article							PHASE-II TRIAL; PROGENITOR CELLS; 1ST-LINE CHEMOTHERAPY; RESPONSE ASSESSMENT; HEMATOPOIETIC STEM; FLOW-CYTOMETRY; CLINICAL-VALUE; VEGF; TEMOZOLOMIDE; GLIOMAS	Background: Recent data suggest that circulating endothelial and progenitor cells (CECs and CEPs, respectively) may have predictive potential in cancer patients treated with bevacizumab, the antibody recognizing vascular endothelial growth factor (VEGF). Here we report on CECs and CEPs investigated in 68 patients affected by recurrent glioblastoma (rGBM) treated with bevacizumab and irinotecan and two Independent Datasets of rGBM patients respectively treated with bevacizumab alone (n=32, independent dataset A: IDA) and classical antiblastic chemotherapy (n=14, independent dataset B: IDB). Methods: rGBM patients with KPS >= 50 were treated until progression, as defined by MRI with RANO criteria. CECs expressing CD109, a marker of tumor endothelial cells, as well as other CEC and CEP subtypes, were investigated by six-color flow cytometry. Results: A baseline count of CD109+ CEC higher than 41.1/ml (1st quartile) was associated with increased progression free survival (PFS; 20 versus 9 weeks, P=0.008) and overall survival (OS; 32 versus 23 weeks, P=0.03). Longer PFS (25 versus 8 weeks, P=0.02) and OS (27 versus 17 weeks, P=0.03) were also confirmed in IDA with CD109+ CECs higher than 41.1/ml but not in IDB. Patients treated with bevacizumab with or without irinotecan that were free from MRI progression after two months of treatment had significant decrease of CD109+ CECs: median PFS was 19 weeks; median OS 29 weeks. The presence of two non-contiguous lesions (distant disease) at baseline was an independent predictor of shorter PFS and OS (P<0.001). Conclusions: Data encourage further studies on the predictive potential of CD109+ CECs in GBM patients treated with bevacizumab.	[Cuppini, Lucia; Anghileri, Elena; Pellegatta, Serena; Porrati, Paola; Di Stefano, Anna Luisa; Finocchiaro, Gaetano; Eoli, Marica] Fdn IRCCS Ist Neurol C, Dept Neurooncol Unit, Milan, Italy; [Calleri, Angelica; Mancuso, Patrizia; Bertolini, Francesco] European Inst Oncol, Dept Hematol Oncol, Milan, Italy; [Bruzzone, Maria Grazia; Prodi, Elena] Fdn IRCCS Ist Neurol C, Dept Neuroradiol, Milan, Italy; [Di Stefano, Anna Luisa; Ceroni, Mauro] Fdn IRCCS Ist Neurol Nazl C, Dept Neurol, Pavia, Italy	IRCCS European Institute of Oncology (IEO)	Finocchiaro, G (corresponding author), Fdn IRCCS Ist Neurol C, Dept Neurooncol Unit, Milan, Italy.	gaetano.finocchiaro@gmail.com	Bruzzone, Maria/AAM-4478-2021; Pellegatta, Serena/AAL-3693-2021; bertolini, francesco/AAC-9780-2019; Eoli, Marica/K-7748-2016; Anghileri, Elena/AAK-4180-2021; ceroni, mauro/G-7080-2011; Di Stefano, Anna Luisa/AAS-7836-2020; Calleri, Angelica/AAO-3747-2020; Finocchiaro, Gaetano/AAG-6791-2020	Bruzzone, Maria/0000-0002-2786-1471; Pellegatta, Serena/0000-0001-7804-9486; bertolini, francesco/0000-0001-5660-3255; Eoli, Marica/0000-0003-4744-9377; Anghileri, Elena/0000-0001-7383-3108; ceroni, mauro/0000-0002-8947-5007; Di Stefano, Anna Luisa/0000-0003-1746-0647; Prodi, Elena/0000-0003-1200-0465; Finocchiaro, Gaetano/0000-0003-3583-4040	Italian Ministry of Health [RF-INN-2008-1142520, RF-2009-1524104]; Italian Association for Research on Cancer [IG 10249]; Fondazione Umberto Veronesi	Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	This work was partially supported by a grant from Italian Ministry of Health (http://www.salute.gov.it/ricercaSanitaria/paginaMenuRicercaSanitaria.jsp?menu=finalizzata&lingua=italiano; http://ricerca.cbim.it/index.html) [RF-INN-2008-1142520 to GF, RF-2009-1524104 to FB]; Italian Association for Research on Cancer; (http://www.airc.it/) [IG 10249 to FB]; and Fondazione Umberto Veronesi (http://www.fondazioneveronesi.it/) [Call 2010 to FB]. Drugs were supplied by Roche S. p. A. (Monza, Italy) and Hospira (Napoli, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bababeygy SR, 2008, STEM CELLS DEV, V17, P11, DOI 10.1089/scd.2007.0117; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Bertolini F, 2011, LANCET ONCOL, V12, P217, DOI 10.1016/S1470-2045(11)70051-1; Bidard FC, 2010, ANN ONCOL, V21, P1765, DOI 10.1093/annonc/mdq052; Bizet AA, 2011, BBA-MOL CELL RES, V1813, P742, DOI 10.1016/j.bbamcr.2011.01.028; Calleri A, 2009, CLIN CANCER RES, V15, P7652, DOI 10.1158/1078-0432.CCR-09-1493; Cao Y, 2012, CANCER, V119, P313; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; Desjardins A, 2012, CANCER-AM CANCER SOC, V118, P1302, DOI 10.1002/cncr.26381; Estes ML, 2010, CYTOM PART A, V77A, P831, DOI 10.1002/cyto.a.20921; Fleitas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047365; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Perez-Larraya JG, 2012, NEURO-ONCOLOGY, V14, P667, DOI 10.1093/neuonc/nos070; Gila MJ, 2012, ANTI-CANCER DRUG, V23, P659, DOI 10.1097/CAD.0b013e3283534d3e; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hashimoto M, 2004, ONCOGENE, V23, P3716, DOI 10.1038/sj.onc.1207418; Iwamoto FM, 2010, ARCH NEUROL-CHICAGO, V67, P285, DOI 10.1001/archneurol.2010.11; Jubb AM, 2010, LANCET ONCOL, V11, P1172, DOI 10.1016/S1470-2045(10)70232-1; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Lambrechts D, 2013, J CLIN ONCOL, V31, P1219, DOI 10.1200/JCO.2012.46.2762; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Maharaj ASR, 2008, J EXP MED, V205, P491, DOI 10.1084/jem.20072041; Malka D, 2012, ANN ONCOL, V23, P919, DOI 10.1093/annonc/mdr365; Mancuso P, 2011, INT J CANCER, V129, P1344, DOI 10.1002/ijc.25816; Mancuso P, 2009, CLIN CANCER RES, V15, P267, DOI 10.1158/1078-0432.CCR-08-0432; Matsusaka S, 2011, CANCER CHEMOTH PHARM, V68, P763, DOI 10.1007/s00280-010-1543-2; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Murakami H, 2011, EXP THER MED, V2, P595, DOI 10.3892/etm.2011.253; Murray LJ, 1999, EXP HEMATOL, V27, P1282, DOI 10.1016/S0301-472X(99)00071-5; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Perry JR, 2010, J CLIN ONCOL, V28, P2051, DOI 10.1200/JCO.2009.26.5520; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Pope WB, 2011, CURR NEUROL NEUROSCI, V11, P336, DOI 10.1007/s11910-011-0179-x; Rafat N, 2010, J NEUROSURG, V112, P43, DOI 10.3171/2009.5.JNS081074; Ronzoni M, 2010, ANN ONCOL, V21, P2382, DOI 10.1093/annonc/mdq261; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Simkens LHJ, 2010, ANN ONCOL, V21, P2447, DOI 10.1093/annonc/mdq640; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tchaicha JH, 2011, CANCER RES, V71, P6371, DOI 10.1158/0008-5472.CAN-11-0991; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Weisshardt P, 2012, HISTOCHEM CELL BIOL, V137, P391, DOI 10.1007/s00418-011-0898-8; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wong ET, 2011, J NATL COMPR CANC NE, V9, P403, DOI 10.6004/jnccn.2011.0037	51	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74345	10.1371/journal.pone.0074345	http://dx.doi.org/10.1371/journal.pone.0074345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069296	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100101
J	Swierts, T; Peijnenburg, KTCA; de Leeuw, C; Cleary, DFR; Hornlein, C; Setiawan, E; Worheide, G; Erpenbeck, D; de Voogd, NJ				Swierts, Thomas; Peijnenburg, Katja T. C. A.; de Leeuw, Christiaan; Cleary, Daniel F. R.; Hornlein, Christine; Setiawan, Edwin; Worheide, Gert; Erpenbeck, Dirk; de Voogd, Nicole J.			Lock, Stock and Two Different Barrels: Comparing the Genetic Composition of Morphotypes of the Indo-Pacific Sponge Xestospongia testudinaria	PLOS ONE			English	Article							ENVIRONMENTAL-CONDITIONS; SPERMONDE ARCHIPELAGO; MARINE BIODIVERSITY; DIVERSITY; REEF; PORIFERA; ELECTROPHORESIS; DEMOSPONGIAE; POPULATIONS; PHYLOGENIES	The giant barrel sponge Xestospongia testudinaria is an ecologically important species that is widely distributed across the Indo-Pacific. Little is known, however, about the precise biogeographic distribution and the amount of morphological and genetic variation in this species. Here we provide the first detailed, fine-scaled (<200 km(2)) study of the morphological and genetic composition of X. testudinaria around Lembeh Island, Indonesia. Two mitochondrial (CO1 and ATP6 genes) and one nuclear (ATP synthase beta intron) DNA markers were used to assess genetic variation. We identified four distinct morphotypes of X. testudinaria around Lembeh Island. These morphotypes were genetically differentiated with both mitochondrial and nuclear markers. Our results indicate that giant barrel sponges around Lembeh Island, which were all morphologically identified as X. testudinaria, consist of at least two different lineages that appear to be reproductively isolated. The first lineage is represented by individuals with a digitate surface area, CO1 haplotype C5, and is most abundant around the harbor area of Bitung city. The second lineage is represented by individuals with a predominantly smooth surface area, CO1 haplotype C1 and can be found all around Lembeh Island, though to a lesser extent around the harbor of Bitung city. Our findings of two additional unique genetic lineages suggests the presence of an even broader species complex possibly containing more than two reproductively isolated species. The existence of X. testudinaria as a species complex is a surprising result given the size, abundance and conspicuousness of the sponge.	[Swierts, Thomas; Peijnenburg, Katja T. C. A.; de Leeuw, Christiaan; de Voogd, Nicole J.] Naturalis Biodivers Ctr, Leiden, Netherlands; [Swierts, Thomas; Peijnenburg, Katja T. C. A.; de Leeuw, Christiaan] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Cleary, Daniel F. R.] Univ Aveiro, CESAM, Ctr Estudos Ambiente & Mar, Dept Biol, P-3800 Aveiro, Portugal; [Hornlein, Christine] Royal Netherlands Inst Sea Res, Yerseke Marine Microbiol, Yerseke, Netherlands; [Setiawan, Edwin; Worheide, Gert; Erpenbeck, Dirk] Univ Munich, Dept Earth & Environm Sci Palaeontol & Geobiol, Munich, Germany; [Worheide, Gert; Erpenbeck, Dirk] Univ Munich, GeoBio Ctr, Munich, Germany; [Worheide, Gert] Bayer Staatssammlung Palaontol & Geol, Munich, Germany	Naturalis Biodiversity Center; University of Amsterdam; Universidade de Aveiro; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Munich; University of Munich	de Voogd, NJ (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.	nicole.devoogd@naturalis.nl	Cleary, Daniel/D-2582-2012; Peijnenburg, Katja TCA/F-7176-2016; Cleary, Daniel/ABA-9393-2021; de Voogd, Nicole/I-9280-2012; Edwin, Setiawan/AAB-5988-2021; Setiawan, Edwin/U-1706-2019; Wörheide, Gert/C-1080-2008	Cleary, Daniel/0000-0002-6143-3390; Peijnenburg, Katja TCA/0000-0001-7544-1079; Cleary, Daniel/0000-0002-6143-3390; de Voogd, Nicole/0000-0002-7985-5604; Edwin, Setiawan/0000-0003-3947-3334; Setiawan, Edwin/0000-0003-3947-3334; Wörheide, Gert/0000-0002-6380-7421; Erpenbeck, Dirk/0000-0003-2716-1085	Percy Sladen Memorial Fund of the Linnean Society of London; Treub-Maatschappij Fund	Percy Sladen Memorial Fund of the Linnean Society of London; Treub-Maatschappij Fund	The project was supported by the Percy Sladen Memorial Fund of the Linnean Society of London and the Treub-Maatschappij Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; Bentlage B, 2007, CORAL REEFS, V26, P807, DOI 10.1007/s00338-007-0267-1; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; Cleary DFR, 2012, MAR POLLUT BULL, V64, P263, DOI 10.1016/j.marpolbul.2011.11.020; Cleary DFR, 2007, J MAR BIOL ASSOC UK, V87, P1669, DOI 10.1017/S0025315407052770; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; de Voogd NJ, 2008, MAR ECOL-EVOL PERSP, V29, P205, DOI 10.1111/j.1439-0485.2008.00238.x; de Voogd NJ, 2006, MAR ECOL PROG SER, V309, P131, DOI 10.3354/meps309131; Diaz MC, 2001, B MAR SCI, V69, P535; Duran S, 2004, MAR BIOL, V144, P31, DOI 10.1007/s00227-003-1178-5; Erpenbeck D, 2006, MOL ECOL NOTES, V6, P550, DOI 10.1111/j.1471-8286.2005.01259.x; Erpenbeck D, 2002, MAR BIOL, V141, P377, DOI 10.1007/s00227-002-0785-x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; Faulkner DJ, 2002, NAT PROD REP, V19, P1, DOI 10.1039/b009029h; FROMONT J, 1991, Beagle, V8, P73; FROMONT J, 1994, CORAL REEFS, V13, P119, DOI 10.1007/BF00300772; Fromont J., 1988, P685; Goetze E, 2010, MOL ECOL, V19, P952, DOI 10.1111/j.1365-294X.2009.04520.x; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Hoeksema Bert W., 2007, V29, P117; HOEKSEMA BW, 2004, CHALLENGING COASTS T, P49; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Kayal E, 2008, GENE, V410, P177, DOI 10.1016/j.gene.2007.12.002; KEIGWIN LD, 1978, GEOLOGY, V6, P630, DOI 10.1130/0091-7613(1978)6<630:PCOTIO>2.0.CO;2; Kelly-Borges M., 1988, INDOMALAYAN ZOOLOGY, V5, P121; KERR RG, 1994, SPONGES IN TIME AND SPACE, P65; KERR RG, 1991, NAT PROD REP, V8, P465, DOI 10.1039/np9910800465; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; McMurray SE, 2008, MAR BIOL, V155, P159, DOI 10.1007/s00227-008-1014-z; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; MUNRO MHG, 1994, SPONGES IN TIME AND SPACE, P473; Oksanen J, 2009, COMMUNITY ECOLOGY PA; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Piola RF, 2008, DIVERS DISTRIB, V14, P329, DOI 10.1111/j.1472-4642.2007.00430.x; Pires ACC, 2012, APPL ENVIRON MICROB, V78, P5520, DOI 10.1128/AEM.00386-12; Rachello-Dolmen PG, 2007, ESTUAR COAST SHELF S, V73, P816, DOI 10.1016/j.ecss.2007.03.017; Reveillaud J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016533; Reveillaud J, 2010, MOL PHYLOGENET EVOL, V56, P104, DOI 10.1016/j.ympev.2010.03.034; Riesgo A, 2008, INVERTEBR BIOL, V127, P357, DOI 10.1111/j.1744-7410.2008.00128.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rua CPJ, 2011, J MAR BIOL ASSOC UK, V91, P1015, DOI 10.1017/S0025315410002122; Sarano F, 1991, CORAL REEFS, V10, P166, DOI [10.1007/BF00572176, DOI 10.1007/BF00572176]; Suchanek TH, 1985, ECOLOGY DEEP SHALLOW, P55; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Teske PR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-176; THORPE JP, 1994, ZOOL SCR, V23, P3, DOI 10.1111/j.1463-6409.1994.tb00368.x; van Oppen M.J.H., 2002, P131; VANSOEST RWM, 1989, NETH J SEA RES, V23, P223, DOI 10.1016/0077-7579(89)90016-1; Worheide G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-24; Worheide G, 2006, MAR BIOL, V148, P907, DOI 10.1007/s00227-005-0134-y; Worheide G, 2005, INTEGR COMP BIOL, V45, P377, DOI 10.1093/icb/45.2.377; Xavier JR, 2010, MOL PHYLOGENET EVOL, V56, P13, DOI 10.1016/j.ympev.2010.03.030	63	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74396	10.1371/journal.pone.0074396	http://dx.doi.org/10.1371/journal.pone.0074396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069308	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100105
J	Teixeira-da-Cunha, MGA; Gomes, RN; Roehrs, N; Bozza, FA; Prescott, SM; Stafforini, D; Zimmerman, GA; Bozza, PT; Castro-Faria-Neto, HC				Teixeira-da-Cunha, Mariana G. A.; Gomes, Rachel N.; Roehrs, Nathassia; Bozza, Fernando A.; Prescott, Stephen M.; Stafforini, Diana; Zimmerman, Guy A.; Bozza, Patricia T.; Castro-Faria-Neto, Hugo C.			Bacterial Clearance Is Improved in Septic Mice by Platelet-Activating Factor-Acetylhydrolase (PAF-AH) Administration	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; RECEPTOR-DEFICIENT MICE; NITRIC-OXIDE PRODUCTION; MCP-1 PROTECTS MICE; ENDOTOXIC-SHOCK; CLINICAL-TRIAL; SEVERE SEPSIS; HOST-DEFENSE; LUNG INJURY; IN-VITRO	Current evidence indicates that dysregulation of the host inflammatory response to infectious agents is central to the mortality of patients with sepsis. Strategies to block inflammatory mediators such as PAF have been investigated as adjuvant therapies for sepsis. PAF-AH, the enzyme responsible for PAF degradation, showed positive results in pre-clinical studies and phase II clinical trials, but the results of a phase III study were disappointing. In this study, we investigated the potential protective mechanism of PAF-AH in sepsis using the murine model of cecal ligation and puncture (CLP). Treatment with rPAF-AH increased peritoneal fluid levels of the anti-inflammatory mediators MCP-1/CCL2 after CLP. The numbers of bacteria (CFU) in the peritoneal cavity were decreased in the rPAF-AH-treated group, indicating more efficient bacterial clearance after rPAF-AH treatment. Interestingly, we observed increased levels of nitric oxide (NO) after PAF-AH administration, and rPAF-AH treatment did not decrease CFU numbers either in iNOS-deficient mice or in CCR2-deficient mice. We concluded that administration of exogenous rPAF-AH reduced inflammatory injury, altered cytokine levels and favored bacterial clearance with a clear impact on mortality through modulation of MCP-1/CCL2 and NO levels in a clinically relevant sepsis model.	[Prescott, Stephen M.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Stafforini, Diana] Huntsman Canc Inst, Salt Lake City, UT USA; [Zimmerman, Guy A.] Univ Utah, Program Human Mol Biol & Genet, Salt Lake City, UT USA	Oklahoma Medical Research Foundation; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah		rachelngomes@gmail.com	Bozza, Patricia T./AAE-2933-2021; Bozza, Patricia T./AAM-4537-2021; Gomes, Rachel N/I-7643-2013; Bozza, Fernando A/A-2618-2013	Bozza, Patricia T./0000-0001-8349-9529; Bozza, Fernando A/0000-0003-4878-0256	PAPES-FIOCRUZ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ, Brazil); NATIONAL CANCER INSTITUTE [P01CA073992] Funding Source: NIH RePORTER	PAPES-FIOCRUZ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by PAPES-FIOCRUZ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), and Fundacao de Amparo a Pesquisa do Rio de Janeiro (FAPERJ, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti JCS, 1999, INFECT IMMUN, V67, P2810, DOI 10.1128/IAI.67.6.2810-2814.1999; Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; Benjamim CF, 2002, INFECT IMMUN, V70, P3602, DOI 10.1128/IAI.70.7.3602-3610.2002; Biswas SK, 2001, NITRIC OXIDE-BIOL CH, V5, P566, DOI 10.1006/niox.2001.0370; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; CUNHA FQ, 1994, IMMUNOLOGY, V81, P211; DePaolo RW, 2005, INFECT IMMUN, V73, P6514, DOI 10.1128/IAI.73.10.6514-6522.2005; Fierro IM, 1999, J LEUKOCYTE BIOL, V65, P508, DOI 10.1002/jlb.65.4.508; Forslund T, 1997, BIOCHEM BIOPH RES CO, V233, P492, DOI 10.1006/bbrc.1997.6490; Franchini A, 1995, ADV NEUROIMMUNOL, V5, P463, DOI 10.1016/0960-5428(95)00029-1; GERRA G, 1995, INT CLIN PSYCHOPHARM, V10, P245, DOI 10.1097/00004850-199511000-00006; Gomes RN, 2006, SHOCK, V26, P457, DOI 10.1097/01.shk.0000228801.56223.92; Gomes RN, 2006, SHOCK, V26, P41, DOI 10.1097/01.shk.0000209562.00070.1a; Gomes RN, 2013, SHOCK, V39, P63, DOI 10.1097/SHK.0b013e31827802b5; Guo HT, 2002, IMMUNOL LETT, V80, P21, DOI 10.1016/S0165-2478(01)00284-X; Hauser B, 2004, SHOCK, V22, P588, DOI 10.1097/00024382-200412000-00016; IMAIZUMI TA, 1995, J INTERN MED, V238, P5, DOI 10.1111/j.1365-2796.1995.tb00894.x; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaplan SS, 1996, INFECT IMMUN, V64, P69, DOI 10.1128/IAI.64.1.69-76.1996; Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017; Linares E, 2001, FREE RADICAL BIO MED, V30, P1234, DOI 10.1016/S0891-5849(01)00516-0; MAKRISTATHIS A, 1993, INFECT IMMUN, V61, P1996, DOI 10.1128/IAI.61.5.1996-2002.1993; MALAWISTA SE, 1992, J CLIN INVEST, V90, P631, DOI 10.1172/JCI115903; Marshall JC, 2003, NAT REV DRUG DISCOV, V2, P391, DOI 10.1038/nrd1084; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Matsukawa A, 1999, J IMMUNOL, V163, P6148; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moreno SE, 2006, J IMMUNOL, V177, P1264, DOI 10.4049/jimmunol.177.2.1264; MOZES T, 1991, J LIPID MEDIATOR, V4, P309; NAKANO Y, 1994, INFECT IMMUN, V62, P377, DOI 10.1128/IAI.62.2.377-383.1994; NARAHARA H, 1993, J CLIN ENDOCR METAB, V77, P1258, DOI 10.1210/jc.77.5.1258; Neto HCCF, 2005, MEM I OSWALDO CRUZ, V100, P83, DOI 10.1590/S0074-02762005000900014; Okuma T, 2006, INT J EXP PATHOL, V87, P475, DOI 10.1111/j.1365-2613.2006.00502.x; Opal S, 2004, CRIT CARE MED, V32, P332, DOI 10.1097/01.CCM.0000108867.87890.6D; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Reddy RC, 2001, IMMUNOL RES, V24, P273, DOI 10.1385/IR:24:3:273; Rijneveld AW, 2004, J INFECT DIS, V189, P711, DOI 10.1086/381392; Schuster DP, 2003, CRIT CARE MED, V31, P1612, DOI 10.1097/01.CCM.0000063267.79824.DB; Souza DG, 2003, BRIT J PHARMACOL, V139, P733, DOI 10.1038/sj.bjp.0705296; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020; Zisman DA, 1997, J CLIN INVEST, V99, P2832, DOI 10.1172/JCI119475	45	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74567	10.1371/journal.pone.0074567	http://dx.doi.org/10.1371/journal.pone.0074567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069320	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100111
J	Angulo, J; Yu, HL; Langousis, A; Kolovos, A; Wang, JF; Madrid, AE; Christakos, G				Angulo, Jose; Yu, Hwa-Lung; Langousis, Andrea; Kolovos, Alexander; Wang, Jinfeng; Esther Madrid, Ana; Christakos, George			Spatiotemporal Infectious Disease Modeling: A BME-SIR Approach	PLOS ONE			English	Article							SPATIAL DYNAMICS; EPIDEMICS; SPREAD; IMPACT; ASSIMILATION; TRANSMISSION; UNCERTAINTY; SYNCHRONY; PATTERNS	This paper is concerned with the modeling of infectious disease spread in a composite space-time domain under conditions of uncertainty. We focus on stochastic modeling that accounts for basic mechanisms of disease distribution and multi-sourced in situ uncertainties. Starting from the general formulation of population migration dynamics and the specification of transmission and recovery rates, the model studies the functional formulation of the evolution of the fractions of susceptible-infected-recovered individuals. The suggested approach is capable of: a) modeling population dynamics within and across localities, b) integrating the disease representation (i.e. susceptible-infected-recovered individuals) with observation time series at different geographical locations and other sources of information (e. g. hard and soft data, empirical relationships, secondary information), and c) generating predictions of disease spread and associated parameters in real time, while considering model and observation uncertainties. Key aspects of the proposed approach are illustrated by means of simulations (i.e. synthetic studies), and a real-world application using hand-foot-mouth disease (HFMD) data from China.	[Angulo, Jose] Univ Granada, Dept Stat & Operat Res, Granada, Spain; [Yu, Hwa-Lung] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan; [Langousis, Andrea] Univ Patras, Dept Civil Engn, GR-26110 Patras, Greece; [Kolovos, Alexander] SpaceTimeWorks LLC, San Diego, CA USA; [Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Esther Madrid, Ana] MDE UPCT, Spanish Air Force Acad, Univ Ctr Def, Murcia, Spain; [Christakos, George] San Diego State Univ, Dept Geog, San Diego, CA 92182 USA; [Christakos, George] Zhejiang Univ, Dept Environm & Nat Resources, Hangzhou 310003, Zhejiang, Peoples R China	University of Granada; National Taiwan University; University of Patras; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; California State University System; San Diego State University; Zhejiang University	Yu, HL (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	hlyu@ntu.edu.tw	Angulo, José/I-5066-2015; Madrid, Ana Esther/I-4488-2015; Kolovos, Alexander/AAI-7091-2020	Angulo, José/0000-0002-6863-7847; Madrid, Ana Esther/0000-0002-1024-0038; Yu, Hwa Lung/0000-0001-9558-2100; Wang, Jinfeng/0000-0002-6687-9420; Christakos, George/0000-0002-1865-5764; Langousis, Andreas/0000-0002-0643-2520	SGPI [MTM2009-13250, MTM2012-32666]; Andalusian CICE, Spain [P08-FQM-3834]; National Science Council of Taiwan [NSC101-2628-E-002-017-MY3, NSC102-2221-E-002-140-MY3]; SpaceTimeWorks, LLC.; Yongqian Chair Professorship (Zhejiang University, China)	SGPI; Andalusian CICE, Spain; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); SpaceTimeWorks, LLC.; Yongqian Chair Professorship (Zhejiang University, China)	J.M. Angulo and A. E. Madrid have been partially supported by grants MTM2009-13250 and MTM2012-32666 of SGPI, and P08-FQM-3834 of the Andalusian CICE, Spain. H-L Yu has been partially supported by a grant from National Science Council of Taiwan (NSC101-2628-E-002-017-MY3 and NSC102-2221-E-002-140-MY3). A. Kolovos was supported by SpaceTimeWorks, LLC. G. Christakos was supported by a Yongqian Chair Professorship (Zhejiang University, China). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON J, 1986, STAT ANAL COMPOSITIO, pR15; Allen LJS, 2000, MATH BIOSCI, V163, P1, DOI 10.1016/S0025-5564(99)00047-4; Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; ANDERSON R M, 1991; ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; ANGULO J, 2012, INT J GEOGRAPHICAL I; Baker R, 2007, STOCH ENV RES RISK A, V21, P435, DOI 10.1007/s00477-006-0076-z; Ball F, 2002, MATH BIOSCI, V180, P73, DOI 10.1016/S0025-5564(02)00125-6; Bettencourt LMA, 2007, LECT NOTES COMPUT SC, V4506, P79; CHRISTAKOS G, 1990, MATH GEOL, V22, P763, DOI 10.1007/BF00890661; Christakos G, 2005, STOCH ENV RES RISK A, V19, P307, DOI 10.1007/s00477-005-0236-6; Christakos G, 2002, ADV WATER RESOUR, V25, P1257, DOI 10.1016/S0309-1708(02)00064-7; CHRISTAKOS G, 1998, SPATIOTEMPORAL ENVIR; Christakos G., 2000, MODERN SPATIOTEMPORA; Christakos G., 2005, INTERDISCIPLINARY PU; Cummings DAT, 2009, AM J EPIDEMIOL, V169, pS40; Dudik M, 2007, J MACH LEARN RES, V8, P1217; Eggo RM, 2011, J R SOC INTERFACE, V8, P233, DOI 10.1098/rsif.2010.0216; Elderd BD, 2006, P NATL ACAD SCI USA, V103, P15693, DOI 10.1073/pnas.0600816103; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; KALNAY E, 2003, ATMOSPHERIC MODELLIN, pR22, DOI DOI 10.1256/00359000360683511; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Li LJ, 2010, FRONT MED-PRC, V4, P139; Lloyd AL, 2004, MATH BIOSCI, V188, P1, DOI 10.1016/j.mbs.2003.09.003; Orton TG, 2007, STOCH ENV RES RISK A, V21, P773, DOI 10.1007/s00477-006-0089-7; Park S.K., 2009, DATA ASSIMILATION AT; Pawlowsky-Glahn V, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, pXVII; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Riley S, 2006, P NATL ACAD SCI USA, V103, P12637, DOI 10.1073/pnas.0510873103; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Schrodle B, 2012, BIOMETRICS, V68, P736, DOI 10.1111/j.1541-0420.2011.01717.x; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang JF, 2006, B WORLD HEALTH ORGAN, V84, P965, DOI 10.2471/BLT.06.030247; West RW, 1997, MATH BIOSCI, V141, P29; Yu HL, 2007, STOCH ENV RES RISK A, V21, P555, DOI 10.1007/s00477-007-0135-0	38	24	24	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e72168	10.1371/journal.pone.0072168	http://dx.doi.org/10.1371/journal.pone.0072168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086257	Green Published, gold, Green Submitted			2022-12-27	WOS:000325223900006
J	Gu, SH; Wu, KM; Guo, YY; Field, LM; Pickett, JA; Zhang, YJ; Zhou, JJ				Gu, Shao-Hua; Wu, Kong-Ming; Guo, Yu-Yuan; Field, Linda M.; Pickett, John A.; Zhang, Yong-Jun; Zhou, Jing-Jiang			Identification and Expression Profiling of Odorant Binding Proteins and Chemosensory Proteins between Two Wingless Morphs and a Winged Morph of the Cotton Aphid Aphis gossypii Glover	PLOS ONE			English	Article							PHEROMONE-BINDING; INSECT CHEMORECEPTION; MAMESTRA-BRASSICAE; GENOME ANNOTATION; CHEMICAL ECOLOGY; SOLUBLE-PROTEINS; ALARM PHEROMONE; CIS-JASMONE; LOCALIZATION; PURIFICATION	Insects interact with their environment and respond to the changes in host plant conditions using semiochemicals. Such ecological interactions are facilitated by the olfactory sensilla and the use of olfactory recognition proteins. The cotton aphid Aphis gossypii can change its phenotype in response to ecological conditions. They reproduce mainly as wingless asexual morphs but develop wings to find mates or new plant hosts under the influence of environmental factors such as temperature, plant nutrition and population density. Two groups of small soluble proteins, odorant binding proteins (OBPs) and chemosensory proteins (CSPs) are believed to be involved in the initial biochemical recognition steps in semiochemical perception. However, the exact molecular roles that these proteins play in insect olfaction remain to be discovered. In this study, we compared the transcriptomes of three asexual developmental stages (wingless spring and summer morphs and winged adults) and characterised 9 OBP and 9 CSP genes. The gene structure analysis showed that the number and length of introns in these genes are much higher and this appears to be unique feature of aphid OBP and CSP genes in general. Another unique feature in aphids is a higher abundance of CSP transcripts than OBP transcripts, suggesting an important role of CSPs in aphid physiology and ecology. We showed that some of the transcripts are overexpressed in the antennae in comparison to the bodies and highly expressed in the winged aphids compared to wingless morphs, suggesting a role in host location. We examined the differential expression of these olfactory genes in ten aphid species and compared the expression profile with the RNA-seq analyses of 25 pea aphid transcriptome libraries hosted on AphidBase.	[Gu, Shao-Hua; Wu, Kong-Ming; Guo, Yu-Yuan; Zhang, Yong-Jun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Field, Linda M.; Pickett, John A.; Zhou, Jing-Jiang] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yjzhang@ippcaas.cn; jing-jiang.zhou@rothamsted.ac.uk		Field, Linda/0000-0002-3328-2513	China National "973" Basic Research Program [2012CB114104]; National Natural Science Foundation of China [31071694, 31171858, 31272048]; Royal Society, UK [31111130203, JP100849]; BBSRC International Partnering Award [BB/J020281]; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; Biotechnology and Biological Sciences Research Council [BB/J020281/1, BBS/E/C/00005194] Funding Source: researchfish; BBSRC [BB/J020281/1, BBS/E/C/00005194] Funding Source: UKRI	China National "973" Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society, UK(Royal Society of London); BBSRC International Partnering Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the China National "973" Basic Research Program (2012CB114104) and the National Natural Science Foundation of China (31071694, 31171858 and 31272048). YJZ and JJZ acknowledge the financial support from the Royal Society, UK for the international joint project between China and UK (31111130203; JP100849) and BBSRC International Partnering Award (BB/J020281). Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Abassi S, 2000, J CHEM ECOL, V26, P1765, DOI 10.1023/A:1005555300476; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ban L, 2003, INSECT MOL BIOL, V12, P125, DOI 10.1046/j.1365-2583.2003.00394.x; CAMPBELL CAM, 1993, J CHEM ECOL, V19, P1569, DOI 10.1007/BF00984897; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; DAWSON GW, 1984, ENTOMOL EXP APPL, V36, P197, DOI 10.1007/BF00569962; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Dewhirst SY, 2012, PEST MANAG SCI, V68, P1419, DOI 10.1002/ps.3326; Dewhirst SY, 2010, VITAM HORM, V83, P551, DOI 10.1016/S0083-6729(10)83022-5; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Hegde M, 2012, PHYTOCHEMISTRY, V78, P81, DOI 10.1016/j.phytochem.2012.03.004; Honson NS, 2005, RECENT ADV PHYTOCHEM, V39, P227; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jacobs SP, 2005, INSECT MOL BIOL, V14, P423, DOI 10.1111/j.1365-2583.2005.00573.x; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mameli M, 1996, INSECT BIOCHEM MOLEC, V26, P875, DOI 10.1016/S0965-1748(96)00055-0; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; PICKETT JA, 1980, J CHEM ECOL, V6, P349, DOI 10.1007/BF01402913; PICKETT JA, 1992, ANNU REV ENTOMOL, V37, P67, DOI 10.1146/annurev.en.37.010192.000435; Pickett JA, 2007, CHEM ECOLOGY; Pickett JA, 2012, PHYSIOL ENTOMOL, V37, P2, DOI 10.1111/j.1365-3032.2011.00828.x; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Sachse S., 2011, E NEUROFORUM, V2, P49, DOI [10.1007/s13295-011-0020-7, DOI 10.1007/S13295-011-0020-7]; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vandermoten S, 2012, INSECT BIOCHEM MOLEC, V42, P155, DOI 10.1016/j.ibmb.2011.11.008; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Zhong T, 2012, J INSECT PHYSIOL, V58, P771, DOI 10.1016/j.jinsphys.2012.01.011; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114	49	50	58	4	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e73524	10.1371/journal.pone.0073524	http://dx.doi.org/10.1371/journal.pone.0073524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073197	Green Submitted, gold, Green Published			2022-12-27	WOS:000324768000006
J	Cui, BY; Yang, X; Li, SW; Lin, ZJ; Wang, Z; Dong, C; Shen, YQ				Cui, Boyang; Yang, Xue; Li, Siwei; Lin, Zhijie; Wang, Zheng; Dong, Cheng; Shen, Yuequan			The Inhibitory Helix Controls the Intramolecular Conformational Switching of the C-Terminus of STIM1	PLOS ONE			English	Article							MECHANISTIC INSIGHTS; ORAI1; OLIGOMERIZATION; MACROMOLECULES; ACTIVATION; INITIATION; DOMAIN; PORE	Store-operated Ca2+ entry (SOCE) is a critical Ca2+ signaling pathway in many cell types. After sensing Ca2+ store depletion in the endoplasmic reticulum (ER) lumen, STIM1 (STromal Interaction Molecule 1) oligomerizes and then interacts with and activates the Orai1 calcium channel. Our previous research has demonstrated that the inhibitory helix (IH) adjacent to the first coiled-coil region (CC1) of STIM1 may keep the whole C-terminus of STIM1 in an inactive state. However, the specific conformational change of CC1-IH that drives the transition of STIM1 from the resting state to the active state remains elusive. Herein, we report the structural analysis of CC1-IH, which revealed that the entire CC1-IH molecule forms a very long helix. Structural and biochemical analyses indicated that IH, and not the CC1 region, contributes to the oligomerization of STIM1. Small-angle X-ray scattering (SAXS) analysis suggested that the C-terminus of STIM1 including the IH region displays a collapsed conformation, whereas the construct without the IH region has an extended conformation. These two conformations may correspond to the conformational states of the C-terminus of STIM1 before and after activation. Taken together, our results provide direct biochemical evidence that the IH region controls the conformational switching of the C-terminus of STIM1.	[Cui, Boyang; Yang, Xue; Li, Siwei; Wang, Zheng; Shen, Yuequan] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Cui, Boyang; Li, Siwei; Lin, Zhijie; Wang, Zheng; Dong, Cheng; Shen, Yuequan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Shen, Yuequan] Synerget Innovat Ctr Chem Sci & Engn, Tianjin, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com	Lin, Zhijie/Y-4836-2019		973 Program [2012CB917200, 2013CB910400]; Natural Science Foundation of China [31170684]; Fundamental Research Funds for the Central Universities [65020241]	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the 973 Program (grants 2012CB917200 and 2013CB910400), the Natural Science Foundation of China (grant 31170684), and the Fundamental Research Funds for the Central Universities (grant 65020241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yu F, 2013, J CELL SCI, V126, P2401, DOI 10.1242/jcs.117200; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842	32	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74735	10.1371/journal.pone.0074735	http://dx.doi.org/10.1371/journal.pone.0074735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069340	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300041
J	Hindrikson, M; Remm, J; Mannil, P; Ozolins, J; Tammeleht, E; Saarma, U				Hindrikson, Maris; Remm, Jaanus; Maennil, Peep; Ozolins, Janis; Tammeleht, Egle; Saarma, Urmas			Spatial Genetic Analyses Reveal Cryptic Population Structure and Migration Patterns in a Continuously Harvested Grey Wolf (Canis lupus) Population in North-Eastern Europe	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; COMPUTER-PROGRAM; SOCIAL BONDS; BROWN BEARS; WOLVES; SIZE; HYBRIDIZATION; DIVERSITY; REPEAT; IDENTIFICATION	Spatial genetics is a relatively new field in wildlife and conservation biology that is becoming an essential tool for unravelling the complexities of animal population processes, and for designing effective strategies for conservation and management. Conceptual and methodological developments in this field are therefore critical. Here we present two novel methodological approaches that further the analytical possibilities of STRUCTURE and DResD. Using these approaches we analyse structure and migrations in a grey wolf (Canis lupus) population in north-eastern Europe. We genotyped 16 microsatellite loci in 166 individuals sampled from the wolf population in Estonia and Latvia that has been under strong and continuous hunting pressure for decades. Our analysis demonstrated that this relatively small wolf population is represented by four genetic groups. We also used a novel methodological approach that uses linear interpolation to statistically test the spatial separation of genetic groups. The new method, which is capable of using program STRUCTURE output, can be applied widely in population genetics to reveal both core areas and areas of low significance for genetic groups. We also used a recently developed spatially explicit individual-based method DResD, and applied it for the first time to microsatellite data, revealing a migration corridor and barriers, and several contact zones.	[Hindrikson, Maris; Remm, Jaanus; Tammeleht, Egle; Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, EE-50090 Tartu, Estonia; [Maennil, Peep] Estonian Environm Informat Ctr, Tartu, Estonia; [Ozolins, Janis] State Forest Res Inst Silava, Salaspils, Latvia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Latvian State Forest Research Institute "Silava"	Saarma, U (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Ulikooli 18, EE-50090 Tartu, Estonia.	Urmas.Saarma@ut.ee	Remm, Jaanus/G-9347-2012; Saarma, Urmas/J-6448-2015; Tammeleht, Egle/J-6528-2015; Saarma, Urmas/AAC-9813-2019; Hindrikson, Maris/G-4573-2017	Remm, Jaanus/0000-0002-8896-0772; Saarma, Urmas/0000-0002-3222-571X; Tammeleht, Egle/0000-0003-0871-051X; Saarma, Urmas/0000-0002-3222-571X; Hindrikson, Maris/0000-0001-8094-1860	Environmental Investment Centre; Estonian Ministry of Education and Sciences [SF0180122s08]; Estonian Science Foundation [7040, 8525]; European Union through the European Regional Development Fund (Centre of Excellence FIBIR); European Commission [PIRSES-GA-2009-247652]; Estonian Doctoral School of Ecology and Environmental Sciences	Environmental Investment Centre; Estonian Ministry of Education and Sciences(Ministry of Education and Research, Estonia); Estonian Science Foundation; European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Estonian Doctoral School of Ecology and Environmental Sciences	This work was supported by grants from the Environmental Investment Centre, the Estonian Ministry of Education and Sciences (target financing project SF0180122s08), the Estonian Science Foundation (grants 7040 and 8525), from the European Union through the European Regional Development Fund (Centre of Excellence FIBIR), from European Commission's project No. PIRSES-GA-2009-247652 (BIOGEAST), and from the Estonian Doctoral School of Ecology and Environmental Sciences. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; Allendorf F. W., 2007, CONSERV GENET, P642, DOI DOI 10.1515/MAMM.2007.038; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Andersone Z, 2002, MAMM BIOL, V67, P79, DOI 10.1078/1616-5047-00012; Aspi J, 2006, MOL ECOL, V15, P1561, DOI 10.1111/j.1365-294X.2006.02877.x; Aspi J, 2009, CONSERV GENET, V10, P815, DOI 10.1007/s10592-008-9642-x; Baltrunaite L, 2013, CENT EUR J BIOL, V8, P440, DOI 10.2478/s11535-013-0154-9; Belkhir K, 2004, GENETIX SOFTWARE WIN; BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981; Boitani L, 2009, NEW ERA WOLVES PEOPL; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Brzustowski J, 2002, DOH ASSIGNMENT TEST; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Cameron EZ, 2009, P NATL ACAD SCI USA, V106, P13850, DOI 10.1073/pnas.0900639106; Caro T, 2012, CONSERV BIOL, V26, P185, DOI 10.1111/j.1523-1739.2011.01752.x; Carroll C, 2013, CONSERV BIO IN PRESS; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Cordoni G, 2009, BEHAVIOUR, V146, P1363, DOI 10.1163/156853909X427722; Cornuet JM, 1996, GENETICS, V144, P2001; Coster SS, 2012, CONSERV GENET, V13, P1247, DOI 10.1007/s10592-012-0368-4; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; FREDHOLM M, 1995, MAMM GENOME, V6, P11, DOI 10.1007/BF00350887; Galpern P, 2012, MOL ECOL, V21, P3996, DOI 10.1111/j.1365-294X.2012.05677.x; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Harris RB, 2002, WILDLIFE SOC B, V30, P634; Hedrick P., 1983, GENETICS POPULATIONS; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; HOLMES NG, 1995, ANIM GENET, V26, P132, DOI 10.1111/j.1365-2052.1995.tb02659.x; Jansson E, 2012, MOL ECOL, V21, P5178, DOI 10.1111/mec.12010; Jedrzejewski W, 2005, ACTA THERIOL, V50, P3, DOI 10.1007/BF03192614; Jedrzejewski W., 2010, WORLD WOLVES NEW PER; Karmapa HHG, 2011, CONSERV BIOL, V25, P1094, DOI 10.1111/j.1523-1739.2011.01765.x; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Mech DL, 2007, OLVES BEHAV ECOLOGY; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; NEI M, 1978, GENETICS, V89, P583; OSTRANDER EA, 1993, GENOMICS, V16, P207, DOI 10.1006/geno.1993.1160; Paetkau D, 1997, GENETICS, V147, P1943; Palsboll PJ, 2010, MOL ECOL RESOUR, V10, P797, DOI 10.1111/j.1755-0998.2010.02887.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2011, R LANG ENV STAT COMP; Randall DA, 2007, BEHAV ECOL, V18, P579, DOI 10.1093/beheco/arm010; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; ROUSSET F, 1995, GENETICS, V140, P1413; Rueness EK, 2003, MOL ECOL, V12, P2623, DOI 10.1046/j.1365-294X.2003.01952.x; Rutledge LY, 2010, BIOL CONSERV, V143, P332, DOI 10.1016/j.biocon.2009.10.017; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; SHIBUYA H, 1994, ANIM GENET, V25, P122, DOI 10.1111/j.1365-2052.1994.tb00094.x; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Smith JE, 2010, BEHAV ECOL, V21, P284, DOI 10.1093/beheco/arp181; Stahler DR, 2006, J NUTR, V136, p1923S, DOI 10.1093/jn/136.7.1923S; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Tiilikainen R, 2010, ANN ZOOL FENN, V47, P159, DOI 10.5735/086.047.0301; Valdmann Harri, 2004, Baltic Forestry, V10, P83; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vila C, 1999, CONSERV BIOL, V13, P195, DOI 10.1046/j.1523-1739.1999.97425.x; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Wabakken P, 2007, J WILDLIFE MANAGE, V71, P1631, DOI 10.2193/2006-222; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	80	18	18	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75765	10.1371/journal.pone.0075765	http://dx.doi.org/10.1371/journal.pone.0075765			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069446	gold, Green Published, Green Submitted			2022-12-27	WOS:000324777300096
J	Jonhson, S; Dominguez-Garcia, V; Munoz, MA				Jonhson, Samuel; Dominguez-Garcia, Virginia; Munoz, Miguel A.			Factors Determining Nestedness in Complex Networks	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; DYNAMICS	Understanding the causes and effects of network structural features is a key task in deciphering complex systems. In this context, the property of network nestedness has aroused a fair amount of interest as regards ecological networks. Indeed, Bastolla et al. introduced a simple measure of network nestedness which opened the door to analytical understanding, allowing them to conclude that biodiversity is strongly enhanced in highly nested mutualistic networks. Here, we suggest a slightly refined version of such a measure of nestedness and study how it is influenced by the most basic structural properties of networks, such as degree distribution and degree-degree correlations (i.e. assortativity). We find that most of the empirically found nestedness stems from heterogeneity in the degree distribution. Once such an influence has been discounted - as a second factor - we find that nestedness is strongly correlated with disassortativity and hence - as random networks have been recently found to be naturally disassortative - they also tend to be naturally nested just as the result of chance.	[Jonhson, Samuel] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Dominguez-Garcia, Virginia; Munoz, Miguel A.] Univ Granada, Dept Electromagnetismo & Fis Mat, Granada, Spain; [Dominguez-Garcia, Virginia; Munoz, Miguel A.] Univ Granada, Inst Carlos Fis Teor & Computac 1, Granada, Spain	Imperial College London; University of Granada; University of Granada	Munoz, MA (corresponding author), Univ Granada, Dept Electromagnetismo & Fis Mat, Granada, Spain.	mamunoz@onsager.ugr.es	Dominguez-Garcia, Virginia/ABF-4746-2020; Domínguez-García, Virginia/ABD-2972-2022; MUÑOZ, MIGUEL A/M-4099-2015; Dominguez-Garcia, Virginia/GYJ-6070-2022; Johnson, Samuel/P-6780-2014; Munoz, Miguel A/J-9627-2012	Domínguez-García, Virginia/0000-0002-4591-4186; MUÑOZ, MIGUEL A/0000-0003-0152-9080; Johnson, Samuel/0000-0002-8648-1735; Munoz, Miguel A/0000-0002-0529-6221	Junta de Andalucia projects [FQM-01505, P09-FQM4682]; Spanish MEC-FEDER project [FIS2009-08451]; European Commision under the Marie Curie Intra-European Fellowship Programme [PIEF-GA-2010-276454]	Junta de Andalucia projects(Junta de Andalucia); Spanish MEC-FEDER project; European Commision under the Marie Curie Intra-European Fellowship Programme	This work was supported by Junta de Andalucia projects FQM-01505 and P09-FQM4682, and by Spanish MEC-FEDER project FIS2009-08451. S.J. is grateful for financial support from the European Commision under the Marie Curie Intra-European Fellowship Programme PIEF-GA-2010-276454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Catanzaro M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.027103; Dorogovtsev SN, PHYS REV E, V81; Fischer J, 2002, OIKOS, V99, P193, DOI 10.1034/j.1600-0706.2002.990121.x; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Gotelli NJ, 2001, GLOBAL ECOL BIOGEOGR, V10, P337, DOI 10.1046/j.1466-822X.2001.00249.x; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Park J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026112; Staniczenko PPA, 2013, NATURE COMMUNICATION, V4, P139; Sugihara G, 2009, NATURE, V458, P979, DOI 10.1038/458979a; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Wang FG, 2001, PHYS REV LETT, V86, P2050, DOI 10.1103/PhysRevLett.86.2050; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469; Xu XK, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056106	26	50	51	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74025	10.1371/journal.pone.0074025	http://dx.doi.org/10.1371/journal.pone.0074025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069264	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300024
J	Cummins, J; Casey, PG; Joyce, SA; Gahan, CGM				Cummins, Joanne; Casey, Pat G.; Joyce, Susan A.; Gahan, Cormac G. M.			A Mariner Transposon-Based Signature-Tagged Mutagenesis System for the Analysis of Oral Infection by Listeria monocytogenes	PLOS ONE			English	Article							PROTOPORPHYRINOGEN OXIDASE; GASTROINTESTINAL PHASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; VIRULENCE GENES; CRP/FNR FAMILY; IDENTIFICATION; GENOME; INTERNALIN; HEME	Listeria monocytogenes is a Gram-positive foodborne pathogen and the causative agent of listerosis a disease that manifests predominately as meningitis in the non-pregnant individual or infection of the fetus and spontaneous abortion in pregnant women. Common-source outbreaks of foodborne listeriosis are associated with significant morbidity and mortality. However, relatively little is known concerning the mechanisms that govern infection via the oral route. In order to aid functional genetic analysis of the gastrointestinal phase of infection we designed a novel signature-tagged mutagenesis (STM) system based upon the invasive L. monocytogenes 4b serotype H7858 strain. To overcome the limitations of gastrointestinal infection by L. monocytogenes in the mouse model we created a H7858 strain that is genetically optimised for oral infection in mice. Furthermore our STM system was based upon a mariner transposon to favour numerous and random transposition events throughout the L. monocytogenes genome. Use of the STM bank to investigate oral infection by L. monocytogenes identified 21 insertion mutants that demonstrated significantly reduced potential for infection in our model. The sites of transposon insertion included lmOh7858_0671 (encoding an internalin homologous to Lmo0610), lmOh7858_0898 (encoding a putative surface-expressed LPXTG protein homologous to Lmo0842), lmOh7858_2579 (encoding the HupDGC hemin transport system) and lmOh7858_0399 (encoding a putative fructose specific phosphotransferase system). We propose that this represents an optimised STM system for functional genetic analysis of foodborne/oral infection by L. monocytogenes.	[Cummins, Joanne; Casey, Pat G.; Joyce, Susan A.; Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Casey, Pat G.; Joyce, Susan A.; Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland	University College Cork; University College Cork; University College Cork	Gahan, CGM (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland.	c.gahan@ucc.ie	Joyce, Susan/ABE-2616-2020; Gahan, Cormac G/AAE-9346-2019	Joyce, Susan/0000-0003-4771-3123; Gahan, Cormac G/0000-0003-2385-8192	Science Foundation Ireland [08/RFP/GEN1320]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by a grant from Science Foundation Ireland under the Research Frontiers Programme (08/RFP/GEN1320). The authors also acknowledge the funding received from Science Foundation Ireland under the Centers for Science Engineering and Technology programme which funds the Alimentary Pharmabiotic Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhuder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008966; [Anonymous], 1998, MMWR WEEKLY, V47, P1085; [Anonymous], 2001, PROGR PROP IN PRESS; Autret N, 2001, INFECT IMMUN, V69, P2054, DOI 10.1128/IAI.69.4.2054-2065.2001; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Bayles DO, 2006, J FOOD PROTECT, V69, P2758, DOI 10.4315/0362-028X-69.11.2758; Begley M, 2005, INFECT IMMUN, V73, P894, DOI 10.1128/IAI.73.2.894-904.2005; Betney R, 2010, RNA, V16, P655, DOI 10.1261/rna.1796210; BEUMER RR, 1992, INT J FOOD MICROBIOL, V15, P153, DOI 10.1016/0168-1605(92)90144-R; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; CAMILLI A, 1990, J BACTERIOL, V172, P3738, DOI 10.1128/jb.172.7.3738-3744.1990; Campbell I, 2009, INTENS CARE MED, V10, P336, DOI [10.1016/j.mpaic.2009.04.018, DOI 10.1016/J.MPAIC.2009.04.018]; Cao M, 2007, APPL ENVIRON MICROB, V73, P2758, DOI 10.1128/AEM.02844-06; Conner CP, 1998, P NATL ACAD SCI USA, V95, P4641, DOI 10.1073/pnas.95.8.4641; Corradi HR, 2006, J BIOL CHEM, V281, P38625, DOI 10.1074/jbc.M606640200; Csonka LNa E W, 1996, ESCHERICHIA COLI SAL, P1210; Cummins J, 2012, GUT MICROBES, V3, P93, DOI 10.4161/gmic.19578; Dharmarha V, 2008, FOCUS LISTERIA MONOC; Dowd GC, 2011, INFECT IMMUN, V79, P369, DOI 10.1128/IAI.00330-10; Dreyfus M, 2011, MOL MICROBIOL, V79, P288, DOI 10.1111/j.1365-2958.2010.07468.x; Fuchs RP, 2004, ADV PROTEIN CHEM, V69, P229; Gahan CGM, 2005, J APPL MICROBIOL, V98, P1345, DOI 10.1111/j.1365-2672.2005.02559.x; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Garsin DA, 2004, J BACTERIOL, V186, P7280, DOI 10.1128/JB.186.21.7280-7289.2004; Gaurivaud P, 2000, MOL PLANT MICROBE IN, V13, P1145, DOI 10.1094/MPMI.2000.13.10.1145; Ghanem ENB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003015; Harvey PC, INFECT IMMUN; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Homuth G, 1999, J BACTERIOL, V181, P5922, DOI 10.1128/JB.181.19.5922-5929.1999; Jin B, 2006, MOL MICROBIOL, V59, P1185, DOI 10.1111/j.1365-2958.2005.05015.x; Kana BD, 2010, J BACTERIOL, V192, P2220, DOI 10.1128/JB.01135-09; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Korbel JO, 2005, PLOS BIOL, V3, P815, DOI 10.1371/journal.pbio.0030134; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Ledala N, 2010, APPL ENVIRON MICROB, V76, P406, DOI 10.1128/AEM.01389-09; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Loo CY, 2003, J BACTERIOL, V185, P6241, DOI 10.1128/JB.185.21.6241-6254.2003; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984; McGann P, 2008, FOODBORNE PATHOG DIS, V5, P417, DOI 10.1089/fpd.2008.0085; MELDRUM SJ, 1972, BRIT MED J, V2, P104; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Monk IR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-318; Nakamura T, 1998, MICROBIOL-SGM, V144, P2281, DOI 10.1099/00221287-144-8-2281; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Picardeau M, 2010, GENETICA, V138, P551, DOI 10.1007/s10709-009-9408-5; Piveteau P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024881; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; PREMARATNE RJ, 1991, APPL ENVIRON MICROB, V57, P3046, DOI 10.1128/AEM.57.10.3046-3048.1991; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; SAIER MH, 1994, MOL MICROBIOL, V13, P755; SASARMAN A, 1993, CAN J MICROBIOL, V39, P1155, DOI 10.1139/m93-174; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Sleator RD, 2007, MED HYPOTHESES, V69, P1090, DOI 10.1016/j.mehy.2007.02.028; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Stoll R, 2010, MICROBIOL-SGM, V156, P1069, DOI 10.1099/mic.0.034934-0; Stumpe SB, 1996, WN KONINGS HRKAJSL, P474; Uhlich GA, 2006, FOOD MICROBIOL, V23, P300, DOI 10.1016/j.fm.2005.03.007; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Ward TJ, 2004, J BACTERIOL, V186, P4994, DOI 10.1128/jb.186.15.4994-5002.2004; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x; Zemansky J, 2009, J BACTERIOL, V191, P3950, DOI 10.1128/JB.00016-09	70	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e75437	10.1371/journal.pone.0075437	http://dx.doi.org/10.1371/journal.pone.0075437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069416	Green Published, Green Submitted, gold			2022-12-27	WOS:000326240100125
J	Wei, Y; Hu, HQ; Lun, ZR; Li, ZY				Wei, Ying; Hu, Huiqing; Lun, Zhao-Rong; Li, Ziyin			The Cooperative Roles of Two Kinetoplastid-Specific Kinesins in Cytokinesis and in Maintaining Cell Morphology in Bloodstream Trypanosomes	PLOS ONE			English	Article							CDC2-RELATED KINASES; PROTEIN-DEGRADATION; CYCLE REGULATION; DNA-REPLICATION; BRUCEI; FLAGELLUM; COMPLEX; CYTOSKELETON; SEGREGATION; FORMS	The cytoskeleton of Trypanosoma brucei, a unicellular eukaryote and a parasitic protozoan, is defined by the subpellicular microtubule corset that is arranged underneath the plasma membrane. We recently identified two orphan kinesins, TbKIN-C and TbKIN-D, that cooperate to regulate the organization of the subpellicular microtubule corset and thereby maintain cell morphology in the procyclic form of T. brucei. In this report, we characterize the function of TbKIN-C and TbKIN-D in the bloodstream form of T. brucei and investigate their functional cooperation in both the bloodstream and procyclic forms. TbKIN-C and TbKIN-D form a tight complex in vivo in the bloodstream form. TbKIN-C is strongly enriched at the posterior tip of the cell, whereas TbKIN-D is distributed throughout the cell body at all cell cycle stages. RNAi of TbKIN-C or TbKIN-D in the bloodstream form inhibits cell proliferation and leads to cell death, due to cytokinesis defects. RNAi of TbKIN-C and TbKIN-D also results in defects in basal body segregation, but does not affect the synthesis and segregation of the flagellum and the flagellum attachment zone (FAZ) filament. Knockdown of TbKIN-C and TbKIN-D does not disrupt the organization of the subpellicular microtubule corset, but produces multinucleated cells with an enlarged flagellar pocket and misplaced flagella. Interestingly, depletion of TbKIN-C results in rapid degradation of TbKIN-D and, similarly, knockdown of TbKIN-C destabilizes TbKIN-D, suggesting that formation of TbKIN-C/TbKIN-D complex stabilizes both kinesins and is required for the two kinesins to execute their essential cellular functions. Altogether, our results demonstrate the essential role of the two kinesins in cell morphogenesis and cytokinesis in the bloodstream form and the requirement of heteromeric complex formation for maintaining the stability of the two kinesins.	[Wei, Ying; Lun, Zhao-Rong] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wei, Ying; Hu, Huiqing; Li, Ziyin] Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX USA	Sun Yat Sen University; University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX USA.	Ziyin.Li@uth.tmc.edu		Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [R56AI090070, R01AI101437]; National Natural Science Foundation of China [31071995, 31272305]; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101437, R56AI090070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grants R56AI090070 and R01AI101437 to ZL, and by grants (numbers 31071995 and 31272305) from the National Natural Science Foundation of China to ZRL. YW was supported by a scholarship from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Dang HQ, 2011, J BIOL CHEM, V286, P32424, DOI 10.1074/jbc.M111.240143; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hu HQ, 2012, J CELL SCI, V125, P4126, DOI 10.1242/jcs.106534; Hu L, 2012, MOL MICROBIOL, V83, P565, DOI 10.1111/j.1365-2958.2011.07951.x; Kabututu ZP, 2010, J CELL SCI, V123, P3587, DOI 10.1242/jcs.073817; Kaseda K, 2002, P NATL ACAD SCI USA, V99, P16058, DOI 10.1073/pnas.252409199; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kohl L, 1998, MOL BIOCHEM PARASIT, V93, P1, DOI 10.1016/S0166-6851(98)00014-0; Li ZY, 2006, EXP CELL RES, V312, P3504, DOI 10.1016/j.yexcr.2006.07.022; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; Mackey ZB, 2004, J BIOL CHEM, V279, P48426, DOI 10.1074/jbc.M402470200; MUNOZANTONIA T, 1991, MOL BIOCHEM PARASIT, V47, P73, DOI 10.1016/0166-6851(91)90149-Z; Ploubidou A, 1999, J CELL SCI, V112, P4641; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; SCHLIMME W, 1993, PARASITOLOGY, V107, P237, DOI 10.1017/S003118200007921X; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Van der Heyden N, 2002, J EUKARYOT MICROBIOL, V49, P407, DOI 10.1111/j.1550-7408.2002.tb00220.x; Van Hellemond JJ, 2000, MOL BIOCHEM PARASIT, V111, P275, DOI 10.1016/S0166-6851(00)00318-2; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Vaughan S, 2010, CURR OPIN MICROBIOL, V13, P453, DOI 10.1016/j.mib.2010.05.006; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; WOODWARD R, 1990, J CELL SCI, V95, P49; Wordeman L, 2010, SEMIN CELL DEV BIOL, V21, P260, DOI 10.1016/j.semcdb.2010.01.018	39	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73869	10.1371/journal.pone.0073869	http://dx.doi.org/10.1371/journal.pone.0073869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069240	Green Published, gold			2022-12-27	WOS:000326240100065
J	Wu, CY; Chang, CK; Robson, D; Jackson, R; Chen, SJ; Hayes, RD; Stewart, R				Wu, Chia-Yi; Chang, Chin-Kuo; Robson, Debbie; Jackson, Richard; Chen, Shaw-Ji; Hayes, Richard D.; Stewart, Robert			Evaluation of Smoking Status Identification Using Electronic Health Records and Open-Text Information in a Large Mental Health Case Register	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; TOBACCO USE; BIPOLAR DISORDER; MEDICAL-RECORDS; SOUTH LONDON; SCHIZOPHRENIA; PEOPLE; CESSATION; ILLNESS; PREVALENCE	Background: High smoking prevalence is a major public health concern for people with mental disorders. Improved monitoring could be facilitated through electronic health record (EHR) databases. We evaluated whether EHR information held in structured fields might be usefully supplemented by open-text information. The prevalence and correlates of EHR-derived current smoking in people with severe mental illness were also investigated. Methods: All cases had been referred to a secondary mental health service between 2008-2011 and received a diagnosis of schizophreniform or bipolar disorder. The study focused on those aged over 15 years who had received active care from the mental health service for at least a year (N=1,555). The 'CRIS-IE-Smoking' application used General Architecture for Text Engineering (GATE) natural language processing software to extract smoking status information from open-text fields. A combination of CRIS-IE-Smoking with data from structured fields was evaluated for coverage and the prevalence and demographic correlates of current smoking were analysed. Results: Proportions of patients with recorded smoking status increased from 11.6% to 64.0% through supplementing structured fields with CRIS-IE-Smoking data. The prevalence of current smoking was 59.6% in these 995 cases for whom this information was available. After adjustment, younger age (below 65 years), male sex, and non-cohabiting status were associated with current smoking status. Conclusions: A natural language processing application substantially improved routine EHR data on smoking status above structured fields alone and could thus be helpful in improving monitoring of this lifestyle behaviour. However, limited information on smoking status remained a challenge.	[Wu, Chia-Yi] Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan; [Chang, Chin-Kuo; Robson, Debbie; Jackson, Richard; Hayes, Richard D.; Stewart, Robert] Kings Coll London, Inst Psychiat, Dept Hlth Serv & Populat Res, London, England; [Chen, Shaw-Ji] Mackay Mem Hosp, Taitung Branch, Taitung, Taiwan; [Chen, Shaw-Ji] Buddhist Tzu Chi Univ, Sch Med, Hualien, Taiwan	National Taiwan University; University of London; King's College London; Mackay Memorial Hospital; Tzu Chi University	Wu, CY (corresponding author), Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan.	jennycyw@ntu.edu.tw	Stewart, Robert/B-1667-2010; Hayes, Richard/D-2382-2010; Robson, Debbie J/B-3143-2011; Chang, Chin-Kuo/E-4991-2010; WU, CHIA-YI/E-4992-2010	Stewart, Robert/0000-0002-4435-6397; Chang, Chin-Kuo/0000-0002-8338-7196; Hayes, Richard/0000-0003-4453-244X; Robson, Deborah/0000-0002-6447-3523; WU, CHIA-YI/0000-0003-1756-557X	Clinical Record Interactive Search system; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London; Maudsley National Health Service (NHS) Foundation Trust; King's College London; Guy's and St Thomas' Charity and the Maudsley Charity; NIHR Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; Medical Research Council; MRC [MR/J01219X/1] Funding Source: UKRI; Medical Research Council [MR/K023195/1, MR/J01219X/1] Funding Source: researchfish	Clinical Record Interactive Search system; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley National Health Service (NHS) Foundation Trust; King's College London(General Electric); Guy's and St Thomas' Charity and the Maudsley Charity; NIHR Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Clinical Record Interactive Search system funded and developed by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley National Health Service (NHS) Foundation Trust and King's College London and a joint infrastructure grant from Guy's and St Thomas' Charity and the Maudsley Charity. CKC and RS are part-funded by the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. RH is funded by a Medical Research Council Population Health Scientist Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banham L, 2010, ADDICTION, V105, P1176, DOI 10.1111/j.1360-0443.2010.02946.x; Brown S, 2010, BRIT J PSYCHIAT, V196, P116, DOI 10.1192/bjp.bp.109.067512; Chang CK, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-77; Chang CK, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019590, DOI 10.1371/J0URNAL.P0NE.0019590.PUBMED:21611123]; Chapman S, 2009, AUST NZ J PSYCHIAT, V43, P277, DOI 10.1080/00048670802653372; de Leon J, 2005, SCHIZOPHR RES, V76, P135, DOI 10.1016/j.schres.2005.02.010; De Vogli R, 2005, TOB CONTROL, V14, P389, DOI 10.1136/tc.2004.010611; DeLisle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013377; Diaz FJ, 2009, BIPOLAR DISORD, V11, P154, DOI 10.1111/j.1399-5618.2009.00664.x; Fernandes AC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-71; Fiore MC, 2008, TREATING TOBACCO USE; Geisler BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009274; Giskes K, 2005, J EPIDEMIOL COMMUN H, V59, P395, DOI 10.1136/jech.2004.025684; Health and Social Care Information Centre, 2012, STAT SMOK ENGL; Hepple M, 2000, P 38 ANN M ASS COMP; Himes BE, 2009, J AM MED INFORM ASSN, V16, P371, DOI 10.1197/jamia.M2846; Johnson JL, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-101; Kelly C, 1999, AM J PSYCHIAT, V156, P1751; Kumari V, 2005, NEUROSCI BIOBEHAV R, V29, P1021, DOI 10.1016/j.neubiorev.2005.02.006; McCreadie RG, 2002, BRIT J PSYCHIAT, V181, P321, DOI 10.1192/bjp.181.4.321; Mehrotra A, 2012, GASTROINTEST ENDOSC, V75, P1233, DOI 10.1016/j.gie.2012.01.045; Rothemich SF, 2008, ANN FAM MED, V6, P60, DOI 10.1370/afm.750; Samele C, 2007, SOC PSYCH PSYCH EPID, V42, P117, DOI 10.1007/s00127-006-0135-2; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Szatkowski L, 2010, FAM PRACT, V27, P673, DOI 10.1093/fampra/cmq046; Taggar JS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-329; Uzuner O, 2008, J AM MED INFORM ASSN, V15, P14, DOI 10.1197/jamia.M2408; Wang CY, 2010, AUST NZ J PSYCHIAT, V44, P456, DOI 10.3109/00048670903493348; Wang Z, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030412, DOI 10.1371/J0URNAL.P0NE.0030412.PUBMED:22276193]; Waxmonsky JA, 2005, GEN HOSP PSYCHIAT, V27, P321, DOI 10.1016/j.genhosppsych.2005.05.003; Wu CY, 2012, PSYCHOL MED, V42, P1581, DOI 10.1017/S0033291711002698; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	33	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74262	10.1371/journal.pone.0074262	http://dx.doi.org/10.1371/journal.pone.0074262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242KO	24069288	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100095
J	Barnes, DG; Vidiassov, M; Ruthensteiner, B; Fluke, CJ; Quayle, MR; McHenry, CR				Barnes, David G.; Vidiassov, Michail; Ruthensteiner, Bernhard; Fluke, Christopher J.; Quayle, Michelle R.; McHenry, Colin R.			Embedding and Publishing Interactive, 3-Dimensional, Scientific Figures in Portable Document Format (PDF) Files	PLOS ONE			English	Article								With the latest release of the S2PLOT graphics library, embedding interactive, 3-dimensional (3-d) scientific figures in Adobe Portable Document Format (PDF) files is simple, and can be accomplished without commercial software. In this paper, we motivate the need for embedding 3-d figures in scholarly articles. We explain how 3-d figures can be created using the S2PLOT graphics library, exported to Product Representation Compact (PRC) format, and included as fully interactive, 3-d figures in PDF files using the movie15 LATEX package. We present new examples of 3-d PDF figures, explain how they have been made, validate them, and comment on their advantages over traditional, static 2-dimensional (2-d) figures. With the judicious use of 3-d rather than 2-d figures, scientists can now publish, share and archive more useful, flexible and faithful representations of their study outcomes. The article you are reading does not have embedded 3-d figures. The full paper, with embedded 3-d figures, is recommended and is available as a supplementary download from PLoS ONE (File S2).	[Barnes, David G.] Monash Univ, Monash Biomed Imaging, Clayton, Vic, Australia; [Barnes, David G.] Monash Univ, Monash ERes Ctr, Clayton, Vic, Australia; [Barnes, David G.] Monash Univ, Fac Informat Technol, Clayton, Vic, Australia; [Vidiassov, Michail] Moscow MV Lomonosov State Univ, Inst Asian & African Studies, Moscow, Russia; [Ruthensteiner, Bernhard] Zool Staatssammlung Munchen, Sect Evertebrata Varia, Munich, Bavaria, Germany; [Fluke, Christopher J.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Quayle, Michelle R.; McHenry, Colin R.] Monash Univ, Dept Anat & Dev Biol, Sch Biomed Sci, Clayton, Vic, Australia	Monash University; Monash University; Monash University; Lomonosov Moscow State University; Swinburne University of Technology; Monash University	Barnes, DG (corresponding author), Monash Univ, Monash Biomed Imaging, Clayton, Vic, Australia.	david.g.barnes@monash.edu		Barnes, David/0000-0002-4594-3438; Fluke, Christopher/0000-0003-0961-2321	VLSCI's Life Sciences Computation Centre	VLSCI's Life Sciences Computation Centre	Parts of this research were supported by the VLSCI's Life Sciences Computation Centre, a collaboration between Melbourne, Monash and La Trobe Universities and an initiative of the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes DG, 2008, NEW ASTRON, V13, P599, DOI 10.1016/j.newast.2008.03.008; Barnes DG, 2006, PUBL ASTRON SOC AUST, V23, P82, DOI 10.1071/AS06009; Crutcher RM, 1998, ASTR SOC P, V145, P3; Drebin R. A., 1988, Computer Graphics, V22, P65, DOI 10.1145/378456.378484; Einhauser W, 2004, EUR J NEUROSCI, V20, P2811, DOI 10.1111/j.1460-9568.2004.03722.x; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FLOYD RW, 1976, P SID, V17, P75; Fluke Christopher J., 2008, Astronomy Education Review, V7, DOI 10.3847/AER2008010; Goodman AA, 2009, NATURE, V457, P63, DOI 10.1038/nature07609; Hubona G. S., 1999, ACM Transactions on Computer-Human Interaction, V6, P214, DOI 10.1145/329693.329695; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; Johnson C, 2004, IEEE COMPUT GRAPH, V24, P13, DOI 10.1109/MCG.2004.20; Lee WH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007675; Lorensen William E., 1987, P ACM SIGGRAPH, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Quayle MR, 2011, THESIS U NEWCASTLE; Raush E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007394; Ruthensteiner B, 2010, MICRON, V41, P886, DOI 10.1016/j.micron.2010.03.010; Ruthensteiner B, 2009, ACTA ZOOL-STOCKHOLM, V90, P166, DOI 10.1111/j.1463-6395.2008.00347.x; Shardt O, 2012, COMPUT AIDED DESIGN, V44, P484, DOI 10.1016/j.cad.2011.05.010; Uselton S., 1994, Proceedings. Visualization '94 (Cat. No.94CH35707), P414, DOI 10.1109/VISUAL.1994.346285	21	54	56	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e69446	10.1371/journal.pone.0069446	http://dx.doi.org/10.1371/journal.pone.0069446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086243	Green Published, gold, Green Submitted			2022-12-27	WOS:000325218700001
J	Nakada, Y; Stewart, TG; Pena, CG; Zhang, S; Zhao, N; Bardeesy, N; Sharpless, NE; Wong, KK; Hayes, DN; Castrillon, DH				Nakada, Yuji; Stewart, Thomas G.; Pena, Christopher G.; Zhang, Song; Zhao, Ni; Bardeesy, Nabeel; Sharpless, Norman E.; Wong, Kwok-Kin; Hayes, D. Neil; Castrillon, Diego H.			The LKB1 Tumor Suppressor as a Biomarker in Mouse and Human Tissues	PLOS ONE			English	Article							LUNG-CANCER; GROWTH-CONTROL; EXPRESSION; DIFFERENTIATION; INACTIVATION; LKB1/STK11; MELANOMA; GENE	Germline mutations in the LKB1 gene (also known as STK11) cause the Peutz-Jeghers Syndrome, and somatic loss of LKB1 has emerged as causal event in a wide range of human malignancies, including melanoma, lung cancer, and cervical cancer. The LKB1 protein is a serine-threonine kinase that phosphorylates AMP-activated protein kinase (AMPK) and other downstream targets. Conditional knockout studies in mouse models have consistently shown that LKB1 loss promotes a highly-metastatic phenotype in diverse tissues, and human studies have demonstrated a strong association between LKB1 inactivation and tumor recurrence. Furthermore, LKB1 deficiency confers sensitivity to distinct classes of anticancer drugs. The ability to reliably identify LKB1-deficient tumors is thus likely to have important prognostic and predictive implications. Previous research studies have employed polyclonal antibodies with limited success, and there is no widely-employed immunohistochemical assay for LKB1. Here we report an assay based on a rabbit monoclonal antibody that can reliably detect endogenous LKB1 protein (and its absence) in mouse and human formalin-fixed, paraffin-embedded tissues. LKB1 protein levels determined through this assay correlated strongly with AMPK phosphorylation both in mouse and human tumors, and with mRNA levels in human tumors. Our studies fully validate this immunohistochemical assay for LKB1 in paraffin-embedded formalin tissue sections. This assay should be broadly useful for research studies employing mouse models and also for the development of human tissue-based assays for LKB1 in diverse clinical settings.	[Nakada, Yuji; Pena, Christopher G.; Castrillon, Diego H.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Nakada, Yuji; Pena, Christopher G.; Castrillon, Diego H.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA; [Stewart, Thomas G.; Zhao, Ni; Sharpless, Norman E.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; [Stewart, Thomas G.; Zhao, Ni; Sharpless, Norman E.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Stewart, Thomas G.; Zhao, Ni; Sharpless, Norman E.; Hayes, D. Neil] Univ N Carolina, Chapel Hill, NC 27599 USA; [Zhang, Song] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Cambridge, MA USA; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wong, Kwok-Kin] Dana Farber Canc Inst, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Hayes, DN (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA.	hayes@med.unc.edu; diego.castrillon@utsouthwestern.edu	Zhao, Ni/P-9086-2014	Zhao, Ni/0000-0002-7762-3949; wong, kwok kin/0000-0001-6323-235X; Sharpless, Norman/0000-0001-7078-9455	National Institutes of Health/National Cancer Institute [R01CA137181, RO1CA163896, U01CA141576]; Cancer Prevention Research Institute of Texas [RP100550]; NATIONAL CANCER INSTITUTE [R01CA137181, P01CA154303, R01CA163896, T32CA106209, R01CA122794, U01CA141576, R01CA166480] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported through National Institutes of Health/National Cancer Institute grants R01CA137181 (DC), RO1CA163896 (NS, KW), U01CA141576 (DC, KW, NB, NS), and Cancer Prevention Research Institute of Texas grant RP100550 (DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Amin RMS, 2008, PATHOL INT, V58, P84, DOI 10.1111/j.1440-1827.2007.02194.x; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Conde E, 2007, HUM PATHOL, V38, P1351, DOI 10.1016/j.humpath.2007.01.022; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Contreras CM, 2010, DIS MODEL MECH, V3, P181, DOI 10.1242/dmm.004440; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Guldberg P, 1999, ONCOGENE, V18, P1777, DOI 10.1038/sj.onc.1202486; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kline ER, 2011, HEAD NECK-J SCI SPEC, V33, P1501, DOI 10.1002/hed.21638; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu S, 2012, APPL IMMUNOHISTOCHEM; Liu WJ, 2012, CANCER CELL, V21, P751, DOI 10.1016/j.ccr.2012.03.048; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shackelford DB, 2009, P NATL ACAD SCI US; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Zhao N, 2012, BRIT J CANCER, V107, P482, DOI 10.1038/bjc.2012.264	26	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e73449	10.1371/journal.pone.0073449	http://dx.doi.org/10.1371/journal.pone.0073449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086281	gold, Green Published, Green Submitted			2022-12-27	WOS:000325218700009
J	Morrison, NA; Stephens, AS; Osato, M; Pasco, JA; Fozzard, N; Stein, GS; Polly, P; Griffiths, LR; Nicholson, GC				Morrison, Nigel A.; Stephens, Alexandre S.; Osato, Motomi; Pasco, Julie A.; Fozzard, Nicolette; Stein, Gary S.; Polly, Patsie; Griffiths, Lyn R.; Nicholson, Geoff C.			Polyalanine Repeat Polymorphism in RUNX2 Is Associated with Site-Specific Fracture in Post-Menopausal Females	PLOS ONE			English	Article							BONE-MINERAL DENSITY; FEMORAL-NECK BMD; CLEIDOCRANIAL DYSPLASIA; GEELONG-OSTEOPOROSIS; OSTEOBLAST DIFFERENTIATION; TANDEM REPEATS; FACIAL LENGTH; GENE; PROMOTER; WOMEN	Runt related transcription factor 2 (RUNX2) is a key regulator of osteoblast differentiation. Several variations within the RUNX2 gene have been found to be associated with significant changes in BMD, which is a major risk factor for fracture. In this study we report that an 18 bp deletion within the polyalanine tract (17A>11A) of RUNX2 is significantly associated with fracture. Carriers of the 11A allele were found to be nearly twice as likely to have sustained fracture. Within the fracture category, there was a significant tendency of 11A carriers to present with fractures of distal radius and bones of intramembranous origin compared to bones of endochondral origin (p = 0.0001). In a population of random subjects, the 11A allele was associated with decreased levels of serum collagen cross links (CTx, p = 0.01), suggesting decreased bone turnover. The transactivation function of the 11A allele showed a minor quantitative decrease. Interestingly, we found no effect of the 11A allele on BMD at multiple skeletal sites. These findings suggest that the 11A allele is a biologically relevant polymorphism that influences serum CTx and confers enhanced fracture risk in a site-selective manner related to intramembranous bone ossification.	[Morrison, Nigel A.; Stephens, Alexandre S.; Fozzard, Nicolette; Griffiths, Lyn R.] Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia; [Osato, Motomi] Natl Univ Singapore, Canc Sci Inst, Ctr Translat Med, Singapore 117548, Singapore; [Pasco, Julie A.] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Stein, Gary S.] Univ Vermont, Vermont Canc Ctr Basic & Translat Res, Burlington, VT USA; [Polly, Patsie] Univ New S Wales, Fac Med, Sch Med Sci, Dept Pathol & Inflammat, Sydney, NSW, Australia; [Polly, Patsie] Univ New S Wales, Fac Med, Sch Med Sci, Infect Res Ctr, Sydney, NSW, Australia; [Nicholson, Geoff C.] Univ Queensland, Sch Med, Rural Clin Sch, Toowoomba, Qld, Australia	Griffith University; National University of Singapore; Deakin University; University of Vermont; University of New South Wales Sydney; University of New South Wales Sydney; University of Queensland	Morrison, NA (corresponding author), Griffith Univ, Sch Med Sci, Gold Coast, Qld, Australia.	N.Morrison@griffith.edu.au	Nicholson, Geoffrey C/F-1901-2010; Morrison, Nigel A/F-4082-2012; Osato, Motomi/N-5056-2014; Stephens, Alexandre S/P-1396-2016	Nicholson, Geoffrey C/0000-0002-0152-1153; Morrison, Nigel A/0000-0003-4774-3808; Osato, Motomi/0000-0003-3982-9054; Stephens, Alexandre S/0000-0003-2465-8117; Griffiths, Lyn/0000-0002-6774-5475	Australian National Health and Medical Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These studies were supported by grants from the Australian National Health and Medical Research Council to NAM, PP, GS, JAP, LRG and GCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ONLINE MENDELIAN INH; Biver E, 2012, JOINT BONE SPINE, V79, P20, DOI 10.1016/j.jbspin.2011.05.003; Bustamante M, 2007, CALCIFIED TISSUE INT, V81, P327, DOI 10.1007/s00223-007-9069-2; CARTER DR, 1992, J BONE MINER RES, V7, P137; Chan MY, 2012, CALCIFIED TISSUE INT, V90, P128, DOI 10.1007/s00223-011-9556-3; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Crisci JL, 2011, GENOME BIOL EVOL, V3, P791, DOI 10.1093/gbe/evr075; Doecke JD, 2006, J BONE MINER RES, V21, P265, DOI 10.1359/JBMR; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Ermakov S, 2008, ANN HUM GENET, V72, P510, DOI 10.1111/j.1469-1809.2008.00441.x; Ermakov S, 2006, BONE, V38, P199, DOI 10.1016/j.bone.2005.08.008; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Franz-Odendaal TA, 2011, FRONT BIOSCI-LANDMRK, V16, P2734, DOI 10.2741/3882; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RM, 2012, THESIS U FLORIDA; Henry MJ, 2000, J CLIN DENSITOM, V3, P261, DOI 10.1385/JCD:3:3:261; Kanatani N, 2006, DEV BIOL, V296, P48, DOI 10.1016/j.ydbio.2006.03.039; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee HJ, 2009, CALCIFIED TISSUE INT, V84, P439, DOI 10.1007/s00223-009-9246-6; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; McGuigan FEA, 2002, J BONE MINER RES, V17, P1273, DOI 10.1359/jbmr.2002.17.7.1273; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Morrison NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042617; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Napierala D, 2005, MOL GENET METAB, V86, P257, DOI 10.1016/j.ymgme.2005.07.012; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pasco JA, 1999, AUST NZ J MED, V29, P203, DOI 10.1111/j.1445-5994.1999.tb00684.x; Pineda B, 2010, J BONE MINER METAB, V28, P696, DOI 10.1007/s00774-010-0183-2; Pointer MA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-103; Rosen HN, 2000, CALCIFIED TISSUE INT, V66, P100, DOI 10.1007/PL00005830; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; Sanders KM, 1999, OSTEOPOROSIS INT, V10, P240, DOI 10.1007/s001980050222; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Sears KE, 2007, EVOL DEV, V9, P555, DOI 10.1111/j.1525-142X.2007.00196.x; Vaughan T, 2002, J BONE MINER RES, V17, P1527, DOI 10.1359/jbmr.2002.17.8.1527; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Yoshida T, 2002, AM J HUM GENET, V71, P724, DOI 10.1086/342717; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e72740	10.1371/journal.pone.0072740	http://dx.doi.org/10.1371/journal.pone.0072740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24086263	Green Published, Green Submitted, gold			2022-12-27	WOS:000326520200003
J	Batra, J; Soares, AS; Mehner, C; Radisky, ES				Batra, Jyotica; Soares, Alexei S.; Mehner, Christine; Radisky, Evette S.			Matrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP Complexes	PLOS ONE			English	Article							TISSUE INHIBITOR; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; KINETIC-ANALYSIS; TIMP-2; MMP-10; STROMELYSIN-2; FLEXIBILITY; BINDING; MATRIX-METALLOPROTEINASE-2	Matrix metalloproteinases (MMPs) play central roles in vertebrate tissue development, remodeling, and repair. The endogenous tissue inhibitors of metalloproteinases (TIMPs) regulate proteolytic activity by binding tightly to the MMP active site. While each of the four TIMPs can inhibit most MMPs, binding data reveal tremendous heterogeneity in affinities of different TIMP/MMP pairs, and the structural features that differentiate stronger from weaker complexes are poorly understood. Here we report the crystal structure of the comparatively weakly bound human MMP-10/TIMP-2 complex at 2.1 angstrom resolution. Comparison with previously reported structures of MMP-3/TIMP-1, MT1-MMP/TIMP-2, MMP-13/TIMP-2, and MMP-10/TIMP-1 complexes offers insights into the structural basis of binding selectivity. Our analyses identify a group of highly conserved contacts at the heart of MMP/TIMP complexes that define the conserved mechanism of inhibition, as well as a second category of diverse adventitious contacts at the periphery of the interfaces. The AB loop of the TIMP N-terminal domain and the contact loops of the TIMP C-terminal domain form highly variable peripheral contacts that can be considered as separate exosite interactions. In some complexes these exosite contacts are extensive, while in other complexes the AB loop or C-terminal domain contacts are greatly reduced and appear to contribute little to complex stability. Our data suggest that exosite interactions can enhance MMP/TIMP binding, although in the relatively weakly bound MMP-10/TIMP-2 complex they are not well optimized to do so. Formation of highly variable exosite interactions may provide a general mechanism by which TIMPs are fine-tuned for distinct regulatory roles in biology.	[Batra, Jyotica; Mehner, Christine; Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory	Radisky, ES (corresponding author), Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Soares, Alexei S/F-4800-2014; Radisky, Evette S/C-8526-2012	Soares, Alexei S/0000-0002-6565-8503; Radisky, Evette S/0000-0003-3121-109X	Florida Department of Health [08KN12, 09BB17, 1BD01]; Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) grant [P50 CA116201]; Office of Biological and Environmental Research of the US Department of Energy; Office of Basic Energy Sciences of the US Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL CANCER INSTITUTE [P50CA116201] Funding Source: NIH RePORTER	Florida Department of Health; Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) grant; Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Florida Department of Health grants 08KN12 and 09BB17 (to ESR) and 1BD01 (to JB), and by the Mayo Clinic Breast Cancer Specialized Program of Research Excellence (SPORE) grant P50 CA116201 (PI James Ingle). Diffraction data were measured at beamline X29 of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and the National Center for Research Resources of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Batra J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050028; Batra J, 2012, J BIOL CHEM, V287, P15935, DOI 10.1074/jbc.M112.341156; Bertini I, 2004, J MOL BIOL, V336, P707, DOI 10.1016/j.jmb.2003.12.033; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bord S, 1998, BONE, V23, P7, DOI 10.1016/S8756-3282(98)00064-7; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chaturvedi M, 2012, NEUROCHEM INT, V61, P1065, DOI 10.1016/j.neuint.2012.07.023; Cohen M, 2008, PROTEINS, V72, P741, DOI 10.1002/prot.21960; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DECLERCK YA, 1993, BIOCHEM J, V289, P65, DOI 10.1042/bj2890065; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Hutton M, 1998, BIOCHEMISTRY-US, V37, P10094, DOI 10.1021/bi980616p; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Justilien V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035040; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kveiborg M, 2010, BIOCHEM J, V430, P79, DOI 10.1042/BJ20100649; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Lee MS, 2011, J PHARM PHARM SCI, V14, P368, DOI 10.18433/J3H88D; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Moy FJ, 2002, J AM CHEM SOC, V124, P12658, DOI 10.1021/ja027391x; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagase H, 2003, BIOCHEM SOC SYMP, V70, P201, DOI 10.1042/bss0700201; Nakamura H, 1998, EUR J BIOCHEM, V253, P67, DOI 10.1046/j.1432-1327.1998.2530067.x; NICHOLSON R, 1989, BIOCHEMISTRY-US, V28, P5195, DOI 10.1021/bi00438a042; Otwinowski Z, 1993, DENZO FILM PROCESSIN; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pilcher BK, 1999, ANN NY ACAD SCI, V878, P12, DOI 10.1111/j.1749-6632.1999.tb07671.x; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Regala RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026439; Rodriguez JA, 2008, FRONT BIOSCI-LANDMRK, V13, P2916, DOI 10.2741/2896; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; SAARIALHOKERE UK, 1994, J CLIN INVEST, V94, P79, DOI 10.1172/JCI117351; Scrutton NS, 1996, BIOCHEM J, V319, P1; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Stetler-Stevenson WG, 2008, CANCER METAST REV, V27, P57, DOI 10.1007/s10555-007-9105-8; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Troeberg L, 2002, BIOCHEMISTRY-US, V41, P15025, DOI 10.1021/bi026454l; Tuuttila A, 1998, J MOL BIOL, V284, P1133, DOI 10.1006/jmbi.1998.2223; Udi Y, 2013, J MOL BIOL, V425, P2330, DOI 10.1016/j.jmb.2013.04.009; Van Themsche C, 2004, J IMMUNOL, V173, P3605, DOI 10.4049/jimmunol.173.6.3605; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; WILLENBROCK F, 1993, BIOCHEMISTRY-US, V32, P4330, DOI 10.1021/bi00067a023; WILLIAMSON RA, 1994, BIOCHEMISTRY-US, V33, P11745, DOI 10.1021/bi00205a010; Williamson RA, 2001, J BIOL CHEM, V276, P32966, DOI 10.1074/jbc.M101843200; Gomis-Ruth FX, 2012, BBA-PROTEINS PROTEOM, V1824, P157, DOI 10.1016/j.bbapap.2011.04.014	62	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75836	10.1371/journal.pone.0075836	http://dx.doi.org/10.1371/journal.pone.0075836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073280	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000090
J	Bollegala, D; Shutova, E				Bollegala, Danushka; Shutova, Ekaterina			Metaphor Interpretation Using Paraphrases Extracted from the Web	PLOS ONE			English	Article								Interpreting metaphor is a hard but important problem in natural language processing that has numerous applications. One way to address this task is by finding a paraphrase that can replace the metaphorically used word in a given context. This approach has been previously implemented only within supervised frameworks, relying on manually constructed lexical resources, such as WordNet. In contrast, we present a fully unsupervised metaphor interpretation method that extracts literal paraphrases for metaphorical expressions from the Web. It achieves a precision of 0: 42, which is high for an unsupervised paraphrasing approach. Moreover, the method significantly outperforms both the baseline and the selectional preference-based method of Shutova employed in an unsupervised setting.	[Bollegala, Danushka] Univ Tokyo, Dept Informat & Commun Engn, Tokyo, Japan; [Shutova, Ekaterina] Univ Calif Berkeley, Inst Cognit & Brain Sci, Berkeley, CA 94720 USA	University of Tokyo; University of California System; University of California Berkeley	Bollegala, D (corresponding author), Univ Tokyo, Dept Informat & Commun Engn, Tokyo, Japan.	danushka@iba.t.u-tokyo.ac.jp			Japanese Society for the Promotion of Science (JSPS)	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Danushka Bollegala is supported by the Japanese Society for the Promotion of Science (JSPS) under the Young Researcher Grant and Microsoft Research Asia (MSRA) under the CORE project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerri Rodrigo, 2008, COLING 08; Ahmad K., 2011, AFFECTIVE COMPUTING, P27; Barnden J.A., 2002, THEORIA HIST SCI, V6, P399; Barzilay R, 2001, 39TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P50; Bejar I. I., 1991, COGNITIVE PSYCHOMETR; Bollegala D., 2009, P 18 INT C WORLD WID, P651, DOI DOI 10.1145/1526709.1526797; Briscoe T, 2006, COLING ACL 2006 INT; Burnard Lou, 2007, REFERENCE GUIDE BRIT; Carbonell JG, 1980, ACL, P17, DOI [10.3115/981436.981441, DOI 10.3115/981436.981441]; Chan TP, 2011, GEMS 11 WORKSH MOD N, P33; CHARLES WG, 1989, APPL PSYCHOLINGUIST, V10, P357, DOI 10.1017/S0142716400008675; Chen D.L., 2011, P 49 ANN M ASS COMP, P190; Chklovski T., 2004, P 2004 C EMP METH NA, P33; Crisp P, 2007, METAPHOR SYMBOL, V22, P1; Dagan I, 2004, PASCAL WORKSH TEXT U; Davidov D, 2008, P ACL 08; Dekang Lin, 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P323; Duc N. T., 2011, AAAI 11, P1237; Fass D., 1991, Computational Linguistics, V17, P49; Firth J.R., 1957, STUDIES LINGUISTIC A, P1; Fujita Atsushi, 2012, P 2012 JOINT C EMP M, P631; Glickman O, 2005, 1 RTE WORKSH; Harris ZS, 1954, WORD, V10, P146, DOI 10.1080/00437956.1954.11659520; Hashimoto C, 2011, ACL 11, P19; Hearst MA, 1992, P 14 C COMP LING, V2, P539, DOI DOI 10.3115/992133.992154; Hovy E., 2009, P 2009 C EMP METH NA, P948; Jurgens David, 2012, P 1 JOINT C LEX COMP; Justeson J. S., 1991, Computational Linguistics, V17, P1; Kilgarriff A, 2006, COMPUT LINGUIST, V1, P1; Kozareva Z, 2010, NAACL HLT 2010; Lakoff George, 2003, METAPHOR WE LIVE BY; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Lin D, 1998, P 36 ANN M ASS COMP, P768, DOI DOI 10.3115/980432.980696; Lin D., 2003, IJCAI, V3, P1492; Lin D., 2001, NAT LANG ENG, V7, P343, DOI DOI 10.1017/S1351324901002765; Martin J., 1990, COMPUTATIONAL MODEL; Martin JH, 1988, P 12 C COMP LING, P396; Matsuo Y, 2007, AAAI 07, P1395; McCarthy D, 2009, LANG RESOUR EVAL, V43, P139, DOI 10.1007/s10579-009-9084-1; Mohammad Saif M., 2008, P C EMP METH NAT LAN, P982, DOI DOI 10.3115/1613715.1613843; Narayanan S, 1997, TECHNICAL REPORT; Pantel P, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P113; Ravichandran D, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P41; RESNIK P, 1993, THESIS U PENNSYLVANI; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Shutova E, 2010, COLING 10; Shutova E., 2010, P LREC 2010 MALT, P3255; Shutova E, 2012, COLING 12; Shutova E, 2011, THESIS U CAMBRIDGE U; Shutova Ekaterina, 2010, P NAACL 2010 LOS ANG, P1; Snow R., 2005, ADV NEURAL INFORM PR, V17, P1297; Sun L., 2009, P 2009 C EMP METH NA, V2, P638; Szpektor Idan, 2004, P 2004 C EMP METH NA, P41; Turney Peter, 2008, P 22 INT C COMP LING, P905, DOI DOI 10.3115/1599081.1599195; Turney PD, 2006, COMPUT LINGUIST, V32, P379, DOI 10.1162/coli.2006.32.3.379; Turney PD, 2012, J ARTIF INTELL RES, V44, P533, DOI 10.1613/jair.3640; Veale T., 2008, P 22 INT C COMP LING, V1, P945; Veale T, 2011, ACL 11, P19; Zanzotto FM, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P849; Zhao Shiqi, 2008, ACL, P780	60	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74304	10.1371/journal.pone.0074304	http://dx.doi.org/10.1371/journal.pone.0074304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073207	Green Submitted, gold, Green Published			2022-12-27	WOS:000324768000016
J	Chang, SLY; Chen, SY; Huang, HH; Ko, HA; Liu, PT; Liu, YC; Chen, PH; Liu, FC				Chang, Sunny Li-Yun; Chen, Shih-Yun; Huang, Huai-Huei; Ko, Hsin-An; Liu, Pei-Tsen; Liu, Ya-Chi; Chen, Ping-Hau; Liu, Fu-Chin			Ectopic Expression of Nolz-1 in Neural Progenitors Promotes Cell Cycle Exit/Premature Neuronal Differentiation Accompanying with Abnormal Apoptosis in the Developing Mouse Telencephalon	PLOS ONE			English	Article							SELECTIVE EXPRESSION; GENE-EXPRESSION; FAMILY; HINDBRAIN; STRIATUM; REGION; IDENTIFICATION; NOLZ-1/ZFP503; MORPHOGENESIS; PROGRESSION	Nolz-1, as a murine member of the NET zinc-finger protein family, is expressed in post-mitotic differentiating neurons of striatum during development. To explore the function of Nolz-1 in regulating the neurogenesis of forebrain, we studied the effects of ectopic expression of Nolz-1 in neural progenitors. We generated the Cre-loxP dependent conditional transgenic mice in which Nolz-1 was ectopically expressed in proliferative neural progenitors. Ectopic expression of Nolz-1 in neural progenitors by intercrossing the Nolz-1 conditional transgenic mice with the nestin-Cre mice resulted in hypoplasia of telencephalon in double transgenic mice. Decreased proliferation of neural progenitor cells were found in the telencephalon, as evidenced by the reduction of BrdU-, Ki67- and phospho-histone 3-positive cells in E11.5-12.5 germinal zone of telencephalon. Transgenic Nolz-1 also promoted cell cycle exit and as a consequence might facilitate premature differentiation of progenitors, because TuJ1-positive neurons were ectopically found in the ventricular zone and there was a general increase of TuJ1 immunoreactivity in the telencephalon. Moreover, clusters of strong TuJ1-expressing neurons were present in E12.5 germinal zone. Some of these strong TuJ1-positive clusters, however, contained apoptotic condensed DNA, suggesting that inappropriate premature differentiation may lead to abnormal apoptosis in some progenitor cells. Consistent with the transgenic mouse analysis in vivo, similar effects of Nozl-1 over-expression in induction of apoptosis, inhibition of cell proliferation and promotion of neuronal differentiation were also observed in three different N18, ST14A and N2A neural cell lines in vitro. Taken together, our study indicates that ectopic expression of Nolz-1 in neural progenitors promotes cell cycle exit/premature neuronal differentiation and induces abnormal apoptosis in the developing telencephalon.	[Chang, Sunny Li-Yun; Chen, Shih-Yun; Ko, Hsin-An; Liu, Fu-Chin] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Chang, Sunny Li-Yun; Huang, Huai-Huei] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Sunny Li-Yun; Huang, Huai-Huei; Liu, Pei-Tsen; Liu, Ya-Chi] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan; [Chen, Ping-Hau] China Med Univ, Sch Pharm Undergrad Program, Taichung, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Liu, FC (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	fuchin@ym.edu.tw			National Science Council [NSC95-3112-B-010-014, NSC96-3112-B-010-007, NSC97-3112-B-010-005, NSC99-2311-B-010-005-MY3, NSC98-2320-B-039-034-MY3]; National Health Research Institutes [NHRI-PD940]; China Medical University [CMU96-132]; Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); China Medical University(China Medical University); Ministry of Education	This work was supported by National Science Council (http://web1.nsc.gov.tw/) grants NSC95-3112-B-010-014, NSC96-3112-B-010-007, NSC97-3112-B-010-005, NSC99-2311-B-010-005-MY3 (to FCL), NSC98-2320-B-039-034-MY3 (to SLYC); National Health Research Institutes (http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do) Postdoctoral Fellowship Award (NHRI-PD940 (to SLYC); China Medical University (CMU96-132 (to SLYC); and Aiming for Top University grant, Ministry of Education (to FCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boix J, 1998, EXP CELL RES, V238, P422, DOI 10.1006/excr.1997.3852; Brown JD, 2009, P NATL ACAD SCI USA, V106, P1462, DOI 10.1073/pnas.0812017106; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Chang CW, 2004, P NATL ACAD SCI USA, V101, P2613, DOI 10.1073/pnas.0308645100; Chang SLY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054485; Chang SLY, 2011, GENE EXPR PATTERNS, V11, P525, DOI 10.1016/j.gep.2011.09.003; Chen HH, 2006, MOL CELL BIOL, V26, P2736, DOI 10.1128/MCB.26.7.2736-2745.2006; Dorfman R, 2002, DEVELOPMENT, V129, P3585; Hoyle J, 2004, DEV DYNAM, V229, P835, DOI 10.1002/dvdy.20001; Inoue T, 1999, J HUM GENET, V44, P152, DOI 10.1007/s100380050133; Ji SJ, 2009, DEVELOPMENT, V136, P231, DOI 10.1242/dev.028043; Ko HA, 2013, NEUROSCI LETT, V548, P44, DOI 10.1016/j.neulet.2013.05.020; Kuiperij HB, 2004, NOVEL CAMP TARGETS C, P54; Liao WL, 2008, P NATL ACAD SCI USA, V105, P6765, DOI 10.1073/pnas.0802109105; Luque CM, 2007, DEV BIOL, V301, P327, DOI 10.1016/j.ydbio.2006.07.050; McGlinn E, 2008, DEV DYNAM, V237, P1172, DOI 10.1002/dvdy.21508; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Nakamura M, 2004, J CELL BIOCHEM, V93, P887, DOI 10.1002/jcb.20255; Nakamura M, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-108; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Runko AP, 2004, J BIOL CHEM, V279, P11917, DOI 10.1074/jbc.M310076200; Runko AP, 2003, DEV BIOL, V262, P254, DOI 10.1016/S0012-1606(03)00388-9; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tseng ASK, 2002, GENETICS, V162, P229; Urban N, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-21; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582; Yu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061362; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zhao XJ, 2002, DEVELOPMENT, V129, P1497; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	35	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74975	10.1371/journal.pone.0074975	http://dx.doi.org/10.1371/journal.pone.0074975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073229	Green Published, gold, Green Submitted			2022-12-27	WOS:000324768000038
J	Cofiel, L; Bassi, DU; Ray, RK; Pietrobon, R; Brentani, H				Cofiel, Luciana; Bassi, Debora U.; Ray, Ryan Kumar; Pietrobon, Ricardo; Brentani, Helena			Detecting Dissonance in Clinical and Research Workflow for Translational Psychiatric Registries	PLOS ONE			English	Article							DATA CAPTURE; AUTISM; CARE	Background: The interplay between the workflow for clinical tasks and research data collection is often overlooked, ultimately making it ineffective. Questions/purposes: To the best of our knowledge, no previous studies have developed standards that allow for the comparison of workflow models derived from clinical and research tasks toward the improvement of data collection processes Methods: In this study we used the term dissonance for the occurrences where there was a discord between clinical and research workflows. We developed workflow models for a translational research study in psychiatry and the clinic where its data collection was carried out. After identifying points of dissonance between clinical and research models we derived a corresponding classification system that ultimately enabled us to re-engineer the data collection workflow. We considered (1) the number of patients approached for enrollment and (2) the number of patients enrolled in the study as indicators of efficiency in research workflow. We also recorded the number of dissonances before and after the workflow modification. Results: We identified 22 episodes of dissonance across 6 dissonance categories: actor, communication, information, artifact, time, and space. We were able to eliminate 18 episodes of dissonance and increase the number of patients approached and enrolled in research study trough workflow modification. Conclusion: The classification developed in this study is useful for guiding the identification of dissonances and reveal modifications required to align the workflow of data collection and the clinical setting. The methodology described in this study can be used by researchers to standardize data collection process.	[Cofiel, Luciana; Bassi, Debora U.; Brentani, Helena] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil; [Ray, Ryan Kumar] Univ Texas Sch Publ Hlth, Dept Management Policy & Community Hlth, Houston, TX USA; [Pietrobon, Ricardo] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Universidade de Sao Paulo; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Duke University	Cofiel, L (corresponding author), Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, Brazil.	cofiel@gmail.com	Brentani, Helena/G-6839-2011	Brentani, Helena/0000-0001-5192-4682	FAPESP [2009/454220-6, 2011/05481-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Research supported by FAPESP (2009/454220-6 and 2011/05481-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Carvalho ECA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039671; Arthur J., 2010, LEAN 6 SIGMA DEMYSTI; Astah, 2012, STAH PROF; Barsoum WK, 2012, J ARTHROPLASTY, V27, P842, DOI 10.1016/j.arth.2011.12.014; Bradley J, 2012, IMPROVING BUSINESS P; Campbell RJ, 2009, J AHIMA, V80, P45; Campbell Robert James, 2009, J AHIMA, V80, P40; Cofiel L, DETECTING DISSONANCE; De Carvalho ECA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013893., DOI 10.1371/JOURNAL.PONE.0013893.]; Dumas M., 2001, INT C UNIFIED MODELI, P76; Fernald DH, 2012, J AM BOARD FAM MED, V25, P83, DOI 10.3122/jabfm.2012.01.110019; Ford AL, 2012, STROKE, V43, P3395, DOI 10.1161/STROKEAHA.112.670687; Fowler M., 2004, UML DISTILLED BRIEF, Vthird; Ghidini C, 2010, P ISWC 2010 DEM TRAC; Grover V., 1997, Journal of Operations Management, V15, P193, DOI 10.1016/S0272-6963(96)00104-0; Gurland B, 2010, DIS COLON RECTUM, V53, P1168, DOI 10.1007/DCR.0b013e3181d87468; Hunt KL, 1997, PROCEEDINGS OF THE 1997 WINTER SIMULATION CONFERENCE, P1275, DOI 10.1145/268437.268771; Jenkins A, 2012, AM J HEALTH-SYST PH, V69, P966, DOI 10.2146/ajhp110389; Khan Sharib A, 2008, AMIA Annu Symp Proc, P363; Khan SA, 2007, STUD HEALTH TECHNOL, V129, P247; Khan Sharib A, 2006, AMIA Annu Symp Proc, P419; Malhotra S, 2007, J BIOMED INFORM, V40, P81, DOI 10.1016/j.jbi.2006.06.002; Nguyen L, 2006, SOURCE CODE BIOL MED, V1, DOI 10.1186/1751-0473-1-7; Paula CS, 2011, REV ASSOC MED BRAS, V57, P2, DOI 10.1590/S0104-42302011000100002; Paxton EW, 2010, CLIN ORTHOP RELAT R, V468, P2646, DOI 10.1007/s11999-010-1463-9; Reijiers HA, 2005, OMEGA-INT J MANAGE S, V33, P283, DOI 10.1016/j.omega.2004.04.012; Shah J, 2010, CLIN ORTHOP RELAT R, V468, P2664, DOI 10.1007/s11999-010-1469-3; Shapiro JS, 2004, ACAD EMERG MED, V11, P1223, DOI 10.1197/j.aem.2004.08.017; Shelby-James TM, 2007, HANDHELD COMPUTERS D, V2, P1; Targum Steven D, 2011, Innov Clin Neurosci, V8, P40; Teixeira MCTV, 2010, REV ASSOC MED BRAS, V56, P607, DOI 10.1590/S0104-42302010000500026; Unertl KM, 2010, J AM MED INFORM ASSN, V17, P265, DOI 10.1136/jamia.2010.004333; Unertl KM, 2009, J AM MED INFORM ASSN, V16, P826, DOI 10.1197/jamia.M3000; van der Aalst WMP, 2003, DATA KNOWL ENG, V47, P237, DOI 10.1016/S0169-023X(03)00066-1; van van der Aalst W, 2004, COOPERATIVE INFORM S; Wilcox AB, 2012, MED CARE, V50, pS68, DOI 10.1097/MLR.0b013e318259c1e7; WordReference, 2012, DISS; Zheng K, 2011, J AM MED INFORM ASSN, V18, P704, DOI 10.1136/amiajnl-2011-000083	38	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75167	10.1371/journal.pone.0075167	http://dx.doi.org/10.1371/journal.pone.0075167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	222YC	24073246	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000055
J	Germain, J; Bruel-Jungerman, E; Grannec, G; Denis, C; Lepousez, G; Giros, B; Francis, F; Nosten-Bertrand, M				Germain, Johanne; Bruel-Jungerman, Elodie; Grannec, Gael; Denis, Cecile; Lepousez, Gabriel; Giros, Bruno; Francis, Fiona; Nosten-Bertrand, Marika			Doublecortin Knockout Mice Show Normal Hippocampal-Dependent Memory Despite CA3 Lamination Defects	PLOS ONE			English	Article							ABNORMAL NEURONAL MIGRATION; MENTAL-RETARDATION GENE; LIS1 MUTANT MICE; NMDA RECEPTORS; DORSAL HIPPOCAMPUS; INTERNEURON MIGRATION; ENHANCED EXCITABILITY; SOCIAL-INTERACTION; ADULT FOREBRAIN; OLFACTORY-BULB	Mutations in the human X-linked doublecortin gene (DCX) cause major neocortical disorganization associated with severe intellectual disability and intractable epilepsy. Although Dcx knockout (KO) mice exhibit normal isocortical development and architecture, they show lamination defects of the hippocampal pyramidal cell layer largely restricted to the CA3 region. Dcx-KO mice also exhibit interneuron abnormalities. As well as the interest of testing their general neurocognitive profile, Dcx-KO mice also provide a relatively unique model to assess the effects of a disorganized CA3 region on learning and memory. Based on its prominent anatomical and physiological features, the CA3 region is believed to contribute to rapid encoding of novel information, formation and storage of arbitrary associations, novelty detection, and short-term memory. We report here that Dcx-KO adult males exhibit remarkably preserved hippocampal-and CA3-dependant cognitive processes using a large battery of classical hippocampus related tests such as the Barnes maze, contextual fear conditioning, paired associate learning and object recognition. In addition, we show that hippocampal adult neurogenesis, in terms of proliferation, survival and differentiation of granule cells, is also remarkably preserved in Dcx-KO mice. In contrast, following social deprivation, Dcx-KO mice exhibit impaired social interaction and reduced aggressive behaviors. In addition, Dcx-KO mice show reduced behavioral lateralization. The Dcx-KO model thus reinforces the association of neuropsychiatric behavioral impairments with mouse models of intellectual disability.	[Germain, Johanne; Grannec, Gael; Denis, Cecile; Giros, Bruno; Nosten-Bertrand, Marika] INSERM UMRS 952, Paris, France; [Germain, Johanne; Grannec, Gael; Denis, Cecile; Giros, Bruno; Nosten-Bertrand, Marika] CNRS UMR 7224, Paris, France; [Germain, Johanne; Bruel-Jungerman, Elodie; Grannec, Gael; Denis, Cecile; Giros, Bruno; Francis, Fiona; Nosten-Bertrand, Marika] Univ Paris 06, Paris, France; [Germain, Johanne] Univ Paris 05, Paris, France; [Bruel-Jungerman, Elodie; Francis, Fiona] INSERM UMR S 839, Paris, France; [Bruel-Jungerman, Elodie; Francis, Fiona] Inst Fer Moulin, Paris, France; [Lepousez, Gabriel] Inst Pasteur, Unite Percept & Memoire, Paris, France; [Giros, Bruno] McGill Univ, Dept Psychiat, Douglas Hosp Res Ctr, Montreal, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; McGill University	Nosten-Bertrand, M (corresponding author), INSERM UMRS 952, Paris, France.	Marika.Nosten@snv.jussieu.fr	Francis, Fiona/B-5854-2016; GIROS, Bruno/ABD-5790-2021	GIROS, Bruno/0000-0001-5876-9822; Gael, Grannec/0000-0002-9694-9899; Francis, Fiona/0000-0001-8542-7537	Agence National de la Recherche [ANR-08-MNP-013]; INSERM; Avenir program; CNRS; UPMC; Fondation Bettencourt Schueller; Region Ile-de-France (NERF); Fondation Jerome Lejeune; Ministere de l'Education et de la Technologie; Fondation pour la Recherche Medicale (FRM)	Agence National de la Recherche(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Avenir program; CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC; Fondation Bettencourt Schueller; Region Ile-de-France (NERF)(Region Ile-de-France); Fondation Jerome Lejeune; Ministere de l'Education et de la Technologie; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	The authors are grateful for financial support from the Agence National de la Recherche (ANR-08-MNP-013; FF), as well as from INSERM, including the Avenir program (FF), the CNRS and UPMC, the Fondation Bettencourt Schueller (FF), the Region Ile-de-France (NERF; EBJ, FF), and the Fondation Jerome Lejeune (FF). JG was supported by a fellowship from the Ministere de l'Education et de la Technologie and the Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bazelot M, 2012, EUR J NEUROSCI, V35, P244, DOI 10.1111/j.1460-9568.2011.07962.x; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Belvindrah R, 2011, J NEUROSCI, V31, P7551, DOI 10.1523/JNEUROSCI.6716-10.2011; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; COLLINS RL, 1968, J HERED, V59, P9, DOI 10.1093/oxfordjournals.jhered.a107656; Corbo JC, 2002, J NEUROSCI, V22, P7548; Cravens CJ, 2006, EUR J NEUROSCI, V24, P1771, DOI 10.1111/j.1460-9568.2006.05044.x; Croarkin PE, 2011, NEUROSCI BIOBEHAV R, V35, P818, DOI 10.1016/j.neubiorev.2010.10.002; D'Adamo P, 2002, HUM MOL GENET, V11, P2567, DOI 10.1093/hmg/11.21.2567; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; ELY DL, 1977, PHYSIOL BEHAV, V18, P1075, DOI 10.1016/0031-9384(77)90014-2; Fleck MW, 2000, J NEUROSCI, V20, P2439; Francis F, 2006, EUR J NEUROSCI, V23, P877, DOI 10.1111/j.1460-9568.2006.04649.x; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Friocourt G, 2007, J NEUROSCI, V27, P3875, DOI 10.1523/JNEUROSCI.4530-06.2007; Gilbert PE, 2003, BEHAV NEUROSCI, V117, P1385, DOI 10.1037/0735-7044.117.6.1385; Glasper ER, 2012, BEHAV BRAIN RES, V227, P380, DOI 10.1016/j.bbr.2011.05.013; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Grouios G, 1999, J INTELL DISABIL RES, V43, P306, DOI 10.1046/j.1365-2788.1999.00217.x; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hunsaker MR, 2007, BEHAV NEUROSCI, V121, P742, DOI 10.1037/0735-7044.121.4.742; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jones DL, 2007, J NEUROPHYSIOL, V98, P2737, DOI 10.1152/jn.00938.2007; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Kato M, 2005, J CHILD NEUROL, V20, P392, DOI 10.1177/08830738050200042001; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kerjan G, 2009, P NATL ACAD SCI USA, V106, P6766, DOI 10.1073/pnas.0812687106; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Marcorelles P, 2010, ACTA NEUROPATHOL, V120, P503, DOI 10.1007/s00401-010-0692-z; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McHugh TJ, 2009, HIPPOCAMPUS, V19, P1153, DOI 10.1002/hipo.20684; McManus MF, 2004, AM J PATHOL, V165, P775, DOI 10.1016/S0002-9440(10)63340-8; Mitsui S, 2009, EUR J NEUROSCI, V30, P2368, DOI 10.1111/j.1460-9568.2009.07029.x; Mizumori SJY, 1999, HIPPOCAMPUS, V9, P444, DOI 10.1002/(SICI)1098-1063(1999)9:4<444::AID-HIPO10>3.0.CO;2-Z; Morice E, 2005, NEUROPSYCHOPHARMACOL, V30, P575, DOI 10.1038/sj.npp.1300570; MORRIS RD, 1993, AM J MENT RETARD, V97, P443; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nasrallah IM, 2006, J COMP NEUROL, V496, P847, DOI 10.1002/cne.20966; Nosten-Bertrand M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002473; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rajji T, 2006, J NEUROSCI, V26, P908, DOI 10.1523/JNEUROSCI.4194-05.2006; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Salinger WL, 2003, BEHAV NEUROSCI, V117, P1257, DOI 10.1037/0735-7044.117.6.1257; SamsDodd F, 1997, PSYCHOPHARMACOLOGY, V132, P303, DOI 10.1007/s002130050349; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; Slomianka L, 2011, BRAIN STRUCT FUNCT, V216, P301, DOI 10.1007/s00429-011-0322-0; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Wiltgen BJ, 2001, BEHAV NEUROSCI, V115, P26, DOI 10.1037/0735-7044.115.1.26; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Yabut O, 2007, BRAIN RES, V1140, P75, DOI 10.1016/j.brainres.2005.09.070	77	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74992	10.1371/journal.pone.0074992	http://dx.doi.org/10.1371/journal.pone.0074992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073232	Green Submitted, Green Published, gold			2022-12-27	WOS:000324768000041
J	Korgaonkar, MS; Antees, C; Williams, LM; Gatt, JM; Bryant, RA; Cohen, R; Paul, R; O'Hara, R; Grieve, SM				Korgaonkar, Mayuresh S.; Antees, Cassandra; Williams, Leanne M.; Gatt, Justine M.; Bryant, Richard A.; Cohen, Ronald; Paul, Robert; O'Hara, Ruth; Grieve, Stuart M.			Early Exposure to Traumatic Stressors Impairs Emotional Brain Circuitry	PLOS ONE			English	Article							EARLY-LIFE STRESS; HUMAN CEREBRAL-CORTEX; HIPPOCAMPAL VOLUME; SEXUAL-ABUSE; DEPRESSION; DISORDER; IMPACT; ADULTS; RISK; MORPHOMETRY	Exposure to early life trauma (ELT) is known to have a profound impact on mental development, leading to a higher risk for depression and anxiety. Our aim was to use multiple structural imaging methods to systematically investigate how traumatic stressors early in life impact the emotional brain circuits, typically found impaired with clinical diagnosis of depression and anxiety, across the lifespan in an otherwise healthy cohort. MRI data and self-reported histories of ELT from 352 healthy individuals screened for no psychiatric disorders were analyzed in this study. The volume and cortical thickness of the limbic and cingulate regions were assessed for all participants. A large subset of the cohort also had diffusion tensor imaging data, which was used to quantify white matter structural integrity of these regions. We found a significantly smaller amygdala volume and cortical thickness in the rostral anterior cingulate cortex associated with higher ELT exposure only for the adolescence group. White matter integrity of these regions was not affected. These findings demonstrate that exposure to early life trauma is associated with alterations in the gray matter of cingulate-limbic regions during adolescence in an otherwise healthy sample. These findings are interesting in the context that the affected regions are central neuroanatomical components in the psychopathology of depression, and adolescence is a peak period for risk and onset of the disorder.	[Korgaonkar, Mayuresh S.; Antees, Cassandra; Williams, Leanne M.; Gatt, Justine M.; Grieve, Stuart M.] Univ Sydney Med Sch Westmead, Brain Dynam Ctr, Sydney, NSW, Australia; [Korgaonkar, Mayuresh S.; Antees, Cassandra; Williams, Leanne M.; Gatt, Justine M.; Grieve, Stuart M.] Westmead Millennium Inst, Sydney, NSW, Australia; [Korgaonkar, Mayuresh S.; Williams, Leanne M.; Gatt, Justine M.] Univ Sydney Med Sch Western, Discipline Psychiat, Westmead Hosp, Sydney, NSW, Australia; [Williams, Leanne M.; O'Hara, Ruth] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Bryant, Richard A.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Cohen, Ronald] Univ Florida, McKnight Inst Aging, Gainesville, FL USA; [Paul, Robert] Univ Missouri, St Louis, MO 63121 USA; [Grieve, Stuart M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Grieve, Stuart M.] Royal Prince Alfred Hosp, Sydney, NSW, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Stanford University; University of New South Wales Sydney; State University System of Florida; University of Florida; University of Missouri System; University of Missouri Saint Louis; University of Sydney; University of Sydney	Korgaonkar, MS (corresponding author), Univ Sydney Med Sch Westmead, Brain Dynam Ctr, Sydney, NSW, Australia.	M.Korgaonkar@sydney.edu.au	Williams, Leanne/GLU-4975-2022; Bryant, Richard/AAA-6479-2019; Williams, Leanne M/B-4095-2012; Gatt, Justine M/C-4624-2008; Korgaonkar, Mayuresh/K-7447-2014; Grieve, Stuart/A-5093-2012	Williams, Leanne/0000-0001-9987-7360; Bryant, Richard/0000-0002-9607-819X; Gatt, Justine M/0000-0002-9276-6358; Korgaonkar, Mayuresh/0000-0002-1339-2221; Grieve, Stuart/0000-0002-2712-157X	National Health & Medical Research Council (NHMRC) of Australia [1008080]; ARC APDI [LP0883621]	National Health & Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); ARC APDI(Australian Research Council)	This research was supported by the National Health & Medical Research Council (NHMRC) of Australia project grants scheme (Project Grant number 1008080). Dr. Justine Gatt was supported by an ARC APDI Fellowship (LP0883621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2008, INT J GERIATR PSYCH, V23, P347, DOI 10.1002/gps.1939; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Andersson J.L.R, 2007, TR07JA2 FMRIB; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Chu DA, 2013, J PSYCHIATR RES, V47, P23, DOI 10.1016/j.jpsychires.2012.08.006; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frodl T, 2013, NEUROBIOL DIS, V52, P24, DOI 10.1016/j.nbd.2012.03.012; Frodl T, 2012, J PSYCHIATR NEUROSCI, V37, P37, DOI 10.1503/jpn.110028; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gatt JM, 2012, TWIN RES HUM GENET, V15, P419, DOI 10.1017/thg.2012.12; Gatt JM, 2010, BIOL PSYCHIAT, V68, P818, DOI 10.1016/j.biopsych.2010.06.025; Gatt JM, 2010, DEPRESS ANXIETY, V27, P752, DOI 10.1002/da.20726; Gershon A, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0352-9; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Lui S, 2013, J PSYCHIATR NEUROSCI, V38; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; McKinnon MC, 2009, J PSYCHIATR NEUROSCI, V34, P41; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; O'Hara Ruth, 2007, Curr Psychiatry Rep, V9, P173, DOI 10.1007/s11920-007-0014-x; Seckfort DL, 2008, BRAIN IMAGING BEHAV, V2, P49, DOI 10.1007/s11682-007-9015-y; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yehuda Rachel, 2004, Psychoneuroendocrinology, V29, P1212, DOI 10.1016/j.psyneuen.2004.01.006; Zannas AS, 2013, J PSYCHIATR RES, V47, P829, DOI 10.1016/j.jpsychires.2013.02.008	40	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75524	10.1371/journal.pone.0075524	http://dx.doi.org/10.1371/journal.pone.0075524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073270	Green Published, gold			2022-12-27	WOS:000324768000080
J	Frazao, N; Hiller, NL; Powell, E; Earl, J; Ahmed, A; Sa-Leao, R; de Lencastre, H; Ehrlich, GD; Tomasz, A				Frazao, Nelson; Hiller, N. Luisa; Powell, Evan; Earl, Josh; Ahmed, Azad; Sa-Leao, Raquel; de Lencastre, Herminia; Ehrlich, Garth D.; Tomasz, Alexander			Virulence Potential and Genome-Wide Characterization of Drug Resistant Streptococcus pneumoniae Clones Selected In Vivo by the 7-Valent Pneumococcal Conjugate Vaccine	PLOS ONE			English	Article							DAY-CARE-CENTERS; ANTIBIOTIC-RESISTANCE; PENICILLIN RESISTANCE; CAPSULAR SEROTYPES; HEALTHY-CHILDREN; SEQUENCE; CARRIAGE; DISEASE; IMPACT; COLONIZATION	We used mouse models of pneumococcal colonization and disease combined with full genome sequencing to characterize three major drug resistant clones of S. pneumoniae that were recovered from the nasopharynx of PCV7-immunized children in Portugal. The three clones - serotype 6A (ST2191), serotype 15A (ST63) and serotype 19A (ST276) carried some of the same drug resistance determinants already identified in nasopharyngeal isolates from the pre-PCV7 era. The three clones were able to colonize efficiently the mouse nasopharyngeal mucosa where populations of these pneumococci were retained for as long as 21 days. During this period, the three clones were able to asymptomatically invade the olfactory bulbs, brain, lungs and the middle ear mucosa and established populations in these tissues. The virulence potential of the three clones was poor even at high inoculum (10(5) CFU per mouse) concentrations in the mouse septicemia model and was undetectable in the pneumonia model. Capsular type 3 transformants of clones 6A and 19A prepared in the laboratory produced lethal infection at low cell concentration (10(3) CFU per mouse) but the same transformants became impaired in their potential to colonize, indicating the importance of the capsular polysaccharide in both disease and colonization. The three clones were compared to the genomes of 56 S. pneumoniae strains for which sequence information was available in the public databank. Clone 15A (ST63) only differed from the serotype 19F clone G54 in a very few genes including serotype so that this clone may be considered the product of a capsular switch. While no strain with comparable degree of similarity to clone 19A (ST276) was found among the sequenced isolates, by MLST this clone is a single locust variant (SLV) of Denmark14-ST230 international clone. Clone 6A (ST2191) was most similar to the penicillin resistant Hungarian serotype 19A clone.	[Frazao, Nelson; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Hiller, N. Luisa; Powell, Evan; Earl, Josh; Ahmed, Azad; Ehrlich, Garth D.] Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; [Hiller, N. Luisa] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, Oeiras, Portugal; [Frazao, Nelson; de Lencastre, Herminia; Tomasz, Alexander] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Allegheny General Hospital; Carnegie Mellon University; Universidade Nova de Lisboa; Rockefeller University	Tomasz, A (corresponding author), Rockefeller Univ, Microbiol Lab, 1230 York Ave, New York, NY 10021 USA.	tomasz@mail.rockefeller.edu	Hiller, N. Luisa/A-3739-2016; Sá-Leão, Raquel/A-9341-2011	Hiller, N. Luisa/0000-0001-6572-1368; Sá-Leão, Raquel/0000-0001-9804-827X; Frazao, Nelson/0000-0003-3509-8338; Ehrlich, Garth/0000-0003-1140-6594; Tomasz, Alexander/0000-0003-1520-1983; /0000-0001-6816-8932	Rockefeller University; PNEUMOPATH project from the European Commission [HEALTH-F3-2009-222983]; Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/73229/2010]; National Institute on Deafness And Other Communication Disorders of the National Institutes of Health (NIH) [R00DC011322]; Allegheny General Hospital, Allegheny-Singer Research Institute; NIH [DC002148, DC02148 - 16S1, AI080935]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002148, R00DC011322] Funding Source: NIH RePORTER	Rockefeller University; PNEUMOPATH project from the European Commission; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institute on Deafness And Other Communication Disorders of the National Institutes of Health (NIH); Allegheny General Hospital, Allegheny-Singer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant (Bridges to Better Medicine Technology Innovation Fund) from the Rockefeller University to AT and the PNEUMOPATH project (contract HEALTH-F3-2009-222983) from the European Commission to HL. NF was supported by a Postdoctoral fellowship from Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/73229/2010). NLH was supported by the National Institute on Deafness And Other Communication Disorders of the National Institutes of Health (NIH) Award Number R00DC011322. GDH, EP, JE and AA were supported by Allegheny General Hospital, Allegheny-Singer Research Institute and NIH grants DC002148 (GDE), DC02148 - 16S1 (GDE), AI080935 (GDE). The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Briles DE, 2005, INFECT IMMUN, V73, P6945, DOI 10.1128/IAI.73.10.6945-6951.2005; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Lencastre H, 2002, J ANTIMICROB CHEMOTH, V50, P75, DOI 10.1093/jac/dkf511; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Dopazo J, 2001, MICROB DRUG RESIST, V7, P99, DOI 10.1089/10766290152044995; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Frazao N, 2005, PEDIATR INFECT DIS J, V24, P243, DOI 10.1097/01.inf.0000154326.77617.3e; Frazao N, 2010, VACCINE, V28, P3445, DOI 10.1016/j.vaccine.2010.02.070; Gertz RE, 2010, J INFECT DIS, V201, P770, DOI 10.1086/650496; Glover DT, 2008, INFECT IMMUN, V76, P2767, DOI 10.1128/IAI.01126-07; Hakenbeck R, 1999, MOL MICROBIOL, V33, P673, DOI 10.1046/j.1365-2958.1999.01521.x; Hanage WP, 2007, J INFECT DIS, V195, P347, DOI 10.1086/510249; Hanage WP, 2011, PEDIATR INFECT DIS J, V30, P302, DOI 10.1097/INF.0b013e318201a154; Heikkinen T, 1999, NEW ENGL J MED, V340, P260, DOI 10.1056/NEJM199901283400402; Hiller NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028850; Hu FZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047983; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kharat AS, 2006, MOL MICROBIOL, V60, P93, DOI 10.1111/j.1365-2958.2006.05082.x; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; LAI WC, 1986, J CLIN MICROBIOL, V23, P817, DOI 10.1128/JCM.23.5.817-821.1986; Mahjoub-Messai F, 2009, J CLIN MICROBIOL, V47, P837, DOI 10.1128/JCM.01547-08; Marra A, 2001, INFECT IMMUN, V69, P7318, DOI 10.1128/IAI.69.12.7318-7325.2001; Mato R, 2005, MICROB DRUG RESIST, V11, P309, DOI 10.1089/mdr.2005.11.309; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Munoz-Almagro C, 2009, J INFECTION, V59, P75, DOI 10.1016/j.jinf.2009.05.012; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Rambaut A, 2012, IGTREE, V1, P4; Roberts RB, 2001, MICROB DRUG RESIST, V7, P137, DOI 10.1089/10766290152045011; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Sa-Leao R, 2001, J INFECT DIS, V184, P1206, DOI 10.1086/323663; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Sanchez-Beato AR, 1998, FEMS MICROBIOL LETT, V164, P207, DOI 10.1016/S0378-1097(98)00206-7; Simoes AS, 2011, J CLIN MICROBIOL, V49, P2810, DOI 10.1128/JCM.00517-11; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tleyjeh IM, 2006, CLIN INFECT DIS, V42, P788, DOI 10.1086/500140; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; van Ginkel FW, 2003, P NATL ACAD SCI USA, V100, P14363, DOI 10.1073/pnas.2235844100; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Yildirim I, 2012, PEDIATR INFECT DIS J, V31, P1016, DOI 10.1097/INF.0b013e3182615615; Yildirim I, 2010, VACCINE, V29, P283, DOI 10.1016/j.vaccine.2010.10.032	56	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74867	10.1371/journal.pone.0074867	http://dx.doi.org/10.1371/journal.pone.0074867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069360	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300053
J	Pathai, S; Lawn, SD; Weiss, HA; Cook, C; Bekker, LG; Gilbert, CE				Pathai, Sophia; Lawn, Stephen D.; Weiss, Helen A.; Cook, Colin; Bekker, Linda-Gail; Gilbert, Clare E.			Retinal Nerve Fibre Layer Thickness and Contrast Sensitivity in HIV-Infected Individuals in South Africa: A Case-Control Study	PLOS ONE			English	Article							AGE-RELATED COMORBIDITIES; CYTOMEGALOVIRUS-RETINITIS; AIDS RESEARCH; VISION; MORTALITY; THERAPY; FRAILTY; PEOPLE; ERA; INFLAMMATION	Background: Antiretroviral treatment (ART) has altered the spectrum of HIV-related eye disease, resulting in a lower prevalence of retinal opportunistic infections (OIs). However, abnormalities in visual function have been reported in HIV-infected individuals despite effective viral suppression and the absence of retinal OIs. These changes may be mediated by an HIV-associated 'neuroretinal disorder', characterized by changes in the retinal nerve fibre layer (RNFL). HIV infection may also be associated with accelerated biological aging. The aim of this study was to investigate the relationships between contrast sensitivity, RNFL thickness, HIV infection and frailty in South African adults. Methods: Case-control study of 225 HIV-infected individuals without retinal OIs and 203 gender/age-matched HIVseronegative individuals. Peri-papillary RNFL thickness was determined with spectral domain optical coherence tomography in four quadrants. CS was measured using a Pelli-Robson chart. Frailty was assessed using standard criteria. Multivariable linear and logistic regression were used to assess associations between HIV status and RNFL/CS and frailty. Results: The median age of both groups was similar (41.2 vs. 41.9 years, p = 0.37). 88% of HIV-infected individuals were receiving ART and their median CD4 count was 468 cells/ml. Adjusted CS score was lower in HIV-infected participants compared to HIV-seronegative individuals (1.76 vs. 1.82, p = 0.002). Independent predictors of poor CS in the HIV-infected group were positive frailty status and current HIV viral load > 2 log copies/ml. Lower CS score was also associated with thin temporal RNFL in HIV-infected individuals (p = 0.04). Superior quadrant RNFL thickness was greatest in ART-naive participants relative to the HIV-uninfected group (p-trend = 0.04). Longer ART duration was associated with thinning of inferior and nasal RNFL quadrants (p-trend = 0.03 and 0.04, respectively). Conclusions: Contrast sensitivity is reduced in HIV-infected individuals and functionally associated with frailty and unsuppressed viraemia. This may reflect structural changes in the RNFL that are evident despite the absence of OIs.	[Pathai, Sophia; Gilbert, Clare E.] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England; [Pathai, Sophia; Lawn, Stephen D.; Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Weiss, Helen A.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, MRC Trop Epidemiol Grp, London WC1, England; [Cook, Colin] Univ Cape Town, Groote Schuur Hosp, Fac Hlth Sci, Dept Ophthalmol, ZA-7925 Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Pathai, S (corresponding author), London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England.	Sophia.pathai@lshtm.ac.uk	Pathai, Sophia/GLU-7811-2022; Bekker, Linda-Gail/AAZ-8929-2020; weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Pathai, Sophia/0000-0002-2835-4666	Wellcome Trust [090354/Z/09/Z, 088590]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Wellcome Trust grant awarded to SP (Grant number: 090354/Z/09/Z). SDL is funded by the Wellcome Trust, (Grant #088590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamouti B, 2003, BRIT J OPHTHALMOL, V87, P899, DOI 10.1136/bjo.87.7.899; Avila-Funes JA, 2008, J GERONTOL A-BIOL, V63, P1089, DOI 10.1093/gerona/63.10.1089; Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; Deeks Steven G, 2009, Top HIV Med, V17, P118; ELLIOTT DB, 1992, OPTOMETRY VISION SCI, V69, P378, DOI 10.1097/00006324-199205000-00007; Arantes TEFE, 2010, AM J OPHTHALMOL, V149, P571, DOI 10.1016/j.ajo.2009.11.026; Freeman WR, 2008, AM J OPHTHALMOL, V145, P453, DOI 10.1016/j.ajo.2007.10.013; Fulop T, 2010, BIOGERONTOLOGY, V11, P547, DOI 10.1007/s10522-010-9287-2; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; High KP, 1999, J ACQ IMMUN DEF SYND, pS1; Holland GN, 2008, AM J OPHTHALMOL, V145, P12, DOI 10.1016/j.ajo.2007.09.040; Holland GN, 2008, AM J OPHTHALMOL, V145, P5, DOI 10.1016/j.ajo.2007.09.023; Holland GN, 2010, AM J OPHTHALMOL, V149, P807, DOI 10.1016/j.ajo.2009.12.019; Hubbard RE, 2010, BIOGERONTOLOGY, V11, P635, DOI 10.1007/s10522-010-9292-5; Kalyani PS, 2012, AM J OPHTHALMOL, V153, P734, DOI 10.1016/j.ajo.2011.09.019; Kirbas S, 2013, J NEURO-OPHTHALMOL, V33, P62, DOI 10.1097/WNO.0b013e3182701745; Kirbas S, 2013, J NEURO-OPHTHALMOL, V33, P58, DOI 10.1097/WNO.0b013e318267fd5f; Kozak I, 2005, AM J OPHTHALMOL, V139, P295, DOI 10.1016/j.ajo.2004.09.039; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Leat SJ, 1999, OPTOMETRY VISION SCI, V76, P198, DOI 10.1097/00006324-199904000-00023; Lott LA, 2010, OPHTHAL EPIDEMIOL, V17, P242, DOI 10.3109/09286586.2010.498660; MARRON JA, 1982, AM J OPTOM PHYS OPT, V59, P413; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mills EJ, 2012, NEW ENGL J MED, V366, P1270, DOI 10.1056/NEJMp1113643; Mothobi NZ, 2012, CURR OPIN INFECT DIS, V25, P4, DOI 10.1097/QCO.0b013e32834ef586; Negin Joel, 2012, AIDS, V26 Suppl 1, pS1; Pathai S, 2013, JAIDS-J ACQ IMM DEF, V63, P307, DOI 10.1097/QAI.0b013e31828ad759; Pathai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057422; Pathai S, 2013, JAIDS-J ACQ IMM DEF, V62, P43, DOI 10.1097/QAI.0b013e318273b631; Pathai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051405; Pierro L, 2012, INVEST OPHTH VIS SCI, V53, P5912, DOI 10.1167/iovs.11-8644; Plummer DJ, 2001, AM J OPHTHALMOL, V131, P216, DOI 10.1016/S0002-9394(00)00787-X; Puts MTE, 2005, J AM GERIATR SOC, V53, P40, DOI 10.1111/j.1532-5415.2005.53008.x; Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223; Shah KH, 2006, AM J OPHTHALMOL, V142, P284, DOI 10.1016/j.ajo.2006.03.046; Solís-Castillo A., 2011, Arch Soc Esp Oftalmol, V86, P103, DOI 10.1016/j.oftal.2011.01.004; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Wong TY, 2005, OPHTHALMOLOGY, V112, P553, DOI 10.1016/j.ophtha.2004.11.026; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001	42	20	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73694	10.1371/journal.pone.0073694	http://dx.doi.org/10.1371/journal.pone.0073694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069225	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000324777300018
J	Pradhapan, P; Kuusela, J; Viik, J; Aalto-Setala, K; Hyttinen, J				Pradhapan, Paruthi; Kuusela, Jukka; Viik, Jari; Aalto-Setala, Katriina; Hyttinen, Jari			Cardiomyocyte MEA Data Analysis (CardioMDA) - A Novel Field Potential Data Analysis Software for Pluripotent Stem Cell Derived Cardiomyocytes	PLOS ONE			English	Article							QT INTERVAL PROLONGATION; MICROELECTRODE ARRAYS; CROSS-CORRELATION; AVERAGING TECHNIQUE; CARDIOACTIVE DRUGS; ECG; MODEL; SAFETY; ELECTROCARDIOGRAM; RECORDINGS	Cardiac safety pharmacology requires in-vitro testing of all drug candidates before clinical trials in order to ensure they are screened for cardio-toxic effects which may result in severe arrhythmias. Micro-electrode arrays (MEA) serve as a complement to current in-vitro methods for drug safety testing. However, MEA recordings produce huge volumes of data and manual analysis forms a bottleneck for high-throughput screening. To overcome this issue, we have developed an offline, semi-automatic data analysis software, 'Cardiomyocyte MEA Data Analysis (CardioMDA)', equipped with correlation analysis and ensemble averaging techniques to improve the accuracy, reliability and throughput rate of analysing human pluripotent stem cell derived cardiomyocyte (CM) field potentials. With the program, true field potential and arrhythmogenic complexes can be distinguished from one another. The averaged field potential complexes, analysed using our software to determine the field potential duration, were compared with the analogous values obtained from manual analysis. The reliability of the correlation analysis algorithm, evaluated using various arrhythmogenic and morphology changing signals, revealed a mean sensitivity and specificity of 99.27% and 94.49% respectively, in determining true field potential complexes. The field potential duration of the averaged waveforms corresponded well to the manually analysed data, thus demonstrating the reliability of the software. The software has also the capability to create overlay plots for signals recorded under different drug concentrations in order to visualize and compare the magnitude of response on different ion channels as a result of drug treatment. Our novel field potential analysis platform will facilitate the analysis of CM MEA signals in semi-automated way and provide a reliable means of efficient and swift analysis for cardiomyocyte drug or disease model studies.	[Pradhapan, Paruthi; Viik, Jari; Hyttinen, Jari] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Kuusela, Jukka; Aalto-Setala, Katriina] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Pradhapan, Paruthi; Kuusela, Jukka; Viik, Jari; Aalto-Setala, Katriina; Hyttinen, Jari] BioMediTech, Tampere, Finland; [Aalto-Setala, Katriina] Tampere Univ Hosp, HeartCtr, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University Hospital	Aalto-Setala, K (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	katriina.aalto-setala@uta.fi; jari.hyttinen@tut.fi	/A-6303-2009; Hyttinen, Jari A/G-4280-2014	/0000-0001-6081-6819; Hyttinen, Jari A/0000-0003-1850-3055	TEKES; Finnish Foundation for Cardiovascular Research; Pirkanmaa Hospital District	TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Foundation for Cardiovascular Research; Pirkanmaa Hospital District	This work was supported by TEKES (http://www.tekes.fi/en/), Finnish Foundation for Cardiovascular Research (http://www.sydantutkimussaatio.fi) and Pirkanmaa Hospital District (www.pshp.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOUD S, 1990, COMPUT BIOL MED, V20, P147, DOI 10.1016/0010-4825(90)90001-6; ABBOUD S, 1984, COMPUT BIOMED RES, V17, P258, DOI 10.1016/S0010-4809(84)80017-8; ALPERIN N, 1986, COMPUT BIOMED RES, V19, P193, DOI 10.1016/0010-4809(86)90015-7; Asai Y, 2010, CURR STEM CELL RES T, V5, P227, DOI 10.2174/157488810791824502; Binah O, 2007, J ELECTROCARDIOL, V40, pS192, DOI 10.1016/j.jelectrocard.2007.05.035; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Bussek A, 2009, CELL PHYSIOL BIOCHEM, V24, P527, DOI 10.1159/000257528; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; Dutta S, 2010, MED ENG PHYS, V32, P1161, DOI 10.1016/j.medengphy.2010.08.007; Egert U, 2005, PRACTICAL METHODS IN CARDIOVASCULAR RESEARCH, P432, DOI 10.1007/3-540-26574-0_22; Escalona OJ, 1996, ENG MED BIOL SOC P A, V4, P1365; GOVRIN O, 1985, COMPUT BIOMED RES, V18, P37, DOI 10.1016/0010-4809(85)90005-9; Halbach M, 2006, CELL PHYSIOL BIOCHEM, V18, P1, DOI 10.1159/000095132; Halbach MD, 2003, CELL PHYSIOL BIOCHEM, V13, P271, DOI 10.1159/000074542; Hannes T, 2008, J ELECTROCARDIOL, V41, P562, DOI 10.1016/j.jelectrocard.2008.06.017; Ifeachor E. C., 1993, DIGITAL SIGNAL PROCE; JOENG HK, 1989, P IEEE EMBS, V11, P42, DOI 10.1109/IEMBS.1989.95562; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kujala K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044660; Kujala VJ, 2011, COMPUT METH PROG BIO, V104, P199, DOI 10.1016/j.cmpb.2011.04.001; Laciar E, 2003, IEEE T BIO-MED ENG, V50, P344, DOI 10.1109/TBME.2003.808821; LAGUNA P, 1990, MED BIOL ENG COMPUT, V28, P67, DOI 10.1007/BF02441680; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Last T, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-26; Liang HM, 2010, CELL PHYSIOL BIOCHEM, V25, P459, DOI 10.1159/000303051; LINDECRANTZ KG, 1988, J BIOMED ENG, V10, P280, DOI 10.1016/0141-5425(88)90012-X; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Meyer T, 2004, DRUG SAFETY, V27, P763, DOI 10.2165/00002018-200427110-00002; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Nam Yoonkey, 2011, Critical Reviews in Biomedical Engineering, V39, P45, DOI 10.1615/CritRevBiomedEng.v39.i1.40; Natarajan A, 2011, BIOMATERIALS, V32, P4267, DOI 10.1016/j.biomaterials.2010.12.022; Pekkanen-Mattila M, 2009, ANN MED, V41, P360, DOI 10.1080/07853890802609542; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Reppel M, 2004, J ELECTROCARDIOL, V37, P104, DOI 10.1016/j.jelectrocard.2004.08.033; Reppel M, 2005, J ELECTROCARDIOL, V38, P166, DOI 10.1016/j.jelectrocard.2005.06.029; Reppel M, 2007, CELL PHYSIOL BIOCHEM, V19, P213, DOI 10.1159/000100628; ROMPELMAN O, 1986, J BIOMED ENG, V8, P24, DOI 10.1016/0141-5425(86)90026-9; Shahanaz Ayub, 2012, IJCA, V58, P33; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Stett A, 2003, ANAL BIOANAL CHEM, V377, P486, DOI 10.1007/s00216-003-2149-x; Strumillo P, 2002, ELECTRON LETT, V38, P682, DOI 10.1049/el:20020499; Suter W, 2006, CURR OPIN CHEM BIOL, V10, P362, DOI 10.1016/j.cbpa.2006.06.023; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka T, 2009, BIOCHEM BIOPH RES CO, V385, P497, DOI 10.1016/j.bbrc.2009.05.073; van Noord C, 2010, BRIT J CLIN PHARMACO, V70, P16, DOI 10.1111/j.1365-2125.2010.03660.x; Vazquez-Seisdedos CR, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-77; Vitek M, 2010, IFMBE PROC, V25, P177; Yokoo N, 2009, BIOCHEM BIOPH RES CO, V387, P482, DOI 10.1016/j.bbrc.2009.07.052; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	49	25	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e73637	10.1371/journal.pone.0073637	http://dx.doi.org/10.1371/journal.pone.0073637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069215	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300015
J	Azari, EK; Leitner, C; Jaggi, T; Langhans, W; Mansouri, A				Azari, Elnaz Karimian; Leitner, Claudia; Jaggi, Thomas; Langhans, Wolfgang; Mansouri, Abdelhak			Possible Role of Intestinal Fatty Acid Oxidation in the Eating-Inhibitory Effect of the PPAR-alpha Agonist Wy-14643 in High-Fat Diet Fed Rats	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; MITOCHONDRIAL 3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE; SPONTANEOUS MEAL SIZE; FOOD-INTAKE; GENE-EXPRESSION; BODY-WEIGHT; PEROXISOME PROLIFERATORS; ENERGY-METABOLISM; LIPID-METABOLISM; C57BL/6J MICE	PPAR-alpha plays a key role in lipid metabolism; it enhances fatty acid oxidation (FAO) and ketogenesis. Pharmacological PPAR-alpha activation improves insulin sensitivity and reduces food intake, but its mechanisms of action remain unknown. We here report that intraperitoneal (IP) administration of the PPAR-alpha agonist Wy-14643 (40 mg/kg BW) reduced food intake in adult male rats fed a high-fat diet (HFD, 49% of the energy) mainly through an increase in the latency to eat after injection, and without inducing a conditioned taste avoidance. Also, IP administered Wy-14643 caused an acute (the first 60 min) decrease in the respiratory quotient (RQ) and an increase in hepatic portal vein beta-hydroxybutyrate level (at 35 min) without affecting plasma non-esterified fatty acids. Given the known stimulatory effect of PPAR-alpha on FAO and ketogenesis, we measured the protein expression level of carnitine palmitoyltransferase-1 (CPT 1A) and mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase (HMG-CoAS2), two key enzymes for FAO and ketogenesis, respectively, in liver, duodenum and jejunum. Wy-14643 induced a significant increase in the expression of CPT 1A in the jejunum and duodenum and of HMG-CoAS2 in the jejunum, but neither CPT 1A nor HMG-CoAS2 expression was increased in the liver. The induction of CPT 1A and HMG-CoAS2 expression was associated with a decrease in the lipid droplet content selectively in the jejunum. Our findings indicate that Wy-14643 stimulates FAO and ketogenesis in the intestine, in particular in the jejunum, rather than in the liver, thus supporting the hypothesis that PPAR-alpha activation inhibits eating by stimulating intestinal FAO.	[Azari, Elnaz Karimian; Leitner, Claudia; Jaggi, Thomas; Langhans, Wolfgang; Mansouri, Abdelhak] Swiss Fed Inst Technol, Physiol & Behav Lab, Schwerzenbach, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Mansouri, A (corresponding author), Swiss Fed Inst Technol, Physiol & Behav Lab, Schwerzenbach, Switzerland.	abdelhak-mansouri@ethz.ch	Mansouri, Abdelhak/D-9100-2013; Langhans, Wolfgang/C-4073-2016	Mansouri, Abdelhak/0000-0003-4471-7276; 	Swiss National Science Foundation [31_130665]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The project was funded by Swiss National Science Foundation Grant No. 31_130665 WL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkan B, 2000, AM J PHYSIOL-REG I, V279, pR1449, DOI 10.1152/ajpregu.2000.279.4.R1449; Baumgartner I, 2010, J NEUROENDOCRINOL, V22, P557, DOI 10.1111/j.1365-2826.2010.01995.x; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Colin S, 2012, EUR HEART J; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; de Vogel-van den Bosch HM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-231; Diep TA, 2011, FASEB J, V25, P765, DOI 10.1096/fj.10-166595; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; FRIEDMAN MI, 1995, AM J CLIN NUTR, V62, P1096; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; Gaetani S, 2010, J NEUROSCI, V30, P8096, DOI 10.1523/JNEUROSCI.0036-10.2010; Gomez R, 2002, J NEUROSCI, V22, P9612; Gonzalez FJ, 1998, J NATL CANCER I, V90, P1702, DOI 10.1093/jnci/90.22.1702; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Horn CC, 2004, PHYSIOL BEHAV, V81, P157, DOI 10.1016/j.physbeh.2004.01.007; Kaidar-Person O, 2011, OBES SURG, V21, P1792, DOI 10.1007/s11695-011-0490-2; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kondo H, 2006, AM J PHYSIOL-ENDOC M, V291, pE1092, DOI 10.1152/ajpendo.00583.2005; Lagakos WS, 2011, AM J PHYSIOL-GASTR L, V300, pG803, DOI 10.1152/ajpgi.00229.2010; LANGHANS W, 1985, PHYSIOL BEHAV, V34, P579, DOI 10.1016/0031-9384(85)90052-6; LANGHANS W, 1987, BEHAV NEURAL BIOL, V47, P7, DOI 10.1016/S0163-1047(87)90112-9; LANGHANS W, 1991, PHYSIOL BEHAV, V49, P1203, DOI 10.1016/0031-9384(91)90352-O; Langhans W, 2011, AM J PHYSIOL-REG I, V300, pR554, DOI 10.1152/ajpregu.00610.2010; Langhans W, 2010, FORUM NUTR, V63, P9, DOI 10.1159/000264392; Leonhardt M, 2004, PHYSIOL BEHAV, V83, P645, DOI 10.1016/j.physbeh.2004.07.033; Mansouri A, 2008, AM J PHYSIOL-REG I, V295, pR799, DOI 10.1152/ajpregu.90381.2008; Decara JM, 2012, DIS MODEL MECH, V5, P660, DOI 10.1242/dmm.009233; Michalik L, 2011, PROSTAG LEUKOTR ESS, V85, P235, DOI 10.1016/j.plefa.2011.04.016; Mochizuki K, 2001, BBA-MOL CELL BIOL L, V1531, P68, DOI 10.1016/S0167-4889(01)00071-4; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Murase T, 2002, J LIPID RES, V43, P1312, DOI 10.1194/jlr.M200094-JLR200; Park MK, 2012, KOREAN J PHYSIOL PHA, V16, P181, DOI 10.4196/kjpp.2012.16.3.181; Piomelli D, 2013, TRENDS ENDOCRIN MET, V24, P332, DOI 10.1016/j.tem.2013.03.001; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Prip-Buus C, 1998, FEBS LETT, V429, P173, DOI 10.1016/S0014-5793(98)00584-5; Riediger T, 2010, PHARMACOL BIOCHEM BE, V97, P112, DOI 10.1016/j.pbb.2010.04.015; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Ruttimann EB, 2009, ENDOCRINOLOGY, V150, P1174, DOI 10.1210/en.2008-1221; SCHARRER E, 1986, AM J PHYSIOL, V250, P1003, DOI 10.1152/ajpregu.1986.250.6.R1003; Scharrer E, 1999, NUTRITION, V15, P704, DOI 10.1016/S0899-9007(99)00125-2; SCHEURINK AJW, 1990, PHYSIOL BEHAV, V48, P909, DOI 10.1016/0031-9384(90)90248-3; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SERRA D, 1993, ARCH BIOCHEM BIOPHYS, V307, P40, DOI 10.1006/abbi.1993.1557; Silberbauer CJ, 2000, AM J PHYSIOL-REG I, V278, pR646, DOI 10.1152/ajpregu.2000.278.3.R646; SURINABAUMGARTNER DM, 1995, AM J PHYSIOL-REG I, V269, pR978, DOI 10.1152/ajpregu.1995.269.5.R978; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Tabarin A, 2005, DIABETES, V54, P3510, DOI 10.2337/diabetes.54.12.3510; Tamura Kotaro, 2006, Journal of Toxicological Sciences, V31, P471, DOI 10.2131/jts.31.471; THUMELIN S, 1993, BIOCHEM J, V292, P493, DOI 10.1042/bj2920493; Uchida A, 2011, BBA-MOL CELL BIOL L, V1811, P170, DOI 10.1016/j.bbalip.2010.12.011; van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d; Vila-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044; WIERSMA J, 1986, LAB ANIM, V20, P57, DOI 10.1258/002367786781062115; Yuan HD, 2009, DRUG METAB DISPOS, V37, P1443, DOI 10.1124/dmd.108.026245; Zorrilla EP, 2005, AM J PHYSIOL-REG I, V288, pR1450, DOI 10.1152/ajpregu.00175.2004	60	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74869	10.1371/journal.pone.0074869	http://dx.doi.org/10.1371/journal.pone.0074869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069361	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300063
J	Cui, GL; Zhu, RA; Qian, Y; Deng, J; Zhao, LQ; Sun, Y; Wang, F				Cui, Guanglin; Zhu, Runan; Qian, Yuan; Deng, Jie; Zhao, Linqing; Sun, Yu; Wang, Fang			Genetic Variation in Attachment Glycoprotein Genes of Human Respiratory Syncytial Virus Subgroups A and B in Children in Recent Five Consecutive Years	PLOS ONE			English	Article							G-PROTEIN GENE; GROUP-A; MOLECULAR EPIDEMIOLOGY; CIRCULATION PATTERNS; STRAIN VARIATION; SOUTH-AFRICA; VARIABILITY; GENOTYPE; PREVALENCE; DUPLICATION	Human respiratory syncytial virus (HRSV) outranks other viral agents as the cause of respiratory tract diseases in children worldwide. Molecular epidemiological study of the virus provides useful information for the development of globally effective vaccine. We investigated the circulating pattern and genetic variation in the attachment glycoprotein genes of HRSV in Beijing during 5 consecutive seasons from 2007 to 2012. Out of 19,942 tested specimens, 3,160 (15.8%) were HRSV antigen-positive. The incidence of HRSV infection in males was significantly higher than in females. Of the total 723 (23.1%) randomly selected HRSV antigen-positive samples, 462 (63.9%) and 239 (33.1%) samples were identified as subgroup A and B, respectively. Subgroups A and B co-circulated in the 5 consecutive HRSV seasons, which showed a shifting mixed pattern of subgroup dominance. Complete G gene sequences were obtained from 190 HRSV-A and 72 HRSV-B by PCR for phylogenetic analysis. Although 4 new genotypes, NA3 and NA4 for HRSV-A and BA-C and CB1 for HRSV-B, were identified here, they were not predominant; NA1 and BA9 were the prevailing HRSV-A and -B genotypes, respectively. We provide the first report of a 9 consecutive nucleotide insertion in 3 CB1 genotype strains. One Beijing strain of ON1 genotype with a 72 nucleotide insertion was found among samples collected in February 2012. The reversion of codon states in glycosylation sites to previous ones were found from HRSV strains in this study, suggesting an immune-escape strategy of this important virus.	[Cui, Guanglin; Qian, Yuan] Peking Univ, Capital Inst Pediat, Teaching Hosp, Virol Lab, Beijing 100871, Peoples R China; [Cui, Guanglin; Zhu, Runan; Qian, Yuan; Deng, Jie; Zhao, Linqing; Sun, Yu; Wang, Fang] Capital Inst Pediat, Virol Lab, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP); Peking University; Capital Institute of Pediatrics (CIP)	Qian, Y (corresponding author), Peking Univ, Capital Inst Pediat, Teaching Hosp, Virol Lab, Beijing 100871, Peoples R China.	yqianbjc@263.net	wang, fang/GYD-4295-2022		Beijing Municipal Science and Technology Commission [Z111107056811041]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202]	Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Key Technologies R&D Program of National Ministry of Science	This work was supported by the grant no. Z111107056811041 from the Beijing Municipal Science (http://www.bjkw.gov.cn) and Technology Commission and grant no. 2013ZX10004-202 from Key Technologies R&D Program of National Ministry of Science (http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; BEEM M, 1967, J IMMUNOL, V98, P1115; Blanc A, 2005, ARCH VIROL, V150, P603, DOI 10.1007/s00705-004-0412-x; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Cane P., 2006, PERSPECT MED VIROL, V14, P89; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; Choi EH, 2000, J INFECT DIS, V181, P1547, DOI 10.1086/315468; Collins P.L., 2007, FIELDS VIROLOGY, P1602; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Deng Jie, 2006, Zhonghua Er Ke Za Zhi, V44, P924; ENGLUND JA, 1991, J CLIN MICROBIOL, V29, P115, DOI 10.1128/JCM.29.1.115-119.1991; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Galiano MC, 2005, J MED VIROL, V77, P311, DOI 10.1002/jmv.20456; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; HENDRICKS DA, 1988, J VIROL, V62, P2228, DOI 10.1128/JVI.62.7.2228-2233.1988; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Khor C.S., 2013, INFECT GENET EVOL; Lee WJ, 2012, J VIROL, V86, P13810, DOI 10.1128/JVI.02571-12; Maitreyi RS, 2000, J CLIN VIROL, V16, P41, DOI 10.1016/S1386-6532(99)00075-X; Martinez I, 1999, J GEN VIROL, V80, P125, DOI 10.1099/0022-1317-80-1-125; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; MUELENAER PM, 1991, J INFECT DIS, V164, P15, DOI 10.1093/infdis/164.1.15; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; Oliveira TFM, 2008, MEM I OSWALDO CRUZ, V103, P417, DOI 10.1590/S0074-02762008000500002; PALOMO C, 1991, J GEN VIROL, V72, P669, DOI 10.1099/0022-1317-72-3-669; Palomo C, 2000, J MED VIROL, V60, P468, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;468::AID-JMV16&gt;3.0.CO;2-E; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; ROBERTS SR, 1994, J VIROL, V68, P4538, DOI 10.1128/JVI.68.7.4538-4546.1994; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; SULLENDER WM, 1991, J CLIN MICROBIOL, V29, P1255, DOI 10.1128/JCM.29.6.1255-1257.1991; Sun Yu, 2006, Zhonghua Er Ke Za Zhi, V44, P450; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terletskaia-Ladwig E, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-20; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Valley-Omar Z, 2013, EMERG INFECT DIS, V19, P668, DOI 10.3201/eid1904.121465; van Niekerk S, 2011, J VIROL, V85, P8789, DOI 10.1128/JVI.02623-10; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; WARIS M, 1991, J INFECT DIS, V163, P464, DOI 10.1093/infdis/163.3.464; WATHEN MW, 1991, BIOCHEMISTRY-US, V30, P2863, DOI 10.1021/bi00225a019; WERTZ GW, 1985, P NATL ACAD SCI USA, V82, P4075, DOI 10.1073/pnas.82.12.4075; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xiang ZC, 2013, J MED VIROL, V85, P348, DOI 10.1002/jmv.23467; Yamaguchi M, 2011, J CLIN MICROBIOL, V49, P1034, DOI 10.1128/JCM.02132-10; Zhang RF, 2010, J CLIN MICROBIOL, V48, P4193, DOI 10.1128/JCM.00179-10; Zhang ZY, 2010, J CLIN MICROBIOL, V48, P1201, DOI 10.1128/JCM.02258-09; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	60	67	77	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75020	10.1371/journal.pone.0075020	http://dx.doi.org/10.1371/journal.pone.0075020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069376	Green Submitted, gold, Green Published			2022-12-27	WOS:000324547300068
J	Saba, ES; Gueyffier, L; Dichtel-Danjoy, ML; Pozzetto, B; Bourlet, T; Gueyffier, F; Mekki, Y; Pottel, H; Sabino, EC; Vanhems, P; Zrein, MA				Saba, Esber S.; Gueyffier, Lucie; Dichtel-Danjoy, Marie-Laure; Pozzetto, Bruno; Bourlet, Thomas; Gueyffier, Francois; Mekki, Yahia; Pottel, Hans; Sabino, Ester C.; Vanhems, Philippe; Zrein, Maan A.			Anti-Trypanosoma cruzi Cross-Reactive Antibodies Detected at High Rate in Non-Exposed Individuals Living in Non-Endemic Regions: Seroprevalence and Association to Other Viral Serologies	PLOS ONE			English	Article							PARASITE PERSISTENCE; AUTOANTIBODIES; INFECTION; PROTEIN; CARDIOMYOPATHY; PATHOGENESIS; DISEASE	Cross-reactive antibodies are characterized by their recognition of antigens that are different from the trigger immunogen. This happens when the similarity between two different antigenic determinants becomes adequate enough to enable a specific binding with such cross-reactive antibodies. In the present manuscript, we report the presence, at an "abnormal" high frequency, of antibodies in blood samples from French human subjects cross-reacting with a synthetic-peptide antigen derived from a Trypanosoma cruzi (T. cruzi) protein sequence. As the vector of T. cruzi is virtually confined to South America, the parasite is unlikely to be the trigger immunogen of the cross-reactive antibodies detected in France. At present, the cross-reactive antibodies are measured by using an in-house ELISA method that employs the T. cruzi -peptide antigen. However, to underline their cross-reactive characteristics, we called these antibodies "Trypanosoma cruzi Cross Reactive Antibodies" or TcCRA. To validate their cross-reactive nature, these antibodies were affinity-purified from plasma of healthy blood donor and were then shown to specifically react with the T. cruzi parasite by immunofluorescence. Seroprevalence of TcCRA was estimated at 45% in serum samples of French blood donors while the same peptide-antigen reacts with about 96% of T. cruzi -infected Brazilian individuals. In addition, we compared the serology of TcCRA to other serologies such as HSV 1/2, EBV, HHV-6, CMV, VZV, adenovirus, parvovirus B19, mumps virus, rubella virus, respiratory syncytial virus, measles and enterovirus. No association was identified to any of the tested viruses. Furthermore, we tested sera from different age groups for TcCRA and found a progressive acquisition starting from early childhood. Our findings show a large seroprevalence of cross-reactive antibodies to a well-defined T. cruzi antigen and suggest they are induced by a widely spread immunogen, acquired from childhood. The etiology of TcCRA and their clinical relevance still need to be investigated.	[Saba, Esber S.; Gueyffier, Lucie; Dichtel-Danjoy, Marie-Laure; Zrein, Maan A.] InfYn Biomarkers, Ecully, France; [Saba, Esber S.; Pozzetto, Bruno; Bourlet, Thomas] Fac Med Jacques Lisfranc, GIMAP EA3064, Lab Bacteriol Virol, St Etienne, France; [Gueyffier, Francois; Mekki, Yahia; Vanhems, Philippe; Zrein, Maan A.] UCBL Hosp Civils Lyon, Fac Med Rockefeller, Lyon, France; [Pottel, Hans] Katholieke Univ Leuven, Interdisciplinary Res Ctr, Kortrijk, Belgium; [Sabino, Ester C.] Univ Sao Paulo, Fac Med, Dep Molestias Infecciosas & Parasitarias, BR-09500900 Sao Paulo, Brazil	KU Leuven; Universidade de Sao Paulo	Zrein, MA (corresponding author), InfYn Biomarkers, Ecully, France.	maan.zrein@chu-lyon.fr	ZREIN, Maan/C-7666-2018; Gueyffier, François/B-8545-2008; Pottel, Hans/AAD-9444-2019; Sabino, Ester C/F-7750-2010	ZREIN, Maan/0000-0002-3301-4252; Gueyffier, François/0000-0002-9921-0977; Pottel, Hans/0000-0003-0074-8919; Sabino, Ester C/0000-0003-2623-5126; Saba, Esber/0000-0003-1525-6394; BOURLET, Thomas/0000-0002-9226-1149; POZZETTO, Bruno/0000-0002-2603-8467	Infynity Biomarkers; region Rhone Alpes	Infynity Biomarkers; region Rhone Alpes(Region Auvergne-Rhone-Alpes)	This study was funded by Infynity Biomarkers and the region Rhone Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Benvenuti LA, 2008, ANN TROP MED PARASIT, V102, P481, DOI 10.1179/136485908X311740; Caballero ZC, 2007, CLIN VACCINE IMMUNOL, V14, P1045, DOI 10.1128/CVI.00127-07; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Elias FE, 2003, AM J TROP MED HYG, V68, P242, DOI 10.4269/ajtmh.2003.68.242; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; Flores-Chavez M, 2012, CLIN VACCINE IMMUNOL, V19, P1353, DOI 10.1128/CVI.00227-12; Giordanengo L, 2002, EUR J IMMUNOL, V32, P1003, DOI 10.1002/1521-4141(200204)32:4<1003::AID-IMMU1003>3.0.CO;2-P; Giordanengo L, 2001, CLIN EXP IMMUNOL, V124, P266, DOI 10.1046/j.1365-2249.2001.01512.x; Ribeiro CH, 2009, MOL IMMUNOL, V46, P1092, DOI 10.1016/j.molimm.2008.10.034; HOFT DF, 1989, INFECT IMMUN, V57, P1959, DOI 10.1128/IAI.57.7.1959-1967.1989; Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976; Ayub MJ, 2009, BIOCHEM BIOPH RES CO, V382, P30, DOI 10.1016/j.bbrc.2009.02.095; Levin MJ, 2008, AUTOIMMUNITY, V41, P429, DOI 10.1080/08916930802031702; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Oelemann WMR, 1999, TRANSFUSION, V39, P711, DOI 10.1046/j.1537-2995.1999.39070711.x; Pais FS, 2008, MICROBES INFECT, V10, P716, DOI 10.1016/j.micinf.2008.03.005; Palomino SAP, 2000, ANN TROP MED PARASIT, V94, P571, DOI 10.1080/00034983.2000.11813580; Rashid T, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/539282; Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612; Talvani A, 2006, MICROBES INFECT, V8, P2459, DOI 10.1016/j.micinf.2006.06.006; Teixeira ARL, 2011, CLIN MICROBIOL REV, V24, P592, DOI 10.1128/CMR.00063-10; Teixeira ARL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001000; Tischer BK, 2010, VET MICROBIOL, V140, P266, DOI 10.1016/j.vetmic.2009.06.020; VANVOORHIS WC, 1993, J EXP MED, V178, P681, DOI 10.1084/jem.178.2.681; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001	29	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74493	10.1371/journal.pone.0074493	http://dx.doi.org/10.1371/journal.pone.0074493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069315	gold, Green Submitted, Green Published			2022-12-27	WOS:000324547300044
J	Scotland, RL; Allen, L; Hennings, LJ; Post, GR; Post, SR				Scotland, Rebecca L.; Allen, Leah; Hennings, Leah J.; Post, Ginell R.; Post, Steven R.			The Ral Exchange Factor Rgl2 Promotes Cardiomyocyte Survival and Inhibits Cardiac Fibrosis	PLOS ONE			English	Article							HAMSTER OVARY CELLS; PHOSPHOLIPASE-D; SIGNALING PATHWAYS; INDUCED APOPTOSIS; IN-VIVO; DIASTOLIC DYSFUNCTION; ISCHEMIA-REPERFUSION; MYOCYTE APOPTOSIS; GENE-EXPRESSION; HEART-FAILURE	Cardiomyocytes compensate to acute cardiac stress by increasing in size and contractile function. However, prolonged stress leads to a decompensated response characterized by cardiomyocyte death, tissue fibrosis and loss of cardiac function. Identifying approaches to inhibit this transition to a decompensated response may reveal important targets for treating heart failure. The Ral guanine nucleotide disassociation (RalGDS) proteins are Ras-interacting proteins that are upregulated by hypertrophic stimuli. The Ral guanine nucleotide dissociation stimulator-like 2 (Rgl2) is a member of the RalGDS family that modulates expression of hypertrophic genes in cardiomyocytes. However, the pathophysiologic consequence of increased Rgl2 expression in cardiomyoctyes remains unclear. To evaluate the effect of increasing Rgl2 activity in the heart, transgenic mice with cardiac-targeted over-expression of Rgl2 were generated. Although Ral activation was increased, there were no apparent morphologic or histological differences between the hearts of Rgl2 transgenic and nontransgenic mice indicating that increased Rgl2 expression had no effect on basal cardiac phenotype. To determine if Rgl2 modulates the cardiac response to stress, mice were infused with the beta-adrenergic receptor agonist, isoproterenol. Isoproterenol infusion increased heart mass in both Rgl2 transgenic and nontransgenic mice. However, unlike nontransgenic mice, Rgl2 transgenic mice showed no morphologic evidence of cardiomyocyte damage or increased cardiac fibrosis following isoproterenol infusion. Increased Rgl2 expression in cultured cardiomyocytes stimulated Ral activation and inhibited staurosporine-induced apoptosis via increased activation of PI3-kinase. Activation of the PI3-kinase signaling pathway was confirmed in hearts isolated from Rgl2 transgenic mice. Increased expression and function of Rgl2 in cardiomyocytes promotes activation of the PI3-kinase signaling cascade and protects from carciomyocyte death and pathologic cardiac fibrosis. Taken further, these results suggest that Rgl2 upregulation in hypertrophic hearts may be a protetive mechanism, and that Rgl2 may be a novel therapeutic target in treating heart disease.	[Scotland, Rebecca L.; Post, Steven R.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Allen, Leah; Post, Ginell R.; Post, Steven R.] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY USA; [Hennings, Leah J.; Post, Ginell R.; Post, Steven R.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA	University of Kentucky; University of Kentucky; University of Arkansas System; University of Arkansas Medical Sciences	Post, SR (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	spost@uams.edu		Post, Steven/0000-0002-4711-1723	American Heart Association [0415225B, 0615085B]; National Institutes of Health [T32 HL072743, R01HL075241]; American Heart Association Established Investigator Award; UAMS College of Medicine Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075241, T32HL072743] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); UAMS College of Medicine Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by: American Heart Association Pre-doctoral Fellowship 0415225B and National Institutes of Health T32 HL072743 (RLS); American Heart Association Pre-doctoral Fellowship 0615085B (LA); National Institutes of Health R01HL075241 and an American Heart Association Established Investigator Award (SRP). The authors also acknowledge intramural funding support from the UAMS College of Medicine Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno Y, 2001, J BIOL CHEM, V276, P35622, DOI 10.1074/jbc.M105673200; BENJAMIN IJ, 1989, CIRC RES, V65, P657, DOI 10.1161/01.RES.65.3.657; Brooks WW, 2009, COMPARATIVE MED, V59, P339; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cohen MV, 1996, CIRCULATION, V94, P1713, DOI 10.1161/01.CIR.94.7.1713; Cook SA, 1999, EUR HEART J, V20, P1619, DOI 10.1053/euhj.1999.1548; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; DeBosch B, 2006, J BIOL CHEM, V281, P32841, DOI 10.1074/jbc.M513087200; Diwan A, 2007, PHYSIOLOGY, V22, P56, DOI 10.1152/physiol.00033.2006; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Hao Y, 2008, MOL CELL BIOL; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Heather LC, 2009, J PHYSIOL PHARMACOL, V60, P31; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; HUNTER JJ, 1995, J BIOL CHEM, V270, P23173, DOI 10.1074/jbc.270.39.23173; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Joneson T, 1997, J MOL MED-JMM, V75, P587, DOI 10.1007/s001090050143; Kam Y, 2004, FASEB J, V18, P311, DOI 10.1096/fj.03-0731com; Kawai M, 2003, HYPERTENSION, V41, P956, DOI 10.1161/01.HYP.0000063884.36641.63; Kudej RK, 1997, J MOL CELL CARDIOL, V29, P2735, DOI 10.1006/jmcc.1997.0508; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; MARSHALL MS, 1995, FASEB J, V9, P1311, DOI 10.1096/fasebj.9.13.7557021; Matsui T, 2001, CIRCULATION, V104, P330; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Matsui T, 2005, J MOL CELL CARDIOL, V38, P63, DOI 10.1016/j.yjmcc.2004.11.005; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; Neuss M, 2001, CARDIOVASC DRUG THER, V15, P507, DOI 10.1023/A:1013715704835; Nozawa Y, 2002, BBA-MOL CELL BIOL L, V1585, P77, DOI 10.1016/S1388-1981(02)00327-X; Parsons M, 2000, FASEB J, V14, P1423, DOI 10.1096/fj.14.10.1423; Post GR, 2002, J BIOL CHEM, V277, P15286, DOI 10.1074/jbc.M111844200; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; Vigil D, 2010, J BIOL CHEM, V285, P34729, DOI 10.1074/jbc.M110.116756; Voss M, 1999, J BIOL CHEM, V274, P34691, DOI 10.1074/jbc.274.49.34691; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Xiang SY, 2011, J CLIN INVEST, V121, P3269, DOI 10.1172/JCI44371; Yamada M, 2004, BIOCHEM J, V378, P649, DOI 10.1042/BJ20031398; Yue TL, 1998, J MOL CELL CARDIOL, V30, P495, DOI 10.1006/jmcc.1997.0614; Zheng MZ, 2004, AM J PHYSIOL-HEART C, V286, pH424, DOI 10.1152/ajpheart.00110.2003; Zhu H, 2000, CELL DEATH DIFFER, V7, P773, DOI 10.1038/sj.cdd.4400721	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73599	10.1371/journal.pone.0073599	http://dx.doi.org/10.1371/journal.pone.0073599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069211	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300016
J	Skinner, C; Patfield, S; Stanker, L; He, XH				Skinner, Craig; Patfield, Stephanie; Stanker, Larry; He, Xiaohua			Development of Monoclonal Antibodies and Immunoassays for Sensitive and Specific Detection of Shiga Toxin Stx2f	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ESCHERICHIA-COLI; IN-VITRO; SEQUENCE; GROWTH; ASSAY; SITE	Background: Shiga toxin 2 (Stx2) is a major virulence factor in gastrointestinal diseases caused by Escherichia coli. Although Stx2a (prototypical Stx2) is well-studied, all seven subtypes of Stx2 have been associated with disease in mammals. Several subtypes of Stx2, including Stx2f, are difficult to detect immunologically. Methods And Findings: Four novel monoclonal antibodies (mAbs) against the Stx2f subtype were produced and characterized. These mAbs react exclusively to the Stx2f A subunit, and do not cross-react with other subtypes of Stx2. A Stx2f-specific sandwich ELISA was established and a limit of detection of 0.123 ng/mL was obtained using one pair of the mAbs. The receptor preference of Stx2f was confirmed using this sandwich ELISA. Three out of four mAbs can partially neutralize the toxicity of Stx2f in a cell-based assay. These mAbs were also demonstrated to be highly specific and reactive when applied to colony immunoblot assays. Conclusions: Novel mAbs specific to Stx2f were developed for the first time, providing new assets for the STEC community. Immunoassays with improved sensitivity and specificity will be useful for the detection of Stx2f present in food, environmental, and clinical samples.	[Skinner, Craig; Patfield, Stephanie; Stanker, Larry; He, Xiaohua] ARS, Western Reg Res Ctr, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	He, XH (corresponding author), ARS, Western Reg Res Ctr, USDA, Albany, CA USA.	xiaohua.he@ars.usda.gov			USDA-ARS National Program [NP108]; CRIS [5325-42000-048-00D]	USDA-ARS National Program; CRIS	This research was supported by USDA-ARS National Program NP108, CRIS project 5325-42000-048-00D. The U.S. Department of Agriculture is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DET IS ID ESCH COL O; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brzuszkiewicz E, 2011, ARCH MICROBIOL, V193, P883, DOI 10.1007/s00203-011-0725-6; CANTEY JR, 1985, J INFECT DIS, V151, P766, DOI 10.1093/infdis/151.5.766; CDC, 2013, ULT OUTBR SHIG TOX P; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P41; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043845; Delannoy S, 2012, J CLIN MICROBIOL, V50, P3485, DOI 10.1128/JCM.01656-12; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P6699, DOI 10.1128/AEM.00370-11; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Gamage SD, 2004, INFECT IMMUN, V72, P7131, DOI 10.1128/IAI.72.12.7131-7139.2004; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; He XH, 2013, J IMMUNOL METHODS, V389, P18, DOI 10.1016/j.jim.2012.12.005; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; Hertig A, 2010, NEPHROL THER, V6, P258, DOI 10.1016/j.nephro.2010.03.002; HULL AE, 1993, J CLIN MICROBIOL, V31, P1167, DOI 10.1128/JCM.31.5.1167-1172.1993; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Kalchayanand N, 2012, J FOOD PROTECT, V75, P1207, DOI 10.4315/0362-028X.JFP-11-531; LAW D, 1992, J MED MICROBIOL, V36, P198, DOI 10.1099/00222615-36-3-198; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Menne J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4565; Momtaz H, 2013, POULTRY SCI, V92, P1305, DOI 10.3382/ps.2012-02542; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; Oloomi M, 2006, PROTEIN PEPTIDE LETT, V13, P509, DOI 10.2174/092986606776819538; Ooka T, 2012, EMERG INFECT DIS, V18, P488, DOI 10.3201/eid1803.111401; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; PAI CH, 1986, INFECT IMMUN, V51, P16, DOI 10.1128/IAI.51.1.16-23.1986; Paton AW, 2000, NAT MED, V6, P265, DOI 10.1038/73111; Paton AW, 2001, INFECT IMMUN, V69, P1967, DOI 10.1128/IAI.69.3.1967-1970.2001; Paton AW, 1996, J CLIN MICROBIOL, V34, P463, DOI 10.1128/JCM.34.2.463-465.1996; SAMUEL JE, 1990, INFECT IMMUN, V58, P611, DOI 10.1128/IAI.58.3.611-618.1990; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Skinner C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059760; Smith MJ, 2009, INFECT IMMUN, V77, P2730, DOI 10.1128/IAI.00005-09; SUGASAWARA RJ, 1985, J IMMUNOL METHODS, V79, P263, DOI 10.1016/0022-1759(85)90106-1; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Thi KNO, 2012, INFECT IMMUN, V80, P469, DOI 10.1128/IAI.05539-11; TYRRELL GJ, 1992, P NATL ACAD SCI USA, V89, P524, DOI 10.1073/pnas.89.2.524; Wagner PL, 2002, MOL MICROBIOL, V44, P957, DOI 10.1046/j.1365-2958.2002.02950.x; Willford J, 2009, J FOOD PROTECT, V72, P741, DOI 10.4315/0362-028X-72.4.741; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	45	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e76563	10.1371/journal.pone.0076563	http://dx.doi.org/10.1371/journal.pone.0076563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069462	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300098
J	Egan, B; O'Connor, PL; Zierath, JR; O'Gorman, DJ				Egan, Brendan; O'Connor, Paul L.; Zierath, Juleen R.; O'Gorman, Donal J.			Time Course Analysis Reveals Gene-Specific Transcript and Protein Kinetics of Adaptation to Short-Term Aerobic Exercise Training in Human Skeletal Muscle	PLOS ONE			English	Article							INDUCED MITOCHONDRIAL BIOGENESIS; MESSENGER-RNA ABUNDANCE; ALPHA ERR-ALPHA; ENDURANCE EXERCISE; RECEPTOR-ALPHA; BIOCHEMICAL ADAPTATIONS; METABOLIC ADAPTATIONS; CONTRACTILE ACTIVITY; ENERGY-METABOLISM; COACTIVATOR PGC-1	Repeated bouts of episodic myofibrillar contraction associated with exercise training are potent stimuli for physiological adaptation. However, the time course of adaptation and the continuity between alterations in mRNA expression and protein content are not well described in human skeletal muscle. Eight healthy, sedentary males cycled for 60 min at 80% of peak oxygen consumption (VO2peak) each day for fourteen consecutive days, resulting in an increase in VO2peak of 17.5 +/- 3.8%. Skeletal muscle biopsies were taken at baseline, and on the morning following (+16 h after exercise) the first, third, seventh, tenth and fourteenth training sessions. Markers of mitochondrial adaptation (Cyt c and COXIV expression, and citrate synthase activity) were increased within the first week of training, but the mtDNA/nDNA ratio was unchanged by two weeks of training. Accumulation of PGC-1 alpha and ERR alpha protein during training suggests a regulatory role for these factors in adaptations of mitochondrial and metabolic gene expression. A subset of genes were transiently increased after one training session, but returned to baseline levels thereafter, which is supportive of the concept of transcriptional capacity being particularly sensitive to the onset of a new level of contractile activity. Thus, gene-specific temporal patterns of induction of mRNA expression and protein content are described. Our results illustrate the phenomenology of skeletal muscle plasticity and support the notion that transcript level adjustments, coupled to accumulation of encoded protein, underlie the modulation of skeletal muscle metabolism and phenotype by regular exercise.	[Egan, Brendan] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Inst Sport & Hlth, Dublin 2, Ireland; [Egan, Brendan; Zierath, Juleen R.] Karolinska Inst, Sect Integrat Physiol, Dept Mol Med & Surg, Stockholm, Sweden; [O'Connor, Paul L.; O'Gorman, Donal J.] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Zierath, Juleen R.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [O'Gorman, Donal J.] Dublin City Univ, Ctr Prevent Med, Dublin 9, Ireland	University College Dublin; Karolinska Institutet; Dublin City University; Karolinska Institutet; Dublin City University	O'Gorman, DJ (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland.	donal.ogorman@dcu.ie	Egan, Brendan/AAR-7017-2020; O'Gorman, Donal J./J-7182-2015	Egan, Brendan/0000-0001-8327-9016; O'Gorman, Donal J./0000-0002-8228-1488; Zierath, Juleen/0000-0001-6891-7497	Dublin City University (DJOG); Irish Research Council for Science, Engineering and Technology (DJOG); European Foundation; Strategic Research Program in Diabetes at Karolinska Institutet; Swedish Research Council; European Research Council	Dublin City University (DJOG); Irish Research Council for Science, Engineering and Technology (DJOG)(Irish Research Council for Science, Engineering and Technology); European Foundation(European Science Foundation (ESF)); Strategic Research Program in Diabetes at Karolinska Institutet; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	This work was supported by a grant from Dublin City University (DJOG), the Irish Research Council for Science, Engineering and Technology (DJOG) and the European Foundation for the Study of Diabetes/Novo Nordisk European Clinical Research Programme in Adolescents with Type 2 Diabetes (DJOG), the Strategic Research Program in Diabetes at Karolinska Institutet (JRZ), Swedish Research Council (JRZ), and the European Research Council Advanced Grant Ideas Programme (JRZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkinstall MJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE25, DOI 10.1152/ajpendo.00557.2003; Baldwin KM, 2010, EXERC SPORT SCI REV, V38, P42, DOI 10.1097/JES.0b013e3181d49644; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE1427, DOI 10.1152/ajpendo.90428.2008; Booth F, 1977, Ann N Y Acad Sci, V301, P431, DOI 10.1111/j.1749-6632.1977.tb38219.x; Booth F, 2012, ACSMS ADV EXERCISE P, P669; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Broholm C, 2008, J PHYSIOL-LONDON, V586, P2195, DOI 10.1113/jphysiol.2007.149781; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Coffey VG, 2006, AM J PHYSIOL-ENDOC M, V290, pE849, DOI 10.1152/ajpendo.00299.2005; Costford SR, 2010, AM J PHYSIOL-ENDOC M, V298, pE117, DOI 10.1152/ajpendo.00318.2009; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Egan B, 2011, PROTEOMICS, V11, P1413, DOI 10.1002/pmic.201000597; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Essig D A, 1996, Exerc Sport Sci Rev, V24, P289; EVANS WJ, 1982, MED SCI SPORT EXER, V14, P101; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; GOVINDASAMY D, 1992, EUR J APPL PHYSIOL, V65, P203, DOI 10.1007/BF00705082; GREEN HJ, 1995, J APPL PHYSIOL, V78, P138, DOI 10.1152/jappl.1995.78.1.138; GREEN HJ, 1992, J APPL PHYSIOL, V72, P484, DOI 10.1152/jappl.1992.72.2.484; HICKSON RC, 1981, MED SCI SPORT EXER, V13, P17; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182; HOPPELER H, 1985, J APPL PHYSIOL, V59, P320, DOI 10.1152/jappl.1985.59.2.320; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Kraniou GN, 2004, EXP PHYSIOL, V89, P559, DOI 10.1113/expphysiol.2004.027409; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mahoney Douglas J, 2005, Phys Med Rehabil Clin N Am, V16, P859; Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005; MICHEL JB, 1994, J CLIN INVEST, V94, P277, DOI 10.1172/JCI117318; Mirebeau-Prunier D, 2010, FEBS J, V277, P713, DOI 10.1111/j.1742-4658.2009.07516.x; Nordsborg NB, 2010, MED SCI SPORT EXER, V42, P1477, DOI 10.1249/MSS.0b013e3181d2d21c; O'Gorman DJ, 2006, DIABETOLOGIA, V49, P2983, DOI 10.1007/s00125-006-0457-3; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031; PUNTSCHART A, 1995, AM J PHYSIOL-CELL PH, V269, pC619, DOI 10.1152/ajpcell.1995.269.3.C619; REICHMANN H, 1985, PFLUG ARCH EUR J PHY, V404, P1, DOI 10.1007/BF00581484; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Spina RJ, 1996, J APPL PHYSIOL, V80, P2250, DOI 10.1152/jappl.1996.80.6.2250; Timmons JA, 2005, FASEB J, V19, P750, DOI 10.1096/fj.04-1980com; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Wallace MA, 2011, J PHYSIOL-LONDON, V589, P2027, DOI 10.1113/jphysiol.2011.205468; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004; Zimmermann-Sloutskis D, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-2	59	76	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74098	10.1371/journal.pone.0074098	http://dx.doi.org/10.1371/journal.pone.0074098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069271	Green Submitted, gold, Green Published			2022-12-27	WOS:000326240100085
J	Lei, L; Zhu, XK; Wang, SW; Zhu, MR; Carver, BF; Yan, LL				Lei, Lei; Zhu, Xinkai; Wang, Shuwen; Zhu, Meirong; Carver, Brett F.; Yan, Liuling			TaMFT-A1 Is Associated with Seed Germination Sensitive to Temperature in Winter Wheat	PLOS ONE			English	Article							ABA RESPONSIVENESS; DORMANCY; RESISTANCE; GENES; EXPRESSION; LOCUS	The ability of seed to germinate under favorable environmental conditions is critical for seedling emergence, plant establishment, subsequent development and growth of adult plants, and it is controlled by internal genetic factors and external environmental factors. Winter wheat in the southern Great Plains is often planted six weeks before the optimal planting date to produce more biomass for cattle grazing during the winter season. A high seed germination rate in this higher soil temperature environment is required for this specific management system. In this study, a major QTL for temperature-sensitive germination was mapped on the short arm of chromosome 3A (QTsg.osu-3A) in a RIL population generated from two winter wheat cultivars. Furthermore, TaMFT-A1, previously reported to regulate seed dormancy and pre-harvest sprouting in spring wheat cultivars, was mapped tightly associated with the peak of QTsg.osu-3A. However, allelic variation in TaMFT-A1 between the two winter wheat cultivars differed from that was observed in spring wheat cultivars. There were 87 SNPs (single nucleotide polymorphisms) and 12 indels (insertions/deletions) in TaMFT-A1 between the Jagger allele for high germination and the 2174 allele for low germination in the after-ripened seeds, in comparison with 2 SNPs between the two alleles for differential pre-harvest sprouting in spring wheat cultivars. The Jagger TaMFT-A1 allele is a novel haplotype and appears extensively in winter wheat cultivars. TaMFT-A1 transcript levels were up-regulated by high temperature but down-regulated by low temperature or seed storage time. These findings suggest that TaMFT-A1 may invoke different mechanisms for controlling seed dormancy/germination among winter wheat cultivars.	[Lei, Lei; Wang, Shuwen; Carver, Brett F.; Yan, Liuling] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Zhu, Xinkai; Zhu, Meirong] Yangzhou Univ, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China	Oklahoma State University System; Oklahoma State University - Stillwater; Yangzhou University	Yan, LL (corresponding author), Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA.	liuling.yan@okstate.edu			National Research Initiative Competitive Grants CAP project from the USDA National Institute of Food and Agriculture [2011-68002-30029]; Oklahoma Wheat Research Foundation	National Research Initiative Competitive Grants CAP project from the USDA National Institute of Food and Agriculture; Oklahoma Wheat Research Foundation	This project was supported by the National Research Initiative Competitive Grants CAP project 2011-68002-30029 from the USDA National Institute of Food and Agriculture and the Oklahoma Wheat Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyris J, 2008, PLANT PHYSIOL, V148, P926, DOI 10.1104/pp.108.125807; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; Cenci A, 2003, THEOR APPL GENET, V107, P931, DOI 10.1007/s00122-003-1331-z; Chen YH, 2010, MOL BREEDING, V26, P573, DOI 10.1007/s11032-010-9392-6; Chen YH, 2009, MOL BREEDING, V24, P141, DOI 10.1007/s11032-009-9279-6; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Edwards J., 2008, FACTORS AFFECTING WH; Fang TL, 2011, CROP SCI, V51, P2455, DOI 10.2135/cropsci2011.03.0161; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Flintham J, 2002, EUPHYTICA, V126, P39, DOI 10.1023/A:1019632008244; Footitt S, 2011, P NATL ACAD SCI USA, V108, P20236, DOI 10.1073/pnas.1116325108; Gale M. D., 1989, Preharvest field sprouting in cereals., P85; Gerjets T, 2010, J EXP BOT, V61, P597, DOI 10.1093/jxb/erp329; Gu YQ, 2004, PLANT PHYSIOL, V135, P459, DOI 10.1104/pp.103.038083; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kulwal PL, 2004, FUNCT INTEGR GENOMIC, V4, P94, DOI 10.1007/s10142-004-0105-2; Liu SB, 2008, THEOR APPL GENET, V117, P691, DOI 10.1007/s00122-008-0810-7; Lohwasser U, 2005, EUPHYTICA, V143, P247, DOI 10.1007/s10681-005-7858-0; Mori M, 2005, THEOR APPL GENET, V110, P1315, DOI 10.1007/s00122-005-1972-1; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Nyachiro JM, 2002, EUPHYTICA, V126, P123, DOI 10.1023/A:1019694800066; Phil SA, 2007, SEED DEV DORMANCY GE, P72; Simpson GM, 1990, SEED DORMANCY GRASSE, P131; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Tamura N, 2006, PLANT CELL PHYSIOL, V47, P1081, DOI 10.1093/pcp/pcj078; TILSNER HR, 1985, PHYSIOL PLANTARUM, V64, P377, DOI 10.1111/j.1399-3054.1985.tb03356.x; WALKERSIMMONS M, 1988, PLANT CELL ENVIRON, V11, P769, DOI 10.1111/j.1365-3040.1988.tb01161.x; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Zhu XK, 2011, MOL BREEDING, V27, P501, DOI 10.1007/s11032-010-9447-8	35	30	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73330	10.1371/journal.pone.0073330	http://dx.doi.org/10.1371/journal.pone.0073330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069187	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100039
J	Bourkiza, B; Vurro, M; Jeffries, A; Pezaris, JS				Bourkiza, Bechir; Vurro, Milena; Jeffries, Ailsa; Pezaris, John S.			Visual Acuity of Simulated Thalamic Visual Prostheses in Normally Sighted Humans	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; ARTIFICIAL VISION; BLIND; RECOGNITION; PERCEPTION; EYE	Simulation in normally sighted individuals is a crucial tool to evaluate the performance of potential visual prosthesis designs prior to human implantation of a device. Here, we investigated the effects of electrode count on visual acuity, learning rate and response time in 16 normally sighted subjects using a simulated thalamic visual prosthesis, providing the first performance reports for thalamic designs. A new letter recognition paradigm using a multiple-optotype two-alternative forced choice task was adapted from the Snellen eye chart, and specifically devised to be readily communicated to both human and non-human primate subjects. Validation of the method against a standard Snellen acuity test in 21 human subjects showed no significant differences between the two tests. The novel task was then used to address three questions about simulations of the center-weighted phosphene patterns typical of thalamic designs: What are the expected Snellen acuities for devices with varying numbers of contacts, do subjects display rapid adaptation to the new visual modality, and can response time in the task provide clues to the mechanisms of perception in low-resolution artificial vision? Population performance (hit rate) was significantly above chance when viewing Snellen 20/200 optotypes (Log MAR 1.0) with 370 phosphenes in the central 10 degrees of vision, ranging to Snellen 20/800 (Log MAR 1.6) with 25 central phosphenes. Furthermore, subjects demonstrated learning within the 1-2 hours of task experience indicating the potential for an effective rehabilitation and possibly better visual performance after a longer period of training. Response time differences suggest that direct letter perception occurred when hit rate was above 75%, whereas a slower strategy like feature-based pattern matching was used in conditions of lower relative resolution. As pattern matching can substantially boost effective acuity, these results suggest post-implant therapy should specifically address feature detection skills.	[Bourkiza, Bechir; Vurro, Milena; Jeffries, Ailsa; Pezaris, John S.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Pezaris, JS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA 02114 USA.	pezaris.john@mgh.harvard.edu		Jeffries, Ailsa/0000-0001-6233-4215	National Eye Institute [EY019679]; Institut d'Optique; Rappaport Foundation; NATIONAL EYE INSTITUTE [R01EY019679] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Institut d'Optique; Rappaport Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was performed with support from the National Eye Institute through grant EY019679 (BB, MV, AJ, JSP; http://www.nei.nih.gov), from Institut d'Optique (BB; http://www.institutoptique.fr), and from the Rappaport Foundation (JSP; http://www.rappaportfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja AK, 2011, BRIT J OPHTHALMOL, V95, P539, DOI 10.1136/bjo.2010.179622; [Anonymous], [No title captured], DOI DOI 10.4102/AVEH.V68I3.162; BIEMILLER A, 1978, READ RES QUART, V13, P223; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Cai SQ, 2005, P ANN INT IEEE EMBS, P5223; CHA KH, 1992, ARCH OPHTHALMOL-CHIC, V114, P40; Chen S C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4400; Chen SC, 2007, J NEURAL ENG, V4, pS108, DOI 10.1088/1741-2560/4/1/S13; Chen SC, 2005, J NEURAL ENG, V2, pS135, DOI 10.1088/1741-2560/2/1/015; Chen SC, 2005, IEEE T NEUR SYS REH, V13, P249, DOI 10.1109/TNSRE.2005.851771; Chen SC, 2009, VISION RES, V49, P2329, DOI 10.1016/j.visres.2009.07.003; Chen SC, 2009, VISION RES, V49, P1493, DOI 10.1016/j.visres.2009.02.003; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; Dagnelie G, 2006, INVEST OPHTH VIS SCI, V47, P1241, DOI 10.1167/iovs.05-0157; Dagnelie G, 2011, VISUAL PROSTHETICS: PHYSIOLOGY, BIOENGINEERING, REHABILITATION, P1, DOI 10.1007/978-1-4419-0754-7; Dobelle WH, 2000, ASAIO J, V46, P3, DOI 10.1097/00002480-200001000-00002; DREYER V, 1964, ACTA OPHTHALMOL, V42, P295; Erwin E, 1999, J COMP NEUROL, V407, P92; Fornos AP, 2005, INVEST OPHTH VIS SCI, V46, P3906, DOI 10.1167/iovs.04-1173; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Guo H, 2010, ARTIF ORGANS, V34, P324, DOI 10.1111/j.1525-1594.2009.00863.x; Hayes JS, 2003, ARTIF ORGANS, V27, P1016, DOI 10.1046/j.1525-1594.2003.07309.x; Haymes SA, 2002, OPHTHAL PHYSL OPT, V22, P79, DOI 10.1046/j.1475-1313.2002.00016.x; Hetherington R, 1954, PSYCHOL FORSCH, V24, P349, DOI 10.1007/BF00422033; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; Humayun MS, 1996, ARCH OPHTHALMOL-CHIC, V114, P40, DOI 10.1001/archopht.1996.01100130038006; Humayun MS, 2003, VISION RES, V43, P2573, DOI 10.1016/S0042-6989(03)00457-7; [ICO International Council of Ophthalmology Visual Functions Committee], 1988, ITALIAN J OPTH, VII, P1; KEESEY UT, 1960, J OPT SOC AM, V50, P769, DOI 10.1364/JOSA.50.000769; NEIWORTH JJ, 1994, J EXP PSYCHOL ANIM B, V20, P429, DOI 10.1037/0097-7403.20.4.429; Nobel PA, 2001, J EXP PSYCHOL LEARN, V27, P384, DOI 10.1037/0278-7393.27.2.384; PANETSOS F, 2011, FRONT NEUROSCI, V5; Panetsos F, 2009, I IEEE EMBS C NEUR E, P56, DOI 10.1109/NER.2009.5109233; Pezaris JS, 2007, P NATL ACAD SCI USA, V104, P7670, DOI 10.1073/pnas.0608563104; Pezaris JS, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0986; Pezaris JS, 2009, IEEE T BIO-MED ENG, V56, P172, DOI 10.1109/TBME.2008.2005973; Raasch TW, 1998, OPTOMETRY VISION SCI, V75, P342, DOI 10.1097/00006324-199805000-00024; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5362, DOI 10.1167/iovs.02-0817; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; Thompson RW, 2003, INVEST OPHTH VIS SCI, V44, P5035, DOI 10.1167/iovs.03-0341; van Rheede JJ, 2010, J VISION, V10, DOI 10.1167/10.14.32; Vurro Milena, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3278; Welford A.T., 1980, REACTION TIMES; WESTHEIMER G, 1975, J OPT SOC AM, V65, P847, DOI 10.1364/JOSA.65.000847; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630; Yang K, 2010, ARTIF ORGANS, V34, P28, DOI 10.1111/j.1525-1594.2009.00778.x; Zhao Y, 2010, INFORM SCIENCES, V180, P2915, DOI 10.1016/j.ins.2010.04.021; Zhou DD, 2009, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-0-387-77261-5_1; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	52	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73592	10.1371/journal.pone.0073592	http://dx.doi.org/10.1371/journal.pone.0073592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086286	Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900017
J	Zabet, NR; Foy, R; Adryan, B				Zabet, Nicolae Radu; Foy, Robert; Adryan, Boris			The Influence of Transcription Factor Competition on the Relationship between Occupancy and Affinity	PLOS ONE			English	Article							DNA-BINDING SITES; FACILITATED DIFFUSION; PHYSICAL CONSTRAINTS; GENE-REGULATION; SPECIFICITY; MODELS; SIMULATIONS; PROTEINS; SEQUENCE; BEHAVIOR	Transcription factors (TFs) are proteins that bind to specific sites on the DNA and regulate gene activity. Identifying where TF molecules bind and how much time they spend on their target sites is key to understanding transcriptional regulation. It is usually assumed that the free energy of binding of a TF to the DNA (the affinity of the site) is highly correlated to the amount of time the TF remains bound (the occupancy of the site). However, knowing the binding energy is not sufficient to infer actual binding site occupancy. This mismatch between the occupancy predicted by the affinity and the observed occupancy may be caused by various factors, such as TF abundance, competition between TFs or the arrangement of the sites on the DNA. We investigated the relationship between the affinity of a TF for a set of binding sites and their occupancy. In particular, we considered the case of the transcription factor lac repressor (lacI) in E. coli, and performed stochastic simulations of the TF dynamics on the DNA for various combinations of lacI abundance and competing TFs that contribute to macromolecular crowding. We also investigated the relationship of site occupancy and the information content of position weight matrices (PWMs) used to represent binding sites. Our results showed that for medium and high affinity sites, TF competition does not play a significant role for genomic occupancy except in cases when the abundance of the TF is significantly increased, or when the PWM displays relatively low information content. Nevertheless, for medium and low affinity sites, an increase in TF abundance (for both cognate and non-cognate molecules) leads to an increase in occupancy at several sites.	[Zabet, Nicolae Radu; Foy, Robert; Adryan, Boris] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Zabet, Nicolae Radu; Foy, Robert; Adryan, Boris] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; University of Cambridge	Zabet, NR (corresponding author), Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England.	n.r.zabet@gen.cam.ac.uk; ba255@cam.ac.uk		Zabet, Nicolae Radu/0000-0001-9964-6271	Medical Research Council [G1002110]; Royal Society (URF); MRC [G1002110] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society (URF)(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council [G1002110 to N.R.Z.] and the Royal Society (URF to B. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Adryan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r167; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Chu D, 2009, J THEOR BIOL, V257, P419, DOI 10.1016/j.jtbi.2008.11.026; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Flyvbjerg H, 2006, NUCLEIC ACIDS RES, V34, P2550, DOI 10.1093/nar/gkl271; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hedglin M, 2010, ACS CHEM BIOL, V5, P427, DOI 10.1021/cb1000185; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; Kampmann M, 2004, J BIOL CHEM, V279, P38715, DOI 10.1074/jbc.M404504200; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Marcovitz A, 2011, P NATL ACAD SCI USA, V108, P17957, DOI 10.1073/pnas.1109594108; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Santillan M, 2004, BIOPHYS J, V86, P1282, DOI 10.1016/S0006-3495(04)74202-2; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Thomas S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r43; van Zon JS, 2006, BIOPHYS J, V91, P4350, DOI 10.1529/biophysj.106.086157; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; Wasson T, 2009, GENOME RES, V19, P2101, DOI 10.1101/gr.093450.109; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Zabet NR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-121; Zabet NR, 2012, MOL BIOSYST, V8, P2815, DOI 10.1039/c2mb25201e; Zabet NR, 2012, BIOINFORMATICS, V28, P1517, DOI 10.1093/bioinformatics/bts178; Zabet NR, 2012, BIOINFORMATICS, V28, P1287, DOI 10.1093/bioinformatics/bts132; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhao Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000590	45	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e73714	10.1371/journal.pone.0073714	http://dx.doi.org/10.1371/journal.pone.0073714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24086290	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000325223900019
J	Chu, HY; Liao, YL; Tsai, YJ; Chu, YC; Wu, SY; Ma, L				Chu, Hsueh-Yen; Liao, Yi-Lin; Tsai, Yueh-Ju; Chu, Yen-Chang; Wu, Shu-Ya; Ma, Lih			Use of Extraocular Muscle Flaps in the Correction of Orbital Implant Exposure	PLOS ONE			English	Article							RETROAURICULAR MYOPERIOSTEAL GRAFT; DERMIS-FAT GRAFT; PATCH GRAFT; REPAIR	Purposes: The study is to describe a new surgical technique for correcting large orbital implant exposure with extraocular muscle flaps and to propose a treatment algorithm for orbital implant exposure. Methods: In a retrospective study, seven patients with orbital implant exposure were treated with extraocular muscle flaps. All data were collected from patients in Chang Gung Memorial Hospital, Taiwan during 2007-2012. All surgeries were performed by one surgeon (Y.J.T). Patient demographics, the original etiology, details of surgical procedures, implant types, and follow-up interval were recorded. Small exposure, defined as exposure area smaller than 3 mm in diameter, was treated conservatively first with topical lubricant and prophylactic antibiotics. Larger defects were managed surgically. Results: Seven patients consisting of two males and five females were successfully treated for orbital implant exposure with extraocular muscle flaps. The average age was 36.4 (range, 3-55) years old. Five patients were referred from other hospitals. One eye was enucleated for retinoblastoma. The other six eyes were eviscerated, including one for endophthalmitis and five for trauma. Mean follow-up time of all seven patients was 19.5 (range, 2-60) months. No patient developed recurrence of exposure during follow-up. All patients were fitted with an acceptable prosthesis and had satisfactory cosmetic and functional results. Conclusions: The most common complication of orbital implant is exposure, caused by breakdown of the covering layers, leading to extrusion. Several methods were reported to manage the exposed implants. We report our experience of treating implant exposure with extraocular muscle flaps to establish a well-vascularized environment that supplies both the wrapping material and the overlying ocular surface tissue. We believe it can work as a good strategy to manage or to prevent orbital implant exposure.	[Chu, Hsueh-Yen; Liao, Yi-Lin; Tsai, Yueh-Ju; Chu, Yen-Chang; Wu, Shu-Ya; Ma, Lih] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chu, Hsueh-Yen; Liao, Yi-Lin; Tsai, Yueh-Ju; Chu, Yen-Chang; Wu, Shu-Ya; Ma, Lih] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Tsai, YJ (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan.	erinyjtsai@gmail.com						Inkster CF, 2002, OPHTHALMOLOGY, V109, P389, DOI 10.1016/S0161-6420(01)00904-6; Jordan DR, 2010, OPHTHAL PLAST RECONS, V26, P80, DOI 10.1097/IOP.0b013e3181b80c30; Karslioglu S, 2012, OPHTHAL PLAST RECONS, V28, P264, DOI 10.1097/IOP.0b013e3182541315; Lee BJ, 2010, OPHTHAL PLAST RECONS, V26, P273, DOI 10.1097/IOP.0b013e3181bf24db; Lee MJ, 2011, AM J OPHTHALMOL, V152, P244, DOI 10.1016/j.ajo.2011.01.048; Lee-Wing MW, 2003, OPHTHALMIC PLAST REC, V19, P401, DOI 10.1097/01.IOP.0000087029.00333.C2; Liao SL, 2005, BRIT J OPHTHALMOL, V89, P92, DOI 10.1136/bjo.2003.038778; Lu LN, 2011, J CRANIOFAC SURG, V22, P1452, DOI 10.1097/SCS.0b013e31821d1860; McInnes AW, 2011, OPHTHAL PLAST RECONS, V27, P52, DOI 10.1097/IOP.0b013e3181e4a770; Mules P H, 1990, Adv Ophthalmic Plast Reconstr Surg, V8, P69; Naugle TC, 1999, AM J OPHTHALMOL, V128, P495, DOI 10.1016/S0002-9394(99)00159-2; Naugle TC, 1997, OPHTHALMOLOGY, V104, P1480, DOI 10.1016/S0161-6420(97)30107-9; Perry A C, 1990, Adv Ophthalmic Plast Reconstr Surg, V8, P75; Ramey N, 2011, OPHTHAL SURG LAS IM, V42, P434, DOI 10.3928/15428877-20110812-03; Sagoo MS, 2004, BRIT J OPHTHALMOL, V88, P942, DOI 10.1136/bjo.2003.026823; SHIELDS CL, 1994, BRIT J OPHTHALMOL, V78, P702, DOI 10.1136/bjo.78.9.702; Wang JK, 2008, OPHTHAL SURG LAS IM, V39, P399, DOI 10.3928/15428877-20080901-17	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2013	8	9							e72223	10.1371/journal.pone.0072223	http://dx.doi.org/10.1371/journal.pone.0072223			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228VC	24086260	Green Submitted, gold, Green Published			2022-12-27	WOS:000325218700005
J	Costa, BS; Sachse, M; Jungandreas, A; Bartulos, CR; Gruber, A; Jakob, T; Kroth, PG; Wilhelm, C				Costa, Benjamin Schellenberger; Sachse, Matthias; Jungandreas, Anne; Bartulos, Carolina Rio; Gruber, Ansgar; Jakob, Torsten; Kroth, Peter G.; Wilhelm, Christian			Aureochrome 1a Is Involved in the Photoacclimation of the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							HIGH LIGHT ACCLIMATION; BLUE-LIGHT; XANTHOPHYLL CYCLE; RED-LIGHT; THALASSIOSIRA-PSEUDONANA; SECONDARY PLASTIDS; PROTEIN; PHYTOCHROME; PHOTOTROPIN; PHOTOPROTECTION	Aureochromes constitute a family of blue light (BL) receptors which are found exclusively in heterokont algae such as diatoms (Bacillariophyceae) and yellow-green algae (Xanthophyceae). Previous studies on the diatom Phaeodactylum tricornutum indicate that the formation of a high light acclimated phenotype is mediated by the absorption of BL and that aureochromes might play an important role in this process. P. tricornutum possesses four genes encoding aureochromes. In this study we confirm the nuclear localisation of the PtAUREO1a, 1b and 2 proteins. Furthermore we studied the physiology of light quality acclimation in genetically transformed P. tricornutum cell lines with reduced expression of the aureochrome 1a gene. The results demonstrate that the AUREO1a protein has a distinct function in light acclimation. However, rather unexpectedly AUREO1a seems to repress high light acclimation which resulted in a state of 'hyper' high light acclimation in aureo1a silenced strains. This was indicated by characteristic changes of several photosynthetic parameters, including increased maximum photosynthesis rates, decreased chlorophyll a contents per cell and increased values of non-photochemical quenching in AUREO1a silenced strains compared to wild type cultures. Strikingly, AUREO1a silenced strains exhibited phenotypic differences compared to wild type cells during cultivation under BL as well as under red light (RL) conditions. Therefore, AUREO1a might influence the RL signalling process, suggesting an interaction of AUREO1a with RL perception pathways.	[Costa, Benjamin Schellenberger; Jungandreas, Anne; Jakob, Torsten; Wilhelm, Christian] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany; [Sachse, Matthias; Bartulos, Carolina Rio; Gruber, Ansgar; Kroth, Peter G.] Univ Konstanz, Fachbereich Biol, Constance, Germany	Leipzig University; University of Konstanz	Costa, BS (corresponding author), Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany.	b_schellenberger@web.de	Rio Bartulos, Carolina/AAX-8484-2021; Gruber, Ansgar/B-9587-2008; Kroth, Peter G/A-9728-2008; Rio Bartulos, Carolina/AAX-8411-2021	Rio Bartulos, Carolina/0000-0003-1203-127X; Gruber, Ansgar/0000-0002-5876-4391; Kroth, Peter G/0000-0003-4734-8955; Rio Bartulos, Carolina/0000-0003-1203-127X	Universitat Konstanz; Deutsche Forschungsgemeinschaft; research group FOR 1261 [KR 1661/8-1, WI 764/19]	Universitat Konstanz; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); research group FOR 1261	Funding came from Universitat Konstanz (http://www.uni-konstanz.de), Deutsche Forschungsgemeinschaft (http://www.dfg.de) and research group FOR 1261, Projects KR 1661/8-1 (MS, PGK) and WI 764/19 (AJ, BSC, CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anning T, 2000, LIMNOL OCEANOGR, V45, P1807, DOI 10.4319/lo.2000.45.8.1807; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ashworth J, 2013, P NATL ACAD SCI USA, V110, P7518, DOI 10.1073/pnas.1300962110; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Beel B, 2012, PLANT CELL, V24, P2992, DOI 10.1105/tpc.112.098947; Beer A, 2011, J PHYCOL, V47, P1266, DOI 10.1111/j.1529-8817.2011.01060.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brautigam K, 2010, PLANT SIGNAL BEHAV, V5, P81, DOI 10.4161/psb.5.1.10294; Brautigam K, 2009, PLANT CELL, V21, P2715, DOI 10.1105/tpc.108.062018; Brunet C, 2010, J PLANKTON RES, V32, P1609, DOI 10.1093/plankt/fbq104; Coesel S, 2009, EMBO REP, V10, P655, DOI 10.1038/embor.2009.59; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Depauw FA, 2012, J EXP BOT, V63, P1575, DOI 10.1093/jxb/ers005; Durnford DG, 1997, PHOTOSYNTH RES, V53, P229, DOI 10.1023/A:1005815725371; Foyer CH, 2012, J EXP BOT, V63, P1637, DOI 10.1093/jxb/ers013; Gallagher S, 2008, JOVE-J VIS EXP; Geider RJ, 2001, GLOBAL CHANGE BIOL, V7, P849, DOI 10.1046/j.1365-2486.2001.00448.x; Gilbert M, 2000, J PLANT PHYSIOL, V157, P307, DOI 10.1016/S0176-1617(00)80052-8; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han IS, 2008, PLANT CELL, V20, P2835, DOI 10.1105/tpc.108.059915; Herman E, 2013, BIOCHEMISTRY-US, V52, P3094, DOI 10.1021/bi400197u; Huysman MJJ, 2013, PLANT CELL, V25, P215, DOI 10.1105/tpc.112.106377; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Jaedicke K, 2012, P NATL ACAD SCI USA, V109, P12231, DOI 10.1073/pnas.1120203109; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kami C, 2012, PLANT CELL, V24, P566, DOI 10.1105/tpc.111.095083; Kasahara M, 2004, PLANT PHYSIOL, V135, P1388, DOI 10.1104/pp.104.042705; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Kroth Peter G., 2007, V390, P257; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lariguet P, 2006, P NATL ACAD SCI USA, V103, P10134, DOI 10.1073/pnas.0603799103; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Lavaud J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036806; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; LOPEZFIGUEROA F, 1989, PHYSIOL PLANTARUM, V76, P391; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nymark M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058722; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Poulsen N, 2005, FEBS J, V272, P3413, DOI 10.1111/j.1742-4658.2005.04760.x; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Ragni M, 2004, J PLANKTON RES, V26, P433, DOI 10.1093/plankt/fbh044; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Schumann A, 2007, PHYCOLOGIA, V46, P113, DOI 10.2216/06-30.1; Stork S, 2012, EUKARYOT CELL, V11, P1472, DOI 10.1128/EC.00183-12; Sturm S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-159; Su WW, 2012, J PHYCOL, V48, P336, DOI 10.1111/j.1529-8817.2012.01128.x; Suetsugu N, 2013, PLANT CELL PHYSIOL, V54, P8, DOI 10.1093/pcp/pcs165; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tsuchida-Mayama T, 2010, PLANT J, V62, P653, DOI 10.1111/j.1365-313X.2010.04180.x; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Walters RG, 1999, PLANTA, V209, P517, DOI 10.1007/s004250050756; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x	67	46	47	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e74451	10.1371/journal.pone.0074451	http://dx.doi.org/10.1371/journal.pone.0074451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24073211	gold, Green Published, Green Submitted			2022-12-27	WOS:000324768000020
J	Hussen, SA; Stephenson, R; del Rio, C; Wilton, L; Wallace, J; Wheeler, D				Hussen, Sophia A.; Stephenson, Robert; del Rio, Carlos; Wilton, Leo; Wallace, Jermel; Wheeler, Darrell		HPTN 061 Protocol Team	HIV Testing Patterns among Black Men Who Have Sex with Men: A Qualitative Typology	PLOS ONE			English	Article							AFRICAN-AMERICAN MEN; RISK BEHAVIORS; HEALTH-CARE; YOUNG MEN; PREVENTION; INFECTION; MSM; PREVALENCE; GAY	Background: Black men who have sex with men (MSM) in the Southeastern United States are disproportionately affected by HIV. Black MSM are more likely to have unrecognized HIV infection, suggesting that testing may occur later and/or infrequently relative to current recommendations. The objective of this qualitative study was to explore the HIV testing behaviors of Black MSM in Atlanta, Georgia, who were participants in the HIV Prevention Trials Network Brothers Study (HPTN 061). Methods and Findings: We conducted 29 in-depth interviews and four focus groups with a community-recruited sample. Modified grounded theory methodologies were used to guide our inductive analysis, which yielded a typology comprised of four distinct HIV testing patterns. Participants could be categorized as: (1) Maintenance Testers, who tested regularly as part of routine self-care; (2) Risk-Based Testers, whose testing depended on relationship status or sexual behavior; (3) Convenience Testers, who tested irregularly depending on what testing opportunities arose; or (4) Test Avoiders, who tested infrequently and/or failed to follow up on results. We further characterized these groups with respect to age, socioeconomic factors, identity, stigma and healthcare access. Conclusions: Our findings highlight the heterogeneity of HIV testing patterns among Black MSM, and offer a framework for conceptualizing HIV testing in this group. Public health messaging must account for the diversity of Black MSM's experiences, and multiple testing approaches should be developed and utilized to maximize outreach to different types of testers.	[Hussen, Sophia A.; Stephenson, Robert; del Rio, Carlos; Wallace, Jermel] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Hussen, Sophia A.; del Rio, Carlos] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Wilton, Leo] SUNY Binghamton, Dept Human Dev, Binghamton, NY USA; [Wheeler, Darrell] Loyola Univ, Grad Sch Social Work, Chicago, IL 60611 USA	Emory University; Rollins School Public Health; Emory University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Loyola University Chicago	Hussen, SA (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	sophia.ahmed.hussen@emory.edu	del Rio, Carlos/B-3763-2012; Frew, Paula M./B-4774-2012	del Rio, Carlos/0000-0002-0153-3517; Frew, Paula M./0000-0002-3078-9124	HPTN Scholars Program; NIAID; National Institute of Allergy and Infectious Disease (NIAID) [HPTN 061]; National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH) [UM1 AI068619, UM1 AI068617, UM1 AI068613]; Fenway Institute CRS: Harvard University CFAR [P30 AI060354]; CTU for HIV Prevention and Microbicide Research [UM1 AI069480]; George Washington University CRS: District of Columbia Developmental CFAR [P30 AI087714]; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU [5U01 AI069466]; ARRA [3U01 AI069466-03S1]; Hope Clinic of the Emory Vaccine Center CRS; The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU [5U01 AI069418]; CFAR [P30 AI050409]; CTSA [UL1 RR025008]; San Francisco Vaccine and Prevention CRS: ARRA [3U01 AI069496-03S1, 3U01 AI069496-03S2]; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU [U01 AI069424]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069466, P30AI050409, P30AI060354, U01AI069418, UM1AI068619, U01AI069496, P30AI087714, UM1AI069480, UM1AI068613, U01AI069424, UM1AI068617] Funding Source: NIH RePORTER	HPTN Scholars Program; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fenway Institute CRS: Harvard University CFAR; CTU for HIV Prevention and Microbicide Research; George Washington University CRS: District of Columbia Developmental CFAR; Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU; ARRA; Hope Clinic of the Emory Vaccine Center CRS; The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU; CFAR; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); San Francisco Vaccine and Prevention CRS: ARRA; UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The primary author's work on this manuscript was supported through the HPTN Scholars Program, funded by NIAID. HPTN 061 grant support provided by the National Institute of Allergy and Infectious Disease (NIAID), National Institute on Drug Abuse (NIDA) and National Institute of Mental Health (NIMH): Cooperative Agreements UM1 AI068619, UM1 AI068617, and UM1 AI068613. Additional site funding - Fenway Institute CRS: Harvard University CFAR (P30 AI060354) and CTU for HIV Prevention and Microbicide Research (UM1 AI069480); George Washington University CRS: District of Columbia Developmental CFAR (P30 AI087714); Harlem Prevention Center CRS and NY Blood Center/Union Square CRS: Columbia University CTU (5U01 AI069466) and ARRA funding (3U01 AI069466-03S1); Hope Clinic of the Emory Vaccine Center CRS and The Ponce de Leon Center CRS: Emory University HIV/AIDS CTU (5U01 AI069418), CFAR (P30 AI050409) and CTSA (UL1 RR025008); San Francisco Vaccine and Prevention CRS: ARRA funding (3U01 AI069496-03S1, 3U01 AI069496-03S2); UCLA Vine Street CRS: UCLA Department of Medicine, Division of Infectious Diseases CTU (U01 AI069424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora A, 2013, P 20 C RETR OPP INF; Angotti N, 2009, SOC SCI MED, V68, P2263, DOI 10.1016/j.socscimed.2009.02.041; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Bowleg L, 2011, CULT HEALTH SEX, V13, P545, DOI 10.1080/13691058.2011.556201; Burt RS, 2005, BROKERAGE CLOSURE IN; Chakravarty D, 2012, AIDS BEHAV, V16, P1944, DOI 10.1007/s10461-012-0181-6; Chen Mi, 2012, MMWR Suppl, V61, P57; Cohall A, 2010, AM J PUBLIC HEALTH, V100, P1961, DOI 10.2105/AJPH.2008.140632; de Wit JBF, 2008, HIV MED, V9, P20, DOI 10.1111/j.1468-1293.2008.00586.x; Dorell CG, 2011, AIDS PATIENT CARE ST, V25, P657, DOI 10.1089/apc.2011.0203; Doshi RK, 2013, AIDS PATIENT CARE ST, V27, P123, DOI 10.1089/apc.2012.0269; Dowing T., 2007, Morbidity and Mortality Weekly Report, V56, P602; Dowson L, 2012, AIDS CARE, V24, P204, DOI 10.1080/09540121.2011.597711; Farmer T, 2006, QUAL HEALTH RES, V16, P377, DOI 10.1177/1049732305285708; Fernandez MI, 2003, AIDS EDUC PREV, V15, P105, DOI 10.1521/aeap.15.1.5.105.23608; Fields EL, 2012, J ADOLESCENT HEALTH, V50, P296, DOI 10.1016/j.jadohealth.2011.07.007; Fuqua V, 2012, AIDS BEHAV, V16, P256, DOI 10.1007/s10461-011-9918-x; German D, 2011, JAIDS-J ACQ IMM DEF, V57, P77, DOI 10.1097/QAI.0b013e318211b41e; Halkitis PN, 2011, ANN BEHAV MED, V42, P361, DOI 10.1007/s12160-011-9299-4; Harawa NT, 2004, JAIDS-J ACQ IMM DEF, V35, P526, DOI 10.1097/00126334-200404150-00011; Helms DJ, 2009, JAIDS-J ACQ IMM DEF, V50, P320, DOI 10.1097/QAI.0b013e3181945f03; Hussen SA, 2012, CULT HEALTH SEX, V14, P863, DOI 10.1080/13691058.2012.703327; Johnson EP, 2008, SWEET TEA: BLACK GAY MEN OF THE SOUTH, P1; Kalichman SC, 1997, AIDS EDUC PREV, V9, P41; Kalichman SC, 2008, J CLIN PSYCHOL MED S, V15, P127, DOI 10.1007/s10880-008-9116-9; Kellerman SE, 2002, JAIDS-J ACQ IMM DEF, V31, P202, DOI 10.1097/00126334-200210010-00011; Kelley CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053284; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Lechuga J, 2013, HEALTH PROMOT PRACT, V14, P433, DOI 10.1177/1524839912460870; Lieb S, 2011, AIDS BEHAV, V15, P596, DOI 10.1007/s10461-010-9820-y; Lo YC, 2012, SEX TRANSM DIS, V39, P306, DOI 10.1097/OLQ.0b013e31824018d4; Lorenc T, 2011, HEALTH EDUC RES, V26, P834, DOI 10.1093/her/cyr064; Magnus M, 2010, AIDS PATIENT CARE ST, V24, P615, DOI 10.1089/apc.2010.0111; Malebranche D, 2008, P AIDS 3 8 AUG 2008; Malebranche DJ, 2009, MEN MASC, V12, P90, DOI 10.1177/1097184X07309504; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Nel JA, 2013, AIDS BEHAV, V17, pS51, DOI 10.1007/s10461-012-0329-4; Nelson KM, 2010, J URBAN HEALTH, V87, P642, DOI 10.1007/s11524-010-9434-8; Paltiel AD, 2012, ANN INTERN MED, V157, P744, DOI 10.7326/0003-4819-157-10-201211200-00545; Parent MC, 2012, J COUNS PSYCHOL, V59, P465, DOI 10.1037/a0028067; PHILLIPS KA, 1995, AIDS, V9, P769, DOI 10.1097/00002030-199507000-00015; Sharma Akshay, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P357, DOI 10.1177/1545109711404946; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Stephenson R, 2011, AIDS BEHAV, V15, pS80, DOI 10.1007/s10461-011-9893-2; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Sullivan PS, 2004, JAIDS-J ACQ IMM DEF, V35, P511, DOI 10.1097/00126334-200404150-00009; United States Census Bureau, 2011, 2008 2011 AM COMM SU; Wagenaar BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042953; Wall Kristin M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P284, DOI 10.1177/1545109710379051; Wilton L, 2009, AIDS BEHAV, V13, P532, DOI 10.1007/s10461-009-9529-y	52	29	29	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75382	10.1371/journal.pone.0075382	http://dx.doi.org/10.1371/journal.pone.0075382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	223BC	24069408	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300076
J	Samelius, G; Andren, H; Kjellander, P; Liberg, O				Samelius, Gustaf; Andren, Henrik; Kjellander, Petter; Liberg, Olof			Habitat Selection and Risk of Predation: Re-colonization by Lynx had Limited Impact on Habitat Selection by Roe Deer	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; FUNCTIONAL-RESPONSES; CAPREOLUS-CAPREOLUS; EURASIAN LYNX; WOLVES; ELK; AVAILABILITY; DYNAMICS; SURVIVAL; BEHAVIOR	Risk of predation is an evolutionary force that affects behaviors of virtually all animals. In this study, we examined how habitat selection by roe deer was affected by risk of predation by Eurasian lynx - the main predator of roe deer in Scandinavia. Specifically, we compared how habitat selection by roe deer varied (1) before and after lynx re-established in the study area and (2) in relation to habitat-specific risk of predation by lynx. All analyses were conducted at the spatial and temporal scales of home ranges and seasons. We did not find any evidence that roe deer avoided habitats in which the risk of predation by lynx was greatest and information-theoretic model selection showed that re-colonization by lynx had limited impact on habitat selection by roe deer despite lynx predation causing 65% of known mortalities after lynx re-colonized the area. Instead we found that habitat selection decreased when habitat availability increased for 2 of 5 habitat types (a pattern referred to as functional response in habitat selection). Limited impact of re-colonization by lynx on habitat selection by roe deer in this study differs from elk in North America altering both daily and seasonal patterns in habitat selection at the spatial scales of habitat patches and home ranges when wolves were reintroduced to Yellowstone National Park. Our study thus provides further evidence of the complexity by which animals respond to risk of predation and suggest that it may vary between ecosystems and predator-prey constellations.	[Samelius, Gustaf; Andren, Henrik; Kjellander, Petter; Liberg, Olof] Swedish Univ Agr Sci, Dept Ecol, Riddarhyttan, Sweden	Swedish University of Agricultural Sciences	Samelius, G (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Riddarhyttan, Sweden.	gustaf.samelius@slu.se	Andrén, Henrik/C-8995-2015	Kjellander, Petter/0000-0002-4272-6737; Andren, Henrik/0000-0002-5616-2426	Swedish Environmental Protection Agency; Swedish Hunting Association; Swedish University of Agricultural Sciences	Swedish Environmental Protection Agency; Swedish Hunting Association; Swedish University of Agricultural Sciences	This study was funded by the Swedish Environmental Protection Agency, the Swedish Hunting Association, and the Swedish University of Agricultural Sciences. Please note that the Swedish Hunting Association is not a profit making body, they are part of wildlife management in Sweden and are partly working on commission by the Swedish government. They also fund research which is part of where the funding for our study came from. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnham K. P., 1998, MODEL SELECTION INFE; CEDERLUND G, 1983, ACTA THERIOL, V28, P443, DOI 10.4098/AT.arch.83-39; Cederlund G, 1981, SWE WILDL RES, V11, P313; Cederlund G, 1979, 1136 SWED ENV PROT A; Conner LM, 2003, ECOLOGY, V84, P526, DOI 10.1890/0012-9658(2003)084[0526:ACODBA]2.0.CO;2; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Haglund B, 1966, SWEDISH WILDLIFE RES, V4, P81; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Hewison AJM, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P189; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Hunter LTB, 1998, BEHAVIOUR, V135, P195, DOI 10.1163/156853998793066320; Jarnemo A, 2005, J WILDLIFE MANAGE, V69, P1090, DOI 10.2193/0022-541X(2005)069[1090:RFRARD]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Kjellander P, 2003, OIKOS, V101, P338, DOI 10.1034/j.1600-0706.2003.11986.x; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Liberg O, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P221; Liberg O., 2006, LYNX POPULATION SWED; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Loison A, 1999, ECOLOGY, V80, P2539, DOI 10.1890/0012-9658(1999)080[2539:ASSIFP]2.0.CO;2; Manly B.F.J., 2002, RESOURCE SELECTION A; Mao JS, 2005, J WILDLIFE MANAGE, V69, P1691, DOI 10.2193/0022-541X(2005)69[1691:HSBEBA]2.0.CO;2; MITCHELL B, 1985, J ZOOL, V207, P1; Mitchell WA, 2002, OIKOS, V99, P249, DOI 10.1034/j.1600-0706.2002.990205.x; Montgomery RA, 2011, J WILDLIFE MANAGE, V75, P702, DOI 10.1002/jwmg.96; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; NEFF DJ, 1968, J WILDLIFE MANAGE, V32, P597, DOI 10.2307/3798941; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; Osko TJ, 2004, J WILDLIFE MANAGE, V68, P576, DOI 10.2193/0022-541X(2004)068[0576:MHPIRT]2.0.CO;2; Ratikainen II, 2007, J ZOOL, V273, P192, DOI 10.1111/j.1469-7998.2007.00314.x; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Sand H, 2006, P R SOC B, V273, P1421, DOI 10.1098/rspb.2005.3447; Sempere Antoine J., 1996, Mammalian Species, V538, P1; White G. C., 1990, ANAL WILDLIFE RADIO, P383, DOI 10.1016/B978-0-08-092657-5.50008-2	37	18	18	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75469	10.1371/journal.pone.0075469	http://dx.doi.org/10.1371/journal.pone.0075469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24069419	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300080
J	Aoyama, T; Tsushita, K; Miyatake, N; Numata, T; Miyachi, M; Tabata, I; Cao, ZB; Sakamoto, S; Higuchi, M				Aoyama, Tomoko; Tsushita, Kazuyo; Miyatake, Nobuyuki; Numata, Takeyuki; Miyachi, Motohiko; Tabata, Izumi; Cao, Zhen-Bo; Sakamoto, Shizuo; Higuchi, Mitsuru			Does Cardiorespiratory Fitness Modify the Association between Birth Weight and Insulin Resistance in Adult Life?	PLOS ONE			English	Article							RISK-FACTORS; THRIFTY PHENOTYPE; PHYSICAL-ACTIVITY; JAPANESE WOMEN; METABOLIC RISK; MEN; FETAL; SIZE; POPULATION; ADIPOSITY	Objective: Lower birth weight is associated with higher insulin resistance in later life. The aim of this study was to determine whether cardiorespiratory fitness modifies the association of birth weight with insulin resistance in adults. Methods: The subjects were 379 Japanese individuals (137 males, 242 females) aged 20-64 years born after 1943. Insulin resistance was assessed using a homeostasis model assessment of insulin resistance (HOMA-IR), which is calculated from fasting blood glucose and insulin levels. Cardiorespiratory fitness (maximal oxygen uptake, VO(2)max) was assessed by a maximal graded exercise test on a cycle ergometer. Birth weight was reported according to the Maternal and Child Health Handbook records or the subject's or his/her mother's memory. Results: The multiple linear regression analysis revealed that birth weight was inversely associated with HOMA-IR (beta = -0.141, p = 0.003), even after adjustment for gender, age, current body mass index, mean blood pressure, triglycerides, HDL cholesterol, and smoking status. Further adjustments for VO(2)max made little difference in the relationship between birth weight and HOMA-IR (beta = -0.148, p = 0.001), although VO(2)max (beta = -0.376, p<0.001) was a stronger predictor of HOMA-IR than birth weight. Conclusions: The results showed that the association of lower birth weight with higher insulin resistance was little modified by cardiorespiratory fitness in adult life. However, cardiorespiratory fitness was found to be a stronger predictor of insulin resistance than was birth weight, suggesting that increasing cardiorespiratory fitness may have a much more important role in preventing insulin resistance than an individual's low birth weight.	[Aoyama, Tomoko] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan; [Aoyama, Tomoko] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Tsushita, Kazuyo] Aichi Comprehens Hlth Sci Ctr, Chita, Aichi, Japan; [Miyatake, Nobuyuki] Kagawa Univ, Fac Med, Dept Hyg, Kita, Kagawa, Japan; [Numata, Takeyuki] Okayama Hlth Fdn, Okayama Southern Inst Hlth, Kita, Kagawa, Japan; [Miyachi, Motohiko] Natl Inst Hlth & Nutr, Shinjuku Ku, Tokyo 162, Japan; [Tabata, Izumi] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Cao, Zhen-Bo; Sakamoto, Shizuo; Higuchi, Mitsuru] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Waseda University; Japan Society for the Promotion of Science; Kagawa University; National Institute of Health & Nutrition - Japan; Ritsumeikan University; Waseda University	Higuchi, M (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	mhiguchi@waseda.jp	Cao, Zhen-Bo/D-3318-2009; Miyachi, Motohiko/AAW-3403-2020	Cao, Zhen-Bo/0000-0002-2652-7279; Miyachi, Motohiko/0000-0002-1146-0905	Ministry of Health, Labor, and Welfare, Japan [19160101]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [23-4764]; Grants-in-Aid for Scientific Research [23500864] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Research Grant for Comprehensive Research on Cardiovascular and Life-Style Related Diseases from the Ministry of Health, Labor, and Welfare, Japan (19160101). This study was partly supported by a Grant-in-Aid for the Global COE "Sport Science for the Promotion of Active Life" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a Grant-in-Aid for Research Fellow of the Japan Society for the Promotion of Science (no. 23-4764). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2002, SEMIN PERINATOL, V26, P260, DOI 10.1053/sper.2002.34772; Anazawa S, 2003, DIABETES CARE, V26, P2210, DOI 10.2337/diacare.26.7.2210; Aoyama T, 2011, J PHYSIOL ANTHROPOL, V30, P133, DOI 10.2114/jpa2.30.133; Barker DJP, 1998, MOTHERS BABIES HLTH; Cao ZB, 2009, EUR J APPL PHYSIOL, V105, P289, DOI 10.1007/s00421-008-0902-8; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Choi CS, 2000, DIABETES RES CLIN PR, V49, P53, DOI 10.1016/S0168-8227(00)00131-5; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x; Laaksonen DE, 2003, DIABETES CARE, V26, P2156, DOI 10.2337/diacare.26.7.2156; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCCANCE DR, 1994, BRIT MED J, V308, P942, DOI 10.1136/bmj.308.6934.942; Mercurio V, 2012, WORLD J CARDIOL, V4, P1, DOI [10.4330/wjc.v4.il.1, 10.4330/wjc.v4.i1.1]; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; O'Donovan G, 2012, METABOLISM, V61, P213, DOI 10.1016/j.metabol.2011.06.009; Odlind V, 2003, ACTA OBSTET GYN SCAN, V82, P516, DOI 10.1034/j.1600-0412.2003.00112.x; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Racette SB, 2006, DIABETES CARE, V29, P673, DOI 10.2337/diacare.29.03.06.dc05-1605; Ridgway CL, 2011, DIABETES CARE, V34, P187, DOI 10.2337/dc10-1178; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Takimoto H, 2003, J OBSTET GYNAECOL RE, V29, P96, DOI 10.1046/j.1341-8076.2002.00078.x; Takimoto H, 2004, AM J PUBLIC HEALTH, V94, P1592, DOI 10.2105/AJPH.94.9.1592; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/s001250050157; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e73967	10.1371/journal.pone.0073967	http://dx.doi.org/10.1371/journal.pone.0073967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069257	gold, Green Published, Green Submitted			2022-12-27	WOS:000324547300025
J	Lin, Z; Su, YS; Zhang, CF; Xing, MJ; Ding, WH; Liao, LW; Guan, YT; Li, ZZ; Cui, DH				Lin, Zheng; Su, Yousong; Zhang, Chengfang; Xing, Mengjuan; Ding, Wenhua; Liao, Liwei; Guan, Yangtai; Li, Zezhi; Cui, Donghong			The Interaction of BDNF and NTRK2 Gene Increases the Susceptibility of Paranoid Schizophrenia	PLOS ONE			English	Article							NEUROTROPHIC FACTOR VAL66MET; HAN CHINESE POPULATION; PREFRONTAL CORTEX; BIPOLAR DISORDER; POLYMORPHISM; ASSOCIATION; METAANALYSIS; RECEPTOR; RISK; ONSET	The association between BDNF gene functional Val66Met polymorphism rs6265 and the schizophrenia is far from being consistent. In addition to the heterogeneous in schizophrenia per se leading to the inconsistent results, the interaction among multi-genes is probably playing the main role in the pathogenesis of schizophrenia, but not a single gene. Neurotrophic tyrosine kinase receptor 2 (NTRK2) is the high-affinity receptor of BDNF, and was reported to be associated with mood disorders, though no literature reported the association with schizophrenia. Thus, in the present study, total 402 patients with paranoid schizophrenia (the most common subtype of schizophrenia) and matched 406 healthy controls were recruited to investigate the role of rs6265 in BDNF, three polymorphisms in NTRK2 gene (rs1387923, rs2769605 and rs1565445) and their interaction in the susceptibility to paranoid schizophrenia in a Chinese Han population. We did not observe significant differences in allele and genotype frequencies between patients and healthy controls for all four polymorphisms separately. The haplotype analysis also showed no association between haplotype of NTRK2 genes (rs1387923, rs2769605, and rs1565445) and paranoid schizophrenia. However, we found the association between the interaction of BDNF and NTRK2 with paranoid schizophrenia by using the MDR method followed by conventional statistical analysis. The best gene-gene interaction model was a three-locus model (BDNF rs6265, NTRK2 rs1387923 and NTRK2 rs2769605), in which one low-risk and three high-risk four-locus genotype combinations were identified. Our findings implied that single polymorphism of rs6265 rs1387923, rs2769605, and rs1565445 in BDNF and NTRK2 were not associated with the development of paranoid schizophrenia in a Han population, however, the interaction of BDNF and NTRK2 genes polymorphisms (BDNF-rs6265, NTRK2-rs1387923 and NTRK2-rs2769605) may be involved in the susceptibility to paranoid schizophrenia.	[Lin, Zheng] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Psychiat, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Yousong; Zhang, Chengfang; Xing, Mengjuan; Ding, Wenhua; Liao, Liwei; Cui, Donghong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Guan, Yangtai; Li, Zezhi] Secondary Mil Med Univ, Shanghai Changhai Hosp, Dept Neurol, Shanghai, Peoples R China; [Cui, Donghong] Shanghai Jiao Tong Univ, Sch Med, Bio X Inst, Shanghai 200030, Peoples R China	Zhejiang University; Shanghai Jiao Tong University; Naval Medical University; Shanghai Jiao Tong University	Li, ZZ (corresponding author), Secondary Mil Med Univ, Shanghai Changhai Hosp, Dept Neurol, Shanghai, Peoples R China.	lizezhi1981@aliyun.com; manyucc@126.com	Li, Zezhi/I-5524-2018; cui, donghong/AAV-2619-2020		National Natural Science Foundation of China [81171266, 81271481]; Natural Science Foundation of Shanghai [13ZR1460500]; Shanghai Pujiang Program [10PJ1408800]; Shanghai science and technology innovation program [11140900400]; Shanghai outstanding leaders plan of public health [GWDTR201230]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai science and technology innovation program; Shanghai outstanding leaders plan of public health	This study was supported by the National Natural Science Foundation of China (81171266, 81271481), the Natural Science Foundation of Shanghai (13ZR1460500), Shanghai Pujiang Program (10PJ1408800), Shanghai science and technology innovation program (11140900400), Shanghai outstanding leaders plan of public health (GWDTR201230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremer T, 2007, MOL DIAGN THER, V11, P161, DOI 10.1007/BF03256238; Buckley PF, 2011, CURR OPIN PSYCHIATR, V24, P122, DOI 10.1097/YCO.0b013e3283436eb7; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; Dervieux T, 2012, PHARMACOGENET GENOM, V22, P1, DOI 10.1097/FPC.0b013e32834d3e0b; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Favalli G, 2012, J PSYCHIATR RES, V46, P1, DOI 10.1016/j.jpsychires.2011.09.022; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; Issa G, 2010, NEUROBIOL DIS, V39, P327, DOI 10.1016/j.nbd.2010.04.017; Kanazawa T, 2007, PSYCHIAT GENET, V17, P165, DOI 10.1097/YPG.0b013e32801da2e2; Kawanishi Y, 1999, J HUM GENET, V44, P428, DOI 10.1007/s100380050196; Lee AH, 2011, J CLIN PSYCHOPHARM, V31, P334, DOI 10.1097/JCP.0b013e31821895c1; Li ZZ, 2013, J PSYCHIATR RES, V47, P8, DOI 10.1016/j.jpsychires.2012.10.003; Lu WH, 2012, J MOL NEUROSCI, V47, P505, DOI 10.1007/s12031-012-9750-4; Miyanishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061152; Muglia P, 2003, MOL PSYCHIATR, V8, P146, DOI 10.1038/sj.mp.4001221; Neves-Pereira M, 2005, MOL PSYCHIATR, V10, P208, DOI 10.1038/sj.mp.4001575; Pandya CD, 2013, ASIAN J PSYCHIATR, V6, P22, DOI 10.1016/j.ajp.2012.08.010; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Suchanek R, 2013, J NEUROPSYCH CLIN N, V25, P88, DOI 10.1176/appi.neuropsych.11100234; Sun MM, 2013, PSYCHIAT GENET; Sun RF, 2011, NEUROSCI LETT, V489, P34, DOI 10.1016/j.neulet.2010.11.061; Thompson M, 2011, J PSYCHIATR NEUROSCI, V36, P195, DOI 10.1503/jpn.100048; Wang Y, 2010, SCHIZOPHR RES, V120, P240, DOI 10.1016/j.schres.2010.03.020; Wang Z, 2012, GENES BRAIN BEHAV, V11, P524, DOI 10.1111/j.1601-183X.2012.00797.x; Weickert CS, 2003, MOL PSYCHIATR, V8, P592, DOI 10.1038/sj.mp.4001308; Weickert CS, 2005, MOL PSYCHIATR, V10, P637, DOI 10.1038/sj.mp.4001678; Xu MQ, 2007, SCHIZOPHR RES, V91, P6, DOI 10.1016/j.schres.2006.12.008; Yi ZH, 2011, BRAIN RES, V1417, P146, DOI 10.1016/j.brainres.2011.08.037; Zhang C, 2011, J MOL NEUROSCI, V43, P406, DOI 10.1007/s12031-010-9458-2; Zhang XY, 2012, PSYCHOPHARMACOLOGY, V222, P277, DOI 10.1007/s00213-012-2643-y; Zhang XY, 2012, HUM GENET, V131, P1187, DOI 10.1007/s00439-012-1150-x	37	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74264	10.1371/journal.pone.0074264	http://dx.doi.org/10.1371/journal.pone.0074264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069289	Green Submitted, Green Published, gold			2022-12-27	WOS:000324547300033
J	Rubio-Moscardo, F; Seto-Salvia, N; Pera, M; Bosch-Morato, M; Plata, C; Belbin, O; Gene, G; Dols-Icardo, O; Ingelsson, M; Helisalmi, S; Soininen, H; Hiltunen, M; Giedraitis, V; Lannfelt, L; Frank, A; Bullido, MJ; Combarros, O; Sanchez-Juan, P; Boada, M; Tarraga, L; Pastor, P; Perez-Tur, J; Baquero, M; Molinuevo, JL; Sanchez-Valle, R; Fuentes-Prior, P; Fortea, J; Blesa, R; Munoz, FJ; Lleo, A; Valverde, MA; Clarimon, J				Rubio-Moscardo, Fanny; Seto-Salvia, Nuria; Pera, Marta; Bosch-Morato, Monica; Plata, Cristina; Belbin, Olivia; Gene, Gemma; Dols-Icardo, Oriol; Ingelsson, Martin; Helisalmi, Seppo; Soininen, Hilkka; Hiltunen, Mikko; Giedraitis, Vilmantas; Lannfelt, Lars; Frank, Ana; Jesus Bullido, Ma; Combarros, Onofre; Sanchez-Juan, Pascual; Boada, Merce; Tarraga, Lluis; Pastor, Pau; Perez-Tur, Jordi; Baquero, Miquel; Molinuevo, Jose L.; Sanchez-Valle, Raquel; Fuentes-Prior, Pablo; Fortea, Juan; Blesa, Rafael; Munoz, Francisco J.; Lleo, Alberto; Valverde, Miguel A.; Clarimon, Jordi			Rare Variants in Calcium Homeostasis Modulator 1 (CALHM1) Found in Early Onset Alzheimer's Disease Patients Alter Calcium Homeostasis	PLOS ONE			English	Article							NO ASSOCIATION; CHANNEL; PRESENILINS; POLYMORPHISM; DISRUPTION; MUTATIONS; PROTEIN; RISK; ER	Calcium signaling in the brain is fundamental to the learning and memory process and there is evidence to suggest that its dysfunction is involved in the pathological pathways underlying Alzheimer's disease (AD). Recently, the calcium hypothesis of AD has received support with the identification of the non-selective Ca2+-permeable channel CALHM1. A genetic polymorphism (p. P86L) in CALHM1 reduces plasma membrane Ca2+ permeability and is associated with an earlier age-at-onset of AD. To investigate the role of CALHM1 variants in early-onset AD (EOAD), we sequenced all CALHM1 coding regions in three independent series comprising 284 EOAD patients and 326 controls. Two missense mutations in patients (p.G330D and p.R154H) and one (p.A213T) in a control individual were identified. Calcium imaging analyses revealed that while the mutation found in a control (p.A213T) behaved as wild-type CALHM1 (CALHM1-WT), a complete abolishment of the Ca2+ influx was associated with the mutations found in EOAD patients (p.G330D and p.R154H). Notably, the previously reported p. P86L mutation was associated with an intermediate Ca2+ influx between the CALHM1-WT and the p.G330D and p. R154H mutations. Since neither expression of wild-type nor mutant CALHM1 affected amyloid beta-peptide (A beta) production or A beta-mediated cellular toxicity, we conclude that rare genetic variants in CALHM1 lead to Ca2+ dysregulation and may contribute to the risk of EOAD through a mechanism independent from the classical A beta cascade.	[Rubio-Moscardo, Fanny; Bosch-Morato, Monica; Plata, Cristina; Gene, Gemma; Munoz, Francisco J.; Valverde, Miguel A.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona, Spain; [Seto-Salvia, Nuria; Pera, Marta; Belbin, Olivia; Dols-Icardo, Oriol; Fortea, Juan; Blesa, Rafael; Lleo, Alberto; Clarimon, Jordi] Univ Autonoma Barcelona, St Pau Biomed Res Inst, Hosp St Pau, Memory Unit,Neurol Dept, E-08193 Barcelona, Spain; [Gene, Gemma; Ingelsson, Martin; Frank, Ana; Jesus Bullido, Ma; Combarros, Onofre; Sanchez-Juan, Pascual; Pastor, Pau; Perez-Tur, Jordi; Fortea, Juan; Blesa, Rafael; Lleo, Alberto; Clarimon, Jordi] Ctr Networked Biomed Res Neurodegenerat Dis, CIBERNED, Madrid, Spain; [Ingelsson, Martin; Giedraitis, Vilmantas; Lannfelt, Lars] Uppsala Univ, Rudbeck Lab, Dept Publ Hlth, Uppsala, Sweden; [Helisalmi, Seppo; Soininen, Hilkka; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Helisalmi, Seppo; Soininen, Hilkka; Hiltunen, Mikko] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Frank, Ana; Jesus Bullido, Ma] Hosp La Paz IdIPaz, Inst Sanitary Res, Madrid, Spain; [Jesus Bullido, Ma] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Combarros, Onofre; Sanchez-Juan, Pascual] Univ Cantabria, Univ Hosp Marques de Valdecilla, Neurol Serv, E-39005 Santander, Spain; [Combarros, Onofre; Sanchez-Juan, Pascual] IFIMAV, Santander, Spain; [Boada, Merce; Tarraga, Lluis] Inst Catala Neurociencies Aplicades, Fundacio ACE, Alzheimer Res Ctr, Barcelona, Spain; [Boada, Merce; Tarraga, Lluis] Inst Catala Neurociencies Aplicades, Fundacio ACE, Memory Clin, Barcelona, Spain; [Boada, Merce] Univ Autonoma Barcelona, VHIR UAB, Inst Recerca, Hosp Univ Vall dHebron, E-08193 Barcelona, Spain; [Pastor, Pau] Univ Navarra, Sch Med, Ctr Appl Med Res CIMA, Neurogenet Lab,Div Neurociences, E-31080 Pamplona, Spain; [Perez-Tur, Jordi] CSIC, Inst Biomed Valencia, Valencia, Spain; [Baquero, Miquel] Hosp Univ La Fe, Dept Neurol, Valencia, Spain; [Molinuevo, Jose L.; Sanchez-Valle, Raquel] IDIBAPS, Hosp Clin, Dept Neurol, Barcelona, Spain; [Fuentes-Prior, Pablo] Hosp Santa Creu & Sant Pau, IIB St Pau, Mol Basis Dis Unit, Pau, Spain	Pompeu Fabra University; Autonomous University of Barcelona; CIBERNED; Uppsala University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Hospital Universitari i Politecnic La Fe; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital of Santa Creu i Sant Pau	Valverde, MA (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona, Spain.	miguel.valverde@upf.edu; jclarimon@santpau.cat	Bullido, maria j/C-8509-2014; Seto-Salvia, Nuria/K-4546-2014; Rubio-Moscardó, Francisca/L-6247-2014; Fortea, Juan/AFU-3179-2022; Pastor, Pau/C-9834-2009; Sanchez-Valle, Raquel/I-4217-2015; Sanchez-Juan, Pascual/B-9282-2009; Dols-Icardo, Oriol/AAC-1181-2020; Muñoz, F/E-6751-2014; García, Ana Frank/I-5159-2015; Molinuevo, Jose Luis/HCH-3881-2022; Perez-Tur, Jordi/A-2143-2010; Lleó, Alberto/K-5783-2019	Bullido, maria j/0000-0002-6477-1117; Seto-Salvia, Nuria/0000-0002-3753-0027; Rubio-Moscardó, Francisca/0000-0002-3609-9992; Fortea, Juan/0000-0002-1340-638X; Pastor, Pau/0000-0002-7493-8777; Sanchez-Valle, Raquel/0000-0001-7750-896X; Sanchez-Juan, Pascual/0000-0002-6081-8037; Dols-Icardo, Oriol/0000-0003-2656-8748; Muñoz, F/0000-0002-1343-3599; García, Ana Frank/0000-0003-3858-9116; Perez-Tur, Jordi/0000-0002-9111-1712; Valverde, Miguel A./0000-0002-6961-3361; Fuentes-Prior, Pablo/0000-0002-6618-3204; Belbin, Olivia/0000-0002-9805-8408; Clarimon, Jordi/0000-0002-6824-6942; Belbin, Olivia/0000-0002-6109-6371; Molinuevo, Jose Luis/0000-0003-0485-6001; Pera, Marta/0000-0003-4317-6623	Instituto de Salud Carlos III [PI12/01311, PI10/000587, Red HERACLES RD12/0042/0014]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain); Spanish Ministry of Economy and Competiveness [SAF2012-38140]; FEDER Funds; Generalitat de Catalunya [SGR05-266]; EVO of Kuopio University Hospital [5772708]; University on Eastern Finland (UEF-Brain); ICREA	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain); Spanish Ministry of Economy and Competiveness(Spanish Government); FEDER Funds(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); EVO of Kuopio University Hospital; University on Eastern Finland (UEF-Brain); ICREA(ICREA)	This study was supported by grants from Instituto de Salud Carlos III (PI12/01311, PI10/000587, Red HERACLES RD12/0042/0014), Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, Spain), Spanish Ministry of Economy and Competiveness (SAF2012-38140), FEDER Funds, and Generalitat de Catalunya (SGR05-266). Council of the Academy of Finland, EVO grant 5772708 of Kuopio University Hospital, the Strategic Funding of the University on Eastern Finland (UEF-Brain) (to M. H and H. S). M. A. V. is the recipient of an ICREA Academia Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertram L, 2008, CELL, V135, P993, DOI 10.1016/j.cell.2008.11.030; Boada M, 2010, J ALZHEIMERS DIS, V20, P247, DOI 10.3233/JAD-2010-1357; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Coma M, 2008, NEUROBIOL AGING, V29, P969, DOI 10.1016/j.neurobiolaging.2007.01.009; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Etcheberrigaray R, 1998, NEUROBIOL DIS, V5, P37, DOI 10.1006/nbdi.1998.0176; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Gallego-Sandin S, 2011, BIOCHEM J, V437, P469, DOI 10.1042/BJ20110479; Garwood C, 2013, NEUROPATHOL APPL NEU; Guardia-Laguarta C, 2009, J NEUROCHEM, V110, P220, DOI 10.1111/j.1471-4159.2009.06126.x; Guerreiro RJ, 2010, NEUROBIOL AGING, V31, P725, DOI 10.1016/j.neurobiolaging.2008.06.012; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; KHACHATURIAN ZS, 1987, NEUROBIOL AGING, V8, P345, DOI 10.1016/0197-4580(87)90073-X; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lambert JC, 2010, J ALZHEIMERS DIS, V22, P247, DOI 10.3233/JAD-2010-100933; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Minster RL, 2009, HUM MUTAT, V30, pE566, DOI 10.1002/humu.20989; Moreno-Ortega AJ, 2010, BIOCHEM BIOPH RES CO, V391, P722, DOI 10.1016/j.bbrc.2009.11.127; Munoz FJ, 2002, J NEUROSCI, V22, P3081, DOI 10.1523/JNEUROSCI.22-08-03081.2002; Nelson O, 2010, J ALZHEIMERS DIS, V21, P781, DOI 10.3233/JAD-2010-100159; Penzes P, 2011, BRAIN RES REV, V67, P184, DOI 10.1016/j.brainresrev.2011.01.003; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Sheng M., 2012, COLD SPRING HARB PER, V4; Sleegers K, 2009, HUM MUTAT, V30, pE570, DOI 10.1002/humu.20990; Supnet C, 2011, CELL CALCIUM, V50, P303, DOI 10.1016/j.ceca.2011.05.013; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Veinbergs I, 2002, J NEUROSCI RES, V67, P379, DOI 10.1002/jnr.10138; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0	38	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74203	10.1371/journal.pone.0074203	http://dx.doi.org/10.1371/journal.pone.0074203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069280	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300032
J	Hou, JM; Lin, Y; Zhang, W; Song, LH; Wu, WJ; Wang, J; Zhou, DQ; Zou, QH; Fang, YF; He, M; Li, HT				Hou, Jingming; Lin, Yun; Zhang, Wei; Song, Lingheng; Wu, Wenjing; Wang, Jian; Zhou, Daiquan; Zou, Qinghua; Fang, Yongfei; He, Mei; Li, Haitao			Abnormalities of Frontal-Parietal Resting-State Functional Connectivity Are Related to Disease Activity in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							SERIAL ADDITION TEST; DEFAULT MODE; COGNITIVE DYSFUNCTION; BRAIN REORGANIZATION; MRI; FMRI; PREVALENCE; ACTIVATION; PATTERN; IMPAIRMENT	Cerebral involvement is common in patients with systemic Lupus erythematosus (SLE) and is characterized by multiple clinical presentations, including cognitive disorders, headaches, and syncope. Several neuroimaging studies have demonstrated cerebral dysfunction during different tasks among SLE patients; however, there have been few studies designed to characterize network alterations or to identify clinical markers capable of reflecting the cerebral involvement in SLE patients. This study was designed to characterize the profile of the cerebral activation area and the functional connectivity of cognitive function in SLE patients by using a task-based and a resting state functional magnetic resonance imaging (fMRI) technique, and to determine whether or not any clinical biomarkers could serve as an indicator of cerebral involvement in this disease. The well-established cognitive function test (Paced Visual Serial Adding Test [PVSAT]) was used. Thirty SLE patients without neuropsychiatric symptoms and 25 age- and gender-matched healthy controls were examined using PVSAT task-based and resting state fMRI. Outside the scanner, the performance of patients and the healthy controls was similar. In the PVSAT task-based fMRI, patients presented significantly expanded areas of activation, and the activated areas exhibited significantly higher functional connectivity strength in patients in the resting state. A positive correlation existed between individual connectivity strength and disease activity scoring. No correlation with cerebral involvement existed for serum markers, such as C3, C4, and anti-dsDNA. Thus, our findings may shed new light on the pathologic mechanism underlying neuropsychiatric SLE, and suggests that disease activity may be a potential effective biomarker reflecting cerebral involvement in SLE.	[Hou, Jingming; Lin, Yun; Zhang, Wei; Song, Lingheng; Wu, Wenjing; Wang, Jian; Zhou, Daiquan; Li, Haitao] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Zou, Qinghua; Fang, Yongfei] Third Mil Med Univ, Southwest Hosp, Dept Rheumatol, Chongqing, Peoples R China; [He, Mei] Third Mil Med Univ, Dept Clin Psychol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	He, M (corresponding author), Third Mil Med Univ, Dept Clin Psychol, Chongqing, Peoples R China.	sunnusunny0105@gmail.com; liihaitao@163.com		Hou, Jing-ming/0000-0002-8964-0359; Hou, Jingming/0000-0002-4991-7587	National Nature Science Foundation of China [81171283]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China (grant no. 81171283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller S, 2005, ARTHRITIS RHEUM-US, V52, P2783, DOI 10.1002/art.21271; Appenzeller S, 2007, NEUROIMAGE, V34, P694, DOI 10.1016/j.neuroimage.2006.09.029; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bonzano L, 2009, NEUROIMAGE, V44, P9, DOI 10.1016/j.neuroimage.2008.08.015; Brunner HI, 2007, ARTHRIT RHEUM-ARTHR, V57, P1174, DOI 10.1002/art.23005; Conti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033824; Diamond B, 2003, ARTHRITIS RHEUM, V48, P2710, DOI 10.1002/art.11278; DiFrancesco MW, 2007, ARTHRITIS RHEUM-US, V56, P4151, DOI 10.1002/art.23132; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Emmer BJ, 2006, PLOS MED, V3, P2285, DOI 10.1371/journal.pmed.0030499; Fitzgibbon BM, 2008, RHEUMATOLOGY, V47, P50, DOI 10.1093/rheumatology/kem287; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; HAWKER G, 1993, J RHEUMATOL, V20, P657; Helekar SA, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00219; Hiraki LT, 2008, J PEDIATR-US, V152, P550, DOI 10.1016/j.jpeds.2007.09.019; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Huang XQ, 2010, NEUROIMAGE, V49, P2901, DOI 10.1016/j.neuroimage.2009.11.072; Ikenouchi-Sugita A, 2010, WORLD J BIOL PSYCHIA, V11, P121, DOI 10.3109/15622970903521131; Jung RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009302; Kozora E, 2012, LUPUS, V21, P402, DOI 10.1177/0961203311429116; Kozora E, 2011, J INT NEUROPSYCH SOC, V17, P385, DOI 10.1017/S1355617711000191; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lazeron RHC, 2003, J NEUROL SCI, V213, P29, DOI 10.1016/S0022-510X(03)00144-8; Leistritz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060956; Levy DM, 2009, NAT CLIN PRACT RHEUM, V5, P106, DOI 10.1038/ncprheum0988; Li BJ, 2013, BIOL PSYCHIAT, V74, P48, DOI 10.1016/j.biopsych.2012.11.007; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Lin Y, 2011, HUM BRAIN MAPP, V32, P1847, DOI 10.1002/hbm.21158; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Luyendijk J, 2011, ARTHRITIS RHEUM-US, V63, P722, DOI 10.1002/art.30157; Mainero C, 2004, NEUROIMAGE, V21, P858, DOI 10.1016/j.neuroimage.2003.10.004; Mak A, 2012, SEMIN ARTHRITIS RHEU, V41, P849, DOI 10.1016/j.semarthrit.2011.11.010; Monastero R, 2001, J NEUROL SCI, V184, P33, DOI 10.1016/S0022-510X(00)00492-5; Nagels G, 2005, CLIN NEUROL NEUROSUR, V107, P218, DOI 10.1016/j.clineuro.2004.11.016; Narayanan A, 2010, BRAIN IMAGING BEHAV, V4, P189, DOI 10.1007/s11682-010-9098-8; Olazaran J, 2009, EUR NEUROL, V62, P49, DOI 10.1159/000215879; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Podrazilova L, 2008, CLIN EXP RHEUMATOL, V26, P604; Prakash RS, 2008, NEUROPSYCHOLOGIA, V46, P2888, DOI 10.1016/j.neuropsychologia.2008.05.027; Rachbauer D, 2006, J NEUROL SCI, V244, P11, DOI 10.1016/j.jns.2005.11.035; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ren T, 2012, ARTHRITIS RHEUM-US, V64, P4048, DOI 10.1002/art.34660; Rish I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050625; Rocca MA, 2006, NEUROIMAGE, V30, P478, DOI 10.1016/j.neuroimage.2005.09.047; Rocca MA, 2007, J NEUROIMAGING, V17, p36S, DOI 10.1111/j.1552-6569.2007.00135.x; Savioz A, 2009, BRAIN RES BULL, V80, P309, DOI 10.1016/j.brainresbull.2009.06.006; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Sibbitt WL, 2002, J RHEUMATOL, V29, P1536; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Wu T, 2011, HUM BRAIN MAPP, V32, P1443, DOI 10.1002/hbm.21118; Xu J, 2010, J RHEUMATOL, V37, P974, DOI 10.3899/jrheum.090967; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Yu Y, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-10; Zeng L., 2013, HUM BRAIN MAPP; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	59	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e74530	10.1371/journal.pone.0074530	http://dx.doi.org/10.1371/journal.pone.0074530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069318	Green Submitted, Green Published, gold			2022-12-27	WOS:000326240100110
J	Kwon, KW; Park, H; Doh, J				Kwon, Keon Woo; Park, Hyoungjun; Doh, Junsang			Migration of T Cells on Surfaces Containing Complex Nanotopography	PLOS ONE			English	Article							INTERACTION DYNAMICS; ARP2/3 COMPLEX; LYMPH-NODE; CHEMOTAXIS; MOTILITY; LAMELLIPODIA; ANTIGEN	T cells navigate complex microenvironments to initiate and modulate antigen-specific immune responses. While recent intravital microscopy study revealed that migration of T cells were guided by various tissue microstructures containing unique nanoscale topographical structures, the effects of complex nanotopographical structures on the migration of T cells have not been systematically studied. In this study, we fabricated surfaces containing nanoscale zigzag structures with various side lengths and turning angles using UV-assisted capillary force lithography and motility of T cells on zigzag patterned surfaces was studied. Motility of T cells was mostly affected by the turning angle, not by the side length, of the zigzag structures. In particular, motility behaviors of T cells near interfaces formed by turning points of zigzag patterns were significantly affected by turning angles. For obtuse turning angles, most of the T cells smoothly crossed the interfaces, but as the turning angle decreased, a substantial fraction of the T cells migrated along the interfaces. When the formation of lamellipodia, thin sheet-like structures typically generated at the leading edges of migrating cells by actin polymerization-driven membrane protrusion, was inhibited by an Arp2/3 inhibitor CK-636, a substantial fraction of T cells on those surfaces containing zigzag patterns with an acute turning angle were trapped at the interfaces formed by the turning points of the zigzag patterns. This result suggests that thin, wide lamellipodia at the leading edges of T cells play critical roles in motility of T cells in complex topographical microenvironments.	[Kwon, Keon Woo; Park, Hyoungjun; Doh, Junsang] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, South Korea; [Doh, Junsang] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn I Bio, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Doh, J (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, South Korea.	jsdoh@postech.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012-004146]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (JD, grant number 2012-004146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062; Kwon KW, 2012, J IMMUNOL, V189, P2266, DOI 10.4049/jimmunol.1102273; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; NELSON RD, 1975, J IMMUNOL, V115, P1650; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3; Suh KY, 2009, ADV FUNCT MATER, V19, P2699, DOI 10.1002/adfm.200900771; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034	24	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e73960	10.1371/journal.pone.0073960	http://dx.doi.org/10.1371/journal.pone.0073960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24069255	Green Published, gold, Green Submitted			2022-12-27	WOS:000326240100077
J	Li, LL; Howell, K; Sands, M; Banahan, M; Frohlich, S; Rowan, SC; Neary, R; Ryan, D; McLoughlin, P				Li, Lili; Howell, Katherine; Sands, Michelle; Banahan, Mark; Frohlich, Stephen; Rowan, Simon C.; Neary, Roisin; Ryan, Donal; McLoughlin, Paul			The alpha and Delta Isoforms of CREB1 Are Required to Maintain Normal Pulmonary Vascular Resistance	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; MUSCLE-CELL-PROLIFERATION; TRANSCRIPTION FACTOR; GENETIC EMPHYSEMA; KEY ROLE; CAMP; ANGIOGENESIS; INHIBITION; EXPRESSION; LUNG	Chronic hypoxia causes pulmonary hypertension associated with structural alterations in pulmonary vessels and sustained vasoconstriction. The transcriptional mechanisms responsible for these distinctive changes are unclear. We have previously reported that CREB1 is activated in the lung in response to alveolar hypoxia but not in other organs. To directly investigate the role of alpha and Delta isoforms of CREB1 in the regulation of pulmonary vascular resistance we examined the responses of mice in which these isoforms of CREB1 had been inactivated by gene mutation, leaving only the beta isoform intact (CREB alpha Delta mice). Here we report that expression of CREB regulated genes was altered in the lungs of CREB alpha Delta mice. CREB alpha Delta mice had greater pulmonary vascular resistance than wild types, both basally in normoxia and following exposure to hypoxic conditions for three weeks. There was no difference in rho kinase mediated vasoconstriction between CREB alpha Delta and wild type mice. Stereological analysis of pulmonary vascular structure showed characteristic wall thickening and lumen reduction in hypoxic wild-type mice, with similar changes observed in CREB alpha Delta. CREB alpha Delta mice had larger lungs with reduced epithelial surface density suggesting increased pulmonary compliance. These findings show that alpha and Delta isoforms of CREB1 regulate homeostatic gene expression in the lung and that normal activity of these isoforms is essential to maintain low pulmonary vascular resistance in both normoxic and hypoxic conditions and to maintain the normal alveolar structure. Interventions that enhance the actions of alpha and Delta isoforms of CREB1 warrant further investigation in hypoxic lung diseases.	[Li, Lili; Howell, Katherine; Sands, Michelle; Banahan, Mark; Frohlich, Stephen; Rowan, Simon C.; Neary, Roisin; McLoughlin, Paul] Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 2, Ireland; [Frohlich, Stephen; Ryan, Donal] St Vincents Univ Hosp, Dept Anaesthesia & Crit Care, Dublin 4, Ireland	University College Dublin; University College Dublin; Saint Vincent's University Hospital	McLoughlin, P (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 2, Ireland.	Paul.mcloughlin@ucd.ie	Rowan, Simon Coyle/AAO-1549-2020; Wang, Chunmei/J-2423-2013	Rowan, Simon Coyle/0000-0002-4103-4421; Wang, Chunmei/0000-0003-4615-0517; McLoughlin, Paul/0000-0001-6200-016X	Health Research Board, Ireland; Science Foundation Ireland; St Vincent's Hospital Anaesthesia Foundation; Medical Research Council [MC_UP_1202/4] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R03CA165122, R01CA136606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK026743] Funding Source: NIH RePORTER	Health Research Board, Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); St Vincent's Hospital Anaesthesia Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funding from the Health Research Board, Ireland (www.hrb.ie), Science Foundation Ireland (www.sfi.ie) and St Vincent's Hospital Anaesthesia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki F, 2005, AM J RESP CRIT CARE, V172, P713, DOI 10.1164/rccm.200412-1620OC; Beitner-Johnson D, 1998, J BIOL CHEM, V273, P19834, DOI 10.1074/jbc.273.31.19834; Bierer R, 2011, AM J PHYSIOL-LUNG C, V301, pL872, DOI 10.1152/ajplung.00405.2010; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Cadogan E, 1999, AM J PHYSIOL-LUNG C, V277, pL616, DOI 10.1152/ajplung.1999.277.3.L616; Cahill E, 2012, EXP PHYSIOL, V97, P796, DOI 10.1113/expphysiol.2012.065474; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Costa M, 2001, EUR J BIOCHEM, V268, P987, DOI 10.1046/j.1432-1327.2001.01957.x; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; Dimova E, 2007, THROMB HAEMOSTASIS, V98, P296, DOI 10.1160/TH07-02-0140; Eberhardt W, 2002, KIDNEY INT, V62, P809, DOI 10.1046/j.1523-1755.2002.00538.x; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Fagan KA, 2004, AM J PHYSIOL-LUNG C, V287, pL656, DOI 10.1152/ajplung.00090.2003; Fediuk J, 2012, AM J PHYSIOL-LUNG C, V302, pL13, DOI 10.1152/ajplung.00016.2011; Fonseca C, 2011, AM J RESP CELL MOL, V44, P1, DOI 10.1165/rcmb.2009-0388TR; Frohlich S, 2013, AM J RESP CELL MOL, V48, P271, DOI 10.1165/rcmb.2012-0137TR; Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; Garat CV, 2010, J CARDIOVASC PHARM, V55, P469, DOI 10.1097/FJC.0b013e3181d64dbe; Grossmann C, 2010, FASEB J, V24, P2010, DOI 10.1096/fj.09-146985; Hai CM, 2005, J APPL PHYSIOL, V98, P1356, DOI 10.1152/japplphysiol.00834.2004; HAKIM TS, 1982, J APPL PHYSIOL, V53, P1110, DOI 10.1152/jappl.1982.53.5.1110; Hardy CL, 2013, THORAX, V68, P9, DOI 10.1136/thoraxjnl-2011-201128; Hopkins N, 2002, J ANAT, V201, P335, DOI 10.1046/j.1469-7580.2002.00096.x; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Howell K, 2009, AM J PHYSIOL-LUNG C, V296, pL1042, DOI 10.1152/ajplung.90327.2008; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Hyvelin JM, 2005, CIRC RES, V97, P185, DOI 10.1161/01.RES.0000174287.17953.83; Hyvelin JM, 2004, AM J PHYSIOL-LUNG C, V287, pL673, DOI 10.1152/ajplung.00331.2003; Illi B, 2000, CIRC RES, V86, pE110; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Klemm DJ, 2011, J CARDIOVASC PHARM, V58, P181, DOI 10.1097/FJC.0b013e31821f2773; Kvietikova I, 1997, KIDNEY INT, V51, P564, DOI 10.1038/ki.1997.80; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Kwapiszewska G, 2012, AM J PATHOL, V181, P2018, DOI 10.1016/j.ajpath.2012.08.028; Leonard MO, 2008, AM J RESP CRIT CARE, V178, P977, DOI 10.1164/rccm.200712-1890OC; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; MARTORANA PA, 1990, AM REV RESPIR DIS, V142, P333, DOI 10.1164/ajrccm/142.2.333; MARTORANA PA, 1989, AM REV RESPIR DIS, V139, P226, DOI 10.1164/ajrccm/139.1.226; McLoughlin P, 2011, COMPR PHYSIOL, V1, P1473, DOI 10.1002/cphy.c100034; Meyuhas R, 2008, MOL CANCER RES, V6, P1397, DOI 10.1158/1541-7786.MCR-07-2086; MORI Y, 1993, J BIOL CHEM, V268, P26482; Nagaoka T, 2004, AM J PHYSIOL-LUNG C, V287, pL665, DOI 10.1152/ajplung.00050.2003; Nakayama K, 2013, J BIOL CHEM; Rich S, 2003, CIRCULATION, V108, P2184, DOI 10.1161/01.CIR.0000094397.19932.78; Robertson TP, 2000, BRIT J PHARMACOL, V131, P5, DOI 10.1038/sj.bjp.0703537; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Signorelli S, 2010, CELL PHYSIOL BIOCHEM, V25, P135, DOI 10.1159/000272066; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Tokunou T, 2003, CIRCULATION, V108, P1246, DOI 10.1161/01.CIR.0000085164.13439.89; West JB, 2004, ANN INTERN MED, V141, P789, DOI 10.7326/0003-4819-141-10-200411160-00010; Winters SJ, 2007, MOL CELL ENDOCRINOL, V271, P45, DOI 10.1016/j.mce.2007.03.006; Yndestad A, 2009, J APPL PHYSIOL, V106, P1356, DOI 10.1152/japplphysiol.90719.2008; Zhang S, 2004, AM J PHYSIOL-CELL PH, V287, pC1192, DOI 10.1152/ajpcell.00158.2004	58	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e80637	10.1371/journal.pone.0080637	http://dx.doi.org/10.1371/journal.pone.0080637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349008	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200009
J	Tagliati, F; Gagliano, T; Gentilin, E; Minoia, M; Mole, D; Uberti, ECD; Zatelli, MC				Tagliati, Federico; Gagliano, Teresa; Gentilin, Erica; Minoia, Mariella; Mole, Daniela; Uberti, Ettore C. Delgi; Zatelli, Maria Chiara			Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines	PLOS ONE			English	Article							HORMONE-RELEASING-HORMONE; PROTEIN IMPORT MOTOR; IN-VITRO; PRESEQUENCE TRANSLOCASE; ANTERIOR-PITUITARY; THYROID-CARCINOMA; GROWTH; EXPRESSION; MITOCHONDRIA; RECEPTOR	Magmas is a nuclear gene that encodes for the mitochondrial import inner membrane translocase subunit Tim16. Magmas is overexpressed in the majority of human pituitary adenomas and in a mouse ACTH-secreting pituitary adenoma cell line. Here we report that Magmas is highly expressed in two out of four rat pituitary adenoma cell lines and its expression levels inversely correlate to the extent of cellular response to staurosporine in terms of apoptosis activation and cell viability. Magmas over-expression in rat GH/PRL-secreting pituitary adenoma GH4C1 cells leads to an increase in cell viability and to a reduction in staurosporine-induced apoptosis and DNA fragmentation, in parallel with the increase in Magmas protein expression. These results indicate that Magmas plays a pivotal role in response to pro-apoptotic stimuli and confirm and extend the finding that Magmas protects pituitary cells from staurosporine-induced apoptosis, suggesting its possible involvement in pituitary adenoma development.	[Tagliati, Federico; Gagliano, Teresa; Gentilin, Erica; Minoia, Mariella; Mole, Daniela; Uberti, Ettore C. Delgi; Zatelli, Maria Chiara] Univ Ferrara, Endocrinol Sect, Dept Med Sci, I-44100 Ferrara, Italy; [Gentilin, Erica; Uberti, Ettore C. Delgi; Zatelli, Maria Chiara] Univ Ferrara, Lab Rete Tecnopolo Tecnol Terapie Avanzate LTTA, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara	Zatelli, MC (corresponding author), Univ Ferrara, Endocrinol Sect, Dept Med Sci, I-44100 Ferrara, Italy.	ztlmch@unife.it	Gentilin, Erica/K-9044-2017; Zatelli, Maria Chiara/Y-1160-2019; Gagliano, Teresa/G-1645-2015; Zatelli, Maria Chiara/U-2649-2018	Gentilin, Erica/0000-0003-3198-6506; Gagliano, Teresa/0000-0002-4877-6292; degli Uberti, Ettore/0000-0002-9441-7223; Zatelli, Maria Chiara/0000-0001-8408-7796	Italian Ministry of Education, Research and University [FIRB RBAP11884M, RBAP1153LS]; Fondazione Cassa di Risparmio di Ferrara; Associazione Italiana per la Ricerca sul Cancro (AIRC)	Italian Ministry of Education, Research and University(Ministry of Education, Universities and Research (MIUR)); Fondazione Cassa di Risparmio di Ferrara(Fondazione Carife); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Ministry of Education, Research and University (FIRB RBAP11884M and RBAP1153LS); Fondazione Cassa di Risparmio di Ferrara; and from Associazione Italiana per la Ricerca sul Cancro (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom E, 1998, ENDOCRINOLOGY, V139, P2465, DOI 10.1210/en.139.5.2465; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Bondanelli M, 2003, NEUROENDOCRINOLOGY, V77, P380, DOI 10.1159/000071310; Candolfi M, 2006, FRONT HORM RES, V35, P9, DOI 10.1159/000094260; Candolfi M, 2002, ENDOCRINOLOGY, V143, P3611, DOI 10.1210/en.2002-220377; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; Fusco A, 2008, J CLIN ENDOCR METAB, V93, P2746, DOI 10.1210/jc.2008-0126; Gentilin E, 2013, J ENDOCRINO IN PRESS; Gentilin E, 2013, ENDOCRINOLOGY, V154, P1690, DOI 10.1210/en.2012-2070; GOEBEL HH, 1980, ACTA NEUROCHIR, V51, P195, DOI 10.1007/BF01406745; Goemans CG, 2008, CELL DEATH DIFFER, V15, P545, DOI 10.1038/sj.cdd.4402290; Guo Y, 2004, J BIOL CHEM, V279, P24813, DOI 10.1074/jbc.M402049200; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Jubinsky PT, 2005, J MOL HISTOL, V36, P69, DOI 10.1007/s10735-004-3840-8; Jubinsky PT, 2003, J HISTOCHEM CYTOCHEM, V51, P585, DOI 10.1177/002215540305100504; Jubinsky PT, 2001, EXP HEMATOL, V29, P1392, DOI 10.1016/S0301-472X(01)00749-4; Lee M, 2011, MOL CANCER THER, V10, P1450, DOI 10.1158/1535-7163.MCT-11-0188; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Minoia M, 2012, J CLIN ENDOCR METAB, V97, pE907, DOI 10.1210/jc.2011-3340; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Molatore S, 2010, HUM MUTAT, V31, pE1825, DOI 10.1002/humu.21354; Nicolier M, 2009, BIOL CELL, V101, P455, DOI 10.1042/BC20080164; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Pais JE, 2011, MOL BIOL CELL, V22, P4740, DOI 10.1091/mbc.E11-08-0715; Peng Jianbin, 2005, In Silico Biology, V5, P251; Roy S, 2012, FASEB J, V26, P3822, DOI 10.1096/fj.11-193540; Saeger W, 2007, EUR J ENDOCRINOL, V156, P203, DOI 10.1530/eje.1.02326; Short MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039428; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Tafani M, 2011, CANCER RES, V61, P2459; Tagliati F, 2006, ENDOCRINOLOGY, V147, P3530, DOI 10.1210/en.2005-1479; Tagliati F, 2010, ENDOCRINOLOGY, V151, P4635, DOI 10.1210/en.2010-0441; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Yang QH, 2007, J PINEAL RES, V42, P172, DOI 10.1111/j.1600-079X.2006.00403.x; Zatelli C, 2005, J MOL ENDOCRINOL, V35, P333, DOI 10.1677/jme.1.01876; Zatelli MC, 2007, ENDOCR-RELAT CANCER, V14, P1029, DOI 10.1677/ERC-07-0114; Zatelli MC, 2007, ENDOCR-RELAT CANCER, V14, P91, DOI 10.1677/ERC-06-0026; Zatelli MC, 2009, EUR J ENDOCRINOL, V161, P467, DOI 10.1530/EJE-09-0353; Zatelli MC, 2009, J CLIN ENDOCR METAB, V94, P3931, DOI 10.1210/jc.2009-1026; Zatelli MC, 2005, J CLIN ENDOCR METAB, V90, P2104, DOI 10.1210/jc.2004-2156; Zhan XQ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-13	42	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75194	10.1371/journal.pone.0075194	http://dx.doi.org/10.1371/journal.pone.0075194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24069394	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300074
J	Song, Y; Garg, S; Girotra, M; Maddox, C; von Rosenvinge, EC; Dutta, A; Dutta, S; Fricke, WF				Song, Yang; Garg, Shashank; Girotra, Mohit; Maddox, Cynthia; von Rosenvinge, Erik C.; Dutta, Anand; Dutta, Sudhir; Fricke, W. Florian			Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; SEQUENCE-ANALYSIS; DISEASE; THERAPY; VANCOMYCIN; COLITIS; DIARRHEA; COMBINATION; SENSITIVITY	Clostridium difficile causes antibiotic-associated diarrhea and pseudomembraneous colitis and is responsible for a large and increasing fraction of hospital-acquired infections. Fecal microbiota transplantation (FMT) is an alternate treatment option for recurrent C. difficile infection (RCDI) refractory to antibiotic therapy. It has recently been discussed favorably in the clinical and scientific communities and is receiving increasing public attention. However, short-and long-term health consequences of FMT remain a concern, as the effects of the transplanted microbiota on the patient remain unknown. To shed light on microbial events associated with RCDI and treatment by FMT, we performed fecal microbiota analysis by 16S rRNA gene amplicon pyrosequencing of 14 pairs of healthy donors and RCDI patients treated successfully by FMT. Post-FMT patient and healthy donor samples collected up to one year after FMT were studied longitudinally, including one post-FMT patient with antibiotic-associated relapse three months after FMT. This analysis allowed us not only to confirm prior reports that RCDI is associated with reduced diversity and compositional changes in the fecal microbiota, but also to characterize previously undocumented post-FMT microbiota dynamics. Members of the Streptococcaceae, Enterococcaceae, or Enterobacteriaceae were significantly increased and putative butyrate producers, such as Lachnospiraceae and Ruminococcaceae were significantly reduced in samples from RCDI patients before FMT as compared to post-FMT patient and healthy donor samples. RCDI patient samples showed more case-specific variations than post-FMT patient and healthy donor samples. However, none of the bacterial groups were invariably associated with RCDI or successful treatment by FMT. Overall microbiota compositions in post-FMT patients, specifically abundances of the above-mentioned Firmicutes, continued to change for at least 16 weeks after FMT, suggesting that full microbiota recovery from RCDI may take much longer than expected based on the disappearance of diarrheal symptoms immediately after FMT.	[Song, Yang; Maddox, Cynthia; Fricke, W. Florian] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Garg, Shashank; Girotra, Mohit; Dutta, Anand; Dutta, Sudhir] Sinai Hosp, Div Gastroenterol, Baltimore, MD 21215 USA; [von Rosenvinge, Erik C.] Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA; [Dutta, Sudhir] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Sinai Hospital of Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Fricke, WF (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	wffricke@som.umaryland.edu	song, yang/P-1033-2015	Garg, Shashank/0000-0001-9917-3021; Song, Haengseok/0000-0002-5027-7310; von Rosenvinge, Erik C./0000-0002-1862-7288; Fricke, W. Florian/0000-0003-1586-0962	Institute for Genome Sciences (IGS), University of Maryland School of Medicine, Baltimore, MD; Division of Gastroenterology, Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD	Institute for Genome Sciences (IGS), University of Maryland School of Medicine, Baltimore, MD; Division of Gastroenterology, Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD	This study or parts thereof were funded by the Institute for Genome Sciences (IGS), University of Maryland School of Medicine, Baltimore, MD and Gastroenterology Research Funds from the Division of Gastroenterology, Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; [Anonymous], 2013, GRID EN STOR; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Berman AL, 2007, J CLIN GASTROENTEROL, V41, P932, DOI 10.1097/01.mcg.0000225685.37465.e7; Borody Thomas J, 2013, Curr Gastroenterol Rep, V15, P337, DOI 10.1007/s11894-013-0337-1; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; BUGGY BP, 1987, J CLIN GASTROENTEROL, V9, P155, DOI 10.1097/00004836-198704000-00009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daneman N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001268; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dutta SK, 2013, GASTROENTEROLO UNPUB; Ebenman B, 2005, TRENDS ECOL EVOL, V20, P568, DOI 10.1016/j.tree.2005.06.011; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Garey KW, 2009, J CLIN GASTROENTEROL, V43, P91, DOI 10.1097/MCG.0b013e31814a4e97; Gorkiewicz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055817; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hamilton MJ, 2013, GUT MICROBES, V4, P125, DOI 10.4161/gmic.23571; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; James White WFF, 2011, NATURE PRECEDINGS; Jangi S, 2010, J PEDIATR GASTR NUTR, V51, P2, DOI 10.1097/MPG.0b013e3181d29767; JOBE BA, 1995, AM J SURG, V169, P480, DOI 10.1016/S0002-9610(99)80199-8; Johnson S, 2007, CLIN INFECT DIS, V44, P846, DOI 10.1086/511870; Johnson S, 2009, ANAEROBE, V15, P290, DOI 10.1016/j.anaerobe.2009.08.004; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; KORUDA MJ, 1990, AM J CLIN NUTR, V51, P685, DOI 10.1093/ajcn/51.4.685; Kump PK, 2013, INFLAMM BOWEL DIS, V19, P2155, DOI 10.1097/MIB.0b013e31829ea325; Lawley B, 2012, GASTROENTEROL CLIN N, V41, P855, DOI 10.1016/j.gtc.2012.08.010; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Ludwig W, 2009, BERGEYS MANUAL SYSTE, V3, P1, DOI DOI 10.1007/978-0-387-68489-5_; Lund-Tonnesen Stein, 1998, Tidsskrift for den Norske Laegeforening, V118, P1027; Maroo S, 2006, GASTROENTEROLOGY, V130, P1311, DOI 10.1053/j.gastro.2006.02.044; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Musa S, 2010, SCAND J GASTROENTERO, V45, P261, DOI 10.3109/00365520903497098; Musher DM, 2007, J ANTIMICROB CHEMOTH, V59, P705, DOI 10.1093/jac/dkl553; Navaneethan U, 2010, WORLD J GASTROENTERO, V16, P4892, DOI 10.3748/wjg.v16.i39.4892; O'Keefe SJD, 2010, WORLD J GASTROENTERO, V16, P139, DOI 10.3748/wjg.v16.i2.139; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Pepin J, 2006, CLIN INFECT DIS, V42, P758, DOI 10.1086/501126; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Pohl JF, 2012, CURR OPIN PEDIATR, V24, P627, DOI 10.1097/MOP.0b013e328355a3e1; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Rivera Emmanuel V, 2003, J Gend Specif Med, V6, P27; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shahinas D, 2012, MBIO, V3, DOI 10.1128/mBio.00338-12; Skraban J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058005; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Vrieze A, 2013, BEST PRACT RES CL GA, V27, P127, DOI 10.1016/j.bpg.2013.03.003; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wettstein A, 2007, 15 GUT UN EUR GAS S1, V39, pA303; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352	70	140	172	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2013	8	11							e81330	10.1371/journal.pone.0081330	http://dx.doi.org/10.1371/journal.pone.0081330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259SK	24303043	Green Submitted, Green Published, gold			2022-12-27	WOS:000327546400060
J	Li, L; Wang, CM; Calvisi, DF; Evert, M; Pilo, MG; Jiang, LJ; Yuneva, M; Chen, X				Li, Lei; Wang, Chunmei; Calvisi, Diego F.; Evert, Matthias; Pilo, Maria G.; Jiang, Lijie; Yuneva, Mariia; Chen, Xin			SCD1 Expression Is Dispensable for Hepatocarcinogenesis Induced by AKT and Ras Oncogenes in Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; FATTY-ACID SYNTHASE; HEPATOCELLULAR-CARCINOMA; COMPLEX 1; CANCER; LIVER; ACTIVATION; HYPERTRIGLYCERIDEMIA; CARCINOGENESIS; INTEGRATION	Increased de novo lipogenesis is one of the major metabolic events in cancer. In human hepatocellular carcinoma (HCC), de novo lipogenesis has been found to be increased and associated with the activation of AKT/mTOR signaling. In mice, overexpression of an activated form of AKT results in increased lipogenesis and hepatic steatosis, ultimately leading to liver tumor development. Hepatocarcinogenesis is dramatically accelerated when AKT is co-expressed with an oncogenic form of N-Ras. SCD1, the major isoform of stearoyl-CoA desaturases, catalyzing the conversion of saturated fatty acids (SFA) into monounsaturated fatty acids (MUFA), is a key enzyme involved in de novo lipogenesis. While many studies demonstrated the requirement of SCD1 for tumor cell growth in vitro, whether SCD1 is necessary for tumor development in vivo has not been previously investigated. Here, we show that genetic ablation of SCD1 neither inhibits lipogenesis and hepatic steatosis in AKT-overexpressing mice nor affects liver tumor development in mice co-expressing AKT and Ras oncogenes. Molecular analysis showed that SCD2 was strongly upregulated in liver tumors from AKT/Ras injected SCD1(-/-) mice. Noticeably, concomitant silencing of SCD1 and SCD2 genes was highly detrimental for the growth of AKT/Ras cells in vitro. Altogether, our study provides the evidence, for the first time, that SCD1 expression is dispensable for AKT/mTOR-dependent hepatic steatosis and AKT/Ras-induced hepatocarcinogenesis in mice. Complete inhibition of stearoyl-CoA desaturase activity may be required to efficiently suppress liver tumor development.	[Li, Lei; Wang, Chunmei; Jiang, Lijie; Chen, Xin] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Li, Lei] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430074, Hubei, Peoples R China; [Calvisi, Diego F.; Pilo, Maria G.] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Evert, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Pathol, Greifswald, Germany; [Yuneva, Mariia] Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA; [Chen, Xin] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Huazhong University of Science & Technology; University of Sassari; Ernst Moritz Arndt Universitat Greifswald; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chen, X (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	xin.chen@ucsf.edu	Rowan, Simon Coyle/AAO-1549-2020; Wang, Chunmei/J-2423-2013	Rowan, Simon Coyle/0000-0002-4103-4421; Wang, Chunmei/0000-0003-4615-0517; McLoughlin, Paul/0000-0001-6200-016X	NIH [R01CA136606, R03CA165122]; AIRC [IG12139]; National Natural Science Foundation of China [81201553]; Deutsche Forschungsgemeinschaft [EV 168/2-1]; Government of China through China Scholarship Council (CSC) [2010616508]; Medical Research Council [MC_UP_1202/4] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R03CA165122, R01CA136606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK026743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC(Fondazione AIRC per la ricerca sul cancro); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Government of China through China Scholarship Council (CSC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from NIH R01CA136606, R03CA165122 (to X. C.), AIRC (IG12139 to D. F. C.), National Natural Science Foundation of China (Grant No. 81201553 to Lei Li) and the Deutsche Forschungsgemeinschaft (EV 168/2-1 to M. E.). Lei Li is also supported by the Government of China through China Scholarship Council (CSC) Contract No. 2010616508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046472; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736; Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Luyimbazi D, 2010, MOL CANCER THER, V9, P2770, DOI 10.1158/1535-7163.MCT-09-0980; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; MORRISON WR, 1964, J LIPID RES, V5, P600; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Ntambi JM, 2003, CURR OPIN LIPIDOL, V14, P255, DOI 10.1097/00041433-200306000-00005; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Spangenberg HC, 2009, NAT REV GASTRO HEPAT, V6, P423, DOI 10.1038/nrgastro.2009.86; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026	34	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75104	10.1371/journal.pone.0075104	http://dx.doi.org/10.1371/journal.pone.0075104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24349008	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300066
J	Gridley, DS; Mao, XW; Stodieck, LS; Ferguson, VL; Bateman, TA; Moldovan, M; Cunningham, CE; Jones, TA; Slater, JM; Pecaut, MJ				Gridley, Daila S.; Mao, Xiao Wen; Stodieck, Louis S.; Ferguson, Virginia L.; Bateman, Ted A.; Moldovan, Maria; Cunningham, Christopher E.; Jones, Tamako A.; Slater, Jerry M.; Pecaut, Michael J.			Changes in Mouse Thymus and Spleen after Return from the STS-135 Mission in Space	PLOS ONE			English	Article							PARTICLE EVENT PROTONS; PERIPHERAL-BLOOD LEUKOCYTES; ACTIVATOR INHIBITOR TYPE-2; T-CELL-ACTIVATION; DOSE GAMMA-RAYS; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; MICROGLIAL RESPONSE; CYTOKINE EXPRESSION; APPLIED PHYSIOLOGY	Our previous results with flight (FLT) mice showed abnormalities in thymuses and spleens that have potential to compromise immune defense mechanisms. In this study, the organs were further evaluated in C57BL/6 mice after Space Shuttle Atlantis returned from a 13-day mission. Thymuses and spleens were harvested from FLT mice and ground controls housed in similar animal enclosure modules (AEM). Organ and body mass, DNA fragmentation and expression of genes related to T cells and cancer were determined. Although significance was not obtained for thymus mass, DNA fragmentation was greater in the FLT group (P<0.01). Spleen mass alone and relative to body mass was significantly decreased in FLT mice (P<0.05). In FLT thymuses, 6/84 T cell-related genes were affected versus the AEM control group (P<0.05; up: IL10, Il18bp, Il18r1, Spp1; down: Ccl7, IL6); 15/84 cancer-related genes had altered expression (P<0.05; up: Casp8, FGFR2, Figf, Hgf, IGF1, Itga4, Ncam1, Pdgfa, Pik3r1, Serpinb2, Sykb; down: Cdc25a, E2F1, Mmp9, Myc). In the spleen, 8/84 cancer-related genes were affected in FLT mice compared to AEM controls (P<0.05; up: Cdkn2a; down: Birc5, Casp8, Ctnnb1, Map2k1, Mdm2, NFkB1, Pdgfa). Pathway analysis (apoptosis signaling and checkpoint regulation) was used to map relationships among the cancer-related genes. The results showed that a relatively short mission in space had a significant impact on both organs. The findings also indicate that immune system aberrations due to stressors associated with space travel should be included when estimating risk for pathologies such as cancer and infection and in designing appropriate countermeasures. Although this was the historic last flight of NASA's Space Shuttle Program, exploration of space will undoubtedly continue.	[Gridley, Daila S.; Mao, Xiao Wen; Moldovan, Maria; Cunningham, Christopher E.; Jones, Tamako A.; Slater, Jerry M.; Pecaut, Michael J.] Loma Linda Univ, Dept Basic Sci, Div Radiat Res, Loma Linda, CA 92350 USA; [Stodieck, Louis S.] Univ Colorado, BioServe Space Technol, Boulder, CO 80309 USA; [Ferguson, Virginia L.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Bateman, Ted A.] Univ N Carolina, Dept Bioengn, Chapel Hill, NC USA	Loma Linda University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill	Gridley, DS (corresponding author), Loma Linda Univ, Dept Basic Sci, Div Radiat Res, Loma Linda, CA 92350 USA.	dgridley@llu.edu	Gridley, Daila S/P-7711-2015; Ferguson, Virginia/K-6962-2012; Pecaut, Michael J/P-6481-2015	Ferguson, Virginia/0000-0002-8448-4406; Pecaut, Michael J/0000-0002-2915-9686	NASA [NNX09AQ76G]; LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059221] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by NASA grant NNX09AQ76G and the LLUMC Department of Radiation Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEBBAN Z, 1994, J LEUKOCYTE BIOL, V55, P209, DOI 10.1002/jlb.55.2.209; Allen BJ, 2003, BRIT J CANCER, V88, P944, DOI 10.1038/sj.bjc.6600838; Antalis TM, 1998, J EXP MED, V187, P1799, DOI 10.1084/jem.187.11.1799; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bejarano-Escobar R, 2012, J EXP BIOL, V215, P3799, DOI 10.1242/jeb.072124; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; CHAPES SK, 1992, J LEUKOCYTE BIOL, V52, P104, DOI 10.1002/jlb.52.1.104; Chapes SK, 2004, J GRAVIT PHYSL, V11, P45; Congdon CC, 1996, J APPL PHYSIOL, V81, P172, DOI 10.1152/jappl.1996.81.1.172; Cowley MJ, 2009, MAMM GENOME, V20, P281, DOI 10.1007/s00335-009-9181-x; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Deckbar D, 2011, CRIT REV BIOCHEM MOL, V46, P271, DOI 10.3109/10409238.2011.575764; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2008, P NATL ACAD SCI USA, V105, P15884, DOI 10.1073/pnas.0806089105; Durante M, 2008, NAT REV CANCER, V8, P465, DOI 10.1038/nrc2391; Fedorenko B S, 2010, Aviakosm Ekolog Med, V44, P9; Garcia-Suarez O, 2002, J NEUROIMMUNOL, V129, P25, DOI 10.1016/S0165-5728(02)00166-2; George K, 2010, MUTAT RES-GEN TOX EN, V701, P75, DOI 10.1016/j.mrgentox.2010.02.007; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gridley DS, 2008, IN VIVO, V22, P159; Gridley DS, 2008, RADIAT RES, V169, P280, DOI 10.1667/RR1155.1; Gridley DS, 2013, INT J RADIAT BIOL, V89, P26, DOI 10.3109/09553002.2012.715792; Gridley DS, 2010, TECHNOL CANCER RES T, V9, P637, DOI 10.1177/153303461000900612; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Gridley DS, 2003, J APPL PHYSIOL, V94, P2095, DOI 10.1152/japplphysiol.01053.2002; Gridley DS, 2012, J PROTEOM BIOINFORM, V5, P256; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Guo FJ, 2012, MOL BIOL REP, V39, P6923, DOI 10.1007/s11033-012-1519-x; Hatton JP, 1999, FASEB J, V13, pS23, DOI 10.1096/fasebj.13.9001.s23; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Ichiki AT, 1996, J LEUKOCYTE BIOL, V60, P37, DOI 10.1002/jlb.60.1.37; Kajioka EH, 2000, COMPARATIVE MED, V50, P288; Kaneda A, 2012, CANCER RES, V72, P3445, DOI 10.1158/0008-5472.CAN-11-3919; Kaur I, 2008, CLIN VACCINE IMMUNOL, V15, P1523, DOI 10.1128/CVI.00065-08; Kominami R, 2006, CANCER SCI, V97, P575, DOI 10.1111/j.1349-7006.2006.00218.x; Lebsack TW, 2010, J CELL BIOCHEM, V110, P372, DOI 10.1002/jcb.22547; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Mao XW, 2012, RADIAT RES, V178, P118, DOI 10.1667/RR2821.1; Medcalf RL, 2005, FEBS J, V272, P4858, DOI 10.1111/j.1742-4658.2005.04879.x; Mehta SK, 2013, CYTOKINE, V61, P205, DOI 10.1016/j.cyto.2012.09.019; Mehta SK, 2001, J APPL PHYSIOL, V91, P1814, DOI 10.1152/jappl.2001.91.4.1814; MILLER ES, 1995, J APPL PHYSIOL, V78, P810, DOI 10.1152/jappl.1995.78.3.810; Misurova E, 1981, Adv Space Res, V1, P225, DOI 10.1016/0273-1177(81)90265-9; Moeller R, 2012, ASTROBIOLOGY, V12, P457, DOI 10.1089/ast.2011.0739; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Onishi Y, 2004, INT J HEMATOL, V80, P43, DOI 10.1532/IJH97.04061; OPDENAKKER G, 1993, BIOCHEM BIOPH RES CO, V191, P535, DOI 10.1006/bbrc.1993.1251; Ortega MT, 2009, J APPL PHYSIOL, V106, P548, DOI 10.1152/japplphysiol.91138.2008; Pecaut MJ, 2003, J APPL PHYSIOL, V94, P2085, DOI 10.1152/japplphysiol.01052.2002; Pecaut MJ, 2000, AM J PHYSIOL-REG I, V279, pR2072, DOI 10.1152/ajpregu.2000.279.6.R2072; Porter BO, 2000, SEMIN IMMUNOL, V12, P465, DOI 10.1006/smim.2000.0264; Qiu XF, 2010, ONCOL LETT, V1, P579, DOI 10.3892/ol_00000102; Rizvi A, 2011, J RADIAT RES, V52, P701, DOI 10.1269/jrr.10107; Rizvi A, 2011, INT J RADIAT BIOL, V87, P24, DOI 10.3109/09553002.2010.518206; Rodriguez-Galan MC, 2005, J IMMUNOL, V174, P2796, DOI 10.4049/jimmunol.174.5.2796; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Santos AM, 2010, J COMP NEUROL, V518, P477, DOI 10.1002/cne.22227; Schieke SM, 2012, J CUTAN PATHOL, V39, P540, DOI 10.1111/j.1600-0560.2012.01874.x; Sekai M, 2013, MOL IMMUNOL, V54, P378, DOI 10.1016/j.molimm.2013.01.002; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; SONNENFELD G, 1993, J LEUKOCYTE BIOL, V54, P253, DOI 10.1002/jlb.54.3.253; SONNENFELD G, 1992, J APPL PHYSIOL, V73, pS191, DOI 10.1152/jappl.1992.73.2.S191; Stacchini A, 2012, HISTOPATHOLOGY, V60, P452, DOI 10.1111/j.1365-2559.2011.04098.x; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stowe RP, 2011, J MED VIROL, V83, P1071, DOI 10.1002/jmv.22079; Stowe RP, 2003, AVIAT SPACE ENVIR MD, V74, P1281; Sun XQ, 2009, BEHAV BRAIN RES, V199, P197, DOI 10.1016/j.bbr.2008.11.035; Surova O, 2012, ONCOGENE; Terada T, 2012, WORLD J GASTROENTERO, V18, P1545, DOI 10.3748/wjg.v18.i13.1545; Tian J, 2010, J APPL PHYSIOL, V108, P162, DOI 10.1152/japplphysiol.00730.2009; Tian J, 2009, RADIAT RES, V172, P30, DOI 10.1667/RR1670.1; Uva BM, 2005, J ENDOCRINOL INVES S, V11, P84; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Wang KX, 2007, P NATL ACAD SCI USA, V104, P14777, DOI 10.1073/pnas.0703236104; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	81	53	58	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75097	10.1371/journal.pone.0075097	http://dx.doi.org/10.1371/journal.pone.0075097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24116253	Green Published, gold, Green Submitted			2022-12-27	WOS:000324777300065
J	Shin, H; Song, H; Suh, CS; Lim, HJ				Shin, Hyejin; Song, Haengseok; Suh, Chang Suk; Lim, Hyunjung Jade			The Formin Protein mDia2 Serves as a Marker of Spindle Pole Dynamics in Vitrified-Warmed Mouse Oocytes	PLOS ONE			English	Article							POLARIZED-LIGHT MICROSCOPY; LIVING HUMAN OOCYTES; MEIOTIC SPINDLE; DEVELOPMENTAL COMPETENCE; THAWED OOCYTES; GAMMA-TUBULIN; CRYOPRESERVATION; VITRIFICATION; MICROTUBULES; ORGANIZATION	The mouse diaphanous 2 (mDia2) protein belongs to the formin family and has been shown to nucleate actin filaments and stabilize microtubules, thus indicating a role in cytoskeleton organization. Our previous study, which showed that mDia2 specifically localizes to spindle poles of metaphase I mouse oocytes and NIH3T3 cells, provided the first evidence of its spindle pole-associated cellular function. In the present study, we aim to determine whether spindle pole proteins, such as mDia2 and pericentrin, can be used to monitor the status of spindle poles in cryopreserved mouse oocytes. We show herein that mDia2 exhibits an overlapping distribution with pericentrin, which is a crucial component of centrosomes and microtubule organizing centers (MTOCs). In vitrified-warmed oocytes, the overlapping distribution of mDia2 and pericentrin was immediately detected after thawing, thereby suggesting that mDia2 maintains a tight association with the spindle pole machinery. Interestingly, we observed that microtubules extend from mDia2 clusters in cytoplasmic MTOCs after thawing. This result suggests that mDia2 is a major MTOC component that is closely associated with pericentrin and that it plays a role in microtubule growth from MTOCs. Collectively, our results provide evidence that mDia2 is a novel marker of spindle pole dynamics before and after cryopreservation.	[Shin, Hyejin; Lim, Hyunjung Jade] Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea; [Song, Haengseok] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul, South Korea; [Suh, Chang Suk] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Songnam, South Korea	Konkuk University; Pochon Cha University; Seoul National University (SNU)	Lim, HJ (corresponding author), Konkuk Univ, Inst Biomed Sci & Technol, Dept Biomed Sci & Technol, Seoul, South Korea.	hlim@konkuk.ac.kr	song, yang/P-1033-2015	Garg, Shashank/0000-0001-9917-3021; Song, Haengseok/0000-0002-5027-7310; von Rosenvinge, Erik C./0000-0002-1862-7288; Fricke, W. Florian/0000-0003-1586-0962	Ministry of Health & Welfare, Republic of Korea [HI12C0055]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0055) (https://www.htdream.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Bromfield JJ, 2009, HUM REPROD, V24, P2114, DOI 10.1093/humrep/dep182; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; Cha Soo Kyung, 2011, Clin Exp Reprod Med, V38, P24, DOI 10.5653/cerm.2011.38.1.24; CHEN C, 1986, LANCET, V1, P884, DOI 10.1016/S0140-6736(86)90989-X; Chen CK, 2004, FERTIL STERIL, V82, P666, DOI 10.1016/j.fertnstert.2003.12.053; Ciotti PM, 2009, FERTIL STERIL, V91, P2399, DOI 10.1016/j.fertnstert.2008.03.013; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Cui XS, 2013, REPROD FERT DEVELOP, V25, P691, DOI 10.1071/RD12138; DIDION BA, 1990, J ANIM SCI, V68, P2803; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; George MA, 1996, MOL HUM REPROD, V2, P445, DOI 10.1093/molehr/2.6.445; Gomes CM, 2008, FERTIL STERIL, V90, P1396, DOI 10.1016/j.fertnstert.2007.08.025; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Jo JW, 2011, FERTIL STERIL, V96, P1239, DOI 10.1016/j.fertnstert.2011.08.023; Kwon Sojung, 2011, Clin Exp Reprod Med, V38, P1, DOI 10.5653/cerm.2011.38.1.1; Kwon S, 2011, MOL HUM REPROD, V17, P317, DOI 10.1093/molehr/gaq088; Lammers M, 2008, J BIOL CHEM, V283, P35236, DOI 10.1074/jbc.M805634200; LANZENDORF SE, 1990, BIOL REPROD, V42, P703, DOI 10.1095/biolreprod42.4.703; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li HB, 2008, NAT CELL BIOL, V10, P1301, DOI 10.1038/ncb1788; MANDELBAUM J, 1988, HUM REPROD, V3, P117, DOI 10.1093/oxfordjournals.humrep.a136642; Moon JH, 2005, HUM REPROD, V20, P2207, DOI 10.1093/humrep/dei044; Moon JH, 2003, HUM REPROD, V18, P817, DOI 10.1093/humrep/deg165; Otoi T, 1997, CRYOBIOLOGY, V34, P36, DOI 10.1006/cryo.1996.1988; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Sereni E, 2009, REPROD BIOMED ONLINE, V19, P191, DOI 10.1016/S1472-6483(10)60071-5; Wang WH, 2001, HUM REPROD, V16, P2374, DOI 10.1093/humrep/16.11.2374; WHITTINGHAM DG, 1977, J REPROD FERTIL, V49, P89, DOI 10.1530/jrf.0.0490089; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	39	140	172	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75729	10.1371/journal.pone.0075729	http://dx.doi.org/10.1371/journal.pone.0075729			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24303043	Green Submitted, Green Published, gold			2022-12-27	WOS:000324777300094
J	Martin, RM; Patel, R; Oken, E; Thompson, J; Zinovik, A; Kramer, MS; Vilchuck, K; Bogdanovich, N; Sergeichick, N; Foo, Y; Gusina, N				Martin, Richard M.; Patel, Rita; Oken, Emily; Thompson, Jennifer; Zinovik, Alexander; Kramer, Michael S.; Vilchuck, Konstantin; Bogdanovich, Natalia; Sergeichick, Natalia; Foo, Ying; Gusina, Nina			Filter Paper Blood Spot Enzyme Linked Immunoassay for Adiponectin and Application in the Evaluation of Determinants of Child Insulin Sensitivity	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PLASMA ADIPONECTIN; MYOCARDIAL-INFARCTION; RESISTANCE; OBESITY; SAMPLES; FAT; SEX; OVERWEIGHT; ADIPOSITY	Background: Adiponectin is an adipocyte-derived hormone that acts as a marker of insulin sensitivity. Bloodspot sampling by fingerstick onto filter paper may increase the feasibility of large-scale studies of the determinants of insulin sensitivity. We first describe the validation of an enzyme-linked immunoassay (ELISA) for quantifying adiponectin from dried blood spots and then demonstrate its application in a large trial (PROBIT). Methods: We quantified adiponectin from 3-mm diameter discs (approximate to 3 mu L of blood) punched from dried blood spots obtained from: i) whole blood standards (validation); and ii) PROBIT trial samples (application) in which paediatricians collected blood spots from 13,879 children aged 11.5 years from 31 sites across Belarus. We examined the distribution of bloodspot adiponectin by demographic and anthropometric factors, fasting insulin and glucose. Results: In the validation study, mean intra-assay coefficients of variation (n = 162) were 15%, 13% and 10% for 'low' (6.78 mg/ml), 'medium' (18.18 mg/ml) and 'high' (33.13 mg/ml) internal quality control (IQC) samples, respectively; the respective inter-assay values (n = 40) were 23%, 21% and 14%. The correlation coefficient between 50 paired whole bloodspot versus plasma samples, collected simultaneously, was 0.87 (95% CI: 0.78 to 0.93). Recovery of known quantities of adiponectin (between 4.5 to 36 mu g/ml) was 100.3-133%. Bloodspot adiponectin was stable for at least 30 months at -80 degrees C. In PROBIT, we successfully quantified fasting adiponectin from dried blood spots in 13,329 of 13,879 (96%) children. Mean adiponectin (standard deviation) concentrations were 17.34 mu g/ml (7.54) in boys and 18.41 mu g/ml (7.92) in girls and were inversely associated with body mass index, fat mass, triceps and subscapular skin-fold thickness, waist circumference, height and fasting glucose. Conclusions: Bloodspot ELISA is suitable for measuring adiponectin in very small volumes of blood collected on filter paper and can be applied to large-scale studies.	[Martin, Richard M.; Patel, Rita; Foo, Ying] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Martin, Richard M.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Martin, Richard M.] Univ Bristol, Univ Hosp Bristol NHS Fdn Trust, Natl Inst Hlth Res Bristol, Nutr Biomed Res Unit, Bristol, Avon, England; [Oken, Emily; Thompson, Jennifer] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Oken, Emily; Thompson, Jennifer] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Zinovik, Alexander; Vilchuck, Konstantin; Bogdanovich, Natalia; Sergeichick, Natalia; Gusina, Nina] Natl Res & Appl Med Mother & Child Ctr, Minsk, BELARUS; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada	University of Bristol; University of Bristol; University of Bristol; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; McGill University; McGill University	Martin, RM (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	richard.martin@bristol.ac.uk		Poynter, Matthew/0000-0002-7578-4570; Lundblad, Lennart/0000-0002-1749-8242; Ather, Jennifer/0000-0003-0484-5599; Hoyt, Laura/0000-0002-0350-4154	European Union [FOOD-DT-2005-007036]; Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research [MOP - 53155]; USA National Institutes of Health [R01 HD 050758]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050758] Funding Source: NIH RePORTER	European Union(European Commission); Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by European Union, grant no. FOOD-DT-2005-007036; Early Nutrition Programming: Long-term Efficacy and Safety Trials; Canadian Institutes of Health Research (MOP - 53155); and the USA National Institutes of Health (reference: R01 HD 050758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asayama K, 2003, OBES RES, V11, P1072, DOI 10.1038/oby.2003.147; Bacha F, 2004, DIABETES CARE, V27, P547, DOI 10.2337/diacare.27.2.547; Barker DJP, 1998, MOTHERS BABIES HLTH; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Cho E, 2002, J AM COLL CARDIOL, V40, P954, DOI 10.1016/S0735-1097(02)02044-2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cruz M, 2004, DIABETES CARE, V27, P1451, DOI 10.2337/diacare.27.6.1451; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Klamer A, 2007, EUR J ENDOCRINOL, V157, P189, DOI 10.1530/EJE-06-0710; Kuh D, 1997, LIFE COURSE APPROACH; Lawlor DA, 2002, BMJ-BRIT MED J, V325, P359, DOI 10.1136/bmj.325.7360.359; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lynch JF, 1998, MED J AUSTRALIA, V168, P61, DOI 10.5694/j.1326-5377.1998.tb126712.x; Martin RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046752; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; McDowell MA, 2010, ANTHROPOMETRIC REFER; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; National Committee for Clinical Laboratory Standards (NCCLS), 1997, A4A3 NCCLS; Okada T, 2006, ATHEROSCLEROSIS, V188, P179, DOI 10.1016/j.atherosclerosis.2005.10.030; Ong KK, 2006, DIABETES, V55, P1337, DOI 10.2337/db05-1272; Parker SP, 1999, J CLIN PATHOL, V52, P633, DOI 10.1136/jcp.52.9.633; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Punthakee Z, 2006, J CLIN ENDOCR METAB, V91, P2119, DOI 10.1210/jc.2005-2346; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Shand BI, 2003, DIABETES OBES METAB, V5, P349, DOI 10.1046/j.1463-1326.2003.00279.x; Singhal A, 2005, J CLIN ENDOCR METAB, V90, P4615, DOI 10.1210/jc.2005-0131; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Smith GD, 1997, LANCET, V349, P284, DOI 10.1016/S0140-6736(05)64894-5; Stefan N, 2002, J CLIN ENDOCR METAB, V87, P4652, DOI 10.1210/jc.2002-020694; Tsao TS, 2002, EUR J PHARMACOL, V440, P213, DOI 10.1016/S0014-2999(02)01430-9; Tsou PL, 2004, DIABETES CARE, V27, P308, DOI 10.2337/diacare.27.2.308; WARNICK GR, 1994, ARCH PATHOL LAB MED, V118, P1110; Weiss R, 2003, J CLIN ENDOCR METAB, V88, P2014, DOI 10.1210/jc.2002-021711; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Williams SR, 2009, J GERONTOL B; Worthman CM, 1997, AM J PHYS ANTHROPOL, V104, P1	45	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2013	8	8							e71315	10.1371/journal.pone.0071315	http://dx.doi.org/10.1371/journal.pone.0071315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219PB	23936498	Green Published, Green Submitted, gold			2022-12-27	WOS:000324518400101
J	McGarry, LJ; Krishnarajah, G; Hill, G; Skornicki, M; Pruttivarasin, N; Masseria, C; Arondekar, B; Pelton, SI; Weinstein, MC				McGarry, Lisa J.; Krishnarajah, Girishanthy; Hill, Gregory; Skornicki, Michelle; Pruttivarasin, Narin; Masseria, Cristina; Arondekar, Bhakti; Pelton, Stephen I.; Weinstein, Milton C.			Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; VACCINE; POPULATION; AGE; US	Objectives: Health benefits and costs of combined reduced-antigen-content tetanus, diphtheria, and pertussis (Tdap) immunization among adults >= 65 years have not been evaluated. In February 2012, the Advisory Committee on Immunization Practices (ACIP) recommended expanding Tdap vaccination (one single dose) to include adults >= 65 years not previously vaccinated with Tdap. Our study estimated the health and economic outcomes of one-time replacement of the decennial tetanus and diphtheria (Td) booster with Tdap in the 10% of individuals aged 65 years assumed eligible each year compared with a baseline scenario of continued Td vaccination. Methods: We constructed a model evaluating the cost-effectiveness of vaccinating a cohort of adults aged 65 with Tdap, by calculating pertussis cases averted due to direct vaccine effects only. Results are presented from societal and payer perspectives for a range of pertussis incidences (25-200 cases per 100,000), due to the uncertainty in estimating true annual incidence. Cases averted were accrued throughout the patient's lifetime, and a probability tree used to estimate the clinical outcomes and costs (US$ 2010) for each case. Quality-adjusted life-years (QALYs) lost to acute disease were calculated by multiplying cases of mild/moderate/severe pertussis by the associated health-state disutility; QALY losses due to death and long-term sequelae were also considered. Incremental costs and QALYs were summed over the cohort to derive incremental cost-effectiveness ratios. Scenario analyses evaluated the effect of alternative plausible parameter estimates on results. Results: At incidence levels of 25, 100, 200 cases/100,000, vaccinating adults aged 65 years costs an additional $336,000, $63,000 and $17,000/QALY gained, respectively. Vaccination has a cost-effectiveness ratio less than $50,000/QALY if pertussis incidence is >116 cases/100,000 from societal and payer perspectives. Results were robust to scenario analyses. Conclusions: Tdap immunization of adults aged 65 years according to current ACIP recommendations is a cost-effective health-care intervention at plausible incidence assumptions.	[McGarry, Lisa J.; Hill, Gregory; Skornicki, Michelle; Pruttivarasin, Narin; Weinstein, Milton C.] OptumInsight, Cambridge, MA USA; [Krishnarajah, Girishanthy; Masseria, Cristina; Arondekar, Bhakti] GlaxoSmithKline, Philadelphia, PA USA; [Pelton, Stephen I.] Boston Univ, Boston, MA 02215 USA; [Weinstein, Milton C.] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA	Optum; GlaxoSmithKline; Boston University; Harvard University; Harvard T.H. Chan School of Public Health	McGarry, LJ (corresponding author), OptumInsight, Cambridge, MA USA.	lisa.mcgarry@ariad.com	Williams, Mathew/G-6140-2016	Williams, Mathew/0000-0001-6117-5208; Mitchard, Edward/0000-0002-5690-4055; Pelton, Stephen/0000-0003-4862-5344; Ryan, Casey/0000-0002-1802-0128	GSK	GSK(GlaxoSmithKline)	Funding for this research was provided by GSK. GSK employees listed as coauthors may have participated in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu B, 2004, HEALTH SERV RES, V39, P627, DOI 10.1111/j.1475-6773.2004.00248.x; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Bureau of Labor Statistics, 2011, CONS PRIC IND; California Department of Public Health, 2011, PERT REP FIG 5 PERT; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Centers for Disease Control and Prevention, 2012, ADV COMM IMM PRACT S; Centers for Disease Control and Prevention, 2011, PERT SUMM VACC REC; Centers for Disease Control and Prevention, 2011, SURV REP TRENDS; Centers for Disease Control and Prevention, 2010, VACC PRIC LIST; Centers for Disease Control and Prevention, 2012, ACIP PROV TDAP REC; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P13; Cortese MM, 2007, AM J PREV MED, V32, P177, DOI 10.1016/j.amepre.2006.10.015; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; de Vries R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013392; Gold MR, 1996, COST EFFECTIVENESS H; Grenfell B, 2011, P NATL ACAD SCI USA, V108, P7279, DOI 10.1073/pnas.1103408108; Hanmer J, 2006, MED DECIS MAKING, V26, P391, DOI 10.1177/0272989X06290497; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989; McDowell Margaret A, 2009, Vital Health Stat 11, P1; Meltzer D, 1997, J HEALTH ECON, V16, P33, DOI 10.1016/S0167-6296(96)00507-3; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; O'Brien JA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-57; PDR Network LLC, 2010, RED BOOK PHARM FUND; Pellissier JM, 2007, VACCINE, V25, P8326, DOI 10.1016/j.vaccine.2007.09.066; Schmitt HJ, 1996, JAMA-J AM MED ASSOC, V275, P37, DOI 10.1001/jama.275.1.37; Smith KJ, 2012, JAMA-J AM MED ASSOC, V307, P804, DOI 10.1001/jama.2012.169; U.S. Bureau of Labor Statistics, 2011, CONS EXP SURV 2010 A; U. S. Bureau of the Census, 2009, AM COMM SURV; US Bureau of Labor Statistics, 2011, CURR POP SURV 2010; US Bureau of Labor Statistics, 2011, EMPL HOURS EARN CURR; Washington State Department of Health, 2012, WEEKL PERT PERT UPD; Wells CD, 2004, DIGEST DIS SCI, V49, P453, DOI 10.1023/B:DDAS.0000020502.46886.c1	35	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e67260	10.1371/journal.pone.0067260	http://dx.doi.org/10.1371/journal.pone.0067260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217DY	24069275	Green Submitted, Green Published, gold			2022-12-27	WOS:000324338200001
J	Cho, YA; Kim, J; Woo, HD; Kang, M				Cho, Young Ae; Kim, Jeongseon; Woo, Hae Dong; Kang, Moonsu			Dietary Cadmium Intake and the Risk of Cancer: A Meta-Analysis	PLOS ONE			English	Article							POSTMENOPAUSAL BREAST-CANCER; BODY IRON STORES; PROSTATE-CANCER; PROSPECTIVE COHORT; TOENAIL CADMIUM; EXPOSURE; POPULATION; WOMEN; HEALTH; ZINC	Background: Diet is a major source of cadmium intake among the non-smoking general population. Recent studies have determined that cadmium exposure may produce adverse health effects at lower exposure levels than previously predicted. We conducted a meta-analysis to combine and analyze the results of previous studies that have investigated the association of dietary cadmium intake and cancer risk. Methods: We searched PubMed, EMBASE, and MEDLINE database for case-control and cohort studies that assessed the association of dietary cadmium intake and cancer risk. We performed a meta-analysis using eight eligible studies to summarize the data and summary relative risks (RRs) and 95% confidence intervals (CIs) were calculated using a random effects model. Results: Overall, dietary cadmium intake showed no statistically significant association with cancer risk (RR = 1.10; 95% CI: 0.99-1.22, for highest vs. lowest dietary cadmium group). However, there was strong evidence of heterogeneity, and subgroup analyses were conducted using the study design, geographical location, and cancer type. In subgroup analyses, the positive associations between dietary cadmium intake and cancer risk were observed among studies with Western populations (RR = 1.15; 95% CI: 1.08-1.23) and studies investigating some hormone-related cancers (prostate, breast, and endometrial cancers). Conclusion: Our analysis found a positive association between dietary cadmium intake and cancer risk among studies conducted in Western countries, particularly with hormone-related cancers. Additional experimental and epidemiological studies are required to verify our findings.	[Cho, Young Ae; Kim, Jeongseon; Woo, Hae Dong] Natl Canc Ctr, Mol Epidemiol Branch, Goyang, South Korea; [Kang, Moonsu] Gangneung Wonju Natl Univ, Dept Informat Stat, Kangnung, South Korea	National Cancer Center - Korea (NCC); Kangnung Wonju National University	Kim, J (corresponding author), Natl Canc Ctr, Mol Epidemiol Branch, Goyang, South Korea.	jskim@ncc.re.kr	KIM, JEONGSEON/AAA-4643-2022; Chun, Jongsik/R-8458-2017	Chun, Jongsik/0000-0003-3385-5171; Shin, Sung Jae/0000-0003-0854-4582; Cho, Yong-Joon/0000-0003-3191-2670; Cho, Young Ae/0000-0001-6076-916X	Korea Food and Drug Administration [10162KFDA994]	Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea)	This research was supported by a grant from Korea Food and Drug Administration (10162KFDA994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2012, CANCER CAUSE CONTROL, V23, P845, DOI 10.1007/s10552-012-9953-6; Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERGLUND M, 1994, ENVIRON HEALTH PERSP, V102, P1058, DOI 10.2307/3431993; Brama M, 2007, MOL CELL ENDOCRINOL, V264, P102, DOI 10.1016/j.mce.2006.10.013; Byrne C, 2009, TOXICOL APPL PHARM, V238, P266, DOI 10.1016/j.taap.2009.03.025; Chen YC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-429; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gallagher CM, 2010, AGING-US, V2, P804, DOI 10.18632/aging.100226; GARCIAMORALES P, 1994, J BIOL CHEM, V269, P16896; Godt J, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-22; International Agency for Research on Cancer, 1993, IARC MON EV CARC RIS, P58; Itoh H, 2013, INT J HYG ENVIR HEAL, DOI [10.1016/j.ijheh.2013.1003.1010, DOI 10.1016/J.IJHEH.2013.1003.1010.PUBMED:23608001]; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jin TY, 2002, BIOMETALS, V15, P397, DOI 10.1023/A:1020229923095; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; Julin B, 2012, BRIT J CANCER, V107, P895, DOI 10.1038/bjc.2012.311; Julin B, 2011, BRIT J CANCER, V105, P441, DOI 10.1038/bjc.2011.238; Julin B, 2012, CANCER RES, V72, P1459, DOI 10.1158/0008-5472.CAN-11-0735; Julin B, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-105; Kristal AR, 2005, CANCER EPIDEM BIOMAR, V14, P2826, DOI 10.1158/1055-9965.EPI-12-ED1; Martin MB, 2002, ENDOCRINOLOGY, V143, P263, DOI 10.1210/en.143.1.263; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; Nagata C, 2013, BREAST CANCER RES TR, V138, P235, DOI 10.1007/s10549-013-2414-4; Nawrot TS, 2010, BIOMETALS, V23, P769, DOI 10.1007/s10534-010-9343-z; Nimptsch K, 2011, CANCER CAUSE CONTROL, V22, P51, DOI 10.1007/s10552-010-9671-x; OGUNLEWE JO, 1989, CANCER, V63, P1388, DOI 10.1002/1097-0142(19890401)63:7<1388::AID-CNCR2820630725>3.0.CO;2-M; Olsson IM, 2002, ENVIRON HEALTH PERSP, V110, P1185, DOI 10.1289/ehp.021101185; Platz EA, 2002, PROSTATE, V52, P288, DOI 10.1002/pros.10115; Reeves PG, 2008, SCI TOTAL ENVIRON, V398, P13, DOI 10.1016/j.scitotenv.2008.03.009; Sawada N, 2012, EPIDEMIOLOGY, V23, P368, DOI 10.1097/EDE.0b013e31824d063c; Smith-Warner SA, 2001, JAMA-J AM MED ASSOC, V285, P769, DOI 10.1001/jama.285.6.769; Strumylaite L, 2011, BREAST CANCER RES TR, V125, P511, DOI 10.1007/s10549-010-1007-8; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; van Wijngaarden E, 2008, PROSTATE, V68, P122, DOI 10.1002/pros.20668; Vinceti M, 2007, SCI TOTAL ENVIRON, V373, P77, DOI 10.1016/j.scitotenv.2006.11.005; Watanabe T, 2000, INT ARCH OCC ENV HEA, V73, P26, DOI 10.1007/PL00007934; WEST DW, 1991, CANCER CAUSE CONTROL, V2, P85, DOI 10.1007/BF00053126; Zhang ZW, 1997, INT ARCH OCC ENV HEA, V69, P273	41	89	91	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e75087	10.1371/journal.pone.0075087	http://dx.doi.org/10.1371/journal.pone.0075087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24312320	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300070
J	Chen, WF; Chang, KP; Chen, CH; Shyu, VBH; Kao, HK				Chen, Wei F.; Chang, Kai-Ping; Chen, Chih-Hao; Shyu, Victor Bong-Hang; Kao, Huang-Kai			Outcomes of Anterolateral Thigh Flap Reconstruction for Salvage Laryngopharyngectomy for Hypopharyngeal Cancer after Concurrent Chemoradiotherapy	PLOS ONE			English	Article							FUNCTIONAL OUTCOMES; PHARYNGOESOPHAGEAL RECONSTRUCTION; CARCINOMA; HEAD; RESECTION	Objective: To evaluate the functional and oncological outcomes of anterolateral thigh flap reconstruction for salvage laryngopharyngectomy after concurrent chemoradiotherapy for patients with hypopharyngeal carcinoma. Materials/Methods: A retrospective review was conducted on patients who underwent pharyngoesophageal reconstruction using anterolateral thigh flap after salvage laryngopharyngectomy for recurrent hypopharyngeal carcinoma between June 2003 and May 2010 at Chang Gung Memorial Hospital. The perioperative morbidity, mortality, functional outcomes, and oncological outcomes were evaluated. Results: 33 patients were entered into the study. The mean follow-up time was 19.5 +/- 12.3 months. Recurrent pathological TNM stages included 3 (9.1%), 2 (6.1%), and 28 (84.8%) patients with stage II, III, and IV disease, respectively. Mean ICU stay was 10.3 days and the mean hospital stay was 39.9 days. Peri-operative mortality occurred in one patient (3%). 16 patients (48.5%) developed recipient site complications. Among them, 14 patients (42.4%) developed fistulas and 9 patients (27.3%) developed strictures. Except for 4 patients (12.1%), all achieved varying degree of oral intake with 29 patients (60.6%) being completely independent from tube feeding. The mean interval to start oral intake was 15.1 days. The 5-year overall survival and disease-free survival rates were 51.8% and 53.7%, respectively. The pN status is an independent predictor of overall survival and disease-free survival (P = 0.027 and 0.038, respectively). Conclusion: Pharyngoesophageal reconstruction after salvage laryngopharyngectomy remains challenging even in the experienced hands. Reconstructive microsurgeons who are prepared to take on these cases should be equally well prepared to manage the potential postoperative complications.	[Chen, Wei F.] Univ Iowa Hosp & Clin, Dept Surg, Div Plast & Reconstruct Surg, Iowa City, IA 52242 USA; [Chang, Kai-Ping] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Chang, Kai-Ping; Chen, Chih-Hao; Shyu, Victor Bong-Hang; Kao, Huang-Kai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Chen, Chih-Hao; Shyu, Victor Bong-Hang; Kao, Huang-Kai] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Tao Yuan, Taiwan	University of Iowa; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Kao, HK (corresponding author), Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Tao Yuan, Taiwan.	kai3488@gmail.com		Chen, Wei/0000-0002-4163-6641; Liu, Jianping/0000-0002-0320-061X; Liu, Bo/0000-0003-3101-650X; Yang, Guoyan (Emily)/0000-0002-8012-2379	NCCIH NIH HHS [R24 AT001293] Funding Source: Medline	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Ali Rozina S, 2009, Plast Reconstr Surg, V124, pe395, DOI 10.1097/PRS.0b013e3181bcf05c; Chan YW, 2011, J PLAST RECONSTR AES, V64, P1022, DOI 10.1016/j.bjps.2011.03.021; Chang MFT, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-91; Chen KT, 2007, PLAST RECONSTR SURG, V120, P187, DOI 10.1097/01.prs.0000264077.07779.50; Chu PY, 2005, HEAD NECK-J SCI SPEC, V27, P901, DOI 10.1002/hed.20262; Guibert M, 2011, EUR ANN OTORHINOLARY, V128, P218, DOI 10.1016/j.anorl.2011.02.010; Kadota H, 2010, LARYNGOSCOPE, V120, P1103, DOI 10.1002/lary.20887; Kao HK, 2009, ORAL ONCOL, V45, P1058, DOI 10.1016/j.oraloncology.2009.07.010; Lewin JS, 2005, LARYNGOSCOPE, V115, P1266, DOI 10.1097/01.MLG.0000165456.01648.B8; Lutz BS, 2005, CLIN PLAST SURG, V32, P421, DOI 10.1016/j.cps.2005.02.006; Murray DJ, 2007, HEAD NECK-J SCI SPEC, V29, P147, DOI 10.1002/hed.20489; Paximadis P, 2012, INT J RADIAT ONCOL, V82, P1515, DOI 10.1016/j.ijrobp.2011.04.064; Relic A, 2009, EUR ARCH OTO-RHINO-L, V266, P1799, DOI 10.1007/s00405-009-0946-3; Sagar B, 2010, J PLAST RECONSTR AES, V63, P970, DOI 10.1016/j.bjps.2009.04.019; Shellenberger TD, 2011, ARCH OTOLARYNGOL, V137, P1086, DOI 10.1001/archoto.2011.177; Takes RP, 2012, HEAD NECK-J SCI SPEC, V34, P270, DOI 10.1002/hed.21613; Tsou YA, 2010, HEAD NECK-J SCI SPEC, V32, P1494, DOI 10.1002/hed.21352; Wang HM, 2002, CANCER, V94, P2989, DOI 10.1002/cncr.10570; Wong CH, 2010, HEAD NECK-J SCI SPEC, V32, P1236, DOI 10.1002/hed.21284; Yu PR, 2006, PLAST RECONSTR SURG, V117, P968, DOI 10.1097/01.prs.0000200622.13312.d3	20	205	209	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2013	8	1							e53985	10.1371/journal.pone.0053985	http://dx.doi.org/10.1371/journal.pone.0053985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069IY	23437162	gold, Green Submitted, Green Published			2022-12-27	WOS:000313429800078
J	Chen, WK; Miao, CH				Chen, Wan-Kun; Miao, Chang-Hong			The Effect of Anesthetic Technique on Survival in Human Cancers: A Meta-Analysis of Retrospective and Prospective Studies	PLOS ONE			English	Article							EPIDURAL-ANESTHESIA; COLORECTAL-CANCER; NEURAXIAL ANESTHESIA; SPINAL-ANESTHESIA; SURGERY; RECURRENCE; ANALGESIA; REDUCTION; ASSOCIATION; MORTALITY	Animal models have shown that regional anesthesia (combined with or without general anesthesia) would attenuate the surgical stress response by preserving immune function and result in better long-term outcome. In order to test the hypothesis that cancer patients who had surgery with epidural anesthesia (EA) would have better outcome (either overall survival [OS] or recurrence-free survival [RFS]) than those who were general anesthesia (GA), we performed this meta-analysis. By searching relevant literature, a total of 14 studies containing 18 sub-studies (seven in OS analysis and eleven in RFS analysis) were identified and meta-analyzed. Adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were used to assess the strength of association. For OS, the random-effects model was used to analyze the data and demonstrated an OS benefit in favor of EA compared with GA alone (HR = 0.84, 95% CI 0.74-0.96, P = 0.013). The influence analysis showed the robustness of the results. Specifically, a significantly positive association between EA and improved OS was observed in colorectal cancer (HR = 0.65, 95% CI 0.43-0.99, P = 0.045). For RFS, the random-effects model was used to analyze the data and no significant relationship between RFS benefit and EA (HR = 0.88, 95% CI 0.64-1.22, P = 0.457) was detected. In conclusion, our meta-analysis suggests that epidural anesthesia and/or analgesia might be associated with improved overall survival in patients with operable cancer undergoing surgery (especially in colorectal cancer), but it does not support an association between epidural anesthesia and cancer control. Prospective studies are needed to determine whether the association between epidural use and survival is causative.	[Chen, Wan-Kun] Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; Fudan Univ, Inst Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Chen, WK (corresponding author), Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	wkchen1981@hotmail.com; miaochh@yahoo.com.cn		Chen, Wei/0000-0002-4163-6641; Liu, Jianping/0000-0002-0320-061X; Liu, Bo/0000-0003-3101-650X; Yang, Guoyan (Emily)/0000-0002-8012-2379	Shanghai Committee of Science and Technology [114119a4400]; NCCIH NIH HHS [R24 AT001293] Funding Source: Medline	Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research is supported by grants from Guide Project of Shanghai Committee of Science and Technology (2011-2013, 114119a4400). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Yosef S, 2001, ANESTHESIOLOGY, V94, P1066, DOI 10.1097/00000542-200106000-00022; BEILIN B, 1989, Brain Behavior and Immunity, V3, P129, DOI 10.1016/0889-1591(89)90013-5; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Christopherson R, 2008, ANESTH ANALG, V107, P325, DOI 10.1213/ane.0b013e3181770f55; Cummings KC, 2012, ANESTHESIOLOGY, V116, P797, DOI 10.1097/ALN.0b013e31824674f6; de Oliveira GS, 2011, REGION ANESTH PAIN M, V36, P271, DOI 10.1097/AAP.0b013e318217aada; ERSKINE R, 1992, CAN J ANAESTH, V39, P905, DOI 10.1007/BF03008337; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Gottschalk A, 2010, ANESTHESIOLOGY, V113, P27, DOI 10.1097/ALN.0b013e3181de6d0d; Gupta A, 2011, BRIT J ANAESTH, V107, P164, DOI 10.1093/bja/aer100; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ismail H, 2010, BRIT J ANAESTH, V105, P145, DOI 10.1093/bja/aeq156; Koodie L, 2010, AM J PATHOL, V177, P984, DOI 10.2353/ajpath.2010.090621; Lai RC, 2012, ANESTH ANALG, V114, P290, DOI 10.1213/ANE.0b013e318239c2e3; Landoni G, 2012, J CARDIOTHOR VASC AN, V26, P764, DOI 10.1053/j.jvca.2012.04.018; Larsson SC, 2010, JAMA-J AM MED ASSOC, V303, P1077, DOI 10.1001/jama.2010.263; LEWIS J W, 1983, Natural Immunity and Cell Growth Regulation, V3, P43; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin L, 2011, BRIT J ANAESTH, V106, P814, DOI 10.1093/bja/aer055; Luo CF, 2010, EUR J ANAESTH, V27, P212, DOI 10.1097/00003643-201006121-00682; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MARKOVIC SN, 1993, ANESTHESIOLOGY, V78, P700, DOI 10.1097/00000542-199304000-00013; Myles PS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1491; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Snyder GL, 2010, BRIT J ANAESTH, V105, P106, DOI 10.1093/bja/aeq164; Tsui BCH, 2010, CAN J ANAESTH, V57, P107, DOI 10.1007/s12630-009-9214-7; Urwin SC, 2000, BRIT J ANAESTH, V84, P450, DOI 10.1093/oxfordjournals.bja.a013468; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Wuethrich PY, 2010, ANESTHESIOLOGY, V113, P570, DOI 10.1097/ALN.0b013e3181e4f6ec; Zhou D, 2012, WORLD J GASTROENTERO, V18, P3089, DOI 10.3748/wjg.v18.i24.3089	31	205	209	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56540	10.1371/journal.pone.0056540	http://dx.doi.org/10.1371/journal.pone.0056540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437162	gold, Green Published, Green Submitted			2022-12-27	WOS:000315184200100
